<SEC-DOCUMENT>0001213900-25-097860.txt : 20251009
<SEC-HEADER>0001213900-25-097860.hdr.sgml : 20251009
<ACCEPTANCE-DATETIME>20251009172004
ACCESSION NUMBER:		0001213900-25-097860
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		133
FILED AS OF DATE:		20251009
DATE AS OF CHANGE:		20251009

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Profusa, Inc.
		CENTRAL INDEX KEY:			0001859807
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				863437271
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-290805
		FILM NUMBER:		251385872

	BUSINESS ADDRESS:	
		STREET 1:		207 WEST 25TH ST, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001
		BUSINESS PHONE:		212-494-9022

	MAIL ADDRESS:	
		STREET 1:		207 WEST 25TH ST, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NorthView Acquisition Corp
		DATE OF NAME CHANGE:	20210429
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>ea0258580-s1_profusa.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 09 20:42:45 UTC 2025 -->
<html xmlns:ck0001859807="http://www.profusa.com/20250630" xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">As filed with the Securities and Exchange Commission on October 9,
2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-________</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-38565">S-1</ix:nonNumeric><br/>
REGISTRATION STATEMENT<br/>
UNDER<br/>
THE SECURITIES ACT OF 1933</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-61"><b>PROFUSA, INC.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(</b>Exact name of registrant as specified
in its charter<b>)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Delaware</b></span></td>
    <td style="white-space: nowrap; width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>3841</b></span></td>
    <td style="white-space: nowrap; width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>26-4589529</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction of <br/>
incorporation or organization)</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Primary Standard Industrial <br/>
Classification Code Number)</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(I.R.S.&#160;Employer <br/>
Identification Number)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>626 Bancroft Way<br/>
Suite A<br/>
Berkeley, CA 94710<br/>
(925) 997-6925<br/>
</b>(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ben C. Hwang</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>626 Bancroft Way<br/>
Suite A</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Berkeley, CA 94710</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(925) 997-6925</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Copies to:</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ralph V. De Martino, Esq.<br/>
Marc Rivera, Esq.<br/>
ArentFox Schiff LLP<br/>
1717 K Street, NW<br/>
Washington, DC 20006<br/>
Phone: (202) 724-6847</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Approximate date of commencement
of proposed sale to the public: </b>As soon as practicable after this registration statement becomes effective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the securities being
registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check
the following box: <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is filed to register
additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging
growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting
company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 6%; padding-bottom: 2.25pt">&#160;</td> <td style="width: 27%; text-align: justify"><span style="font-size: 10pt">Large accelerated filer</span></td> <td style="width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="white-space: nowrap; width: 10%; padding-bottom: 2.25pt">&#160;</td> <td style="width: 27%; text-align: justify"><span style="font-size: 10pt">Accelerated&#160;filer</span></td> <td style="width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-232"><span style="font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="text-align: justify"><span style="font-size: 10pt">Smaller&#160;reporting&#160;company</span></td> <td style="text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="ixv-240"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="text-align: justify"><span style="font-size: 10pt">Emerging&#160;growth&#160;company</span></td> <td style="text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-250"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="ixv-256"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>This registration statement shall hereafter become effective in accordance
with the provisions of Section 8(a) of the Securities Act of 1933.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: Red"><b>The information in
this preliminary prospectus is not complete and may be changed. The selling stockholder may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell, nor does
it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="color: Red"><b>SUBJECT TO COMPLETION, DATED <span style="text-transform: uppercase">october
8</span>, 2025.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="color: Red"><b>PRELIMINARY PROSPECTUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_001.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>42,594,048 Shares of Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to the resale, from time to time, by the Selling
Stockholders identified in this prospectus under the caption &#8220;Selling Stockholders,&#8221; of up to 42,594,048 shares of common
stock, par value $0.0001 per share, of the Company (the &#8220;<span style="text-decoration:underline">Common Stock</span>&#8221;) comprising: (a) up to 42,211,548 shares of
Common Stock by Ascent Partners Fund LLC, whom we refer to in this prospectus as &#8220;Ascent,&#8221; pursuant to a common stock purchase
agreement, dated as of July 28, 2025, we entered into with Ascent, which we refer to in this prospectus as the Purchase Agreement; and
(b) up to 382,500 shares of Common Stock issued to certain parties in satisfaction of transaction costs incurred in connection with the
Business Combination we completed on July 11, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our registration statement,
filed on August 22, 2025 and declared effective on August 25, 2025, we previously registered the resale of up to 8,970,830 shares by Ascent
pursuant to the Purchase Agreement. This prospectus registers the resale of up to an additional 42,211,548 shares of Common Stock (the
&#8220;Purchase Shares&#8221;) that we may, in our sole discretion, elect to sell to Ascent, from time to time over a period of up to
36 months from and after the Effective Date (defined below) pursuant to the Purchase Agreement. Ascent is deemed to be an &#8220;underwriter&#8221;
within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended, or the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering the offer and sale and/or resale of these securities
to satisfy certain registration obligations we have and certain registration rights we have granted. The Selling Stockholders may offer
all or part of the Resale Securities for resale from time to time through public or private transactions, at either prevailing market
prices or at privately negotiated prices. The Resale Securities are being registered to permit the Selling Stockholders to sell Resale
Securities from time to time, in amounts, at prices and on terms determined at the time of offering. The Selling Stockholders may sell
the Resale Securities through ordinary brokerage transactions, in underwritten offerings, directly to market makers of our securities
or through any other means described in the section entitled &#8220;<i>Plan of Distribution</i>&#8221; herein. In connection with any
sales of Resale Securities offered hereunder, the Selling Stockholders, any underwriters, agents, brokers or dealers participating in
such sales may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act, or the Exchange Act. We are registering
the Resale Securities for resale by the Selling Stockholders, or their donees, pledgees, transferees, distributees or other successors<b>-</b>in-interest
selling our Common Stock received after the date of this prospectus from the Selling Stockholders as a gift, pledge, partnership distribution
or other transfer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders may
sell the shares of our common stock offered by this prospectus from time to time on terms to be determined at the time of sale through
ordinary brokerage transactions or through any other means described in this prospectus under the caption <i>&#8220;Plan of Distribution.&#8221;</i>
The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing
market price or at negotiated prices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay the expenses incurred
in registering under the Securities Act the offer and sale of the shares of Common Stock to which this prospectus relates by the Selling
Stockholders, including legal and accounting fees. See <i>&#8220;Plan of Distribution&#160;&#8212;&#160;Offer and Resale of Common Stock
by the Selling Stockholders&#8221;</i> beginning on page&#160;145.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on the Nasdaq Global Market under the symbol &#8220;PFSA.&#8221; On October 7, 2025, the last sale price for our common stock as reported
on the Nasdaq Global Market was $0.33&#160;per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a &#8220;smaller reporting
company&#8221; as defined under the federal securities laws and, as such, have elected to comply with certain reduced public company reporting
requirements for this prospectus and may elect to do so in future filings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Investing in our securities
involves a high degree of risk. See the section entitled </b><i>&#8220;<b><span style="text-decoration:underline">Risk Factors</span></b>&#8221;</i> <b>appearing on page&#160;5&#160;of
this prospectus for a discussion of information that should be considered in connection with an investment in our securities.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Neither the Securities and
Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy
of this prospectus. Any representation to the contrary is a criminal offense.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is__________, 2025</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 90%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_001">ABOUT THIS PROSPECTUS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">ii</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_002">PROSPECTUS SUMMARY</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_003">THE OFFERING</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">4</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_004">RISK FACTORS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_005">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">69</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_006">THE COMMITTED EQUITY FACILITY</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">70</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_007">USE OF PROCEEDS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">75</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_008">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">76</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_009">DIVIDEND POLICY</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">90</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_010">MARKET INFORMATION</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">90</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_011">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS&#160;OF OPERATIONS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">91</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_012">BUSINESS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_013">MANAGEMENT</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">131</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_014">EXECUTIVE COMPENSATION</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">136</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_015">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">138</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_016">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">139</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_017">SELLING STOCKHOLDERS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">143</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_018">PLAN OF DISTRIBUTION</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">145</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_019">DESCRIPTION OF SECURITIES</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">150</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_020">LEGAL MATTERS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">154</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_021">EXPERTS</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">154</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_022">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">154</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt"><a href="#a_023">INDEX TO FINANCIAL INFORMATION</a></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-1</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should rely only on the information contained in this prospectus
or any amendment or supplement to this prospectus. This prospectus is an offer to sell only the securities offered hereby, but only under
the circumstances and in jurisdictions where it is lawful to do so. Neither we nor the Selling Stockholders have authorized anyone to
provide you with information different from that contained in this prospectus or any amendment or supplement to this prospectus. Neither
we nor the Selling Stockholders take any responsibility for, or can provide any assurance as to the reliability of, any information other
than the information in this prospectus or any amendment or supplement to this prospectus. The information in this prospectus or any amendment
or supplement to this prospectus is accurate only as of its date, regardless of the time of delivery of this prospectus or any amendment
or supplement to this prospectus, as applicable, or any sale of the securities offered by this prospectus. Our business, financial condition,
results of operations and prospects may have changed since that date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For Investors Outside the United&#160;States: The Selling Stockholders
are offering to sell, and seeking offers to buy, the securities offered by this prospectus only in jurisdictions where offers and sales
are permitted. Neither we nor the Selling Stockholders have done anything that would permit this offering or the possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than in the United&#160;States. Persons outside
the United&#160;States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating
to, the offering of the securities offered by this prospectus and the distribution of this prospectus outside the United&#160;States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ABOUT THIS PROSPECTUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of a registration statement that we filed with
the SEC.&#160;The Selling Stockholders may, from time to time, sell the securities offered by it described in this prospectus through
any means described in the section titled &#8220;Plan of Distribution.&#8221; We will not receive any proceeds from the sale by the Selling
Stockholders of the securities offered by it described in this prospectus. However, we may receive up to $100,000,000 in aggregate gross
proceeds from Ascent under the Purchase Agreement in connection with sales of our shares of Common Stock to Ascent pursuant to the Purchase
Agreement after the date of this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also file a prospectus
supplement or post-effective amendment to the registration statement of which this prospectus forms a part that may contain material information
relating to these offerings. The prospectus supplement or post-effective amendment may also add, update or change information contained
in this prospectus with respect to that offering. If there is any inconsistency between the information in this prospectus and the applicable
prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable.
Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded
will be deemed not to constitute a part of this prospectus. Before purchasing any securities, you should carefully read this prospectus,
any post-effective amendment, and any applicable prospectus supplement, together with the additional information described under the heading
<i>&#8220;Where You Can Find More Information&#8221;</i> and <i>&#8220;Incorporation of Certain Information by Reference.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus contains summaries
of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete
information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to
herein have been filed, will be filed, or will be incorporated by reference as exhibits to the registration statement of which this prospectus
forms a part, and you may obtain copies of those documents as described below under <i>&#8220;Where You Can Find More Information.&#8221;</i>
You should assume that the information in this prospectus is accurate only as of the date on the front of the document and that any information
we have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of
delivery of this prospectus or any sale of a security.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The distribution of this prospectus
and the issuance of the securities in certain jurisdictions may be restricted by law. Persons outside the United&#160;States who come
into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the issuance of the securities
and the distribution of this prospectus outside the United&#160;States. This prospectus does not constitute, and may not be used in connection
with, an offer to sell, or a solicitation of an offer to buy, the securities offered by this prospectus by any person in any jurisdiction
in which it is unlawful for such person to make such an offer or solicitation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid">

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<a id="a_002"></a><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS SUMMARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>This summary highlights
information contained elsewhere in this prospectus. This summary does not contain all of the information that you should consider before
deciding to invest in our securities. You should read this entire prospectus carefully, including the </i>&#8220;<i><span style="text-decoration:underline">Risk Factors</span></i>&#8221;
<i>section in this prospectus and under similar captions in the documents incorporated by reference into this prospectus. The terms the
</i>&#8220;<i>Company</i>&#8221;<i>, </i>&#8220;<i>our</i>&#8221;<i>, or </i>&#8220;<i>we</i>&#8221; <i>refer to Profusa, Inc. and its
subsidiaries.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, Profusa,
Inc., a Delaware corporation formerly known as NorthView Acquisition Corporation (the &#8220;Company&#8221;), consummated its previously
announced business combination (the &#8220;Business Combination&#8221;) with Profusa, Inc., a California corporation (&#8220;Profusa&#8221;),
pursuant to that certain Merger Agreement and Plan of Reorganization, dated as of November&#160;7, 2022 (as the same has been amended,
supplemented or otherwise modified from time to time, the &#8220;Merger Agreement&#8221;), between the Company, Profusa, and NV Profusa
Merger Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (&#8220;Merger Sub&#8221; and, collectively,
the &#8220;Parties&#8221;). The consummation of the Business Combination involved the merger (the &#8220;Merger&#8221;) of Merger Sub
with and into Profusa, pursuant to which, at the closing of the transactions contemplated by the Merger Agreement (the &#8220;Closing&#8221;),
the separate corporate existence of Merger Sub ceased, with Profusa as the surviving corporation becoming a wholly-owned subsidiary of
the Company, pursuant to the terms of the Merger Agreement and in accordance with the Delaware General Corporation Law (the &#8220;DGCL&#8221;).&#160;As
a result of the Business Combination, the Company owns 100% of the outstanding common stock of Profusa. In connection with the closing
of the Business Combination, the Company changed its name from &#8220;NorthView Acquisition Corporation&#8221; to &#8220;Profusa, Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa, Inc. was incorporated
in the state of California on May&#160;11, 2009. The Company is engaged in the development of a new generation of biointegrated sensors
that potentially empowers the individual with the ability to monitor their unique body chemistry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s technology
enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable,
clinical-grade data for personal and medical use. The Company&#8217;s first offering in the European Union, the Lumee&#8482; Oxygen Platform,
is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee&#8482; Oxygen
Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease
that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores)
that do not heal properly; and reconstructive surgery.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s research
and development efforts are primarily focused on its Lumee&#8482; Glucose Platform, which is a system designed to monitor glucose levels
in interstitial fluid, continuously and long-term. A tiny, biocompatible gel injected under the skin acts as a continuous glucose monitor
(CGM) for several&#160;months. The ability of Lumee&#8482; Glucose to provide continuous glucose monitoring with only an initial single
injection, is an attractive alternative for people with diabetes to manage their disease without the need for frequent finger sticks
required by standard glucometers, or the need for weekly sensor replacement as required by current short-term needle-type CGMs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</div><div>


</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Committed Equity Facility</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;28, 2025, we entered into the Purchase
Agreement and a related registration rights agreement (the &#8220;ELOC Registration Rights Agreement&#8221;), with Ascent. Pursuant to
the terms and conditions set forth in the Purchase Agreement, we may, from time to time and at our discretion, issue and sell to Ascent
shares of its common stock (the &#8220;Purchased Securities&#8221;) for an aggregate purchase price of up to $100,000,000 (the &#8220;Maximum
Aggregate Purchase Price&#8221;), subject to certain limitations and conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Purchase Agreement, we may deliver advance
notices (each, an &#8220;Advance Notice&#8221;) to the Purchaser to request the purchase of shares of common stock, with each closing
(a &#8220;Closing&#8221;) to occur on a&#160;trading day following the end of a 10 or fewer&#160;trading day valuation period commencing
on the trading date immediately following the delivery of the Advance Notice, or as determined by the Purchaser. The purchase price per
share at each Closing will be equal to 97% of the lowest volume-weighted&#160;average price (&#8220;VWAP&#8221;) of the Company&#8217;s
common stock during the applicable valuation period, subject to a floor price and other adjustments as set forth in the Purchase Agreement.
The maximum purchase price at any single Closing is limited to the lower of (a)&#160;$5,000,000 or (b)&#160;100% of the average daily
traded value of the common stock for the five&#160;trading days immediately preceding such Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains certain limitations,
including that the aggregate number of shares issued under the Purchase Agreement may not exceed the number of shares registered under
the applicable registration statement or the exchange cap (generally 19.9% of the Company&#8217;s outstanding common stock as of the effective
date), unless stockholder approval is obtained or as otherwise permitted by the rules of the principal trading market. In addition, the
Purchaser&#8217;s beneficial ownership of the Company&#8217;s common stock is limited to 9.99% of the outstanding shares immediately after
giving effect to any issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to deliver the Purchased
Securities as DWAC shares to the Purchaser on the date that it delivers the applicable Advance Notice. If the Company fails to timely
deliver the shares, the Purchaser may, among other remedies, deem the Advance Notice rescinded or require the Company to pay certain cover
costs. The Purchaser may resell the Purchased Securities during the valuation period, and the Company is obligated to return any surplus
shares if the Maximum Aggregate Purchase Price is exceeded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the value of all of the Purchase
Shares delivered to Ascent exceeds $100,000,000, then Ascent shall return to the to the Company the surplus amount of Purchase Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with our obligations under the ELOC Registration Rights
Agreement, we filed a registration statement that was declared effective on August 25, 2025 to register under the Securities Act, the
offer and resale by Ascent of up to 8,970,830 shares of Common Stock, consisting of (i)&#160;up to 8,070,830&#160;shares of Common Stock
(the &#8220;Purchase Shares&#8221;) that we may, in our sole discretion, elect to sell to Ascent, from time to time over a period of up
to 36&#160;months from and after the Effective Date (defined below) pursuant to the Purchase Agreement and (ii)&#160;900,000 Commitment
Warrant Shares issuable upon the exercise of the Commitment Warrants we issued to Ascent, upon our execution of the term sheet relating
to the Purchase Agreement on July&#160;20, 2025, as consideration for its commitment to purchase shares of our Common Stock that we may,
in our sole discretion, direct Ascent to purchase from us pursuant to the Purchase Agreement. This registration statement registers an
additional 42,211,548 Purchase Shares that we may, in our sole discretion, elect to sell to Ascent, from time to time over a period of
up to 36&#160;months from and after the Effective Date (defined below) pursuant to the Purchase Agreement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will control the timing and amount of any sales
of Common Stock to Ascent that we may elect, in our sole discretion, to effect from time to time from and after the Effective Date and
during the term of the Purchase Agreement. Actual sales of shares of Common Stock to Ascent under the Purchase Agreement will depend on
a variety of factors to be determined by us from time to time, including, among other things, market conditions, the trading price of
the Common Stock and determinations by us as to the appropriate sources of funding for our business and operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may not issue or sell any shares of Common Stock to Ascent under
the Purchase Agreement which, when aggregated with all other shares of Common Stock then beneficially owned by Ascent and its affiliates
(as calculated pursuant to Section&#160;13(d)&#160;of the Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the &#8220;Exchange&#160;Act&#8221;),
and Rule&#160;13d-3&#160;thereunder), would result in Ascent beneficially owning more than 9.99% of the outstanding shares of Common Stock
(the &#8220;Beneficial Ownership Limitation&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net proceeds to us from sales that we elect
to make to Ascent under the Purchase Agreement, if any, will depend on the frequency and prices at which we sell shares of our Common
Stock to Ascent. We expect that any proceeds received by us from such sales of Common Stock to Ascent will be used solely for the purchase
of Bitcoin (which can be used for debt repayment) provided that the Company&#8217;s cash balance on the date of the applicable sale exceeds
$5,000,000. If the cash balance is less than $5,000,000, proceeds to the Company shall be allocated first to bring the balance to $5,000,000
and the remaining proceeds to purchase Bitcoin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no restrictions on future financings,
rights of first refusal, participation rights, penalties or liquidated damages in the Purchase Agreement or ELOC Registration Rights Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent has agreed that, during the term of the
Purchase Agreement, none of Ascent, any of its officers, or any entity managed or controlled by Ascent will engage in or effect, directly
or indirectly, for its own principal account or for the principal account of any such entity managed or controlled by Ascent, any short
sales (as such term is defined in Rule&#160;200 of Regulation&#160;SHO of the Exchange&#160;Act) of the Common Stock or hedging transaction
that establishes a net short position in the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement will automatically terminate
on the earliest to occur of (i)&#160;July&#160;27, 2028, (ii)&#160;the date on which Ascent shall have purchased from us under the Purchase
Agreement shares of Common Stock for an aggregate gross purchase price of $100,000,000, and (iii)&#160;the date either party effectively
delivers notice to the other party of such termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As consideration for Ascent&#8217;s commitment to purchase shares
of Common Stock at our direction upon the terms and subject to the conditions set forth in the Purchase Agreement, upon our execution
of the term sheet relating to the Purchase Agreement, we issued Ascent Commitment Warrant to purchase 900,000&#160;shares of Common Stock
(the &#8220;Commitment Warrant Shares&#8221;). The Commitment Warrants have an exercise price of $0.01 and may be exercised for cash or,
if at the time of exercise there is no effective registration statement covering the resale of the Commitment Warrant Shares, on a cashless
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we have agreed to reimburse Ascent
for the reasonable legal fees and disbursements of Ascent&#8217;s legal counsel in connection with the transactions contemplated by the
Purchase Agreement and the Registration Rights Agreement in an amount not to exceed $30,000 upon our execution of the Purchase Agreement
and Registration Rights Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement and the Registration Rights
Agreement contain customary representations, warranties, conditions, and indemnification obligations of the parties. Copies of the agreements
have been filed as exhibits to the registration statement that includes this prospectus and are available electronically on the SEC&#8217;s
website at&#160;<i>www.sec.gov</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the per share purchase
price that Ascent will pay for Purchase Shares in any Purchase that we may elect to effect pursuant to the Purchase Agreement will be
determined by reference to the VWAP during the applicable Valuation Period on the applicable Closing Date, as of the date of this prospectus,
we cannot determine the actual purchase price per share that Ascent will be required to pay for any Purchase Shares that we may elect
to sell to Ascent under the Purchase Agreement from and after Commencement and, therefore, we cannot be certain how many Purchase Shares,
in the aggregate, we may issue and sell to Ascent under the Purchase Agreement from and after Commencement. As of October 8, 2025, there
were 41,759,307 shares of our Common Stock outstanding, of which 34,982,922&#160;shares were held by non-affiliates&#160;of our Company.
If all of the 42,211,548 Purchase Shares offered for resale by Ascent under this prospectus were issued and outstanding as of the date
hereof, such shares would represent approximately 50.3% of the total number of outstanding shares of Common Stock and approximately 54.7%
of the total number of outstanding shares of Common Stock held by non-affiliates&#160;of our Company, in each case as of October 8, 2025.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the Purchase Agreement provides that we may sell up to $100,000,000
of our Common Stock to Ascent, only an additional 42,211,548 Purchase Shares are being registered under the Securities Act for resale
by Ascent under the registration statement which includes this prospectus. This amount is in addition to the 8,970,830 shares previously
registered for resale in our prior registration statement, which was declared effective on August 25, 2025, including 900,000 Commitment
Warrant Shares (for which we have not and will not receive any cash consideration). If we were to issue and sell all of such 42,211,548
Purchase Shares to Ascent at an assumed purchase price per share of $0.34, representing the closing sale price of our Common Stock on
Nasdaq on October 7, 2025, we would only receive approximately $14.4&#160;million in aggregate gross proceeds from the sale of such
Purchase Shares to Ascent under the Purchase Agreement. Depending on the market prices of our Common Stock on the Purchase Dates on which
we elect to sell such Purchase Shares to Ascent under the Purchase Agreement, we may in the future need to register under the Securities
Act additional shares of our Common Stock for resale by Ascent which, together with the 42,211,548 Purchase Shares included in this prospectus,
will enable us to issue and sell to Ascent such aggregate number of shares of Common Stock under the Purchase Agreement as will be necessary
in order for us to receive aggregate proceeds equal to Ascent&#8217;s $100,000,000 maximum aggregate purchase commitment available to
us under the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The number of Purchase Shares ultimately offered
for resale by Ascent through this prospectus is dependent upon the number of shares of Common Stock, if any, we elect to issue and/or
sell to Ascent under the Purchase Agreement from and after the Effective Date. The issuance of our Common Stock to Ascent pursuant to
the Purchase Agreement will not affect the rights or privileges of our existing stockholders, except that the economic and voting interests
of each of our existing stockholders will be diluted. Although the number of shares of our Common Stock that our existing stockholders
own will not decrease, the shares of our Common Stock owned by our existing stockholders will represent a smaller percentage of our total
outstanding shares of our Common Stock after any such issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal executive offices
are located at 626 Bancroft Way, Suite A, Berkeley, CA&#160;94710, and our telephone number is (925)&#160;997-6925. Our website address
is <i>www.profusa.com</i>. Information on our website is not part of this prospectus. We have included our website address as an inactive
textual reference only. The information on or accessible through our website is not part of this prospectus supplement and the accompanying
prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

</div><div>


</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid">

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<a id="a_003"></a><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE OFFERING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 35%; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Shares of common stock offered by the&#160;Selling Stockholders</b></span></td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 2.25pt">&#160;</td>
    <td style="width: 64%; text-align: justify">Up to 42,594,048 shares of common stock comprising (i) 42,211,548 shares
of Common Stock by Ascent of which we may, at our election, issue and sell to Ascent pursuant to the Purchase Agreement from time to time
after the date of this prospectus, subject to the satisfaction of specified conditions and (ii) 382,500 shares issued to certain parties
in satisfaction of transaction costs incurred in connection with the Business Combination we completed on July 11, 2025.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Shares of common stock outstanding (as of October 8, 2025)</b></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-size: 10pt">41,759,307 shares of Common Stock</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Shares of common stock outstanding after giving effect to the issuance of the shares registered hereunder:</b></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">83,453,355 shares of Common Stock</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Use of proceeds</b></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt"/>
    <td style="padding-bottom: 2.25pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not receive any proceeds from the
sale of the Resale Securities by the Selling Stockholders. However, we may receive up to $100,000,000 in aggregate gross proceeds from
sales of the Purchase Shares to Ascent that we may, in our discretion, elect to make, from time to time after the date of this prospectus,
pursuant to the Purchase Agreement.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net proceeds from sales, if any, under the Purchase Agreement,
will depend on the frequency and prices at which we sell the Purchase Shares to Ascent after the date of this prospectus. To the extent
we sell Purchase Shares to Ascent, we intend to use any proceeds therefrom for the purchase of Bitcoin (which can be used for debt repayment)
provided that the Company&#8217;s cash balance on the date of the applicable sale exceeds $5,000,000. If the cash balance is less than
$5,000,000, proceeds to the Company shall be allocated first to bring the balance to $5,000,000 and the remaining proceeds to purchase
Bitcoin. See &#8220;Use of Proceeds&#8221; on page 75 of this prospectus.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Terms of this offering</b></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">The Selling Stockholders, including their transferees, donees, pledgees,
assignees and successors-in-interest, may sell, transfer or otherwise dispose of any or all of the shares of common stock offered by this
prospectus from time to time on The Nasdaq Global Market or any other stock exchange, market or trading facility on which the shares are
traded or in private transactions. The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of
sale, at prices related to prevailing market price or at negotiated prices.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Nasdaq symbol</b></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our common stock is listed on the Nasdaq Global Market under the symbols
&#8220;PFSA&#8221; and &#8220;PFSAW,&#8221; respectively.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Risk Factors</b></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Investing in our securities involves a high degree of risk and purchasers of our securities may lose their entire investment. See <i>&#8220;Risk Factors&#8221;</i>&#160;for a discussion of factors you should carefully consider before deciding whether to invest in our securities.</span></td></tr>
  </table>
<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div><div>


</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RISK FACTORS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Investing in our securities
includes a high degree of risk. Prior to making a decision about investing in our securities, you should consider carefully the specific
factors discussed below, together with all of the other information contained in this prospectus. If any of the following risks actually
occurs, our business, financial condition, results of operations and future prospects would likely be materially and adversely affected.
This could cause the market price of our Common Stock to decline and could cause you to lose all or part of your investment.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary of Risk Factors:</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below is a summary of the principal
factors that make an investment in our company speculative or risky. This summary does not address all of the risks that we face. Additional
discussion of the risks summarized in this risk factor summary, and other risks that we face, can be found below, after this summary,
and should be carefully considered, together with other information in this prospectus and our other filings with the SEC before making
an investment decision in our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks Related to the Committed Equity Facility</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">It is not possible to predict the actual number of shares
of Common Stock, if any, we will sell under the Purchase Agreement to Ascent, or the actual gross proceeds resulting from those sales.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The sale and issuance of our Common Stock to Ascent will
cause dilution to our existing stockholders, and the sale of Purchase Shares acquired by Ascent, or the perception that such sales may
occur, could cause the price of our Common Stock to fall.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Investors who buy Purchase Shares from Ascent at different
times will likely pay different prices.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We may use the net proceeds from sales of shares of our Common
Stock made pursuant to the Purchase Agreement, if any, in ways with which you may not agree or in ways which may not yield a significant
return.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We will primarily use the net proceeds from this offering
to purchase Bitcoin, the price of which has been, and will likely continue to be, highly volatile.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Our Business and Operations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We have substantial doubt about our ability to continue as a going concern, which may hinder our ability
to obtain further financing.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We have a limited operating history on which to assess the prospects for our business and we have incurred
losses since inception. We anticipate that we will continue to incur significant losses for at least the next several&#160;years as we
continue to commercialize our existing products and services and seek to develop and commercialize new products and services.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We operate in a highly competitive market and face competition from large, well-established companies
with significant resources, and, as a result, we may not be able to compete effectively.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We are subject to a variety of risks due to our international operations that could adversely affect our
business, our operations or profitability and operating results.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">There are a variety of oxygen monitoring and CGM products and technologies, and consumer confusion about
product features and technology could lead consumers to purchase competitive products instead of our products, or to conflate any adverse
events or safety issues associated with oxygen monitoring and CGM products with our products, which could adversely affect our business,
financial condition and results of operations.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We expect the commercialization of the Lumee Oxygen Platform to generate nearly all our commercial revenue
until we obtain regulatory approval for additional products.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions,
suboptimal quality, noncompliance and/or price fluctuations, which could harm our business.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Healthcare Industry Shifts
and Changing Regulations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">There is no guarantee that the FDA will grant 510(k)&#160;clearance or PMA approval of our products, and
failure to obtain necessary clearances or approvals for our future products would adversely affect our ability to grow our business.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support
additional PMA, De Novo, or 510(k)&#160;applications or supplements, we may be unable to commercialize our CGM systems under development,
which could impair our business, financial condition and operating results.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our products may cause or contribute to adverse medical events or be subject to failures or malfunctions
that we are required to report to the FDA, and if we fail to do so, we would be subject to sanctions that could harm our reputation, business,
financial condition and results of operations. The discovery of serious safety issues with our products, or a recall of our products either
voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on us.</td></tr></table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Quality problems could lead to recalls or safety alerts, reputational harm, and could have a material
adverse effect on our business, results of operations, financial condition and cash flows.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our current or future products may be subject to product recalls even after receiving FDA clearance or
approval. A recall of our products, either voluntarily or at the direction of the FDA, or the discovery of serious safety issues with
our products, could have a significant adverse impact on us.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Changes to the regulatory landscape may impact our ability to obtain marketing authorization for future
product developments.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our failure to comply with laws, regulations and contract requirements relating to reimbursement of health
care goods and services may subject us to penalties and adversely impact our reputation, business, financial condition and cash flows.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We are subject to complex and evolving U.S.&#160;and foreign laws and regulations and other requirements
regarding privacy, data protection, security, and other matters. Many of these laws and regulations are subject to change and uncertain
interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines
in user growth or engagement, or otherwise harm our business.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical
data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer
protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation,
and otherwise be disruptive to our business and operations.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Intellectual Property Protection
and Use</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may become subject to claims of infringement or misappropriation of the intellectual property rights
of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing
alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which
could be expensive, time-consuming and unsuccessful.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may not be able to protect our intellectual property rights throughout the world, which could materially,
negatively affect our business.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">If we are unable to protect the confidentiality of our trade secrets, the value of our technology could
be materially adversely affected and our business could be harmed.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may need or may choose to obtain licenses from third parties to advance our research or allow commercialization
of our current or future products, and we cannot provide any assurances that we would be able to obtain such licenses.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Obtaining and maintaining our patent protection depends on compliance with various procedural requirements,
document submission, fee payment and other requirements imposed by government patent agencies and our patent protection could be reduced
or eliminated for non-compliance with these requirements.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">If we do not obtain patent term extension and/or data exclusivity for any product candidates we decide
to develop as drug product candidates, our business may be materially harmed.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>




</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>General Risks of Profusa&#8217;s Business</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">If we are unable to successfully maintain effective internal control over financial reporting, investors
may lose confidence in our reported financial information and our stock price and our business may be adversely impacted.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Environmental, social and corporate governance, or ESG regulations, policies and provisions may make our
supply chain more complex and may adversely affect our relationships with customers.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Current uncertainty in domestic and global economic and political conditions makes it particularly difficult
to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Changes in financial accounting standards or practices or existing taxation rules or practices may cause
adverse unexpected revenue and/or expense fluctuations and affect our reported results of operations.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We identified material weaknesses in our internal control over financial reporting. These material weaknesses
could continue to adversely affect our ability to report our results of operations and financial condition accurately and in a timely
manner.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">If we fail to maintain an effective system of disclosure controls and internal control over financial
reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired, which
may adversely affect investor confidence in our Company and, as a result, the market price of our common stock.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to our Bitcoin Treasury Strategy
and Holdings</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our bitcoin treasury strategy exposes us to various risks associated with bitcoin.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Bitcoin is a highly volatile asset, and fluctuations in the price of bitcoin are likely to influence our
financial results and the market price of our common stock.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Bitcoin and other digital assets are novel assets, and are subject to significant legal, commercial, regulatory
and technical uncertainty.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our historical financial statements do not reflect our acquisition of bitcoin, the fact that our bitcoin
holdings could be a substantial part of our assets, or the potential variability in earnings that we may experience in the future relating
to our bitcoin holdings.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The concentration of our bitcoin holdings will enhance the risks inherent in our bitcoin treasury strategy.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our bitcoin holdings are less liquid than our existing cash and cash equivalents and may not be able to
serve as a source of liquidity for us to the same extent as cash and cash equivalents.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Regulatory change reclassifying bitcoin as a security could lead to our classification as an &#8220;investment
company&#8221; under the Investment Company Act of 1940, as amended, or the 1940 Act, and could adversely affect the market price of bitcoin
and the market price of our common stock.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may be subject to regulatory developments related to crypto assets and crypto asset markets, which
could adversely affect our business, financial condition, and results of operations.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our custodially-held bitcoin may become part of the custodian&#8217;s insolvency estate if one or more
of our custodians enters bankruptcy, receivership or similar insolvency proceedings.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Additional Risks Related to Ownership of
Profusa Common Stock Following the Business Combination</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq,
a failure of which could result in a de-listing of our common stock.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Future sales, or the perception of future sales, by Profusa shareholders in the public market could cause
the market price for Profusa Common Stock to decline.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The grant and future exercise of registration rights may adversely affect the market price of Profusa
shares.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">In addition, the shares of Profusa Common Stock reserved for future issuance under the Equity Incentive
Plan will become eligible for sale in the public market once those shares are issued.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Because there are no current plans to pay cash dividends on Profusa Common Stock for the foreseeable future,
you may not receive any return on investment unless you sell Profusa Common Stock for a price greater than that which you paid for it.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may issue additional shares of its common stock or other equity securities without your approval, which
would dilute your ownership interests and may depress the market price of Profusa Common Stock.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We may redeem the unexpired NorthView Public Warrants prior to their exercise at a time that is disadvantageous
to you, thereby making your warrants worthless.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>In addition to the other
information contained in (or incorporated by reference into) this prospectus, including the matters addressed under the heading &#8220;Cautionary
Note&#160;Regarding Forward-Looking Statements,&#8221; you should carefully consider the following risk factors. The occurrence of one
or more of the events or circumstances described in these risk factors, alone or in combination with other events or circumstances, may
have a material adverse effect on Profusa&#8217;s business, reputation, revenue, financial condition, results of operations and future
prospects, in which event the market price of Profusa Common Stock could decline, and you could lose part or all of your investment. There
may be additional risks that we do not presently know, or that we believe are immaterial as of the date hereof.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>You should consider carefully
the following risk factors, together with all of the other information included in this prospectus. If any of the following risks, either
alone or taken together, or other risks not presently known to us or that we currently believe to not be significant, develop into actual
events, then our business, financial condition, results of operations or prospects could be materially adversely affected. If that happens,
the market price of our common stock could decline, and stockholders may lose all or part of their investment.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Related to the Committed Equity Facility</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>It is not possible to predict the actual
number of shares of Common Stock, if any, we will sell under the Purchase Agreement to Ascent, or the actual gross proceeds resulting
from those sales.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;28, 2025, we
entered into the Purchase Agreement with Ascent, pursuant to which Ascent has committed to purchase up to $100,000,000 of shares of our
Common Stock, subject to certain limitations and conditions set forth in the Purchase Agreement. The shares of our Common Stock that may
be issued under the Purchase Agreement may be sold by us to Ascent at our discretion from time to time for a period of up to 36&#160;months
(unless the Purchase Agreement is earlier terminated) beginning on the Effective Date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generally have the right
to control the timing and amount of any sales of our shares of Common Stock to Ascent under the Purchase Agreement. Sales of our Common
Stock, if any, to Ascent under the Purchase Agreement will depend upon market conditions and other factors to be determined by us. We
may ultimately decide to sell to Ascent all, some or none of the shares of our Common Stock that may be available for us to sell to Ascent
pursuant to the Purchase Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the per share purchase
price that Ascent will pay for Purchase Shares in any Purchase that we may elect to effect pursuant to the Purchase Agreement will be
determined by reference to the VWAP during the applicable Valuation Period, on the applicable Purchase Date for such Purchase, as of the
date of this prospectus, it is not possible for us to predict the number of shares of Common Stock that we will sell to Ascent as Purchase
Shares under the Purchase Agreement, the purchase price per share that Ascent will pay for Purchase Shares purchased from us under the
Purchase Agreement, or the aggregate gross proceeds that we will receive from those purchases by Ascent under the Purchase Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the Purchase Agreement provides that we may sell up to $100,000,000
of our Common Stock to Ascent, only an additional 42,211,548 Purchase Shares are being registered under the Securities Act for resale
by Ascent under the registration statement in addition to the previously registered shares of, 8,970,830 shares, declared effective on
August 25, 2025, including 900,000 Commitment Warrant Shares (for which we have not and will not receive any cash consideration). The
total ELOC registered Purchase Shares of 42,211,548 may or may not cover all of the shares of Common Stock we ultimately sell to Ascent
under the Purchase Agreement. Shares issuable upon exercise of the Commitment Warrants that we issued to Ascent upon our execution of
the term sheet relating to the Purchase Agreement on July&#160;20, 2025, as consideration for its commitment to purchase shares of our
Common Stock at our direction from time to time under the Purchase Agreement. If it becomes necessary for us to issue and sell to Ascent
under the Purchase Agreement more than the total 42,211,548 Purchase Shares being registered under the Securities Act for resale by Ascent
under the registration statement that includes this prospectus in order to receive aggregate gross proceeds equal to $100,000,000 under
the Purchase Agreement, we must file with the SEC one or more additional registration statements to register under the Securities Act
the resale by Ascent of any such additional shares of our Common Stock we wish to sell from time to time under the Purchase Agreement,
which the SEC must declare effective, in each case before we may elect to sell any additional shares of our Common Stock to Ascent under
the Purchase Agreement. Any issuance and sale by us under the Purchase Agreement of a substantial amount of shares of Common Stock in
addition to the total 42,211,548 Purchase Shares being registered for resale by Ascent under the registration statement that includes
this prospectus could cause additional substantial dilution to our stockholders. The number of Purchase Shares ultimately offered for
resale by Ascent through this prospectus is dependent upon the number of shares of Common Stock, if any, we elect to sell to Ascent under
the Purchase Agreement from and after the Effective Date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The sale and issuance of our Common Stock
to Ascent will cause dilution to our existing stockholders, and the sale of Purchase Shares acquired by Ascent, or the perception that
such sales may occur, could cause the price of our Common Stock to fall.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purchase price for the shares that we may sell to Ascent under
the Purchase Agreement will fluctuate based on the price of our Common Stock. Depending on a number of factors, including market liquidity,
sales of such shares may cause the trading price of our Common Stock to fall.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent may resell all, some, or none of shares that we sell to Ascent
subsequent to the date of this prospectus at its discretion, subject to the terms of the Purchase Agreement. Therefore, sales to Ascent
by us could result in dilution to the interests of other holders of our Common Stock. Additionally, the sale of a substantial number of
shares of our Common Stock to Ascent, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related&#160;securities
in the future at a desirable time and price.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Investors who buy Purchase Shares from
Ascent at different times will likely pay different prices.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
we will have discretion, subject to market demand, to vary the timing, price and number of shares of Common Stock sold to Ascent. If and
when we elect to sell Common Stock to Ascent pursuant to the Purchase Agreement, after Ascent has acquired Purchase Shares, Ascent may
resell all, some or none of such shares at any time or from time to time in its sole discretion and at different prices. As a result,
investors who purchase shares from Ascent in this offering at different times will likely pay different prices for those shares, and so
may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results.
Investors may experience a decline in the value of the shares they purchase from Ascent in this offering as a result of future sales made
by us to Ascent at prices lower than the prices such investors paid for their shares in this offering. In addition, if we sell a substantial
number of shares to Ascent under the Purchase Agreement, or if investors expect that we will do so, the actual sales of shares or the
mere existence of our arrangement with Ascent may make it more difficult for us to sell equity or equity-related&#160;securities in the
future at a time and at a price that we might otherwise wish to effect such sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will use the net proceeds from this offering
exclusively to purchase additional Bitcoin, the price of which has been, and will likely continue to be, highly volatile.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The proceeds from the sale
of the Purchase Shares are to be used exclusively for the purchase of Bitcoin (which may be used for repayment of indebtedness), provided
the Company&#8217;s cash balance on any Closing Date exceeds $5,000,000. If the cash balance is less than $5,000,000, proceeds must first
be used to bring the cash balance to that amount, with the remainder used to purchase Bitcoin. The Company is prohibited from using proceeds
for executive compensation, distributions, or repayment of indebtedness to security holders. Bitcoin is a highly volatile asset that has
traded below $53,000 per bitcoin and above $123,000 per bitcoin on Coinbase in the 12&#160;months preceding the date of this prospectus
supplement. In addition, Bitcoin does not pay interest or other returns and so the ability to generate a return on investment from the
net proceeds from this offering will depend on whether there is appreciation in the value of Bitcoin following our purchases of Bitcoin
with the net proceeds from this offering. Future fluctuations in Bitcoin trading prices may result in our converting Bitcoin purchased
with the net proceeds from this offering into cash with a value substantially below the net proceeds from this offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Profusa</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Unless the context otherwise
requires, references in this subsection to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;Company&#8221; refer to
Profusa, Inc.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Risks Related to Our Business and Operations</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have substantial doubt about our ability
to continue as a going concern, which may hinder our ability to obtain further financing.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our recurring losses from operations
raise substantial doubt about our ability to continue as a going concern. As a result, management has included disclosures in Note 1 of
the financial statements and our independent registered public accounting firm included an explanatory paragraph in its report on our
financial statements for the year ended December 31, 2024 with respect to this uncertainty. Additionally, management has disclosed in
Note 1 of the unaudited financial statements for the three and six months ended June 30, 2025 that there continues to be factors which
raise substantial doubt about our ability to continue as a going concern. Our audited 2024 financial statements and unaudited June 30,
2025 interim financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification
of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. Our ability to continue
as a going concern will require us to obtain additional funding. If we are unable to raise capital when needed or on acceptable terms,
we could be forced to delay, reduce or eliminate certain of our operations, and our stockholders could lose all, or a significant portion,
of their investment in us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a limited operating history on which
to assess the prospects for our business and we have incurred losses since inception. We anticipate that we will continue to incur significant
losses for at least the next several&#160;years as we continue to commercialize our existing products and services and seek to develop
and commercialize new products and services.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since inception, we have devoted substantially all of our financial
resources to developing our products and related services. We have financed our operations primarily through the issuance of equity and
debt securities. We have incurred significant losses. The amount of our future net losses will depend, in part, on regulatory approval,
commercialization and on-going development of our products and related services, the rate of our future expenditures and our ability to
obtain funding through the issuance of our securities, strategic collaborations or grants. We expect to continue to incur significant
losses for several&#160;years as we continue to commercialize our Lumee Oxygen and Glucose Platform and seek to develop and commercialize
new products and services. We anticipate that our expenses will increase substantially if and as we:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">continue to build our sales, marketing and distribution infrastructure to commercialize our products and
services;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">continue to develop our products and services;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">as we continue to conduct clinical studies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">seek to identify, assess, acquire, license and/or develop other products and services and subsequent generations
of our current products and services;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">seek to maintain, protect and expand our intellectual property portfolio;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">seek to attract and retain skilled personnel; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">support our operations as a public company.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to generate future
revenue from product and service sales depends heavily on our success in many areas, including, but not limited to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">launching and commercializing current and future products and services;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">obtaining and maintaining marketing authorization with respect to each of our products and maintaining
regulatory compliance throughout relevant jurisdictions;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">maintaining clinical and economical value for end-users and customers in changing environments;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">addressing any competing technological and market developments;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">establishing and maintaining manufacturing facilities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">establishing and maintaining distribution relationships with third-parties that can provide adequate (in
amount and quality) infrastructure to support market demand for our products; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">maintaining, protecting and expanding our portfolio of intellectual property rights, including patents,
trade secrets and know-how.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have incurred significant losses in the
past and will likely incur losses in the future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have incurred significant
operating losses in the past. We have financed our operations primarily through the issuance of equity and debt. We have devoted substantial
resources to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">research and development relating to our Lumee Oxygen and Glucose Platform;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">clinical studies for our Lumee Oxygen and Glucose Platform;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">execution and maintenance of our intellectual property portfolio;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">expenses associated with the commercialization of our Lumee Oxygen Platform; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">expansion of our workforce.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect our research
and development expenses to increase in connection with our continued clinical trials and other development activities related to
our products. We also expect that our general and administrative expenses will continue to increase due, among other things, to our
expansion of commercialization for the Lumee Oxygen and Glucose Platform and the additional operational and regulatory burdens
applicable to public healthcare and medical device companies. As a result, we will likely continue to incur operating losses in the
future. These losses, among other things, may have an adverse effect on our stockholders&#8217; equity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may need to raise additional funding
to expand the commercialization of our products and services and to expand our research and development efforts. This additional financing
may not be available on acceptable terms, or at all. Failure to obtain this necessary capital when needed may force us to delay, limit
or terminate our product commercialization or development efforts or other operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations have consumed
substantial amounts of cash since inception. We expect to expend substantial additional amounts to commercialize our products and services
and to develop new products and services. We expect to use the funds received in connection with the Business Combination to scale our
operations, develop new products and services, expand internationally, and for working capital and general corporate purposes. We may
require additional capital to conduct clinical trials, expand the commercialization of our existing product and services and to develop
new products and services. In addition, our operating plans may change as a result of many factors that may currently be unknown to us,
and we may need to seek additional funds sooner than planned.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amount of funding we may
need will depend on many factors, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the revenue generated by our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the costs, timing and risks of delay of regulatory approvals;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the expenses we incur in manufacturing, developing, selling and marketing our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to scale our manufacturing operations to meet demand for our current and any future products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the costs to produce our continuous glucose monitoring systems;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property
rights;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the rate of progress and cost of our clinical trials and other development activities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the success of our research and development efforts;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the emergence of competing or complementary technologies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the cost of ongoing compliance with legal and regulatory requirements, and third-party payors&#8217; policies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the cost of obtaining and maintaining regulatory or payor clearance or approval for our current or future
products including those integrated with other companies&#8217; products; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the acquisition of business, products and technologies, although we currently have no commitments or agreements
relating to any of these types of transactions.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If adequate funds are not available,
we may not be able to commercialize our products at the rate we desire and/or we may have to delay the development or commercialization
of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize.
We also may have to reduce sales, marketing, customer support or other resources devoted to our products. Any of these factors could harm
our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The clinical trial process is lengthy and
expensive with uncertain outcomes. Results of earlier studies may not be predictive of future clinical trial results, or the safety or
efficacy profile for such products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may not sell any of
our products in any jurisdiction until we have obtained marketing authorization in such jurisdiction. None of our products are
approved for commercial sale in the United&#160;States. In order to obtain marketing approval for our products in the
United&#160;States and in other jurisdictions, we will be required to conduct additional clinical trials. Clinical testing is
difficult to design and implement, can take many&#160;years, can be expensive and carries uncertain outcomes. The long-term effects
of using our products in a large number of patients have not been studied and the results of short-term clinical use of such
products do not necessarily predict long-term clinical benefits or reveal long-term adverse effects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The results of preclinical
studies and clinical trials of our products conducted to date and ongoing or future studies and trials of our current, planned or future
products may not be predictive of the results of later clinical trials, and interim results of a clinical trial do not necessarily predict
final results. Regulatory authorities may disagree with our interpretation of data and results from our clinical trials, and favorable
results do not ensure that we will achieve similar results in future clinical trials. Preclinical and clinical data are often susceptible
to various interpretations and analyses, and many companies that have believed their products performed satisfactorily in preclinical
studies and earlier clinical trials have nonetheless failed to replicate results in later clinical trials. Failure can occur at any stage
of clinical testing. Our clinical studies may produce negative or inconclusive results, and we may decide, or regulators may require us,
to conduct additional clinical and nonclinical testing in addition to those we have planned. In addition, it is possible that FDA will
impose, as a condition of marketing authorization for future products, requirements that we conduct post-market surveillance studies or
clinical studies as a condition of clearance or approval, which may reduce or delay our ability to obtain profitability with such products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The initiation and completion
of any clinical studies may be prevented, delayed or halted for numerous reasons. We may experience delays in our ongoing clinical trials
for a number of reasons, which could adversely affect the costs, timing or successful completion of our clinical trials, including related
to the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may be required to submit an investigational device exemption application, or IDE, to the FDA, which
must become effective prior to commencing certain human clinical trials of medical devices, and the FDA may reject our IDE and notify
us that we may not begin clinical trials;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">regulators may disagree as to the design or implementation of our clinical trials; regulators and/or institutional
review boards, or IRBs, or other reviewing bodies may not authorize us or our investigators to commence a clinical trial, or to conduct
or continue a clinical trial at a prospective or specific trial site;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may not reach agreement on acceptable terms with prospective contract research organizations, or CROs,
and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and
trial sites;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">clinical trials may produce negative or inconclusive results, and we may decide, or regulators may require
us, to conduct additional clinical trials or abandon product development programs;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the number of subjects required for clinical trials may be larger than we anticipate, enrollment in these
clinical trials may be insufficient or slower than we anticipate, and the number of clinical trials being conducted at any given time
may be high and result in fewer available subjects for any given clinical trial, or subjects may drop out of these clinical trials at
a higher rate than we anticipate;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our third-party contractors, including those manufacturing products or conducting clinical trials or preclinical
studies on our behalf, may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner,
or at all;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we might have to suspend or terminate clinical trials for various reasons, including a finding that the
subjects are being exposed to unacceptable health risks;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may have to amend clinical trial protocols or conduct additional studies to reflect changes in regulatory
requirements or guidance, which we may be required to submit to an IRB and/or regulatory authorities for re-examination;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">regulators, IRBs or other parties may require or recommend that we or our investigators suspend or terminate
clinical research for various reasons, including safety signals or noncompliance with regulatory requirements;</td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the cost of clinical trials may be greater than we anticipate;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">clinical sites may not adhere to the clinical protocol or may drop out of a clinical trial;</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>


</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may be unable to recruit a sufficient number of clinical trial sites or study participants;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">regulators, IRBs or other reviewing bodies may find fault with our manufacturing processes or facilities
of third-party manufacturers with which we enter into agreement for clinical and commercial supplies, the supply of devices or other materials
necessary to conduct clinical trials may be insufficient, inadequate or not available at an acceptable cost, or we may experience interruptions
in supply;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">approval policies or regulations of FDA or applicable foreign regulatory agencies may change in a manner
rendering our clinical data insufficient for approval;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our current or future products may have undesirable side effects or other unexpected characteristics;
and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">impacts of regional or global public health crises including the recent COVID-19 pandemic could adversely
affect any clinical trials we are conducting or plan to conduct, including by causing delays or difficulties in enrolling or onboarding
patients, initiating clinical sites, or obtaining the requisite regulatory approvals, interruption of key clinical trial activities, or
supply chain disruptions that delay or make it more difficult or costly to obtain the supplies and materials we need for clinical trials.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of these occurrences may
significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in
the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Patient enrollment in clinical
trials and completion of patient follow up depend on many factors, including the size of the patient population, the nature of the trial
protocol, the proximity of patients to clinical sites, the eligibility criteria for the clinical trial, patient compliance, competing
clinical trials and clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the product being studied in relation
to other available therapies, including any new treatments that may be approved for the indications we are investigating. For example,
patients may be discouraged from enrolling in our clinical trials if the trial protocol requires them to undergo extensive post treatment
procedures or follow up to assess the safety and efficacy of a product candidate, or they may be persuaded to participate in contemporaneous
clinical trials of a competitor&#8217;s product candidate. In addition, patients participating in our clinical trials may drop out before
completion of the trial or experience adverse medical events unrelated to our products. Delays in patient enrollment or failure of patients
to continue to participate in a clinical trial may delay commencement or completion of the clinical trial, cause an increase in the costs
of the clinical trial and delays, or result in the failure of the clinical trial.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Clinical trials must be conducted
in accordance with the laws and regulations of the FDA and other applicable regulatory authorities&#8217; legal requirements, regulations
or guidelines, and are subject to oversight by these governmental agencies and IRBs at the medical institutions where the clinical trials
are conducted. In addition, clinical trials must be conducted with supplies of our devices produced under applicable current good manufacturing
practice, or cGMP, requirements and other regulations. Furthermore, we rely on CROs, investigators and clinical trial sites to ensure
the proper and timely conduct of our clinical trials and while we have agreements governing their committed activities, we have limited
influence over their actual performance. We depend on our collaborators and on medical institutions and CROs to conduct our clinical trials
in compliance with good clinical practice, or GCP, requirements. To the extent our collaborators or the CROs fail to enroll participants
for our clinical trials, fail to conduct the study to GCP standards or are delayed for a significant time in the execution of trials,
including achieving full enrollment, we may be affected by increased costs, program delays or both. Investigators may also be subject
to disqualification, which may impact their ability to participate in clinical studies. In addition, clinical trials that are conducted
in countries outside the United&#160;States may subject us to further delays and expenses as a result of increased shipment costs, additional
regulatory requirements and the engagement of non-U.S.&#160;CROs, as well as expose us to risks associated with clinical investigators
who are unknown to the FDA, and different standards of diagnosis, screening and medical care.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even if our future products
are cleared or approved in the United&#160;States, commercialization of our products in foreign countries would require clearance or approval
by regulatory authorities in those countries. Clearance or approval procedures vary among jurisdictions and can involve requirements and
administrative review periods different from, and greater than, those in the United&#160;States, including additional preclinical studies
or clinical trials. Any of these occurrences could have an adverse effect on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our products may not achieve or maintain
market acceptance.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have developed, and we are
engaged in the development of, continuous glucose monitoring (CGM) systems, and we are in the early stages of commercializing the Lumee
Oxygen Platform in the EU (in addition to ongoing clinical development of the Lumee Oxygen Platform) in the United&#160;States. Our success
will depend on the acceptance of our products and services in the U.S., if approved, and international healthcare markets. We are faced
with the risk that the marketplace will not be receptive to our products and services over competing products and that we will be unable
to compete effectively. Factors that could affect our ability to successfully commercialize our current products and services and to commercialize
any potential future products and services include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">challenges of developing (or acquiring externally-developed) technology solutions that are adequate and
competitive in meeting the requirements of next-generation design challenges;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">anticipation and responsiveness to our competitors&#8217; development of new products and services and
technological innovations; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">dependence upon physicians&#8217; and other healthcare practitioners&#8217; acceptance of our products.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure investors
that our current products and services or any future products and services will gain broad market acceptance or that treatment guidelines
will promote the market acceptance of our products. If the market for our current products and services or any future products and services
fails to develop or develops more slowly than expected, or if any of the services and standards supported by us do not achieve or sustain
market acceptance, our business and operating results would be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We operate in a highly competitive market
and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete
effectively.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The industry in which we operate
in general, and the market for products like the Lumee Oxygen and Glucose Platform and glucose monitoring devices in particular, are intensely
competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants,
including enhanced software capabilities, and related data and IT platforms. Our CGM products are based on our proprietary technology,
but a number of companies and medical researchers are pursuing new technologies for the monitoring of glucose levels. FDA or other regulatory
approval of a commercially viable continuous glucose monitor or sensor produced by one of our competitors could significantly reduce market
acceptance of our systems. In addition, certain development efforts throughout the diabetes industry, including that of the National Institutes
of Health and other supporters of diabetes research are continually seeking ways to prevent, cure or improve treatment of diabetes. Therefore,
our products may be rendered obsolete by technological breakthroughs in diabetes monitoring, treatment, prevention or cure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our CGM systems are approved
for commercial sale, we will compete directly with the Diabetes Care division of, among others, Abbott Laboratories; Medtronic plc&#8217;s
Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each
of which manufactures and markets products for the single-point finger stick device market. Collectively, these companies currently account
for a significant amount of the worldwide sales of self-monitored glucose testing systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Several companies are developing
and/or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that
compete directly with our products. Abbott has their Libre family of CGM products and Medtronic markets and sells a standalone glucose
monitoring product called Guardian Connect both internationally and in the United&#160;States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Medtronic and other third parties
have developed or are developing insulin pumps integrated with CGM systems that provide, among other things, the ability to suspend insulin
administration while the user&#8217;s glucose levels are low and to automate basal and bolus insulin dosing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also have begun to become
aware of companies outside the traditional medical device sector that are attempting to develop competitive products and services, including
for the general health and wellness, or population health space.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Lumee Oxygen Platform primarily
faces competition from Siemens Healthineers, Perimed AB, SenTec AG, Radiometer Medical, MESI, ATYS Medical, among other related companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of the companies developing
or marketing competing devices are large and well-known publicly traded companies, and these companies may possess competitive advantages
over us, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">greater name recognition;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">established relations with healthcare professionals, customers and third-party payors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">established distribution networks;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">additional lines of products, and the ability to bundle products to offer higher discounts or incentives
to gain a competitive advantage;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">greater experience in conducting research and development, manufacturing, clinical trials, obtaining regulatory
approval for products and marketing approved products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">duration of sensor life;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the ability to integrate multiple products to provide additional features beyond CGM systems; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">greater financial and human resources for product development, manufacturing, sales and marketing, and
patent litigation.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, we may not be
able to compete effectively against these companies or their products, which may adversely impact our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The research and development efforts we
undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development
of commercially viable products, the generation of significant future revenues or adequate profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to address the anticipated
needs of our customers, pursue new markets for our existing products, and remain competitive, we focus our research and development efforts
and strategic third-party collaboration activities on the enhancement of our current products, the development of next-generation products
and the development of novel technologies and services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The development of new products,
or novel technologies and services and the enhancement of our current products (including seeking and obtaining new indications for use),
requires significant investment in research and development, intellectual property protection, clinical trials, regulatory approvals and
third-party reimbursement. The results of our product development and commercialization efforts may be affected by a range of factors,
including our ability to anticipate customer needs, innovate and develop new products, determine a feasible or timely regulatory pathway
or approach, and launch those products cost effectively into multiple markets and geographies. If we are unable to successfully anticipate
customer needs, innovate, develop new products and successfully launch them, we may not be able to generate significant future revenues
or profits from these efforts. Failing to timely launch our products may cause them to become obsolete and materially and adversely affect
our business and financial position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The development and commercial
launch timelines for our products depend a great deal on our ability to achieve clinical endpoints and regulatory requirements and to
overcome technology challenges, and may be delayed due to scheduling issues with patients and investigators, requests from institutional
review boards, or inquiries from regulators about our independent and collaborative product development activities, product performance
and manufacturing supply constraints, among other factors. In addition, support of these clinical trials requires significant resources
from employees involved in the production of our products, including research and development, manufacturing, quality assurance, and clinical
and regulatory personnel. Even if our development and clinical trial efforts succeed, the FDA may not approve the products or may require
additional product testing and clinical trials before approving the products, which would result in product launch delays and additional
expense. If approved by the FDA, the products may not be accepted in the marketplace by physicians or users.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may enter into
collaborative arrangements to develop new products and to pursue new markets. As a result of these relationships, our operating
results depend, to some extent, on the ability of our partners to successfully commercialize their systems or products. Any factors
that may limit our partners&#8217; ability to achieve widespread adoption of their systems, including competitive pressures,
technological breakthroughs for the treatment or prevention of diabetes, adverse regulatory or legal actions relating to their
products, or changes in reimbursement rates or policies of third-party payors relating to these products, could have an adverse
impact on our operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of the companies that
we collaborate with are also competitors or potential competitors who may decide to terminate our collaborative arrangement. In the event
of such a termination, we may be required to devote additional resources to product development and commercialization, we may need to
cancel some development programs and we may face increased competition. Additionally, collaborations may not result in the development
of products that achieve commercial success and could be terminated prior to developing any products. Former collaborators may use the
experience and insights they develop in the course of their collaborations with us to initiate or accelerate their development of products
that compete with our products, which may create competitive disadvantages for us. Accordingly, we cannot provide assurance that any of
our collaborations will result in the successful development of a commercially viable product or result in significant additional future
revenues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Medical device development is costly and
involves continual technological change, which may render our current or future products obsolete.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for medical devices
is characterized by rapid technological change, medical advances and evolving industry standards. Any one of these factors could reduce
the demand for our devices or services or require substantial resources and expenditures for research, design and development to avoid
technological or market obsolescence.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success will depend on
our ability to enhance our current technology, services and systems and develop or acquire and market new technologies to keep pace with
technological developments and evolving industry standards, while responding to changes in customer needs. A failure to adequately develop
or acquire device enhancements or new devices that will address changing technologies and customer requirements adequately, or to introduce
such devices on a timely basis, may have a material adverse effect on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We might have insufficient
financial resources to improve existing devices, advance technologies and develop new devices at competitive prices. Technological advances
by one or more competitors or future entrants into the field may result in our current devices becoming non-competitive or obsolete, which
may decrease revenues and profits and adversely affect our business and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may encounter significant
competition across our existing and future planned products and services and in each market in which we sell or plan to sell our products
and services from various companies, many of which have greater financial and marketing resources than we do.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our competitors,
which are well-established manufacturers with significant resources, may engage in aggressive marketing tactics. Competitors may also
possess the ability to commercialize additional lines of products, bundle products or offer higher discounts and incentives to customers
in order to gain a competitive advantage. If the prices of competing products are lowered as a result, we may not be able to compete effectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to successfully develop
and effectively manage the introduction of new products, our business may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We must successfully manage
introductions of new or advanced products and associated management services. Introductions of new or advanced products could also adversely
impact the commercialization of Lumee&#8482; Oxygen Platform or other existing products to consumers. For instance, the introduction or
announcement of new or advanced products may shorten the life cycle of our existing products or reduce demand, thereby reducing any benefits
of successful new product introductions and potentially lead to challenges in managing write-downs or write-offs of inventory of existing
products. In addition, any new products may have higher manufacturing costs than legacy products, which could negatively impact our gross
margins and operating results. Accordingly, if we fail to effectively manage introductions of new or advanced products, our business may
be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may experience challenges
managing the inventory of monitors and other items, which can lead to excess inventory and discounting of our products, or alternatively
insufficient inventory levels. Inventory levels in excess of consumer demand may result in inventory write-downs or write-offs, product
expiration and the sale of inventory at discounted prices, which would affect our gross margin and could impair the strength of our brand.
Reserves and write-downs for rebates, promotions and excess inventory will be recorded based on our forecast of future demand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Actual future demand could be less than our forecast,
which may result in additional reserves and write-downs in the future, or actual demand could be stronger than our forecast, which may
result in a reduction to previously recorded reserves and write-downs in the future and increase the volatility of our operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to establish and maintain
adequate sales and marketing capabilities or enter into and maintain arrangements with third parties to sell and market our products,
our business may be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We must continue to develop
and grow our sales and marketing organization and enter into partnerships or other arrangements to market and sell our products and/or
collaborate with third parties, including distributors and others, to commercialize the Lumee&#8482; Oxygen Platform and to achieve commercial
success for any of our future products. Developing and managing a direct sales organization is a difficult, expensive and time-consuming
process.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To continue to develop our
sales and marketing organization to successfully achieve market awareness and sell our products, we must:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">continue to recruit and retain adequate numbers of effective and experienced sales and marketing personnel;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">effectively train our sales and marketing personnel in the benefits and risks of our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">establish and maintain successful sales, marketing, training and education programs that educate health
care professionals so they can appropriately inform their patients about our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">manage geographically dispersed sales and marketing operations; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">effectively train our sales and marketing personnel on the applicable fraud and abuse laws that govern
interactions with healthcare practitioners as well as current and prospective patients and maintain active oversight and auditing measures
to ensure continued compliance.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may not be able to successfully
manage our sales force or increase our product sales at acceptable rates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have limited experience in marketing
and selling our products and related services, and if we are unable to successfully commercialize our products and related services, our
business and operating results will be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We only recently received CE
Mark approval in the EU for our first product, the Lumee Oxygen Platform, and accordingly we have limited experience marketing and selling
our products and related services. Sales of our Lumee Oxygen Platform in the EU will depend on our ability to maintain CE Mark approval,
including requirements to comply with European Medical Devices Regulation and renew the CE Mark as required. Sales of Lumee Oxygen Platform
outside of the EU, including in the U.S., and sales of Lumee Glucose in any jurisdiction, will depend on our ability to obtain and maintain
applicable regulatory approvals in such jurisdictions. Following regulatory approvals, future sales of our products will depend in large
part on our ability to effectively market and sell our products and services, successfully manage and expand our sales force, and increase
the scope of our marketing efforts. We may also enter into distribution arrangements in the future. Because we have limited experience
in marketing and selling our products, our ability to forecast demand, the infrastructure required to support such demand and the sales
cycle to customers is unproven. If we do not build an efficient and effective marketing and sales force, our business and operating results
will be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to a variety of risks due
to our international operations that could adversely affect our business, our operations or profitability and operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not currently generating
revenues in international countries. We currently operate clinical trial studies internationally in Vietnam, Germany and Austria and intend
to continue to pursue growth opportunities outside the United&#160;States and we may increase our use of administrative and support functions
from locations outside the United&#160;States, which could expose us to greater risks associated with our sales and operations. As we
pursue opportunities outside the United&#160;States, we may become more exposed to these risks and our ability to scale our operations
effectively may be affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, our international
expansion efforts may not be successful and we may experience difficulties in scaling these functions from locations outside the United&#160;States
and may not experience the expected cost efficiencies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our profitability and international
operations are, and will continue to be, subject to a number of risks and potential costs, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">local product preferences and product requirements;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain
foreign legal systems;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">fluctuations in foreign currency exchange rates;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">less intellectual property protection in some countries outside the United&#160;States than exists in
the United&#160;States;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">trade protection measures and import and export licensing requirements;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">trade relations among the United&#160;States and foreign countries in which our customers or future customers,
distributors, manufacturers and suppliers may have operations;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">required compliance with foreign regulatory requirements and laws;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">required compliance with anti-bribery laws, such as the U.S.&#160;Foreign Corrupt Practices Act, data
privacy requirements, labor laws and anti-competition regulations;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">workforce instability;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">political and economic instability; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the potential impact of tariffs and the resulting impact of administration changes in the U.S.&#160;government.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Changes in foreign currency
exchange rates may reduce the reported value of our foreign currency denominated revenues, expenses, and cash flows. We cannot predict
changes in currency exchange rates, the impact of exchange rate changes, nor the degree to which we will be able to manage the impact
of currency exchange rate changes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There are a variety of oxygen monitoring
and CGM products and technologies, and consumer confusion about product features and technology could lead consumers to purchase competitive
products instead of our products, or to conflate any adverse events or safety issues associated with oxygen monitoring and CGM products
with our products, which could adversely affect our business, financial condition and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that many individuals
do not have full information regarding the types of oxygen monitoring and CGM products and available in the market, in part due to the
lack of consumer education regarding these types of products. Consumers may not have sufficient information about oxygen monitors or CGMs
generally or how these products and technologies compare to each other.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This lack of information may
result in consumers purchasing devices from our competitors, even if our product would provide consumers with their desired product features.
In addition, any adverse events or safety issues relating to competitive products and related negative publicity, even if such events
are not attributable to our products, could result in reduced purchases of our products by consumers generally. Any of these occurrences
could lead to reduced sales of our products and adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We expect the commercialization of the Lumee
Oxygen Platform to generate nearly all our commercial revenue until we obtain regulatory approval for additional products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our first offering is the Lumee
Oxygen Platform, from which we expect to continue to derive nearly all our commercial revenue until such time as we obtain regulatory
approval for additional products, such as Lumee Glucose, which may never occur. Accordingly, our ability to continue to generate revenue
is highly reliant on our ability to market and sell the Lumee Oxygen Platform and to retain consumers using the product. We have not yet
established that our commercial model will be successful. We cannot control the completion or timing of our distribution partners&#8217;
protocols or other internal processes or procedures, and the timing and execution of our expanded launch is dependent on our ability to
distribute our products pursuant to our agreements with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The outbreak of the SARS-CoV-2 virus and
its variants and the COVID-19 disease that it causes, or similar public health crises, could have a material adverse impact on our business,
financial condition and results of operations, including our manufacturing, commercial operations and sales.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2019, a novel
strain of coronavirus (SARS-CoV-2) was reported and it has since spread throughout the world. The COVID-19 pandemic caused by SARS-CoV-2
has had significant impacts on our business operations, and any future outbreak of contagious diseases, or other adverse public health
developments, could have a material adverse effect on our business operations. These impacts to our operations have included, and could
again in the future include, disruptions or restrictions on the ability of our employees and customers to travel or of us to pursue collaborations
and other business transactions, travel to customers and/or conduct live demonstrations of our products at promotional events, maintain
our presence in medical schools and other educational institutions, oversee the activities of our third-party manufacturers and suppliers
and make shipments of materials. The COVID-19 pandemic may also continue to cause financial strain on our customer base due to decreased
funding and other revenue shortfalls.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Travel restrictions and business
closures have and may in the future adversely impact our operations locally and worldwide, including our ability to manufacture, market,
sell or distribute our products, and such restrictions and closure have caused or may cause temporary closures of facilities of suppliers,
manufacturers or customers. Disruptions in the operations of our suppliers, customers, and manufacturers and access to customers have
and may in the future adversely impact our sales and operating results. In addition, travel restrictions have made it more difficult for
us to monitor the quality of our third-party manufacturing operations when we are unable to conduct in-person quality audits of those
facilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the issues originally
brought on by COVID-19 continue to have an ongoing adverse impact on global supply chains, including ours. We have experienced constraints
in availability, increasing lead times and costs required to obtain some inventory components. As a result of the COVID-19 pandemic and
the measures designed to contain its spread, our suppliers may not have the materials, capacity, or capability to supply our components
according to our schedule and specifications. Further, there may be logistics issues, including our ability and our supply chain&#8217;s
ability to maintain production, as well as transportation demands that may cause further delays. If our suppliers&#8217; operations are
curtailed, we may need to seek alternate sources of supply, which may be more expensive. Alternate sources may not be available or may
result in delays in shipments to us from our suppliers and subsequently to our customers. In addition, the COVID-19 pandemic and the measures
designed to stop the spread of the virus may have similar effects on our customers. The current pandemic may also give rise to force majeure
contractual protections being asserted by customers and/or suppliers that we maintain contracts with, potentially relieving contractual
obligations these parties have to us. In any case, any disruption of our suppliers&#8217; or customers&#8217; businesses would likely
negatively impact our sales and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business, financial condition and results
of operations could be adversely affected by disruptions in the global economy caused by the ongoing conflict between Russia and Ukraine.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The global economy has been
negatively impacted by the military conflict between Russia and Ukraine. Furthermore, governments in the U.S., United Kingdom, and European
Union have each imposed export controls on certain products and financial and economic sanctions on certain industry sectors and parties
in Russia. Although we have no operations in Russia or Ukraine, we may experience shortages in materials and increased costs for transportation,
energy, and raw materials due in part to the negative impact of the Russia-Ukraine military conflict on the global economy. The scope
and duration of the military conflict in Ukraine is uncertain, rapidly changing and hard to predict. Further escalation of geopolitical
tensions related to the military conflict, including increased trade barriers or restrictions on global trade, could result in, among
other things, cyberattacks, supply disruptions, lower consumer demand, and changes to foreign exchange rates and financial markets, any
of which may adversely affect our business and supply chain.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may face risks associated with acquisitions
of companies, products and technologies and our business could be harmed if we are unable to address these risks.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may in the future
seek to acquire or invest in businesses, applications or technologies that we believe could complement or expand our portfolio,
enhance our technical capabilities or otherwise offer growth opportunities. However, we cannot assure you that we would be able to
successfully complete any acquisition we choose to pursue, or that we would be able to successfully integrate any acquired business,
product or technology in a cost-effective and non-disruptive manner. The pursuit of potential acquisitions may divert the attention
of management and cause us to incur various costs and expenses in identifying, investigating and pursuing suitable acquisitions,
whether or not they are consummated. We may not be able to identify desirable acquisition targets or be successful in entering into
an agreement with any particular target or obtain the expected benefits of any acquisition or investment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To date, the growth of our
operations has been largely organic, and we have limited experience in acquiring other businesses or technologies. We may not be able
to successfully integrate any acquired personnel, operations and technologies, or effectively manage the combined business following an
acquisition. Acquisitions could also result in dilutive issuances of equity securities, the use of our available cash, or the incurrence
of debt, which could harm our operating results. In addition, if an acquired business fails to meet our expectations, our operating results,
business and financial condition may suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our success will depend on our ability to
attract and retain our personnel and manage our human capital, while controlling labor costs.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future success depends
on our ability to attract, recruit, train, retain, motivate and integrate key personnel, including Ben Hwang, our Chief Executive Officer,
as well as other members of our management team and our research and development, manufacturing, software engineering and sales and marketing
personnel. Competition for qualified personnel is intense. The loss or incapacity of existing members of our executive management team
could adversely affect our operations if we experience difficulties in hiring qualified successors. Our executive officers have signed
offer letters or employment agreements with us, but their service is at-will and may end at any point in time. In addition, all of our
employees are at-will, which means that either we or the employee may terminate their employment at any time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our management
team must be able to act decisively to apply and adapt our business model in the rapidly changing markets in which we will compete. In
addition, we rely upon technical and scientific employees or third-party contractors to effectively establish, manage and grow our business.
Consequently, we believe that our future viability will depend largely on our ability to attract and retain highly skilled managerial,
sales, scientific and technical personnel. In order to do so, in the future we may need to pay higher compensation or fees to our employees
or consultants than we currently expect, and such higher compensation payments may have a negative effect on our operating results. Competition
for experienced, high-quality personnel is intense, and there is no assurance that we will be able to recruit and retain such personnel.
Our growth depends, in particular, on attracting and retaining highly-trained sales personnel with the necessary technical background
and ability to understand our products and services at a technical level to effectively identify and sell to potential new customers and
develop new products. Because of the technical nature of our products and the dynamic market in which we compete, any failure to attract,
recruit, train, retain, motivate and integrate qualified personnel could materially harm our operating results and growth prospects. Recruiting,
training and retention difficulties can limit our ability to support our research and development and commercialization efforts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to export and import control
laws and regulations that could impair our ability to compete in international markets or subject us to liability if we violate such laws
and regulations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to comply with
export and import control laws, which may affect our ability to enter into or complete transactions with certain customers, business partners,
and other persons. In certain circumstances, export control regulations may prohibit the export of certain products, services, and technologies.
We may be required to obtain an export license before exporting a controlled item, and granting of a required license cannot be assured.
Compliance with the import laws that apply to our businesses may restrict our access to, and may increase the cost of obtaining, certain
products and could interrupt our supply of imported inventory.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Exported technologies necessary
to develop and manufacture certain products are subject to U.S.&#160;export control laws and similar laws of other jurisdictions. We may
be subject to adverse regulatory consequences, including government oversight of facilities and export transactions, monetary penalties,
and other sanctions for violations of these laws. In certain instances, these regulations may prohibit us from developing or manufacturing
certain of our products for specific applications outside the United&#160;States. Failure to comply with any of these laws and regulations
could result in civil and criminal, monetary, and nonmonetary penalties; disruptions to our business; limitations on our ability to import
and export products and services; or damage to our reputation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our ability to use our net operating losses
to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the year ended December&#160;31,
2024, we had federal net operating loss carryforwards (&#8220;NOLs&#8221;) to offset future taxable income of approximately $114.8&#160;million,
subject to certain limitations (including the limitations described below). If not utilized, U.S.&#160;federal net operating loss carryforward
amounts generated prior to January&#160;1, 2018 will begin to expire 20&#160;years after the tax year in which such losses originated.
State net operating loss carryforward amounts may also be subject to expiration. A lack of future taxable income would adversely affect
our ability to utilize these NOLs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, under Section&#160;382
of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), a corporation that undergoes an &#8220;ownership change&#8221;
is subject to limitations on its ability to utilize its pre-change NOLs and other pre-change tax attributes (such as research tax credits)
to offset post-change taxable income. For these purposes, an ownership change generally occurs where the equity ownership of one or more
stockholders or groups of stockholders considered by the rules as owning, directly or indirectly, 5% or more of a corporation&#8217;s
stock increases its ownership by more than 50 percentage points over its lowest ownership percentage within a three-year period (calculated
on a rolling basis) as well as changes in ownership arising from new issuances of stock by us. Our existing NOLs may be subject to limitations
arising out of previous ownership changes or in connection with the Business Combination and we may be limited as to the amount that can
be utilized each year as a result of such ownership changes and related transactions. In addition, future changes in our stock ownership,
including future offerings, as well as other changes that may be outside of our control, could result in additional ownership changes
under Section&#160;382 of the Code. There are additional limitations found in Sections 269, 383 and 384 of the Code that may also limit
the use of NOL carryforwards that may apply and result in increased tax liability to us. Our NOLs may also be impaired under similar provisions
of state law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have recorded a full valuation
allowance related to our NOLs and other deferred tax assets due to the uncertainty of the ultimate realization of the future benefits
of those assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our manufacturing capabilities are insufficient
to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations have consumed
substantial amounts of cash since inception. We expect to continue to spend substantial amounts on commercialization of our products,
including growth of our manufacturing capacity, on research and development, and conducting clinical trials for our CGM sensors and systems.
We may need funds to continue the commercialization of our current products and to develop and commercialize our sensors and systems or
pursue other strategic initiatives. Additional financing may not be available on a timely basis on terms acceptable to us, or at all.
Any additional financing may be dilutive to stockholders or may require us to grant a lender a security interest in our assets. The amount
of funding we may need will depend on many factors, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the revenue generated by sales of our products and other future products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the costs, timing and risks of delay of additional regulatory approvals;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the expenses we incur in manufacturing, developing, selling and marketing our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to scale our manufacturing operations to meet demand for our current and any future products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the costs to produce the Lumee&#8482; Oxygen Platform or our CGM systems;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property
rights;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the rate of progress and cost of our clinical trials and other development activities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the success of our research and development efforts;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the emergence of competing or complementary technologies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the cost of ongoing compliance with legal and regulatory requirements, and third-party payors&#8217; policies;</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the cost of obtaining and maintaining regulatory or payor clearance or approval for our current or future
products including those integrated with other companies&#8217; products; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the acquisition of business, products and technologies, although we currently have no commitments or agreements
relating to any of these types of transactions.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If adequate funds are not available,
we may not be able to commercialize our products at the rate we desire and/or we may have to delay the development or commercialization
of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize.
We also may have to reduce sales, marketing, customer support or other resources devoted to our products. Any of these factors could harm
our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We depend upon third-party suppliers and
outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, noncompliance and/or price fluctuations, which
could harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We manufacture our products
and procure important third-party services at numerous facilities worldwide. We purchase many of the components, materials and services
needed to manufacture these products from numerous suppliers in various countries. We have generally been able to obtain adequate supplies
of such materials, components and services. However, we also rely on single and/or sole sources for certain components and materials used
in manufacturing our products. For example, currently we purchase all of the microbeads used in our Lumee Oxygen hydrogel from Microbeads
AS, all of our glucose sensing dye from Laurus Labs, all of our reference dye from Biotium and all of our bacterial catalase from Roche.
In some cases, our agreements with these and other suppliers can be terminated by either party upon short notice. Our contract manufacturers
may also rely on single- or sole-source suppliers to manufacture some of the components used in our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we work with our suppliers
to try to ensure continuity of supply while maintaining quality, timeliness and reliability, the supply of these components, materials
and services has in some cases been, and may continue to be impacted, interrupted or insufficient. Our manufacturers and suppliers may
also encounter problems during manufacturing for a variety of reasons. They may fail to follow specific protocols and procedures, fail
to comply with applicable regulations, or be the subject of FDA or other regulatory authority audits or inspections that result in allegations
of non-compliance (for example, resulting in Form&#160;483 Observations, Warning Letters, or other FDA enforcement actions). Our manufacturers
and suppliers may also experience or be impacted by equipment malfunction, environmental factors, and public health emergencies including
but not limited to the COVID-19 pandemic, any of which could delay or impede their ability to meet our demand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, if our sole- or single-source
suppliers shift their manufacturing and assembly sites to other locations, depending on the circumstances and nature of the item supplied,
in addition to quality system activities such as verification and validation, there could be a need for FDA notifications or submissions,
and the new locations could be subject to regulatory inspections. If there are regulatory delays or impediments impacting our suppliers
or us for any reason, we may not be able to quickly establish additional or replacement suppliers, particularly for our single-source
components, in part because of the custom nature of various parts we design. Any interruption or delay in the supply of components or
materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair
our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products. For supply risks related
to the COVID-19 pandemic see our Risk Factor entitled, <i>&#8220;The outbreak of the SARS-Cov-2 virus and its variants and the COVID-19
disease that it causes, or similar public health crises, could have a material adverse impact on our business, financial condition and
results of operations, including our manufacturing, commercial operations and sales.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our reliance on these outside
manufacturers and suppliers also subjects us to other risks that could harm our business, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may experience a reduction or interruption in supply, and may not be able to obtain adequate supply
in a timely manner or on commercially reasonable terms from additional or replacement sources;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our products are technologically complex and it is difficult to develop alternative supply sources;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers&#8217;
needs higher priority than ours;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our suppliers may make errors in manufacturing components that could negatively affect the quality, effectiveness
or safety of our products or cause delays in shipment of our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may have difficulty locating and qualifying alternative suppliers for our single-source supplies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">switching components may require product redesign and submission to the FDA of new applications (such
as new 510(k)&#160;submissions or PMA supplements) which could significantly delay production;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our suppliers manufacture products for a range of customers, and fluctuations in demand for the products
these suppliers manufacture for others may affect their ability to deliver components to us in a timely manner or at the current pricing;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our suppliers may discontinue the production of components that are critical to our products; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our suppliers may encounter financial and/or other hardships unrelated to our demand for components, including
those related to changes in global economic conditions and/or disease outbreaks, which could inhibit their ability to fulfill our orders
and meet our requirements.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also outsource certain services
to other parties, including inside sales, certain transaction processing, accounting, information technology, manufacturing, and other
areas. Outsourcing of services to third parties could expose us to suboptimal quality of service delivery or deliverables and potentially
result in repercussions such as missed deadlines or other timeliness issues, erroneous data, supply disruptions, non-compliance (including
with applicable legal or regulatory requirements and industry standards) and/or reputational harm, with potential negative effects on
our results. Closure of non-essential businesses and shelter-in-place orders that may reoccur in the U.S.&#160;and globally as a result
of the COVID-19 pandemic or other epidemics may also adversely impact our outsourced operations. We continue to monitor this situation
closely.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also require the suppliers,
service providers and business partners of components or services for our products and related services to comply with law and certain
of our policies regarding sourcing practices, but we do not control them or their practices. If any supplier, service provider or business
partner violates laws or implements unethical practices, there could be disruptions to our supply chain, cancellation of our orders, a
termination of the relationship with the partner or damage to our reputation, and the FDA or other regulators could seek to hold us responsible
for such violations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will need to expand our organization,
and we may experience difficulties in recruiting needed additional employees and consultants, which could disrupt our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As our development and commercialization
plans and strategies develop, we will need additional managerial, operational, sales, marketing, financial, legal and other resources.
The competition for qualified personnel in the medical device industry is intense. Due to this intense competition, we may be unable to
attract and retain the qualified personnel necessary for the development of our business or to recruit suitable replacement personnel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management may need to
divert a disproportionate amount of its attention away from our&#160;day-to-day activities and devote a substantial amount of time to
managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses
in our infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining
employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects,
such as the development of additional products. If our management is unable to effectively manage our growth, our expenses may increase
more than expected, our ability to generate and/or grow revenue could be reduced and we may not be able to implement our business strategy.
Our future financial performance and our ability to commercialize products and services and compete effectively will depend, in part,
on our ability to effectively manage any future growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The failure to comply with U.S.&#160;Foreign
Corrupt Practices Act and similar worldwide anti-bribery laws in non-U.S.&#160;jurisdictions could materially adversely affect our business
and result in civil and/or criminal sanctions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are currently subject to
certain provisions of the U.S.&#160;Foreign Corrupt Practices Act, or FCPA, and as a public company we will be subject to additional provisions
of the FCPA.&#160;The FCPA prohibits companies and their intermediaries from making payments in violation of law to non-U.S.&#160;government
officials for the purpose of obtaining or retaining business or securing any other improper advantage. Our planned future reliance on
independent distributors to sell our products internationally demands a high degree of vigilance in enforcing our policy against participation
in corrupt activity, because these distributors could be deemed to be our agents, and we could be held responsible for their actions.
Other U.S.&#160;companies in the medical device and pharmaceutical fields have faced criminal penalties under the FCPA for allowing their
agents to deviate from appropriate practices in doing business with such non-U.S.&#160;government officials. We are also subject to similar
anti-bribery laws in the jurisdictions in which we operate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any violations of these laws,
or allegations of such violations, could disrupt our operations, involve significant management distraction, involve significant costs
and expenses, including legal fees, and could result in a material adverse effect on our business, prospects, financial condition, or
results of operations. We could also incur severe penalties, including criminal and civil penalties, disgorgement, and other remedial
measures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unfavorable global economic conditions could
adversely affect our business, financial condition or results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our results of operations could
be adversely affected by general conditions in the global economy and in the global financial markets, including changes in inflation,
interest rates and overall economic conditions and uncertainties. To the extent inflation or other factors increase our business costs,
it may not be feasible to pass price increases on to our customers or offset higher costs through manufacturing efficiencies. Inflation
could also adversely affect the ability of our customers to purchase our products. An economic downturn could result in a variety of risks
to our business, including weakened demand for our products and our inability to raise additional capital when needed on acceptable terms,
if at all. A weak or declining economy could also result in further constraints on our suppliers or cause future customers to delay making
payments for our products. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current
economic climate and financial market conditions could adversely impact our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may experience pricing pressures from
contract suppliers or manufacturers on which we rely.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect that there will be
supply constraints and our suppliers may continue to raise prices, which we may not be able to offset through manufacturing efficiencies
or pricing actions. Pricing pressures from third parties could increase our costs and force us to increase the prices of our products
if we are unable to enter into alternative arrangements with other suppliers or manufacturers, potentially leading to decreased customer
demand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Manufacturing difficulties and/or any disruption
at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are manufactured
at two facilities located in California, with limited alternate facilities. If an event occurs at one of our facilities that results in
damage to, or closure of, one or more of such facilities, or if our distributions from those facilities are limited or restricted in any
way, we may be unable to manufacture the relevant products at the previous levels or at all. Because of the time required to approve and
lease a manufacturing facility, an alternate facility and/or a third-party may not be available on a timely basis to replace production
capacity in the event manufacturing capacity is lost.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We take precautions to safeguard
our facilities, which include manufacturing protocols, insurance, health and safety protocols, and off-site storage of data. However,
a natural or man-made disaster, such as fire, flood, earthquake, act of terrorism, cyber-attack or other disruptive event, such as the
COVID-19 pandemic or another public health emergency, could cause substantial delays in our operations, damage, destroy or limit our manufacturing
equipment, inventory, or records and cause us to incur additional expenses. Earthquakes and fires are of particular significance since
our manufacturing facilities in California are located in an earthquake-prone area. In the event our existing manufacturing facilities
or equipment are affected by man-made or natural disasters, we may be unable to manufacture products for sale or meet customer demands
or sales projections. If our manufacturing operations were curtailed or ceased, it would seriously harm our business. The insurance we
maintain against fires, floods, earthquakes and other natural disasters and similar events may not be adequate to cover our losses in
any particular case. Further, insurance coverage may not be available or successfully secured for loss profits or business interruption
relating to the COVID-19 pandemic and its impacts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Customer or third-party complaints or negative
reviews or publicity about our company or our products could harm our reputation and brand.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to rely on customers
who use our products to provide good reviews and word-of-mouth recommendations to contribute to our future growth. Customers who are dissatisfied
with their experiences with our products or services may post negative reviews. We may also be the subject of blog, forum or other media
postings that include inaccurate statements and create negative publicity. Any negative reviews or publicity, whether real or perceived,
disseminated by word-of-mouth, by the general media, by electronic or social networking means or by other methods, could harm our reputation
and brand and could severely diminish consumer confidence in our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The size and expected growth of our addressable
market has not been established with precision, and may be smaller than we estimate.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our estimates of the addressable
market for our current products and future products are based on a number of internal and third-party estimates and assumptions, including
the prevalence of diabetes across income levels and demographic profiles. While we believe our assumptions and the data underlying our
estimates are reasonable, these assumptions and estimates may not be correct. In addition, the statements in this prospectus relating
to, among other things, the expected growth in the market for our products, are based on a number of internal and third-party estimates
and assumptions and may prove to be inaccurate. For example, although we expect that the prevalence of diabetes will increase in the general
population, demographic trends could shift and the prevalence of diabetes could decrease. Furthermore, even if the prevalence of diabetes
increases as we expect, technological or medical advances could provide alternatives to address diabetes and reduce demand for automatic
glucose monitoring. As a result, our estimates of the addressable market for our current or future products may prove to be incorrect.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Another key element of our
business strategy is utilizing market research and ad hoc user feedback from our clinical studies to understand and improve our products.
This strategy underlies our entire product design, marketing and customer support approach and is the basis on which we developed our
current products and are pursuing the development of new products. However, our market research participants may represent only a small
percentage of the overall market. As a result, the responses we receive may not be reflective of the broader market and may not provide
us accurate insight into the desires of our potential customers. In addition, understanding the meaning and significance of such market
research responses necessarily requires that analysis be conducted and conclusions be drawn. We may not be able to perform an analysis
that yields meaningful results, or the conclusions we draw from the analysis could be misleading or incorrect. Moreover, even if our market
research has allowed us to better understand the features and functionality consumers are seeking in our products, there can be no assurance
that consumers will actually purchase our products or that our competitors will not develop products with similar features.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the actual number of consumers
who would benefit from our products, the price at which we can sell future products or the addressable market for our products is smaller
than we estimate, it could have a material adverse effect on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We or the third parties upon whom we depend
may be adversely affected by disasters, and our business continuity and disaster recovery plans may not adequately protect us from a serious
disaster. Any interruption in the operations of our or our suppliers&#8217; manufacturing or other facilities may have a material adverse
effect our business, financial condition and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our corporate headquarters
are located near the San Francisco Bay Area, which has experienced both severe earthquakes and wildfires. We do not carry earthquake insurance.
Severe weather, natural disasters and other calamities, such as pandemics (including the COVID-19 pandemic), earthquakes, tsunamis and
hurricanes, fires and explosions, accidents, mechanical failures, unscheduled downtimes, civil unrest, strikes, transportation interruptions,
unpermitted discharges or releases of toxic or hazardous substances, other environmental risks, sabotage or terrorist attacks, could severely
disrupt our operations, or our third-party manufacturers&#8217; and suppliers&#8217; operations, and have a material adverse effect on
our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a natural disaster, power
outage or other event occurs that prevents us from using all or a significant portion of our headquarters or other facilities, or those
of our third-party manufacturers or suppliers, that damages critical infrastructure, such as our enterprise financial systems or manufacturing
resource planning and enterprise quality systems, or that otherwise disrupts operations, it may be difficult or, in certain cases, impossible,
for us to continue our business for a substantial period of time. A mechanical failure or disruption affecting any major operating line
may result in a disruption to our ability to supply customers, and standby capacity may not be available. The disaster recovery and business
continuity plans we have in place currently are limited and are unlikely to prove adequate in the event of a serious disaster or similar
event. The potential impact of any disruption would depend on the nature and extent of the damage caused by a disaster. There can be no
assurance that alternative production capacity will be available in the future in the event of a major disruption or, if it is available,
that it could be obtained on favorable terms. We may incur substantial expenses as a result of the limited nature of our disaster recovery
and business continuity plans, which, particularly when taken together with our lack of earthquake insurance, could have a material adverse
effect on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, integral parties
in our supply chain are similarly vulnerable to natural disasters or other sudden, unforeseen and severe adverse events. If such an event
were to affect our supply chain, it could have a material adverse effect on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our operating results may fluctuate significantly
in the future, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations
or any guidance we may provide.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our quarterly and annual operating
results may fluctuate significantly, which makes it difficult for us to predict our future operating results. These fluctuations may occur
due to a variety of factors, many of which are outside our control, including, but not limited to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the timing and amount of expenditures that we may incur to develop, commercialize or acquire additional
products and technologies or for other purposes, such as the expansion of our sales team and our facilities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">changes in governmental funding of life sciences research and development or changes that impact budgets
or budget cycles;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the timing of when we recognize any revenues;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">future accounting pronouncements or changes in our accounting policies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the outcome of any future litigation or governmental investigations involving the Company, our industry
or both;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">higher than anticipated service, replacement and warranty costs;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the impact of the COVID-19 pandemic on the economy, investment in the life sciences and medical technology
industries, our business operations, and resources and operations of our suppliers, future distributors and current and potential customers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the impact of political instability and military conflict, such as the conflict in Ukraine, which has
resulted in instability in the global financial markets and export controls, and which could result in supply disruptions for us; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">general industry, economic and market conditions and other factors, including factors unrelated to our
operating performances or the operating performance of our competitors.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The cumulative effects of the
factors discussed above could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result,
comparing our operating results on a period-to-period basis may not be meaningful.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This variability and unpredictability
could also result in us failing to meet the expectations of industry or financial analysts or investors for any period. If we are unable
to further commercialize products or generate revenue, or if our operating results fall below the expectations of analysts or investors
or below any guidance we may provide, or if the guidance we provide is below the expectations of analysts or investors, the market price
of our common stock could decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our financial performance fails to meet
the expectations of investors and public market analysts, the market price of our common stock could decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our revenues and operating
results may fluctuate significantly from quarter to quarter. We believe that period-to-period comparisons of our operating results may
not be meaningful and should not be relied on as an indication of our future performance. If quarterly revenues or operating results fall
below the expectations of investors or public market analysts, the trading price of our common stock could decline substantially. Factors
that might cause quarterly fluctuations in our operating results include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our inability to manufacture an adequate supply of product at appropriate quality levels and acceptable
costs;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">possible delays in our research and development programs or in the completion of any clinical trials;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a lack of acceptance of our products in the marketplace;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the inability of customers to receive reimbursements from third-party payors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the purchasing patterns of our customers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">failures to comply with regulatory requirements, which could lead to withdrawal of products from the market;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our failure to continue the commercialization of any of our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">competition;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">inadequate financial and other resources; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">global political and economic conditions, political instability and military hostilities.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In the unlikely event that payment of certain
outstanding promissory notes issued by Profusa to its founders and insiders is demanded at an inopportune time for Profusa, Profusa management
believes it would still have sufficient funds to operate its business, but may need to adjust certain expenditures or raise additional
funds to operate at its currently planned levels.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa has issued a number
of promissory notes to its founders and insiders, which are either payable on demand or past due. As of December&#160;31, 2024, these
notes had an aggregate outstanding amount, including principal and accrued interest, of approximately $910,000. Profusa has an understanding
with these noteholders that they will withhold from demanding or pursuing repayment until a date to be agreed upon by the parties that
will be subsequent to the closing of the Business Combination. However, in the unlikely event that the noteholders demand or pursue repayment
of these promissory notes at an inopportune time for Profusa, it is Profusa management&#8217;s belief that it would still have sufficient
funds to operate its business, but may need to adjust certain expenditures or raise additional funds to operate at its currently planned
levels.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Risks Related to Healthcare Industry Shifts
and Changing Regulations</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There is no guarantee that the FDA will
grant 510(k)&#160;clearance or PMA approval of our products, and failure to obtain necessary clearances or approvals for our future products
would adversely affect our ability to grow our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before a new medical device,
or a significant modification of a medical device, including a new use of or claim for an existing product, can be marketed in the United&#160;States,
it must first receive either 510(k)&#160;clearance or pre-market approval, or PMA, from the FDA, unless an exemption applies. In the 510(k)&#160;clearance
process, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a device legally on the market, known
as a &#8220;predicate&#8221; device, with respect to intended use, technology and safety and effectiveness, in order to clear the proposed
device for marketing. Clinical data is sometimes required to support substantial equivalence. Further, if a previously unclassified new
medical device does not qualify for the 510(k)&#160;pre-market notification process because no predicate device to which it is substantially
equivalent can be identified, the device is automatically classified into Class&#160;III.&#160;If such a device would be considered low
or moderate risk (in other words, it does not rise to the level of requiring the approval of a PMA), it may be eligible for the De Novo
classification process.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The FDA or other regulators
could delay, limit, or deny clearance or approval of a device for many reasons, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Our inability to demonstrate to the satisfaction of the FDA or the applicable regulatory entity or notified
body that any of our devices (including any future devices) and any of our device accessories is substantially equivalent to a legally
marketed predicate device or safe or effective for the proposed intended use;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the disagreement of the FDA with the design or implementation of any clinical trials or the interpretation
of data from preclinical studies or clinical trials;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">serious and unexpected adverse device effects experienced by participants in our clinical trials;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the insufficiency of the data from preclinical studies or clinical trials to support clearance or approval,
where required;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our inability to demonstrate that the clinical and other benefits of the device outweigh the risks;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the failure of our manufacturing process or facilities to meet applicable requirements; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the potential for approval policies or regulations of the FDA or applicable foreign regulatory bodies
to change significantly in a manner rendering our clinical data or regulatory filings insufficient for clearance or approval.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Obtaining 510(k)&#160;clearance,
De Novo classification, or PMA approval for medical devices can be expensive and time-consuming, and entails significant user fees, unless
an exemption is available. The FDA&#8217;s process for obtaining 510(k)&#160;clearance usually takes three to 12&#160;months, but it can
last longer. In the PMA approval process, the FDA must determine that a proposed device is safe and effective for its intended use based,
in part, on extensive data, including but not limited to, technical, non-clinical, clinical trial, manufacturing and labeling data. The
process for obtaining a PMA is more costly and uncertain than for a 510(k), and approval can take anywhere from at least one year to,
in some cases, multiple&#160;years from the time the application is initially filed with the FDA.&#160;Modifications to products that
are approved through a PMA application generally require further FDA approval. Some of our products may require PMA approval. In addition,
the FDA may require that we obtain a PMA prior to marketing future changes of our existing products. Further, we may not be able to obtain
additional 510(k)&#160;clearances or PMAs for new products or for modifications to, or additional indications for, our products in a timely
fashion or at all. Delays in obtaining future clearances or approvals could adversely affect our ability to introduce new or enhanced
products in a timely manner, which in turn could harm our revenue and future profitability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of our new or modified
products will require FDA clearance of a 510(k)&#160;notification or FDA approval of a PMA application or supplement, or potentially a
grant of a De Novo classification. The FDA may refuse our requests for 510(k)&#160;clearance or PMA of new products or may not clear or
approve these products for the indications that are necessary or desirable for successful commercialization. Early stage review may also
result in delays or other issues. For example, the FDA has issued guidance intended to explain the procedures and criteria used in assessing
whether 510(k)&#160;and PMA submissions should be accepted for substantive review. Under the &#8220;Refuse to Accept&#8221; guidance,
the FDA conducts an early review against specific acceptance criteria to inform 510(k)&#160;and PMA submitters if the submission is administratively
complete, or if not, to identify the missing element(s). Submitters are given the opportunity to provide the FDA with any information
identified as missing. If the information is not provided within a specified time, the submission will not be accepted for FDA review.
The FDA may also change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other
actions that may prevent or delay approval or clearance of our products under development or impact our ability to gain clearance or approval
for modifications to our currently approved or cleared products in a timely manner. Significant delays in receiving clearance or approval,
or the failure to receive clearance or approval for our new products, would have an adverse effect on our ability to expand our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, even in instances
where we determine modifications to our cleared or approved products do not require a new 510(k)&#160;clearance or a PMA, the FDA may
review our decision and disagree, or otherwise determine on its own initiative that a new clearance or approval is required. In this case,
we may ultimately be required to make additional changes to our products, we may need to submit a new 510(k)&#160;application or a PMA
and obtain clearance or approval, we may be required to temporarily suspend shipment of, withdraw or recall our products until such clearance
or approval is obtained (which may not happen in a timely manner or at all), and/or we may be subject to other enforcement actions or
proceedings and litigation, all of which would materially and adversely disrupt and harm our business and future growth. Where we determine
that modifications to our approved or cleared products do require a new 510(k)&#160;clearance from the FDA or PMA approval, we may not
be able to obtain such clearance or approval in a timely manner, or at all. Obtaining clearances or approvals can be a time-consuming
and costly process, which may in some cases require us to conduct clinical trials, and delays in obtaining required future clearances
or approval could adversely affect our ability to make updates and enhancements to our products in a timely manner, which in turn would
harm our future growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We conduct business in a heavily regulated
industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from
participation in government programs, and/or be required to make significant changes to our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products and associated
services are subject to extensive pre-market and post-market regulation by the FDA and various other federal, state, local and foreign
government authorities. Government regulation of medical devices is meant to assure their safety and effectiveness, and includes requirements
for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">design, development and manufacturing processes;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">labeling, content and language of instructions for use and storage;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product testing, non-clinical studies and clinical trials;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">regulatory authorizations, such as pre-market clearance or pre-market approval;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">establishment registration, device listing and ongoing compliance with the QSR requirements;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">advertising and promotion;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">marketing, sales and distribution;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">conformity assessment procedures;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product traceability and record-keeping procedures;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">review of product complaints, complaint reporting, recalls and field safety corrective actions;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if
they were to recur, could lead to death or serious injury;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">post-market studies (if applicable); and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product import and export.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The laws and regulations to
which we and our products are subject are complex and subject to periodic changes. Regulatory changes could result in restrictions on
our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to successfully complete
the pre-clinical studies or clinical trials necessary to support additional PMA, De Novo, or 510(k)&#160;applications or supplements,
we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating
results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To support current and any
future additional PMA, 510(k), <i>De Novo </i>applications or supplements, we together with our partners, must successfully complete pre-clinical
studies, bench-testing, and in some cases clinical trials that will demonstrate that the product is safe and effective. Product development,
including pre-clinical studies and clinical trials, is a long, expensive and uncertain process and is subject to delays (including any
potential delays due to the ongoing COVID-19 pandemic) and failure at any stage. Furthermore, the data obtained from the studies and trials
may be inadequate to support approval of an application and the FDA may request additional clinical data in support of those applications,
which may result in significant additional clinical expenses and may delay product approvals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we have in the past obtained, and may in
the future obtain, an investigational device exemption, or IDE, prior to commencing clinical trials for our products, FDA approval of
an IDE application permitting us to conduct testing does not mean that the FDA will consider the data gathered in the trial to be sufficient
to support approval of a PMA, <i>De Novo</i> or 510(k)&#160;application or supplement, even if the trial&#8217;s intended safety and effectiveness
endpoints are achieved.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failure to obtain any required regulatory
authorization in foreign jurisdictions will prevent us from marketing our products abroad.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conduct limited commercial
and marketing efforts in Europe with respect to our Lumee Oxygen Platform systems and may seek to market our products in other regions
in the future. Outside the United&#160;States, we can market a product only if we receive a marketing authorization and, in some cases,
pricing approval, from the appropriate regulatory authorities. The marketing authorization procedures vary among countries and can involve
additional testing, and the time required to obtain any required authorization or approval may differ from that required to obtain FDA
marketing authorization(s). Foreign regulatory authorization or approval processes may include all of the risks associated with obtaining
FDA marketing authorization(s)&#160;in addition to other risks. We may not obtain foreign regulatory authorizations or approvals on a
timely basis, if at all. Obtaining a marketing authorization from the FDA does not ensure authorization or approval by regulatory authorities
in other countries will follow, and authorization or approval by one foreign regulatory authority does not ensure authorization or approval
by regulatory authorities in other foreign countries or by the FDA.&#160;In addition, in order to obtain the authorization to market our
products in certain foreign jurisdictions, we may need to obtain a Certificate to Foreign Government from the FDA.&#160;The FDA may refuse
to issue a Certificate to Foreign Government in certain instances, including without limitation, during the pendency of any outstanding
warning letter. As a result, we may not be able to file for regulatory approvals or marketing authorizations and may not receive necessary
approvals or authorizations to commercialize our products in any market outside the United&#160;States on a timely basis, or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Potential long-term complications from our
current or future products under development may not be revealed by our clinical experience to date.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on our experience, complications
from use of our products may include sensor errors, sensor failures, broken sensors, lodged sensors or skin irritation under the adhesive
dressing of the sensor. Inflammation or redness, swelling, minor infection, and minor bleeding at the sensor insertion site are also possible
risks with an individual&#8217;s use of our products. However, if unanticipated long-term side-effects result from the use of our products
systems we have under development, we could be subject to liability and the adoption of our systems may become more limited. It is possible
that the data from our clinical studies and trials may not be indicative of long-term patient outcomes. We cannot assure you that repeated,
long-term use would not result in unanticipated adverse effects, potentially even after the sensor is removed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our products may cause or contribute to
adverse medical events or be subject to failures or malfunctions that we are required to report to the FDA, and if we fail to do so, we
would be subject to sanctions that could harm our reputation, business, financial condition and results of operations. The discovery of
serious safety issues with our products, or a recall of our products either voluntarily or at the direction of the FDA or another governmental
authority, could have a negative impact on us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our products are approved
or cleared, we will be subject to the FDA&#8217;s medical device reporting regulations and similar foreign regulations, which require
us to report to the FDA when we receive or become aware of information that reasonably suggests that one or more of our products may have
caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were to recur, could cause or contribute
to a death or serious injury. The timing of our obligation to report is triggered by the date we become aware of the adverse event as
well as the nature of the event. We may fail to report adverse events of which we become aware within the prescribed timeframe. We may
also fail to recognize that we have become aware of a reportable adverse event, especially if it is not reported to us as an adverse event
or if it is an adverse event that is unexpected or removed in time from the use of the product. Manufacturers are also expected to maintain
certain policies, procedures, and records regarding complaints and medical device reporting. If we fail to comply with our reporting and
recordkeeping obligations, the FDA could take action, including warning letters, untitled letters, it has come to our attention letters,
administrative actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device clearance or approval,
seizure of our products or delay in clearance or approval of future products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The FDA and foreign regulatory
bodies have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design
or manufacture of a product or in the event that a product poses an unacceptable risk to health. The FDA&#8217;s authority to require
a recall must be based on a finding that there is reasonable probability that the device could cause serious injury or death. We may also
choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall by us could occur
as a result of an unacceptable risk to health, component failures, malfunctions, manufacturing defects, labeling or design deficiencies,
packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects or other errors may occur in
the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depending on the corrective
action we take to redress a product&#8217;s deficiencies or defects, the FDA may require, or we may decide, that we will need to obtain
new clearances or approvals for the device before we may market or distribute the corrected device. Seeking such clearances or approvals
may delay our ability to replace the recalled devices in a timely manner. Moreover, if we do not adequately address problems associated
with our devices, we may face additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions, administrative
penalties or civil or criminal fines.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Quality problems could lead to recalls or
safety alerts, reputational harm, and could have a material adverse effect on our business, results of operations, financial condition
and cash flows.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Quality is very important to
us and our customers due to the serious and costly consequences of product failure, and our business exposes us to potential product liability
risks that are inherent in the design, manufacture, and marketing of medical devices. To comply with the FDA&#8217;s medical device reporting
requirements, for example, we have are required to file reports of applicable field failures. Although we believe we have taken and are
taking appropriate action aimed at reducing and/or eliminating field failures, we may have other product failures in the future. Product
or component failures, manufacturing nonconformances, design defects, off-label use, or inadequate disclosure of product-related risks
or product-related information with respect to our products, if they were to occur, could result in an unsafe condition or injury to,
or death of, a patient. These problems could lead to recalls, corrections or removals of, or issuance of a safety alert relating to, our
products, and could result in product liability claims and lawsuits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the production
of our products must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants.
Weaknesses in process control or minute impurities in materials may cause a substantial percentage of defective products. If we are not
able to maintain stringent quality controls, or if contamination problems arise, our clinical development and commercialization efforts
could be delayed, which would harm our business and our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to meet any applicable
product quality standards and our products are the subject of recalls or safety alerts, our reputation could be damaged, we could lose
customers, our reputation could be harmed and our revenue and results of operations could decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we or our suppliers or distributors fail
to comply with ongoing regulatory requirements, or if we have unanticipated problems with our products, the products could be subject
to restrictions or withdrawal from the market.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products, if cleared or
approved, would be subject to extensive regulation as medical devices in the United&#160;States and elsewhere, including by the FDA and
its foreign counterparts. Any product for which we obtain marketing approval, clearance or authorization (and the activities related to
its production, distribution, and promotion, sale, and marketing) will be subject to continual review and periodic inspections by the
FDA and other regulatory bodies, which may include inspection of our manufacturing processes, complaint handling and adverse event reporting,
post-approval clinical data and promotional activities for such product. The FDA&#8217;s Medical Device Reporting, or MDR, regulations
require that we report to the FDA any incident in which our product may have caused or contributed to a death or serious injury, or in
which our product malfunctioned and, if the malfunction were to recur, it would likely cause or contribute to a death or serious injury.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, government regulations
specific to medical devices are wide ranging and govern, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product design, development, manufacture, and release;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">laboratory and clinical testing, labeling, packaging, storage and distribution;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product safety and efficacy;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">premarketing clearance or approval;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">record keeping;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product marketing, promotion and advertising, sales and distribution;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">post-marketing surveillance, including reporting of deaths or serious injuries and recalls and correction
and removals;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">post-market approval studies; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product import and export.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the FDA determines that
there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the
agency may issue a cease distribution and notification order and a mandatory recall order. We may also decide to recall a product voluntarily
if we find a material deficiency, including unacceptable risks to health, manufacturing defects, design errors, component failures, labeling
defects, or other issues. Recalls of our products could divert the attention of our management and have an adverse effect on our reputation,
financial condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We and certain of our suppliers
are also required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and other regulations which cover the methods and
documentation of the design, testing, production, control, selection and oversight of suppliers or contractors, quality assurance, labeling,
packaging, storage, complaint handling, shipping and servicing of our products. The FDA may enforce the QSR through announced (through
prior notification) or unannounced inspections.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Compliance with ongoing regulatory
requirements can be complex, expensive and time-consuming. Failure by us or one of our suppliers or distributors to comply with statutes
and regulations administered by the FDA, competent authorities and other regulatory bodies, or failure to take adequate response to any
observations, could result in, among other things, any of the following actions:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">warning letters or untitled letters that require corrective action;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">delays in approving, or refusal to approve, our systems;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">fines and civil or criminal penalties;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">unanticipated expenditures;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other
countries;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">suspension or withdrawal of clearance or approval by the FDA or other regulatory bodies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product recall or seizure;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">administrative detention;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">interruption of production, partial suspension, or complete shutdown of production;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">interruption of the supply of components from our key component suppliers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">operating restrictions;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">court consent decrees;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">FDA orders to repair, replace, or refund the cost of devices;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">injunctions; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">criminal prosecution.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The potential effect of these
events can in some cases be difficult to quantify. If any of these actions were to occur, it would harm our reputation and cause our product
sales and profitability to suffer. In addition, we believe events that could be classified as reportable events pursuant to MDR regulations
are generally underreported by physicians and users, and any underlying problems could be of a larger magnitude than suggested by the
number or types of MDRs filed by us. Furthermore, while we select and monitor our key component suppliers to ensure key quality objectives
are met and maintained, and performance of each key component supplier is continually re-evaluated based on objective evidence gathered
by our quality assurance department, we cannot be certain that our key component suppliers currently are or will always continue to be
in compliance with all applicable regulatory requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even if regulatory approval
or clearance of a product is granted, the approval or clearance may be subject to limitations on the indicated uses for which the product
may be marketed or contain requirements for costly post-marketing testing or surveillance to monitor the safety or effectiveness of the
product. Later discovery of previously unknown problems with our products, including software bugs, unanticipated adverse events or adverse
events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as the QSR,
MDR reporting, or other post-market requirements may result in restrictions on such products or manufacturing processes, withdrawal of
the products from the market, voluntary or mandatory recalls, fines, suspension of regulatory approvals, product seizures, injunctions,
the imposition of civil or criminal penalties, or criminal prosecution. In addition, our distributors have rights to create marketing
materials for their sales of our products, and may not adhere to contractual, legal or regulatory limitations that are imposed on their
marketing efforts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to fines, penalties and
injunctions if we are determined to be promoting the use of our products for unapproved or improper off-label uses or determined to have
made claims that are untruthful or misleading or not adequately substantiated.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe our marketing, promotional
and educational materials and practices comply with FDCA, Federal Trade Commission Act, and other applicable laws and regulations, as
may be amended from time to time. If the FDA, FTC or other regulatory body with competent jurisdiction over us, our activities or products
takes the position that our marketing, promotional or other materials or activities constitute improper promotion or marketing of an unapproved
or improper use, or that they contain untruthful, misleading, or inadequately substantiated statements or claims, such regulatory body
could request that we modify our materials or practices, or subject us to regulatory enforcement actions, including the issuance, depending
on the regulatory body and the nature of the alleged violation, of a warning letter, injunction, seizure, civil fine and criminal penalties.
It is also possible that other federal, state or foreign enforcement authorities might take action if they consider promotional, marketing
or other materials or activities to constitute improper promotion of an unapproved use, which could result in significant fines or penalties
under other statutory authorities, such as laws prohibiting false claims for reimbursement. Recent court decisions have impacted the FDA&#8217;s
enforcement activity regarding off-label promotion in light of First Amendment considerations; however, there are still significant risks
in this area in part due to the potential False Claims Act exposure and the FDA&#8217;s continued focus on ensuring devices are marketed
in a manner consistent with their FDA-required labeling.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is also possible that other
federal, state or foreign enforcement authorities might take action if they consider our educational and promotional activities or training
methods to constitute promotion of an off-label use, which could result in significant fines or penalties under other statutory authorities,
such as laws prohibiting false claims for reimbursement. In that event, our reputation could be damaged, and adoption of the products
could be impaired. Although our policy is to refrain from statements that could be considered off-label promotion of our products, if
cleared or approved, the FDA or another regulatory agency could disagree and conclude that we have engaged in off-label promotion. It
is also possible that other federal, state or foreign enforcement authorities might take action, including, but not limited to, through
a whistleblower action under the FCA, if they consider our business activities to constitute promotion of an off-label use, which could
result in significant penalties, including, but not limited to, criminal, civil or administrative penalties, treble damages, fines, disgorgement,
exclusion from participation in government healthcare programs, reporting requirements and compliance oversight if we become subject to
a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, and the curtailment or
restructuring of our operations. In addition, the off-label use of any products for which we receive approval or clearance may increase
the risk of product liability claims. Product liability claims are expensive to defend and could divert our management&#8217;s attention,
result in substantial damage awards against us, and harm our reputation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our current or future products may be subject
to product recalls even after receiving FDA clearance or approval. A recall of our products, either voluntarily or at the direction of
the FDA, or the discovery of serious safety issues with our products, could have a significant adverse impact on us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Medical devices can experience
performance problems in the field that require review and possible corrective action. The occurrence of component failures, manufacturing
errors, software errors, design defects or labeling inadequacies affecting a medical device could lead to a government-mandated or voluntary
recall by the device manufacturer, in particular when such deficiencies may endanger health. The FDA and similar governmental bodies in
other countries have the authority to require the recall of our products if we or our third-party manufacturers fail to comply with relevant
regulations pertaining to, among other things, manufacturing practices, labeling, advertising or promotional activities, or if new information
is obtained concerning the safety or efficacy of these products. For example, under the FDA&#8217;s MDR regulations, we are required to
report to the FDA any incident in which our products may have caused or contributed to a death or serious injury or in which our products
malfunctioned in a manner likely to cause or contribute to death or serious injury if that malfunction were to recur. Repeated adverse
events or product malfunctions may result in a voluntary or involuntary product recall, or administrative or judicial seizure or injunction,
when warranted. A government-mandated recall may be ordered if the FDA finds that there is a reasonable probability that the device would
cause serious, adverse health consequences or death. A voluntary recall by us could occur as a result of any material deficiency in a
device, such as manufacturing defects, labeling deficiencies, packaging defects or other failures to comply with applicable regulations,
such as a failure to obtain marketing approval or clearance before launching a new product. In general, if we decide to make a change
to our product, we are responsible for determining whether to classify the change as a recall. It is possible that the FDA could disagree
with our initial classification. The FDA requires that certain classifications of recalls be reported to the FDA within 10 working&#160;days
after the recall is initiated. If a change to a device addresses a violation of the federal Food, Drug, and Cosmetic Act, or FDCA, that
change would generally constitute a medical device recall and require submission of a recall report to the FDA.&#160;A future recall announcement
could harm our reputation with customers, potentially lead to product liability claims against us and negatively affect our sales. Any
corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, will require the dedication of our time
and capital, will distract management from operating our business and may harm our reputation and financial results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Recalls of any of our products
would divert managerial and financial resources and have an adverse effect on our reputation, results of operations and financial condition,
which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers&#8217; demands.
We may also be subject to product liability claims, be required to bear other costs, or be required to take other actions that may have
a negative impact on our future sales and our ability to generate profits. Companies are required to maintain certain records of recalls,
even if they are not reportable to the FDA.&#160;We may initiate voluntary recalls involving our products in the future that we determine
do not require notification to the FDA.&#160;If the FDA disagrees with our determinations, the FDA could require us to report those actions
as recalls. A future recall, withdrawal, or seizure of any product could materially and adversely affect consumer confidence in the Profusa
brand, lead to decreased demand for our products and negatively affect our sales. In addition, the FDA could take enforcement action for
failing to report recalls when they were conducted by us or one of our agents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Health care policy changes, including U.S.&#160;health
care reform legislation, may have a material adverse effect on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we do not currently
have a product on the market in the U.S.&#160;and do not make patient referrals or bill Medicare, Medicaid, or other government or commercial
third-party payors, we may be subject to a number of healthcare statutory and regulatory requirements, and therefore may be affected by
changes in health care laws and regulations. In response to increases in health care costs in recent&#160;years, there have been and continue
to be proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally,
to reform the U.S.&#160;health care system. Certain of these proposals could limit the prices we are able to charge for the products we
may commercialize or the amounts of reimbursement available for the products we may commercialize and could limit the acceptance and availability
of our products. Further, while the United&#160;States has begun shifting to pay-for-performance rather than fee-for-service models and
has been embracing many shared-risk arrangements, the Centers for Medicare&#160;&amp; Medicaid Services (CMS) and the Department of Health
and Human Services, Office of Inspector General (OIG) specifically excluded medical device manufacturers from utilizing the new, more
flexible Stark Law exceptions and Anti-Kickback Statute safe harbors under the Final Rules, part of the U.S.&#160;Department of Health
and Human Services&#8217; Regulatory Sprint to Coordinated Care, which were published on December&#160;2, 2020 in the Federal Register
and were largely effective January&#160;19, 2021. The exclusion of manufacturers from utilizing these exceptions and safe harbors may
not allow us to avail ourselves of immunity from liability under the laws, potentially inviting greater scrutiny over any potential shared
risk arrangements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;16, 2020 the
OIG published a Special Fraud Alert addressing manufacturer Speaker Programs signaling both a narrower government view of AKS compliance
with respect to such programs as well as the potential for increased enforcement in this space by government oversight agencies such as
the OIG and the Department of Justice (DOJ). We continue to assess industry response to the Special Fraud Alert and have and may continue
to make modifications to certain aspects of our speaker programs, which may have a detrimental impact on our ability to educate healthcare
providers about our products and to promote use of our products, which may lead to decreased product sales and negatively impact our business,
financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Comprehensive healthcare legislation,
signed into law in the United&#160;States in March&#160;2010, titled the Patient Protection and Affordable Care Act, as amended by the
Health Care and Education Affordability Reconciliation Act&#160;of&#160;2010, collectively, the ACA, imposes certain stringent compliance,
recordkeeping, and reporting requirements on companies in various sectors of the life sciences industry, and enhanced penalties for non-compliance.
There have been numerous legal and Congressional challenges to the law&#8217;s provisions. On June&#160;17, 2021, the U.S.&#160;Supreme
Court dismissed a legal challenge to the law brought by several states arguing that, without the individual mandate, the entire Affordable
Care Act ACA was unconstitutional. The Supreme Court dismissed the lawsuit without ruling on the merits of the states&#8217; constitutionality
arguments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other legislative changes have
been proposed and adopted in the U.S.&#160;since the ACA was enacted. In August&#160;2011, the Budget Control Act&#160;of&#160;2011, among
other things, created measures for spending reductions by the U.S.&#160;Congress. This includes aggregate reductions of Medicare payments
to providers of 2% per fiscal year, which went into effect in April&#160;2013. As a result of the COVID-19 pandemic, this reduction was
temporarily suspended from May&#160;1, 2020 through March&#160;31, 2022, with subsequent reductions to 1% from April&#160;1, 2022 until
June&#160;30, 2022. The 2% reduction was then reinstated and has been in effect since June&#160;30, 2022, and will remain in effect (with
additional reductions of 2.25% in the first half of 2030 and 3% in the second half of 2030 to offset the COVID-19 suspension) until 2031
unless additional Congressional action is taken. In January&#160;2013, the American Taxpayer Relief Act&#160;of&#160;2012 was enacted
which, among other things, further reduced Medicare payments to several providers, including hospitals and outpatient clinics, and increased
the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot predict what additional
new legislation, agency priorities, and rulemakings may be on the horizon as the United&#160;States continues to reassess how it pays
for healthcare. As a result, we cannot quantify or predict what impact any changes might have on our business and results of operations.
However, any changes that lower reimbursement for our products could materially and adversely affect our business, financial condition
and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other legal, regulatory and
commercial policy influences are subjecting our industry to significant changes, and we cannot predict whether new regulations or policies
will emerge from U.S.&#160;federal or state governments, foreign governments, or third-party payors. Third-party payors in the United&#160;States
often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies. There may be significant
delays in obtaining coverage and reimbursement for products we are able to commercialize, as the process of determining coverage and reimbursement
is often time consuming and costly which will require us to provide scientific and clinical support for the use of our products to each
payor separately, with no assurance that coverage or adequate reimbursement will be obtained. It is difficult to predict at this time
what government authorities and third-party payors will decide with respect to coverage and reimbursement for our products. Government
and third-party payors may, in the future, consider healthcare policies and proposals intended to curb rising healthcare costs, including
those that could significantly affect reimbursement for healthcare products such as our systems. These policies have included, and may
in the future include: basing reimbursement policies and rates on clinical outcomes, the comparative effectiveness, and costs, of different
treatment technologies and modalities; imposing price controls and taxes on medical device providers; and other measures. Future significant
changes in the healthcare systems in the United&#160;States or elsewhere could also have a negative impact on the demand for our current
and future products. These include changes that may reduce reimbursement rates for our products and changes that may be proposed or implemented
by the current or future laws or regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to federal, state and foreign
laws prohibiting &#8220;kickbacks&#8221; and false or fraudulent claims, and other fraud and abuse laws, transparency laws, and other
health care laws and regulations, which, if violated, could subject us to substantial penalties. Additionally, any challenge to or investigation
into our practices under these laws could cause adverse publicity and be costly to respond to, and thus could harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we do not currently
have an approved or commercialized product in the U.S., our relationships with customers and third-party payors for our products, once
approved and commercialized, may be subject to broadly applicable fraud and abuse and other health care laws and regulations that may
constrain our sales, marketing and other promotional activities by limiting the kinds of financial arrangements, including sales programs
and certain customer and product support programs, we may have with hospitals, physicians or other purchasers of medical devices. Other
federal and state laws generally prohibit individuals or entities from knowingly presenting, or causing to be presented, claims for payment
from Medicare, Medicaid, or other third-party payors that are false or fraudulent, or are for items or services that were not provided
as claimed. These laws include, among others, the federal Anti-Kickback Statute, the federal civil False Claims Act, other federal health
care false statement and fraud statutes, the federal Physician Payments Sunshine Act, the Civil Monetary Penalties Law, and analogous
fraud and abuse and transparency laws in most states. While the federal laws generally apply only to products or services for which payment
may be made by a federal healthcare program, state laws often apply regardless of whether federal funds may be involved.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we believe and make every
effort to ensure that our business arrangements with third parties and other activities and programs comply with all applicable laws,
these laws are complex, and our activities may be found not to be compliant with one or more of these laws, which may result in significant
civil, criminal and/or administrative penalties, fines, damages and exclusion from participation in federal health care programs. Even
an unsuccessful challenge or investigation into our practices could cause adverse publicity, and be costly to respond to, and thus could
have a material adverse effect on our business, financial condition and results of operations. Our compliance with Medicare and Medicaid
regulations may be reviewed by federal or state agencies, including the OIG, CMS, and DOJ, or may be subject to whistleblower lawsuits
under federal and state false claims laws. To ensure compliance with Medicare, Medicaid and other regulations, government agencies conduct
periodic audits of the Company to ensure compliance with various supplier standards and billing requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Similarly, our international
operations are subject to the provisions of the FCPA, which prohibits U.S.&#160;companies and their intermediaries from making payments
in violation of law to non-U.S.&#160;government officials for the purpose of obtaining or retaining business or securing any other improper
advantage. In many countries, the healthcare professionals that medical device distributors regularly interact with may meet the definition
of a foreign official for purposes of the FCPA.&#160;International business operations are also subject to various other international
anti-bribery laws such as the U.K.&#160;Anti-Bribery Act. Despite meaningful measures that we undertake to facilitate lawful conduct,
which include training and compliance programs and internal policies and procedures, we may not always prevent unauthorized, reckless
or criminal acts by our employees or agents, or employees or agents of businesses or operations we may acquire. Violations of these laws,
or allegations of such violations, could disrupt operations, involve significant management distraction and have a material adverse effect
on our business, financial condition and results of operations, among other adverse consequences.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes to the regulatory landscape may
impact our ability to obtain marketing authorization for future product developments.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Development or changes to the
FDA or foreign regulatory approval standards and processes, including both legal and policy changes, could also delay or prevent the approval
of our products submitted for review. For example, as part of the 21<sup>st</sup> Century Cures Act passed in 2016, Congress enacted several
reforms that further affect medical device regulation both pre- and post-approval, and FDA implementation and development of guidance
in many areas is still ongoing. In addition, the FDA is in the process of reviewing the 510(k)&#160;approval process and criteria and
has announced initiatives to improve the current pre- and post-market regulatory processes and requirements associated with infusion pumps
and other home-use medical devices. As part of this effort, the FDA is reviewing the adverse event reporting and recall processes for
insulin pumps. Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future
products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute
existing products. The data contained in our submissions, including data drawn from our clinical trials, may not be sufficient to support
clearance or approval of our products or additional or expanded indications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Medical device company stock
prices have declined significantly in certain circumstances where companies have failed to meet expectations in regard to the timing of
regulatory approval. If the FDA&#8217;s response causes product approval delays, or is not favorable for any of our products, our stock
price (and the market price of our senior convertible notes) could decline substantially. It is uncertain how these potential changes
may impact our ability to gain clearance or approval from FDA for our products in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, legislation
is drafted and introduced in Congress that could significantly change the statutory provisions governing the regulatory approval, manufacture
and marketing of regulated products or the reimbursement thereof. In addition, the FDA may change its clearance and approval policies,
adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay approval or clearance of
our future products under development or impact our ability to modify our currently cleared products on a timely basis. Any new regulations
or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of planned or future products.
It is impossible to predict whether legislative changes will be enacted or FDA regulations, guidance or interpretations changed, and what
the impact of such changes, if any, may be.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FDA regulations and guidance
are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Any new statutes, regulations
or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of any future products
or make it more difficult to obtain clearance or approval for, manufacture, market or distribute our products. We cannot determine what
effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our
business in the future. Such changes could, among other things, require: additional testing prior to obtaining clearance or approval;
changes to manufacturing methods; recall, replacement or discontinuance of our products; or additional record keeping.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The FDA&#8217;s and other regulatory
authorities&#8217; policies may change and additional government regulations may be promulgated that could prevent, limit or delay regulatory
clearance or approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may
arise from future legislation or administrative action, either in the United&#160;States or abroad.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any change in the laws or regulations
that govern the clearance and approval processes relating to our current, planned and future products could make it more difficult and
costly to obtain clearance or approval for new products or to produce, market and distribute existing products. Significant delays in
receiving clearance or approval or the failure to receive clearance or approval for any new products would have an adverse effect on our
ability to expand our business. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements
or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing clearance that we may have obtained and
we may not achieve or sustain profitability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our failure to comply with laws, regulations
and contract requirements relating to reimbursement of health care goods and services may subject us to penalties and adversely impact
our reputation, business, financial condition and cash flows.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to laws, regulations
and contractual requirements regulating the provision of, and reimbursement for, health care goods and services, both in our capacity
as a medical device manufacturer and/or as a supplier of covered items and services to federal health care program beneficiaries, with
respect to which items and services we submit claims for reimbursement from such programs. The laws and regulations of health care goods
and services that apply to us, including those described above, are subject to evolving interpretations and enforcement discretion. As
part of our compliance program, we have reviewed our sales contracts, marketing materials, referral source relationships, programmatic
offerings, and billing practices (among others) to reduce the risk of non-compliance with these and other foreign, federal and state laws.
If a governmental authority was to conclude that we are not in compliance with applicable laws and regulations, we and our officers, directors
and employees could be subject to criminal and civil penalties, including, for example, exclusion from participation as a supplier of
product to beneficiaries covered by federal healthcare programs, including but not limited to Medicare and Medicaid. Any failure to comply
with laws, regulations or contractual requirements relating to reimbursement and health care goods and services could adversely affect
our reputation, business, financial condition and cash flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to complex and evolving U.S.&#160;and
foreign laws and regulations and other requirements regarding privacy, data protection, security, and other matters. Many of these laws
and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary
penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to a number
of foreign, federal and state laws and regulations protecting the use, disclosure and confidentiality of certain patient health and personal
information, including patient records, and restricting the use and disclosure of that protected information. These laws include foreign,
federal and state medical privacy laws, breach notification laws and consumer protection laws. As our customer base grows to include U.S.&#160;federal
government agencies, Profusa may also need comply with Federal Risk and Authorization Management Program and Cybersecurity Maturity Model
Certification requirements. These frameworks impose stringent cybersecurity standards and potentially significant non-compliance penalties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, foreign data protection,
privacy, and other laws and regulations can be more restrictive than those in the United&#160;States. For example, data localization laws
in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that
country. We may be subject to inquiries, investigations and audits in Europe and around the world, particularly in the areas of consumer
and data protection, which will arise in the ordinary course of business and may increase in frequency as we continue to grow and expand
our operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make
our products less useful to our customers, require us to incur substantial costs, expose us to unanticipated civil or criminal liability,
or cause us to change our business practices. These changes or increased costs could negatively impact our business and results of operations
in material ways.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the ordinary course of our
business, we collect and store sensitive data, such as our proprietary business information and that of our clients, contractors, vendors
and others as well as personally identifiable information of our customers, vendors and others, which data may include full names, social
security numbers, addresses, and birth dates, in our data centers and on our networks. Our employees, contractor and vendors may also
have access to and may use personal health information in the ordinary course of our business. The secure processing, maintenance and
transmission of this information is critical to our operations. Despite our security measures and business controls, our information technology
and infrastructure may be vulnerable to attacks by hackers, breaches due to employee, contractor or vendor error, or malfeasance or other
disruptions or subject to the inadvertent or intentional unauthorized release of information. Any such occurrence could compromise our
networks and the information stored thereon could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other
loss of information could result in legal claims or proceedings, and liability under laws that protect the privacy of personal information
and regulatory penalties, disrupt our operations and the services we provide to our clients or damage our reputation, any of which could
adversely affect our profitability, revenue and competitive position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As we grow and expand our administrative,
customer support or IT support services, we may also utilize the services of personnel and contractors located outside of the United&#160;States
to perform certain functions. While we make every effort to review our applicable contracts and other payor requirements, a local, state,
or federal government agency or one of our customers may find the use of offshore resources to be a violation of a legal or contractual
requirement, which could result in termination of the contractual relationship, penalties, or changes in our business operations that
could adversely affect our business, financial condition, and results of operations. Additionally, while we have implemented industry
standard security measures for offshore access to protected health information and other personal information, unauthorized access or
disclosure of such information by offshore personnel could result in legal claims or proceedings, and liability under laws that protect
the privacy of personal information and regulatory penalties, disrupt our operations and the services we provide to our clients, damage
to our reputation or result in the termination of contractual relationships, penalties or the loss of coverage, any of which could adversely
affect our profitability, revenue and competitive position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Security breaches and other disruptions
that compromise our information and expose us to liability, could cause our business and reputation to suffer and could subject us to
substantial liabilities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrative Simplification
Provisions of the Health Insurance Portability and Accountability Act&#160;of&#160;1996, as amended, and implementing regulations, or
HIPAA, extensively regulate the use and disclosure of individually identifiable health information, known as &#8220;protected health information,&#8221;
and require covered entities, including health plans and most health care providers, to implement administrative, physical and technical
safeguards to protect the security of such information. Certain provisions of the security and privacy regulations apply to business associates
(entities that handle protected health information on behalf of covered entities), and business associates are subject to direct liability
for violation of these provisions. In addition, a covered entity may be subject to penalties as a result of a business associate violating
HIPAA, if the business associate is found to be an agent of the covered entity. Profusa is a covered entity under HIPAA and may also function
in a business associate capacity to other covered entities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Covered entities must report
breaches of unsecured protected health information to affected individuals without unreasonable delay and notification must also be made
to the U.S.&#160;Department of Health&#160;&amp; Human Services, Office for Civil Rights, or OCR and, in certain situations involving
large breaches, to the media. Various U.S.&#160;state laws and regulations may also require us to notify affected individuals and state
agencies in the event of a data breach involving individually identifiable information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Violations of the HIPAA privacy
and security regulations may result in criminal and civil penalties. The OCR enforces the regulations and performs compliance audits.
In addition to enforcement by OCR, state attorneys general are authorized to bring civil actions seeking either injunction or damages
in response to violations that threaten the privacy of state residents. We follow and maintain a HIPAA compliance plan, which we believe
complies with the HIPAA privacy and security regulations, but there can be no assurance that OCR or other regulators will agree. The HIPAA
privacy regulations and security regulations have and will continue to impose significant costs on us in order to comply with these standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are numerous other laws
and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. We also remain subject
to federal or state privacy-related laws that are more restrictive than the regulations issued under HIPAA.&#160;These laws vary and could
impose additional penalties. For example, the Federal Trade Commission uses its consumer protection authority to initiate enforcement
actions in response to alleged privacy and data security violations. The California Consumer Privacy Act, or CCPA, which came into effect
January&#160;1, 2020 and was amended and expanded by the California Privacy Rights Act, or CPRA, which came into effect on January&#160;1,
2023. The CCPA, including as amended by CPRA, among other things, create new data privacy obligations for covered companies and provide
new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also
creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with
a data breach. As of January&#160;1, 2023, the CCPA applies broadly to California employees and personal information of business contacts,
which we anticipate will increase our compliance costs. It remains unclear what, if any, additional modifications will be made to this
legislation or how it will be interpreted and regulations implementing CPRA amendments will not be finalized before CPRA amendments come
into effect. Therefore, the effects of the CCPA and CPRA are significant and will likely require us to modify our data processing practices,
and may cause us to incur substantial costs and expenses to comply, particularly given our base of operations in California. There are
also a number of other legislative proposals worldwide, including in the United&#160;States at both the federal and state level, that
could impose additional and potentially conflicting obligations in areas affecting our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also subject to laws
and regulations in foreign countries covering data privacy and other protection of health and employee information that may be more onerous
than corresponding U.S.&#160;laws, including in particular the laws of Europe.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For instance, in the European
Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient
data across the healthcare industry became effective in May&#160;2018. The EU General Data Protection Regulation, or GDPR, applies across
the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory
authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20&#160;million euros,
or up to 4% of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies
processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the
company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties,
or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview
are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. For example,
following a decision of the Court of Justice of the EU in October&#160;2015, the transfer of personal data to US companies that had certified
as members of the US Safe Harbor Scheme was declared invalid. In July&#160;2016, the European Commission adopted the EU-US Privacy Shield
Framework, or the Privacy Shield Framework, which replaced the US Safe Harbor Scheme. On July&#160;16, 2020, the Court of Justice of the
European Union issued a decision that declared the Privacy Shield Framework invalid, and will also result in additional compliance obligations
for companies that implement standard contractual clauses to ensure a valid basis for the transfer of personal data outside of Europe.
We expect continued costs associated with maintaining compliance with GDPR into the future, and these provisions as interpreted by EU
agencies, could negatively impact our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the laws discussed
above, we may see more stringent state and federal privacy legislation in 2022 and beyond, as the increased cyber attacks during the COVID-19
pandemic have once again put a spotlight on data privacy and security in the U.S.&#160;and other jurisdictions. We cannot predict where
new legislation might arise, the scope of such legislation, or the potential impact to our business and operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cybersecurity risks and cyber incidents
could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation
and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation
and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cyber incidents can result
from deliberate attacks or unintentional events. We collect and store on our networks sensitive information, including intellectual property,
proprietary business information and personally identifiable information of individuals, such as our customers and employees. The secure
maintenance of this information and technology is critical to our business operations. We have implemented multiple layers of security
measures to protect the confidentiality, integrity and availability of this data and the systems and devices that store and transmit such
data. We utilize current security technologies, and our defenses are monitored and routinely tested internally and by external parties.
Additionally, we use third party products such as Amazon Cognito that provide advanced user authentication services that aim to prevent
bad actors from accessing our systems. Despite these efforts, threats from malicious persons and groups, new vulnerabilities and advanced
new attacks against information systems create risk of cybersecurity incidents. These incidents can include, but are not limited to, gaining
unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational
disruption. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently
and may not immediately produce signs of intrusion, we may be unable to anticipate these incidents or techniques, timely discover them,
or implement adequate preventative measures. When we leverage third-party tools to manage security features, we add an additional potential
attack surface that is capable of being exploited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In response to the COVID-19
pandemic, we have modified our business practices and implemented telework policies wherever possible for appropriate categories of &#8220;nonessential&#8221;
employees to minimize the disruption to our operations, to the extent possible. The continuation of these telework policies means additional
operational risk, including increased cybersecurity risk. These cyber risks include, among other risks, greater phishing, malware, and
other cybersecurity attacks, vulnerability to or disruptions of our information technology infrastructure and systems to support remote
operations, increased risk of unauthorized access, use or dissemination of confidential information, limited ability to restore the systems
in the event of a systems failure or interruption, greater risk of a security breach resulting in destruction, alteration or misuse of
valuable information, including proprietary business information and personally identifiable information of individuals, all of which
could expose us to risks of data or financial loss, litigation and liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These threats can come from
a variety of sources, ranging in sophistication from an individual hacker to malfeasance by employees, consultants or other service providers
to criminal or other unauthorized threat actors, including state-sponsored attacks. Cyber threats may be generic, or they may be custom-crafted
against our information systems. Over the past several&#160;years, cyber attacks have become more prevalent and much harder to detect
and defend against. These threat actors may be able to penetrate our security measures, breach our information technology systems, misappropriate
or compromise confidential and proprietary information of our Company and our customers, cause system disruptions and shutdowns, or introduce
ransomware, malware, or vulnerabilities into our products, systems, and networks or those of our customers and partners. Our network and
storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of
data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service
providers. In addition, hardware, software or applications we develop or procure from third parties may contain defects in design or manufacture
or other problems that could unexpectedly compromise information security or other problems that unexpectedly could interfere with the
operation of our products. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or
other forms of deceiving our employees, contractors and temporary staff.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are and may continue to
be subject to cybersecurity incidents that bypass our security measures. Such incidents may impact the integrity, availability or privacy
of personal health information or other data subject to privacy laws or disrupt our information systems, devices or business, including
our ability to deliver services to our customers. As a result, cybersecurity, physical security and the continued development and enhancement
of our controls, processes and practices designed to protect our enterprise, information systems and data from attack, damage or unauthorized
access remain a priority for us. As cyber threats continue to evolve, we may be required to expend significant additional resources to
continue to modify or enhance our protective measures or to investigate and remediate any cybersecurity vulnerabilities. The occurrence
of any of these events could result in:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">harm to customers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">business interruptions and delays;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the loss, misappropriation, corruption or unauthorized access of data;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">litigation, including potential class action litigation, and potential liability under privacy, security
and consumer protection laws or other applicable laws;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reputational damage;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">increase to insurance premiums; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">foreign, federal and state governmental inquiries, any of which could have a material, adverse effect
on our financial position and results of operations and harm our business reputation.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failure to protect our information technology
infrastructure against cyber-based attacks, network security breaches, service interruptions, or data corruption could significantly disrupt
our operations and adversely affect our business and operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We rely on information technology
and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or
support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing,
and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results
of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. System failures
or outages, including any potential disruptions due to significantly increased global demand on certain cloud-based systems during or
as a result of the COVID-19 pandemic, or failures to adequately scale our data platforms and architectures support patient care could
compromise our ability to perform these functions in a timely manner, which could harm our ability to conduct business or delay our financial
reporting. Such failures could materially adversely affect our operating results and financial condition. Our information technology systems,
some of which are managed by third parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, ransomware
or other malware, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components
thereof, power outages, hardware failures, telecommunication failures, user errors or catastrophic events. Although we have developed
systems and processes that are designed to protect customer information and prevent data loss and other security breaches, including systems
and processes designed to reduce the impact of a security breach at a third-party vendor, such measures cannot provide absolute security.
In addition, certain countries have implemented or may implement legislative and technological actions that either do or can effectively
regulate access to the internet, including the ability of internet service providers to limit access to specific websites or content.
Other countries have attempted or are attempting to change or limit the legal protections available to businesses that depend on the internet
for the delivery of their services. If our systems are breached or suffer severe damage, disruption or shutdown and we are unable to effectively
resolve the issues in a timely manner, our business and operating results may significantly suffer and we may be subject to litigation,
government enforcement actions and other actions for which we could face financial liability and other adverse consequences which may
include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">additional government oversight of our operations;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">loss of existing customers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">difficulty in attracting new customers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">problems in determining product cost estimates and establishing appropriate pricing;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">difficulty in preventing, detecting, and controlling fraud;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">disputes with customers, physicians, and other health care professionals;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">increases in operating expenses, incurrence of expenses, including notification and remediation costs;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">regulatory fines or penalties;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">individual actions or class actions for damages;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">loss of revenues (including through loss of coverage or reimbursement);</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product development delays;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">disruption of key business operations; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">diversion of attention of management and key information technology resources.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Inadequate funding for the FDA, the SEC
and other government agencies could hinder their ability to hire and retain key leadership and other personnel, thereby preventing new
products and services from being developed or commercialized in a timely manner or otherwise preventing those agencies from performing
normal business functions on which the operation of our business may rely, which could negatively impact our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ability of the FDA to review
and approve or clear new medical device products can be affected by a variety of factors, including government budget and funding levels,
ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review
times at the agency have fluctuated in recent&#160;years as a result. In addition, government funding of the SEC and other government
agencies on which our operations may rely, including those that fund research and development activities, is subject to the political
process, which is inherently fluid and unpredictable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Disruptions at the FDA and
other agencies may also increase the time necessary for new products to be reviewed and/or approved by necessary government agencies,
which would adversely affect our business. For example, over the last several&#160;years, the U.S.&#160;government has shut down several
times, and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical employees and stop critical activities.
Separately, in response to the COVID-19 pandemic, in March&#160;2020, the FDA temporarily postponed routine surveillance inspections of
domestic manufacturing facilities and provided guidance regarding the conduct of clinical trials, which has since been further updated
and is being refreshed on a periodic basis. The FDA has also noted that it is continuing to ensure timely reviews of applications for
medical products during the COVID-19 pandemic in line with its user fee performance goals and conducting &#8220;mission-critical&#8221;
domestic and foreign inspections to ensure compliance of manufacturing facilities with FDA quality standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subsequently, in July&#160;2020,
the FDA announced its intention to resume certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization
system. The FDA intends to use this risk-based assessment system to identify the categories of regulatory activity that can occur within
a given geographic area, ranging from mission-critical inspections to resumption of all regulatory activities. The agency&#8217;s rating
system is used to assist in determining when and where it is safest to conduct such inspections based on data about the virus&#8217;s
trajectory in a given state and locality and the rules and guidelines that are put in place by state and local governments. The FDA&#8217;s
assessment of whether an inspection is mission-critical considers many factors related to the public health benefit of U.S.&#160;patients
having access to the product subject to inspection, including whether the products are used to diagnose, treat, or prevent a serious disease
or medical condition for which there is no other appropriate substitute. Both for-cause and pre-approval inspections can be deemed mission-critical.
The COVID-19 public health emergency determinations and declarations ended May&#160;11, 2023. This is nonetheless subject to change.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Risks Related to Intellectual Property Protection
and Use</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become subject to claims of infringement
or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us
to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive
relief. We may also be subject to other claims or suits.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Third parties may assert infringement
or misappropriation claims against us with respect to our current or future products. We are aware of numerous patents issued to third
parties that may relate to aspects of our business, including the design and manufacture of CGM sensors and membranes, as well as methods
for oxygen and continuous glucose monitoring. Whether a product infringes a patent involves complex legal and factual issues, the determination
of which is often uncertain. Therefore, we cannot be certain that we have not infringed the intellectual property rights of such third
parties or others. Our competitors may assert that our systems or the methods we employ in the use of our systems are covered by U.S.&#160;or
foreign patents held by them. This risk is exacerbated by the fact that there are numerous issued patents and pending patent applications
relating to our systems in the medical technology field. Because patent applications may take&#160;years to issue, there may be applications
now pending of which we are unaware that may later result in issued patents that our products infringe. There could also be existing patents
of which we are unaware that one or more components of our system may inadvertently infringe. As the number of competitors in the market
grows, the possibility of patent infringement by us or a patent infringement claim against us increases. If we are unable to successfully
defend any such claims as they may arise or enter into or extend settlement and license agreements on acceptable terms or at all, our
business operations may be harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any infringement or misappropriation
claim could place significant strain on our financial resources, divert management&#8217;s attention from our business and harm our reputation.
In addition, if the relevant patents are upheld as valid and enforceable and we are found to infringe such patents, we could be prohibited
from selling any of our products that is found to infringe unless we could obtain licenses to use the technology covered by the patent
or are able to design around the patent. We may be unable to obtain a license on terms acceptable to us, if at all, and we may not be
able to redesign our products to avoid infringement. We may be unable to maintain or renew licenses on terms acceptable to us, if at all,
and we may be prohibited from selling any of our products that required the technology covered by the relevant licensed patents. Even
if we are able to redesign our products to avoid an infringement claim, we may not receive FDA approval for such changes in a timely manner
or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any adverse determination in
litigation or derivation proceedings to which we are or may become a party relating to patents or other intellectual property rights could
subject us to significant liabilities to third parties or require us to seek licenses from other third parties. If we are found to infringe
third-party patents, a court could order us to pay damages to compensate the patent owner for the infringement, such as a reasonable royalty
amount and/or profits lost by the patent owners, along with prejudgment and/or post-judgment interest. Furthermore, if we are found to
willfully infringe third-party patents, we could, in addition to other penalties, be required to pay treble damages; and if the court
finds the case to be exceptional, we may be required to pay attorneys&#8217; fees for the prevailing party. If we are found to infringe
third-party copyrights or trademarks or misappropriate third-party trade secrets, based on the intellectual property at issue, a court
could order us to pay statutory damages, actual damages, or profits, such as reasonable royalty or lost profits of the owners, unjust
enrichment, disgorgement of profits, and/or a reasonable royalty, and the court could potentially award attorneys&#8217; fees or exemplary
or enhanced damages. Although patent and intellectual property disputes in the medical device area have often been settled through licensing
or similar arrangements, costs associated with such arrangements may be substantial and would likely include ongoing royalties. We may
be unable to obtain necessary intellectual property licenses on satisfactory terms. If we do not obtain any such necessary licenses, we
may not be able to redesign our products to avoid infringement and any redesign may not receive FDA approval or other requisite marketing
authorization in a timely manner or at all. Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary
intellectual property licenses could prevent us from manufacturing and selling our products, which would have a significant adverse impact
on our business. If litigation were to be initiated by intellectual property owners, there could significant legal fees and costs incurred
in defending litigation (which may include filing administrative actions to attack the intellectual property) as well as a potential monetary
settlement payment to the owners, even if the matter is resolved before going to trial. Moreover, the owners may take an overly aggressive
approach and/or include multiple allegations in a single litigation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, from time to time,
we are subject to various claims, complaints and legal actions arising out of the ordinary course of business, including commercial insurance,
product liability or employment-related matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also, from time to time, we
may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our
business, including commercial and employment-related matters. We do not believe we are party to any currently pending legal proceedings,
the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be
no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material
adverse effect on our business, financial condition or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our inability to adequately protect our
intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair
our ability to compete.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success and our ability
to compete depend, in part, upon our ability to maintain the proprietary nature of our technologies. We rely on a combination of patent,
copyright and trademark law, and trade secrets and nondisclosure agreements to protect our intellectual property. However, such methods
may not be adequate to protect us or permit us to gain or maintain a competitive advantage. Our patent applications may not issue as patents
in a form that will be advantageous to us, or at all. Our issued patents, and those that may issue in the future, may be challenged, invalidated
or circumvented, which could limit our ability to stop competitors from marketing related products. In addition, there are numerous changes
to the patent laws and proposed changes to the rules of the U.S.&#160;Patent and Trademark Office, which may have a significant impact
on our ability to protect our technology and enforce our intellectual property rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To protect our proprietary
rights, we may in the future need to assert claims of infringement against third parties. The outcome of litigation to enforce our intellectual
property rights in patents, copyrights, trade secrets or trademarks is highly unpredictable, could result in substantial costs and diversion
of resources, and could have a material adverse effect on our business, financial condition and results of operations regardless of the
final outcome of such litigation. In the event of an adverse judgment, a court could hold that some or all of our asserted intellectual
property rights are not infringed, or are invalid or unenforceable, and could award attorney fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Despite our efforts to safeguard
our unpatented and unregistered intellectual property rights, we may not succeed in doing so or the steps taken by us in this regard may
not be adequate to detect or deter misappropriation of our technology or to prevent an unauthorized third party from copying or otherwise
obtaining and using our products, technology or other information that we regard as proprietary. In addition, third parties may be able
to design around our patents. Furthermore, the laws of foreign countries may not protect our proprietary rights to the same extent as
the laws of the United&#160;States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be involved in lawsuits to protect
or enforce our patents or the patents of our licensors, which could be expensive, time-consuming and unsuccessful.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Competitors may infringe on
our patents or the patents that we license. In the event of infringement or unauthorized use, we may file one or more infringement lawsuits,
which can be expensive and time-consuming. An adverse result in any such litigation proceedings could put one or more of our patents at
risk of being invalidated, being found to be unenforceable or being interpreted narrowly and could put our patent applications at risk
of not issuing. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation,
there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of our competitors are
larger than we are and have substantially greater resources. They are, therefore, likely to be able to sustain the costs of complex patent
litigation longer than we could. In addition, the uncertainties associated with litigation could have a material adverse effect on our
ability to raise any funds necessary to continue our operations, continue our internal research programs, in-license needed technology,
or enter into development partnerships that would help us bring our products to market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to claims that our employees,
consultants or independent contractors have wrongfully used or disclosed alleged trade secrets of their other clients or former employers
to us, which could subject us to costly litigation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As is common in the medical
device industry, we engage the services of consultants and independent contractors to assist us in the development of our products. Many
of these consultants and independent contractors were previously employed at, or may have previously provided or may be currently providing
consulting or other services to, universities or other technology, biotechnology or pharmaceutical companies, including our competitors
or potential competitors. We may become subject to claims that we, a consultant or an independent contractor inadvertently or otherwise
used or disclosed trade secrets or other information proprietary to their former employers or their former or current clients. We may
similarly be subject to claims stemming from similar actions of an employee, such as one who was previously employed by another company,
including a competitor or potential competitor. Litigation may be necessary to defend against these claims. Even if we are successful
in defending against these claims, litigation could result in substantial costs and be a distraction to our management team. If we were
to be unsuccessful, we could lose access or exclusive access to valuable intellectual property.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to protect our intellectual
property rights throughout the world, which could materially, negatively affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Filing, prosecuting and defending
patents on current and future products in all countries throughout the world would be prohibitively expensive, and our intellectual property
rights in some countries outside the United&#160;States can be less extensive than those in the United&#160;States. In addition, the laws
of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United&#160;States.
Consequently, regardless of whether we are able to prevent third parties from practicing our inventions in the United&#160;States, we
may not be able to prevent third parties from practicing our inventions in all countries outside the United&#160;States, or from selling
or importing products made using our inventions in and into the United&#160;States or other jurisdictions. Competitors may use our technologies
in jurisdictions where we have not pursued and obtained patent protection to develop their own products, and further, may export otherwise
infringing products to territories where we have patent protection, but enforcement is not as strong as it is in the United&#160;States.
These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient
to prevent them from competing. Even if we pursue and obtain issued patents in particular jurisdictions, our patent claims or other intellectual
property rights may not be effective or sufficient to prevent third parties from competing. Patent protection must ultimately be sought
on a country-by-country basis, which is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not
to seek patent protection in certain countries, and we will not have the benefit of patent protection in such countries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many companies have encountered
significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries,
particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, which could
make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights
generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts
and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent
applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that
we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce
our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual
property that we develop or license and may adversely impact our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we also face the
risk that our products are imported or reimported into markets with relatively higher prices from markets with relatively lower prices,
which would result in a decrease of sales and any payments we receive from the affected market. Recent developments in U.S.&#160;patent
law have made it more difficult to stop these and related practices based on theories of patent infringement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to protect the confidentiality
of our trade secrets, the value of our technology could be materially adversely affected and our business could be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We rely heavily on trade secrets
and confidentiality agreements to protect our unpatented know-how, technology and other confidential proprietary information, and to maintain
our competitive position. However, trade secrets and know-how can be difficult to protect. In particular, we anticipate that with respect
to our technologies, these trade secrets and know-how will over time be disseminated within the industry through independent development,
the publication of journal articles describing the methodology, and the movement of personnel from academic to industry scientific positions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to pursuing patents
on our technology, we take steps to protect our intellectual property and proprietary technology by entering into agreements, including
confidentiality agreements, non-disclosure agreements and intellectual property assignment agreements, with our employees, consultants,
academic institutions, corporate partners and, when needed, our advisers. However, we cannot be certain that such agreements have been
entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information
will not be disclosed or that competitors or other third parties will not otherwise gain access to our trade secrets or independently
develop substantially equivalent information and techniques. For example, any of these parties may breach the agreements and disclose
our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Such agreements
may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of
unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure, which
could materially and adversely impact our ability to establish or maintain a competitive advantage in the market, and our business, financial
condition, results of operations and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Monitoring unauthorized disclosure
is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce
a claim that a third party had wrongfully obtained and was using our trade secrets, it would be expensive and time-consuming, it could
distract our personnel, and the outcome would be unpredictable. In addition, courts outside the United&#160;States may be less willing
to protect trade secrets or may not recognize certain claims of intellectual property infringement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also seek to preserve the
integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical
and electronic security of our information technology systems, but it is possible that these security measures could be breached. If any
of our confidential proprietary information were to be lawfully obtained or independently developed by a competitor or other third party,
absent patent and copyright protection, we would have no right to prevent such competitor from using that technology or information to
compete with us, which could harm our competitive position. Competitors or third parties could purchase our products and attempt to replicate
some or all of the competitive advantages we derive from our development efforts, design around our protected technology, develop their
own competitive technologies that fall outside the scope of our intellectual property rights or independently develop our technologies
without reference to our trade secrets. If any of our trade secrets were to be disclosed to or independently discovered by a competitor
or other third party, it could materially and adversely affect our business, financial condition, results of operations and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Obtaining and maintaining our patent protection
depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent
agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The USPTO and various foreign
governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the
patent process. There are situations in which noncompliance can result in abandonment or lapse of a patent or patent application, resulting
in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market
earlier than would otherwise have been the case. In some cases, our licensors may be responsible for, for example, these payments, thereby
decreasing our control over compliance with these requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may need or may choose to obtain licenses
from third parties to advance our research or allow commercialization of our current or future products, and we cannot provide any assurances
that we would be able to obtain such licenses.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may need or may choose to
obtain licenses from third parties to advance our research or allow commercialization of our current or future products, and we cannot
provide any assurances that third-party patents do not exist that might be enforced against our current or future products in the absence
of such a license. We may fail to obtain any of these licenses on commercially reasonable terms, if at all. Even if we are able to obtain
a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. If we could not obtain
a license, we may be required to expend significant time and resources to develop or license replacement technology. If we are unable
to do so, we may be unable to develop or commercialize the affected products, which could materially harm our business and the third parties
owning such intellectual property rights could seek either an injunction prohibiting our sales, or, with respect to our sales, an obligation
on our part to pay royalties and/or other forms of compensation. Licensing intellectual property involves complex legal, business and
scientific issues. Disputes may arise between us and our licensors regarding intellectual property subject to a license agreement, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the scope of rights granted under the license agreement and other interpretation-related issues;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">whether and the extent to which our technology and processes infringe on intellectual property of the
licensor that is not subject to the licensing agreement;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our right to sublicense patent and other rights to third parties under collaborative development relationships;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our diligence obligations with respect to the use of the licensed technology in relation to our development
and commercialization of our products, and what activities satisfy those diligence obligations; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property
by our licensors and us and our partners.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If disputes over licensed intellectual
property prevent or impair our ability to maintain the licensing arrangements on acceptable terms, we may be unable to successfully develop
and commercialize the affected product, or the dispute may have an adverse effect on our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to agreements pursuant
to which we in-license intellectual property, we have in the past, and we may in the future, grant licenses under our intellectual property.
Like in-licenses, out-licenses are complex, and disputes may arise between us and our licensees, such as the types of disputes described
above. Moreover, our licensees may breach their obligations, or we may be exposed to liability due to our failure or alleged failure to
satisfy our obligations. Any such occurrence could have an adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our trademarks and trade names are not
adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our registered or unregistered
trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks.
We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition by potential partners
or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our
ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark
infringement claims brought by owners of other registered trademarks. Over the long term, if we are unable to establish name recognition
based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The measures that we use to protect the
security of our intellectual property and other proprietary rights may not be adequate, which could result in the loss of legal protection
for, and thereby diminish the value of, such intellectual property and other rights.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to pursuing patents
on our technology, we also rely upon trademarks, trade secrets, copyrights and unfair competition laws, as well as license agreements
and other contractual provisions, to protect our intellectual property and other proprietary rights. Despite these measures, any of our
intellectual property rights could be challenged, invalidated, circumvented or misappropriated. In addition, we take steps to protect
our intellectual property and proprietary technology by entering into confidentiality agreements and intellectual property assignment
agreements with our employees, consultants, corporate partners and, when needed, our advisors. Our suppliers also have access to the patented
technology owned or used by us as well as other proprietary information, and these suppliers are subject to confidentiality provisions
under their agreements with us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Such agreements or provisions
may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of
unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure. Notwithstanding
any such agreements, there is no assurance that our current or former manufacturers or suppliers will not use and/or supply our competitors
with our trade secrets, know-how or other proprietary information to which these parties gained access or generated from their relationship
with us. This could lead to our competitors gaining access to patented or other proprietary information. Moreover, if a party to an agreement
with us has an overlapping or conflicting obligation to a third party, our rights in and to certain intellectual property could be undermined.
Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or
will be, adequate. If we were to enforce a claim that a third party had illegally obtained and was using our trade secrets, it would be
expensive and time-consuming, the outcome would be unpredictable, and any remedy may be inadequate. In addition, courts outside the United&#160;States
may be less willing to protect trade secrets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, competitors could
purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully
infringe our intellectual property rights, design around our protected technology or develop their own competitive technologies that fall
outside of our intellectual property rights. If our intellectual property does not adequately protect our market share against competitors&#8217;
products and methods, our competitive position could be adversely affected, as could our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our issued patents could be found invalid
or unenforceable if challenged in court, which could have a material adverse impact on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we or any of our partners
were to initiate legal proceedings against a third party to enforce a patent covering one of our products or services, the defendant in
such litigation could counterclaim that our patent is invalid and/or unenforceable. In patent litigation in the United&#160;States, defendant
counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure
to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement, or failure to claim patent eligible
subject matter. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent
withheld relevant information from the USPTO, or made a misleading statement during prosecution. Third parties may also raise similar
claims before the USPTO even outside the context of litigation. The outcome following legal assertions of invalidity and unenforceability
is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art of
which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or
unenforceability, we would lose at least part, and perhaps all, of the challenged patent. Such a loss of patent protection would have
a material adverse impact on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in patent laws or patent jurisprudence
could diminish the value of patents in general, thereby impairing our ability to protect our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The America Invents Act, or
AIA, introduced changes that limit where a patent holder may file a patent infringement suit and providing additional opportunities for
third parties to challenge any issued patent in the USPTO.&#160;This applies to all of our owned and in-licensed U.S.&#160;patents, even
those issued before March&#160;16, 2013 (the effective date of the AIA). Because of a lower evidentiary standard in USPTO proceedings
compared to the evidentiary standard in U.S.&#160;federal courts necessary to invalidate a patent claim, a third party could potentially
provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient
to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use the USPTO procedures
to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district
court action. The AIA and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications
and the enforcement or defense of our issued patents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the U.S.&#160;Supreme
Court has ruled on several patent cases in recent&#160;years, such as <i>Impression Products, Inc. v. Lexmark International, Inc., Association
for Molecular Pathology v. Myriad Genetics, Inc.</i>, <i>Mayo Collaborative Services v. Prometheus Laboratories, Inc.</i> and <i>Alice
Corporation Pty. Ltd. v. CLS Bank International</i>, either narrowing the scope of patent protection available in certain circumstances
or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain
patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending
on actions by the U.S.&#160;Congress and decisions by the federal courts and the USPTO, the laws and regulations governing patents could
change in unpredictable ways that could weaken our ability to obtain new patents or to enforce our existing patents and patents that we
might obtain in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>


</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Several inventions covered by our patent
portfolio were made using U.S.&#160;government funding. The U.S.&#160;government has an irrevocable, non-exclusive, royalty-free license
to use such other inventions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S.&#160;government grant
funding was used in the inventions covered by four U.S.&#160;patents and two pending U.S.&#160;patent applications in Profusa&#8217;s
patent portfolio. As a result of this funding, the government is granted an irrevocable, non-exclusive, royalty-free license to use these
patents/applications. The government&#8217;s ability to practice the inventions described in these patents/applications is limited to
practice for or on behalf of the United&#160;States. However, the license can be used to allow a third party to practice the invention
solely for the government&#8217;s benefit.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In some circumstances, the
U.S.&#160;government agency that provided the grants has the right to &#8220;march-in&#8221; and require Profusa to license its invention
to a third party. These circumstances are as follows: (a)&#160;the inventing party has not tried to achieve practical application of the
invention; (b)&#160;such a license is needed to alleviate health or safety concerns; (c)&#160;such a license is needed to meet public
use requirements specified in federal regulations; or (d)&#160;the inventing party fails to ensure that the invention will be &#8220;manufactured
substantially&#8221; in the United&#160;States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The negative effects of march-in
rights on Profusa&#8217;s business could be profound. Most importantly, Profusa could be compelled to grant licenses for its patented
inventions to third parties, including competitors. This scenario could lead to increased competition, loss of market exclusivity, and
diminished control over the commercialization of its innovations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, the forced licensing
of patents under march-in rights may result in reduced revenues and profitability for Profusa. The terms and conditions of such licenses
could be dictated by the government, potentially impacting the company&#8217;s ability to generate income from its intellectual property
on favorable terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, the uncertainty surrounding
the potential exercise of march-in rights creates a challenging business environment. It introduces regulatory risks and can complicate
strategic planning and investment decisions for Profusa, as Profusa must navigate the possibility of government intervention in its intellectual
property rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The invocation of March-in
rights by the government could lead to increased competition, revenue reduction, loss of control over intellectual property, and heightened
regulatory complexities, all of which could have a negative impact on Profusa&#8217;s business operations and financial performance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, government support
may have implications for Profusa&#8217;s right to license the inventions covered by these patents/applications. For example, generally
when granting an exclusive license, the licensee must ensure that the invention will be &#8220;manufactured substantially&#8221; within
the United&#160;States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Obtaining and maintaining our patent protection
depends on compliance with various procedural requirements, document submission, fee payment and other requirements imposed by government
patent agencies and our patent protection could be reduced or eliminated for non-compliance with these requirements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Periodic maintenance fees,
renewal fees, annuity fees and various other government fees on patents and applications will be due to be paid to the USPTO and various
government patent agencies outside of the United&#160;States over the lifetime of our owned patents and applications. The USPTO and various
foreign government agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the
patent application process. In some cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance
with the applicable rules. There are situations, however, in which non-compliance can result in abandonment or lapse of the patent or
patent application, resulting in a partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential
competitors might be able to enter the market with similar or identical products or technology, which could have a material adverse effect
on our business, financial condition, results of operations and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Patent terms may be inadequate to protect
our competitive position on products or product candidates for an adequate amount of time.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Patents have a limited lifespan.
In most countries, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20&#160;years from its earliest
national or international (i.e., PCT) filing date. Various extensions may be available, but the life of a patent, and the protection it
affords, is limited. After patents expire, we may be open to competition with respect to products that were covered by the expired patents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we do not obtain patent term extension
and/or data exclusivity for any product candidates we decide to develop as drug product candidates, our business may be materially harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depending upon the timing,
duration and specifics of any FDA marketing approval of any product candidates we decide to develop as product candidates, one or more
of the U.S.&#160;patents we may obtain may be eligible for limited patent term extension under the Drug Price Competition and Patent Term
Restoration Act, also known as the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term extension of up to five&#160;years as
compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of
a patent beyond a total of 14&#160;years from the date of product approval, only one patent may be extended and only those claims covering
the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar extensions as compensation for patent
term lost during regulatory review processes are also available in certain foreign countries and territories, such as in Europe under
a Supplementary Protection Certificate. However, we may not be granted an extension in the United&#160;States and/or foreign countries
and territories because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing
to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable
requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. We may not
be eligible for patent term extension, or PTE, as it is only available in the U.S.&#160;if any component of a product candidate has never
been approved as a drug substance. If we are unable to obtain patent term extension or the term of any such extension is shorter than
what we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial
condition, results of operations and prospects could be materially harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to claims challenging
the inventorship or ownership of our patents and other intellectual property.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be subject to claims
that former employees, collaborators or other third parties have an interest in our owned patent rights, trade secrets or other intellectual
property as an inventor or co-inventor. For example, we may have disputes arise from conflicting obligations of employees, consultants
or others who are involved in developing our products, product candidates, or other technologies. Litigation may be necessary to defend
against these and other claims challenging inventorship or our ownership of our owned patent rights, trade secrets or other intellectual
property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property
rights, such as exclusive ownership of, or right to use, intellectual property that is important to our products, product candidates,
or other technologies. Even if we are successful in defending against such claims, litigation could result in substantial costs and be
a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial
condition, results of operations and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Intellectual property rights do not necessarily
address all potential threats.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The degree of future protection
afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately
protect our business or permit us to maintain our competitive advantage. For example:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">others may be able to make products that are similar to products and technologies we may develop or utilize
similar technology that are not covered by the claims of the patents that we own or license now or in the future;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we, or our licensor(s), might not have been the first to make the inventions covered by the issued patent
or pending patent application that we license or may own in the future;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we, or our licensor(s), might not have been the first to file patent applications covering certain of
our or their inventions;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">others may independently develop similar or alternative technologies or duplicate any of our technologies
without infringing, misappropriating or otherwise violating our owned or licensed intellectual property rights;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">it is possible that our pending licensed patent applications or those that we may own in the future will
not lead to issued patents;</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">issued patents that we own, in-license, or otherwise hold rights to may be held invalid or unenforceable
or have their scope narrowed, including as a result of legal challenges by our competitors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">our competitors might conduct research and development activities in countries where we do not have patent
rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may not develop additional proprietary technologies that are patentable;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the patents of others may harm our business; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">we may choose not to file a patent application for certain trade secrets or know-how, and a third party
may subsequently file a patent application covering such intellectual property.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Should any of these events
occur, they could materially adversely affect our business, financial condition, results of operations and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">General Risks of Profusa&#8217;s Business</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to successfully maintain
effective internal control over financial reporting, investors may lose confidence in our reported financial information and our stock
price and our business may be adversely impacted.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company, we will
be required to maintain internal control over financial reporting and our management is required to evaluate the effectiveness of our
internal control over financial reporting as of the end of each fiscal year. If we are not successful in maintaining effective internal
control over financial reporting, there could be inaccuracies or omissions in the financial information we are required to file with the
SEC.&#160;Additionally, even if there are no inaccuracies or omissions, we will be required to publicly disclose the conclusion of our
management that our internal control over financial reporting or disclosure controls and procedures are not effective. These events could
cause investors to lose confidence in our reported financial information, adversely impact our stock price, result in increased costs
to remediate any deficiencies, attract regulatory scrutiny or lawsuits that could be costly to resolve and distract management&#8217;s
attention, limit our ability to access the capital markets or cause our stock to be delisted from The Nasdaq Stock Market or any other
securities exchange on which it is then listed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Environmental, social and corporate governance,
or ESG regulations, policies and provisions may make our supply chain more complex and may adversely affect our relationships with customers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is an increasing focus
on the governance of environmental and social risks. A number of our customers who are payors or distributors have adopted, or may adopt,
procurement policies that include ESG provisions that their suppliers or manufacturers must comply with, or they may seek to include such
provisions in their terms and conditions. An increasing number of participants in the medical device industry are also joining voluntary
ESG groups or organizations, such as the Responsible Business Alliance. These ESG provisions and initiatives are subject to change, can
be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and the outsourced
manufacturing of certain components of our products. If we are unable to comply, or are unable to cause our suppliers to comply, with
such policies or provisions, a customer may stop purchasing products from us, and may take legal action against us, which could harm our
reputation, revenue and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Current uncertainty in domestic and global
economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more
likely that our actual results could differ materially from expectations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations and performance
depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty,
political instability and military hostilities in multiple geographies, concerns over the potential downgrade of U.S.&#160;sovereign
debt and continued sovereign debt, monetary and financial uncertainties in Europe and other foreign countries, and global health pandemics
such as the COVID-19 pandemic. These include potential reductions in the overall stability and suitability of the Euro as a single currency,
given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make
it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products
or to use them less frequently. If that were to occur, our revenue may&#160;decrease and our performance may be negatively
impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles
and limits on durable medical equipment, which may cause seasonality in purchasing patterns.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, during economic
uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or
credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. While the
potential economic impact brought by and the duration of the COVID-19 pandemic may be difficult to assess or predict, it has already caused,
and is likely to result in further, significant disruption of global financial markets, which may reduce our ability to access capital
on favorable terms or at all. In addition, a recession, depression or other sustained adverse market event resulting from the spread of
COVID-19 could materially and adversely affect our business and the value of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot predict the reoccurrence
of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United&#160;States, or in our industry.
These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in financial accounting standards
or practices or existing taxation rules or practices may cause adverse unexpected revenue and/or expense fluctuations and affect our reported
results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A change in accounting standards
or practices or a change in existing taxation rules or practices can have a significant effect on our reported results and may even affect
our reporting of transactions completed before the change is effective. New accounting pronouncements and taxation rules and varying interpretations
of accounting pronouncements and taxation practice have occurred and may occur in the future. The method in which we market and sell our
products may have an impact on the manner in which we recognize revenue. In addition, changes to existing rules or the questioning of
current practices may adversely affect our reported financial results or the way we conduct our business. Additionally, changes to existing
accounting rules or standards, such as the potential requirement that U.S.&#160;registrants prepare financial statements in accordance
with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may further require
us to incur greater accounting fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Climate change may have a long-term impact
on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are inherent risks related
to climate change wherever business is conducted. Access to clean water and reliable energy in the communities where we conduct our business,
whether for our offices or for our vendors, is a priority. Our manufacturing sites in California are vulnerable to climate change effects.
For example, in California, increasing intensity of droughts throughout the states and annual periods of wildfire danger increase the
probability of planned and unplanned power outages in the communities where we work and live. While this danger has a low-assessed risk
of disrupting normal business operations, it has the potential impact on employees&#8217; abilities to commute to work or to work from
home and stay connected effectively. Climate-related events, including the increasing frequency of extreme weather events and their impact
on the U.S.&#160;and other major regions&#8217; critical infrastructure, have the potential to disrupt our business, our third-party suppliers,
and/or the business of our customers, and may cause us to experience higher attrition, losses, and additional costs to maintain or resume
operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We face the risk of product liability claims
and may be subject to damages, fines, penalties and injunctions, among other things.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business exposes us to
the risk of product liability claims that is inherent in the testing, manufacturing and marketing of medical devices, including those
which may arise from the misuse (including system hacking or other unauthorized access by third parties to our systems) or malfunction
of, or design flaws in, our products. This liability may vary based on the FDA classification associated with our devices. We may be subject
to product liability claims if our products cause, or merely appear to have caused, an injury. Claims may be made by customers, healthcare
providers or others selling our products. The risk of claims may also increase if our products are subject to a product recall or seizure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have
insurance at levels that we believe is appropriate, this insurance is subject to deductibles and coverage limitations. Our current
product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverage
may not be adequate to protect us against any future product liability claims. Further, if additional products are approved for
marketing, we may seek additional insurance coverage. If we are unable to obtain insurance at an acceptable cost or on acceptable
terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant
liabilities, which may harm our business. A product liability claim, recall or other claims with respect to uninsured liabilities or
for amounts in excess of insured liabilities could result in significant costs and significant harm to our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be subject to claims
against us even if the apparent injury is due to the actions of others or misuse of the device or a partner device. Our customers, either
on their own or following the advice of their physicians, may use our products in a manner not described in the products&#8217; labeling
and that differs from the manner in which it was used in clinical studies and approved by the FDA.&#160;Off-label use of products by customers
is common, and any such off-label use of our products could subject us to additional liability, or require design changes to limit this
potential off-label use once discovered.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we cannot successfully defend
ourselves against product liability claims, we may incur substantial liabilities or be required to limit or halt the marketing and sale
of our products, if approved. Even successful defense would require significant financial and management resources. Regardless of the
merits or eventual outcome, liability claims may result in:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">decreased demand for our approved products, if any;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">harm to our reputation;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">initiation of investigations by regulators, which could result in enforcement action against us or our
contract manufacturers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">costs to defend the related litigation;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a diversion of management&#8217;s time and our resources;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">substantial monetary awards to trial participants or patients;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">product recalls, withdrawals or labeling, marketing or promotional restrictions;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">loss of revenue; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">exhaustion of any available insurance and our capital resources.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will incur increased costs and become
subject to additional regulations and requirements as a result of becoming a public company, which could lower our profits or make it
more difficult to run our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company, we will
incur significant legal, accounting and other expenses that we have not incurred as a private company, including costs associated with
public company reporting requirements. We also have incurred and will continue to incur costs associated with the Sarbanes-Oxley Act,
and related rules implemented by the Securities and Exchange Commission, or SEC, and the exchange our securities are listed on. The expenses
generally incurred by public companies for reporting and corporate governance purposes have been increasing. We expect these rules and
regulations to increase our legal and financial compliance costs and to make some activities more time-consuming and costly, although
we are currently unable to estimate these costs with any degree of certainty. These laws and regulations also could make it more difficult
or costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept
reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. These laws and regulations
could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, on our board committees
or as our executive officers. Furthermore, if we are unable to satisfy our obligations as a public company, we could be subject to delisting
of our common stock, fines, sanctions, other regulatory action and potentially civil litigation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an Emerging Growth Company</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &#8220;emerging growth
company&#8221; as defined in the Jumpstart Our Business Startups Act&#160;of&#160;2012 (&#8220;JOBS Act&#8221;). We will remain an emerging
growth company until the earlier of (i)&#160;December&#160;31, 2026, the last&#160;day of the fiscal year following the fifth anniversary
of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities Act; (ii)&#160;the
last&#160;day of the fiscal year in which we have total annual gross revenues of $1&#160;billion or more; (iii)&#160;the date on which
we have issued more than $1&#160;billion in nonconvertible debt during the previous three&#160;years; or (iv)&#160;the date on which we
are deemed to be a large accelerated filer under applicable SEC rules.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect that we will remain
an emerging growth company for the foreseeable future but cannot retain our emerging growth company status indefinitely and will no longer
qualify as an emerging growth company on or before December&#160;31, 2026. References herein to &#8220;emerging growth company&#8221;
have the meaning associated with it in the JOBS Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For so long as we remain an
emerging growth company, we are permitted and intend to rely on exemptions from specified disclosure requirements that are applicable
to other public companies that are not emerging growth companies. These exemptions include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">being permitted to provide only two&#160;years of audited financial statements, in addition to any required
unaudited interim financial statements, with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations&#8221; disclosure;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">not being required to comply with the requirement of auditor attestation of our internal controls over
financial reporting;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">not being required to comply with any requirement that may be adopted by the Public Company Accounting
Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information
about the audit and the financial statements;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reduced disclosure obligations regarding executive compensation; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">not being required to hold a nonbinding advisory vote on executive compensation and stockholder approval
of any golden parachute payments not previously approved.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For as long as we continue
to be an emerging growth company, we expect that we will take advantage of the reduced disclosure obligations available to us as a result
of that classification. We have taken advantage of certain of those reduced reporting burdens in this prospectus. Accordingly, the information
contained herein may be different than the information you receive from other public companies in which you hold stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An emerging growth company
can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B)&#160;of the Securities Act for complying with
new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until
those standards would otherwise apply to private companies. We have irrevocably elected to avail ourselves of this extended transition
period and, as a result, we will not be required to adopt new or revised accounting standards on the dates on which adoption of such standards
is required for other public reporting companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also a &#8220;smaller
reporting company&#8221; as defined in Rule&#160;12b-2 of the Exchange&#160;Act, and have elected to take advantage of certain of the
scaled disclosure available for smaller reporting companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We identified material weaknesses in our
internal control over financial reporting. These material weaknesses could continue to adversely affect our ability to report our results
of operations and financial condition accurately and in a timely manner.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company, we are
required to comply with SEC rules that implement Section 404 of the Sarbanes-Oxley Act and make an ongoing, formal assessment of the effectiveness
of our internal controls over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you that the
measures we have taken to date, and actions we may take in the future, will prevent or avoid control deficiencies that could lead to material
weaknesses in our internal control over financial reporting in the future. Our current controls, and any new controls that we develop,
may become inadequate because of changes in conditions in our business. Further, deficiencies in our disclosure controls and internal
control over financial reporting may be discovered in the future. Any failure to develop or maintain effective controls or any difficulties
encountered in their implementation or improvement could harm our operating results or cause us to fail to meet our reporting obligations
and may result in a restatement of our financial statements for prior periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have performed a
formal evaluation of our internal control over financial reporting under the supervision and with the participation of management,
including our principal executive officer and principal financial officer, as required by Section 404 of the Sarbanes-Oxley Act.
Based upon their evaluation, our principal executive officer and principal financial and accounting officer, concluded that our
internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) were not effective
as of June 30, 2025 due to the existence of material weaknesses. Our internal controls were not adequately designed and appropriate
to address the following material weaknesses related to (i) segregation of duties in recording journal entries, (ii) segregation of
duties within the procurement business cycle, and (iii) in the procurement cycle our controls were insufficient for reviewing and
reconciling accounts payable and accrued liabilities. In addition, our internal controls did not detect an error in (i) the review
of the convertible promissory notes valuation and warrant valuation (ii) proper recording of accounts payable and accrued expenses,
expensing or prepaid expenses, common stock subject to possible redemption, and the calculation of our income tax provision (iii)
the proper safeguarding of trust assets and the monitoring process of the use of trust funds. The company plans to remediate such
weaknesses. In connection with the business combination, the company has hired a new CFO with significant experience, including
financial reporting and internal controls. The CFO plans to establish reporting controls consistent with a public company of this
size, including segregation of duties and controls related to Sarbanes-Oxley, to the extent applicable. However, we can give no
assurance that the measures we have taken, or will take, will prevent any future material weaknesses or deficiencies in internal
control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not engaged an independent
registered public accounting firm to perform an audit of our internal control over financial reporting as of any balance sheet date or
for any period reported in our financial statements. We are required to evaluate and disclose changes made in our internal controls and
procedures on a quarterly basis. Failure to comply with the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations
by the SEC, the applicable stock exchange or other regulatory authorities, which would require additional financial and management resources.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to maintain an effective system
of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements
or comply with applicable regulations could be impaired, which may adversely affect investor confidence in our Company and, as a result,
the market price of our common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company, we are
required to comply with the requirements of the Sarbanes-Oxley Act, including, among other things, that we maintain effective disclosure
controls and procedures and internal control over financial reporting. We continue to develop and refine our disclosure controls and other
procedures that are designed to ensure that information we are required to disclose in the reports that we will file with the SEC are
recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms and that information required to
be disclosed in reports under the Exchange&#160;Act, is accumulated and communicated to our management, including our principal executive
and financial officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to maintain and improve
the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate
that we will continue to expend, significant resources, including dedicated to internal resources. We may also need to engage outside
consultants and adopt a detailed work plan to assess and document the adequacy of our internal control over financial reporting. If any
of these new or improved controls and systems do not perform as expected, we may experience additional material weaknesses in our controls.
Moreover, our testing, or the subsequent testing by our independent registered public accounting firm, may reveal additional deficiencies
in our internal control over financial reporting that are deemed to be material weaknesses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any failure to implement and
maintain effective disclosure controls and procedures and internal control over financial reporting, including the identification of one
or more material weaknesses, could cause investors to lose confidence in the accuracy and completeness of our financial statements and
reports, which would likely adversely affect the market price of our common stock. In addition, we could be subject to sanctions or investigations
by the stock exchange on which our common stock is listed, the SEC and other regulatory authorities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Bitcoin Treasury Strategy
and Holdings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our bitcoin treasury strategy exposes us
to various risks associated with bitcoin.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bitcoin treasury strategy
exposes us to various risks associated with bitcoin, including the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Bitcoin is a highly volatile
asset. </i>Bitcoin is a highly volatile asset that has traded below $53,000 per bitcoin and above $123,000 per bitcoin on the Coinbase
exchange in the 12&#160;months preceding the date of this prospectus. The trading price of bitcoin significantly decreased during prior
periods, and such declines may occur again in the future. We intend to engage in hedging strategies from time to time as part of our treasury
management operations if deemed appropriate. As of the date of this prospectus, the Company has purchased $1.0 million of Bitcoin as part
of the Company&#8217;s ongoing treasury strategy, representing 8.53 Bitcoins.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Bitcoin does not pay interest
or dividends. </i>Bitcoin does not pay interest or other returns and we can only generate cash from our bitcoin holdings if we sell our
bitcoin or implement strategies to create income streams or otherwise generate cash by using our bitcoin holdings. Even if we pursue any
such strategies, we may be unable to create income streams or otherwise generate cash from our bitcoin holdings, and any such strategies
may subject us to additional risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Our bitcoin holdings may
significantly impact our financial results and the market price of our common stock. </i>Our bitcoin holdings may significantly affect
our financial results and if we continue to increase our overall holdings of bitcoin in the future, they will have an even greater impact
on our financial results and the market price of our common stock. See &#8220;&#8212;&#160;<i>Our historical financial statements do not
reflect our acquisition of bitcoin, the fact that our bitcoin holdings will be the substantial majority of our assets, or the potential
variability in earnings that we may experience in the future relating to our bitcoin holdings</i>&#8221; below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Our bitcoin treasury strategy
has not been tested over an extended period of time or under different market conditions. </i>We will be using the proceeds from this
offering to facilitate the recent adoption our bitcoin treasury strategy and we will need to continually examine the risks and rewards
of this new strategy. This new strategy has not been tested over an extended period of time or under different market conditions. For
example, although we believe bitcoin, due to its limited supply, has the potential to serve as a hedge against inflation in the long term,
the short-term price of bitcoin declined in recent periods during which the inflation rate increased. Some investors and other market
participants may disagree with our bitcoin treasury strategy or actions we undertake to implement it. If bitcoin prices were to decrease
or our bitcoin treasury strategy otherwise proves unsuccessful, our financial condition, results of operations, and the market price of
our common stock could be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>We are subject to counterparty
risks, including in particular risks relating to our custodians. </i>Although we intend to implement various measures that are designed
to mitigate our counterparty risks, including by storing substantially all of the bitcoin we own in custody accounts at U.S.-based, institutional-grade
custodians and negotiating contractual arrangements intended to establish that our property interest in custodially-held bitcoin is not
subject to claims of our custodians&#8217; creditors, applicable insolvency law is not fully developed with respect to the holding of
digital assets in custodial accounts. If our custodially-held bitcoin were nevertheless considered to be the property of our custodians&#8217;
estates in the event that any such custodians were to enter bankruptcy, receivership or similar insolvency proceedings, we could be treated
as a general unsecured creditor of such custodians, inhibiting our ability to exercise ownership rights with respect to such bitcoin and
this may ultimately result in the loss of the value related to some or all of such bitcoin. Even if we are able to prevent our bitcoin
from being considered the property of a custodian&#8217;s bankruptcy estate as part of an insolvency proceeding, it is possible that we
would still be delayed or may otherwise experience difficulty in accessing our bitcoin held by the affected custodian during the pendency
of the insolvency proceedings. Any such outcome could have a material adverse effect on our financial condition and the market price of
our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The broader digital assets
industry is subject to counterparty risks, which could adversely impact the adoption rate, price, and use of bitcoin. </i>A series of
recent high-profile bankruptcies, closures, liquidations, regulatory enforcement actions and other events relating to companies operating
in the digital asset industry, including the filings for bankruptcy protection by Three Arrows Capital, Celsius Network, Voyager Digital,
FTX Trading and Genesis Global Capital, the closure or liquidation of certain financial institutions that provided lending and other services
to the digital assets industry, including Signature Bank and Silvergate Bank, SEC enforcement actions against Coinbase, Inc. and Binance
Holdings Ltd., the placement of Prime Trust, LLC into receivership following a cease-and-desist order issued by Nevada&#8217;s Department
of Business and Industry, and the filing and subsequent settlement of a civil fraud lawsuit by the New&#160;York Attorney General against
Genesis Global Capital, its parent company Digital Currency Group, Inc., and former partner Gemini Trust Company, have highlighted the
counterparty risks applicable to owning and transacting in digital assets. Although these bankruptcies, closures, liquidations and other
events have not resulted in any loss or misappropriation of our bitcoin, nor have such events adversely impacted our access to our bitcoin,
they have, in the short-term, likely negatively impacted the adoption rate and use of bitcoin. Additional bankruptcies, closures, liquidations,
regulatory enforcement actions or other events involving participants in the digital assets industry in the future may further negatively
impact the adoption rate, price, and use of bitcoin, limit the availability to us of financing collateralized by bitcoin, or create or
expose additional counterparty risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Changes in our
ownership of bitcoin could have accounting, regulatory and other impacts. </i>While we currently plan to own bitcoin directly, we
may investigate other potential approaches to owning bitcoin, including indirect ownership (for example, through ownership interests
in a fund that owns bitcoin). If we were to own all or a portion of our bitcoin in a different manner, the accounting treatment for
our bitcoin, our ability to use our bitcoin as collateral for additional borrowings, and the regulatory requirements to which we are
subject, may correspondingly change. For example, the volatile nature of bitcoin may force us to liquidate our holdings to use it as
collateral, which could be negatively affected by any disruptions in the crypto market and, if liquidated, the value of the
collateral would not reflect potential gains in the market value of bitcoin, all of which could negatively affect our business and
implementation of our bitcoin strategy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Changes in the accounting
treatment of our bitcoin holdings could have significant accounting impacts, including increasing the volatility of our results. </i>In
December&#160;2023, the FASB issued ASU&#160;2023-08, which upon our adoption will require us to measure in-scope crypto assets (including
our bitcoin holdings) at fair value in our statement of financial position, and to recognize gains and losses from changes in the fair
value of our bitcoin in net income each reporting period. ASU&#160;2023-08 will also require us to provide certain interim and annual
disclosures with respect to our bitcoin holdings. Due to the volatility in the price of bitcoin, the adoption of ASU&#160;2023-08 could
have a material impact on our financial results in future periods, increase the volatility of our financial results, affect the carrying
value of our bitcoin on our balance sheet, and could result in tax-related adjustments, which in turn could have a material adverse effect
on our financial results and the market price of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The broader digital assets
industry, including the technology associated with digital assets, the rate of adoption and development of, and use cases for, digital
assets, market perception of digital assets, and the legal, regulatory, and accounting treatment of digital assets are constantly developing
and changing, and there may be additional risks in the future that are not possible to predict.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Bitcoin is a highly volatile asset, and
fluctuations in the price of bitcoin are likely to influence our financial results and the market price of our common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Bitcoin is a highly volatile
asset, and fluctuations in the price of bitcoin are likely to influence our financial results and the market price of our common stock.
Our financial results and the market price of our common stock would be adversely affected, and our business and financial condition would
be negatively impacted, if the price of bitcoin decreased substantially (as it has in the past, such as during 2022), including as a result
of:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">decreased user and investor confidence in bitcoin, including due to the various factors described herein;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">investment and trading activities, such as (i)&#160;trading activities of highly active retail and institutional
users, speculators, miners and investors, (ii)&#160;actual or expected significant dispositions of bitcoin by large holders, and (iii)&#160;actual
or perceived manipulation of the spot or derivative markets for bitcoin or spot bitcoin ETPs;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">negative publicity, media or social media coverage, or sentiment due to events in or relating to, or perception
of, bitcoin or the broader digital assets industry, for example, (i)&#160;public perception that bitcoin can be used as a vehicle to circumvent
sanctions, including sanctions imposed on Russia or certain regions related to the ongoing conflict between Russia and Ukraine, or to
fund criminal or terrorist activities, such as the purported use of digital assets by Hamas to fund its terrorist attack against Israel
in October&#160;2023; (ii)&#160;expected or pending civil, criminal, regulatory enforcement or other high profile actions against major
participants in the bitcoin ecosystem, including the SEC&#8217;s enforcement actions against Coinbase, Inc. and Binance Holdings Ltd.;
(iii)&#160;additional filings for bankruptcy protection or bankruptcy proceedings of major digital asset industry participants, such as
the bankruptcy proceeding of FTX Trading and its affiliates; and (iv)&#160;the actual or perceived environmental impact of bitcoin and
related activities, including environmental concerns raised by private individuals, governmental and non-governmental organizations, and
other actors related to the energy resources consumed in the bitcoin mining process;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">changes in consumer preferences and the perceived value or prospects of bitcoin;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">competition from other digital assets that exhibit better speed, security, scalability, or energy efficiency,
that feature other more favored characteristics, that are backed by governments, including the U.S.&#160;government, or reserves of fiat
currencies, or that represent ownership or security interests in physical assets;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a decrease in the price of other digital assets, including stablecoins, or the crash or unavailability
of stablecoins that are used as a medium of exchange for bitcoin purchase and sale transactions, such as the crash of the stablecoin Terra
USD in 2022, to the extent the decrease in the price of such other digital assets or the unavailability of such stablecoins may cause
a decrease in the price of bitcoin or adversely affect investor confidence in digital assets generally;</td></tr></table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the identification of Satoshi Nakamoto, the pseudonymous person or persons who developed bitcoin, or the
transfer of substantial amounts of bitcoin from bitcoin wallets attributed to Mr.&#160;Nakamoto or other &#8220;whales&#8221; that hold
significant amounts of bitcoin;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">disruptions, failures, unavailability, or interruptions in service of trading venues for bitcoin, such
as, for example, digital asset exchange FTX Trading&#8217;s freezing of withdrawals and transfers from its accounts in 2022;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the filing for bankruptcy protection by, liquidation of, or market concerns about the financial viability
of digital asset custodians, trading venues, lending platforms, investment funds, or other digital asset industry participants, such as
the filing for bankruptcy protection by digital asset trading venues FTX Trading and BlockFi and digital asset lending platforms Celsius
Network and Voyager Digital Holdings in 2022, the ordered liquidation of the digital asset investment fund Three Arrows Capital in 2022,
the announced liquidation of Silvergate Bank in 2023, the government-mandated closure and sale of Signature Bank in 2023, the placement
of Prime Trust, LLC into receivership following a cease-and-desist order issued by the Nevada Department of Business and Industry in 2023,
and the exit of Binance Holdings Ltd. from the U.S.&#160;market in 2023 as part of its settlement with the Department of Justice and other
federal regulatory agencies;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">regulatory, legislative, enforcement and judicial actions that adversely affect the price, ownership,
transferability, trading volumes, legality or public perception of bitcoin, or that adversely affect the operations of or otherwise prevent
digital asset custodians, trading venues, lending platforms or other digital assets industry participants from operating in a manner that
allows them to continue to deliver services to the digital assets industry;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">further reductions in mining rewards of bitcoin, including block reward halving events, which are events
that occur after a specific period of time that reduce the block reward earned by &#8220;miners&#8221; who validate bitcoin transactions,
or increases in the costs associated with bitcoin mining, including increases in electricity costs and hardware and software used in mining,
that may cause a decline in support for the Bitcoin network;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">transaction congestion and fees associated with processing transactions on the bitcoin network;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">macroeconomic changes, such as changes in the level of interest rates and inflation, fiscal and monetary
policies of governments, trade restrictions, and fiat currency devaluations;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">developments in mathematics or technology, including in digital computing, algebraic geometry and quantum
computing, that could result in the cryptography used by the bitcoin blockchain becoming insecure or ineffective; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">changes in national and international economic and political conditions, including, without limitation,
the adverse impact attributable to the economic and political instability caused by the current conflict between Russia and Ukraine and
the economic sanctions adopted in response to the conflict, and the potential broadening of the Israel-Hamas conflict to other countries
in the Middle East.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Bitcoin and other digital assets are novel
assets, and are subject to significant legal, commercial, regulatory and technical uncertainty.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Bitcoin and other digital assets
are relatively novel and are subject to significant uncertainty, which could adversely impact their price. The application of state and
federal securities laws and other laws and regulations to digital assets is unclear in certain respects, and it is possible that regulators
in the United&#160;States or foreign countries may interpret or apply existing laws and regulations in a manner that adversely affects
the price of bitcoin.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The U.S.&#160;federal
government, states, regulatory agencies, and foreign countries may also enact new laws and regulations, or pursue regulatory,
legislative, enforcement or judicial actions, that could materially impact the price of bitcoin or the ability of individuals or
institutions such as us to own or transfer bitcoin. For example, the U.S.&#160;executive branch, SEC, the European Union&#8217;s
Markets in Crypto Assets Regulation, among others have been active in recent&#160;years, and in the U.K., the Financial Services and
Markets Act&#160;2023, or FSMA&#160;2023 became law. It is not possible to predict whether, or when, any of these developments will
lead to Congress granting additional authorities to the SEC, Commodity Futures Trading Commission (&#8220;CFTC&#8221;), or other
regulators, or whether, or when, any other federal, state or foreign
legislative bodies will take any similar actions. It is also not possible to predict the nature of any such additional authorities,
how additional legislation or regulatory oversight might impact the ability of digital asset markets to function or the willingness
of financial and other institutions to continue to provide services to the digital assets industry, nor how any new regulations or
changes to existing regulations might impact the value of digital assets generally and bitcoin specifically. The consequences of
increased regulation of digital assets and digital asset activities could adversely affect the market price of bitcoin and in turn
adversely affect the market price of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, the risks of engaging
in a bitcoin treasury strategy are relatively novel and have created, and could continue to create, complications due to the lack of experience
that third parties have with companies engaging in such a strategy, such as increased costs of director and officer liability insurance
or the potential inability to obtain such coverage on acceptable terms in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The growth of the digital assets
industry in general, and the use and acceptance of bitcoin in particular, may also impact the price of bitcoin and is subject to a high
degree of uncertainty. The pace of worldwide growth in the adoption and use of bitcoin may depend, for instance, on public familiarity
with digital assets, ease of buying, accessing or gaining exposure to bitcoin, institutional demand for bitcoin as an investment asset,
the participation of traditional financial institutions in the digital assets industry, consumer demand for bitcoin as a means of payment,
and the availability and popularity of alternatives to bitcoin. Even if growth in bitcoin adoption occurs in the near or medium-term,
there is no assurance that bitcoin usage will continue to grow over the long-term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because bitcoin has no physical
existence beyond the record of transactions on the bitcoin blockchain, a variety of technical factors related to the bitcoin blockchain
could also impact the price of bitcoin. For example, malicious attacks by miners, inadequate mining fees to incentivize validating of
bitcoin transactions, hard &#8220;forks&#8221; of the bitcoin blockchain into multiple blockchains, and advances in digital computing,
algebraic geometry, and quantum computing could undercut the integrity of the bitcoin blockchain and negatively affect the price of bitcoin.
The liquidity of bitcoin may also be reduced and damage to the public perception of bitcoin may occur, if financial institutions were
to deny or limit banking services to businesses that hold bitcoin, provide bitcoin-related services or accept bitcoin as payment, which
could also decrease the price of bitcoin. Similarly, the open-source nature of the bitcoin blockchain means the contributors and developers
of the bitcoin blockchain are generally not directly compensated for their contributions in maintaining and developing the blockchain,
and any failure to properly monitor and upgrade the bitcoin blockchain could adversely affect the bitcoin blockchain and negatively affect
the price of bitcoin.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The liquidity of bitcoin may
also be impacted to the extent that changes in applicable laws and regulatory requirements negatively impact the ability of exchanges
and trading venues to provide services for bitcoin and other digital assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our historical financial statements do not
reflect our acquisition of bitcoin, the fact that our bitcoin holdings could be a substantial part of our assets, or the potential variability
in earnings that we may experience in the future relating to our bitcoin holdings.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our historical financial statements
do not reflect our intended acquisition of bitcoin, that we intend for our bitcoin holdings to comprise most of our total assets, or the
potential variability in earnings that we may experience in the future from holding or selling significant amounts of bitcoin, given our
expected asset concentration. The price of bitcoin has historically been subject to dramatic price fluctuations and is highly volatile.
We expect to determine the fair value of our bitcoin based on quoted (unadjusted) prices on the Coinbase exchange, and following early
adoption of ASU&#160;2023-08, will be required to measure our bitcoin holdings at fair value in our statement of financial position, and
to recognize gains and losses from changes in the fair value of our bitcoin in net income each reporting period, which may create significant
volatility in our reported earnings, amplified by our asset concentration in bitcoin, and decrease the carrying value of our digital assets,
which in turn could have a material adverse effect on the market price of our common stock. Conversely, any sale of bitcoins at prices
above our carrying value for such assets creates a gain for financial reporting purposes even if we would otherwise incur an economic
or tax loss with respect to such transaction, which also may result in significant volatility in our reported earnings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because we intend to purchase
additional bitcoin in future periods and increase our overall holdings of bitcoin, we expect that the proportion of our total assets that
will be represented by our bitcoin holdings will increase in the future. As a result, and in particular with respect to the quarterly
periods and full fiscal year with respect to which ASU&#160;2023-08 will apply, and for all future periods, volatility in our earnings
may be significantly more than what we experienced in prior periods. As of the date of this prospectus, the Company has purchased $1.0
million of Bitcoin as part of the Company&#8217;s ongoing treasury strategy, representing 8.53 Bitcoins.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to the currently unregulated nature
and lack of transparency surrounding the operations of many bitcoin trading venues, bitcoin trading venues may experience greater fraud,
security failures or regulatory or operational problems than trading venues for more established asset classes, which may result in a
loss of confidence in bitcoin trading venues and adversely affect the value of our bitcoin.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Bitcoin trading venues are
relatively new and, in many cases, currently unregulated. Even if regulated, such venues may not be complying with such regulations. Furthermore,
there are many bitcoin trading venues that do not provide the public with significant information regarding their ownership structure,
management teams, corporate practices and regulatory compliance. As a result, the marketplace may lose confidence in bitcoin trading venues,
including prominent exchanges that handle a significant volume of bitcoin trading and/or are subject to regulatory oversight, in the event
one or more bitcoin trading venues cease or pause for a prolonged period the trading of bitcoin or other digital assets, or experience
fraud, significant volumes of withdrawal, security failures or operational problems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2019 there were reports
claiming that&#160;80-95% of bitcoin trading volume on trading venues was false or non-economic in nature, with specific focus on currently
unregulated exchanges located outside of the United&#160;States. The SEC also alleged as part of its June&#160;2023, complaint that Binance
Holdings Ltd. committed strategic and targeted &#8220;wash trading&#8221; through its affiliates to artificially inflate the volume of
certain digital assets traded on its exchange. Such reports and allegations may indicate that the bitcoin market is significantly smaller
than expected and that the United&#160;States makes up a significantly larger percentage of the bitcoin market than is commonly understood.
Any actual or perceived false trading in the bitcoin market, and any other fraudulent or manipulative acts and practices, could adversely
affect the value of our bitcoin. Negative perception, a lack of stability in the broader bitcoin markets and the closure, temporary shutdown
or operational disruption of bitcoin trading venues, lending institutions, institutional investors, institutional miners, custodians,
or other major participants in the bitcoin ecosystem, due to fraud, business failure, cybersecurity events, government-mandated regulation,
bankruptcy, or for any other reason, may result in a decline in confidence in bitcoin and the broader bitcoin ecosystem and greater volatility
in the price of bitcoin. For example, in 2022, each of Celsius Network, Voyager Digital, Three Arrows Capital, FTX Trading, and BlockFi
filed for bankruptcy, following which the market prices of bitcoin and other digital assets significantly declined. In addition, in June&#160;2023,
the SEC announced enforcement actions against Coinbase, Inc., and Binance Holdings Ltd., two providers of large trading venues for digital
assets, which similarly was followed by a decrease in the market price of bitcoin and other digital assets. These were followed in November&#160;2023,
by an SEC enforcement action against Kraken, another large trading venue for digital assets. As the price of our common stock is affected
by the value of our bitcoin holdings, the failure of a major participant in the bitcoin ecosystem could have a material adverse effect
on the market price of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The concentration of our bitcoin holdings
will enhance the risks inherent in our bitcoin treasury strategy.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use the net proceeds
from the Committed Equity Facility to purchase bitcoin and we may increase our overall holdings of bitcoin in the future. Once we complete
the planned acquisition of bitcoin, a substantial majority of our treasury holdings could be bitcoin. The concentration of our bitcoin
holdings may limit the risk mitigation that we could take advantage of by purchasing a more diversified portfolio of treasury assets,
and the absence of diversification enhances the risks inherent in our bitcoin treasury strategy. Any future significant declines in the
price of bitcoin would have a more pronounced impact on our financial condition than if we used our cash to purchase a more diverse portfolio
of assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The emergence or growth of other digital
assets, including those with significant private or public sector backing, could have a negative impact on the price of bitcoin and adversely
affect our financial condition and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of our bitcoin
treasury strategy, a substantial amount of our cash could be concentrated in our bitcoin holdings. Accordingly, the emergence or growth
of digital assets other than bitcoin may have a material adverse effect on our financial condition. While bitcoin is the largest digital
asset by market capitalization as of the date of this prospectus, there are numerous alternative digital assets and many entities, including
consortiums and financial institutions, are researching and investing resources into private or permissioned blockchain platforms or
digital assets that do not use proof-of-work mining like the bitcoin network. For example, in late 2022, the ethereum network transitioned
to a &#8220;proof-of-stake&#8221; mechanism for validating transactions that requires significantly less computing power than proof-of-work
mining. The ethereum network has completed another major upgrade since then and may undertake additional upgrades
in the future. If the mechanisms for validating transactions in ethereum and other alternative digital assets are perceived as superior
to proof-of-work mining, those digital assets could gain market share relative to bitcoin.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other alternative digital assets
that compete with bitcoin in certain ways include &#8220;stablecoins,&#8221; which are designed to maintain a constant price because of,
for instance, their issuers&#8217; promise to hold high-quality liquid assets (such as U.S.&#160;dollar deposits and short-term U.S.&#160;treasury
securities) equal to the total value of stablecoins in circulation. Stablecoins have grown rapidly as an alternative to bitcoin and other
digital assets as a medium of exchange and store of value, particularly on digital asset trading platforms. As of the date of this prospectus,
two of the seven largest digital assets by market capitalization are U.S.&#160;dollar-backed stablecoins.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, central banks
in some countries have started to introduce digital forms of legal tender. For example, China&#8217;s CBDC project was made available
to consumers in January&#160;2022, and governments including the United&#160;States, the European Union, and Israel have been discussing
the potential creation of new CBDCs. Whether or not they incorporate blockchain or similar technology, CBDCs, as legal tender in the issuing
jurisdiction, could also compete with, or replace, bitcoin and other digital assets as a medium of exchange or store of value. As a result,
the emergence or growth of these or other digital assets could cause the market price of bitcoin to decrease, which could have a material
adverse effect on our financial condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our bitcoin holdings are less liquid than
our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash
equivalents.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Historically, the bitcoin markets
have been characterized by significant volatility in price, limited liquidity and trading volumes compared to sovereign currency markets,
relative anonymity, a developing regulatory landscape, potential susceptibility to market abuse and manipulation, compliance and internal
control failures at exchanges, and various other risks inherent in its entirely electronic, virtual form and decentralized network. During
times of market instability, we may not be able to sell our bitcoin at favorable prices or at all. For example, a number of bitcoin trading
venues temporarily halted deposits and withdrawals in 2022. As a result, our bitcoin holdings may not be able to serve as a source of
liquidity for us to the same extent as cash and cash equivalents. Further, bitcoin we hold with our custodians and transact with our trade
execution partners does not enjoy the same protections as are available to cash or securities deposited with or transacted by institutions
subject to regulation by the Federal Deposit Insurance Corporation or the Securities Investor Protection Corporation. Additionally, we
may be unable to enter into term loans or other capital raising transactions collateralized by our unencumbered bitcoin or otherwise generate
funds using our bitcoin holdings, including in particular during times of market instability or when the price of bitcoin has declined
significantly. If we are unable to sell our bitcoin, enter into additional capital raising transactions using bitcoin as collateral, or
otherwise generate funds using our bitcoin holdings, or if we are forced to sell our bitcoin at a significant loss, in order to meet our
working capital requirements, our business and financial condition could be negatively impacted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we or our third-party service providers
experience a security breach or cyberattack and unauthorized parties obtain access to our bitcoin, or if our private keys are lost or
destroyed, or other similar circumstances or events occur, we may lose some or all of our bitcoin and our financial condition and results
of operations could be materially adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantially all of the bitcoin
we will own will be held in custody accounts at U.S.-based institutional-grade digital asset custodians. Security breaches and cyberattacks
are of particular concern with respect to our bitcoin. Bitcoin and other blockchain-based cryptocurrencies and the entities that provide
services to participants in the bitcoin ecosystem have been, and may in the future be, subject to security breaches, cyberattacks, or
other malicious activities. For example, in October&#160;2021 it was reported that hackers exploited a flaw in the account recovery process
and stole from the accounts of at least 6,000 customers of the Coinbase exchange, although the flaw was subsequently fixed and Coinbase
reimbursed affected customers. Similarly, in November&#160;2022, hackers exploited weaknesses in the security architecture of the FTX
Trading digital asset exchange and reportedly stole over $400&#160;million in digital assets from customers. A successful security breach
or cyberattack could result in:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a partial or total loss of our bitcoin in a manner that may not be covered by insurance or the liability
provisions of the custody agreements with the custodians who hold our bitcoin;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">harm to our reputation and brand;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">improper disclosure of data and violations of applicable data privacy and other laws; or</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">significant regulatory scrutiny, investigations, fines, penalties, and other legal, regulatory, contractual
and financial exposure.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, any actual or perceived
data security breach or cybersecurity attack directed at other companies with digital assets or companies that operate digital asset networks,
regardless of whether we are directly impacted, could lead to a general loss of confidence in the broader bitcoin blockchain ecosystem
or in the use of the bitcoin network to conduct financial transactions, which could negatively impact us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Attacks upon systems across
a variety of industries, including industries related to bitcoin, are increasing in frequency, persistence, and sophistication, and, in
many cases, are being conducted by sophisticated, well-funded and organized groups and individuals, including state actors. The techniques
used to obtain unauthorized, improper or illegal access to systems and information (including personal data and digital assets), disable
or degrade services, or sabotage systems are constantly evolving, may be difficult to detect quickly, and often are not recognized or
detected until after they have been launched against a target. These attacks may occur on our systems or those of our third-party service
providers or partners. We may experience breaches of our security measures due to human error, malfeasance, insider threats, system errors
or vulnerabilities or other irregularities. In particular, we expect that unauthorized parties will attempt, to gain access to our systems
and facilities, as well as those of our partners and third-party service providers, through various means, such as hacking, social engineering,
phishing and fraud. Threats can come from a variety of sources, including criminal hackers, hacktivists, state-sponsored intrusions, industrial
espionage, and insiders. In addition, certain types of attacks could harm us even if our systems are left undisturbed. For example, certain
threats are designed to remain dormant or undetectable, sometimes for extended periods of time, or until launched against a target and
we may not be able to implement adequate preventative measures. Further, there has been an increase in such activities due to the increase
in work-from-home arrangements. The risk of cyberattacks could also be increased by cyberwarfare in connection with the ongoing Russia-Ukraine
and Israel-Hamas conflicts, or other future conflicts, including potential proliferation of malware into systems unrelated to such conflicts.
Any future breach of our operations or those of others in the bitcoin industry, including third-party services on which we rely, could
materially and adversely affect our financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We face risks relating to the custody of
our bitcoin, including the loss or destruction of private keys required to access our bitcoin and cyberattacks or other data loss relating
to our bitcoin</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will hold our bitcoin with
regulated custodians that have duties to safeguard our private keys. Our custodial services contracts will not restrict our ability to
reallocate our bitcoin among our custodians, and our bitcoin holdings may be concentrated with a single custodian from time to time, including
immediately after this offering. In light of the significant amount of bitcoin we hold, we continually evaluate the need to engage additional
custodians. Additional custodians could achieve a greater degree of diversification in the custody of our bitcoin as the extent of potential
risk of loss is dependent, in part, on the degree of diversification. If there is a decrease in the availability of digital asset custodians
that we believe can safely custody our bitcoin, for example, custodians discontinue or limit their services in the United&#160;States,
we may need to enter into agreements that are less favorable than our currently anticipated agreements or take other measures to custody
our bitcoin, and our ability to seek a greater degree of diversification in the use of custodial services would be materially adversely
affected. In addition, holding our bitcoin with regulated custodians could affect the availability of receiving digital assets that may
result from &#8220;forks&#8221; of the bitcoin blockchain if our custodians are unable to support or otherwise provide us with such digital
assets, thereby reducing the amount of digital assets we may hold as a result. While our custodians will carry insurance policies to cover
losses for commercial crimes and cyber and tech errors or omissions, the policy limits vary per provider and would be shared among all
of their customers, and subject to various limitations and exclusions (such as if a loss arises due to our failure to protect our login
credentials and devices). The insurance that covers losses of our bitcoin holdings may cover only a small fraction of the value of the
entirety of our bitcoin holdings, and there can be no guarantee that such insurance will be maintained as part of the custodial services
we will have or that such coverage will cover losses with respect to our bitcoin. Moreover, our use of custodians exposes us to the risk
that the bitcoin our custodians hold on our behalf could be subject to insolvency proceedings and we could be treated as a general unsecured
creditor of the custodian, inhibiting our ability to exercise ownership rights with respect to such bitcoin. Any loss associated with
such insolvency proceedings is unlikely to be covered by any insurance coverage we maintain related to our bitcoin.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Bitcoin is controllable only
by the possessor of both the unique public key and private key(s)&#160;relating to the local or online digital wallet in which the bitcoin
is held. While the bitcoin blockchain ledger requires a public key relating to a digital wallet to be published when used in a transaction,
private keys must be safeguarded and kept private in order to prevent a third party from accessing the bitcoin held in such wallet. To
the extent the private key(s)&#160;for a digital wallet are lost, destroyed, or otherwise compromised and no backup of the private key(s)&#160;is
accessible, neither we nor our custodians will be able to access the bitcoin held in the related digital wallet. Furthermore, we cannot
provide assurance that our digital wallets, nor the digital wallets of our custodians held on our behalf, will not be compromised as a
result of a cyberattack. The bitcoin and blockchain ledger, as well as other digital assets and blockchain technologies, have been, and
may in the future be, subject to security breaches, cyberattacks, or other malicious activities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Regulatory change reclassifying bitcoin
as a security could lead to our classification as an &#8220;investment company&#8221; under the Investment Company Act&#160;of&#160;1940,
as amended, or the 1940 Act, and could adversely affect the market price of bitcoin and the market price of our common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Sections 3(a)(1)(A)&#160;and
(C)&#160;of the 1940 Act, a company generally will be deemed to be an &#8220;investment company&#8221; for purposes of the 1940 Act if
(1)&#160;it is, or holds itself out as being, engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting
or trading in securities or (2)&#160;it engages, or proposes to engage, in the business of investing, reinvesting, owning, holding or
trading in securities and it owns or proposes to acquire investment securities having a value exceeding 40% of the value of its total
assets (exclusive of U.S.&#160;government securities and cash items) on an unconsolidated basis. We do not believe that we are an &#8220;investment
company,&#8221; as such term is defined in the 1940 Act, and are not registered as an &#8220;investment company&#8221; under the 1940
Act as of the date of this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While senior SEC officials
have stated their view that bitcoin is not a &#8220;security&#8221; for purposes of the federal securities laws, a contrary determination
by the SEC could lead to our classification as an &#8220;investment company&#8221; under the 1940 Act, if the portion of our assets consists
of investments in bitcoins exceeds 40% safe harbor limits prescribed in the 1940 Act, which would subject us to significant additional
regulatory controls that could have a material adverse effect on our business and operations and may also require us to change the manner
in which we conduct our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We monitor our assets and income
for compliance under the 1940 Act and seek to conduct our business activities in a manner such that we do not fall within its definitions
of &#8220;investment company&#8221; or that we qualify under one of the exemptions or exclusions provided by the 1940 Act and corresponding
SEC regulations. If bitcoin is determined to constitute a security for purposes of the federal securities laws, we would take steps to
reduce the percentage of bitcoins that constitute investment assets under the 1940 Act. These steps may include, among others, selling
bitcoins that we might otherwise hold for the long term and deploying our cash in non-investment assets, and we may be forced to sell
our bitcoins at unattractive prices. We may also seek to acquire additional non-investment assets to maintain compliance with the 1940
Act, and we may need to incur debt, issue additional equity or enter into other financing arrangements that are not otherwise attractive
to our business. Any of these actions could have a material adverse effect on our results of operations and financial condition. Moreover,
we can make no assurance that we would successfully be able to take the necessary steps to avoid being deemed to be an investment company
in accordance with the safe harbor. If we were unsuccessful, and if bitcoin is determined to constitute a security for purposes of the
federal securities laws, then we would have to register as an investment company, and the additional regulatory restrictions imposed by
1940 Act could adversely affect the market price of bitcoin and in turn adversely affect the market price of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to regulatory developments
related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As bitcoin and other digital
assets are relatively novel and the application of state and federal securities laws and other laws and regulations to digital assets
is unclear in certain respects, it is possible that regulators in the United&#160;States or foreign countries may interpret or apply
existing laws and regulations in a manner that adversely affects the price of bitcoin. The U.S.&#160;federal government, states, regulatory
agencies, and foreign countries may also enact new laws and regulations, or pursue regulatory, legislative, enforcement or judicial actions,
that could materially impact the price of bitcoin or the ability of individuals or institutions such as us to own or transfer bitcoin.
For examples, see &#8220;<i>Risk Factors-Risks Related to Our Bitcoin Treasury Strategy and Holdings-Bitcoin and other digital assets
are novel assets, and are subject to significant legal, commercial, regulatory and technical uncertainty</i>&#8221; elsewhere in this
prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our bitcoin treasury strategy exposes us
to risk of non-performance by counterparties</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bitcoin treasury strategy
exposes us to the risk of non-performance by counterparties, whether contractual or otherwise. Risk of non-performance includes inability
or refusal of a counterparty to perform because of a deterioration in the counterparty&#8217;s financial condition and liquidity or for
any other reason. For example, our execution partners, custodians, or other counterparties might fail to perform in accordance with the
terms of our agreements with them, which could result in a loss of bitcoin, a loss of the opportunity to generate funds, or other losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect our primary counterparty
risk with respect to our bitcoin will be custodian performance obligations under the various custody arrangements we enter into. A series
of recent high-profile bankruptcies, closures, liquidations, regulatory enforcement actions and other events relating to companies operating
in the digital asset industry, the closure or liquidation of certain financial institutions that provided lending and other services to
the digital assets industry, SEC enforcement actions against other providers, or placement into receivership or civil fraud lawsuit against
digital asset industry participants have highlighted the perceived and actual counterparty risk applicable to digital asset ownership
and trading. Legal precedent created in these bankruptcy and other proceedings may increase the risk of future rulings adverse to our
interests in the event one or more of our custodians becomes a debtor in a bankruptcy case or is the subject of other liquidation, insolvency
or similar proceedings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While our custodians will be
subject to regulatory regimes intended to protect customers in the event of a custodial bankruptcy, receivership or similar insolvency
proceeding, no assurance can be provided that our custodially-held bitcoin will not become part of the custodian&#8217;s insolvency estate
if one or more of our custodians enters bankruptcy, receivership or similar insolvency proceedings. Additionally, if we pursue any strategies
to create income streams or otherwise generate funds using our bitcoin holdings, we would become subject to additional counterparty risks.
We will need to carefully evaluate market conditions, including price volatility as well as service provider terms and market reputations
and performance, among others, prior to implementing any such strategy, all of which could effect our ability to successfully implement
and execute on any such future strategy. These risks, along with any significant non-performance by counterparties, including in particular
the custodian or custodians with which we will custody substantially all of our bitcoin, could have a material adverse effect on our business,
prospects, financial condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If bitcoin is determined to
constitute a security for purposes of the federal securities laws, the additional regulatory restrictions imposed by such a determination
could adversely affect the market price of bitcoin and in turn adversely affect the market price of our common stock. See &#8220;<i>Risk
Factors&#160;&#8212;&#160;Regulatory change reclassifying bitcoin as a security could lead to our classification as an &#8220;investment
company&#8221; under the Investment Company Act&#160;of&#160;1940, as amended, or the 1940 Act, and could adversely affect the market
price of bitcoin and the market price of our common stock</i>&#8221; above. Moreover, the risks of us engaging in a bitcoin treasury strategy
could create complications due to the lack of experience that third parties have with companies engaging in such a strategy, such as increased
costs of director and officer liability insurance or the potential inability to obtain such coverage on acceptable terms in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A temporary or permanent blockchain &#8220;fork&#8221;
to bitcoin or other crypto assets could adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Blockchain protocols, including
bitcoin, are open source. Any user can download the software, modify it, and then propose that bitcoin or other blockchain protocols users
and miners adopt the modification. When a modification is introduced and a substantial majority of users and miners consent to the modification,
the change is implemented and the bitcoin or other blockchain protocol networks, as applicable, remain uninterrupted. However, if less
than a substantial majority of users and miners consent to the proposed modification, and the modification is not compatible with the
software prior to its modification, the consequence would be what is known as a &#8220;fork&#8221;, <i>i.e</i>., &#8220;split&#8221; of
the impacted blockchain protocol network and respective blockchain, with one prong running the pre-modified software and the other running
the modified software. The effect of such a fork would be the existence of two parallel versions of the bitcoin or other blockchain protocol
network, as applicable, running simultaneously, but with each split network&#8217;s crypto asset lacking interchangeability. A &#8220;hard
fork&#8221; &#8212;&#160;where there is disagreement among the users about the rules of the network&#160;&#8212;&#160;can have a significant
negative impact on value of the crypto asset.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The bitcoin has been subject
to &#8220;forks&#8221; that resulted in the creation of new networks, including bitcoin cash ABC, bitcoin cash SV, bitcoin diamond, bitcoin
gold and others. Some of these forks have caused fragmentation among platforms as to the correct naming convention for forked crypto assets.
Due to the lack of a central registry or rulemaking body, no single entity has the ability to dictate the nomenclature of forked crypto
assets, causing</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">disagreements and a lack of uniformity among
platforms on the nomenclature of forked crypto assets, and which results in further confusion to customers as to the nature of assets
they hold on platforms, and which can negatively impact the value of the crypto assets. In addition, several of these forks were contentious
and as a result, participants in certain communities may harbor ill will towards other communities. As a result, certain community members
may take actions that adversely impact the use, adoption, and price of bitcoin, or any of their forked alternatives.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, hard forks can
lead to new security concerns. For instance, when the Ethereum and Ethereum Classic networks split in July&#160;2016, replay attacks,
in which transactions from one network were rebroadcast on the other network to achieve &#8220;double-spending,&#8221; plagued platforms
that traded Ethereum through at least October&#160;2016, resulting in significant losses to some crypto asset platforms. Similar replay
attacks occurred in connection with the bitcoin cash and bitcoin cash SV network split in November&#160;2018. Another possible result
of a hard fork is an inherent decrease in the level of security due to the splitting of some mining power across networks, making it easier
for a malicious actor to exceed 50% of the mining power of that network, thereby making crypto assets that rely on proof-of-work more
susceptible to attack, as has occurred with Ethereum Classic.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to recognize forked
and airdropped assets consistent with our custodians. We may not immediately or ever have the ability to withdraw a forked or airdropped
bitcoin by virtue of bitcoins that we hold with our custodians. Future forks may occur at any time. A fork can lead to a disruption of
networks and our information technology systems, cybersecurity attacks, replay attacks, or security weaknesses, any of which can further
lead to temporary or even permanent loss of our and our assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The due diligence procedures conducted by
us and our liquidity providers to mitigate transaction risk may fail to prevent transactions with a sanctioned entity.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will execute trades through
U.S.-based liquidity providers, and rely on these third parties to implement controls and procedures to mitigate the risk of transacting
with sanctioned entities. While we expect our third party service providers to conduct their business in compliance with applicable laws
and regulations and in accordance with our contractual arrangements, there is no guarantee that they will do so. Accordingly, we are exposed
to risk that our due diligence procedures may fail. If we are found to have transacted in bitcoin with bad actors that have used bitcoin
to launder money or with persons subject to sanctions, we may be subject to regulatory proceedings and any further transactions or dealings
in bitcoin by us may be restricted or prohibited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional Risks Relating to Ownership of Profusa
Common Stock Following the Business Combination</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There can be no assurance that we will be
able to comply with the continued listing standards of Nasdaq, a failure of which could result in a de-listing of our common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nasdaq Capital Market requires
that the trading price of its listed stocks remain above one dollar in order for the stock to remain listed. If a listed stock trades
below one dollar for more than 30 consecutive&#160;trading days, then it is subject to delisting from Nasdaq. In addition, to maintain
a listing on Nasdaq, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding
director independence and independent committee requirements, minimum stockholders&#8217; equity, and certain corporate governance requirements.
If we are unable to satisfy these requirements or standards, we could be subject to delisting, which would have a negative effect on the
price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a
delisting, we would expect to take actions to restore our compliance with the listing requirements, but we can provide no assurance that
any such action taken by us would allow our common stock to become listed again, stabilize the market price or improve the liquidity of
our common stock, prevent our common stock from dropping below the minimum bid price requirement, or prevent future non-compliance with
the listing requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Nasdaq delists our shares
from trading on its exchange for failure to meet the listing standards, Profusa and its stockholders could face significant negative consequences
including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">limited availability of market quotations for Profusa&#8217;s securities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reduced liquidity for Profusa&#8217;s securities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a determination that Profusa Common Stock is a &#8220;penny stock&#8221; which will require brokers trading
in Profusa Common Stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary
trading market for shares of Profusa Common Stock;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a limited amount of analyst coverage; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a decreased ability to issue additional securities or obtain additional financing in the future.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The National Securities Markets
Improvement Act&#160;of&#160;1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities,
which are referred to as &#8220;covered securities.&#8221; If Profusa&#8217;s securities were not listed on the Nasdaq, such securities
would not qualify as covered securities and we would be subject to regulation in each state in which we offer our securities because states
are not preempted from regulating the sale of securities that are not covered securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future sales, or the perception of future
sales, by Profusa shareholders in the public market could cause the market price for Profusa Common Stock to decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sale of shares of Profusa
Common Stock in the public market, or the perception that such sales could occur, could harm the prevailing market price of shares of
Profusa Common Stock. These sales, or the possibility that these sales may occur, also might make it more difficult for Profusa to sell
equity securities in the future at a time and at a price that it deems appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The grant and future exercise of registration
rights may adversely affect the market price of Profusa shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Registration
Rights Agreement which is described elsewhere in this prospectus, the parties can each demand that Profusa register their registrable
securities under certain circumstances and will each also have piggyback registration rights for these securities in connection with certain
registrations of securities that Profusa undertakes. In addition, Profusa is required to file and maintain an effective registration statement
under the Securities Act covering such securities and certain other securities of Profusa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The registration of these securities
will permit the public sale of such securities. The registration and availability of such a significant number of securities for trading
in the public market may have an adverse effect on the market price of Profusa shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In addition, the shares of Profusa Common
Stock reserved for future issuance under the Equity Incentive Plan will become eligible for sale in the public market once those shares
are issued.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A total of approximately 15%
of the fully diluted shares of Profusa Common Stock common stock has been reserved for future issuance under its equity incentive plan.
The compensation committee of Profusa&#8217;s board of directors may determine the exact number of shares to be reserved for future issuance
under its equity incentive plan at its discretion. Profusa is expected to file one or more registration statements on Form&#160;S-8 under
the Securities Act to register shares of Profusa Common Stock or securities convertible into or exchangeable for shares of Profusa Common
Stock issued pursuant to Profusa&#8217;s equity incentive plan. Any such Form&#160;S-8 registration statements will automatically become
effective upon filing. Accordingly, shares registered under such registration statements will be available for sale in the open market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the future, Profusa may
also issue its securities in connection with investments or acquisitions. The amount of shares of Profusa Common Stock issued in connection
with an investment or acquisition could constitute a material portion of Profusa&#8217;s then-outstanding shares of common stock. Any
issuance of additional securities in connection with investments or acquisitions may result in additional dilution to Profusa&#8217;s
stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because there are no current plans to pay
cash dividends on Profusa Common Stock for the foreseeable future, you may not receive any return on investment unless you sell Profusa
Common Stock for a price greater than that which you paid for it.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa may retain future
earnings, if any, for future operations, expansion and debt repayment and has no current plans to pay any cash dividends for the foreseeable
future. Any decision to declare and pay dividends as a public company in the future will be made at the discretion of Profusa&#8217;s
board of directors and will depend on, among other things, Profusa&#8217;s results of operations, financial condition, cash requirements,
contractual restrictions and other factors that Profusa&#8217;s board of directors may deem relevant. In addition, Profusa&#8217;s ability
to pay dividends may be limited by covenants of any existing and future outstanding indebtedness it or its subsidiaries incur. As a result,
you may not receive any return on an investment in Profusa Common Stock unless you sell your shares of common stock for a price greater
than that which you paid for it.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue additional shares of its common
stock or other equity securities without your approval, which would dilute your ownership interests and may depress the market price of
Profusa Common Stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Equity Incentive
Plan and the ESPP, following the completion of the proposed transactions, Profusa may issue an aggregate of approximately 15% of the fully
diluted shares of Profusa Common Stock, which amount will be subject to increase from time to time. Profusa may also issue additional
shares of Profusa Common Stock or other equity securities of equal or senior rank in the future in connection with, among other things,
future acquisitions or repayment of outstanding indebtedness, without stockholder approval, in a number of circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of additional
shares or other equity securities of equal or senior rank would have the following effects:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">existing stockholders&#8217; proportionate ownership interest in Profusa will decrease;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the amount of cash available per share, including for payment of dividends in the future, may decrease;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the relative voting strength of each previously outstanding Profusa Common Stock may be diminished; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the market price of Profusa Common Stock may decline.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Anti-takeover provisions in our amended
and restated certificate of incorporation and under Delaware law could make an acquisition of Profusa, which may be beneficial to its
stockholders, more difficult and may prevent attempts by its stockholders to replace or remove Profusa&#8217;s current management.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation that will be in effect upon completion of the Business Combination will contain provisions that may delay or prevent
an acquisition of Profusa or a change in its management. These provisions may make it more difficult for stockholders to replace or remove
members of its board of directors. Because the board of directors is responsible for appointing the members of the management team, these
provisions could in turn frustrate or prevent any attempt by its stockholders to replace or remove its current management. In addition,
these provisions could limit the price that investors might be willing to pay in the future for shares of Profusa Common Stock. Among
other things, these provisions include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the limitation of the liability of, and the indemnification of, its directors and officers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a prohibition on actions by its stockholders except at an annual or Special Meeting of stockholders;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a prohibition on actions by its stockholders by written consent; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the ability of the board of directors to issue preferred stock without stockholder approval, which could
be used to institute a &#8220;poison pill&#8221; that would work to dilute the stock ownership of a potential hostile acquirer, effectively
preventing acquisitions that have not been approved by the board of directors.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, because Profusa
is incorporated in Delaware, it is governed by the provisions of Section&#160;203 of the DGCL, which prohibits a person who owns 15%
or more of its outstanding voting stock from merging or combining with Profusa for a period of three&#160;years after the date of the
transaction in which the person acquired 15% or more of Profusa&#8217;s outstanding voting stock, unless such merger or combination is
approved in a prescribed manner. This could discourage, delay or prevent a third party from acquiring or merging with Profusa, whether
or not it is desired by, or beneficial to, its stockholders. This could also have the effect of discouraging others from making tender
offers for Profusa Common Stock, including transactions that may be in its stockholders&#8217; best interests. Finally, these provisions
establish advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted
upon at stockholder meetings. These provisions would apply even if the offer may be considered beneficial by some stockholders. For more
information, see &#8220;<i>Description of Profusa Capital Stock</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our amended and restated certificate of
incorporation provides that the Court of Chancery of the State of Delaware and the federal district courts of the United&#160;States of
America will be the exclusive forums for substantially all disputes between Profusa and its stockholders, which could limit its stockholders&#8217;
ability to obtain a favorable judicial forum for disputes with Profusa or its directors, officers or employees.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s amended and
restated certificate of incorporation will provide that the Court of Chancery of the State of Delaware will be the exclusive forum for
the following types of actions or proceedings under Delaware statutory or common law:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any derivative action or proceeding brought on Profusa&#8217;s behalf;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any action asserting a breach of fiduciary duty;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any action asserting a claim against Profusa arising under the DGCL, its amended and restated certificate
of incorporation or its amended and restated bylaws; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any action asserting a claim against Profusa that is governed by the internal-affairs doctrine or otherwise
related to Profusa&#8217;s internal affairs.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To prevent having to litigate
claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, Profusa&#8217;s
amended and restated certificate of incorporation further provides that the federal district courts of the United&#160;States of America
will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. This provision would
not apply to suits brought to enforce a duty or liability created by the Exchange&#160;Act. Furthermore, Section&#160;22 of the Securities
Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal
courts have jurisdiction to entertain such claims. While the Delaware courts have determined that such choice of forum provisions are
facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions.
In such instance, Profusa would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of its amended
and restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other
jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These exclusive forum provisions
may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with Profusa or its
directors, officers or other employees, which may discourage lawsuits against Profusa and its directors, officers and other employees.
If a court were to find either exclusive-forum provision in its amended and restated certificate of incorporation to be inapplicable or
unenforceable in an action, Profusa may incur further significant additional costs associated with resolving the dispute in other jurisdictions,
all of which could harm its business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to securities litigation,
which is expensive and could divert management attention.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of our securities
may be volatile and, in the past, companies that have experienced volatility in the market price of their securities have been subject
to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us
could result in substantial costs and divert management&#8217;s attention from other business concerns, which could seriously harm its
business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Profusa does not intend to pay cash dividends
for the foreseeable future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the Business Combination,
Profusa currently intends to retain its future earnings, if any, to finance the further development and expansion of its business and
does not intend to pay cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of
our board of directors and will depend on its financial condition, results of operations, capital requirements and future agreements and
financing instruments, business prospects and such other factors as its board of directors deems relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of the information in
this prospectus, and the documents we incorporate by reference, contain forward-looking statements within the meaning of the federal securities
laws. You should not rely on forward-looking statements in this prospectus, and the documents we incorporate by reference. Forward-looking
statements typically are identified by use of terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221;
&#8220;future,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221;
&#8220;potential,&#8221; &#8220;continue,&#8221; and similar words, although some forward-looking statements are expressed differently.
This prospectus, and the documents we incorporate by reference, may also contain forward-looking statements attributed to third parties
relating to their estimates regarding the markets we may enter in the future. All forward-looking statements address matters that involve
risk and uncertainties, and there are many important risks, uncertainties and other factors that could cause our actual results to differ
materially from the forward-looking statements contained in this prospectus, and the documents we incorporate by reference.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should also carefully consider
the statements under <i>&#8220;<span style="text-decoration:underline">Risk Factors</span>&#8221;</i> and other sections of this prospectus, which address additional facts that
could cause our actual results to differ from those set forth in the forward-looking statements. We caution investors not to place significant
reliance on the forward-looking statements contained in this prospectus, and the documents we incorporate by reference. We undertake no
obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or
otherwise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE COMMITTED EQUITY FACILITY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 28, 2025, we entered
into the Purchase Agreement and the ELOC Registration Rights Agreement with Ascent. Upon the terms and subject to the satisfaction of
the conditions contained in the Purchase Agreement, from and after the Effective Date, we will have the right, in our sole discretion,
to sell to Ascent up to $100,000,000 of shares of our Common Stock, subject to certain limitations set forth in the Purchase Agreement,
from time to time after the date of this prospectus and during the term of the Purchase Agreement. Sales of Common Stock by us to Ascent
under the Purchase Agreement, and the timing of any such sales, are solely at our option, and we are under no obligation to sell any securities
to Ascent under the Purchase Agreement. In accordance with our obligations under the ELOC Registration Rights Agreement, we previously
filed a registration statement, declared effective on August 25, 2025, registering the resale of up to 8,970,830 shares by Ascent pursuant
to the Purchase Agreement. In addition, we have filed the registration statement that includes this prospectus with the SEC to register
under the Securities Act the resale by Ascent of up to an additional 42,211,548 Purchase Shares that we may, in our sole discretion, elect
to sell to Ascent, from time to time over a period of up to 36&#160;months from and after the Effective Date (defined below) pursuant
to the Purchase Agreement.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Purchase Agreement,
we have the right, but not the obligation, from time to time at our sole discretion for a period of up to 36 months, unless the Purchase
Agreement is earlier terminated, to direct Ascent to purchase up to a specified maximum amount of shares of Common Stock in one or more
Purchases as set forth in the Purchase Agreement, by delivering a written Advance Notice, if any, to Ascent in accordance with the Purchase
Agreement on any trading day we select.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From and after Commencement,
the Company will control the timing and amount of any sales of Common Stock to Ascent. Actual sales of shares of our Common Stock to Ascent
under the Purchase Agreement will depend on a variety of factors to be determined by us from time to time, including, among other things,
market conditions, the trading price of our Common Stock and determinations by us as to the appropriate sources of funding for our Company
and its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, we may not issue
or sell any shares of Common Stock to Ascent under the Purchase Agreement which, when aggregated with all other shares of Common Stock
then beneficially owned by Ascent and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 thereunder),
would result in Ascent beneficially owning shares of Common Stock in excess of the 9.99% Beneficial Ownership Limitation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net proceeds to us from
sales that we elect to make to Ascent under the Purchase Agreement, if any, will depend on the frequency and prices at which we sell shares
of our Common Stock to Ascent. We expect that any proceeds received by us from such sales to Ascent will be used for working capital and
general corporate purposes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither we nor Ascent may assign
or transfer our respective rights and obligations under the Purchase Agreement or the ELOC Registration Rights Agreement, and no provision
of the Purchase Agreement or the ELOC Registration Rights Agreement may be modified or waived by us or Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As consideration for Ascent&#8217;s
commitment to purchase shares of Common Stock at our direction upon the terms and subject to the conditions set forth in the Purchase
Agreement, upon our execution of the term sheet relating to the Purchase Agreement, we issued Ascent Commitment Warrants to purchase up
to 900,000 Commitment Warrant Shares. The Commitment Warrants have an exercise price of $0.01 and may be exercised for cash or, if at
the time of exercise there is no effective registration statement covering the resale of the Commitment Warrant Shares, on a cashless
basis. If we do not require Ascent to purchase any Purchase Shares on or before the 100<sup>th</sup> day following the execution of the
Purchase Agreement, the number of Commitment Warrant Shares underlying the Commitment Warrants will be reduced to 450,000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we have agreed
to reimburse Ascent for costs, fees and expenses of up to $30,000 of the negotiation, preparation and closing of the Purchase Agreement
up to the Effective Date and ELOC Registration Rights Agreement, and additional costs, fees and expenses thereafter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement and
the ELOC Registration Rights Agreement contain customary representations, warranties, conditions and indemnification obligations of the
parties. Copies of the agreements have been filed as exhibits to the registration statement that includes this prospectus and are available
electronically on the SEC&#8217;s website at <i>www.sec.gov</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Purchases of Common Stock Under the Purchase
Agreement</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Purchases</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have the right, but not
the obligation, from time to time at our sole discretion for a period of up to 36 months, unless the Purchase Agreement is earlier terminated,
beginning on the Effective Date, to direct Ascent to purchase a specified number of shares of Common Stock, not to exceed the applicable
Maximum Closing Purchase Price, in a Purchase under the Purchase Agreement, by timely delivering a written Advance Notice to Ascent to
purchase a specified number of Purchase Shares. On the same date, the Company must deliver the specified number of Purchase Shares to
Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Purchase Agreement,
we may deliver from time to time an Advance Notice to the Purchaser to request the purchase of shares of common stock, with each closing
(a &#8220;Closing&#8221;) to occur on a trading day following the end of a 10 or fewer trading day valuation period commencing on the
trading date immediately following the delivery of the Advance Notice, or as determined by the Purchaser. The purchase price per share
at each Closing will be equal to 97% of the lowest VWAP of the Company&#8217;s common stock during the applicable valuation period, subject
to a floor price and other adjustments as set forth in the Purchase Agreement. The maximum purchase price at any single Closing is limited
to the lower of (a) $5,000,000 or (b) 100% of the average daily traded value of the common stock for the five trading days immediately
preceding such Closing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
certain limitations, including that Ascent&#8217;s beneficial ownership of the Company&#8217;s common stock is limited to 9.99% of the
outstanding shares immediately after giving effect to any issuance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
deliver the Purchased Securities as DWAC shares to the Purchaser on the date that it delivers the applicable Advance Notice. If the Company
fails to timely deliver the shares, the Purchaser may, among other remedies, deem the Advance Notice rescinded or require the Company
to pay certain cover costs. The Purchaser may resell the Purchased Securities during the valuation period, and the Company is obligated
to return any surplus shares if the Maximum Aggregate Purchase Price is exceeded.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the value
of all of the Purchase Shares delivered to Ascent exceeds $100,000,000, then Ascent shall return to the to the Company the surplus amount
of Purchase Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Conditions Precedent to Commencement and Each
Purchase</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent&#8217;s obligation to
accept Advance Notices that are timely delivered by us under the Purchase Agreement and to purchase shares of our Common Stock in Purchases
under the Purchase Agreement, are subject to (i) the initial satisfaction, at the Commencement, and (ii) the satisfaction, on the applicable
Purchase Date for each Purchase after the Effective Date, of the conditions precedent thereto set forth in the Purchase Agreement, all
of which are entirely outside of Ascent&#8217;s control, which conditions including the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the accuracy in all material respects of the representations and warranties of the Company included in
the Purchase Agreement;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the Company having performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Purchase Agreement to be performed, satisfied or complied with by the Company;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the registration statement that includes this prospectus (and any one or more additional registration
statements filed with the SEC that include shares of Common Stock that may be issued and sold by the Company to Ascent under the Purchase
Agreement) having been declared effective under the Securities Act by the SEC, and Ascent being able to utilize this prospectus (and the
prospectus included in any one or more additional registration statements filed with the SEC under the ELOC Registration Rights Agreement)
to resell all of the Purchase Shares included in this prospectus (and included in any such additional prospectuses);</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">trading in the Company shares of Common Stock shall not have been suspended by the SEC or Nasdaq and,
at any time prior to such Closing Date (or, as the case may be, the Effective Date), trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on Securities of the Company whose trades
are reported by such service or on any Trading Market for such securities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">there shall not have occurred any breach, default or event of default under any indebtedness of the Company
or any of its subsidiaries (A) having (individually or in the aggregate for all such indebtedness) an aggregate maximum principal amount
or commitment greater than $150,000, or (B) any such indebtedness shall become or be declared due and payable prior to the date on which
it would otherwise become due and payable;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">there shall not have occurred any breach, default or event of default under any other contractual obligation
to which the Company or any of its subsidiaries is obligated that, if determined adversely to any Company Group Member, could reasonably
be expected to result in any injunction affecting the Company or any of its subsidiaries $150,000;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">there shall not have occurred any monetary judgment, writ or similar final process shall be entered or
filed against the Company of any of its subsidiaries or any of their assets for an injunction or for monetary damages of more than $150,000,
and such judgment, writ or similar final process shall remain unvacated, unbonded or unstayed for a period of forty-five (45) calendar
days;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">none of the Company or its subsidiaries have commenced a case or other proceeding under any bankruptcy,
reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency, winding up, reorganization, arrangement,
adjustment, protection, relief or composition of debts or liquidation or similar regulation of any jurisdiction relating to the Company
or such subsidiary;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">no change of control of the Company shall have occurred;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the Company shall not have amended its charter documents in any manner that materially and adversely affects
any rights of the Ascent or change the nature of the Company&#8217;s business;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the Company&#8217;s Common Stock shall not have become &#8220;penny stock&#8221; as defined in Regulations
for purposes of 3(a)(51) of the Exchange Act, and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the transfer of shares of Common Stock through the Depository Trust Company System shall remain available
for the &#8220;Deposit and Withdrawal at Custodian&#8221; (DWAC) service of the Deposit Trust Corporation and shall not be subject to
any restriction or limitation imposed by or on behalf of the Deposit Trust Corporation on any of its services or any other restriction
or limitation on the use of the services provided by the Deposit Trust Corporation (DTC chill).</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Termination of the Purchase Agreement</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement will
automatically terminate on the earliest to occur of (i) July 27, 2028, (ii) the date on which Ascent shall have purchased from us under
the Purchase Agreement shares of Common Stock for an aggregate gross purchase price of $100,000,000, and (iii) the date either party effectively
delivers notice to the other party of such termination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Short-Selling or Hedging by Ascent</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent has represented to us
that at no time prior to the date of the Purchase Agreement has Ascent, any of its officers, or any entity managed or controlled by Ascent,
engaged in or effected, in any manner whatsoever, directly or indirectly, for Ascent&#8217;s own principal account or for the principal
account of any such entity managed or controlled by Ascent, any short sale (as such term is defined in Rule 200 of Regulation SHO of the
Exchange Act) of our Common Stock or any hedging transaction, which establishes a net short position with respect to our Common Stock
that remained in effect as of the date of the Purchase Agreement. Ascent has agreed that, during the term of the Purchase Agreement, none
of Ascent, any of its officers, or any entity managed or controlled by Ascent will engage in or effect, directly or indirectly, any of
the foregoing transactions either for Ascent&#8217;s own principal account or for the principal account of any such entity managed or
controlled by Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect of Sales of our Common Stock under the
Purchase Agreement on our Stockholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Commitment Warrant Shares
that we issued, and the Purchase Shares to be issued or sold by us, to Ascent under the Purchase Agreement that are being registered under
the Securities Act for resale by Ascent in this offering are expected to be freely tradable. The 42,211,548 Purchase Shares being registered
for resale in this offering may be issued and sold by us to Ascent from time to time at our discretion over a period of up to 36 months
(unless the Purchase Agreement is earlier terminated), beginning on the Effective Date. The resale by Ascent of a significant amount of
Purchase Shares registered for resale in this offering at any given time, or the perception that these sales may occur, could cause the
market price of our Common Stock to decline and to be highly volatile. Sales of our Common Stock, if any, to Ascent under the Purchase
Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Ascent all,
some or none of the shares of our Common Stock that may be available for us to sell to Ascent pursuant to the Purchase Agreement.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If and when we do elect to
sell shares of our Common Stock to Ascent pursuant to the Purchase Agreement, after Ascent has acquired such shares, Ascent may resell
all, some or none of such shares at any time or from time to time in its discretion and at different prices. As a result, investors who
purchase shares from Ascent in this offering at different times will likely pay different prices for those shares, and so may experience
different levels of dilution, and in some cases substantial dilution, and different outcomes in their investment results. Investors may
experience a decline in the value of the shares they purchase from Ascent in this offering as a result of future sales made by us to Ascent
at prices lower than the prices such investors paid for their shares in this offering. In addition, if we sell a substantial number of
shares of our Common Stock to Ascent under the Purchase Agreement, or if investors expect that we will do so, the actual sales of shares
or the mere existence of our arrangement with Ascent may make it more difficult for us to sell equity or equity-related securities in
the future at a time and at a price that we might otherwise wish to effect such sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the per share purchase
price that Ascent will pay for Purchase Shares in any Purchase that we may elect to effect pursuant to the Purchase Agreement will be
determined by reference to the VWAP during the applicable Valuation Period on the applicable Closing Date, as of the date of this prospectus,
we cannot determine the actual purchase price per share that Ascent will be required to pay for any Purchase Shares that we may elect
to sell to Ascent under the Purchase Agreement from and after Commencement and, therefore, we cannot be certain how many Purchase Shares,
in the aggregate, we may issue and sell to Ascent under the Purchase Agreement from and after Commencement. As of October 8, 2025, there
were 41,759,307&#160;shares of our Common Stock outstanding, of which 34,982,922&#160;shares were held by non-affiliates&#160;of our Company.
If all of the 42,211,548 Purchase Shares offered for resale by Ascent under this prospectus were issued and outstanding as of the date
hereof, such shares would represent approximately 50.3% of the total number of outstanding shares of Common Stock and approximately 54.7%
of the total number of outstanding shares of Common Stock held by non-affiliates&#160;of our Company, in each case as of October 8, 2025.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the Purchase Agreement provides that we may sell up to $100,000,000
of our Common Stock to Ascent, only an additional 42,211,548 Purchase Shares are being registered under the Securities Act for resale
by Ascent under the registration statement which includes this prospectus. This amount is in addition to the 8,970,830 shares previously
registered for resale in our prior registration statement, which was declared effective on August 25, 2025, including 900,000 Commitment
Warrant Shares (for which we have not and will not receive any cash consideration). If we were to issue and sell all of such 42,211,548
Purchase Shares to Ascent at an assumed purchase price per share of $0.34, representing the closing sale price of our Common Stock on
Nasdaq on October 7, 2025, we would only receive approximately $14.4&#160;million in aggregate gross proceeds from the sale of such Purchase
Shares to Ascent under the Purchase Agreement. Depending on the market prices of our Common Stock on the Purchase Dates on which we elect
to sell such Purchase Shares to Ascent under the Purchase Agreement, we may in the future need to register under the Securities Act additional
shares of our Common Stock for resale by Ascent which, together with the 42,211,548 Purchase Shares included in this prospectus, will
enable us to issue and sell to Ascent such aggregate number of shares of Common Stock under the Purchase Agreement as will be necessary
in order for us to receive aggregate proceeds equal to Ascent&#8217;s $100,000,000 maximum aggregate purchase commitment available to
us under the Purchase Agreement.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The number of Purchase Shares
ultimately offered for resale by Ascent through this prospectus is dependent upon the number of shares of Common Stock, if any, we elect
to issue and/or sell to Ascent under the Purchase Agreement from and after the Effective Date. The issuance of our Common Stock to Ascent
pursuant to the Purchase Agreement will not affect the rights or privileges of our existing stockholders, except that the economic and
voting interests of each of our existing stockholders will be diluted. Although the number of shares of our Common Stock that our existing
stockholders own will not decrease, the shares of our Common Stock owned by our existing stockholders will represent a smaller percentage
of our total outstanding shares of our Common Stock after any such issuance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the amount of gross proceeds we would receive from Ascent from our sale of Purchase Shares (which are being registered for resale by Ascent
under the registration statement that includes this prospectus) to Ascent as Purchase Shares under the Purchase Agreement at varying purchase
prices:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Assumed Average Purchase Price Per Share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> Registered<br/> Purchase<br/> Shares to be<br/> Issued if<br/> Full&#160;Purchase<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of <br/> Outstanding Shares<br/> After Giving Effect <br/> to the Issuance to <br/> Ascent<sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Proceeds <br/> from the<br/> Sale of <br/> Purchase Shares<br/> to Ascent Under <br/> the Purchase<br/> Agreement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">$0.14</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">42,211,548</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">50.3</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,909,617</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">$0. 34<sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,211,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">14,351,926</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$0.50</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,211,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">21,105,774</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">$0.75</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,211,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">31,658,661</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$1.00</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,211,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">42,211,548</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 24pt">(1)</td><td style="text-align: justify">As the following table sets forth the amount of gross proceeds we would
receive from Ascent from our sale of Purchase Shares being registered for resale by Ascent under this registration statement, it excludes
both the 900,000 Commitment Warrant Shares issued upon exercise of the Commitment Warrants that we issued to Ascent upon our execution
of the term sheet relating to the Purchase Agreement on July 20, 2025, as consideration for its commitment to purchase shares of Common
Stock and the 8,070,830 shares previously registered under the agreement for resale. Although the Purchase Agreement provides that we
may sell up to $100,000,000 of our Common Stock to Ascent, we are only registering and additional 42,211,548 shares under the registration
statement that includes this prospectus, , which may or may not cover all of the shares of Common Stock we ultimately sell to Ascent under
the Purchase Agreement.</td></tr>
                                                                                                                                                      </table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 24pt">(2)</td><td style="text-align: justify">The denominator is based on 41,759,307 shares of Common Stock outstanding
as of October 8, 2025, adjusted to include the issuance of the number of Purchase Shares set forth in the adjacent column that we would
have sold to Ascent, assuming the average purchase price in the first column. The numerator is based on the number of Purchase Shares
issuable under the Purchase Agreement (which are included in this prospectus) at the corresponding assumed average purchase price set
forth in the first column.</td></tr>
                                                                                                                                              </table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 24pt">(3)</td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The closing sale price of our Common Stock on Nasdaq on October 7,
2025.</p></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>USE OF PROCEEDS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will not receive any proceeds
from the sale of Common Stock by any of the Selling Stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may receive
up to $100,000,000 aggregate gross proceeds under the Purchase Agreement from any sales we make to Ascent pursuant to the Purchase Agreement.
The net proceeds from sales, if any, under the Purchase Agreement, will depend on the frequency and prices at which we sell our Common
Stock to Ascent after the date of this prospectus. See the section titled &#8220;The Committed Equity Facility&#8221; in this prospectus
for more information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to use any proceeds
that we receive under the Purchase Agreement for the purchase of Bitcoin (which can be used for debt repayment) provided that the Company&#8217;s
cash balance on the date of the applicable sale exceeds $5,000,000. If the cash balance is less than $5,000,000, proceeds to the Company
shall be allocated first to bring the balance to $5,000,000 and the remaining proceeds to purchase Bitcoin. As of the date of this prospectus,
we cannot specify with certainty all of the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds
we receive. Accordingly, we will retain broad discretion over the use of these proceeds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Introduction</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following unaudited pro
forma condensed combined financial information presents the combination of financial information of Northview Acquisition, Corporation
(&#8220;NorthView&#8221;) and Profusa, Inc. (&#8220;Profusa&#8221;), adjusted to give effect to the Business Combination and related transactions.
The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article&#160;11 of Regulation&#160;S-X.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the context otherwise
requires, following the Closing (as defined below), references to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;New Profusa,&#8221;
and the &#8220;Company&#8221; refer to Profusa, Inc., a Delaware corporation formerly known as NorthView Acquisition Corporation, and
its consolidated subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following unaudited pro
forma condensed combined balance sheet as of June 30, 2025, assumes that the Business Combination occurred on June 30, 2025. The unaudited
pro forma condensed combined statements of operations for the six&#160;months ended June 30, 2025, and for the year ended December&#160;31,
2024, present pro forma effect to the Business Combination as if it had been completed on January&#160;1, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Business Combination is
accounted for as a reverse recapitalization under U.S.&#160;GAAP.&#160;Under this method of accounting, NorthView will be treated as the
&#8220;acquired&#8221; company for financial reporting purposes. This determination is primarily based on Profusa Stockholders comprising
a relative majority of the voting power of Profusa (the combined entity) and having the ability to nominate majority of the members of
the New Profusa Board, Profusa&#8217;s operations prior to the acquisition comprising the only ongoing operations of New Profusa, and
Profusa&#8217;s senior management comprising the senior management of New Profusa. Accordingly, for accounting purposes, the financial
statements of New Profusa will represent a continuation of the financial statements of Profusa with the Business Combination treated as
the equivalent of Profusa issuing stock for the net assets of NorthView, accompanied by a recapitalization. The net assets of NorthView
will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination
will be presented as those of Profusa in future reports of New Profusa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined financial statements have been presented for illustrative purposes only and do not necessarily reflect what the Combined Company&#8217;s
financial condition or results of operations would have been had the acquisition occurred on the dates indicated. Further, the pro forma
condensed combined financial information also may not be useful in predicting the future financial condition and results of operations
of the Combined Company. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected
herein due to a variety of factors. The unaudited pro forma condensed combined financial statements give effect to the warrants issued
in association with the Committed Equity Facility. Management has started drawing down on the ELOC and believes it is probable at this
point that all shares registered of 8,970,830 shares will be issued. As such, the Purchase Shares and have been reflected in the unaudited
pro forma condensed combined financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The historical financial information
of NorthView was derived from the unaudited financial statements of Northview as of and for the six&#160;months ended June 30, 2025, and
the audited financial statements of NorthView as of and for the year ended December&#160;31, 2024, which are included in the Proxy Statement/Prospectus.
The historical financial information of Profusa was derived from the unaudited financial statements of Profusa as of and for the six&#160;months
ended June 30, 2025, and audited financial statements of Profusa as of and for the year ended December&#160;31, 2024, which are included
in the Proxy Statement/Prospectus. This information should be read together with NorthView&#8217;s and Profusa&#8217;s audited financial
statements, and related notes, the sections titled &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations of NorthView</i>&#8221; and &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
of Profusa</i>&#8221; and other financial information included in the Proxy Statement/Prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Description of the Business Combination</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">On November&#160;7, 2022, NorthView entered into a Merger Agreement with Profusa and Merger Sub, pursuant
to which, Merger Sub merged with and into Profusa with Profusa as the surviving corporation and becoming a wholly-owned subsidiary of
NorthView. In connection with the Merger, NorthView changed its name to &#8220;Profusa, Inc.&#8221;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">More specifically, and as described
in greater detail below, at the Effective Time of the Merger:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">a.</td><td style="text-align: justify">each share of issued and outstanding Profusa Common Stock was converted into a number of shares of New
Profusa common stock, par value $0.0001 per share (&#8220;New Profusa Common Stock&#8221;), based on the Exchange Ratio that reflects
an equity valuation of Profusa of $155,000,000 (as adjusted for the Incentive Equity Value, the Private Placement Value and the Aggregate
Company Incentive Amount), divided by an assumed value of New Profusa Common Stock of $10.00 per share.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">b.</td><td style="text-align: justify">each option to purchase Profusa Common Stock was converted into an option to purchase New Profusa Common
Stock based on the Exchange Ratio, and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">c.</td><td style="text-align: justify">each warrant to purchase Profusa Common Stock was converted into a warrant to purchase New Profusa Common
Stock based on the Warrant Ratio (as defined in the Merger Agreement).</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>PIPE Transaction</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">On February&#160;11, 2025, NorthView executed a Securities Purchase Agreement (the &#8220;PIPE Subscription
Agreement&#8221;) with Ascent Partners Fund LLC (&#8220;Ascent&#8221;, and together with any additional investors who become parties to
the PIPE Subscription Agreement, the &#8220;PIPE Investors&#8221;). Pursuant to the PIPE Subscription Agreement, the PIPE Investors are
expected, subject to the conditions relating to such purchase set forth in the PIPE Subscription Agreement, to purchase from NorthView
senior secured convertible notes in an aggregate principal amount of up to $22,222,222 (the &#8220;PIPE Convertible Notes&#8221;) for
a purchase price of up to $20,000,000, after 10% OID.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">At the Closing and pursuant to the PIPE
Subscription Agreement, New Profusa issued a PIPE Convertible Note in the principal amount of $10,000,000 (the &#8220;Initial Note&#8221;),
reflecting a 10% original issue discount to the face amount (&#8220;OID&#8221;) thereof. The Initial Note matures on January 11, 2027,
which is 18-months from Closing on July 11, 2025 (the &#8220;Maturity Date&#8221;) and is convertible at any time at the holder&#8217;s
option at the lower of $10 or 95% of the lowest daily volume-weighted average price per share (&#8220;VWAP&#8221;) of New Profusa Common
Stock in the 10&#160;trading days prior to the original issue date for each PIPE Convertible and shall be adjusted, without limitation,
based on down-round and most-favored nation (MFN) price and terms protections (the &#8220;Conversion Price&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Interest shall accrue on the aggregate
unconverted and then outstanding principal amount of the Initial Note at a rate of 10% per annum and increase upon an event of default
to 24% per annum. Payments made in cash under the Initial Note shall be subject to a 5% fee, which shall be in addition to any amounts
owed thereunder. The Initial Note provides for certain events of default that are typical for a transaction of this type, including, among
other things, any breach of the representations or warranties made by New Profusa or its subsidiaries. The Initial Note also provides
for a 10% late fee in case of late payments and mandatory prepayments upon Subsequent Offerings (as defined in the Initial Note) and,
in the absence of an event of default, may be prepaid upon 10 business&#160;day&#8217;s prior notice, subject to certain conversion rights
of the PIPE Investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The Initial Note may not be converted
by the PIPE Investors into shares of New Profusa Common Stock if such conversion would result in the investors or their affiliates owning
in excess of 4.99% of the number of shares of New Profusa Common Stock outstanding immediately after giving effect to the issuance of
all shares issuable upon conversion of the Initial Note.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The outstanding principal balance of
the Profusa Senior Convertible Promissory Notes and all accrued but unpaid interest converted into Profusa Common Stock and NorthView
exchanged the Profusa Common Stock for 4,170,932 shares of New Profusa, on an as converted price of $0.34 per share. The Exchange Ratio
and the Company Reference Share Value were $0.94 and $9.40, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The outstanding principal balance of
the Profusa Senior Secured Convertible Promissory Notes and all accrued but unpaid interest converted into Profusa Common Stock and NorthView
exchanged the Profusa Common Stock for 5,542,261 shares of New Profusa, an as converted price of $0.50 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">On August 25, 2025, the Company entered into Amendment No. 1 (the &#8220;<b>SPA Amendment</b>&#8221;)
to the PIPE Subscription Agreement. Pursuant to the SPA Amendment, Section 2.1 of the PIPE Subscription Agreement was amended and restated
to provide for four tranches of Notes: (i) an initial closing for Notes in an aggregate principal amount of $10,000,000 (the &#8220;<b>First
Tranche</b>&#8221;), which already occurred in July 11, 2025; (ii) a second closing for Notes in an aggregate principal amount of $2,222,222
(the &#8220;<b>Second Tranche</b>&#8221;) for a purchase price of $2,000,000, subject to the satisfaction of certain conditions including
the filing of a registration statement on Form S-1 covering all conversion shares and no Nasdaq listing deficiency; (iii) a third closing
for Notes in an aggregate principal amount of $5,555,556 (the &#8220;<b>Third Tranche</b>&#8221;) for a purchase price of $5,000,000,
subject to the satisfaction of certain conditions including the full conversion or repayment of the First Tranche, effectiveness of a
registration statement, no Nasdaq listing deficiency, and receipt of stockholder approval; and (iv) a fourth closing for Notes in an aggregate
principal amount of $4,444,444 (the &#8220;<b>Fourth Tranche</b>&#8221;) for a purchase price of $4,000,000, subject to the satisfaction
of certain conditions including the full repayment of the First and Second Tranches, at least fifty percent (50%) repayment or conversion
of the Third Tranche, effectiveness of a registration statement, and no Nasdaq listing deficiency. The Amendment supersedes and replaces
all prior provisions relating to &#8220;Additional Closings&#8221; and &#8220;Additional Notes,&#8221; and all references to such terms
in the PIPE Subscription Agreement and related documents are to be construed in accordance with the new tranche structure.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Concurrently, on August 25, 2025, the Company entered into Amendment No. 1 (the &#8220;<b>Note Amendment</b>&#8221;)
to the Initial Note. The Note Amendment modifies the terms of the Initial Note, specifically amending Section 4(b) to revise the conversion
price provisions on any conversion date to be the lower of (i) the Conversion Price on such date and (ii) ninety-five percent (95%) of
the lowest daily volume weighted average price (&#8220;<b>VWAP</b>&#8221;) for the Company&#8217;s common stock during the ten consecutive
trading days immediately preceding the applicable conversion date (the &#8220;<b>Alternate Conversion Price</b>&#8221;), provided that
in no event shall the conversion price be less than the Floor Price of twenty percent (20%) of the closing sale price of the common stock
on the principal trading market on the trading day immediately preceding the Note Amendment&#8217;s effective date, which was August 22,
2025.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">NorthView&#8217;s Convertible Working Capital loan will be being converted subsequent to the close of
the Business Combination in a future registration statement. The principal outstanding of the note was $1,919,796 as of June 30, 2025
which has been fair value adjusted on the balance sheet at June 30, 2025 to $10,288,111 which is included in the pro forma at the current
balance as no interest accrues on this note and will be converted into 863,908&#160;shares of New Profusa, at an as converted price of
$2.22 per share.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Upon consummation of the Merger the former holders of Profusa&#8217;s common stock, senior convertible
notes, junior convertible notes and vested in-the-money&#160;Profusa Options (the &#8220;Participating Securityholders&#8221;) received
certain rights, under which in the future New Profusa may issue to the Participating Securityholders an aggregate of 3,875,000&#160;shares
of New Profusa&#8217;s common stock (the &#8220;Milestone Earnout Shares&#8221;) during the respective earnout periods in equal &#188;
installments upon achievement of the following four Milestone Events:</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Milestone&#160;I Earnout Rights: share price of New Profusa Common Stock is equal to or greater than $12.50
for any 20&#160;trading&#160;days during any 30&#160;days trading period or consummation of a Subsequent Transaction where the stockholders
of New Profusa will receive a consideration of at least $12.50 for each share of New Profusa Common Stock (&#8220;Milestone Event&#160;I&#8221;).
The Milestone&#160;I period will commence on the 18-month&#160;anniversary and end on the two-year&#160;anniversary of the closing date
of the Merger (&#8220;Milestone Event&#160;I Period&#8221;);</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Milestone&#160;II Earnout Rights: share price of New Profusa Common Stock is equal to or greater than
$14.50 for any 20&#160;trading&#160;days during any 30&#160;days trading period or consummation of a Subsequent Transaction where the
stockholders of New Profusa will receive a consideration of at least $14.50 for each share of New Profusa Common Stock (&#8220;Milestone
Event&#160;II&#8221;). The Milestone&#160;II period will commence on the 360-day&#160;anniversary and end on the two-year&#160;anniversary
of the closing date of the Merger (&#8220;Milestone Event&#160;II Period&#8221;); provided that such 30&#160;days trading period does
not overlap with the 30&#160;days trading period used to satisfy the requirements of Milestone Event&#160;I; provided, further, that in
the event that such 30&#160;days trading period could satisfy either Milestone Event&#160;I or Milestone Event&#160;II, then Milestone
Event&#160;II shall be deemed to be satisfied first;</td></tr></table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Milestone&#160;III Earnout: the closing of the APAC Joint Venture, as described in this proxy statement/prospectus,
and the Companies receipt of the related $6&#160;million funding, during the fiscal year ended December&#160;31, 2025 (&#8220;Milestone
Event&#160;III&#8221;);</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Milestone&#160;IV Earnout: achievement of revenue of $11,864,000 for the fiscal year ended December&#160;31,
2026 (&#8220;Milestone Event&#160;IV,&#8221; and, together with Milestone Event&#160;I, Milestone Event&#160;II and Milestone Event&#160;III
the &#8220;Milestone Events&#8221;). Milestone&#160;I Earnout Rights, Milestone&#160;II Earnout Rights, Milestone&#160;III Earnout Rights
and Milestone&#160;IV Earnout Rights are further referred to collectively as &#8220;Milestone Earnout Rights&#8221;.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>PIPE Lock-Up Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, the
PIPE Investors entered into a lock-up agreement (the &#8220;PIPE Lock-Up Agreement&#8221;), pursuant to which they agreed to, subject
to certain customary exceptions, not offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of any shares of New Profusa
Common Stock or securities convertible, exchangeable or exercisable into, shares of New Profusa Common Stock beneficially owned, held
or acquired by them. The period for such restrictions shall apply from the Closing date until the termination of the PIPE Lock-Up Agreement
in accordance with its terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description of
the PIPE Lock-Up Agreement is not complete and is qualified in its entirety by reference to the text of such document, a form of which
is filed as Exhibit 10.8 hereto and incorporated herein by reference.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>PIPE Registration Rights Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, New
Profusa and the PIPE Investors entered into a registration rights agreement (the &#8220;PIPE Registration Rights Agreement&#8221;). The
PIPE Registration Rights Agreement provides customary demand and piggyback registration rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the PIPE Registration
Rights Agreement, New Profusa will, as soon as practicable, but in any event within 20 calendar&#160;days after the Closing Date, use
its reasonable best efforts to file with the SEC a registration statement registering the resale of certain New Profusa Common Stock issuable
to the PIPE Investors upon conversion of the PIPE Convertible Notes. New Profusa will use its reasonable efforts to have the registration
statement declared effective as soon as practicable after the filing thereof, but no later than the 45<sup>h</sup> calendar&#160;day (but
in any event no later than the 60<sup>th</sup> calendar&#160;day) following the Closing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After giving effect to the Business Combination transaction and the
issuance of the Merger Consideration described above, there are 111,250,017 shares of our Common Stock issued and outstanding.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summarizes the
pro forma Common Stock:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma Combined</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Shareholder</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NorthView public shareholders<sup>(3)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,999,277</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1.9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NorthView other shareholders<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,483,530</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former Profusa shareholders<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.9</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued to other parties<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">382,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior secured convertible note<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,542,261</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Profusa bridge notes<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,170,932</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Northview working capital loan<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">863,908</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.8</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE Subscription<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,125,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24.4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascent ELOC Commitment shares<sup>(9)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51,182,378</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46.0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Common Stock shares on closing date of the Business Combination</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">111,250,017</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Includes Sponsor and Representative shares in NorthView and
has been reduced by the 710,220 sponsor shares allocated to the senior secured convertible note holders.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Includes 8,593,991 shares issued to existing Profusa common
and preferred shareholders, 6,699,365 shares issued to the holders of Profusa&#8217;s junior convertible notes and senior convertible
notes, and 206,644 shares reserved for Profusa option holders.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Includes 1,897,500 shares issuable pursuant to outstanding NorthView
Rights.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents $1,325,000 of transaction costs paid in shares of New Profusa Common Stock at $10 per share to H.C. Wainwright &amp; Co. and $500,000 of transaction costs paid in shares of New Profusa Common Stock at $2 per share to The Benchmark Company LLC.</span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: justify">Represents 22,193,371 shares issuable upon conversion of the
$10 million first tranche of the PIPE Investor convertible note facility ($22.22M total) and 4,931,860 shares issuable upon conversion
of the $2.22 million second tranche of the PIPE Investor convertible note facility. Both tranches are estimated to convert at a price
of $0.4506 per share which is calculated based on 95% of the VWAP rate on August 26, 2025 of $0.4743 per share.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: justify">Senior secured convertible note which includes 710,220 Sponsor
shares that were utilized as inducement shares for the notes.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: justify">Represents 1,277,502 shares issued upon the conversion and exchange
of Profusa bridge notes and 2,893,430 shares issued in exchange for the shares issued pursuant to the Bridge Note&#160;Buyout Agreement.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(8)</td><td style="text-align: justify">Represents shares from the conversion of the NorthView working
capital convertible loan at a $2.22 per share.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Ascent ELOC Commitment shares represent 900,000 warrants issued for common stock with an exercise price of $0.01 which are issued and expected to be exercised, and the total shares registered under the ELOC agreement through the filing of our last Form S-1 of 8,970,830 shares with an additional 42,211,548 shares which are probable to be issued</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following unaudited pro
forma condensed combined balance sheet as of June 30, 2025 and the unaudited pro forma condensed combined statements of operations for
the six&#160;months ended June 30, 2025 and for the year ended December&#160;31, 2024 are based on the unaudited and audited historical
financial statements of NorthView and Profusa. The unaudited pro forma adjustments are based on information currently available, and assumptions
and estimates underlying the unaudited pro forma adjustments are described in the accompanying notes. Actual results may differ materially
from the assumptions used to present the accompanying unaudited pro forma condensed combined financial information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE
SHEET</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(in thousands, except share and per share data)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Profusa,&#160;Inc. <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NorthView <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction <br/>
Accounting <br/>
Adjustments</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pro Forma <br/>
Combined</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ASSETS</b></span></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current assets:</span></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,277</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,365</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,146</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(328</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,745</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,648</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(253</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,164</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>T</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash held in Trust Account</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">661</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(661</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>P</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid taxes</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">209</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8212;</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">209</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total current assets</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">688</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,658</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,599</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash held in Trust Account</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,275</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,275</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred offering costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,136</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,837</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,299</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other non-current assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,444</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,963</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,247</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,654</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current liabilities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,884</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,745</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,629</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excise tax payable</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,953</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,953</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses and other current liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,299</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,534</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,299</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,461</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,971</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,745</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,971</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(328</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible debt payable, net of discount</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,971</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,288</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27,594</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,844</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,533</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>O</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,288</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to redeeming stockholders</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">661</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(661</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>P</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory notes</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">940</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">940</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PPP loan</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,383</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,383</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,477</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,181</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50,448</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,210</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant liability</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,962</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,962</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total liabilities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,477</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,143</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50,448</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,172</span></td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE
SHEET&#160;&#8212;&#160;(Continued)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(in thousands, except share and per share data)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Profusa,&#160;Inc. <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NorthView <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction <br/>
Accounting <br/>
Adjustments</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pro Forma <br/>
Combined</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments and contingencies</span></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Preferred Stock:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 46%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series&#160;A convertible preferred stock: $0.0001 par value &#8211; 4,350,314 shares authorized at June&#160;30, 2025 and December&#160;31, 2024, and 4,350,314 shares issued and outstanding at June&#160;30, 2025 and December&#160;31, 2024, (Liquidation preference $5,307 at June&#160;30, 2025 and December&#160;31, 2024)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,231</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,231</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>K</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series&#160;B convertible preferred stock: $0.0001 par value &#8211; 5,293,175 shares authorized at June&#160;30, 2025 and December&#160;31, 2024, and 5,293,175 shares issued and outstanding at June&#160;30, 2025 and December&#160;31, 2024, (Liquidation preference $13,815 at June&#160;30, 2025 and December&#160;31, 2024)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,701</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,701</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>L</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series&#160;C/C-1 convertible preferred stock: $0.0001 par value &#8211; 8,907,893 shares authorized at June&#160;30, 2025 and December&#160;31, 2024, and 8,220,445 shares issued and outstanding at June&#160;30, 2025 and December&#160;31, 2024, (Liquidation preference $45,062 at June&#160;30, 2025 and December&#160;31, 2024)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,217</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(46,217</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common shares subject to possible redemption</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,331</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,331</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders&#8217; equity (deficit):</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock, $0.0001 par value; 100,000,000 shares authorized; pro forma; 33,161,159 shares issued and outstanding</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>T</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in capital</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,840</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,331</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,493</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,511</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,971</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,217</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,231</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>K</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,701</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>L</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,825</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,837</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,340</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,920</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,533</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>O</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,728</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">983</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,163</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>T</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(130,022</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,511</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,511</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(128,013</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,648</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,728</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,368</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(983</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total stockholders&#8217; equity (deficit)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(124,182</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,511</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,175</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,518</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total liabilities, redeemable convertible preferred stock and stockholders&#8217; equity (deficit)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,444</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,963</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,247</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,654</span></td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i>&#160;</p><div>


</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT
OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE SIX MONTHS ENDED JUNE 30, 2025</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(in thousands, except share and per share data)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Profusa,&#160;Inc. <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NorthView <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction <br/>
Accounting <br/>
Adjustments</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pro Forma <br/>
Combined</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">827</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">827</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,600</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,551</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,648</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FF</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,527</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,728</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>HH</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total operating expenses</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,427</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,551</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,376</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,354</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss from operations</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,427</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,551</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,376</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,354</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income (expenses)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest income earned on cash and marketable securities held in Trust Account</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(95</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AA</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of convertible loan</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(118</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,380</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,380</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DD</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(118</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of Securities Purchase Agreement</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(194</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">194</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KK</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,519</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,482</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BB</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,056</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EE</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,019</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>II</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrant liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,265</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,265</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income (expense), net</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(983</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JJ</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(983</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (loss) before income taxes</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,295</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,417</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17,776</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for income taxes</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CC</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (loss)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,317</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,395</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17,776</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed dividend</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,684</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GG</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,684</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to common stockholders</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,317</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,079</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27,460</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net (loss) per share subject to possible redemption</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.66</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">412,717</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net (loss) per share, common stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.66</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average shares outstanding, common stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,193,750</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share-Profusa</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.90</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares outstanding of Profusa Common Stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,604,651</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share of New Profusa common stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.25</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares outstanding of New Profusa common stock&#160;&#8211;&#160;basic and diluted</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,250,017</span></td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT
OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE YEAR ENDED DECEMBER 31, 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(in thousands, except share and per share data)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Profusa,&#160;Inc. <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NorthView <br/>
(Historical)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction <br/>
Accounting <br/>
Adjustments</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pro Forma <br/>
Combined</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,608</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,608</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,992</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,351</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,606</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FF</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,704</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,755</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>HH</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total operating expenses</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,600</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,351</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,361</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,312</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss from operations</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,351</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,361</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,212</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income (expenses)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest income earned on cash and marketable securities held in Trust Account</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(425</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AA</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of convertible loan</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(311</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,166</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,166</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DD</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(311</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,424</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,349</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BB</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,216</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EE</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,037</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>II</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrant liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(539</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(539</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income (expense), net</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(983</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JJ</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(978</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss) before income taxes</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,230</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,631</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,605</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,256</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for income taxes</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(81</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CC</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,230</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,712</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,686</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,256</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed dividend</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,684</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GG</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,684</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to common stockholders</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,230</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,712</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,998</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,940</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net (loss) per share subject to possible redemption</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.47</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">747,644</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net (loss) per share, common stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.47</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average shares outstanding, common stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,193,750</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share-Profusa</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.65</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares outstanding of Profusa Common Stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,604,651</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share of New Profusa common stock</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.23</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares outstanding of New Profusa common stock&#160;&#8211;&#160;basic and diluted</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,534,620</span></td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED
FINANCIAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>1. Basis of Presentation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Business Combination will
be accounted for as a reverse recapitalization under U.S.&#160;GAAP.&#160;Under this method of accounting, NorthView Acquisition Corporation
(&#8220;NorthView&#8221;), will be treated as the &#8220;acquired&#8221; company for financial reporting purposes. This determination
is primarily based on Profusa, Inc. (&#8220;Profusa&#8221;) Stockholders comprising a relative majority of the voting power of Profusa
(the combined entity) and having the ability to nominate majority of the members of the New Profusa Board, Profusa&#8217;s operations
prior to the acquisition comprising the only ongoing operations of New Profusa, and Profusa&#8217;s senior management comprising the senior
management of New Profusa. Accordingly, for accounting purposes, the financial statements of New Profusa will represent a continuation
of the financial statements of Profusa with the Business Combination treated as the equivalent of Profusa issuing stock for the net assets
of NorthView, accompanied by a recapitalization. The net assets of NorthView will be stated at historical cost, with no goodwill or other
intangible assets recorded. Operations prior to the Business Combination will be presented as those of Profusa in future reports of New
Profusa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Business
Combination, all outstanding stock of Profusa were cancelled in exchange for the right to receive newly issued shares of Common Stock
of New Profusa, par value $0.0001 per share (&#8220;Common Stock&#8221;), and all outstanding options to purchase Profusa stock were exchanged
for options exercisable for newly issued shares of New Profusa Common Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total consideration received
by Profusa Security Holders at the Closing of the transactions contemplated by the Merger Agreement is the newly issued shares of Common
Stock and securities convertible or exchangeable for newly issued shares of Common Stock with an aggregate value equal $255,958,617, with
each Profusa Stockholder receiving for each share of Profusa Common Stock held (after giving effect to the exchange or conversion of all
outstanding Profusa Preferred Stock for shares of Profusa Common Stock and treating all vested&#160;in-the-money&#160;Profusa Convertible
Securities (including, on a net exercise basis, all vested qualified Profusa Options) as if such securities had been exercised as of immediately
prior to the Merger, but excluding all unvested Profusa Options) a number of shares of Common Stock equal to a conversion ratio of approximately
0.34. As a result, the Profusa Security Holders received an aggregate of 25,595,862 shares of newly issued Common Stock as Merger Consideration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an additional consideration,
each Profusa Stockholder is entitled to earn, on a pro rata basis, an aggregate of 3,875,000 shares of New Profusa&#8217;s common stock
(the &#8220;Milestone Earnout Shares&#8221;) during the respective earnout periods in equal &#188; installments upon achievement of
the following defined Milestone Events. The Milestone Earnout Shares will be placed in escrow and will be outstanding from and after the
Closing, subject to cancellation if the applicable price targets are not achieved. While in escrow, the shares will be&#160;non-voting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma combined
financial information contained herein does not account for the assumption by New Profusa at the Closing of unvested Profusa Stock Options
or future issuances of shares of Common Stock upon exercise thereof. The unaudited pro forma combined financial information contained
herein does account for the subsequent execution of the ELOC Agreement and secondary tranche of PIPE funding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After giving effect to the Business Combination transaction and the
issuance of the Merger Consideration described above, there are 111,250,017 shares of our Common Stock issued and outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2. Basis of Pro Forma Presentation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined balance sheet as of June 30, 2025 assumes that the Business Combination and related transactions occurred on June 30, 2025. The
unaudited pro forma condensed combined statements of operations for the six&#160;months ended June 30, 2025 and for the year ended December&#160;31,
2024 presents pro forma effect to the Business Combination as if it had been completed on January&#160;1, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined balance sheet as of June 30, 2025 has been prepared using, and should be read in conjunction with, the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">NorthView&#8217;s unaudited condensed consolidated balance sheet as of June 30, 2025 and the related notes
for the six&#160;months ended June 30, 2025, included in the Proxy Statement/Prospectus; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Profusa&#8217;s unaudited condensed consolidated balance sheet as of June 30, 2025 and the related notes
for the six&#160;months ended June 30, 2025, included in the Proxy Statement/Prospectus.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined statement of operations for the six&#160;months ended June 30, 2025 has been prepared using, and should be read in conjunction
with, the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">NorthView&#8217;s unaudited condensed consolidated statement of operations for the six&#160;months ended
June 30, 2025 and the related notes, included in the Proxy Statement/Prospectus; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Profusa&#8217;s unaudited condensed consolidated statement of operations for the six&#160;months ended
June 30, 2025 and the related notes, included in the Proxy Statement/Prospectus.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined statement of operations for the year ended December&#160;31, 2024 has been prepared using, and should be read in conjunction
with, the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">NorthView&#8217;s audited consolidated statement of operations for the year ended December&#160;31, 2024
and the related notes, included in the Proxy Statement/Prospectus; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Profusa&#8217;s audited consolidated statement of operations for the year ended December&#160;31, 2024
and the related notes, included in the Proxy Statement/Prospectus.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the unaudited pro forma
condensed combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ
materially from the information presented.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings or cost savings
that may be associated with the Business Combination. In addition, on July 28, 2025, we entered into the Committed Equity Facility with
Ascent, pursuant to which Ascent has committed to purchase up to $100,000,000 of shares of our Common Stock, subject to certain limitations
and conditions set forth in the Purchase Agreement. The shares of our Common Stock that may be issued under the Purchase Agreement may
be sold by us to Ascent at our discretion from time to time for a period of up to 36 months (unless the Purchase Agreement is earlier
terminated) beginning on the Effective Date. The proceeds from the Committed Equity Facility are to be used exclusively for the purchase
of Bitcoin (which may be used for repayment of indebtedness), provided the Company&#8217;s cash balance on any Closing Date exceeds $5,000,000.
If the cash balance is less than $5,000,000, proceeds must first be used to bring the cash balance to that amount, with the remainder
used to purchase Bitcoin.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined financial information is not necessarily indicative of what the actual results of operations and financial position would have
been had the Business Combination taken place on the dates indicated, nor are they indicative of the future consolidated results of operations
or financial position of the Combined Company. They should be read in conjunction with the historical financial statements and notes thereto
of NorthView and Profusa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying pro forma financial statements reflect the impact
of transactions that are either completed or considered probable in accordance with Regulation S-X Article 11. Management has considered
the impact of the Committed Equity Facility on these pro forma financial statements, and notes that the agreement is written in a manner
in which the Company will issue a variable number of shares at a variable issuance price, based on the then current market rates, less
a fixed discount. The number of shares registered to date related to the ELOC facility are expected to be issued, which totals 51,182,378
shares, made up of the 8,970,830 shares previously registered and an additional 42,211,548 shares being registered, which is calculated
as the maximum number of shares able to be registered based on authorized shares of 300,000,000. The Company has now started to draw on
the ELOC and has estimated the issuance price based on the last actual conversion price of .4743 for the first tranche of shares registered,
which is based on the VWAP on August 26, 2025, and an estimated conversion price of $0.14 to align with the floor price as defined by
the agreement for this next tranche of 42,211,548 shares being registered, as seen in Tickmark (T) on the unaudited pro forma balance
sheet.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
900,000 Commitment Warrant Shares are issuable upon exercise of the Commitment Warrants we issued to Ascent upon our execution of the
term sheet relating to the Purchase Agreement on July 20, 2025, as consideration for its commitment to purchase shares of our Common Stock
that we may, in our sole discretion, direct Ascent to purchase from us pursuant to the Purchase Agreement. The Commitment Warrants have
an exercise price of $0.01 and may be exercised for cash or, if at the time of exercise there is no effective registration statement covering
the resale of the Commitment Warrant Shares, on a cashless basis. The warrants issued to Ascent are currently being analyzed for their
accounting treatment, which the Company expects to be equity classified based on their cashless exercise option. As such, the Company
will finalize the accounting conclusions on these warrants, and validate their equity classification for the upcoming September 30, 2025
financial statements. As the Company has drawn on the ELOC facility, the 900,000 warrants were issued to Ascent and have been included
within the unaudited pro forma financial statements at their fair value as calculated using the Black Scholes valuation method.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>3. Accounting Policies and Reclassifications</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon consummation of the Business
Combination, management has performed a comprehensive review of the two entities&#8217; accounting policies. As a result of the review,
management has not identified differences between the accounting policies of the two entities which have a material impact on the financial
statements of the Combined Company. Based on its analysis, management did not identify any differences that would have a material impact
on the unaudited pro forma condensed combined financial information. As a result, the unaudited pro forma condensed combined financial
information does not assume any differences in accounting policies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4. Adjustments to Unaudited Pro Forma Condensed
Combined Financial Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined financial information has been prepared to illustrate the effect of the Business Combination and has been prepared for informational
purposes only.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following unaudited pro
forma condensed combined financial information has been prepared in accordance with Article&#160;11 of Regulation&#160;S-X&#160;as amended
by the final rule, Release No.&#160;33-10786&#160;&#8220;Amendments to Financial Disclosures about Acquired and Disposed Businesses&#8221;
to depict the accounting for the transaction (&#8220;Transaction Accounting Adjustments&#8221;) and present the reasonably estimable synergies
and other transaction effects that have occurred or are reasonably expected to occur (&#8220;Management&#8217;s Adjustments&#8221;). NorthView
has elected not to present Management&#8217;s Adjustments and is only presenting Transaction Accounting Adjustments in the unaudited pro
forma condensed combined financial information. The historical financial statements have been adjusted in the unaudited pro forma condensed
combined financial information to include all necessary Transaction Accounting Adjustments pursuant to Article&#160;11 of Regulation&#160;S-X,
including those that are not expected to have a continuing impact.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audited historical financial
statements have been adjusted in the unaudited pro forma condensed combined financial information to give pro forma effect to transaction
accounting adjustments that reflect the accounting for the transaction under GAAP.&#160;All activity between Profusa and Northview has
been eliminated between the companies on the pro forma statement under tickmark J.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The pro forma combined statement
of operations does not reflect a provision for income taxes or any amounts that would have resulted had the Combined Company filed consolidated
income tax returns during the periods presented. The pro forma condensed combined balance sheet does not reflect the deferred taxes of
the Combined Company as a result of the Business Combination. Upon Closing of the Business Combination, it is likely that the Combined
Company will record a full valuation allowance against the total U.S.&#160;and state deferred tax assets given the net operating losses
and valuation allowance of Profusa as the recoverability of the tax assets is uncertain. The Company used the separate return method in
calculating the pro forma tax provision and tax effects of our pro forma adjustments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The pro forma basic and diluted
earnings per share amounts presented in the unaudited pro forma condensed combined statement of operations are based upon the number of
the Combined Company&#8217;s shares outstanding, assuming the Business Combination occurred on January&#160;1, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Transaction Accounting Adjustments to Unaudited
Pro Forma Condensed Combined Balance Sheet</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transaction Accounting
Adjustments included in the unaudited pro forma condensed combined balance sheet as of June 30, 2025 are as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">A.</td><td style="text-align: justify">Reflects the reclassification of the remaining shares of NorthView Common Stock to permanent equity immediately
prior to the Merger.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">B.</td><td style="text-align: justify">Reflects the liquidation and reclassification of the balance of investments held in the trust account
to cash and cash equivalents that becomes available to fund the Transaction. This is the full trust account balance as of June 30, 2025,
which is further adjusted for redemptions reflected in adjustment (P)&#160;below to reflect the remaining trust account balance following
such redemptions which were distributed at closing.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">C.</td><td style="text-align: justify">Reflects the gross proceeds from the issuance and sale of PIPE Convertible Notes of NorthView that
                                                                                 are convertible into shares of NorthView common stock at $10.00 per share pursuant to the PIPE Subscription Agreement entered into
                                                                                 with the PIPE Investors, assuming no redemptions. The PIPE Subscription Agreement provides for a total facility up to
                                                                                 $22.22&#160;million which is split into tranches. The Initial Note was funded upon closing the merger for $10&#160;million which was
                                                                                 subject to a 10% OID ($9.0&#160;million net). A subsequent $2.22 million subject to a 10% OID ($2.0 million net) is considered
                                                                                 probable based on the terms of the convertible note. The notes did not convert as of the closing date. As such, the notes will
                                                                                 remain in the pro forma balance sheet for pro forma purposes, as the notes convert at the election of the note holder until the
                                                                                 shares are registered.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">D.</td><td style="text-align: justify">Reflects the recapitalization and elimination of Northview&#8217;s&#160;pre-merger&#160;accumulated deficit
balance.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">E.</td><td style="text-align: justify">Represents direct and incremental transaction costs incurred by New Profusa related to the Merger and
PIPE Subscription Agreement of approximately $6.0&#160;million for advisory, banking, printing, legal and accounting that are incurred
and anticipated to be incurred. These costs will not affect the Company&#8217;s combined statements of operations and comprehensive loss
beyond 12&#160;months after the acquisition date.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">F.</td><td style="text-align: justify">Represents the payment of estimated direct and incremental transaction costs that are incurred and anticipated
to be incurred, of which $1.8&#160;million is expected to be paid in shares and $4.2&#160;million is expected to be paid in cash, including
the Business Combination Marketing Fee of $2.0&#160;million. These costs will not affect the Company&#8217;s combined statements of operations
and comprehensive loss beyond 12&#160;months after the acquisition date.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">G.</td><td style="text-align: justify">Represents reclassification of Profusa&#8217;s deferred offering costs to permanent equity and payment
of the respective accrued and unpaid portion of the deferred offering costs.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">H.</td><td style="text-align: justify">Represents payment of Northview accrued offering costs and expenses.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">I.</td><td style="text-align: justify">Represents payment of direct and incremental transaction costs incurred by NorthView of approximately
$1.6&#160;million in advisory, banking, printing, legal, and accounting fees and other transaction related expenses in connection with
the Merger and PIPE Subscription Agreement.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">J.</td><td style="text-align: justify">Elimination of transactions between the two companies.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">K.</td><td style="text-align: justify">Reflects exchange of Profusa&#8217;s Series&#160;A Convertible Preferred Stock for common stock of Profusa
with $0.0001 par value.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">L.</td><td style="text-align: justify">Reflects exchange of Profusa&#8217;s Series&#160;B Convertible Preferred Stock for common stock of Profusa
with $0.0001 par value.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">M.</td><td style="text-align: justify">Reflects exchange of Profusa&#8217;s Series&#160;C/C1 Convertible Preferred Stock for common stock of
Profusa with $0.0001 par value.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">N.</td><td style="text-align: justify">Reflects conversion of Senior Notes and Senior Bridge Notes into 6,819,763&#160;shares of Profusa in accordance
with their terms.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">O.</td><td style="text-align: justify">Reflects conversion of Junior Notes into 2,801,697 shares of Profusa in accordance with their terms.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">P.</td><td style="text-align: justify">Reflects the remaining redemptions in the trust to settle all balances due to redeeming shareholders.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">Q.</td><td style="text-align: justify">Represents reclassification of Profusa&#8217;s transaction costs incurred in excess of proceeds received
from additional paid-in&#160;capital to accumulated deficit.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">R.</td><td style="text-align: justify">Represents issuance of shares in New Profusa upon conversion of Northview&#8217;s convertible loan at
the Closing of the Merger. The balance of the note was $1,919,796, which was fair value adjusted on the balance sheet to $10,288,111 is
included in the pro forma at the current balance as no interest accrues on this note and was converted into 863,908 shares of New Profusa,
at an as converted price of $2.22 per share.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">S.</td><td style="text-align: justify">Reflects the impact from the warrants issued to Ascent according to the ELOC Registration Rights Agreement.
The warrants are equity classified and recorded at their fair value on the agreement date.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T.</span></td>
    <td style="text-align: justify; font-size: 10pt">Reflects the cash received and the shares issued from the ELOC facility,
assuming additional 42,211,548&#160;shares issued at the floor price of $0.14 per share for approximately $5.9 million additional financing,
plus the 8,970,830 previously registered shares assuming an average conversion price using the VWAP rate on August 26, 2025 of $0.4743
per share.</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Transaction Accounting Adjustments to Unaudited
Pro Forma Condensed Combined Statements of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-indent: 0.5in; text-align: justify">The Transaction Accounting Adjustments
included in the unaudited pro forma condensed combined statements of operations for the six&#160;months ended June 30, 2025 and the year
ended December&#160;31, 2024 are as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">AA.</td><td style="text-align: justify">Represents the elimination of investment income related to the investments held in the NorthView Trust
Account.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">BB.</td><td style="text-align: justify">Represents elimination of interest expense related to Profusa&#8217;s Junior Notes, and the interest expense
related to Profusa&#8217;s Senior Notes Senior Secured Notes, and Senior Bridge Notes which was incurred following the modification of
the Senior Notes on September&#160;27, 2022 which was accounted for as debt extinguishment. Interest expense incurred prior to the September&#160;27,
2022 modification is not eliminated because prior to that date the Senior Notes did not contain conversion feature requiring conversion
of the Senior Notes upon a merger with a SPAC.&#160;Accordingly, the Senior Notes were deemed to have been extinguished as of September&#160;27,
2022, and re-issued&#160;immediately as new debt that is convertible upon the Merger. All expenses incurred with respect to the Senior
Notes following the September&#160;27, 2022 modification, including interest expense and gains or losses incurred with subsequent modifications
of the Senior Notes, are eliminated.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">CC.</td><td style="text-align: justify">Represents the income tax impact on the elimination of investment income related to the investments held
in NorthView&#8217;s Trust Account.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">DD.</td><td style="text-align: justify">Represents elimination of the changes in the fair value of Northview&#8217;s convertible loan upon the
closing of the Business Combination.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">EE.</td><td style="text-align: justify">To account for the Profusa Senior Secured Working Capital Loan interest at 12.0% during the year ended
December&#160;31, 2024, for the portion not already accounted for in accrued interest. All Profusa Senior Secured Working Capital Loan
interest was accounted for as of June 30, 2025 in Tickmark BB for the period. No new notes were issued between June 30, 2025 and the closing
of the Business Combination on July 11, 2025.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">FF.</td><td style="text-align: justify">Represents the accrual of estimated Transaction related costs incurred by NorthView after June 30, 2025
and December&#160;31, 2024, respectively.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">GG.</td><td style="text-align: justify">Represents issuance of the Milestone Earnout Rights and Profusa Inducement Recoupment Earnout Rights to
the equity holders of Profusa, which are treated as dividend distributions and recorded in additional paid-in&#160;capital. Earnout right
represents a right to receive shares in future upon meeting certain earnout targets. The issuance date fair values of Milestone Earnout
Rights and Profusa Inducement Recoupment Earnout Rights was determined using Monte Carlo Simulation approach. The Company estimated the
vesting and payoff of the Milestone Earnout Shares and the Inducement Shares related to Milestone&#160;I Event and Milestone&#160;II Event
for each simulated stock price path, and the vesting and payoff of the Milestone Earnout Shares related to Milestone&#160;III Event and
Milestone&#160;IV Event for each simulated revenue path and the correlated stock price path. The fair value is then determined by averaging
the payoff across all simulated paths and discounting it to the valuation date.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">HH.</td><td style="text-align: justify">Reflects transaction costs incurred in excess of proceeds.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">II.</td><td style="text-align: justify">To account for the PIPE Investors interest at 10% related to the first tranche of the PIPE Convertible
Note.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">JJ.</td><td style="text-align: justify">To account for the warrant expense associated to the 900,000 warrants issued to Ascent associated with
the ELOC Registration Rights Agreement, calculated based on the warrant fair value on the warrant agreement date.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">KK.</td><td style="text-align: justify">Represents elimination of the changes in the fair value of Northview&#8217;s Securities Purchase Agreement
upon the closing of the Business Combination.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>5. Net Loss per Share</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Represents the net loss per
share calculated using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the
Business Combination, assuming the shares were outstanding since January&#160;1, 2024. As the Business Combination and related transactions
are being reflected as if they had occurred at the beginning of January&#160;1, 2024, the calculation of weighted average shares outstanding
for basic and diluted net loss per share assumes that the shares issuable relating to the Business Combination have been outstanding for
the entire periods presented.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited pro forma condensed
combined financial information has been prepared with the actual redemptions of Public Shares by NorthView Public Stockholders for the
six&#160;months ended June 30, 2025 and for the year ended December&#160;31, 2024:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six&#160;Months <br/> Ended June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Pro forma net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(15,256</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(17,776</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deemed dividend</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(9,684</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,684</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.25in; padding-left: 0.25in">Pro forma net loss used in calculation of weighted-average pro forma net loss per share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(24,940</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(27,460</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Basic weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110,534,620</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,250,017</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Pro forma net loss per share &#8211; Basic and Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.23</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.25</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average shares outstanding-basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">NorthView Common shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,535,591</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,482,807</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Former Profusa shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shares issued to underwriters</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">382,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">382,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Senior secured convertible note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,660,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,542,261</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Profusa bridge notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,285,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,170,932</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Northview working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">863,908</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">863,908</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">PIPE Subscription</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,125,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,125,231</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Ascent ELOC Commitment Shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51,182,378</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51,182,378</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">110,534,620</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">111,250,017</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>


</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DIVIDEND POLICY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared or paid
any cash dividends on our common stock, and we do not currently intend to pay any cash dividends on our common stock for the foreseeable
future. We expect to retain future earnings, if any, to fund the development and growth of our business. Any future determination to pay
dividends on our common stock will be at the discretion of our board of directors and will depend upon, among other factors, our results
of operations, financial condition, capital requirements and any contractual restrictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MARKET INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is currently
listed on Nasdaq under the symbol &#8220;PFSA&#8221;. Prior to the consummation of the Business Combination, our Common Stock was listed
on the OTC under the symbol &#8220;NVAC&#8221;. As of August 28, 2025, there were 194 holders of record of our Common Stock and the closing
sale price of our Common Stock was $0.72 per share. The actual number of stockholders of our Common Stock is greater than the number of
record holders and includes holders of our Common Stock whose shares of Common Stock are held in street name by brokers and other nominees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MANAGEMENT</b>&#8217;<b>S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND<br/>
RESULTS OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">References to &#8220;Profusa,&#8221;
the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our,&#8221; refer to Profusa, Inc. and its subsidiaries. The
following discussion and analysis of the Company&#8217;s financial condition and results of operations should be read in conjunction with
the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this prospectus (this &#8220;Report&#8221;).
Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and
uncertainties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa, Inc., our wholly owned
California subsidiary (&#8220;Old Profusa&#8221;), became our accounting predecessor upon the closing of the Business Combination on July
11, 2025. The results of operations discussed below are those of Old Profusa and its consolidated subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cautionary Note&#160;Regarding Forward-Looking
Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Prospectus includes forward-looking
statements within the meaning of Section&#160;27A of the Securities Act&#160;of&#160;1933, as amended, and Section&#160;21E of the Securities
Exchange&#160;Act&#160;of&#160;1934, as amended (the &#8220;Exchange&#160;Act&#8221;). We have based these forward-looking statements
on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks,
uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements.
In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221;
&#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
&#8220;continue,&#8221; or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy
include, but are not limited to, those described in our other Securities and Exchange Commission (&#8220;SEC&#8221;) filings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Overview</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a clinical-stage digital
health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients in a variety
of different diseases and conditions. Our first product is Lumee Oxygen, which enables physicians to ascertain the extent of perfusion,
or passage of blood through the circulatory system to an organ or tissue, in patients with Critical Limb Ischemia (CLI) both during and
after endovascular revascularization procedures. Lumee Oxygen has already received regulatory approval in Europe through the attainment
of a CE mark; however, prior to commercialization in the U.S., Lumee Oxygen must obtain FDA clearance or approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The latest version of Lumee
Oxygen is called Wireless Lumee Oxygen System. It has multiple components, one of which is a microsensor that is injected into the tissue
of the patient using a hypodermic needle. The sensor is designed so it does not need to be removed as it overcomes the foreign body response
that usually inhibits the ability of permanent implants to function. The sensor contains no electronics, utilizing luminescence to send
a light signal to a reader that is placed over the incision site, which in turn can send a signal to an app on a smartphone. We are in
clinical trials for Lumee Glucose, our sensing solution being developed for use in continuous glucose monitoring (CGM). This system targets
diabetics and pre-diabetics to allow them real-time access to their glucose data, at a price point that our management thinks is comparable
or lower to existing systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We already sell our oxygen
sensor for research use only applications, namely animal models and in vitro testing. Management is targeting the European market (those
jurisdictions that accept CE mark) for early launch for both Lumee Oxygen and Lumee Glucose. Lumee Oxygen&#8217;s launch in Europe occurred
in 2023 and Lumee Glucose launch is expected to occur in 2025, subject to regulatory approval. We have access to key opinion leaders (KOLs)
in both Europe and the United&#160;States, who deal with peripheral arterial disease (PAD) and Critical Limb Ischemia (CLI). We will sell
directly to facilities based on the endorsement of these KOLs. In Germany, Austria and France, some KOLs have already used Lumee Oxygen
on a trial basis. We have worked with reimbursement consultants to develop potential Category&#160;I CPT codes for Lumee Oxygen use.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regarding Lumee Glucose, if
and when we obtained marketing authorization, we plan to embark on a dual strategy of both direct to hospital sales, for our professional-use
and personal-use CGM product, and direct to pharmacy sales for our personal use product only, thereby maximizing flexibility for the consumer.
By aiming for coverage under a user&#8217;s pharmacy benefit, we believe we can diversify our user base, while accounting for any risk
related to unlikely delay of attainment of a category&#160;I CPT code for sensor insertion. We feel a difference between other insertable
or implantable CGMs and Lumee Glucose, is that the latter can be simply inserted with a hypodermic needle and does not require a surgical
implantation, similar to how pharmacists use these needles to administer flu shots and other vaccines. At the same time, physicians can
still leverage existing CPT codes related to interpretation of CGM data and we have, in parallel, initiated steps for CPT codes related
to our sensor insertion. We will target both public and private payors for coverage.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since our launch, we have significantly
devoted all of our resources to research and development, as well as all clinical study activities related but not limited to Lumee Oxygen,
Lumee Glucose and prototypes for sensors of at least eight other analytes. We have also invested, on a smaller scale, in making sales
of Lumee Oxygen for research- use only clients, which include entities working with animal models. Furthermore, we also performed research
and development under government grants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since inception, we have incurred
recurring annual losses from operations. For the three&#160;months ended June&#160;30, 2025 and 2024, we incurred a net loss of $2.3&#160;million
and $2.0&#160;million, respectively. For the six&#160;months ended June&#160;30, 2025 and 2024, we incurred a net loss of $5.1&#160;million
and $4.5&#160;million, respectively. During the six&#160;months ended June&#160;30, 2025 and 2024, we have used $1.1&#160;million and
$1.0&#160;million, respectively, of cash in our operating activities. We have notes and loans payable and interest due of $52.3&#160;million
within twelve&#160;months of June&#160;30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have been able to finance
our operations primarily with the proceeds from the issuance of equity and debt instruments and to a lesser extent, revenues from government
grants. For the six&#160;months ending June&#160;30, 2025, we obtained net cash from financing activities of $1.0&#160;million compared
to $0.9&#160;million for the same period in 2024. We held cash of less than $0.1&#160;million as of June&#160;30, 2025, and $0.2&#160;million
as of December&#160;31, 2024, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s condensed
consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business. The Company has reviewed the relevant conditions and events surrounding its ability to
continue as a going concern including among others: historical losses, projected future results, including the effects of COVID-19, cash
requirements for the upcoming year, funding capacity, net working capital, total stockholders&#8217; deficit and future access to capital.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025 Profusa,
Inc., a Delaware corporation formerly known as NorthView Acquisition Corporation, consummated its previously announced business combination
with Profusa, Inc., a California corporation, pursuant to that certain Merger Agreement and Plan of Reorganization. At the Closing and
pursuant to the PIPE Subscription Agreement, New Profusa issued a PIPE Convertible Note in the principal amount of $10,000,000 (the &#8220;Initial
Note&#8221;) for a purchase price of $9,000,000, reflecting a 10% Original Issuance Discount (&#8220;OID&#8221;). Management believes
this liquidity has not alleviated the relevant conditions or events that raise substantial doubt about the Company&#8217;s ability to
continue as a going concern within one year from the date the condensed consolidated financial statements are issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the closing, the
Company had cash inflows of $1.3&#160;million from the NorthView trust account, net of redemptions, and the $9&#160;million net PIPE convertible
note. Cash outflows included marketing fees and vendor payments which totaled $3.4&#160;million due at closing. Subsequent to the closing
of the Merger, there continue to be factors which raise substantial doubt about the Company&#8217;s ability to continue as a going concern
within one year from the date the condensed consolidated financial statements are issued. The condensed consolidated financial statements
do not contain any adjustments that might result from the outcome of this uncertainty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is our expectation to continue
to make substantial investments in building its European and United&#160;States commercial infrastructure and enhancing existing products
and developing new ones. Furthermore, we aim to continue discussions with potential partners in Asia.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to incur additional
expenses due to operating as a public company, including expenses related to compliance with the rules and regulations of the U.S.&#160;Securities
and Exchange Commission, or the SEC, and those of the Nasdaq Stock Market LLC (&#8220;NASDAQ&#8221;) Stock Market, additional insurance
expenses, investor relations activities and other administrative, professional and consulting services. As a result of these and other
factors, we expect that we will require additional financing to fund our operations and planned growth. We may seek to raise any additional
capital through equity offerings or debt financings, additional credit or loan facilities or a combination of one or more of these funding
sources. In the scenario that we are unable to acquire sufficient financing or financing on terms satisfactory to our management or Board
of Directors, our ability to continue to pursue our business objectives and to respond to business opportunities, challenges or unforeseen
circumstances could be significantly limited, and our business, financial condition and results of operations could be materially adversely
affected. For the current period and for twelve&#160;months following the issuance of these financial statements, our risk of going concern
has been mitigated but not fully alleviated by the Tranche 1 PIPE Convertible Note issued for a gross $10.0&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Combination</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, the
Company entered into an Agreement and Plan of Merger (&#8220;Merger Agreement&#8221;) with NorthView Acquisition Corp (&#8220;NorthView&#8221;),
where a subsidiary of NorthView will merge with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.
Pursuant to the Merger Agreement, and assuming a favorable vote of NorthView&#8217;s stockholders, Merger Sub, a newly formed subsidiary
of NorthView, will be merged with and into Profusa. Upon consummation of the Business Combination, the separate corporate existence of
Merger Sub shall cease; Profusa will survive and become a wholly owned subsidiary of NorthView, which will be renamed New Profusa, Inc.
The aggregate consideration to be received by the Profusa stockholders is based on a pre-transaction equity value of $155,000,000. The
exchange ratio will be equal to (a)&#160;$155,000,000, divided by an assumed value of NorthView Common Stock of $10.00 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
the parties to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the &#8220;Amendment&#8221;) pursuant to which
the parties agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received
by Profusa prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment
(i)&#160;revised the definition of &#8220;Milestone Event&#160;III&#8221; such that the parties extended the period for Profusa to consummate
the APAC Joint Venture (as defined in the Merger Agreement) and receive the related funding from December&#160;31, 2024 until December&#160;31,
2025, and (ii)&#160;revised the definition of &#8220;Milestone Event&#160;IV&#8221; to change the earnout revenue target from $99,702,000
for the fiscal year ended December&#160;31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December&#160;31,
2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;2, 2025, the
parties to the Merger Agreement entered into an Amendment No. 5 to the Merger Agreement (&#8220;Amendment No. 5&#8221;) pursuant to which
Section&#160;9.01 of the Merger Agreement is hereby amended such that the reference to &#8220;March&#160;22, 2025&#8221; shall be replaced
with &#8220;June&#160;22, 2025&#8221;. The closing date was then further amended to July&#160;11, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subsequent to these financials
statements, on July&#160;11, 2025, the Business Combination was successfully completed and was accounted for as a reverse capitalization
in accordance with GAAP.&#160;Profusa was deemed the accounting predecessor of the combined business, and New Profusa, Inc. (&#8220;New
Profusa&#8221;) as the parent company of the combined business, is the successor SEC registrant, meaning that our financial statements
for previous periods will be disclosed in the registrant&#8217;s future periodic reports filed with the SEC.&#160;The Business Combination
will have a significant impact on our future capital structure and operating results, de-risking our product development, manufacturing
and commercialization. The most significant changes in New Profusa&#8217;s future reported financial positions are expected to be an estimated
increase in cash (as compared to our balance sheets at June&#160;30, 2025 and at December&#160;31, 2024) of approximately $9.0&#160;million
in proceeds from the PIPE Investment. This $9.0&#160;million is offset by various deferred offering costs and $2.0&#160;million closing
fees related to the underwriters marketing fee for the NorthView IPO, which became payable upon a successful consummation of the Business
Combination. See &#8220;Unaudited Pro Forma Condensed Combined Financial Information.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June&#160;2023, the Company
entered into a short-term loan agreement with a related party under which it may borrow up to $1.6&#160;million, of which $1.0&#160;million
was borrowed on June&#160;26, 2023, $0.3&#160;million was borrowed on July&#160;20, 2023, $0.3&#160;million was borrowed on August&#160;15,
2023 (the &#8220;Tasly Convertible debt&#8221;). An additional amount of less than $0.02&#160;million was drawn on February&#160;6, 2024.
The loans bear interest at a rate of 12% per annum and originally matured on December&#160;31, 2023. The original maturity date was extended
to March&#160;31, 2024, subject to the parties&#8217; decision to extend thereafter. The Company is currently in default, as this loan
will be repaid subsequent to the SPAC transaction. The Company is currently incurring a default interest rate of 24% per annum, and has
classified the entire amount outstanding under the Tasly Convertible Debt as current under the convertible debt payable line item on the
Condensed Consolidated Balance Sheet.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Merger,
the Company has become the successor to an SEC-registered and NASDAQ- listed company, which will require us to hire additional personnel
and implement procedures and processes to address public company regulatory requirements and customary practices. We expect to incur additional
annual expenses as a public company for, among other things, directors&#8217; and officers&#8217; liability insurance, director fees,
and additional internal and external accounting, legal and administrative resources.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Developments</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus,
the Company has purchased $1.0 million of Bitcoin as part of the Company&#8217;s ongoing treasury strategy, representing 8.53 Bitcoins.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><i>Inflation, Monetary Response, and
Economic Impacts</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The world economy is experiencing
stubbornly high inflation, a challenge not faced for decades. Following the global financial crisis, with inflationary pressures muted,
interest rates were extremely low for&#160;years and investors became accustomed to low volatility. The resulting easing of financial
conditions supported economic growth, but it also contributed to a buildup of financial vulnerabilities. With inflation at multi-decade
highs, monetary authorities in advanced economies are accelerating the pace of policy normalization. Policymakers have continued to tighten
policy against a backdrop of rising inflation and currency pressures, albeit with notable differences across regions. Global financial
conditions have tightened notably this year, leading to capital outflows. Amid heightened economic and geopolitical uncertainties, investors
have aggressively pulled back from risk-taking and adjusted their investment preferences generally. Key gauges of systemic risk, such
as higher dollar funding costs and counterparty credit spreads, have risen. There is a risk of a disorderly tightening of financial conditions
that may be amplified by vulnerabilities built over the&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our business,
growth, financial condition or results of operations could be materially adversely affected by instability or changes in a country&#8217;s
or region&#8217;s economic conditions; inflation; changes in laws or regulations or in the interpretation of existing laws or regulations,
whether caused by a change in government or otherwise; increased difficulty of conducting business in a country or region due to actual
or potential political or military conflict; or action by the U.S.&#160;or foreign governments that may restrict our ability to transact
business in a foreign country or with certain foreign individuals or entities. A possible slowdown in global trade caused by increasing
tariffs or other restrictions could decrease consumer or corporate confidence and reduce consumer, government and corporate spending in
countries inside or outside the U.S., which could adversely affect our operations. Climate-related&#160;events, including extreme weather
events and natural disasters and their effect on critical infrastructure in the U.S.&#160;or internationally, could have similar adverse
effects on our operations, users, or third-party&#160;suppliers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PIPE Transaction</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Initial Note</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
NorthView executed a Securities Purchase Agreement (the &#8220;PIPE Subscription Agreement&#8221;) with Ascent Partners Fund LLC (&#8220;Ascent&#8221;,
and together with any additional investors who become parties to the PIPE Subscription Agreement, the &#8220;PIPE Investors&#8221;). Pursuant
to the PIPE Subscription Agreement, the PIPE Investors are expected, subject to the conditions relating to such purchase set forth in
the PIPE Subscription Agreement, to purchase from NorthView senior secured convertible notes in an aggregate principal amount of up to
$22,222,222 (the &#8220;PIPE Convertible Notes&#8221;) for a an aggregate purchase price of up to $20,000,000, reflecting a 10% original
issue discount to the face amount (&#8220;OID&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the closing of our Business
Combination and pursuant to the PIPE Subscription Agreement, we issued a PIPE Convertible Note in the principal amount of $10,000,000
(the &#8220;Initial Note&#8221;) for a purchase price of $9,000,000, reflecting a 10% OID.&#160;The Initial Note matures on January 11,
2027, which is 18-months from Closing on July 11, 2025 (the &#8220;Maturity Date&#8221;) and is convertible at any time at the PIPE Investor&#8217;s
option at a conversion price equal to the lower of $10 or 95% of the lowest daily volume-weighted average price per share (&#8220;VWAP&#8221;)
of our Common Stock in the 10&#160;trading days prior to the original issue date of the Initial Note and shall be adjusted, without limitation,
based on down-round and most-favored nation (MFN) price and terms protections (the &#8220;Conversion Price&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Initial Note includes a
&#8220;Minimum Interest Amount&#8221; equal to 10% of the principal amount, which represents a full year of interest payments under the
Initial Note; provided, that such Minimum Interest Amount shall be reduced by the amount of interest accrued on the principal amount of
the Initial Note. Interest shall accrue on the aggregate unconverted and then outstanding principal amount of the Initial Note at a rate
of 10% per annum, provided that the Minimum Interest Amount shall be fully earned and accrued on the original issue date of the Initial
Note. Upon an event of default, the interest rate shall be adjusted and increase to 24% per annum. Payments made in cash under the Initial
Note shall be subject to a 5% fee, which shall be in addition to any amounts owed thereunder. The Initial Note provides for certain events
of default that are typical for a transaction of this type, including, among other things, any breach of the representations or warranties
made by us and our subsidiaries. The Initial Note also provides for a 10% late fee in case of late payments and mandatory prepayments
upon Subsequent Offerings (as defined in the Initial Note) and, in the absence of an event of default, may be prepaid upon 10&#160;business
days prior notice, subject to certain conversion rights of the PIPE Investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Initial Note may not be
converted by the PIPE Investors into shares of our Common Stock if such conversion would result in the investors or their affiliates owning
in excess of 4.99% of the number of shares of our Common Stock outstanding immediately after giving effect to the issuance of all shares
issuable upon conversion of the Initial Note (the &#8220;Beneficial Ownership Limitation&#8221;); provided, that the PIPE Investors may
increase or decrease the Beneficial Ownership Limitation upon at least 61&#160;days&#8217; prior notice to us so long as such increase
does not exceed 9.99% of the number of shares of our Common Stock outstanding immediately after giving effect to the issuance of all shares
issuable upon conversion of the Initial Note. On August 1, 2025, pursuant to a Notice and Waiver, the Beneficial Ownership Limitation
was increased from 4.99% to 9.99% and we waived the requirement for the 60 days&#8217; advance notice for such increase.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued the Initial
Note pursuant to the exemption from the registration requirements of the Securities Act available under Section&#160;4(a)(2).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description of
the Initial Note is not complete and is qualified in its entirety by reference to the text of such document, which is filed as Exhibit
10.6 hereto and incorporated herein by reference.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amendment No. 1 to the Securities Purchase
Agreement and Initial Note</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 25, 2025, the Company
entered into Amendment No. 1 (the &#8220;<b>SPA Amendment</b>&#8221;) to the PIPE Subscription Agreement. Pursuant to the SPA Amendment,
Section 2.1 of the PIPE Subscription Agreement was amended and restated to provide for four tranches of Notes: (i) an initial closing
for Notes in an aggregate principal amount of $10,000,000 (the &#8220;<b>First Tranche</b>&#8221;), which already occurred in July 11,
2025; (ii) a second closing for Notes in an aggregate principal amount of $2,222,222 (the &#8220;<b>Second Tranche</b>&#8221;) for a purchase
price of $2,000,000, subject to the satisfaction of certain conditions including the filing of a registration statement on Form S-1 covering
all conversion shares and no Nasdaq listing deficiency; (iii) a third closing for Notes in an aggregate principal amount of $5,555,556
(the &#8220;<b>Third Tranche</b>&#8221;) for a purchase price of $5,000,000, subject to the satisfaction of certain conditions including
the full conversion or repayment of the First Tranche, effectiveness of a registration statement, no Nasdaq listing deficiency, and receipt
of stockholder approval; and (iv) a fourth closing for Notes in an aggregate principal amount of $4,444,444 (the &#8220;<b>Fourth Tranche</b>&#8221;)
for a purchase price of $4,000,000, subject to the satisfaction of certain conditions including the full repayment of the First and Second
Tranches, at least fifty percent (50%) repayment or conversion of the Third Tranche, effectiveness of a registration statement, and no
Nasdaq listing deficiency. The Amendment supersedes and replaces all prior provisions relating to &#8220;Additional Closings&#8221; and
&#8220;Additional Notes,&#8221; and all references to such terms in the PIPE Subscription Agreement and related documents are to be construed
in accordance with the new tranche structure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrently, on August 25,
2025, the Company entered into Amendment No. 1 (the &#8220;<b>Note Amendment</b>&#8221;) to the Initial Note. The Note Amendment modifies
the terms of the Initial Note, specifically amending Section 4(b) to revise the conversion price provisions on any conversion date to
be the lower of (i) the Conversion Price on such date and (ii) ninety-five percent (95%) of the lowest daily volume weighted average price
(&#8220;<b>VWAP</b>&#8221;) for the Company&#8217;s common stock during the ten consecutive trading days immediately preceding the applicable
conversion date (the &#8220;<b>Alternate Conversion Price</b>&#8221;), provided that in no event shall the conversion price be less than
the Floor Price of twenty percent (20%) of the closing sale price of the common stock on the principal trading market on the trading day
immediately preceding the Note Amendment&#8217;s effective date, which was August 22, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description of
SPA Amendment, Note Amendment, and the Form of Amended Senior Secured Convertible Promissory Note, is a summary only and does not purport
to be complete and is qualified in its entirety by reference to the full text of the SPA Amendment, Note Amendment, and Form of Amended
Senior Secured Convertible Promissory Note, copies of which are filed herewith as Exhibits 10.21, 10.22, and 10.23 and are incorporated
herein by reference.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>PIPE Lock-Up Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, the
PIPE Investors entered into a lock-up agreement (the &#8220;PIPE Lock-Up Agreement&#8221;), pursuant to which they agreed to, subject
to certain customary exceptions, not offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of any shares of our Common
Stock or securities convertible, exchangeable or exercisable into shares of our Common Stock beneficially owned, held or acquired by them.
The period for such restrictions shall apply from the Closing Date until the termination of the PIPE Lock-Up Agreement in accordance with
its terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>PIPE Registration Rights Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, we and
the PIPE Investors entered into a registration rights agreement (the &#8220;PIPE Registration Rights Agreement&#8221;), which provides
customary demand and piggyback registration rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PIPE Registration Rights
Agreement provided that we will, as soon as practicable, but in any event within 20 calendar&#160;days after the Closing Date (the &#8220;Filing
Date&#8221;), use our reasonable best efforts to file with the SEC a registration statement registering the resale of certain Common Stock
issuable to the PIPE Investors upon conversion of the PIPE Convertible Notes. We will use our reasonable efforts to have the registration
statement declared effective within 45&#160;days (but in any event no later than the 60<sup>th</sup>&#160;calendar&#160;day) after the
filing thereof.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2025, we entered
into Amendment No. 1 to the PIPE Registration Rights Agreement, whereby we amended the Filing Date to September 14, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Security Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, we and
old Profusa (collectively, the &#8220;Profusa Parties&#8221;) entered into a Security Agreement with Ascent, as collateral agent (the
&#8220;Security Agreement&#8221;), pursuant to which the Profusa Parties granted a security interest in substantially all of their respective
assets to Ascent, to secure their respective obligations under the PIPE Convertible Notes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Guaranty</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, the
Profusa Parties and their respective subsidiaries, successors and permitted assigns entered into a guaranty (the &#8220;Guaranty&#8221;),
pursuant to which each such party guaranteed the other parties&#8217; obligations under the PIPE Convertible Notes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The Committed Equity Facility</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 28, 2025, we entered
into the Purchase Agreement and the ELOC Registration Rights Agreement with Ascent. Upon the terms and subject to the satisfaction of
the conditions contained in the Purchase Agreement, from and after the Effective Date, we will have the right, in our sole discretion,
to sell to Ascent up to $100,000,000 of shares of our Common Stock, subject to certain limitations set forth in the Purchase Agreement,
from time to time after the date of this prospectus and during the term of the Purchase Agreement. Sales of Common Stock by us to Ascent
under the Purchase Agreement, and the timing of any such sales, are solely at our option, and we are under no obligation to sell any securities
to Ascent under the Purchase Agreement. See the section titled &#8220;<i>The Committed Equity Facility</i>&#8221; in this prospectus for
more information. As of August 27, 2025, approximately $0.9 million in shares of our Common Stock was sold pursuant to the Purchase Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Principles of Accounting and Consolidation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed
consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States
of America (&#8220;U.S.&#160;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;)
and include all adjustments necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2025, and
June&#160;30, 2024 and the results of operations and cash flows for the three and six month periods then ended. The accompanying condensed
consolidated financial statements include the accounts of Profusa Inc. and its wholly owned subsidiary, APAC.&#160;All intercompany balances
and transactions have been eliminated in consolidation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Components of Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Government Grant Revenue</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Government grant revenue consists
of amounts we earn under grants from two government agencies: NIH and DARPA.&#160;These grants are provided either in the form of expense
reimbursement (expense reimbursement grants) or on a fixed fee basis (fixed fee grants). Under the expense reimbursement grants the government
agencies reimburse us for a portion of our expenses (allowable expenses) that have been incurred in a given period on the basis of reports
that we provide to these agencies. Fixed fee grants are awarded for specific research and development programs undertaken by us. Under
these grants we receive milestone payments from the government agencies upon our submission and approval by the government of agreed upon
deliverables, consisting primarily of the documented results of the specific research and development programs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Research and Development Expenses</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses
consist primarily of personnel expenses, including salaries, benefits, and stock-based compensation, costs of consulting, supplies, depreciation
and amortization and allocations of facility- related expenses. We expect our research and development expenses to increase as we increase
staffing to support product development, continue our clinical trials, build prototypes, and continue to explore and develop next generation
technologies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and Administrative Expenses</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses consist of personnel expenses, including salaries, benefits, and stock-based compensation, related to executive management, finance,
legal, human resource functions, and business development, contractor and professional services fees, audit and compliance expenses, insurance
costs and general corporate expenses, including allocated facility-related expenses and information technology costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Loss on Change in the Fair Value of Tasly
Convertible Debt</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We elected to apply fair value
option to account for the convertible loans issued between June&#160;2023 and March&#160;2024 (the &#8220;Tasly Convertible Debt&#8221;),
under which none of the embedded conversion or redemption features were bifurcated and separately accounted for. Rather, the Tasly Convertible
Debt in its entirety was recorded at fair value at inception and is subject to remeasurement to fair value at each balance sheet date,
with the change in fair value reflected in the statements of operations and comprehensive loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Gain on PPP Loan Forgiveness</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;16, 2020 and
May&#160;25, 2021, we borrowed $1.2&#160;million (the &#8220;PPP Loan 1&#8221;) and $1.3&#160;million (the &#8220;PPP Loan 2&#8221;),
respectively, as a Paycheck Protection Program loan (together the &#8220;PPP Loans&#8221;). The Paycheck Protection Program, established
as part of the Coronavirus Aid, Relief, and Economic Security (&#8220;CARES&#8221;) Act, provides for loans to qualifying businesses and
is administered by the U.S.&#160;Small Business Administration (the &#8220;SBA&#8221;). The annual interest rate of the PPP Loans is 1%.
The PPP Loans are eligible for forgiveness, provided the borrower has met the respective forgiveness requirements, has timely submitted
an application for forgiveness and the forgiveness has been granted by the SBA.&#160;PPP Loan 1 has been approved for loan forgiveness,
and management intends to apply for PPP Loan 2 forgiveness in 2025. PPP Loan 2 is currently in default due to non-payment, and is classified
as a current liability on the balance sheet.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Interest Expense</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interest expense consists primarily
of the interest on our convertible notes, senior notes, Tasly convertible debt, and PPP Loans.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other Income</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other income consists primarily
of income earned from sale of equipment and a short-term sublease of a portion of our facilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of the Three&#160;months ended June&#160;30,
2025 to the Three&#160;months ended June&#160;30, 2024</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
our unaudited condensed consolidated statements of operations and comprehensive loss for the interim periods indicated (in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months <br/> Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(25</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(100</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">393</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(39</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">610</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">569</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,001</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,003</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(976</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(57</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(42</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">280</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,289</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,081</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(208</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income (expense)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,345</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,095</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,348</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,071</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(277</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">13</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Revenue&#160;</i>&#8212;&#160;Grant
revenue was recognized in 2024, while no grant revenue was recognized in 2025 while the Company focused on the closing on the Merger transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Research and Development&#160;</i>&#8212;&#160;Research
and development expenses remained constant and decreased by $39 thousand or 9% during the three&#160;months ended June&#160;30, 2025 due
to a reduction in research studies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>General and Administrative&#160;</i>&#8212;&#160;General
and administrative expenses increased by $41 thousand million, or 7%, to $610 thousand during the three&#160;months ended June&#160;30,
2025 from $569 thousand during the three&#160;months ended June&#160;30, 2024. The increase was driven primarily by the increase in accounting
costs as a result of increased audit and accounting fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Loss on Change in the Fair
Value of the Tasly Convertible Loans&#160;</i>&#8212;&#160;Loss on change in the fair value of the Tasly Convertible Loan was less than
$0.1&#160;million during the three&#160;months ended June&#160;30, 2025. The loss during the three&#160;months ended June&#160;30, 2025
was driven by the remeasurement of the Tasly Convertible Loans.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Interest Expense&#160;</i>&#8212;&#160;Interest
expense increased by $0.2&#160;million to $1.3&#160;million during the three&#160;months ended June&#160;30, 2025 from $1.1&#160;million
during the three&#160;months ended June&#160;30, 2024. The increase was primarily due to interest accrued on $3.5&#160;million in additional
senior notes that have been issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of the Six&#160;months ended June&#160;30,
2025 to the Six&#160;months ended June&#160;30, 2024</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
our unaudited condensed consolidated statements of operations and comprehensive loss for the interim periods indicated (in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months <br/> Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(25</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(100</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(111</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,600</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,402</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">198</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,427</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,340</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">87</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,315</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(112</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(118</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(107</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,519</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,161</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(358</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(100</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,637</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,166</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(471</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,064</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(4,481</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(583</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">13</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Research and Development&#160;</i>&#8212;&#160;Research
and development expenses decreased by $0.1&#160;million, or 12%, to $0.8&#160;million during the six&#160;months ended June&#160;30, 2025
from $0.9&#160;million during the six&#160;months ended June&#160;30, 2024. The decrease was driven primarily by the decrease in CRO and
personnel costs of $0.1&#160;million as a result of the completion of several clinical studies and a reduction of personnel while the
Company focused on closing the business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>General and Administrative&#160;</i>&#8212;&#160;General
and administrative expenses increased by $0.2&#160;million, or 14%, to $1.6&#160;million during the six&#160;months ended June&#160;30,
2025 from $1.4&#160;million during the six&#160;months ended June&#160;30, 2024. The increase was driven primarily by the increase in
accounting costs of $0.2&#160;million as a result of increased audit and accounting fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Loss on Change in the Fair
Value of the Tasly Convertible Loans&#160;</i>&#8212;&#160;Loss on change in the fair value of the Tasly Convertible Loan was $0.1&#160;million
during the six&#160;months ended June&#160;30, 2025. The loss during the six&#160;months ended June&#160;30, 2025 was driven by the remeasurement
of the Tasly Convertible Loans.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Interest Expense&#160;</i>&#8212;&#160;Interest
expense increased by $0.4&#160;million, or 17%, to $2.5&#160;million during the six&#160;months ended June&#160;30, 2025 from $2.1&#160;million
during the six&#160;months ended June&#160;30, 2024. The increase was primarily due to the $3.5&#160;million in additional senior notes
that have been issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Income&#160;</i>&#8212;&#160;Other
income decreased by less than $0.1&#160;million during the six&#160;months ended June&#160;30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sources of Liquidity</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incurred net losses and
negative operating cash flows from operations since inception, and we expect to continue to incur losses and negative operating cash flows
for the foreseeable future until we successfully commence sustainable commercial operations. To date, we have funded our operations primarily
with proceeds from the issuance of convertible preferred stock, junior and senior convertible notes, PPP Loans available to us under the
Paycheck Protection Program and promissory notes. From inception through June&#160;30, 2025, we raised gross proceeds of $98.0&#160;million
from the issuances of convertible preferred stock and convertible notes and loans, received $2.5&#160;million from PPP Loans and received
$0.9&#160;million from issuance of promissory notes. As of June&#160;30, 2025, we had cash and cash equivalents of $0.1&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our junior convertible notes
bear interest at 12% per annum and, as of June&#160;30, 2025, their then outstanding principal and accrued but unpaid interest automatically
converted into common shares of New Profusa at $7.00 per share upon consummation of the Merger transaction. In addition, upon consummation
of the Merger, all junior noteholders have a right to receive additional shares upon achievement by New Profusa of certain share price
and sales milestones (the earnout shares). We refer you to Footnote 14, Subsequent Events, 14 for the conversion of these notes as of
the closing of the Merger on July&#160;11, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We commenced issuance of our
senior convertible notes in April&#160;2021 and continued issuing them to date. Our senior convertible notes bear interest at 12% per
annum and their then outstanding principal and accrued but unpaid interest automatically converted into common shares of New Profusa between
$0.50 and $4.00 per share upon consummation of the Merger transaction, which occurred on July&#160;11, 2025, based on the fixed conversion
price defined in the agreement. In addition, upon consummation of the Merger, all senior noteholders obtained the right to receive additional
shares upon achievement by New Profusa of certain share price and sales milestones (the earnout shares).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;8, 2023, a new
wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (&#8220;APAC&#8221;), was created and incorporated by the Company under the laws
of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $1,000 for 1,000&#160;Ordinary Shares. As a result,
at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created with the expectation
of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee Oxygen products, currently
under development by the Company, together with a third party. No business or activities will have been conducted by the entity from the
date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement between the Company
and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (&#8220;Tasly&#8221;). Subsequent to the
closing of the Merger between the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders
Agreement (the &#8220;APAC Joint Venture&#8221;) setting forth the relative and other terms under which the development and business activities
of the entity will be conducted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is in the process
of negotiating the formation of the joint venture (&#8220;APAC Joint Venture&#8221;), which includes the related party from which the
amounts under the Tasly Convertible Debt was borrowed. The proceeds of the loan are intended to continue the development and commercialization
of the Company&#8217;s technology in certain countries of the Asia Pacific region.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event we either fail
to complete the formation of the APAC Joint Venture or fail to repay the amounts under the Tasly Convertible Debt when they become due,
the lender will have an option to convert the outstanding balance and accrued but unpaid interest (in part or in full) into senior unsecured
promissory notes on substantially the same terms as the outstanding Senior Notes as of June&#160;30, 2025 (which terms include conversion
into common stock of New Profusa).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the conversion
provisions above, any repayment obligations (in part or in full) of the outstanding principal balance and accrued but unpaid interest
under the Tasly Convertible Debt may, at the lender&#8217;s option, be made through conversion of part or all amounts payable into (i)&#160;senior
unsecured promissory notes on substantially the same terms as the outstanding Senior Notes as of June&#160;30, 2025 (which terms include
conversion into common stock of New Profusa), or (ii)&#160;our common stock at a conversion price of $1.92 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our outstanding PPP Loan of
$1.4&#160;million bears interest at 1% per annum. The repayment of the PPP Loan is expected to be made in equal monthly payments of principal
and interest from October&#160;25, 2022 until May&#160;25, 2026; however, we are currently in the process of applying for forgiveness
for this loan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our outstanding promissory
notes accrue interest at 5% and 12% per annum, most of which do not have a set maturity date. Any promissory notes that did have an initial
maturity date, which has passed, the Company has verbally agreed to pay off these loans subsequent to the consummation of the business
combination. The Company is currently in default; accordingly, the Company classified the entire outstanding amount as a current liability
on the condensed consolidated balance sheet.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additional funds may be necessary
to maintain current operations and will be required for successful product commercialization efforts. Subsequent to the period ended June&#160;30,
2025, management obtained additional funds as a result of the Business Combination and PIPE investment, which mitigates the relevant conditions
or events that raise substantial doubt about our ability to continue as a going concern within one year from the date the unaudited condensed
consolidated financial statements as of and for the six&#160;months ended June&#160;30, 2025 are issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 0.5in"><b><i>Long-Term Liquidity Requirements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect our cash and cash
equivalents on hand, and cash that we received from the Business Combination and PIPE Investment, together with the cash we expect to
generate from future operations will provide sufficient funding to support initial commercial operations. The cash generated from the
business combination includes an initial net $9&#160;million in PIPE proceeds from the first tranche of a convertible note, along with
an expected $2&#160;million additional tranche from the PIPE convertible note to be received within the nine&#160;months ended September&#160;30,
2025. Until we generate sufficient operating cash flow to cover our operating expenses, working capital needs and planned capital expenditures,
or if circumstances evolve differently than anticipated, we expect to utilize a combination of equity and debt financing to fund any future
capital needs. If we raise funds by issuing equity securities, dilution to stockholders may result. Any equity securities issued may also
provide for rights, preferences, or privileges senior to those of holders of common stock. If we raise funds by issuing debt securities,
these debt securities may have rights, preferences, and privileges senior to those of common stockholders. The terms of debt securities
or borrowings could impose significant restrictions on our operations. The capital markets are currently experiencing, and may continue
to experience in the future, periods of upheaval that could impact the availability and cost of equity and debt financing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal uses of cash
in recent periods have been funding our research and development activities and other personnel cost. Near-term capital requirements through
June&#160;30, 2025 leading to and supporting initial commercialization are estimated to total approximately $7.3&#160;million and include
further research and development to enable us to obtain the required regulatory approvals, manufacturing, commercialization and wide-scale
marketing for our Lumee Oxygen and Lumee Glucose devices. Our future capital requirements will depend on many factors, including our revenue
growth rate, the timing and the amount of cash received from our customers, the expansion of sales and marketing activities, the timing
and extent of spending to support development efforts. In the future, we may enter into arrangements to acquire or invest in complementary
businesses, products, and technologies. For any periods after the twelve&#160;months subsequent to the filing of these financial statements
as of June&#160;30, 2025, we may be required to seek additional equity or debt financing. In the event that we require additional financing
we may not be able to raise such financing on acceptable terms or at all. If we are unable to raise additional capital or generate cash
flows necessary to continue our research and development and invest in continued innovation, we may not be able to compete successfully,
which would harm our business, results of operations, and financial condition. If adequate funds are not available, we may need to reconsider
our production investments, the pace of our production ramp-up, expansion plans or limit our research and development activities, which
could have a material adverse impact on our business prospects and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash Flow Summary</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
our cash flows for the periods presented (in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Net cash provided by (used in):</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,126</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,008</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Investing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">974</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">904</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Operating Activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash used in operating activities
for the six&#160;months ended June&#160;30, 2025 of $1.1&#160;million was primarily driven by our net loss of $5.1&#160;million, adjusted
for non-cash charges of $2.7&#160;million and net cash inflows of $1.2&#160;million provided by changes in our operating assets and liabilities.
Non-cash charges primarily consisted of non-cash interest expense of $2.5&#160;million, and the change in the fair value of related party
convertible loan of $0.1&#160;million. The main driver of the cash inflows from the changes in operating assets and liabilities was primarily
related to an increase in accounts payable of $1.0&#160;million and in accrued liabilities of $0.3&#160;million and a decrease in prepaid
expenses and other current assets of less than $0.1&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash used in operating
activities for the six&#160;months ended June&#160;30, 2024 of $1.0&#160;million was primarily driven by our net loss of
$4.5&#160;million, adjusted for non-cash charges of $2.2&#160;million and net cash inflows of $1.3&#160;million provided by changes
in our operating assets and liabilities. Non-cash charges primarily consisted of non-cash interest expense of $2.2&#160;million,
partially offset by change in the fair value of related party convertible loan of less than $0.1&#160;million. The main driver of
the cash inflows from the changes in operating assets and liabilities was primarily related to an increase in accounts payable of
$0.5&#160;million and in accrued liabilities of $0.8&#160;million and a decrease in prepaid expenses and other current assets of
$0.1&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Financing Activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash provided by financing
activities was $1.0&#160;million the six&#160;months ended June&#160;30, 2025, which consisted primarily of net proceeds from the issuance
of senior notes of $1.4&#160;million, offset by payment of deferred offering costs of $0.4&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash provided by financing
activities was $0.9&#160;million for the six&#160;months ended June&#160;30, 2024, which consisted primarily of net proceeds from the
issuance of senior notes of $1.1&#160;million, offset by payment of deferred offering costs of $0.1&#160;million and repayment of related
party promissory notes of $0.1&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Contractual Obligations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
our contractual obligations as of June&#160;30, 2025, and the&#160;years in which these obligations are due (in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Thereafter</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Convertible notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,533</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,533</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Tasly convertible loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,543</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,543</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Senior notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">PPP loan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,383</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,383</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Total contractual obligations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">52,294</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">52,294</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Accounting Estimates</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management&#8217;s discussion
and analysis of our financial condition and results of operations is based on our unaudited condensed consolidated financial statements,
which have been prepared in accordance with U.S.&#160;GAAP.&#160;The preparation of these unaudited condensed consolidated financial statements
requires us to make estimates and assumptions for the reported amounts of assets, liabilities, revenue, expenses and related disclosures.
Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances,
the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences
may be material.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We consider an accounting estimate
to be critical if: (1)&#160;the accounting estimate requires us to make assumptions about matters that were highly uncertain at the time
the accounting estimate was made, and (2)&#160;changes in the estimate that are reasonably likely to occur from period to period, or use
of different estimates that we reasonably could have used in the current period, would have a material impact on our financial condition
or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management has discussed the
development and selection of these critical accounting estimates with the Audit Committee of our Board of Directors. In addition, there
are other items within our financial statements that require estimation, but are not deemed critical as defined above. Changes in estimates
used in these and other items could have a material impact on our financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair Value of Financial Instruments</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s financial
instruments consist of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company
states accounts payable at their carrying value, which approximates fair value due to the short time to the expected payment. The promissory
notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate those that
would be available to it on a similar loan from an unrelated party.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Tasly convertible debt
issued between June&#160;2023-February&#160;2024 (Notes 3 and 5) is carried at fair value based on unobservable market inputs. The fair
value of financial instruments is determined using various valuation techniques, including the market approach. Where observable market
prices are not available, we use models that incorporate assumptions about credit risk, interest rates, and market volatility. These estimates
require significant judgment, particularly for instruments classified as Level 3 in the fair value hierarchy. Changes in these assumptions
could materially affect the reported fair values and related income or expense. We regularly review and update our valuation to reflect
current market conditions and ensure consistency with accounting standards. Level 3 fair value financial liabilities consisted of solely
the Tasly convertible debt which was $2.2&#160;million as of December&#160;31, 2024 and $2.5&#160;million as of June&#160;30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Share-Based Compensation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">We account for share-based compensation arrangements with employees and non-employees using a fair value
method which requires the recognition of compensation expense for costs related to all share-based payments including stock options. The
fair value method requires us to estimate the fair value of share-based payment awards on the date of grant using an option pricing model.
We use the Black-Scholes pricing model to estimate the fair value of options granted that are then expensed on a straight-line basis over
the vesting period. We account for forfeitures as they occur. Option valuation models, including the Black-Scholes option-pricing model,
require the input of highly subjective assumptions, and changes in the assumptions used can materially affect the grant-date fair value
of an award and affect the amount of compensation expense recognized. These assumptions include the risk-free rate of interest, expected
dividend yield, expected volatility, and the expected life of the award. These assumptions involve significant judgment and are based
on historical data and future expectations. We periodically reassess our estimates and assumptions to reflect actual experience and any
changes in future expectations.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Expected Term</i>. The expected term is calculated using the simplified method, which is available
where there is insufficient historical data about exercise patterns and post-vesting employment termination behavior. The simplified method
is based on the vesting period and the contractual term for each grant, or for each vesting-tranche for awards with graded vesting. The
mid-point between the vesting date and the maximum contractual expiration date is used as the expected term under this method. For awards
with multiple vesting-tranches, the times from grant until the mid-points for each of the tranches may be averaged to provide an overall
expected term.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Expected Volatility</i>. The expected stock price volatility assumption was determined by examining
the historical volatilities for industry peers, as we did not have any trading history for our common stock. We will continue to analyze
the historical stock price volatility and expected term assumptions as historical data for our common stock becomes available.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Risk-Free Interest Rate</i>. The risk-free interest rate is based on the implied yield currently available
on the U.S.&#160;Treasury zero-coupon issues with a remaining term equivalent to the expected term of a stock award.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Dividend Yield</i>. We have not paid and does not anticipate paying any dividends in the near future.
Accordingly, we have estimated the dividend yield to be zero.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Accounting Pronouncements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See the section titled &#8220;Recent
Accounting Pronouncements&#8221; in Note&#160;2 of the notes to our unaudited condensed consolidated financial statements included in
this Report for more information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BUSINESS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Overview</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa is a digital health
technology company based in Berkeley, CA, that has invested over the last twelve&#160;years more than $100&#160;million from sophisticated
venture investors as well as the most sophisticated research institutions in the U.S.&#160;(including approximately $30&#160;million from
Defense Advance Research Projects Agency, or DARPA, and the National Institutes of Health, of NIH) to develop a unique biosensor platform
that is easily injected subcutaneously to provide, for the first time, real-time, individual biochemistry, that is cost effective while
functioning for more than six times longer than known best in class solutions on the market today. Profusa&#8217;s Lumee&#8482; technology
does not consist of a single product, but is rather a platform that can potentially launch products for multiple applications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s overall strategy
has been to robustly invest and therefore develop and protect its technology as a private company, first in Europe where the barriers
to regulatory approval traditionally are not as great as they are in the U.S.&#160;Accordingly, Profusa has validated its technology and
gained approval of its first product, Lumee Oxygen, with CE approval in the EU and in the process of migrating to meet new MDR requirements
in Europe. In 2026 Profusa plans to launch this product, if approved by FDA, for sophisticated wound care management through a partner
with distribution, sales and in-servicing experience. The accessible markets for Profusa&#8217;s technology are not limited to U.S.&#160;and
EU.&#160;Sophisticated investors from Asia, such as 3E Bioventures, Tasly Pharma, and VMS Capital, who already see the far-reaching benefit
of Profusa&#8217;s platform have not only been interested for several&#160;years, but have invested in Profusa&#8217;s development to
date with the continuing interest of being partners in the near future. To date, these investors have collectively invested over $50&#160;million
in preferred stock and convertible notes of Profusa. Profusa is in continuing discussions with investors to establish a joint venture
to provide Profusa with access to Asia Pacific markets. See &#8220;<i>Certain Relationships and Related Person Transactions&#160;&#8212;&#160;Profusa&#160;&#8212;&#160;APAC
Joint Venture Term Sheet</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following validation of Profusa&#8217;s
technology and application via Lumee Oxygen in the EU, Profusa&#8217;s next step in the development process is to seek approval of both
Lumee Oxygen as well as Lumee Glucose from the U.S.&#160;Food and Drug Administration. Profusa believes that the generation of additional
clinical data, which it plans to collect in connection with obtaining regulatory approval, combined with Profusa&#8217;s sophisticated
patent protection, will expand partnership interest from prospective medical partners in the U.S.&#160;and worldwide. Profusa&#8217;s
plan is to gain approval of Lumee Oxygen in the US by-early 2026 followed by approval of Lumee Glucose in late 2026 or early 2027. While
Lumee Oxygen is authorized for commercialization in the EU pending migration of CE approval to new MDR regulations, Lumee Glucose is not
yet authorized for commercial sale in any jurisdiction and Profusa does not yet have regulatory approval for the sale of any of its products
in the U.S.&#160;Profusa&#8217;s plans for commercialization of its products are dependent upon obtaining regulatory approval in relevant
jurisdictions on a timely basis, which cannot be assured. See &#8220;<i>&#8212;&#160;Government Regulation&#160;&#8212;&#160;FDA Premarket
Clearance and Approval Requirements</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s sensor platform
has the potential to generate an individualized real time biochemistry data stream, with a substantially better user-friendly form factor,
accessibility for a broad user base, lower burden of healthcare costs, and significantly increased total addressable user base compared
to current market solutions. Profusa believes that the combination of the potential advantages of this platform will enable it to generate
both short-term revenue in the high-value clinical applications of wound care and diabetes management as noted above, but to also leverage
core technology and develop and add to Profusa&#8217;s product portfolio to potentially tackle the management of other chronic conditions,
while in the future creating the foundation for the technology enabled health care where the large volume of biomarker data aligned with
up-to-the-minute actions and choices of the individual. Therefore, Profusa&#8217;s data stream could become a key enabler for high-growth
healthcare sectors such as telemedicine and health and wellness coaching, and sophisticated evaluation of biomarkers for both molecular
diagnostics and potentially therapeutic purposes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Importantly today, Profusa
believes that Lumee&#8217;s biosensor and artificial intelligence platform compares very attractively with some of the largest products
in this market sector. Profusa believes its validated core technology can easily bridge the gap that exists in the current technology
landscape for monitoring real time biochemistry. The current approaches either have tailored clinical application at high costs and burdensome
user experiences, such as CGMs today; or broad potential user base in consumer-friendly costs and user experience, but limited clinical
utility, such as health and wellness wearables. Other products are strictly software and analytics-driven solutions such as telemedicine
and coaching apps which have limited clinical utility due to the lack of real time data. Profusa&#8217;s technology today has the potential
to provide the solution of bringing sophisticated, real-time to a broad population of needy patients globally at a more reasonable cost.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s core platform
technology is the foundation for its growth strategy, which includes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Near term product revenue in Europe from the CE approved Lumee Oxygen which measures dissolved tissue
oxygen for up to six&#160;months following sensor injection. Initial product uses include application for the management of wound care
for critical limb ischemia patients in surgical settings, followed by use in ambulatory settings, subject to future regulatory approval.
Profusa estimates that the current total addressable market size for critical limb ischemia across the United&#160;States and European
Union is approximately five million patients. Profusa anticipates beginning commercialization of Lumee Oxygen in Europe in early 2026
and continuing its U.S.&#160;study for submission for U.S.&#160;FDA marketing authorization late 2026. Lumee Oxygen may not be commercialized
in the U.S.&#160;until FDA marketing authorization has been obtained.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Future product revenues from Profusa&#8217;s second product, Lumee Glucose, a continuous glucose monitoring
platform, that will provide real time glucose levels for patients suffering from diabetes, subject to regulatory approval. Profusa has
generated proof-of-concept clinical data from 54 diabetes subjects over four clinical sites (two in Europe and two in Asia) in human trials.
Using Profusa&#8217;s current data analytics algorithm, the glucose platform has demonstrated potential for mean absolute relative difference
(MARD) of approximately 11% with up to nine&#160;months of functionality post injection. To date, there have been zero incidences of device-related
severe adverse events (SAE). Profusa anticipates the start of its next validation study in the first half of 2026 and regulatory submission
in early 2026. Profusa believes that its technological approach may create advantages to current glucose monitoring solutions on the market
to substantially increase the number of users who can benefit from this data stream from the current type&#160;1 diabetes population to
the much larger type 2 and pre-diabetes populations, as well as any individuals outside of these aforementioned populations interested
in having access to long-lasting continuous glucose data. Across all of these four segments, Profusa anticipates a total addressable market
of just over 500&#160;million patients across the United&#160;States and European Union by end of 2025.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Potential future product revenues from other analytes such as lactate, CO2, ethanol, pH and other important
metrics in the management of other chronic conditions, which may be targeted by Profusa&#8217;s research and development.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Potential future revenues from the data streams of the above applications, which could become a key enabler
to achieve the technology-enabled future for healthcare being brought to bear by nascent healthcare growth sectors such as telemedicine
and health and wellness coaching platforms. The total value of this space is expected to reach almost $400&#160;billion by end of 2028.
While these platforms are beginning to gain users and engagement demonstrating some degree of clinical utility, Profusa believes that
the growth of these platforms suffer from the lack of real time clinical data. In the field of telemedicine, physician and patient interactions
still require visits to labs for blood test to inform physician diagnosis and feedback. In the case of coaching platforms, the lack of
inexpensive real time data relegates the business model to rely on expensive technologies and nurses/coaches to provide the clinical feedback
to users. Profusa believes that, at scale, the data Profusa&#8217;s platform generates from its initial products will be a key enabler
for the productivity and business models for both of these sectors to expand and reach more of their full potential. Profusa&#8217;s plan
is to partner and provide such data streams as a further growth driver for Profusa.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Profusa&#8217;s Addressable Market</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There have been many attempts
to develop technologies that provide real time biochemistry and biomarker data for individuals. The most compelling use case has been
for measurement of glucose in the management of diabetes. The first traditional approach to glucose measurement is to take measurements
at discrete points in time via a self-monitoring of blood glucose (SMBG) method, which requires the collection of a drop of blood via
a lancet and applying that drop of blood in a test strip which is then read by a reader. A second approach is to have a patient monitor
their glucose levels by using a continuous glucose monitoring (CGM) device which provides a continuous stream or real time glucose measurement.
The CGM approach has the benefit of being able to provide a data stream which elucidate not just the glucose level at any given time,
but the trending of the glucose levels throughout the&#160;day. This ability to visualize trending of a patient&#8217;s glycemic levels
is important to predict significant excursions of an individual&#8217;s blood sugar levels and prevent serious adverse events caused by
hypoglycemic or hyperglycemic to the patient and enable the patient to inject insulin or take medication to manage the disease. The following
graphic illustrates the comparative advantage of CGM over SMBC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img alt="" src="image_002.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Comparison of finger-pricking
self-monitoring of blood glucose (SMBC) and continuous glucose monitoring (CGM).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While there have been attempts
to use energy waves to non-invasively measure glucose in a patient&#8217;s body, those efforts have proven to be unsuccessful due to their
lack of ability to deliver accurate and reliable measurements Other experimental approaches utilize molecular spectroscopy, but have to
date not received U.S.&#160;regulatory approval and, despite some attaining European Regulatory Approval, have not gained significant
commercial traction there. Profusa believes this demonstrates that the non-invasive nature of a technology, even in the unlikely case
it was of comparable accuracy to existing devices, has little bearing on marketability if other criteria are not met, such as competitive
pricing, low production costs, user-friendliness and as well as pre-existing relationships with larger CGM players who can contribute
to a plan to bring the product to market, all of which are areas where Profusa believes it has a winning advantage.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are also other non-invasive
approaches to measure biomarkers and analytes available, such as those measuring steps, blood oxygen levels, heart rate, and body temperature.
These solutions provide some data for general wellness management; however, their clinical utility has been limited since there is not
a large defined set of clinical evaluation that links these parameters to specific clinical diagnosis or outcomes. Accordingly, Profusa
believes that for a technology platform to measure clinically reliable data that can inform high-value clinical decisions, a sensing element
inside the body to take direct measurements of the analyte of interest is of critical importance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current CGM sensors typically
have a small needle coated with a sensing chemistry which is placed through the skin so the needle can take measurements in the interstitial
space of a patient. These needles, however small, elicits a &#8220;foreign body response&#8221; within the patient as the body&#8217;s
natural defense mechanism against objects that are recognized as foreign. The foreign body response begins to encapsulate the sensing
needle of these CGMs in scar tissue and renders the data from these sensors unreliable within a matter of&#160;days. This is the major
reason the longevity of these CGMs is limited to approximately&#160;7-14&#160;days. A longer-term 12-month solution where a sensor is
surgically implanted into a patient&#8217;s body is available as well, however the sensor requires a surgical implantation with sutures
to close the surgical wound. This approach has a limitation of a much more invasive deployment procedure and associated higher cost.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_003.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>All data is from the manufacturer
website. The products provided in this chart are:</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Dexcom G6</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Abbott Freestyle Libre 2</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Medtronic Guardian Connect</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Senseonics Eversense E3</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Profusa&#8217;s CGM Product
(Lumee Glucose) is not approved in the United&#160;States. The &gt; 270&#160;days usage time is based on the data acquired through Profusa&#8217;s
glucose program clinical study.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Profusa&#8217;s Technology</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is Profusa&#8217;s belief,
based on an understanding of the biological response to current available sensors, that a viable solution that could provide data for
clinical utility and wide-scale adoptions, needs to have the following three key characteristics: direct measurement of the body&#8217;s
chemistry to enable accuracy, ease of deployment of the platform and long-term functionality to encourage adoption by a large population,
and low cost to breakdown the economic barrier for adoption by those who can benefit from this data stream.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s sensor platform
has the potential to deliver on these requirements and are composed of the following components:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Hydrogel Sensor</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_004.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.75in; text-align: justify">Profusa&#8217;s passive sensor is composed
of a class of materials called hydrogels, which are similar to the material from which modern contact lenses are made. The sensor is designed
to overcome the effect of the foreign body response and thus has been demonstrated to be able to collect biochemical data for up to 6-months
in the case of Lumee Oxygen, and up to 9-months based on the data acquired through Profusa&#8217;s glucose program clinical study. This
hydrogel scaffolding is soft and pliable and serves as the base material on which specific fluorescent molecules are bound. These fluorescent
molecules bind specifically to the analyte of interest and their fluorescent characteristics change depending on whether the analyte is
bound or unbound. The hydrogel sensors are devoid of any electronics or power source, and are simply composed of the hydrogel scaffolding
and the fluorescence sensing chemistry. Depending on the sensor type, Profusa may also imbed a reference chemistry for reference purposes
during data processing. The hydrogel sensor measures approximately 400 microns in diameter by 3 millimeters in length and is injected
subcutaneously via a hypodermic needle injection at a depth of 2 &#8211;&#160;6 millimeters from the surface. Upon injection, the sensor
is designed to be integrated as a part of the tissue and is not noticeable. As this sensor is passive in nature, while the binding and
unbinding of the analyte of interest is constantly occurring, data from the sensor is not actively broadcasted outside of the body until
a reader (described below) is placed on the skin over the sensor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By &#8220;decoupling the sensor
and the reading elements,&#8221; we believe that our approach has a few major advantages:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">The cost of the system is quite low as the sensors are low cost to manufacture and the more expensive
reader component can be reused through multiple sensor injections;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">The act of data acquisition is controlled by the user and action is secure;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">3.</td><td style="text-align: justify">The sensor deployment is a common hypodermic needle procedure that can be performed by healthcare professionals
across a variety of common settings; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">4.</td><td style="text-align: justify">The sensor functionality lifetime is limited by the stability of the fluorescence molecule and not by
the foreign body response, which translates into&#160;months of functionality.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Reusable Reader</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_005.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.75in; text-align: justify">An optical reader has been developed
to be worn on the skin above the sensor and is designed to interrogate and gather sensor signal for data processing. This optical reader
has a small wearable form factor dimensions of the oxygen reader and is worn on the skin via a double-sided medical grade adhesive. The
readers are rechargeable via conductive charging and currently have a functional lifetime of 24&#160;hours on a single charge in the case
of Lumee Oxygen. When a datapoint is desired, the firmware of the reader instructs the device to pulse a light source shining an excitation
light of a specific wavelength to illuminate the sensor under the skin. The return fluorescent light from the sensor is then detected
by the reader via a series of photo detectors and the data is captured for algorithm processing. By continuously pulsing the light and
capturing the return signal from the hydrogel sensor, the reader is designed to be able to collect a stream of data allowing for the continuous
monitoring of the biochemistry inside the body. This device is also designed to have the capability to measure multiple wavelengths of
light allowing for the capture of changes in tissue optical properties and reference chemistry signals, providing input to the data algorithm
to potentially correct for variability of subject tissue types and individuals change in tissue properties over time. Additionally, the
reader is designed to be able to include thermistors, or temperature-sensitive resistors, and motion detectors, enabling the collection
of additional parameters the algorithm may use to increase the accuracy of the analyte measurement. The externally worn device is designed
to be a durable component of the system and can be reused for multiple sensor injections.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.5in; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_006.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Data Algorithm</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.75in; text-align: justify">Software algorithms operating in firmware
and mobile applications compute clinically relevant values based on optical signals and temperature measurements provided by the reader
hardware. Lumee Oxygen uses an oxygen sensor whose optical intensity, after excitation from an LED, decreases at a rate that is a function
of tissue oxygen. The hardware is designed to provide rapid optical intensity measurements. The firmware fits the decrease in intensity
to a model whose coefficients represent the oxygen intensity. The firmware produces a Lumee Oxygen Index (LOI) value every few seconds
and the tablet application visualizes the data and determines the percent change over time. The glucose hydrogel is an intensity-based
system with two dyes: a reference dye whose intensity is independent of glucose and other chemical properties of its environment, and
a glucose dye whose intensity after excitation changes predictably with glucose concentration. The ratio of the glucose and reference
intensity provides an approximation of the glucose signal. The glucose system is designed to use several wavelengths of light from defined
LED sources and optical detectors. Every measurement sample includes 84 unique optical measurements that form a data set that is used
to determine the glucose dye intensity, tissue optical properties, and position of the sensor. The hardware and firmware in the glucose
system capture and store these raw measurements. The data processing on the glucose system is performed primarily on a mobile device.
The mobile application computes glucose intensity changes and calibrates the values to establish a measurement of blood glucose.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.75in; text-align: justify">The glucose algorithm in the mobile application
is designed to perform a series of corrections to account for changes in the optical signals that do not originate in the glucose dye.
These include correcting for variability in the LED brightness at different temperatures; correcting for changes in the reader&#8217;s
position relative to the sensor, by triangulating the position of the sensor using 4 opposing LEDs that excite the reference dye; and
correcting for changes in the tissue&#8217;s light absorption using 72 source-detector pairs. The reader position and tissue absorptions
are computed by fitting the measurements to a principle-based optical model. Finally, the glucose signal intensity is corrected for temperature
changes to account for the glucose dye&#8217;s sensitivity to temperature. The corrected optical glucose signal is calibrated into a measurement
of blood glucose. Profusa&#8217;s calibration model includes support for different user calibration schemes. Profusa has also developed
a collection of machine-learning models which use these same optical signals as inputs to improve corrections. These machine learning
models include using the tissue optical property measurements as inputs to generate background fluorescence, a deep learning model which
uses all the optical signals to generate a blood glucose estimate, and machine learning models to detect signal errors. Additionally,
in conjunction of work with DARPA, Profusa developed machine learning models that operate over time-series data to detect specific events.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.75in; text-align: justify">Both the glucose and oxygen systems have
firmware and Bluetooth low energy (BLE) hardware designed to communicate between the reader and the mobile device. The mobile device is
initially paired with the reader using a passkey and later utilizes 128-bit encryption for data transmission. The reader identifies if
the connection between the reader and the mobile device is disconnected. It retains the data and transmits the data once the connection
is re-established. The mobile device also notifies the user if a disconnection occurs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><i>&#9679;</i></td><td style="text-align: justify"><i>App and Data Visualization</i></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.75in; text-align: justify">Lumee Oxygen includes a tablet device
that is designed to provide real-time traces of tissue oxygen levels from multiple readers simultaneously, and allow the operator to annotate
events and normalize values at a point in time to identify the relative improvement of a patient&#8217;s tissue oxygen. The system also
supports PDF and CSV data export. Profusa has also developed Lumee O2 Go, currently for research use only, that operates on a mobile phone
and uploads data to the cloud. This mobile application is being developed to provide real-time visualization of changes in oxygen, data
annotation, and incorporation of 3<sup>rd</sup> party data via Apple&#8217;s HealthKit.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0px 0pt 0.75in; text-align: justify">The initial glucose professional product,
once approved, is intended to allow physicians and care providers to visualize a patient&#8217;s glucose over a series of&#160;days. This
first product mobile interface is designed to encourage compliance, log activities, and facilitate correct operation without providing
the patients access to the system&#8217;s measured blood glucose values. The second real time use product, once approved, is planned to
allow for users to have real time access to the system&#8217;s measured blood glucose values to enable care decisions. An essential feature
of the glucose system is a visualization that allows the patient to correctly locate the reader over the sensor. This mobile user interface
will show a real-time depiction of the reader as it is moved over the sensor in the body to maximize signal quality and optimal position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa uses Amazon Web Services
(AWS) infrastructure to host and secure data. For authentication and authorization, Profusa&#8217;s web application utilizes Amazon Cognito.
To provide network security, data is transmitted over the public network using TLS.&#160;All data communication from Profusa&#8217;s application
is transmitted through Amazon&#8217;s Application Load Balancer which provides both data encryption and allows Profusa&#8217;s system
to reside entirely on a private network. Amazon&#8217;s systems provide the capabilities to ensure that data is encrypted during transmission
and at rest. Profusa&#8217;s mobile applications upload data regularly but do not rely on a network connection to operate. Nonetheless,
to deliver a robust service, Profusa&#8217;s cloud infrastructure is hosted on redundant, fault-tolerant application servers, to improve
availability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The core technology platform
described above is the foundation for Profusa&#8217;s future products for the measurement of real time biochemistry, including Lumee Oxygen,
Lumee Glucose. By tailoring the fluorescence chemistry with the optical properties of the multi-channel reader, Profusa believes that
its ability to develop products to measure other analytes and expand our product portfolio is enhanced while maintaining the key value
propositions of the platform. It is conceivable in the future that Profusa may be able to develop a sensor and reader pair to measure
multiple analytes within one product, creating streams of data for a biochemical panel for broader applications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Short-Term Opportunity with Lumee Oxygen
and Lumee Glucose</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Realtime monitoring of validated
and clinically relevant data from individuals have profound upside. By monitoring real-time metabolic parameters such as tissue oxygen
and glucose, Profusa&#8217;s technology, if approved, could benefit chronic conditions affecting more than 500&#160;million people across
the world. Over the past two decades, the health care community has begun the trend of developing technology solutions to create infrastructure
and real time data in an effort to bring the potential of clinical decisions away from the costly hospital and clinics to the individuals
in the comfort of their homes and daily lives. From chronic conditions that can benefit from real time monitoring, such as diabetes management,
dialysis treatment, infection monitoring, surgical recovery, to the infrastructure of telemedicine and remote access to healthcare professional
for diagnosis and health data interpretation, the technology enabled future of health care has gained greater footing to becoming more
mainstream. The total market size of telemedicine platforms have doubled from $41&#160;billion to over $80&#160;billion from 2019 to 2021,
and the market for remote coaching platforms has also grown from hundreds of millions to just under $14&#160;billion over the past decade.
Additionally, CMS has implemented reimbursement codes for remote patient monitoring (RPM) for chronic conditions and data interpretation.
This can lead to reimbursement of more than $200&#160;monthly per patient as of 2022. Furthermore, these codes can be used in addition
to existing Chronic Care Management (CCM) codes. These trends provide significant momentum for Profusa&#8217;s technology platform to
potentially be the indispensable data stream to support this vision of the technology-enabled health care future, potentially replicating
the impact that technology platforms such as Google have had in advertising to the high-value arena of healthcare. With respect to oxygen
and glucose monitoring specifically, the size of the continuous glucose monitoring market is estimated to be approximately $2.8&#160;billion
in the U.S.&#160;and over $800&#160;million in Europe by the end of 2024. The oxygen monitoring market is over $2&#160;billion in the
U.S.&#160;and over $700&#160;million in Europe.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s plan to capture
this opportunity is anchored by its product launch plan, beginning with the near-term launch of Lumee Oxygen, once approved, as it serves
the critical limb ischemia wound care population. Creating a solution that aligns to a critical clinical need and demonstrating the benefit
of a real time biochemical data stream from operating room to the home in ambulatory care would create credibility and capability build
for Profusa on this journey. The second phase would be to launch Profusa&#8217;s glucose product, once approved, for the well-defined
diabetes market and leveraging its value proposition to expand the number of patients who can benefit from CGM to beyond the current type
1 diabetes population. Profusa believes that its solution could benefit those in the type 2 and pre-diabetes populations to both potentially
broaden the product reach beyond the currently available solutions, but also generate a broad set of clinical data across a large heterogeneous
population to inform the clinical science behind diabetes care throughout the disease spectrum. Lastly, by adding additional analytes
and partnering with the telemedicine and health and wellness coaching sectors, Profusa hopes to truly bring the power of the broad real
time biochemistry data stream and create enduring value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lumee Oxygen for Critical Limb Ischemia management
and management of peripheral arterial disease (PAD)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Peripheral arterial disease
(PAD) is a vascular condition caused by the blockage of arteries below the knee of a patient. These blockages decrease the blood supply
to the extremities, in this case the foot, and is characterized by pain in walking, neuropathy, resting pain, and ultimately tissue death
requiring amputation. The progression of PAD is described clinically by the Rutherford Scale, a medical classification describing seven
categories of peripheral artery disease, including both the patient&#8217;s clinical symptoms as well as objective findings, with class
1 being the mildest form of the disease characterized by the patient experience foot pain from walking, to the most severe of class 6
characterized by major tissue death/loss in the foot. The classes of patients with Rutherford classes&#160;4-6 are described as having
Critical Limb Ischemia (CLI). According to articles in Endovascular Today and various market research firms, the number of cases across
the United&#160;States and European Union of CLI has grown from approximately two to six million over the past 10&#160;years and growing
at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2027 due to increased diagnosis rates. This patient population usually present
with multiple comorbidities, including diabetes in approximately 45% of cases CLI costs healthcare systems more than $200&#160;billion
in the United&#160;States alone annually.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The current therapeutic regimen
for treating CLI is to debride the usually heavily infected wounds of the foot, to remove dead tissue to prevent further infections, and
to perform vascular therapy surgically or endovascularly through ballooning and stenting the blockages of the arteries to restore blood
flow to the foot. While surgical or endovascular procedures in restoring blood flow to the extremities are usually achieved in the operating
room, the causality of technical success in the OR leading to healing of the wounds caused by the tissue loss of the disease is less certain.
In approximately 50% of endovascularly treated cases, the wounds of these patients are not healed within six&#160;months post-surgery.
This is caused by the fact that the surgical procedure performed on the large arteries in the leg does not necessarily restore oxygenation
to the tissues to the wound. The need for healthy microvasculature that enables oxygen exchange between blood and tissue are compromised
in this patient population. Lumee Oxygen is designed to provide the physician the data to understand whether their surgical procedure
not only could restore blood flow to the lower extremities, but more importantly, whether the tissue in the effective area is receiving
sufficient oxygen as a result.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lumee Glucose for Diabetes Management</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Diabetes is a chronic metabolic
disorder suffered by more than 400&#160;million individuals globally, according to the World Health Organization, and approximately 1&#160;billion
individuals when including pre-diabetic patients. The cause of this condition is due to the patient&#8217;s inability to product or use
insulin, which cause the body to ineffectively manage the level of blood glucose. The resulting inability to maintain adequate control
of blood glucose level cause a variety of serious downstream health conditions and complications including vascular disorders, chronic
wounds and tissue loss, amputations, heart disease, kidney malfunction, blindness, coma, and even death. Unfortunately, diabetes is a
condition that continues to see global rise in patient populations due to lifestyle choices, improvements in global living standards which
lead to dietary changes, and the increase in the aging population.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Diabetes can be characterized
into three populations: type 1 diabetes, type 2 diabetes, and pre-diabetes. Type 1 diabetes is a genetic disorder that typically develops
while the patient is in childhood and is primarily caused by the patient&#8217;s inability to produce insulin, or inability to respond
to the presence of insulin (insulin resistance). Patients suffering from type 1 diabetes must maintain their glucose level in healthy
range through the frequent and dose-specific administration of insulin. Type 1 diabetes is a genetic disorder that is characterized by
the patient&#8217;s inability to either produce the hormone insulin, or becomes resistant to the effect of insulin in the management of
their blood glucose levels. Individuals suffering from type 2 diabetes similarly have impairments that lead to the body&#8217;s inability
to manage glucose well. This is primarily caused by either the body&#8217;s insufficient production of insulin, or cells&#8217; poor response
to insulin. Type 2 diabetes is primarily a chronic condition that is lifestyle driven, and usually present symptoms later in a patient&#8217;s
life. Those who suffer from type 2 diabetes usually require the management of their disease through careful monitoring of their diet and
nutritional intake, level of exercise, and maintaining a regimen of oral medications or the injection of insulin to regulate their blood
glucose levels within the healthy range. Pre-diabetes refers to those individuals whose blood glucose levels are higher than normal, but
not high enough yet to trigger the clinical definition of type 2 diabetes. Those identified as having pre-diabetes have a much higher
likelihood of developing type 2 diabetes without intervention. For individuals who have been diagnosed as pre-diabetic, the management
of their condition is typically through nutritional counseling, management of their dietary habits, and exercise in an attempt to slow
down the progression of their diabetes to the clinical threshold.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the monitoring of the blood
glucose level in a patient is a critical component to effectively manage the disease or progress of the disease, many individuals with
diabetes utilize technologies to actively measure their blood glucose levels throughout the&#160;day. One traditional method of monitoring
blood glucose levels is through self-monitoring of blood glucose (SMBG). SMBG technology approach requires the collection of a small drop
of blood through lancing the fingertips and applying that drop of blood sample to a test strip which is read by a glucose meter. This
traditional approach, more commonly referred to as &#8220;fingersticks&#8221;, are usually done multiple times throughout the&#160;day
and night and generate a point-in-time measurement of the blood glucose level of the patient. This method is painful, at times difficult
to self-administer to get an accurate reading and does not provide the important information of blood glucose trends that is important
for effective disease management. Alternatively, continuous glucose monitoring (CGM) technologies are generally less painful to deploy,
create a stream of continuous glucose level data to the patient and care providers throughout the&#160;day and night, and have the ability
to present blood glucose trending data that is important to disease management. Current CGM solutions available to patients are often
inconvenient and require frequent changes. Deployment of the technology in certain cases requires surgical implantation that is often
a barrier to adoption from the points of view of both the user and physicians. Additionally, the cost of the current CGM solutions are
typically at a level where insurance reimbursement will only be available to the most brittle of type 1 and 2 patients (the latter of
which, to be covered by insurance, often require daily insulin intake). The high costs and cumbersome usability exclude the adoption of
such solutions to the larger type-2 population, particularly those not regularly using insulin, and pre-diabetes patients who can benefit
clinically from the real time glucose data.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Profusa&#8217;s Product Path and Clinical
Programs</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Lumee Oxygen</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lumee Oxygen is designed to
be an adjunct instrument intended for continuous and long-term monitoring of the oxygen in the subcutaneous tissue in the upper extremity,
shoulder, or lower extremity. In jurisdictions where it has received regulatory approval, the Platform is indicated for use in patients
with potential acute and/or chronic changes in tissue oxygen levels who may benefit from monitoring. Its use in those jurisdictions in
conjunction with the physician&#8217;s diagnosis and judgement has the potential to create a potential new paradigm for wound care.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lumee Oxygen is designed, developed
and manufactured by Profusa. The first generation Lumee Oxygen Platform received its CE Mark on September&#160;27, 2016. The device had
undergone significant design updates since to include wireless components. This updated platform is referred to as the Wireless Lumee
Oxygen Platform to reflect this change. The Wireless Lumee Oxygen Platform received CE Mark on Jan&#160;14, 2020. Profusa&#8217;s commercialization
efforts of this product were critically hampered by the closure of hospitals and operating suites to non-essential personnel due to the
COVID pandemic. Profusa plans to take advantage of the relaxation of COVID protocols to execute on its commercial plans in Europe beginning
in early 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There have been ongoing communications
with FDA along the device development path in consideration of submission for FDA marketing authorization. Early during the development
in 2014 it had been established with FDA, that the Profusa Oxygen sensing device would be a good candidate for an Investigational Device
Exemptions (IDE) application with &#8220;significant risk designation&#8221; acknowledging permanent injection of the hydrogel sensor
in subcutaneous tissue. Frequent FDA communication followed during the time period 2015 &#8211;&#160;2017 which resulted in approval of
an IDE application for performing studies in the U.S.&#160;as described below. Communications with FDA in 2019 did focus on design questions
for a pivotal study with the Wireless Lumee Oxygen Platform which would serve the needs of a subsequent De Novo submission. An IDE application
was approved in April&#160;2019 and a supplement to accommodate Covid pandemic conditions was subsequently approved. Nevertheless, the
practical execution of the study had been significantly and negatively impacted by the pandemic due to the lack of access of non-essential
personnel in health care settings. Today the pilot phase of the study has been completed confirming the pivotal study phase design, and
the study will continue into the pivotal phase.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lumee Oxygen Clinical Study Overview</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Profusa Wireless Lumee
Oxygen Platform and its predecessor, the Lumee Oxygen Platform, are designed to measure changes of oxygen level in the tissue, continuously
and long-term. It is designed to report oxygen levels intra-operatively during an operation at a medical facility, and/or used as a monitoring
method pre- or post-operatively at a clinic. Up to four anatomical sites can be measured and reported concurrently. It is intended for
use in patients with potential acute and/or chronic changes in tissue oxygen levels who may benefit from monitoring.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The features of both the Profusa
Wireless Lumee Oxygen Platform and the Lumee Oxygen Platform are expected to provide added value to clinicians when compared with current
alternative technologies. Both Lumee systems provide a new method for measuring tissue oxygen concentration in the interstitial fluid
without perturbing the tissue after the initial injection. In addition, the Wireless Lumee Platform uses a small portable reader and tablet
to display tissue oxygen. This increased usability lends itself to use within many settings, such as ambulatory care settings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Lumee Oxygen Platform and
the Wireless Lumee Oxygen Platform do not estimate oxygen saturation in the vasculature, nor is it an averaged measurement across a large
volume of tissue, rather it provides a direct measure of oxygen availability in the interstitial fluid (referred to as tissue oxygen concentration).
The Lumee Oxygen sensor can be placed at a target depth of&#160;3-6mm beneath the skin, enabling clinicians to monitor tissues of interest,
and it is not limited to measurement of superficial tissue layers. Furthermore, it can provide insight into the changes occurring in tissue
oxygen levels in both acute and chronic use cases. The Lumee Oxygen system has been tested in measuring changes in oxygen in specific
tissues due to systemic oxygen challenges (hypoxia model), peripheral flow disturbances (occlusion/reperfusion protocols and monitoring
of vascular interventions), and wound healing state (ulcerated feet in peripheral artery disease). Because of its small footprint and
a portable design, the Wireless Lumee Oxygen Platform especially provides a method for continuous and long-term monitoring of tissue oxygen
levels.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lumee Oxygen Clinical Study History</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Wireless Lumee Oxygen Platform
had been registered in various European countries upon CE Mark following a determination that it was equivalent to its predecessor platform,
Lumee Oxygen Platform. The sensors involved are the same. The following is a description of Profusa&#8217;s clinical study history for
this product from proof-of-concept through approval in Europe. To date, these clinical studies have involved 140 sensor insertions, in
35 of subjects, with no device related serious adverse events (SAE). Study results served investigational device development purposes
in support of the CE approval of the first generation device in 2016.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Proof-of-Concept study&#160;&#8212;&#160;<i>A Feasibility Study to Characterize the Performance of the
PROFUSA Oxygen Sensor System.</i> The first-in-human &#8220;Si Se Puede&#8221; Study used micro-oxygen sensors that were injected into
the feet of patients with limb-threatening ischemia to measure oxygen changes during endovascular therapy. A total of 48 sensors were
studied in 10 CLI patients and 4 healthy volunteers. The injected sensors could be readily located during measurement attempts. There
were no adverse events of safety concern related to the investigational product.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><i>&#9679;</i></td><td style="text-align: justify"><i>Feasibility of Continuous Tissue Oxygen Monitoring in Healthy Adults. </i>This study was an interventional
feasibility study that was designed to characterize the performance of the Lumee Oxygen Platform in healthy adult volunteers. The analysis
summarized here includes data on multiple study end points, including usability, safety, and effectiveness. Tissue oxygen levels were
measured in 7 subjects (total of 14 sensors) during provocation tests that were used to induce changes in peripheral tissue oxygen. During
provocations, local tissue oxygen was measured continuously using both Lumee Oxygen sensors and a commercially available transcutaneous
oximetry (non-invasive measuring of oxygen levels through the skin) device. Results showed that Lumee Oxygen measurements were reliably
obtained and provided signals sufficiently above a signal to noise threshold. There were no adverse events of safety concern related to
the investigational product.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><i>&#9679;</i></td><td style="text-align: justify"><i>OMNIA (Oxygen Monitoring Near Ischemic Areas) European Registry Study</i>. This study was a Post-Market
Follow-up study which explored use cases and characterizing the diagnostic value of the Lumee Oxygen Platform in Critical Limb Ischemia
patients. As a registry, the study intended to provide real-world experience and to prepare implementation of the Lumee Oxygen Platform
in the European market. Enrollment of the study has concluded with a total of 35 subjects. There was no indication of adverse reactions
specific to the hydrogels. Data analysis confirmed Lumee Oxygen is responsive to interventions during revascularization therapies.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Physiology Baseline Data of Tissue Oxygen Levels in Healthy Volunteers.</i> This study was a development
study was conducted in the U.S.&#160;toward the development of a next generation device and was aimed at collecting physiological integration
and baseline data of tissue oxygen levels in various anatomical locations and usability data in healthy adult volunteers in daily life
using a prototype version of Profusa&#8217;s Wireless Lumee Oxygen Platform. The study has been completed, it generated observations to
inform wireless technology development, attachment and formfactor design, as well as software considerations for a next generation device.
No design changes to Lumee Oxygen will occur prior to regulatory approval of the current existing device. Once FDA marketing authorization
has been obtained, any design changes for a next generation of Lumee Oxygen will be planned, implemented, and verified and additional
performance data or proof of equivalency will be submitted to FDA in an amendment to the original submission.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Ongoing Pivotal Study in the U.S.&#160;for submission purposes to FDA&#160;&#8212;&#160;<i>Effectiveness
of Measuring Local Tissue Oxygen in Response to Induced Hemodynamic Changes with The Profusa Wireless Lumee Oxygen Platform in Patients
with PAD.</i> This is an ongoing IDE study in the United&#160;States with the objective to assess the effectiveness of monitoring changes
in local tissue oxygen with Profusa&#8217;s Wireless Lumee Oxygen Platform in comparison to transcutaneous oxygen measurements in patients
with peripheral artery disease (PAD). This study characterizes the response to hemodynamic changes, or changes in cardiovascular function
such as arterial pressure or cardiac output, induced by vascular occlusion tests and positional maneuvers. The study has been approved
for conduct at four study sites with enrollment of up to 65 subjects.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Device Safety</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of November&#160;2024, no
serious adverse events (SAEs) or other related to Lumee Oxygen have been reported.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Continuous Glucose Monitoring product</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lumee Glucose is an investigative
product development system as Profusa has yet to receive the regulatory approval necessary for commercialization in any jurisdiction.
It is under development to monitor optical signals that represent glucose levels in the interstitial fluid of subcutaneous tissue continuously
and long-term. This glucose sensing system is composed of 1) a Glucose Sensing Hydrogel, 2) a Hydrogel delivery/injection pen, and 3)
a Hydrogel Reader and software. The software is designed to be used with a User Interface on a Tablet or Smartphone.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lumee Glucose is designed and
developed by Profusa. The Profusa Glucose First-In-Human (FIH) Platform had been approved for investigational use by the Competent Authority
in Germany (BfArM) on May&#160;4, 2018. Follow-up development studies with significantly improved Glucose Platform components, including
the sensing hydrogel and reader, received approval for investigational use in several jurisdictions: by the Competent Authority in Austria
(AGES) on May&#160;8, 2020 and January&#160;11, 2021; by the Competent Authority in Germany (BfArM) on</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">November&#160;26, 2020; by
the Competent Authority in Vietnam (Ministry of Health) on September&#160;10, 2020. Study conduct took place in all jurisdictions with
a total enrollment of 54 subjects. The active glucose monitoring phase for up to 12&#160;months had been completed by the end of 2021.
The European studies are still open for extended safety monitoring per protocol for up to 3&#160;years observation. The study in Vietnam
does allow amendments for additional device iterations, which will be implemented as soon as practical for the next phase of Profusa&#8217;s
clinical study program.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa continues to have ongoing
communication with the Competent Authorities in Europe for the current studies periodically reporting on extended safety observations
for long-term sensor placement. Submission of new study protocols is expected early 2024, employing the first commercial generation platform
demonstrating safety and effectiveness (accuracy and intended use performance) aiming at regulatory clearance purposes, i.e. CE Mark.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 118; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In parallel the technology
is going be presented to FDA to obtain Investigational Device Exemptions for study conduct in the U.S.&#160;Potential clinical study sites
have been targeted and respective IDE submission documentation is in preparation. A PMA (Pre-Market Approval) pathway is expected for
marketing authorization in the U.S.&#160;It will likely require a pivotal study performed in the United&#160;States with an estimated
enrollment of 120 &#8211;&#160;160 subjects and an active glucose measurement period of at least 3&#160;months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The first commercial implementation
of Lumee Glucose will be, subject to regulatory approval, a professional-use device for retrospective data download and data evaluation
by health care professionals. This approach is typical in the CGM market and will be a controlled and limited use case in preparation
for the release of a fully featured real-time use CGM device generation in the near future, subject to obtaining required regulatory approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lumee Glucose Clinical Study History</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lumee Glucose is a CGM product
candidate that was first entered into clinical study through our first-in-human (FIH) in 2021. To date, we have tested 108 sensors in
54 subjects in our clinical program for the glucose product. These studies have been conducted in global sites in Germany, Austria, and
Vietnam. No serious adverse events have been reported with safety data for 12&#160;months post injection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Proof of Concept Feasibility Assessment:</i> The study was conducted in Germany in 2018/19. The objective
of the study was to evaluate the Lumee Glucose FIH Platform in human subjects, establishing long-term Lumee Glucose measurements in the
subcutaneous interstitial space as representation of glycemia. The Lumee hydrogel signal was to be compared to established glucose reference
measurements of capillary blood under controlled conditions for potential signal artefacts like movement, temperature, and ambient light.
Initial signal processing algorithms would be established including retrospective accuracy evaluation considering a defined relationship
between the Lumee signal and blood glucose reference measurements. 10 subjects had been enrolled with insulin-dependent diabetes, male
and female, of 18&#160;years and older. The study served as Proof-of Concept for the technology and for safe use in human. Both the hydrogel
sensor and the reader design have been significantly modified since in order to improve sensing sensitivity/responsiveness of the system
for the subsequent study.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Tissue Integration and Monitoring with the Lumee Glucose Hydrogel in the Subcutaneous Interstitium:
</i>The study was conducted in Austria in 2020/21 employing two versions of the reader system and an upgraded sensor version. Twelve subjects
with insulin-dependent diabetes, 18&#160;years and older have been enrolled. The objective of the study was to evaluate tissue integration,
location reliability and glucose response characteristics over a period of three and six&#160;months after sensor placement. Correlation
of Lumee signals with&#160;IV sampled blood reference values was to be established during glucose excursions at meals at repeated in clinic
visits. Reader localization effectiveness was checked additionally by using an infrared sensitive camera and by high frequency ultrasound.
The active monitoring phase has been completed. Long-term safety observations are ongoing.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><i>&#9679;</i></td><td style="text-align: justify"><i>Glucose Monitoring with the Lumee Glucose Hydrogel in the Subcutaneous Tissue: </i>The multi-site study
was initiated in Austria, Germany, and Vietnam in August/October&#160;2021. Total of 54 subjects across all sites with insulin-dependent
diabetes, 18&#160;years and older have been enrolled. The objective of the study was to evaluate glucose response characteristic of the
Lumee Glucose hydrogel in tissue over a period &gt;3&#160;months with active monitoring sessions and 3&#160;years of placement safety
observations. Analysis endpoints did include: Correlation of Lumee signals with&#160;IV sampled blood reference values, Signal processing/algorithm
effectiveness, correction approaches for motion, temperature, ambient light, signal stability over time. Selected in-clinic 24-hour monitoring
sessions were performed.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 119; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Demographics For Lumee Glucose Studies</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A total of 54 subjects have
been enrolled with 108 Lumee Glucose sensors injected and 398 study visits completed. These visits have yielded 745 glucose traces and
more than 18,000 paired reference points.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="border: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Site</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>1</i></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>2</i></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>3</i></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>4</i></span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Location</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>Germany</i></span></td>
    <td colspan="2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>Austria</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>Vietnam</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>Vietnam</i></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Subjects</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>12</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>12</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>16</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>7</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>7</i></span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Data Sets</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>121</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>60</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>124</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>63</i></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><i>68</i></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td rowspan="2" style="border-right: Black 1pt solid; width: 14%; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Diabetes</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; width: 14%; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Type 1</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; width: 16%; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">12</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; width: 14%; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; width: 14%; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">15</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; width: 14%; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; width: 14%; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Type 2</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td rowspan="2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Gender</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Male</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">10</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">8</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">2</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Female</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">4</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td rowspan="3" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Age (years)</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Mean</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">60</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">55</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">43</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">57</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">55</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Min</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">44</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">29</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">20</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">45</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">40</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Max</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">69</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">82</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">72</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">66</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">62</span></td></tr>
  <tr>
    <td rowspan="3" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>BMI (kg/m<sup>2</sup>)</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Mean</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">27.2</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">26.5</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">26</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">25.3</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">26.3</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Min</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">22.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">21.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">19.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">18.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">19.3</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Max</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">40.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">40.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">40.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">31.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">34.9</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td rowspan="3" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>Therapy (%)</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Insulin</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">100</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">100</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">94</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">29</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Oral</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">71</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">29</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Both</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">29</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">42</span></td></tr>
  <tr>
    <td rowspan="3" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 3pt"><span style="font-size: 10pt"><b>HbA1C (%)</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Mean</b></span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6.9</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">7.5</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">9.6</span></td>
    <td style="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">8.6</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Min</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">7.7</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 9pt; text-align: justify"><span style="font-size: 10pt"><b>Max</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">7.9</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">9.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">14.8</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">9.4</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Results</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The feasibility study at the
four clinical sites provided data on sensor locatability, system performance (the ability to accurately estimate glucose), in addition
to monitoring for adverse events. All the sensors were locatable. The feasibility study was not designed and powered to provide a robust
estimate of the commercial performance of the system, however, data collected in the study enabled the refinement of the algorithm. Using
the data, Profusa was able to show evidence of the system&#8217;s ability to track glucose. Data indicate that the sensors were responsive
to glucose during the study period and provided a significant body of data for algorithm development and evaluation. Performance analysis
of the data yielded an aggregate mean absolute relative difference (MARD) of 11.7% for sessions from 7 &#8211;&#160;90&#160;days post-injection.
The consensus error grid and cumulative MARD distribution are presented below, representing 163 sessions from 37 patients that passed
the data quality filters, resulting in 2406 paired blood glucose reference points. Data quality filters that were developed and automated
during the algorithm development exclude problematic traces including poorly placed readers over the sensor, unexpected fluorescence contamination
of the skin surface over the sensor, and poor adhesion of the reader over the sensor yielding low signal to noise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image-007.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 120; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The figure above shows a standard
Consensus Error grid, which is a tool used to evaluate the accuracy of blood glucose meters. It visualizes the paired data points that
passed the quality filters. This includes 163 sessions of data collection approximately 6&#160;hours in duration from 37 patients over
the course of 90-days. Measured signals are calibrated using 3-point blood glucose calibration in each session. Each dot on the figure
shows the relationship between the Profusa reported blood glucose value (Y-axis) compared with the corresponding reference measured blood
glucose value (X-axis). The colors of the dots distinguish patients. The grid is divided into zones signifying the degree of risk posed
by the incorrect measurement: zone A represents no effect on clinical action; zone B represents altered clinical action&#160;&#8212;&#160;little
or no effect on clinical outcome; zone C represents altered clinical action&#160;&#8212;&#160;likely to affect clinical outcome; zone
D represents altered clinical action&#160;&#8212;&#160;could have significant medical risk; and zone E represents altered clinical action&#160;&#8212;&#160;could
have dangerous consequences.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_008.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The pair of figures above shows
an alternative visualization of the data presented above. For each data collection session, the system accuracy (MARD) is computed. The
per-session MARD distribution shows performance across the 163 sessions. &#8220;Held-out test set&#8221; refers to the machine learning
technique. Following the FDA&#8217;s recommendations for utilizing machine learning, the algorithm used to process the data was not used
in its training.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 121; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Glucose predictions modeled from held-out clinical
sessions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Performance beyond 90&#160;days was also evaluated
in two separate groups&#160;&#8212;&#160;days 91 &#8211;&#160;150 and&#160;days 151 &#8211;&#160;275.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_009.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The figures above were processed
using the same filters and methods as in prior figures. Subjects had the opportunity to stay in the study after 90&#160;days from the
initial injection. The population of 13 subjects in the 91 &#8211;&#160;150&#160;days period and 8 subjects in the 151 &#8211;&#160;275&#160;day
period is a subset of those in the initial 90&#160;&#8211;&#160;day data.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Device Safety</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of May&#160;1, 2023, no
serious adverse events (SAEs) related to Lumee Glucose have been reported. As of May&#160;1, 2023, seven adverse events (AEs) related
and four AEs possibly related to Lumee Glucose have been reported. All of the related and possibly related AEs were mild, such as slight
pain or small induration, or thickening and hardening of the skin. All but one of the AEs resolved within three&#160;days, and the last
AE resolved within 12&#160;days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Commercial Strategy</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s commercial
strategy centers around leveraging its core expertise in product development and scientific excellence, while augmenting its capabilities
through local partnerships in commercial execution. For Lumee Oxygen and Lumee Glucose, Profusa aims to continue investing in its key
opinion leader relationships and create clinical relevancy through building upon its current body of publications and conference presentations.
To date, Profusa has been featured in more than 25 publications in peer-reviewed journals and public presentations of its science and
product applications. None of these publications were commissioned by Profusa or written at the direction of Profusa&#8217;s management,
but certain service providers of Profusa have served as co-authors for some of these publications. Additionally, Profusa&#8217;s goal
is to build upon our distribution strategy to create a network of commercial partners covering key geographic regions, while building
focused technical sales leadership team to manage key local relationships and maintain performance excellence of its local distribution
partners. Lastly, Profusa plans to strategically engage in commercial B2B relationships to capture a portion of the large coaching, telemedicine,
and health and wellness segments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 122; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lumee Oxygen</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa received CE approval
for Lumee Oxygen on January&#160;28, 2020. Due to pandemic-related restrictions at hospitals and clinics for non-essential personnel visits,
Profusa was unable to carry out its commercialization plans in Europe. Profusa anticipates initiating its commercialization effort beginning
in early 2026. By taking advantage of the identified distributor partners in key countries in Europe, Profusa&#8217;s marketing infrastructure
and collateral, the KOL network and associated publications and conference presentations, Profusa expects to be able to accelerate its
product launch in Europe. Profusa is also in the midst of its clinical program for U.S.&#160;approval. Profusa anticipates being able
to launch Lumee Oxygen in the U.S.&#160;late 2026, subject to regulatory approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Glucose Product</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s strategy to
commercialize its glucose CGM product will mirror that of Lumee Oxygen. While there are a few large companies with significant CGM offering,
the large patient population and the high cost to health care system have attracted many other attempts to provide alternative solutions
by other potential healthcare companies. Unfortunately, those attempts have historically been unsuccessful technically, and unproductively
economically for these companies. Profusa believes that upon achieving the clinical and regulatory milestones over the next 18&#160;months,
it could become an attractive candidate to partner with one of these large players and leverage their commercial footprint to enter this
patient population.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Data Partnerships</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa believes that the data
stream its platform can generate could become a critical component of solutions being offered today in sectors such as telemedicine, pre-diabetes
management, lifestyle coaching platforms/apps, and health and wellness apps. Profusa bases this hypothesis on the belief that clinically
relevant data, in real time, is central to these AI-driven platforms&#8217; ability to deliver automated meaningful insights to the users.
In telemedicine, a physician/patient interaction would be more efficient if real time biochemistry parameters are available during the
tech-enabled visit. As these platforms and apps are also much more consumer-oriented, the user-experience and cost of the real-time sensor
technology need to be aligned to the user expectation and consumer cost levels. Profusa believes its technology could ultimately be that
enabling data stream to these other high-growth healthcare sectors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s strategy to
enter and create value in these more consumer sectors centers around a B2B approach. The relationships and expertise of reaching a large
scale consumer-based population belong with the telemedicine and apps providers. Additionally, the cost of customer acquisition and marketing
infrastructure to acquire users are high and complex. Profusa&#8217;s aim is to partner with these providers on a B2B level, and make
available our technology and data stream to enable our partner&#8217;s success. This approach would align the core competencies of the
respective organizations, while creating value for both partners. The partner would have a data stream that drives their adoption and
business model, while Profusa would benefit from accessing a large user population without the associated marketing and user acquisition
costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Key Opinion Leaders (KOLs)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa has worked with a small
number of key opinion leaders (KOLs) in both oxygen and glucose applications, receiving their advice and expertise on product development,
physician use cases, clinical needs, and clinical study support. In certain instances, KOLs are the principal investigators in Profusa&#8217;s
clinical studies and have summarized its product and clinical data in podium talks at major conferences and through publications. With
the exception of two KOLs who provided services to Profusa and received stock options for 10,000&#160;shares and 30,000&#160;shares, respectively,
of Profusa&#8217;s common stock, KOLs are not compensated or provided equity awards; however, KOLs do receive customary expense reimbursement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 123; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Intellectual Property</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa protects its intellectual
property through patents, trade secrets, and copyright/trademarks. Additionally, Profusa requires all officers, employees, and third parties
to enter into standard agreements containing provisions requiring confidentiality of proprietary information and assignment to Profusa
of all inventions made during the course of their employment or consulting relationship. Profusa also enter into nondisclosure agreements
with its commercial counterparties and limits access to, and distribution of, its proprietary information. Except in the case of certain
software, Profusa currently require no 3<sup>rd</sup> party licenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Patents and applications cover
several different technology classes, including in vivo sensors, sensor signaling chemistry compositions and scaffolding compositions,
methods of and apparatus for sensor interrogation by fluorescent readers, data reduction algorithms for signal processing, and combined
biochemical data and sensor data methods. As of July&#160;23, 2023, Profusa owns 20 issued U.S.&#160;patents; 80 rest-of-world patents,
including patents in Australia, Belgium, Canada, China, Europe, France, Germany, Hong&#160;Kong, India, Italy, Ireland, Japan, the Netherlands,
South Korea, and the United Kingdom; 14 pending U.S.&#160;patents; and 63 pending rest-of-world patents, including pending patents in
Australia, Canada, China, Europe, Germany, Hong&#160;Kong, India, Israel, Japan and South Korea. Profusa&#8217;s issued patents expire
between March&#160;2030 and January&#160;2040.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below summarizes
Profusa&#8217;s portfolio of issued patents, all of which are utility patents and all of which are owned by Profusa:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Technology Addressed</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Jurisdiction</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Expiration Date</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2036</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">France</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">France</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Germany</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Germany</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Ireland</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Ireland</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2036</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United Kingdom</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United Kingdom</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/15/2035</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">9/20/2035</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/20/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Belgium</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Belgium</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 124; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Technology Addressed</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Jurisdiction</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Expiration Date</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Belgium</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Belgium</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/21/2037</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">France</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">France</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">France</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">France</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Germany</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Germany</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Germany</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Germany</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Hong&#160;Kong</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">India</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">India</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Ireland</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Ireland</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Ireland</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Ireland</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Italy</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Italy</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Italy</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Italy</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2037</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Netherlands</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Netherlands</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Netherlands</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Netherlands</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Republic of Korea</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United Kingdom</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/28/2030</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United Kingdom</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United Kingdom</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United Kingdom</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 125; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Technology Addressed</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Jurisdiction</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Expiration Date</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/21/2037</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Misc</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United&#160;States of America</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/20/2042</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2/7/2032</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/11/2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2037</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/16/2037</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2037</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/14/2039</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/22/2037</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1/3/2040</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below summarizes
Profusa&#8217;s portfolio of pending patents, all of which are utility patents and all of which are owned by Profusa:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Technology Addressed</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Jurisdiction</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Date of Application</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8/20/2020</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2014</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2016</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8/20/2020</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2014</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2016</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8/20/2020</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2014</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2014</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2016</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8/20/2020</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Hong&#160;Kong</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2014</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">India</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2016</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">India</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8/20/2020</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/6/2014</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/6/2014</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8/20/2020</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Republic of Korea</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2016</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Republic of Korea</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8/20/2020</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United&#160;States of America</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/4/2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United&#160;States of America</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2016</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United&#160;States of America</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2/11/2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Readers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">United&#160;States of America</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2/19/2021</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2017</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Australia</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/28/2019</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2017</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/29/2018</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 126; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Technology Addressed</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Jurisdiction</b></span></td>
    <td style="white-space: nowrap; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Date of Application</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/28/2019</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3/13/2014</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/21/2017</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2017</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">China</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/28/2019</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/21/2017</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2017</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">European Patent Office</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/28/2019</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Hong&#160;Kong</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">10/6/2011</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">India</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2017</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">India</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/29/2018</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">India</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Republic of Korea</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/27/2017</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Republic of Korea</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/29/2018</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Republic of Korea</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">11/4/2019</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/26/2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">12/8/2020</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5/26/2020</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">9/14/2020</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Sensors and Chemistry</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">US</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6/27/2019</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Misc</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Canada</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">4/21/2021</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center"><span style="font-size: 10pt">Misc</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Japan</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">4/21/2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Misc</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Patent Cooperation Treaty</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">4/21/2021</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Manufacturing and Quality Systems</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa manufactures class&#160;III
medical device implantable sensors within an ISO compliant manufacturing facility and quality system. All internal manufacturing activities
are conducted and managed per current Good Manufacturing Practices (cGMP), which are the recognized standards for the FDA and other global
regulatory agencies. Profusa manufacturing processes comply with all aspects of cGMP and has procedures in place for the following activities:
Supplier selection, evaluation and monitoring, Incoming receiving inspection requirements, Documented manufacturing procedures and work
instructions, Operator training program, and compliant manufacturing spaces including a certified, class&#160;7, controlled environment
room (CER). Over 90% of the implantable sensor manufacturing process, including production, cleaning, sizing, testing and packaging is
conducted within a clean room, which is inspected and certified on a quarterly basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, all devices are
produced utilizing a validated production process with multiple inspection and testing points to ensure quality throughout the process.
The overall process, including embedded test methods, is re-validated as necessary to ensure continued compliance with cGMP over time.
All manufacturing steps, materials, equipment, personnel and tools utilized in the production process are documented in highly detailed
Device History Records (DHR) to provide a written production history. The DHR also documents demonstrated compliance to Manufacturing
Process Instructions (MPI) used and followed throughout the process.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Externally, Profusa only selects,
utilizes, and monitors qualified vendors for services or products related to manufacturing processes, which include Contract Manufacturers,
and Testing and Sterilization services. Prior to selection, Profusa Quality Assurance conducts on-site Quality System audits to ensure
they are compliant with cGMP requirements and any other required regulatory requirements. Additionally, all external produced products
or services conducted for Profusa manufactured products undergo testing at nationally accredited and certified testing facilities and
must meet Incoming Inspection criteria which Profusa had previously established prior to acceptance and utilization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 127; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Competition</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The competitive landscape regarding
both the Lumee Oxygen and Lumee Glucose sensing systems, if approved, is multi-faceted, with many companies with device offerings that
provide biochemical data in real time, as further described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lumee Oxygen is designed to
be used complementarily with angiographic (radiographic visualization of blood vessels after injection of a radiopaque substance) and
computer tomographic (imaging of parts of the body with any kind of penetrating waves) technologies, or alone. We anticipate the creation
of a guidance algorithm to be used by a physician or other vascular specialist to incorporate both Lumee Oxygen values and angiographic
or computer tomographic readings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Examples of such technologies
include digital subtraction angiography devices developed by Philips or Computed Tomography (CT) for peripheral use developed by Siemens
Healthineers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lumee Oxygen will also compete
with devices that use transcutaneous oximetry (TCPO2) to measure peripheral perfusion, such as those developed by Perimed AB, Radiometer
Medical or SenTec AG, to name examples.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, doppler or cuff
devices measuring Ankle-Brachial Index (ABI), Toe-Brachial Index (TBI) or Segmental Pressure Values (SPP), as well as those enabling Pulse
Volume Recording (PVR) are anticipated to be competitive with Lumee Oxygen. Other experimental approaches include Near-Infrared Spectroscopy
(NIRS) for peripheral purposes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the personal use case, Lumee
Glucose will compete with existing Continuous Glucose Monitoring technologies, including those manufactured by Dexcom, Abbott, Medtronic,
Senseonics, Diamontech, Movano and Nemaura Medical. Each of these companies currently market Continuous Glucose Monitoring products that
target both Type 1 and Type 2 diabetes patients, as well as pre-diabetics.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the professional use case
Lumee Glucose will compete with Dexcom, Abbott and Medtronic technologies. Profusa anticipates the launch of multiple noninvasive technologies
in the next&#160;years which may affect the competitive landscape, which may take the form of wristbands or smartwatches.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Government Regulation</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">United&#160;States Food and Drug Administration</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the United&#160;States,
our products are subject to regulation by the FDA as medical devices pursuant to the Federal Food Drug and Cosmetic Act (FDCA). The FDA
regulates the development, design, non-clinical and clinical research, manufacturing, safety, efficacy, labeling, packaging, storage,
installation, servicing, recordkeeping, premarket clearance or approval, adverse event reporting, advertising, promotion, marketing and
distribution, and import and export of medical devices to ensure that medical devices distributed domestically are safe and effective
for their intended uses and otherwise meet the requirements of the FDCA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">FDA Premarket Clearance and Approval Requirements</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless an exemption applies,
each medical device commercially distributed in the United&#160;States requires either FDA clearance of a 510(k)&#160;premarket notification,
approval of a De Novo application, or approval of a premarket approval (PMA). Under the FDCA, medical devices are classified into one
of three classes&#160;&#8212;&#160;Class&#160;I, Class&#160;II or Class&#160;III&#160;&#8212;&#160;depending on the degree of risk associated
with each medical device and the extent of manufacturer and regulatory control needed to ensure its safety and effectiveness. Class&#160;I
includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be assured by adherence to the
FDA&#8217;s General Controls for medical devices, which include compliance with the applicable portions of the Quality System Regulation
(QSR) facility registration and product listing, reporting of adverse medical events, and truthful and non-misleading labeling, advertising,
and promotional materials. Class&#160;II devices are subject to the FDA&#8217;s General Controls, and special controls as deemed necessary
by the FDA to ensure the safety and effectiveness of the device. These special controls can include performance standards, post-market
surveillance, patient registries and FDA guidance documents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 128; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While most Class&#160;I devices
are exempt from the 510(k)&#160;premarket notification requirement, manufacturers of most Class&#160;II devices are required to submit
to the FDA a premarket notification under Section&#160;510(k)&#160;of the FDCA requesting permission to commercially distribute the device.
The FDA&#8217;s permission to commercially distribute a device subject to a 510(k)&#160;premarket notification is generally known as 510(k)&#160;clearance.
Devices deemed by the FDA to pose the greatest risks, such as life sustaining, life supporting or some implantable devices, or devices
that have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device, are
placed in Class&#160;III, requiring approval of a PMA.&#160;Some pre-amendment devices are unclassified, but are subject to FDA&#8217;s
premarket notification and clearance process in order to be commercially distributed. Based on discussion with FDA to date, we believe
that Lumee Oxygen is a Class&#160;III device and that Lumee Glucose is a Class&#160;III device.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>510(k)&#160;Clearance Marketing Pathway</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To obtain 510(k)&#160;clearance,
we must submit to the FDA a premarket notification submission demonstrating that the proposed device is &#8220;substantially equivalent&#8221;
to a predicate device already on the market. A predicate device is a legally marketed device that is not subject to PMA, i.e., a device
that was legally marketed prior to May&#160;28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been
reclassified from Class&#160;III to Class&#160;II or&#160;I, or a device that was found substantially equivalent through the 510(k)&#160;process.
The FDA&#8217;s 510(k)&#160;clearance process usually takes from three to twelve&#160;months, but often takes longer. The FDA may require
additional information, including clinical data, to make a determination regarding substantial equivalence. In addition, the FDA collects
user fees for certain medical device submissions and annual fees for medical device establishments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the FDA agrees that the
device is substantially equivalent to a predicate device currently on the market, it will grant 510(k)&#160;clearance to commercially
market the device. If the FDA determines that the device is &#8220;not substantially equivalent&#8221; to a previously cleared device,
the device is automatically designated as a Class&#160;III device. The device sponsor must then fulfill more rigorous PMA requirements,
or can request a risk-based classification determination for the device in accordance with the &#8220;De Novo&#8221; process, which is
a route to market for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device.
If a De Novo request is granted, the device may be legally marketed and a new classification is established. If the device is classified
as Class&#160;II, the device may serve as a predicate for future 510(k)&#160;submissions. If the device is not approved through De Novo
review, then it must go through the standard PMA process for Class&#160;III devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After a device receives 510(k)&#160;marketing
clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change or modification
in its intended use, will require a new 510(k)&#160;clearance or, depending on the modification, PMA approval. The FDA requires each manufacturer
to determine whether the proposed change requires submission of a 510(k)&#160;or a PMA in the first instance, but the FDA can review any
such decision and disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination,
the FDA can require the manufacturer to cease marketing and/or request the recall of the modified device until 510(k)&#160;marketing clearance
or PMA approval is obtained. Also, in these circumstances, the manufacturer may be subject to significant regulatory fines or penalties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PMA Approval Pathway</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Class&#160;III devices require
approval of a PMA before they can be marketed, although some pre-amendment Class&#160;III devices for which the FDA has not yet required
a PMA are cleared through the 510(k)&#160;process. The PMA process is more demanding than the 510(k)&#160;premarket notification process.
In a PMA application, the manufacturer must demonstrate that the device is safe and effective, and the PMA application must be supported
by extensive data, including data from preclinical studies and human clinical trials. The PMA application must also contain a full description
of the device and its components, a full description of the methods, facilities, and controls used for manufacturing, and proposed labeling.
Following receipt of a PMA application, the FDA determines whether the application is sufficiently complete to permit a substantive review.
If the FDA accepts the application for review, it has 180&#160;days under the FDCA to complete its review of a PMA application, although
in practice, the FDA&#8217;s review often takes significantly longer, and can take up to several&#160;years. An advisory panel of experts
from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability
of the device. The FDA may or may not accept the panel&#8217;s recommendation. In addition, the FDA will generally conduct a pre-approval
inspection of the applicant or its third-party manufacturers&#8217; or suppliers&#8217; manufacturing facility or facilities to ensure
compliance with the QSR.&#160;PMA devices are also subject to the payment of user fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 129; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The FDA will approve the new
device for commercial distribution if it determines that the data and information in the PMA application constitute valid scientific evidence
and that there is reasonable assurance that the device is safe and effective for its intended use(s). A PMA may include post-approval
conditions intended to ensure the safety and effectiveness of the device, including, among other things, restrictions on labeling, promotion,
sale and distribution, and collection of long-term follow-up data from patients in the clinical study that supported the PMA or requirements
to conduct additional clinical studies post-approval. The FDA may condition PMA approval on some form of post-market surveillance when
deemed necessary to protect the public health or to provide additional safety and efficacy data for the device in a larger population
or for a longer period of use. In such cases, the manufacturer might be required to follow certain patient groups for a number of&#160;years
and to make periodic reports to the FDA on the clinical status of those patients. Failure to comply with the conditions of approval can
result in material adverse enforcement action, including withdrawal of the approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain changes to an approved
device, such as changes in manufacturing facilities, methods, or quality control procedures, or changes in the design performance specifications,
which affect the safety or effectiveness of the device, require submission of a PMA supplement. PMA supplements often require submission
of the same type of information as a PMA, except that the supplement is limited to information needed to support any changes from the
device covered by the original PMA and may not require as extensive clinical data or the convening of an advisory panel. Certain other
changes to an approved device require the submission of a new PMA, such as when the design change causes a different intended use, mode
of operation, and technical basis of operation, or when the design change is so significant that a new generation of the device will be
developed, and the data that were submitted with the original PMA are not applicable for the change in demonstrating a reasonable assurance
of safety and effectiveness. None of our products are currently marketed pursuant to a PMA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>De Novo Classification</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Medical device types that the
FDA has not previously classified as Class&#160;I,&#160;II or&#160;III are automatically classified into Class&#160;III regardless of
the level of risk they pose. To market low to moderate risk medical devices that are automatically placed into Class&#160;III due to the
absence of a predicate device, a manufacturer may request a De Novo down-classification. This procedure allows a manufacturer whose novel
device is automatically classified into Class&#160;III to request classification of its medical device into Class&#160;I or Class&#160;II
on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA application. A
medical device may be eligible for De Novo classification if the manufacturer first submitted a 510(k)&#160;premarket notification and
received a determination from the FDA that the device was not substantially equivalent or a manufacturer may request De Novo classification
directly without first submitting a 510(k)&#160;premarket notification to the FDA and receiving a not substantially equivalent determination.
The FDA is required to classify the device within 120 calendar&#160;days following receipt of the De Novo application, although in practice,
the FDA&#8217;s review may take significantly longer. During the pendency of the FDA&#8217;s review, the FDA may issue an additional information
letter, which places the De Novo request on hold and stops the review clock pending receipt of the additional information requested. In
the event the De Novo requestor does not provide the requested information within 180 calendar&#160;days, the FDA will consider the De
Novo request to be withdrawn. If the manufacturer seeks reclassification into Class&#160;II, the manufacturer must include a draft proposal
for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of the medical device. In addition,
the FDA may reject the De Novo request for classification if it identifies a legally marketed predicate device that would be appropriate
for a 510(k)&#160;or determines that the device is not low to moderate risk or that general controls would be inadequate to control the
risks and special controls cannot be developed. In the event the FDA determines the data and information submitted demonstrate that general
controls or general and special controls are adequate to provide reasonable assurance of safety and effectiveness, the FDA will grant
the De Novo request for classification. When the FDA grants a De Novo request for classification, the device is granted marketing authorization
and further can serve as a predicate for future devices of that type, through a 510(k)&#160;premarket notification.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 130; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Clinical Trials</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Clinical trials are almost
always required to support a PMA and are sometimes required to support a 510(k)&#160;submission. All clinical investigations of devices
to determine safety and effectiveness must be conducted in accordance with the FDA&#8217;s IDE regulations which govern investigational
device labeling, prohibit promotion of the investigational device, and specify an array of recordkeeping, reporting and monitoring responsibilities
of study sponsors and study investigators. If the device presents a &#8220;significant risk,&#8221; to human health, as defined by the
FDA, the FDA requires the device sponsor to submit an IDE application to the FDA, which must become effective prior to commencing human
clinical trials. A significant risk device is one that presents a potential for serious risk to the health, safety or welfare of a patient
and either is implanted, used in supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating
disease or otherwise preventing impairment of human health, or otherwise presents a potential for serious risk to a subject. An IDE application
must be supported by appropriate data, such as animal and laboratory test results, showing that it is safe to test the device in humans
and that the testing protocol is scientifically sound. The IDE will automatically become effective 30&#160;days after receipt by the FDA
unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns
with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the study must
be approved by, and conducted under the oversight of, an Institutional Review Board (IRB) for each clinical site. The IRB is responsible
for the initial and continuing review of the IDE study, and may pose additional requirements for the conduct of the study. If an IDE application
is approved by the FDA and one or more IRBs, human clinical trials may begin at a specific number of investigational sites with a specific
number of patients, as approved by the FDA.&#160;If the device presents a non-significant risk to the patient, a sponsor may begin the
clinical trial after obtaining approval for the trial by one or more IRBs without separate approval from the FDA, but must still follow
abbreviated IDE requirements, such as monitoring the investigation, ensuring that the investigators obtain informed consent, and labeling
and record-keeping requirements. Acceptance of an IDE application for review does not guarantee that the FDA will allow the IDE to become
effective and, if it does become effective, the FDA may or may not determine that the data derived from the trials support the safety
and effectiveness of the device or warrant the continuation of clinical trials. An IDE supplement must be submitted to, and approved by,
the FDA before a sponsor or investigator may make a change to the investigational plan that may affect its scientific soundness, study
plan or the rights, safety or welfare of human subjects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During a study, the sponsor
is required to comply with the applicable FDA requirements, including, for example, trial monitoring, selecting clinical investigators
and providing them with the investigational plan, ensuring IRB review, adverse event reporting, record keeping and prohibitions on the
promotion of investigational devices or on making safety or effectiveness claims for them. The clinical investigators in the clinical
study are also subject to FDA regulations and must obtain patient informed consent, rigorously follow the investigational plan and study
protocol, control the disposition of the investigational device, and comply with all reporting and recordkeeping requirements. Additionally,
after a trial begins, we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, including a
belief that the risks to study subjects outweigh the anticipated benefits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Post-market Regulation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After a device is cleared or
approved for marketing, numerous and pervasive regulatory requirements continue to apply. These include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">establishment registration and device listing with the FDA;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">QSR requirements, which require manufacturers, including third-party manufacturers, to follow stringent
design, testing, control, documentation and other quality assurance procedures during all aspects of the design and manufacturing process;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">labeling regulations and FDA prohibitions against the promotion of investigational products, or the promotion
of &#8220;off-label&#8221; uses of cleared or approved products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">requirements related to promotional activities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect
safety or effectiveness or that would constitute a major change in intended use of one of our cleared devices, or approval of certain
modifications to PMA-approved devices;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">medical device reporting regulations, which require that a manufacturer report to the FDA if a device
it markets may have caused or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it
markets would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 131; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">correction, removal and recall reporting regulations, which require that manufacturers report to the FDA
field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation
of the FDCA that may present a risk to health;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the FDA&#8217;s recall authority, whereby the agency can order device manufacturers to recall from the
market a product that is in violation of governing laws and regulations; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">post-market surveillance activities and regulations, which apply when deemed by the FDA to be necessary
to protect the public health or to provide additional safety and effectiveness data for the device.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Quality Systems Regulation&#160;Requirements</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our manufacturing processes
are required to comply with the applicable portions of the QSR, which cover the methods and the facilities and controls for the design,
manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation and servicing
of finished devices intended for human use. The QSR requires that each manufacturer establish a quality systems program by which the manufacturer
monitors the manufacturing process and maintains records that show compliance with FDA regulations and the manufacturer&#8217;s written
specifications and procedures relating to the devices. The QSR also requires, among other things, maintenance of records and certain documentation,
a device master file, device history file, and complaint files. QSR compliance is necessary to receive and maintain FDA clearance or approval
to market new and existing products. As a manufacturer, we are subject to periodic scheduled or unscheduled audits or inspections by the
FDA.&#160;Our failure to maintain compliance with the QSR requirements could result in the shut-down of, or restrictions on, our manufacturing
operations and the recall or seizure of our products, which would have a material adverse effect on our business. The discovery of previously
unknown problems with any of our products, including unanticipated adverse events or adverse events of increasing severity or frequency,
whether resulting from the use of the device within the scope of its clearance or off-label by a physician in the practice of medicine,
could result in restrictions on the device, including the removal of the product from the market or voluntary or mandatory device recalls.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The FDA has broad regulatory
compliance and enforcement powers. If the FDA determines that we failed to comply with applicable regulatory requirements, it can take
a variety of compliance or enforcement actions, which may result in any of the following sanctions:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">FDA untitled letters, FDA Form&#160;483s, FDA warning letters, it has come to our attention letters, fines,
injunctions, consent decrees and civil penalties;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">unanticipated expenditures to address or defend such actions;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">customer notifications or repair, replacement, refunds, recall, detention or seizure of our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">recall, detention or seizure of our products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">operating restrictions, partial suspension or total shutdown of production;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">refusing or delaying our requests for regulatory approvals or clearances of new products or modified products;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">withdrawing of 510(k)&#160;clearances or PMA approvals that have already been granted;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">refusal to grant export approval for our products; or</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">criminal prosecution.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The FDA can also publish Safety
Communications or Letters to Health Care Providers when the agency becomes aware of new issues involving a specific product or, or more
broadly, a product family. These communications are posted on the FDA&#8217;s website and describe the FDA&#8217;s analysis of a current
issue and provide specific regulatory approaches and clinical recommendations for patient management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 132; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Healthcare Laws</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Coverage and Reimbursement</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to commercialize
any products successfully will depend in part on the extent to which coverage and adequate reimbursement for our product candidates, either
directly or through procedures utilizing our products performed by health care providers, once approved, will be available from government
health administration authorities, private health insurers and other organizations. Government authorities and third-party payors, such
as private health insurers and health maintenance organizations, determine which items and services they will cover and establish reimbursement
levels. Assuming coverage is obtained for the relevant items and/or services covering a given product by a third-party payor, the resulting
reimbursement payment rates may not be adequate to cover our costs or may require co-payments that patients find unacceptably high. Patients
and their providers generally rely on third-party payors to reimburse all or part of the costs associated with our products. Physicians
are unlikely to order, and patients are unlikely to use, our products unless coverage is provided and the reimbursement is adequate to
cover all or a significant portion of the direct or indirect cost of our products. Therefore, coverage and adequate reimbursement for
new products is critical to the acceptance of such new products. Coverage decisions may depend upon clinical and economic standards that
disfavor new products when more established or lower cost alternatives are already available or subsequently become available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Government authorities and
third-party payors are developing increasingly sophisticated methods of cost containment, such as including price controls, restrictions
on coverage and reimbursement, and requirements for substitution of less expensive products and procedures. Government and other third-party
payors are increasingly challenging the prices charged for health care items and procedures, examining the cost effectiveness of products,
in addition to their safety and efficacy, and limiting or attempting to limit both coverage and the level of reimbursement. Further, no
uniform policy requirement for coverage and reimbursement exists among third-party payors in the United&#160;States, which causes significant
uncertainty related to the insurance coverage and reimbursement of newly approved products. Therefore, coverage and reimbursement can
differ significantly from payor to payor and health care provider to health care provider. As a result, the coverage determination process
is often a time-consuming and costly process that requires the provision of scientific and clinical support for the use of new products
to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first
instance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There may also be significant
delays in obtaining coverage and reimbursement for newly approved products, and coverage may be more limited than the purposes for which
the product is approved or cleared by the FDA.&#160;Moreover, eligibility for coverage and reimbursement does not imply that a product
will be paid for, directly or indirectly, in all cases or at a rate which the health care providers who purchase those products will find
cost effective. Additionally, we expect pricing pressures in connection with the sale of any of our product candidates due to the trend
toward managed healthcare, the increasing influence of health maintenance organizations, and additional legislative changes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot be sure that coverage
and reimbursement will be available for any product that we commercialize and, if reimbursement is available, what the level of reimbursement
will be. Coverage and reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval
or clearance. If coverage and reimbursement are not available or reimbursement is available only to limited levels, we may not successfully
commercialize any product candidate for which we obtain marketing approval or clearance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Healthcare Reform</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The United&#160;States and
some foreign jurisdictions are considering or have enacted a number of legislative and regulatory proposals to change the healthcare system
in ways that could affect our ability to sell our products profitably. Among policy makers and payors in the United&#160;States and elsewhere,
there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving
quality or expanding access.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 133; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the United&#160;States there
have been, and continue to be, proposals by the federal government, state governments, regulators and third-party payors to control or
manage the costs of health care and, more generally, to reform the U.S.&#160;healthcare system. For example, in March&#160;2010, the ACA
was enacted, which included changes to the coverage and payment for products under government health care programs. This law was designed
to expand access to health insurance coverage for uninsured and underinsured individuals while containing overall healthcare costs. The
ACA and certain of its provisions have been subject to judicial challenges as well as legislative and regulatory efforts to repeal or
replace them or to alter their interpretation or implementation. For example, on June&#160;17, 2021, the U.S.&#160;Supreme Court dismissed
a lawsuit challenging the constitutionality of certain aspects of the ACA without ruling on the merits of the constitutionality arguments.
The American Rescue Plan Act also temporarily increased premium tax credit assistance for individuals eligible for subsidies under the
ACA for 2021 and 2022 and removed the 400% federal poverty level limit that otherwise applies for purposes of eligibility to receive premium
tax credits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Most recently, the Inflation
Reduction Act&#160;of&#160;2022 (IRA) extended this increased tax credit assistance and removal of the 400% federal poverty limit through
2025. In the future, there may be additional challenges and/or amendments to the ACA.&#160;It remains to be seen precisely what any new
legislation will provide, when or if it will be enacted, and what impact it will have on the availability and cost of healthcare items
and services, including medical devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other legislative changes designed
to reduce healthcare expenditures have been proposed and adopted in the United&#160;States since the ACA was enacted. For example, through
the process created by the Budget Control Act&#160;of&#160;2011, there are automatic reductions of Medicare payments to providers up to
2% per fiscal year, which went into effect in April&#160;2013 and, following passage of the BBA and the Infrastructure Investment and
Jobs Act, will remain in effect until 2031 unless additional Congressional action is taken (with the exception of a temporary suspension
from May&#160;1, 2020 through March&#160;31, 2022 and a subsequent reduction to 1% from April&#160;1, 2022 until June&#160;30, 2022).
To offset the temporary suspension during the COVID-19 pandemic, in 2030, the sequestration will be 2.25% for the first half of the year,
and 3% in the second half of the year. In January&#160;2013, the American Taxpayer Relief Act&#160;of&#160;2012 was signed into law, which,
among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment
centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect that these initiatives,
as well as other healthcare reform measures that may be adopted in the future, as well as the trend toward managed healthcare and increasing
influence of managed care organizations, may result in more rigorous coverage criteria and lower reimbursement, and in additional downward
pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government-funded
programs may result in a similar reduction in payments from private payors. The implementation of current and future cost containment
measures or other healthcare reforms may adversely affect our operations and prevent us from being able to generate revenue, attain profitability
or commercialize our product candidates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 134; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MANAGEMENT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors and Executive Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the names and ages of all of our directors and executive officers as of April&#160;28, 2025. Our officers are appointed by, and serve
at the pleasure of, the Board of Directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: center"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 60%; text-align: center"><span style="font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Directors and Executive Officers:</i></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">Ben C.&#160;Hwang, Ph.D.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">57</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chairman of the Board; Chief Executive Officer</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">Fred Knechtel</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">64</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">Rajesh Asorpota</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">56</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">Lauren Chung</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">48</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">Peter O&#8217;Rourke</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">52</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Lead Independent Director</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">Jack Stover</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">71</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is information
about the experience and attributes of the members of our board of directors and senior executive officers as of the date of this prospectus.
The experience and attributes of our directors discussed below provide the reasons that these individuals were selected for board membership,
as well as why they continue to serve in such positions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Ben C.&#160;Hwang, Ph.D.
</b>&#8212;&#160;Dr.&#160;Hwang has served as Profusa&#8217;s Chairman of the Board and Chief Executive Officer since January&#160;2012.
Prior to Profusa, Dr.&#160;Hwang served in a variety of leadership roles at Life Technologies Corp. (acquired by Thermo Fisher Scientific,
Inc.), including President of the Asia Pacific Region and Head of the qPCR Division. Prior to joining Life Technology, Dr.&#160;Hwang
was a consultant with McKinsey&#160;&amp; Company. Dr.&#160;Hwang received his M.A. in Biology and Ph.D. in Biology from The Johns Hopkins
University. We believe that Dr.&#160;Hwang is well-qualified to serve as a director of our company based on his familiarity with Profusa&#8217;s
business, his experience in the life science industry, and his educational background.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Fred Knechtel</b>&#160;&#8212;&#160;Fred
Knechtel has served as our Chief Financial Officer and director since July&#160;2025. From August&#160;2022 to August&#160;2023, Mr.&#160;Knechtel
served as chief financial officer of DiamiR Biosciences. From January&#160;2020 to January&#160;2021, Mr.&#160;Knechtel served as chief
financial officer of Interpace Biosciences, Inc. From June&#160;2018 to December&#160;2018, Mr.&#160;Knechtel served as chief financial
officer of GENEWIZ, Inc. From November&#160;2014 to November&#160;2017, Mr.&#160;Knechtel served as group chief financial officer of Sims
Metal Management. From November&#160;2009 to October&#160;2014, Mr.&#160;Knechtel served as chief financial officer of Remy International,
Inc. Mr.&#160;Knechtel received a Bachelor of Engineering from Stony Brook University and a M.B.A in Finance from Hofstra University.
We believe that Mr.&#160;Knechtel is well-qualified to serve as a director of our company based on Mr.&#160;Knechtel&#8217;s experience
holding high level executive positions in the life sciences industry, and his financial and accounting experience.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Rajesh Asarpota</b>&#160;&#8212;&#160;Mr.&#160;Asarpota
is currently the chief financial officer at Augmedics, a company that has pioneered cutting-edge augmented reality technologies to improve
surgical outcomes for spine surgery. Prior to Augmedics, from September&#160;2020 to October&#160;2021, he served at ApiJect as executive
vice president, chief financial officer and head of technology. ApiJect is a medical technology company that seeks to revolutionize how
medicines and vaccines are filled, finished and delivered. Prior to ApiJect, from August&#160;2017 to September&#160;2020, Asarpota served
as executive vice president and chief financial officer with NuVasive, a global public company and leader in minimally invasive, procedurally
integrated spine solutions. Prior to NuVasive, he spent two&#160;years in the private equity space at Imaging Advantage and Cole Parmer
as executive vice president and chief financial officer. Imaging Advantage was acquired by Envision in 2015. In 2014, he served as the
executive vice president and chief financial officer for Questcor Pharmaceuticals which was acquired by Mallinckrodt in a $5.6B transaction.
Mr.&#160;Asarpota also spent a decade at Life Technologies, a global life sciences company where he was responsible for helping scale
the organization, driving growth through organic and M&amp;A channels. During his tenure, the company revenue grew from approximately
$1B to more than $4B in 2014, leading to the company&#8217;s sale to Thermo Fisher for $13.6&#160;billion that year. Prior to Life Technologies,
Mr.&#160;Asarpota spent 11&#160;years at GE in several finance leadership roles. Mr.&#160;Asarpota holds a M.B.A. from Marquette University
and a Bachelor of Commerce from the University of Bombay. We believe that Mr.&#160;Asarpota is well-qualified to serve as a director of
our company based on his healthcare focused experience.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 135; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Lauren Chung</b>&#160;&#8212;&#160;Lauren
Chung has served as a director since July&#160;2025. Since November&#160;2019, Dr.&#160;Chung has served as chief executive officer of
MINLEIGH LLC, identifying, evaluating and partnering with companies for investments and strategic, operational, and commercial opportunities,
and venture partner at Yozma Group. From May&#160;2017 to November&#160;2019, Dr.&#160;Chung was an Equity Research Managing Director
at WestPark Capital. From August&#160;2016 to April&#160;2017, Dr.&#160;Chung as in equity research at Maxim Group. Previously, Dr.&#160;Chung
founded and served as chief operating officer and chief compliance officer of Tokum Capital Management, a global healthcare investment
fund. Prior to that, she managed healthcare investment portfolios at institutional investment firms. Dr.&#160;Chung serves as director
of Todos Medical Ltd. Dr.&#160;Chung previously served as director of Cure Pharmaceutical Holding Corp from August&#160;2019 until November&#160;2021,
UltraSight, Inc from December&#160;2020 to December&#160;2021, and AdiTxt, Inc. from June&#160;2021 until December&#160;2021. Dr.&#160;Chung
holds a Ph.D. in Neuropathology from Columbia University-College of Physicians&#160;&amp; Surgeons, an M.B.A from Columbia Business School,
and a BA with honors in Biochemistry and Economics from Wellesley College. We believe that Dr.&#160;Chung is well-qualified to serve as
a director of our company based on Dr.&#160;Chung&#8217;s extensive corporate board and investment analysis experience.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Peter O&#8217;Rourke&#160;</b>&#8212;&#160;Peter
O&#8217;Rourke has served as Lead Independent Director since July&#160;2025. Since December&#160;2018, Mr.&#160;O&#8217;Rourke has served
as Managing Partner at TCI Partners, a consulting firm focused on healthcare, aerospace and the public sector. From November&#160;2020-August&#160;2022,
Mr.&#160;O&#8217;Rourke was President and Director for Western Magnesium, where he created the U.S.&#160;operations strategy and team
during the successful technology pilot phase of the company, and led enterprise and defense business development, government affairs,
and communications. From January&#160;2017 to December&#160;2018, Mr.&#160;O&#8217;Rourke served as the Acting Secretary and Chief of
Staff of the Department of Veteran Affairs. From May&#160;2015 to July&#160;2016, Mr.&#160;O&#8217;Rourke served as a principal of Calibre
Systems, Inc., a consulting firm. Mr.&#160;O&#8217;Rourke also served in both the U.S.&#160;Navy and Air Force. Mr.&#160;O&#8217;Rourke
served as Director for AXIM Biotechnologies from July&#160;2020 to present. AXIM is a vertically integrated research and development company
focused on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease (DED) through rapid diagnostic
tests. Mr.&#160;O&#8217;Rourke received a Bachelor of Arts in Political Science from the University of Tennessee in Knoxville as well
as a Master of Science in Logistics and Supply Chain Management from the United&#160;States Air Force&#8217;s Institute of Technology.
We believe that Mr.&#160;O&#8217;Rourke is well-qualified&#160;to serve as a director of our company based on Mr.&#160;O&#8217;Rourke&#8217;s
leadership and consulting experience in the healthcare industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Jack Stover</b>&#160;&#8212;<b>&#160;</b>Jack
Stover has served as a director since July&#160;2025. Since November&#160;2018, Mr.&#160;Stover has been director, member of the compensation
committee, chairman of the audit committee, chairman of the special deal committee and recently Lead Independent Director of Traws Pharma
Inc. (TRAW) (formerly Onconova Therapeutics, Inc. (ONTX)) a Nasdaq-based&#160;novel small molecule anti-viral&#160;and oncology therapeutics
company with products in various clinical trials. Mr.&#160;Stover has also been a member of the board of directors of Stero Therapeutics,
Inc., a private medical company, since February&#160;2024. Mr.&#160;Stover was appointed to the board of directors and chairman of the
audit committee of PharmaCyte Biotech, Inc. (PMBC) effective August&#160;15, 2022 and resigned from the Board effective November&#160;1,
2022. From June&#160;2016 to November&#160;2020, Mr.&#160;Stover served as president, chief executive officer and director of Interpace
Biosciences, Inc., (IDXG) a publicly-traded&#160;small cap life sciences company providing complex molecular analysis for the early diagnosis
and treatment of cancer and supporting the development of targeted therapeutics and previously from December&#160;2015 until June&#160;2016,
served as interim president and chief executive officer of IDXG.&#160;Mr.&#160;Stover was also on the board of directors of IDXG from
August&#160;2005 until November&#160;2020, and was chairman of the audit committee from August&#160;2005 until December&#160;2015. From
June&#160;2016 to December&#160;2016, Mr.&#160;Stover was chairman of the audit committee and a member of the board of directors of Viatar
CTC Solutions, Inc. From 2004 to 2008, he served as chief executive officer, president and director of Antares Pharma, Inc., a publicly
held specialty pharmaceutical company then listed on the American Stock Exchange. In addition to other relevant experience, Mr.&#160;Stover
was also formerly a partner with PricewaterhouseCoopers (then Coopers and Lybrand), working in the bioscience industry division in Pennsylvania
and New Jersey. Mr.&#160;Stover received his B.A. in Accounting from Lehigh University and is a Certified Public Accountant. We believe
that Mr.&#160;Stover is well-qualified&#160;to serve as a director of our company based on Mr.&#160;Stover&#8217;s experience holding
senior leadership positions in the life sciences industry, and his specific experience and skills in the areas of general operations,
financial operations and administration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No director is related to any
other director or executive officer of our company or our subsidiaries, and, there are no arrangements or understandings between a director
and any other person pursuant to which such person was elected as director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 136; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>GOVERNANCE OF THE COMPANY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Classification of Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors (the
&#8220;Board&#8221;) consists of five members, divided into three classes of directors that will serve staggered three-year&#160;terms.
At each annual meeting of stockholders, a class of directors will be elected for a three-year&#160;term to succeed the same class whose
term is then expiring. As a result, only one class of directors will be elected at each annual meeting of our stockholders, with the other
classes continuing for the remainder of their respective three-year&#160;terms. Our directors are divided among the three classes as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the Class&#160;I director is Lauren Chung, and her terms will expire at the first annual meeting of stockholders;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the Class&#160;II directors are Jack Stover and Peter O&#8217;Rourke, and their terms will expire at the
second annual meeting of stockholders; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the Class&#160;III directors are Ben Hwang and Rajesh Asarpota, and their terms will expire at the third
annual meeting of stockholders.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board intends for Dr.&#160;Hwang
to serve as both Chairman of the Board and Chief Executive Officer, and for Mr.&#160;O&#8217;Rourke to serve as the Lead Independent Director.
Our board believes that this strikes an appropriate balance between strong Company leadership with deep knowledge of our business through
a combined Chairman of the Board and Chief Executive Officer role, and independent oversight through a Lead Independent Director position.
More specifically, our Board believes that the Lead Independent Director position helps maintain an appropriate level of independent checks
and balances, enables independent oversight of management and encourages objective oversight of management&#8217;s performance, reinforcing
the independence of the Board as a whole and enhancing its overall effectiveness. In the role of Lead Independent Director, Mr.&#160;O&#8217;Rourke
will (i)&#160;preside over Board meetings at which the Chairman of the Board is not present, (ii)&#160;preside over executive sessions
of the independent directors, (iii)&#160;serve as a liaison between the independent directors and the Chairman of the Board, (iv)&#160;be
authorized to call meetings of the independent directors, (v)&#160;lead the Board in discussions concerning our Chief Executive Officer&#8217;s
performance and succession, (vi)&#160;consult with the Chairman of the Board regarding meeting agendas and meeting schedules for the Board,
(vii)&#160;be available for consultation and direct communication if requested by major stockholders and (viii)&#160;perform such other
duties as requested by the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the Board has concluded
that this leadership structure is appropriate for us at this time, the Nominating and Corporate Governance Committee will be charged with
periodically reviewing the Board&#8217;s leadership structure. With the committee&#8217;s support, the Board will continue to regularly
evaluate its leadership structure and may exercise its discretion to make changes designed to ensure an appropriate and effective framework
of governance and accountability, taking into consideration the needs of our business and the long-term&#160;interests of our stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each director&#8217;s term
continues until the election and qualification of his or her successor, or his or her earlier death, resignation or removal. Our certificate
of incorporation and bylaws authorize only our board of directors to fill vacancies on the board of directors. Any increase or decrease
in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third&#160;of
the directors. This classification of our board of directors may have the effect of delaying or preventing changes in control.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Independence of our Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Three (3)&#160;of our five&#160;(5)&#160;directors
are independent directors and our Board consists of an independent audit committee, nominating committee and compensation committee. Peter
O&#8217;Rourke, Rajesh Asorpota, and Lauren Chung are &#8220;independent directors,&#8221; as defined in Nasdaq listing standards and
applicable SEC rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 137; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Committees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audit committee is responsible
for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered
public accounting firm;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">discussing with our independent registered public accounting firm their independence from management;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reviewing, with our independent registered public accounting firm, the scope and results of their audit;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">approving all audit and permissible non-audit&#160;services to be performed by our independent registered
public accounting firm;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">overseeing the financial reporting process and discussing with management and our independent registered
public accounting firm the annual financial statements that we file with the SEC;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">overseeing our financial and accounting controls and compliance with legal and regulatory requirements;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reviewing our policies on risk assessment and risk management;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reviewing related person transactions; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting,
internal controls or auditing matters.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audit committee consists
of Lauren Chung (Chair), Rajesh Asarpota and Peter O&#8217;Rourke each of whom qualify as independent directors according to the rules
and regulations of the SEC and Nasdaq with respect to audit committee membership. In addition, all of the audit committee members meet
the requirements for financial literacy under applicable SEC and Nasdaq rules and qualify as an &#8220;audit committee financial expert,&#8221;
as such term is defined in Item&#160;407(d)&#160;of Regulation&#160;S-K.&#160;Our Board has adopted a written charter for the audit committee,
which is be available on our website. The reference to our website address in this prospectus does not include or incorporate by reference
the information on our website into this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation committee
is responsible for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing
and approving, (either alone or, if directed by the board of directors, in conjunction with a majority of the independent members of the
board of directors) the compensation of our Chief Executive Officer;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">overseeing an evaluation of the performance of and reviewing and setting or making recommendations to
our board of directors regarding the compensation of our other executive officers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reviewing and approving or making recommendations to our board of directors regarding our incentive compensation
and equity-based&#160;plans, policies and programs;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">reviewing and approving all employment agreement and severance arrangements for our executive officers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">making recommendations to our board of directors regarding the compensation of our directors; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">retaining and overseeing any compensation consultants.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation committee
consists of Rajesh Asarpota (Chair), Lauren Chung, and Peter O&#8217;Rourke, each of whom qualify as independent directors according to
the rules and regulations of the SEC and Nasdaq with respect to compensation committee membership, including the heightened independence
standards for members of a compensation&#160;committee. Our Board adopted a written charter for the compensation committee, which is available
on our website. The reference to our website address in this prospectus does not include or incorporate by reference the information on
our website into this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 138; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nominating Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our nominating committee is
responsible for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">identifying individuals qualified to become members of our board of directors, consistent with criteria
approved by our board of directors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">overseeing succession planning for our Chief Executive Officer and other executive officers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">periodically reviewing our board of directors&#8217; leadership structure and recommending any proposed
changes to our board of directors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">overseeing an annual evaluation of the effectiveness of our board of directors and its committees; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">developing and recommending to our board of directors a set of corporate governance guidelines.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our nominating committee consists
of Peter O&#8217;Rourke (Chair), Jack Stover and Lauren Chung, each of whom qualify as independent directors according to the rules and
regulations of the SEC and Nasdaq with respect to nominating committee membership. Our Board adopted a written charter for the nominating
committee, which is available on our website after adoption. The reference to our website address in this prospectus does not include
or incorporate by reference the information on our website into this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Oversight</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors is responsible
for overseeing our risk management process. Our board of directors focuses on our general risk management strategy, the most significant
risks facing us, and oversees the implementation of risk mitigation strategies by management. Our audit committee is also responsible
for discussing our policies with respect to risk assessment and risk management. Our board of directors believes its administration of
its risk oversight function has not negatively affected our board of directors&#8217; leadership structure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Ethics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board adopted a Code of
Ethics applicable to our directors, executive officers and team members that complies with the rules and regulations of Nasdaq and the
SEC.&#160;The Code of Ethics is available on our website. In addition, we intends to post on the Corporate Governance section of our website
all disclosures that are required by law or Nasdaq listing standards concerning any amendments to, or waivers from, any provision of the
Code of Ethics. The reference to our website address in this prospectus does not include or incorporate by reference the information on
our website into this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 139; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXECUTIVE COMPENSATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This section discusses the
material components of the executive compensation program for Profusa&#8217;s named executive officers identified in the Summary Compensation
Table below. This discussion may contain forward-looking&#160;statements that are based on our current plans, considerations, expectations
and determinations regarding future compensation programs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have opted to comply with
the executive compensation disclosure rules applicable to emerging growth companies, as we are an emerging growth company. The scaled
down disclosure rules are those applicable to &#8220;smaller reporting companies,&#8221; as such term is defined in the rules promulgated
under the Securities Act. Such rules, in the context of an S-4&#160;Registration Statement, require compensation disclosure for Profusa&#8217;s
principal executive officer and its two most highly compensated executive officers other than the principal executive officer whose total
compensation for 2024 exceeded $100,000, who were serving as executive officers as of December&#160;31, 2024. We refer to these individuals
as &#8220;named executive officers.&#8221; For 2024, Ben Hwang, Chief Executive Officer and Chairman, was Profusa&#8217;s only &#8220;named
executive officer.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Compensation of Named Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Base salaries are intended
to provide a level of compensation sufficient to attract and retain an effective management team, when considered in combination with
the other components of the executive compensation program. In general, Profusa provides a base salary level designed to reflect the executive
officer&#8217;s scope of responsibility and accountability. While cash bonuses have been provided on a discretionary basis in prior&#160;years,
Dr.&#160;Hwang did not receive a cash bonus with respect to 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Equity Awards</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While Profusa maintains an
equity compensation plan, during 2024, Dr.&#160;Hwang did not receive any equity awards with respect to Profusa and, as of December&#160;31,
2024, Dr.&#160;Hwang did not hold any outstanding equity awards with respect to Profusa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Compensation Table</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table shows information
regarding the compensation of Dr.&#160;Hwang, our sole named executive officer, for services performed in the&#160;years ended December&#160;31,
2024 and 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Option <br/> Awards <br/> ($)<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock <br/> Awards <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Non-Equity <br/> Incentive Plan <br/> Compensation <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">All Other <br/> Compensation <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 10%; font-weight: bold; text-align: left">Ben Hwang</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: center">&#160;</td><td style="width: 9%; font-weight: bold; text-align: center">2024</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">470,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">&#8212;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">&#8212;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">&#8212;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">&#8212;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">&#8212;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">470,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; font-style: italic; text-align: left">Chief&#160;Executive&#160;Officer&#160;and&#160;Chairman</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">470,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8212;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8212;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8212;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8212;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8212;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">470,000</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Equity Awards at 2023 Fiscal Year-End</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
Dr.&#160;Hwang did not hold any outstanding equity awards with respect to Profusa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 140; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional Narrative Disclosure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Severance Arrangements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa generally executes
an offer of employment before an executive joins Profusa. This offer describes the basic terms of the executive&#8217;s employment, including
his or her start date, starting salary, annual incentive target (if any) and equity awards. Profusa does not maintain a general severance
policy. However, Dr.&#160;Hwang&#8217;s offer letter, dated January&#160;1, 2013, provides that, upon a termination of employment by Profusa
without cause, Profusa will pay him six&#160;months&#8217; base salary plus a pro-rata&#160;portion of any earned bonus payment (in a
lump sum payment), as well as pay his monthly COBRA premiums for up to six&#160;months, subject to Dr.&#160;Hwang&#8217;s execution of
a release of claims in favor of Profusa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>401(k)&#160;Plan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa maintains a qualified
401(k)&#160;savings plan which allows participants to defer a portion of their compensation to the 401(k)&#160;savings plan on a before-tax&#160;and
after-tax&#160;basis. Profusa provides discretionary profit sharing contributions on behalf of its eligible participants. Profusa did
not make any profit sharing contributions in 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa&#8217;s historical
director compensation program has consisted of equity awards. However, in 2024, Profusa did not grant any equity awards to its non-employee&#160;directors
and did not pay any cash director fees or other compensation to its non-employee&#160;directors. As of December&#160;31, 2024, the non-employee&#160;directors
held outstanding options to purchase Profusa shares as follows: Joan Braddi&#160;&#8212;&#160;80,000&#160;shares. As Profusa&#8217;s Chief
Executive Officer, Dr.&#160;Hwang does not receive any additional compensation for his service on the Profusa board of directors. Please
see the Summary Compensation Table for the compensation paid or awarded to Dr.&#160;Hwang in 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Granting of Certain Equity Awards Close in
Time to the Release of Material Nonpublic Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do&#160;not&#160;grant equity
awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common
stock, and do not time the public release of such information based on award grant dates. During the last completed fiscal year, we have
not made awards to any named executive officer or director during the period beginning four&#160;business days before and ending one business&#160;day
after the filing of a period report on Form&#160;10-Q or Form&#160;10-K or the filing or furnishing of a current report on Form&#160;8-K,
and we have&#160;not&#160;timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 141; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information, as of August 28, 2025, regarding beneficial ownership of our common stock by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each of our directors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each of our named executive officers;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">all directors and executive officers as a group; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each person, or group of affiliated persons, known by us to beneficially own more than five percent of
our shares of common stock.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beneficial ownership is determined
according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses
sole or shared voting or investment power over that security, including options, warrants and certain other derivative securities that
are currently exercisable or will become exercisable within 60&#160;days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The percentage of beneficial
ownership is based on 41,759,307 shares of Common Stock issued and outstanding as of October 8, 2025.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with SEC rules,
shares of our Common Stock which may be acquired upon exercise of stock options or warrants which are currently exercisable or which become
exercisable within 60&#160;days of the date of the Closing are deemed beneficially owned by the holders of such options and warrants and
are deemed outstanding for the purpose of computing the percentage of ownership of such person, but are not treated as outstanding for
the purpose of computing the percentage of ownership of any other person.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated,
the business address of each of the entities, directors and executives in this table is 626 Bancroft Way, Suite A, Berkeley, CA&#160;94710.
Unless otherwise indicated and subject to community property laws and similar laws, the Company believes that all parties named in the
table below have sole voting and investment power with respect to all shares of Common Stock beneficially owned by them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Beneficial Ownership Table</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: justify">Executive Officers and Directors:</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ben Hwang, Ph.D.<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">844,228</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fred Knechtel<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,985,042</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Rajesh Asarpota</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 9pt">Lauren Chung</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Peter O&#8217;Rourke</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Stover<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,658,652</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All directors and executive officers as a group (six individuals)<sup>(1)(2)(3)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,829,270</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Five Percent or More Holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NorthView Sponsor&#160;I, LLC<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,368,872</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascent Partners Fund LLC<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,433,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: justify"><span style="font-style: normal; font-weight: normal">Jesse Santana</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,140,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.1</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Includes 366,886&#160;shares held by Samantha Chiu, the spouse
of Ben Hwang, Ph.D.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Consists of (i)&#160;288,407&#160;shares and 37,983&#160;shares
issuable upon exercise of warrants held directly by Mr.&#160;Knechtel and (ii)&#160;shares and shares issuable upon exercise of warrants
held by NorthView Sponsor&#160;I, LLC, of which Mr.&#160;Knechtel is a manager. Mr.&#160;Knechtel disclaims beneficial ownership of the
reported shares other than to the extent of his ultimate pecuniary interest therein.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Consists of shares and shares issuable upon exercise of warrants
held by NorthView Sponsor&#160;I, LLC, of which Mr.&#160;Stover is a manager. Mr.&#160;Stover disclaims beneficial ownership of the reported
shares other than to the extent of his ultimate pecuniary interest therein.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">Consists of 4,743,750&#160;shares and 4,625,122&#160;shares
issuable upon exercise of warrants. The business address of NorthView Sponsor, LLC is 207 West 25<sup>th</sup>&#160;St, 9<sup>th</sup>&#160;Floor,
New&#160;York, NY&#160;10001.</td>
</tr></table><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: justify">Comprised of 1,863,593&#160;shares currently outstanding as
of August&#160;1, 2025, 1,000,000 shares issuable upon conversion of the Initial Note, and 570,000 of the Commitment Warrant Shares.
The 8,070,830 Purchase Shares and the balance of 330,000 Commitment Warrant Shares are not included in the table above because these
share issuances are subject to a beneficial ownership limitation of 9.99%. The business address of Ascent Partners Fund LLC is 19505
Biscayne Blvd., Suite 2350, Aventura, FL&#160;33180.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 142; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Investor Rights Agreement</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May&#160;2018, Profusa entered
into an amended and restated investor rights agreement (the &#8220;IRA&#8221;) with certain holders of its preferred stock and common
stock, including certain holders of 5% of its capital stock, and including certain affiliates of its directors, and certain of its executive
officers. The IRA provides the holders of Profusa&#8217;s convertible preferred stock with certain registration rights, including the
right to demand that Profusa files a registration statement or request that their shares be covered by a registration statement that Profusa
is otherwise filing. The IRA also provides certain major stockholders with information rights and a right of first refusal with regard
to certain issuances of Profusa&#8217;s capital stock. The IRA will terminate upon the closing of the merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Voting Agreement</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May&#160;2018, Profusa entered
into an amended and restated voting agreement (the &#8220;Voting Agreement&#8221;) with certain holders of its preferred stock and common
stock, including certain holders of 5% of its capital stock, and including certain affiliates of its directors, and certain of its executive
officers. Pursuant to the Voting Agreement, certain holders of its preferred stock and common stock have agreed to vote their shares in
favor of the election of certain directors and specified transactions approved by the requisite number of the shares of its voting capital
stock held by investors party thereto. The Voting Agreement will terminate upon the closing of the merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Right of First Refusal and Co-Sale Agreement</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May&#160;2018, Profusa entered
into an amended and restated right of first refusal and co-sale&#160;agreement (the &#8220;Co-Sale&#160;Agreement&#8221;) with certain
holders of its preferred stock and common stock, including certain holders of 5% of its capital stock, and including certain affiliates
of its directors, and certain of its executive officers. Pursuant to the Co-Sale&#160;Agreement, Profusa has a right of first refusal
in respect of certain sales of securities by certain holders of its capital stock. To the extent Profusa does not exercise such right
in full, certain holders of its preferred stock are granted certain rights of first refusal and co-sale&#160;in respect of such sales.
The Co-Sale&#160;Agreement will terminate upon the closing of the merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>APAC Joint Venture Term Sheet</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July&#160;2020, Profusa
entered into a Binding Term Sheet for APAC Joint Venture (the &#8220;Original Term Sheet&#8221;) with Carbis Bay Limited, BC hSensor Limited,
and Tasly (International) Healthcare Capital Company Limited (collectively, the &#8220;Investors&#8221;), pursuant to which Profusa and
the Investors are negotiating definitive transaction agreements for a joint venture (the &#8220;JV&#8221;) intended to commercialize Lumee
Glucose and Lumee Oxygen (collectively, the &#8220;Licensed Products&#8221;) in the Asia Pacific region, which includes Greater China
(which includes the People&#8217;s Republic of China (&#8220;China&#8221;), Hong&#160;Kong SAR, Macau SAR, Taiwan), South Korea, New Zealand,
Australia and the 10 ASEAN countries (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam)
(together the &#8220;Asia Pacific Region&#8221;). Subsequently, on May&#160;10, 2023, Profusa and the Investors entered into Amendment
Number One to Binding Term Sheet for APAC Joint Venture, which amended the Original Term Sheet (the Original Term Sheet, as so amended,
the &#8220;Term Sheet&#8221;). Pursuant to the Term Sheet, Profusa and the Investors intend for Profusa to form the JV, initially to be
wholly owned by Profusa. Profusa would grant the JV an irrevocable, exclusive, perpetual, sub-licensable&#160;and assignable license to
its intellectual property to use, implement, develop, improve, manufacture, register, distribute, sell and promote the Licensed Products
in the Asia Pacific Region. The term of the license would be perpetual. As up-front, lump-sum&#160;consideration for the license, the
JV would issue to Profusa ordinary shares of the JV with value equal to $10&#160;million, contingent upon an independent third-party&#160;valuation
firm determining that the value of the license is no less than $10&#160;million and a sub-licensing&#160;agreement to be entered into
between certain of the Investors and the JV.&#160;Subject to certain closing conditions, Tasly Holding Group Co. Ltd. or its affiliates
(collectively, &#8220;Tasly&#8221;) would then purchase 60% of the share capital of the JV from Profusa for $6&#160;million, resulting
in the JV being 60% owned by Tasly and 40% owned by Profusa. The JV would also pay Profusa 5% royalties on sales, and 30% royalties on
income from royalties, sub-licensing&#160;fees or collaboration payments received by the JV, with the definitive payment terms of such
royalties and fees to be agreed in a written definitive agreement for the license. Between 18 and 36&#160;months following the transfer
of equity to Tasly, the Investors would also have an option to invest in preference shares of the JV at a pre-money&#160;valuation of
$10&#160;million, with allocations of investment amounts and ownership percentages in the JV among the Investors being 24.95% for each
of Carbis Bay Limited, BC hSensor Limited and 50.1% for Tasly. The Term
Sheet also contemplates that the definitive transaction documents would include provisions for the governance of the JV and the rights
of Profusa and the Investors in respect thereof. If the definitive agreements required to consummate the APAC Joint Venture have not been
executed or the JV has not been formed as of May&#160;10, 2024, the Term Sheet will terminate automatically, unless otherwise extended
by mutual agreement among the Company and the Investors. Further, if the definitive agreements required to consummate the APAC Joint Venture
are under negotiation as of May&#160;10, 2024, the Term Sheet shall not expire and shall remain in effect. As of the date of this filing,
Profusa has entered into the binding Term Sheet with Tasly, and the associated definitive agreements are in final agreed form.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 143; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tasly Convertible Debt</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June&#160;2023, Profusa
entered into a short-term&#160;loan agreement with Tasly (International) Healthcare Investment&#160;&amp; Development Company Limited,
a shareholder of Profusa, which it may borrow up to $1.6&#160;million, of which $1.0&#160;million was borrowed on June&#160;26, 2023,
and the remainder was available to be borrowed by August&#160;31, 2023 (the &#8220;Tasly Convertible Debt&#8221;). The loan bears interest
at a rate of 12% per annum and matured on December&#160;31, 2023, subject to the parties&#8217; decision to extend. Upon occurrence of
certain events of default by Profusa, including failure to repay in full the amounts owed at maturity, the lender will have an option
to convert the entire outstanding balance and accrued but unpaid interest under the Tasly Convertible Debt into senior unsecured promissory
notes on substantially the same terms as the outstanding Senior Notes as of June 30, 2025. In the event Profusa fails to repay the Tasly
Convertible Debt, the lender will have an option to convert the entire outstanding balance and accrued but unpaid interest under the Tasly
Convertible Debt into either (i)&#160;senior unsecured promissory notes on substantially the same terms as the outstanding Senior Notes
as of June 30, 2025, or (ii)&#160;the Company&#8217;s common stock at a conversion price of $1.92 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa elected to apply the
fair value option to account for the Tasly Convertible Debt. Accordingly, no features of the Tasly Convertible Debt are bifurcated and
separately accounted for. The fair value of the Tasly Convertible Debt was $1.003&#160;million at issuance and $2.5&#160;million as of
June 30, 2025, respectively. Accrued stated interest on the Tasly Convertible Debt was $0.2&#160;million for the six months ended June
30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Equity Grants to Executive Officers and
Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa has granted stock options
to its executive officers and certain directors, as more fully described in the section titled &#8220;<i>Management of Profusa&#160;&#8212;&#160;Executive
and Director Compensation</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Director and Executive Officer Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see the section titled
&#8220;<i>Management of Profusa&#160;&#8212;&#160;Executive and Director Compensation</i>&#8221; for information regarding the compensation
of Profusa&#8217;s executive officers and directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Severance Arrangements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa has entered into severance
arrangements with certain of its executive officers. For more information regarding these agreements, see the section titled &#8220;<i>Management
of Profusa&#160;&#8212;&#160;Executive and Director Compensation of Profusa&#160;&#8212;&#160;Additional Narrative Disclosure&#160;&#8212;&#160;Severance
Arrangements</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Indemnification Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We entered into new indemnification
agreements with each of our directors and executive officers that are not already party to indemnification agreements. The indemnification
agreements, our amended and restated certificate of incorporation and our amended and restated bylaws require us to indemnify our directors
to the fullest extent not prohibited by Delaware law. Subject to certain limitations, our amended and restated bylaws also require it
to advance expenses incurred by the combined company&#8217;s directors and officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 144; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>NorthView Related Party Transactions Pre-Business
Combination</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Founder Shares</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2021, our sponsor
purchased 5,175,000 founder shares for an aggregate purchase price of $25,000. In October&#160;2021, our sponsor forfeited 862,500 founder
shares. On December&#160;20, 2021, we effected a 1.1-for-1&#160;stock dividend of our common stock, resulting in an aggregate of 4,743,750
founder shares (up to 618,750 of which are subject to forfeiture).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our sponsor purchased an aggregate
of 5,162,500 private placement warrants, each exercisable to purchase one share of common stock at $11.50 per share, at a price of $1.00
per warrant ($5,162,500 in the aggregate), in a private placement that closed simultaneously with the closing of our initial public offering.
The private placement warrants (including the shares of common stock issuable upon exercise of the private placement warrants) may not,
subject to certain limited exceptions, be transferred, assigned or sold until 30&#160;days after the completion of our initial business
combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of our officers or directors
becomes aware of a business combination opportunity that falls within the line of business of any entity to which he or she has then-current&#160;fiduciary
or contractual obligations, he or she may be required to present such business combination opportunity to such entity prior to presenting
such business combination opportunity to us. Our executive officers and directors currently have certain relevant fiduciary duties or
contractual obligations that may take priority over their duties to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Administrative Services Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We entered into an Administrative
Services Agreement pursuant to which we pay NorthView Sponsor&#160;I, LLC, an affiliate of one of our officers, a total of $5,000 per
month for office space, utilities, secretarial support and other administrative and consulting services which the Company and the sponsor
terminated on June 30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our sponsor, executive officers
and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket&#160;expenses incurred in connection with
activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates
and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement
of out-of-pocket&#160;expenses incurred by such persons in connection with activities on our behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Promissory Notes</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to the closing of our
initial public offering, our sponsor loaned us $204,841 to be used for a portion of the expenses of our initial public offering. These
loans were non-interest&#160;bearing, unsecured and were repaid on the closing of our initial public offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in order to finance
transaction costs in connection with an intended initial business combination, our initial stockholders or an affiliate of our initial
stockholders or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Shortly after completing
the initial business combination, we will repay such loaned amounts. Up to $1,500,000 of such loans may be, at the option of the lender,
convertible into warrants at a price of $1.00 per warrant of the post business combination entity. The warrants would be identical to
the private placement warrants, including as to exercise price, exercisability and exercise period. The terms of such loans, if any, have
not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than
our initial stockholders or an affiliate of our initial stockholders or certain officers and directors as we do not believe third parties
will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may pay consulting, finder or success fees
to our initial stockholders, officers, directors or their affiliates for assisting us in consummating our initial business combination.
Other than these consulting, finder or success fees, no compensation of any kind will be paid by us to our initial stockholders, executive
officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of
an initial business combination. However, these individuals will be reimbursed for any out-of-pocket&#160;expenses incurred in connection
with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
Our audit committee will review on a quarterly basis all payments that were made to our initial stockholders, officers, directors or our
or their affiliates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 145; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We entered into a registration
rights agreement with respect to the founder shares and private placement warrants (and underlying securities).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $1,200,000. The Note is non-interest&#160;bearing
and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert all
or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant. On January&#160;10, 2024,
the Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor. On May&#160;31,
2024, the Company&#8217;s Board of Directors approved and the Company entered into a second amendment of its Convertible Working Capital
Promissory Note with the sponsor to increase the principal amount of the Note that could be drawn on to $2.5&#160;million. The second
amended and restated Note also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company
common stock at a price of $2.22 per share at the election of the sponsor. As of December&#160;31, 2024, the Company had principal outstanding
of $1,919,796 and is presenting the Note at fair value on its balance sheet at December&#160;31, 2024 in the amount of $8,908,052.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Procedures for Approval of Related Party Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A &#8220;related party transaction&#8221;
is any actual or proposed transaction, arrangement or relationship or series of similar transactions, arrangements or relationships, including
those involving indebtedness not in the ordinary course of business, to which we or our subsidiaries were or are a party, or in which
we or our subsidiaries were or are a participant, in which the amount involved exceeded or exceeds the lesser of (i)&#160;$120,000 or
(ii)&#160;one percent of the average of our total assets at year-end for the last two completed fiscal&#160;years and in which any related
party had or will have a direct or indirect material interest. A &#8220;related party&#8221; includes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any person who is, or at any time during the applicable period was, one of our executive officers or one
of our directors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any person who beneficially owns more than 5% of our common stock;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any immediate family member of any of the foregoing; or</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any entity in which any of the foregoing is a partner or principal or in a similar position or in which
such person has a 10% or greater beneficial ownership interest.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Audit Committee is responsible
for reviewing and approving in advance any related party transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 146; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SELLING STOCKHOLDERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus covers the resale of up to an aggregate of 42,594,048
shares of common stock, comprising: (a) up to 42,211,548 shares of Common Stock that we may, at our election, issue and sell to Ascent
Partners from time to time pursuant to the Purchase Agreement, subject to the satisfaction of specified conditions; and (b) up to 382,500
shares of Common Stock issued to certain parties in satisfaction of transaction costs incurred in connection with the Business Combination
we completed on July 11, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth certain information with respect to
the Selling Stockholders, including (i)&#160;the shares of our common stock beneficially owned by the Selling Stockholders prior to this
offering, (ii)&#160;the number of shares being offered by the Selling Stockholders pursuant to this prospectus and (iii)&#160;the Selling
Stockholders&#8217; beneficial ownership after completion of this offering, assuming that all of the shares covered hereby (but none of
the other shares, if any, held by the Selling Stockholder) are sold.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table is based on information
supplied to us by the Selling Stockholders, with beneficial ownership and percentage ownership determined in accordance with the rules
and regulations of the SEC and includes voting or investment power with respect to shares of stock. This information does not necessarily
indicate beneficial ownership for any other purpose. In computing the number of shares beneficially owned by the Selling Stockholders
and the percentage ownership of the Selling Stockholders, shares of common stock subject to warrants held by the Selling Stockholders
that are exercisable within 60&#160;days after the date hereof, are deemed outstanding. Such shares, however, are not deemed outstanding
for the purposes of computing the percentage ownership of any other person. The percentage of beneficial ownership after this offering
is based on 41,759,307 shares outstanding on October 8, 2025.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The registration of these shares of common stock does not mean that
the Selling Stockholders will sell or otherwise dispose of all or any of those securities. The Selling Stockholders may sell or otherwise
dispose of all, a portion or none of such shares from time to time. We do not know the number of shares, if any, that will be offered
for sale or other disposition by the Selling Stockholders under this prospectus. Furthermore, the Selling Stockholders may have sold,
transferred or disposed of the shares of common stock covered hereby in transactions exempt from the registration requirements of the
Securities Act since the date on which we filed this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To our knowledge and except as noted below, the Selling Stockholders
have not, nor within the past three&#160;years has had, any position, office or other material relationship with us or any of our predecessors
or affiliates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Shares of<span style="text-decoration:underline"><br/> </span>common stock<span style="text-decoration:underline"><br/> </span>beneficially<span style="text-decoration:underline"><br/> </span>owned prior to<span style="text-decoration:underline"><br/> </span>this offering</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><b>Number of<br/> shares of common</b></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Shares of common stock <br/> beneficially owned after <br/> sale of all shares of common <br/> stock offered pursuant to <br/> this prospectus<sup>(3)</sup></b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><b>Selling Stockholder<sup>(1)</sup></b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent of <br/> Class</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b> stock<span style="text-decoration:underline"><br/></span>
    offered<sup>(2)</sup></b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent of <br/> Class</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 3pt; width: 40%">Ascent Partners Fund LLC<sup>(4)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,634,767</td><td style="width: 1%; text-align: left"><sup>(5)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9.99</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">42,211,548</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,319,728</td><td style="width: 1%; text-align: left"><sup>(6)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9.99</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>The Benchmark Company LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">--</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>H.C. Wainwright &amp; Co.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">132,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">132,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">--</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">*</td><td style="text-align: justify">Less than 1%</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify">The information in this table and the related notes is based upon information supplied by the Selling
Stockholders.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">(2)</td><td style="text-align: justify">Represents the total number of shares of our common stock issued or issuable to each Selling Stockholders
as of the date of this prospectus, without regard to ownership limitations described in footnote (3) below and without regard to initial
exercise dates of the warrants described in footnote (3) below, including (i) all of the shares offered hereby, and (ii) to our knowledge,
all other securities held by each of the Selling Stockholders as of the date hereof.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">(3)</td><td style="text-align: justify">Assumes that, after the date of this prospectus and prior to completion of this offering, the Selling
Stockholders have not (i)&#160;acquired additional shares of our common stock or other securities or (ii)&#160;sold or otherwise disposed
of shares of our common stock or other securities held by it as of the date hereof and not offered hereby.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 147; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(4)</td><td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ascent Partners Fund LLC (&#8220;Ascent&#8221;),
a Delaware limited liability company, beneficially owns the shares listed on this table. Each of Mikhail Gurevich and Gennadiy Gurevich
manages Dominion Capital Holdings LLC (&#8220;DCH&#8221;) and Dominion Capital GP LLC (&#8220;Dominion GP&#8221;), each a Delaware limited
liability company, Dominion Capital LLC (&#8220;DC&#8221;), a Connecticut limited liability company, Ascent Partners LLC (&#8220;AP&#8221;),
a Delaware limited liability company and Ascent. DCH manages DC, Dominion GP, AP and Ascent. Dominion GP manages DC, AP and Ascent. DC
manages AP and Ascent. Alon Brenner manages Masada Group Holdings LLC (&#8220;Masada&#8221;), a Florida limited liability company, AP
and Ascent. Masada manages AP and Ascent. AP manages Ascent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ascent has the power to dispose of and the power
to vote the shares beneficially owned by it. Each of Mikhail Gurevich, Gennadiy Gurevich, DCH, Dominion GP, DC, Alon Brenner, Masada and
AP may be deemed to beneficially own, and have the power to vote, the shares beneficially owned by Ascent and the other companies they
are listed above as managing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The business address of each of the entities and
persons named in this footnote is 19505 Biscayne Blvd., Suite 2350, Aventura, FL 33180.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On February 11, 2025, NorthView executed a Securities Purchase Agreement
(the &#8220;PIPE Subscription Agreement&#8221;) with Ascent. At the closing of the Business Combination and pursuant to the PIPE Subscription
Agreement, the Company issued the Initial Note for a purchase price of $9,000,000, reflecting a 10% OID. On September 30, 2025, the Company
issued the second tranche note for a purchase price of $2,222,222 (the &#8220;Second Tranche Note&#8221;), reflecting a 10% OID. The Initial
Note and the Second tranche Note mature on the Maturity Date and are convertible at any time at the PIPE Investor&#8217;s option at a
conversion price equal to the lower of $10 or 95% of the lowest daily VWAP of the Common Stock in the 10 trading days prior to the original
issue date of the Initial Note and shall be adjusted, without limitation, based on down-round and most-favored nation price and terms
protections.</p>

</td></tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(5)</td><td style="text-align: justify">Comprised of 441,395 conversion shares held by Ascent as of October
8, 2025 and 4,193,372 shares issuable upon conversion of the Initial Note and the Second Tranche Note. The 42,211,548 Purchase Shares
and the balance of the shares issuable under the Initial Note and the Second Tranche Note are not included in this column because these
share issuances are subject to a beneficial ownership limitation of 9.99%.</td></tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised of 441,395 conversion shares held by Ascent as of October 8, 2025 and 8,878,333 shares issuable upon conversion of the Initial Note and the Second Tranche Note. The balance of the shares issuable under the Initial Note and the Second Tranche Note are not included in this column because these share issuances are subject to a beneficial ownership limitation of 9.99%.</span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 148; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PLAN OF DISTRIBUTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering the shares
of common stock issuable to the Selling Stockholders to permit the resale of these shares of Common Stock by the holders of the shares
of Common Stock from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the Selling
Stockholders of the shares of Common Stock. We will bear all fees and expenses incident to the registration of the shares of Common Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
may sell all or a portion of the shares of Common Stock beneficially owned by them and offered hereby from time to time directly or through
one or more underwriters, broker-dealers or agents. If the shares of Common Stock are sold through underwriters or broker-dealers, the
Selling Stockholders will be responsible for underwriting discounts or commissions or agent&#8217;s commissions. The shares of Common
Stock may be sold on any national securities exchange or quotation service on which the securities may be listed or quoted at the time
of sale, in the over-the-counter market or in transactions otherwise than on these exchanges or systems or in the over-the-counter market
and in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at
the time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Selling Stockholders may use any one or more
of the following methods when selling shares:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"/>
    <td style="padding: 0.25pt; width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">an exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">privately negotiated transactions;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">broker-dealers may agree with the Selling Stockholders to sell a specified number of such shares at a stipulated price per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">through the writing or settlement of options or other hedging transactions, whether such options are listed on an options exchange or otherwise;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">a combination of any such methods of sale; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding: 0.25pt">&#9679;</td>
    <td style="padding: 0.25pt; text-align: justify"><span style="font-size: 10pt">any other method permitted pursuant to applicable law.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, as permitted
by that rule, or Section 4(a)(1) under the Securities Act, if available, rather than under this prospectus, provided that they meet the
criteria and conform to the requirements of those provisions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other broker-dealers to participate in sales. If the Selling Stockholders effect such transactions
by selling shares of Common Stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may
receive commissions in the form of discounts, concessions or commissions from the Selling Stockholders or commissions from purchasers
of the shares of Common Stock for whom they may act as agent or to whom they may sell as principal. Such commissions will be in amounts
to be negotiated, but, except as set forth in a supplement to this registration statement, in the case of an agency transaction will not
be in excess of a customary brokerage commission in compliance with applicable rules of the Financial Industry Regulatory Authority, or
FINRA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with sales
of the shares of Common Stock or otherwise, and unless limited by any contractual arrangements with us, the Selling Stockholders may enter
into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the shares of
common stock in the course of hedging in positions they assume and the Selling Stockholders may also sell shares of Common Stock short
and if such short sale shall take place after the date that this registration statement is declared effective by the SEC, the Selling
Stockholders may deliver shares of Common Stock covered by this prospectus to close out short positions and to return borrowed shares
in connection with such short sales. The Selling Stockholders may also loan or pledge shares of Common Stock to broker-dealers that in
turn may sell such shares, to the extent permitted by applicable law. The Selling Stockholders may also enter into option or other transactions
with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to
such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial
institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). Notwithstanding the foregoing,
the Selling Stockholders have been advised that they may not use shares registered pursuant to this registration statement to cover short
sales of our Common Stock made prior to the date the registration statement is declared effective by the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 149; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
may, from time to time, pledge or grant a security interest in some or all of the shares of Common Stock owned by them and, if they default
in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of Common Stock from time
to time pursuant to this registration statement or any amendment to this registration statement under Rule 424(b)(3) or other applicable
provision of the Securities Act, amending, if necessary, the list of Selling Stockholders to include the pledgee, transferee or other
successors in interest as Selling Stockholders under this registration statement. The Selling Stockholders also may transfer and donate
the shares of Common Stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will
be the selling beneficial owners for purposes of this registration statement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
and any broker-dealer or agents participating in the distribution of the shares of Common Stock offered hereby may be deemed to be &#8220;underwriters&#8221;
within the meaning of Section 2(a)(11) of the Securities Act in connection with such sales. In such event, any commissions paid, or any
discounts or concessions allowed to, any such broker-dealer or agent and any profit on the resale of the shares purchased by them may
be deemed to be underwriting commissions or discounts under the Securities Act. Selling Stockholders who are &#8220;underwriters&#8221;
within the meaning of Section 2(a)(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities
Act and may be subject to certain statutory liabilities of, including without limitation, Sections 11, 12 and 17 of the Securities Act
and Rule 10b-5 under the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder
has informed us that it is not a registered broker-dealer. Upon being notified in writing by a Selling Stockholder that any material arrangement
has been entered into with a broker-dealer for the sale of common stock through a block trade, special offering, exchange distribution
or secondary distribution or a purchase by a broker or dealer, a supplement to this prospectus will be filed, if required, pursuant to
Rule 424(b) under the Securities Act, disclosing (i) the name of each such Selling Stockholder and of the participating broker-dealer(s),
(ii) the number of shares involved, (iii) the price at which such the shares of common stock were sold, (iv) the commissions paid or discounts
or concessions allowed to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any investigation to
verify the information set out or incorporated by reference in this prospectus, and (vi) other facts material to the transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the securities laws
of some states, the shares of common stock may be sold in such states only through registered or licensed brokers or dealers. In addition,
in some states the shares of common stock may not be sold unless such shares have been registered or qualified for sale in such state
or an exemption from registration or qualification is available and is complied with in all respects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder
and any other person participating in such distribution will be subject to applicable provisions of the Exchange Act, and the rules and
regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing of purchases and sales
of any of the shares of common stock by the Selling Stockholder and any other participating person. Regulation M may also restrict the
ability of any person engaged in the distribution of the shares of common stock to engage in market-making activities with respect to
the shares of common stock. All of the foregoing may affect the marketability of the shares of common stock and the ability of any person
or entity to engage in market-making activities with respect to the shares of common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay all expenses
of the registration of the shares of common stock, including, without limitation, SEC filing fees and expenses of compliance with state
securities or &#8220;blue sky&#8221; laws; provided, however, that each Selling Stockholder will pay all underwriting discounts and selling
commissions, if any, and any legal expenses incurred by it. We may indemnify the Selling Stockholders against certain liabilities, including
some liabilities under the Securities Act, in accordance with the agreements with the Selling Stockholders, or the Selling Stockholders
may be entitled to contribution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 150; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Plan of Distribution Related to Purchase
Shares</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Purchase Shares offered by
this prospectus are being offered for resale by Ascent. The shares may be sold or distributed from time to time by Ascent directly to
one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time
of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of
the shares of Purchase Shares offered by this prospectus could be effected in one or more of the following methods:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">ordinary brokers&#8217; transactions;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">transactions involving cross or block trades;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">through brokers, dealers, or underwriters who may act solely
as agents;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">&#8220;at the market&#8221; into an existing market for our
Common Stock;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">in other ways not involving market makers or established business
markets, including direct sales to purchasers or sales effected through agents;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">in privately negotiated transactions; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">any combination of the foregoing.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state&#8217;s registration or qualification requirement is available and complied with.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent is deemed an &#8220;underwriter&#8221;
within the meaning of Section&#160;2(a)(11)&#160;of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent may engage one or
more other registered broker-dealers&#160;to effectuate resales, if any, of Purchase Shares that it may acquire from us. Such resales
will be made at prices and at terms then prevailing or at prices related to the then current market price. Each such registered broker-dealer&#160;will
be an underwriter within the meaning of Section&#160;2(a)(11)&#160;of the Securities Act. Ascent has informed us that each such broker-dealer&#160;it
engages to effectuate resales of Purchase Shares on its behalf may receive commissions from Ascent for executing such resales for Ascent
and, if so, such commissions will not exceed customary brokerage commissions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth above,
we know of no existing arrangements between Ascent and any other stockholder, broker, dealer, underwriter or agent relating to the sale
or distribution of Purchase Shares offered by this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brokers, dealers, underwriters
or agents participating in the distribution of the shares of our Common Stock offered by this prospectus may receive compensation in the
form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers&#160;may act as agent, of Purchase Shares
sold by Ascent through this prospectus. The compensation paid to any such particular broker-dealer&#160;by any such purchasers of Purchase
Shares sold by Ascent may be less than or in excess of customary commissions. Neither we nor Ascent can presently estimate the amount
of compensation that any agent will receive from any purchasers of Purchase Shares sold by Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may from time to time
file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms
a part to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act,
to disclose certain information relating to a particular sale of shares offered by this prospectus by Ascent, including with respect to
any compensation paid or payable by Ascent to any brokers, dealers, underwriters or agents that participate in the distribution of such
shares by Ascent, and any other related information required to be disclosed under the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay the expenses
incident to the registration under the Securities Act&#160;of&#160;the offer and sale of Purchase Shares covered by this prospectus by
Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As consideration for its
irrevocable commitment to purchase our Common Stock at our direction under the Purchase Agreement, we issued to Ascent Commitment Warrants
exercisable for up to 900,000&#160;shares of our Common Stock as Commitment Warrant Shares. In accordance with FINRA Rule&#160;5110, the
Commitment Warrants we issued to Ascent upon our execution of the term sheet relating to the Purchase Agreement may be deemed to be underwriting
compensation in connection with sales of Purchase Shares by Ascent to the public.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we have agreed
to reimburse Ascent the fees, costs and expenses of $30,000 for the negotiation, preparation, execution and closing of the Purchase Agreement
and related documents up to the Effective Date and additional fees, costs and expenses relating to the Purchase Agreement thereafter.
In accordance with FINRA Rule&#160;5110, these reimbursed fees and expenses may be deemed to be underwriting compensation in connection
with sales of Purchase Shares by Ascent to the public. Moreover, in accordance with FINRA Rule&#160;5110, the 3.0% fixed discount to current
market prices of our Common Stock reflected in the purchase prices payable by Ascent for our Common Stock that we may require it to purchase
from us from time to time in one or more Purchases under the Purchase Agreement may be deemed to be underwriting compensation in connection
with sales of Purchase Shares by Ascent to the public.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 151; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also have agreed to indemnify
Ascent and certain other persons against certain liabilities in connection with the offering of Purchase Shares offered hereby, including
liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to be paid in respect
of such liabilities. Ascent has agreed to indemnify us against liabilities under the Securities Act that may arise from certain written
information furnished to us by Ascent specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts
required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be
permitted to our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC this indemnification
is against public policy as expressed in the Securities Act and is therefore, unenforceable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We estimate that the total
expenses for the offering will be approximately $147,087.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent has represented to
us that at no time prior to the date of the Purchase Agreement has Ascent, any of its officers, or any entity managed or controlled by
Ascent, engaged in or effected, in any manner whatsoever, directly or indirectly, for Ascent&#8217;s own principal account or for the
principal account of any such entity managed or controlled by Ascent, any short sale (as such term is defined in Rule&#160;200 of Regulation&#160;SHO
of the Exchange&#160;Act) of our Common Stock or any hedging transaction, which establishes a net short position with respect to our Common
Stock that remained in effect as of the date of the Purchase Agreement. Ascent has agreed that during the term of the Purchase Agreement,
none of Ascent, any of its officers, or any entity managed or controlled by Ascent, will enter into or effect, directly or indirectly,
any of the foregoing transactions either for Ascent&#8217;s own principal account or for the principal account of any such entity managed
or controlled by Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have advised Ascent that
it is required to comply with Regulation&#160;M promulgated under the Exchange&#160;Act. With certain exceptions, Regulation&#160;M precludes
Ascent, any affiliated purchasers, and any broker-dealer&#160;or other person who participates in the distribution from bidding for or
purchasing or attempting to induce any person to bid for or purchase any security which is the subject of the distribution until the entire
distribution is complete. Regulation&#160;M also prohibits any bids or purchases made in order to stabilize the price of a security in
connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered by this
prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This offering will terminate
on the date that all Purchase Shares offered by this prospectus have been sold by Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is currently
listed on Nasdaq under the symbol &#8220;PFSA&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent and/or one or more
of its affiliates has provided, currently provides and/or from time to time in the future may provide various investment banking and other
financial services for us and/or one or more of our affiliates that are unrelated to the transactions contemplated by the Purchase Agreement
and the offering of Purchase Shares for resale by Ascent to which this prospectus relates, for which investment banking and other financial
services they have received and may continue to receive customary fees, commissions and other compensation from us, aside from any discounts,
fees and other compensation that Ascent has received and may receive in connection with the transactions contemplated by the Purchase
Agreement, including (i)&#160;the Commitment Warrants exercisable for up to 900,000 Commitment Warrant Shares we issued to Ascent as consideration
for its irrevocable commitment to purchase shares of our Common Stock from us at our direction under the Purchase Agreement, (ii)&#160;the
3.0% fixed discount to current market prices of our Common Stock reflected in the purchase prices payable by Ascent for our Common Stock
that we may require it to purchase from us from time to time in one or more Purchases under the Purchase Agreement, and (iii)&#160;our
reimbursement of Ascent&#8217;s legal fees up to $30,000 for the negotiation, preparation, execution and closing of the Purchase Agreement
and related documents up to the Effective Date and additional fees, costs and expenses relating to the Purchase Agreement thereafter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total underwriting compensation
to be received by all participating FINRA members, in the aggregate, in connection with this offering, as determined under FINRA Rule&#160;5110,
will not exceed 8.0% of the maximum aggregate offering price of all Purchase Shares that may be resold by Ascent to the public through
this prospectus. Accordingly, the total amount of any specific item of underwriting compensation described herein that may be received
by any participating FINRA member in connection with this offering shall, in each case, be subject to the limitation on the total underwriting
compensation to be received by all participating FINRA members, in the aggregate, in connection with this offering, as determined under
FINRA Rule&#160;5110, described in the immediately preceding sentence.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of the Common Stock
offered hereby may be effected by Ascent from time to time in one or more types of transactions (which may include block transactions),
including but not limited to, in negotiated transactions, through put or call options transactions relating to the securities offered
hereby, through short sales of the securities offered hereby, or a combination of such methods of sale. Such transactions may or may not
involve brokers or dealers. In effecting sales, brokers or dealers engaged by Ascent may arrange for other brokers or dealers to participate.
Broker-dealer&#160;transactions may include purchases of the securities by a broker-dealer&#160;as principal and resales of the securities
by the broker-dealer&#160;for its account pursuant to this prospectus, ordinary brokerage transactions or transactions in which the broker-dealer&#160;solicits
purchasers. Such broker-dealers&#160;may receive compensation in the form of discounts, concessions or commissions from Ascent and/or
the purchasers of the securities offered hereby for whom such broker-dealers&#160;may act as agents or to whom they sell as principal,
or both (which compensation as to a particular broker-dealer&#160;might be in excess of customary commissions). Any broker-dealers&#160;participating
in the distribution of the securities covered by this prospectus may be deemed to be &#8220;underwriters&#8221; within the meaning of
the Securities Act, and any commissions received by any of those broker-dealers&#160;may be deemed to be underwriting commissions under
the Securities Act. Ascent has not advised us that they have entered into any agreements, understandings or arrangements with any broker-dealers&#160;regarding
the sale of the Common Stock to which this prospectus relates in part.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 152; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Ascent may elect
to make a pro rata in-kind&#160;distribution of Common Stock to its members, partners or shareholders pursuant to the registration statement
of which this prospectus is a part by delivering a prospectus with a plan of distribution. Such members, partners or shareholders would
thereby receive freely tradeable shares of Common Stock pursuant to the distribution through a registration statement. To the extent a
distributee is an affiliate of ours (or to the extent otherwise required by law), we may file a prospectus supplement in order to permit
the distributees to use the prospectus to resell the shares of Common Stock acquired in the distribution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There can be no assurance
that Ascent will sell all or any of the Common Stock offered by this prospectus. In addition, any shares that qualify for sale pursuant
to Rule&#160;144 may be sold under Rule&#160;144 of the Securities Act, if available, or in other transactions exempt from registration,
rather than pursuant to this prospectus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the time a particular
offer of securities is made, if required, a prospectus supplement will be distributed that will set forth the number of securities being
offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter,
any discount, commission and other item constituting compensation, any discount, commission or concession allowed or reallowed or paid
to any dealer, and the proposed selling price to the public.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent may enter into hedging
transactions with broker-dealers&#160;or other financial institutions. In connection with such transactions, broker-dealers&#160;or other
financial institutions may engage in short sales of shares of Common Stock offered hereby in the course of hedging positions they assume
with Ascent. Ascent may also enter into options or other transactions with broker-dealers&#160;or other financial institutions which require
the delivery to such broker-dealers&#160;or other financial institutions of the shares offered by this prospectus, which shares such broker-dealer&#160;or
other financial institution may resell pursuant to this prospectus (as amended or supplemented to reflect such transaction).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ascent may enter into derivative
transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions.
If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered
by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities
pledged by Ascent or borrowed from Ascent or others to settle those sales or to close out any related open borrowings of stock, and may
use securities received from Ascent in settlement of those derivatives to close out any related open borrowings of securities. The third
party in such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective&#160;amendment).
In addition, Ascent may otherwise loan or pledge the securities to a financial institution or other third party that in turn may sell
the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to
investors in our securities or in connection with a concurrent offering of other securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent required, we
will use our best efforts to file one or more supplements to this prospectus to describe any material information with respect to the
plan of distribution not previously disclosed in this prospectus or any material change to such information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 153; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF SECURITIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The following summary is
a description of the material terms of our capital stock. This summary is not complete and is qualified by reference to our amended and
restated certificate of incorporation, and our amended and restated bylaws, which are filed as exhibits to the registration statement
that includes this prospectus and are incorporated by reference herein. We encourage you to read our amended and restated certificate
of incorporation, our amended and restated bylaws and the applicable provisions of the Delaware General Corporations Law for additional
information.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation authorizes 300,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of undesignated preferred
stock, $0.0001 par value per share, the rights, preferences and privileges of which may be designated from time to time by our board of
directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Dividend Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to preferences that
may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of Common Stock will be entitled to
receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and only
then at the times and in the amounts that our board of directors may determine.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Voting Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of Common Stock
will be entitled to one vote per share. Stockholders will not have the ability to cumulate votes for the election of directors. Our amended
and restated certificate of incorporation and bylaws provide for a classified board of directors consisting of three classes of approximately
equal size, each serving staggered three-year terms. Only one class of directors will be elected at each annual meeting of stockholders,
with the other classes continuing for the remainder of their respective three-year terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>No Preemptive or Similar Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Common Stock will not be entitled
to preemptive rights and will not be subject to redemption or sinking fund provisions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Right to Receive Liquidation Distributions</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon our liquidation, dissolution
or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of Common
Stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities
and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Preferred Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our amended and
restated certificate of incorporation, our board of directors will be authorized, subject to limitations prescribed by Delaware law, to
issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to
fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions,
in each case without further vote or action by our stockholders. Our board of directors can also increase or decrease the number of shares
of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action
by our stockholders. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could
adversely affect the voting power or other rights of the holders of Common Stock. The issuance of preferred stock, while providing flexibility
in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring
or preventing a change in our control and might adversely affect the market price of our Common Stock and the voting and other rights
of the holders of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 154; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover Provisions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions of the DGCL,
our amended and restated certificate of incorporation and our bylaws could have the effect of delaying, deferring or discouraging another
person from acquiring control of our Company. These provisions, which are summarized below, are expected to discourage certain types of
coercive takeover practices and inadequate takeover bids and encourage persons seeking to acquire control of our Company to first negotiate
with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly
or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire our Company because negotiation of these proposals
could result in an improvement of their terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Section&#160;203 of the DGCL</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the provisions
of Section&#160;203 of the DGCL regulating corporate takeovers. In general, Section&#160;203 prohibits a publicly held Delaware corporation
from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a three-year period following the
date that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under
Section&#160;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of
the following conditions:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">before the stockholder became interested, our board of directors approved either the business combination
or the transaction, which resulted in the stockholder becoming an interested stockholder;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">upon consummation of the transaction, which resulted in the stockholder becoming an interested stockholder,
the interested stockholder owned at least 85% of the voting stock outstanding at the time the transaction commenced, excluding for purposes
of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans in
some instances, but not the outstanding voting stock owned by the interested stockholder; or</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">at or after the time the stockholder became interested, the business combination was approved by our board
and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting
stock, which is not owned by the interested stockholder.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#160;203 defines a
business combination to include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any merger or consolidation involving the corporation and the interested stockholder;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or
more of the assets of the corporation;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">subject to exceptions, any transaction that results in the issuance of transfer by the corporation of
any stock of the corporation to the interested stockholder;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">subject to exceptions, any transaction involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or
other financial benefits provided by or through the corporation.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, Section&#160;203
defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation
and any entity or person affiliated with or controlling or controlled by the entity or person.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>


</div><!-- Field: Page; Sequence: 155; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certificate of Incorporation and Bylaw Provisions</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation and our bylaws include a number of provisions that may have the effect of deterring hostile takeovers, or delaying or
preventing changes in control of our management team or changes in our board of directors or our governance or policy, including the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Board Vacancies</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation and bylaws authorize generally only our board of directors to fill vacant directorships resulting from any cause or created
by the expansion of our board of directors. In addition, the number of directors constituting our board of directors may be set only by
resolution adopted by a majority vote of our entire board of directors. These provisions prevent a stockholder from increasing the size
of our board of directors and gaining control of our board of directors by filling the resulting vacancies with its own nominees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Classified Board</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation and bylaws will provide that its board of directors is classified into three classes of directors. The existence of a
classified board of directors could delay a successful tender offeror from obtaining majority control of our board of directors, and the
prospect of that delay might deter a potential offeror.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Directors Removed Only for Cause</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation will provide that stockholders may remove directors only for cause.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Supermajority Requirements for Amendments of
Our Amended and Restated Certificate of Incorporation and Bylaws</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation further provides that the affirmative vote of holders of at least 75% of the voting power of our outstanding common stock
is required to amend certain provisions of our amended and restated certificate of incorporation, including provisions relating to the
classified board, the size of the board of directors, removal of directors, special meetings, actions by written consent and designation
of our preferred stock. The affirmative vote of holders of at least 75% of the voting power of our outstanding common stock are required
to amend or repeal our bylaws, although our bylaws may be amended by a simple majority vote of our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stockholder Action; Special Meetings of Stockholders</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation provides that our stockholders may not take action by written consent, but may only take action at annual or special
meetings of stockholders. As a result, holders of our capital stock would not be able to amend our bylaws or remove directors without
holding a meeting of stockholders called in accordance with our bylaws. Our amended and restated certificate of incorporation and bylaws
provides that special meetings of stockholders may be called only by a majority of our board of directors, the chairperson of the board
of directors, or our chief executive officer, thus prohibiting a stockholder from calling a special meeting. These provisions might delay
the ability of our stockholders to force consideration of a proposal or for stockholders to take any action, including the removal of
directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Advance Notice Requirements for Stockholder
Proposals and Director Nominations</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide advance notice procedures for
stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at
our annual meeting of stockholders. To be timely, a stockholder&#8217;s notice generally must be delivered to us not later than the close
of business on the 90<sup>th</sup>&#160;day nor earlier than the close of business on the 120<sup>th</sup>&#160;day prior to the first
anniversary of the preceding year&#8217;s annual meeting of stockholders. Our bylaws also specify certain requirements regarding the form
and content of a stockholder&#8217;s notice. With respect to nominations of persons for election to our board of directors, the notice
shall provide information about the nominee, including, among other things, name, age, address, principal occupation, ownership of our
capital stock and whether they meet applicable independence requirements. With respect to the proposal of other business to be considered
by our stockholders at an annual meeting, the notice shall provide a brief description of the business desired to be brought before the
meeting, the text of the proposal or business, the reasons for conducting such business at the meeting and any material interest in such
business by such stockholder and any beneficial owners and associated persons on whose behalf the notice is made, or the proposing persons.
In addition, a stockholder&#8217;s notice must set forth certain information related to the proposing persons, including, among other
things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the name and address of the proposing persons;</td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 156; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">information as to the ownership by the proposing persons of our capital stock and any derivative interest
or short interest in any of our securities held by the proposing persons;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">information as to any material relationships and interest between the proposing persons and us, any of
our affiliates and any of our principal competitors;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a representation that the stockholder is a holder of record of our stock entitled to vote at that meeting
and that the stockholder intends to appear in person or by proxy at the meeting to propose such nomination or business; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">a representation whether the proposing persons intend or are part of a group which intends to deliver
a proxy statement or form of proxy to holders of at least the percentage of outstanding Common Stock required to elect the nominee or
carry the proposal.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These provisions may preclude
our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual
meeting of stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>No Cumulative Voting</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The DGCL provides that stockholders
are not entitled to the right to cumulate votes in the election of directors unless a corporation&#8217;s certificate of incorporation
provides otherwise. Our amended and restated certificate of incorporation and bylaws do not provide for cumulative voting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Issuance of Undesignated Preferred Stock</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board has the authority,
without further action by the stockholders, to issue up to 5,000,000 shares of undesignated preferred stock with rights and preferences,
including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred
stock enables our board of directors to render more difficult or to discourage an attempt to obtain control of our Company by means of
a merger, tender offer, proxy contest or otherwise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exclusive Forum</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation provides that, unless we consents in writing to the selection of an alternative forum, to the fullest extent permitted
by law, the sole and exclusive forum for (1)&#160;any derivative action or proceeding brought on our behalf under Delaware law, (2)&#160;any
action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to the Company or its
stockholders, (3)&#160;any action asserting a claim against the Company or any of its directors, officers or other employees arising pursuant
to any provision of the Delaware General Corporation Law or our amended and restated certificate of incorporation or bylaws, (4)&#160;any
other action against the Company or any of its directors, officers or other employees asserting a claim that is governed by the internal
affairs doctrine shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the
federal district court for the District of Delaware) or (5)&#160;any other action asserting an &#8220;internal corporate claim,&#8221;
as defined in Section&#160;115 of the Delaware General Corporation Law, in all cases subject to the court having jurisdiction over indispensable
parties named as defendants. These exclusive-forum provisions do not apply to claims under the Securities Act or the Exchange&#160;Act.
Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of and consented
to this provision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Transfer Agent and Registrar</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent and registrar
for our common stock is Continental Stock Transfer&#160;&amp; Trust Company. The transfer agent&#8217;s address is 1 State Street, 30<sup>th</sup>
floor, New&#160;York, NY&#160;10004.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 157; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>LEGAL MATTERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the securities
offered hereby will be passed upon for us by ArentFox Schiff LLP, Washington, DC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXPERTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements of
NorthView Acquisition Corp. as of December 31, 2024 and 2023, and for each of the two years in the period ended December 31, 2024, have
been audited by Marcum LLP, an independent registered accounting firm, as stated in their report, which includes an explanatory paragraph
as to NorthView Acquisition Corp.&#8217;s ability to continue as a going concern, and which is included in this prospectus. Such financial
statements have been included herein in reliance on the report of said firm given upon their authority as experts in accounting and auditing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements of
Profusa, Inc. as of December 31, 2024 and 2023, and for each of the two years in the period ended December 31, 2024, have been audited
by Marcum LLP, an independent registered public accounting firm, as stated in their report, which includes an explanatory paragraph as
to the Company&#8217;s ability to continue as a going concern, which is included in this prospectus. Such financial statements have been
included herein in reliance on the report of said firm given upon their authority as experts in accounting and auditing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WHERE YOU CAN FIND MORE INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the reporting
and information requirements of the Exchange&#160;Act and, as a result, will file periodic and current reports, proxy statements and other
information with the SEC.&#160;We make our periodic reports and other information filed with or furnished to the SEC, available, free
of charge, through our website as soon as reasonably practicable after those reports and other information are filed with or furnished
to the SEC.&#160;Additionally, these periodic reports, proxy statements and other information will be available for inspection and copying
at the public reference room and SEC&#8217;s website at <i>www.sec.gov</i>. You may read and copy any document that we file at the SEC&#8217;s
public reference room located at 100 F Street, NE, Washington, D.C. 20549. Please call the SEC at&#160;1-800-SEC-0330 for further information
on the public reference rooms. SEC filings are also available to the public at the SEC&#8217;s website referred to above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 158; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.<br/>
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Profusa, Inc.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 90%; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Profusa, Inc. Financial Statements as of and for the years ended December&#160;31, 2024 and 2023</b></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 2.25pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_001">Report of Independent Registered Public Accounting Firm (PCAOB ID # 688)</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-2</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">Consolidated Financial Statements:</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 2.25pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_002">Consolidated Balance Sheets</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-3</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_003">Consolidated Statements of Operations and Comprehensive Loss</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-4</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_004">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-5</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_005">Consolidated Statements of Cash Flows</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-6</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_006">Notes to Consolidated Financial Statements</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-7&#160;&#8211;&#160;F-29</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 90%; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">Condensed Consolidated Financial Statements:</span></td>
    <td style="white-space: nowrap; vertical-align: top; width: 1%; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; padding-bottom: 2.25pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_007">Condensed Consolidated Balance Sheets</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-30</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_008">Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-31</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_009">Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit for the Three and Six Months Ended June&#160;30, 2025 and 2024 (Unaudited)</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-32</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_010">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-33</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_011">Notes to the Condensed Consolidated Financial Statements (Unaudited)</a></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 2.25pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-34&#160;&#8211;&#160;F-53</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NorthView Acquisition Corporation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 90%; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>NorthView Acquisition Corporation Financial Statements as of and for the&#160;years ended December&#160;31, 2024 and 2023</b></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_012">Report of Independent Registered Public Accounting Firm (PCAOB ID # 688)</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-54</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">Consolidated Financial Statements:</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_013">Consolidated Balance Sheets</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-55</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_014">Consolidated Statements of Operations</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-56</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_015">Consolidated Statements of Changes in Stockholders&#8217; Deficit</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-57</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_016">Consolidated Statements of Cash Flows</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-58</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_017">Notes to Consolidated Financial Statements</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-59&#160;&#8211;&#160;F-79</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 90%; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_018">Condensed Consolidated Balance Sheets as of June&#160;30, 2025 (Unaudited) and December&#160;31, 2024</a></span></td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 2.25pt">&#160;</td>
    <td style="width: 9%; text-align: center"><span style="font-size: 10pt">F-80</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_019">Unaudited Condensed Consolidated Statements of Operations for the three and six&#160;months ended June&#160;30, 2025 and 2024</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-81</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_020">Unaudited Condensed Consolidated Statements of Changes in Stockholders&#8217; Deficit for the three and six&#160;months ended June&#160;30, 2025 and 2024</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-82</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_021">Unaudited Condensed Consolidated Statements of Cash Flows for the three&#160;months ended June&#160;30, 2025 and 2024</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-83</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><a href="#f_022">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">F-84&#160;&#8211;&#160;F-109</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 159; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><div><a id="f_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Report
of Independent Registered Public Accounting Firm</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Stockholders and Board of Directors of<br/>
Profusa, Inc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have audited the accompanying
consolidated balance sheets of Profusa, Inc. and Subsidiary (the &#8220;Company&#8221;) as of December&#160;31, 2024 and 2023, the related
consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#8217; deficit and cash flows
for each of the two&#160;years in the period ended December&#160;31, 2024, and the related notes (collectively referred to as the &#8220;financial
statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company
as of December&#160;31, 2024 and 2023, and the results of its operations and its cash flows for each of the two&#160;years in the period
ended December&#160;31, 2024, in conformity with accounting principles generally accepted in the United&#160;States of America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Explanatory Paragraph&#160;&#8212;&#160;Going
Concern</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying financial
statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note&#160;1, the
Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its
obligations and sustain its operations. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going
concern. Management&#8217;s plans in regard to these matters are also described in Note&#160;1. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These financial statements
are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United&#160;States)
(&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S.&#160;federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conducted our audits in
accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United&#160;States of America.
Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are
free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an
audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control
over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control
over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audits included performing
procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for
our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Marcum <span style="font-variant: small-caps">llp</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Marcum <span style="font-variant: small-caps">llp</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&#8217;s auditor
since 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Francisco, CA<br/>
April 3, 2025</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 160; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONSOLIDATED BALANCE SHEETS<br/>
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December&#160;31,<span style="text-decoration:underline"><br/> </span>2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-38566">191</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-38567">142</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivables" scale="3" unitRef="usd" id="ixv-38568">45</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-38569">69</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-38570">146</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-38571">260</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-38572">333</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-38573">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCosts" scale="3" unitRef="usd" id="ixv-38574">2,757</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCosts" scale="3" unitRef="usd" id="ixv-38575">1,527</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-38576">56</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-38577">31</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-38578">3,073</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-38579">1,893</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Liabilities, convertible preferred stock, and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-38580">4,954</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-38581">3,993</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-38582">3,968</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-38583">2,351</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Convertible debt payable (including loans and notes payable to a related party of $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-38584">25,056</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-38585">21,755</ix:nonFraction> as of December&#160;31, 2024 and December&#160;31, 2023, respectively.)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" unitRef="usd" id="ixv-38586">45,921</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" unitRef="usd" id="ixv-38587">38,185</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Promissory notes (including notes payable to related parties of $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="3" unitRef="usd" id="ixv-38588">850</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="3" unitRef="usd" id="ixv-38589">801</ix:nonFraction> as of December&#160;31, 2024 and December&#160;31, 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableCurrent" scale="3" unitRef="usd" id="ixv-38590">910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableCurrent" scale="3" unitRef="usd" id="ixv-38591">849</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">PPP loan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaycheckProtectionProgramLoan" scale="3" unitRef="usd" id="ixv-38592">1,376</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaycheckProtectionProgramLoan" scale="3" unitRef="usd" id="ixv-38593">1,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-38594">57,129</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-38595">46,740</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-38596">57,129</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-38597">46,740</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Commitments and contingencies (Note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Preferred Stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Series&#160;A convertible preferred stock: $<ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38598"><ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38599">0.0001</ix:nonFraction></ix:nonFraction> par value&#160;&#8211;&#160;<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-38600"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-38601"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-38602">4,350,314</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized at December&#160;31, 2024 and December&#160;31, 2023, and <ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-38603"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-38604"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-38605">4,350,314</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2024 and December&#160;31, 2023, (Liquidation preference $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-38606"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-38607">5,307</ix:nonFraction></ix:nonFraction> at December&#160;31, 2024 and December&#160;31, 2023)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-38608">5,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-38609">5,231</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Series&#160;B convertible preferred stock: $<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38610"><ix:nonFraction contextRef="c8" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38611">0.0001</ix:nonFraction></ix:nonFraction> par value&#160;&#8211;&#160;<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-38612"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-38613"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-38614">5,293,175</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized at December&#160;31, 2024 and December&#160;31, 2023, and <ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-38615"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-38616"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-38617">5,293,175</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2024 and December&#160;31, 2023, (Liquidation preference $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-38618"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-38619">13,815</ix:nonFraction></ix:nonFraction> at December&#160;31, 2024 and December&#160;31, 2023)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-38620">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-38621">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Series&#160;C/C-1 convertible preferred stock: $<ix:nonFraction contextRef="c9" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38622"><ix:nonFraction contextRef="c10" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38623">0.001</ix:nonFraction></ix:nonFraction> par value&#160;&#8211;&#160;<ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-38624"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-38625">8,907,893</ix:nonFraction></ix:nonFraction> shares authorized at December&#160;31, 2024 and December&#160;31, 2023, and <ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-38626"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-38627"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-38628"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-38629">8,220,445</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2024 and December&#160;31, 2023, (Liquidation preference $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-38630"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-38631">45,062</ix:nonFraction></ix:nonFraction> at December&#160;31, 2024 and December&#160;31, 2023)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-38632">46,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-38633">46,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total convertible preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-38634">65,149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-38635">65,149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stockholders&#8217; deficit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Common stock: $<ix:nonFraction contextRef="c1" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38636"><ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-38637">0.0001</ix:nonFraction></ix:nonFraction> par value&#160;&#8211;&#160;<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-38638"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-38639">40,000,000</ix:nonFraction></ix:nonFraction> authorized shares at December&#160;31, 2024 and December&#160;31, 2023, and <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-38640"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-38641"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-38642"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-38643">5,604,651</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2024 and December&#160;31, 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-38644">5,753</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-38645">5,732</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-38646">124,958</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-38647">115,728</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38648">119,205</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38649">109,996</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total liabilities, convertible preferred stock and stockholders&#8217; deficit</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-38650">3,073</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-38651">1,893</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying notes are an integral
part of these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 161; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="f_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONSOLIDATED&#160;STATEMENTS&#160;OF&#160;OPERATIONS&#160;AND&#160;COMPREHENSIVE&#160;LOSS<br/>
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended&#160; <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-38652">100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-38653">45</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-38654">1,608</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-38655">2,036</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-38656">2,992</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-38657">4,079</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-38658">4,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-38659">6,115</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-38660">4,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-38661">6,070</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-38662">311</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-38663">22</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Interest expense (including related parties amounts of $<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-38664">2,400</ix:nonFraction> and $<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-38665">2,530</ix:nonFraction> for the year ended December&#160;31, 2024 and 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-38666">4,424</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-38667">4,283</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-38668">5</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-38669">94</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-38670">4,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-38671">4,211</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Net loss and comprehensive loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-38672">9,230</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-38673">10,281</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net loss per share, basic and diluted</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c22" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-38674"><ix:nonFraction contextRef="c22" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-38675">1.65</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c23" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-38676"><ix:nonFraction contextRef="c23" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-38677">1.84</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Weighted-average common shares outstanding, basic and diluted</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-38678"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-38679">5,604,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-38680"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-38681">5,600,741</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying notes are an integral
part of these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 162; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="f_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONSOLIDATED&#160;STATEMENTS&#160;OF&#160;CONVERTIBLE&#160;PREFERRED&#160;STOCK&#160;AND&#160;STOCKHOLDERS&#8217;<br/>
DEFICIT FOR THE YEARS DECEMBER 31, 2024 and 2023<br/>
(IN THOUSANDS, EXCEPT SHARE AMOUNTS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;<span style="font-size: 10pt"><b>Series&#160;A <br/> Convertible <br/> Preferred Stock</b></span> &#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series&#160;B <br/> Convertible <br/> Preferred Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series&#160;C/C-1 <br/> Convertible <br/> Preferred Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Common Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional <br/> Paid-In </td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated </td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total <br/> Stockholders&#8217; </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;<span style="font-size: 10pt"><b>Shares</b></span> &#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Capital</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Deficit</b></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Deficit</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 39%; font-weight: bold">Balance at January&#160;1, 2023</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c39" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38682">4,350,314</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38683">5,231</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c40" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38684">5,293,175</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38685">13,701</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c41" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38686">8,220,445</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38687">46,217</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c42" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38688">5,570,901</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 4%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">&#8212;</div></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38689">5,676</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 4%; text-align: right">(<ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38690">105,447</ix:nonFraction></td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 4%; text-align: right">(<ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38691">99,771</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Issuance of common stock upon exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-38692">33,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-38693">23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-38694">23</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-38695">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-38696">33</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-38697">10,281</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-38698">10,281</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; padding-bottom: 4pt">Balance at December&#160;31, 2023</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c52" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38699">4,350,314</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38700">5,231</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c53" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38701">5,293,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38702">13,701</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c54" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38703">8,220,445</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38704">46,217</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c55" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38705">5,604,651</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38706">5,732</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38707">115,728</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38708">109,996</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold">Balance at January&#160;1, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38709">4,350,314</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38710">5,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38711">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38712">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38713">8,220,445</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38714">46,217</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c55" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38715">5,604,651</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38716">5,732</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38717">115,728</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38718">109,996</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Issuance of common stock upon exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-38719">21</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-38720">21</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-38721">9,230</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-38722">9,230</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt; font-weight: bold">Balance at December&#160;31, 2024</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c64" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38723">4,350,314</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38724">5,231</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c65" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38725">5,293,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38726">13,701</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c66" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38727">8,220,445</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38728">46,217</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c67" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-38729">5,604,651</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-38730">5,753</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38731">124,958</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-38732">119,205</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying notes are an integral
part of these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 163; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><div><a id="f_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONSOLIDATED STATEMENTS OF CASH FLOWS<br/>
(IN THOUSANDS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cash flows from operating activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-38733">9,230</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-38734">10,281</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-cash interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashExpense" scale="3" unitRef="usd" id="ixv-38735">4,424</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashExpense" scale="3" unitRef="usd" id="ixv-38736">4,283</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Gain on change in fair value of related party convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" scale="3" sign="-" unitRef="usd" id="ixv-38737">311</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" scale="3" sign="-" unitRef="usd" id="ixv-38738">22</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on disposition of property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" sign="-" unitRef="usd" id="ixv-38739">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-38740">21</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-38741">33</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" sign="-" unitRef="usd" id="ixv-38742">45</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" unitRef="usd" id="ixv-38743">45</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" sign="-" unitRef="usd" id="ixv-38744">77</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-38745">64</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" unitRef="usd" id="ixv-38746">25</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" unitRef="usd" id="ixv-38747">1</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-38748">645</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-38749">533</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-38750">1,664</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-38751">1,118</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-38752">2,066</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-38753">4,402</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-38754">2</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-38755">2</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of senior notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="3" unitRef="usd" id="ixv-38756">3,210</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="3" unitRef="usd" id="ixv-38757">3,235</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of convertible loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-38758">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-38759">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromNotesPayable" scale="3" unitRef="usd" id="ixv-38760">375</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Repayment of senior notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="3" unitRef="usd" id="ixv-38761">150</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Repayment of related party promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" unitRef="usd" id="ixv-38762">151</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Payment of deferred offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-38763">961</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-38764">614</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Proceeds from issuance of common stock upon exercise of stock options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-38765">23</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-38766">2,115</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-38767">4,468</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net increase in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-38768">49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-38769">64</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash at the beginning of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-38770">142</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-38771">78</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash at the end of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-38772">191</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-38773">142</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Increase in unpaid deferred offering costs</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-38774">269</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-38775">72</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 164; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c22_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ixv-20148"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;1 &#8212;&#160;Organization, Description of Business,
Going Concern and Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa, Inc. (the &#8220;Company&#8221;)
was incorporated in the state of California on May&#160;11, 2009. The Company engaged in the development of a new generation of biointegrated
sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s technology
enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable,
clinical-grade data for personal and medical use. The Company&#8217;s first offering in the European Union, the Lumee&#8482; Oxygen Platform,
is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee&#8482; Oxygen
Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease
that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores)
that do not heal properly; and reconstructive surgery.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s research
and development efforts are primarily focused on its Lumee&#8482; Glucose Platform which is a system designed to monitor glucose levels
in interstitial fluid, continuously and long-term. A tiny, biocompatible gel injected under the skin acts as a continuous glucose monitor
(CGM) for several&#160;months. The&#160;ability of Lumee&#8482; Glucose to provide continuous glucose monitoring with only an initial
single injection, is an attractive alternative for people with diabetes to manage their disease without the need for frequent finger sticks
required by standard glucometers, or the need for weekly sensor replacement as required by current short-term needle-type CGMs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;6, 2022, the
Company&#8217;s board of directors unanimously approved the pursuit of a business combination transaction involving the Company. On November&#160;7,
2022, the Company entered into an Agreement and Plan of Merger (&#8220;Merger&#8221;) with NorthView Acquisition Corp (&#8220;NorthView&#8221;),
where a subsidiary of NorthView will merge with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 11, 2025, the parties
to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the &#8220;Amendment&#8221;) pursuant to which the parties
agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received by Profusa
prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment (i) revised
the definition of &#8220;Milestone Event III&#8221; such that the parties extended the period for Profusa to consummate the APAC Joint
Venture (as defined in the Merger Agreement) and receive the related funding from December 31, 2024 until December 31, 2025, and (ii)
revised the definition of &#8220;Milestone Event IV&#8221; to change the earnout revenue target from $<ix:nonFraction contextRef="c175" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RevenueTarget" scale="0" unitRef="usd" id="ixv-38776">99,702,000</ix:nonFraction> for the fiscal year ended
December 31, 2025 to an earnout revenue target of $<ix:nonFraction contextRef="c176" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RevenueTarget" scale="0" unitRef="usd" id="ixv-38777">11,864,000</ix:nonFraction> for the fiscal year ended December 31, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In relation to Milestone Event
III: On August&#160;8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (&#8220;APAC&#8221;), was created and incorporated
by the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $<ix:nonFraction contextRef="c177" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-38778">1,000</ix:nonFraction> for <ix:nonFraction contextRef="c177" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-38779">1,000</ix:nonFraction>&#160;Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (&#8220;Tasly&#8221;)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the &#8220;APAC Joint
Venture&#8221;) setting forth the relative and other terms under which the development and business activities of the entity will be conducted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has incurred significant
net operating losses from operations. As of December&#160;31, 2024, the Company has a working capital deficit of approximately $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapitalDeficit" scale="6" unitRef="usd" id="ixv-38780">56.9</ix:nonFraction>&#160;million.
For the year ended December&#160;31, 2024, the Company incurred a net loss of approximately $<ix:nonFraction contextRef="c22" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" sign="-" unitRef="usd" id="ixv-38781">9.2</ix:nonFraction>&#160;million and used approximately $<ix:nonFraction contextRef="c22" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" sign="-" unitRef="usd" id="ixv-38782">2.1</ix:nonFraction>&#160;million
of cash in operating activities.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 165; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Organization, Description
of Business, Going Concern and Significant Risks and Uncertainties</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has been able to
finance its operations primarily with the proceeds from the issuance of equity and debt instruments and to a lesser extent, revenues from
government grants. Additional funds may be necessary to maintain current operations and will be required for successful product commercialization
efforts. The Company&#8217;s management plans to obtain additional funds through the merger with a special purpose acquisition company
(&#8220;SPAC&#8221;), issuance of additional equity or refinancing of current debt, which is intended to mitigate the relevant conditions
or events that raise substantial doubt about the Company&#8217;s ability to continue as a going&#160;concern within one year from the
date the consolidated financial statements are issued. As the ability to refinance its current debt or raise additional equity financing
is outside of management&#8217;s control, the Company cannot conclude that management&#8217;s plans will be effectively implemented within
one year from the date the consolidated financial statements are issued. These factors raise substantial doubt about the Company&#8217;s
ability to continue as a going concern within one year from the date the consolidated financial statements are issued. The consolidated
financial statements do not contain any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company operates in a dynamic
and highly competitive industry and believes that changes in any of the following areas could have a material adverse effect on the Company&#8217;s
future financial position, results of operations, or cash flows: ability to obtain future financing; advances and trends in new technologies
and industry standards; results of clinical trials; regulatory approval and market acceptance of the Company&#8217;s products; development
of sales channels; certain strategic relationships; litigation or claims against the Company based on intellectual property, patent, product,
regulatory, or other factors; and the Company&#8217;s ability to attract and retain employees necessary to support its growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Products developed by the Company
require approvals from the U.S.&#160;Food and Drug Administration (&#8220;FDA&#8221;) or other international regulatory agencies prior
to commercial sales. There can be no assurance that the products will receive the necessary approvals. If the Company is denied approval,
approval is delayed or the Company is unable to maintain approval, it could have a materially adverse impact on the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has expended and
will continue to expend substantial funds to complete the research, development and clinical testing of product candidates. The Company
also will be required to expend additional funds to establish commercial-scale manufacturing arrangements and to provide for the marketing
and distribution of products that receive regulatory approval. The Company will require additional funds to commercialize its products.
The Company is unable to entirely fund these efforts with its current financial resources. If adequate funds are unavailable on a timely
basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more
of its research or development programs which would materially and adversely affect its business, financial condition and results of operations.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_SignificantAccountingPoliciesTextBlock-c22_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-20215"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;2 &#8212;&#160;Summary of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-20220"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States of America
(&#8220;U.S.&#160;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;)
and include all adjustments necessary for the fair presentation of the Company&#8217;s financial position as of December&#160;31, 2024
and 2023, and the results of operations and cash flows for the&#160;years then ended. The accompanying consolidated financial statements
include the accounts of Profusa Inc. and its wholly owned subsidiary, APAC.&#160;All intercompany balances and transactions have been
eliminated in consolidation.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>


</div><!-- Field: Page; Sequence: 166; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c22_cont_2" id="_SignificantAccountingPoliciesTextBlock-c22_cont_1"><ix:nonNumeric contextRef="c22" continuedAt="_UseOfEstimates-c22_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-20255"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_UseOfEstimates-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated
financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses in
the consolidated financial statements and accompanying notes. The Company&#8217;s management regularly assesses these estimates, including
those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance for deferred tax assets,
and valuation of stock-based awards. Actual results could differ from these estimates, and such differences could be material to the Company&#8217;s
financial position and results of operations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_TradeAndOtherAccountsReceivablePolicy-c22_cont_1" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="ixv-20263"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounts Receivable and Allowance for Credit Losses</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_TradeAndOtherAccountsReceivablePolicy-c22_cont_2" id="_TradeAndOtherAccountsReceivablePolicy-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have any
accounts receivable with customers in the years ended December 31, 2024 and 2023. The Company has developed policies that when accounts
receivables are held with customers, they are recorded at the point in time in which management determines it is probable that the Company
will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services transferred to
the customer.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_TradeAndOtherAccountsReceivablePolicy-c22_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of December 31, 2024 and 2023.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_ConcentrationRiskCreditRisk-c22_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-20274"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c22_cont_2" id="_ConcentrationRiskCreditRisk-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#8217;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c22_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s other receivables
are represented by amounts owned by two government agencies under the government grants.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-20285"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all highly
liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of December&#160;31, 2024
and 2023, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_DeferredChargesPolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock" id="ixv-20293"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Deferred Offering Costs</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_DeferredChargesPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of securities,
all of the costs are expensed. Offering costs capitalized as of December&#160;31, 2024 and December&#160;31, 2023 were $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedContractCostNetCurrent" scale="6" unitRef="usd" id="ixv-38783">2.8</ix:nonFraction>&#160;million
and $<ix:nonFraction contextRef="c2" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedContractCostNetCurrent" scale="6" unitRef="usd" id="ixv-38784">1.5</ix:nonFraction>&#160;million, respectively. The deferred offering costs as of December 31, 2024 and 2023 includes $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="6" unitRef="usd" id="ixv-38785">0.8</ix:nonFraction> million and $<ix:nonFraction contextRef="c2" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="6" unitRef="usd" id="ixv-38786">0</ix:nonFraction>, respectively,
of advances to NorthView to fund costs associated with the business combination.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ixv-20301"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Share-Based Compensation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for
share-based compensation arrangements with employees and non-employees using a fair value method which requires the recognition of
compensation expense for costs related to all share-based payments including stock options. The fair value method requires the
Company to estimate the fair value of share-based payment awards on the date of grant using an option pricing model. The Company
uses the Black-Scholes pricing model to estimate the fair value of options granted that are then expensed on a straight-line basis
over the vesting period. The Company accounts for forfeitures as they occur. Option valuation models, including the Black-Scholes
option-pricing model, require the input of highly subjective assumptions, and changes in the assumptions used can materially affect
the grant-date fair value of an award. These assumptions include the risk-free rate of interest, expected dividend yield, expected
volatility, and the expected life of the award.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 167; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c22_cont_3" id="_SignificantAccountingPoliciesTextBlock-c22_cont_2"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_3" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_2"><ix:nonNumeric contextRef="c22" continuedAt="ck0001859807_ConvertiblePreferredStockPolicyTextBlock-c22_cont_1" escape="true" name="ck0001859807:ConvertiblePreferredStockPolicyTextBlock" id="ixv-20335"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Preferred Stock</b></p></ix:nonNumeric></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_4" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_3"><ix:continuation id="ck0001859807_ConvertiblePreferredStockPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company records all shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The convertible preferred
stock is recorded outside of permanent equity because while it is not mandatorily redeemable, in certain events considered not solely
within the Company&#8217;s control, such as a merger, acquisition, or sale of all or substantially all of the Company&#8217;s assets (each,
a &#8220;deemed liquidation event&#8221;), the convertible preferred stock will become redeemable at the option of the holders of at least
a majority of the then outstanding preferred shares. The Company has not adjusted the carrying values of the convertible preferred stock
to its liquidation preference because a deemed liquidation event obligating the Company to pay the liquidation preferences to holders
of shares of convertible preferred stock is not probable of occurring. Subsequent adjustments to the carrying values to the liquidation
preferences will be made only when it becomes probable that such a deemed liquidation event will occur.</p></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_5" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_4"><ix:nonNumeric contextRef="c22" continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="ixv-20345"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Government Grants</b></p></ix:nonNumeric></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_6" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_5"><ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_2" id="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives payments
from government entities under non-refundable grants in support of our product development programs. The grants received fall within two
categories:</p></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_7" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_6"><ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_3" id="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">a.</td><td style="text-align: justify">Expense Reimbursement Grants&#160;&#8212;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;</td></tr></table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_8" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_7"><ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_4" id="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">b.</td><td style="text-align: justify">Fixed Fee Grants&#160;&#8212;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.</td></tr></table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_9" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_8"><ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_5" id="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non-exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as we are a business entity, and the grants are with governmental agencies
or units.</p></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_10" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_9"><ix:continuation id="_RevenueFromContractWithCustomerPolicyTextBlock-c22_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In absence of explicit U.S.
GAAP guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#8220;IAS
20&#8221;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method
the Company recognizes grant income using the same proportion as the costs incurred to date to the total expected cost of the project,
but limiting the income to be recognized to the amount to which it is entitled based on the submitted deliverables.</p></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_11" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_10"><ix:nonNumeric contextRef="c22" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="ixv-20379"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p></ix:nonNumeric></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c22_cont_11">The Company&#8217;s financial instruments consist
primarily of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company states
accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. The
promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party.</ix:continuation> The Tasly convertible debt issued between June 2023-February
2024 (Notes 3 and 5) carried at fair value based on unobservable market inputs.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 168; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c22_cont_4" id="_SignificantAccountingPoliciesTextBlock-c22_cont_3"><ix:nonNumeric contextRef="c22" continuedAt="_ResearchAndDevelopmentExpensePolicy-c22_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-20413"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Research and Development</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses
consist of costs related to employee compensation and benefits, costs for contract manufacturing organizations (&#8220;CMOs&#8221;), costs
for contract research organizations (&#8220;CROs&#8221;), costs for sponsored research, costs for clinical trials, consultant services,
laboratory supplies, product licenses, facility-related expenses and depreciation. All research and development costs are charged to research
and development expenses within the statements of operations as incurred. Payments associated with licensing agreements to acquire exclusive
licenses to develop, use, manufacture and commercialize products that have not reached technological feasibility and do not have alternate
commercial use are also expensed as incurred. Payments made to third parties under these arrangements in advance of the performance of
the related services by the third parties are recorded as prepaid expenses until the services are rendered.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_IncomeTaxPolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-20421"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c22_cont_2" id="_IncomeTaxPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes using the asset and liability method whereby deferred tax asset and liability accounts are determined based on differences between
financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are for the year
in which the differences are expected to affect taxable income. Valuation allowances are established where necessary to reduce deferred
tax assets to the amounts expected to be realized.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c22_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain
tax positions by assessing all material positions taken in any assessment or challenge by relevant taxing authorities. Assessing an uncertain
tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit
that is greater than fifty percent likely of being realized upon ultimate settlement. The Company&#8217;s policy is to recognize interest
and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. The Company recognizes interest
and penalties related to unrecognized tax benefits within the income tax expense line. Accrued interest and penalties are included within
the Accrued liabilities in the balance sheets. To date, there have been no interest or penalties charged in relation to the unrecognized
tax benefits.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_EarningsPerSharePolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-20432"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Net Loss per Share Attributable to Common Stockholders</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic net loss per common
share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock
outstanding during the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing
the net loss attributable to common stockholders by the weighted-average number of shares of common stock and potentially dilutive securities
outstanding for the period. For purposes of the diluted net loss per share calculation, the convertible preferred stock, common stock
subject to repurchase and stock options are considered to be potentially dilutive securities. Basic and diluted net loss attributable
to common stockholders per share is presented in conformity with the two-class method required for participating securities as the convertible
preferred stock is considered a participating security. The Company&#8217;s participating securities do not have a contractual obligation
to share in the Company&#8217;s losses. As such, the net loss is attributed entirely to common stockholders. Because the Company has reported
a net loss for the reporting periods presented, the diluted net loss per common share is the same as basic net loss per common share for
those periods.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-20440"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recent Accounting Standards</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_2" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the year ended December 31, 2024 and through the date of issuance of these consolidated
financial statements, there have been no new, or existing, recently issued accounting pronouncements that are of significance, or potential
significance, that impact the Company&#8217;s consolidated financial statements.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 169; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c22_cont_4"><ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_3" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently issued accounting standards as adopted</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_4" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued
ASU 2020-06, Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#160;&#8212;&#160;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40)&#160;&#8212;&#160;Accounting for Convertible Instruments and Contracts in an Entity&#8217;s
Own Equity (&#8220;ASU 2020-06&#8221;). ASU 2020-06 reduces the number of accounting models for convertible debt instruments and redeemable
convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives
under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded
conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered
in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging&#160;&#8212;&#160;Contracts in Entity&#8217;s
Own Equity, and clarifies the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related
to the disclosures and earnings per-share (EPS) for convertible instruments and contracts in an entity&#8217;s own equity. For private
companies, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. The Company early adopted the standard in prior years, which did not have a material impact on its consolidated financial statements
and related disclosures.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_5" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued ASU&#160;2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures, requiring public entities
to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis.
Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing
segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. The Company adopted ASU 2023-07 effective
December 31, 2024, on a retrospective basis. The adoption of 2023-07 did not change the way that the Company identifies its reportable
segment. However, it has resulted in incremental disclosures within the notes of the Company&#8217;s consolidated financial statements
(Note 14).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_6" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently issued accounting standards not yet adopted</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_7" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU 2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early adoption permitted and can be
applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine its impact on our income
tax disclosures.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c22_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2024, the FASB
issued ASU No. 2024-03 (&#8220;ASU 2024-03&#8221;), Disaggregation of Income Statement Expenses (&#8220;DISE&#8221;). ASU 2024-03 requires
disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an
entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories
in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement&#160;&#8212;&#160;Reporting
Comprehensive Income&#160;&#8212;&#160;Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years
beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted.
With the exception of expanding disclosures to include more granular income statement expense categories, the Company does not expect
the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements taken as a whole.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 170; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_FairValueDisclosuresTextBlock-c22_cont_1" escape="true" name="us-gaap:FairValueDisclosuresTextBlock" id="ixv-20518"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;3 &#8212;&#160;Fair Value Measurement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities recorded
at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used
to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize
the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes
a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;1&#160;&#8212;&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;2&#160;&#8212;&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;3&#160;&#8212;&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining fair value,
the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the
extent possible as well as considers counterparty credit risk in its assessment of fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities measured
at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The
Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management
to make judgments and consider factors specific to the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the Company had no financial assets measured at fair value on a recurring basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="ixv-20558"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the Company&#8217;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c191" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38788">2,235</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c192" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38789">2,235</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c191" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38790">2,235</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c192" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38791">2,235</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38792">1,714</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c196" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38793">1,714</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total assets measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38794">1,714</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c196" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-38795">1,714</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><!-- Field: Page; Sequence: 171; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Fair Value Measurement</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_FairValueDisclosuresTextBlock-c22_cont_1"><ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="ixv-20741"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the changes in the fair value of the Company&#8217;s Level&#160;3 financial instruments for the&#160;years ended December&#160;31,
2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> convertible <br/> debt at fair <br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value as of January&#160;1, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Issuance of Convertible Notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="3" unitRef="usd" id="ixv-38796">1,600</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" scale="3" unitRef="usd" id="ixv-38797">92</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" unitRef="usd" id="ixv-38798">22</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c199" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-38799">1,714</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value as of January&#160;1, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c199" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-38800">1,714</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Issuance of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c200" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="3" unitRef="usd" id="ixv-38801">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c200" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" scale="3" unitRef="usd" id="ixv-38802">194</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c200" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" unitRef="usd" id="ixv-38803">311</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c201" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-38804">2,235</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to measure
its Tasly convertible debt at fair value (Note&#160;5) with changes in fair value reported in earnings as they occur. The Convertible
Debt fair values were determined using the discounted cash flow methodology based on probability weighted scenarios of the convertible
notes conversion. At issuance of the first $<ix:nonFraction contextRef="c178" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-38805">1</ix:nonFraction>&#160;million on June&#160;26, 2023 the time to event was <ix:nonNumeric contextRef="c179" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-38806">0.28</ix:nonNumeric>&#160;years and the discount
rate applied was <ix:nonFraction contextRef="c179" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38807">14.54</ix:nonFraction>%. At issuance of the next $<ix:nonFraction contextRef="c180" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-38808">0.3</ix:nonFraction>&#160;million on July&#160;20, 2023, the time to event was <ix:nonNumeric contextRef="c181" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-38809">0.22</ix:nonNumeric>&#160;years and the
discount rate applied was <ix:nonFraction contextRef="c181" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38810">13.82</ix:nonFraction>%. At issuance of the additional $<ix:nonFraction contextRef="c182" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-38811">0.3</ix:nonFraction>&#160;million on August&#160;15, 2023, the time to event was <ix:nonNumeric contextRef="c183" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-38812">0.15</ix:nonNumeric>&#160;years
and the discount rate applied was <ix:nonFraction contextRef="c183" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38813">13.70</ix:nonFraction>%. The final amount which was less than $<ix:nonFraction contextRef="c184" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-38814">0.02</ix:nonFraction> million was issued on February 6, 2024; the time
to event was <ix:nonNumeric contextRef="c185" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-38815">0.66</ix:nonNumeric> years and the discount rate applied was <ix:nonFraction contextRef="c185" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38816">13.69</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;31, 2024
the time event was <ix:nonNumeric contextRef="c186" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-38817">0.41</ix:nonNumeric>&#160;years and the discount rate applied was <ix:nonFraction contextRef="c186" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38818">11.78</ix:nonFraction>%. The fair value of the convertible debt as of December&#160;31,
2023 was $<ix:nonFraction contextRef="c187" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-38819">1.71</ix:nonFraction>&#160;million and the fair value as of December&#160;31, 2024 was $<ix:nonFraction contextRef="c188" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShorttermDebtFairValue" scale="6" unitRef="usd" id="ixv-38820">2.2</ix:nonFraction> million.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_CondensedFinancialStatementsTextBlock-c22_cont_1" escape="true" name="srt:CondensedFinancialStatementsTextBlock" id="ixv-20828"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;4 &#8212;&#160;Balance Sheet Components</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="ixv-20833"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid expenses and other current assets (in
thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Employee advances</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdvanceRoyalties" scale="3" unitRef="usd" id="ixv-38821">96</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid legal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PrepaidLegal" scale="3" unitRef="usd" id="ixv-38822">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidInsurance" scale="3" unitRef="usd" id="ixv-38823">37</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-38824">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-38825">50</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-38826">69</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-38827">146</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><!-- Field: Page; Sequence: 172; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;4 &#8212;&#160;Balance Sheet Components</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="ixv-20933"><ix:continuation id="_CondensedFinancialStatementsTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accrued Liabilities (in thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Accrued compensation</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" unitRef="usd" id="ixv-38828">3,472</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" unitRef="usd" id="ixv-38829">1,960</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-38830">496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-38831">391</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" scale="3" unitRef="usd" id="ixv-38832">3,968</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" scale="3" unitRef="usd" id="ixv-38833">2,351</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_DebtDisclosureTextBlock-c22_cont_1" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-20985"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="ixv-20989"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the debt instruments (which are all classified as current liabilities in the accompanying consolidated balance sheets and
their changes during the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balance at January 1, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c296" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38834">13,981</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c298" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38835">15,149</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c299" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38836">576</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c300" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38837">1,326</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c302" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-38838">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-38839">3,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c304" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-38840">375</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c304" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="3" unitRef="usd" id="ixv-38841">151</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c302" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd" id="ixv-38842">22</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-213">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-214">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c301" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38843">1,820</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c302" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38844">92</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c303" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38845">1,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c304" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38846">49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c305" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38847">36</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c301" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" unitRef="usd" id="ixv-38848">515</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" unitRef="usd" id="ixv-38849">0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c306" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38850">16,316</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c307" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38851">1,714</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c308" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38852">20,155</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c309" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38853">849</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c310" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38854">1,362</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at January 1, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c306" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38855">16,316</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c307" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38856">1,714</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c308" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38857">20,155</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c309" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38858">849</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c310" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38859">1,362</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c312" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-38860">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c313" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-38861">3,210</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c313" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="3" unitRef="usd" id="ixv-38862">150</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c312" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd" id="ixv-38863">311</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c311" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38864">2,057</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c312" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38865">193</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c313" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38866">2,053</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c314" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38867">61</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c315" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-38868">14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c311" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" unitRef="usd" id="ixv-38869">46</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c316" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38870">18,419</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c317" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38871">2,234</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c318" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38872">25,268</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c319" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38873">910</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c320" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-38874">1,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c316" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-38875">18,419</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c317" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-38876">2,234</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c318" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-38877">25,268</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c319" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-38878">910</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c320" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-38879">1,376</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Debt</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>August&#160;2020 Convertible
Notes</i>&#160;&#8212;&#160;In August, September, October and December&#160;2020 the Company received $<ix:nonFraction contextRef="c202" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38880"><ix:nonFraction contextRef="c203" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38881"><ix:nonFraction contextRef="c204" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38882"><ix:nonFraction contextRef="c205" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38883">9.1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million in total gross
proceeds from the issuance of convertible promissory notes (the &#8220;2020 Convertible Notes&#8221;). Interest on the unpaid principal
balance of the August&#160;2020 Convertible Notes accrues from the issuance date at a rate of <ix:nonFraction contextRef="c206" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-38884">12</ix:nonFraction>% per year, compounded semi-annually,
and is payable at maturity. Unless converted or redeemed upon the occurrence of certain events, the August&#160;2020 Convertible Notes
were to mature within <ix:nonNumeric contextRef="c207" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="ixv-38885">12&#160;months</ix:nonNumeric> of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of an equity financing with
aggregate proceeds to the Company of no less than $<ix:nonFraction contextRef="c208" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38886">20.0</ix:nonFraction>&#160;million (the &#8220;Qualified Financing&#8221;), the notes&#8217; outstanding
principal balance and accrued but unpaid interest are to convert into the shares of convertible preferred stock issued in such a Qualified
Financing at a conversion price equal to the lesser of (i)&#160;the per share price obtained by dividing $<ix:nonFraction contextRef="c209" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="6" unitRef="usdPershares" id="ixv-38887">150.0</ix:nonFraction>&#160;million by the Company&#8217;s
fully diluted capitalization, or (ii)&#160;the per share price paid by investors in the Qualified Financing, subject to <ix:nonFraction contextRef="c209" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:DebtInstrumentDiscount" scale="-2" unitRef="pure" id="ixv-38888">30</ix:nonFraction>%&#160;discount.
Upon the occurrence of a change of control, the August&#160;2020 Convertible Notes are required to be repaid in the amount equal to <ix:nonFraction contextRef="c208" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" unitRef="pure" id="ixv-38889">200</ix:nonFraction>%
of the notes&#8217; outstanding principal balance plus accrued but unpaid interest.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 173; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c22_cont_2" id="_DebtDisclosureTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The August&#160;2020 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that is required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The aggregate issuance date estimated fair values of the derivative liability
issued with the August&#160;2020 Convertible Notes was $<ix:nonFraction contextRef="c209" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilities" scale="6" unitRef="usd" id="ixv-38890">1.8</ix:nonFraction>&#160;million and was recorded as a debt discount. The discount on the August&#160;2020
Convertible Notes was to be amortized over the contractual term of <ix:nonNumeric contextRef="c209" format="ixt-sec:durmonth" name="ck0001859807:DebtInstrumentsContractualTerm" id="ixv-38891">12</ix:nonNumeric>&#160;months from issuance, using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;25, 2021, the
August&#160;2020 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2021 (the &#8220;Amendment&#160;1&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the August&#160;2020 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022 (the &#8220;Amendment&#160;2&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January&#160;2021 Convertible
Notes</i>&#160;&#8212;&#160;In January&#160;2021 the Company received $<ix:nonFraction contextRef="c210" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38892">1.0</ix:nonFraction>&#160;million in gross proceeds from the issuance of convertible
promissory notes (the &#8220;January&#160;2021 Convertible Notes&#8221;). Interest on the unpaid principal balance of the January&#160;2021
Convertible Notes accrues from the issuance date at a rate of <ix:nonFraction contextRef="c211" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-38893">12</ix:nonFraction>% per year, compounded semi-annually, and is payable at maturity. Unless
converted or redeemed upon the occurrence of certain events, the January&#160;2021 Convertible Notes were to mature within <ix:nonNumeric contextRef="c210" format="ixt-sec:durmonth" name="us-gaap:DebtInstrumentTerm" id="ixv-38894">12</ix:nonNumeric>&#160;months
of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of a
Qualified Financing, the notes&#8217; outstanding principal balance and accrued but unpaid interest are to convert into the shares of
convertible preferred stock issued in such a Qualified Financing at a conversion price equal to the lesser of (i)&#160;the per share price
obtained by dividing $<ix:nonFraction contextRef="c211" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="6" unitRef="usdPershares" id="ixv-38895">150.0</ix:nonFraction>&#160;million by the Company&#8217;s fully diluted capitalization, or (ii)&#160;the per share price paid by
investors in the Qualified Financing, subject to <ix:nonFraction contextRef="c211" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:DebtInstrumentDiscount" scale="-2" unitRef="pure" id="ixv-38896">30</ix:nonFraction>% discount. Upon the occurrence of a change of control, the January&#160;2021 Convertible
Notes are required to be repaid in the amount equal to <ix:nonFraction contextRef="c210" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" unitRef="pure" id="ixv-38897">200</ix:nonFraction>% of the notes&#8217; outstanding principal balance plus accrued but unpaid
interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The January&#160;2021 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that were required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The issuance date estimated fair values of the derivative liability issued
with the January&#160;2021 Convertible Notes was $<ix:nonFraction contextRef="c211" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilities" scale="6" unitRef="usd" id="ixv-38898">0.2</ix:nonFraction>&#160;million and was recorded as a debt discount. The discount on the January&#160;2021
Convertible Notes was to be amortized over the contractual term of <ix:nonNumeric contextRef="c211" format="ixt-sec:durmonth" name="ck0001859807:DebtInstrumentsContractualTerm" id="ixv-38899">12</ix:nonNumeric>&#160;months from issuance, using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the January&#160;2021 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;2021 Convertible
Notes</i>&#160;&#8212;&#160;In April, May and June&#160;2021 the Company received $<ix:nonFraction contextRef="c212" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38900"><ix:nonFraction contextRef="c213" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38901"><ix:nonFraction contextRef="c214" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38902">1.2</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million in total gross proceeds from the issuance
of convertible promissory notes (together with January&#160;2021 Convertible Notes, the &#8220;2021 Convertible Notes&#8221;). Interest
on the unpaid principal balance of the April&#160;2021 Convertible Notes accrues from the issuance date at a rate of <ix:nonFraction contextRef="c215" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-38903">12</ix:nonFraction>% per year, compounded
semi-annually, and is payable at maturity. Unless converted or redeemed upon the occurrence of certain events, the April&#160;2021 Convertible
Notes were to mature within <ix:nonNumeric contextRef="c213" format="ixt-sec:durmonth" name="us-gaap:DebtInstrumentTerm" id="ixv-38904">12</ix:nonNumeric>&#160;months of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of a Qualified Financing,
the notes&#8217; outstanding principal balance and accrued but unpaid interest are to convert into the shares of convertible preferred
stock issued in such a Qualified Financing at a conversion price equal to the lesser of (i)&#160;the per share price obtained by dividing
$<ix:nonFraction contextRef="c215" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="6" unitRef="usdPershares" id="ixv-38905">150.0</ix:nonFraction>&#160;million by the Company&#8217;s fully diluted capitalization, or (ii)&#160;the per share price paid by investors in the Qualified
Financing, subject to <ix:nonFraction contextRef="c216" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:DebtInstrumentDiscount" scale="-2" unitRef="pure" id="ixv-38906">30</ix:nonFraction>% discount. Upon the occurrence of a change of control, the April&#160;2021 Convertible Notes are required to
be repaid in the amount equal to <ix:nonFraction contextRef="c213" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" unitRef="pure" id="ixv-38907">200</ix:nonFraction>% of the notes&#8217; outstanding principal balance plus accrued but unpaid interest.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 174; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c22_cont_3" id="_DebtDisclosureTextBlock-c22_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The April&#160;2021 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that were required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The issuance date estimated fair values of the derivative liabilities issued
with the April&#160;2021 Convertible Notes was $<ix:nonFraction contextRef="c215" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilities" scale="6" unitRef="usd" id="ixv-38908">0.3</ix:nonFraction>&#160;million and was recorded as debt discounts. The discount on the April&#160;2021
Convertible Notes was to be amortized over the contractual term of <ix:nonNumeric contextRef="c215" format="ixt-sec:durmonth" name="ck0001859807:DebtInstrumentsContractualTerm" id="ixv-38909">12</ix:nonNumeric>&#160;months from issuance, using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the April&#160;2021 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Notes November&#160;2022 Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;3, 2022,
all of the convertible notes outstanding, referred to as the 2020 Convertible Notes and 2021 Convertible Notes based on the original board
approvals (together the &#8220;Convertible Notes&#8221;) were amended as follows: 1) all unpaid interest and principal shall be due and
payable on the date which is <span style="-sec-ix-hidden: hidden-fact-242">five</span>&#160;business days after the termination of the Merger prior to the occurrence of the Merger closing,
2)&#160;the maximum aggregate initial principal amount was increased from $<ix:nonFraction contextRef="c218" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="6" unitRef="usd" id="ixv-38910">11.0</ix:nonFraction>&#160;million to $<ix:nonFraction contextRef="c219" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="6" unitRef="usd" id="ixv-38911">11.3</ix:nonFraction>&#160;million, 3)&#160;automatic
conversion to SPAC shares of at then outstanding all notes and accrued interest upon the Merger at $<ix:nonFraction contextRef="c220" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-38912">7.00</ix:nonFraction> per share was introduced, 4)
upon consummation of the Merger, all noteholders will have a right to receive additional shares upon achievement by the combined company
of certain share price and sales milestones (the&#160;earnout shares) (the &#8220;November&#160;2022 Convertible Notes Amendment&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The November&#160;2022 Convertible
Notes Amendment represented a troubled debt restructuring (the &#8220;TDR&#8221;). The TDR did not result in a gain recognition. As a
result, a new effective interest rate was established based on the $<ix:nonFraction contextRef="c221" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" unitRef="usd" id="ixv-38913">14.4</ix:nonFraction>&#160;million carrying value of the debt immediately prior to
the November&#160;2022 Convertible Notes Amendment and the future cash flows after such amendment, net of the issuance costs paid to or
received from the Convertible Notes holders, which were capitalized and amortized based on the new effective interest rate. Fees paid
to third parties in connection with the November&#160;2022 Convertible Notes Amendment were expensed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Convertible Notes was estimated from <ix:nonFraction contextRef="c222" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-38914">12.54</ix:nonFraction>% to <ix:nonFraction contextRef="c223" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-38915">53.28</ix:nonFraction>% and <ix:nonFraction contextRef="c224" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-38916">12.95</ix:nonFraction>% to <ix:nonFraction contextRef="c225" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-38917">53.28</ix:nonFraction>% per year for the&#160;years ended December&#160;31,
2024 and 2023, respectively. The interest expense for the&#160;years ended December&#160;31, 2024 and 2023 was $<ix:nonFraction contextRef="c226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-38918">2.1</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c227" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-38919">2.3</ix:nonFraction>&#160;million,
which includes the amortization of debt discount and issuance costs of $<ix:nonFraction contextRef="c226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" unitRef="usd" id="ixv-38920">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c227" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" unitRef="usd" id="ixv-38921">0.5</ix:nonFraction>&#160;million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the outstanding balance of convertible notes includes related party convertible notes of $<ix:nonFraction contextRef="c228" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-38922">13.3</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c229" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-38923">11.8</ix:nonFraction>&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tasly Convertible Debt</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June&#160;2023, the Company
entered into a short-term loan agreement with a related party under which it may borrow up to $<ix:nonFraction contextRef="c230" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" unitRef="usd" id="ixv-38924">1.6</ix:nonFraction>&#160;million, of which $<ix:nonFraction contextRef="c230" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-38925">1.0</ix:nonFraction>&#160;million
was borrowed on June&#160;26, 2023, $<ix:nonFraction contextRef="c231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-38926">0.3</ix:nonFraction>&#160;million was borrowed on July&#160;20, 2023, $<ix:nonFraction contextRef="c232" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-38927">0.3</ix:nonFraction>&#160;million was borrowed on August&#160;15,
2023 and the final $<ix:nonFraction contextRef="c233" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-38928">0.02</ix:nonFraction> million was borrowed in February 2024 (the &#8220;Convertible debt&#8221;).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 175; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c22_cont_4" id="_DebtDisclosureTextBlock-c22_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The loans bear interest
at a rate of <ix:nonFraction contextRef="c234" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:DebtInterestRate" scale="-2" unitRef="pure" id="ixv-38929">12</ix:nonFraction>% per annum and originally matured on December 31, 2023. The original maturity date was extended to March&#160;31,
2024, subject to the parties&#8217; decision to extend thereafter. The Company is currently in default, as this loan will be repaid
in parallel with the closing of the SPAC transaction. Accordingly, the Company classified the entire amount outstanding under the
Tasly Convertible Debt as current on the Consolidated Balance Sheet. Upon occurrence of certain events of default by the Company,
including failure to repay in full the amounts owed at&#160;maturity, the lender will have an option to convert the entire
outstanding balance and accrued but unpaid interest under the Convertible debt into senior unsecured promissory notes on
substantially the same terms as the outstanding Senior Notes as of December&#160;31, 2024. In the event the Company fails to
complete the Merger, the lender will have an option to convert the entire outstanding balance and accrued but unpaid interest under
the Convertible debt into either (i)&#160;senior unsecured promissory notes on substantially the same terms as the outstanding
Senior Notes as of December&#160;31, 2024 or (ii)&#160;the Company&#8217;s common stock at a conversion price of $<ix:nonFraction contextRef="c235" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:CommonStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-38930">2.33</ix:nonFraction> per
share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to apply
the fair value option to account for the Tasly Convertible debt. Accordingly, no features of the Convertible debt are bifurcated and separately
accounted for. The fair value of the Convertible debt was $<ix:nonFraction contextRef="c235" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="6" unitRef="usd" id="ixv-38931">2.2</ix:nonFraction> million as of December 31, 2024, compared to $<ix:nonFraction contextRef="c236" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="6" unitRef="usd" id="ixv-38932">1.71</ix:nonFraction>&#160;million as of December&#160;31,
2023. Accrued stated interest on the Convertible debt was $<ix:nonFraction contextRef="c237" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" unitRef="usd" id="ixv-38933">0.2</ix:nonFraction> million for the year ended December 31, 2024 compared to less than $<ix:nonFraction contextRef="c234" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" unitRef="usd" id="ixv-38934">0.1</ix:nonFraction>&#160;million
for the year ended December&#160;31, 2023. The total loss on fair value remeasurement is $<ix:nonFraction contextRef="c238" decimals="-4" format="ixt:num-dot-decimal" name="ck0001859807:LossOnFairValueRemeasurement" scale="6" unitRef="usd" id="ixv-38935">0.33</ix:nonFraction> million, of which, $<ix:nonFraction contextRef="c239" decimals="-4" format="ixt:num-dot-decimal" name="ck0001859807:LossOnFairValueRemeasurement" scale="6" unitRef="usd" id="ixv-38936">0.31</ix:nonFraction> million in loss
on fair value remeasurement is from the year ended December 31, 2024, compared to less than $<ix:nonFraction contextRef="c234" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:LossOnFairValueRemeasurement" scale="6" unitRef="usd" id="ixv-38937">0.1</ix:nonFraction> million in loss on fair value remeasurement
from the year ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes 2021</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>August&#160;2021 Senior
Notes</i>&#160;&#8212;&#160;In August&#160;2021 the Company received $<ix:nonFraction contextRef="c240" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38938">4.0</ix:nonFraction>&#160;million in total gross proceeds from the issuance of senior
unsecured promissory notes (the &#8220;August&#160;2021 Senior Notes&#8221;). Simple interest on the unpaid principal balance of the August&#160;2021
Senior Notes accrued from the issuance date at a rate of <ix:nonFraction contextRef="c241" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-38939">12</ix:nonFraction>% per year and is payable at maturity. The August&#160;2021 Senior Notes were
to mature on the earlier of (a)&#160;issuance of the next round of preferred stock of (b)&#160;August&#160;25, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the August&#160;2021 Senior Notes were amended to provide the note holders with an option to convert the notes&#8217; outstanding principal
balance and accrued but unpaid interest into (a)&#160;the shares of convertible preferred stock issued upon consummation of a Qualified
Financing at a conversion price equal to the per share price paid by investors in such Qualified Financing, subject to <ix:nonFraction contextRef="c242" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:DebtInstrumentDiscount" scale="-2" unitRef="pure" id="ixv-38940">20</ix:nonFraction>% discount, or
(b)&#160;shares of the Company&#8217;s Series&#160;C convertible preferred stock at the conversion price equal to the original issue price
prior to Qualified Financing in the event the Qualified Financing had not occurred prior to February&#160;25, 2022, or (c)&#160;shares
of the Company&#8217;s Series&#160;C convertible preferred stock at the conversion price equal to the original issue price upon change
of control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The optional conversion upon
Qualified Financing represents an embedded feature that is required to be bifurcated and accounted for separately as a derivative instrument
initially and subsequently measured at fair value with the change in the gain (loss) on change in the fair value of derivative liabilities
in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>December&#160;2021 Senior
Notes</i>&#160;&#8212;&#160;In December&#160;2021 the Company received $<ix:nonFraction contextRef="c243" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" unitRef="usd" id="ixv-38941">1.3</ix:nonFraction>&#160;million in total gross proceeds from the issuance of
senior unsecured promissory notes (the &#8220;December&#160;2021 Senior Notes&#8221;, together with August&#160;2021 Senior Notes, the
&#8220;2021 Senior Notes&#8221;). Simple interest on the unpaid principal balance of the December&#160;2021 Senior Notes accrued from
the issuance date at a rate of <ix:nonFraction contextRef="c244" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-38942">12</ix:nonFraction>% per year and is payable at maturity. The December&#160;2021 Senior Notes mature on August&#160;25,
2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2022 the Company issued additional Senior Notes to the existing investors for the aggregate principal amount of $<ix:nonFraction contextRef="c245" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38943">5.5</ix:nonFraction>&#160;million (the
&#8220;2022 Senior Notes&#8221;) on substantially the same terms as the other Senior Notes issued in 2021 (as amended in December&#160;2021).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 176; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c22_cont_5" id="_DebtDisclosureTextBlock-c22_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Senior Notes September&#160;2022 Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September&#160;2022,
the <ix:nonFraction contextRef="c215" decimals="2" name="ck0001859807:DebtInstrumentDiscount" scale="-2" unitRef="pure" id="ixv-38944">2021</ix:nonFraction> Senior Notes and 2022 Senior Notes (together &#8220;Senior Notes&#8221;) were amended as follows: a) the maturity dates for
all Senior Notes were extended to December&#160;31, 2022, b) the conversion price discount in the event of a Qualified Financing was
increased to <ix:nonFraction contextRef="c246" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38945">60</ix:nonFraction>%, c) the February&#160;25, 2022 deadline for the occurrence of a Qualified Financing for conversion of the Senior
Notes into Series&#160;C convertible preferred stock prior to a Qualified Financing was extended to December&#160;31, 2022 and the
respective conversion price discount of <ix:nonFraction contextRef="c247" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38946">60</ix:nonFraction>% was introduced for conversion prior to a Qualified Financing; d) the conversion price
discount of <ix:nonFraction contextRef="c248" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-38947">60</ix:nonFraction>% in the event of change of control was introduced; e) conversion option prior to entering into a definitive agreement
with a SPAC (the &#8220;Definitive Qualified Agreement&#8221;) was introduced. Under this option, in the event that the Company
executes a Definitive Qualified Agreement, then the Senior Note&#160;holders will have the option (but not the obligation) to
convert the entire outstanding principal balance and all accrued but unpaid interest into shares of the Company&#8217;s common stock
at a conversion price equal to <ix:nonFraction contextRef="c249" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-38948">40</ix:nonFraction>% of the per share price of the common stock as determined pursuant to the Definitive Qualified
Agreement; provided, that, if such conversion price per share of the common stock is greater than $<ix:nonFraction contextRef="c248" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockConvertibleConversionPriceIncrease" scale="0" unitRef="usdPershares" id="ixv-38949">4.00</ix:nonFraction>, then such conversion price
shall be deemed to be $<ix:nonFraction contextRef="c250" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-38950">4.00</ix:nonFraction> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This 2022&#160;amendment was
accounted for as debt extinguishment resulting in $<ix:nonFraction contextRef="c251" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" unitRef="usd" id="ixv-38951">8.8</ix:nonFraction>&#160;million debt extinguishment loss recognized in loss on debt extinguishment,
net in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The optional conversion upon
a Qualified Financing and Qualified conversion option represents embedded features that are required to be bifurcated and accounted for
separately as a combined single derivative instrument initially and subsequently measured at fair value with the change in the gain (loss)
on change in the fair value of derivative liabilities in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>October&#160;2022 Senior
Notes</i>&#160;&#8212;&#160;In September and October&#160;2022, the Company issued an additional Senior Notes to existing investors with
the principal amount of $<ix:nonFraction contextRef="c252" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38952"><ix:nonFraction contextRef="c253" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38953">1.3</ix:nonFraction></ix:nonFraction>&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in September&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes November&#160;2022 Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;3, 2022,
all Senior Notes were amended as follows: 1) all unpaid interest and principal shall be due and payable on the date which is <span style="-sec-ix-hidden: hidden-fact-243">five</span>&#160;business
days after the termination of the Merger prior to the occurrence of the Merger closing, 2) automatic conversion to SPAC shares of at then
outstanding all notes and accrued interest upon the Merger at $<ix:nonFraction contextRef="c255" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-38954">4.00</ix:nonFraction> per share was introduced, 3) upon consummation of the Merger, all
noteholders will have a right to receive additional shares upon achievement by the combined company of certain share price and sales milestones
(the earnout shares) (the &#8220;November&#160;2022 Senior Notes Amendment&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The November&#160;2022 Senior
Notes Amendment represented a TDR.&#160;Since the total future undiscounted cash flows under Senior Notes were less than their outstanding
principal amount and unpaid accrued interest plus fair value of the bifurcated derivative immediately before November&#160;2022 Senior
Notes Amendment, the Company recognized TDR gain of $<ix:nonFraction contextRef="c256" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38955">3.98</ix:nonFraction>&#160;million for the Senior Notes issued to unrelated parties in its Statement
of Operations for the year ended December&#160;31, 2022 and it recognized $<ix:nonFraction contextRef="c257" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="6" unitRef="usd" id="ixv-38956">3.97</ix:nonFraction>&#160;million in Additional Paid-in Capital for the year
ended December&#160;31, 2022 for the Senior Notes issued to related parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>December&#160;2022 Senior
Notes</i>&#160;&#8212;&#160;In November and December&#160;2022, the Company issued additional Senior Notes to investors with the principal
amount of $<ix:nonFraction contextRef="c258" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38957"><ix:nonFraction contextRef="c259" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38958">1.0</ix:nonFraction></ix:nonFraction>&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes 2023</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>March&#160;2023 Senior
Notes</i>&#160;&#8212;&#160;In January, February and March&#160;2023, the Company issued additional Senior Notes to investors with the
principal amount of $<ix:nonFraction contextRef="c260" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38959"><ix:nonFraction contextRef="c261" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38960"><ix:nonFraction contextRef="c262" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38961">1.6</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;2023 Senior
Notes</i>&#160;&#8212;&#160;In April&#160;2023, the Company issued additional Senior Notes to investors with the principal amount of $<ix:nonFraction contextRef="c263" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38962">0.6</ix:nonFraction>&#160;million
on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 177; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c22_cont_6" id="_DebtDisclosureTextBlock-c22_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>October-December&#160;2023
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months October through December&#160;2023, the Company issued additional Senior Notes
to investors with the principal amount of $<ix:nonFraction contextRef="c264" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38963">1.1</ix:nonFraction>&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022). These notes were issued at the same <ix:nonFraction contextRef="c264" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-38964">12</ix:nonFraction>% interest terms as all of their other Senior Convertible Notes, and will
convert into New Profusa shares at $<ix:nonFraction contextRef="c264" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare" scale="0" unitRef="usdPershares" id="ixv-38965">2.22</ix:nonFraction> per share upon the successful closing of the business combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes 2024</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January-March 2024 Senior
Notes</i> &#8212; During the months January through March 2024, the Company issued additional Senior Notes to investors with the principal
amount of $<ix:nonFraction contextRef="c265" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38966">0.7</ix:nonFraction> million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April-June 2024 Senior
Notes &#8212; </i>During the months April through June 2024, the Company issued additional Senior Notes to investors with the principal
amount of $<ix:nonFraction contextRef="c266" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38967">0.4</ix:nonFraction> million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022). Additionally,
the Company repaid $<ix:nonFraction contextRef="c267" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38968">0.11</ix:nonFraction> million of principal on Senior Notes with investors during the respective period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>July-September 2024 Senior
Notes </i>&#8212; During the months July through September 2024, the Company issued additional Senior Notes to investors with the principal
amount of $<ix:nonFraction contextRef="c268" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38969">0.7</ix:nonFraction> million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022). Additionally,
during the months of July through September 2024, the Company issued a Senior Secured Convertible Note with the principal amount of $<ix:nonFraction contextRef="c269" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38970">0.25</ix:nonFraction>
million. This note was issued at the same <ix:nonFraction contextRef="c268" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-38971">12</ix:nonFraction>% interest terms as all of their other Senior Convertible Notes, and has an <ix:nonNumeric contextRef="c270" format="ixt-sec:durmonth" name="ck0001859807:MaturityMonth" id="ixv-38972">18</ix:nonNumeric>-month maturity,
which will be accelerated and converts into New Profusa shares upon the successful closing of the business combination. The Company repaid
$<ix:nonFraction contextRef="c271" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38973">0.04</ix:nonFraction> million of principal on Senior Notes with investors during the respective period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>October-December 2024 Senior
Notes</i> &#8212; During the months October through December 2024, the Company issued two Senior Secured Convertible Notes with a total
principal amount of $<ix:nonFraction contextRef="c272" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-38974">1.1</ix:nonFraction> million. These notes were issued at the same <ix:nonFraction contextRef="c272" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-38975">12</ix:nonFraction>% interest terms as all of their other Senior Convertible Notes,
and have an <ix:nonNumeric contextRef="c273" format="ixt-sec:durmonth" name="ck0001859807:MaturityMonth" id="ixv-38976">18</ix:nonNumeric>-month maturity, which will be accelerated and converted into New Profusa shares upon the successful closing of the business
combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2024, the
outstanding balance of senior notes totaled $<ix:nonFraction contextRef="c274" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SeniorNotes" scale="6" unitRef="usd" id="ixv-38977">25.3</ix:nonFraction> million, of which $<ix:nonFraction contextRef="c275" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" unitRef="usd" id="ixv-38978">9.5</ix:nonFraction> million is outstanding with related parties and $<ix:nonFraction contextRef="c276" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" unitRef="usd" id="ixv-38979">15.8</ix:nonFraction> million
is outstanding with unrelated parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Senior Notes was estimated from <ix:nonFraction contextRef="c277" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-38980">0</ix:nonFraction>% to <ix:nonFraction contextRef="c278" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-38981">12.15</ix:nonFraction>% and <ix:nonFraction contextRef="c279" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-38982">0</ix:nonFraction>% to <ix:nonFraction contextRef="c280" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-38983">12.55</ix:nonFraction>% per year for the&#160;years ended December&#160;31, 2024 and 2023,
respectively. The interest expense was $<ix:nonFraction contextRef="c251" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-38984">2.1</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c281" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-38985">1.8</ix:nonFraction>&#160;million for the&#160;years ended December&#160;31, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock" id="ixv-21734"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
future minimum payments for the convertible notes payable were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Total future principal payments</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c321" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-38986">19,533</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c188" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-38987">1,998</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c274" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-38988">24,396</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Add: fair value remeasurement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c188" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueRemeasurement" scale="3" sign="-" unitRef="usd" id="ixv-38989">333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Add (less): unamortized debt (premium) discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c321" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" unitRef="usd" id="ixv-38990">2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c274" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" sign="-" unitRef="usd" id="ixv-38991">2,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c321" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:InterestExpensesNotesPayable" scale="3" unitRef="usd" id="ixv-38992">1,112</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c188" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:InterestExpensesNotesPayable" scale="3" unitRef="usd" id="ixv-38993">97</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c274" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:InterestExpensesNotesPayable" scale="3" unitRef="usd" id="ixv-38994">1,183</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c321" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-38995">18,419</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c188" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-38996">2,234</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c274" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-38997">25,268</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 178; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_DebtDisclosureTextBlock-c22_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Promissory Notes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In a series of transactions
during 2010 and 2011 two of the Company&#8217;s founders provided $<ix:nonFraction contextRef="c22" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-38998">0.2</ix:nonFraction>&#160;million to the Company to fund general corporate purposes
in exchange for promissory notes. The notes accrue interest annually at a simple interest rate of <ix:nonFraction contextRef="c282" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtInterestRateIncrease" scale="-2" unitRef="pure" id="ixv-38999">5</ix:nonFraction>% with no set maturity date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2022, the Company borrowed $<ix:nonFraction contextRef="c283" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" unitRef="usd" id="ixv-39000">0.3</ix:nonFraction>&#160;million from two of its founders at zero interest rate to finance its short-term operations, from
which $<ix:nonFraction contextRef="c283" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" unitRef="usd" id="ixv-39001">0.2</ix:nonFraction>&#160;million was repaid in the same period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2023, the Company borrowed short-term promissory notes of $<ix:nonFraction contextRef="c284" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39002">0.3</ix:nonFraction>&#160;million from an existing investor and an additional $<ix:nonFraction contextRef="c285" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:UnrelatedPartyRepayable" scale="6" unitRef="usd" id="ixv-39003">0.1</ix:nonFraction>&#160;million
from an unrelated party repayable on demand at any time after December&#160;31, 2024, with annual interest rate of <ix:nonFraction contextRef="c286" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" unitRef="pure" id="ixv-39004">12</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interest expense on the promissory
notes was less than $<ix:nonFraction contextRef="c285" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39005"><ix:nonFraction contextRef="c282" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39006">0.1</ix:nonFraction></ix:nonFraction>&#160;million for each of the&#160;years ended December&#160;31, 2024 and 2023. The carrying value of the promissory
notes as of December&#160;31, 2024 and 2023 was $<ix:nonFraction contextRef="c282" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39007">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c285" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39008">0.8</ix:nonFraction>&#160;million, respectively. As of December&#160;31, 2024 and
2023, outstanding balance of promissory notes includes all related party promissory notes of $<ix:nonFraction contextRef="c287" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39009">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c288" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39010">0.8</ix:nonFraction>&#160;million,
respectively. The Company recognized that the promissory notes from December 31, 2023 are in default as of the date of this filing. The
note holders will be repaid upon closing the business transaction, and the full balance of these notes are held in current liabilities
on the Consolidated Balance Sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Paycheck Protection Program</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;25, 2021, the
Company borrowed $<ix:nonFraction contextRef="c289" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39011">1.3</ix:nonFraction>&#160;million (the &#8220;PPP Loan 2&#8221;) as a Paycheck Protection Program loan. The Paycheck Protection Program,
established as part of the Coronavirus Aid, Relief, and Economic Security (&#8220;CARES&#8221;) Act, provides for loans to qualifying
businesses and is administered by the U.S.&#160;Small Business Administration (the &#8220;SBA&#8221;). The annual interest rate of the
PPP Loan 2 is <ix:nonFraction contextRef="c290" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39012">1</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of PPP Loan
2, if the Company does not submit forgiveness application within 24&#160;weeks the initial disbursement of the loan (the &#8220;Covered
Period&#8221;), the Company must begin to make equal monthly payments of principal and interest starting <ix:nonNumeric contextRef="c291" format="ixt-sec:durwordsen" name="ck0001859807:MonthlyPayments" id="ixv-39013">10&#160;months</ix:nonNumeric> from the end of
the Covered Period until May&#160;25, 2026. Interest on the loan continues to accumulate during any deferment period. As of December&#160;31,
2024, and as of the date of this filing, the Company has not applied for forgiveness under PPP Loan 2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and December 31, 2023, the Company was in default on PPP Loan 2 due to non-payment of minimal repayment amounts required by the terms
of PPP Loan 2. Accordingly, the Company classified the entire amount outstanding under PPP Loan 2 as current and accrued respective late
penalties for the total amount of less than $<ix:nonFraction contextRef="c292" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:LatePenaltiesAmount" scale="6" unitRef="usd" id="ixv-39014"><ix:nonFraction contextRef="c293" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:LatePenaltiesAmount" scale="6" unitRef="usd" id="ixv-39015">0.1</ix:nonFraction></ix:nonFraction>&#160;million as of December&#160;31, 2024 and December 31, 2023, respectively. The total
past due amount of PPP Loan 2 repayments as of December&#160;31, 2024 and December 31, 2023 was $<ix:nonFraction contextRef="c294" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtDefaultLongtermDebtAmount" scale="6" unitRef="usd" id="ixv-39016">0.8</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c295" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtDefaultLongtermDebtAmount" scale="6" unitRef="usd" id="ixv-39017">0.4</ix:nonFraction>&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="ixv-21880"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
the contractual future minimum payments for the PPP Loan 2 were as follows (in&#160;thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Year Ending December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="0" unitRef="usd" id="ixv-39018">1,231</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="0" unitRef="usd" id="ixv-39019">145</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="0" unitRef="usd" id="ixv-39020">1,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 179; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-21929"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Lease Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2022 the Company
entered into a new lease agreement (the &#8220;Amended Lease&#8221;) whereby the Company agreed to rent its office and lab facilities
under month-to-month tenancy. The monthly rent payable under the Amended Lease was $<ix:nonFraction contextRef="c322" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseAndRentalExpense" scale="3" unitRef="usd" id="ixv-39021">25</ix:nonFraction> thousand. This month-to-month lease ended in July
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beginning in October 2024,
the Company entered into a new lease agreement whereby the Company agreed to rent its office and lab facilities under month-to-month tenancy.
The monthly rent payable under the new lease is also $<ix:nonFraction contextRef="c323" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseAndRentalExpense" scale="3" unitRef="usd" id="ixv-39022">25</ix:nonFraction>&#160;thousand. This month-to-month lease automatically renews every four months,
unless written termination is provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Operating costs for short-term
leases and variable lease costs were less than $<ix:nonFraction contextRef="c22" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeasePayments" scale="6" unitRef="usd" id="ixv-39023">0.1</ix:nonFraction>&#160;million during the&#160;years ended December&#160;31, 2024 and 2023. The Company
recognized a total of $<ix:nonFraction contextRef="c324" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="6" unitRef="usd" id="ixv-39024">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c325" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="6" unitRef="usd" id="ixv-39025">0.3</ix:nonFraction>&#160;million in lease expense for the&#160;years ended December&#160;31, 2024 and 2023,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Contingencies and Indemnifications</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company
may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability
for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant
judgment is required to determine both probability and the estimated amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the normal course of business,
the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications.
The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future, but that have not yet been made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To date, the Company has not
paid any claims; however, the Company may record charges in the future as a result of these indemnification obligations. The Company is
currently defending one litigation with a vendor. Management has accrued estimated incremental legal costs which totals less than $<ix:nonFraction contextRef="c22" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="6" unitRef="usd" id="ixv-39026">0.1</ix:nonFraction>
million related to the matter.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_PreferredStockTextBlock-c22_cont_1" escape="true" name="us-gaap:PreferredStockTextBlock" id="ixv-21960"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;7 &#8212;&#160;Convertible Preferred Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Company&#8217;s
Amended and Restated Certificate of Incorporation, as amended, the Company is authorized to issue two classes of shares: preferred and
common stock. The preferred stock is issuable in series, and the Company&#8217;s Board of Directors is authorized to determine the rights,
preferences, and terms of each series. Under the Company&#8217;s Articles of Incorporation, as amended, the Company is authorized to issue
<ix:nonFraction contextRef="c326" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39027">18,551,382</ix:nonFraction> shares of convertible preferred stock at a par value of $<ix:nonFraction contextRef="c326" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39028">0.0001</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock" id="ixv-21966"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
as of December&#160;31, 2024 and December 31, 2023 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share <br/> Issued and <br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liquidation <br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying <br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Original <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">New Series&#160;A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c327" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39029">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c327" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39030">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c327" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39031">5,307</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c327" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39032">5,231</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c327" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39033">1.22</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">New Series&#160;B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c328" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39034">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c328" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39035">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c328" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39036">13,815</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c328" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39037">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c328" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39038">2.61</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Series&#160;C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c329" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39039">7,358,151</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c329" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39040">6,670,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c329" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39041">37,623</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c329" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39042">37,476</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c329" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39043">5.64</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">New Series&#160;C-1</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c330" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39044">1,549,742</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c330" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39045">1,549,742</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c330" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39046">7,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c330" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39047">8,741</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c330" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39048">4.80</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c326" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39049">18,551,382</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c326" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39050">17,863,934</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c326" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39051">64,184</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c326" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39052">65,149</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 180; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;7 &#8212;&#160;Convertible Preferred Stock</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_PreferredStockTextBlock-c22_cont_2" id="_PreferredStockTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of convertible
preferred stock shares are entitled to vote on all matters on which the common stockholders are entitled to vote. Each holder of convertible
preferred stock is entitled to the number of votes equal to the number of common stock shares into which the shares held by such holder
could be converted as of the Record Date. Holders of convertible preferred stock and common stock generally vote as a single class.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividends</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of convertible preferred
stock are entitled to receive dividends, when, as and if declared by the board of directors, at the annual rate of <ix:nonFraction contextRef="c22" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" unitRef="pure" id="ixv-39053">8</ix:nonFraction>% of the original
issue price, payable in preference and priority to any declaration or payment of any distribution on common stock of the Company in such
calendar year. No distributions may be made with respect to the common stock unless dividends on the convertible preferred stock have
been declared and all declared dividends on the convertible preferred stock have been paid or set aside for payment to the holders of
the convertible preferred stock. Dividends are noncumulative, and <span style="-sec-ix-hidden: hidden-fact-244"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:fixed-zero" name="us-gaap:Dividends" scale="0" unitRef="usd" id="ixv-39054">none</ix:nonFraction></span> were declared as of December&#160;31, 2024 and December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidation Preference</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any liquidation,
dissolution, or winding up of the Company, the holders of Series&#160;C/C-1 convertible preferred stock shall be entitled to receive,
prior and in preference to any distribution of any of the assets of the Company to the holders of the Series&#160;B convertible preferred
stock, the Series&#160;A convertible preferred stock or common stock, an amount per share for each share of Series&#160;C/C-1 convertible
preferred stock held by them equal to the sum of the liquidation preference amount of respective original issue price per share, as adjusted
for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event
(&#8220;anti-dilution adjustments&#8221;) plus all declared but unpaid dividends on such shares. Should the Company&#8217;s legally available
assets be insufficient to satisfy the liquidation preferences, the funds will be distributed with equal priority and <i>pro rata</i> among
the holders of Series&#160;C/C-1 convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled
to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;C/C-1 convertible preferred stock, payment should be made to the holders of Series&#160;B convertible preferred stock,
in preference to the holders of the Series&#160;A convertible preferred stock or common stock, in the amount per share for each share
of Series&#160;B convertible preferred stock held by them equal to the original issue price of such share, adjusted for any anti-dilution
adjustments, plus all declared and unpaid dividends on such shares. Should the Company&#8217;s legally available assets be insufficient
to satisfy the liquidation preferences, the funds will be distributed with equal priority and <i>pro rata</i> among the holders of Series&#160;B
convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;B convertible preferred stock, payment should be made to the holders of Series&#160;A convertible preferred stock,
in preference to the holders of the common stock, in the amount per share for each share of Series&#160;A convertible preferred stock
held by them equal to the original issue price of such share, adjusted for any anti-dilution adjustments, plus all declared and unpaid
dividends on such shares. Should the Company&#8217;s legally available assets be insufficient to satisfy the liquidation preferences,
the funds will be distributed with equal priority and <i>pro rata</i> among the holders of Series&#160;A convertible preferred stock in
proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the payment to the holders
of convertible preferred stock of the full preferential amounts specified above, the entire remaining assets of the Company legally available
for distribution by the Company shall be distributed with equal priority and <i>pro rata</i> among the holders of the common stock and
holders of convertible preferred stock as-if-converted to common stock basis in proportion to the number of shares of common stock held
by them.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 181; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;7 &#8212;&#160;Convertible Preferred Stock</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation id="_PreferredStockTextBlock-c22_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conversion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible
preferred stock is convertible, at the option of the holder, into the number of fully-paid and non-assessable shares of common stock that
result from dividing the applicable original issue price per share by the applicable conversion price per share at the time of conversion,
as adjusted for any anti-dilution adjustments If, after the issuance date of convertible preferred stock, the Company issues or sells,
or is deemed to have sold, additional shares of common stock at a price lower than the original issuance price, except for certain exceptions
allowed, the conversion price of convertible preferred stock would be adjusted. As of December&#160;31, 2024 and December 31, 2023, the
Company&#8217;s convertible preferred stock was convertible into the Company&#8217;s shares of common stock on a one-for-one basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible
preferred stock is convertible into common stock automatically upon the earlier of (i)&#160;immediately upon the closing of a firmly underwritten
public offering pursuant to an effective registration statement under the Securities Act&#160;of&#160;1933, as amended, covering the offer
and sale of any class or security of the Company in which (a)&#160;the gross offering price per share reflects a pre-offering valuation
of the Company of not less than $<ix:nonFraction contextRef="c22" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" unitRef="usd" id="ixv-39055">200</ix:nonFraction>&#160;million, calculated on a fully-diluted and as-converted basis before giving effect to the issuance
of the securities to be sold in such public offering, and (b)&#160;the cash proceeds to the Company (net of underwriting discounts and
commissions) are at least $<ix:nonFraction contextRef="c22" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-39056">50</ix:nonFraction>&#160;million (a &#8220;Qualified IPO&#8221;); or (ii)&#160;the Company&#8217;s receipt of a written request
for such conversion from at least a majority of holders of the then outstanding shares of convertible preferred stock, voting as a single
class on an as-if-converted basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Redemption and Balance Sheet Classification</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
is recorded in mezzanine equity because while it is not mandatorily redeemable, it will become redeemable at the option of the stockholders
upon the occurrence of certain deemed liquidation events that are considered not solely within the Company&#8217;s control.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-22205"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;8 &#8212;&#160;Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and December 31, 2023, the Company&#8217;s certificate of incorporation authorized issuance of <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39057">40,000,000</ix:nonFraction>&#160;shares of common stock.
Each share of common stock is entitled to <ix:nonNumeric contextRef="c23" name="us-gaap:CommonStockVotingRights" id="ixv-39058">one</ix:nonNumeric> vote. The holders of common stock are also entitled to receive dividends whenever funds
are legally available and when declared by the Board of Directors, subject to prior rights of the preferred stockholders. As of December&#160;31,
2024, no dividends have been declared to date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfConversionsOfStockTextBlock" id="ixv-22211"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Conversion of Series&#160;A preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39059">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c332" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39060">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Conversion of Series&#160;B preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c333" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39061">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c334" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39062">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Series&#160;C/C-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c335" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39063">8,220,445</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c336" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39064">8,220,445</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding options under 2010 Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c337" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39065">2,972,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c338" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39066">2,982,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of options under the 2010 Plan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c339" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39067">1,560,091</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c340" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39068">1,550,091</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c341" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39069">22,396,080</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c342" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39070">22,396,080</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock-c22_cont_1" escape="true" name="us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" id="ixv-22289"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Stock Option Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2010, the Company adopted
the 2010 Equity Incentive Plan (the &#8220;Plan&#8221;) under which <ix:nonFraction contextRef="c343" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP" scale="0" unitRef="shares" id="ixv-39071">2,000,000</ix:nonFraction> shares of the Company&#8217;s common stock have been initially
reserved for issuance to employees, directors and consultants. Options granted under the Plan may be either incentive stock options (&#8220;ISO&#8221;)
or nonqualified stock options (&#8220;NSO&#8221;). ISOs may be granted only to Company employees, including officers and directors who
are also employees. NSOs may be granted to Company employees, consultants and advisors.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 182; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Stock Option Plan</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A person who owns (or is deemed
to own) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company will not
be granted an ISO unless the exercise price of such option is at&#160;least one hundred ten percent (<ix:nonFraction contextRef="c343" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfExcercisePriceOption" scale="-2" unitRef="pure" id="ixv-39072">110</ix:nonFraction>%) of the Fair Market Value on
the date of grant and the option is not exercisable after the expiration of <ix:nonNumeric contextRef="c343" name="us-gaap:EmployeeStockOwnershipPlanESOPPlanDescription" id="ixv-39073">five</ix:nonNumeric>&#160;years from the date of grant. Options granted generally
vest over <span style="-sec-ix-hidden: hidden-fact-254">four</span>&#160;years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-22327"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity under the Plan is
set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Stock Option Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available <br/> for Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price Per <br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at January&#160;1, 2024</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c344" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-39074">1,550,091</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c344" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-39075">2,982,055</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c344" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39076">0.40</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c345" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-39077">3.70</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" scale="0" unitRef="shares" id="ixv-39078">10,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-39079">10,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39080">0.001</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at December&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-39081">1,560,091</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-39082">2,972,055</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39083">0.40</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><ix:nonNumeric contextRef="c22" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-39084">3.00</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at December&#160;31, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-39085">1,548,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39086">0.49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c22" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-39087">4.32</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at December 31, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" unitRef="shares" id="ixv-39088">2,972,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39089">0.40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c22" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-39090">3.00</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were no new options
granted or exercised during the year ended December&#160;31, 2024. Intrinsic values are calculated as the difference between the exercise
price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the
fair value per share of the common stock on the date of exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total fair value of options
vested for the&#160;year-ended December&#160;31, 2024 was less than $<ix:nonFraction contextRef="c22" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" unitRef="usd" id="ixv-39091">0.1</ix:nonFraction>&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
the total unrecognized stock-based compensation expense for stock options was less than $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" unitRef="usd" id="ixv-39092">0.1</ix:nonFraction>&#160;million which is expected to be recognized
over a weighted-average period of <ix:nonNumeric contextRef="c22" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="ixv-39093">0.4</ix:nonNumeric>&#160;years. On the grant date, the Company estimates the fair value of stock options using the Black
Scholes option-pricing model. The fair value of stock options is being recognized on a straight-line basis over the requisite service
period of the awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nonrecourse Promissory Notes to Early Exercise Stock Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2018, one of the Company&#8217;s
executives early exercised <ix:nonFraction contextRef="c343" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-39094">1,380,015</ix:nonFraction> of his stock options by issuing a promissory note to the Company. As the promissory note is nonrecourse
this exercise of stock options with a promissory note is not considered a substantive exercise for accounting purposes. Therefore, no
receivable for the promissory note was recorded on the Company&#8217;s balance sheet. This arrangement was accounted for as modifications
to the original stock options which were exercised by issuing a promissory note. Such modification did not result in additional stock-based
compensation expense. As of December&#160;31, 2024 these options were fully vested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock-Based Compensation Expense by Function</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="ixv-22531"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table is a summary
of stock compensation expense by function recognized for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c346" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-39095">7</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c347" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-39096">10</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c348" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-39097">14</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c349" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-39098">23</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-39099">21</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-39100">33</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 183; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-22602"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;10 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued convertible
notes (also referred to as junior notes), Tasly convertible debt, and promissory notes to certain shareholders. Refer to Note&#160;5 for
detail.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_EarningsPerShareTextBlock-c22_cont_1" escape="true" name="us-gaap:EarningsPerShareTextBlock" id="ixv-22611"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;11 &#8212;&#160;Net Loss per Share Attributable to Common
Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic net loss per share is
computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Because the Company reported
a net loss for the years ended December&#160;31, 2024 and 2023, the number of shares used to calculate diluted net loss per common share
is the same as the number of shares used to calculate basic net loss per common share for those periods presented because the potentially
dilutive shares would have been antidilutive if included in the calculation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-22617"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39101">9,230</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39102">10,281</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39103"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39104">5,604,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39105"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39106">5,600,741</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c22" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39107"><ix:nonFraction contextRef="c22" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39108">1.65</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c23" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39109"><ix:nonFraction contextRef="c23" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39110">1.84</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" continuedAt="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c22_cont_1" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-22682"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding
shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c350" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39111">17,863,934</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c351" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39112">17,863,934</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c352" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39113">3,363,624</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c353" decimals="INF" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares">2,251,941</ix:nonFraction></span></td><td style="text-align: left"><sup>(1)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-255; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c356" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39115">2,972,055</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c357" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39116">2,982,055</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39117">24,199,613</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39118">23,097,930</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"></p><div>

</div><ix:continuation id="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c22_cont_1"><ix:continuation id="_EarningsPerShareTextBlock-c22_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.</span></ix:footnote></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.</span></ix:footnote></td></tr> </table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:GovernmentAssistanceTextBlock" id="ixv-22786"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;12 &#8212;&#160;Government Grant Revenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Government grant revenue consists
of amounts the Company earns under grants from two government agencies: NIH and DARPA.&#160;These grants are provided either in the form
of expense reimbursement (expense reimbursement grants) or on a fixed fee basis (fixed fee grants). Under the expense reimbursement grants
the government agencies reimburse us for a portion of our expenses (allowable expenses) that have been incurred in a given period on the
basis of reports that the Company provides to these agencies. Fixed fee grants are awarded for specific research and development programs
undertaken by us. Under these grants the Company receives milestone payments from the government agencies upon our submission and approval
by the government of agreed upon deliverables, consisting primarily of the documented results of the specific research and development
programs.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 184; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_IncomeTaxDisclosureTextBlock-c22_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-22813"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;13 &#8212;&#160;Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income taxes in the Company&#8217;s
combined financial statements have been calculated on a separate tax return basis. <ix:nonNumeric contextRef="c22" continuedAt="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c22_cont_1" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-39119">The following table presents the principal reasons
for the difference between the effective tax rate and the federal statutory income tax rate (in thousands):</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c22_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Tax benefit at U.S.&#160;federal statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c22" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-39120">21.00</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-39121">1,941</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c23" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-39122">21.00</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-39123">2,159</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State Tax, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" unitRef="pure" id="ixv-39124">14.58</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="0" sign="-" unitRef="usd" id="ixv-39125">1,347</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" unitRef="pure" id="ixv-39126">0.14</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="0" sign="-" unitRef="usd" id="ixv-39127">14</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Permanent difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" sign="-" unitRef="pure" id="ixv-39128">0.06</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="0" unitRef="usd" id="ixv-39129">6</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" sign="-" unitRef="pure" id="ixv-39130">0.06</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="0" unitRef="usd" id="ixv-39131">6</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prior-Year deferred taxes adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" unitRef="pure" id="ixv-39132">0.32</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="0" sign="-" unitRef="usd" id="ixv-39133">30</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" sign="-" unitRef="pure" id="ixv-39134">0.57</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="0" unitRef="usd" id="ixv-39135">58</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change of valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" sign="-" unitRef="pure" id="ixv-39136">35.84</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-39137">3,312</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" sign="-" unitRef="pure" id="ixv-39138">20.51</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-39139">2,109</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective income tax rate</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c22" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-39140">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c23" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-39141">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="ixv-22945"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The components of the provision for income taxes
are as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Current:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Federal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd" id="ixv-39142">1,607</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-39143">2,127</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd" id="ixv-39144">1,705</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd" id="ixv-39145">18</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd" id="ixv-39146">3,312</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-39147">2,109</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-39148">3,312</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" sign="-" unitRef="usd" id="ixv-39149">2,109</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total provision for income taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ixv-23092"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant components of the Company&#8217;s deferred
tax assets as of December&#160;31, 2024 and 2023 were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Deferred tax assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Accrued expenses&#160;&amp; other</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="0" unitRef="usd" id="ixv-39150">70</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="0" unitRef="usd" id="ixv-39151">38</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:DeferredTaxAssetsDepreciationAndAmortization" scale="0" unitRef="usd" id="ixv-39152">7</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:DeferredTaxAssetsDepreciationAndAmortization" scale="0" unitRef="usd" id="ixv-39153">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="0" unitRef="usd" id="ixv-39154">52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="0" unitRef="usd" id="ixv-39155">38</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:DeferredTaxAssetsConvertibleDebt" scale="0" unitRef="usd" id="ixv-39156">93</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:DeferredTaxAssetsConvertibleDebt" scale="0" unitRef="usd" id="ixv-39157">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Capitalized R&amp;D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="0" unitRef="usd" id="ixv-39158">1,549</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="0" unitRef="usd" id="ixv-39159">1,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Net operating loss carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-39160">32,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-39161">29,033</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">R&amp;D credit carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="0" unitRef="usd" id="ixv-39162">3,511</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="0" unitRef="usd" id="ixv-39163">3,485</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="0" unitRef="usd" id="ixv-39164">37,455</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="0" unitRef="usd" id="ixv-39165">34,143</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-39166">37,455</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-39167">34,143</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No income tax expense was recorded during the year
ended December&#160;31, 2024 and 2023.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 185; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;13 &#8212;&#160;Income Taxes</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c22_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
Profusa, Inc. had Federal and state net operating loss carryforwards of $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" unitRef="usd" id="ixv-39168">114.8</ix:nonFraction>M and $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="6" unitRef="usd" id="ixv-39169">116.3</ix:nonFraction>M, respectively. The Federal and state net operating
loss carryforwards begin to expire in 2029. Federal net operating losses generated in tax&#160;years 2018 or thereafter have an indefinite
carryforward period. The amount of Federal net operating loss that does not expire is $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" unitRef="usd" id="ixv-39170">91.6</ix:nonFraction>&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
Profusa, Inc. had Federal and California research credit carryforwards of $<ix:nonFraction contextRef="c358" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" unitRef="usd" id="ixv-39171">2.1</ix:nonFraction>M and $<ix:nonFraction contextRef="c359" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" unitRef="usd" id="ixv-39172">1.8</ix:nonFraction>M, respectively. The Federal tax credit carryforwards
begin to expire in 2032. The state tax credit carryforwards carryforward indefinitely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management believes that,
based upon a number of factors, which include the Company&#8217;s historical operating performance and accumulated deficit, it is more
likely than not that the deferred tax assets will not be utilized. Therefore, the Company has recorded a full valuation allowance against
its deferred tax assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Internal Revenue Code (IRC)
section 382 limits the use of net operating loss and tax credit carryforwards in certain situations where changes occur in stock ownership
of a company. The annual limitation may result in the expiration of the Company&#8217;s net operating loss and tax credit carryforwards
prior to utilization. The Company has not completed an IRC section 382 study as of December&#160;31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No liability related to uncertain
tax positions is recorded in the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accrues for interest
and penalties as part of income tax expense. As of December&#160;31, 2024 and 2023, the Company has not accrued interest and/or penalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company files tax returns
in the U.S.&#160;Federal, California and various other states. Due to the Company&#8217;s net operating losses, its Federal and state
income tax returns remain subject to examination since inception. As of December&#160;31, 2024, there are no ongoing tax examinations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;27, 2020, Congress
passed the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The act contains many tax incentives intended
to assist companies and individuals during the COVID-19 outbreak. The Company received Paycheck Protection Program Loans during the&#160;years
ended December&#160;31, 2021 and December&#160;31, 2020 of $<ix:nonFraction contextRef="c360" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:ReceivedPaycheckProtectionProgramLoans" scale="6" unitRef="usd" id="ixv-39173">1.3</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c361" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:ReceivedPaycheckProtectionProgramLoans" scale="6" unitRef="usd" id="ixv-39174">1.2</ix:nonFraction>&#160;million, respectively. The Company had $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PaycheckProtectionProgramLoansOutstanding" scale="6" unitRef="usd" id="ixv-39175"><ix:nonFraction contextRef="c2" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PaycheckProtectionProgramLoansOutstanding" scale="6" unitRef="usd" id="ixv-39176">1.4</ix:nonFraction></ix:nonFraction>&#160;million
of Paycheck Protection Program loans outstanding as of December&#160;31, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (&#8220;IRA&#8221;) was signed into federal law. IRA, among other things, imposes a nondeductible
<ix:nonFraction contextRef="c362" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" unitRef="pure" id="ixv-39177">1</ix:nonFraction>% excise tax after December&#160;31, 2022 on the fair market value of certain stock that is &#8220;repurchased&#8221; by a publicly traded
U.S.&#160;corporation or acquired by certain of its subsidiaries. The taxable amount is reduced by the fair market value of certain issuances
of stock throughout the year. The Company does not expect this tax law change to have a material impact on its consolidated financial
position; however, it will continue to evaluate its impact as further information becomes available. If average annual adjusted financial
statement income exceeds $<ix:nonFraction contextRef="c362" decimals="-9" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" scale="9" unitRef="usd" id="ixv-39178">1</ix:nonFraction>&#160;billion over a 3-taxable-year period, IRA also imposes a <ix:nonFraction contextRef="c362" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-39179">15</ix:nonFraction>% corporate alternative minimum tax on adjusted
financial statement income for taxable&#160;years beginning after December&#160;31, 2022. The Company does not expect to incur this tax
in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Tax Cuts and Jobs
Act&#160;of&#160;2017, research and development costs are no longer fully deductible and are required to be capitalized and amortized
for U.S.&#160;tax purposes effective January&#160;1, 2022. The mandatory capitalization requirement increases our deferred tax assets
and is fully offset with the valuation allowance.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" continuedAt="_SegmentReportingDisclosureTextBlock-c22_cont_1" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock" id="ixv-23274"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;14 &#8212;&#160;Segments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company operates as <ix:nonFraction contextRef="c22" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" unitRef="pure" id="ixv-39180">one</ix:nonFraction> operating segment.
The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is its Chief Executive Officer, Ben Hwang, who reviews financial
information presented on a consolidated net loss basis as reported on the consolidated statement of operations in order to make decisions
about allocating resources and assessing performance for the entire Company. The CODM also utilizes the Company&#8217;s long-range plan,
which includes product development roadmaps and long-range financial models, as a key input to resource allocation. The CODM function
approves of key operating and strategic decisions. The CODM function views the Company&#8217;s operations and manages its business on
a consolidated basis and as a single reportable operating segment. The CODM function is regularly provided with the following significant
segment expenses. Significant expenses include research and development and general and administrative expenses, which are each separately
presented in the Company&#8217;s Consolidated Statements of Operations. The CODM reviews significant expenses within both the research
and development and the general and administrative categories. <ix:nonNumeric contextRef="c22" continuedAt="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c22_cont_1" escape="true" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="ixv-39181">Other segment items within net loss include interest income, interest expense
and loss on change in fair value of related party loan. See the consolidated financial statements for other financial information regarding
the Company&#8217;s operating segment.</ix:nonNumeric></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 186; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;14 &#8212;&#160;Segments</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c22_cont_2" id="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c22_cont_1"><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c22_cont_2" id="_SegmentReportingDisclosureTextBlock-c22_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-39182">100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-39183">45</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Research personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-39184">1,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-39185">1,641</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" unitRef="usd" id="ixv-39186">36</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" unitRef="usd" id="ixv-39187">186</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" scale="3" unitRef="usd" id="ixv-39188">1,592</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" scale="3" unitRef="usd" id="ixv-39189">1,434</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:RentAndOfficeCosts" scale="3" unitRef="usd" id="ixv-39190">279</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:RentAndOfficeCosts" scale="3" unitRef="usd" id="ixv-39191">365</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:LegalAndAccountingCosts" scale="3" unitRef="usd" id="ixv-39192">1,223</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:LegalAndAccountingCosts" scale="3" unitRef="usd" id="ixv-39193">2,287</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd" id="ixv-39194">120</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd" id="ixv-39195">202</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39196">4,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39197">6,115</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39198">4,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39199">6,070</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39200">311</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39201">22</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest expense (including related parties amounts of $<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-39202">2,400</ix:nonFraction> and $<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-39203">2,530</ix:nonFraction> for the year ended December&#160;31, 2024 and 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39204">4,424</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39205">4,283</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-39206">5</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-39207">94</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39208">4,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39209">4,211</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39210">9,230</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39211">10,281</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><ix:continuation id="_SegmentReportingDisclosureTextBlock-c22_cont_2"><ix:continuation id="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c22_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses includes small balances of research materials and supplies along with insurance costs.</span></td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c22" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-23509"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;15 &#8212;&#160;Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has evaluated
its subsequent events from December&#160;31, 2024, through the date these consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in these consolidated financial statements other than the items noted below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On various dates in February
and March 2025, the Company received an aggregate amount of $<ix:nonFraction contextRef="c363" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39212"><ix:nonFraction contextRef="c364" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39213">0.8</ix:nonFraction></ix:nonFraction> million from the issuance of Senior Secured Convertible Notes which are
expected to be converted in 2025 upon the closing of the Company&#8217;s Qualified Financing transaction. These subsequent notes issued
in 2025 are on similar terms as all other Senior Secured Convertible Notes in issued in 2024.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 187; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONDENSED CONSOLIDATED BALANCE SHEETS<br/>
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; text-transform: uppercase; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-transform: uppercase; text-align: center">June 30, <br/> 2025 <br/> (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-transform: uppercase">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31 <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Current assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-39214">44</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-39215">191</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-39216">209</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-39217">69</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-39218">253</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-39219">260</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Deferred offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCosts" scale="3" unitRef="usd" id="ixv-39220">4,136</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCosts" scale="3" unitRef="usd" id="ixv-39221">2,757</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-39222">55</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-39223">56</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-39224">4,444</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-39225">3,073</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities, convertible preferred stock, and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-39226">6,884</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-39227">4,954</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39228">4,299</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39229">3,968</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Convertible debt payable (including loans and notes payable to a related party of $<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-39230">26,670</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-39231">25,056</ix:nonFraction> as of June 30, 2025 and December&#160;31, 2024, respectively.)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" unitRef="usd" id="ixv-39232">49,971</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" unitRef="usd" id="ixv-39233">45,921</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Promissory notes (including notes payable to related parties of $<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="3" unitRef="usd" id="ixv-39234">878</ix:nonFraction> and $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="3" unitRef="usd" id="ixv-39235">850</ix:nonFraction> as of June 30, 2025 and December&#160;31, 2024, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableCurrent" scale="3" unitRef="usd" id="ixv-39236">940</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableCurrent" scale="3" unitRef="usd" id="ixv-39237">910</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">PPP loan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaycheckProtectionProgramLoan" scale="3" unitRef="usd" id="ixv-39238">1,383</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaycheckProtectionProgramLoan" scale="3" unitRef="usd" id="ixv-39239">1,376</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39240">63,477</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39241">57,129</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-39242">63,477</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-39243">57,129</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Commitments and contingencies (Note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible Preferred Stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Series&#160;A convertible preferred stock: $<ix:nonFraction contextRef="c13" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39244"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39245">0.0001</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-39246"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39247"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-39248">4,350,314</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares&#160;authorized at June 30, 2025 and December&#160;31, 2024, and <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-39249"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39250"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-39251">4,350,314</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at June 30, 2025 and December&#160;31, 2024, (Liquidation preference $<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-39252"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-39253">5,307</ix:nonFraction></ix:nonFraction> at June 30, 2025 and&#160;December&#160;31,&#160;2024)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-39254">5,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-39255">5,231</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Series&#160;B convertible preferred stock: $<ix:nonFraction contextRef="c14" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39256"><ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39257">0.0001</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-39258"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39259"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-39260">5,293,175</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized at June 30, 2025 and December&#160;31, 2024, and <ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-39261"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39262"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-39263">5,293,175</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at June 30, 2025 and December&#160;31, 2024, (Liquidation preference $<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-39264"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-39265">13,815</ix:nonFraction></ix:nonFraction> at June 30, 2025 and December&#160;31, 2024)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-39266">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-39267">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><div style="-sec-ix-hidden: hidden-fact-10"><div style="-sec-ix-hidden: hidden-fact-11">Series&#160;C/C-1 convertible preferred stock: $0.0001 par value &#8211; <ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-39268"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-39269">8,907,893</ix:nonFraction></ix:nonFraction> shares authorized at June 30, 2025 and December&#160;31, 2024, and <ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39270"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39271"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-39272"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-39273">8,220,445</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at June 30, 2025 and December&#160;31, 2024, (Liquidation preference $<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-39274"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" unitRef="usd" id="ixv-39275">45,062</ix:nonFraction></ix:nonFraction> at June 30, 2025 and December&#160;31, 2024)</div></div></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-39276">46,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd" id="ixv-39277">46,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total convertible preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39278">65,149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39279">65,149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stockholders&#8217; deficit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Common stock: $<ix:nonFraction contextRef="c11" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39280"><ix:nonFraction contextRef="c1" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39281">0.0001</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39282"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39283">40,000,000</ix:nonFraction></ix:nonFraction> authorized shares at June 30, 2025 <br/>
and December&#160;31, 2024, and <ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-39284"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-39285"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39286"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39287">5,604,651</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at June 30, 2025 and December&#160;31, 2024, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-39288">5,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-39289">5,753</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-39290">130,022</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-39291">124,958</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39292">124,182</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39293">119,205</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities, convertible preferred stock and stockholders&#8217; deficit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-39294">4,444</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-39295">3,073</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 188; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS<br/>
(UNAUDITED)<br/>
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months Ended <br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended <br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-39296">25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-39297">25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-39298">393</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-39299">432</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-39300">827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-39301">938</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-39302">610</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-39303">569</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-39304">1,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-39305">1,402</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39306">1,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39307">1,001</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39308">2,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39309">2,340</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39310">1,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39311">976</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39312">2,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39313">2,315</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss on change in the fair value of related party&#160;Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39314">57</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39315">15</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39316">118</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39317">11</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest expense (including related parties amounts of $<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-39318">629</ix:nonFraction> and $<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-39319">575</ix:nonFraction> for the three&#160;months ended June 30, 2025 and June&#160;30, 2024, and $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-39320">1,333</ix:nonFraction> and $<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" unitRef="usd" id="ixv-39321">1,199</ix:nonFraction> for the six months ended June 30, 2025 and June 30, 2024, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39322">1,289</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39323">1,081</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39324">2,519</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39325">2,161</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-39326">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-39327">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-39328">6</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39329">1,345</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39330">1,095</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39331">2,637</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39332">2,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39333">2,348</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39334">2,071</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39335">5,064</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39336">4,481</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share, basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39337"><ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39338">0.42</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39339"><ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39340">0.37</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39341"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39342">0.90</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39343"><ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39344">0.80</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Weighted-average common shares outstanding, basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39345"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39346">5,604,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39347"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39348">5,601,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39349"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39350">5,604,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39351"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39352">5,601,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 189; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; DEFICIT<br/>
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025 AND&#160;2024<br/>
(UNAUDITED)<br/>
(IN THOUSANDS, EXCEPT SHARE AMOUNTS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series&#160;A <br/> Convertible <br/> Preferred Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series&#160;B <br/> Convertible <br/> Preferred Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series&#160;C/C-1 <br/> Convertible <br/> Preferred Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional <br/> Paid-In</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total <br/> Stockholders&#8217;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.25in; width: 23%; font-weight: bold">Balance at January&#160;1, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c52" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39353">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39354">5,231</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c53" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39355">5,293,175</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39356">13,701</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c54" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39357">8,220,445</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39358">46,217</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c55" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39359">5,604,651</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39360">5,732</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">(<ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39361">115,728</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39362">109,996</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c74" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39363">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39364">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39365">2,071</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39366">2,071</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 1.5pt">Balance at March&#160;31, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c77" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39367">4,350,314</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39368">5,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c78" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39369">5,293,175</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c78" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39370">13,701</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c79" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39371">8,220,445</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39372">46,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c80" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39373">5,604,651</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39374">5,737</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39375">117,799</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39376">112,062</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39377">6</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39378">6</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39379">2,410</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39380">2,410</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt">Balance at June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39381">4,350,314</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39382">5,231</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c88" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39383">5,293,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c88" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39384">13,701</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c89" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39385">8,220,445</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c89" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39386">46,217</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c90" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39387">5,604,651</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c91" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39388">5,743</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c92" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39389">120,209</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c93" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39390">114,466</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Balance at January&#160;1, 2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c64" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39391">4,350,314</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39392">5,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c65" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39393">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39394">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c66" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39395">8,220,445</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39396">46,217</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c67" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39397">5,604,651</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-99">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39398">5,753</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39399">124,958</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39400">119,205</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c98" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39401">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c100" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39402">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c99" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39403">2,716</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c100" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39404">2,716</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 1.5pt">Balance at March&#160;31, 2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c101" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39405">4,350,314</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39406">5,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c102" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39407">5,293,175</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c102" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39408">13,701</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c103" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39409">8,220,445</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c103" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39410">46,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c104" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39411">5,604,651</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39412">5,758</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39413">127,674</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39414">121,916</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c112" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39415">82</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd" id="ixv-39416">82</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c113" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39417">2,348</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-39418">2,348</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt">Balance at June&#160;30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39419">4,350,314</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c114" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39420">5,231</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39421">5,293,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c115" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39422">13,701</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39423">8,220,445</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39424">46,217</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c117" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-39425">5,604,651</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-39426">5,840</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39427">130,022</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-39428">124,182</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 190; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS<br/>
(UNAUDITED)<br/>
(IN THOUSANDS)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cash flows from operating activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39429">5,064</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39430">4,481</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Non-cash interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashExpense" scale="3" unitRef="usd" id="ixv-39431">2,519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashExpense" scale="3" unitRef="usd" id="ixv-39432">2,161</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on change in fair value of related party convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" scale="3" sign="-" unitRef="usd" id="ixv-39433">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" scale="3" sign="-" unitRef="usd" id="ixv-39434">11</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Loss on disposition of property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" sign="-" unitRef="usd" id="ixv-39435">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-39436">82</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-39437">11</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Changes in assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" sign="-" unitRef="usd" id="ixv-39438">44</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-39439">140</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-39440">110</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" sign="-" unitRef="usd" id="ixv-39441">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" unitRef="usd" id="ixv-39442">1</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-39443">1,027</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-39444">513</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-39445">331</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-39446">842</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-39447">1,126</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-39448">1,008</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from issuance of senior notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="3" unitRef="usd" id="ixv-39449">1,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="3" unitRef="usd" id="ixv-39450">1,120</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of convertible loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-39451">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Repayment of senior notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="3" unitRef="usd" id="ixv-39452">115</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Payment of deferred offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-39453">476</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-39454">117</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-39455">974</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-39456">904</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net (decrease) in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-39457">152</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-39458">104</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash at the beginning of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-39459">191</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-39460">142</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash at the end of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-39461">39</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c172" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-39462">38</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Increase (decrease) in unpaid deferred offering costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-39463">904</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts" scale="3" unitRef="usd" id="ixv-39464">102</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 191; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ixv-25339"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Organization, Description
of Business, Going Concern and Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa, Inc. (the &#8220;Company&#8221;)
was incorporated in the state of California on May&#160;11, 2009. The Company engaged in the development of a new generation of biointegrated
sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s technology
enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable,
clinical-grade data for personal and medical use. The Company&#8217;s first offering in the European Union, the Lumee&#8482; Oxygen Platform,
is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee&#8482; Oxygen
Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease
that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores)
that do not heal properly; and reconstructive surgery.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s research
and development efforts are primarily focused on its Lumee&#8482; Glucose Platform which is a system designed to monitor glucose levels
in interstitial fluid, continuously and long-term. A tiny, biocompatible gel injected under the skin acts as a continuous glucose monitor
(CGM) for several&#160;months. The ability of Lumee&#8482; Glucose to provide continuous glucose monitoring with only an initial single
injection, is an attractive alternative for people with diabetes to manage their disease without the need for frequent finger sticks required
by standard glucometers, or the need for weekly sensor replacement as required by current short-term needle-type CGMs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;6, 2022,
the Company&#8217;s board of directors unanimously approved the pursuit of a business combination transaction involving the Company. On
November&#160;7, 2022, the Company entered into an Agreement and Plan of Merger (&#8220;Merger&#8221;) with NorthView Acquisition Corp
(&#8220;NorthView&#8221;). The Company obtained Shareholder approval and successfully completed the merger on July&#160;11, 2025 where
a subsidiary of NorthView merged with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
the parties to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the &#8220;Amendment&#8221;) pursuant to which
the parties agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received
by Profusa prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment
(i)&#160;revised the definition of &#8220;Milestone Event&#160;III&#8221; such that the parties extended the period for Profusa to consummate
the APAC Joint Venture (as defined in the Merger Agreement) and receive the related funding from December&#160;31, 2024 until December&#160;31,
2025, and (ii)&#160;revised the definition of &#8220;Milestone Event&#160;IV&#8221; to change the earnout revenue target from $<ix:nonFraction contextRef="c365" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RevenueTarget" scale="0" unitRef="usd" id="ixv-39465">99,702,000</ix:nonFraction>
for the fiscal year ended December&#160;31, 2025 to an earnout revenue target of $<ix:nonFraction contextRef="c176" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RevenueTarget" scale="0" unitRef="usd" id="ixv-39466">11,864,000</ix:nonFraction> for the fiscal year ended December&#160;31,
2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In relation to Milestone Event&#160;III:&#160;On
August&#160;8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (&#8220;APAC&#8221;), was created and incorporated by
the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $<ix:nonFraction contextRef="c366" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-39467">1,000</ix:nonFraction> for <ix:nonFraction contextRef="c366" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-39468">1,000</ix:nonFraction>&#160;Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (&#8220;Tasly&#8221;)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the &#8220;APAC Joint
Venture&#8221;) setting forth the relative and other terms under which the development and business activities of the entity will be conducted.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 192; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1&#160;&#8212;&#160;Organization,&#160;Description&#160;of&#160;Business,&#160;Going&#160;Concern&#160;and&#160;Significant&#160;Risks&#160;and&#160;Uncertainties</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has incurred significant
net operating losses from operations. As of June&#160;30, 2025, the Company has a working capital deficit of approximately $<ix:nonFraction contextRef="c11" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapitalDeficit" scale="6" unitRef="usd" id="ixv-39469">63.2</ix:nonFraction>&#160;million.
For the six&#160;months-ended June&#160;30, 2025, the Company incurred a net loss of approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" sign="-" unitRef="usd" id="ixv-39470">5.1</ix:nonFraction>&#160;million and used approximately
$<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" sign="-" unitRef="usd" id="ixv-39471">1.1</ix:nonFraction>&#160;million of cash in operating activities. Management expects to continue to incur additional substantial losses in the foreseeable
future as a result of research and development activities. The Company has been able to finance its operations primarily with the proceeds
from the issuance of equity and debt instruments and to a lesser extent, revenues from government grants. Additional funds may be necessary
to maintain current operations and will be required for successful product commercialization efforts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s condensed
consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business. The Company has reviewed the relevant conditions and events surrounding its ability to
continue as a going concern including among others: historical losses, projected future results, increased tariffs, cash requirements
for the upcoming year, funding capacity, net working capital, and future access to capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025 Profusa,
Inc., a Delaware corporation formerly known as NorthView Acquisition Corporation, consummated its previously announced business combination
with Profusa, Inc., a California corporation, pursuant to that certain Merger Agreement and Plan of Reorganization. At the Closing and
pursuant to the PIPE Subscription Agreement, New Profusa issued a PIPE Convertible Note in the principal amount of $<ix:nonFraction contextRef="c367" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="0" unitRef="usd" id="ixv-39472">10,000,000</ix:nonFraction> (the &#8220;Initial
Note&#8221;) for a purchase price of $<ix:nonFraction contextRef="c368" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PurchasePrice" scale="0" unitRef="usd" id="ixv-39473">9,000,000</ix:nonFraction>, reflecting a <ix:nonFraction contextRef="c368" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfOriginalIssuanceDiscount" scale="-2" unitRef="pure" id="ixv-39474">10</ix:nonFraction>% Original Issuance Discount (&#8220;OID&#8221;). Management believes
this liquidity is not sufficient to alleviate the relevant conditions or events that raise substantial doubt about the Company&#8217;s
ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued in August&#160;2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the closing, the
Company had cash inflows of $<ix:nonFraction contextRef="c369" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="6" unitRef="usd" id="ixv-39475">1.3</ix:nonFraction>&#160;million from the NorthView trust account, net of redemptions, and the $<ix:nonFraction contextRef="c369" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39476">9</ix:nonFraction>&#160;million net PIPE convertible
note. Cash outflows included marketing fees and vendor payments which totaled $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentForAdministrativeFees" scale="6" unitRef="usd" id="ixv-39477">3.4</ix:nonFraction>&#160;million due at closing. Subsequent to the closing
of the Merger, there continue to be factors which raise substantial doubt about the Company&#8217;s ability to continue as a going concern
within one year from the date the condensed consolidated financial statements are issued. The condensed consolidated financial statements
do not contain any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company operates in a
dynamic and highly competitive industry and believes that changes in any of the following areas could have a material adverse effect on
the Company&#8217;s future financial position, results of operations, or cash flows: ability to obtain future financing; advances and
trends in new technologies and industry standards; results of clinical trials; regulatory approval and market acceptance of the Company&#8217;s
products; development of sales channels; certain strategic relationships; litigation or claims against the Company based on intellectual
property, patent, product, regulatory, or other factors; and the Company&#8217;s ability to attract and retain employees necessary to
support its growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Products developed by the
Company require approvals from the U.S.&#160;Food and Drug Administration (&#8220;FDA&#8221;) or other international regulatory agencies
prior to commercial sales. There can be no assurance that the products will receive the necessary approvals. If the Company is denied
approval, approval is delayed or the Company is unable to maintain approval, it could have a materially adverse impact on the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has expended and will continue to
expend substantial funds to complete the research, development and clinical testing of product candidates. The Company also will be required
to expend additional funds to establish commercial-scale manufacturing arrangements and to provide for the marketing and distribution
of products that receive regulatory approval. For any periods after the twelve&#160;months subsequent to the filing of these financial
statements as of June&#160;30, 2025, the Company may be required to seek additional equity or debt financing to commercialize its products. </p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 193; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1&#160;&#8212;&#160;Organization,&#160;Description&#160;of&#160;Business,&#160;Going&#160;Concern&#160;and&#160;Significant&#160;Risks&#160;and&#160;Uncertainties
</b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If adequate funds are unavailable on a timely
basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more
of its research or development programs which would materially and adversely affect its business, financial condition and results of
operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Inflation, Monetary Response, and Economic
Impacts</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The world economy is experiencing
stubbornly high inflation, a challenge not faced for decades. Following the global financial crisis, with inflationary pressures muted,
interest rates were extremely low for&#160;years and investors became accustomed to low volatility. The resulting easing of financial
conditions supported economic growth, but it also contributed to a buildup of financial vulnerabilities. With inflation at multi-decade
highs, monetary authorities in advanced economies are accelerating the pace of policy normalization. Policymakers have continued to tighten
policy against a backdrop of rising inflation and currency pressures, albeit with notable differences across regions. Global financial
conditions have tightened notably this year, leading to capital outflows. Amid heightened economic and geopolitical uncertainties, investors
have aggressively pulled back from risk-taking and adjusted their investment preferences generally. Key gauges of systemic risk, such
as higher dollar funding costs and counterparty credit spreads, have risen. There is a risk of a disorderly tightening of financial conditions
that may be amplified by vulnerabilities built over the&#160;years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our business,
growth, financial condition or results of operations could be materially adversely affected by instability or changes in a country&#8217;s
or region&#8217;s economic conditions; inflation; changes in laws or regulations or in the interpretation of existing laws or regulations,
whether caused by a change in government or otherwise; increased difficulty of conducting business in a country or region due to actual
or potential political or military conflict; or action by the U.S.&#160;or foreign governments that may restrict our ability to transact
business in a foreign country or with certain foreign individuals or entities. A possible slowdown in global trade caused by increasing
tariffs or other restrictions could decrease consumer or corporate confidence and reduce consumer, government and corporate spending
in countries inside or outside the U.S., which could adversely affect our operations. Climate-related&#160;events, including extreme
weather events and natural disasters and their effect on critical infrastructure in the U.S.&#160;or internationally, could have similar
adverse effects on our operations, users, or third-party&#160;suppliers.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-25451"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-25456"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<ix:continuation continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2" id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed
consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States
of America (&#8220;U.S.&#160;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission
(&#8220;SEC&#8221;).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_3" id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unaudited Interim Financial Information</i></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<ix:continuation continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_4" id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S.&#160;(&#8220;U.S.&#160;GAAP&#8221;).
The interim unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated
financial statements and in accordance with the rules and regulations of the United&#160;States Securities and Exchange Commission (the
&#8220;SEC&#8221;). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only
normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2025,
the results of its operations and changes to stockholders&#8217; equity for the three and six&#160;months ended June&#160;30, 2025 and
2024, and its cash flows for the six&#160;months ended June&#160;30, 2025 and 2024. The results for the three and six&#160;months ended
June&#160;30, 2025, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2025, or any other
interim periods, or any future year or period. All amounts included herein have been rounded except where otherwise stated. As figures
are rounded, numbers presented throughout this document may not add up precisely to the totals we provide and percentages may not precisely
reflect the absolute figures. Certain disclosures have been consolidated or omitted from the unaudited interim condensed consolidated
financial statements.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 194; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying interim
unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and the related disclosures as of December&#160;31, 2024 and for the year then ended as found in the Form&#160;S-4/A filed by the Company
with the SEC on April&#160;3, 2025.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-25509"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of condensed
consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and
expenses in the condensed consolidated financial statements and accompanying notes. The Company&#8217;s management regularly assesses
these estimates, including those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance
for deferred tax assets, and valuation of stock-based awards. Actual results could differ from these estimates, and such differences
could be material to the Company&#8217;s financial position and results of operations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="ixv-25518"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accounts Receivable and Allowance for Credit
Losses</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<ix:continuation continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_2" id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have
any accounts receivable with customers in the six&#160;months ended June&#160;30, 2025 and 2024. The Company has developed policies that
when accounts receivables are held with customers, they are recorded at the point in time in which management determines it is probable
that the Company will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services
transferred to the customer.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of June&#160;30, 2025 and 2024.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-25530"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#8217;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash. The Company&#8217;s other receivables are represented by amounts owned by two government agencies under the government
grants.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-25538"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all
highly liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of June&#160;30,
2025 and 2024, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DeferredChargesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock" id="ixv-25547"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred Offering Costs</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<ix:continuation id="_DeferredChargesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of
securities, all of the costs are expensed. Offering costs capitalized as of June&#160;30, 2025 and December&#160;31, 2024 were $<ix:nonFraction contextRef="c11" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:OfferingCosts" scale="6" unitRef="usd" id="ixv-39478">4.1</ix:nonFraction>&#160;million
and $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:OfferingCosts" scale="6" unitRef="usd" id="ixv-39479">2.8</ix:nonFraction>&#160;million, respectively. The deferred offering costs as of June&#160;30, 2025 and December&#160;31, 2024 includes $<ix:nonFraction contextRef="c370" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="6" unitRef="usd" id="ixv-39480">1.3</ix:nonFraction>&#160;million
and $<ix:nonFraction contextRef="c371" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="6" unitRef="usd" id="ixv-39481">0.8</ix:nonFraction>&#160;million respectively, of advances to NorthView to fund costs associated with the business combination.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 195; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="ixv-25585"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Government Grants</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_2" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives payments
from government entities under non-refundable grants in support of product development programs. The grants received fall within two categories:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_3" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">a.</td><td style="text-align: justify">Expense Reimbursement Grants&#160;&#8212;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;</td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_4" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">b.</td><td style="text-align: justify">Fixed Fee Grants&#160;&#8212;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.</td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_5" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non- exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as the Company is a business entity, and the grants are with governmental
agencies or units.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In absence of explicit U.S.&#160;GAAP
guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#8220;IAS
20&#8221;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method,
grant income is recognized using the same proportion as the costs incurred to date to the total expected cost of the project, but limiting
the income to be recognized to the amount to which the Company is entitled based on the submitted deliverables.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="ixv-25613"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value of Financial Instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s financial
instruments consist of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company
states accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment.
The promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June&#160;2023-February&#160;2024
(Note&#160;5) is carried at fair value based on unobservable market inputs.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-25621"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Accounting Standards</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the six&#160;months ended June&#160;30, 2025 and through the date of issuance
of these condensed consolidated financial statements, there have been no new, or existing, recently issued accounting pronouncements that
are of significance, or potential significance, that impact the Company&#8217;s condensed consolidated financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_3" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Recently issued accounting standards not yet
adopted</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_4" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU&#160;2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early
adoption permitted and can be applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine
its impact on the income tax disclosures. No material financial impact will result in this expanded disclosure requirement.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 196; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2024, the
FASB issued ASU No.&#160;2024-03 (&#8220;ASU&#160;2024-03&#8221;), Disaggregation of Income Statement Expenses (&#8220;DISE&#8221;). ASU&#160;2024-03
requires disaggregated disclosure of income statement expenses for public business entities. ASU&#160;2024-03 does not change the expense
captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified
categories in disclosures within the footnotes to the financial statements. As revised by ASU No.&#160;2025-01, Income Statement&#160;&#8212;&#160;Reporting
Comprehensive Income&#160;&#8212;&#160;Expense Disaggregation Disclosures, the provisions of ASU&#160;2024-03 are effective for fiscal&#160;years
beginning after December&#160;15, 2026, and interim periods within fiscal&#160;years beginning after December&#160;15, 2027, with early
adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, the Company
does not expect the adoption of ASU&#160;2024-03 to have a material effect on our consolidated financial statements taken as a whole.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_FairValueDisclosuresTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueDisclosuresTextBlock" id="ixv-25668"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Fair Value Measurement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities recorded
at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used
to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize
the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes
a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 0.5in; padding-bottom: 2.25pt">&#160;</td>
    <td style="width: 0.65in; text-align: justify"><span style="font-size: 10pt">Level&#160;1&#160;&#8212;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Level&#160;2&#160;&#8212;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Level&#160;3&#160;&#8212;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining fair value,
the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the
extent possible as well as considers counterparty credit risk in its assessment of fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities measured
at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The
Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management
to make judgments and consider factors specific to the asset or liability. As of June&#160;30, 2025 and December&#160;31, 2024, the Company
had no financial assets measured at fair value on a recurring basis.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 197; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Fair Value Measurement</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_FairValueDisclosuresTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="ixv-39482">As of June&#160;30, 2025, the
Company&#8217;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands)</ix:nonNumeric>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of June&#160;30, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c383" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39483">2,543</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c384" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39484">2,543</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c383" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39485">2,543</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c384" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39486">2,543</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c387" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39487">2,234</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c388" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39488">2,234</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c387" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39489">2,234</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c388" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" unitRef="usd" id="ixv-39490">2,234</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="ixv-25887"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments for the three and six&#160;months ended
June&#160;30, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> convertible <br/> debt at fair <br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of January&#160;1, 2024</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c199" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-39491">1,714</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Issuance of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c389" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="3" unitRef="usd" id="ixv-39492">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c389" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" scale="3" unitRef="usd" id="ixv-39493">48</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 0.125in">Change in fair value included in other income and gain on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c389" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" sign="-" unitRef="usd" id="ixv-39494">4</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of March&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c390" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-39495">1,774</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c391" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" scale="3" unitRef="usd" id="ixv-39496">49</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c391" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" unitRef="usd" id="ixv-39497">15</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c392" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-39498">1,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of January&#160;1, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c201" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-39499">2,234</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c393" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" scale="3" unitRef="usd" id="ixv-39500">95</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c393" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" unitRef="usd" id="ixv-39501">61</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of March&#160;31, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c394" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-39502">2,390</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c395" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" scale="3" unitRef="usd" id="ixv-39503">96</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c395" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" unitRef="usd" id="ixv-39504">57</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c396" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-39505">2,543</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to measure
its Tasly convertible debt at fair value (Note&#160;5) with changes in fair value reported in earnings as they occur. The Convertible
Debt fair values were determined using the discounted cash flow methodology based on probability weighted scenarios of the convertible
notes conversion. At issuance of the first $<ix:nonFraction contextRef="c178" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="6" unitRef="usd" id="ixv-39506">1</ix:nonFraction>&#160;million on June&#160;26, 2023 the time to event was <ix:nonNumeric contextRef="c179" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-39507">0.28</ix:nonNumeric>&#160;years and the discount
rate applied was <ix:nonFraction contextRef="c372" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-39508">14.54</ix:nonFraction>%. At issuance of the next $<ix:nonFraction contextRef="c180" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="6" unitRef="usd" id="ixv-39509">0.3</ix:nonFraction>&#160;million on July&#160;20, 2023, the time to event was <ix:nonNumeric contextRef="c181" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-39510">0.22</ix:nonNumeric>&#160;years and the
discount rate applied was <ix:nonFraction contextRef="c373" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-39511">13.82</ix:nonFraction>%. At issuance of the additional $<ix:nonFraction contextRef="c182" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="6" unitRef="usd" id="ixv-39512">0.3</ix:nonFraction>&#160;million on August&#160;15, 2023, the time to event was <ix:nonFraction contextRef="c374" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="0" unitRef="usd" id="ixv-39513">0.15</ix:nonFraction>&#160;years
and the discount rate applied was <ix:nonFraction contextRef="c375" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-39514">13.70</ix:nonFraction>%. The final amount which was less than $<ix:nonFraction contextRef="c376" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="0" unitRef="usd" id="ixv-39515">0.02</ix:nonFraction>&#160;million was issued on February&#160;6, 2024;
the time to event was <ix:nonNumeric contextRef="c377" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-39516">0.66</ix:nonNumeric>&#160;years and the discount rate applied was <ix:nonFraction contextRef="c378" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-39517">13.69</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;30, 2025, the
time event was .<ix:nonNumeric contextRef="c379" format="ixt-sec:duryear" name="ck0001859807:ConvertibleDebtOfTermFairValue" id="ixv-39518">03</ix:nonNumeric>&#160;years and the discount rate applied was <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleDebtOfDiscountRate" scale="-2" unitRef="pure" id="ixv-39519">12.66</ix:nonFraction>%. Based on this method, the Fair value of the convertible debt at
the date of inception was $<ix:nonFraction contextRef="c380" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="0" unitRef="usd" id="ixv-39520">1.6</ix:nonFraction>&#160;million, the fair value at June&#160;30, 2025 was $<ix:nonFraction contextRef="c11" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:ShorttermDebtFairValue" scale="0" unitRef="usd" id="ixv-39521">2.1</ix:nonFraction>&#160;million.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 198; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="srt:CondensedFinancialStatementsTextBlock" id="ixv-26020"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;4 &#8212;&#160;Balance Sheet Components</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="ixv-26025"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid expenses and other current assets (in
thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid legal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PrepaidLegal" scale="3" unitRef="usd" id="ixv-39522">48</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:PrepaidLegal" scale="3" unitRef="usd" id="ixv-39523">25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidInsurance" scale="3" unitRef="usd" id="ixv-39524">31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidInsurance" scale="3" unitRef="usd" id="ixv-39525">37</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-39526">130</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-39527">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-39528">209</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-39529">69</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="ixv-26085"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accrued Liabilities (in thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Accrued compensation</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" unitRef="usd" id="ixv-39530">4,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" unitRef="usd" id="ixv-39531">3,472</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39532">209</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39533">496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39534">4,299</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-39535">3,968</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DebtDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-26137"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDebtInstrumentsTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="ixv-26141"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the debt instruments and their changes during the six&#160;months ended June&#160;31, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px">Balance at January&#160;1, 2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c316" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39536">18,419</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c317" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39537">2,234</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c318" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39538">25,268</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c319" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39539">910</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c320" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39540">1,376</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-39541">1,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd" id="ixv-39542">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c413" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39543">1,098</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39544">191</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39545">1,176</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39546">30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39547">7</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c413" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" unitRef="usd" id="ixv-39548">16</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c446" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" unitRef="usd" id="ixv-39549">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Balance at June&#160;30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c449" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39550">19,533</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c450" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39551">2,543</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c451" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39552">27,895</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c452" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39553">940</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c453" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39554">1,383</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c449" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-39555">19,533</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c450" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-39556">2,543</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c451" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-39557">27,895</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c452" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-39558">940</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c453" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd" id="ixv-39559">1,383</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 36px">Long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 199; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_2" id="_DebtDisclosureTextBlock-c0_cont_1"><ix:continuation id="_ScheduleOfDebtInstrumentsTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px">Balance at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c306" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39560">16,316</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c307" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39561">1,714</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c308" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39562">20,155</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c309" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39563">849</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c310" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39564">1,362</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c454" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-39565">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c455" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" unitRef="usd" id="ixv-39566">1,120</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c455" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="3" unitRef="usd" id="ixv-39567">115</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c454" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd" id="ixv-39568">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c415" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39569">993</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c454" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39570">97</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c455" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39571">994</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c456" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39572">31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c457" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:StatedInterest" scale="3" unitRef="usd" id="ixv-39573">7</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c415" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" unitRef="usd" id="ixv-39574">39</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Balance at June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c458" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39575">17,348</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c459" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39576">1,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c460" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39577">22,154</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c461" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39578">880</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c462" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-39579">1,369</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Long term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All debt was classified as
current debt as of June&#160;30, 2024 and 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Debt</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Convertible Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Convertible Notes was estimated from <ix:nonFraction contextRef="c397" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-39580">12.54</ix:nonFraction>% to <ix:nonFraction contextRef="c398" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-39581">53.28</ix:nonFraction>% per year for the six&#160;months ended June&#160;30, 2025 and <ix:nonFraction contextRef="c399" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-39582">12.66</ix:nonFraction>% to
<ix:nonFraction contextRef="c400" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-39583">53.28</ix:nonFraction>% per year for the six&#160;months ended June&#160;30, 2024. The interest expense for the three&#160;months ended June&#160;30, 2025
and 2024 was $<ix:nonFraction contextRef="c24" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="0" unitRef="usd" id="ixv-39584">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39585">0.5</ix:nonFraction>&#160;million, respectively. The interest expense for the six&#160;months ended June&#160;30, 2025,
and 2024 was $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39586">1.1</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c26" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39587">1.0</ix:nonFraction>&#160;million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 the
outstanding balance of convertible notes includes related party convertible notes of $<ix:nonFraction contextRef="c402" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39588">14.1</ix:nonFraction>&#160;million. As of December&#160;31, 2024
the outstanding balance of convertible notes includes related party convertible notes of $<ix:nonFraction contextRef="c403" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39589">13.3</ix:nonFraction>&#160;million. These notes were converted
into New Profusa common stock upon the successful closing of the merger on July&#160;11, 2025; see subsequent events (Note&#160;14).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tasly Convertible Debt</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June&#160;2023, the Company
entered into a short-term loan agreement with a related party under which it may borrow up to $<ix:nonFraction contextRef="c404" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" unitRef="usd" id="ixv-39590">1.6</ix:nonFraction>&#160;million, of which $<ix:nonFraction contextRef="c405" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39591">1.0</ix:nonFraction>&#160;million
was borrowed on June&#160;26, 2023, $<ix:nonFraction contextRef="c406" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39592">0.3</ix:nonFraction>&#160;million was borrowed on July&#160;20, 2023, $<ix:nonFraction contextRef="c407" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39593">0.3</ix:nonFraction>&#160;million was borrowed on August&#160;15,
2023 and the final $<ix:nonFraction contextRef="c408" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39594">0.02</ix:nonFraction>&#160;million was borrowed in February&#160;2024 (the &#8220;Convertible debt&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The loans bear interest at
a rate of <ix:nonFraction contextRef="c409" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:DebtInterestRate" scale="-2" unitRef="pure" id="ixv-39595">12</ix:nonFraction>% per annum, <ix:nonFraction contextRef="c410" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:DebtInterestRate" scale="-2" unitRef="pure" id="ixv-39596">24</ix:nonFraction>% per annum default interest rate, and originally matured on December&#160;31, 2023. The original maturity
date was extended to March&#160;31, 2024, subject to the parties&#8217; decision to extend thereafter. Upon occurrence of certain events
of default by the Company, including failure to repay in full the amounts owed at maturity, the lender will have an option to convert
the entire outstanding balance and accrued but unpaid interest under the Convertible debt into senior unsecured promissory notes on substantially
the same terms as the outstanding Senior Notes as of June&#160;30, 2025. In the event the Company fails to complete the formation of the
APAC Joint Venture or fail to repay the amounts under the Tasly Convertible Debt when they become due, the lender will have an option
to convert the entire outstanding balance and accrued but unpaid interest under the Convertible debt into either (i)&#160;senior unsecured
promissory notes on substantially the same terms as the outstanding Senior Notes as of June&#160;30, 2025, or (ii)&#160;the Company&#8217;s
common stock at a conversion price of $<ix:nonFraction contextRef="c411" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:CommonStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39597">1.92</ix:nonFraction> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to apply
the fair value option to account for the Tasly Convertible debt. Accordingly, no features of the Convertible debt are bifurcated and separately
accounted for. The fair value of the Convertible debt was $<ix:nonFraction contextRef="c11" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="6" unitRef="usd" id="ixv-39598">2.1</ix:nonFraction>&#160;million as of June&#160;30, 2025. Accrued stated interest on the Tasly
Convertible debt was $<ix:nonFraction contextRef="c412" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" unitRef="usd" id="ixv-39599">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c413" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" unitRef="usd" id="ixv-39600">0.2</ix:nonFraction>&#160;million for the three and six&#160;months ended June&#160;30, 2025, respectively.
Accrued stated interest on the Tasly Convertible debt was $<ix:nonFraction contextRef="c414" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" unitRef="usd" id="ixv-39601">0.05</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c415" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" unitRef="usd" id="ixv-39602">0.1</ix:nonFraction>&#160;million
for the three and six&#160;months ended June&#160;30, 2024, respectively. Accrued interest since note origination is $<ix:nonFraction contextRef="c379" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="0" unitRef="usd" id="ixv-39603">0.47</ix:nonFraction>&#160;million
in total. The total loss on fair value remeasurement from origination through June&#160;30, 2025 was $<ix:nonFraction contextRef="c416" decimals="-4" format="ixt:num-dot-decimal" name="ck0001859807:LossOnFairValueRemeasurement" scale="6" unitRef="usd" id="ixv-39604">0.45</ix:nonFraction>&#160;million, and the loss
on fair value remeasurement was recognized of $<ix:nonFraction contextRef="c416" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:GainOnFairValueRemeasurement" scale="6" unitRef="usd" id="ixv-39605">0.1</ix:nonFraction>&#160;million through June&#160;30, 2025.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 200; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_3" id="_DebtDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Senior Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January &#8211; March&#160;2024
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months January through March&#160;2024, the Company issued additional Senior Notes
to investors with the principal amount of $<ix:nonFraction contextRef="c417" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-39606">0.7</ix:nonFraction>&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;&#8211;&#160;June&#160;2024
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months April through June&#160;2024, the Company issued additional Senior Notes to
investors with the principal amount of $<ix:nonFraction contextRef="c418" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-39607">0.4</ix:nonFraction>&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022). Additionally, the Company repaid $<ix:nonFraction contextRef="c25" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="6" unitRef="usd" id="ixv-39608">0.1</ix:nonFraction>&#160;million of principal on Senior Notes with investors during the respective
period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January &#8211; March&#160;2025
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months January through March&#160;2025, the Company issued additional Senior Secured
Convertible Notes to investors with the principal amount of $<ix:nonFraction contextRef="c419" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-39609">0.8</ix:nonFraction>&#160;million on substantially the same terms as the Senior Notes issued
in 2022 (as amended in November&#160;2022). These notes were issued at the same <ix:nonFraction contextRef="c419" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39610">12</ix:nonFraction>% interest terms as all of their other Senior Secured
Convertible Notes, and will convert into New Profusa shares at $<ix:nonFraction contextRef="c419" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare" scale="0" unitRef="usdPershares" id="ixv-39611">0.50</ix:nonFraction> per share. These notes have an <ix:nonNumeric contextRef="c420" format="ixt-sec:durmonth" name="ck0001859807:MaturityMonth" id="ixv-39612">18</ix:nonNumeric>-month maturity, which will be accelerated
and convert into New Profusa shares upon the successful closing of the business combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;&#8211;&#160;June&#160;2025
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months April through June&#160;2025, the Company issued additional Senior Secured Convertible
Notes to investors with the principal amount of $<ix:nonFraction contextRef="c421" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-39613">0.4</ix:nonFraction>&#160;million issued on substantially the same terms as the Senior Notes issued in
2022 (as amended in November&#160;2022). These notes were issued at the same <ix:nonFraction contextRef="c422" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39614">12</ix:nonFraction>% interest terms as all of their other Senior Secured Convertible
Notes, and will convert into New Profusa shares at $<ix:nonFraction contextRef="c422" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare" scale="0" unitRef="usdPershares" id="ixv-39615">0.50</ix:nonFraction> per share. These notes have an <ix:nonNumeric contextRef="c24" format="ixt-sec:duryear" name="ck0001859807:MaturityMonth" id="ixv-39616">18</ix:nonNumeric>-month maturity, which will be accelerated and
convert into New Profusa shares upon the successful closing of the business combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the Company issued
$<ix:nonFraction contextRef="c422" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" unitRef="usd" id="ixv-39617">0.3</ix:nonFraction>&#160;million in Senior Notes repayable upon the closing of the Business Combination which accrue interest at <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfAccrueInterest" scale="-2" unitRef="pure" id="ixv-39618">0</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Of the $<ix:nonFraction contextRef="c423" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SeniorNotes" scale="6" unitRef="usd" id="ixv-39619">27.9</ix:nonFraction>&#160;million of
Senior Notes, $<ix:nonFraction contextRef="c424" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" unitRef="usd" id="ixv-39620">10.0</ix:nonFraction>&#160;million is outstanding with related parties and $<ix:nonFraction contextRef="c425" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" unitRef="usd" id="ixv-39621">17.9</ix:nonFraction>&#160;million is outstanding with unrelated parties as of
June&#160;30, 2025. Of the $<ix:nonFraction contextRef="c274" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SeniorNotes" scale="6" unitRef="usd" id="ixv-39622">25.3</ix:nonFraction>&#160;million of Senior Notes outstanding on December&#160;31, 2024, $<ix:nonFraction contextRef="c426" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" unitRef="usd" id="ixv-39623">9.5</ix:nonFraction>&#160;million was outstanding
with related parties and $<ix:nonFraction contextRef="c427" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="6" unitRef="usd" id="ixv-39624">15.8</ix:nonFraction>&#160;million was outstanding with unrelated parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Senior Notes was estimated from <ix:nonFraction contextRef="c428" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39625">0</ix:nonFraction>% to <ix:nonFraction contextRef="c429" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39626">12.15</ix:nonFraction>% and <ix:nonFraction contextRef="c430" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39627">0</ix:nonFraction>% to <ix:nonFraction contextRef="c431" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39628">12.55</ix:nonFraction>% per year for the six&#160;months ended June&#160;30, 2025 and 2024,
respectively. The interest expense for the three&#160;months ended June&#160;30, 2025 and 2024 was $<ix:nonFraction contextRef="c432" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39629">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c433" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39630">0.5</ix:nonFraction>&#160;million,
respectively. The interest expense for the six&#160;months ended June&#160;30, 2025 and 2024 was $<ix:nonFraction contextRef="c434" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39631">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c435" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39632">1.0</ix:nonFraction>&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock" id="ixv-26761"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, future
minimum payments for the convertible notes payable were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; padding-bottom: 1.5pt">As of June&#160;30, 2025</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c463" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares" id="ixv-39633">19,603</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c379" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares" id="ixv-39634">2,287</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c464" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares" id="ixv-39635">26,003</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total future payments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c465" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-39636">19,603</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c466" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-39637">2,287</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c467" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-39638">26,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 12px">Less: fair value remeasurement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c466" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:FairValueRemeasurement" scale="3" sign="-" unitRef="usd" id="ixv-39639">451</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 12px">Less: unamortized debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c467" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" sign="-" unitRef="usd" id="ixv-39640">1,967</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 12px">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c465" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:InterestExpensesNotesPayable" scale="3" unitRef="usd" id="ixv-39641">70</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c466" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:InterestExpensesNotesPayable" scale="3" unitRef="usd" id="ixv-39642">195</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c467" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:InterestExpensesNotesPayable" scale="3" unitRef="usd" id="ixv-39643">75</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c465" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-39644">19,533</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c466" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-39645">2,543</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c467" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" unitRef="usd" id="ixv-39646">27,895</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 201; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_DebtDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These notes were converted
into New Profusa common stock upon the successful closing of the merger on July&#160;11, 2025; see subsequent events (Note&#160;14).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Promissory Notes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In a series of transactions
during 2010 and 2011 two of the Company&#8217;s founders provided $<ix:nonFraction contextRef="c436" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39647"><ix:nonFraction contextRef="c437" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39648">0.2</ix:nonFraction></ix:nonFraction>&#160;million to the Company to fund general corporate purposes
in exchange for promissory notes. The notes accrue interest annually at a simple interest rate of <ix:nonFraction contextRef="c438" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtInterestRateIncrease" scale="-2" unitRef="pure" id="ixv-39649">5</ix:nonFraction>% with no set maturity date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2022, the Company borrowed $<ix:nonFraction contextRef="c439" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" unitRef="usd" id="ixv-39650">0.3</ix:nonFraction>&#160;million from two of its founders at <span style="-sec-ix-hidden: hidden-fact-324">zero</span> interest rate to finance its short-term operations, from
which $<ix:nonFraction contextRef="c439" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" unitRef="usd" id="ixv-39651">0.2</ix:nonFraction>&#160;million was repaid in the same period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2023, the Company borrowed short-term promissory notes of $<ix:nonFraction contextRef="c284" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39652">0.3</ix:nonFraction>&#160;million from an existing investor and additional $<ix:nonFraction contextRef="c440" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:UnrelatedPartyRepayable" scale="6" unitRef="usd" id="ixv-39653">0.1</ix:nonFraction>&#160;million
from an unrelated party repayable on demand at any time after December&#160;31, 2023, with annual interest rate of <ix:nonFraction contextRef="c284" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" unitRef="pure" id="ixv-39654">12</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the three and six&#160;months
ended June&#160;30, 2025 and 2024, the Company did not make any repayments from the outstanding balance of the promissory notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, accrued and unpaid interest on the promissory notes was $<ix:nonFraction contextRef="c441" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DepositLiabilitiesAccruedInterest" scale="6" unitRef="usd" id="ixv-39655">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c286" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:UnpaidInterest" scale="6" unitRef="usd" id="ixv-39656">0.3</ix:nonFraction>&#160;million, respectively.
Interest expense on the promissory notes was less than $<ix:nonFraction contextRef="c438" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" unitRef="usd" id="ixv-39657">0.1</ix:nonFraction>&#160;million for each of the three and six&#160;months ended June&#160;30,
2025 and 2024. The carrying value of the promissory notes as of June&#160;30, 2025 and December&#160;31, 2024 was $<ix:nonFraction contextRef="c438" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39658">0.9</ix:nonFraction>&#160;million and
$<ix:nonFraction contextRef="c282" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:PromissoryNotes" scale="6" unitRef="usd" id="ixv-39659">0.9</ix:nonFraction>&#160;million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Paycheck Protection Program</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;25, 2021, the Company
borrowed $<ix:nonFraction contextRef="c289" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="6" unitRef="usd" id="ixv-39660">1.3</ix:nonFraction>&#160;million (the &#8220;PPP Loan 2&#8221;) as a Paycheck Protection Program loan. The Paycheck Protection Program, established
as part of the Coronavirus Aid, Relief, and Economic Security (&#8220;CARES&#8221;) Act, provides for loans to qualifying businesses and
is administered by the U.S.&#160;Small Business Administration (the &#8220;SBA&#8221;). The annual interest rate of the PPP Loan 2 is
<ix:nonFraction contextRef="c290" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure" id="ixv-39661">1</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of PPP Loan
2, if the Company does not submit forgiveness application within <ix:nonNumeric contextRef="c442" format="ixt-sec:durweek" name="us-gaap:LoansHeldForSaleTerm" id="ixv-39662">24</ix:nonNumeric>&#160;weeks the initial disbursement of the loan (the &#8220;Covered
Period&#8221;), the Company must begin to make equal monthly payments of principal and interest starting <ix:nonNumeric contextRef="c443" format="ixt-sec:durwordsen" name="ck0001859807:MonthlyPayments" id="ixv-39663">10&#160;months</ix:nonNumeric> from the end of
the Covered Period until May&#160;25, 2026. Interest on the loan continues to accumulate during any deferment period. As of June&#160;30,
2025, the Company has not applied for forgiveness under PPP Loan 2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and June&#160;30, 2025, the Company was in default on PPP Loan 2 due to non-payment of minimal repayment amounts required by the terms
of PPP Loan 2. Accordingly, the Company classified the entire amount outstanding under PPP Loan 2 as current and accrued respective late
penalties for the total amount of less than $<ix:nonFraction contextRef="c442" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:LatePenaltiesAmount" scale="6" unitRef="usd" id="ixv-39664"><ix:nonFraction contextRef="c292" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:LatePenaltiesAmount" scale="6" unitRef="usd" id="ixv-39665">0.1</ix:nonFraction></ix:nonFraction>&#160;million as of June&#160;30, 2025 and December&#160;31, 2024, respectively. The total
past due amount of PPP Loan 2 repayments as of June&#160;30, 2025 and December&#160;31, 2024 was $<ix:nonFraction contextRef="c444" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtDefaultLongtermDebtAmount" scale="6" unitRef="usd" id="ixv-39666">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c294" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtDefaultLongtermDebtAmount" scale="6" unitRef="usd" id="ixv-39667">0.8</ix:nonFraction>&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="ixv-26929"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
contractual future minimum payments for the PPP Loan 2 were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year Ending December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0pt">2025 (remainder)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" unitRef="usd" id="ixv-39668">1,245</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" unitRef="usd" id="ixv-39669">145</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 12px">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd" id="ixv-39670">1,390</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 202; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-26981"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Operating Lease Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beginning in October&#160;2024,
the Company entered into a lease agreement whereby the Company agreed to rent its office and lab facilities under month-to-month tenancy.
The monthly rent payable under the lease is $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd" id="ixv-39671">25</ix:nonFraction> thousand. This month-to-month lease automatically renews every four&#160;months, unless
written termination is provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Operating costs for short-term
leases include variable lease costs of $<ix:nonFraction contextRef="c24" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeaseCost" scale="6" unitRef="usd" id="ixv-39672">0.1</ix:nonFraction>&#160;million and less than $<ix:nonFraction contextRef="c25" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:VariableLeasePayment" scale="6" unitRef="usd" id="ixv-39673">0.1</ix:nonFraction>&#160;million during the three&#160;months ended June&#160;30,
2025 and 2024, compared to $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:VariableLeasePayment" scale="6" unitRef="usd" id="ixv-39674">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c26" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:VariableLeasePayment" scale="6" unitRef="usd" id="ixv-39675">0.1</ix:nonFraction>&#160;million during the six&#160;months ended June&#160;30, 2025 and 2024. Starting
from August&#160;2022 the Company recognized lease expense in the amount of monthly rent as incurred. The Company recognized operating
lease costs for monthly rent of $<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" unitRef="usd" id="ixv-39676">75</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" unitRef="usd" id="ixv-39677">150</ix:nonFraction> thousand for each of the three and six month periods ending June&#160;30, 2025 and
2024. Total operating lease costs with common area maintenance variable costs were $<ix:nonFraction contextRef="c468" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:VariableLeasePayment" scale="6" unitRef="usd" id="ixv-39678">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c469" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:VariableLeasePayment" scale="6" unitRef="usd" id="ixv-39679">0.2</ix:nonFraction>&#160;million for the six&#160;months
ended June&#160;30, 2025 and 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Contingencies and Indemnifications</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company
may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability
for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant
judgment is required to determine both probability and the estimated amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the normal course of business,
the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications.
The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future, but that have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to
its indemnification obligations. However, the Company may record charges in the future as a result of these indemnification obligations.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_PreferredStockTextBlock-c0_cont_1" escape="true" name="us-gaap:PreferredStockTextBlock" id="ixv-27008"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;7 &#8212;&#160;Convertible Preferred
Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Company&#8217;s Amended
and Restated Certificate of Incorporation, as amended, the Company is authorized to issue two classes of shares: preferred and common
stock. The preferred stock is issuable in series, and the Company&#8217;s Board of Directors is authorized to determine the rights, preferences,
and terms of each series. Under the Company&#8217;s Articles of Incorporation, as amended, the Company is authorized to issue <ix:nonFraction contextRef="c470" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39680">18,551,382</ix:nonFraction>
shares of convertible preferred stock at a par value of $<ix:nonFraction contextRef="c470" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39681">0.0001</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock" id="ixv-27014"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
as of June&#160;30, 2025 and December&#160;31, 2024 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share <br/> Issued and <br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liquidation <br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying <br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Original <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">New Series&#160;A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c471" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39682">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c471" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39683">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c471" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39684">5,307</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c471" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39685">5,231</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c471" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39686">1.22</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">New Series&#160;B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c472" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39687">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c472" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39688">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c472" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39689">13,815</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c472" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39690">13,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c472" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39691">2.61</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Series&#160;C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c473" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39692">7,358,151</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c473" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39693">6,670,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c473" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39694">37,623</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c473" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39695">37,476</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c473" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39696">5.64</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">New Series&#160;C-1</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c474" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39697">1,549,742</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c474" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39698">1,549,742</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c474" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39699">7,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c474" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39700">8,741</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c474" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares" id="ixv-39701">4.80</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c470" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39702">18,551,382</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c470" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39703">17,863,934</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c470" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="3" unitRef="usd" id="ixv-39704">64,184</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c470" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="3" unitRef="usd" id="ixv-39705">65,149</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of convertible
preferred stock shares are entitled to vote on all matters on which the common stockholders are entitled to vote. Each holder of convertible
preferred stock is entitled to the number of votes equal to the number of common stock shares into which the shares held by such holder
could be converted as of the Record Date. Holders of convertible preferred stock and common stock generally vote as a single class.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 203; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;7 &#8212;&#160;Convertible Preferred
Stock</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_PreferredStockTextBlock-c0_cont_2" id="_PreferredStockTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dividends</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of convertible preferred
stock are entitled to receive dividends, when, as and if declared by the board of directors, at the annual rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" unitRef="pure" id="ixv-39706">8</ix:nonFraction>% of the original
issue price, payable in preference and priority to any declaration or payment of any distribution on common stock of the Company in such
calendar year. No distributions may be made with respect to the common stock unless dividends on the convertible preferred stock have
been declared and all declared dividends on the convertible preferred stock have been paid or set aside for payment to the holders of
the convertible preferred stock. Dividends are noncumulative, and <span style="-sec-ix-hidden: hidden-fact-325"><span style="-sec-ix-hidden: hidden-fact-326">none</span></span> were declared as of December&#160;31, 2024 and June&#160;30, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidation Preference</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any liquidation,
dissolution, or winding up of the Company, the holders of Series&#160;C/C-1 convertible preferred stock shall be entitled to receive,
prior and in preference to any distribution of any of the assets of the Company to the holders of the Series&#160;B convertible preferred
stock, the Series&#160;A convertible preferred stock or common stock, an amount per share for each share of Series&#160;C/C-1 convertible
preferred stock held by them equal to the sum of the liquidation preference amount of respective original issue price per share, as adjusted
for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event
(&#8220;anti-dilution adjustments&#8221;) plus all declared but unpaid dividends on such shares. Should the Company&#8217;s legally available
assets be insufficient to satisfy the liquidation preferences, the funds will be distributed with equal priority and&#160;<i>pro rata</i>&#160;among
the holders of Series&#160;C/C-1 convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled
to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;C/C-1 convertible preferred stock, payment should be made to the holders of Series&#160;B convertible preferred stock,
in preference to the holders of the Series&#160;A convertible preferred stock or common stock, in the amount per share for each share
of Series&#160;B convertible preferred stock held by them equal to the original issue price of such share, adjusted for any anti-dilution
adjustments, plus all declared and unpaid dividends on such shares. Should the Company&#8217;s legally available assets be insufficient
to satisfy the liquidation preferences, the funds will be distributed with equal priority and&#160;<i>pro rata</i>&#160;among the holders
of Series&#160;B convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;B convertible preferred stock, payment should be made to the holders of Series&#160;A convertible preferred stock,
in preference to the holders of the common stock, in the amount per share for each share of Series&#160;A convertible preferred stock
held by them equal to the original issue price of such share, adjusted for any anti-dilution adjustments, plus all declared and unpaid
dividends on such shares. Should the Company&#8217;s legally available assets be insufficient to satisfy the liquidation preferences,
the funds will be distributed with equal priority and&#160;<i>pro rata</i>&#160;among the holders of Series&#160;A convertible preferred
stock in proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the payment to the holders
of convertible preferred stock of the full preferential amounts specified above, the entire remaining assets of the Company legally available
for distribution by the Company shall be distributed with equal priority and&#160;<i>pro rata</i>&#160;among the holders of the common
stock and holders of convertible preferred stock as-if-converted to common stock basis in proportion to the number of shares of common
stock held by them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Conversion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible preferred
stock is convertible, at the option of the holder, into the number of fully-paid and non-assessable shares of common stock that result
from dividing the applicable original issue price per share by the applicable conversion price per share at the time of conversion, as
adjusted for any anti-dilution adjustments If, after the issuance date of convertible preferred stock, the Company issues or sells, or
is deemed to have sold, additional shares of common stock at a price lower than the original issuance price, except for certain exceptions
allowed, the conversion price of convertible preferred stock
would be adjusted. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#8217;s convertible preferred stock was convertible
into the Company&#8217;s shares of common stock on a one-for-one basis.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 204; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;7 &#8212;&#160;Convertible Preferred
Stock</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_PreferredStockTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible preferred
stock is convertible into common stock automatically upon the earlier of (i)&#160;immediately upon the closing of a firmly underwritten
public offering pursuant to an effective registration statement under the Securities Act&#160;of&#160;1933, as amended, covering the offer
and sale of any class or security of the Company in which (a)&#160;the gross offering price per share reflects a pre-offering valuation
of the Company of not less than $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" unitRef="usd" id="ixv-39707">200</ix:nonFraction>&#160;million, calculated on a fully-diluted and as-converted basis before giving effect to the issuance
of the securities to be sold in such public offering, and (b)&#160;the cash proceeds to the Company (net of underwriting discounts and
commissions) are at least $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-39708">50</ix:nonFraction>&#160;million (a &#8220;Qualified IPO&#8221;); or (ii)&#160;the Company&#8217;s receipt of a written request
for such conversion from at least a majority of holders of the then outstanding shares of convertible preferred stock, voting as a single
class on an as-if-converted basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Redemption and Balance Sheet Classification</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
is recorded in mezzanine equity because while it is not mandatorily redeemable, it will become redeemable at the option of the stockholders
upon the occurrence of certain deemed liquidation events that are considered not solely within the Company&#8217;s control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the closing of the merger,
all Profusa Convertible Preferred stock was converted into New Profusa common shares, as further described in the Subsequent Events disclosure
below (See Note&#160;14).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-27254"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, the Company&#8217;s certificate of incorporation authorized issuance of <ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39709"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39710">40,000,000</ix:nonFraction></ix:nonFraction> shares of common stock. Each
share of common stock is entitled to <ix:nonNumeric contextRef="c100" name="us-gaap:CommonStockVotingRights" id="ixv-39711">one</ix:nonNumeric> vote. The holders of common stock are also entitled to receive dividends whenever funds are legally
available and when declared by the Board of Directors, subject to prior rights of the preferred stockholders. As of June&#160;30, 2025,
<span style="-sec-ix-hidden: hidden-fact-327">no</span> dividends have been declared to date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfConversionsOfStockTextBlock" id="ixv-27261"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Conversion of Series&#160;A preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39712">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39713">4,350,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Conversion of Series&#160;B preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39714">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39715">5,293,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Series&#160;C/C-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c475" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39716">8,220,445</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c476" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39717">8,220,445</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding options under 2010 Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c477" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39718">4,520,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c478" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39719">2,972,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of options under the 2010 Plan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c479" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39720">11,896</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c480" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39721">1,550,091</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39722">22,396,080</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-39723">22,396,080</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" id="ixv-27339"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Stock Option Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2010, the Company adopted
the 2010 Equity Incentive Plan (the &#8220;Plan&#8221;) under which <ix:nonFraction contextRef="c481" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP" scale="0" unitRef="shares" id="ixv-39724">2,000,000</ix:nonFraction> shares of the Company&#8217;s common stock have been initially
reserved for issuance to employees, directors and consultants. The number of reserved shares has been increased over the&#160;years and
currently equals <ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP" scale="0" unitRef="shares" id="ixv-39725">4,636,454</ix:nonFraction> shares. Options granted under the Plan may be either incentive stock options (&#8220;ISO&#8221;) or nonqualified
stock options (&#8220;NSO&#8221;). ISOs may be granted only to Company employees, including officers and directors who are also employees.
NSOs may be granted to Company employees, consultants and advisors.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 205; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Stock Option Plan</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock-c0_cont_2" id="_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A person who owns (or is deemed
to own) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company will not
be granted an ISO unless the exercise price of such option is at least one hundred ten percent (<ix:nonFraction contextRef="c481" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfExcercisePriceOption" scale="-2" unitRef="pure" id="ixv-39726">110</ix:nonFraction>%) of the Fair Market Value on the
date of grant and the option is not exercisable after the expiration of <span style="-sec-ix-hidden: hidden-fact-343">five</span>&#160;years from the date of grant. Options granted generally
vest over <span style="-sec-ix-hidden: hidden-fact-344">four</span>&#160;years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-27377"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity under the Plan is
set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Stock Option Activity</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available for <br/> Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at January&#160;1, 2025</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-39727">1,560,091</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-39728">2,972,055</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39729">0.40</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c483" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-39730">3.00</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" scale="0" unitRef="shares" id="ixv-39731">1,560,091</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-39732">1,560,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39733">1.26</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" scale="0" unitRef="shares" id="ixv-39734">11,896</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-39735">11,896</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39736">0.63</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at June&#160;30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-39737">11,896</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-39738">4,520,250</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39739">0.70</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-39740">6.48</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at June&#160;30, 2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-39741">2,364,814</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39742">1.04</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-39743">5.48</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at June&#160;30, 2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" unitRef="shares" id="ixv-39744">4,520,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39745">0.70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-39746">6.48</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Stock Option Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available for <br/> Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at December&#160;31, 2023</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-39747">1,550,091</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-39748">2,982,055</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39749">0.40</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c484" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-39750">3.70</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-335">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-337">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" scale="0" unitRef="shares" id="ixv-39751">10,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-39752">10,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39753">0.001</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c172" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-39754">1,560,091</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c172" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-39755">2,972,055</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction contextRef="c172" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39756">0.40</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><ix:nonNumeric contextRef="c26" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-39757">3.53</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at June&#160;30, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c172" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-39758">1,464,429</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c172" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39759">0.49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c26" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-39760">4.88</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at June&#160;30, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c172" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" unitRef="shares" id="ixv-39761">2,972,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c172" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-39762">0.40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c26" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-39763">3.53</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the three and six&#160;months
ended June&#160;30, 2025, stock option activity comprised of grants totaling <ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="0" unitRef="shares" id="ixv-39764"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="0" unitRef="shares" id="ixv-39765">1,560,091</ix:nonFraction></ix:nonFraction> options, with no options exercised during the period.
Intrinsic values are calculated as the difference between the exercise price of the underlying options and the fair value of the common
stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total fair value of options
vested for the three and six&#160;months ended June&#160;30, 2025 and 2024 was less than $<ix:nonFraction contextRef="c26" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" unitRef="usd" id="ixv-39766"><ix:nonFraction contextRef="c24" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" unitRef="usd" id="ixv-39767"><ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" unitRef="usd" id="ixv-39768"><ix:nonFraction contextRef="c25" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" unitRef="usd" id="ixv-39769">0.1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
total unrecognized stock-based compensation expense for stock options was $<ix:nonFraction contextRef="c11" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" unitRef="usd" id="ixv-39770">3.0</ix:nonFraction>&#160;million which is expected to be recognized over a
weighted-average period of <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="ixv-39771">1.3</ix:nonNumeric>&#160;years. The Company estimates the fair value of stock options using the Black Scholes option-pricing
model. The fair value of stock options is being recognized on a straight-line basis over the requisite service period of the awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2024, the
total unrecognized stock-based compensation expense for stock options was less than $<ix:nonFraction contextRef="c172" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" unitRef="usd" id="ixv-39772"><ix:nonFraction contextRef="c172" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" unitRef="usd" id="ixv-39773">0.1</ix:nonFraction></ix:nonFraction>&#160;million which is expected to be recognized
over a weighted-average period of <ix:nonNumeric contextRef="c26" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="ixv-39774">1.1</ix:nonNumeric>&#160;years. The Company estimates the fair value of stock options using the Black Scholes option-pricing
model. The fair value of stock options is being recognized on a straight-line basis over the requisite service period of the awards.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 206; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Stock Option Plan</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nonrecourse Promissory Notes to Early Exercise
Stock Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2018, one of the Company&#8217;s
executives early exercised <ix:nonFraction contextRef="c482" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-39775">1,380,015</ix:nonFraction> of his stock options by issuing a promissory note to the Company. As the promissory note is nonrecourse
this exercise of stock options with a promissory note is not considered a substantive exercise for accounting purposes. Therefore, no
receivable for the promissory note was recorded on the Company&#8217;s balance sheet. This arrangement was accounted for as modifications
to the original stock options which were exercised by issuing a promissory note. Such modification did not result in additional stock-based
compensation expense. As of June&#160;30, 2025 these options were fully vested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stock-Based Compensation Expense by Function</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="ixv-27794"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table is a summary
of stock compensation expense by function recognized for the three and six&#160;months ended June&#160;30, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c485" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39776">33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c486" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39777">4</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c487" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39778">54</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c488" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39779">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39780">87</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39781">11</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c489" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39782">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c490" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39783">2</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c491" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39784">51</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c492" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39785">4</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39786">82</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-39787">6</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-27892"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;10 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued convertible
notes (also referred to as junior notes), Tasly convertible debt and promissory notes to certain shareholders. Refer to Note&#160;5 for
detail.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerShareTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerShareTextBlock" id="ixv-27901"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;11 &#8212;&#160;Net Loss per Share
Attributable to Common Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net loss per common share is
calculated in accordance with ASC Topic&#160;260, Earnings Per Share. Basic net loss per share is computed by dividing net loss by the
weighted-average number of shares of common stock outstanding during the period. The computation of diluted net loss per share does not
include dilutive common stock equivalents in the weighted-average shares outstanding, as the inclusion of common share equivalents would
be antidilutive. The common share equivalents consist of stock options, convertible notes, convertible preferred stock and common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-27907"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39788">2,348</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39789">2,071</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39790"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39791">5,604,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39792"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39793">5,601,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39794"><ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39795">0.42</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39796"><ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39797">0.37</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 207; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;11 &#8212;&#160;Net Loss per Share
Attributable to Common Stockholders</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-28001"><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_2" id="_EarningsPerShareTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;months ended <br/> June&#160;30,</td><td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c493" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39798">17,863,934</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="vertical-align: top; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Convertible notes payable<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c494" decimals="INF" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares">42,430,263</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,721,548</td><td style="vertical-align: top; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">&#8212;</div></td><td style="text-align: left"><sup>(2)&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="vertical-align: top; text-align: left"><sup>(2)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c496" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39800">4,520,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="vertical-align: top; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39801">64,814,447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">46,557,537</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_3" id="_EarningsPerShareTextBlock-c0_cont_2"><ix:continuation continuedAt="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_2" id="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">(1)</td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td/><td>(2)</td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</ix:footnote></td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39804">5,064</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39805">4,481</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39806"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39807">5,604,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39808"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39809">5,601,651</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39810"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39811">0.90</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39812"><ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39813">0.80</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_3" id="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c497" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39814">17,863,934</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Convertible notes payable<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c498" decimals="INF" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares">42,430,263</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,721,548</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">&#8212;</div></td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left"><sup>(2)</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c500" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39816">4,520,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-39817">64,814,447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">46,557,537</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><ix:continuation id="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_3"><ix:continuation id="_EarningsPerShareTextBlock-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td/><td>(2)</td><td style="text-align: justify">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</td></tr></table></ix:continuation></ix:continuation><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 208; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:GovernmentAssistanceTextBlock" id="ixv-28286"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;12 &#8212;&#160;Government Grant
Revenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Government grant revenue consists
of amounts we earn under grants from two government agencies: NIH and DARPA.&#160;These grants are provided either in the form of expense
reimbursement (expense reimbursement grants) or as on a fixed fee basis (fixed fee grants). Under the expense reimbursement grants the
government agencies reimburse us for a portion of our expenses (allowable expenses) that have been incurred in a given period on the basis
of reports that we provide to these agencies. Fixed fee grants are awarded for specific research and development programs undertaken by
us. Under these grants we receive milestone payments from the government agencies upon our submission and approval by the government of
agreed upon deliverables, consisting primarily of the documented results of the specific research and development programs.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock" id="ixv-28295"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;13 &#8212;&#160;Segments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription" id="ixv-28300">The Company operates as <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" unitRef="pure" id="ixv-39818">one</ix:nonFraction>
operating segment. The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is its <span style="-sec-ix-hidden: hidden-fact-353">Chief Executive Officer</span>, Ben Hwang,
who reviews financial information presented on a consolidated net loss basis as reported on the consolidated condensed statement of operations
and comprehensive loss in order to make decisions about allocating resources and assessing performance for the entire Company. The CODM
also utilizes the Company&#8217;s long-range plan, which includes product development roadmaps and long-range financial models, as a key
input to resource allocation. The CODM function approves of key operating and strategic decisions. The CODM function views the Company&#8217;s
operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly
provided with the following significant segment expenses. Significant expenses include research and development and general and administrative
expenses, which are each separately presented in the Company&#8217;s consolidated condensed statements of operations and comprehensive
loss. The CODM reviews significant expenses within both the research and development and the general and administrative categories. Other
segment items within net loss include interest income, interest expense and loss on change in fair value of related party loan. <ix:nonNumeric contextRef="c0" continuedAt="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_1" escape="true" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="ixv-39819">See the
consolidated condensed financial statements for other financial information regarding the Company&#8217;s operating segment.</ix:nonNumeric></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_2" id="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; width: 76%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-39820">25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Research personnel compensation costs, including stock-based
    compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-39821">320</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-39822">385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" scale="3" unitRef="usd" id="ixv-39823">401</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" scale="3" unitRef="usd" id="ixv-39824">350</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:RentAndOfficeCosts" scale="3" unitRef="usd" id="ixv-39825">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:RentAndOfficeCosts" scale="3" unitRef="usd" id="ixv-39826">80</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:LegalAndAccountingCosts" scale="3" unitRef="usd" id="ixv-39827">110</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:LegalAndAccountingCosts" scale="3" unitRef="usd" id="ixv-39828">179</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; padding-bottom: 1.5pt"><span style="font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:OtherExpenses" scale="3" unitRef="usd">54</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:OtherExpenses" scale="3" unitRef="usd">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39831">1,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39832">1,001</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39833">1,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39834">976</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39835">57</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39836">15</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39837">1,289</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39838">1,081</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-39839">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-39840">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39841">1,345</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39842">1,095</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39843">2,348</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39844">2,071</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>


</div><ix:continuation continuedAt="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_3" id="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_2"><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_2" id="_SegmentReportingDisclosureTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><sup>(1)</sup></td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US">Other expenses includes small balances of research materials
and supplies along with insurance costs.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 209; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;13 &#8212;&#160;Segments</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_4" id="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_3"><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_3" id="_SegmentReportingDisclosureTextBlock-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government grant revenuet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-39846">25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Research personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-39847">658</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-39848">818</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" unitRef="usd" id="ixv-39849">15</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" scale="3" unitRef="usd" id="ixv-39850">736</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" scale="3" unitRef="usd" id="ixv-39851">712</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:RentAndOfficeCosts" scale="3" unitRef="usd" id="ixv-39852">318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:RentAndOfficeCosts" scale="3" unitRef="usd" id="ixv-39853">162</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:LegalAndAccountingCosts" scale="3" unitRef="usd" id="ixv-39854">649</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="ck0001859807:LegalAndAccountingCosts" scale="3" unitRef="usd" id="ixv-39855">592</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; padding-bottom: 1.5pt"><span style="font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:OtherExpenses" scale="3" unitRef="usd">66</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:OtherExpenses" scale="3" unitRef="usd">41</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39858">2,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-39859">2,340</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39860">2,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39861">2,315</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39862">118</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-39863">11</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39864">2,519</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseNonoperating" scale="3" unitRef="usd" id="ixv-39865">2,161</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-39866">6</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39867">2,637</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-39868">2,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39869">5,064</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c504" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-39870">4,481</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:continuation></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><ix:continuation id="_SegmentReportingDisclosureTextBlock-c0_cont_3"><ix:continuation id="_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">Other expenses includes small balances of research materials and supplies along with insurance costs.</td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-28734"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;14 &#8212;&#160;Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has evaluated its
subsequent events from June&#160;30, 2025, through the date these condensed consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in&#160;these condensed consolidated financial statements other than the items
noted below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, the
Company entered into the Merger Agreement with NorthView, and on July&#160;11, 2025, the Business Combination closed. In accordance with
the terms and subject to the conditions of the Merger Agreement, at Closing, each share of issued and outstanding Profusa Common Stock
was converted into a number of shares of New Profusa Common Stock, based on the Exchange Ratio that reflects an equity valuation of Profusa
of $<ix:nonFraction contextRef="c505" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockAmountConverted1" scale="0" unitRef="usd" id="ixv-39871">155,000,000</ix:nonFraction> (as adjusted for the Incentive Equity Value, the Private Placement Value and the Aggregate Company Incentive Amount),
divided by an assumed value of New Profusa Common Stock of $<ix:nonFraction contextRef="c506" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39872">10.00</ix:nonFraction> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total consideration received
by Profusa Security Holders at the Closing of the transactions contemplated by the Merger Agreement is the newly issued shares of Common
Stock and securities convertible or exchangeable for newly issued shares of Common Stock with an aggregate value equal $<ix:nonFraction contextRef="c507" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-39873">255,958,617</ix:nonFraction>, with
each Profusa Stockholder receiving for each share of Profusa Common Stock held (after giving effect to the exchange or conversion of all
outstanding Profusa Preferred Stock for shares of Profusa Common Stock and treating all vested in-the-money Profusa Convertible Securities
(including, on a net exercise basis, all vested qualified Profusa Options) as if such securities had been exercised as of immediately
prior to the Merger, but excluding all unvested Profusa Options) a number of shares of Common Stock equal to a conversion ratio of approximately
0.34. As a result, the Profusa Security Holders received an aggregate of <ix:nonFraction contextRef="c507" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-39874">25,595,862</ix:nonFraction> shares of newly issued Common Stock as Merger Consideration.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 210; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.&#160;AND SUBSIDIARY<br/>
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;14 &#8212;&#160;Subsequent Events</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Business Combination was
accounted for as a reverse capitalization in accordance with GAAP.&#160;Profusa was deemed the accounting predecessor of the combined
business, and New Profusa is the successor SEC registrant, meaning that Profusa&#8217;s financial statements for previous periods will
be disclosed in the registrant&#8217;s future periodic reports filed with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
Company had outstanding Profusa Preferred Stock of <ix:nonFraction contextRef="c508" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39875">17,863,934</ix:nonFraction> shares, common stock of <ix:nonFraction contextRef="c117" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-39876">6,984,666</ix:nonFraction> shares which are made up of <ix:nonFraction contextRef="c509" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39877">5,604,651</ix:nonFraction>
common shares outstanding and <ix:nonFraction contextRef="c510" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39878">1,380,015</ix:nonFraction> shares of common stock from in-substance nonrecourse promissory notes, and fully vested options
outstanding and exercisable of <ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" id="ixv-39879">2,364,814</ix:nonNumeric> shares. These shares were fully converted at the completion of the Business Combination. Additionally,
as of June&#160;30, 2025, the Convertible Notes of $<ix:nonFraction contextRef="c511" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39880">19.5</ix:nonFraction>&#160;million and Senior Convertibles Notes of $<ix:nonFraction contextRef="c512" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39881">27.9</ix:nonFraction>&#160;million were converted
in full at the closing of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From June&#160;30, 2025 through
the closing of the Business Combination, options continued to vest on normal vesting schedules, and interest continued to accrue on the
notes. Upon completing the Business Combination on July&#160;11, 2025, all outstanding Profusa Preferred Stock of <ix:nonFraction contextRef="c513" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39882">17,863,934</ix:nonFraction> shares, common
stock of <ix:nonFraction contextRef="c514" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-39883">6,984,666</ix:nonFraction> shares, were converted into New Profusa at an exchange ratio of .3459 for <ix:nonFraction contextRef="c515" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-39884">6,178,315</ix:nonFraction> shares from Profusa Preferred Stock,
and <span style="-sec-ix-hidden: hidden-fact-355">2,415,67</span> shares of Common Stock of which <ix:nonFraction contextRef="c514" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39885">1,938,392</ix:nonFraction> were from common shares outstanding and <ix:nonFraction contextRef="c367" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-39886">477,284</ix:nonFraction> were from common shares issued
from the in-substance nonrecourse promissory notes. Additionally, <ix:nonFraction contextRef="c516" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39887">2.3</ix:nonFraction>&#160;million outstanding options which were vested or expected to
vest were rolled over from Profusa into New Profusa outstanding options at an exchange rate of .3459.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the following
convertible notes were converted into New Profusa Common Stock based on the principal and accrued interest as of July&#160;11, 2025. Convertible
Notes with an outstanding balance of $<ix:nonFraction contextRef="c517" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39888">19.6</ix:nonFraction>&#160;million in principal and accrued interest converted into <ix:nonFraction contextRef="c518" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" unitRef="shares" id="ixv-39889">2,801,697</ix:nonFraction> shares of New Profusa
at $<ix:nonFraction contextRef="c519" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-39890">7.00</ix:nonFraction>/share, Senior Convertible Notes with an outstanding balance of $<ix:nonFraction contextRef="c520" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39891">20.8</ix:nonFraction>&#160;million in principal and accrued interest converted
into <ix:nonFraction contextRef="c521" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" unitRef="shares" id="ixv-39892">5,189,138</ix:nonFraction> shares of New Profusa at $<ix:nonFraction contextRef="c520" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-39893">4.00</ix:nonFraction>/share, Senior Convertible Bridge Notes of $<ix:nonFraction contextRef="c522" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="6" unitRef="usd" id="ixv-39894">3.1</ix:nonFraction>&#160;million in principal and accrued interest
were repaid in cash in the amount of $<ix:nonFraction contextRef="c522" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepaidPrincipal" scale="6" unitRef="usd" id="ixv-39895">0.25</ix:nonFraction>&#160;million with the remaining $<ix:nonFraction contextRef="c523" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" unitRef="usd" id="ixv-39896">2.85</ix:nonFraction>&#160;million converted into <ix:nonFraction contextRef="c522" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" unitRef="shares" id="ixv-39897">1,277,162</ix:nonFraction> shares of New Profusa
at $<ix:nonFraction contextRef="c523" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-39898">2.22</ix:nonFraction>/share, Senior Secured Convertible Notes of $<ix:nonFraction contextRef="c524" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="6" unitRef="usd" id="ixv-39899">2.8</ix:nonFraction>&#160;million in principal and accrued interest converted into <ix:nonFraction contextRef="c524" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" unitRef="shares" id="ixv-39900">5,542,261</ix:nonFraction> shares
of New Profusa at $<ix:nonFraction contextRef="c525" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-39901">0.50</ix:nonFraction>/share. Of the <ix:nonFraction contextRef="c526" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" unitRef="shares" id="ixv-39902">5,542,261</ix:nonFraction> New Profusa shares issued to Senior Secured Note holders, <ix:nonFraction contextRef="c527" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" unitRef="shares" id="ixv-39903">710,220</ix:nonFraction> shares were contributed
by the Sponsor. As part of the initial shares at closing, the Incentive Equity Value of $<ix:nonFraction contextRef="c528" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashMergerRelatedCosts" scale="0" unitRef="usd" id="ixv-39904">29,018,330</ix:nonFraction> was converted to shares at $<ix:nonFraction contextRef="c517" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-39905">10</ix:nonFraction> per
share for <ix:nonFraction contextRef="c368" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" scale="0" unitRef="shares" id="ixv-39906">2,901,833</ix:nonFraction> shares allocated to the merger consideration, as defined in the Business Combination Amendment No. 4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;28, 2025, the
Company entered into the Purchase Agreement and a related registration rights agreement (the &#8220;ELOC Registration Rights Agreement&#8221;),
with Ascent (&#8220;Purchaser&#8221;). Pursuant to the terms and conditions set forth in the Purchase Agreement, the Company may issue
and sell to Ascent, shares of its common stock for an aggregate purchase price of up to $<ix:nonFraction contextRef="c529" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" unitRef="usd" id="ixv-39907">100</ix:nonFraction>&#160;million, subject to certain limitations
and conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Purchase Agreement,
the Company may deliver advance notices to the Purchaser to request the purchase of shares of common stock, with each closing to occur
on a&#160;trading&#160;day following the end of a 10 or fewer&#160;trading&#160;day valuation period commencing on the trading date immediately
following the delivery of the Advance Notice, or as determined by the Purchaser. The purchase price per share at each Closing will be
equal to <ix:nonFraction contextRef="c530" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice" scale="-2" unitRef="pure" id="ixv-39908">97</ix:nonFraction>% of the lowest volume-weighted average price (&#8220;VWAP&#8221;) of the Company&#8217;s common stock during the applicable
valuation period, subject to a floor price and other adjustments as set forth in the Purchase Agreement. The maximum purchase price at
any single Closing is limited to the lower of (a)&#160;$<ix:nonFraction contextRef="c531" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" unitRef="usd" id="ixv-39909">5.0</ix:nonFraction>&#160;million or (b)&#160;<ix:nonFraction contextRef="c532" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfAverageDailyTradedValueOfCommonStock" scale="-2" unitRef="pure" id="ixv-39910">100</ix:nonFraction>% of the average daily traded value of the common
stock for the <span style="-sec-ix-hidden: hidden-fact-354">five</span>&#160;trading&#160;days immediately preceding such Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net proceeds from sales
that the Company makes to Ascent under the Purchase Agreement, will depend on the frequency and prices at which the Company sells shares
of Common Stock. We expect that any proceeds received from sales of Common Stock to Ascent will be used solely for the purchase of Bitcoin
(which can be used for debt repayment) provided that the Company&#8217;s cash balance on the date of the applicable sale exceeds $<ix:nonFraction contextRef="c533" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" unitRef="usd" id="ixv-39911">5.0</ix:nonFraction>&#160;million.
If the cash balance is less than $<ix:nonFraction contextRef="c534" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" unitRef="usd" id="ixv-39912">5.0</ix:nonFraction>&#160;million, proceeds to the Company shall be allocated first to bring the balance to $<ix:nonFraction contextRef="c531" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" unitRef="usd" id="ixv-39913">5.0</ix:nonFraction>&#160;million
and the remaining proceeds to purchase Bitcoin. As of the filing date of these June&#160;30, 2025 financial statements, the Company has
purchased $<ix:nonFraction contextRef="c535" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfEquity" scale="6" unitRef="usd" id="ixv-39914">1.0</ix:nonFraction>&#160;million of Bitcoin as part of the Company&#8217;s ongoing treasury strategy.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 211; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Stockholders and Board of Directors of<br/>
Northview Acquisition Corporation</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Opinion on the Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have audited the accompanying
consolidated balance sheets of Northview Acquisition Corporation (the &#8220;Company&#8221;) as of December 31, 2024 and 2023, the related
consolidated statements of operations, changes in stockholders&#8217; deficit and cash flows for each of the two years in the period ended
December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results
of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles
generally accepted in the United States of America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Explanatory Paragraph &#8212; Going Concern</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying financial
statements have been prepared assuming that the Company will continue as a going concern. As described in Note 1 to the financial statements,
the Company is a Special Purpose Acquisition Corporation that was formed for the purpose of effecting a merger, capital stock exchange,
asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses on or before June 22, 2025.
The Company entered into a definitive business combination agreement with a business combination target on November 7, 2022; however,
the completion of this transaction is subject to the approval of the Company&#8217;s stockholders among other conditions. There is no
assurance that the Company will obtain the necessary approvals, satisfy the required closing conditions, raise the additional capital
it needs to fund its operations, and complete the transaction prior to June 22, 2025, if at all. The Company also has no approved plan
in place to extend the business combination deadline and fund operations for any period of time after June 22, 2025, in the event that
it is unable to complete a business combination by that date. These matters raise substantial doubt about the Company&#8217;s ability
to continue as a going concern. Management&#8217;s plans with regard to these matters are also described in Note 1. The financial statements
do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These financial statements
are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conducted our audits in
accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance
about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to
have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required
to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness
of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audits included performing
procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for
our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Marcum <span style="font-variant: small-caps">llp</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marcum <span style="font-variant: small-caps">llp</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&#8217;s auditor since 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boston, MA<br/>
March 28, 2025</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 212; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="f_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
CONSOLIDATED BALANCE SHEETS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold">Current Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-39915">16,204</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-39916">4,519</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-39917">14,166</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-39918">6,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidTaxes" scale="0" unitRef="usd" id="ixv-39919">30,492</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Cash and marketable securities held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="0" unitRef="usd" id="ixv-39920">1,565,078</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Total Current Assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd" id="ixv-39921">60,862</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd" id="ixv-39922">1,576,347</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Cash and marketable securities held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-39923">8,330,835</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-39924">9,308,328</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd" id="ixv-39925">8,391,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd" id="ixv-39926">10,884,675</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Liabilities, Redeemable Common Stock and Stockholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Current Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-39927">684,483</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-39928">449,114</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Advance from Profusa</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AdvanceFromProfusa" scale="0" unitRef="usd" id="ixv-39929">791,407</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Excise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-39930">1,880,944</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-39931">1,864,106</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left"><span style="font-size: 10pt">Common stock to be redeemed<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="0" unitRef="usd">1,565,078</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="0" unitRef="usd" id="ixv-39933">49,061</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Convertible promissory note&#160;&#8211;&#160;related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-39934">8,908,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-39935">944,118</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Due to related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-39936">50,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-39937">50,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Total Current Liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-39938">12,314,886</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-39939">4,921,477</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" unitRef="usd" id="ixv-39940">13,661</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-39941">696,170</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-39942">156,639</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-39943">13,011,056</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-39944">5,091,777</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Commitments and Contingencies (Note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Common stock subject to possible redemption,&#160;<ix:nonFraction contextRef="c18" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39945">687,519</ix:nonFraction> and <ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-39946">833,469</ix:nonFraction> shares at redemption value of approximately $<ix:nonFraction contextRef="c18" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" unitRef="usdPershares" id="ixv-39947">12.13</ix:nonFraction> and $<ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" unitRef="usdPershares" id="ixv-39948">11.10</ix:nonFraction> at December&#160;31, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-39949">8,337,388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-39950">9,252,208</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Stockholders&#8217; Deficit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Preferred stock, $<ix:nonFraction contextRef="c16" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39951"><ix:nonFraction contextRef="c17" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39952">0.0001</ix:nonFraction></ix:nonFraction>&#160;par value;&#160;<ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39953"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39954">1,000,000</ix:nonFraction></ix:nonFraction>&#160;shares authorized; <span style="-sec-ix-hidden: hidden-fact-24"><span style="-sec-ix-hidden: hidden-fact-25"><span style="-sec-ix-hidden: hidden-fact-26"><span style="-sec-ix-hidden: hidden-fact-27">none</span></span></span></span> issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Common stock, $<ix:nonFraction contextRef="c16" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39955"><ix:nonFraction contextRef="c17" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-39956">0.0001</ix:nonFraction></ix:nonFraction>&#160;par value;&#160;<ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39957"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-39958">100,000,000</ix:nonFraction></ix:nonFraction>&#160;shares authorized;&#160;<ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-39959"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-39960"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39961"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-39962">5,193,750</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;shares issued and outstanding at December&#160;31, 2024 and 2023 (excluding 687,519 and 833,469 shares subject to possible redemption at December&#160;31, 2024 and 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd" id="ixv-39963">519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd" id="ixv-39964">519</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-39965">12,957,266</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-39966">3,459,829</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Stockholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-39967">12,956,747</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-39968">3,459,310</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Liabilities, Redeemable Common Stock and Stockholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd" id="ixv-39969">8,391,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd" id="ixv-39970">10,884,675</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">(1)</td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US">In connection with the special meeting of stockholders to vote on extending the Combination Period, on
December 21, 2023, 140,663 shares of the Company&#8217;s common stock were redeemed at a per share price of $11.13. In January 2024, $1,565,078
was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company has recorded a liability
of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December 31, 2023 on the consolidated
balance sheet.</ix:footnote></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 213; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="f_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
CONSOLIDATED STATEMENTS OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended <br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Formation and operating costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-39972">1,351,038</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-39973">1,508,683</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -12px; padding-left: 24px">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-39974">1,351,038</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-39975">1,508,683</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -12px; padding-left: 12px">Other income (expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 24px">Interest income earned on investments held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-39976">425,416</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-39977">2,248,538</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 24px">Change in fair value of convertible note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertibleNote" scale="0" unitRef="usd" id="ixv-39978">7,165,953</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertibleNote" scale="0" sign="-" unitRef="usd" id="ixv-39979">177,697</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-39980">539,531</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-39981">701,148</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Total other (expense) income, net</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-39982">7,280,068</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-39983">3,127,383</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -12px; padding-left: 12px">(Loss) income before provision for income tax</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-39984">8,631,106</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" unitRef="usd" id="ixv-39985">1,618,700</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Income tax provision</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-39986">80,513</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-39987">456,790</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Net (loss) income</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-39988">8,711,619</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd" id="ixv-39989">1,161,910</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39990"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39991">747,644</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c30" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-39992"><ix:nonFraction contextRef="c30" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39993">4,866,356</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Basic and diluted net (loss) income per share, common stock subject to possible redemption</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c29" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-39994"><ix:nonFraction contextRef="c29" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-39995">1.47</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c30" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-39996"><ix:nonFraction contextRef="c30" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-39997">0.12</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Basic and diluted weighted average shares outstanding, common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39998">5,193,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-39999">5,193,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Basic and diluted net (loss) income per share, common stock</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c27" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40000"><ix:nonFraction contextRef="c27" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40001">1.47</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c28" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-40002"><ix:nonFraction contextRef="c28" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-40003">0.12</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 214; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p><div>

</div><div><a id="f_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT<br/>
FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional <br/> Paid-In</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total <br/> Stockholders&#8217;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; width: 50%; font-weight: bold">Balance as of December&#160;31, 2022</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c120" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40004">5,193,750</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c120" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40005">519</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40006">619,995</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40007">619,476</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Accretion of common stock to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40008">2,137,638</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40009">2,137,638</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Excise tax payable attributable to redemption of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40010">1,864,106</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40011">1,864,106</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" unitRef="usd" id="ixv-40012">1,161,910</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" unitRef="usd" id="ixv-40013">1,161,910</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c128" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40014">5,193,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40015">519</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40016">3,459,829</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40017">3,459,310</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional <br/> Paid-In</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total <br/> Stockholders&#8217;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Amount</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Capital</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Deficit</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Deficit</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; width: 50%; font-weight: bold">Balance as of December 31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c128" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40018">5,193,750</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40019">519</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">&#8212;</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40020">3,459,829</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40021">3,459,310</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Accretion of common stock to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c134" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40022">768,980</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40023">768,980</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Excise tax payable attributable to redemption of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c134" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40024">16,838</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40025">16,838</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c134" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40026">8,711,619</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40027">8,711,619</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c136" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40028">5,193,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c136" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40029">519</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40030">12,957,266</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40031">12,956,747</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 215; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="f_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Year Ended <br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold">Cash flows from operating activities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left">Net (loss) income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40032">8,711,619</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd" id="ixv-40033">1,161,910</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Adjustments to reconcile net (loss) income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 36px; text-align: left">Interest income on cash and&#160;marketable securities&#160;held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40034">425,416</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40035">2,248,538</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 36px; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40036">539,531</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-40037">701,148</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 36px; text-align: left">Changes in fair value of convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" unitRef="usd" id="ixv-40038">7,165,953</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" sign="-" unitRef="usd" id="ixv-40039">177,697</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 36px; text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 48px; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" unitRef="usd" id="ixv-40040">7,416</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" sign="-" unitRef="usd" id="ixv-40041">311,468</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 48px; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd" id="ixv-40042">235,369</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd" id="ixv-40043">634</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 48px; text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="0" unitRef="usd" id="ixv-40044">30,492</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 48px; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" sign="-" unitRef="usd" id="ixv-40045">49,061</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" sign="-" unitRef="usd" id="ixv-40046">413,210</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 48px; text-align: left">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="0" unitRef="usd" id="ixv-40047">13,661</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="0" unitRef="usd" id="ixv-40048">23,279</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 48px; text-align: left; padding-bottom: 1.5pt">Due to related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="0" unitRef="usd" id="ixv-40049">25,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 36px; font-weight: bold; text-align: left">Net cash used in operating activities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40050">1,296,812</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40051">2,064,860</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Payment of extension fee into Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfExtensionFeeIntoTrustAccount" scale="0" unitRef="usd" id="ixv-40052">485,350</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfExtensionFeeIntoTrustAccount" scale="0" unitRef="usd" id="ixv-40053">438,360</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Cash withdrawn from Trust Account in connection with redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption" scale="0" unitRef="usd" id="ixv-40054">3,248,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption" scale="0" unitRef="usd" id="ixv-40055">184,845,836</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Reimbursement of franchise and income taxes from Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDecommissioningFund" scale="0" unitRef="usd" id="ixv-40056">204,459</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDecommissioningFund" scale="0" unitRef="usd" id="ixv-40057">1,192,438</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 36px; font-weight: bold; text-align: left">Net cash provided by investing activities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" unitRef="usd" id="ixv-40058">2,967,987</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" unitRef="usd" id="ixv-40059">185,599,914</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Proceeds from convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" unitRef="usd" id="ixv-40060">797,981</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" unitRef="usd" id="ixv-40061">1,121,815</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Advance from Profusa</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="usd" id="ixv-40062">791,407</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Redemption of common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="0" unitRef="usd" id="ixv-40063">3,248,878</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="0" unitRef="usd" id="ixv-40064">184,845,836</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 36px; font-weight: bold; text-align: left">Net cash used in financing activities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40065">1,659,490</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40066">183,724,021</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Net change in cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" unitRef="usd" id="ixv-40067">11,685</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" sign="-" unitRef="usd" id="ixv-40068">188,967</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Cash, beginning of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40069">4,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40070">193,486</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash, end of the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40071">16,204</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40072">4,519</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; font-weight: bold; text-align: left">Supplemental disclosure of cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Income taxes paid, inclusive of interest and penalties</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd" id="ixv-40073">173,727</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd" id="ixv-40074">912,437</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Excise tax payable attributable to redemption of common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxPayableRedemptionOfCommonStock" scale="0" unitRef="usd" id="ixv-40075">16,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxPayableRedemptionOfCommonStock" scale="0" unitRef="usd" id="ixv-40076">1,864,106</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Accretion of common stock to redemption value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40077">768,980</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40078">2,137,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Reclassification of common stock subject to redemption to common stock to be&#160;redeemed</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" scale="0" unitRef="usd" id="ixv-40079">1,565,078</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 216; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="f_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ixv-30272"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;1 &#8212;&#160;Description of Organization and Business
Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NorthView Acquisition Corporation
(the &#8220;Company&#8221; or &#8220;Northview&#8221;) is a blank check company incorporated in Delaware on April&#160;19, 2021. The Company
was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar
business combination with one or more businesses (&#8220;Business Combination&#8221;). The Company has identified a target company for
a business combination and is consummating the acquisition of Profusa.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a wholly-owned
subsidiary, NV Profusa Merger Sub Inc. (&#8220;Merger Sub&#8221;), a Delaware corporation incorporated on October&#160;13, 2022, formed
solely in contemplation of the Merger with Profusa (See Note&#160;6). Merger Sub has not commenced any operations and has only nominal
assets and no liabilities or contingent liabilities, nor any outstanding commitments other than in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company consummated its Initial Public Offering (&#8220;IPO&#8221;) of <ix:nonFraction contextRef="c536" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40080">18,975,000</ix:nonFraction>&#160;units (the &#8220;Units&#8221;), which included
<ix:nonFraction contextRef="c537" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40081">2,475,000</ix:nonFraction>&#160;Units&#160;issued pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists
of <ix:nonFraction contextRef="c538" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40082">one</ix:nonFraction> share of common stock of the Company, par value $<ix:nonFraction contextRef="c539" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40083">0.0001</ix:nonFraction> per share, <ix:nonFraction contextRef="c540" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40084">one</ix:nonFraction> right (the &#8220;Rights&#8221;), and one-half of <ix:nonFraction contextRef="c541" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40085">one</ix:nonFraction> redeemable
warrant of the Company (the &#8220;Warrants&#8221;). Each Right entitles the holder thereof to receive one-tenth (1/10) of <ix:nonFraction contextRef="c542" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40086">one</ix:nonFraction> share of
common stock. Each Warrant entitles the holder thereof to purchase <ix:nonFraction contextRef="c543" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40087">one</ix:nonFraction> share of common stock for $<ix:nonFraction contextRef="c544" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40088">11.50</ix:nonFraction> per share, subject to adjustment.
The Units&#160;were sold at a price of $<ix:nonFraction contextRef="c539" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40089">10.00</ix:nonFraction> per Unit, generating gross proceeds to the Company of $<ix:nonFraction contextRef="c536" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40090">189,750,000</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Simultaneously with the closing
of the IPO, the Company completed the private sale of an aggregate of <ix:nonFraction contextRef="c545" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-40091">7,347,500</ix:nonFraction>&#160;warrants (the &#8220;Private Placement Warrants&#8221;),
which included <ix:nonFraction contextRef="c546" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-40092">697,500</ix:nonFraction> Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters,
to NorthView Sponsor&#160;I, LLC (&#8220;the Sponsor&#8221;),&#160;I-Bankers Securities, Inc., and Dawson James Securities, Inc. at a
purchase price of $<ix:nonFraction contextRef="c545" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40093">1.00</ix:nonFraction> per Private Placement Warrant, generating gross proceeds to the Company of $<ix:nonFraction contextRef="c547" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-40094">7,347,500</ix:nonFraction>, which is discussed in Note&#160;4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Transaction costs amounted
to $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:TransactionCost" scale="0" unitRef="usd" id="ixv-40095">7,959,726</ix:nonFraction> consisting of $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnderwritingDiscountAmount" scale="0" unitRef="usd" id="ixv-40096">3,450,000</ix:nonFraction> of underwriting discount, $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RepresentativeSharesCost" scale="0" unitRef="usd" id="ixv-40097">3,570,576</ix:nonFraction> of Representative&#8217;s Shares cost, $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RepresentativeWarrantCost" scale="0" unitRef="usd" id="ixv-40098">259,527</ix:nonFraction> of Representative&#8217;s
Warrants cost and $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:OtherOfferingCosts" scale="0" unitRef="usd" id="ixv-40099">679,623</ix:nonFraction> of other offering costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Business
Combination must be with one or more target businesses that together have a fair market value equal to at least <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfAggregateFairMarketValueOfAsset" scale="-2" unitRef="pure" id="ixv-40100">80</ix:nonFraction>% of the value of the
assets held in the Trust Account (as defined below) (excluding taxes payable on the interest earned on the Trust Account) at the time
of the signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business
Combination if the post-transaction company owns or acquires <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" scale="-2" unitRef="pure" id="ixv-40101">50</ix:nonFraction>% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the closing of
the Public Offering on December&#160;22, 2021, an amount of $<ix:nonFraction contextRef="c539" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentsForInvestmentOfCashInTrustAccount" scale="0" unitRef="usd" id="ixv-40102">191,647,500</ix:nonFraction> ($<ix:nonFraction contextRef="c539" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40103">10.10</ix:nonFraction> per Unit), excluding $<ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:OperatingBankAccount" scale="0" unitRef="usd" id="ixv-40104">741,228</ix:nonFraction> that was wired to the
Company&#8217;s operating bank account on December&#160;31, 2021 for working capital purposes, from the net proceeds of the sale of the
public units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account (&#8220;Trust Account&#8221;) and
invested in United&#160;States government treasury bills with a maturity of <ix:nonNumeric contextRef="c549" format="ixt-sec:durwordsen" name="ck0001859807:MaturityDays" id="ixv-40105">185&#160;days</ix:nonNumeric> or less or in money market funds investing
solely in United&#160;States Treasuries and meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act as determined
by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to
pay its taxes, if any, the proceeds from the IPO will not be released from the Trust Account until the earliest of (i)&#160;the completion
of the Company&#8217;s initial Business Combination, (ii)&#160;the redemption of any public shares properly tendered in connection with
a stockholder vote to amend the Company&#8217;s amended and restated certificate of incorporation (A)&#160;to modify the substance or
timing of the Company&#8217;s obligation to redeem <ix:nonFraction contextRef="c549" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" unitRef="pure" id="ixv-40106">100</ix:nonFraction>% of the public shares if the Company does not complete the initial Business Combination
within the extended period (or any additional extension from the closing of our IPO if we extend the period of time to consummate a business
combination) (the &#8220;Combination Period&#8221;), or (B)&#160;with respect to any other provision relating to stockholders&#8217;
rights or pre-Business Combination activity, and (iii)&#160;the redemption of all of the Company&#8217;s public shares if the Company
is unable to complete the Business Combination within the Combination Period, subject to applicable law. The proceeds deposited in the
Trust Account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims
of the Company&#8217;s public stockholders.</p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 217; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will provide its
public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business
Combination either (i)&#160;in connection with a stockholder meeting called to approve the initial Business Combination or (ii)&#160;by
means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination
or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a
portion of their public shares upon the completion of the initial Business Combination at a per-share&#160;price, payable in cash, equal
to the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to the consummation of the initial Business
Combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares,
subject to the limitations described herein. The per share amount the Company will distribute to investors who properly redeem their shares
will not be reduced by the fee payable to&#160;I-Bankers&#160;and Dawson James pursuant to the Business Combination Marketing Agreement
(see Note&#160;6).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company is unable to
complete an initial Business Combination within the Combination Period, it will: (i)&#160;cease all operations except for the purpose
of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten&#160;business days thereafter, redeem the public shares,
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust account, including interest (which interest
shall be net of taxes payable, and less up to $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentofInteresttoDistributionExpense" scale="0" unitRef="usd" id="ixv-40107">100,000</ix:nonFraction> of interest to pay dissolution expenses) divided by the number of then outstanding
public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive
further liquidation distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such
redemption, subject to the approval of the Company&#8217;s remaining stockholders and its board of directors, dissolve and liquidate,
subject in each case to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#8217;s rights and warrants,
which will expire worthless if the Company fails to complete the Business Combination within the Combination Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 10, 2023, the Company
held a vote to amend its amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business
Combination from March 22, 2023 to December 22, 2023 (the &#8220;First Extension Meeting&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024. In connection with the extension, <ix:nonFraction contextRef="c550" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40108">140,663</ix:nonFraction> shares of the Company&#8217;s
common stock were redeemed, with <ix:nonFraction contextRef="c551" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-40109">6,027,219</ix:nonFraction> shares of Common Stock remaining outstanding after the Redemption; <ix:nonFraction contextRef="c552" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-40110">833,469</ix:nonFraction> shares of Common
Stock remaining outstanding after the Redemption are shares issued in connection with our initial public offering. In January&#160;2024,
$<ix:nonFraction contextRef="c553" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40111">1,565,078</ix:nonFraction> was paid from the Trust Account to redeeming stockholders in connection with the extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;2, 2024, the
Company and Continental Stock Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;) entered into Amendment No. 1 to Investment Management
Trust Agreement, dated December&#160;20, 2021, by and between the Company and CST, to allow CST, upon written instruction of the Company,
to (i)&#160;hold the funds in the Company&#8217;s trust account uninvested or (ii)&#160;hold the funds in an interest-bearing bank demand
deposit account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024,
the Company&#8217;s Board of Directors approved, and the Company amended, its Convertible Working Capital Promissory Note (the &#8220;Note&#8221;)
with the sponsor to increase the principal amount of the Note that could be drawn on to $<ix:nonFraction contextRef="c554" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapital" scale="6" unitRef="usd" id="ixv-40112">1.5</ix:nonFraction>&#160;million. The amended and restated Note
also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company common stock at a price
of $<ix:nonFraction contextRef="c554" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40113">2.22</ix:nonFraction> per share at the election of the sponsor. On May 31, 2024, the Company&#8217;s Board of Directors approved and the Company entered
into a second amendment of its Convertible Working Capital Promissory Note with the sponsor to increase the principal amount of the Note
that could be drawn on to $<ix:nonFraction contextRef="c555" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40114">2.5</ix:nonFraction> million. The second amended and restated Note also allows for the conversion of the outstanding principal
balance of the Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c555" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40115">2.22</ix:nonFraction> per share at the election of the sponsor.</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>


</div><!-- Field: Page; Sequence: 218; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_3" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;21, 2024, the
Company held its 2024 Annual Meeting of Stockholders (the &#8220;Meeting&#8221;). At the meeting, the Company&#8217;s stockholders approved
the amendment of the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase <ix:nonFraction contextRef="c556" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" unitRef="pure" id="ixv-40116">100</ix:nonFraction>% of the shares of the Company&#8217;s
common stock issued in the Company&#8217;s initial public offering, from March&#160;22, 2024, monthly for up to six additional&#160;months
at the election of the Company and only upon contribution of $<ix:nonFraction contextRef="c557" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40117">0.05</ix:nonFraction> per month per outstanding public share, ultimately until September&#160;22,
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the meeting,
the holders of&#160;<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40118">95,394</ix:nonFraction>&#160;Public Shares properly exercised their right to redeem, with <ix:nonFraction contextRef="c559" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40119">5,931,825</ix:nonFraction> shares of Common Stock remaining
outstanding after the Redemption; <ix:nonFraction contextRef="c136" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40120">738,075</ix:nonFraction> shares of Common Stock remaining outstanding after the Redemption are shares issued in connection
with the initial public offering. Consequently, the contribution is $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40121">36,904</ix:nonFraction>&#160;per month needed for the Company to continue to extend
the Combination Period monthly. On May&#160;8, 2024 and May&#160;31, 2024, the Company made two deposits of $<ix:nonFraction contextRef="c555" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40122">36,904</ix:nonFraction> each for April and
May extension contributions. On September&#160;10, 2024, the Company made a deposit of $<ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40123">112,114</ix:nonFraction>, of which $<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40124">110,714</ix:nonFraction> was for June, July
and August extension contributions and $<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeOther" scale="0" unitRef="usd" id="ixv-40125">1,400</ix:nonFraction> for lost interest due to late trust payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September&#160;19, 2024,
the Company held an extraordinary general meeting of stockholders (the &#8220;Meeting&#8221;). At the Meeting, the Company&#8217;s stockholders
approved an amendment to the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company
must consummate its initial Business Combination to March&#160;22, 2025. In connection with the approval of the extension amendment, holders
of&#160;<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40126">50,556</ix:nonFraction>&#160;shares of the Company&#8217;s common stock exercised their right to redeem, with <ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40127">5,881,269</ix:nonFraction> shares of common stock
remaining outstanding after the redemption; <ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40128">687,519</ix:nonFraction> shares of common stock remaining outstanding after the redemption are shares issued
in connection with our initial public offering. Consequently, the contribution is $<ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40129">34,376</ix:nonFraction>&#160;per month needed for the Company to continue
to extend the Combination Period monthly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 13, 2024, the Company
made a deposit of $<ix:nonFraction contextRef="c567" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40130">68,752</ix:nonFraction> for the October and November extension contributions and on December 23, 2024, the company made a deposit of
<ix:nonFraction contextRef="c568" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40131">34,376</ix:nonFraction> for the December extension contribution. In October 2024, $<ix:nonFraction contextRef="c569" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40132">595,439</ix:nonFraction> was paid from the trust account to redeeming stockholders in
connection with the extension. On February 27, 2025, the Company made a deposit of $<ix:nonFraction contextRef="c570" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40133">49,376</ix:nonFraction> for the January extension contribution and
a portion ($<ix:nonFraction contextRef="c571" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40134">15,000</ix:nonFraction>) of the February extension contribution. On March 7, 2025, the Company deposited the remainder of the February extension
contribution of $<ix:nonFraction contextRef="c572" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40135">19,376</ix:nonFraction>, plus interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the meeting and the stockholders approved the extension of the business combination period until June 22, 2025.
In connection with the approval of the extension amendment, holders of <ix:nonFraction contextRef="c573" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40136">532,958</ix:nonFraction> shares of the Company&#8217;s common stock exercised their
right to redeem, for an aggregate redemption amount of approximately $<ix:nonFraction contextRef="c574" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="6" unitRef="usd" id="ixv-40137">6.5</ix:nonFraction> million, with <ix:nonFraction contextRef="c574" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40138">5,348,311</ix:nonFraction> shares of common stock remaining outstanding
after the redemption; <ix:nonFraction contextRef="c574" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40139">154,561</ix:nonFraction> shares of common stock remaining outstanding after the redemption are shares issued in connection with our
initial public offering. As a condition of the extension, the Company contributed $<ix:nonFraction contextRef="c573" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40140">30,000</ix:nonFraction> to the Trust Account, for the entire extension
period, on March 21, 2025. Additionally, the stockholders at the meeting approved the amendment of the Company&#8217;s charter to remove
the requirement that prevented the Company from redeeming public shares to the extent that it would cause the Company&#8217;s net tangible
assets to be less than $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" scale="0" unitRef="usd" id="ixv-40141">5,000,001</ix:nonFraction> (the &#8220;NTA Requirement&#8221;), and our charter was amended on March 21, 2025 to reflect the extension
of the business combination and the removal of the NTA Requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Public Shares,
or shares of our common stock sold as part of the IPO, contain a redemption feature which allows for the redemption of such Public Shares
in connection with our liquidation, if there is a stockholder vote or tender offer in connection with our initial business combination
and in connection with certain amendments to our amended and restated certificate of incorporation. In accordance with SEC and its guidance
on redeemable equity instruments, which has been codified in ASC&#160;480-10-S99, redemption provisions not solely within the control
of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were
issued with other freestanding instruments (i.e., public warrants), the initial carrying value of common stock classified as temporary
equity was the allocated proceeds determined in accordance with ASC&#160;470-20. The common stock is subject to ASC&#160;480-10-S99.
If it is probable that the equity instrument will become redeemable, the Company has the option to either (i)&#160;accrete changes in
the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become
redeemable, if later) to the earliest redemption date of the instrument or (ii)&#160;recognize changes in the redemption value immediately
as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The
Company has elected to recognize the changes immediately.</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 219; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_4" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor, officers and directors
have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with the completion
of the initial Business Combination, (ii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to
their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will
be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete
the Business Combination within such time period); and (iii)&#160;vote their Founder Shares and any public shares purchased during or
after the IPO in favor of the initial Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor
has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to
the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount
of funds in the Trust Account to below (i)&#160;$<ix:nonFraction contextRef="c575" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40142">10.10</ix:nonFraction> per public share or (ii)&#160;such lesser amount per public share held in the Trust
Account as of the date of the liquidation of the Trust Account due to reductions in value of the trust assets, in each case net of the
amount of interest which may be released to the Company to pay taxes, except as to any claims by a third party who executed a waiver of
any and all rights to seek access to the Trust Account and except as to any claims under indemnity of the underwriters of the IPO against
certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Nasdaq Delisting Notification</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 20, 2024, the Company
received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market that the Company&#8217;s securities
would be delisted from The Nasdaq Stock Market by reason of the failure of the Company to complete its initial business combination by
December 20, 2024 (36 months from the effectiveness of its IPO registration statement) as required by Listing Rule IM-5101-2. Accordingly,
trading in the Company&#8217;s Common Stock, Rights and Warrants was suspended at the opening of business on December 27, 2024 and a Form
25-NSE was filed by Nasdaq with the Securities and Exchange Commission, which removed the Company&#8217;s securities from on the Nasdaq
Stock Market. The Company&#8217;s Common Stock, Rights and Warrants began to be quoted on the Pink Markets operated on The OTC Market
systems (&#8220;OTC Market&#8221;) under the symbols &#8220;NVAC,&#8221; &#8220;NVACR&#8221; and &#8220;NVACW.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of&#160;December 31, 2024,
the Company had $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-40143">16,204</ix:nonFraction> in cash and a working capital deficit of $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapitalDeficit" scale="0" unitRef="usd" id="ixv-40144">12,254,024</ix:nonFraction>. Prior to the completion of the Company&#8217;s IPO, the
Company&#8217;s liquidity needs had been satisfied through a capital contribution from the Sponsor of $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PartnersCapitalAccountContributions" scale="0" unitRef="usd" id="ixv-40145">25,000</ix:nonFraction> for the founder shares to
cover certain of the offering costs and the loan under an unsecured promissory note from the Sponsor of $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnsecuredPromissoryNote" scale="0" unitRef="usd" id="ixv-40146">204,841</ix:nonFraction>, which was fully paid
upon the IPO. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company&#8217;s liquidity
needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account, and the drawdowns
on the convertible promissory note.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 220; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_5" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain
of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note&#160;5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $<ix:nonFraction contextRef="c576" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapital" scale="0" unitRef="usd" id="ixv-40147">1,200,000</ix:nonFraction>. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $<ix:nonFraction contextRef="c577" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares" id="ixv-40148">1.00</ix:nonFraction> per warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024, the
Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $<ix:nonFraction contextRef="c554" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40149">1.5</ix:nonFraction>&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c554" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40150">2.22</ix:nonFraction> per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;31, 2024, the Company&#8217;s
Board of Directors approved, and the Company second amended its Note to increase the principal amount of the Note that could be drawn
on to $<ix:nonFraction contextRef="c555" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40151">2.5</ix:nonFraction>&#160;million. The second amended and restated Note also allows for the conversion of the outstanding principal balance of the
Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c555" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40152">2.22</ix:nonFraction>&#160;per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had principal outstanding
of $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:OutstandingPrincipalAmount" scale="0" unitRef="usd" id="ixv-40153">1,919,796</ix:nonFraction> and is presenting the Note at fair value on its balance sheet at December 31, 2024 in the amount of $<ix:nonFraction contextRef="c578" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40154">8,908,052</ix:nonFraction>. As of December
31, 2024, no amounts were repaid against the loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has until June&#160;22,
2025 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by June&#160;22,
2025. If a Business Combination is not consummated by the required date, there will be an option to either extend the time available for
us to consummate our initial business combination or execute a mandatory liquidation and subsequent dissolution. In connection with the
Company&#8217;s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standards
Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;)&#160;2014-15, &#8220;Disclosure of Uncertainties About an Entity&#8217;s
Ability to Continue as a Going Concern,&#8221; management has determined that mandatory liquidation, and subsequent dissolution, should
the Company be unable to complete a business combination, raises substantial doubt about the Company&#8217;s ability to continue as a
going concern for the next twelve&#160;months from the issuance of these consolidated financial statements. No adjustments have been made
to the carrying amounts of assets and liabilities should the Company be required to liquidate after June&#160;22, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for, among other
things, a new U.S.&#160;federal <ix:nonFraction contextRef="c579" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-40155">1</ix:nonFraction>% excise tax on certain repurchases of stock occurring on or after January&#160;1, 2023, by publicly
traded U.S.&#160;domestic corporations, by certain U.S.&#160;domestic subsidiaries of publicly traded foreign corporations, by &#8220;covered
surrogate foreign corporations&#8221; (as defined in the IR Act) and by certain affiliates of the foregoing. The excise tax is imposed
on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally
<ix:nonFraction contextRef="c580" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther" scale="-2" unitRef="pure" id="ixv-40156">1</ix:nonFraction>% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock
repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any redemption or other repurchase
that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the
excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension
vote or otherwise would depend on a number of factors, including (i)&#160;the fair market value of the redemptions and repurchases in
connection with the Business Combination, extension or otherwise, (ii)&#160;the structure of a Business Combination, (iii)&#160;the nature
and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination (or otherwise issued not in
connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv)&#160;the content of
regulations and other guidance from the Treasury. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#8217;s ability to complete a Business Combination.</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 221; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c135_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;22, 2023 and
December&#160;21, 2023, the Company&#8217;s stockholders redeemed <ix:nonFraction contextRef="c581" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40157">18,000,868</ix:nonFraction> and <ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40158">140,663</ix:nonFraction> shares, respectively, for a total of $<ix:nonFraction contextRef="c583" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40159">184,845,836</ix:nonFraction>
and $<ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40160">1,565,078</ix:nonFraction>, respectively. On March&#160;26, 2024, the Company&#8217;s stockholders redeemed <ix:nonFraction contextRef="c585" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40161">95,394</ix:nonFraction> shares for a total of $<ix:nonFraction contextRef="c586" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40162">1,088,361</ix:nonFraction>.
On September&#160;30, 2024, the Company&#8217;s stockholders redeemed <ix:nonFraction contextRef="c587" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40163">50,556</ix:nonFraction> shares for a total of $<ix:nonFraction contextRef="c587" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40164">595,439</ix:nonFraction>. The Company determined that
an excise tax liability should be recorded due to the redeemed shares. As of December 31, 2024, the Company has a charge to stockholders&#8217;
deficit of $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" scale="0" unitRef="usd" id="ixv-40165">1,880,944</ix:nonFraction> of excise tax liability, including $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExciseAndSalesTaxes" scale="0" unitRef="usd" id="ixv-40166">16,838</ix:nonFraction> charged during the year ended December 31, 2024, calculated as <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:SharesRedeemedPercentage" scale="-2" unitRef="pure" id="ixv-40167">1</ix:nonFraction>% of
the value of shares redeemed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;3, 2024, the Treasury
issued final regulations with respect to the procedure and administration of the Excise Tax. These regulations provided that the filing
and payment deadline for any liability incurred during the period from January&#160;1, 2023 to December&#160;31, 2023 would be October&#160;31,
2024. As of December 31, 2024 and the date of this report, the excise tax was not paid and recorded as excise tax payable. Any amount
of such Excise Tax not paid in full, could be subject to additional interest and penalties which are currently estimated at <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:EstimatedInterestRate" scale="-2" unitRef="pure" id="ixv-40168">7</ix:nonFraction>% interest
per annum and a <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:UnderpaymentPenaltyRate" scale="-2" unitRef="pure" id="ixv-40169">5</ix:nonFraction>% underpayment penalty per month or portion of a month up to <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:UnpaidTotalLiabilityRate" scale="-2" unitRef="pure" id="ixv-40170">25</ix:nonFraction>% of the total liability for any amount that is unpaid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2024 and
2023, $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-40171">1,880,944</ix:nonFraction> and $<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-40172">1,864,106</ix:nonFraction> were accrued on the accompanying consolidated balance sheets, respectively. On January 29, 2025, the Company
claimed disaster relief under IRC Section 7508A relating to Hurricane Beryl as announced in IRS Announcement TX-2024-08. Under the disaster
relief claim, the time for filing of the September 30, 2024 Quarterly Federal Excise Tax Return and payment of the 2023 excise taxes on
repurchases of corporate stock normally due on October 31, 2024 should be postponed to February 3, 2025. The Company was not subject to
excise tax interest and penalties until February 3, 2025. On January 29, 2025, the Company filed their 2024 excise tax return. No excise
tax payment had been made by the Company.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="_SignificantAccountingPoliciesTextBlock-c135_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-30499"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;2 &#8212;&#160;Summary of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-30504"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements are presented in conformity with accounting principles generally accepted in the United&#160;States of America (&#8220;GAAP&#8221;)
and pursuant to the rules and regulations of the SEC.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_ConsolidationPolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-30512"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principles of Consolidation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ConsolidationPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c135_cont_1" escape="true" name="ck0001859807:EmergingGrowthCompanyStatusPolicyTextBlock" id="ixv-30520"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Emerging Growth Company Status</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c135_cont_2" id="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an &#8220;emerging
growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 222; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c135_cont_2" id="_SignificantAccountingPoliciesTextBlock-c135_cont_1"><ix:continuation id="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public company, which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_UseOfEstimates-c135_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-30557"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_UseOfEstimates-c135_cont_2" id="_UseOfEstimates-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of these consolidated
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_UseOfEstimates-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Some of the more significant estimates are in connection with
determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results could differ significantly
from those estimates.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_ConcentrationRiskCreditRisk-c135_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-30568"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashFDICInsuredAmount" scale="0" unitRef="usd" id="ixv-40173">250,000</ix:nonFraction>. The Company has not experienced losses on this account.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-30576"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company did not have any
cash equivalents as of December&#160;31, 2024 and 2023.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_MarketableSecuritiesPolicy-c135_cont_1" escape="true" name="us-gaap:MarketableSecuritiesPolicy" id="ixv-30584"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Marketable Securities Held in Trust Account</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c135_cont_2" id="_MarketableSecuritiesPolicy-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2024, substantially
all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank and at December&#160;31,
2023, substantially all of the assets held in the Trust Account were held in U.S.&#160;Treasury Bills. All of the Company&#8217;s investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the consolidated balance sheets at
fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust
Account are shown in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c135_cont_3" id="_MarketableSecuritiesPolicy-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;
Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesTaxable" scale="0" unitRef="usd" id="ixv-40174">204,459</ix:nonFraction> of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 223; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c135_cont_3" id="_SignificantAccountingPoliciesTextBlock-c135_cont_2"><ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:MarketableSecuritiesTextBlock" id="ixv-30620"><ix:continuation continuedAt="_MarketableSecuritiesPolicy-c135_cont_4" id="_MarketableSecuritiesPolicy-c135_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2023, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;
Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesTaxable" scale="0" unitRef="usd" id="ixv-40175">1,192,438</ix:nonFraction> of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c135_cont_5" id="_MarketableSecuritiesPolicy-c135_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December
    31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c595" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40176">8,330,835</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c596" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40177">1,406</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">U.S.&#160;Treasury Bills</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c598" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40178">10,872,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c599" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40179">8,330,835</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c600" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40180">10,873,406</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c135_cont_6" id="_MarketableSecuritiesPolicy-c135_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December 21, 2023, <ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40181">140,663</ix:nonFraction> shares of the Company&#8217;s common stock were redeemed. In January&#160;2024,
$<ix:nonFraction contextRef="c588" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PayableCommonStockRedeemed" scale="0" unitRef="usd" id="ixv-40182">1,565,078</ix:nonFraction> was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $<ix:nonFraction contextRef="c589" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="0" unitRef="usd" id="ixv-40183">1,565,078</ix:nonFraction> as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$<ix:nonFraction contextRef="c590" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="0" unitRef="usd" id="ixv-40184">1,565,078</ix:nonFraction> of the trust account as a current asset on the consolidated balance sheets, which was paid from the Trust Account in January&#160;2024
to redeeming stockholders.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c135_cont_7" id="_MarketableSecuritiesPolicy-c135_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial business combination
from March 22, 2025 to June 22, 2025. The meeting was adjourned until March 21, 2025, at which the stockholders approve the extension
of the business combination period until June 22, 2025. As a condition of the extension, the Company contributed $<ix:nonFraction contextRef="c573" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40185">30,000</ix:nonFraction> to the Trust
Account, for the entire extension period, on March 21, 2025.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_MarketableSecuritiesPolicy-c135_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2024, all
of the Trust assets were classified as noncurrent assets.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c135_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-30682"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
assets and liabilities approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to
their short-term nature, except for the warrant liabilities and convertible promissory note.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_IncomeTaxPolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-30690"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c135_cont_2" id="_IncomeTaxPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes under ASC&#160;740, &#8220;Income Taxes.&#8221; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the consolidated financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires
a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
As of December&#160;31, 2024 and 2023, the Company&#8217;s deferred tax asset had a full valuation allowance recorded against it.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c135_cont_3" id="_IncomeTaxPolicyTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure
and transition.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 224; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c135_cont_4" id="_SignificantAccountingPoliciesTextBlock-c135_cont_3"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c135_cont_4" id="_IncomeTaxPolicyTextBlock-c135_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. Interest and penalties expense amounted
to $<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="0" unitRef="usd" id="ixv-40186">0</ix:nonFraction> and $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="0" unitRef="usd" id="ixv-40187">19,158</ix:nonFraction> during the years ended December 31, 2024 and 2023, respectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c135_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has identified
the United&#160;States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_DerivativesPolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:DerivativesPolicyTextBlock" id="ixv-30733"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Derivative Financial Instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_DerivativesPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the consolidated statements of
operations. Derivative assets and liabilities are classified in the consolidated balance sheets as current or non-current&#160;based on
whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_DebtPolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:DebtPolicyTextBlock" id="ixv-30741"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Promissory Note</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_DebtPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c135_cont_1" escape="true" name="ck0001859807:WarrantLiabilitiesPolicyTextBlock" id="ixv-30749"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Warrant Liabilities</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c135_cont_2" id="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for the&#160;<ix:nonFraction contextRef="c591" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40188">17,404,250</ix:nonFraction>
warrants issued in connection with the IPO (the&#160;<ix:nonFraction contextRef="c592" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40189">9,487,500</ix:nonFraction>&#160;Public Warrants, the&#160;<ix:nonFraction contextRef="c593" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40190">7,347,500</ix:nonFraction>&#160;Private Placement Warrants,
and the <ix:nonFraction contextRef="c594" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40191">569,250</ix:nonFraction> Representative Warrants inclusive of the underwriters&#8217; over-allotment&#160;option) in accordance with the guidance
contained in ASC&#160;815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder,
each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This
liability is subject to re-measurement&#160;at each balance sheet date. With each such re-measurement, the warrant liabilities will be
adjusted to fair value, with the change in fair value recognized in the Company&#8217;s consolidated statements of operations (See Note&#160;8).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the fair value
of the Private Placement Warrants and the Representative&#8217;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 225; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c135_cont_5" id="_SignificantAccountingPoliciesTextBlock-c135_cont_4"><ix:nonNumeric contextRef="c135" continuedAt="_EarningsPerSharePolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-30787"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Net (Loss) Income Per Common Stock</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c135_cont_2" id="_EarningsPerSharePolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-40192">17,404,250</ix:nonFraction> potential shares of common stock for outstanding warrants to purchase the Company&#8217;s
shares were excluded from diluted earnings per share for the years ended December 31, 2024 and 2023 because the warrants are contingently
exercisable, and the contingencies have not yet been met. As a result, diluted net (loss) income per share of common stock is the same
as basic net (loss) income per share of common stock for the periods presented.&#160;<ix:nonNumeric contextRef="c135" continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c135_cont_1" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-40193">The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:</ix:nonNumeric></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c135_cont_1"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c135_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Basic and diluted net (loss) income per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net (loss) income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c601" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40194">1,096,239</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40195">7,615,380</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c602" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" unitRef="usd" id="ixv-40196">562,049</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" unitRef="usd" id="ixv-40197">599,861</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c601" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40198">747,644</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c132" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40199">5,193,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c602" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40200">4,866,356</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c124" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40201">5,193,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Basic and diluted net (loss) income per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c601" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40202"><ix:nonFraction contextRef="c601" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40203">1.47</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c132" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40204"><ix:nonFraction contextRef="c132" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40205">1.47</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c602" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-40206"><ix:nonFraction contextRef="c602" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-40207">0.12</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c124" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-40208"><ix:nonFraction contextRef="c124" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-40209">0.12</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" id="ixv-30949"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Stock Subject to Possible Redemption</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c135_cont_2" id="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s common
stock sold as part of the Units&#160;in the IPO (&#8220;public common stock&#8221;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#8217;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#8217;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:TemporaryEquityTableTextBlock" id="ixv-30956"><ix:continuation continuedAt="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c135_cont_3" id="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c135_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2022</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40210">193,525,484</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RedemptionPremium" scale="0" unitRef="usd" id="ixv-40211">186,410,914</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="0" unitRef="usd" id="ixv-40212">2,137,638</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40213">9,252,208</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RedemptionPremium" scale="0" unitRef="usd" id="ixv-40214">1,683,800</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="0" unitRef="usd" id="ixv-40215">768,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40216">8,337,388</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c135" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-31030"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recently Issued Accounting Standards</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_2" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued ASU 2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments in this ASU
require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating
officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in the reported measure of
segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the
CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public
entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single
reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures
in Topic 280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years
beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU 2023-07, which was applied retrospectively
to all prior periods presented. See Note 10 for further details regarding this adoption.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 226; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c135_cont_5"><ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_3" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Standards not yet Adopted</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_4" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#8220;ASU&#160;2023-09&#8221;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c135_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#8217;s consolidated financial statements.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="ck0001859807_InitialPublicOfferingTextBlock-c135_cont_1" escape="true" name="ck0001859807:InitialPublicOfferingTextBlock" id="ixv-31077"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;3 &#8212;&#160;Initial Public Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Public Units</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company sold <ix:nonFraction contextRef="c539" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40217">18,975,000</ix:nonFraction>&#160;Units, (which included <ix:nonFraction contextRef="c603" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40218">2,475,000</ix:nonFraction>&#160;Units&#160;issued pursuant to the full exercise of the over-allotment
option) at a purchase price of $<ix:nonFraction contextRef="c603" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40219">10.00</ix:nonFraction> per Unit. Each unit that the Company is offering has a price of $<ix:nonFraction contextRef="c604" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40220">10.00</ix:nonFraction> and consists of <ix:nonFraction contextRef="c538" decimals="0" format="ixt-sec:numwordsen" name="ck0001859807:NumberOfSharesIssuedPerUnit" scale="0" unitRef="shares" id="ixv-40221">one</ix:nonFraction> share
of common stock, one right, and one-half&#160;of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth&#160;(1/10)
of <ix:nonFraction contextRef="c542" decimals="0" format="ixt-sec:numwordsen" name="ck0001859807:NumberOfSharesIssuedPerUnit" scale="0" unitRef="shares" id="ixv-40222">one</ix:nonFraction> share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof
to purchase <ix:nonFraction contextRef="c605" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares" id="ixv-40223">one</ix:nonFraction> share of common stock at a price of $<ix:nonFraction contextRef="c606" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40224">11.50</ix:nonFraction> per share, subject to adjustment as described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Public Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each whole warrant entitles
the holder to purchase <ix:nonFraction contextRef="c607" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares" id="ixv-40225">one</ix:nonFraction> share of common stock at a price of $<ix:nonFraction contextRef="c607" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40226">11.50</ix:nonFraction>&#160;per share, subject to adjustment as discussed herein. In addition,
if (x)&#160;the Company issues additional shares of common stock or equity-linked&#160;securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $<ix:nonFraction contextRef="c608" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40227">9.20</ix:nonFraction>&#160;per share of common
stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any
such issuance to the initial stockholders or their affiliates, without taking into account any founder shares held by such stockholders
or their affiliates, as applicable, prior to such issuance (the &#8220;Newly Issued Price&#8221;)), (y)&#160;the aggregate gross proceeds
from such issuances represent more than&#160;<ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:EquityProceedOwnershipPercentage" scale="-2" unitRef="pure" id="ixv-40228">60</ix:nonFraction>% of the total equity proceeds, and interest thereon, available for funding the initial
Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of the common stock during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates the Business Combination (such price,
the &#8220;Market Value&#8221;) is below $<ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" scale="0" unitRef="usdPershares" id="ixv-40229">9.20</ix:nonFraction>&#160;per share, the exercise price shall be adjusted (to the nearest cent) to be equal
to&#160;<ix:nonFraction contextRef="c139" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" scale="-2" unitRef="pure" id="ixv-40230">115</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, and the $<ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" scale="0" unitRef="usdPershares" id="ixv-40231">18.00</ix:nonFraction>&#160;per share redemption trigger price described
in the section &#8220;Redemption of warrants&#8221; will be adjusted (to the nearest cent) to be equal to&#160;<ix:nonFraction contextRef="c609" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" scale="-2" unitRef="pure" id="ixv-40232">180</ix:nonFraction>% of the higher of the
Market Value and the Newly Issued Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warrants will become exercisable
on the later of 12&#160;months from the closing of the IPO or 30&#160;days after the completion of its initial Business Combination and
will expire <span style="-sec-ix-hidden: hidden-fact-357">five</span>&#160;years after the completion of the Company&#8217;s initial Business Combination, at 5:00&#160;p.m., New&#160;York
City time, or earlier upon redemption or liquidation.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 227; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Initial Public Offering</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="ck0001859807_InitialPublicOfferingTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has agreed that as soon as practicable,
but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company will use its reasonable
best efforts to file, and within 60&#160;business days after the closing of the initial Business Combination, to have declared effective,
a registration statement relating to those shares of common stock, and to maintain a current prospectus relating to such shares of common
stock until the warrants expire or are redeemed. Notwithstanding the foregoing, if a registration statement covering the shares of common
stock issuable upon exercise of the warrants is not effective within the above specified period following the consummation of the initial
Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when
the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption
provided by Section&#160;3(a)(9)&#160;of the Securities Act&#160;of&#160;1933, as amended, or the Securities Act, provided that such exemption
is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Redemption of Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td>in whole and not in part;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td>at a price of $<ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:RedemptionPricePerWarrant" scale="0" unitRef="usdPershares" id="ixv-40233">0.01</ix:nonFraction> per warrant;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td>upon a minimum of <ix:nonNumeric contextRef="c135" format="ixt-sec:durday" name="ck0001859807:NumberOfDaysForWrittenNoticeOfRedemption" id="ixv-40234">30</ix:nonNumeric> days&#8217; prior written notice of redemption (the &#8220;30-day redemption period&#8221;);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">if, and only if, the last sale price of the common stock equals or exceeds $<ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" scale="0" unitRef="usdPershares" id="ixv-40235">18.00</ix:nonFraction> per share for any <ix:nonNumeric contextRef="c135" format="ixt-sec:durday" name="ck0001859807:CommonStockThresholdTradingDays" id="ixv-40236">20</ix:nonNumeric>
trading days within a <ix:nonNumeric contextRef="c135" format="ixt-sec:durday" name="ck0001859807:CommonStockThresholdConsecutiveTradingDays" id="ixv-40237">30</ix:nonNumeric>-trading day period ending on the third trading day prior to the date on which the Company sends the notice of
redemption to the warrant holders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company calls the warrants
for redemption as described above, management will have the option to require all holders that wish to exercise warrants to do so on a
&#8220;cashless basis.&#8221; In determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221;
management will consider, among other factors, the Company&#8217;s cash position, the number of warrants that are outstanding and the
dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants.
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to
the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair
market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of the common stock for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" escape="true" name="ck0001859807:PrivatePlacementsTextBlock" id="ixv-31165"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;4 &#8212;&#160;Private Placement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor,&#160;I-Bankers
and Dawson James have purchased an aggregate of <ix:nonFraction contextRef="c593" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40238">7,347,500</ix:nonFraction> Private Placement Warrants (which included <ix:nonFraction contextRef="c610" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40239">697,500</ix:nonFraction> Private Placement Warrants
issued pursuant to the full exercise of the over-allotment option) at a price of $<ix:nonFraction contextRef="c593" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40240">1.00</ix:nonFraction> per warrant ($<ix:nonFraction contextRef="c611" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-40241">7,347,500</ix:nonFraction> in the aggregate) in a
private placement that closed simultaneously with the closing of the IPO.&#160;Of such amount, <ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40242">5,162,500</ix:nonFraction> Private Placement Warrants were
purchased by the Sponsor and <ix:nonFraction contextRef="c613" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40243">2,185,000</ix:nonFraction> Private Placement Warrants were purchased by&#160;I-Bankers and Dawson James.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Private Placement Warrants
are identical to the warrants included in the units sold in the IPO, except that the Private Placement Warrants: (i)&#160;will not be
redeemable by the Company and (ii)&#160;may be exercised for cash or on a cashless basis, in each case so long as they are held by the
initial purchasers or any of their permitted transferees. If the Private Placement Warrants are held by holders other than the initial
purchasers or any of their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by
the holders on the same basis as the warrants included in the Units&#160;being sold in the IPO.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c135_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-31176"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Founder Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2021, the Sponsor
paid $<ix:nonFraction contextRef="c614" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-40244">25,000</ix:nonFraction>, or approximately $<ix:nonFraction contextRef="c615" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40245">0.005</ix:nonFraction> per share, to cover certain of the offering costs in exchange for an aggregate of <ix:nonFraction contextRef="c614" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40246">5,175,000</ix:nonFraction> shares
of common stock, par value $<ix:nonFraction contextRef="c615" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40247">0.0001</ix:nonFraction> per share (the &#8220;Founder Shares&#8221;). In October&#160;2021, the Sponsor irrevocably surrendered
to the Company for cancellation and for no consideration <ix:nonFraction contextRef="c616" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-40248">862,500</ix:nonFraction> shares of common stock. On December&#160;20, 2021, the Company effected
a 1.<ix:nonNumeric contextRef="c617" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-40249">1-for-1 stock dividend of its common stock</ix:nonNumeric>, resulting in the Sponsor holding an aggregate of <ix:nonFraction contextRef="c618" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AggregateNumberOfSharesOwned" scale="0" unitRef="shares" id="ixv-40250">4,743,750</ix:nonFraction> shares of common stock. The
Founder Shares include an aggregate of up to <ix:nonFraction contextRef="c619" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" unitRef="shares" id="ixv-40251">618,750</ix:nonFraction> shares subject to forfeiture if the over-allotment option is not exercised by the
underwriters in full. On December&#160;22, 2021, the over-allotment option was fully exercised and such shares are no longer subject to
forfeiture.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 228; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c135_cont_2" id="_RelatedPartyTransactionsDisclosureTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor has agreed not
to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of the initial
Business Combination or (B)&#160;the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction
after the initial Business Combination that results in all of the Company&#8217;s public stockholders having the right to exchange their
shares of common stock for cash, securities or other property (the &#8220;Lock-up&#8221;). Notwithstanding the foregoing, if the last
sale price of the Company&#8217;s common stock equals or exceeds $<ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:CommonStockExceedsPerShare" scale="0" unitRef="usdPershares" id="ixv-40252">12.00</ix:nonFraction> per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any <ix:nonNumeric contextRef="c620" format="ixt-sec:durday" name="ck0001859807:NumberOfTradingDay" id="ixv-40253">20</ix:nonNumeric>&#160;trading days within any <ix:nonNumeric contextRef="c621" format="ixt-sec:durday" name="ck0001859807:NumberOfTradingDay" id="ixv-40254">30</ix:nonNumeric>-trading&#160;day period commencing at least 150&#160;days after
the initial Business Combination, the Founder Shares will be released from the Lock-up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Promissory Note&#160;&#8212;&#160;Related Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $<ix:nonFraction contextRef="c622" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleWorkingCapitalPromissoryNote" scale="0" unitRef="usd" id="ixv-40255">1,200,000</ix:nonFraction>. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $<ix:nonFraction contextRef="c623" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40256">1.00</ix:nonFraction> per warrant. On January&#160;10, 2024,
the Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $<ix:nonFraction contextRef="c554" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40257">1.5</ix:nonFraction>&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c554" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40258">2.22</ix:nonFraction> per share at the election of the sponsor. On May&#160;31,
2024, the Company&#8217;s Board of Directors approved and the Company entered into a second amendment of its Convertible Working Capital
Promissory Note with the sponsor to increase the principal amount of the Note that could be drawn on to $<ix:nonFraction contextRef="c555" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40259">2.5</ix:nonFraction>&#160;million. The second
amended and restated Note also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company
common stock at a price of $<ix:nonFraction contextRef="c555" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40260">2.22</ix:nonFraction>&#160;per share at the election of the sponsor. As of December 31, 2024, the Company had principal outstanding
of $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="0" unitRef="usd" id="ixv-40261">1,919,796</ix:nonFraction> and is presenting the Note at fair value on its balance sheet at December 31, 2024 in the amount of $<ix:nonFraction contextRef="c624" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40262">8,908,052</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Related Party Loans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended initial Business Combination, the initial stockholders or an affiliate of the initial stockholders
or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the
&#8220;Working Capital Loans&#8221;). If the Company completes the initial Business Combination, the Company would repay such loaned amounts
out of the proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside
the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital
held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned
amounts. Up to $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="0" unitRef="usd" id="ixv-40263">1,500,000</ix:nonFraction> of such loans may be convertible, at the option of the lender, into warrants at a price of $<ix:nonFraction contextRef="c625" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-40264">1.00</ix:nonFraction> per warrant
of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants, including as to exercise price,
exercisability and exercise period. At December&#160;31, 2024 and 2023, the Company had no borrowings under the Working Capital Loans,
other than the Note described in &#8220;Note&#160;5 &#8212;&#160;Related Party Transactions&#160;&#8212;&#160;Convertible Promissory Note&#160;&#8212;&#160;Related
Party&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Administrative Service Fee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing on the effective
date of the IPO, the Company began paying its Sponsor a total of $<ix:nonFraction contextRef="c626" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" scale="0" unitRef="usd" id="ixv-40265">5,000</ix:nonFraction>&#160;per month for office space, utilities, secretarial support
and other administrative and consulting services. As of June&#160;30, 2023, the Company and the Sponsor terminated this agreement. For
the year ended December 31, 2024, $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40266">0</ix:nonFraction> had been incurred and billed relating to the administrative service fee, respectively. For the year
ended December 31, 2023, $<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40267">30,000</ix:nonFraction> had been incurred and billed relating to the administrative service fee. As of December&#160;31, 2024
and 2023, $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" scale="0" unitRef="usd" id="ixv-40268"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" scale="0" unitRef="usd" id="ixv-40269">50,000</ix:nonFraction></ix:nonFraction> relating to the administrative service fee was not paid and recorded as due to related party.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 229; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advances from Profusa</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ending December
31, 2024, Profusa agreed to advance funds to the Company to pay for operating expenses. As of December 31, 2024, there was $<ix:nonFraction contextRef="c627" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" unitRef="usd" id="ixv-40270">791,407</ix:nonFraction> owed
to Profusa, which is due upon demand or at the completion of the Business Combination.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c135_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-31266"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Registration Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of the Founder
Shares, the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any underlying securities)
are entitled to registration rights pursuant to a registration rights agreement signed on the closing date of the IPO requiring the Company
to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration
rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective
until termination of the applicable Lock-up&#160;period described in Note&#160;5. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Underwriters Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters had a <ix:nonNumeric contextRef="c135" format="ixt-sec:durday" name="ck0001859807:NumberOfDaysForUnderwriterOptions" id="ixv-40271">30</ix:nonNumeric>-day&#160;option
from the date of IPO to purchase up to an additional&#160;<ix:nonFraction contextRef="c552" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40272">2,475,000</ix:nonFraction>&#160;units to cover over-allotments, if any. On December&#160;22,
2021, the over-allotment was fully exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters received a
cash underwriting discount of approximately&#160;<ix:nonFraction contextRef="c550" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:UnderwritingExpenseRatio" scale="-2" unitRef="pure" id="ixv-40273">1.82</ix:nonFraction>% of the gross proceeds of the IPO, or $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnderwritingDiscountAmount" scale="0" unitRef="usd" id="ixv-40274">3,450,000</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Business Combination Marketing Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under a Business Combination
marketing agreement, the Company engaged&#160;I-Bankers and Dawson James as advisors in connection with the Business Combination to assist
the Company in holding meetings with the stockholders to discuss the potential Business Combination and the target business&#8217;s attributes,
introduce the Company to potential investors that are interested in purchasing the Company&#8217;s securities in connection with the potential
Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company was obligated to pay&#160;I-Bankers and Dawson
James a cash fee for such marketing services upon the consummation of the initial Business Combination in an amount of&#160;<ix:nonFraction contextRef="c139" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:InitialPublicOfferingGrossProceedPercentage" scale="-2" unitRef="pure" id="ixv-40275">3.68</ix:nonFraction>% of the
gross proceeds of the IPO, or $<ix:nonFraction contextRef="c628" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40276">6,986,250</ix:nonFraction>. The agreement was amended on November&#160;7, 2022 to allow for the <ix:nonFraction contextRef="c629" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:BusinessCombinationPercentageRate" scale="-2" unitRef="pure" id="ixv-40277">3.68</ix:nonFraction>% business combination
fee to be paid as (a)&#160;<ix:nonFraction contextRef="c629" decimals="3" format="ixt:num-dot-decimal" name="ck0001859807:CashPercentage" scale="-2" unitRef="pure" id="ixv-40278">27.5</ix:nonFraction>% cash and (b)&#160;<ix:nonFraction contextRef="c629" decimals="3" format="ixt:num-dot-decimal" name="ck0001859807:EquityPercentage" scale="-2" unitRef="pure" id="ixv-40279">72.5</ix:nonFraction>% to be rolled into equity at closing. Subsequently, on January 19, 2025, the agreement
was modified by the parties such that the Company will be required to pay $<ix:nonFraction contextRef="c630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherCommitmentDueInSecondAndThirdYear" scale="0" unitRef="usd" id="ixv-40280">2,000,000</ix:nonFraction>, payable in cash, if a business combination is consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Representative&#8217;s Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company issued&#160;<ix:nonFraction contextRef="c631" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares" id="ixv-40281">450,000</ix:nonFraction>&#160;shares (Representative Shares) of common stock (which included&#160;<ix:nonFraction contextRef="c632" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares" id="ixv-40282">37,500</ix:nonFraction>&#160;Representative Shares
issued pursuant to the full exercise of the over-allotment option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James
(and/or their designees).&#160;I-Bankers&#160;and Dawson James (and/or their designees) have agreed not to transfer, assign or sell any
such shares until the completion of the initial Business Combination. In addition,&#160;I-Bankers&#160;and Dawson James (and/or their
designees) have agreed (i)&#160;to waive their redemption rights with respect to such shares in connection with the completion of the
initial Business Combination and (ii)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to
such shares if the Company fails to complete its initial Business Combination within the Combination Period. The fair value of the Representative&#8217;s
Shares issued are recognized as&#160;offering costs directly attributable to the issuance of an equity contract to be classified in equity
and are recorded as a reduction of equity (see Note&#160;1).</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 230; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c135_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Representative&#8217;s Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company granted to&#160;I-Bankers&#160;and
Dawson James (and/or their designees)&#160;<ix:nonFraction contextRef="c633" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40283">569,250</ix:nonFraction>&#160;warrants (which included&#160;<ix:nonFraction contextRef="c546" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40284">74,250</ix:nonFraction>&#160;warrants issued pursuant to the full
exercise of the over-allotment option) exercisable at $<ix:nonFraction contextRef="c594" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40285">11.50</ix:nonFraction>&#160;per share (or an aggregate exercise price of $<ix:nonFraction contextRef="c619" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-40286">6,546,375</ix:nonFraction>) at the closing
of the IPO.&#160;The Representative Warrants issued are recognized as derivative liabilities in accordance with ASC&#160;815-40 and recorded
as liabilities at fair value each reporting period (see Notes 1 and 8). The warrants may be exercised for cash or on a cashless basis,
at the holder&#8217;s option, at any time during the period commencing on the later of the first anniversary of the effective date of
the registration statement of which the IPO forms a part and the closing of the initial Business Combination and terminating on the fifth
anniversary of such effectiveness date. Notwithstanding anything to the contrary,&#160;I-Bankers&#160;and Dawson James have agreed that
neither they nor their designees will be permitted to exercise the warrants after the&#160;<ix:nonNumeric contextRef="c139" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="ixv-40287">five year</ix:nonNumeric>&#160;anniversary of the effective
date of the registration statement of which the IPO forms a part. The warrants and such shares purchased pursuant to the warrants have
been deemed compensation by FINRA and are therefore subject to a lock-up&#160;for a period of <ix:nonNumeric contextRef="c135" format="ixt-sec:durwordsen" name="ck0001859807:LockupPeriod" id="ixv-40288">180&#160;days</ix:nonNumeric> immediately following the
date of the effectiveness of the registration statement of which the IPO forms a part pursuant to FINRA Rule&#160;5110I(1). Pursuant to
FINRA Rule&#160;5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the economic disposition of the securities by any person for a period of 180&#160;days immediately following the effective
date of the registration statement of which the IPO forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated
for a period of 180&#160;days immediately following the effective date of the registration statement of which the IPO forms a part except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The warrants grant to holders
demand and &#8220;piggy back&#8221; rights for periods of five and seven&#160;years, respectively, from the effective date of the registration
statement of which the IPO forms a part with respect to the registration under the Securities Act&#160;of&#160;the shares issuable upon
exercise of the warrants. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting
commissions, which will be paid for by the holders themselves. The exercise price and number of shares issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a share dividend, or the Company&#8217;s recapitalization, reorganization,
merger or consolidation. However, the warrants will not be adjusted for issuances of shares at a price below its exercise price. The Company
will have no obligation to net cash settle the exercise of the warrants. The holder of the warrants will not be entitled to exercise the
warrants for cash unless a registration statement covering the securities underlying the warrants is effective or an exemption from registration
is available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Merger Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, NorthView
entered into a Merger Agreement and Plan of Reorganization (the &#8220;Merger Agreement&#8221;), by and among Merger Sub., and Profusa,
Inc., a California corporation (&#8220;Profusa&#8221;). The Merger Agreement provides that, among other things, at the closing of the
transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Profusa (the &#8220;Merger&#8221;), with Profusa
surviving as a wholly-owned subsidiary of NorthView. In connection with the Merger, NorthView will change its name to &#8220;Profusa,
Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Business Combination is
subject to customary closing conditions, including the satisfaction of the minimum available cash condition of $<ix:nonFraction contextRef="c634" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd" id="ixv-40289">15,000,000</ix:nonFraction>, the receipt
of certain governmental approvals and the required approval by the stockholders of NorthView and Profusa. There is no assurance that the
Business Combination will be completed.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 231; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advisory Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 19, 2024, the Company
engaged A.G.P to serve as the placement agent in connection with a proposed business combination transaction. The Company shall pay to
A.G.P. a cash fee (the &#8220;Cash Fee&#8221;) equal to <ix:nonFraction contextRef="c635" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" scale="-2" unitRef="pure" id="ixv-40290">9.0</ix:nonFraction>% in a convertible note offering, note, or other similar equity-linked offerings,
and shall be calculated from the face value of notes issued, which is payable at the close of a Business Combination. If the Business
Combination does not successfully close, A.G.P. will not be entitled to any cash fee.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-31372"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;7 &#8212;&#160;Stockholders&#8217; Deficit</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Preferred stock</i></b>&#160;&#8212;&#160;The
Company is authorized to issue&#160;<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40291">1,000,000</ix:nonFraction>&#160;shares of preferred stock with a par value of $<ix:nonFraction contextRef="c139" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40292">0.0001</ix:nonFraction>&#160;and with such designations,
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.&#160;As of December&#160;31,
2024 and 2023, there was <span style="-sec-ix-hidden: hidden-fact-358"><span style="-sec-ix-hidden: hidden-fact-359"><span style="-sec-ix-hidden: hidden-fact-360"><span style="-sec-ix-hidden: hidden-fact-361">no</span></span></span></span> preferred stock issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Common Stock&#160;</i></b>&#8212;&#160;The
Company is authorized to issue a total of&#160;<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40293">100,000,000</ix:nonFraction>&#160;shares of common stock at par value of $<ix:nonFraction contextRef="c139" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40294">0.0001</ix:nonFraction>&#160;each. In April&#160;2021,
the Company issued&#160;<ix:nonFraction contextRef="c636" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40295">5,175,000</ix:nonFraction>&#160;shares of common stock to its Sponsor for $<ix:nonFraction contextRef="c637" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-40296">25,000</ix:nonFraction>, or approximately $<ix:nonFraction contextRef="c638" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40297">0.005</ix:nonFraction>&#160;per share. In October&#160;2021,
the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration&#160;<ix:nonFraction contextRef="c639" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-40298">862,500</ix:nonFraction>&#160;shares of common stock.&#160;On
December&#160;20, 2021,&#160;the Company effected a 1.<ix:nonNumeric contextRef="c640" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-40299">1-for-1&#160;stock dividend of its common stock</ix:nonNumeric>, resulting in an aggregate of <ix:nonFraction contextRef="c641" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:FounderSharesIssued" scale="0" unitRef="shares" id="ixv-40300">4,743,750</ix:nonFraction>
Founder Shares issued&#160;and outstanding.&#160;On December&#160;22, 2021, the Company has also issued&#160;<ix:nonFraction contextRef="c538" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40301">450,000</ix:nonFraction>&#160;shares (Representative&#8217;s
Shares) of common stock (which included&#160;<ix:nonFraction contextRef="c537" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-40302">37,500</ix:nonFraction>&#160;Representative Shares issued pursuant to the full exercise of the over-allotment
option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James (and/or their designees).&#160;As of December&#160;31,
2024 and 2023, there were&#160;<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-40303"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-40304"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40305"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40306">5,193,750</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of common stock issued and outstanding, excluding&#160;<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40307">687,519</ix:nonFraction> and <ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40308">833,469</ix:nonFraction> shares of common
stock subject to redemption, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Common stockholders of record
are entitled to <ix:nonNumeric contextRef="c135" name="us-gaap:CommonStockVotingRights" id="ixv-40309">one</ix:nonNumeric> vote for each share held on all matters to be voted on by stockholders. Unless specified in the Company&#8217;s amended
and restated certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange
rules, the affirmative vote of a majority of the Company&#8217;s common stock that are voted is required to approve any such matter voted
on by the stockholders. There is no cumulative voting with respect to the election of directors, with the result that the holders of more
than&#160;<ix:nonFraction contextRef="c139" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:VotingSharesPercentage" scale="-2" unitRef="pure" id="ixv-40310">50</ix:nonFraction>% of the shares voted for the election of directors can elect all of the directors (prior to consummation of the initial Business
Combination). The Company&#8217;s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors
out of funds legally available therefor.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="_FairValueDisclosuresTextBlock-c135_cont_1" escape="true" name="us-gaap:FairValueDisclosuresTextBlock" id="ixv-31397"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Fair value is defined as the
price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants
at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). The Company&#8217;s financial instruments are classified as either
Level 1, Level 2 or Level 3. These tiers include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in
active markets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly
observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets
that are not active; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring
an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs
or significant value drivers are unobservable.</td></tr></table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 232; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c135_cont_2" id="_FairValueDisclosuresTextBlock-c135_cont_1"><ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="ixv-31448"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables present
information about the Company&#8217;s assets and liabilities that are measured at fair value on December&#160;31, 2024 and 2023, and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted <br/> Prices In<br/> Active <br/> Markets <br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Observable <br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Unobservable <br/> Inputs <br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash and marketable securities held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c643" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40311">8,330,835</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c644" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40312">8,330,835</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c647" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40313">379,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c649" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40314">379,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c651" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40315">293,900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c654" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40316">293,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c655" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40317">22,770</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c658" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40318">22,770</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c659" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40319">8,908,052</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40320">8,908,052</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-40321">9,604,222</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c664" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-40322">379,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c665" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-40323">9,224,722</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active <br/> Markets <br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Observable <br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Unobservable <br/> Inputs <br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash and marketable securities held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40324">10,873,406</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c667" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-40325">10,873,406</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c670" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40326">85,388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c671" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40327">85,388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c674" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40328">66,128</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c677" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40329">66,128</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c678" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40330">5,123</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c681" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40331">5,123</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c682" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40332">944,118</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c685" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40333">944,118</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-40334">1,100,757</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-40335">85,388</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c688" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-40336">1,015,369</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Public Warrants, the Private
Placement Warrants and the Representative&#8217;s Warrants were accounted for as liabilities in accordance with ASC&#160;815-40 and are
presented within liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on
a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilized a Monte
Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants at December
31, 2024 was classified as Level 2 due to the lack of an active market. At December&#160;31, 2023, the Public Warrants was classified
as Level 1 due to the use of an observable market quote in an active market. As of December&#160;31, 2024 and 2023, the aggregate value
of Public Warrants was $<ix:nonFraction contextRef="c607" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40337">379,500</ix:nonFraction> and $<ix:nonFraction contextRef="c642" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40338">85,388</ix:nonFraction>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company uses a Monte Carlo
simulation model to value the Private Placement Warrants and the Representative&#8217;s Warrants. The Private Placement Warrants and the
Representative&#8217;s Warrants were classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent
in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates
the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 233; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c135_cont_3" id="_FairValueDisclosuresTextBlock-c135_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The risk-free interest rate
is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of
the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="ixv-31845"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at December&#160;31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, <br/> 2023</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c689" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40339">4.18</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c690" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40340">5.06</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c691" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40341">0.89</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c692" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40342">0.71</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">De&#160;minimis </div></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c695" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40343">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c696" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40344">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c697" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40345">12.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c698" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-40346">11.16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at December&#160;31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, <br/> 2023</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c689" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40347">4.18</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c690" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40348">5.48</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c691" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40349">0.27</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c692" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40350">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c695" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40351">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c696" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40352">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c697" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40353">12.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c698" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-40354">11.16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="ixv-31996"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the years ended December 31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c699" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40355">66,128</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c700" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40356">5,123</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c701" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40357">71,251</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c611" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40358">227,772</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c702" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40359">17,647</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c703" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40360">245,419</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c593" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40361">293,900</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c704" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40362">22,770</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c705" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40363">316,670</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c706" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40364">377,857</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c707" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40365">29,274</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c708" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40366">407,131</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c709" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-40367">311,729</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c710" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-40368">24,151</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c711" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-40369">335,880</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c699" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40370">66,128</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c700" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40371">5,123</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c701" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40372">71,251</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c135" continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c135_cont_1" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="ixv-32117"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Promissory <br/> Note</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c712" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40373">944,118</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Principal borrowing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c713" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PrincipalBorrowing" scale="0" unitRef="usd" id="ixv-40374">797,981</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c713" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" unitRef="usd" id="ixv-40375">7,165,953</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December&#160;31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c714" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40376">8,908,052</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 234; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_FairValueDisclosuresTextBlock-c135_cont_3"><ix:continuation id="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c135_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Promissory <br/> Note</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value at December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Principal borrowing</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c716" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PrincipalBorrowing" scale="0" unitRef="usd" id="ixv-40377">1,121,815</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c716" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" sign="-" unitRef="usd" id="ixv-40378">177,697</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c712" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40379">944,118</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The convertible promissory
note was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent in pricing models are assumptions
related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common
stock based on historical volatility that matches the expected remaining life of the note. The risk-free interest rate is based on the
U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the note. The expected
life of the note is assumed to be equivalent to their remaining contractual term.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="_IncomeTaxDisclosureTextBlock-c135_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-32221"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;9 &#8212;&#160;Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ixv-32225"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s net deferred
tax assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Deferred tax asset/(liability)</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Organizational costs/Startup expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-40380">694,480</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-40381">436,196</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Unrealized gain/loss&#160;&#8211;&#160;Trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" scale="0" unitRef="usd" id="ixv-40382">13,661</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="usd" id="ixv-40383">694,480</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="usd" id="ixv-40384">422,535</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-40385">694,480</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-40386">436,196</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Deferred tax (liability), net of allowance</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" unitRef="usd" id="ixv-40387">13,661</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="ixv-32300"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The income tax provision consists
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Federal</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40388">94,174</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40389">480,069</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd" id="ixv-40390">271,945</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="usd" id="ixv-40391">226,991</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-40392">258,284</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-40393">203,712</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40394">80,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40395">456,790</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the Company had $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-40396"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-40397">0</ix:nonFraction></ix:nonFraction> in U.S.&#160;federal net operating loss carryovers available to offset future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In assessing the realization
of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets
will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during
the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration
of all of the information available, management believes that significant uncertainty exists with respect to future realization of the
deferred tax assets and has therefore established a full valuation allowance. For the&#160;years ended December&#160;31, 2024 and 2023,
the change in the valuation allowance was $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-40398">258,284</ix:nonFraction> and $<ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-40399">203,712</ix:nonFraction>.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 235; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Income Taxes</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c135_cont_1"><ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-32418"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A reconciliation of the federal
income tax rate to the Company&#8217;s effective tax rate is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c135" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-40400">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c127" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-40401">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prior Year Trueup</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" unitRef="pure" id="ixv-40402">0.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" unitRef="pure" id="ixv-40403">0.00</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" sign="-" unitRef="pure" id="ixv-40404">18.7</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c127" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" sign="-" unitRef="pure" id="ixv-40405">11.4</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Business combination expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" unitRef="pure" id="ixv-40406">0.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" unitRef="pure" id="ixv-40407">5.8</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Penalties and interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" scale="-2" unitRef="pure" id="ixv-40408">0.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="3" format="ixt:num-dot-decimal" name="ck0001859807:EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" scale="-2" unitRef="pure" id="ixv-40409">0.2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c135" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" sign="-" unitRef="pure" id="ixv-40410">3.0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c127" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="pure" id="ixv-40411">12.6</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c135" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" sign="-" unitRef="pure" id="ixv-40412">0.90</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c127" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-40413">28.2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company files income tax
returns in the U.S.&#160;federal, New&#160;York and New&#160;York City jurisdictions and is subject to examination by the various taxing
authorities since inception.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" continuedAt="_SegmentReportingDisclosureTextBlock-c135_cont_1" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock" id="ixv-32508"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;10 &#8212;&#160;Segment Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC Topic 280, &#8220;Segment
Reporting,&#8221; establishes standards for companies to report in their financial statement information about operating segments, products,
services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business
activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is
regularly evaluated by the Company&#8217;s chief operating decision maker, or group, in deciding how to allocate resources and assess
performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s chief operating
decision maker (&#8220;CODM&#8221;) has been identified as its Chief Financial Officer, who reviews the assets, operating results, and
financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that there is only <ix:nonFraction contextRef="c135" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" unitRef="pure" id="ixv-40414">one</ix:nonFraction> reportable segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The CODM assesses performance
for the single segment and decides how to allocate resources based on net loss that also is reported on the statement of operations as
net loss. The measure of segment assets is reported on the balance sheet as total assets. <ix:nonNumeric contextRef="c135" continuedAt="_ScheduleOfCondensedIncomeStatementTableTextBlock-c135_cont_1" escape="true" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock" id="ixv-40415">When evaluating the Company&#8217;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net (loss) income and total assets,
which include the following:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ScheduleOfCondensedIncomeStatementTableTextBlock-c135_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c717" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-40416">8,330,835</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c718" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-40417">10,873,406</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c717" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd" id="ixv-40418">16,204</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c718" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd" id="ixv-40419">4,519</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General and administrative expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c719" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40420">1,351,038</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c720" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40421">1,508,683</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest earned on the Trust Account</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c719" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40422">425,416</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c720" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40423">2,248,538</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 236; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;10 &#8212;&#160;Segment Information</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_SegmentReportingDisclosureTextBlock-c135_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key measures of segment
profit or loss reviewed by our CODM are interest earned on the Trust Account and general and administrative expenses. The CODM reviews
interest earned on the Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment
with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and
monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the
business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c135" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-32622"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11 &#8212; Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued.
Based on the Company&#8217;s review, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the consolidated financial statements other than as previously disclosed, and as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 11, 2025, the Company
entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an institutional investor (the &#8220;Investor&#8221;). Pursuant
to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth in the SPA, to purchase from the Company
senior secured convertible promissory notes in an aggregate principal amount of up to $<ix:nonFraction contextRef="c721" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40424">22,222,222</ix:nonFraction> (the &#8220;Convertible Notes&#8221;)
for a purchase price of up to $<ix:nonFraction contextRef="c722" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40425">20,000,000</ix:nonFraction>, after a <ix:nonFraction contextRef="c723" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfOriginalIssueDiscount" scale="-2" unitRef="pure" id="ixv-40426">10</ix:nonFraction>% original issue discount (&#8220;OID&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 21, 2025, the Sponsor
and its designees have now agreed to contribute an amount (the &#8220;Revised Contribution Amount&#8221;) equal to $<ix:nonFraction contextRef="c724" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiability" scale="0" unitRef="usd" id="ixv-40427">30,000</ix:nonFraction> for the entire
Extension Period. All funds in the Company&#8217;s trust account, including those funds deposited in connection with the Revised Contribution
Amount, will be held in an interest-bearing demand deposit account at a bank until the earlier of the consummation of the Company&#8217;s
initial business combination or liquidation. The Revised Contribution Amount will be deposited in the Company&#8217;s trust account promptly
at the beginning of the Extension Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company announced that
is has agreed to waive its right to withdraw up to $<ix:nonFraction contextRef="c725" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="0" unitRef="usd" id="ixv-40428">100,000</ix:nonFraction> of interest from the Company&#8217;s trust account to pay dissolution expenses,
should the Company ultimately liquidate prior to a business combination (the &#8220;Dissolution Expense Waiver&#8221;). As a result, the
Company will not be able to withdraw up to $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="0" unitRef="usd" id="ixv-40429">100,000</ix:nonFraction> of interest for such dissolution expenses upon liquidation, and such interest will
be held in the trust account and no be released until the earliest to occur of (i) the completion of the initial business combination,
(ii) the redemption of <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfNonRedeemingPublicShareholders" scale="-2" unitRef="pure" id="ixv-40430">100</ix:nonFraction>% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination
within the Extension, and (iii) the redemption of Public Shares in connection with a vote seeking to amend the provisions of our Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also announced
that is has agreed to waive its right to withdraw interest from the Company&#8217;s trust account to pay the Company&#8217;s tax expenses
(the &#8220;Tax Expense Waiver&#8221;). As a result, the Company will not be able to withdraw interest in order to pay future tax expenses,
and such interest will be held in the trust account and not be released until the earliest to occur of (i) the completion of the initial
business combination, (ii) the redemption of <ix:nonFraction contextRef="c726" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfNonRedeemingPublicShareholders" scale="-2" unitRef="pure" id="ixv-40431">100</ix:nonFraction>% of the Offering Shares (as defined below) if the Company is unable to complete its initial
Business Combination within the Extension, and (iii) the redemption of Public Shares in connection with a vote seeking to amend the provisions
of our Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to such announcement,
and subsequent to the record date of February 21, 2025, for the Special Meeting, the Company withdrew approximately $<ix:nonFraction contextRef="c727" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="0" unitRef="usd" id="ixv-40432">23,400</ix:nonFraction> of interest
from the trust account for tax expenses.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 237; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
CONDENSED CONSOLIDATED BALANCE SHEETS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June&#160;30,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December
    31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>(Unaudited)</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-40433">16,204</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd" id="ixv-40434">1,751</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Cash held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="0" unitRef="usd" id="ixv-40435">661,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-40436">14,166</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidTaxes" scale="0" unitRef="usd" id="ixv-40437">9,504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidTaxes" scale="0" unitRef="usd" id="ixv-40438">30,492</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Prepaid franchise tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PrepaidFranchiseTax" scale="0" unitRef="usd" id="ixv-40439">15,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total Current Assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd" id="ixv-40440">687,867</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd" id="ixv-40441">60,862</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-40442">1,274,549</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-40443">8,330,835</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd" id="ixv-40444">1,962,416</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd" id="ixv-40445">8,391,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Liabilities, Redeemable Common Stock and Stockholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40446">1,744,538</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40447">684,483</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Advance from Profusa</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AdvanceFromProfusa" scale="0" unitRef="usd" id="ixv-40448">1,299,040</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AdvanceFromProfusa" scale="0" unitRef="usd" id="ixv-40449">791,407</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Excise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-40450">1,952,662</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-40451">1,880,944</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Convertible promissory note&#160;&#8211;&#160;related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40452">10,288,111</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40453">8,908,052</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Securities purchase agreement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:SecuritiesPurchaseAgreementCurrent" scale="0" unitRef="usd" id="ixv-40454">193,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Due to redeeming stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonRedemptionValue" scale="0" unitRef="usd" id="ixv-40455">661,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Due to related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40456">41,180</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40457">50,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total Current Liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40458">16,180,421</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40459">12,314,886</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40460">6,961,700</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-40461">696,170</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Liabilities</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-40462">23,142,121</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-40463">13,011,056</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Commitments and Contingencies (Note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Common stock subject to possible redemption,&#160;<ix:nonFraction contextRef="c21" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40464">101,777</ix:nonFraction> and <ix:nonFraction contextRef="c18" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40465">687,519</ix:nonFraction> shares at redemption value of approximately $<ix:nonFraction contextRef="c21" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40466">13.07</ix:nonFraction> and $<ix:nonFraction contextRef="c18" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40467">12.13</ix:nonFraction> at June&#160;30, 2025 and December&#160;31, 2024, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40468">1,330,515</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40469">8,337,388</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; Deficit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Preferred stock, $<ix:nonFraction contextRef="c20" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40470"><ix:nonFraction contextRef="c16" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40471">0.0001</ix:nonFraction></ix:nonFraction>&#160;par value;&#160;<ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40472"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40473">1,000,000</ix:nonFraction></ix:nonFraction>&#160;shares authorized;&#160;<span style="-sec-ix-hidden: hidden-fact-39"><span style="-sec-ix-hidden: hidden-fact-40"><span style="-sec-ix-hidden: hidden-fact-41"><span style="-sec-ix-hidden: hidden-fact-42">none</span></span></span></span>&#160;issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Common stock, $<ix:nonFraction contextRef="c20" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40474"><ix:nonFraction contextRef="c16" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40475">0.0001</ix:nonFraction></ix:nonFraction>&#160;par value;&#160;<ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40476"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40477">100,000,000</ix:nonFraction></ix:nonFraction>&#160;shares authorized; <ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-40478"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-40479"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40480"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40481">5,193,750</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;shares issued and outstanding at June&#160;30, 2025 and December&#160;31, 2024 (excluding 101,777 and 687,519 shares subject to possible redemption at June&#160;30, 2025 and December&#160;31, 2024, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd" id="ixv-40482">519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd" id="ixv-40483">519</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-40484">22,510,739</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-40485">12,957,266</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Stockholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40486">22,510,220</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40487">12,956,747</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Liabilities, Redeemable Common Stock and Stockholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd" id="ixv-40488">1,962,416</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd" id="ixv-40489">8,391,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
the unaudited condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 238; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Three&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Six&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Formation and operating costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-40490">967,084</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-40491">253,130</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-40492">1,550,665</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd" id="ixv-40493">723,971</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40494">967,084</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40495">253,130</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40496">1,550,665</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40497">723,971</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other (expense) income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Interest income earned on cash held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40498">15,159</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40499">108,520</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40500">95,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40501">225,184</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Change in fair value of convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertibleNote" scale="0" unitRef="usd" id="ixv-40502">1,154,729</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertibleNote" scale="0" sign="-" unitRef="usd" id="ixv-40503">66,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertibleNote" scale="0" unitRef="usd" id="ixv-40504">1,380,059</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertibleNote" scale="0" sign="-" unitRef="usd" id="ixv-40505">126,098</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Change in fair value of securities purchase agreement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement" scale="0" unitRef="usd" id="ixv-40506">170,391</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement" scale="0" unitRef="usd" id="ixv-40507">193,878</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40508">5,917,445</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40509">295,872</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40510">6,265,530</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40511">800,595</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-40512">7,227,406</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-40513">121,331</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-40514">7,744,383</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-40515">449,313</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before provision for income tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-40516">8,194,490</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-40517">374,461</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-40518">9,295,048</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-40519">1,173,284</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Income tax provision</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40520">2,386</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40521">23,026</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40522">21,738</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd" id="ixv-40523">44,480</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Net loss</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40524">8,196,876</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40525">397,487</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40526">9,316,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40527">1,217,764</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Basic and diluted weighted average shares outstanding, common stock subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c35" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40528"><ix:nonFraction contextRef="c35" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40529">146,440</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c36" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40530"><ix:nonFraction contextRef="c36" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40531">738,075</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c37" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40532"><ix:nonFraction contextRef="c37" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40533">412,717</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c38" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40534"><ix:nonFraction contextRef="c38" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40535">783,151</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Basic and diluted net loss per share, common stock subject to possible redemption</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c35" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40536"><ix:nonFraction contextRef="c35" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40537">1.53</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c36" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40538"><ix:nonFraction contextRef="c36" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40539">0.07</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c37" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40540"><ix:nonFraction contextRef="c37" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40541">1.66</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40542"><ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40543">0.20</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Basic and diluted weighted average shares outstanding, common stock</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40544"><ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40545">5,193,750</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c32" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40546"><ix:nonFraction contextRef="c32" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40547">5,193,750</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40548"><ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40549">5,193,750</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c34" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-40550"><ix:nonFraction contextRef="c34" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40551">5,193,750</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Basic and diluted net loss per share, common stock</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c31" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40552"><ix:nonFraction contextRef="c31" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40553">1.53</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c32" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40554"><ix:nonFraction contextRef="c32" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40555">0.07</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c33" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40556"><ix:nonFraction contextRef="c33" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40557">1.66</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40558"><ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40559">0.20</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
the unaudited condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 239; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30,
2025</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="font-style: normal; vertical-align: bottom; font-weight: normal">
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="font-style: normal; border-bottom: Black 1.5pt solid; text-align: center; font-weight: normal"><b>Common stock</b></td>
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-style: normal; text-align: center; padding-bottom: 1.5pt; font-weight: normal"><b>Additional<br/>

    Paid-In</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td colspan="2" style="font-style: normal; font-weight: normal"><b>Accumulated</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td colspan="2" style="font-style: normal; text-align: center; padding-bottom: 1.5pt; font-weight: normal"><b>Total<br/>
    Stockholder&#8217;</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Capital</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Deficit</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Deficit</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; font-weight: bold">Balance as of December&#160;31, 2024</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c136" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40560">5,193,750</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td>
    <td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c136" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40561">519</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td>
    <td style="width: 7%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8239;&#8212;</div></td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td>
    <td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40562">12,957,266</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">)</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td>
    <td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40563">12,956,747</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accretion of common stock to redemption value</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c142" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40564">155,999</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40565">155,999</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Excise tax payable attributable to redemption of common stock</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c142" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40566">65,108</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40567">65,108</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c142" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40568">1,119,910</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40569">1,119,910</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><b>Balance as of March&#160;31, 2025 (unaudited)</b></td>
    <td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c144" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40570">5,193,750</ix:nonFraction></b></td>
    <td style="font-weight: bold; text-align: left"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b><ix:nonFraction contextRef="c144" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40571">519</ix:nonFraction></b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-145">&#8212;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b>(<ix:nonFraction contextRef="c146" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40572">14,298,283</ix:nonFraction></b></td>
    <td style="text-align: left"><b>)</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b>(<ix:nonFraction contextRef="c147" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40573">14,297,764</ix:nonFraction></b></td>
    <td style="text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accretion of common stock to redemption value</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40574">8,970</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40575">8,970</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Excise tax payable attributable to redemption of common stock</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40576">6,610</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40577">6,610</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40578">8,196,876</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40579">8,196,876</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Balance as of June&#160;30, 2025 (unaudited)</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c152" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40580">5,193,750</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40581">519</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">&#8212;</div></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c154" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40582">22,510,739</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40583">22,510,220</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30,
2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="font-style: normal; vertical-align: bottom; font-weight: normal">
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="font-style: normal; border-bottom: Black 1.5pt solid; text-align: center; font-weight: normal"><b>Common stock</b></td>
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-style: normal; text-align: center; font-weight: normal"><b>Additional<br/> Paid-In</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td colspan="2" style="font-style: normal; font-weight: normal"><b>Accumulated</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; font-weight: normal"><b>&#160;</b></td>
    <td colspan="2" style="font-style: normal; text-align: center; font-weight: normal"><b>Total<br/>
    Stockholders&#8217;</b></td>
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Capital</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Deficit</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Deficit</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; font-weight: bold">Balance as of December&#160;31, 2023</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c128" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40584">5,193,750</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td>
    <td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40585">519</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-153">&#8212;</div></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td>
    <td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40586">3,459,829</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">)</td>
    <td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td>
    <td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40587">3,459,310</ix:nonFraction></td>
    <td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accretion of common stock to redemption value</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-154">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-155">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c158" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40588">205,732</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c159" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40589">205,732</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Excise tax payable attributable to redemption of common stock</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c158" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40590">10,884</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c159" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" scale="0" sign="-" unitRef="usd" id="ixv-40591">10,884</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c158" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40592">820,277</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c159" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40593">820,277</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><b>Balance as of March&#160;31, 2024 (unaudited)</b></td>
    <td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c160" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40594">5,193,750</ix:nonFraction></b></td>
    <td style="font-weight: bold; text-align: left"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b><ix:nonFraction contextRef="c160" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40595">519</ix:nonFraction></b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-160">&#8212;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b>(<ix:nonFraction contextRef="c162" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40596">4,496,722</ix:nonFraction></b></td>
    <td style="text-align: left"><b>)</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="text-align: right"><b>(<ix:nonFraction contextRef="c163" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40597">4,496,203</ix:nonFraction></b></td>
    <td style="text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accretion of common stock to redemption value</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">&#8212;</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c166" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40598">181,330</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40599">181,330</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c166" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40600">397,487</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-40601">397,487</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 4pt">Balance as of June&#160;30, 2024 (unaudited)</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c168" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-40602">5,193,750</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c168" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-40603">519</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">&#8212;</div></td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c170" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40604">5,075,539</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td>
    <td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c171" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-40605">5,075,020</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
the unaudited condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 240; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Six&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cash flows from operating activities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40606">9,316,786</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-40607">1,217,764</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Interest income on cash held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40608">95,084</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd" id="ixv-40609">225,184</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40610">6,265,530</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-40611">800,595</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Changes in fair value of convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" unitRef="usd" id="ixv-40612">1,380,059</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" sign="-" unitRef="usd" id="ixv-40613">126,098</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Changes in fair value of securities purchase agreement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangesInFairValueOfSecuritiesPurchaseAgreement" scale="0" unitRef="usd" id="ixv-40614">193,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.375in; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" sign="-" unitRef="usd" id="ixv-40615">14,166</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" unitRef="usd" id="ixv-40616">33,750</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd" id="ixv-40617">1,060,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd" id="ixv-40618">255,717</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.375in; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" sign="-" unitRef="usd" id="ixv-40619">49,061</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="0" sign="-" unitRef="usd" id="ixv-40620">20,988</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="0" unitRef="usd" id="ixv-40621">66,525</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.375in; text-align: left">Prepaid franchise taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:IncreaseDecreaseInPrepaidFranchiseTaxes" scale="0" unitRef="usd" id="ixv-40622">15,600</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-align: left">Due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="0" sign="-" unitRef="usd" id="ixv-40623">8,820</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.375in; text-align: left; padding-bottom: 1.5pt">Deferred tax liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="0" unitRef="usd" id="ixv-40624">13,661</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left">Net cash used in operating activities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40625">501,614</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40626">675,731</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Payment of extension fee into Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfExtensionFeeIntoTrustAccount" scale="0" unitRef="usd" id="ixv-40627">99,285</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentOfExtensionFeeIntoTrustAccount" scale="0" unitRef="usd" id="ixv-40628">235,733</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash withdrawn from Trust Account in connection with redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption" scale="0" unitRef="usd" id="ixv-40629">6,510,830</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption" scale="0" unitRef="usd" id="ixv-40630">2,653,439</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Reimbursement of franchise and income taxes from Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDecommissioningFund" scale="0" unitRef="usd" id="ixv-40631">78,813</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDecommissioningFund" scale="0" unitRef="usd" id="ixv-40632">204,460</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left">Net cash provided by investing activities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" unitRef="usd" id="ixv-40633">6,490,358</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" unitRef="usd" id="ixv-40634">2,622,166</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" unitRef="usd" id="ixv-40635">708,981</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advance from Profusa</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="usd" id="ixv-40636">507,633</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Redemption of common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="0" unitRef="usd" id="ixv-40637">6,510,830</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="0" unitRef="usd" id="ixv-40638">2,653,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left">Net cash used in financing activities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40639">6,003,197</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-40640">1,944,458</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net change in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" sign="-" unitRef="usd" id="ixv-40641">14,453</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" unitRef="usd" id="ixv-40642">1,977</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Cash, beginning of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40643">16,204</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40644">4,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Cash, end of the period</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40645">1,751</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c171" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40646">6,496</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Income taxes paid</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd" id="ixv-40647">750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd" id="ixv-40648">173,727</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Excise tax payable attributable to redemption of common stock</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxPayableRedemptionOfCommonStock" scale="0" unitRef="usd" id="ixv-40649">71,718</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ExciseTaxPayableRedemptionOfCommonStock" scale="0" unitRef="usd" id="ixv-40650">10,884</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Accretion of common stock to redemption value</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40651">164,969</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" scale="0" unitRef="usd" id="ixv-40652">387,062</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Redemption payments due to redeeming stockholders</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RedemptionPaymentsDueToRedeemingStockholders" scale="0" unitRef="usd" id="ixv-40653">661,012</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Reconciliation of Cash and Restricted Cash:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash, beginning of the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40654">16,204</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40655">4,519</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash&#160;&#8211;&#160;beginning of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Cash and Restricted Cash, Beginning of the period</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40656">16,204</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40657">4,519</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Reconciliation of Cash and Restricted Cash:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash, end of the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c171" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-40658">6,496</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash&#160;&#8211;&#160;end of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd" id="ixv-40659">1,751</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Cash and Restricted Cash, End of the period</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40660">1,751</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c171" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-40661">6,496</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
the unaudited condensed consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 241; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ixv-34590"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NorthView Acquisition Corporation
(now known as Profusa, Inc.) (the &#8220;Company&#8221; or &#8220;Northview&#8221;) was a blank check company incorporated in Delaware
on April&#160;19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more businesses (&#8220;Business Combination&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had a wholly-owned
subsidiary, NV Profusa Merger Sub Inc. (&#8220;Merger Sub&#8221;), a Delaware corporation incorporated on October&#160;13, 2022, which
was formed solely in contemplation of the Merger with Profusa (See below). In connection with the Merger, which was consummated on July&#160;11,
2025, Merger Sub is no longer in existence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Combination</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, the
Company, Profusa, Inc., a California corporation (&#8220;Profusa&#8221;) and Merger Sub entered into a Merger Agreement and Plan of Reorganization
(as the same has been amended, supplemented or otherwise modified from time to time, the &#8220;Merger Agreement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;5, 2025 (the &#8220;Redemption
Date&#8221;), the Company received requests to redeem a total of <ix:nonFraction contextRef="c728" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" unitRef="pure" id="ixv-40662">52,784</ix:nonFraction> Public Shares (as defined below), representing <ix:nonFraction contextRef="c728" decimals="3" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfPublicShares" scale="-2" unitRef="pure" id="ixv-40663">32.4</ix:nonFraction>% of the total
Public Shares of the Company outstanding prior to the Redemption Date. Following the redemption, <ix:nonFraction contextRef="c728" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RedemptionPublicShares" scale="0" unitRef="shares" id="ixv-40664">5,295,527</ix:nonFraction> Public Shares were outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the special meeting of the
stockholders held on June&#160;9, 2025 (the &#8220;Special Meeting&#8221;), the Company&#8217;s stockholders voted to approve the proposals
outlined in the final prospectus and definitive proxy statement filed by the Company with the U.S.&#160;Securities and Exchange Commission
(the &#8220;SEC&#8221;) on May&#160;15, 2025 (the &#8220;Proxy Statement/Prospectus&#8221;), including, among other things, the adoption
of the Merger Agreement and approval of the transactions contemplated thereby, including the merger of Merger Sub with and into Profusa,
with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;), and the
issuance of the Company&#8217;s common stock as consideration thereunder (together with the other transactions contemplated by the Merger
Agreement, the &#8220;Business Combination&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025 (the
&#8220;Closing Date&#8221;), the Company closed the Business Combination with Profusa. As a result of the Business Combination, the Company
owns <ix:nonFraction contextRef="c729" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" unitRef="pure" id="ixv-40665">100</ix:nonFraction>% of the outstanding common stock of Profusa.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the closing
of the Business Combination, the Company changed its name from &#8220;NorthView Acquisition Corporation&#8221; to &#8220;Profusa, Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Prior to the Business Combination</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company consummated its Initial Public Offering (&#8220;IPO&#8221;) of <ix:nonFraction contextRef="c536" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40666">18,975,000</ix:nonFraction>&#160;units (the &#8220;Units&#8221;), which included
<ix:nonFraction contextRef="c537" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40667">2,475,000</ix:nonFraction>&#160;Units&#160;issued pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists
of <ix:nonFraction contextRef="c538" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40668">one</ix:nonFraction> share of common stock of the Company, par value $<ix:nonFraction contextRef="c539" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40669">0.0001</ix:nonFraction> per share, <ix:nonFraction contextRef="c540" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40670">one</ix:nonFraction> right (the &#8220;Rights&#8221;), and one-half of <ix:nonFraction contextRef="c541" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40671">one</ix:nonFraction> redeemable
warrant of the Company (the &#8220;Warrants&#8221;). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of
common stock. Each Warrant entitles the holder thereof to purchase <ix:nonFraction contextRef="c543" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-40672">one</ix:nonFraction> share of common stock for $<ix:nonFraction contextRef="c730" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40673">11.50</ix:nonFraction> per share, subject to adjustment.
The Units&#160;were sold at a price of $<ix:nonFraction contextRef="c539" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40674">10.00</ix:nonFraction> per Unit, generating gross proceeds to the Company of $<ix:nonFraction contextRef="c536" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40675">189,750,000</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Simultaneously with the closing
of the IPO, the Company completed the private sale of an aggregate of <ix:nonFraction contextRef="c731" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-40676">7,347,500</ix:nonFraction>&#160;warrants (the &#8220;Private Placement Warrants&#8221;),
which included <ix:nonFraction contextRef="c732" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-40677">697,500</ix:nonFraction> Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters,
to NorthView Sponsor&#160;I, LLC (&#8220;the Sponsor&#8221;),&#160;I-Bankers Securities, Inc., and Dawson James Securities, Inc. at a
purchase price of $<ix:nonFraction contextRef="c731" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40678">1.00</ix:nonFraction> per Private Placement Warrant, generating gross proceeds to the Company of $<ix:nonFraction contextRef="c733" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-40679">7,347,500</ix:nonFraction>, which is discussed in Note&#160;4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Transaction costs in connection
with the IPO amounted to $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:TransactionCost" scale="0" unitRef="usd" id="ixv-40680">7,959,726</ix:nonFraction>, consisting of $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnderwritingDiscountAmount" scale="0" unitRef="usd" id="ixv-40681">3,450,000</ix:nonFraction> of underwriting discount, $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RepresentativeSharesCost" scale="0" unitRef="usd" id="ixv-40682">3,570,576</ix:nonFraction> of Representative&#8217;s Shares cost,
$<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RepresentativeWarrantCost" scale="0" unitRef="usd" id="ixv-40683">259,527</ix:nonFraction> of Representative&#8217;s Warrants cost and $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:OtherOfferingCosts" scale="0" unitRef="usd" id="ixv-40684">679,623</ix:nonFraction> of other offering costs.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 242; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the closing of the
IPO on December&#160;22, 2021, an amount of $<ix:nonFraction contextRef="c539" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentsForInvestmentOfCashInTrustAccount" scale="0" unitRef="usd" id="ixv-40685">191,647,500</ix:nonFraction> ($<ix:nonFraction contextRef="c539" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40686">10.10</ix:nonFraction> per Unit), excluding $<ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:OperatingBankAccount" scale="0" unitRef="usd" id="ixv-40687">741,228</ix:nonFraction> that was wired to the Company&#8217;s operating
bank account on December&#160;31, 2021 for working capital purposes, from the net proceeds of the sale of the public units in the IPO
and the sale of the Private Placement Warrants was placed in a Trust Account (&#8220;Trust Account&#8221;) and invested in United&#160;States
government treasury bills with a maturity of <ix:nonNumeric contextRef="c549" format="ixt-sec:durwordsen" name="ck0001859807:MaturityDays" id="ixv-40688">185&#160;days</ix:nonNumeric> or less or in money market funds investing solely in United&#160;States Treasuries
and meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act as determined by the Company. Except with respect
to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from
the IPO will not be released from the Trust Account until the earliest of (i)&#160;the completion of the Company&#8217;s initial Business
Combination, (ii)&#160;the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company&#8217;s
amended and restated certificate of incorporation (A)&#160;to modify the substance or timing of the Company&#8217;s obligation to redeem
<ix:nonFraction contextRef="c549" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" unitRef="pure" id="ixv-40689">100</ix:nonFraction>% of the public shares if the Company does not complete the initial Business Combination within the extended period (or any additional
extension from the closing of our IPO if we extend the period of time to consummate a business combination) (the &#8220;Combination Period&#8221;),
or (B)&#160;with respect to any other provision relating to stockholders&#8217; rights or pre-Business Combination activity, and (iii)&#160;the
redemption of all of the Company&#8217;s public shares if the Company is unable to complete the Business Combination within the Combination
Period, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#8217;s
creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company provided its public
stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination
in connection with a stockholder meeting called to approve the initial Business Combination. The decision as to whether the Company will
seek stockholder approval of a proposed initial Business Combination or conduct a tender offer was made by the Company, solely in its
discretion. The stockholders were entitled to redeem all or a portion of their public shares upon the completion of the initial Business
Combination at a per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two&#160;business
days prior to the consummation of the initial Business Combination, including interest (which interest shall be net of taxes payable)
divided by the number of then outstanding public shares, subject to the limitations described herein. The per share amount the Company
distributed to investors who properly redeemed their shares was not reduced by the fee payable to&#160;I-Bankers&#160;and Dawson James
pursuant to the Business Combination Marketing Agreement (see Note&#160;6).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;10, 2023, the
Company held a vote to amend its amended and restated certificate of incorporation to extend the date by which the Company must consummate
a Business Combination from March&#160;22, 2023 to December&#160;22, 2023 (the &#8220;First Extension Meeting&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024. In connection with the extension, <ix:nonFraction contextRef="c734" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40690">140,663</ix:nonFraction> shares of the Company&#8217;s
common stock were redeemed, with <ix:nonFraction contextRef="c735" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-40691">6,027,219</ix:nonFraction> shares of Common Stock remaining outstanding after the Redemption; <ix:nonFraction contextRef="c736" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-40692">833,469</ix:nonFraction> shares of Common
Stock remaining outstanding after the Redemption are shares issued in connection with our IPO (the &#8220;Public Shares&#8221;). In January&#160;2024,
$<ix:nonFraction contextRef="c737" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40693">1,565,078</ix:nonFraction> was paid from the Trust Account to redeeming stockholders in connection with the extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;2, 2024, the
Company and Continental Stock Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;) entered into Amendment No. 1 to Investment Management
Trust Agreement, dated December&#160;20, 2021, by and between the Company and CST, to allow CST, upon written instruction of the Company,
to (i)&#160;hold the funds in the Company&#8217;s trust account uninvested or (ii)&#160;hold the funds in an interest-bearing bank demand
deposit account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024, the
Company&#8217;s Board of Directors approved, and the Company amended, its Convertible Working Capital Promissory Note (the &#8220;Note&#8221;)
with the sponsor to increase the principal amount of the Note that could be drawn on to $<ix:nonFraction contextRef="c554" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapital" scale="6" unitRef="usd" id="ixv-40694">1.5</ix:nonFraction>&#160;million. The amended and restated Note
also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company common stock at a price
of $<ix:nonFraction contextRef="c554" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40695">2.22</ix:nonFraction> per share at the election of the sponsor. On May&#160;31, 2024, the Company&#8217;s Board of Directors approved and the Company
entered into a second amendment of its Convertible Working Capital Promissory Note with the sponsor to increase the principal amount of
the Note that could be drawn on to $<ix:nonFraction contextRef="c738" decimals="-5" format="ixt:num-dot-decimal" name="ck0001859807:AmountDrawn" scale="6" unitRef="usd" id="ixv-40696">2.5</ix:nonFraction>&#160;million. The second amended and restated Note also allows for the conversion of the outstanding
principal balance of the Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c155" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40697">2.22</ix:nonFraction>&#160;per share at the election of the
sponsor.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 243; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_3" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;21, 2024, the
Company held its 2024 Annual Meeting of Stockholders (the &#8220;Meeting&#8221;). At the meeting, the Company&#8217;s stockholders approved
the amendment of the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase <ix:nonFraction contextRef="c556" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" unitRef="pure" id="ixv-40698">100</ix:nonFraction>% of the shares of the Company&#8217;s
common stock issued in the Company&#8217;s initial public offering, from March&#160;22, 2024, monthly for up to six additional&#160;months
at the election of the Company and only upon contribution of $<ix:nonFraction contextRef="c557" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40699">0.05</ix:nonFraction> per month per outstanding public share, ultimately until September&#160;22,
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the meeting,
the holders of&#160;<ix:nonFraction contextRef="c739" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40700">95,394</ix:nonFraction>&#160;Public Shares properly exercised their right to redeem, with <ix:nonFraction contextRef="c740" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40701">5,931,825</ix:nonFraction> shares of Common Stock remaining
outstanding after the Redemption; <ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40702">738,075</ix:nonFraction> shares of Common Stock remaining outstanding after the Redemption are Public Shares. Consequently,
the contribution was $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40703">36,904</ix:nonFraction>&#160;per month needed for the Company to continue to extend the Combination Period monthly. On May&#160;8,
2024 and May&#160;31, 2024, the Company made two deposits of $<ix:nonFraction contextRef="c741" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40704"><ix:nonFraction contextRef="c555" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40705">36,904</ix:nonFraction></ix:nonFraction> each for April and May extension contributions. On September&#160;10,
2024, the Company made a deposit of $<ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40706">112,114</ix:nonFraction>, of which $<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40707">110,714</ix:nonFraction> was for June, July and August extension contributions and $<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeOther" scale="0" unitRef="usd" id="ixv-40708">1,400</ix:nonFraction> for lost
interest due to late trust payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September&#160;19, 2024,
the Company held a special meeting of stockholders (the &#8220;Meeting&#8221;). At the Meeting, the Company&#8217;s stockholders approved
an amendment to the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
its initial Business Combination to March&#160;22, 2025. In connection with the approval of the extension amendment, holders of&#160;<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40709">50,556</ix:nonFraction>&#160;shares
of the Company&#8217;s common stock exercised their right to redeem, with <ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40710">5,881,269</ix:nonFraction> shares of common stock remaining outstanding after
the redemption; <ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40711">687,519</ix:nonFraction> shares of common stock remaining outstanding after the redemption are Public Shares. Consequently, the contribution
is $<ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40712">34,376</ix:nonFraction>&#160;per month needed for the Company to continue to extend the Combination Period monthly. On December&#160;13, 2024, the
Company made a deposit of $<ix:nonFraction contextRef="c567" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40713">68,752</ix:nonFraction> for the October and November extension contributions and on December&#160;23, 2024, the Company made
a deposit of <ix:nonFraction contextRef="c568" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40714">34,376</ix:nonFraction> for the December extension contribution. In October&#160;2024, $<ix:nonFraction contextRef="c569" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40715">595,439</ix:nonFraction> was paid from the trust account to redeeming
stockholders in connection with the extension. On February&#160;27, 2025, the Company made a deposit of $<ix:nonFraction contextRef="c742" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40716">49,376</ix:nonFraction> for the January extension
contribution and a portion ($<ix:nonFraction contextRef="c743" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40717">15,000</ix:nonFraction>) of the February extension contribution. On March&#160;7, 2025, the Company deposited the remainder
of the February extension contribution of $<ix:nonFraction contextRef="c744" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40718">19,376</ix:nonFraction>, plus interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the meeting and the stockholders approved the extension of the business combination period
until June&#160;22, 2025. In connection with the approval of the extension amendment, holders of&#160;<ix:nonFraction contextRef="c745" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40719">532,958</ix:nonFraction>&#160;shares of the Company&#8217;s
common stock exercised their right to redeem, for an aggregate redemption amount of approximately $<ix:nonFraction contextRef="c746" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="6" unitRef="usd" id="ixv-40720">6.5</ix:nonFraction>&#160;million, with <ix:nonFraction contextRef="c746" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40721">5,348,311</ix:nonFraction> shares
of common stock remaining outstanding after the redemption; <ix:nonFraction contextRef="c746" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-40722">154,561</ix:nonFraction> shares of common stock remaining outstanding after the redemption
are Public Shares. As a condition of the extension, the Company contributed $<ix:nonFraction contextRef="c745" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40723">30,000</ix:nonFraction> to the Trust Account, for the entire extension period,
on March&#160;21, 2025. Additionally, the stockholders at the meeting approved the amendment of the Company&#8217;s charter to remove
the requirement that prevented the Company from redeeming public shares to the extent that it would cause the Company&#8217;s net tangible
assets to be less than $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" scale="0" unitRef="usd" id="ixv-40724">5,000,001</ix:nonFraction> (the &#8220;NTA Requirement&#8221;), and our charter was amended on March&#160;21, 2025 to reflect the
extension of the business combination and the removal of the NTA Requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;2, 2025, the
parties to the Merger Agreement entered into an Amendment No. 5 to the Merger Agreement (&#8220;Amendment No. 5&#8221;) pursuant to which
Section&#160;9.01 of the Merger Agreement was amended such that the reference to &#8220;March&#160;22, 2025&#8221; shall be replaced with
&#8220;June&#160;22, 2025&#8221; by which the Company must consummate a Business Combination.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 244; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_4" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;8, 2025, the Company
entered into a non-redemption&#160;agreement (the &#8220;Non-Redemption&#160;Agreement&#8221;) with&#160;I-Bankers Securities, Inc. and
Dawson James Securities, Inc. (together, the &#8220;Investors&#8221;), pursuant to which such Investors agreed that to the extent that
redemptions in connection with the vote to approve the Business Combination reduces the Company&#8217;s trust account balance below $1.25&#160;million,
the Investors would offer such redeeming shareholders an opportunity to rescind the redemption of their shares and would instead purchase
such shares. Such purchases would be structured in compliance with the requirements of&#160;Rule&#160;14e-5&#160;under the&#160;Exchange&#160;Act&#160;or
would otherwise not constitute a tender offer pursuant to the&#160;Exchange&#160;Act. As of the Closing Date, the Company&#8217;s trust
account balance was not below $<ix:nonFraction contextRef="c155" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PaymentsForInvestmentOfCashInTrustAccount" scale="0" unitRef="usd" id="ixv-40725">1.25</ix:nonFraction>&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;9, 2025, the Company
held a special meeting of stockholders. At the meeting, the Company&#8217;s stockholders approved the Merger Agreement and the actions
and transactions contemplated thereby, including (i)&#160;adopt an amended and restated Certificate of Incorporation, to be effective
upon closing of the Merger, (ii)&#160;approving certain advisory proposals related to the amended and restated Certificate of Incorporation,
(iii)&#160;approved the issuance of new shares of the Company&#8217;s Common Stock as merger consideration, (iv)&#160;elected new directors,
and (v)&#160;approved new employee incentive plans. In connection with the meeting, the holders of <ix:nonFraction contextRef="c747" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40726">52,784</ix:nonFraction> Public Shares properly exercised
their right to redeem, with <ix:nonFraction contextRef="c748" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40727">5,295,527</ix:nonFraction> shares of Common Stock remaining outstanding after such redemptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;1, 2025, the Company
filed an amendment to its Certificate of Incorporation (the &#8220;Amendment&#8221;) to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase <ix:nonFraction contextRef="c749" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" unitRef="pure" id="ixv-40728">100</ix:nonFraction>% of the shares of the Company&#8217;s
common stock issued in the Company&#8217;s initial public offering, from June&#160;22, 2025 to August&#160;22, 2025. Previously, on June&#160;27,
2025, the Company had filed a copy of the Amendment with a date that mistakenly referenced &#8220;July&#160;22, 2025&#8221; rather than
&#8220;August&#160;22, 2025,&#8221; however such filing was corrected in connection with the filing of the Amendment on July&#160;1, 2025.
The Company&#8217;s stockholders approved the Amendment by a supermajority of at least <ix:nonFraction contextRef="c750" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:StockholdersAmendmentPercentage" scale="-2" unitRef="pure" id="ixv-40729">65</ix:nonFraction>% via written consent on June&#160;27, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company agreed to waive
its right to withdraw up to $<ix:nonFraction contextRef="c751" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentofInteresttoDistributionExpense" scale="0" unitRef="usd" id="ixv-40730">100,000</ix:nonFraction> of interest from the Company&#8217;s trust account to pay dissolution expenses, should the Company
ultimately liquidate prior to a business combination (the &#8220;Dissolution Expense Waiver&#8221;). As a result, the Company was no longer
able to withdraw up to $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:PaymentofInteresttoDistributionExpense" scale="0" unitRef="usd" id="ixv-40731">100,000</ix:nonFraction> of interest for such dissolution expenses upon liquidation, and such interest will be held in the trust
account and not be released until the earliest to occur of (i)&#160;the completion of the initial business combination, (ii)&#160;the
redemption of <ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfRedeemingPublicShareholders" scale="-2" unitRef="pure" id="ixv-40732">100</ix:nonFraction>% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination within
the Extension, and (iii)&#160;the redemption of Public Shares in connection with a vote seeking to amend the provisions of our Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also agreed to
waive its right to withdraw interest from the Company&#8217;s trust account to pay the Company&#8217;s tax expenses (the &#8220;Tax Expense
Waiver&#8221;). As a result, the Company was no longer able to withdraw interest in order to pay future tax expenses, and such interest
will be held in the trust account and not be released until the earliest to occur of (i)&#160;the completion of the initial business combination,
(ii)&#160;the redemption of <ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfRedeemingPublicShareholders" scale="-2" unitRef="pure" id="ixv-40733">100</ix:nonFraction>% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination
within the Extension, and (iii)&#160;the redemption of Public Shares in connection with a vote seeking to amend the provisions of our
Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to such announcement,
and subsequent to the record date of February&#160;21, 2025, for the Special Meeting, the Company withdrew approximately $<ix:nonFraction contextRef="c752" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="0" unitRef="usd" id="ixv-40734">23,200</ix:nonFraction> of interest
from the trust account for tax expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Public Shares contain
a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder
vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and
restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified
in ASC&#160;480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to
be classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., public
warrants), the initial carrying value of common stock classified as temporary equity was the allocated proceeds determined in accordance
with ASC&#160;470-20. The common stock is subject to ASC&#160;480-10-S99. If it is probable that the equity instrument will become redeemable,
the Company has the option to either (i)&#160;accrete changes in the redemption value over the period from the date of issuance (or from
the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument
or (ii)&#160;recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal
the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 245; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_5" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor, officers and directors
have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with the completion
of the initial Business Combination, (ii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to
their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will
be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete
the Business Combination within such time period); and (iii)&#160;vote their Founder Shares and any public shares purchased during or
after the IPO in favor of the initial Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor
has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to
the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount
of funds in the Trust Account to below (i)&#160;$<ix:nonFraction contextRef="c753" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40735">10.10</ix:nonFraction> per public share or (ii)&#160;such lesser amount per public share held in the Trust
Account as of the date of the liquidation of the Trust Account due to reductions in value of the trust assets, in each case net of the
amount of interest which may be released to the Company to pay taxes, except as to any claims by a third party who executed a waiver of
any and all rights to seek access to the Trust Account and except as to any claims under indemnity of the underwriters of the IPO against
certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nasdaq Delisting Notification</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;20, 2024,
the Company received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market that the Company&#8217;s
securities would be delisted from The Nasdaq Stock Market by reason of the failure of the Company to complete its initial business combination
by December&#160;20, 2024 (36&#160;months from the effectiveness of its IPO registration statement) as required by Listing Rule IM-5101-2.
Accordingly, trading in the Company&#8217;s Common Stock, Rights and Warrants was suspended at the opening of business on December&#160;27,
2024 and a Form&#160;25-NSE was filed by Nasdaq with the Securities and Exchange Commission, which removed the Company&#8217;s securities
from on the Nasdaq Stock Market. The Company&#8217;s Common Stock, Rights and Warrants began to be quoted on the Pink Markets operated
on The OTC Market systems (&#8220;OTC Market&#8221;) under the symbols &#8220;NVAC,&#8221; &#8220;NVACR&#8221; and &#8220;NVACW.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Funds Restricted for Payment of Taxes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From inception to date, the
Company has withdrawn a total of $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:InterestFromTrustAccount" scale="0" unitRef="usd" id="ixv-40736">1,484,219</ix:nonFraction> of interest from the Trust Account of which $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="0" unitRef="usd" id="ixv-40737">1,453,297</ix:nonFraction> was paid for franchise and income taxes.
Of the aggregate withdrawals, $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCash" scale="0" unitRef="usd" id="ixv-40738">30,922</ix:nonFraction> was restricted for the payment of the Company&#8217;s income taxes. The Company utilized $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:FundingOperatingExpenses" scale="0" unitRef="usd" id="ixv-40739">29,171</ix:nonFraction>
of these withdrawals towards funding operating expenses, as well as the monthly extension deposits. As of June&#160;30, 2025, the Company
has restricted cash of $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd" id="ixv-40740">1,751</ix:nonFraction>. The Company intends to deposit $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="0" unitRef="usd" id="ixv-40741">29,171</ix:nonFraction> back into the Trust Account or use the $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrust" scale="0" unitRef="usd" id="ixv-40742">29,171</ix:nonFraction> (or a portion thereof)
for tax obligations until a deposit is made into the trust on a future date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of&#160;June&#160;30, 2025,
the Company had $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd" id="ixv-40743">1,751</ix:nonFraction> in restricted cash and a working capital deficit of $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapitalDeficit" scale="0" unitRef="usd" id="ixv-40744">15,492,554</ix:nonFraction>. Prior to the completion of the Company&#8217;s
IPO, the Company&#8217;s liquidity needs had been satisfied through a capital contribution from the Sponsor of $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PartnersCapitalAccountContributions" scale="0" unitRef="usd" id="ixv-40745">25,000</ix:nonFraction> for the founder
shares to cover certain of the offering costs and the loan under an unsecured promissory note from the Sponsor of $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnsecuredPromissoryNote" scale="0" unitRef="usd" id="ixv-40746">204,841</ix:nonFraction>, which was
fully paid upon the IPO.&#160;Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company&#8217;s
liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account,
and the drawdowns on the convertible promissory note.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 246; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_6" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain
of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note&#160;5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $<ix:nonFraction contextRef="c576" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:WorkingCapital" scale="0" unitRef="usd" id="ixv-40747">1,200,000</ix:nonFraction>. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $<ix:nonFraction contextRef="c577" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares" id="ixv-40748">1.00</ix:nonFraction> per warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024, the
Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $<ix:nonFraction contextRef="c554" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40749">1.5</ix:nonFraction>&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c554" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40750">2.22</ix:nonFraction> per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;31, 2024, the Company&#8217;s
Board of Directors approved, and the Company second amended its Note to increase the principal amount of the Note that could be drawn
on to $<ix:nonFraction contextRef="c555" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40751">2.5</ix:nonFraction>&#160;million. The second amended and restated Note also allows for the conversion of the outstanding principal balance of the
Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c555" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40752">2.22</ix:nonFraction>&#160;per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had principal outstanding
of $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:OutstandingPrincipalAmount" scale="0" unitRef="usd" id="ixv-40753">1,919,796</ix:nonFraction> and is presenting the Note at fair value on its balance sheet at June&#160;30, 2025 in the amount of $<ix:nonFraction contextRef="c754" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40754">10,288,111</ix:nonFraction>. As of
June&#160;30, 2025, no amounts were repaid against the loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company incurred significant
costs in pursuit of its Business Combination. As part of the closing, the Company had cash inflows of $<ix:nonFraction contextRef="c155" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="6" unitRef="usd" id="ixv-40755">1.3</ix:nonFraction>&#160;million from the Trust
Account, net of redemptions, and the $<ix:nonFraction contextRef="c173" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="6" unitRef="usd" id="ixv-40756">9</ix:nonFraction>&#160;million net PIPE convertible note. Cash outflows included marketing fees and vendor payments
which totaled $<ix:nonFraction contextRef="c173" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentForAdministrativeFees" scale="6" unitRef="usd" id="ixv-40757">3.4</ix:nonFraction>&#160;million due at closing. In connection with the Company&#8217;s assessment of going concern considerations in accordance
with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;)&#160;2014-15, &#8220;Disclosures
of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management believes that subsequent to the closing
of the Merger, there continues to be factors which raise substantial doubt about the Company&#8217;s ability to continue as a going concern
within one year from the date the condensed consolidated financial statements are issued. The condensed consolidated financial statements
do not contain any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for, among other
things, a new U.S.&#160;federal <ix:nonFraction contextRef="c579" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-40758">1</ix:nonFraction>% excise tax on certain repurchases of stock occurring on or after January&#160;1, 2023, by publicly
traded U.S.&#160;domestic corporations, by certain U.S.&#160;domestic subsidiaries of publicly traded foreign corporations, by &#8220;covered
surrogate foreign corporations&#8221; (as defined in the IR Act) and by certain affiliates of the foregoing. The excise tax is imposed
on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally
<ix:nonFraction contextRef="c580" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther" scale="-2" unitRef="pure" id="ixv-40759">1</ix:nonFraction>% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock
repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any redemption or other repurchase
that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the
excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension
vote or otherwise would depend on a number of factors, including (i)&#160;the fair market value of the redemptions and repurchases in
connection with the Business Combination, extension or otherwise, (ii)&#160;the structure of a Business Combination, (iii)&#160;the nature
and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination (or otherwise issued not in connection
with a Business Combination but issued within the same taxable year of a Business Combination) and (iv)&#160;the content of regulations
and other guidance from the Treasury. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination
and in the Company&#8217;s ability to complete a Business Combination.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 247; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c173_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;22, 2023 and
December&#160;21, 2023, the Company&#8217;s stockholders redeemed <ix:nonFraction contextRef="c581" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40760">18,000,868</ix:nonFraction> and <ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40761">140,663</ix:nonFraction> shares, respectively, for a total of $<ix:nonFraction contextRef="c583" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40762">184,845,836</ix:nonFraction>
and $<ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40763">1,565,078</ix:nonFraction>, respectively. On March&#160;26, 2024, the Company&#8217;s stockholders redeemed <ix:nonFraction contextRef="c585" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40764">95,394</ix:nonFraction> shares for a total of $<ix:nonFraction contextRef="c586" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40765">1,088,361</ix:nonFraction>.
On September&#160;30, 2024, the Company&#8217;s stockholders redeemed <ix:nonFraction contextRef="c755" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40766">50,556</ix:nonFraction> shares for a total of $<ix:nonFraction contextRef="c756" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40767">595,439</ix:nonFraction>. On March&#160;26, 2025, the
Company&#8217;s stockholders redeemed <ix:nonFraction contextRef="c757" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40768">532,958</ix:nonFraction> shares for a total of $<ix:nonFraction contextRef="c758" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40769">6,510,830</ix:nonFraction>. On June&#160;16, 2025, the Company&#8217;s stockholders
redeemed <ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40770">52,784</ix:nonFraction> shares for a total of $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-40771">661,012</ix:nonFraction>. The Company determined that an excise tax liability should be recorded due to the redeemed
shares. As of June&#160;30, 2025 and December&#160;31, 2024, the Company has a charge to stockholders&#8217; deficit of $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" scale="0" unitRef="usd" id="ixv-40772">1,952,662</ix:nonFraction> and
$<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" scale="0" unitRef="usd" id="ixv-40773">1,880,944</ix:nonFraction> of excise tax liability, including $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExciseAndSalesTaxes" scale="0" unitRef="usd" id="ixv-40774">71,718</ix:nonFraction> and $<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExciseAndSalesTaxes" scale="0" unitRef="usd" id="ixv-40775">16,838</ix:nonFraction> charged during the six&#160;months ended June&#160;30, 2025 and the
year ended December&#160;31, 2024, respectively, calculated as <ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:SharesRedeemedPercentage" scale="-2" unitRef="pure" id="ixv-40776">1</ix:nonFraction>% of the value of shares redeemed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;3, 2024, the Treasury
issued final regulations with respect to the procedure and administration of the Excise Tax. These regulations provided that the filing
and payment deadline for any liability incurred during the period from January&#160;1, 2023 to December&#160;31, 2023 would be October&#160;31,
2024. As of June&#160;30, 2025 and the date of this report, the excise tax was not paid and was recorded as excise tax payable. Any amount
of such Excise Tax not paid in full, could be subject to additional interest and penalties which are currently estimated at <ix:nonFraction contextRef="c759" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:EstimatedInterestRate" scale="-2" unitRef="pure" id="ixv-40777">7</ix:nonFraction>% or <ix:nonFraction contextRef="c760" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:EstimatedInterestRate" scale="-2" unitRef="pure" id="ixv-40778">9</ix:nonFraction>% interest
per annum and a <ix:nonFraction contextRef="c173" decimals="3" format="ixt:num-dot-decimal" name="ck0001859807:UnderpaymentPenaltyRate" scale="-2" unitRef="pure" id="ixv-40779">0.5</ix:nonFraction>% underpayment penalty per month or portion of a month up to <ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:UnpaidTotalLiabilityRate" scale="-2" unitRef="pure" id="ixv-40780">25</ix:nonFraction>% of the total liability for any amount that is unpaid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-40781">1,952,662</ix:nonFraction> and $<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="usd" id="ixv-40782">1,880,944</ix:nonFraction> in excise tax was accrued on the accompanying condensed consolidated balance sheets,
respectively. On January&#160;29, 2025, the Company claimed disaster relief under IRC Section&#160;7508A relating to Hurricane Beryl as
announced in IRS Announcement TX-2024-08. Under the disaster relief claim, the time for filing of the September&#160;30, 2024 Quarterly
Federal Excise Tax Return and payment of the 2023 excise taxes on repurchases of corporate stock normally due on October&#160;31, 2024
should be postponed to February&#160;3, 2025. The Company was not subject to excise tax interest and penalties until February&#160;3,
2025. On January&#160;29, 2025, the Company filed their 2024 excise tax return. The Company did not repay the excise tax in full by June&#160;30,
2025. As of June&#160;30, 2025, the Company accrued approximately $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="0" unitRef="usd" id="ixv-40783">105,970</ix:nonFraction> interest and penalties in the accompanying condensed consolidated
statements of operations.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="_SignificantAccountingPoliciesTextBlock-c173_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-34871"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-34876"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c173_cont_2" id="_BasisOfAccountingPolicyPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements are presented in U.S.&#160;dollars in conformity with accounting principles generally accepted
in the United&#160;States of America (&#8220;GAAP&#8221;) for financial information and pursuant to the rules and regulations of the SEC.&#160;Accordingly,
they do not include all of the information and footnotes required by GAAP.&#160;In the opinion of management, the unaudited condensed
consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement
of the balances and results for the periods presented. The interim results for the three and six&#160;months ended June&#160;30, 2025
are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any future periods.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited financial statements and notes
thereto included in the Form&#160;10-K annual report filed by the Company with the SEC on March&#160;31, 2025.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 248; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c173_cont_2" id="_SignificantAccountingPoliciesTextBlock-c173_cont_1"><ix:nonNumeric contextRef="c173" continuedAt="_ConsolidationPolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-34912"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Principles of Consolidation</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ConsolidationPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances
and transactions have been eliminated in consolidation.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c173_cont_1" escape="true" name="ck0001859807:EmergingGrowthCompanyStatusPolicyTextBlock" id="ixv-34920"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging Growth Company Status</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c173_cont_2" id="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an &#8220;emerging
growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act&#160;of&#160;2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#8217;s condensed consolidated financial statements with another public company,
which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period
difficult or impossible because of the potential differences in accounting standards used.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_UseOfEstimates-c173_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-34931"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_UseOfEstimates-c173_cont_2" id="_UseOfEstimates-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of these condensed
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial
statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_UseOfEstimates-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates are in
connection with determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results
could differ significantly from those estimates.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_ConcentrationRiskCreditRisk-c173_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-34942"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashFDICInsuredAmount" scale="0" unitRef="usd" id="ixv-40784">250,000</ix:nonFraction>. The Company has not experienced losses on this account.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 249; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c173_cont_3" id="_SignificantAccountingPoliciesTextBlock-c173_cont_2"><ix:nonNumeric contextRef="c173" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-34977"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents and Restricted Cash</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. At June&#160;30, 2025 and December&#160;31,
2024, the Company had $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd" id="ixv-40785">1,751</ix:nonFraction>&#160;and <span style="-sec-ix-hidden: hidden-fact-393">$0</span>&#160;of restricted cash, respectively, related to funds withdrawn from the Trust Account reserved
for the payment of income and state franchise taxes. The Company did not have any cash equivalents as of June&#160;30, 2025 and December&#160;31,
2024.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_MarketableSecuritiesPolicy-c173_cont_1" escape="true" name="us-gaap:MarketableSecuritiesPolicy" id="ixv-34986"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash Held in Trust Account</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c173_cont_2" id="_MarketableSecuritiesPolicy-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June&#160;30, 2025 and December&#160;31,
2024, substantially all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c173_cont_3" id="_MarketableSecuritiesPolicy-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six&#160;months
ended June&#160;30, 2025, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesTaxable" scale="0" unitRef="usd" id="ixv-40786">78,813</ix:nonFraction> of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c173" continuedAt="_MarketableSecuritiesTextBlock-c173_cont_1" escape="true" name="us-gaap:MarketableSecuritiesTextBlock" id="ixv-34996"><ix:continuation continuedAt="_MarketableSecuritiesPolicy-c173_cont_4" id="_MarketableSecuritiesPolicy-c173_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six&#160;months
ended June&#160;30, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesTaxable" scale="0" unitRef="usd" id="ixv-40787">204,460</ix:nonFraction> of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.</p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c173_cont_4" id="_SignificantAccountingPoliciesTextBlock-c173_cont_3"><ix:continuation id="_MarketableSecuritiesTextBlock-c173_cont_1"><ix:continuation continuedAt="_MarketableSecuritiesPolicy-c173_cont_5" id="_MarketableSecuritiesPolicy-c173_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c770" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-40788">1,935,561</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c595" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-40789">8,330,835</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c173_cont_6" id="_MarketableSecuritiesPolicy-c173_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December&#160;21, 2023, <ix:nonFraction contextRef="c761" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40790">140,663</ix:nonFraction> shares of the Company&#8217;s common stock were redeemed. In January&#160;2024,
$<ix:nonFraction contextRef="c588" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PayableCommonStockRedeemed" scale="0" unitRef="usd" id="ixv-40791">1,565,078</ix:nonFraction> was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $<ix:nonFraction contextRef="c589" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="0" unitRef="usd" id="ixv-40792">1,565,078</ix:nonFraction> as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$<ix:nonFraction contextRef="c762" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="0" unitRef="usd" id="ixv-40793">1,565,078</ix:nonFraction> of the trust account as a current asset on the condensed consolidated balance sheets, which was paid from the Trust Account
in January&#160;2024 to redeeming stockholders.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c173_cont_7" id="_MarketableSecuritiesPolicy-c173_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial
business combination from March&#160;22, 2025 to June&#160;22, 2025. The meeting was adjourned until March&#160;21, 2025, at which the
stockholders approve the extension of the business combination period until June&#160;22, 2025. As a condition of the extension, the Company
contributed $<ix:nonFraction contextRef="c763" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoncashContributionExpense" scale="0" unitRef="usd" id="ixv-40794">30,000</ix:nonFraction> to the Trust Account, for the entire extension period, on March&#160;21, 2025. On July&#160;1, 2025, the Company filed
the Amendment to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations
and redeem or repurchase <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:OperationsAndRedeemRepurchasePercentage" scale="-2" unitRef="pure" id="ixv-40795">100</ix:nonFraction>% of the shares of the Company&#8217;s common stock issued in the Company&#8217;s initial public offering,
from June&#160;22, 2025 to August&#160;22, 2025.&#160;In connection with the special meeting of stockholders to approve the Business Combination,
stockholders of the Company redeemed <ix:nonFraction contextRef="c764" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" unitRef="shares" id="ixv-40796">52,784</ix:nonFraction> shares of common stock for an aggregate amount of $<ix:nonFraction contextRef="c765" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40797">661,012</ix:nonFraction>.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 250; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c173_cont_5" id="_SignificantAccountingPoliciesTextBlock-c173_cont_4"><ix:continuation id="_MarketableSecuritiesPolicy-c173_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, $<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-40798">1,274,549</ix:nonFraction>
of the Trust assets were classified as noncurrent assets and $<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustCurrent" scale="0" unitRef="usd" id="ixv-40799">661,012</ix:nonFraction> of the Trust assets due to redeeming stockholders were classified
as current assets. As a result of the Business Combination, the $<ix:nonFraction contextRef="c765" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" unitRef="usd" id="ixv-40800">661,012</ix:nonFraction> due to redeeming stockholders was paid at the Closing.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c173_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-35085"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value of Financial Instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
assets and liabilities approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily
due to their short-term nature, except for the warrant liabilities, convertible promissory note, and securities purchase agreement.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_IncomeTaxPolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-35093"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income Taxes</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c173_cont_2" id="_IncomeTaxPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes under ASC&#160;740, &#8220;Income Taxes.&#8221; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the condensed consolidated financial statements and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#8217;s deferred tax asset had a full valuation allowance
recorded against it.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c173_cont_3" id="_IncomeTaxPolicyTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s condensed consolidated financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c173_cont_4" id="_IncomeTaxPolicyTextBlock-c173_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company incurred $<ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsIncurred" scale="0" unitRef="usd" id="ixv-40801"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsIncurred" scale="0" unitRef="usd" id="ixv-40802">340</ix:nonFraction></ix:nonFraction> and <span style="-sec-ix-hidden: hidden-fact-394"><span style="-sec-ix-hidden: hidden-fact-395">no</span></span> amount
of interest and penalty expenses during the three and six&#160;months ended June&#160;30, 2025 and 2024, respectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c173_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has identified
the United&#160;States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_DerivativesPolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:DerivativesPolicyTextBlock" id="ixv-35112"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Derivative Financial Instruments</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_DerivativesPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the condensed consolidated statements
of operations. Derivative assets and liabilities are classified in the condensed consolidated balance sheets as current or non-current&#160;based
on whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet
date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_DebtPolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:DebtPolicyTextBlock" id="ixv-35120"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Convertible Promissory Note</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_DebtPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 251; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c173_cont_6" id="_SignificantAccountingPoliciesTextBlock-c173_cont_5"><ix:nonNumeric contextRef="c173" continuedAt="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock-c173_cont_1" escape="true" name="ck0001859807:SecuritiesPurchaseAgreementPolicyTextBlock" id="ixv-35154"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Purchase Agreement</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
securities purchase agreement is valued using Monte Carlo models on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. The instrument
is subject to re-measurement at each balance sheet date, with changes in fair value recognized in the condensed consolidated statements
of operations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c173_cont_1" escape="true" name="ck0001859807:WarrantLiabilitiesPolicyTextBlock" id="ixv-35162"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrant Liabilities</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c173_cont_2" id="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for the&#160;<ix:nonFraction contextRef="c766" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40803">17,404,250</ix:nonFraction>&#160;warrants
issued in connection with the IPO (the&#160;<ix:nonFraction contextRef="c767" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40804">9,487,500</ix:nonFraction>&#160;Public Warrants, the&#160;<ix:nonFraction contextRef="c768" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40805">7,347,500</ix:nonFraction>&#160;Private Placement Warrants, and the&#160;<ix:nonFraction contextRef="c769" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40806">569,250</ix:nonFraction>&#160;Representative
Warrants inclusive of the underwriters&#8217; over-allotment&#160;option) in accordance with the guidance contained in ASC&#160;815-40.
Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded
as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement&#160;at
each balance sheet date. With each such re-measurement, the warrant liabilities will be adjusted to fair value, with the change in fair
value recognized in the Company&#8217;s condensed consolidated statements of operations (See Note&#160;8).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="ck0001859807_WarrantLiabilitiesPolicyTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the fair value
of the Private Placement Warrants and the Representative&#8217;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_EarningsPerSharePolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-35173"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Net Loss Per Common Stock</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c173_cont_2" id="_EarningsPerSharePolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-40807">17,404,250</ix:nonFraction>&#160;potential shares of common stock for outstanding warrants to purchase the
Company&#8217;s shares were excluded from diluted earnings per share for the three and six&#160;months ended June&#160;30, 2025 and 2024
because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per share
of common stock is the same as basic net loss per share of common stock for the periods presented.&#160;The table below presents a reconciliation
of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c173" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-35180"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c173_cont_3" id="_EarningsPerSharePolicyTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below presents a
reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c173_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Allocation of net loss</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c771" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40808">224,777</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c148" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40809">7,972,099</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c772" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40810">49,458</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c164" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40811">348,029</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c773" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40812">685,851</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c774" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40813">8,630,935</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c775" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40814">159,563</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(<ix:nonFraction contextRef="c776" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityNetIncome" scale="0" sign="-" unitRef="usd" id="ixv-40815">1,058,201</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c771" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40816">146,440</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c148" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40817">5,193,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c772" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40818">738,075</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c164" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40819">5,193,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c773" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40820">412,717</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c774" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40821">5,193,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c775" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40822">783,151</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c776" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-40823">5,193,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c771" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40824"><ix:nonFraction contextRef="c771" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40825">1.53</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c148" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40826"><ix:nonFraction contextRef="c148" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40827">1.53</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c772" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40828"><ix:nonFraction contextRef="c772" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40829">0.07</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c164" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40830"><ix:nonFraction contextRef="c164" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40831">0.07</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c773" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40832"><ix:nonFraction contextRef="c773" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40833">1.66</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c774" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40834"><ix:nonFraction contextRef="c774" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40835">1.66</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c775" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40836"><ix:nonFraction contextRef="c775" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40837">0.20</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c776" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-40838"><ix:nonFraction contextRef="c776" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-40839">0.20</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:continuation></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 252; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c173_cont_7" id="_SignificantAccountingPoliciesTextBlock-c173_cont_6"><ix:nonNumeric contextRef="c173" continuedAt="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" id="ixv-35524"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock Subject to Possible Redemption</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c173_cont_2" id="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s common
stock sold as part of the Units&#160;in the IPO (&#8220;public common stock&#8221;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#8217;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#8217;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c173" escape="true" name="us-gaap:TemporaryEquityTableTextBlock" id="ixv-35531"><ix:continuation continuedAt="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c173_cont_3" id="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the
following table:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c173_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40840">9,252,208</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RedemptionPremium" scale="0" unitRef="usd" id="ixv-40841">1,683,800</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="0" unitRef="usd" id="ixv-40842">768,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40843">8,337,388</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RedemptionPremium" scale="0" unitRef="usd" id="ixv-40844">6,510,830</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c147" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="0" unitRef="usd" id="ixv-40845">155,999</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, March&#160;31, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c147" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40846">1,982,557</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Redemption payment due to stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="0" sign="-" unitRef="usd" id="ixv-40847">661,012</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="0" unitRef="usd" id="ixv-40848">8,970</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd" id="ixv-40849">1,330,515</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c173" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-35635"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recently Issued Accounting Standards</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_2" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Standards Adopted</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_3" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued&#160;ASU&#160;2023-07,&#160;Segment Reporting&#160;(Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments
in this&#160;ASU&#160;require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided
to the chief operating officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in
the reported measure of segment profit or loss. The&#160;ASU&#160;requires that a public entity disclose the title and position of the
CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and
deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280&#160;in
interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments
in this&#160;ASU&#160;and existing segment disclosures in Topic&#160;280. This&#160;ASU&#160;is effective for fiscal&#160;years beginning
after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption
permitted. The Company adopted ASU&#160;2023-07, which was applied retrospectively to all prior periods presented. See Note&#160;9 for
further details regarding this adoption.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 253; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c173_cont_7"><ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_4" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Standards not yet Adopted</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_5" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#8220;ASU&#160;2023-09&#8221;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c173_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#8217;s condensed consolidated financial statements.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="ck0001859807_InitialPublicOfferingTextBlock-c173_cont_1" escape="true" name="ck0001859807:InitialPublicOfferingTextBlock" id="ixv-35689"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Initial Public Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Public Units</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company sold <ix:nonFraction contextRef="c539" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40850">18,975,000</ix:nonFraction>&#160;Units, (which included <ix:nonFraction contextRef="c603" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40851">2,475,000</ix:nonFraction>&#160;Units&#160;issued pursuant to the full exercise of the over-allotment
option) at a purchase price of $<ix:nonFraction contextRef="c603" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40852">10.00</ix:nonFraction> per Unit. Each unit that the Company is offering has a price of $<ix:nonFraction contextRef="c604" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40853">10.00</ix:nonFraction> and consists of <ix:nonFraction contextRef="c538" decimals="0" format="ixt-sec:numwordsen" name="ck0001859807:NumberOfSharesIssuedPerUnit" scale="0" unitRef="shares" id="ixv-40854">one</ix:nonFraction> share
of common stock, one right, and one-half&#160;of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth&#160;(1/10)
of one share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof
to purchase <ix:nonFraction contextRef="c605" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares" id="ixv-40855">one</ix:nonFraction> share of common stock at a price of $<ix:nonFraction contextRef="c606" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40856">11.50</ix:nonFraction> per share, subject to adjustment as described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Public Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each whole warrant entitles
the holder to purchase <ix:nonFraction contextRef="c777" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares" id="ixv-40857">one</ix:nonFraction> share of common stock at a price of $<ix:nonFraction contextRef="c777" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40858">11.50</ix:nonFraction>&#160;per share, subject to adjustment as discussed herein. In addition,
if (x)&#160;the Company issues additional shares of common stock or equity-linked&#160;securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $<ix:nonFraction contextRef="c778" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40859">9.20</ix:nonFraction>&#160;per share of common
stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any
such issuance to the initial stockholders or their affiliates, without taking into account any founder shares held by such stockholders
or their affiliates, as applicable, prior to such issuance (the &#8220;Newly Issued Price&#8221;)), (y)&#160;the aggregate gross proceeds
from such issuances represent more than&#160;<ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:EquityProceedOwnershipPercentage" scale="-2" unitRef="pure" id="ixv-40860">60</ix:nonFraction>% of the total equity proceeds, and interest thereon, available for funding the initial
Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of the common stock during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates the Business Combination (such price,
the &#8220;Market Value&#8221;) is below $<ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" scale="0" unitRef="usdPershares" id="ixv-40861">9.20</ix:nonFraction>&#160;per share, the exercise price shall be adjusted (to the nearest cent) to be equal
to&#160;<ix:nonFraction contextRef="c155" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" scale="-2" unitRef="pure" id="ixv-40862">115</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, and the $<ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" scale="0" unitRef="usdPershares" id="ixv-40863">18.00</ix:nonFraction>&#160;per share redemption trigger price described
in the section &#8220;Redemption of warrants&#8221; will be adjusted (to the nearest cent) to be equal to&#160;<ix:nonFraction contextRef="c779" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" scale="-2" unitRef="pure" id="ixv-40864">180</ix:nonFraction>% of the higher of the
Market Value and the Newly Issued Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warrants will become exercisable
on the later of 12&#160;months from the closing of the IPO or 30&#160;days after the completion of its initial Business Combination and
will expire <span style="-sec-ix-hidden: hidden-fact-396">five</span>&#160;years after the completion of the Company&#8217;s initial Business Combination, at 5:00&#160;p.m., New&#160;York
City time, or earlier upon redemption or liquidation.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 254; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Initial Public Offering</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="ck0001859807_InitialPublicOfferingTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has agreed that as soon as
practicable, but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company
will use its reasonable best efforts to file, and within 60&#160;business days after the closing of the initial Business
Combination, to have declared effective, a registration statement relating to those shares of common stock, and to maintain a
current prospectus relating to such shares of common stock until the warrants expire or are redeemed. Notwithstanding the foregoing,
if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective within the
above specified period following the consummation of the initial Business Combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company shall have failed to maintain an effective
registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section&#160;3(a)(9)&#160;of the
Securities Act&#160;of&#160;1933, as amended, or the Securities Act, provided that such exemption is available. If that exemption,
or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Redemption of Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">in whole and not in part;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">at a price of $<ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:RedemptionPricePerWarrant" scale="0" unitRef="usdPershares" id="ixv-40865">0.01</ix:nonFraction> per warrant;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">upon a minimum of 30&#160;days&#8217; prior written notice
of redemption (the &#8220;30-day&#160;redemption period&#8221;);</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">if, and only if, the last sale price of the common stock equals
or exceeds $<ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" scale="0" unitRef="usdPershares" id="ixv-40866">18.00</ix:nonFraction> per share for any 20&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior
to the date on which the Company sends the notice of redemption to the warrant holders.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company calls the warrants
for redemption as described above, management will have the option to require all holders that wish to exercise warrants to do so on a
&#8220;cashless basis.&#8221; In determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221;
management will consider, among other factors, the Company&#8217;s cash position, the number of warrants that are outstanding and the
dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants.
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to
the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair
market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of the common stock for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" escape="true" name="ck0001859807:PrivatePlacementsTextBlock" id="ixv-35780"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;4 &#8212;&#160;Private Placement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor,&#160;I-Bankers
and Dawson James have purchased an aggregate of <ix:nonFraction contextRef="c768" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40867">7,347,500</ix:nonFraction> Private Placement Warrants (which included <ix:nonFraction contextRef="c780" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40868">697,500</ix:nonFraction> Private Placement Warrants
issued pursuant to the full exercise of the over-allotment option) at a price of $<ix:nonFraction contextRef="c768" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40869">1.00</ix:nonFraction> per warrant ($<ix:nonFraction contextRef="c781" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-40870">7,347,500</ix:nonFraction> in the aggregate) in a
private placement that closed simultaneously with the closing of the IPO.&#160;Of such amount, <ix:nonFraction contextRef="c782" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40871">5,162,500</ix:nonFraction> Private Placement Warrants were
purchased by the Sponsor and <ix:nonFraction contextRef="c783" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40872">2,185,000</ix:nonFraction> Private Placement Warrants were purchased by&#160;I-Bankers and Dawson James.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Private Placement Warrants
are identical to the warrants included in the units sold in the IPO, except that the Private Placement Warrants: (i)&#160;will not be
redeemable by the Company and (ii)&#160;may be exercised for cash or on a cashless basis, in each case so long as they are held by the
initial purchasers or any of their permitted transferees. If the Private Placement Warrants are held by holders other than the initial
purchasers or any of their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by
the holders on the same basis as the warrants included in the Units&#160;being sold in the IPO.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c173_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-35791"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Founder Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2021, the Sponsor
paid $<ix:nonFraction contextRef="c784" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-40873">25,000</ix:nonFraction>, or approximately $<ix:nonFraction contextRef="c785" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40874">0.005</ix:nonFraction> per share, to cover certain of the offering costs in exchange for an aggregate of <ix:nonFraction contextRef="c784" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40875">5,175,000</ix:nonFraction> shares
of common stock, par value $<ix:nonFraction contextRef="c785" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40876">0.0001</ix:nonFraction> per share (the &#8220;Founder Shares&#8221;). In October&#160;2021, the Sponsor irrevocably surrendered
to the Company for cancellation and for no consideration <ix:nonFraction contextRef="c616" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-40877">862,500</ix:nonFraction> shares of common stock. <ix:nonNumeric contextRef="c786" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-40878">On December&#160;20, 2021, the Company effected
a 1.1- for-1 stock dividend of its common stock</ix:nonNumeric>, resulting in the Sponsor holding
an aggregate of 4,743,750 shares of common stock. The Founder Shares include an aggregate of up to <ix:nonFraction contextRef="c787" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" unitRef="shares" id="ixv-40879">618,750</ix:nonFraction> shares subject to forfeiture
if the over-allotment option is not exercised by the underwriters in full. On December&#160;22, 2021, the over-allotment option was fully
exercised and such shares are no longer subject to forfeiture.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 255; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c173_cont_2" id="_RelatedPartyTransactionsDisclosureTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The Sponsor has agreed not to transfer, assign
or sell any of their Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of the initial Business Combination
or (B)&#160;the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the initial
Business Combination that results in all of the Company&#8217;s public stockholders having the right to exchange their shares of common
stock for cash, securities or other property (the &#8220;Lock-up&#8221;). Notwithstanding the foregoing, if the last sale price of the
Company&#8217;s common stock equals or exceeds $<ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:CommonStockExceedsPerShare" scale="0" unitRef="usdPershares" id="ixv-40880">12.00</ix:nonFraction> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any <ix:nonNumeric contextRef="c759" format="ixt-sec:durday" name="ck0001859807:NumberOfTradingDay" id="ixv-40881">20</ix:nonNumeric>&#160;trading days within any <ix:nonNumeric contextRef="c760" format="ixt-sec:durday" name="ck0001859807:NumberOfTradingDay" id="ixv-40882">30</ix:nonNumeric>-trading&#160;day period commencing at least 150&#160;days after the initial
Business Combination, the Founder Shares will be released from the Lock-up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Convertible Promissory Note&#160;&#8212;&#160;Related
Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $<ix:nonFraction contextRef="c622" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ConvertibleWorkingCapitalPromissoryNote" scale="0" unitRef="usd" id="ixv-40883">1,200,000</ix:nonFraction>. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $<ix:nonFraction contextRef="c623" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40884">1.00</ix:nonFraction> per warrant. On January&#160;10, 2024,
the Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $<ix:nonFraction contextRef="c554" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40885">1.5</ix:nonFraction>&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $<ix:nonFraction contextRef="c554" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40886">2.22</ix:nonFraction> per share at the election of the sponsor. On May&#160;31,
2024, the Company&#8217;s Board of Directors approved and the Company entered into a second amendment of its Convertible Working Capital
Promissory Note with the sponsor to increase the principal amount of the Note that could be drawn on to $<ix:nonFraction contextRef="c555" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="6" unitRef="usd" id="ixv-40887">2.5</ix:nonFraction>&#160;million. The second
amended and restated Note also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company
common stock at a price of $<ix:nonFraction contextRef="c555" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40888">2.22</ix:nonFraction>&#160;per share at the election of the sponsor. As of June&#160;30, 2025 and December&#160;31, 2024, the
Company had principal outstanding of $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="0" unitRef="usd" id="ixv-40889"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="0" unitRef="usd" id="ixv-40890">1,919,796</ix:nonFraction></ix:nonFraction> and is presenting the Note at fair value on its balance sheet at June&#160;30, 2025 and
December&#160;31, 2024 in the amount of $<ix:nonFraction contextRef="c788" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40891">10,288,111</ix:nonFraction> and $<ix:nonFraction contextRef="c624" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-40892">8,908,052</ix:nonFraction>, respectively. The Company has deferred the repayment of the Note to
six&#160;months after the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
in a private transaction, the Company entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an institutional investor
(the &#8220;Investor&#8221;). Pursuant to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth
in the SPA, to purchase from the Company&#8217;s senior secured convertible promissory notes (&#8220;Ascent Note&#8221;) in an aggregate
principal amount of up to $<ix:nonFraction contextRef="c789" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40893">22,222,222</ix:nonFraction> for a purchase price of up to $<ix:nonFraction contextRef="c790" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40894">20,000,000</ix:nonFraction>, after a <ix:nonFraction contextRef="c790" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfOriginalIssueDiscount" scale="-2" unitRef="pure" id="ixv-40895">10</ix:nonFraction>% original issue discount (&#8220;OID&#8221;).
As of June&#160;30, 2025 and December&#160;31, 2024, the Company is presenting the Ascent Note at fair value on its balance sheet at June&#160;30,
2025 and December&#160;31, 2024 in the amount of $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement" scale="0" unitRef="usd" id="ixv-40896">193,878</ix:nonFraction> and <ix:nonFraction contextRef="c135" decimals="0" format="ixt:fixed-zero" name="ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement" scale="0" unitRef="usd" id="ixv-40897">$0</ix:nonFraction>, respectively (See details on Note&#160;6).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Business
Combination, pursuant to the SPA, the Company issued a PIPE Convertible Note in the principal amount of $<ix:nonFraction contextRef="c791" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40898">10,000,000</ix:nonFraction> (the &#8220;Initial
Note&#8221;) for a purchase price of $<ix:nonFraction contextRef="c792" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40899">9,000,000</ix:nonFraction>, reflecting a <ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfOriginalIssueDiscount" scale="-2" unitRef="pure" id="ixv-40900">10</ix:nonFraction>% OID.&#160;The Initial Note matures on the date that is <ix:nonNumeric contextRef="c792" format="ixt-sec:durmonth" name="us-gaap:DebtInstrumentTerm" id="ixv-40901">18</ix:nonNumeric>-months from
the Closing and is convertible at any time at the Investor&#8217;s option at a conversion price equal to the lower of $<ix:nonFraction contextRef="c791" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-40902">10</ix:nonFraction> or <ix:nonFraction contextRef="c791" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice" scale="-2" unitRef="pure" id="ixv-40903">95</ix:nonFraction>% of the
lowest daily volume-weighted average price per share of the post-combination company common stock in the <ix:nonNumeric contextRef="c792" format="ixt-sec:duryear" name="ck0001859807:NumberOfTradingDay" id="ixv-40904">10</ix:nonNumeric>&#160;trading days prior to
the original issue date of the Initial Note and shall be adjusted, without limitation, based on down-round and most-favored nation (MFN)
price and terms protections (the &#8220;Conversion Price&#8221;).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 256; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Related Party Loans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended initial Business Combination, the initial stockholders or an affiliate of the initial stockholders
or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the
&#8220;Working Capital Loans&#8221;). If the Company completes the initial Business Combination, the Company would repay such loaned amounts
out of the proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside
the Trust Account. Up to $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="0" unitRef="usd" id="ixv-40905">1,500,000</ix:nonFraction> of such loans may be convertible, at the option of the lender, into warrants at a price of $<ix:nonFraction contextRef="c793" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-40906">1.00</ix:nonFraction> per
warrant of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants, including as to exercise
price, exercisability and exercise period. At June&#160;30, 2025 and December&#160;31, 2024, the Company had no borrowings under the Working
Capital Loans, other than the Note described in &#8220;Note&#160;5 &#8212;&#160;Related Party Transactions&#160;&#8212;&#160;Convertible
Promissory Note&#160;&#8212;&#160;Related Party&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Administrative Service Fee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing on the effective
date of the IPO, the Company began paying its Sponsor a total of $<ix:nonFraction contextRef="c794" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" scale="0" unitRef="usd" id="ixv-40907">5,000</ix:nonFraction>&#160;per month for office space, utilities, secretarial support
and other administrative and consulting services. As of June&#160;30, 2023, the Company and the Sponsor terminated this agreement. For
the three and six&#160;months ended June&#160;30, 2025 and 2024, <ix:nonFraction contextRef="c151" decimals="0" format="ixt:fixed-zero" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40908"><ix:nonFraction contextRef="c795" decimals="0" format="ixt:fixed-zero" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40909"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:fixed-zero" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40910"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:fixed-zero" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-40911">$0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> had been incurred and billed relating to the administrative service
fee, respectively. As of June&#160;30, 2025 and December&#160;31, 2024, $<ix:nonFraction contextRef="c796" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40912"><ix:nonFraction contextRef="c797" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40913">50,000</ix:nonFraction></ix:nonFraction> relating to the administrative service fee was not paid
and recorded as due to related party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Advances from Profusa</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the three and six&#160;months
ended June&#160;30, 2025 and 2024, Profusa agreed to advance funds to the Company to pay for operating expenses. As of June&#160;30, 2025
and December&#160;31, 2024, there was $<ix:nonFraction contextRef="c798" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" unitRef="usd" id="ixv-40914">1,299,040</ix:nonFraction> and $<ix:nonFraction contextRef="c627" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" unitRef="usd" id="ixv-40915">791,407</ix:nonFraction>, respectively owed to Profusa, which is due upon demand or at the completion
of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Due to Related Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, $<ix:nonFraction contextRef="c796" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40916"><ix:nonFraction contextRef="c797" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-40917">50,000</ix:nonFraction></ix:nonFraction> relating to the administrative service fee was not paid and recorded as due to related party. On February&#160;24,
2025, the Company paid costs on behalf of its Sponsor which reduced the balance due by $<ix:nonFraction contextRef="c799" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SponsorFees" scale="0" unitRef="usd" id="ixv-40918">8,820</ix:nonFraction>.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-35897"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Registration Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of the Founder
Shares, the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any underlying securities)
are entitled to registration rights pursuant to a registration rights agreement signed on the closing date of the IPO requiring the Company
to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration
rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective
until termination of the applicable Lock-up&#160;period described in Note&#160;5. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 257; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Underwriters Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters had a <ix:nonNumeric contextRef="c173" format="ixt-sec:durday" name="ck0001859807:NumberOfDaysForUnderwriterOptions" id="ixv-40919">30</ix:nonNumeric>-day&#160;option
from the date of IPO to purchase up to an additional&#160;<ix:nonFraction contextRef="c800" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40920">2,475,000</ix:nonFraction>&#160;units to cover over-allotments, if any. On December&#160;22,
2021, the over-allotment was fully exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters received a
cash underwriting discount of approximately&#160;<ix:nonFraction contextRef="c801" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:UnderwritingExpenseRatio" scale="-2" unitRef="pure" id="ixv-40921">1.82</ix:nonFraction>% of the gross proceeds of the IPO, or $<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:UnderwritingDiscountAmount" scale="0" unitRef="usd" id="ixv-40922">3,450,000</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Business Combination Marketing Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under a Business Combination
marketing agreement, the Company engaged&#160;I-Bankers and Dawson James as advisors in connection with the Business Combination to assist
the Company in holding meetings with the stockholders to discuss the potential Business Combination and the target business&#8217;s attributes,
introduce the Company to potential investors that are interested in purchasing the Company&#8217;s securities in connection with the potential
Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company was obligated to pay&#160;I-Bankers and Dawson
James a cash fee for such marketing services upon the consummation of the initial Business Combination in an amount of&#160;<ix:nonFraction contextRef="c155" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:InitialPublicOfferingGrossProceedPercentage" scale="-2" unitRef="pure" id="ixv-40923">3.68</ix:nonFraction>% of the
gross proceeds of the IPO, or $<ix:nonFraction contextRef="c802" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40924">6,986,250</ix:nonFraction>. The agreement was amended on November&#160;7, 2022 to allow for the <ix:nonFraction contextRef="c629" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:BusinessCombinationPercentageRate" scale="-2" unitRef="pure" id="ixv-40925">3.68</ix:nonFraction>% business combination
fee to be paid as (a)&#160;<ix:nonFraction contextRef="c629" decimals="3" format="ixt:num-dot-decimal" name="ck0001859807:CashPercentage" scale="-2" unitRef="pure" id="ixv-40926">27.5</ix:nonFraction>% cash and (b)&#160;<ix:nonFraction contextRef="c629" decimals="3" format="ixt:num-dot-decimal" name="ck0001859807:EquityPercentage" scale="-2" unitRef="pure" id="ixv-40927">72.5</ix:nonFraction>% to be rolled into equity at closing. Subsequently, on January&#160;19, 2025,
the agreement was modified by the parties such that the Company will be required to pay $<ix:nonFraction contextRef="c803" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherCommitmentDueInSecondAndThirdYear" scale="0" unitRef="usd" id="ixv-40928">2,000,000</ix:nonFraction>, payable in cash, if a business combination
is consummated. As a result of the Business Combination,&#160;I-Bankers was paid $<ix:nonFraction contextRef="c804" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40929">900,000</ix:nonFraction> and Dawson James was paid $<ix:nonFraction contextRef="c805" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-40930">600,000</ix:nonFraction> under the
Business Combination marketing agreement. The payment of the remaining $<ix:nonFraction contextRef="c798" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="0" unitRef="usd" id="ixv-40931">500,000</ix:nonFraction> has been deferred until after the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Non-Redemption Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;8, 2025, the Company
entered into a non-redemption&#160;agreement (the &#8220;Non-Redemption&#160;Agreement&#8221;) with&#160;I-Bankers Securities, Inc. and
Dawson James Securities, Inc. (together, the &#8220;Investors&#8221;), pursuant to which such Investors agreed that to the extent that
redemptions in connection with the vote to approve the Business Combination reduces the Company&#8217;s trust account balance below $<ix:nonFraction contextRef="c806" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrust" scale="6" unitRef="usd" id="ixv-40932">1.25</ix:nonFraction>&#160;million,
the Investors would offer such redeeming shareholders an opportunity to rescind the redemption of their shares and would instead purchase
such shares. Such purchases would be structured in compliance with the requirements of&#160;Rule&#160;14e-5&#160;under the&#160;Exchange&#160;Act&#160;or
would otherwise not constitute a tender offer pursuant to the&#160;Exchange&#160;Act. As of the Closing Date, the Company&#8217;s trust
account balance was not below $<ix:nonFraction contextRef="c806" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-40933">1.25</ix:nonFraction>&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Representative&#8217;s Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company issued&#160;<ix:nonFraction contextRef="c631" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares" id="ixv-40934">450,000</ix:nonFraction>&#160;shares (Representative Shares) of common stock (which included&#160;<ix:nonFraction contextRef="c632" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares" id="ixv-40935">37,500</ix:nonFraction>&#160;Representative Shares
issued pursuant to the full exercise of the over-allotment option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James
(and/or their designees).&#160;I-Bankers&#160;and Dawson James (and/or their designees) have agreed not to transfer, assign or sell any
such shares until the completion of the initial Business Combination. In addition,&#160;I-Bankers&#160;and Dawson James (and/or their
designees) have agreed (i)&#160;to waive their redemption rights with respect to such shares in connection with the completion of the
initial Business Combination and (ii)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to such
shares if the Company fails to complete its initial Business Combination within the Combination Period. The fair value of the Representative&#8217;s
Shares issued are recognized as&#160;offering costs directly attributable to the issuance of an equity contract to be classified in equity
and are recorded as a reduction of equity (see Note&#160;1).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 258; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_3" id="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Representative&#8217;s Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company granted to&#160;I-Bankers&#160;and
Dawson James (and/or their designees) <ix:nonFraction contextRef="c807" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40936">569,250</ix:nonFraction>&#160;warrants (which included <ix:nonFraction contextRef="c732" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-40937">74,250</ix:nonFraction>&#160;warrants issued pursuant to the full exercise
of the over-allotment option) exercisable at $<ix:nonFraction contextRef="c769" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-40938">11.50</ix:nonFraction>&#160;per share (or an aggregate exercise price of $<ix:nonFraction contextRef="c787" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-40939">6,546,375</ix:nonFraction>) at the closing of the
IPO.&#160;The Representative Warrants issued are recognized as derivative liabilities in accordance with ASC&#160;815-40 and recorded
as liabilities at fair value each reporting period (see Notes 1 and 8). The warrants may be exercised for cash or on a cashless basis,
at the holder&#8217;s option, at any time during the period commencing on the later of the first anniversary of the effective date of
the registration statement of which the IPO forms a part and the closing of the initial Business Combination and terminating on the fifth
anniversary of such effectiveness date. Notwithstanding anything to the contrary,&#160;I-Bankers&#160;and Dawson James have agreed that
neither they nor their designees will be permitted to exercise the warrants after the&#160;<ix:nonNumeric contextRef="c155" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="ixv-40940">five year</ix:nonNumeric>&#160;anniversary of the effective
date of the registration statement of which the IPO forms a part. The warrants and such shares purchased pursuant to the warrants have
been deemed compensation by FINRA and are therefore subject to a lock-up&#160;for a period of <ix:nonNumeric contextRef="c173" format="ixt-sec:durwordsen" name="ck0001859807:LockupPeriod" id="ixv-40941">180&#160;days</ix:nonNumeric> immediately following the
date of the effectiveness of the registration statement of which the IPO forms a part pursuant to FINRA Rule&#160;5110I(1). Pursuant to
FINRA Rule&#160;5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the economic disposition of the securities by any person for a period of 180&#160;days immediately following the effective
date of the registration statement of which the IPO forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated
for a period of 180&#160;days immediately following the effective date of the registration statement of which the IPO forms a part except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The warrants grant to holders
demand and &#8220;piggy back&#8221; rights for periods of five and seven&#160;years, respectively, from the effective date of the registration
statement of which the IPO forms a part with respect to the registration under the Securities Act&#160;of&#160;the shares issuable upon
exercise of the warrants. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting
commissions, which will be paid for by the holders themselves. The exercise price and number of shares issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a share dividend, or the Company&#8217;s recapitalization, reorganization,
merger or consolidation. However, the warrants will not be adjusted for issuances of shares at a price below its exercise price. The Company
will have no obligation to net cash settle the exercise of the warrants. The holder of the warrants will not be entitled to exercise the
warrants for cash unless a registration statement covering the securities underlying the warrants is effective or an exemption from registration
is available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Merger Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, NorthView
entered into a Merger Agreement and Plan of Reorganization (the &#8220;Merger Agreement&#8221;), by and among Merger Sub., and Profusa,
Inc., a California corporation (&#8220;Profusa&#8221;). The Merger Agreement provides that, among other things, at the closing of the
transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Profusa (the &#8220;Merger&#8221;), with Profusa
surviving as a wholly-owned subsidiary of NorthView.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Special Meeting held
on June&#160;9, 2025, the Company&#8217;s stockholders voted to approve the proposals outlined in the Proxy Statement/Prospectus, including,
among other things, the adoption of the Merger Agreement and approval of the transactions contemplated by the Merger Agreement, including
the merger of Merger Sub with and into Profusa, with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary
the Company, and the issuance of the Company&#8217;s common stock as consideration thereunder. On July&#160;11, 2025, the Closing was
completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Closing,
the Company changed its name to &#8220;Profusa, Inc.&#8221;</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 259; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_4" id="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Advisory Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;19,
2024, the Company engaged A.G.P to serve as the placement agent in connection with a proposed business combination transaction. The
Company shall pay to A.G.P. a cash fee (the &#8220;Cash Fee&#8221;) equal to <ix:nonFraction contextRef="c808" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" scale="-2" unitRef="pure" id="ixv-40942">9.0</ix:nonFraction>% in a convertible note offering, note, or other
similar equity-linked offerings, and shall be calculated from the face value of notes issued, which is payable at the close of a
Business Combination. On June&#160;17, 2025, the Company entered a settlement agreement with A.G.P. for the Cash Fee of $<ix:nonFraction contextRef="c809" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredLeasingFees" scale="0" unitRef="usd" id="ixv-40943">968,000</ix:nonFraction>
related to the debt private placement (the &#8220;Offering&#8221;) that was issued at the Closing. Pursuant to the settlement
agreement, as a result of the Business Combination, the Company paid A.G.P. $<ix:nonFraction contextRef="c810" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="0" unitRef="usd" id="ixv-40944">550,000</ix:nonFraction> at the Closing and the remaining $<ix:nonFraction contextRef="c811" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="0" unitRef="usd" id="ixv-40945">418,000</ix:nonFraction> of
the fees was deferred and due on the earlier of (i)&#160;the second tranche of the debt private placement being issued and
(ii)&#160;December&#160;31, 2025. The Company also agreed to reimburse A.G.P. $<ix:nonFraction contextRef="c811" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="0" unitRef="usd" id="ixv-40946">50,000</ix:nonFraction> for expenses incurred in connection with the
offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;15, 2023, the
Company engaged the Benchmark Company LLC (&#8220;Benchmark&#8221;) to provide advisory services related to the Business Combination and
the Convertible Notes. The Company was to pay Benchmark at the closing of the Business Combination an advisory fee of $<ix:nonFraction contextRef="c812" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="0" unitRef="usd" id="ixv-40947">750,000</ix:nonFraction> in two
tranches. The first tranche will be $<ix:nonFraction contextRef="c813" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="0" unitRef="usd" id="ixv-40948">500,000</ix:nonFraction> earned upon the closing of the Business Combination in the surviving public entity&#8217;s
common stock (&#8220;Tranche 1&#8221;). The number of shares to be issued is calculated on the 30<sup>th</sup>&#160;day following the
Closing by dividing $<ix:nonFraction contextRef="c814" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="0" unitRef="usd" id="ixv-40949">500,000</ix:nonFraction> and the trailing 5-day VWAP of the Company&#8217;s common stock as calculated by Bloomburg with a minimum
price of $<ix:nonFraction contextRef="c815" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40950">2.00</ix:nonFraction>. The second tranche will be $<ix:nonFraction contextRef="c816" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="0" unitRef="usd" id="ixv-40951">250,000</ix:nonFraction>, at the Company&#8217;s option, in either cash or in the surviving entity&#8217;s
common shares calculated by dividing $<ix:nonFraction contextRef="c816" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="0" unitRef="usd" id="ixv-40952">250,000</ix:nonFraction> by the lowest trailing 5-day VWAP in the prior 30&#160;days (&#8220;Tranche 2&#8221;). Upon
funding of the Convertible Notes by investors introduced by Benchmark, the Company will pay to Benchmark fees in cash equal to <ix:nonFraction contextRef="c817" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfNetProceeds" scale="-2" unitRef="pure" id="ixv-40953">5</ix:nonFraction>% of the
net proceeds of any Convertible Note draw at the time of funding of such draw (&#8220;Arrangement Fees&#8221;). The Tranche 2 fee shall
be reduced by the amount of any fees paid to Benchmark for other transactions during the Term other than Arrangement Fees associated with
Convertible Notes, after the Business Combination, up to $<ix:nonFraction contextRef="c817" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="0" unitRef="usd" id="ixv-40954">250,000</ix:nonFraction>. As a result of the Business Combination, Benchmark was paid in shares
of the post-combination company in the amount of $<ix:nonFraction contextRef="c813" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="0" unitRef="usd" id="ixv-40955">500,000</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
in a private transaction, the Company entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an institutional investor
(the &#8220;Investor&#8221;). Pursuant to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth
in the SPA, to purchase from the Company&#8217;s senior secured convertible promissory notes in an aggregate principal amount of up to
$<ix:nonFraction contextRef="c721" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40956">22,222,222</ix:nonFraction> (the &#8220;Convertible Notes&#8221;) for a purchase price of up to $<ix:nonFraction contextRef="c722" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40957">20,000,000</ix:nonFraction>, after a <ix:nonFraction contextRef="c722" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-40958">10</ix:nonFraction>% original issue discount (&#8220;OID&#8221;).
As a result of the Business Combination, pursuant to the SPA, the Company issued a Convertible Note in the principal amount of $<ix:nonFraction contextRef="c818" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40959">10,000,000</ix:nonFraction>
(the &#8220;Initial Note&#8221;) for a purchase price of $<ix:nonFraction contextRef="c723" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermPurchaseCommitmentAmount" scale="0" unitRef="usd" id="ixv-40960">9,000,000</ix:nonFraction>, reflecting a <ix:nonFraction contextRef="c819" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-40961">10</ix:nonFraction>% OID.&#160;The Initial Note matures on the date that
is 18-months from the closing of the Business Combination and is convertible at any time at the Investor&#8217;s option at a conversion
price equal to the lower of $<ix:nonFraction contextRef="c820" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-40962">10</ix:nonFraction> or <ix:nonFraction contextRef="c723" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:WeightedAveragePricePerSharePercentage" scale="-2" unitRef="pure" id="ixv-40963">95</ix:nonFraction>% of the lowest daily volume-weighted average price per share of the post-combination company common
stock in the <ix:nonNumeric contextRef="c723" format="ixt-sec:duryear" name="ck0001859807:NumberOfTradingDay" id="ixv-40964">10</ix:nonNumeric>&#160;trading days prior to the original issue date of the Initial Note and shall be adjusted, without limitation, based
on down-round and most-favored nation (MFN) price and terms protections (the &#8220;Conversion Price&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SPA contemplates that additional
Convertible Notes will be purchased in multiple tranches:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Prior to the one-year anniversary of the Initial Closing Date,
subject to the conditions set forth in the SPA, the Company may request that the Investor purchase additional Convertible Notes having
an aggregate principal amount of up to $<ix:nonFraction contextRef="c821" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40965">12,222,222</ix:nonFraction> at a purchase price of $<ix:nonFraction contextRef="c822" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40966">11,000,000</ix:nonFraction> (reflecting a <ix:nonFraction contextRef="c822" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-40967">10</ix:nonFraction>% OID), as follows:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">Provided a registration statement has been filed for the
shares underlying the Initial Note, shares of combined company common stock, par value $<ix:nonFraction contextRef="c823" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40968">0.0001</ix:nonFraction> (&#8220;New Profusa Common Stock&#8221;)
have traded a volume of at least <ix:nonFraction contextRef="c823" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-40969">15,000,000</ix:nonFraction> shares in the aggregate, and no default or event of default has occurred, the Company may
call and thereby require the Investor to purchase Convertible Notes in the aggregate principal amount of $<ix:nonFraction contextRef="c824" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40970">2,222,222</ix:nonFraction> for a purchase price
of $<ix:nonFraction contextRef="c825" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40971">2,000,000</ix:nonFraction> (reflecting a <ix:nonFraction contextRef="c825" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-40972">10</ix:nonFraction>% OID) (&#8220;Second Purchase&#8221;);</td>
</tr></table></ix:continuation><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 260; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c173_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(b)</td><td style="text-align: justify">Provided a registration statement is effective for the shares
underlying the Initial Note, New Profusa Common Stock has traded a volume of at least $<ix:nonFraction contextRef="c823" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd" id="ixv-40973">35,000,000</ix:nonFraction> in the aggregate after the $<ix:nonFraction contextRef="c826" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40974">2,000,000</ix:nonFraction>
Second Purchase has closed, no default or event of default has occurred and the stock has traded at a trading price of no less than $<ix:nonFraction contextRef="c827" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:TradingPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40975">4.00</ix:nonFraction>
for a period of <ix:nonNumeric contextRef="c827" continuedAt="ck0001859807_NumberOfTradingDay-c827_cont_1" format="ixt-sec:durwordsen" name="ck0001859807:NumberOfTradingDay" id="ixv-40976">five</ix:nonNumeric>&#160;trading<ix:continuation id="ck0001859807_NumberOfTradingDay-c827_cont_1"> days</ix:continuation> preceding such purchase, the Company may call and thereby require the Investor to purchase Convertible
Notes in the aggregate principal amount of $<ix:nonFraction contextRef="c828" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40978">5,555,555</ix:nonFraction> for a purchase price of $<ix:nonFraction contextRef="c829" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40979">5,000,000</ix:nonFraction> (reflecting a <ix:nonFraction contextRef="c829" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-40980">10</ix:nonFraction>% OID); and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(c)</td><td style="text-align: justify">The Investor at its sole discretion may call from the Company
and thereby require the Company to sell an additional Convertible Note having an aggregate principal amount of $<ix:nonFraction contextRef="c830" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-40981">4,444,444</ix:nonFraction> at a purchase
price of $<ix:nonFraction contextRef="c831" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="usd" id="ixv-40982">4,000,000</ix:nonFraction> (reflecting a <ix:nonFraction contextRef="c831" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-40983">10</ix:nonFraction>% OID) to be purchased at any time within 12&#160;months of the Initial Closing.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Business
Combination, the Company paid $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd" id="ixv-40984">90,000</ix:nonFraction> at the Closing to an advisor for legal services in connection with the issuance of the Convertible
Note.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-36105"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;7 &#8212;&#160;Stockholders&#8217;
Deficit</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Preferred stock</i></b>&#160;&#8212;&#160;The
Company is authorized to issue&#160;<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40985">1,000,000</ix:nonFraction>&#160;shares of preferred stock with a par value of $<ix:nonFraction contextRef="c155" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40986">0.0001</ix:nonFraction>&#160;and with such designations,
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.&#160;As of June&#160;30, 2025
and December&#160;31, 2024, there was <span style="-sec-ix-hidden: hidden-fact-397"><span style="-sec-ix-hidden: hidden-fact-398"><span style="-sec-ix-hidden: hidden-fact-399"><span style="-sec-ix-hidden: hidden-fact-400">no</span></span></span></span> preferred stock issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Common Stock&#160;</i></b>&#8212;&#160;The
Company is authorized to issue a total of&#160;<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-40987">100,000,000</ix:nonFraction>&#160;shares of common stock at par value of $<ix:nonFraction contextRef="c155" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-40988">0.0001</ix:nonFraction>&#160;each. In April&#160;2021,
the Company issued&#160;<ix:nonFraction contextRef="c636" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40989">5,175,000</ix:nonFraction>&#160;shares of common stock to its Sponsor for $<ix:nonFraction contextRef="c637" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-40990">25,000</ix:nonFraction>, or approximately $<ix:nonFraction contextRef="c638" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-40991">0.005</ix:nonFraction>&#160;per share. In October&#160;2021,
the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration&#160;<ix:nonFraction contextRef="c832" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-40992">862,500</ix:nonFraction>&#160;shares of common stock.&#160;<ix:nonNumeric contextRef="c833" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-40993">On
December&#160;20, 2021,&#160;the Company effected a 1.1- for-1&#160;stock dividend of its common stock</ix:nonNumeric>, resulting in an aggregate of <ix:nonFraction contextRef="c834" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:FounderSharesIssued" scale="0" unitRef="shares" id="ixv-40994">4,743,750</ix:nonFraction>
Founder Shares issued&#160;and outstanding.&#160;On December&#160;22, 2021, the Company has also issued&#160;<ix:nonFraction contextRef="c538" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-40995">450,000</ix:nonFraction>&#160;shares (Representative&#8217;s
Shares) of common stock (which included&#160;<ix:nonFraction contextRef="c537" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-40996">37,500</ix:nonFraction>&#160;Representative Shares issued pursuant to the full exercise of the over-allotment
option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James (and/or their designees).&#160;As of June&#160;30, 2025
and December&#160;31, 2024, there were&#160;<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-40997"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-40998"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-40999"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-41000">5,193,750</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of common stock issued and outstanding, excluding&#160;<ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-41001">101,777</ix:nonFraction> and <ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-41002">687,519</ix:nonFraction>
shares of common stock subject to redemption, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Common stockholders of record
are entitled to <ix:nonNumeric contextRef="c173" name="us-gaap:CommonStockVotingRights" id="ixv-41003">one</ix:nonNumeric> vote for each share held on all matters to be voted on by stockholders. Unless specified in the Company&#8217;s amended
and restated certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange
rules, the affirmative vote of a majority of the Company&#8217;s common stock that are voted is required to approve any such matter voted
on by the stockholders. There is no cumulative voting with respect to the election of directors, with the result that the holders of more
than&#160;<ix:nonFraction contextRef="c155" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:VotingSharesPercentage" scale="-2" unitRef="pure" id="ixv-41004">50</ix:nonFraction>% of the shares voted for the election of directors can elect all of the directors (prior to consummation of the initial Business
Combination). The Company&#8217;s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors
out of funds legally available therefor.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="_FairValueDisclosuresTextBlock-c173_cont_1" escape="true" name="us-gaap:FairValueDisclosuresTextBlock" id="ixv-36130"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Fair value is defined as the
price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants
at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). The Company&#8217;s financial instruments are classified as either
Level 1, Level 2 or Level 3. These tiers include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Level 1, defined as observable inputs such as quoted prices
(unadjusted) for identical instruments in active markets;</td>
</tr></table></ix:nonNumeric><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 261; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c173_cont_2" id="_FairValueDisclosuresTextBlock-c173_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Level 2, defined as inputs other than quoted prices in active
markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices
for identical or similar instruments in markets that are not active; and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Level 3, defined as unobservable inputs in which little or
no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques
in which one or more significant inputs or significant value drivers are unobservable.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c173" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="ixv-36181"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables present
information about the Company&#8217;s assets and liabilities that are measured at fair value on June&#160;30, 2025 and December&#160;31,
2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Quoted<span style="text-decoration:underline"><br/> </span>Prices In<span style="text-decoration:underline"><br/> </span>Active<span style="text-decoration:underline"><br/> </span>Markets<span style="text-decoration:underline"><br/> </span>(Level 1)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Observable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 2)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Unobservable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 3)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c835" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-41005">1,935,561</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c836" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-41006">1,274,549</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c777" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41007">3,795,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c840" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41008">3,795,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c768" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41009">2,939,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c844" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41010">2,939,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c845" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41011">227,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c848" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41012">227,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible Promissory Note&#160;&#8211;&#160;Related Party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c849" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41013">10,288,111</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c852" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41014">10,288,111</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Securities Purchase Agreement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c853" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:SecuritiesPurchaseAgreementCurrent" scale="0" unitRef="usd" id="ixv-41015">193,878</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c856" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:SecuritiesPurchaseAgreementCurrent" scale="0" unitRef="usd" id="ixv-41016">193,878</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c853" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-41017">17,443,689</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-413">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c855" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-41018">3,795,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c856" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-41019">13,648,689</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Quoted<span style="text-decoration:underline"><br/> </span>Prices In<span style="text-decoration:underline"><br/> </span>Active<span style="text-decoration:underline"><br/> </span>Markets<span style="text-decoration:underline"><br/> </span>(Level 1)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Observable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 2)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Unobservable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 3)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c857" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-41020">8,330,835</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c644" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="0" unitRef="usd" id="ixv-41021">8,330,835</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c607" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41022">379,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c649" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41023">379,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c593" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41024">293,900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c654" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41025">293,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c704" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41026">22,770</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c658" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41027">22,770</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible Promissory Note&#160;&#8211;&#160;Related Party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c858" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41028">8,908,052</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41029">8,908,052</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c858" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-41030">9,604,222</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c661" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-41031">379,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="usd" id="ixv-41032">9,224,722</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Public Warrants, the Private
Placement Warrants and the Representative&#8217;s Warrants were accounted for as liabilities in accordance with ASC&#160;815-40 and are
presented within liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception
and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated
statements of operations.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 262; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c173_cont_3" id="_FairValueDisclosuresTextBlock-c173_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilized a Monte
Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants at June&#160;30,
2025 and December&#160;31, 2024 was classified as Level 2 due to the lack of an active market. As of June&#160;30, 2025 and December&#160;31,
2024, the aggregate value of Public Warrants was $<ix:nonFraction contextRef="c777" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41033">3,795,000</ix:nonFraction> and $<ix:nonFraction contextRef="c607" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41034">379,500</ix:nonFraction>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company uses a Monte Carlo
simulation model to value the Private Placement Warrants and the Representative&#8217;s Warrants. The Private Placement Warrants and the
Representative&#8217;s Warrants were classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent
in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates
the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free
interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining
life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c173" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="ixv-36639"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, <span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, <span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c859" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41035">4.22</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c689" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41036">4.18</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c860" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41037">0.61</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c691" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41038">0.89</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c862" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41039">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c695" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41040">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c863" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41041">12.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c697" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-41042">12.12</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, <span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, <span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c859" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41043">4.28</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c689" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41044">4.18</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c860" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41045">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c691" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41046">0.27</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt">De minimis</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c862" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41047">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c695" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41048">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c863" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41049">12.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c697" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41050">12.12</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the securities purchase agreement were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c864" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41051">3.83</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c866" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41052">1.59</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c868" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41053">4.84</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c870" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41054">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c872" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" unitRef="pure" id="ixv-41055">12.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 263; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c173_cont_4" id="_FairValueDisclosuresTextBlock-c173_cont_3"><ix:nonNumeric contextRef="c173" escape="true" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="ixv-36911"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the three and six&#160;months ended June&#160;30, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c593" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41056">293,900</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c704" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41057">22,770</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c874" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41058">316,670</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c875" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41059">146,950</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c876" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41060">11,385</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c877" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41061">158,335</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c878" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41062">440,850</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c879" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41063">34,155</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c880" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41064">475,005</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c881" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41065">2,498,150</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c882" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41066">193,545</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c883" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41067">2,691,695</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c768" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41068">2,939,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c845" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41069">227,700</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c884" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41070">3,166,700</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c699" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41071">66,128</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c700" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41072">5,123</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c885" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41073">71,251</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c886" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41074">213,077</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c887" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41075">16,509</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c888" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41076">229,586</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c889" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41077">279,205</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c890" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41078">21,632</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c891" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41079">300,837</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c892" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41080">124,908</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c893" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41081">9,676</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c894" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-41082">134,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c895" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41083">404,113</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c896" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41084">31,308</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c897" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-41085">435,421</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c173" continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c173_cont_1" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="ixv-37088"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Convertible<span style="text-decoration:underline"><br/> </span>Promissory<span style="text-decoration:underline"><br/> </span>Note&#160;&#8211;&#160;related<span style="text-decoration:underline"><br/> </span>party</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2024</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c898" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41086">8,908,052</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c899" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" unitRef="usd" id="ixv-41087">225,330</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c900" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41088">9,133,382</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c901" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" unitRef="usd" id="ixv-41089">1,154,729</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c902" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41090">10,288,111</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Convertible<span style="text-decoration:underline"><br/> </span>Promissory<span style="text-decoration:underline"><br/> </span>Note</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c903" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41091">944,118</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Principal proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c904" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" unitRef="usd" id="ixv-41092">378,185</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c904" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" sign="-" unitRef="usd" id="ixv-41093">60,077</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Fair value at March&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c905" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41094">1,262,226</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds received through convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c906" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" unitRef="usd" id="ixv-41095">330,796</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c906" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" sign="-" unitRef="usd" id="ixv-41096">66,021</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c907" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41097">1,527,001</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>


</div><!-- Field: Page; Sequence: 264; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_FairValueDisclosuresTextBlock-c173_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The convertible promissory
note was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent in pricing models are assumptions
related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common
stock based on historical volatility that matches the expected remaining life of the note.
The risk-free interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the
expected remaining life of the note. The expected life of the note is assumed to be equivalent to their remaining contractual term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c173_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Securities<span style="text-decoration:underline"><br/> </span>Purchase<span style="text-decoration:underline"><br/> </span>Agreement</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at February&#160;11, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">Change in fair value of securities purchase agreement</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c909" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" unitRef="usd" id="ixv-41098">23,487</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c910" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41099">23,487</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of securities purchase agreement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c911" decimals="0" format="ixt:num-dot-decimal" name="ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote" scale="0" unitRef="usd" id="ixv-41100">170,391</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c912" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd" id="ixv-41101">193,878</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilizes a Monte
Carlo model to estimate the fair value of the conversion feature within the securities purchase agreement, which is required to be recorded
at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the
conversion feature are recognized as non-cash gains or losses in the accompanying condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key assumptions in the
model relate to expected share-price volatility, risk-free interest rate, exercise price, expected term and the probability of occurrence
of the transaction. The expected volatility was based on the average volatility of special purpose acquisition companies that are searching
for an acquisition target. The risk-free interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for
a maturity similar to the expected remaining life of the note. The expected life of the note is assumed to be equivalent to their remaining
contractual term.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="_SegmentReportingDisclosureTextBlock-c173_cont_1" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock" id="ixv-37274"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Segment Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC Topic&#160;280,&#160;&#8220;Segment
Reporting,&#8221; establishes standards for companies to report in their financial statement information about operating segments, products,
services, geographic areas, and major customers.&#160;Operating segments are defined as components of an enterprise that engage in business
activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is
regularly evaluated by the Company&#8217;s chief operating decision maker, or group, in deciding how to allocate resources and assess
performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s chief operating
decision maker (&#8220;CODM&#8221;) has been identified as its Chief Financial Officer, who reviews the assets, operating results, and
financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that there is only <ix:nonFraction contextRef="c173" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" unitRef="pure" id="ixv-41102">one</ix:nonFraction> reportable segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The CODM assesses performance
for the single segment and decides how to allocate resources based on net loss that also is reported on the statement of operations as
net loss. The measure of segment assets is reported on the balance sheet as total assets. <ix:nonNumeric contextRef="c173" continuedAt="_ScheduleOfCondensedIncomeStatementTableTextBlock-c173_cont_1" escape="true" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock" id="ixv-41103">When evaluating the Company&#8217;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net loss and total assets, which
include the following:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfCondensedIncomeStatementTableTextBlock-c173_cont_2" id="_ScheduleOfCondensedIncomeStatementTableTextBlock-c173_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>As of<span style="text-decoration:underline"><br/> </span>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>As of<span style="text-decoration:underline"><br/> </span>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-41104">1,935,561</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd" id="ixv-41105">8,330,835</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-41106">16,204</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c155" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd" id="ixv-41107">1,751</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 265; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Segment Information</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_SegmentReportingDisclosureTextBlock-c173_cont_1"><ix:continuation id="_ScheduleOfCondensedIncomeStatementTableTextBlock-c173_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Three&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Six&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Formation and operating costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-41108">967,084</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-41109">253,130</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-41110">1,550,665</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-41111">723,971</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest income earned on cash and marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesOtherUSGovernment" scale="0" unitRef="usd" id="ixv-41112">15,159</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesOtherUSGovernment" scale="0" unitRef="usd" id="ixv-41113">108,520</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesOtherUSGovernment" scale="0" unitRef="usd" id="ixv-41114">95,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeSecuritiesOtherUSGovernment" scale="0" unitRef="usd" id="ixv-41115">225,184</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key measures of segment
profit or loss reviewed by our CODM are interest earned on the Trust Account and general and administrative expenses. The CODM reviews
interest earned on the Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment
with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and
monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the
business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c173" continuedAt="_SubsequentEventsTextBlock-c173_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-37440"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;10 &#8212;&#160;Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements
were issued. Based on the Company&#8217;s review, the Company did not identify any subsequent events that would have required adjustment
or disclosure in the condensed consolidated financial statements, other than as previously disclosed, and as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Consummation of Business Combination</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, the
Company, consummated its previously announced Business Combination Profusa, pursuant to that certain Merger Agreement and Plan of Reorganization,
dated as of November&#160;7, 2022 (as the same has been amended, supplemented or otherwise modified from time to time, the &#8220;Merger
Agreement&#8221;), between the Company, Profusa, and NV Profusa Merger Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary
of the Company (&#8220;Merger Sub&#8221; and, collectively, the &#8220;Parties&#8221;). The consummation of the Business Combination involved
the merger (the &#8220;Merger&#8221;) of Merger Sub with and into Profusa, pursuant to which, at the closing of the transactions contemplated
by the Merger Agreement (the &#8220;Closing&#8221;), the separate corporate existence of Merger Sub ceased, with Profusa as the surviving
corporation becoming a wholly-owned subsidiary of the Company, pursuant to the terms of the Merger Agreement and in accordance with the
DGCL.&#160;As a result of the Business Combination, the Company owns <ix:nonFraction contextRef="c913" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" unitRef="pure" id="ixv-41116">100</ix:nonFraction>% of the outstanding common stock of Profusa. In connection with
the closing of the Business Combination, the Company changed its name from &#8220;NorthView Acquisition Corporation&#8221; to &#8220;Profusa,
Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Securities Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;28, 2025, the
Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Ascent Partners Fund LLC (the &#8220;Purchaser&#8221;).
Pursuant to the terms and conditions set forth in the Purchase Agreement, the Company may, from time to time and at its discretion, issue
and sell to the Purchaser shares of its common stock (the &#8220;Purchased Securities&#8221;) for an aggregate purchase price of up to
$<ix:nonFraction contextRef="c914" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd" id="ixv-41117">100,000,000</ix:nonFraction> (the &#8220;Maximum Aggregate Purchase Price&#8221;), subject to certain limitations and conditions described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Purchase Agreement,
the Company may deliver advance notices (each, an &#8220;Advance Notice&#8221;) to the Purchaser to request the purchase of shares of
common stock, with each closing (a &#8220;Closing&#8221;) to occur on a&#160;trading day following the end of a 10 or fewer&#160;trading
day valuation period commencing on the trading date immediately following the delivery of the Advance Notice, or as determined by the
Purchaser. The purchase price per share at each Closing will be equal to <ix:nonFraction contextRef="c915" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice" scale="-2" unitRef="pure" id="ixv-41118">97</ix:nonFraction>% of the lowest volume-weighted average price (&#8220;VWAP&#8221;)
of the Company&#8217;s common stock during the applicable valuation period, subject to a floor price and other adjustments as set forth
in the Purchase Agreement. The maximum purchase price at any single Closing is limited to the lower of (a)&#160;$<ix:nonFraction contextRef="c916" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd" id="ixv-41119">5,000,000</ix:nonFraction> or (b)&#160;<ix:nonFraction contextRef="c915" decimals="2" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfAverageDailyTradedValueOfCommonStock" scale="-2" unitRef="pure" id="ixv-41120">100</ix:nonFraction>%
of the average daily traded value of the common stock for the <ix:nonNumeric contextRef="c915" continuedAt="ck0001859807_NumberOfTradingDays-c915_cont_1" format="ixt-sec:durwordsen" name="ck0001859807:NumberOfTradingDays" id="ixv-41121">five</ix:nonNumeric>&#160;trading<ix:continuation id="ck0001859807_NumberOfTradingDays-c915_cont_1"> days</ix:continuation> immediately preceding such Closing.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 266; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NORTHVIEW ACQUISITION CORPORATION<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;10 &#8212;&#160;Subsequent Events</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c173_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
certain limitations, including that the aggregate number of shares issued under the Purchase Agreement may not exceed the number of shares
registered under the applicable registration statement or the exchange cap (generally 19.9% of the Company&#8217;s outstanding common
stock as of the effective date), unless stockholder approval is obtained or as otherwise permitted by the rules of the principal trading
market. In addition, the Purchaser&#8217;s beneficial ownership of the Company&#8217;s common stock is limited to <ix:nonFraction contextRef="c915" decimals="4" format="ixt:num-dot-decimal" name="ck0001859807:PercentageOfLimitForOutstandingCommonStock" scale="-2" unitRef="pure" id="ixv-41123">9.99</ix:nonFraction>% of the outstanding
shares immediately after giving effect to any issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement also
provides for the issuance of a warrant to the Purchaser for the purchase of <ix:nonFraction contextRef="c917" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-41124">900,000</ix:nonFraction> shares of common stock, and includes a Registration
Rights Agreement, Lock-Up Agreements from the Company&#8217;s officers and directors, and a Transfer Agent Instruction Letter. The Company
is required to reserve sufficient shares of common stock to satisfy its obligations under the Purchase Agreement and to maintain the listing
of its common stock on its principal trading market.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 267; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROFUSA, INC.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>42,594,048 Shares of Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 30%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 30%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">__________________, 2025</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not authorized any
dealer, salesperson or other person to give any information or to make any representations not contained in this prospectus. You must
not rely on any unauthorized information. This prospectus is not an offer to sell these securities in any jurisdiction where an offer
or sale is not permitted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 268 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART&#160;II</b>&#160;&#8212;&#160;<b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;13. Other Expenses of Issuance and
Distribution.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the estimated costs and expenses to be incurred in connection with the issuance and distribution of the securities of Profusa, Inc. (the
&#8220;Registrant&#8221;) which are registered under this Registration Statement on Form&#160;S-1 (this &#8220;Registration Statement&#8221;),
other than underwriting discounts and commissions. All amounts are estimates except the Securities and Exchange Commission registration
fee and the Financial Industry Regulatory Authority, Inc. filing fee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following expenses will
be borne solely by the Registrant:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount to be<span style="text-decoration:underline"><br/> </span>Paid</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">SEC Registration fee</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2,087</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Legal fees and expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">85,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounting fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Miscellaneous fees and expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">147,087</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;14. Indemnification of Directors
and Officers.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Delaware law allows a corporation
to indemnify its directors, officers, employees and agents against all reasonable expenses (including attorneys&#8217; fees and amounts
paid in settlement) and, provided that such individual, or indemnitee, acted in good faith and for a purpose which he or she reasonably
believed to be in, or not opposed to, the best interests of the corporation and, in the case of a criminal proceeding, had reasonable
grounds to believe his or her conduct was lawful. Delaware law authorizes a corporation to indemnify its directors, officers, employees
and agents against all reasonable expenses including amounts paid in settlement and attorneys&#8217; fees in connection with a lawsuit
by or in the right of the corporation to procure a judgment in its favor if such person acted in good faith and in a manner reasonably
believed to be in or not opposed to the best interest of the corporation, except that no indemnification may be paid as to any claim,
issue or matter as to which such person has been adjudged liable to the corporation unless it is determined by the court making such adjudication
of liability that, despite such finding, such person is fairly and reasonably entitled for such expenses deemed proper.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Delaware law also provides
for discretionary indemnification made by the corporation only as authorized in the specific case upon a determination that indemnification
of the director, officer, employee or agent is proper in the circumstances. The determination must be made either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left">(i)</td><td style="text-align: justify">by the stockholders;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left">(ii)</td><td style="text-align: justify">by the board of directors by majority vote of a quorum consisting
of directors who were not parties to the actions, suit or proceeding;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left">(iii)</td><td style="text-align: justify">if a majority vote of a quorum consisting of directors who
were not parties to the actions, suit or proceeding so orders, by independent legal counsel in a written opinion; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left">(iv)</td><td style="text-align: justify">if a quorum consisting of directors who were not parties to
the actions, suit or proceeding cannot be obtained, by independent legal counsel in a written opinion.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The certificate of
incorporation, the bylaws or an agreement made by the corporation may provide that the expenses of officers and directors incurred
in defending a civil or criminal action, suit or proceeding must be paid by the corporation as they are incurred and in advance of
the final disposition of the actions, suit or proceeding, upon receipt of an undertaking by or on behalf of the director or officer
to repay the amount if it is ultimately determined by a court of competent jurisdiction that he is not entitled to be indemnified by
the corporation. The provisions do not affect any right to advancement of expenses to which corporate personnel other than directors
or officers may be entitled under any contract or otherwise by law. The indemnification and advancement of expenses authorized in or
ordered by a court pursuant to Delaware law does not exclude any other rights to which a person seeking indemnification or
advancement of expenses may be entitled under the certificate of incorporation or any bylaw, agreement, vote of stockholders or
disinterested directors or otherwise, for either an action in his official capacity or an action in another capacity while holding
office, except that indemnification, unless ordered by a court or for the advancement of expenses, may not be made to or
on behalf of any director or officer if his acts or omissions involved intentional misconduct, fraud or a knowing violation of the law
and was material to the cause of action. In addition, indemnification continues for a person who has ceased to be a director, officer,
employee or agent and inures to the benefit of the heirs, executors and administrators of such a person.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 269; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act, as amended, may be permitted to directors, officers or persons controlling the Registrant
pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the SEC such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;15. Recent Sales of Unregistered
Securities.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2025 PIPE Transaction</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Initial Note</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
NorthView executed a Securities Purchase Agreement (the &#8220;PIPE Subscription Agreement&#8221;) with Ascent Partners Fund LLC (&#8220;Ascent&#8221;,
and together with any additional investors who become parties to the PIPE Subscription Agreement, the &#8220;PIPE Investors&#8221;). Pursuant
to the PIPE Subscription Agreement, the PIPE Investors are expected, subject to the conditions relating to such purchase set forth in
the PIPE Subscription Agreement, to purchase from NorthView senior secured convertible notes in an aggregate principal amount of up to
$22,222,222 (the &#8220;PIPE Convertible Notes&#8221;) for a an aggregate purchase price of up to $20,000,000, reflecting a 10% original
issue discount to the face amount (&#8220;OID&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Closing and pursuant
to the PIPE Subscription Agreement, we issued a PIPE Convertible Note in the principal amount of $10,000,000 (the &#8220;Initial Note&#8221;)
for a purchase price of $9,000,000, reflecting a 10% OID.&#160;The Initial Note matures on the date that is 18-months from Closing (the
&#8220;Maturity Date&#8221;) and is convertible at any time at the PIPE Investor&#8217;s option at a conversion price equal to the lower
of $10 or 95% of the lowest daily volume-weighted average price per share (&#8220;VWAP&#8221;) of our Common Stock in the 10&#160;trading
days prior to the original issue date of the Initial Note and shall be adjusted, without limitation, based on down-round and most-favored
nation (MFN) price and terms protections (the &#8220;Conversion Price&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Initial Note includes a
&#8220;Minimum Interest Amount&#8221; equal to 10% of the principal amount, which represents a full year of interest payments under the
Initial Note; provided, that such Minimum Interest Amount shall be reduced by the amount of interest accrued on the principal amount of
the Initial Note. Interest shall accrue on the aggregate unconverted and then outstanding principal amount of the Initial Note at a rate
of 10% per annum, provided that the Minimum Interest Amount shall be fully earned and accrued on the original issue date of the Initial
Note. Upon an event of default, the interest rate shall be adjusted and increase to 24% per annum. Payments made in cash under the Initial
Note shall be subject to a 5% fee, which shall be in addition to any amounts owed thereunder. The Initial Note provides for certain events
of default that are typical for a transaction of this type, including, among other things, any breach of the representations or warranties
made by Profusa or its subsidiaries. The Initial Note also provides for a 10% late fee in case of late payments and mandatory prepayments
upon Subsequent Offerings (as defined in the Initial Note) and, in the absence of an event of default, may be prepaid upon 10&#160;business
days prior notice, subject to certain conversion rights of the PIPE Investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Initial Note may not be
converted by the PIPE Investors into shares of Profusa Common Stock if such conversion would result in the investors or their affiliates
owning in excess of 4.99% of the number of shares of Profusa Common Stock outstanding immediately after giving effect to the issuance
of all shares issuable upon conversion of the Initial Note (the &#8220;Beneficial Ownership Limitation&#8221;); provided, that the PIPE
Investors may increase or decrease the Beneficial Ownership Limitation upon at least 61&#160;days&#8217; prior notice to Profusa so long
as such increase does not exceed 9.99% of the number of shares of Profusa Common Stock outstanding immediately after giving effect to
the issuance of all shares issuable upon conversion of the Initial Note. On August 1, pursuant to a Notice and Waiver, the Beneficial
Ownership Limitation was increased from 4.99% to 9.99% and we waived the requirement for the 60 days&#8217; advance notice for such increase.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 270; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued the Initial
Note pursuant to the exemption from the registration requirements of the Securities Act available under Section&#160;4(a)(2).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the securities above
were issued in reliance on the exemption from registration provided by Section&#160;4(a)(2)&#160;of the Securities Act or Regulation&#160;D
promulgated thereunder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Amendment No. 1 to the Securities Purchase
Agreement and Initial Note</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 25, 2025, the Company
entered into Amendment No. 1 (the &#8220;<b>SPA Amendment</b>&#8221;) to the PIPE Subscription Agreement. Pursuant to the SPA Amendment,
Section 2.1 of the PIPE Subscription Agreement was amended and restated to provide for four tranches of Notes: (i) an initial closing
for Notes in an aggregate principal amount of $10,000,000 (the &#8220;<b>First Tranche</b>&#8221;), which already occurred in July 11,
2025; (ii) a second closing for Notes in an aggregate principal amount of $2,222,222 (the &#8220;<b>Second Tranche</b>&#8221;) for a purchase
price of $2,000,000, subject to the satisfaction of certain conditions including the filing of a registration statement on Form S-1 covering
all conversion shares and no Nasdaq listing deficiency; (iii) a third closing for Notes in an aggregate principal amount of $5,555,556
(the &#8220;<b>Third Tranche</b>&#8221;) for a purchase price of $5,000,000, subject to the satisfaction of certain conditions including
the full conversion or repayment of the First Tranche, effectiveness of a registration statement, no Nasdaq listing deficiency, and receipt
of stockholder approval; and (iv) a fourth closing for Notes in an aggregate principal amount of $4,444,444 (the &#8220;<b>Fourth Tranche</b>&#8221;)
for a purchase price of $4,000,000, subject to the satisfaction of certain conditions including the full repayment of the First and Second
Tranches, at least fifty percent (50%) repayment or conversion of the Third Tranche, effectiveness of a registration statement, and no
Nasdaq listing deficiency. The Amendment supersedes and replaces all prior provisions relating to &#8220;Additional Closings&#8221; and
&#8220;Additional Notes,&#8221; and all references to such terms in the PIPE Subscription Agreement and related documents are to be construed
in accordance with the new tranche structure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrently, on August 25,
2025, the Company entered into Amendment No. 1 (the &#8220;<b>Note Amendment</b>&#8221;) to the Initial Note. The Note Amendment modifies
the terms of the Initial Note, specifically amending Section 4(b) to revise the conversion price provisions on any conversion date to
be the lower of (i) the Conversion Price on such date and (ii) ninety-five percent (95%) of the lowest daily volume weighted average price
(&#8220;<b>VWAP</b>&#8221;) for the Company&#8217;s common stock during the ten consecutive trading days immediately preceding the applicable
conversion date (the &#8220;<b>Alternate Conversion Price</b>&#8221;), provided that in no event shall the conversion price be less than
the Floor Price of twenty percent (20%) of the closing sale price of the common stock on the principal trading market on the trading day
immediately preceding the Note Amendment&#8217;s effective date, which was August 22, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2025 Committed Equity Facility</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Commitment Warrants</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As consideration for Ascent&#8217;s
commitment to purchase shares of Common Stock upon our execution of the term sheet relating to the Purchase Agreement, we issued Ascent
Commitment Warrants to purchase 900,000 shares of Common Stock and an exercise prices of $0.01 per share (the &#8220;Commitment Warrant
Shares&#8221;), which Commitment Warrant Shares have a total aggregate value equal to 0.9% of Ascent&#8217;s $100,000,000 total aggregate
purchase commitment under the Purchase Agreement (assuming a value per Commitment Warrant Share of $1.00).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;28, 2025, we entered
into the Purchase Agreement and a related registration rights agreement (the &#8220;ELOC Registration Rights Agreement&#8221;), with Ascent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 271; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;16. Exhibits and Financial Statement
Schedules.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#160;<b><i>Exhibits</i></b>:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has filed with
this registration statement or incorporated by reference herein certain exhibits as specified below pursuant to Rule&#160;12b-32 under
the Exchange&#160;Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; width: 9%"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%; text-align: center"><span style="font-size: 10pt"><b>Exhibit Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.1</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390021067165/ea152951ex3-1_northview.htm"><span style="font-size: 10pt">Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed December 23, 2021)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.2</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000114036123011314/brhc10049650_3-1.htm"><span style="font-size: 10pt">Amendment to the Amended and Restated Certificate of Incorporation of NorthView Acquisition Corp., dated March 10, 2023 (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K, filed with the SEC on March 13, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.3</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390023099295/ea190861ex3-1_northviewacq.htm"><span style="font-size: 10pt">Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K, filed with the SEC on December 28, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.4</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390021032773/fs12021ex3-3_northview.htm"><span style="font-size: 10pt">Bylaws (incorporated by reference to exhibit 3.3 of the Form S-1 file no 333-257156)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">4.1</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025067855/ea025038001ex4-1_profusa.htm"><span style="font-size: 10pt">Form of Commitment Warrant (incorporated by reference to Exhibit 4.1 of the Form 8-K filed with the SEC on July 28, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">5.1*</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea025858001ex5-1_profusa.htm">Opinion of ArentFox Schiff LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.1+</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1479362/000121390025042224/ea0224454-09.htm#T99053"><span style="font-size: 10pt">Profusa, Inc. 2023 Equity and Incentive Plan (incorporated by reference to Annex&#160;C to the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.2#</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000114036123035626/ny20006207x4_ex10-5.htm"><span style="font-size: 10pt">Binding Term Sheet for APAC Joint Venture, between Profusa, Carbis Bay Limited, BC hSensor Limited, Tasly (International) Healthcare Capital Company Limited (incorporated by reference to Exhibit 10.5 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.3</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000114036123035626/ny20006207x4_ex10-6.htm"><span style="font-size: 10pt">Business Combination Marketing Agreement (incorporated by reference to Exhibit 10.6 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.4</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000114036123035626/ny20006207x4_ex10-7.htm"><span style="font-size: 10pt">Omnibus Amendment to Business Combination Marketing Agreement (incorporated by reference to Exhibit 10.7 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.5</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1479362/000121390025041151/ea022445407ex10-8_northview.htm"><span style="font-size: 10pt">Amendment Number One to Binding Term Sheet for APAC Joint Venture (incorporated by reference to Exhibit 10.8 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.6</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025012354/ea022445401ex10-9_north.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement, dated as of February&#160;11, 2025, by and between NorthView and Ascent (incorporated by reference to Exhibit 10.9 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.7</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000114036124002200/ny20006207x14_ex10-10.htm"><span style="font-size: 10pt">Senior Convertible Promissory Note&#160;Purchase Agreement (incorporated by reference to Exhibit 10.10 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.8</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/ea024926701ex10-6_profusa.htm"><span style="font-size: 10pt">Senior Secured Convertible Promissory Note (incorporated by reference to Exhibit 10.6 of the Current Report on Form&#160;8-K filed with the SEC on July&#160;18, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.9</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1479362/000121390025041151/ea022445407ex10-12_northview.htm"><span style="font-size: 10pt">Loan Agreement between Profusa and Tasly, dated June&#160;15, 2023 (incorporated by reference to Exhibit&#160;10.12 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.10</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025012354/ea022445401ex10-13_north.htm"><span style="font-size: 10pt">Henry Jackson Foundation Subaward Agreement to Profusa (incorporated by reference to Exhibit 10.13 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.11</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025012354/ea022445401ex10-14_north.htm"><span style="font-size: 10pt">Amendment No. 1 to Loan Agreement between Profusa and Tasly (incorporated by reference to Exhibit&#160;10.14 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.12</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025012354/ea022445401ex10-15_north.htm"><span style="font-size: 10pt">Form of Senior Secured Convertible Promissory Note to be issued by NorthView to PIPE Investors pursuant to the Securities Purchase Agreement, dated February&#160;11, 2025 (incorporated by reference to Exhibit 10.15 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.13</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1479362/000121390025041151/ea022445407ex10-16_northview.htm"><span style="font-size: 10pt">Non-Redemption Agreement, dated May&#160;8, 2025, between NorthView,&#160;I-Bankers Securities and Dawson James (incorporated by reference to Exhibit 10.16 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.14#</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1479362/000121390025041151/ea022445407ex10-17_northview.htm"><span style="font-size: 10pt">Form of APAC Joint Venture License Agreement (incorporated by reference to Exhibit 10.17 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.15</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1479362/000121390025041151/ea022445407ex10-18_northview.htm"><span style="font-size: 10pt">Form of Shareholders Agreement for APAC Joint Venture (incorporated by reference to Exhibit 10.18 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.16</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1479362/000121390025041151/ea022445407ex10-19_northview.htm"><span style="font-size: 10pt">Form of Share Purchase Agreement for APAC Joint Venture (incorporated by reference to Exhibit 10.19 of the Form&#160;S-4 File No.&#160;333-269417)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.17</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/ea024926701ex10-9_profusa.htm"><span style="font-size: 10pt">Security Agreement, dated as of July&#160;11, 2025, by and among Profusa and the PIPE Investors (incorporated by reference to Exhibit 10.9 to the Current Report on Form&#160;8-K filed with the SEC on July&#160;18, 2025)</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 272; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>



</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; width: 9%"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%; text-align: center"><span style="font-size: 10pt"><b>Exhibit Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.18</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/ea024926701ex10-10_profusa.htm"><span style="font-size: 10pt">Guaranty, dated as of Jully 11, 2025, by and among New Profusa, Profusa, and its subsidiaries (incorporated by reference to Exhibit 10.10 to the Current Report on Form&#160;8-K filed with the SEC on July&#160;18, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.19</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025067855/ea025038001ex10-1_profusa.htm"><span style="font-size: 10pt">Securities Purchase Agreement dated as of July 28, 2025 by and between Profusa, Inc. and Ascent Partners Fund LLC (incorporated by reference to Exhibit 10.1 of the Form 8-K filed with the SEC on July 28, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.20</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025067855/ea025038001ex10-1_profusa.htm"><span style="font-size: 10pt">Registration Rights Agreement dated as of July 28, 2025 by and between Profusa, Inc. and Ascent Partners Fund LLC (incorporated by reference to Exhibit 10.1 of the Form 8-K filed with the SEC on July 28, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.21</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025080457/ea025456401ex10-1_profusa.htm"><span style="font-size: 10pt">Amendment No. 1, dated August 25, 2025, to the Securities Purchase Agreement, dated February 11, 2025, by and among Profusa, Inc. and Ascent Partners Fund LLC (incorporated by reference to Exhibit 10.1 of the Form 8-K filed with the SEC on August 25, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.22</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025080457/ea025456401ex10-2_profusa.htm"><span style="font-size: 10pt">Amendment No. 1, dated August 25, 2025, to the Senior Secured Convertible Promissory Note issued by Profusa, Inc. on February 11, 2025, for the benefit of Ascent Partners Fund LLC (incorporated by reference to Exhibit 10.2 of the Form 8-K filed with the SEC on August 25, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.23</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390025080457/ea025456401ex10-3_profusa.htm"><span style="font-size: 10pt">Form of Amended Senior Secured Convertible Promissory Note (incorporated by reference to Exhibit 10.3 of the Form 8-K filed with the SEC on August 25, 2025)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.24</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390021067165/ea152951ex10-3_northview.htm">Registration Rights Agreement, dated December 20, 2021, by and among the Company and certain holders party thereto (incorporated by reference to Exhibit 10.3 to NorthView&#8217;s Current Report on Form 8-K, filed with the SEC on December 22, 2021)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.25</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390022071254/ea168243ex10-4_northviewacq.htm">Form of Amended and Restated Registration Rights Agreement, by and among NorthView, the NorthView Initial Stockholders, and certain Profusa shareholders (incorporated by reference to Exhibit 10.4 to NorthView&#8217;s Current Report on Form 8-K, filed with the SEC on November 10, 2022)</a></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.26</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1859807/000121390022071254/ea168243ex10-3_northviewacq.htm">Form of Lock-Up Agreement by and among NorthView, the NorthView Initial Stockholders, and certain Profusa shareholders (incorporated by reference to Exhibit 10.3 to NorthView&#8217;s Current Report on Form 8-K, filed with the SEC on November 10, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">23.1*</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea025858001ex23-1_profusa.htm">Consent of Marcum LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">23.2*</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea025858001ex23-2_profusa.htm">Consent of Marcum LLP</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">23.3*</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea025858001ex5-1_profusa.htm">Consent of ArentFox Schiff LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">24.1</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="#p_001">Power of Attorney (included on the signature page)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">101.INS</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Instance Document</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">101.SCH</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Schema Document</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">101.CAL</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Calculation Document</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">101.DEF</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Linkbase Document</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">101.LAB</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Label Linkbase Document</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">101.PRE</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Presentation Linkbase Document</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">107*</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea025858001ex-fee_profusa.htm">Filing Fee Table</a></span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Filed herewith.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">**</td><td style="text-align: justify">To be filed by amendment.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">+</td><td style="text-align: justify">Management contract or compensatory plan, contract or arrangement.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">#</td><td style="text-align: justify">Portions of the exhibit have been excluded because it is both
not material and is the type of information that the registrant treats as private or confidential.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#160;<b><i>Consolidated
Financial Statement Schedules</i></b>: All schedules are omitted because the required information is inapplicable or the information is
presented in the consolidated financial statements and the related notes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;17. Undertakings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned registrant
hereby undertakes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.35in; text-align: left">(i)</td><td style="text-align: justify">To include any prospectus required by section 10(a)(3)&#160;of
the Securities Act;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.35in; text-align: left">(ii)</td><td style="text-align: justify">To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of the shares of common stock offered (if the total dollar value of the shares of common offered would
not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected
in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b)&#160;if, in the aggregate, the changes in volume and price
represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;<i>Calculation of Registration Fee</i>&#8221;
table in the effective registration statement.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 273; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.35in; text-align: left">(iii)</td><td style="text-align: justify">To include any material information with respect to the plan
of distribution not previously disclosed in the registration statement or any material change to such information in the registration
statement;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of the offering.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">That, for the purpose of determining liability under the Securities
Act to any purchaser, if the registrant is subject to Rule&#160;430C, each prospectus filed pursuant to Rule&#160;424(b)&#160;as part
of a registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses
filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date it is first
used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such
document immediately prior to such date of first use.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: justify">That, for the purpose of determining liability of the registrant
under the Securities Act to any purchaser each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7)&#160;(&#167;
230.424(b)(2), (b)(5), or (b)(7)&#160;as part of a registration statement in reliance on Rule&#160;430B relating to an offering made
pursuant to Rule&#160;415(a)(1)(i), (vii), or (x)&#160;for the purpose of providing the information required by section 10(a)&#160;of
the Securities Act&#160;of&#160;1933 shall be deemed to be part of and included in the registration statement as of the earlier of the
date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering
described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date
an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the
registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such effective date;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant
to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against
public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the shares of common stock being registered, the registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 274; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="p_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of Section&#160;13 or 15(d)&#160;of the Securities Exchange&#160;Act&#160;of&#160;1934, the registrant has duly caused this prospectus
to be signed on its behalf by the undersigned, thereunto duly authorized.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><b>PROFUSA, INC.</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 60%; text-align: justify"><span style="font-size: 10pt">Date: October 9, 2025</span></td>
    <td style="width: 5%; text-align: justify"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 35%"><span style="font-size: 10pt"><i>/s/&#160;Ben&#160;Hwang</i></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Name:</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Ben&#160;Hwang</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Title:</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chairman&#160;of&#160;the&#160;Board&#160;and&#160;Chief&#160;Executive</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>(Principal&#160;Executive&#160;Officer)</i></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Date: October 9, 2025</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/&#160;Fred&#160;Knechtel</i></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Name:</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Fred&#160;Knechtel</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Title:</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Chief&#160;Financial&#160;Officer</i></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>(Principal&#160;Financial&#160;and&#160;Accounting&#160;Officer)</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>POWER OF ATTORNEY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">KNOW ALL MEN BY THESE PRESENTS,
that the undersigned officers and directors of Profusa, Inc., a Delaware corporation, that is filing a registration statement on Form&#160;S-1&#160;with
the Securities and Exchange Commission under the provisions of the Securities Act&#160;of&#160;1933, as amended, hereby constitute and
appoint Ben Hwang and Fred Knechtel their true and lawful attorneys-in-fact&#160;and agents, with full power of substitution and re-substitution,
for him and in his name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective&#160;amendments,
exhibits thereto and other documents in connection therewith) to the registration statement, any subsequent registration statement filed
by the registrant pursuant to Rule&#160;462(b)&#160;of the Securities Act&#160;of&#160;1933, as amended, which relates to this registration
statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact&#160;and agents full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all interests and purposes as they might or could do in person,
hereby ratifying and confirming all that said attorneys-in-fact&#160;and agents or either of them, or their substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act&#160;of&#160;1933, as amended, this registration statement has been signed below by the following persons in the
capacities and on the dates indicated:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 30%"><span style="font-size: 10pt"><b>Signature</b></span></td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 45%; text-align: center"><span style="font-size: 10pt"><b>Title</b></span></td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 23%; text-align: center"><span style="font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Ben Hwang</i></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director and Chief Executive Officer</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">October 9, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Ben Hwang</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(Principal Executive Officer)</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Fred Knechtel</i></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chief Financial Officer</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">October 9, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Fred Knechtel</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(Principal Financial and Accounting Officer)</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Peter O&#8217;Rourke</i></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Lead Independent Director</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">October 9, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Peter O&#8217;Rourke</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Lauren Chung</i></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">October 9, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Lauren Chung</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Jack Stover</i></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">October 9, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Jack Stover</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Rajesh Asorpota</i></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">October 9, 2025</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Rajesh Asorpota</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="padding-bottom: 2.25pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.25pt">&#160;</td></tr>
  </table><div>
</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">II-7</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c1" id="hidden-fact-0" name="us-gaap:OtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-1" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-2" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-3" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-4" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-5" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-6" name="us-gaap:OtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-7" name="us-gaap:OtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-8" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-9" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" decimals="3" id="hidden-fact-10" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="usdPershares">0.001</ix:nonFraction>
<ix:nonFraction contextRef="c9" decimals="3" id="hidden-fact-11" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="usdPershares">0.001</ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-12" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-13" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-14" name="us-gaap:PrepaidTaxes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-15" name="us-gaap:AssetsHeldInTrustCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-16" name="ck0001859807:AdvanceFromProfusa" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-17" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-18" name="us-gaap:AccruedIncomeTaxesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-19" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-20" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-21" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-22" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-23" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-24" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-25" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-26" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-27" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-28" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-29" name="us-gaap:RestrictedCashCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-30" name="us-gaap:AssetsHeldInTrustCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-31" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-32" name="ck0001859807:PrepaidFranchiseTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-33" name="ck0001859807:SecuritiesPurchaseAgreementCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-34" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-35" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-36" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-37" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-38" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-39" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-40" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-41" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-42" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-43" name="us-gaap:Revenues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-44" name="us-gaap:Revenues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-45" name="us-gaap:OtherIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-46" name="ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c34" id="hidden-fact-47" name="ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-48" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-49" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-50" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-51" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-52" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-53" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-54" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-55" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-56" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-57" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-58" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-59" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-60" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-61" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-62" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-63" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-64" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-65" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-66" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-67" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-68" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-69" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-70" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-71" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-72" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-73" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-74" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-75" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-76" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-77" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-78" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-79" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-80" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-81" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-82" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-83" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-84" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-85" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c67" id="hidden-fact-86" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-87" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-88" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-89" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c72" id="hidden-fact-90" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" id="hidden-fact-91" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c75" id="hidden-fact-92" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-93" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-94" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c72" id="hidden-fact-95" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" id="hidden-fact-96" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-97" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-98" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c67" id="hidden-fact-99" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c94" id="hidden-fact-100" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c95" id="hidden-fact-101" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c96" id="hidden-fact-102" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c97" id="hidden-fact-103" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c99" id="hidden-fact-104" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c94" id="hidden-fact-105" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c95" id="hidden-fact-106" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c96" id="hidden-fact-107" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c97" id="hidden-fact-108" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c98" id="hidden-fact-109" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-110" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-111" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c109" id="hidden-fact-112" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-113" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-114" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-115" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-116" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c109" id="hidden-fact-117" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-118" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-119" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-120" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c117" id="hidden-fact-121" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-122" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-123" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-124" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-125" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-126" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-127" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-128" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c129" id="hidden-fact-129" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c129" id="hidden-fact-130" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c132" id="hidden-fact-131" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c133" id="hidden-fact-132" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c132" id="hidden-fact-133" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c133" id="hidden-fact-134" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c132" id="hidden-fact-135" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c133" id="hidden-fact-136" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c137" id="hidden-fact-137" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c137" id="hidden-fact-138" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-139" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c141" id="hidden-fact-140" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-141" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c141" id="hidden-fact-142" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-143" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c141" id="hidden-fact-144" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c145" id="hidden-fact-145" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c148" id="hidden-fact-146" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c149" id="hidden-fact-147" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c148" id="hidden-fact-148" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c149" id="hidden-fact-149" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c148" id="hidden-fact-150" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c149" id="hidden-fact-151" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c153" id="hidden-fact-152" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c129" id="hidden-fact-153" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c156" id="hidden-fact-154" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c157" id="hidden-fact-155" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c156" id="hidden-fact-156" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c157" id="hidden-fact-157" name="ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c156" id="hidden-fact-158" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c157" id="hidden-fact-159" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c161" id="hidden-fact-160" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c164" id="hidden-fact-161" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c165" id="hidden-fact-162" name="ck0001859807:AccretionOfCommonStockToRedemptionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c164" id="hidden-fact-163" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c165" id="hidden-fact-164" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c169" id="hidden-fact-165" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-166" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-167" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-168" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-169" name="us-gaap:ProceedsFromNotesPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-170" name="us-gaap:RepaymentsOfSeniorDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-171" name="us-gaap:RepaymentsOfRelatedPartyDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-172" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-173" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-174" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-175" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-176" name="us-gaap:RepaymentsOfSeniorDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-177" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-178" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-179" name="us-gaap:ProceedsFromRelatedPartyDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-180" name="ck0001859807:ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-181" name="ck0001859807:ChangesInFairValueOfSecuritiesPurchaseAgreement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c173" id="hidden-fact-182" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-183" name="ck0001859807:IncreaseDecreaseInPrepaidFranchiseTaxes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-184" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c173" id="hidden-fact-185" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c173" id="hidden-fact-186" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-187" name="us-gaap:ProceedsFromRelatedPartyDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-188" name="ck0001859807:RedemptionPaymentsDueToRedeemingStockholders" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-189" name="us-gaap:RestrictedCashCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c131" id="hidden-fact-190" name="us-gaap:RestrictedCashCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c155" id="hidden-fact-191" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c171" id="hidden-fact-192" name="us-gaap:RestrictedCashCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c189" id="hidden-fact-193" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c190" id="hidden-fact-194" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c189" id="hidden-fact-195" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c190" id="hidden-fact-196" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c193" id="hidden-fact-197" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c194" id="hidden-fact-198" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c193" id="hidden-fact-199" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c194" id="hidden-fact-200" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-201" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-202" name="us-gaap:AdvanceRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-203" name="ck0001859807:PrepaidLegal" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-204" name="us-gaap:PrepaidInsurance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c297" id="hidden-fact-205" name="us-gaap:DebtInstrumentFaceAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c301" id="hidden-fact-206" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c305" id="hidden-fact-207" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c301" id="hidden-fact-208" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c302" id="hidden-fact-209" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c303" id="hidden-fact-210" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c305" id="hidden-fact-211" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c301" id="hidden-fact-212" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c303" id="hidden-fact-213" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c304" id="hidden-fact-214" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c305" id="hidden-fact-215" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c302" id="hidden-fact-216" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c304" id="hidden-fact-217" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c305" id="hidden-fact-218" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c311" id="hidden-fact-219" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c314" id="hidden-fact-220" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-221" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c311" id="hidden-fact-222" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-223" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c314" id="hidden-fact-224" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-225" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c311" id="hidden-fact-226" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c313" id="hidden-fact-227" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c314" id="hidden-fact-228" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-229" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-230" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c313" id="hidden-fact-231" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c314" id="hidden-fact-232" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-233" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c316" id="hidden-fact-234" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c317" id="hidden-fact-235" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c318" id="hidden-fact-236" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c319" id="hidden-fact-237" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c320" id="hidden-fact-238" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c321" id="hidden-fact-239" name="ck0001859807:FairValueRemeasurement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c274" id="hidden-fact-240" name="ck0001859807:FairValueRemeasurement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c188" id="hidden-fact-241" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c217" id="hidden-fact-242" name="ck0001859807:BusinessDays">P5Y</ix:nonNumeric>
<ix:nonNumeric contextRef="c254" id="hidden-fact-243" name="ck0001859807:BusinessDays">P5Y</ix:nonNumeric>
<ix:nonFraction contextRef="c22" id="hidden-fact-244" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-245" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-246" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-247" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-248" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-249" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-250" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-251" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-252" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-253" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c22" id="hidden-fact-254" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P4Y</ix:nonNumeric>
<ix:nonFraction contextRef="c354" id="hidden-fact-255" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c355" id="hidden-fact-256" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-257" name="us-gaap:IncomeTaxReconciliationTaxContingenciesOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-258" name="us-gaap:IncomeTaxReconciliationTaxContingenciesOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-259" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-260" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-261" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-262" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-263" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-264" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-265" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-266" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-267" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-268" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-269" name="us-gaap:DeferredTaxAssetsOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-270" name="us-gaap:DeferredTaxAssetsOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c381" id="hidden-fact-271" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c382" id="hidden-fact-272" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c381" id="hidden-fact-273" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c382" id="hidden-fact-274" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c385" id="hidden-fact-275" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c386" id="hidden-fact-276" name="us-gaap:NotesPayableFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c385" id="hidden-fact-277" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c386" id="hidden-fact-278" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c413" id="hidden-fact-279" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c445" id="hidden-fact-280" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-281" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c448" id="hidden-fact-282" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c413" id="hidden-fact-283" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c445" id="hidden-fact-284" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c446" id="hidden-fact-285" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-286" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c448" id="hidden-fact-287" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c413" id="hidden-fact-288" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c446" id="hidden-fact-289" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-290" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c448" id="hidden-fact-291" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c445" id="hidden-fact-292" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-293" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c448" id="hidden-fact-294" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c449" id="hidden-fact-295" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c450" id="hidden-fact-296" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c451" id="hidden-fact-297" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c452" id="hidden-fact-298" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c453" id="hidden-fact-299" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c415" id="hidden-fact-300" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c456" id="hidden-fact-301" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c457" id="hidden-fact-302" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c415" id="hidden-fact-303" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c454" id="hidden-fact-304" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c456" id="hidden-fact-305" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c457" id="hidden-fact-306" name="us-gaap:RepaymentsOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c415" id="hidden-fact-307" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c455" id="hidden-fact-308" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c456" id="hidden-fact-309" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c457" id="hidden-fact-310" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c454" id="hidden-fact-311" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c455" id="hidden-fact-312" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c456" id="hidden-fact-313" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c457" id="hidden-fact-314" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c458" id="hidden-fact-315" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c459" id="hidden-fact-316" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c460" id="hidden-fact-317" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c461" id="hidden-fact-318" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c462" id="hidden-fact-319" name="us-gaap:LongTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c465" id="hidden-fact-320" name="ck0001859807:FairValueRemeasurement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c467" id="hidden-fact-321" name="ck0001859807:FairValueRemeasurement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c465" id="hidden-fact-322" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c466" id="hidden-fact-323" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c45" id="hidden-fact-324" name="us-gaap:InvestmentInterestRate" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-325" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-326" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c100" id="hidden-fact-327" name="us-gaap:CommonStockDividendsShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-328" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-329" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-330" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-331" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-332" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-333" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-334" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-335" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-336" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-337" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-338" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-339" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-340" name="ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-341" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-342" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c481" id="hidden-fact-343" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">P5Y</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-344" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P4Y</ix:nonNumeric>
<ix:nonFraction contextRef="c495" id="hidden-fact-345" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c499" id="hidden-fact-346" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c501" id="hidden-fact-347" name="us-gaap:Revenues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c501" id="hidden-fact-348" name="us-gaap:OtherCostAndExpenseOperating" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c502" id="hidden-fact-349" name="us-gaap:OtherCostAndExpenseOperating" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c503" id="hidden-fact-350" name="us-gaap:Revenues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c503" id="hidden-fact-351" name="us-gaap:OtherCostAndExpenseOperating" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c503" id="hidden-fact-352" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-353" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember</ix:nonNumeric>
<ix:nonNumeric contextRef="c532" id="hidden-fact-354" name="ck0001859807:NumberOfTradingDays">P5Y</ix:nonNumeric>
<ix:nonFraction contextRef="c515" decimals="0" id="hidden-fact-355" name="us-gaap:CommonStockSharesIssued" unitRef="shares">241567</ix:nonFraction>
<ix:nonFraction contextRef="c597" id="hidden-fact-356" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c139" id="hidden-fact-357" name="us-gaap:WarrantsAndRightsOutstandingTerm">P5Y</ix:nonNumeric>
<ix:nonFraction contextRef="c139" id="hidden-fact-358" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-359" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c131" id="hidden-fact-360" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c131" id="hidden-fact-361" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c645" id="hidden-fact-362" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c646" id="hidden-fact-363" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c648" id="hidden-fact-364" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c650" id="hidden-fact-365" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c652" id="hidden-fact-366" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c653" id="hidden-fact-367" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c656" id="hidden-fact-368" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c657" id="hidden-fact-369" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c660" id="hidden-fact-370" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c661" id="hidden-fact-371" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c663" id="hidden-fact-372" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c668" id="hidden-fact-373" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c669" id="hidden-fact-374" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c672" id="hidden-fact-375" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c673" id="hidden-fact-376" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c675" id="hidden-fact-377" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c676" id="hidden-fact-378" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c679" id="hidden-fact-379" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c680" id="hidden-fact-380" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c683" id="hidden-fact-381" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c684" id="hidden-fact-382" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c687" id="hidden-fact-383" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c693" id="hidden-fact-384" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c694" id="hidden-fact-385" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c693" id="hidden-fact-386" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c694" id="hidden-fact-387" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c715" id="hidden-fact-388" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-389" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-390" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-391" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-392" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-393" name="us-gaap:RestrictedCashCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c167" id="hidden-fact-394" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-395" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c155" id="hidden-fact-396" name="us-gaap:WarrantsAndRightsOutstandingTerm">P5Y</ix:nonNumeric>
<ix:nonFraction contextRef="c155" id="hidden-fact-397" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-398" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c155" id="hidden-fact-399" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-400" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c837" id="hidden-fact-401" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c838" id="hidden-fact-402" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c839" id="hidden-fact-403" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c841" id="hidden-fact-404" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c842" id="hidden-fact-405" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c843" id="hidden-fact-406" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c846" id="hidden-fact-407" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c847" id="hidden-fact-408" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c850" id="hidden-fact-409" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c851" id="hidden-fact-410" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c854" id="hidden-fact-411" name="ck0001859807:SecuritiesPurchaseAgreementCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c855" id="hidden-fact-412" name="ck0001859807:SecuritiesPurchaseAgreementCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c854" id="hidden-fact-413" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c645" id="hidden-fact-414" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c646" id="hidden-fact-415" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c648" id="hidden-fact-416" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c650" id="hidden-fact-417" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c652" id="hidden-fact-418" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c653" id="hidden-fact-419" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c656" id="hidden-fact-420" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c657" id="hidden-fact-421" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c660" id="hidden-fact-422" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c661" id="hidden-fact-423" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c660" id="hidden-fact-424" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c861" id="hidden-fact-425" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c693" id="hidden-fact-426" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c861" id="hidden-fact-427" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c693" id="hidden-fact-428" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c865" id="hidden-fact-429" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c867" id="hidden-fact-430" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c869" id="hidden-fact-431" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c871" id="hidden-fact-432" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c873" id="hidden-fact-433" name="us-gaap:DerivativeLiabilityMeasurementInput" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c908" id="hidden-fact-434" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c155" id="hidden-fact-435" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-436" name="us-gaap:RestrictedCashCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-41564">0001859807</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-41565">false</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="ck0001859807-20250630.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="hidden-fact-17 ix_0_fact" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_1_fact" toRefs="ix_1_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-255" toRefs="ix_2_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_2_fact ix_3_fact" toRefs="ix_3_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-345 hidden-fact-346" toRefs="ix_4_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_4_fact ix_5_fact ix_6_fact ix_7_fact" toRefs="ix_5_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-01-01</xbrli:startDate>
    <xbrli:endDate>2026-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:ProfusaAsiaPacificPteLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-08-28</xbrli:startDate>
    <xbrli:endDate>2023-08-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-26</xbrli:startDate>
    <xbrli:endDate>2023-06-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-07-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-20</xbrli:startDate>
    <xbrli:endDate>2023-07-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-08-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-08-15</xbrli:startDate>
    <xbrli:endDate>2023-08-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-02-06</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-02-06</xbrli:startDate>
    <xbrli:endDate>2024-02-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-31</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c204">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-01</xbrli:startDate>
    <xbrli:endDate>2020-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c205">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-10-01</xbrli:startDate>
    <xbrli:endDate>2020-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c206">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c207">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-30</xbrli:startDate>
    <xbrli:endDate>2020-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c208">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c209">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c210">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c211">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c212">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c213">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c214">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-05-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c215">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c216">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c217">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-03</xbrli:startDate>
    <xbrli:endDate>2022-11-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c218">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-03</xbrli:startDate>
    <xbrli:endDate>2022-11-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c219">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-03</xbrli:startDate>
    <xbrli:endDate>2022-11-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c220">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-03</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c221">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c222">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c223">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c224">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c225">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c226">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c227">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c228">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c229">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c230">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c231">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c232">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c233">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-02-29</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c234">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c235">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c236">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c237">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c238">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c239">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c240">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-08-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c241">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c242">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-06</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c243">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c244">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c245">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c246">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-30</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c247">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c248">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c249">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c250">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c251">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c252">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c253">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c254">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-03</xbrli:startDate>
    <xbrli:endDate>2022-11-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c255">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-03</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c256">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c257">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c258">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c259">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c260">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:MarchTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c261">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:MarchTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-01-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c262">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:MarchTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c263">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c264">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c265">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarchTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c266">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJuneTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c267">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c268">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JulySeptemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c269">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c270">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JulySeptemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2024-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c271">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c272">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c273">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-10-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c274">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c275">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c276">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:UnrelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c277">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c278">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c279">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c280">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c281">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c282">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c283">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c284">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c285">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c286">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c287">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c288">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c289">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c290">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c291">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c292">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c293">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c294">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c295">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c296">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c297">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c298">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c299">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c300">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c301">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c302">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c303">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c304">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c305">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c306">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c307">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c308">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c309">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c310">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c311">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c312">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c313">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c314">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c315">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c316">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c317">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c318">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c319">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c320">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c321">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c322">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c323">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c324">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ShortTermDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c325">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ShortTermDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c326">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c327">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c328">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c329">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c330">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesC1ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c331">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c332">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c333">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c334">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c335">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c336">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c337">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c338">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c339">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c340">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c341">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c342">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c343">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001859807:EquityIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c344">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c345">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-01-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c346">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c347">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c348">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c349">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c350">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c351">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c352">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c353">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c354">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c355">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c356">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c357">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c358">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ProfusaIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c359">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c360">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c361">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c362">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-16</xbrli:startDate>
    <xbrli:endDate>2022-08-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c363">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c364">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c365">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c366">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:ProfusaAsiaPacificPteLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-08-08</xbrli:startDate>
    <xbrli:endDate>2023-08-08</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c367">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c368">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c369">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewTrustMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c370">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c371">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c372">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-26</xbrli:startDate>
    <xbrli:endDate>2023-06-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c373">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-20</xbrli:startDate>
    <xbrli:endDate>2023-07-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c374">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-08-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c375">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-08-15</xbrli:startDate>
    <xbrli:endDate>2023-08-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c376">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-02-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c377">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-02-04</xbrli:startDate>
    <xbrli:endDate>2024-02-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c378">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-02-04</xbrli:startDate>
    <xbrli:endDate>2024-02-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c379">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c380">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c381">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c382">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c383">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c384">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c385">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c386">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c387">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c388">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c389">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c390">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c391">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c392">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c393">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c394">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c395">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c396">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c397">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c398">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c399">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c400">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c401">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c402">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c403">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c404">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c405">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c406">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c407">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-08-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c408">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-02-29</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c409">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c410">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c411">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c412">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c413">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c414">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c415">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c416">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c417">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2024SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c418">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2024SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c419">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2025SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c420">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c421">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2025SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c422">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c423">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c424">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c425">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c426">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c427">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c428">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c429">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c430">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c431">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c432">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c433">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c434">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c435">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c436">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2010-01-01</xbrli:startDate>
    <xbrli:endDate>2010-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c437">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2011-01-01</xbrli:startDate>
    <xbrli:endDate>2011-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c438">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c439">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c440">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c441">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c442">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c443">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c444">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c445">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c446">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c447">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c448">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c449">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c450">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c451">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c452">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c453">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c454">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c455">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
<!-- [WMV6][iOn4YwGR7A03ybIihQMFG+ONb5enQ9G90Nk14k3cwPn3kSAxv0zbCw5VVTMCytJQC2HiJMRGyz2+fRDud0KJPuC4FwxLVop0sHy3bxZrwIlT7yqzx2ofItV9P6Q2Kxp07muxhAOE7Hlc6ORu1QvbooYlrhq+GFYGSWpEGpDNSSejqRUBsBqp9UrwZ3G6dxpveKAScMrE7hA+mGr+cMQ1MgZjJrjC9+wOYP7+Kti3jizlYZo3WlcXlhVwiZ7QZEr3DU8FyKr9w2OjRcY1flTsnaCBi4bfW5Hsc1FogOZzIePMnif+me+dp1NRbb8RXpmfCHD0nw8G8g==] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c456">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c457">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c458">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c459">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c460">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c461">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c462">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c463">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c464">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c465">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c466">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c467">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c468">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ck0001859807:ShortTermLeasesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c469">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ck0001859807:ShortTermLeasesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c470">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c471">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c472">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c473">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c474">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesC1ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c475">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:SeriesCC1PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c476">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:SeriesCC1PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c477">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c478">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c479">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c480">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c481">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001859807:EquityIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c482">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001859807:Plan2018Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c483">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-31</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c484">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-31</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c485">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c486">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c487">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c488">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c489">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c490">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c491">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c492">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c493">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c494">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c495">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c496">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c497">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c498">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c499">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c500">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c501">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c502">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c503">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c504">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c505">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:MergerAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c506">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:MergerAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c507">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:MergerAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c508">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c509">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c510">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c511">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNoteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c512">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:SeniorConvertiblesNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c513">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c514">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c515">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:ProfusaPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c516">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NonrecoursePromissoryNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c517">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c518">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c519">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c520">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertiblesNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c521">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertiblesNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c522">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertibleBridgeNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c523">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertibleBridgeNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c524">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c525">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c526">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredNoteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c527">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredNoteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c528">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c529">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-28</xbrli:startDate>
    <xbrli:endDate>2025-07-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c530">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c531">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-28</xbrli:startDate>
    <xbrli:endDate>2025-07-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c532">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c533">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-28</xbrli:startDate>
    <xbrli:endDate>2025-07-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c534">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-28</xbrli:startDate>
    <xbrli:endDate>2025-07-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c535">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c536">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c537">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c538">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c539">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c540">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:RightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c541">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RedeemableWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c542">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c543">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c544">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c545">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c546">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c547">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c548">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-31</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c549">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c550">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c551">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c552">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c553">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c554">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-01-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c555">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c556">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-03-22</xbrli:startDate>
    <xbrli:endDate>2024-03-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c557">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c558">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c559">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c560">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:JuneJulyAndAugustExtensionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c561">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c562">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-10</xbrli:startDate>
    <xbrli:endDate>2024-09-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c563">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-19</xbrli:startDate>
    <xbrli:endDate>2024-09-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c564">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-19</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c565">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-19</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c566">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-19</xbrli:startDate>
    <xbrli:endDate>2024-09-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c567">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-13</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c568">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c569">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-10-01</xbrli:startDate>
    <xbrli:endDate>2024-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c570">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:JanuaryExtensionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c571">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c572">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c573">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-18</xbrli:startDate>
    <xbrli:endDate>2025-03-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c574">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c575">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c576">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c577">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-27</xbrli:startDate>
    <xbrli:endDate>2023-04-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c578">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleWorkingCapitalPromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c579">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:USFederalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-16</xbrli:startDate>
    <xbrli:endDate>2022-08-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c580">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-16</xbrli:startDate>
    <xbrli:endDate>2022-08-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c581">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-03-22</xbrli:startDate>
    <xbrli:endDate>2023-03-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c582">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-21</xbrli:startDate>
    <xbrli:endDate>2023-12-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c583">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-03-22</xbrli:startDate>
    <xbrli:endDate>2023-03-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c584">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-21</xbrli:startDate>
    <xbrli:endDate>2023-12-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c585">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-03-26</xbrli:startDate>
    <xbrli:endDate>2024-03-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c586">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-03-26</xbrli:startDate>
    <xbrli:endDate>2024-03-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c587">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c588">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-01-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c589">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustAccountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c590">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustAccountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c591">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c592">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c593">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c594">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c595">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c596">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c597">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c598">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c599">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:AssetHeldInTrustMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c600">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:AssetHeldInTrustMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c601">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c602">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c603">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c604">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c605">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c606">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c607">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c608">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c609">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c610">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c611">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c612">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c613">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:IBankersAndDawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c614">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-30</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c615">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c616">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-10-31</xbrli:startDate>
    <xbrli:endDate>2021-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c617">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c618">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-20</xbrli:startDate>
    <xbrli:endDate>2021-12-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c619">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c620">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c621">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c622">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-27</xbrli:startDate>
    <xbrli:endDate>2023-04-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c623">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c624">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c625">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:RelatedPartyLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c626">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c627">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c628">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c629">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c630">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-19</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c631">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c632">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-22</xbrli:startDate>
    <xbrli:endDate>2021-12-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c633">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c634">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c635">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-19</xbrli:startDate>
    <xbrli:endDate>2024-12-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c636">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-30</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c637">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-30</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c638">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c639">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-10-01</xbrli:startDate>
    <xbrli:endDate>2021-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c640">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c641">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c642">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c643">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c644">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c645">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c646">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c647">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c648">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c649">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c650">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c651">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c652">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c653">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c654">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c655">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c656">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c657">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c658">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c659">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c660">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c661">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c662">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c663">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c664">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c665">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c666">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c667">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c668">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c669">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c670">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c671">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c672">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c673">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c674">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c675">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c676">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c677">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c678">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c679">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c680">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c681">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c682">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c683">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c684">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c685">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c686">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c687">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c688">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c689">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c690">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c691">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c692">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c693">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c694">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c695">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c696">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c697">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c698">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c699">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c700">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c701">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c702">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c703">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c704">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c705">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c706">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c707">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c708">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c709">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c710">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c711">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c712">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c713">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c714">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c715">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c716">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c717">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c718">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c719">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c720">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c721">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c722">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-11</xbrli:startDate>
    <xbrli:endDate>2025-02-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c723">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-11</xbrli:startDate>
    <xbrli:endDate>2025-02-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c724">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c725">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:DissolutionExpenseWaiverMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c726">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:NoRedemptionScenarioMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c727">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-21</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c728">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-05</xbrli:startDate>
    <xbrli:endDate>2025-06-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c729">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-05</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c730">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c731">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c732">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c733">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c734">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-21</xbrli:startDate>
    <xbrli:endDate>2023-12-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c735">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-21</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c736">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-21</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c737">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-31</xbrli:startDate>
    <xbrli:endDate>2024-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c738">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-10</xbrli:startDate>
    <xbrli:endDate>2024-01-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c739">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c740">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c741">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-05-08</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c742">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:JanuaryExtensionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c743">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:FebruaryExtensionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c744">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c745">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ck0001859807:SpecialMeetingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-18</xbrli:startDate>
    <xbrli:endDate>2025-03-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c746">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ck0001859807:SpecialMeetingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c747">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c748">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c749">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-01</xbrli:startDate>
    <xbrli:endDate>2025-07-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c750">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-27</xbrli:startDate>
    <xbrli:endDate>2025-06-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c751">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:DissolutionExpenseWaiverMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c752">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-21</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c753">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c754">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleWorkingCapitalPromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c755">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-30</xbrli:startDate>
    <xbrli:endDate>2024-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c756">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-30</xbrli:startDate>
    <xbrli:endDate>2024-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c757">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-26</xbrli:startDate>
    <xbrli:endDate>2025-03-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c758">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-26</xbrli:startDate>
    <xbrli:endDate>2025-03-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c759">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c760">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c761">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-21</xbrli:startDate>
    <xbrli:endDate>2023-12-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c762">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustAccountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-01-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c763">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-18</xbrli:startDate>
    <xbrli:endDate>2025-03-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c764">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:BusinessCombinationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c765">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c766">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c767">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c768">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c769">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c770">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c771">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c772">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c773">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c774">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c775">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c776">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c777">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c778">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c779">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c780">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c781">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c782">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c783">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:IBankersAndDawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c784">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShares1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-30</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c785">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShares1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c786">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-10-31</xbrli:startDate>
    <xbrli:endDate>2021-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c787">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c788">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c789">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AscentNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c790">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AscentNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-11</xbrli:startDate>
    <xbrli:endDate>2025-02-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c791">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PIPEConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c792">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PIPEConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c793">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:RelatedPartyLoanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c794">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c795">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c796">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c797">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c798">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c799">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-24</xbrli:startDate>
    <xbrli:endDate>2025-02-24</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c800">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c801">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c802">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c803">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-19</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c804">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:IBankersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-19</xbrli:startDate>
    <xbrli:endDate>2025-01-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c805">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:DawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-19</xbrli:startDate>
    <xbrli:endDate>2025-01-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c806">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-08</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c807">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c808">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-19</xbrli:startDate>
    <xbrli:endDate>2024-12-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c809">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-17</xbrli:startDate>
    <xbrli:endDate>2025-06-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c810">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:CashFeeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-17</xbrli:startDate>
    <xbrli:endDate>2025-06-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c811">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-17</xbrli:startDate>
    <xbrli:endDate>2025-06-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c812">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:AdvisoryFeeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-15</xbrli:startDate>
    <xbrli:endDate>2023-06-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c813">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-15</xbrli:startDate>
    <xbrli:endDate>2023-06-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c814">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-15</xbrli:startDate>
    <xbrli:endDate>2023-06-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c815">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c816">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ArrangementFeeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-15</xbrli:startDate>
    <xbrli:endDate>2023-06-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c817">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-15</xbrli:startDate>
    <xbrli:endDate>2023-06-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c818">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:InitialNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c819">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:InitialNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-11</xbrli:startDate>
    <xbrli:endDate>2025-02-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c820">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c821">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c822">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c823">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c824">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SecondPurchaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c825">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SecondPurchaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c826">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SecondPurchaseMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c827">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c828">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c829">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c830">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c831">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c832">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-10-31</xbrli:startDate>
    <xbrli:endDate>2021-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c833">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c834">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:FounderShares1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c835">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c836">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c837">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c838">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c839">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c840">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c841">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c842">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c843">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c844">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c845">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c846">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c847">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c848">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c849">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c850">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c851">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c852">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c853">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c854">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c855">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c856">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c857">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c858">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c859">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c860">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c861">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c862">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c863">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c864">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c865">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c866">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c867">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c868">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c869">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c870">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c871">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c872">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c873">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c874">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c875">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c876">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c877">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c878">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c879">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c880">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c881">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c882">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c883">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c884">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c885">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c886">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c887">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c888">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c889">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c890">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c891">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c892">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c893">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c894">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c895">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c896">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c897">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c898">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c899">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c900">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c901">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c902">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c903">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c904">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c905">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c906">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c907">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c908">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c909">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-11</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c910">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c911">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-04-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c912">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c913">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:BusinessCombinationProfusaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c914">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c915">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c916">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c917">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-11</xbrli:startDate>
    <xbrli:endDate>2025-07-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea025858001ex5-1_profusa.htm
<DESCRIPTION>OPINION OF ARENTFOX SCHIFF LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 163px; width: 680px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">October 8, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Board of Directors<BR>
626 Bancroft Way<BR>
Suite A<BR>
Berkeley, CA 94710</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD><U>Registration Statement on Form S-1</U></TD></TR></TABLE>

<DIV STYLE="padding: 0in auto; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We have acted as counsel to Profusa, Inc., a Delaware
corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), in connection with the preparation and filing with the Securities and Exchange
Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;) of the Company&rsquo;s Registration Statement on Form S-1 (the &ldquo;<B><I>Registration
Statement</I></B>&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;<B><I>Act</I></B>&rdquo;). The Registration Statement
relates to the offer and resale by the selling stockholders (the &ldquo;<B><I>Selling Stockholders</I></B>&rdquo;) of up to 42,594,048
shares (the &ldquo;<B><I>Shares</I></B>&rdquo;) of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<B><I>Common
Stock</I></B>&rdquo;), comprising: (a) up to 382,500 shares of Common Stock (the &ldquo;<B><I>Settlement Shares</I></B>&rdquo;) issued
to certain parties in satisfaction of transaction costs incurred in connection with the business combination completed by the Company
on July 11, 2025, and (b) up to 42,211,548 shares of Common Stock (the &ldquo;<B><I>Purchase Shares</I></B>&rdquo;) that the Company may
elect, in its sole discretion to issue and sell to the Selling Stockholder from time to time after the effective date of the Registration
Statement, including the related prospectus contained therein and forming a part thereof (the &ldquo;<B><I>Prospectus</I></B>&rdquo;),
pursuant to and subject to the satisfaction of the conditions contained in the purchase agreement between the Company and the Selling
Stockholder, dated as of July 28, 2025 (the &ldquo;<B><I>Purchase Agreement</I></B>&rdquo;) as described in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In connection with our opinion, we have examined
(i) Amended and Restated Articles of Incorporation of the Company in the form filed as an Exhibit to the Registration Statement, as filed
with the Secretary of State of the State of Delaware on July 11, 2025; (ii) the Bylaws of the Company in the form filed as Exhibit 3.3
to the Registration Statement, as filed with the Commission on September 17, 2025; (iii) the amendment to the Bylaws of the Company in
the form filed as Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed with the Commission on October 7, 2025; (iv) the
Purchase Agreement; (v) the Registration Rights Agreement, between the Company and the Selling Stockholder dated as of July 28, 2025 (the
&ldquo;<B><I>Registration Rights Agreement</I></B>&rdquo;) in the form filed as Exhibit 10.20 to the Registration Statement; (vi) the
Registration Statement, including the exhibits thereto, and such other documents, corporate records and instruments, and have examined
such laws and regulations, as we have deemed necessary for the purposes of this opinion. In making our examination, we have assumed the
genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity with the originals of all
documents submitted to us as copies and the legal capacity of all natural persons. As to matters of fact material to our opinions in this
letter, we have relied on certificates and statements from officers and other employees of the Company, public officials and other appropriate
persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P></DIV>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 0in auto; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;<IMG SRC="ex5-1_002.jpg" ALT="" STYLE="height: 107px; width: 180px"></TD>
  <TD STYLE="width: 50%"><P STYLE="text-align: right; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">October 8, 2025</P>
                         <P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Based on the foregoing and subject to the qualifications
set forth below, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

</DIV>

<DIV STYLE="padding: 0in 7pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">The Settlement Shares are duly authorized, validly issued,
fully paid and nonassessable; and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">The Purchase Shares, when sold and issued by the Company
and delivered against payment therefor in accordance with the terms and conditions of the Purchase Agreement, will be duly authorized,
validly issued, fully paid and nonassessable.</TD>
</TR></TABLE>

</DIV>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The foregoing opinions are limited to the Corporations
Code of the State of Delaware, including all Delaware statutes and all Delaware court decisions that affect the interpretation of such
Corporations Code, as of the date hereof. This opinion is rendered pursuant to Item 601(b)(5)(i) of Regulation S-K under the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The opinions expressed in this opinion letter
are as of the date of this opinion letter only and as to laws covered hereby only as they are in effect on that date, and we assume no
obligation to update or supplement such opinions to reflect any facts or circumstances that may come to our attention after that date
or any changes in law that may occur or become effective after that date. The opinions herein are limited to the matters expressly set
forth in this opinion letter, and no opinion or representation is given or may be inferred beyond the opinions expressly set forth in
this opinion letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We hereby consent to the filing of this opinion
with the Commission as an exhibit to the Registration Statement and to the use of this firm&rsquo;s name under the caption &ldquo;Legal
Matters&rdquo; in the Registration Statement. In giving this consent, we do not thereby admit that we are within the category of persons
whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt">Very truly yours,</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp; &nbsp;</TD>
    <TD>/s/ ArentFox Schiff LLP</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea025858001ex23-1_profusa.htm
<DESCRIPTION>CONSENT OF MARCUM LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the inclusion in this Registration
Statement on Form S-1 of our report dated March 28, 2025, with respect to the consolidated financial statements of NorthView Acquisition
Corporation included in this Registration Statement. We also consent to the reference to us under the heading &ldquo;Experts&rdquo; in
such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ MARCUM LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boston, MA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 9, 2025</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ea025858001ex23-2_profusa.htm
<DESCRIPTION>CONSENT OF MARCUM LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Independent Registered Public Accounting
Firm&rsquo;s Consent</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the use in this Registration Statement
on Form S-1 of our report dated April 3, 2025 relating to the financial statements of Profusa, Inc. appearing in this Registration Statement.
We also consent to the reference to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Francisco, CA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 9, 2025</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ea025858001ex-fee_profusa.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.3a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: a4825389886563d4fc3e6d244e835363 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-1</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001859807</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_004"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_005">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-08</xbrli:startDate>
          <xbrli:endDate>2025-10-08</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001859807</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-08</xbrli:startDate>
          <xbrli:endDate>2025-10-08</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">S-1</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">Profusa, Inc.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_009">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_010">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_011">Common Stock, $0.0001 par value per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_012">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">42,594,048</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">0.32</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">13,630,095.36</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">2,086.77</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_018">13,630,095.36</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_019">2,086.77</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_020">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_021">2,086.77</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_022">Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act of 1933, as amended, based upon the average of the high and low prices for a share of the registrant&#8217;s common stock as reported on The NASDAQ Stock Market on October 3, 2025.<br/><br/>Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder for the selling shareholders include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !< 0P# 2(  A$! Q$!_\0
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M((HKR..:..>&.X6*91*C4FK>CU6J>GG;2_="7]?\#R/5****0PHHHH ****
M"BBB@ HHHH **** "BD)"C)Z>P)_0 FO+_%GQO\ @WX#U./1?&OQ3^'_ (4U
M>0*4TOQ!XMT/2M0(9MJEK2]O89T#-P-\:Y/2C<#U&BJ.F:IINM:?::MH]_9Z
MII>H01W5AJ.GW,-Y8WMM*H:*XM;JW>2"X@D4@I+$[HPY5C5Z@ HHHH ****
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M]B4-6=M?GHQA15>2YAB;;)+%&>PDEC0D=,A68$CWZ>_7#+B^M;2$W%W<6]K
MN-T]S<16\()Z RRLJ#/4989YQFN>>*PU.-6=3$4*<*$7.O.I6HPA1BMY5ISK
M0A1BK:RK3I1OIS7T*49-Q2C*3DTHJ,92<F]E%1C)R;>EHJ3OH6Z*R+/7]$U&
M0Q6&KZ5>S#.8K34;2YDP!DG9#*[''?Y>,UI^8 ,X'KP>W?MV_7M6>%Q^!QU+
MV^!QN$QU!MQ]O@L5AL90YHWYH^WPF)Q5'FC9J4753BTU))Z#J4JE*7)5IU*4
M]^2K"=*=GL^6K"G*SZ/EL^C)**KM<PIP\D2'L'E1"1R#@,03R.PP>QJK>:OI
MNGQ"?4+^QL86X6:\O(+6)CZ*\[HK''/!/!S55<;@\/3J5L1B\+AZ5&//7JU\
M5AJ%*A#3WJ]2MB:5.C%\R:E6G2BTTU*S5U&$YRC&$)SE)VA&$)RE-]5",82E
M)KJHQ;-*BJ-KJ-G?0BXL;JUO;<DA9[2YBN8F88R!)"74X!!.#G!SBF7>JZ?I
MZ"34+VSL(SG:]Y=06R-@ G:TTB*0.Y&<<9QW3QV!CA?KLL;@XX+V:J_798S"
M1P3I.]JBQDL7'".%DWSK%.%E?GML_9U/:>R5.HZMW'V:IU'4YE:\735-U%)7
M7NN"?EN:-%9%GKVCZB=NG:IIM^_)\NSO[6ZDP#R=D$LC8'<XQZFM,/DXQCWS
M^OT]?QHPV.P6-I1Q&"QF$QN'F[0Q&"Q6&QF'D]-(U\)B<51;U6BJW\NY.G4I
M3=.K3J4IK>%6G.G-+NX5(4Y6?1\MGT9\)_\ !17]HO7/V</V<]7\0>#Y_L?C
MGQAJ]GX&\*:B$#MHUWJMM=W.H:Y$C<-<:;I5G>269(94OI+9V&$(/XD_L@?\
M$Z?%_P"V'X4\0?&#QK\1K[PEHNH:W?6&E:O=:<_B?Q%XPU:U<KK&KW5SJ%]!
MLL+>[=K02RR7$]U=QW"((([<%_NG_@MG<1M\,_@G!'.C,OC[Q"9H4F4LK+H%
MN%:6)6R"H8A69<J&(!&_G[:_X)UKI&E?L8_ >**>SMGN_"L^HW,9N($=KR_U
MC4KBZD=2X8/)*Y=MXW'()SD&O0C+DI1E'24IM-VWBEMJM-?FT97NW%[67]?D
M?0?P ^%C_!'X-?#OX3/K$?B ^ O#EIX?&M1V1TU=26T:4I=?8#/=?92Z.H:(
M7,P# D.00![!59[VSC"%[NU02+O0O<1*'0YPR$N-RG!^89'!YJP"& 92"",@
M@@@@]""."#ZBL;W;[[_>5MH+14,UQ!;@-//# &)"F:1(PQ'4 NR@D=P*>DL<
MB+)'(DB/]UT=61N<?*RDAN>.">>* 'T5RFH^// ^CZ@-(U?QEX4TO52R*NF:
MCXBTBQU F3&P"RN;R*Y)?(V#RLMD8SD5U*LKJK(RNK*&5E(965AE64@D%2""
M""00<@T?UL ZBBN1U/X@> ]$O#IVL^-O".D:@K;&L=3\2Z-87BOQ\IM;J]BG
M#9(&TH#R/49 .NHJM#>6ES:QWL%U;S6<T8FBNXIXI;:6%N5FCN(W:%XF!!61
M7*D$'--&H6!Z7UF?I<P__%T ?$7Q3\8_%=/BOXJ^&7BW7O@9X*^&_P 2?!?]
MA_LYZSXJ-MK7B_5OC:MN'MVN/"FI_:;75;;2+R1+MH&LXHU$5BEG+<W4TD P
M/!GCKQ'<Z/XZ^!>E>._ ?CC]OSX8_"6-]<\?7W@632="N+O6)GN-$SJDFEP+
M=:; T]BES9+L@-T(KFYLBC2BO'?!GP?T?X?^)/B%\$IO ^H6$_PYU*^\=_LV
M?M/?M$>(]*\56DWQB^(MH/LEEX5@OX[(S-HNHV]M-;Z;:MJ%_>S6%S=7EH)F
MM0_T)X=^)$WPWU+X7_L_?%WQ7INK?M=_%WX=^(6'Q/\ "7P[$7A[4K[P_%J8
ML[W4[V"RLX1'I/EKY%G<PQ0326I=[>U2YC9Z=GLK^B:=E]J^MU_,KZO9"6F_
MW^;Z?Y&]XD^%GQ)\4>&?V?O&OQ6^.EY\,/$_P<EM_%?Q;_X0>YL]&^'_ (ZO
MA9VR:E9:U+J,EI;V6D0312+'/()+-4OKZ-;0>9 \'KGQ?^+EI\/? MKXLTB&
MS\0MK$UM;:%+;W23:7<&\A-Q%??:K9G6XL_LZF:-K>0K<*5VRJIW5Y=X0^%<
MOB#X'M^S9^U1\2?#_P :_&WB30M7;Q@;>\B\.ZQXA\.7&K2SV=S:Z997%EKJ
MVVE1BVL_[8CMX-TT'SL2#GFOVD_"'A[X?_!3X=^!_"6GII7AGPI?Z3H&@Z:L
MLUPMCI6EZ-<VME;":YDEGF,4,2*99I)))""SLS'-?@WTGN,N(?#WZ/OBUQIP
MICO[-XCX=X-S#&Y-F"HT:SP6,GB,NPD,73IUZ=6C*M0CCJU2@ZM*K"%94ZCI
MS=)1?U_ 65X+.N,^&\JS&DZ^!QN:4*.*HJ<J?MJ2AB*LJ3G!J48S=&$9\K3<
M'.*:YKKXY\:?$#Q=\0K\W_BK5[B]"N6M=/1C#IEDI((2ULD/E)MZ;VWRMC+N
M6)-<=VQV]N*:.I'ICZ\\G-.K_E*XCXEXBXNSG'<0<4YYFO$6>9E6E7QV;9SC
M\5F./Q523E9U,1BZU:HH03Y:5&#IT,/!1IT*-&$(Q7^BN7Y?@<LPE' Y=@\-
M@<'0BHT<-A*,*%&G%;-0IQBN9I)RG)SG)W<JDGJ]KP]XCU[PGJ46K^'-6O=(
MU"(C]_:2E!*@.3%<1',5S"W(:.='4@D8K](?V>OC5J'Q0@U/2=>L8+?7="@M
M)Y;RT#):ZE:SNT1G\DL?L]S'*BB5$)A<2*\87&P?F&> ?H:^ROV,O^1I\8D_
M] *Q///_ "^'FO[D_9W^*_B#P[](+@3P\RSBC,X\#\88[-,+GO"V)Q%3%Y+7
ME#(\UQM'&X7!XF5:GEV8T,3@,/..+P"P<ZD'4IUXUXU)(_(O&_AO)<;P9FV>
MU\OP[S?*J>%J83,805+%Q4\;AJ$J-6M3C&6(H2IUZB]E6=11;4H2A9I_17QQ
M^('PRCDT?X!^+?B1=> /&GQ\TW7_  MX"?1I9[;Q+/=BR\NYO-&NXX98;2[M
M3/&MO)<-$LD[K$CAFR/$M4^&FIZ(G[./[/O@?]K;7O"_C3X77EAXO\3:7J]Y
M8ZOX\^,?@#2IY$U"QUNW:Z@N%T^25I+9)"EU"EN 729K191]-ZU)\*O$WCNV
MTV:+P'XE^+WP]TRX\1:#I.H2:1=>+_"\.JP?9X[^U$HFU/0[;4SY$$E["D:^
M7(DAR"A;Y#A\1>%O#/A6+]I#]LGP5X(_9Z^-MW=Z_P#!CPWXYT6^N-9U?3O#
MOB&YN++PU+IU] +T6U].)[NZ0S)(MK% T[2007+VZ_\ 21>VUMUT7WZKHF['
M\,G)G3-+\;?%;P;#\>[2U_97\1^$_P!H[7=6^!?AKP/XRT[2%_:,AM[:WD.J
M^*]+M+;=K$ETL=N+AY6MS=?:[FS7YG(;]/\ CMVX^GM7Y0ZQX#U#PK/X2_9L
MG/B[QW\5/#O@7Q5X]^$O[;/Q>T#2=4\-_#_Q=KNI.NG:3%J%W)>/;ZDJM':V
M$:W-W=I<3VT]K:S.$6+])?AII7C'0_ 'A'1_B#XEM?&'C?3="L+/Q3XHLK$:
M;::YK,$*I>:A!9!(_(CFD!(!CC9R#(\:.[(&^G];:7Z]NO7H!\,_MA7%U;_$
M/P\+>[NX%/A:*1HX+J>%'*ZI>[LK%(@)=0!G!/ ["IO#OP^^)/[14,/B3Q1X
MAF\.>#;>..QT2RB$UPLT%HBV[RV=B)88I S1LLM_>2.TTVXQ(ZIQ0_;*9Q\0
M=!V]_"*[1CO_ &E?'COU_"ONGX<0V$7@'P;'I806(\.Z5Y'E ;"/LD1?&."3
M(7#'G<V22<5_D'P3X5X#QL^FI]+'A3C;/\_J^'F1YOP]GF:\"Y=GV:95@>+,
MP>&RG Y/3SF> Q]#%RR/)Y2QN*J9?A:F$P^,QN*H2Q5^2"?])9MQ!5X4\+/#
M?,\IP6"AGF,PV/P>'SBM@\-BL1EU"-7%5<7/"QKT*E*.,Q/[JG'$58UIT:-*
M?L>24M/B/QQ^ROXA\$Z7/XH\">);S4Y]'C:]GLT@;3=5$-N"\T]A/:2LL\D4
M:F0P,J.RK\C,V%KV/]FGXS7_ ([M;SPGXIN/M'B+1K59[/4'&R76-,5Q&[3C
M 4WMHY59G'S31.DC_.&+?6<JIY;AAA2K!L\@*1AR0>HVYR#U&:_,#X(@1?M%
ME=%+_P!F_P!K^+HP(B/+&E*;L+NV_+Y'F+;D= #Y?.<&OMN-> <F^B)](;Z/
MN9>#%?-,BX,\9^+<3X><<^&7]LYIFF0XKGP]"I@^(\LP&8XW&UL#B\!/%1J3
MKTG)4ZN&<(5(T,5B<-+R,KS?%>)'!?&E'BF.'QN:\*Y93SS*.('AL-A\=3Y:
MLXUL#B:V'HT(XB%94_<577DE91YX0D=)^U_<W4'C_P .K#>7D$;>& S)!=3P
M1DKJ,^<K%(BDD9!9LD@8SBC2_@S\2_CMIUGXR\0^(+;1=)FLK:U\.:7?+=76
MW3;.%+:*9+.-A#!%<&$RF61FN+AF,D@*D$P?MC@-X^\.]#N\*X]"0VH3#'IT
M)]^M?H!X,MXK?PCX9@C142+0-'144 *H&GVQX XZY.<<G.<\U\?P=X+9)X\?
M2\^E]PYX@9KQ)B^ <CSSA;&XCA'*^(<TR7 9WG&)P.%PV65<TJ8#$JM4P&3T
M/[1Q&'RZE['"5L?BZ>(Q,*LL/3BO1S+B?%<(>&OAGC\EP^ I9UC,)FE*GF6(
MP.%Q5;!X2GBZE3$0H0KTI4U6Q554(5,1)5*L:%)TX3CSRD_D%IC^RI\-)K*6
MYL]6\=^*M5NVL8HGGDTR"&W588[OR)=CI;6ENR/)&J)YUW,(RQ3)'BOA/X4_
M%;X]3S>*=;U>1-+GED":QKTMP\%RX8[X])TN'"&VBY0.B06X_P!6LA*X._\
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MDKNU^S)E=.U].GE^1_1;XY\(V5A\0/ /PZ_;(O\ 6_C_ "_$3]H/5?&7[/\
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M&1\+&Q#JK.%%=A^R[\(-4\+)>>.O%-G)9ZMJ]I]DTC3KE2MU9Z=,ZS3W=VA
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M$'DJ23N0D\?G?BAX!>,W"'C%G/C]]&+.N%Z6?\98'!X#Q)\...)UL-PUQ;/
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4 !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #6 :X# 2(  A$! Q$!_\0
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M>#2M&TV_UG7=8U">PT/0M+M);W5M2M(C$9"\>T_O@!1_X:[_ &9/^BX?#O\
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M$7A@:*^N*VUM'75#>?86U13@M8+.;I5(9H@I!/@OQ)M[*+]I?X=/9P6\22_
MCXIMNMHHXUD0_$#X0LK!HE4.K9+*<E2#N'!R31[*2ZZ\OZ ?8]%%%( HHHH
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M-3TJ=?CDS3V&B:IH^I7JV6B>(-9,>I4 ?:WQ>_X*0_!*Q_9B^-7QZ_9K\;>
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M\7O#5M\0?AOX42YE7S)K#P/>2^+/!F@J9)!8^&="T/21@:?D_>^E?\@O3?\
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M6X\-^+?%6B_V!:Z?I_A:>U\!2GP^='UC6=:U>[&I6-]I6CW%M9#4?5U_;O\
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M*_#>V_: \,:W8:M\3;;PWX C\/\ B:+PGX/M%O/BMXGM_A+K.AZP(-2U*_\
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MAXY8G5T8'#*P(X- '\^&H?\ !-+]I/4= ^%>GWT/ABY^'7PLU'XP^$/"_P
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M7_\ @J-HGQ1U_P#9,U>P^&FE>-O$&FI\2_@[??&OPQ\-!J3_ !$\4?LYZ?\
M$CP]=_'#0/!T&B36VOW^I:AX%CU)+[2O#UU!KNL:"NKZ5IAENKR.WF_&/XK?
MLS^ OC9\*_VR;?X$_LY^/+C]C'6_BI_P3QU/X(_##Q%\+?B)X6TN\^+^A?M
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MRU71M2^'/Q5^(/P<\;^'-=CMXM7\/^,_AYK3Z=>V]TMI<75N]IK>D3:+XO\
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M96564@@$"U:7=I?>[ ?4T;(Z*Z,'210ZN""'5@&5@1P0P(((X(Z5\\_M:?\
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MMN[PW%O<0N&5E;*MNC<+(C* #J  .@ QTQ1@>GM^'I110 A (P0"/0CC\J"
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M^PZA>Z3!8ZG(&!\F'3[BYEN1\UNDB\UZ=@8Q@8],<<]>*" 0 1P""/J.GY4
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M3WU\ZKX<@U"XU,77A/Q-86/E:9*L-V;+4[W2H-/U)P[#R(]/N;F2Z3,ENLJ
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M5#IVIOO5O(33[FY>Y4;[<2*03Z7@ 8  'H.!^GZ^M!4$8(R.#@]L<C'ICVH
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MXBEBJDIIX6<*G/%T(I7;C9RTO9KZE_X>A? 3_HGG[2G_ (8WQ-_\=H_X>A?
M3_HGG[2G_AC?$W_QVOROHK]Q_P"(!\-_]#O/?_!>5_\ RL_F[_B:;BW_ *)G
MAK_P=G/_ ,T'ZH?\/0O@)_T3S]I3_P ,;XF_^.T?\/0O@)_T3S]I3_PQOB;_
M ..U^5]%'_$ ^&_^AWGO_@O*_P#Y6+_B:;B[_HF>&O\ P=G/_P T'ZH?\/0O
M@)_T3S]I3_PQOB;_ ..T?\/0O@)_T3S]I3_PQOB;_P".U^5]%'_$ ^&_^AWG
MO_@O*_\ Y6'_ !--Q=_T3/#7_@[.?_F@]T_:O_X*%? [P[XV^ O[6/AOP-^T
M!I.L? ;QC)X;^)]YJ/P4\16-KK7[-GQ8DL/#OQ0TZ_N6N(XV/@W5H/"/Q4T@
MW)E\NX\%ZCIUC''<:_+(?MW_ (>@_ 08Q\/?VDR.,%?@=XE((P""#YO0@@@]
M,$'H17Y'^+?"NG^.O"?BCP1JT44^F>,?#VL^&+Z.8 QFWUNPGTYF8$,"(S<"
M3!'\ /2O'_V6O%5]XM^ GP\GUFXEN/$?AC3[WX<>*Y+@@WC>)OAIJ=WX)U.>
M]QQ]JU$:+;ZQ*>KG40Y^]7'+P+X=CCH866=9TH5L+4KT9*&7<TIX>M&&(@[T
M>6T:-6E62CK\;5XI'HKZ37%,LJJ8^'#G#KJX?,*.%Q%)U,X]G&ABL+.KAJT9
M*NY.;KX?$T:BNX*U-)1E=2_<_P#X>A? 3_HGG[2G_AC?$W_QVC_AZ%\!/^B>
M?M*?^&-\3?\ QVOROHKL_P"(!\-_]#O/?_!>5_\ RL\[_B:;B[_HF>&O_!V<
M_P#S0?JA_P /0O@)_P!$\_:4_P##&^)O_CM'_#T+X"?]$\_:4_\ #&^)O_CM
M?E?11_Q /AO_ *'>>_\ @O*__E8?\33<7?\ 1,\-?^#LY_\ F@_5#_AZ%\!/
M^B>?M*?^&-\3?_':/^'H7P$_Z)Y^TI_X8WQ-_P#':_*^BC_B ?#?_0[SW_P7
ME?\ \K#_ (FFXN_Z)GAK_P '9S_\T'ZH?\/0O@)_T3S]I3_PQOB;_P".T?\
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M[2G_ (8WQ-_\=K\KZ*^H_P"(!\-_]#O/?_!>5_\ RL^3_P")IN+O^B9X:_\
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M]$SPU_X.SG_YH/U0_P"'H7P$_P"B>?M*?^&-\3?_ !VC_AZ%\!/^B>?M*?\
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M3:O[-NAZ7:V_C/Q98^*/A5K<_C?5-*O;K2_@WIB:/X+T9M&TI-*1HK*2_O\
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M(P^)I^VPF,PSG/#8JDFH2E3<X0J4ZE*I>EB,-6A"OAJMJ=5/FIU:R4445TG
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M:=\:OALLRVMOX]TJRC(MK/Q/H]P8])^(WAVS)32M8>'5;1!H^K6K1?1_^?\
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MT>:[M--A6X6PUC2?"5WIFHPQ,X0W-A=7-NT@=$E)1MO[MD \&D  QCMTY/\
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M_CT:3\1M(FO;6V\(RR::]]-XGU1X;:[C@F>*#[28MEQ&[?V/5^>UI<+\$/\
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M+K=K82_:+#1_-M? 5I8:9HL%R%NI;6TC>6^NDBENIBL4<:<SGQ)_T2KX[_\
MAAOB_P#U\%Y_3/M7]/&![_F?\:6N#@?CVCX;<.X3A/@;@SA'AKA[!3K5<-EF
M6X7'TZ,:V(G[2O6J3GC:M:O7JS2=2M6JSJ3Y8IR?*CLX\\(*7B=Q)B^+N/>.
MN-N)^(<;"C1KYEF.*RJ514,/!PH8>C3I9=2H4*%*+ER4:-*G!.4I-2E)R/YA
M<^)?^B4_';_PP_Q?_P#F*HSXE_Z)3\=O_##_ !?_ /F*K^GJBOL/^(]<4_\
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M'AW1?#&DC2-#T?39M49M4U*=(3/<ZAJ=Z+<W$\RQVUG;6\*(7T^: ]JHHHI
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M:?!B_P! ^+'Q \5:<GC235[CP/\ $/Q';^%?$&C>%WB\(36FDQ1Z9J41NY)
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MG:;HUI:F]NM6O[ZUL],MK,*'-U<:A<2QVD-L%(8W$DJQ;2&WX(-<M\1/A?\
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MD\JVMXTWN[;<L36U7S#_ ,+)_:<_Z-HT7_P]GAK_ .4='_"R?VG/^C:-%_\
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MV&H:1!J%Y]F\*>"+7QUJ^IRQ:?</86@TZZGB%M9B_2"6\GC#2RPJULIB$ID
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MJ6":A807&ISW5Y<WFHWNGB^:\N(;F:6YGED5I/2[WQIXCC\:6WA)?AEXGO=
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MY_9R:IK6OZQ>Z[K-Y::-;-9:+I\FH7SO*+#2+1W@L;9 JQB6:20RSRR2N44
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MDHL+S5=#TR&VL[*ZF4@QVEH]S'<36EO)&44 >V4C E3MQGL3T!]?PZX[T44
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GTO3X"YBM;.V0)%$&E9Y)&P-TDTKO+-(6EE=G=F.Y110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "R ET# 2(  A$! Q$!_\0
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M_P"-M"/G^,/@QXETS38QONM1\.ZQ8^+H[2('#2S0VMGI\Q1!\SB(228^ZC'
M/OV,_P 1_0?R%,,2G')&/3'Y<@__ %^]*7AUX@48NI@?'GCZ>*C9T8YWPQX4
MYKECDM4L9@<)P5D&)KT9-14XT,VP=;V;J*E5A4<)P3SK*9VC4X1R6--M<\L)
MCN(</B+=52K5<VQM.$K7M*>%JI2Y6XN/,GRWA/QOX:\;Z6NL>&=4MM2M"_ER
MA',=S:3 '=;WMK(JSVMPA!5HIHU;<"!G!KK%.X XQG/\\=P/Y5\V?%#PK-X
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M((4NK[[3U7]DWX1:S\%?B+\ ;VSUUOAY\4?$?BGQ5XKMX]:E359M6\8^+?\
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M%IFEZCX@OM*T*XFT/0=3^(NL>-]2T'397BTJZM9B9ZYEO^"=WP0.JFU7Q/\
M&-/@^?&R_$7_ (9C7XB7"_L[?\)>NO\ _"7"\'@H:;_;2Z"/&./%@\!)XK7X
M>KK:K(GA5;15M  ?./B;]I7]MK7;+]MKXH> ;SX%>&/AK^QG\5_&WA_PSX0\
M0^#?%7B3Q/\ M >&_ OPJ^'_ ,2]<TC6_$EMXPT2U^%-X7\3:CH.C>(=,T+Q
ME]LNA!=7^AV4%HZW>%H/[2_B:/XV_'GP#\"?AU\)_"/Q6^.'[37PI^'V@>//
M$-AK"6,]O??LE6'QK\0_$CXH65CJD4_C3Q+X5\&>'[CPOX3\,Z'=^'UUBZ_L
M6"^O+33+/5M3C_22#]G'X:V_A'X\>"H[75O[$_:.\2^,?%GQ,C.JRFXNM8\=
M>%-#\%Z^^CW'E[M)MWT+P]IL5I!&DHM;A)+@,[2,*\IU[]@WX!Z_I_CBVEM?
M&6EZKXV\<> ?B;#XOT#QCJ6B^,O WQ%^&/@2P^&_@OQK\/-?L%AN/#6MZ9X3
ML#IMT-E[IVLVM_JUAK-A?Z5JM]I\P!Y7\5?%'[>_P,^#WQ UB_\ $/PL^-M_
M9:W\.5T/XA_#SX(>,;7QEX0\&ZSXGCT_XN^*]6_9]L_B%KX^(+?#3PJP\2^'
MM&\)_$.UUGQ<ZW]C+IMK+:6T=]]>_L]>.9OB5\%OAWXYG\>^"OBA-XC\/6]_
M)X_^'>E:CH/A#Q2WFRPG5-*\/ZO?:GJOAUY/*\O4?#^I7]U?:)JD=[I=U*9K
M5U'C=I^QEH]KH?BJWE_:#_:GO_'/BR[\+W%S\7[OXNI'\0='M?!MY<7VA:)X
M>LK#PW9?#72]!$][J/\ :^ECX>30^(UU&X'B$ZH8[0VWN_P5^#O@OX!_#7PU
M\*?A_;ZA#X8\,0W@MI]8U&?6-<U34-5U"[UC6]=UW5KG$NHZUKNM7]_JVIW?
MEPQR7EW+Y$%O (H(P#U.O!OVC)I?^%97UC&^R+6=;\.Z-=$9RUI>ZK;K.BG@
MJ7$8&Y<84$ D'GWFO OVC<CX?VV,8'C'PAV_ZBT7],_C^-?DWCO*<?!KQ-4)
M./M.#LWH3LVFZ6)_LW"UH7334:N'Q6)HSLTW3KU$M[/Z'A-)\39%=)VS/#32
M>JYJ?MZL';O&I2IR79P3Z(]FD-KHVB/(EN_V;3-,+);VJ9D,-G:DK#;QC@ML
MCVQKC&<9P*^4=#O%N;'Q!XLUQ-4N;F.WU?Q'?P/;V#:AI\*K,\$"!8?L]K$]
MCIL%B]]!/9O<RBVO%M[BVGAN6^N;FWBN]/GM9T$D-S9R03(<D/%-"T;J<%3A
ME8C@@\\$'FOE/2WBTVZUOPAXE0J&MKS2;VRA$<TLVE7EM;1ZA/:74EZ)8A):
MPVT<ETMK96RW=['"]W>QV*.?O\;2Q\>'L=0R%X;#9JLBQ-'))5X+ZGA\RCDU
M6EE,J\%%Q^JT<:LO=2'(XJA2G'D<4X/Q:3HO%4I8KGG0>)ISQ2@W[6=%XB$\
M0H23YO:3I>V47>_/-.]W<\3T?]I+^U_%:0:IX)TFW\.ZM?):V=OI;D:AIMUJ
M5TBMJCI<B72KZ^,C[W>2Q0QB281.R2.K_0+2'PC\0-%O('+VQU2\\/7R36^H
MM=_V;=?9(4FM+6._O(WLH;R..=5LX)5A6ZT^26*S:XN+=/(M*^ /@/1-:/B&
M[\0WVI:/87:7VFZ$'6(JMI)]J>:[UR*$0WEM9PK!/MACMTFDG@LY[N&2=';U
M72[6Z\:?$#3IHKNTM[30KR36]6METRZO(W>UO9E%M'<2S26&G2W=_<W$"[)W
M,EII][)&ET9DEL_Y?^B3D_THLHR/CFG])S.<)FN85N)E4X/<,9DN/QE#+?98
MR.:2G7R3!X2C')\5C)8.KD.#JQEB<+@Z<HM8>%2-,^_\1<5X?XK&96^ <+6P
MN'A@.3,W4I8JG"IB%*G]6Y:>+K5:CQ-.FJL,;5CR4ZE9WBYJ*E+MK_XB^.)M
M?\=:3X=\-:%=6G@,VLMY>:IK%S:OJ<=UI4>J&TM(8+280WB1F8++<,MH (=S
M;G8+BR?&_5;M[B^T;0+%O#NE^#]#\;:QJ&J:A+;WL.EZJER\EG:6<%M(D^HH
M;?9!OE6WE=@79%(-7X_A6NM>+OB)JVM/K6GV>OZCI<=K)I&L3Z>FLZ1!HEG:
MW-KJ"6S$RP)<I/" XBGV/)Y<JH[9[JW^'?ABUNM7FCLV%MK/ANP\*76E,P.F
M)HNFQSPVUM;VP0-&QCG=&D,C<!2 K D^S@\I\>\ZJXK$T>)L1D6!J\0\40E'
M,,5E4\3+!8/B#C>'#4LOP$>&H8C*LIA@*'"6&S6A6Q&88W/,)*IC\'C<#&=:
MI6\^IBN$L+&G3E@(8NJL)@+.C#$QIJI6P>5_7G5KRQ\J>*Q/MGF,\/.-.A1P
M<^2G5HUN6$3S?4_B9\1;+3(FU/P=H5BWBW1]7C\&-'XBF<Q:_P#V%>:IHVF^
M)Y!8YT^*]6!4N+ZP6Z^QREE$<F Q^1_V#_&_B'PGX+^ OPTU7X<^#= B^*O@
M[QWXXA\6>'=:FOM9UT^&+K3);G5_%L,VCVCSZYJU[K\T3O-?WS0VUK'MN6W>
M3#]P:1\(-+TZ\L9[O7O$^O6FBP75MX;TS6=1CN++P_#=VDEC(]F([>.2ZNH[
M21[>UN;UYI+>!M@/4UYOJO[)/A(^#OA9X9\&^-_B#\/=8^#-AJNE> _'7AO5
MM/?Q3::3KZ+#KVEZJ=1TNZTK6++4X$B#QW.G*;>>"WNK9HYX0Q_6_#7"<<8/
M*\RI\<8G$8C$5,?A9Y9#,,RRC.,SP]".58.GFOUK,,BRG)LOJ87%9]',,7DV
M&C@OK. RBIA\+BZU6JH>R\'.:F5U,11>5PA&"I35=T:.(PV'G-UZCPZIT,7B
M,57A4IX/V-/%5)5W"OBHU*M*,(-I^,>%/VV/%/BCQI\--#N_ _A'P7X8\9^(
MO&.A7GBKQCXJU33M.U&Y\+^/M;\&/HG@O4DT*31;WQA%9Z3%KMQX>UV_TJ6\
MCO8[+2I+F5#([M;_ &O?C';>!=9^-NA_!KPMJ/P5@\<0>"]"N;[QQ=6/CV_M
M/^$\M_ %SXSOM%31)]*M-%;5&N;BVTN+4)=8-C'#=2QJLK1Q^D7/[$_P_ET;
MP7X1M_&OQ,M?A_X7ETJ\UKP&?$=O>:!X[UG1?$<OC"R\1>)/MFFS7EOX@N?$
M\IU+6=4T*YTJ?6(UCLKO-O&H$&M_L1>!==&M:'-\0OBMI_PTUCQ=%X_3X4:1
MXDL;/P=IGC)/$4/BJ;4;!WT>?6TTNXUR'^T6\.2:H^C1WDT\Z6VYT$?Z1I>Z
MMZ:_J>.?7FN6<-_I&J64ZAH[O3;ZUD&,@QSVLD4@(SR"K'@Y'K7E_P"SY+))
M\'_!HD8N;>'6;&,DDX@T[Q%J]A;)SV2WMHD4=@H X%>N7H!L[K(!_P!%G_\
M139QW_K7D'[//_)(?"O_ %W\3_\ J7Z_7Y!FD(Q\>."*D5:=7PG\2Z562LO:
M4J'%_AK7H0FTKRC1K5ZU2G%MJ,ZU245&4VW]%AW?A/-HN[4>(<BE%7TBYY;G
ML)M+HYQA"+:WC!)W25O::*^??'&J:G;>*-3AM]1O8(4^Q;(HKB2.--VG6CMM
M16 &YF9C@<L23R:Y3^V]9_Z"VH_^!<W_ ,57[ H-J^FO]=CYESLVK;/O_P
M^K:*^4O[;UG_ *"VH_\ @7-_\51_;>L_]!;4?_ N;_XJCD?=?C_D'M/+\?\
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M;X=^'/B_QE>:YX)\+VIO29;2/0=)N%L_[.C9K6Q(,%LWE!0/TS\(?\BUHO\
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M!PV?K["OQW\::9;:;XIU>-V:5;>ZGDCW$EAYCDJ#D@<9&5 R5[D<5_*&#S'
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M;/TH****0!1110!^-G_!?D9_X)4_M-#&?]#\$C'U\=>'Q_7\Z_SL('5) N2
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M6>]Q_P"KC_W%_P#013Z9'_JX_P#<7_T$4^OU/#_P*/\ UYH?^F*!\^]WZO\
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MB#!=K C!XYSD=O?CU)/]:[FQS]CM\]?+'\S7Y#)_P5$^'MO>-;:I\-?%%K$
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M7;>#]1NO"FIW_@JPOM0\4Q:9J\1;[1!IT&EZL(+M[>*WU232[Z/3)+IHE\P
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M%[B2QT3PMI^OZCJ%KX9T*S>[N&@TK1H[6V4.B,K106Z0^[;'_P"><G_?M_\
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M<FVE*Z5DW?E\M!>V7=?<S]J_[?\ #G_05TK_ ,";?_XJC^W_  Y_T%=*_P#
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M\.QW\EQ;^(O%'BOPKK\;>'M/\22VXO/$>GRQV]Q;V=[&+< ^J/\ A7O[0O\
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M=+X4OI-5@6UOYM>AU.6Z\0):L"S6EW:VJ7 8J[J% K[/KP']HX#_ (5_;_\
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M:O(Y+.P+,<DU>HKSJF(Q%:,8UJU2JHMN*G)RM)JS>O5K3T'HM$K);(****Q
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MSIINH7=M!?W%F][$EQ0!YG\//C[\#/"NAPZ%\/\ P7X_TR778](\3^$_"?\
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #1 B4# 2(  A$! Q$!_\0
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M^>?\O\:-B?\ //\ E_C1]5SG_H<4?_#/A_\ YM*]KAO^@6K\L6__ )G/,O\
MA;/@KO=ZISTQH&LG_P!LN*3_ (6UX)[7FJ9[?\2#6?\ Y#KT[8G_ #S_ )?X
MTNU1_P LQ^2G^9H^J9Q_T-J%^_\ 8^'O_P"IHO:X:]_JM3_PJ?Y_5[GF/_"V
M?!0&3=:I_P""+6/_ )!--_X6WX)_Y^]3_P#!#K/_ ,@UZ?L3_GG_ "_QHV)_
MSS_E_C3^JYOI;-J"?5K)\/=^O^V_,/:X76V%J*^[6+?_ ,SGF/\ PMOP2>EU
MJG'7_B0ZR?\ VQ%)_P +;\%?\_>I_P#@AUG_ .0:]/V)_P \_P"7^-&Q/^>?
M\O\ &AX7-^F;4(^F3X;7[\:"JX5;86IK_P!1;_\ F<\Q_P"%M^"/^?S5/_!!
MK/\ \ATI^+/@L?\ +UJG_@AUD_RLJ]-V)_SS_E_C1L3_ )Y_R_QI?5<XZ9O1
M_P##1A__ )M'[;#?] M3_P *W_\ ,YYD/BUX)P2;K5?_  0ZS_6RS2'XM>"N
MHN]4P>F=!UG/_I%]:].V)_SS_E_C1L3_ )Y_R_QI_5<WMIFU!/JUD^'N_P#R
M]%[3"IM_5:FO_44__E!YD/BUX(/_ "^:F/KH&LX_](J/^%M>">GVS5,]O^)#
MK'\Q9FO3=B?\\_Y?XT;$_P">?\O\:7U3-UMFU!>F48?7U_VU_H"JX57_ -EJ
M:_\ 44_/_J'/,?\ A;7@H'!N]3_\$.L__()H/Q;\$X_X^M4'N=!UG'_I *].
MV+_<_#"?_K_6C8G_ #S_ )?XT_JN;VUS:@WW_L?#W7_EZ/VN%O?ZK4OW^M/_
M .9SS$?%KP4<_P"EZIQZ:!K)_/\ T+BD_P"%M^"O^?O4_P#P0ZS_ /(->G[$
M_P">?\O\:-B]/+_]!_GG-+ZKG'_0XH_^&?#?_-H>UPW_ $"U?EBW_P#,YYE_
MPMKP3M!^UZIG/_0!UK'?_IQ_K2?\+:\$][O5!Z?\2#6>?_)(5Z=L3_GG_+_&
MC8G_ #S_ )?XT_JN;],UH+NUE&'N_P#R][ZB53"IW6%JZ[_[6_\ YG/,?^%M
M>"3_ ,OFJ?\ @@UG_P"0Z7_A;7@K./M>J9]/[ UGZ]?L?I7INQ/^>?\ +_&E
MV+G/EC\EQ^6<4?5<X_Z&]'_PT8?_ .;1^VPW_0+4_P#"M_\ S.>8#XM>"R2!
M=ZGD?]0'6?\ Y"I/^%M^"C_R]ZG_ ."'6?\ Y!KT_8G_ #S_ )?XT;$_YY_R
M_P :/JN;_P#0VH-]_P"Q\/?_ -31>TPM[_5:E_\ L+?_ ,SGF/\ PMGP4.MW
MJ@'K_8.LG_VRQ^M:FA?$+PMXAU1='TR\N7U"2UGO8X+G3;^R,EM:M%'/(CW=
MO%'((GFB#*K,WSCY<9-=UL4_\L__ $$?R-<!JJ@?$?PC@ 8\-^+3VSS/H0YQ
MUQG'>N/&3S; +!U:F84,3"KF678.K2>6TJ'-2QF(E0J-5:>+G*$HJTHODDFT
MDU8TA]6K^TBJ%2#C1K58R>(YTI4J?,DXNA&Z>J?O1:W3Z'H0Z#Z"BEHKZ,XC
M$\.?\@>U_P!^[_'_ $VXK;K"\.MC1[7O\]WSS_S^7/<*0?7/'TXK:W_3_P >
M_P#B:5U=KJG;Y_K\KKS ?13=V.H_G_4#^=)O'_Z__K T77</ZZ#Z*;NST&?^
M^O\ XFDW_3_Q[_XFBZ[@/HIF\>WYG_XFEW'T_P#0O_B:+KN ZBF;Q[?F?_B:
M-V>F#_WU_P#$T77<!]%-W'T_]"_^)HW'T_\ 0O\ XFBZ_I/_ " =13=Q]/\
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MRA5JQ2N\RN[**5WKH?-!M_VL/^?_ .$QS_=@UG/XY@Z_3'>D$'[6'>_^$_\
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M3U^FL>Y_,_XTW9ZG/US_ /%4?\0=I_\ 1S_&G_Q8V(_^AH/]9_\ JG.$]_\
MH0P_^>1\S^1^U?\ ]!#X4?\ @-K'\O)Q_P"/'Z>A]G_:P_Z"/PF_\!M9_P#C
M!KZ8V#V_(_\ Q5&P>WY'_P"*H_X@]#_HY_C1;_LX^(_7AEA_K/\ ]4YPGO\
M]"&G_P#/(^:?L_[5W_01^$__ (#:R1_Z(']*I:=XM^.7A[XA>!_#OQ E\"W>
MD>,+C5+13X=M]02\ADL+!KO>TET$103M  #;@2#@8KZCV#V_(_\ Q5>!_$T8
M^*_P*';^VO$_TXT7=GN>V.M?,\5<"XS@_ 9;GV7>)'BOB\3AN*^"\,\)FW'%
M7,LLQ>%S+BS)<MQN%QN!J9!AXXC#XC!XVO2G#ZQ2?O)J:<5?OR_-Z.:5J^"K
M\/\ #5*G5R[-9JKA<G6'Q%*IA\MQ>(HU*->./J.G.%6C!I^SDGJFM=/?&&(R
M#SA#^BGG_P#4._2N'^&__(G:1_OW_P#Z7W==P_W6^C?^@GI_GIFN'^&W_(G:
M1_OZA_Z<+ROW&IKG&#_[%V._'%X(^1A_NM;_ +"*/_INJ6_B#XWT?X;>!_%O
MQ \0QW\NA>"_#VK>)M832[1K[43INC6<M]>?8[-&1[F<6\,C1Q*RERN,BO,=
M-_:,\$:M\2OAM\,;#3_$MSJGQ4^&E[\5?"^LPZ9'+X?7PS81Z;).-6O8[IIM
M+OC_ &M9110W-J(YKB4V\<S2HRCUGQCX1\/^/O"OB#P5XKL$U7PSXITF^T/7
MM,EDEBCU#2M1@>VO;222"2*9$G@D>-S'(K;6.&%<9X!^"'PO^&5Y;ZAX)\*V
M>CW]KX>M_"=K>B:ZO+JW\.6LT=S#H]O/>7$\D-DMQ%%.T,157D1'8$J*]<P/
M2#JNG+))$UW$)8F"RI\VZ-B,@, #@D$$>H((R"#2?VMIPZW<0_[Z_P#B:KV*
MJ=3USY5_U]CV'7^SX/Z?E^-:^Q/[J_\ ?(_PH H?VMIW:[C/TW$_^@TU=9TM
MAN6]B93T9=S*<<<$*0><CZBM':@Q\JCT^4?X5D:&J_V9:@JG"R_P\\3R>V,4
M 6/[6T[_ )^XQ]0X_+*\_A37UG2XE9Y+V%$12SLY*JJCJ6)4 #W-:.Q/[J_]
M\C_"L3Q(B?V#JOR+_P >DG\(]O:@"Y_:^F_\_<0]CN!_'Y:/[6T[_G[C]LAQ
MGZ97G\*O[$_NK_WR/\*-J_W5_(?X4 9[:QIBE0UY$I<[4!+ NP!)51MRQ &2
M "0.>@-+_:^F_P#/W%_X]_\ $U!?JGV[1OE7_CZN,<#@_8YO:M;8G]U?^^1_
MA0!0.KZ:/^7N+_Q\_P EIIUG2PQ3[9%O4 E/FW 'H2NW(!((!Q@D$ Y!QH[$
M_NK_ -\C_"LB%%.M7>53C3[4?='_ #WN?KZ9H L?VOIW:[C/L-V?RVT?VOIW
M_/U&?8!B1]1MJ_L3^ZO_ 'R/\*-B?W5_[Y'^% &<NLZ8WW;R(X8H<;CAEX93
MA3AE)PP['(/(-/\ [6T[I]KCSZ?-_P#$TS347;>?*O\ R$;[^$?\]VSV[_SR
M>]:.Q/[J_P#?(_PH H'5]. )-W%@ D_>X &23\O  Y)]*Q)/'G@B);%I?%_A
MF-=4OWTK3&DUS3$74M4C8I)IFGLUR%O-0C<&.2RMS)<QN-CQ*W%<1^T#=?$S
M3_@K\2[GX,:!9>)?BF/">IP^"=&O;R+3;>[UJZC%I"[7DRF&*2TBGEO8%FQ%
M-/;QPR,L<C,/Y>_A[\+?B9I/PBU?P'\6_@+\5_">OVG@W]H/PE^RO9ZE%KWC
M/5D_:*UGXZ:#KFG>(#K>AP2VFEZM?6O]DZGIVMZJUGITNB:;KCV-[':--$R;
M:V5]']]M/OU&E>^MK']8MIXN\+:A=:A8:?XAT;4+_29EM]6L;'4;2\O=*N'&
MZ.#4[6VEEGT^9U!*1W<<+L 2H(%7VUG2TQOO(DRP4;MP!9ONKG;C)[#.37X:
M_L)>&?%7AWXBZMKUKX0\8:+\3/#G[/'QLTS]I'4=:\/:]8P>(/CM<_&NZUSP
M*\UUJ=NFG^(]1E\-6^H7^CRZ-)?PQ>'K^RMFF3*PGF/^%L_MW^ _#=A\3O%O
MQ)\?:]8Z/X<^$7C/7/#/B3X8>&M.\/07/CGPOX^OO'EGJ<UGH]E?V^F>";SP
M_P"'YK6$WT,VESSS#4[J9;Y$43OM^37YB/W?UOQCX7\-Z5?:[X@UW3=%T738
MEFO]5U.YCL["SB>6.!)+BYG*11*\TT4*%V&Z61(UR[*"DGC/PG%?)IDWB+1X
M=3DM(K^/3IK^WAOI+&XE$%O=QVDDBSO;W$Y6&&54*23,(D)D.VOP.^ _QH^(
M?[5GP_\ AG\&/B7\4'^(?BKXX?'SPKXH\:^#;JSBMM:^%_P7^''@[0?B?KFE
M:ND?ASPX#:^+?$]II4VF3BWNK>#2-:LM-6_N[A&=O*]3\7_%KQ7\6;7XQ_$N
MX^+FJW7A3_A4B_%*SN/A=K6DZ#\)K[0?VEM2N]6\%>&?["\/17GB30]*\+P6
M&JW,T(UZ5].DBO7O)5NFC1@?TP07UI<R-%!.DDBKN9!D,%SC.U@#C/!QT/!K
MB-6_Y*1X1_[%OQ;_ .E&@_YX_EFM30-?TGQ5'H?B70;AKO1]<T'^T]-NWL[N
MQ>YLKN2&6WF>TU"WM;ZV:2-E<PW=O!.F=LL2-P,S5O\ DI'A+_L6O%O_ *4:
M#7AY]_NV!_['N1?^K$ZL)\=;_L$Q7_II'H-%%%>X<I\5_M _&OQA\'_#W@23
MPHFEE]=O-<AO&U*S>[VQVDS2)Y2K/ J$M(=[MNSA0%!.*^2T_;T^(THNBFL_
M#]A82>3?;;>W_P!"F) 6*[8ZN1;2LVY5CG".3\H7.*I?\%.FUR?PE^SQI.@Z
MQ<:)=^(/&'CK16O+>0IM^U^$O$(MGF ^_';7JVUWMP3YD"./F45^$&B_LT>,
M-2^$;?#:Z^"7A7PKXABU#X<0>+?'EIXU&H3_ !1M_#_BZUU/Q)JEXJ(EV$U&
MQBGOF;4)#=R3W$EF#Y:K7X9B<LJYQQ)Q=5Q_&G$>54<)Q%A<OP>!R_/\5EV&
MPV7K)\KJ5J]/"TJE"$TL16J-*G*=656LI57&+O'[C#5:>&RO*_8Y%@<=5K83
M%5:U:M@XUYU:\<97A1HNHU-Q;IQ:4FH)0IJW-)._[Y6?[=GQ+U"5(;'5O 5]
M++"UQ#%9VUO<RRVZN4,T<<.JN\D2OE#(BE X*DAOEK4_X;2^,088/A7DX*_V
M'(<8 SG.H8/S'!P>/P-?A=\*/V4]:^&GQ.\,>-=*\-:+HD&D_&?XN:M=7-AJ
MCM-'\*_$FC?9_!^BPP,[+]C@U("4:2JJME*QGR9"<?9?Q(^*OA?X5Z)8^(/%
MUQ<VVFZCXC\/^%K:2UMGO)3K'B;4(]+TF QI@B.6[FC668DB)<N1@&O+S7(I
MX3%X>AE/&G&>:PKT[\RXJS>%6%;VLH.FX4\153BZ<?:1?-JE*5EHGW8&O2KT
M:M3%Y%E.$E3E;E>7T))QE%.+3E&$M';73XUOJ?H2_P"VA\9< J/"W/0_V+(.
MG7@:AZ^_^%1?\-J?&90<KX4..O\ Q)92>O&!_:'IR<'BOCQ;IBI5L J2."O)
M'8=<XSDDXSQTZUY_\1/B5X6^&?A'Q!XZ\;:Q;:!X3\,6+:CK6M7>\VUA9HR1
MO*XB221@7D2-5C0L\C* .>/)A@<QG5A3CQ)QFYSJ*G&*XNSQN4I2Y8Q2YGK*
M5DM%K;N=O)A(IREE>3J,8N3D\LP]E&-VY-WVLK_<?H"?VUOC%Z>%LGD#^Q9/
MJ<8U _3! ]!SQ3U_;2^,;8(_X1C!_P"H)(?S/]H#IWK\'=6_;)T+XS_L6?%K
M]HKX$ZCK>E0Z/H_B^S\+ZSJMI%:WL6J>&[Z*R;4X+63SU,$Q<3VGFH6,;J98
MT?Y1]Y^%=7N;WP[X>O+V4R75YH6C75S*%P9+BXTRUGN'8*  TDSO(VW !/ Q
MP>S'9)FV#INIB.(^,Z,X8F>%E2EQ=G?/&K"G"LXR2FK>Y.+5U>^EK(SIRP%>
M2C2RW*)_NHUDUEF&Y90E)QBXRV>L7HWLNY]WR?MI_&1",#PK@@G/]B3$#@')
MSJ!Y]O?KTJ'_ (;8^,F!\OA@'WT27D9'./[0..#D>W6OCMKD')SDD;L=2.N1
MR?4'MTYQ6)K&OV&A:;J&L:K.EGINEVEQ?ZA>3%A';65I&99[APH8A8H5:1^#
M\JGJ<5PQPN/E>+XEXS;O&.G%V>7;FTH12C-:MZ+3\C5T<*[_ /"9E"LK_P#(
MMPZBTKWN[VTL_FNI]O\ _#:WQDQD#PL3_P!@64C![Y^WCI_GW:?VVOC*H.5\
M*<'OHLK'' [7_'7OZX]:^(=,U^QU?3[#5M-N4NM.U.TM[_3[N%B8[JTNXEGM
MIT)&2DL4BNN0#@C@'FL/Q/XMT[PMH>M>)-<O!8Z+X?TR_P!9U6\ERT=KI^FV
MTM[>SN%^8B*WB>3:O)VX&6(%7'!XWVGL%Q#QLZW/R*W%^=<SFW&/(U[2RY6T
MGM9OSL'LL(H.;RO)8QC'FYGEN'2<;7NF_+\C[U_X;>^,?!(\)]><:/+Q[8^W
M@CZ_3IW^@?V<_P!I'X@_%+X@#PSXD70_[.?2+^\S86#VMP)[;RRA60W4P,9W
M%64J#C'-?S(_"'_@HK\%_P!I*Q^)VD_"N;Q;I?B?P?X#UOQCI\'BOP_+HCZM
MH45K>Q:=XGT!YWEBU'36O($97R" 49D(XK]??^"37B?7?&=I\*?$WB>^?5/$
M&N?"*WU76=0=51KV^O+."6:Y*(JHIE9@2J*JY'"UZ&)RW/\ (,;D.*J9WQ92
MG/BWAC+ZN&S#B3-,91Q&'S+&N-6%;#5Y5,/7H5J#E!J6G-!*ZDF<LO[,Q>"S
M&-/ Y7+ERO'UZ=6A@</3E3JT*<7&4*M-QJ0G&3;BTI7UNF?O956\NX;&UGN[
MB18X+>-Y9G8@!452QZD DXPHSR2!W%6&.%)SC SDC^E<1>,/$VL?V5%(3INA
MW44NL$!=EW?K&)H-+>)UQ+!&CQW4[*VT2"&,\[\?OF8XN6&I1A1BJF+Q4UA\
M'2_GK24G*I)77[G#TU+$5VVDJ=*U^:I3O^=4H*I-\SY:<(\]66ND%T7]Z;7)
M#^]*_P!EEKP[:SWLL_B/4(FAN=4BC2SM7 W:?I49+V]N_4&YG9FN;EEQAG2$
M[A"IKC?CX-OP>\>C/']AR'GVN;;TQTR?SKUU%V\8P.1C/ ^[C SQTZ#C]*\B
M^/O_ "1_Q[_V Y.^/^7FV[_SKX[CK"QP?AIQQ24G4F^$.)ZE>M+XZ^(J9+F+
MK5Y[:U)W:6T::IP248I'J9+/VN?Y,[6C_:V6QA#I""QN&4(+K:,=+Z.3O)J\
MG;TGP]_R =$_[!.G?^DD-;%8_A[_ ) &B?\ 8)T[_P!)(:V*^RRG_D597_V+
M,M_]5^!/,Q'^\8C_ +"*_P#Z?K!1117>8GS=^TE^T;I7[/&@^&+R3PW=^-/$
MOC3Q ^@^&O"]IK6D>'$DBL=-NM:\0>(M;\1:[)'I7A_PQX:TBSEO=9UF_/V:
MU\RT@8B2ZCSX%\'?V_\ 1OB=X^\+>"=7^'EGX:M/%^JW/AO2_%WAWXM_#KXH
M>'[3Q2-+GU?1M!UU_!U]+<Z+-XGM++4(_#]Q>1"'4+ZRELH@9B!7!_$WXLQ_
M"[_@H;X7L_BOX?M]2\)?$CX=^'/A[\*/$$TOGZ?X/M?$&JZC;^+;I["XC:W&
MH>)?&I\+^'O$MR2BVWAT^')5D,,FHPMI?\%&?B+X)^&WPETSX8Z'X1MKGXD_
M%35;2;P*GAF#3M+U?PKXB\+:A83^$_'-JUO )6U+3?'5_P"&-+T.%DCAO9M4
MOHY;A+*WU!&5G??3M;]2K;*VKV=]-?ETLS].**P_#/\ ;Q\.Z"?%*V:>)3HN
ME'Q#'ISM)I\>N_88/[62PD=4=[(7_GBV=U#-#M9@"<#<IDA1110 4444 %%%
M% !1110 'H?\_P J\_\ B5\4_A]\'_"M[XW^)?BS1?!GA33YK6WO-<UZ]@T^
MP@FO)UM[6)[BXDC3S+B9UCBC!,CLWRJ<$#OST/T-?C%XPU_PM^TE_P %&=8^
M 'QR;5D\(?#7P=JUE\)OAQ&)AX;\4>*-0\,6.N>(/BCKFI6UQ;2P>(=,T+4[
MG1?!5FN7TW[/K&L0307KVLBY59N"2CK.;48I[7;>KOZ/K=Z'H9=@X8NK4=64
MH8?#49XC$.FDZGLH-)JG%_%-WZ)V2<K.UC]2?A_\<?@_\5;:*[^'/Q-\#>,X
M9F=(_P#A'/%&BZQ(SH SQ^5I]_<2"1 ?WB%0Z' 90:]4&?7.>1QBOP5_:/\
MV'_A'^QI!8_M4_"_Q?XBTS7OAKXM\&^,+?PEXBUB'4[G4](T/7!<_$2VT7Q'
MJ@D\57EWJO@*;6(I=&N]4U&RFBT^&?R/-A$J?NYIE_!JFGV&IVCA[34+*UOK
M9@00T-W"DT1##(;*./F!P>HXYI4IU).<:D5&4;/22DFI7L]&[/1WCNOF7F&$
MPU&&'Q."K5:^%Q+J1C*K3=.4)T^5RAJES:2TE9)V?8OUX#\3O^2L_ D?]1GQ
M2>G_ %! /IW_ #XKWZO /B:/^+L_ K_L,^*2?_!(H_SU_P /SSQ7_P"23H>7
M%_A\_NXZX:L='#__ ",9?]BS._\ U39@>^/G8W'\+9'7^$\?GZ _2N'^&W_(
MG:1_OW__ *7WE=P^-C#'&UNW^R?RX_PKA_AO_P B=I'^_?\ _I?=U]E4_P"1
MS@_^Q?C[?^%>"/+C_NM;_L(H_P#INJ<[\??%_B?X?_!/XJ>-_!=E-J7B[PIX
M$\2:]X9T^WT#4/%4]_KNFZ9/<Z991>'-)EAU+6'NKN.*!;&RECGF+X1@:^-O
M@_\ M7?'#XF?M*?#?X?W'PA\8:)\(/$'P#B\6^(_&6M> =>\,BR^*,%OI]QK
M.F7MYK:Q)IMG#<7BZ;I6DQ)+>7DYNIY)&@M2Q_2.1TC1GD941 6=V8(JJ.2S
M,Q 4 <DD@ =:@%U:M((!/$9G3S5@\Y#*\0(!D6+?O,0) +A=G(R:]<P,"SN-
M2&J:Z$T^)T%Q8A'-XB%E_L^#!*^4VTG^[GBM+[3K'_0+@_\  ]?_ (S26&/[
M3ULCO-8_^D$..M;% &0+G6.^F0=#TOUZ]O\ EB:S-$N=5_LRUQIT)7;*0?MR
M <S.>,0GOGOTQW.!U59.A@#2[0 ?PRC)!SCSY.^* #[5JV#C2X@>V;^/&?PB
MK$\1W.K?V#JN=,AW?9).E\@7''<QY_#')XXZUV-8GB3_ ) 6J?\ 7I)_2@"0
MW.L9.-+@QV_T]?\ XS1]IUCC_B66X]<WZ_\ QG_&M>B@#E;^XU4W^C_\2V+
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M,?CG_P %*7\NR_93/(!^*/B<<#@D^&M>)!] H&>3^O7X^L[F,( ?O8Y;  (
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MB[X:@A($EQXD^"/Q%TZ$ L%#[H]#N3LR<[@,!02< &OLOX,?M5_LZ?M"I/\
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MI-J*NFVEMO8]1U+4+/2K*ZU+4+F&SL+.WFN;NZN9$AM[>VA0R2SS2N0D<<:
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ME8;>WBDGFE*QQ1N[ 5\DW'_!1[]F:#P-X&^(<>J>-[WP_P".]-\4>(+>.R\
M^(9]8\+^%/!?B3_A$?%'B[QUHYMTOO"GAS1_$&+"YO\ 4HD(8AEB(#[3;<#[
M?_LYQTU'4/QF4C_T 5E1Z>_]M7G^GW__ "#[3I,@ZSW&3_JSZ?J?6OGKX3?M
MG? SXU>.=2\ ^!]8UR74[;2-6\0:'J^L>&]4T;PQXZT#P_KA\-Z]K?@37;V-
M+/Q+INDZV/L5W/:-\K%9462 ^;7T)%K.DC6;L_VC:8-A:_\ +9?^>]SGOSR<
M<>WX %'QGX6UCQ#X0\3^']"\9ZYX0UK6]"U/2M*\5Z<+6YU'PW?7UI);VVM6
M$%W"UM->:=+(+JV2=6B,L:;@0*_-'3_^"9FH67@OPAX7U7]I;QA/J&EZ5XN\
M ^+O$EMX8\-:=J/Q%^&7Q U32=>\8>&O$&5F:;Q)KNNZ4-1G\8"636&>]NX@
M#&T:I^J/]MZ3_P!!"U_[^K7R3^UKXA@@LO@0;#66MC-^T=\,+>Z-G>R0&6TD
MNK[SX+CR77S;9UVF:%]T;X7>IKJP.%>-Q5'"QFH.LYI3:NER4J]5Z75[JBU_
MV]Y&&)K?5Z%2MRN7LTGRIV;O.$-_^W[_ ".)_9N_86\._ 3QN/$FF_$7Q7XA
M\*>!],\<>#_@AX$U*WTZ"R^%'A;QYXFM_$WB[2[74K>$7NNRW^IV-I':W6H'
M?9:?"MJ@8EFK[N_LYO\ H(:CG_KN@'Y>5S6;IVLZ4J78.H6O.HWQ_P!:.]PW
M]?\ ]9K0_MO2?^@A:_\ ?U:Y3H:LVM_Z7^9!>:<WV2Y_XF&H_P"HES^_4_P-
MSCR\?ATXKXR_;'LGB\/_ +-0^VWLA;]J_P"!JAGE5BNZYU;+)\@P00<,<A<_
M=[U]FW6M:2;6X']H6O,$H_UH_N-^OI[U\9?MBZIITVA?LV>5?6S[?VK_ (&R
M/ME!V1K<:QN=NX53C)/3([]/4R5O^U<$O^GE1[7_ .8;&?K8XL?_ +I7>WNQ
MU_[BT#CO^"AGQ%^(&A_#KPM\!O@O=QR_&S]J?Q)=_"3P8^JW$GV#P]H-SI5W
M=>.O&5V+>/SDMO#GAY9Y5D3[ES<6V002#Z]^SC^R?\+?V7O@[X:^%/P]T&TT
M:S1]%NO%\UJ!<#Q5XI^RVL.LZ]J,E^L\]VU]>1/-"D[%((RJQ1QXVU\X:5K'
M_"^O^"D^I:YBTC^'?[%OP\U+PI::E-<)_P 3+XO_ !=M+.;58[>,\;=#\(PF
MVFE!W)<7>PD;L5^DVHZSI)6S_P")A:?\A"TY\Y2<"3.!C)'Z?6OB\NI4\=F&
M.S>HG5=*K6RG+W-*4*6&PLE#&5:$;.TL7C?:PJU/BJ4\+""M&#YOV#BK,,;P
MUP?PKP!@ZSP4<=@L)QSQ?1P]2=*MCL[SEUJO#N&S*=.K!U:61\+T\NJX'"54
MXX/%YWBL5&V)KMPT/[+  "WU^H P )D"J , *HB   X '0<"C^R\G<;Z^)'
M;S(MP'<!O)R >X!P2 2#BC^VM)'_ #$+7_OZIH_MO2?^@A:_]_5KZ"WEM;IM
M;;TMK;MTL?E?];[WU[ZW>KO>[U=WJ5X;8V^L)_I%S.&T^3BXD5PI\].4VHF"
M<8.<\8QU-<UJW_)2/"7_ &+7BW_THT&NDAO;.\U>/[+<0W#)82E_*8.4!G0
MMCH"<@>M<UJQ'_"R/"//_,M^+1^/VC03C\N:\3/O]VP"_P"I[D6B_P"QA?\
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M)\,O^"GFL^$K2^DC>UTOQ/\ ';X7_$[3=&6)2%@TH>++1M3@MQGB*359@
M<"OP_P 0?";-^)<QK9K@:^39O5GB)UZ6"XC>.BL+3J1IP6"PU;#RK8=8&DJ<
MJM.G/"0FJM6;<JE^9_BO$/!V/S/%U<9A\;"K[6K%JAC)S4:$$HIPIRBI1=*,
MHJ<(64KRE>2LC\5-6\;_ +2%K)?)I#^++B"!;@17&I?#^Q6273]NG2>'[FW.
MG6T\T/B#Q!*VH0:FKVEYI^AQ")9[!'3SVZ/P;K'C?3(5^*_B34-8\!_M#^$/
M'6I77P1OO"^E16?C[3->:2XMM!\.:)8:5I&GR_$"#Q# \&G:MI5S'KFE:G9S
MW E:W5W,7Z_V?[(W["MY97NF^+O^"M5OJMI?0RPM+X8\9? SP3JMNLH93)::
MI;V^K2VTP0X6:.-7##>"#@"]X_\ C%_P2W_X)-?!(?M"_!CQEX$_:2\=^&_'
M?A.W\6^(/$?Q7\._%WXZW/@_Q'J,>E:_>>&]3N;EY[%-%C=-42RT:QL8PL<T
M88*^*^;X=\$N):.(PU?'8KAWAF>%QN$Q*QG#,<74S:K3PV(A7G0IXFI#"X>A
M3Q"A[*NYTYRG3E*"CR3G!\66\#YG2KTIU\7AL&J%2E.-;!RJRK3C"3E*"NJ<
M(\[25YJ>C=UV_H.T+Q%XE3X9>"]6\<6<6E>--0\&^&K[Q=IT*&*+3O$]SHUE
M/K]C%&&?RH[759+N!(O,?:$"AWQN/R;X_P#BS);74L44P\P%EV \8SG)./EY
MZ=#GWY/J(^,_@3XU_"+PC\6/A;XDTWQ5X#\=^';'Q#X?UO2KV&\MKFRU"U2X
M6)Y;:61$NX"_DW,#-O@F1D=0P('XP?M[_';Q)\!_@)\2OBEX5M[>Y\4:8=%T
M;0&OD$]E9:MXIU_3_#EGJEW;M)&MW!I+ZD+YK7>OVEH1&2 Q(_H?-\7]4I<S
MDXPI4YSJ2LW)QIP<Y2LK7;C%RT23=VFDS^QO"7A&AG352K1^LUJU>AAL/3ER
MIU:V(KX?#T(J53W(NI6KTH-R]R+FW+1,^ZYOBMJSL2&XSWR3TZ_=R1VSCOGG
MFJ__  M750"0RD@'/#X^7DC&..!@XQC/ %?P\7GQ<_:2U"^N]1NOVJOVB%N+
MZYGO)X[+XBW=A912W$C2R1V5E;VZPV=HC,4MK6("."$)&@PH)KO\4OVBV^[^
MU9^TDG7(7XG:A@Y]2UN>3@9QCOZU^8/Q*R1-Q]OF*UM?ZE+E\FOWVJ>Z=K6[
M']^1^A9XKJG&?^JW"#]VG*5*7%^ 511;HRE&48Y3-*:C.*DHMQC)22E)*[_I
M@U/1?$O[>N@^)'^.7B2.W^$6F^//$.D>&?AAX=T^*-)+OPEJ.K>'TU[7]<N8
MWOKK4;A));FVAL!96]A+Y$D<DT\0D'U?\(/AM\-?@YX#\&^ ="\-:7JUKX)T
M+3= L-8UG3K2ZUN]M-+A@MK>?4;O[.#<WK1VUNT\XQYTL,<S_.BE?XU]$\8?
M'#PU9OI^@?M-?M#Z-8R7MYJ,MGI_Q'O;>"2^U&=[J_NW"6WS3W=R\D\TA(+R
M.6(YK8/Q0_:+(P/VKOVE5!&#_P 7/U#=SDG#"W^4GIN )!.1VKDH\?</P]^K
M7S"K7?,JDYX.3<G=WLG5Y4K62LNEKMGNXSZ(OC+54Z.%X<X3P>"BJ:HT*7&&
M6TVJ<8+252EE"D^:<JDGS-J[;T5S^S']H3XV^&/#/P0\5:5>6NFVNI:Y93:9
MX6TZ#3([EKC7Q&TUG]GM;>VE$DUJ(I+M,PLD B:4[ F:]B\1?#:SF^#Y_:6_
M94OM3T/XJ)\/=):SA\%+#-HOQ TRV@C,=EJ?ARYA;3;NYLX[BZFTZXM[>WOX
MIP(EF*,T9_GZ_93^*/B#]I7]G3QU9_%;QS=CQA^S;KD,_AOQW-JEEI>N:Y8W
M/@ZZFTW_ (2N]NHS9SWK(;W3K[53%&=06XCGDC6YC9V_33]G+_@KA^R!\!?@
M+\)M" ^(_CO5['P?H%IJG@_X1^"=;^(NJ^'M0DT^!KRSU.^M;>UTV1X+SSX9
MKE+Z1FG21I%1CBOJL'F6$QU:IB\?B<+@\JQ66T'EV85J\,)5I3E[2?M'.K4H
MJC5IN?,XRK6E!65TYG\L>*^78+PQX=PE&6(6$XJR3C#-:'%'#^8XS"3R7,,'
M0I4<-B<#6>(KK#YAE^(>"A%2I4JMI595^:C4C1/UN_8D\?>/O'_P^\8WOCC7
M=5\46NB_$+7/#WA;Q#X@T^QTKQ)J&C:>EJLR:_INGQ006FHV&HR7=FT;6MK.
M8HHVFMXV;GU/XEY_X6Q\"L\8UKQ0/7G^PUQ_+.>W2OP6_9T_X+$_ CX.^-?V
MC(M?^!'[76G?"WX@_%F;XI_#Z_M?@=/?WEI-XOT739O'=EJ^FV>N&[MDA\5V
M]W<6,@BD:6RN(_E+)NK]*O"?[>G[*7[1WQ/^ *_#7XMZ&/$$NIZ]+<^"?&$=
MWX(\::=+=Z(%ALKW0?$\&G3/?ERL?V>QDO2TC+&C.Q KRN.\PRW'\'8' X#-
M\%F^*I<5< N:PF-PN+Q$X4>.>'IUJKI8;$XBIRTZ4)3F^22A3@Y3FHIS/Y$>
M?9/G/&&:9AE\\HPF&QN$S>M1P67XK"RPV']KD&)@J4/9SIQYW5C+GY:5*,Z]
M2I[.E",Z<%^GC_<;KPI^OW3U]?P[U\K?$K4+[3/V2?BG?:;/K]MJT7PS^(@T
MJY\+Q-+XCM]3EM-7M].FT6-(;G_B81WDD#V\A@F2)U\R1&C1A7U0S H>.J$\
MCU4\?7\.1FO#9/#^N^*O@3X@\,^&=770/$/B#PIXLT?1];^T7MDVDWVIMJ5I
M;:@E]IN;^SEM'E$T5W9JUS;2HD\*,\:H?TNH_P#A9P?\W]G8_3_N:P7X?U?M
M\Y'_ '2M_P!A%#_TW6^:V/S"_P""5W@5/'_P ^/GA7XIV$HM?BWKTMQXW\-'
MXJ:-XKO=:NO$NCW5MXRU^2R\)MI]]\/'\1O-%97/A[R=/6U%BGV15+2,WZ8^
M"OV6/@-\/O%'A7QOX7^'VG6GC/P5H6H>&/#7BNZNM2U/Q!IOA[4['3=-N]'3
M4]1O+FYFL&LM(L((K>X>5+=86-N(VEE+_FM^R#\/?&'[-/P4_:D^(7AGXB_#
M;XS^,T\,:QKVGZIHWC[Q1\=?&MUXO\+Z;?\ V31O$L]QI'A[7+2PN+V#RH?"
MJVK7YOY9)3= 8!^L/ '[2GQ3\<_'GX(>#;3P=J<?PY\:_!#6_%/Q(U&_\$:_
MHUUX/^(^F6GAV^L[0:OJ#Q6L.EZDVJ7^GV]E-!)<M=63HK?NI&KUE>ROOU,'
MJV_-GV]8P0G5-<+0Q']_8\F-"3_Q+X>22,D\_P#U\YK7^SV__/"'_OTG_P 3
M7-VL^HC5-=$>GB11<6.U_ML2%E%A$-VTH2N[K@G(Z9.*U!<:I@_\2T?^!T)_
M4ID4Q&A]GM_^>$/_ 'ZC_P#B?Y5D:)!;_P!EVI,$/*R\F*(?\MY?1??Z>E3B
MYU0$;M-4+D9/VZ$G&>>=@S]._2OPQT+]JS]J#0_%-Y^SI\0_$>J>!?C7\0/C
M'X;TW1/$VH:'X*U#P'X5^"WB[Q5X_M=$\2_#^XL;POJ6N7-GX<TK1[NV\8^6
MUKJ-W/<Q1S!40 '[O?9[?_GA#_WZ3_XFL3Q);P#0M5Q!"/\ 1)/^62>WHM?.
MW[(7Q8\>_&']GCX>>/\ QO96%SXJU2'7M.UC4-->&PT_6+CPWXFUGPVFN6=F
M?,%K#K,6E1Z@(8Y'A0W!\EC"4)]Z\1W.I'0=5!TY<?8Y.?ML!P,KDX"9Z9H
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M$I3<A.QX+UW4?$.E37NIP0VMU%J-W926\45Q&(S;,$()N$1G;/)= 8SN^5W
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M]8L;&2\N;&>WMX[RV\12:5J6L6]M:R0VMHNZWDN?+>)^4_8]N_#VN_ WXY^
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M]'Z%71V]H]MJ\>^[NKK=82X^TM&VS$T>=NR-,9SSG-<YJW_)2/"/_8M^+?\
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MXX4962XMK7:2>KR+(&D^JTZ[+M<]?&J^%R>-]/[/FWM?_?L9;KUU->":/.)
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MS3T:?FOZNM5H+7C_ ,??^2/^/?\ L!R?^E-M7L%>/?'[_DCWCW/_ $ Y.O\
MU\VWN/PYZU\AXD?\F\X[_P"R/XE_]4F8GJY!_P CW)?^QMEO_J;ACTGP]_R
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M $X7F?UK[*I_R.<)_P!B_'?^I>"/+C_NM;_L(H_^FZIC_'+QAKWP^^#GQ/\
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MOK+_ )[UO7G_ !Z7)]()C],1L:=:_P#'M;_]<(?_ $6M &-_:^HX_P"1?O\
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M]=UN:T<ZA0JTJU/)\LC4I5*=6#?UV24Z<XS@W&6.<9)2BKIJSV:9_$M\1?\
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M4+_6M%-_HQ_M?3.+JY_Y?[0C_CRFZGS>*UO[<T7_ *#&E_\ @PM/_CU %?\
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MG0,=R/&-L3_Z!_0_X'_">?M(#_FC.A-['QA;#^40_G3_ .(U<+WM_J]XH?\
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M,?OY'X4T*W@BC2PA(A0E"XR=P0G+-W.0,=,#IZUB_#&%(?!>CHBJJJ^H8"C
MYU&\8\#CKSGKGTK]PRWPTR_!YS@5CL3]<H+ 8FK]6IT8T*<JU+$850E5JJ3J
MU8Q=2I9MJ4DTI-I:_DG'/TH?'#Q&R;-<KXDX\SF>5YGF;Q>*RS 5HY9@I0Q-
M*<7@52P4:%1990ITZ<:&7>WEA%-2JU(5:TYU)<IXA^ 'PX\8?#[Q#\-?%.D-
MJ/AKQ3IJZ9J\4-S/I]UY22PW$$ME>6CQSV5U:7-O!<6=S Z26\T,;IRM>>^
M?V+O@#\,OB3X2^+?A;PWJUOXU\!^ [GX:^%-0OO$FL:E;Z/X,NA ;C1[6SN[
MF6%8))(!.5(*M=22W3*US)YH^KJ9(K.A56*E@R[E.&7<K#<I[,"00<'!YK]=
MP^&P^%HTZ&'HTZ-&FDH4Z4(PA&W5**BFWNVTVW=MMZG\\MM[MOU;?F_O;;?=
MN[N]3Y.\!_M,?LI_%#XA7/P^\'^,?"NN?$2\U7Q1IE]X=ET:ZM]7CUSP/<W.
MF^(]-O4U#3H?L^I6+6%W(;>=TDN[:UGN[<2PHTE?3'_",^'/^@#H_P#X+;/_
M .,U\B?"/]@GX'?!GX@Z#\3_  U)XTU3QAX=B\5+9ZAXF\3W.K+=7/B_5==U
M34M4U9&AB.J:O ?$VMV5CJ5X\MU#87@MG>188BGVO6XCSCQUJ7PQ^&G@[Q)X
M_P#'*>&?#?@_PAI%YKOB/7=2L+2.RTO2K",RW5U.RP.Q5$&%1$>221DCC5G9
M5/FWP6^,?[-_QXCUV'X.^(/"/C>/PI_9PU@Z;IO_ !YIK,4US82B2[LX?M$,
MY@NH?-@,J1W-K<6LC)+ R#T'XS?!WP#\?OAEXO\ A#\3](?7? OCC2Y-(\0:
M7%>W>G2W%H[I*IAO;&6&YMYH9HXYX9(Y!MEC0D, 0?(_V8OV-O@I^R-9>(M.
M^#NG:]8V?B./2+>YCU[7[S7WL[+15O7L['3YKTF:"U:[U+4=0N%=Y))KV\FE
M9]NQ5 /H_P#X1GPY_P! '1__  6V?_QFO(_BO\0_@)\(H/#]K\4M5\(^$X_&
M]_>Z-H$6I6MM#)JMS86+ZGJ*V_EP,PCL+&,W-W,<+$C1@G=(BM[Q7S+^TA^R
M5\'?VJH/ ]M\7-,U;48?A]KL^OZ -)U>XTAS<W2V@NK>\DMOWDUG.]A8RO$K
M1L7M54R>5)+&X!WWPP\6_"#XS^#-)^(7PV?P[XG\):V+C^S]6M-*CA5Y+.=[
M6Z@FM[JT@N;6YMYXVCFM[B&*9" 2F""?0/\ A&?#G_0!T?\ \%MI_P#&:X#X
M'_!;P9^S]\-]"^%_@)=3/A[0FOIDNM;U"75=9U&]U*[DO;[4-4U"8*]W>7,\
MK&24JORJBA>*];/(/TH ^0/BS^U!^R'\%/&I\!_%+QOX+\)^,[#0]/\ %/\
M8-[I<CWW]C:W=W&E6-ZD5KI\PF2::WN?E4LT45O-/(JI&S#Z9LM&\):E96FH
MV.DZ%=V-_;07MG=0V%F\-S:7423VUQ$XBP\<T+I(C#AE8$=:^-?C[_P3I_9S
M_:2^)TGQ<^)5CXNF\:-H.D>'8[S1/%%[I$-MI^C3W<EN(8;="N;B"]O+.ZC<
MM#+#<R.(DG_>U]P:3IEGHNEZ;HVG0BVT_2;&TTRPMU)*P65A!':VL0+9)$<$
M4: DDG&23UH'IYWZ]C)O=%\)Z=9W=_>:-HT%I8VUQ>74QTRV816UK$\\\A5(
M&=A'%&[E55F(4A5)P*^.+S]MS]A?3KNQ>Z^*/@&*YUK0],U>Q0Z1=,UUHUZE
MU?+=1QC2\JNG6-M=:MK(95ETC2X6O]06"V7?7W#J%HM_97=D\DT*7EK<VCS6
M[;)XEN86A:6%]K!)HU<M$Q4A7 8@@8/YJ3_\$F/V4;N;2[N_B^(U_?:1IITB
MVO9_'-^)FT^\T[4="\003>7%&DG_  E/AS5+KP_X@?8&O-,$4:&&6)9""/T9
M3PWX:=5=-"T9D90RLNG695E8 AE80X92""&'!'(KC/B!K_PK^%GAJ;Q?X\7P
M_P"'?#MO?Z3I<VJ76DQR01WVN:E;:1I<#BVM)I%^UZC>6ULKE1&C2AI'1 6'
MID:I"B1(%1(U5$1%(5$10J(HYP%4 *.,@<#(->:_&'X4^'_C7X!U7X=>*;W6
M[#0]8NM'N[R?P_J#:7J9?1-7LM;LXXKQ8Y&CB:^L+8SJ$(EB5HB=K&@#QCPI
M^TM^RAXK^(Y^$/A[Q;X2N_B.^O\ B#09O"<VA7%KJEOKN@J+K5-/NA=Z9%%;
MW!@9KFQCDE7[= DDEIYJQOCZ:_X1GPY_T ='_P#!;9__ !FOCWX>_L"? [X<
M_$[1/B]I]UXZUSQKH.K^*-?MK_Q'XJN-3BO-6\5W>H7UW?:K$8(CJ4]A/JVI
M_P!DR73R/917KP(6ACA2/[=!SS@CZC% 'B/Q&^(?P-^%=UI6F?$34O"GA6;Q
M!I'BW6=,&IZ;''%=:3X)TD:UXJNA<QVCPQKI6E.+J5))$EE5E6W25_EKFO@[
M\;_V:?CQ=ZSIOPA\1^#O&ESX<TW1-3U.+2],"FWTW7;<S:9=JUS8P"XAD"M#
M*\)?[-<H]M<>7,I2I/V@/V6?A=^TR?"]M\58M>U+1O"L/B>"#0=+UNYT?3-6
MA\7:0FC:M'K(LMES=*MI'&UGLN(3;3+YJ[B2#S'[,O[$_P "_P!DJX\0S?!W
M3-?T^/Q%IND:/+!KGB&_UZ+3M,T=I9HK/3#?L\MO%=7UQ/J-\6DD:>[E+E@H
M"@ ^FSX9\. $_P!@Z/QS_P @VT_^,U\\^._C_P#LN?#OQ'?^$?'7BSP3X<\1
M:-J?AZQO-*U+3UMKB"^\0Z=J.M:. SV:Q3QRZ7I.HZA-+%))#;VMI.UPR%=M
M?41Z&OA_XZ_\$_?@'^T?XMUGQ?\ %:+Q?K=UKH\.)>:7;>)+C3](BMO#6FZQ
MI-M:V5M;1"2TCO+'7=2AU!XIO.G$^Y9$90: /H#X7>,?@[\9_"=OXW^&LOAS
MQ1X8N;[4M,34[32HX4&H:1=/9:A:2075I!<136\Z%662)<J4D0LCJQ]#;PSX
M;"L3H.CX )/_ !+;3H!G_GC7G7P,^"'@K]GSP%:_#GP"NJ?V!;:GJ^L-/K>I
M2ZMJUYJ.MWC7MY<7=],%>7#LL$"@*L5O%%&!\FX^PD$@@'!((!]#Z]_Y4 ?%
M&I_MQ?L8>"-0BCOOBQX/T/4KS2];O(;6+3M0MKV[LO#WB.3PSK 2WATU9II;
M+7K>>R:'8TA:&5T4QJ7/T.=4T_7/&GP_UO2;N*_TK6/!?B'5-,OK=MT%YI^H
M#P[=V=U"V!NAN+::.6,X!*.I(ZU\2>*O^"5'[+_C;77\3>)Y/B1JNN_:_$-]
M;:G+XWO(KJPNO$WB*Y\2ZG)8R00)Y$;7]Y>+#;8-ND-U)NC>54=?M.TT/3?#
M'BGX;>&](A^SZ3X>\"ZYH6E6^YW-OI^DQ>&[&RA9W)9S':P1(78EG8%B237B
M9\KX? +OGN1[[:8]O\D=6$^.K_V"8K_TRCUFBBBO;.4Q/#G_ "![3_?N_P#T
MMN*VZQ/#G_('M1Z/=CIC_E]N/\\5MT %%%% !7DGQS^'7_"U_A;XI\!"UT>\
MDUR+3VMXM>FU:WTV&]TO5K'6-/OGN=#9=4M[G3;^PMM0L9;82*+VUMUN()[5
MIXG];HH _*YO^"=5[?W7B7_A)_'EIXEO?$<7BW6+OQU<W'CG3_$MYXH\9?"P
M?#+4H+[PCI7B:S^'Z>'(8[C4M2AA@TPVWV::QTV'0+2XTNVU4>K^,/V+X;_Q
M-)K/@74O#7@N.XU_P3?6=UINBS66I>#],\.>#[7P;XA_X1NTM5;0]1O_ !5I
M5J+.Y36K0);*++4;>[@U72;.X7[ZHH _.GPY^Q!,OB/X7ZQXLU/P']@^$*>!
M](T71_"?A&;3[#QYIO@C69M9L?%/Q%L[V26"^\<>?'9G3)D-W:Z+>S>(]3@O
MKB7Q"UO8_HJ.@[<>F/TI:* "BBB@ HHHH **** "C /49HHH , =!BDP/0?E
M2T4 %%<KXU\;^%OAWX<O_%GC+6;70M TWR%N;ZY6XF9I[NXBM+*RLK*SAN;_
M %/4]0NYH;/3=+TZVNM1U&\FAM+*VGN)4C/A7A/]KOX*>.?B/;?#7PQXG6\U
MF5+NQN5OK#6-"O\ 3/&-G#HNHR> M7\/Z]IFFZ[I'B@:!KMEK\EEJ-E:O;V#
M8N%29@E ' ?M/W>G0_$KX2VWQ9U3QOHW[.MYI?BZ+Q!=>#[GQ3I^CWGQ3,VA
MKX*TWXGZGX,*ZW9>")- ;Q7<6"W4UKX;N?%,&F1Z[.VVR@E\,\8?&S6_A]X?
MTJU^"WC3QQIOP^7X<^,O%OPBF\;_  Y^(?Q(UOXQ?$:R\57MEIOPK&L^)8$\
M2Z/H#-';Z?H%IJ"6NMZEH^LV6LZ1J[:'HC^9]IM^TY\"KB\T[3+7QU;:Q)JU
MR]EOT30O$OB'3],D7Q'?>$%;Q1J&CZ-?:=X3M+GQ/IFHZ%9WGBBYTFSOK^RN
MH[2>98)63-U#]K']GO3GU^.^^(=G!_PB[SI<3-X?\4O:ZK<6FNVOA2Z@\$W:
M:$UIX_N;+Q'?VN@WL/@6?7Y;/4KJ*SN$BDD"T ?!'C3XD_M@>)_@CK4^OZAJ
M_AS6_BK\.?VMI&T7PAX N[/6_@_JGPE\9_V9\,[31-7MY[J\U;6/$6@F>WN[
MZ^\H>()A!JOAFUMDB/GI\6?V@OCRB7?A=]3NM0\5ZKXS^*O@7QA\"$^#_BR[
M&A_#SP]\-/'NM>#_ !E'\1]"ELP+GQ/JF@^%=2DUV&__ +(U@^+_ /A$]#M+
M+5M'GF;]%=-_:2^"6K>.[?X9V/C_ $M_&MS=?V9!I,]GJ]E$^O)HL?B2;PG_
M &K?6$&CIXUM/#\B:S>^#)-07Q18V DN+O28(XIFC;XB_:1^"GA.^\5V6N>-
MK:SNO!FH:)H>OK%HOB&_ \0:^IDT;PKI$^FZ/=P^)?%=Q&_VC_A%/#LNJZ]:
MVTHN;K3K>!O-H _/CQO\4?VHM-^'?PG\6:C9CQ5-XQU[5]43P;:?#KQ!I\?P
M_N/A]\2="B\!W4]QIFJ-K-[-<Z)]KFUR/7&;3]:FAM;F"RBLHKJVN>BF^/?[
M1'@U_ ^C?$_QH-&\-^+? /P-\;^-OB]8?!_49[SP)K/CSP]\4+OQ;X-T/PCI
MYU<743^(O!7A;2[2YO;36=1\%6WBJXO/$,4]J+.X3[,A_:U_9XN9] M[3XGZ
M/>/XDTW3M:LFL]/UZ[@T[1]5\0ZAX0LM3\4W5MI4EMX+LF\5Z3J7ARXG\7RZ
M''9:W9W&FWIM[J)HQXQ\8?VF?V?=?TGPU!X@\+Q_%3P'K.JE=.O;?1]>GU&'
MQ)IWQ"\%_#I-3\.:!+X<75M3T>PU+QNK7'CK0[I=)M3!_9\-U<OJ&^$ \[\#
M?M(?%KQ9^S3H?Q%U+Q1;6CWW[2/Q2^&'B+XLZ9\+-:B&A_"?PA\7O'O@OPYX
MU/PWN9[Z_P!'OM6T7P]X=M;W4M42YT_1;O5)M=O[!;)1;P\_+^U!\7;7X)>$
M?%.M>.K?0O\ A(OVRK[X)+\3KSX+^([6YU#X-)-XG;1O%=A\/[N07UOJ>N6>
MCV"1>*)+:;1($N)O$)TPZ4A@3ZZ^'7QQ^!&C?"K1-0@U?P#\./#&E!M"F\/:
M?J=H="\+W,'AI?&EQI_VN&PT^U:S@\)3Q>)[W4C96]E'871NKN=7+LW0:'\9
M_@#\5_#NK>,;/Q3X;UC1/A/<P>+-;N_$6GW>AW7@.:#1M0O-/\4ZAIGBBPTO
M5=$MKGP]-J=WI&N2V45IJ.EO?3:=<7$*SE0#X5L/V@_VH-07QOJYUF2W^&GA
M'3M"M?#?Q"C^#.LS7WC7POKOQ4M?#FI?&VX\-&5-1$'ACP6VK!?">F6,0O;S
M1F\=RQ_\(Y>V^EUSY_:R^+K>)[[PWJWQ5A\,>#+#P_\ $[6/AQ\21\#=<UC5
M_C7)X7U71K/PRTF@PQ'^P+-;RXU?09GBTNU'Q#DLDNO"<VG$-YWW%X&_:^^#
M?C[XF:S\,=%UBXL]1T;PWH?B".[\1:3K7A)[X:Y9ZWJL&G1:-XHTG1M7MYO[
M T*\UZRGN+5+36=)AN;S2)+N"QO'@T=(_:&_9I\0?$/P]I6C^.O">I>.?$&F
M:7HGA_4K>QO6@O+?6;-?%>B>%8O%;:=_85OK&K:<R>(-,\*2ZI!K=[:/%?6V
MFR1O$[ 'YL7'[0?[:$.D>$?B=XE\#1:=XMU[5OBKX6U[3AX0U?2;#X)^ -,^
M(OP*T<7DLDUQJ-EJVHSZ=K'B2]EU_7+"\AMVL1>V]L-*TC5XKKLX/B]^U'=W
M?A+XL2WVH/'9?!3X]Z:ZZ+X/UOQ#X2FTFP^/7P;T3P]\4M7\-VMGI5SK_B_2
M/ =SK^L6VD:-#;6^O6^FZG?Z!$='O+R)_OSQ1^UC^S]X1\2ZEX*U_P ?QQ^)
MM,U2X\/76C6'AGQAK=Q-XEMM(/B";PAIYT;0-1@UCQ@?#RRZ^GA'2Y;SQ%/H
M$-SK,6F2:9;7%U'3\0?M<? C0K":>T\;66N7"^&$\2:?'I5AK,FD7AN_#MWX
MF\/^'KGQ6-,/A70/$_B;3+0R:%X<U[5M.UN]\V$0:;(9X4D /C;P7\:?VIOB
M+\4OB#X*^&_Q TSQ-X#\$:1XCU_P;\0?$'P8U+PQ;?$C4-)\,>!=3TCP=>ZW
MJ4^GZ.NFS^)];\0:)J_BK0M/B6:RMB^G0I<Z5<RS?77[,OQ[N/C;X;TWQ5K5
MG=>'9OB/9:G\1?AIX1NM'U&#4;#X0V=UIGAG2]6U_5A!)HTNI>(-;6\\1V-D
M;V#4T\/:_HT;:>6L;ZXJ3P[^U9^SYXXM].\-ZAXST+3-1\1^$DU/4O#^MK=0
M:3I\-[X2B\3ZQX5U'Q0]G'X2?Q#I/AN[DO=9\/Q:N=6L]/2>ZGL8X(W9>N^'
M_P <_@GXA.@^%/!6OQ6+3E='\*>';SPIXE\&M>V6GZ+)JEL?#FFZ_H6BF]T)
M-"M9+NPU+389M'GM(<6=U(5"D ]WHKY+3]M?]GV.75)K_P ;V5KHMO=V]OH&
ML6EOJ>N?\)7;)I3:KKFKZ5I.AZ=?ZS#H?A9(WA\1:W=V$6DZ4VR2\O((Y8B_
MU)I&K:7K^E:;KFB:C9:OHVLZ?9:MI.JZ;=0WNG:GIFHVT=Y8:A87EN\EO=V5
M[:S17-K<P2/#/!)'+&[(ZL0#0P#U&:,#.<#/KWHHHLNR 9)]QNGW6X/<[3Q[
M9_\ K=ZX?X;<^#=(.",O?D9]/M]Y@_C7=,H8$'IS_(C^M?/-C\$?$NFZI-=6
M'QP^)MKH[7-Y/;>&HU\-?V38QW4KS"VMG;13>F*!W8Q&2YD<CAB17S^9SS#"
MXW#XW!956S6-/!XVA*C0Q>!P=55*E7#5*24LPG3HN-3V4H)J7NRLY6B[G;A8
MX>I2JTJ^*AA>:K2G&<Z&(K1DHQJ1DK8=-JW-%Z[WLMF?0]%>/?\ "M/$C<'X
MN>/\'K_R!%_4:9D4O_"L?$(_YJWX^QZ;M&_F-,S^9Q^E>=_K#Q+_ -$#FW_B
M0\)W_P#4PZ/J67?]#O#_ /ANS3_Y ]@R!U.*,@]#FO'A\,_$(SCXN>/_ %^]
MH_'7_J%_6@_#/Q'T'Q;^(&,<@'1?YG3/Z4?ZP<2_]$#FW_B0<)W_ /4VP?4L
MN_Z'>'_\-V:?_*_U/8:*\<_X5IXDZ?\ "W/B!CC_ * N/8?\@W]/I1_PK/Q)
M_P!%;\?_ ):)_P#*VE_K#Q-_T0&;?^)#PG_\V!]2R[_H=X?_ ,-V:?\ R!['
M17CY^&7B/K_PMWQ_QT^?1?Z:71_PK/Q$?^:N>/\ /KG1L_F=+Q3_ -8>)?\
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M6^H3:='%I.LW6IQM8644ICU.PM]QL#-<N!:+*Y>Z0M$@#QLS>[?\*U\2]/\
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M9G2Q$OJU>$*<,%CZ<ISJ04(Q4JT8PCU;E)M)*W5'L=%(.@^@HK[,\HQ/#?\
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MO"'ASP]H&G:';:/!-H]K9KJ2S/8M?R7-S;Q&&6Y:TM(8+*&"%/0J* "BBB@
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MCP1-XH%L]C;(UT%_L236EL))-/MXM[7@T]WT^-!9,83Z%>:K\(-'&JP:A?\
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MKE;&"1FBM%N)Q;I&)9 P!?HHHH **** ,/PV<Z-:_P"_=Y_\#+@UN5A^&_\
MD#6N.F^[Q_X&7'L,_P"?H-R@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/U72M.US3-0T;5[
M.WU'2M6LKG3M2T^[C6:UOK"\A>WN[.YA;Y9;>YMY)(9HV!62-V5A@FI-/T^R
MTFPLM+TRU@L=.TVTMK#3[&UB2&UL[*SA2WM+2VAC"I#;VT$<<,,2 )'&BHH
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MB"TT"_UCP-X?\-Z2S6?AK0=%NO&^AZE>Z5X:UO6M$BO-,GCO?U]HH ^$+?\
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M #_-FNAHHH **** "BBB@ HHHH **** ,O1O^0=!_O3_ /H^2M2BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
LB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $  C # 2(  A$! Q$!_\0
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M"$D!(*.00K '&!BFVT1BMX8BTK-''&I::7S9F*J 6FDP/,D8@F1\?,Q;L<4
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MOF@CL)K]HH=.O)[AXH>2$ACB:<W( (2R$9N).=D9-;6T=.>F.I''IQ@X]O\
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M7V@W/PMNKG66EM=1TSX17'@72]0GUNVTE3I=GK=E:QW&N!&E>MK]._3[^O\
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M]EW]I$UJAM6D.38+<>6VHKAK-9@<U<MM<MK^QAO;:&_CBN;!=1B%SIE];SI
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MVVDF*==,60:AJSXTC3I=+LBDNIW4D;?9)I))/M)C9?MUSNVWM[]HNXU1)E4
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MMNOA;X"TG1O%&K:=XO\ B+<V<,OQ!^(EM9SVMWXW\1A<7FKW"WDUS>0K,_\
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M"RWQSQ0D/;JQ(Q)'$26A##'S;AR37S>^J6,D<A-TD9$+G,P($85=Q=E(^=0
M3L&[?]WJU6[2[MYK:&07$,RM#&_FQGR8W4H"'2'&8@W4)SL& <8S7Q-3/^(Z
M+Y:N"49*U^;!UH2?SO*.OE>^NBW/L)<+8-73ABX.^CYG9+IO%M_J?1S_ !&\
M,(N5BN6&_P T 6V"TJ@C?DMC>!QN;D]":R+OXEZ"#'+#I,TLT?FF*0B%603
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MD=*/$-RS$B&URR)",QDD1Q B$9R ?+!.W.0"?EQS65J5Q)?S>>8XQ-A!(-C
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M#,[2<  @Y/$F<;P3NW$GBGW _=S!E\P^7*IBR(S(P4KM\W :(L#C?C,9^?<
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M] 5"XSDGWS7M/P=U./4_!EC?HNX2RQR'?%) X:6-9)$,4H26(ARXV.%<8 <
M@@<=\2+-+;Q#)(BD+>0"95'!W$X// XR!GKGCM@^?AJKCC:]-MN+OR]HM*+D
MOQNK*VY\MEF-K/.LRPE6<I0J2=6E&5GRNGRJ7+UC%QELFKR3;6UN!PI],8(
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MWES*A+91QA2.< $,N#@X'.<#D#OBO1=.\.ZIJ>R.UA9HV";IBI58U;.&+<Y
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M]#;'\1XK&P=&A3CA:$U)3<92G4E?>/-9<J?;?:W4N18$<86!1M51\JX4(JJ
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M>3M!,R08V+('R@B*L,<[QG%>GZCX9%LK-#)%/CG$<R3 %N>2A.PGG&XC ZC
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M!MR228^PY.#D'I5^F!R7B6:]70M<S:Q86"ZC5C<')LS;MFY(* "53D" 'Y@
M=XR*_.MKBXF5HIK2W,9^UB0M,)%PCE;(JK1$'[0@#2DG]PQ8?O!@G]'O%0QX
M<U\^FE7A/?/^CN?Z >PK\TS= Y.5!8L,<@]1NQR!T(_H<C-?Y8?M$LZED^?>
M&$X-Q=;*.);252I3DI+'X**BI4FIJ+<WMLI-J]K'[%X7455P^;W7,O:X1/2Z
MTA.6J[;M]'U,G3-1L_#6L:S=:GX?BD35+:VDL+RTM/MT4,D42I-IDBPV[26R
M"0&59VC"R[\ 9XJ"Q@34+OQ#<S:-;II.J7^FW-CI-[+M$,:0[+R]%D$;^SYI
M3^^BCCV2W!4/(8B2*VEE"!OFP&;"@;E"J>-H(()(ZYSSSGBJ<5XOVR\1'@W@
M6N\Q#-T%*2&,W3D[3'@,;8  A0^X]*_A3$>-N<8_(8936P\*=14,/2J8F&+Q
M51PI9?.*H1H4:DXTJ-:25/VV)C4<JFZ@KSB?H]+(Z-'$5*\9)QJ2E*4%&&]2
MW.GJ[Q35K+2RT)8=.DCCEM8M0U>UL9FFMWM8M6>:W:R=2J.(KB*0IO5O+-NK
M$*N&#G@#S_5M#N_"NI:5XFT&QU+5K33ENTUCPPVISWEK>!5S:W5E8R'R(]4D
M+,'U#8Y10B2JZ+E?21.", CC&1R>>3GZG.>X!/'>@3#&0V3W(+9/3&<$#(Q[
M>]9Y-XX\6917HS6:5<=A*,ZJE@<36J_5ZM*M1]A4IRG27,ZL8.7L:KDW3FDX
MVM85?(,%B(RC[*,')QE[2,5S7A)25DHKW7+?WK/JK:',6FM:3XUU2'6=#T6.
M*SL[&XTS6)+E%M9;B_N B7>C744D8F9]-8$/<H#%(S$Q$KM)U[C0HIK>3399
MM2N=*#1QPZ=-JK_81"Q 8["AE @&3! SLI*H">U8FMV-_#=-K^@L!J\:)]JL
M9)%6VUVT@#LFG22RDP6$YD8R1ZAY9ER/+DW(2!IZ3XBM=3MGN5+0O S0W]M*
M66>RGB'^DQ2HZHS",APDRJ(IDP\3,AQ73FWC#Q!CL=_:>78[$X"E5HX?#+#T
ML35G."P_-&G]:K5(2<J[E4E"&)AR3Y?84N=RBT*CDF&I4E2JP55WF[N,8M1=
MY<L5HE&*3W=K?>>5_%C]ICPW^S+X5LM=^*4\UUIEI-?V7ARST6]\[6M7;:T>
MGVTFD8B-V/)"&>[8BVL&9BQ+@!OQJ^,W_!3;XG_$?4))_ %KX>^%MA;2RC3;
M_3[87GBIXR3\VHW\X\E_,'+01P&-3RK^GSY^U]\8M7^-'QO\9ZK<7-U)X?\
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MK)#G]VFXF; (:,MBM;SI&>)I(8RRM)\[.&:,+D1;"8RQW *"JD;,X)-<I#;
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M'3'&.X!-=A\+?%]YJ7Q*\#6FEZ/?&%];MOME]?QO:0QP[7#F%'(=VP<C=T[
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MC%2P8$G/R[@,$'W//< @ TJW^T9<A., [ANRWR@X^I'//6N"OO$>DZ6XCO\
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MX6XLQ>8PH1BU&E2QO$"S:EA806D9T, Z\-X5TXI']-+ <+2DZF*S26+@_?\
M8>VR_"4E)O[4:-12=UISW=N9V5W<X^TUJ-#CPOX9NKEF5E^VSH+92-V5:2XG
M FD()R2.3P<#G%\Z?XGU1O,U/6A8(X_>6FE(,[/NNCW$@WG@8)4 9R>_/H \
M-^(,A1X?U?Y9&BPNG7>/,49V;1&.@Y].F00:#H&OAHHO[#U?S+@3&-/[-N@S
M^0 9]H$0SY0(+#DC-?E.89=XIXW%SQKX*XYJ9A4FYO,\TR3BG.,R=11Y5..)
MQ^62I8=QUY/J^%I1CS.,%&*L_4AFN3X:,:6 6582G=)-5Z%6=DK7<JE3EO;K
MR[W:>]^'M_!WAVW#N]A#>3-C=->C[1-(,DY=G.T$<],#GH.E/'A7386+Z<UQ
MH\I.?-L)F0 /U#1,QC< 9&"..,=..P30]>DB2:+1=7>%H5G21=/NR#$21OQY
M0."?49'0CU<^A>((L&31-90'RASI]TIQ.1'!@M%@>9(RH#C&3SCBC*Z7COEF
M*=;!X/Q(HSJ-JJJV1<1XO#335N6KA<7DN(PTZ>B7LW2Y5&\8.,7RG/BL9EF+
M2CB<9@*J3O!O&4J?L[;<BI5X*^M]D[I-6:1YW'I6LA;V$7UCJ=N+V=3!J:1W
M#RA50$O+"K&T9@<"UPNP8;8"3GGKC2]1LW7[+I6H:.Y.Z6[T2[%U;E"#]RQD
M/50,L&4 @';[^PP:!XE9YXSHNIN1=/$JPZ9=KLD55+0R$Q_/.  SN#DCY>E2
M'1->&U1H6L#='/*H&GW;%H[;_CX<8A/RQ9^8]B,#=7W$<X\0ZF-G5S_P;Q/$
M,*]/#*K57!_$^2XV7)A\-3<IRRC+J>7XB:<)<D<1E<TY-1G3:CRG%3JTL+#D
MP'$4L)'F;E2>/P^+P\KMO6ABJE2[5[7A4BTN;LCR*RU?4+7<4\06-_)R577+
M-]/NQGY6B@E5=L08CYE11DYYP:T&\>-:%?MVGQ2JW233;Z"Z4G!S\N5D&#P<
MY/. 3V]#DT#5+@HLF@:A,S0)=1[M,N7/V>1UCCGPT. KR.%'1MQZ#%'_  B>
MJ0-N_P"$9OXV$L<&X:/<*//E/[F)2(,;WY('UR?7FS3(\%G:HU<S\(/%ESIT
M?9PPU'+J\:6%DF[QPM6EPUA)*C&ZC%SP4:JY=:DDE%=-+-7!6J8KAJLW+6K>
MIAJDTU]M4L5*#E?7F<='?EY4<);_ !&\-2L$FFN+.3!^6YMI4Z8P P4@DGH%
MSSCUK0;Q59M+";6QU6[C>*1DEAM98U(+*2$C<*)02<^9MPG(/7GI;_PC?:E&
MEE?>&=2G%Q=2V42MI5RK/=QQ/+)"C>2")(HT:0L"H4+D-6!'\,_%FG!FTI?$
MEE9"%[DPS:==7*I&A 9X7EC)6) I#)RO?!(R?-R_@'+8TL7)^$OB92Q,Y36&
M69T.*I8;ZM."Y:<IY5PNJKJ3<6Y-Z1VYM4WT5,1EN)A3E3SS Y=66E6GS4,5
M0F[ZSHU95XU(=N24$UHG*25P?Q%=[0T/AW5I%QDDFWB"@@G.&?/0'@#D?HR3
MQ=IML =2M[_2PPVEKVW94!(!R&0D,!G[PXQR3Z6Y/ OB^=V6>Y\3D 6[.D.E
MS6[%;QG6U?*0$[)BC+'G^[SC(S+#\,;HNINO#VOZC(LODAM0M;^X'GD<IL>/
M8I(Q@< @8JUP1E+@XX[P:XTC>%J<L@P?B L5&=M)3J9UD%3!S5[74J%EM:UT
M8J6&IZ?ZUX:JNL8T,(]>UYXN%E:]W&:DNBZF9-XU\-1P&1-3MYV92(X86W32
M/M^5 G52W !;CU/%8[>,+QU:X8Z7I,"<P)>RO=7=QR?E6V@RWXL><C&ZNN/@
M&.41$>#[AP\EQ%"5T><;WM'=;E%(A&6A9'#]=NT@9&*MV_@.YMGWP^$[T,(1
M<J_]DW#-Y.2%=&: MM)]P1Z8K7+.'L#D.%KU,O\  [CO,<VJ3DZ>/XKR?-\V
MI82"2Y%A,NPV1X/ JLW)Q]MBZ6*;C=1I7(JRRRK4C[7B"2H)7EA\'4P>&G5G
M=:2Q4L1B)0BTMH<KN]'>QY9+JOCG71Y6G+!86;2VZ&_N(UM-_P"_38\!=A)N
M!8-&F!YQ"P$,7*G8MO TL5S]OU#7;C4+[.6EGMH945CR1'',2J@,.XR#@\<
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M/#N;P&>SR]MN_L,RP]2D];V>'Q&(K4>5[.*BDUIHCY[M=<U#3;ZR>?Q(T]S
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MDU^I_0.;:+J(8L_]<T!ZD]><^AR>GKS3EMH<$&*,=1CRTZ$8/\)Z]Q[<]J_
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M2. N$)RBX#-MK1N !!,=VW$4GS,AE5?E)W&(?ZP+U\H?? V#DBOC3]OGX/\
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M#.?7/!^O^%_';W6@F:.XT=/&CWWAN\EECNU;[\_8G_8P\2? [X^_'/XI>/\
M2=1UNXO?A7^R]\,O@WX[\;>*=.\4^.8?#G@+X-Z?H'Q&T?4CHQ72=)NW\7V5
ME9:O?Z5:11^)X]'TZ]6:Z@M;=P ?>OB'XI_#/X;:#XO\8>.O''@+PCX9\/>(
M;/3O$6NWOB"RM+'2-2U:YT[3M+L_$MQ<2JFGZY?WU]96L-I)M:0W-J$!WC;L
M:%\5OAMXFU[QOX8\/^//"6L>(/AK<:=:?$#1].UW3[F_\'W.KZ)IWB33(_$$
M$<Y;3?MN@ZKINJ0/<;4>TO()=X# 5_.'\0/^">G[8_QI;X_:EXT^$'@*"_\
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M<S1NLL<?-_"G]J/X5_$WXN?&_P"%&@:CIMMXK^%?B;PGHERTNJZ81XZ;Q/\
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M#=1UB?P=X2UC5]1AT#5?AWXDTG3++4+O7M>@&LW<EEJ5TL?W?^S]X8^/5A\
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MHO"X+-1T;]COX$6WQ=_X7E=^ M!N?$S?##X??#33/#&K>'/!^H>%/!=I\/\
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MR/$FL37?A8?#_4I?^$7\+V\^H:X@\$>7IEY)-?VD.H-[)J7_  3E\-:A\/\
MXM^ 1\3?$T%O\5/VLOA%^U1+J"6B-/I%_P#"L?L\*O@PI]M4:IIVL+\ ;58M
M4O'-[HO_  DUV=.1?L%OY@![[:?M=_!;0=4E\#_$SQ[8>#/B%X?^'&K?$7Q9
M'X@\)>/_  )X4N-#\&Z1HVH_$+7_  CK?COP]I%EKN@^%O[:L+C4([+4=0U3
M2[*^LQJ<*7'G*F=>?MS?LV:=H>F>(-5\6^*])L-9L-8UJPM]5^$GQ=T[6Y/"
M_A^VTZ[USQK-X;N_ T/B&S\":5;ZOIK7WC6\TR#PS;R7:0/J8N%DB3XM\?\
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MZDEGX3\1>&UL_$^GZ?X>N?[+M]$MIM.OM-UVQM=1T9-=L?*OKRX6O>?VG_V
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MLJL+$.B6-G;K!;++''&EZL:_:[DE?M\LMQ=$2RS2/N>:5V1F8B $)#Y:*JT
M:5N<01Y:1SL4[I0!,WR*29%4 "0G)90.&S5@'(SZUS4OARPO[6YCF?4(5O\
M3;739TMM5O(S%;VV6C:VFAF1H+DECYEY 8YYU"^8Y &+W]BVN2QEO2QU&/5#
MB\N IN8D"*FP2;1:;5&ZS'^CNV6:,L2: -?.?Y_G7XV?M2_\%$/B_P#"SX^?
M'+X5_#GX<QIX<_9V\%?LQZ]XG\3>,/"FLW.B^-];_:6^,NG_  ]L;+1O$]AK
MEM9:'I_AG0$U.ZM3=:;=W?B/Q&MY8QFRM=$FDO/UQ_X1C3]UNWG:D#:W6I7<
M>-2O &EU6VGM;I91YV)H4CN)&M(9 T=E*(YK98Y(T8?$_P 9/V _!GQCUOX^
MZSJ7Q!\8Z*WQ\\+_ ++?A75K:PBL+A?#UE^RW\2]6^)>@7.FS7>Z:\OO%5_J
MTFF:U<WS/)9VD*3Z>R7+R,0#O(/VYOV=Y=3\,:9/XIO]._X2OXG?M#?"73]1
MU72)].TBT\5_LN#Q(_QBDU?4;ET@TS1-!A\)ZW<6NL7)%MJ,%J)8=JR)GSF;
M_@I+^RUHOAWQ+XMUS6_B/H-EIT?P^UVPTOQ'\-?&6G^(?%W@WXJ^+M+\ ?#[
MQ[\._#5QI:ZUXJ\&>*/%>IV.DV<^DVDVJP7D\:7VD6LEU:)/YCJ__!*KX<>*
M/B%K&K>+_BGXW\0_!Z]\=?M*_$'2_@;)INAV.D:7K'[7'A76O#7QRM)_&EG&
MGBO5M*UN7Q'KVL^'[2YN(G\-7FJW,5O/=0+;B%]Q_P $R=)\77_A37OBG^T!
MXZ^)?C+X7O\  C0OA?XHN?#7A30;KP?X"^!'Q;\+_&'3O"^H6.B)'9>)-<\8
MZUX6TK3_ !;XOU2..\GTZ*)M-TW3YHP[@'T&_P"WQ^S3:>))_#6L^+=6\.-9
M2ZKI.J:YX@\,:UIOAK2?&^@>#+OXA>(_AEJ.L/;/%%\1?#O@VPU#6M8\-QI*
M]L+&[TQ+F768'TX64_;A^"]QX!^&/CNQT_XF:I+\:3JT_P )? >E?#O7=0^)
M'Q T71+2WU/4?%6@^$[5)+@>$H-#O;#7'\1:E<:?ID=AJ.G0S3Q:I?6NG2^*
MZ)_P32^&GA/XX?$'XQ>&=5\)E/'WC/QW\3GTGQE\&O 7COQ/X9^)'Q#T.33-
M>U[P[\2M<3_A)[;26OG.IVWAZZ6ZCMH)]0T2WU"'1]0FMA@>"_\ @F59_#-/
M!WB;X;_'CQ+X+^+7@W6OBB^G>*=)\#>%T^'=IX"^,#^&Y_&/PI\/?!3[0GA+
MP?X(;4_!GA7Q!I%IX8O-.NM+\1:7-J$4\D&HWEBX![EK?_!0C]F'P[J7BW3]
M7\7:O9P^#M-^(MS>ZQ+X9U:/0M4UOX1^&=3\7_$[P1X?U62%+?5_&W@?P]HV
MJ7VN:' 5V/I]_8VEU=W]A?6MMXQX]_X*M_ ?PQX?\.:QX7\!?'3XA:GKWQ6^
M!/PX/@S1?AKJN@^-(-$_:*M]8NOAE\4+/0O%_P#84NL^!?$2>']=M-+N;&47
MMYJ^D7VES6]E/$&;F7_X)+?"C[9\<(D\2Z&^B_&Z+XS:I>7=_P#!WP!?_$SP
M9XZ^.?AS4]'\:>*?!_Q9EC3Q186":EK6JZMI7AB1);&VM+Q_#\UW<Z5E&[;Q
MY_P34\*>+O$8\;Z1\6_&/A7QOI/A/]DO2/!FNQZ)H.MVWACQ3^R'XD\8Z_X*
M\8RZ-J@:SUS_ (2*+QMJNE>(?#MZT6E"W2"XL3!<JSL 7_VNOVR-?_9V^*W@
M31H+#PO;>#;_ /9G_:9^.7B;6_%-OKT]QHMU\%['P/?:=:SV/A^22\FL)XO$
M.H+JMM:P3WXFMH([1U/F%N]\9?\ !0#X >"O$:^#-1U7Q5?:O)XV\$?"8^)-
M%\#>)-3^'UE\9/B'!IMQX9^&6H>,H;8Z/:^*3:ZOINJZI827)32=,O(5U"YA
MU!UL32_:H_8<\(?M1:U8ZAXD\?ZYX4N_^&??V@/@$]OH>FZ1/]KTKX]:?X<M
M?$7B>*._\SR]2T-] CNK"R4-8RF^F2ZRB1"OC#XB_L#_ !,UWXYZ/X$^'7_"
M9>%OV<[[]J#X6?M5?$2\U6[^'$OA*[\3_#[1=-;4U\+74$U[\4;B?Q;K?ASP
M['<>!]0TVP\.Z7>C4/$5OXFEB6+1Y #5\!?\%C/A_!^QX/CO\3? ?C_5/BMH
M?PBO?BUJOPU\"^!]=TNV\=Z'I/Q%'P[\0WGPJUKQ:+32?$FG^#]5OM$C\631
MZF[Z:-2MKJ%+NTN893]N_&7]LO0O@[>_LJZ=J/PA^-?B&\_:J^(W_"M]"T_P
M_P"%["76_ &I+X)UWQM+<_$#2KG5HI---M8Z#=1W=I:37<UM#!J=^S/%ICQ3
M_-^M_P#!)OX5^(?@[\,_@_J7Q-\;-IGPO_9\^-/P%T36X].T.+4;@?&#Q=X0
M\:CQS<P>4;0:SX2UGP;8'3M-2/\ LK4[:YNH=1C93&4^J?B;^R_<_$NP_9\U
M:X^)U]H7Q3^ 'Q0TSXKZ;\1=,\)Z');>*?$,_A?7O!7CVWU;P9=S2Z/9V'CK
MPSXHU^SE33[B.;P]=W5OJ&DS":R1) #Y[_9-_P""BWA7XQIJ/A+XFV&K^&_B
M:_Q%_:=\-^%(-'\">,1X.\;Z3^SY\0O%FBW^D^#?$EQ97&G^)_&]AX)T.Q\1
MZWHFF7+RS&6^.F1RFRO+:TT=2_X*6?![4O'/P/\ AQX5^'7QP\9:O\9_BWXS
M^#.LVVA>#UL-5^#_ (T\!^"]*^(EY:_$73M0U.SN+.&\\+ZSHGB&*;29]1A7
MPY?2ZI)(YM+BRKF]<_X)8^ =7^'7@KX>6?QA^)7AR/P'XW_:O\;Z'XB\/+I>
MG:]!<_M6Q^-1K^FQW,:;;>R\+/XSF33WA5;G5["S.GZG*(=0NV,'P^_X)B>%
M?A)J7A/QOX5^+ \.^./"G[0<7Q\DU/0?A3\/?"?@>^GU+X.>'/@3XM\&1_#O
M0;>RT#2=+\5>#/#MG,^M6DKZ_8>)KF[UXW=_<SO&P!^IYE1<#<I.=N-P^\ #
MM&2,M@@A>I'/8U(&'J/S'Z5D'0-)>1)C91EX]4_MI&S)E=5\A[87H(<#S!!(
M\07!BVL?DS@AJ>']+C-GY<$B"P-\;11=716,ZD"+S<#,1+YF3L$H<09_<"/%
M &U1D>HK!M_#>E6L!MH89EA.GQZ65-Y>N?L44DDL<6][AG#J\KGS]WGLI"M*
M550)KC0].NUNEN(Y7%Y+9SS[;FYB+26!0VS*8ID:,)Y:;DC*I+@^<L@8@@&N
M2"#@@\>O'XXJO:_ZILM*W[Z89F #C$K * H V#I$<9,>PG))-4X='L+>6XGC
MCD62ZOCJ<[&XN&#7OD1VYE56E9(T,,2+Y$:K ""XC#LS&I'H=G*(W9[U##;Z
MC8JJ:C<NIAOY"9WD*R 23]&AF8&6T+%(F4#% '057NKJ&S@FNKAMD%M%+//)
MM9A'#!&TLLA5%9VV1J6VHK,V,*"2 <B+PY816K6:S:CY36EA9%FU*\:81::0
M;=EG:4RK.^/]*N WG79)\]W!Q3Y- LIII9GEOM\VIV.K2!+^[C3[5IWEFW1$
M24*EHQB3[39C_1KH%A/&X9@0#X_^$_\ P41_8]^,W@3P+\0/"_Q?T;3=$^)/
MBOQ5X(\#6?C&TU#PGKGB7Q1X,\11>&==TK2-'U>VANM1N;?4+K3Y8_L0N UE
MJ-I<N8LW"0>F+^UY^S&VA^*_$[_&WX?VV@^!/$>B>$O&6K7VNQ:=;>&M=\37
M[:;X;LM6>^%L]M#XBU&.6ST+4&4Z7K$\,R6%Y<&&39\5?!__ ()\?$CX=ZC^
MS_\ VG\2_ LEI^S3<?ML6?PUU_1/">IOXG%A^U+J]EKWA3Q%?6^MW5YI-MXN
M\ 7S:O;ZFMDHTC5K)K)+:*V#W<1\'\*?\$G/BO)J&LZ]\2_BQX$\3>)?$<O[
M'X\5:PA^*_B5_&]Q^S'\;?$OQ5\0^+/$B?$#QAXBAT_Q%\1[+78K*#1?"EMH
MO@_POJ%NRZ;I/V0[W /U!TC]KG]F36])\(^+-&^-W@?5M ^(OB.[\#^"9['6
MX[N+7?%NB7SV&LZ'8:7 CZC;ZIHUY)';Z^+VSM8]*::R_M&2V6>!GP=9_;T_
M8ST"^\5:7K?[27PGTW4_!B:@?$^G77BFU2^TG^R-;G\.ZU'+:#,\\^A:S:SV
M>O6]G'<3Z&(S<ZK':6C+.WQU\0O^">?Q+UWXH_$#Q[X!\>?#CP=KOB_]IZ+X
M\^'_ (B0P>/]-^)WPF\-W7@[X-^%O$/A;PI;^'-=T_PKXBA\:M\-/$0\5Z#X
MTT[4?"NLCQ)::G-8OK6DQW5=!X'_ ."<=WX1U[X-:X_BCPA>3?#;QW_P4"\:
MZ\?^$=OFE\1R?MG:[X@U+0H;<W%S(EL?!^F:O:6'B"*0-::M):R36,$!E!H
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MTKGM(AU:'4O$#ZA';I:W%_%+I)AU+4;V22T6S@CD>YMKPFVTR07"R*MKIO\
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?TT+0QJ7GCG^2UD#AU\BV_<D!9/OEL:U !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "] ;,# 2(  A$! Q$!_\0
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MXP_!O5'U_P '>,M?M(HKI62SBO+F2UE="I6*XMMSJT'/S @+SCIS7Z]_L_\
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M.=N""<< G&1W^O:IJ:=VU;;K_6I(4444P"BBB@ HHHH **** "BBB@ HHHH
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M37/#6I:=X1\;OI>D>'(=2B\+Z_=01V&L-9RVTHNDL)YC"8&$P1D K3_X((?
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M]H#]JWPC\*] U"XCU"#[1;1S&:5Y$"HL2L7,9!'(QG)/.,#&:_@?_P""O?\
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M1K;P*"JPQHI.2%15RWJ=H!)]\U-10 TJO]U?;@<?Y]J H'8>O3G\R33J* #
M]!1TZ444 %%%% !1110 4A( )/8$^G ZTM<OXRUN/P]X=U+5'D6,P6[^66(
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ML:374$=U<E4C1KB%)4@0?*?*=D>60J<$QAMH^4D'@+Y2H !A@,$'W'.0<]\
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MM\;8!#?*3D87&#GG\??T%>;5ARUFG%J_5WUU?6][G(Y246U>ZDNG2]VONO\
MD:0Y /J!13(CF*,_["]\]O7O16)JMC^)[_@IEIOB;Q+^W7\:-.O-7U*XTFRU
MNQ@T^P>XEDM+*%M$L9 EO"TABC4R,S9" EF//-?+&B_"!!=0#SVE$>"J@859
M& X.#DX8D_,<9(Z<FOU:_;A^'5YK'[8WQ?U."#<EUJ^FR-<"/."FE6>Y1[X
M ;)QSP0.?*=.^'T=F1F$O)M)#!/E!'&7?&T#=QG' [9Z_P !<;\29S7XGXDR
MR%2K3ITLWQ<*2JN_[J,O=C#FC)*RUD]'?:Q_J!X9YKA<J\/N%84%2ISJ9#@W
MBG&E34W)POK)QDY7;WOS+S/G#PK\';>UD^T!0DDH+.XX8@N,*Q+'(!!. /H
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M7?W?<CT'P+X(O/B1\2OAE\)--)>;Q'XAT721&BDKY^H3Q1RC8.6W(2&!)'7
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M)JGA>6%]%U]K6%S%+?:?IEY(;BYM\@%9T!0KR&!K!^/_ /P48_89_9H\93>
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M DJ><5\Y_!OX86'C.2]\8^/;F?6]4O&:_N[B^4/,%E8O;VUN\RN$&,$!0,
M<=ZO_!.?X<?M)>'/^"8D'P(_:BBL+SQ[X4O/$FG?#M]-UVV\4?:?AY9O!+X8
MM[G7K9WCO#;R&ZB#^8[%47<1@ =S\%?B)I]GX9OO#^M8M[RWEAL+P21J\ZZA
M:2) \$(4[HP@RVY@%(7CC%?#>*6(X[RWPTXPQ7AEA\/CN.:.659<.T,34A"E
M4S)R@J2G&K*-&=DW)*I*--M+G=D>ID]'+JF<X&GG$I4\L^M0^OR@[RCAU?GM
MR-N2NXZ1YG;H[,E^)/P1TR?0Y/%7AJ\.CZEH\3O!);[8+NVN@VZT57A5#-O
M16WDJ&SD'I7T9^SWXZ/Q!^%NGWFH7$L_B+0;F;0]?N)?EFFO+?[K/MQN)@*D
MG)[]B17DGQ/^('A?1_#M]86U\+]]DEU%(K+%+/(L)VVZ6^XM/,)-J*@X)XKO
M/V8O!>J>$_ADD^J1QQ:GXKU.?Q%);+)^]CBNQMB6Y7^"8)L.PX(Z<UXG@=F/
MBQF_A7P[BO&C"8/!^(2K8REF^#PT\,E%*K+ZK.4<))X/GJ4YQG;"3E!.\9M2
MT73Q73R.CG>)APW4G5R7V<%A93C.'[VWOKEJQC.Z=VI62M:S/?K=G2:(1X5U
M<.A/3?TRQ/53@9W$X^O3\ O^"NO[/UC'\9_ 7Q!TJTM[>W^*.AWFG:V\2%MG
MB71A&845NC2SAC*2P#$*<5_0!LX*JRMM8B;H&5?XE5NH(( !QD'MFO@C_@I5
MX=MM0^#?PB\4SVGFW/A/XU>'IG(QEK;4K6Z@N8W?!)C<$,V."5Y!Q7['E_/'
M%>SG-QI*$IU-&[32NEU=E+2R1X'5=KJ_I=7_  N?PW^-M)F^&W[5&D03/+!I
MWQ.T2XT/58 66$W^EN;8M+P%+N5SG 8DG+'%=5HVGRVGC;5-!N8\1K)/;K""
M K1A3Y>%'!#KM(QU]>F?4?\ @I!H]GX3_:$\&:OI\2>3IGQ1-K;K'CY8]1,L
MLD:XQ^[\PECD=<8P<"N4U:^$7QFCN#"@%]%IY6+&/G:V0$[L=^H) /;N<>M\
M<XQ3NZFL=&N9-VO9I-:K1-"J7<Y*%^1O3:UM->_FCD_@KXMO/@9^UG\*O'NF
MR-8W'ACX@^'M4CCB/E+Y$&J6_P!H)92.JDD@CYN017^L)X-U^V\8^"/"?BBU
MF6:V\1:#HNL1RKA@XO[""Y?##(R&<J2,#Y2/7/\ DN?'_1;SP[\0M!OU;R4F
MFM;W*#:R*94EX<8;(*XR#[\=#_IX?\$XO&4_C3]AS]G'Q%>2^=<S_#C1;::9
MW+L[6J&W#,S#.0B*&&<Y ((R,<V/?\.27PR=*37\ZY;=-VGW>U[G/*-IRAL]
M+?/^M>FI]QHH1%0=%  _"BG Y /J,T5P#/YX/VO[N*#]H3XDAO*C>75;+,C@
MJPQIMODD_>?CT [@YKYWM1</Y26(#6K%C(TN2Y#8.8PW/WNF>!C->M?ME+(G
M[4WQ"F+/($U"Q:.!LE9/^)=;9(##@ GJ,8(->?Z;:WEVD4WV=K9$4$H.@&,]
MSSM'3CGIQ7\)<486O6XQXCG3PR2I9AB9N:M*W-+WVY*._F[V^\_T'X(J1I\%
M<+4Y)OGR?#3LVWO'35^\DE]GX4M%H<IX]O)]+TNVLM.!>?4F6.50P+GCYN#R
M,YP.,9QQ7;^#+&ZCT:S+DS74<*H;=F!VNJ[CD\@%5!SG^( 9SC/E%W%?>*O&
M_D1)+%;Z84!F(9HB4X8C/ <D D8SBOI/P_-8Z5:3(MF]Q>I'N1E'R@XP68>A
MYR/3J/3Y_)<"L3F&(JU9N,8SY5%2:3T;DU%M7MHFTM7ZGTN;5U0PU"BHMS<4
MYI)W<KKE;=K:W7HEY$[?;--MH-2D@1"2!N52!A.3N/(."2">H&!C/->KZ!<Q
M:O':W\3B*15'GI'G#C(P<#HQ!P3CH#[UY[9:K;ZYI;65X562%G5XU !&YCA1
MU(*CKU]N*U_#]S_8S"WC8^06V1Q#E^>,Y(SGD=<_D.?T;*KX>K3<9-TI+T:O
M)Q::>KVT?J?%9BI5:+4H2C-RL[>\]=FG;5-._*NSUT9ZG<72^8@&Y5+[ I;I
MQD$KGHQXSR3WZU6US_2-,EMMV\E264'YBBD'C/)SG! Z'';BJELT-SN?:X96
M5MK+C+<8'3KU)[\XYP:^G?A!\#IO%ES%K?B.&2#1D*,B$',XZE0#C<GW<GCC
M.>3Q^E9-E.*S?VM&C%/#RY>>;6MW*S26ZM&]M5=[]#X/.,\R_AZE#&8B<G*E
M-^S4;/GJ6?[MPNV]4KNUGLMFCSOX$?"OQ+XR3;#!/8Z-!(#]HGCPLF6 ;RRV
M-Q"DD8R?88K]*/!7PX\/>#;:,I&ES?[!ON[E%>7>@!^^03@'IDYP16]I.F6.
M@64-II-M:6MI:QB*&"!!'@C@.Q499B!R3D\X-7'N97,;NJC=D,H)V_-SU.#Q
MCY<YSG)!ZU^TY-D]#+,)1H4TTX)W;5GS3]Z5M9*UWHV^Y_./$O$^8Y_B<37E
M+V&&E5E*-&G*2;CS6M+EY5=QL[<KC&]M7H;,$KMMVQQL<$,RMC _A )4<;L#
M&#_C,@E? D78%)X!!W YZG_#]*SFG$<&R$%9"-H. 3C[V!SV[#' SFEMKB5$
M(D<%R3PW) YQ@YY'L,X]NE>OR.[MTMHW9M/JO(^12:C=MV\UJKOKIOKYZLV,
M\X_Q_P ,?K2GD$>M4OM2CK*B\#C&>>_(/^3GMBHFO C8,J,&&1C *C.,?J".
MASD4E%N_EW!MK5QE]S_K\"\8Q@Y.1W&.H[]Z<,   $ < !3_ (5C/>QAALWE
M0 3N<DYSR !P1C''USQ3VO0XW L"!QCZ^G0GGH?T-/DD^J?SO_F"4K:0MZ-?
MBK&OG/K^1'\Q2U3M9O-#L2< @98!3G&>@^OX8Q5S(/0YJ6G%M/IHQ^NC[73_
M ""BB@'/Z_I2 **3=DXP?R_SU[4M !1110 4444 %%%% !7Q=^UY:277AHA(
MRS"$L3C@849P>X&.<<<<YQ7VC7S]^T)H#ZQX5\Q4#+#YBR9)_P!6R@G@9]^H
MY]<5,E[LO.+3\TTU;37J;X:?LZ].=[6DE][2_*Y_(7^TIH<EE=>(7,++N$[#
MU<$\X[< D]2".2/3^,W]KP.?CKXG=DP R%/[Y R!D Y*YW#@'VXK^]']K;P'
M+$FJSI!A)(;D@@<C:K8 XQR""#CMUQT_A:_;>T&?1OCGK,DZ[?M,9*Y!S\LF
M#C@YY8C(ZX Z5\3DD94\]Q%%WC=5IR[)3E*S6WO-+9]%L?7YG5YN'L.HMZ5N
M9VM;2<=?FKO3L]#Y"@D8W$:G"Y(^;OG..G';WSWKKM15?[2T*XXP%0'!R,[B
MH.1T'H/7C'>N)5\3JP&2I! /'(.0/RX'O^==KJ4;OIFGW:+\\+ '&,JJ?,2>
M.F>IX&/05]Q_7X+L?&PE=:O5]'\_ZW/T^_X(LZO%H7_!2WX!-</#']M\71VA
M>9@JC[2X &[/+''R\D9_&O\ 2&\0+)#J5PBAU1)Y%#,@.1)EBVPE=RD'( &#
M@<^O^5+^S1\2'^#?[2?P7^*L5W)9P>&/&_AW5IYT(4B"*[3[00><*P(W?X\'
M_4]TGQCI_P 0?"_A3QKILZ75EXI\.:-K-E<V_,3075A%(4XR"R.2"1SD')XK
M?$I/#TU?6$XREUMS+W%?9W:U_ NH_P!VHZ[N3M>Z=DK:;:13_I'P_P#MI?L/
M:'^U_K'P,\>:?\3/%/P9^*WP"\4V?B+P/\0/"49FU PP2^=>:5?KOCV65X"T
M38<@(S J58FOC[XT_P#!'CQEXE^+7CSXK?LK_MH?$K]E<_&VSB3X\^%O#EM+
M/HWC359;>.WUG6].A@N;:'3[O655IIBH=Q-)(ROESG]L(0ZABP7)&TY]#@YY
M],8)/ S5A7VC;UP<YZ$GU[X]@.E<,Y.HVY-MNUWMMZ>AE2FZ>SE;723;WOJD
M]C\EO!7_  2%^#GPKOOV-;OP%X^\0Z=)^R9XSU_XBZC<ZE:IJ&H_%SQCXA,3
MZIJWB*]DD0V\TTD?[ML2LD96,EMI)^G_ -K7]CO1/VL/VAOV3_C_ *IXXU#P
MIJ'[+OC"\\5Z3H%GIT=]:^)FN)A.]I>W#RQFP"M&%1T64X/('!K['?,A.3UY
MYQ@G&,'(XP .1C)]:15V]<\]1T!^G&:SY4XRA?W924I+^9QBDFWN[6OUW[#<
MGS*<9--Q<7KTYG+;IOTZ'R=^U+^S#9?M-_%']FCXG:SXON_#I_9U\=3>-8-$
M33$U!/%$<]O<6D^BW@:1/LMK-%.RO,HDW)D$<G'R7KG_  1A^.>A_$_QM\2_
MV"_VP/BQ^R-X9^,FJ76O^+OASH-I+K'@R75[]FEO=7T6V-S;06,LX>158('B
M8\,0N#^L-R-T<K D,ZD%N,CY3P/RR#QBOI'Q?K_BW0O@SX,?PW]M2.X$4&I7
MUFKR7D$.P['41*2D;.>6&,=.>AJ,(RDKJ]D[>2[+RN'M)M6<F]]_/<_)OX+?
M\$P/A[\ ?@E\9O@%\7_%'Q!^/%S^T6L\OQF\6_$S4)M2NO%6L7\7D)J&BVT[
M3QZ7+82;+BS$$K8DC0CC-?&MI_P0<_:XTCPC/\)?A[_P4F_:!\)_LD:G.\$?
MPC%M<W.M6/A6ZES-X9T_6A?I+9Z?+$[6Y,485$Y$>#@_T?PSWFL^ ?AU=>.=
MB:L?$EFD,]UD7%S:+=+Y+3!P&S)'C*GC))R3TQ?&_C'XGV'Q:M]&TC[?#HR7
M]G;V%M!;[K*XL9&4RO)(!MPB9XSW]:VY806RU?;7H*,Y0ORR:3Z=+]SPS]D;
M]D[PU^S[X,\)?L[Z!8^);KP1\-/##Z?87?B34I=3U:Z>8O+!=7M_,1-.;N4R
M,P8 *&V<XR? O'_[&^A>,_'&L#P?_;_@CQE<:DTEZVBQ&6RN8"7,CW%KE8<R
MGK(7#9^;TK]-4U/4X/CO?V(G9+:X\%VT]S$K_NS/ DC#]W@@E78%03D?B,</
MX,U?6HO"?Q0\1Z4[:AXMBU6:+<8]]Q!;)(RY@4?,6$8)0#'SX)SFIY:<_=:Y
MEOROX?G&]FT]4]^P.<FVVVVS\_H/V$;#X?ZC:^*?&\_B+Q9]F>*:);\;+"RO
MO,"12,$,PV,C#(.5#$<#&#]O^._A;=?:O"4?@GP_<)!)HEG=:A]B5O(24Q*#
MG)"[F 4;<#)/3H*\]O/'7Q-U'PY=PZB^K76ESSPB]%Q:S,L >Z0 M(R*$*CE
MUSQ@X.*]J^*?C'Q+X?U7X6Z1HVJW%A:W%OI$NH,H %XC>6K0NP((!09XR.F>
M*JT86=M5L[;;?=L#E*5DVVEMY=#YGNK:\T^_N]'OXVT^^MYSY\4J;94B?)4G
M(^96;@$<#OWKX[_;]NE'[/\ X:TJ>(/)JOQ2\,+;@D$LUM;74I*G^$[%=A],
M=^/TB^/]K''X\@GCCCB%YH5I<7$N%#/(RR8R1TRR DC YS7XO_\ !17XE6UC
MJ/PM\$I,7B\/VNJ>/_$:9(%M<1P&'2(F&>-Z32[,@G([C-7AN;ZS>/-9TJD;
MI7O92?1;^]UTM;YTI/ELM]M+WM;?8_DZ_P""DC/K?Q4\%6]@K/=3_%BWDB8D
M$RI#O!8 G)0 $'))^IX''^++9G^+>GQN1YMM#I:NZ':IS;P<@8X(QSN/0<8P
M:P/V@M9N_B;^UC\,-!M9F_XDUQJOBG4(E)*L)KCS;5F [B#*J>1\IYYKJKK4
MK;6/BA<7 3:D=V+9'(&3]E/E!?8G;R#WZ#GCOH.2J824I-))0;V5[N5[^FGJ
M5&]E>][G+?M3R1W/B/PP\<XFECMK:)@H),;#RP"Q)''(SU/UYK_1V_X))PM'
M_P $]?V=[2259WA\(P*&Y*\2%@N6XP!D9!XZ<\FO\X']HN"*[\<^&;*U1[BY
MFDT]8XHN,&6148''+9XQG(R.<U_I@?\ !-OPQ/X-_8@_9QT/4(#:W<'P[TF>
MZB=0K&:Y#S@L!U8HZ9."> <<TL9SJFZ?*W[2M*JI;-)<MFOYM59VU.2I4?UI
M):63<G:22OJK2:L]M=;KT/NX< ?044H.0#ZC-%<)J?S=_M:7EI;?M5_$^[OG
MD8G4]*ABAD1MBQ-I]L)'C9AMR&R-WL>E<KIVLZ1-97<GVF1 8655,9)7:I4Y
MR,D9Y  Y'<\5_1QJOPW\":W>2:CJ_A'PYJ-_-@S7MYHNGW-S,5&%,TT\$CR%
M0  78X [U"/A=\.0NT>!_"F#@'_B0Z9T7L/]&XY /U K\;Q'AAC<1F&:8V6:
MX2FLQJUJG+#"2YH^T;=IR<O>WM=6=C]_R?QJPV5Y1E66RR/%5YY=@L/A'568
M0A3G]7C93C#V-XMV3MK?:1_+WX"U&.#6-;E663R'N9I(EEC;+DD_-\R$E23T
M/K@8!KMW\0S'[3-:W.^11)LAB5PKE0P *JO()!)'8#&.#C^DM/A9\.(RQC\#
M^%$9OO%=!TQ<_E;=^X[\^M2#X8?#M>5\$>%5/]Y=!TP$>X(MN#GG-?-?\0,Q
M*P\Z4>(8PJ2JRJ1K1PC4X*=VTFI7:3LE=[+S/;K_ $@Z%:<92X<Q,N6,5KF%
M):IJ_P#RYZI'\PGP[\723ZQJT&IR7"7?FNZ1E)%0+&Q/&5&0<$ \]17N"ZY!
M+-"\'FM-(PS&48>6#QP0H)QC)([G)&!S_0(OPH^&R2><O@;PJ).=SC0=+#MG
MU86H)_.K0^&O@!0/+\&^&(V4Y#KH>G;AR3U^S^Y'\L<8]7*_!_$9?2A&KGOU
MF<9>\Y8>2YES7NWSWYOS7H<N)\=\%7::X:Q$$H_"LQI[J]M?8:;GY=? ;X:W
MWBVXBUG7X)X-(A:-P&.%N&4@J1NP"I&0>I))]*_2#35M].M(+.R3R;:!%CCB
M& <+MP2 N"2!GGKG\:]$M= TBQ@6VM-/L[:%0 L4%M#%&H'8(B*N!VXXJZ+&
MT''V>'C&,1J#P,=0,X/7&:_7<DR?#9+A8T:,92J.SK5$XQ]I)I.7,FI.2<E>
MSMLNUS\;XBXJQ&?XR>(G25&DZG/3HN;GR1NY<K:48N5W;G2N[:Z'!QWS9QQM
M)9B-W)   Z#@ D=.F/7D3)=%L;VR!S\VP<^P(X/IGGI[UW L[8<>1%CI@QH>
M.PSMS@<8Y["G?9;?_GA%_P!\+_A7N^U5K<OSTO\ U_F?-O$.[<:<8WNW=MWD
M^NGZ_<<<;K@9<YP2,JV <<X*CGG Z<CFG+=\<9;CH01CKZ^O0GM@5V0AB'_+
M./\ [X3CZ86D\B'M%&/7$:<_7Y:7M.EORN3[>6CY*;DG>[3:OZ/31;:;G(02
MDLP^?YL#"X..?H2!Z]>PJSO)!)+X4J<O&,<9  RG3U// &373^3&!PBJ?540
M'Z?=_I3BBD8(!!]A_AC]/I2<T].3;JWN2ZLWU2?=)7^^QS(=\_=@.1QR",_G
MG\@?Q[:,%NDB*S*!C.%3D9/..>.A[=\= *T_*3^ZO_?"?_$U( !P!@>@I.>F
MB2]+?Y$<TMU)I]T9X'V?Y G!Y)+KUZ8X&.V>E/#DD,RD=MH922!GJ ,DD]<'
M.!QS5S /4 _A1@>@_*IO=6U?FW^G<A+6[=WZ+^O4APDB\H^#VP1T/OCTIZQJ
M% &0.N,]/_KU)12*&@CL#P=O3T_H,TZBB@ HS_G!HHH **** "BBB@ K#\1Z
M/%KFCWNFR@;9XFP< D,HR,9Z9( /MQTK<I&4,I4]&!!^AZT7MJMUJ";333LU
MJFMTT?AG^U/\)FF&J0M;LR/%<(%V H" < $CJ1CC'0_G_ =_P5N^$\_@KXJ0
M:MY,D44[2PME"JKF1B/F(P1E??!K_4H^.WPQM_$FCW%Y;PY<H?/VJ"0$0_,J
MY')QECSGITXK^++_ (+E_LDW>M> ;OQCINGC[3HJ27$SI ?FP78,Y5<G@<]P
M2*\*MAUALTAC>3GC4251?R\R<6OA763=[ON?083$1Q6#J8!OWHTN>E%K3VD;
MW:;=DY7LW;6R2VU_B?!(D'/(.-QZ],?3V''3IZUZ!H[?;],N+1QYDH1S& >D
M.,R[>"-VT$@=R?4$5PES;O!++!*K))!(Z.I&"'C8J<CKV_+%:^AZBUA<1S'!
M!D"E0."F0&4]>&&03WY!(KW8N+LW\+5].UM//L>%&R;4KJ2DUU2NG;KTO?<O
M7*2O9>2O$U@ZO 5SO6WR-LG&"!&XR2".HR1CG^]W_@@/^V_IG[2'[,D?P3\4
MZIGXH_ Z&/37MYYB]SJ_A0?+IU];([>9,]HS&*?8& #*37\'^NP$NNJV$1:V
ME788U "X/WH<#!*@DG^+'3-?1O[%W[4?Q$_8R^.7A#XX?#;5)86TN^C36M*\
MQEL=:TB>1!>Z/?0YVRJ8\E=ZMM900>.=ZL54I.,:G*[JZ3W44^7ULF].K.F#
MII+F5]VU:_>UNFNG^9_J./E)8FW,4="'FA!=7E0D&,J<A"I&,L0/J ,.!R,D
M8/<'@CV([?2OEG]D']L3X3_MI?"S3OB9\,-6LQ=W%E;?\)=X7%U$^IZ#K0B4
MW*3VP(D2WDE)\J4*$.0IY%?41DPTBA7'EH&9RNY2< GD8SQQG.1UXXK@Y>32
M]^M_7_(RK4I1Y9VBHRO:SL[=/=MOW=]=RYY2D*0V1U<#!/ [>G)]_?IFI&0/
M@'C;D CJ1QC/4=\]/:JH92D<D3@AU)]\^N/3MWY'8THN'Y#;1P!C!'4<GCN>
MOXU#4MUK;9O=?X7T7:^J,".[CVQL%)Y1^OKM;!Z=A[>I]J^C+WXBS>&?AUX#
MM_#][IM[>DF#4]/N@LBB 0EL/&P/ 8<9 R1D8YKYT9P>2H?T^8 C\_\ ]?KF
MH0T89W949\#RRPR(OEVGRU'RJ2.>!G/< UI&]U;>WZ:C2;T1UWC'QGXB\;3V
ML^K7,*I8%/[/@L5:&&RFC8%)1&A&=I *\<#&",<==%\;_&]KI]M:"+3Y[JU$
M5NFKSP(\IVG &]QN!(/4D$XZUY,':,)L*A@G4  Y.<D@8&XCCD=,4,WF*XE?
M*MM!'  *G(8<9!SQGICBJD[I+JKW^[[A-6T._P#^%E^)F\62^+9'MDU1+#^R
M9U$>(9874@M@#:2. "">G85C^&O&.N^&=8OM6T:Y$4U_*\NH6DBDP3ER6.8W
M_=LO. >I[]JY>9_.79D$?+T'=>A/'7KW(]AQ2M*S;BP5F(7!QC!7&,#/L.I.
M*<9127?KI=_>4VN5+KUT]3T?Q-\6_%7B;2Y](Q8Z;:RKON8[.W1&F>.02988
M !;:01CD=.,5S/B;QCJOB>_\-ZGJ$L/F>'TMH+!(5!#O;QQA?/&,$DJ,@@C=
MW%<V-T\VZ2,I.ZC=O'*JI(#($.#O .<GG-6-D<%G/=W,MI!9VJO//<W!CABL
MU@!D>YN)9&55A"#<S9PJ#/)Q1[.573FY5OMNGZ/3_@A%*5T_SMU+GQ$\?'4X
M[_QQXLN;6TTKPSH\DE_,3'##!96,;R,7+%5=B3M3/5G&"0<5_)C^V!^T='\2
MO%?C_P <FXG@LO$+26]A;M.P.G>$]#\Y8G=<XB\Q 6<!0I#<\@&OJ+_@I9_P
M4*T?QT]U\"?@QK/F^"-+N77XA>,]-F$<6M7=LVR30]*E0K]IL9) RW+QL^-J
MDM@'/\R_[2OQ=\1:]>V_PJ\+SS2>+/'$:6%VUHQ?^Q?#LI3S))GC)\J>:+)?
M(V@DD\')[,.Y4KWD[M2BGUY7?2]NJ>O7HV;4H27-.-TD^6-[I2?-9J]ME:]^
MO1F/\&M4F\8?$CXI_'B^A?\ L<+<^'?!MVWF%98-/D-FCP%L%"RX9MHP<EN]
M?1_PC\'?VK?W^N:A(\D5G/)?F8D;79E:5E)/WCD\X!XSP#T\?>PM/"/AOP7\
M)?"Y'E:7;Q?VL%51]INW4-++*R$!I)),LY.22>@KZ*U6^_X5O\'KW4),6@-O
M,@E7B1YI5)1.#N^<\+G Y.*ZJ,7*<82^&4KV[-MZ^5U9^KO8=964791<GJHM
MV=M[7\SS/X>>%;O]H']L?X<?#[18)G.I^.M#T6-XA)*C";4H8BK*/NJ%4DE3
M@@D]>O\ J@^!/"UOX)\#>"_!EE%%%;>'- TC2%0Y! TVP@MY?+XP29D9C@#C
M.!G-?P2?\&WG[,.H_&W]JS4/CCK=FTWACX9)-X@+W< /_$XNM\>F!6<$&6&X
M59 !RJX. #FO]!.:/?+%\^ N24.!G!4Y7OGGJ/3!/H\=52E2H)12H0EK'6\I
MMN[:W?J_*UD<TG*45%ZI.]G:VNCOU>FUWIT+-%%%>8 4#.!GKCGZT44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2TC +M'3<!P 17^;]XL\%ZOX4U_5_#&NV<]AK6C7<]K=VD\4D$B2P2%7W1N
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M,<T ?XB_B+PAJ7A_5=0\/^(M.O=)UG2;B>UO;'4898+V":)BC;TE56V;Q@$
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%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image-007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image-007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #' 1H# 2(  A$! Q$!_\0
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MJU*GL75C"<J:J<KFHR<;I,33C;F3C=77,G&ZO:ZNE=7TTZZ'=T44US@="W(
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M$B[9#'):6<F5@Q7U5O&<*0=P()'J.G;D=#R<#C\85Z(  D2J$"  "(*"$1%
M&$  4*  JJJXXR+D:!1GJ3_7_' -?X;^)7'V;^(W&&<\7YY-O%YGB&L/AU-S
MI8# 4.:E@,OH)OEA1PF&C3I\M.%.,ZKQ%:474K3D_P *YZ^+Q%7$8FHZM:O5
MG6K56V^=S>BB[^[&,>6,8]$O4GMT'F1JRA@[HK9!/!(4@<\9'7'?IT%?SE?"
MK]M/]K&/]LO0K?QAX^^+L/P+\1?\%%/C'^RQJVH^-/ 7@>[_ &:)/".E:9?-
M\/?AUX&\2:#:R_$;1/C1/K5K!;VE_KB6_A>YM_MT=Y?[O*S^VG[17[4'P?\
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MM&TS]D#X#1>'O&FG_$32+WP7_;MIXVTGPSK_ (,TSQ'_ ,)+J^J>(KC4=/\
M"OBJ"U\2:!9O=:I/';Z;KEO#J=O%&JW<:R[A7^CARGUQCG.3WQ[?ATX]_P :
M1N@P2,$=,<\XQS]:=33V'T_1E_QH$S^-;_@N3N_X>$6!QD#]G+P$<Y QCQ;X
MR[>_?BOR?>.-L,R+QACT)SG)5E.>P!R<X]"3BOUD_P""Y!4?\%![($D'_AF_
MP(0 ">1XN\9<Y'IQ@>OX5^3N>@Z$@D< 'CJ,\<D#L3SC-?R5X@W_ -<L[LVO
MW]/9M:K#8>^S2M9OJEO?H?\ 0I]#AM?1J\+G%N+_ +-S1-J33M+B#-]-']YQ
M?BJ%?^$>UUPS*QTZ_B49^7]Y!(  3T)8A0/]H$ X K];O"J>5X3\)Q!=C)X7
M\/(R=T9='LPR\# (QG\"<#H/R3\82;]!OXE4J;@V<('/_+>]MK9L9R=S!\ J
M3U^8\<?L-;VXM+2RMD78+:PLK<*#G_4VD$70GC&S&.,<@^U<,J4:.+E*,>65
M>G",KWEI3UU3>EU?1Z[O<]CQHJ*6>9%%MN=/)<1%Q<KW53,(J#MT;5*=M6WI
MK?9X;8""%8Y_B)S@\]01CTZ#U/K4D;-T^]G@ X.,<?*< ]/7-0<@DL!SC'&3
M[=3CG!S@^G-2(<%<=LX[\G(!SVYR#V'/;!KZ:<8J,Y14;V;^&S;2>O,[-/72
MQ^-M+EGHKN+LVMG;?=.]NM][;G-:S8IK_C?X0^%3'YXUSXBZ?J>I09P#HG@Z
MUN?$%S<*3T>VO;>P?&#N!(SBOO5W9G=R<L[LQ)R<LQW$\>I.<8'7/L/C#X8V
MIUK]H"*9DW6_P^^&5[J!#X_<ZOXUU;^R[*>+@#>=/TC5(9<\!94)P,$_8^2>
MXVC  Z$9Z<KC//7MT]P?Y<\8\PCB^*H812E)9;EV%HI-IQ4L1*>)J65DU*/[
MN#NWI8_*\[K.OG>92YFXT9T,)#5M<M"@E-=DU4E)V735ZZEN-NC,5VJ005SG
M)['GTQQ@=.:^-OVD/AY\=/&GQL_96\:_##P5X USPC\$OB%K7COQ;?\ B?QR
M?#&MWAU[P1XG\ RZ1I>GKHU\;F/3K'Q(VOP7,ERJ3W%N^GK%&TWG+]BH0%"@
M-GDG.-N2#@YSGGC^?/.1G"JP[%3M7 X<?Q'D_*2#T'3\J_-LHS*KDN/68T*&
M&Q57ZMC\(J6,C6E0Y,PP&*P%>\:%?#SE+ZMBL1&DW4Y8U)QJ.,W!)?/YEEU'
M-<)]3KU<11@J^#Q'-AI4XU.?!XS#XNE9U:59<KK4:;FDHMI:36S_ #]_:U^&
M?[5GQV^#^B>"O#WP^^#K^)[#X]>'O',MS=_$:^TK3;;P!\+OB+H?B[P2BW5U
MH$UQ-X@\::?I;0>(K&(1VF@7RPO')?QA<8W[0_['WC#XM^/M=^*_@+P_X,^'
M_CJQT;PQXDTN?3]=,>J>/?BDVI:/=>)IM=UB6VN+#P_9>&M&T2UT[PKJHL&D
MU?Q3#I/BO5X6'AK1T'Z-&=M@##.0 P7((8YQZ@@X'(Q@CIS56_U.QTFPO=6U
M2[6RL-,M9KN_O9RHA@M;2(R32."?FV@< <LQ"KEV"GZ#+N-\URM9=#*L/EV#
M>6_7YTHTL/BG3KQS:O@:^,P^*HU<PJT:^'@\OHQC2E3]V%;%23YYJK2\;'<)
MY9C98ZKCZ^,K+%PPJJRK5Z47066T<33PV(HU(86G*G52Q-:4I\\4W1HOX>:#
M\K\*/\4O#?PQ^&7@+Q!J=OXU^/GB72]/\*OJ4)6YM[[Q(8Y#J_B:]E$%MY^D
M^'K%C>:KJ(MX$O9+8,(P]VJG]$/AKX TCX7^"M*\&:1*UT]B);C6=5F(:]\0
M:]>,)M5UO49" TMSJ-V7<L<[(Q%$NU(U6O!OV:/ M_J!O?CEXOL[JSUOQ=8G
M3_ &B7ZD7'A3X>F?S[9C$P!M=6\5R*NJ:J-JSQ6IL["0[866OK7:H9B. 6X4
M<*-W\)(.<@] ,@=<=!7^0?TQ?&[_ %YXKK<#9!BX?ZL<+YCB,1F4L!R4\'FW
M%<ZM7ZY*DL.U1GEV2.I5R[+J<>>E&O'&5J;?+3F_S'B'-UF.(A2HU*D\!EU-
M8+ .K.=2K6A3A&E4Q=:4[NI/$>R3C5E>:BVOM-DL*YRQ&,]CD\C.1[<GG(YQ
MUQQ5C\ /85$K; 0W(R1GOD8SZ#T _P#KTOF9/"G\>/T_R>1ZU_$4U*;O=;*R
M[65G^GKJ]V[^50J4^6,$[2?2UM;=[6^Y_J?$O_!0/X%_&W]I3]GN\^#7P3O/
MA9I6I^(O%W@?7-?UCXIZGXLL+"QTWP)XOT/QM:6^DP^$M#UJXOKO5-1T*#3;
MN*^%I;VUG<O>1///$D+?/_QL_P""?/Q>^+?[1?PG_:;TS]H>3P3XGTWXR?!/
MXG?$[P#%X;\/>)_"VD:7\*/#&L:,_AGX5^)]8\-KXL%A<WVN:O=VNG:^UCI$
MMSKNL:W=6<6KM R?J]_GU%!)"DX8@ G@9(X[?SQT]:_;>"?I!>(7A_DF6</<
M*5>'\NP>6OC"#KUN%\KS/'9EA^.L'@\!Q#@\VQ&:U,=#%82M1R[+WA:=#"Y;
M4PM3!8>4<1B(*K0Q'!C,CP&.K5:^*CB*DZGU;W8XBI2C!X24IT90C1]G%3C*
M4^:7O<RF_@DN8_(;]K/_ ()^?M"_M;:5I'C?5OVA-!^%OQFL;#POX4F\.>$O
M#5IXD^#D'A3PW\;+'XEKJ6B7'C'1=1\9:'XOU/1]&\/1ZU+IS0V.JZSH=E8W
MC2:&)4=G[2/[!_B[6O$WC?XW?#7QK\/_ (&^-[/Q%ID_AG6_#EUKGP\FU;3;
MG0=;C\<_$/QGXH\&6']L'XI^+/%FM0ZC;PZ-;2Z?:^']+OO#\3D^+-7(_0SX
MH?&[0_AV;;1[6VN?%'CK50W]B>"M$,<NIW '_+_JTK$V^A:%!]ZXU+43$'4;
M+5)YBL=?.HN/&?BJ\C\1_$C5K?4M8W%]/\.:9OA\)^&$)W+!IMJX!U"]"DK<
M:SJ >XE8?Z.EO$ I_J#PBXT^D!CLLX:S"MFO#W"? ?#]'-,#PYED^#,IMF.1
M9UC,+BLUR'*\CG*-/,>&ZLL$L-3QO$L,RP6!IXG&+ 8W%8K$5JY^=<59QPUE
M6(Q>&A1KYAFV(=.5?V>-J6H5J,6J=?%UUSJC64I\RH491JU5%0Y:=-<JNWOB
M_P"('CK0]/\ "FN7US9>$].T?1M*U36X'DT[Q1\3-0M-+@AUG6=0@@"'PSH6
ML7JR3QZ9"XU2XAD)N7@C81-+INGV6D6%OI>EV$&G:=;((K:RMD2WMH$4@A8H
MT"JO(RS<NS%F8EFJV,N6;)W-@E%4^8!GJH7/R]?O''0^E2);NTGEM<V]HBV\
MMR9+HNJND>"L<84'$L@.U%;!SS7Z!@,ORO(\!_9N49=@LGRYUJN+K83!T73I
MXG&5:DYUL7B(T8J6+Q52K6DE/WH8>BZ6'PF'PF#P]&%/\KS#,L;G&*>,QN(J
M8BO*]*DG)^SH0BE:E14I)4X<L4K_ !S:;J3E)N\:X+'=P.5QSDOP>#W7UZC@
MD'I7DOBCXMZ3X6^(/A;X?7.C:U>W_BJ RV]_9PJ]E:-YCQQK*Q82-MV[YRBD
M1H5)S7&VOQ+\1:7\9O$_ASQ=J&CZ/X'L='6^TJYO[JVM6$3>64>:60(J2$&0
M/ND+,-K  <#U[Q5-J$O@G7?$O@*QTSQ7KR:)=W/A5(7MKA+ZZ:!UMUM;P!B(
MYRV3Y,BAG"@GK7]"1\,Y^'W$7"=#Q R.CQ!D7B%PEE.+X<S7 YUCLEX>P.9<
M<9?".08[,.(YY<\'[;AG$8F.8YYE<,34C['"5:->I3I.55*6%A@:]&./HTZ\
M,7@:>(PTJ&,E3I)8Z@WA*TZZH^SY\+5=\1AK[TIT9S6LET\-U;W!=;:XMIC"
MP6<131S%),YVN8W;:_JC8*\Y Q4X.1CC .#G!'KUSQV(..N/K7R=^R5H>L:1
MX1UF\\:7WV?XA:UJ=S?>(_"4^IVUW=^'HUGE6U::PCF>>U%Q&QD+.!D%!GJ#
M]5QW%O*TB12PR21J3*D<B.\?(XDC5BZ'LN0"3BOD_%C@"AX;\?\ %/!679M5
MXGP?#-7#49\04LLQ.$PN/5?!8*K4QF$3A.%3*I8O$UJ&6YI3JO!YC0I4\5AJ
M]55HQ)S+#4,'C<5A</BOKM"C*,8XR-*="->,J5-NK3IN4G&BYRJ0HU4XQKQI
M^U@W[56_/']M#]FKXX_&3PEKVG> /%.G>)-'U7Q9X'UB^^'.HZI'X2UH:'X<
M\1Z1K%]-\-O'FH0W5A\/OB1IZZ?+<^%?&#V[C3;V>1U:&=HYD^$=9_X)<?M+
M:K\ ["ST?QA\-] \?:5J?B*/0_AUXNT73_'-Y9Z5XE^.&B?$1_%WB'XPZ=K_
M (;L-<^,#>&]+32_&'C";P_JLGB>VLAI=M=VT^HW-Z?Z  "6P0-IR2P!8\D_
M*01CI@9'YFD9WV%6W !EV-_>  X[#@=0,\GGH#7V>7?21\3<KRW+LJP4^&Z-
M# /+X\U+AS+\.L9@\NP=' T<'C\+@I8'!8I5</0HQQ6/>'6;UY4U5JXV=2=2
MJ^'%5*N+J>TJ3<7]5H82:H4Z>'C*AA[>R56%"-.-6I#EB^:HIRE-1G*3E[Q^
M?7[4/PY^/?QA\&_9;?X,0ZM\1_ OC?Q6OP9\>_#_ /:0N_@UK6A'4_ K>'=*
M^,MU>V<<=UI)O[W5M;M-9^&RW6NR6^DPPH9]1%VP3R3XO_L/_%;XDZ1X+U)Y
M?#NK?'#PQ\$/#S?$#XL7VNSQ6WQN^-6@Z3I/A^PT.^\)WLDOAS3M#DT[23-X
ME\6:KHTEQXDL[?P]X:N_,T5-8@/ZOY=U;^+Y@5"DJV.ASQCW(!(SD>A.'KGB
M'1O#5FU_KFIPV%OO$47GOF:[G;)6TL;50]S>W4O*Q6MK%-/(W"(3T\'(_%GB
MS)H97@.'L'DV%GEN)S*O@Z&&PF.K^UEFM+"PQV%J4\1F-5K*ZKP]7&SRN$X8
M%9CB\3FE6FL92P>(P?%.A!WE5<GS<J;E[J5KZM)2;F]$FDVU[JC=V?CGPZT_
MXLZ9^S7J.G?'&]BU/XFIX*\?C6IDNM'OIXK.6SUN30-.U+4?#EEIN@:GK.FZ
M(+*PU/4-%L;33;V\@>6T@2(@5_1=^SN"/V?_ (%@C!'P=^&0(]"/!6B<?ATK
M\&=5\-?$CQ_X!\:ZI)9W'PW\"1>!?%]Y!=ZS:!O&_B.*/0-1DC-GI$Y:+P]I
MMR.&FU-6U3RBP6U@8@K^[O[.\JG]G[X%D*I!^#OPR():0DC_ (0K1,$D<$^N
M.]?W%^S_ ,ZP6=XWQMJT,5DM3,/[<X<Q6;9?D/LY9;E&)Q]'.Z\,OI2PWM,#
M3E1C&<)8+"8G%+!./LZ]95Y5*4*S/+\5A:6!JXBA6H4L12J/#NO%TZE:,)QY
MJJIRM45*3G'V<YQA[17<8I(^8?VM(_CH?B+H_C3PSI?QP^$-IX-BU;PKHOQL
M^ VE_#GX^VFN^ _%MMI%WXBM_B5\#/%\6C^)]'NM$UFP@F\,:IX$@\<ZO;W=
MO)=R:==VETVGVOVM^SGX;\%>$?@E\._#_P /-1\1ZQX1LM#,FFZUXPLM4TSQ
M9K=S?WUYJ6M:UXET[6M,T74]/UW5]=N]3U+5;&ZT?2C:7MU-;Q:=9P1Q0)^:
M/_!5F?X1>%/$OP$^(?QR\*_#OXH>";'2_BCX1TGX9^,OVCI_V=M5_P"$I\1V
M7A^:/QGH=V=4TO3O&5EIFGZ?-I.NPW=PM_X/M=3AU[0H+^^N'M1[#_P3#^".
MO?!SX2ZXL>NZ%J_PK\9+X U[X70^%OB;XI^*?AJ2*#P/86WC'Q+H>O>+&EU&
M#3/$?B(M#! +@C5GT67Q1<6>FW6O3647^BQYA]8^+OVK/@+X%\4_$7P5XG\>
MV]AXG^%'A#P[XX\>:5#HWB+49=$T'Q=J3Z1X819M-TB[M=3U[7-0$$&G^%=)
MGOO$TPOM-G_LE;?4;*6?F=._;8_9NU74?#ND6GCJ_P#[1\1ZE#HCVMQX'\>V
MDOA'6KOQ7JO@6RTGXE?:O#,*_##4+_QGH.M>&M/MO'S>'GO=7TF_M[;S/L[L
M/G7X@_\ !/.]UCQ9\0?&W@?XT^)]-U?Q5%I?B?2-.\:V2>*-%M?BMH?Q<T_X
MMZ7K^MFQ;1M4U3PJMYI=GX=_X1R&^MGL=&!@T^[ACBAC',Z%_P $_OB;9>)/
M&NJ:M\5? MUH_P"T)XG\)^,_VDM*LO!?B.VN&U[P7\9/&GQCTBR^#%]+XKE3
MP[HU]>>-)O#NJOXOMO$FH?8]'L]1M)H;^]O R;LKVOY?-?\ #_(+7T/PT_X+
MDJ?^'@VG?*3N_9N\"<\+@CQAXSYW'KT/'(X/4U^3C?*"<8PI&"?]D=#COCH>
M3VXZ_IU_P6B\'Z)X1_X*&:E-HYUB2;Q5\$?"'B?5O[5US5=9ACU.]\5^+TFC
MTJ+4[JY32-."1)Y.EZ<(+"W;S'A@C\QA7YBNXP 03Z=,?,/_ *Y.>>GH*_DS
MC^[XPSS9WQ%)V[?[/05K]?A_'RU_Z$_H<:_1J\+E_P!2_-/N_P!8,W?_  #E
M?$T1EL;2T0;Y;_6-"M8P.JR7&LV*K\O)))'/'YFOV,N,">1>5VD #&>51%/.
M<_>!X/0GCCFOR+L8DU#Q?\/[*;!BO/B9X+M'5@1NCDU^U5\#.&0 <DG[HY]*
M_76]#?;)PO($CCL,X) ]>3@'IR36_#E/EP$VV[SQDKZ:1Y*:2U5[WYNRZ)M7
M-_&*NI<783#V7/A\@PE25MW&MCL4X7Z;1DUHNK;(7V\'!)]<9S@8Z'],]3N]
M*;&"2F,_,<  D DD#!QSQD8_0<8IK#&>W?!],'Z8R<@D<\GH>@UQ!9Q37EPZ
MI!9P7%Y+)(0(TCMH9)W>0Y $85#N/0 Y/&:^DC_>O)7UYKIM=5K?I<_*KV3D
MV[1C*3O9^ZE=OM9)-ZZ>:.P_9NT]]0U/XU^+VR?MWC:P\(V;.1YD=EX.T.TB
MG2&087[+-J%]/.@4E5E,H;#Y!^EP N3DXQU_+VY[?K^'D?[.&EMI/P0\&R31
M-%>>(QK'BZZ\U1]H,_BO6+[6461@095A@N88("_SBV2)1@ 5ZX5Y/J!A1C).
M.YSP.O(R2#VQ7\1\8Y@\QXIS_&IMT:V:8B%)ZMJ&'E]7C':ZCRT;VT2E?2]V
M?C4G*=7$5I2<OK%>M73>_OU)RU?VK4^1<VUB9,!68<_=SQC.?0CKC/7'IZTU
MVZ\<@XR> .<<GGCGV[YS@4]!P%/8 \=R>I.,#GK@C].*3: " 1@')W#(X))'
M Z]/\FOF9M\EXZOIM9>;N]-'Z_K4;7N^W];;?UV(P'!#8ST8<''/! !ZX['@
M FN=\/>"I/CC\1/^$+*O)\-O %Q8Z[\2+E&(@UW6XBM[X?\  2L,^=#YBPZM
MXEC0_N[5;6R8[KEPM?QGK6KZ=;:;H_A2VBU/QUXOU.'P]X.TE]Q5]3N4=I]6
MO% RNC:!:";4]4F8!%6&.W)#SIG[C^%GP\T?X2>!=%\$Z1*+V[C22_\ $FNR
M BZ\0^)-1;[3K6MWLC#<T^H7C2/&OW8+98($VI$@'\U_2=\9(^%O!4\IRC$J
M'&W&%"KALI]G4INOD^3\M2CF&>I)\]"O+VKP653<;3Q%3$5N22PD6OS[C7/?
M8T5DV&JQ6)Q--2Q\HIVH8.2<HT')-N-2LU"[6OLF_P"9W[2/"*D<8"K$BK'$
M%VQQHJA514Z*L8 "*  H '2K0!(RVT$X X)/#=R#VY)':H>A/)//0<CCKC /
MIR?:G X]SCH>00.0#R<=P>^":_QWJRE4<Y2E*<IR<Y2;<I2E*3G*4FWK*4Y2
ME)MMN4I-MMGY3+9Z62LHI+9*WDM+6M=+R'EP02<XY)))QU YR5VY')R0..^3
MA%D12#D$G( ZA@"3E<GGD]0<_A2&/S  &(W9+<###)( P0,'LP SCWKE/&GC
M7PS\/M G\2^+M5@T;1[0QVZ2RQR3W-W>3MLM;#3[2!7N;^_NI"L5K96T;33.
MP& /F'5EF68W-\=A,LRS"8K,,QQU>GA<)@<)2G6Q.(Q%67+2I4:5.G.=2<W=
MV5E&,93G.$(RG'*=:EAX2Q%:K"A1HQE4J5JLE"G"$%S3<IRM%>ZFE=N[T2;:
M1UDER$5W+*D:(SRR,5"0H@+.\CL=L:*H+.[%5502Q ''RIXS^/\ JNN7E]X3
M^"QMKEX6>QU_XG7D/VSPQHS JL]KX6BXB\1^(%RR"0/_ &582*?/DGD A'F/
MBCQ5XS^-C26^L6NJ^ ?A>)2(_!\=RUIXN\:6WF#RY_%]W:N!I&CW  =/#EG,
MUU(A*ZC=%6:!>@L;&TTVQMK#3;6"PT^SC6&ULK.!(;2TA082**")5CC55R<(
M@!)R3DYK^S_#CP$RKA:.&SOCNCA,ZXBLJN%X8O2Q62Y/4T=*IG56C.=+.<SI
MI<_]F4)/+,-52CCZ^-JTJE!?DO%'B'7QSJY=D%66'PJTJ9LG:K73TE3PD7%2
MHTVFU]:J152>KHTHQ<9F-H/A72_#@OI[1K[4=8U:4WFN^)-8G:]US7+QO];<
MZA=O\S*#\D%M$L5G:QJL=O#&B5N#8X#,VP*&^8$'<%!)9ST7&,@<<9Y[5*P.
MP2ERBQL22V-C?[+8QT')SCC<>@Q7/Z_XATKP_P"';[Q!JMP&TJQC=KJ6R470
M8,=BQH(F*M(>1@LH!ZGIC^C,!@<TS_,\#@L+AL?F>-S#'8#*L+0P>'E6KU,1
MC*M+"X/+L'2A".'5:K%0HX'"4Y4*;]G"E1I1A&;C^8J%Y6BG.I.5]5*<JE:<
MKIRE)2E*<YRYFIR<YMW2::OQ'Q#U36;_ ,(7%Y\/]1M;C5+#48H]3G620Q6E
MJF3.)Q !+D,5P$S\P[@D&MX[^+WACX9^ /#WB#Q/K>G6NH:U]@TJUGNWGECU
M'59 B7(ABC!?$6\O*&*A 5+<\5\E_&7Q5IMW\#+SQ3\(O&#?#VP?7A>:^=9O
M#9ZAKNF2*T,,%FI)F\NTF#3/;JI XW2-]VO!_"OQDT;XI_#ZP^#GQ.\ :CJM
MLK3CP1\5_+NKN*+Q%<%E74@7"I+]E<QK/B5LJP)0=O\ 3O@;Z(RX@X(X1QV/
MR+,LSX:X-\:LSH<8\/U<IRWA_P 4(<.5\HPBS2EGE>OCXX#-J&5X^C0Q^'RG
M(,PQN*EDCQ\Z$7F<*M"E]S@>'/K&583&2@JU/!<35<%C\NI8=4LW6$GAL,ZK
MKU)S5"I[.JN:EA\+4JXB%&->I)Q:4#]!/&G[/_@'XVVH\1>-;&[M;_6]#M[>
M[.G7[VSQQQ*K6US;B-]K*T01FB96#*P#\@XNZYXPUGP1I?AS3_AGI^B7O@[P
MG:Z=HFMNMO)"+*R@,JRW4R;XY);APL(C:UCE1F9B<X(I/@;\.-7\/>$O#ESK
M'C+4O$-U8)>6;_:?-$;A08$@C:1G#6<<3#:-I+28*M@8/J=QX0T%K/4--2T2
MUM-3D22[$+.LA>-RRNDA^Z%8DA0-G+# !K^=.*/$/AWA?C67!7%_%..\9. N
M <[Q&"X4X5Q. KT."<BR^OC\RR//,%A\NS#%8;-98W*.'XX:'#N+HXS$4H9A
M3A.<G24N?R*V.6&QCPN)QO\ ;67X"JL-A\%5I57@:=*.)Q-.K2A2KRHXB"PU
M"3JX6:K-*M)2DJD5%/Y>^%/P>TJ3QWXZ^-?P\\6ZKJ/B7Q?9S23^'KS LK,W
MKAK\6MP9)OM>&C9=/B:+?"VX-$F,U[%X5\)^,O#OBO[;=3"YTS5X0-1F;85A
MNF9YI(F^6.Y^U1SE8\&(1A0W?%>@6?A*#0-&33?!;P>&[JWD2YL[V*,,WVJ*
M7S':>1%#NTVYQ(=I.UB ,&MK3[75+2UCBU?4#JFI2;Y[K46R/.N99"[RD$#;
MC=LQ@'"@X&:^7X]\=LTXCJ\98[ YCE.;\/\ $6&P_!.79-Q7EF#Q'&^ X1R?
M+<)AL@57,,KP.$P7]G90L/3JY9'ZQ/&4L;%+&_6:D?;'/B\VJ8B6,J1KU*T:
MU18)4\=2HU:ZRS"X>A2RZ#Q4*=.G;#1IJ%)4U&=U"<Y3:DI7]I*YQA1_$!GU
MR"PXXZ>N1[BH9)$C266:2.."W0R-)-((XHXU!+R/(Y5450"S,Q55QUKC]5\;
M6EKJD?A;0=-U+QMXXG3?;^#?#:QSWJ1;MHN]8NW=+#0M/#%3->ZG-'L3+10S
MOB.O1- _9\O_ !3-::Q\;-3M]1MD59[7X7>'[NXC\(V<C;9%C\1ZCF&\\6W=
MN1LDAE%KI&XL$M)$*EOY1X@SW(.#<'2S'BW,O[+HUX2J8'+:-..*X@S:-GR1
MP&4<_M(4*MN5YGF,L%ED+O\ >8AQY7AEF49EG-1PRO#JM&,N6OBJLE3P6':O
M_$KM)5*D;-K#X=5JTFDI<ES@-+U/Q5\1+@V/PHTBVU:T4R17OC_6#+:^!-'<
M'8QLYXU6Y\5W\+986&D_Z*&4"YOXP64>_P#@CX%^&/">H1>*-=O+CQ[X[,"Q
M_P#"4Z_#%Y.G,WS/%X9T1=UCH%OO) >!9+V4*#/=L<J/8K2UL[&TMM/T^TM=
M/L+.%(+/3[*WAM+2S@C 2.&VM(%C@@C0 *J1JHQGC)(J8 [@<8P",G=[?W<X
M[DXYSQ[5_*W&_C3Q+Q']8ROA^,N$.'I*5"IAL+5=3.<VH3DW-YQG,53KRIU8
M**EEV7_4\ME%RI55C8V;_7LAX+RG*H4\3BTLTS!^]+$5H7H8>I9>[A<-K3BX
MR>E6NJE96O\ N]4<1\2V,OP\^)#.7)'P_P#&^<\*?^*:U+KC@!>.#GMR>0?T
M8_9S_P"3>_@3_P!D:^&'_J$:'7YW?$P9^&'Q*(!W?\*_\;],YX\,ZICCWQSQ
MZU^B/[.0;_AGKX#\'_DC/PO['_H2-#K_ %Z_8Z5?:9'X\VBH*&=\"048WLN7
M)\[O+77WY-RUZMZO<^&\48*&(R=IW<J&+N_^XM&RMLK7MIIH].WQ/_P4>\4>
M(? WQO\ V;_%&A_%N]^ D%SX-^,&AWOQ+T[]F'4/VHVOS(_@^_MO!VJ^'K>T
MO8/ ]E<M;R:K9>)?)CN-7NK2;1!,(-\<OZ3? 36)]=^#?PWU:[\7-X]NM2\*
MZ==S>,V\#O\ #4^)7D1MVK'P%)'$_A-KG&\Z(\4;6>-I49KRGXE_L[_%77?%
MVH^,_@U^U9\4O@7=^(!!_P )+X8@\.?#[XJ> =0N8(8K9=6TCPU\3/#VLS>$
M-7-M$HF?PMJVF:3J%PJ7>K:1J,P<OZE\&OA-J'PJT2_M=>^)_P 1/C!XJUV^
M75/$OCGXD:EILVIZC>I MO%#I6@>'=*T'PAX1T:WB7%OH7A70M*TV.1I;AX9
M;F:::3_9<_*3V.FMV]F%.I&Y&/4C^8H!_P# ^^Z/XT?^"Y4F/^"A=BIR?^,;
M_ 0P,\#_ (2[QD>H'7)[G&,@]J_*!<'Z 9&2<G'3J>.3^'2OU=_X+EDC_@H9
M8<9!_9N\!C@^OB_QEQ@ GG!/I[BORD "H&/( "X"M@G'ZCIVSP3GI7\G<?Z<
M7Y[:UUB*6^S;PN&:72VFMS_H5^AQ*WT:?"U:7_LW-%MJW_;^;Z-WT]?S+7A&
MV2[^)_PJLBF!+\2O#TH0Y(/V SZCNZ_Q?9=Y(/& V:_5>X_X^9SSS)N!R1UY
M]>QZ9K\M_AR7?XU?!]",M_PG*RD+\RI$GAO7<O@YRJNT9;/(;:1QBOU&G):X
MD8= [*>HS@D=/8_KFNGAV,HY>W=2]IB*DK)[-QBG&_5VC\NYS^*U3VG'.)32
M7LLDRG#N2=U:?MZ[=[7T=:2C?[*VZM!&9%8Y(' SGGISD'G'8'(SV->>_%BZ
MEA^'?B:VM4C:^UBTA\,V$9R&N+WQ+=P:+' @!&9I([R81@'/F ;3G@^A E?F
M!]NO4]E([\8R,'Y?4UQ^M6*>(O'WP8\'E?-AU;XC6OB'4;8XQ+I7@BQN?$%Q
M('PVUK2XAM9]JX+GCVKMS7'++LIS3'OW?J.7XS%*UWK1P]5Q6KWE-P44FM=M
M;'Y%G->>#RK,*RE9K#SA1?52Q$HX97UC>TJL6M=$V[.S1]T:%ID'A_P]H&@V
MV\P:)H>EZ1;LYQ(4TVR@M8_,'9U$8# #'N3P+QY)W8!R>!S@X]QUSS]#3Y)R
M\KRMABY+,I&0-W)![CD[@3SGH":A9L@Y(')8\'@8^Z!P<>^.<X!['^$ISG4J
M5*E1N]2I.K)N3]^=5NI4G)V=N>524K6U<GMJ?EZA&*5M&E%.-[I-16WIJKV2
M:MN3 E1V)QSP>!U'.<=QTZGFJMWJ5CI=G>:GJ=S!9:?I]M/>7MY.XC@M[6WB
M>:>:9VPH6.)&?KG<!C)JPJED&T>N=O("@=\Y!.[YL'G'&17):-X/F^-_Q''P
M]1F?X>>"'TW7_BQ=)O6'5KYF%[X<^'2S ;'-]*D&K^(H@Q9=)BBLI@/MA!\'
MB7B3)>#N'LYXJXAKQPV29%@ZV.QM1-2E44%:A@\.FXNKC,;7=/"86C%.4\16
MA9.,*KCYF<9KA\GR^OC*[3DE[+#TVVG6Q4E:G35K:7:E4=FHP4MFTCU[]F7P
M1?ZO>W_Q[\76+6VH>)[$Z5\,])NU;SO#/P]>07 U*>&11]GUSQDXAU*_=5+I
MIR:=:Y4(X/U\S %OESO.<]R><<GISCG'3(Z\T1A$BBB0*B0PK%% @1(TCB4+
M&(T'RQQQ*N%C0;50  8 !:Q!QD=QM"]P!@@D<XY.<MSGJ"!7^'OBAXA9QXH<
M:YSQAG$I1J9A7]E@,$IRG1RO*<,YTLLRS#Q=HJGA<+[-59PBO;8FIBL1-2J5
M9-?@N*Q%;%8B>)Q4_;8BO4G4K5%*5I3<KJ"L]*<(VA3BFXQC%+E=K@2HSDXZ
M<<X Z<=P2<=/4CI0IW#!!\M,,X!Y/9A_P'!P"1^.!4L<+RJ$C7>[EBI4C:K+
MG[S9R.!SG'/-<?XZ\;Z!\,/#=WXK\4W+16D>VVL],M8S<:QKNJ2D_9-$T*R7
M][?ZI?2E8H(D4[0S2RLD*,P^2RK)\RSG'8/+,KP6)Q^89EB:6$P.#PU*=2OB
ML15DHQITHJ-FU?GG*4HTZ=*-2K4J4Z=.=2')B,3A\)1KXC$5J&'HT82J5ZE:
MHE3ITXQ<I3FVXM1BEYW=HZ-I!XZ\=^&OAKX;NO%GB:]FL[*U,<-K:1(9]1UC
M4+K]W9Z5I%BA:74-1O)=L<$$2D@;I'VQH[K\6:E?:GX[\16?Q!^*-QIVD7D4
MLB?#[P'>7\"6/A.UD&5O)(7<)J?C.Z@ -[?A95T]6^Q6)50TDE'7?$+^(/$6
MG?$?XQ:E8:5JLDLMIX$\%M=))IW@73[A5RLBJSQ7GBBYA91JNL21H+<,]G9&
M.%6>3PS]HOP!<?%.ULM<^&_B^UL?B%X3E$>C)+>;?#L[K,EQ<)<S*LEO%=P(
M1(LP?8 NR8%.!_J)]&[Z.V4\.YCE/^MM3.LKQ6?X+-*.;<>Y=P[C<[R[(5#!
MUXT,AR&M'#4Z53#5LR^K9=Q'Q%1K2E4C5Q%# 1_LVA.IC_PGB+BB?$>(>'H4
M\PCD%"-2O['+L'/$8_&JE&I*6-J8=J/M*4:T:?L*$9W5-_6*MVHTSZT*DAF!
MRPP&;/,>1D,W(&".OK7BGBCX8_$W6_C+X'\;:#\27TKP#X?T^6'Q!X($4C)K
M-Q(TG[Q&7]U-YOF*=TS;H @V##&G>(/'^L?"WX.VWB#QM?:5KWCFPTBP@UE=
M*DC^PWFMSA84G")N*62NZM.ZJJL%8@HK 5\#?%']J'XR>(? %M8> -=L/#_C
M*\UI8M2N=(8//#X9G4!Y].A/G+$\)W@3QG>&D1N"O']7^!7T7O&+Q1GF>=<%
M?ZLX#(J69YEP95XCXJISEEE:>*PM2&)Q>&PE;+JN)5"G1C3]AF-.G"6'KXBF
MH.,TY0\?*>"\XXIRJOFF$P>)AEN$Q&$A+$5JE6A*695HSK83!*&&A5K5'/DE
M&O-4*V%HS7)B)TG.#/1OCQ^UCX^T#Q]J/PY\*^&;6WTJQ@OK'Q%?7TN;M6DB
MFA_T>1@D=K<(I641C<X1MQ )#5SG[(/C"_\ BCHOCCX)>*Y;BQL]>CN-7T.^
MNW-Q#/<07$4EY:0;MIFA: *S1I(<'<V037S#KG@SQ'KNBRWT_BBYU#Q+J0%U
MKUSJTDEP=7NO+"2S/+A9TN<;1Y@8;SE6&TXKJ/A[HWQ#T#1!J_@F^M-1\4>
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M/(S\K*7&4#*<@]!GFL=9;^VE-J$3RWEB:"W"SW3/%-,D,J"Z;:L?DH3*0ZG
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M"K%-.$W9_%J[,X[XE'/PQ^)1  _XM_XW&?4_\(UJ?KR![]LCI@8_1+]G(_\
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M1/ 3S9?Q1-:LN8-9\>.D6I,TG^D6^B+I]HPC9I4K[%D>3:%+!@I;'))#,<G
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MZM#'^VG5:?O4ZF'Y>2,8VC=37-O>2O=[GY9_\%=-0L+#QG\,XOC]XJ_9 E^
MEU8W=U\.?!?Q<_9X_:3^,'Q:MOB39WFD6^IZ[9ZA\ ?B'X9U6R\,SRWNA:=
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M_=6,JRDZU/Y$\XE56@18PH_-^,X7;@Y)8Y/ X[A>0>._IS7ZH_\ !=.6-/\
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MF\2Z0P=S&=0F@,K09"2B4C:3O&/I[X!:[IOB+0?C/J7@/X':7X#\4Z+INCW
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M7E>!FIX+ 86C-+E]JJ-.=:3W;E6JQJU')[IIQL^EU<DEN9IL&5FSM X)RS#
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M*V^[)8^&^8D#@^O'/I@=?3'Z4UT#$OD!F?!'('3D\=\'('J:RM7\0>'_  W
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M<3CI9C.,,5B*<\-@UF6+P^/S&.&ITL-2FWBL9A,/.]>M7E"$%3ING%RYN/\
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M#VL^)=4%A\7/AU=WSZ=HFG3ZE>I:6L-\TUS=&VMY?)@B4O,X$:99L5_(\OH
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MI)?ZL9C=63TPS2^<<2M%?I]W4K_B,/AJU9\:Y/;TQ"?9V_V71ON[VWW/ ?B
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M;:WUO=_&'AW]J7XH3OX-TW5?VC]7TCX$>*?"/@+7_'WQ^@?P-:2?#OXY:S\
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M 'FO@_\ X)]2Z?\ $[X<?$G5[7X7:U#X=_:Z_;&_:0UR>?PZEQJ>N>'OVC-
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0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #@ A<# 2(  A$! Q$!_\0
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MEM<O#/J\]O+%I\=S(I6@#UZB@'(SZ\T4 %%%% !1110 4444 %%%% !1110
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M.3Q,=4T'Q=X<^)$NFWTGBS4/"VCZ+IFN:5J'CJW\9:A)K9M8_P!V=R>WY?\
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M@BMK;3%@MHDVQ1+<WGEQKG<Q -QP7=C(['+.[,QR2:F\;_\ (IZ[_P!>+_\
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MOF7X9_L3>'/AIXC\)^(K+QOK&JS^%/BNGQ6@@N]%TFW%YJ"?LYV'[.:Z5-/
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M>H2Z'XP_:F\#77BB.22 ^#_!_@UO'?BL74)'FVLVB^$-3UFYL+B,9+1:D+/
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M+VVJBZ4Y-<UKV;C>UM_F?17_  U_^U/_ -%7T[_P@?#/_P 8H_X:_P#VI_\
MHJ^G?^$#X9_^,5\\45K_ *I\-?\ 0FP/_@B)C_K7Q'_T-\=_X/?_ ,B?0_\
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M B#ZOIV+2:-8@BV]O&/,L+<16%QFXMI37:5!N</_ ,+)\$?]!^W_ / >^_\
MD6N-^(7Q#\&W'@KQ)##KD$DDFF2JJB"]!+%XP!\UL!SGU[>I%>U5Q/Q'_P"1
M&\3_ /8+F_\ 0DH[?UKY?\ "O;?$CP2+:W!U^W&((A_Q[WW_ #S7_IU_^OZB
MIO\ A9/@C_H/V_\ X#WW_P BUV-K_P >UO\ ]<(O_1:U/0!P_P#PLGP1_P!!
M^W_\![[_ .1:#\2?! !/]OV_'I;7V?\ TEKN** /&C\1?!A\;I/_ &W#Y7_"
M+/%O-M>CYQJH?&TVV[IWQ@DX!SFNM_X63X(_Z#]O_P" ]]_\BU9/_(^I_P!B
MD_\ Z>%_PKKZ .'_ .%D^"/^@_;_ /@/??\ R+1_PLGP1_T'[?\ \![[_P"1
M:[BB@#R3Q;X_\(7OAS5;.UUN":YNK<6\$0@O%:2666-40%[95!)/<@>IKTC5
M-7L=%MENM0D>* L4#)!/<'<D4D[92WCE< 10R-DC!*A%)=T4YGC."XN?"VN0
MVL$ES</82F.WA&Z:8QXD,<2D@-(RHP1<_,V%X)K/M?B'X1O;>*ZMM4:6&9=R
M2)8Z@5."59<BU(W(X:-QG*NK*>5- $I\=^&Q%YQNY_+W;2PT_4"03YN/E%KO
MP?)DS\OR[>?O+NT]+\2:3K,[V]A-+++'$9W#VMU !&LK0,=T\,:[A*I0KG=T
M8 J03G_\)UX8_P"@A)_X :A_\BT?\)UX8_Z"$G_@!J'_ ,BT <Q\;_BMI_P0
M^%GC'XJ:KHFK>(['P?I]O?3:%H)LQK.K/=ZG8Z5;V.FG4+BTL1=3W-_"L9N[
MJVM\_P"MGB3,B_$%I_P4HT31[KQS)\4_@AXZ^&GA[X9M\;-(\<>))?$'A7Q3
M:Z?XS^!G@/1OBEXE\.Z78Z+="_U>RU/P%K^FWVC:^(;.WEUPW>@W%G"+8:C-
M]P>,+GX8^/\ PYJ7A'QE:V_B'PUK"6\>J:-J&G:F]G?):W=O?VRS+'!&Y$-[
M:VURFUU(DA3)(R#YEJ'PP_9>N;K5IM4\#^%[FX\7^(_&/B'6$O\ 1]2G37O$
MGQ!\(V/@KQM?7-O/&\-W=^)?!FBV.AZI&8S%+IE@BK$A5W8 ^7_$/_!33PWX
M2^$/B+XH>*?A1JOAF[\+>(HM+O/#GB+QIHVB6_B71Y/"L7C-]3^&VOZEIELG
MC_5+/1YTM-3T#2=+B_LG7DGT[5-4L[-8-5N?6O#'[<.B^*/C'X5^&UO\+?&=
MGX2\:>.[WX6^'?BA=ZAX?_LN\^(-O\(;CXX6^D2^&X;R77;72KCP+8ZBDFNS
MJL=MXCM5TC['-;SIJBZFI?LR_L?ZUX<TCPGK7@,ZSH>@S:W+HT&K:_\ $S4K
MW38O$ND6V@>(=.M=8O=>GUB/1=;T:RL].U301?\ ]C7UO:6_VFQE>&-U]&TW
MX>?L[:/J&@:KI?@_1;'4/"WC"7X@>'KN#2]8672?&<W@:Z^&DGB*TRK*NH-X
M#OKSPN6=7B_LRX>,1^9B0 'T;7F_C35].T3Q)X#OM4N5M+47GB"'S761QYDN
MAS"-=L22/\Q&,[< D9(S6R/'/A@ #^T)#@ ?\>&H?_(M9#ZE!XC\6>%9M'6X
MNK711K5UJ=TUK<V]O;I>Z<UE:Q"6XBB62XEG8$0Q[G$2M*P"KF@#T1&#HKKR
MKJ&4^JL,@\X/((/(SZTZBB@ HHHH **\'N?VF?@?:?&*#X!3_$/0XOBO<NMO
M!X7D%XH?59-%_P"$DA\.-J_V8Z+'XJG\-D>(8/#,FH)K<VB,FIQV+6TB.TA_
M:2^"J_%<?!%O'ND_\++^VII$GA]8K]XH?$$NA1^*8O"MQK26C:';^+9O"\L?
MB.'PS/J,>LRZ)+%J269MI8W8 B^.G_'Q\$O^R\^"/_37XFKWFO!OCI_Q\?!+
M_LO/@C_TU^)J]YH **** "N0\)_ZWQ9_V-^I_P#I'IM=?7(>$_\ 6^+/^QOU
M+_TCTV@#KZ**X'XG?$;P?\(_ GBKXE>/M:M_#_@[P9H]UKFO:K<\BWL[5 ?+
M@CR&N;RZE:.TL;./=->7D\-M"#)*HJH4ZE6I3I4:<ZM6K4A2I4J<7*I4J5)1
MA3A",4Y2G.<HQC&*<I-VBKM&5:M2P]&KB*]2G1H4*<ZU:M5DH4Z5*G&4ZE2I
M-M*,(0C*4I-V48MZVL[OCSQ]X,^&'A76/''Q!\3Z+X.\(>'[5KS6?$/B"_@T
MW3+"!.=TUQ<.BM)(0(X8(]\]Q*R0P1O(ZJ?QD^-/_!1_QG\7H;WPK^S?X'?P
M_P##F[<1W/QO^)MK<6>I:JL$T<]G?_#CX<2I'>S6RWT,$]MK/B][*TO+<'R=
M*;(>ODOXH_$SQ[^UYXUM_BC\7K>ZTCP#IEV;[X,_ RY<-HWA'32Q:P\8>.K(
M,UMXA^(^K0%+M_MJ3V7AB&6/3].C6>.:=W7.3"W4D&/IV = ,>@ P!Z# %?N
MF1>'6797A'C,\A',<U='VOU.4F\OR^:BI1ISC&2688JE>U5SG'!4ZC=*-+%*
M$ZA^$9WXAYEG.+CALEJ5,JR9UE36)C!1S3,J=YPE54ZD9_V;A*OQ4(TH/'5:
M7+4J5<*JD:4<"VT#4+KQ/J/Q!\<>,/%/Q/\ B;K-LMGJOC[QO>QWVK?80YD_
MLG0K&WC@TGPKH*28:/1=!M+2TR \_GR9D/2T45^E_9A",8PA3IPI4Z=.$*=*
ME3@FH4Z5*G&%.G3BF[0ITX0BVVEJV_SF,5%S:<G*I4E5J3G.=2I5JS=YU:U6
MI*=2K5FTG.I4G4G)K66B2****+,K^OOW^_J0K_KG_P"N:_\ HR6IJA7_ %S_
M /7-/UDE(_3FIJQH_#5_["*W_I2.C$;T/^P:A_Z3(****VL^QSAV;_=;_P!!
M-,C_ -7'_N+_ .@BGD@!LG'RMU_W33(_]6G^XO\ (5BT_K$/^O,__3B-D_\
M9Y+K[>G_ .F:H^BBBMK/L8A4$IP\/'>0Y]MHX^AJ>HI/]9 O?>YQTXVCU^AK
M#$:05U_R]H?^GZ7]?,WPW\9?]>L1_P"H]<EHHHK>S[& 4C=#]#_*EI&Z'Z'^
M5*S$]GZ?H?T(?LY_\D,^%W_8H:7_ .@-11^SI_R0SX7?]BAIG_H#45_)V:?\
MC/,O^QACO_4S%']995_R*\L_[%V!_P#4/#'M-%%%<!WA17A4G[3'P+C^,"?
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M3Y6,>@1N >Y5U8=CZ^Q5Q/Q'_P"1%\3_ /8+F_\ 0DHZKNVDO4!MMX7U3[/
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M"GAK!P<X./#H.#T/(XKL:* &HNQ%4L6*@ LV-S$?Q-@ 9/4X &2< #BG444
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M:GJ"X&86'NG_ *,6ML2U]7K?]>Y_^DD89KZQ0U_Y>P[]WY$]%%%;W7=?>O\
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MO^$<\<X_X19X_+_X0W7/-R-55M_E_9=_E_PE\;0Q52<FNJ_X6!9?]"SX]_\
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MMOVN$H2;?M>>7M]<3\1_^1%\3_\ 8+F_]"2NU!R,BN*^(_\ R(OB?_L%S?\
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MT>6/[TG_ '\?_&I**W^KT?\ GVOOG_\ +#'ZWB/^?K_\!I__ "HC\L?WI/\
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MJ'LU>E%_O:#WJ=*])_\ /TWPV*Q#K).J_P"%B/LT^F'K?].A?+']Z3_OX_\
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M_7O=?^G"\H ?_P )1XG_ .B>:W_X-O#G_P LZ/\ A*/$_P#T3S6__!MX<_\
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MW9_<]2"L#Q5_R+6M_P#7A)_Z''73?9;C_GA+_P!\-_A6!XIM;D^&];Q!,?\
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M.G5=6DOQ:%)22;<9))/[+Z)O\D_,_H,_9S_Y(9\+O^Q0TO\ ] :BG?L[*R?
M[X7*ZE6'A#2\AA@X,9(R#Z@@CV-%?R9F;3S/,6M4\PQS3[IXS$M/YIG]8Y6K
M97EJ>ZR_ I^JP>&1[/01GBBBN$[S\^=3_8FUJ3XM:MXRT?XK1:=X"/QIU_\
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M>5V\8QCBK='MJW_/ZM_X-J?_ "8_94EM3IKTIP_^1/DO_AA?]E7_ *)/:_\
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M;9EC.LR23*<YVYYSE;;FE*5O3FE*Q<80C?EA&+>[C&*;];)'Z;_\,:?LX?\
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M/^B?W?'_ %/GQ'_^:ZC_ (8T_9P_Z)_=_P#A>?$?_P":ZO+O^">UFUE\(OB
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M<@-M  \*_P""IB_M%ZIX4\*:;\-/A3\1_&/PN\,ZAX7\?^*=:^%7CKPSX?\
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MMMMMMMMMMMMMMMMMMMN[;9TI))))))))))))))))))))))))))))']+]%%%
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'HIU% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &Q E<# 2(  A$! Q$!_\0
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MFT70?"_BWP+X+U;6_&EK\-M,U!/#?A^VM=,\7WOA[6+G3M0NKK4;33T<6\<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNKWGP0^)OAKQ[X?T'3K+Q]H6EVFC:QH/B[2-8TFUNKO6-7>WU22_^RH ??\
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M444 %%%% !1110 4444 %%%% !12$@#)X IOF)_>% #Z*:'1B &!)Z8_.G4
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MZ?A_6ODWX,_M?>#/C9XVOO V@^"_'N@ZA86&HZA+J'B2W\,Q:9+%IMTMK+'
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M_P (VGA?3K"VL+:WGM;V&,HWS(G_  3J_9^AM9;>T\=^.K::T.@Z?X6FDO\
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MU2ZU><IJ5HBWMVD5U>SI"ES_ ,LRH8[D!K^K3_@X'14^!G[.J*, ?':\55
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MX*2!6!  /SUM_P!N+QY<>)I/AA+\+=&T#XW:]X\\8Z'X(^%7B_5O%OA;6?\
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M/8_YYHJ!II[/8***!R0/6C^MD_P>C^8_ZT'AN,'D>G3&/P^GY4F[G@  \$$
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M%G=PW$^FWA\3>))?LE\D+,;:Y$,L<QMYBL@C='("M7Y/0C:A/OGZ_*OU]/\
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MQ+N;+BULU"65C 2%AM8E10H8@_S[])+QCAX4\#5:675X+BWBBC7R[(Z%U[3
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M-?ZUXFU/6-1O=8U.[N;B\N;B23SI$*&@#@_$G[#GPJ\6>+M4^(NM>*OBK/\
M$RYGLHM"^(L/C:6V\7>"_#]FWB,?\(CX8U""P2&+P]=P>+=?L[Z'5;75;^ZM
M;NUC>_W:5I;VF]\/_P!C3X*?"SQAHGBWP58^(],M?"^+WPOX)?Q%>W7@70/%
M,G@S3_A[?^.K#0K@2,WC+5?!NEVNAZAK-W=W+312ZC=+#'?ZKJ%U<?5],D^Z
M3Z<_H:!/9^C/XX/^"X6FZ?8?MUZ-+86-G92:C\ /"-UJ$UI;0V\M_=?\)1XF
M3[7>/"B&YN-BI%YTV^38JINVH!7Y.Q$R)\P"G[O7C&!@]?0Y/^17ZW?\%S6
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M"7XS_P""4?Q.\&>-_'OQ:TGX9>,/V!O#O@C3?">AZI<? C]A;X>>(?#^D?\
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M>SE?^>^*\Z>;8]8>DXO"8&52G:E-N.(K*?*Y35U?DO[K3<79V)<_GG^@'Y#
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MY/\ I$83$8+B?)(8APYZF33FO9MN*C]=JZ)M*_Q=+KSZM]%%%?U8?@ 4444
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MM(P#7RWH/@7XOZ^GQ"N[:]7PIINA:5<76JVMFLQ26*6">XETF7;DR211$/
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M,7KLV[O2]V]\"X^)?QHUD Z)X+\+^#[:8$"Z\5:S+K&J1*ZYW+I>CQ"V2>(
M,8Y;LQ$G&_!S6!<:)\1->R/%?Q8\3O'*I#Z?X/M[7PC9+@X4Q7-IY^IKE24<
M->D.,' /%=XJ*K;L9.<\^^,X[#..<#VZ<5)E0#@88GKG_P#5Q[8]^M?H&7\
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M#P?,[1;E&,JB<FNJLF.VKW +9)+=>N.0?Z?S(S2L%*$G:-@+,6( "CDMDD<
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M08"G=8AU,7=6?/)4U9VU2IR3NNJDWIW;=_-9_A?I>KMYOB[Q!XO\:S$[I/\
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M#;@EJW^K^"?JZNG]:"?C/XG.W_&6X_3^YAU?U_=K]?Q/SV;_ ()F?M#-U_:
M^%/&,?\ %K/$AQUZ?\5GW'&*:/\ @F7^T,/^;@/A1]?^%6>(\GGG.?&9&1T'
M7BOVYV+Z?J?\:-B^GZG_ !H_XAKP3_T3^"_\J?\ R0WXS^);U?%.-_\ !>'_
M /E)^) _X)E_M#'A?C_\*?I_PJWQ(,^_'C0?G@_X@_X)E_M!%P'^/_PM(RN
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MFM&TU9\VMUW9^  ^'/[173_AF'XMYQG)F\(8SZ#/B'C\>._IA5^'?[1*$_\
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M]]^R[\5OMVD:9%;7OD2>%98//#2/*L$C:\#)&78E#C@,>@S75'X*?M1$@?\
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M9+\5R6E\[:FG_$R/B$_^7>0W\\MO^=9H_,3_ (4E^U#_ -&O?%DCN<>%P??
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MP?"UG<V'[[1G*+TSCG!) (." 3U .0/84_\ B#/"'+9/,D^[QG,O_ 94[?\
M!\@_XF2\1/\ J2^?_"<M_P#P9;S/YH/^%)_M1=OV7?BR,>O_  BK9^G_ !4
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MM%%% !1110 4444 %%%% !1110 4$ ]0#]:** # YX')R?<\<GWX'Y"BBB@
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MXT>-],\76_B6")PTR:#8G3W&K:>6^VWM[,+F&7)<M\;>*?@E^T'X:^+?P_\
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MOVC/A[\&?"7A?QGXRB\53:3XNEMHM*3P]X:OM?U!7NM.35(_MMEIP=[51;.
MSL2@ES&"3S7G?QB_:DG\*_LD^+_VI?A7X.'C2R\-^$-3\<0>&O&-]?\ @.ZN
M= T&><:Z\ZG2M7OK?48+6SNGT_3Y;.);ZX^SQRWEE#(;A #Z_HKYO\/_ !G\
M4:C^U3\1/V>]5\):7I_A_P *?!/X;_%[PWXRM=?N+_5-?'C3QG\1/!NIZ5JV
MA-I-G;:&-*NO JSV3V^J:L^H0WS2S&S>/[/6!^U3\??%O[/FE> _$^C>%]"\
M2>'M<\;^&O"7B1-5NO$-C=VP\3>)-"T&UEM-4T[1K_PYX>MK2VU/4=5O=?\
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M1U/T8?XT;T_O+_WT/\: %P/0<]>!SGK^=&U?[H_(4AD0=70?5A_C1O3^^O\
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MMW,FKQ>'[;[1;7^CVUQH-O?Z[/%HNF7OB*/2;+5-6D73M/N+F[/E5XG\5_\
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M[!;>V$=M%&3J%BI95P2CSA77@@X9<J1Z''>NIK'UH?N+4]O[2T_/T^T#W]Z
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M]OAZ6T@UU_#6MKI-Q?QO+80W[/"+26]AC9))K9)BC2QQLKNH*J<G('ZV\_\
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M_@QK%[XOU:V\.6<NC6EIXJ^$GB*[TF2VM+Q=3LM8\-V,TUG?W5QY,&Q^JO\
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M%'=V-Q'=V5W''.CJEU9W<4-U:7"@2VUS%'-"Z2(K#D[_ .&/PZU72]1T/5?
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M2EJ![JVCFAMY+B".XN?,^SP/-&LT_D@--Y,3,'E\I2#)L5M@(+8!H E*J<Y
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M&"X &,UTU4X?^/R\/<+; ^_R.<^WI0!F_P!D7_\ T,&I?]^[/_Y'I/[(O_\
MH8-1_P"_5G_\8K?HH P/[(O_ /H8-1_[]6?_ ,8JA:6&I27>I02:_J12VF@$
M1V66=LT"R$$_9>S$X]!CZ#KJR+'_ )"6M?\ 76R_])%H$^GF_P!&5_[(O^WB
M#4OQCLS_ "MQ2C2+_OX@U(_]L[,?^V];U% SGFT%YVB^V:MJ%Y#%-'/]GE^S
M)&[Q,'C+F&"-R$<!@-P!( /K70T44 %%%% !1110 4444 %(> 2.P-+45Q+%
M!!-/.ZQ00Q22S2-PL<4:,\CL1SM1%+'V!H ^3OB1^VC\&/@M\4M-^%OQDOM3
M^&UQXEEMXO!?C+7(+&\\%^*Y)--.I7Z)>Z%J.J:QX5@T2..=-7UGQSH?AKPU
M;^4DD>NS+/$#<^._[+?@7]HZ[TGQ'>^,/%_AB:Z\ >,OA?KNH^ ]6TV*W\=_
M!_XG6]B/%O@S57O;#5;=K#5H[*UNM+US2OLVJ:5+)+<V%V3,I3\GO GQV/C;
M]K_Q!<67QT\.:CX6^.?Q9\*R3:!X8^&OP&@\80^"+'PIH'A__A1'B[XA7FN7
MWBWQ#X=LM9T/4Y-:-EI=]+>0:I>V^E2Q"\NG/[_Z?96>FV-IIVG6EM86%C!'
M:65E901VUG9VENHBM[6UMX52*WMX(D2*&&)$CBC541550  ?)7Q1_8A^"?QG
MM;5/B''XNU/4=(U+PG)X;UO2O%NL>%=4\.>%_!?CSPM\1= \ V#>%;G1K.\\
M)VGB'PG8L(=9L]2U007%WY>I1S_9I[?S[_@HAX>T'4?A9\*=2U'1M,O]1T/]
MI?\ 9\?1M1O["VO+[27NOB3HD%TVG7EQ')<6;W, \FX>"2-IHR%E9AT_0*OA
M7_@H)G_A3_P]]OVE/V=3_P"9/T44 ?<!L;(];.U.>N;>(Y_\<I/L%C_SY6G_
M (#0_P#Q%6ZJWM[:Z?;R7=Y,EO;Q#=)-(0L<8]68\*.V3QFCT3;V22;;;T22
M6K?H)M13;:22NVVDDN[;:27FV)]@L/\ GRM/_ :'_P"(K&UK3[$V]L/L5KM_
MM+3\_P"CPCC[0!@ (.F?KR>:@_X3GPC@$>(M).?^GR+_ !_SVXJA?>*_#VH_
M8[.PUG3[JZFU&Q$4$-S&\C[9@S%5!R=H )QT%:2HUHQ<I4*T8K5MTII);7=X
MZ+S:L9QKT9-1C5I.3V2J0;?HE)M_(YGQO9Q1^+OANMM:7BQ'6M0%TMCHFG7M
M@T/]G2%1JM]<KY^EPEO]3/9AI99ML+81B:XSQ59S/^T%\*1!:Z\-+'A3QN;R
M.Q\'Z%?^%)+C=9?9O[<\63K_ &QH6H(0QTZQT\&VU$;Q=M\BBNP\?);/XX^%
MOGC3O.&MZF8#>ZY<Z=<LXTN7<-,TNW_<ZW.J\RV]T2D,8:55WJ!7#>,%LS^T
MM\&VE7P_]N'@[Q\EO]M\8ZCIGB'RO]!,W]C^"("NF>([10 +[5+W=/I2%3;@
M&1JNJ[TL,NU.?_IV1-+^)B'WG#6ZU_=JW],^D!I]AC_CQL_?%M#C_P! K%US
M3K!H;+-E:?\ (6T_'^CQ#I-GLG!Y('%=-6+K8_=6/_86T\_E,/\ "L#<O'3M
M/.,V5H<=/]'B_7Y.?QS2_8+'_GRM/_ :'_XBK=% %3[!8_\ /E:?^ T/_P 1
M6-J5C8_;]%'V&SYO9\YMH3P+*8_W,=3R?8<&NDK%U$?\3'1#ZW=QV_Z<IAU[
M_C0!>73[# _T*TZ#_EVA]/\ <I?L%A_SY6G_ (#0_P#Q%6EZ#Z#^5+0!4_L^
MP_Y\K3_P&A_^(K&OM.T]=1T<BRM 3<7>?]'BY+6K?['?VQ^5=)6/J'_(0T;_
M *^+G_TF:@"[_9]A_P ^5I_X#0__ !%'V"Q_Y\K3_P !H?\ XBK=% %3^S[
M];*T/_;M#_\ $5C7UE8#5M%7[#9G<U_R;>'M:_\ 7,Y]>U=)6/?#_B:Z*>/O
MWPYZ_P#'KV[?X<D4 7/[/L!TL;,?]NT/_P 12_V?8?\ /E:?^ T/_P 15NB@
M"I_9]A_SY6G_ (#0_P#Q%2Q6]O#DPP0P[OO>5&D>['3.Q03CWXJ:B@ HHHH
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M)NISSN.3^==C6-$/^)]=GTTRT!^IN+@_TH /L.I_]!B7_P  [;_XJC[#J?\
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M'7*'''T_*O@/\E]]M7\WKY;'Z*7?[;TD#_D(6N?^NH_^N?TH_MS2/^@A;?\
M?P?X5>%K;<?Z/!]?*C_/A:/LMO\ \\(O^^%_PH I?VWI/_00M?\ OZM8VH:U
MI+7^B?\ $PM,B[N3GS5[6<G XSDAAZ#ZUTWV6V_YX0GZQ1G]2I/ZUCZC;VZW
MVBCR( #=W'_+*,8_T.4\';U./7D#IQF@"W_;>D?]!"U_[^K1_;6DCKJ%J/\
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M)<:O=QVSHU 'VS7PQ_P4"_Y)#\/O^SD_V=?;_FI^BUVWQY^/OB_X7^!/A_\
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MK/9HS^$?'.Q)?!$NJ7KA&LW9[?QTBF'PQ&N?WNDR,&UG($88Q8KO?% <^*/
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MU#_D(:-_U\7/_I,W\O\ ]= &ML3^ZO\ WR/\*-B?W5_[Y'^%.HH ;L3^ZO\
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M.,IS;5*6+@E2IXZC%^T5?FJQINE63A[3_;FG?\]9?_ :X_\ C58NI:YIIO\
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M* ,@Z[IW_/28_P#;M<?UC%6[2_MKW>(&<E/O;XI(^O3&]5!_#-7** "BBB@
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MQ,'[K?$KXEGH3S@>+ROK[\G(%2C_ ()\_LI#I\/M9'_=2/B9_P#-=C]*^O\
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M>HV+Q14 ?JPG[$'P1=0WV_XP#/8_'#XI''XKXJ*GZ@D'L2.:=_PP[\$?^?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ-;>&M)AURSL);J]O9+2UU)+475O UWJ.H3[8I$P]]>[<"ZF#^C=* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #J \\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9%XFA+#U94I[HR[OQ)HMA=/;7>J6L$Z8W1O( 1D9''T-0?\ "8>'/^@U9?\
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M4I-;WV-,)A</F5&$W:,J;]^VEUO?3TW]3T?X?:IXE\0ZE+=WVHR'3X."GEH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ^)?$_AV9<&*WT]M0<#IODPBCZ@[ORH [2BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ ILDB1(7D=40=68X I)9$AB>60X1%+,?0"
MOFS5M9\0?%3Q=_9UC(RVK,WD6^_;''&/XWQU/^.!5QCS&<Y\OJ?0JZ_H[R^4
MNJV1?^Z)US_.M ,&4,I!!Y!'>O"Y/@#>BV!CUJV,^/NM"0N?KG-=Y\,/#6K^
M&=#O+7696:4W)\I?-+H$"C!7TR2?RH<8VT8HRFW:2.YHHHJ#4*H:W?2:9H.H
M7T2JTEM;R2J&Z$JI(S^57ZQ_%O\ R)^M?]>4W_H!IK<3V.+^&?Q$U3QGJE[;
M7]M:Q)!"LBF$'))..<FO3*\$^ G_ ",&J_\ 7JG_ *%7O=5424M#.BVX784R
M66.")I975(T&69C@ >I-/KG_ !MX>F\4>%;O2K>Z-M++@JW8D'.UO8U*-'>V
MAKV.H6>IVJW5C<Q7,#<"2)PRG\13KV]M].LIKR[E6&WA0O)(QX4"N*^%_@F_
M\&Z7=KJ-TKSW4@8PQ-E(\<=>Y-9GQSOY;;P;;6L;$+=W:K)CNJJ6Q^8%5RIR
MLB'-J',T86K_ !VN&O6AT'2$DB!PLER26?W"KT_6H]/^.U_!<K'K6AH(SU,#
M,C@>N&Z_I6_\%?#]E;^$_P"V&@1[R[E8>8PR513@ >G()K;^*=E8/X!U2YN+
M*"6:*/,3L@W(Q( (/7O5^[?EL9)5''GN<IK_ ,=K6%UCT#3C<Y )ENLH,GL%
M')_.HO#7Q<\0ZMXDT_2[O1;9$NY1'N ="!W(SUXK-^!N@6=_?ZCJMU"DSVFR
M.$.,A6;)+8]<#%>ZF&(LK&)"R_=)49'TI2Y8Z6'#GFN9L?11161T!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%)%1LCD8(!P/7KBN9L]-\7Z58KIMI=Z3/;0KY<%Q<"02H@X&5 P2![BNMHH
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ME;0_VA/:W$%M][<; ! /RIGP-TZVO/%EU<SQ+(]I;;HMPSM9CC/UQG\Z^A2
MRE6 ((P0>]:3DE+8QI0E*.]CS/X<_%,^*+L:3JT4<.HE2T4D?"38&2,=FQS7
M4^/-;O/#O@^]U2Q\O[1#MV^8N1RP'2O"S:QZ/\;XK:R7RHH]70(J]%5F&1].
M2*]B^+7_ "3?4_\ @'_H0J917,K=2X3DX.^Z*7PO\9:MXNTK5;C4O),EM(JQ
M^4FWJN>?QKR3QOXG\5Z[:00:_8FWMXIBT3&W,>6P1U/7BN^^ 7_((UO_ *^8
M_P#T&IOCW_R+ND_]?A_] -4K*=K$2O*E>YP_A?QGXWTC0(++1M-,UBA;8XM&
M?.22>1[T_P 2>-?'6JZ!=6>KZ88;&0 2O]D9,#/J>G->K?"'_DF^G?[TO_H9
MJ?XJ_P#)-]6_W%_]"%',N:UA\CY+WZ'AW@GQ+XIT"WO$\.V)N8Y75IB+<R;2
M <=.E>Z?#O6/$.MZ)<7?B&W%O/YY2*/R3&=@ Y(/N3^5<9\ ?^09KG_7>+_T
M$U[%4U&KVL51B[)W"BBBLCH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#F_',+'PT][&"9M/FCO8\>L; G_QW=7.:G =<M_%&N6V'>T>);)\
M\C[/B1B/J2PKT*ZMX[NTFMI1F.9&C<#T(P:HZ-H-GHFBKI5OYDEN-VXS$%GW
M$D[B ,]: ,#1KN/5-;USQ )A%!%:Q6T,SC*Q@)YKD^N"P_*N;O-3DLK2SU#3
M]6\17DXGB#W4Z.EI,&8 _*V  >P'YUWNE>&-/TGP_)HL7FRVDH=9/.;+,&&"
M"0!VX_"LQ_ -E+9QVD^JZO-!"5,"27(*Q%2,8&W!P!CG/!- &3X@&JP:UJ$M
M_)K\=FP!L[C2GW10KMZR1@Y/.<YHO4&N>)O"_DZK.4FT^5FN[;]V\@ 7)']S
M)Z]QR*Z&\\(6MS>W-S#J.IV?VH[KB*UN J2'&,D$'!QZ8JS!X:T^UO=.N;<2
M1?V? UO#&K#;M;&<Y&2>.N: .0O+O4-,T?QGIZ:G>2C3Q"UM/+*3*F]0Q&_K
MQ5U8;O6/&$MA)JVH6]HNFP3%+><H2Y)&<]NO..O'I6]>>%;&]&LB26X']KB,
M3[67Y=BA1MXXX'?-6;70[:TUA]3C>8S/;);%6(V[5.0>F<_C0!QD6JZH-#72
MAJ4_FOKSZ4+UB#(L0).<_P!X@8!K3CLKK1O&^D6B:Q?W-G<07#&"YN#(0RA>
M2>XY&,YP0<=:GUK0;:RT*\BCL;W4([F_-Y*L,H6:)F.2\6!R5.,#K[UF:!I<
M]SXPM]31-9-O:VSH]QJXVR2,W157 X R<X[T =_7+K_R5.3_ + J_P#H]JU-
M!M+RTM+A;V69V>ZE>,32^8RH6^49^G( Z U6U/PQ%J6L#5$U/4;*Y%N+<FTD
M104#%N<J>Y_04 9_B#/_  GGA40%?/S<[_7R]@SGV]/>CX?X&E:CYG_'Y_:4
M_P!IS][?N[_ABM32O#5II=[+?&>ZO+Z1/+-S=R[W"_W1P !]!45]X3M+K4I-
M0MKR_P!.N9@!,]E,$$N.A8$$$^^* +]O=:8^L7MM;^5_:$:HUSMCPV"/EW-C
MGCIS4>L7VEZ/$NJ:@L8DC!CB?RPTI+?P)WR<=!2Z/H=GHD,J6OFO),_F33S.
M7DE;U9C536_"T&N:A:7LNH7]M+: ^3]F=0%)ZM\RGGW]J .5UO3]0?PEXEUZ
M^A^SWFH0QJML#DPPJ1PQ[L023Z5M^+_+_LW0?LNW/]J6OV?TZG'X;<_A6K9:
M MM%<PW6I7^HPW">6\=[(KJ!WQA1US573_!]C87EM<&[O[I;3/V6&YFWQP9&
M/E&/3@9)Q0!7\'[/^*C\[;N_MBX\S=_=^7;GVVXKF/!V[^T?"?FY\K[!=^1G
MU\T]/?9BNPU'PC97]Y<7*W=_9FZ4+<I:3;$GP,?,,'G'&1BK%_X:T^^LK.V7
MS;3[%C[++:OL>'C'RGGMZYS0!Q/B_P P7OC$V^=O]G6PFQ_>W_\ Q.:U+QM6
MTM-%O[^[M;^SFNH4-F;1 L#/PK1'[V5SWY^E='I_ARPT^SN[<^;=?;23=2W3
M[WFR,?,>.,<8%4[+P98VEU:RO>:A=1V;;K:WN9]\<)[%1@'CMDG% '1T444
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M /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%%
M'/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%% '/\ _"">
M#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#
M_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#_P#!=#_\
M31_P@G@__H5-#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@_
M_H5-#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\
M!=#_ /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$U
MT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%% '/\
M_"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%% '/\ _"">#_\
MH5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#_P#!
M=#_\31_P@G@__H5-#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P
M@G@__H5-#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-
M#_\ !=#_ /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_
M /$UT%% '/\ _"">#_\ H5-#_P#!=#_\31_P@G@__H5-#_\ !=#_ /$UT%%
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MOLWF_P"C^7N_U>SI]WOUKI+K2[[7;];J35;BTTG[.K0Q64YBD9SR6=@.F,8
M-<WC5SX-'A#^R+T7VT6OVGRO]'\O=_K-_3[O;K5KQ+=WCZA%H"V.KIHL,2BX
MGL[1Y&N.!B-6 P%QU(]Q0!L^"KVYO-)NQ/=/>1P7LL%O=/UFB4C#$]^<C/M6
M=XCN\^+(;+4]7N=)TH6ADBDAG\D32[CD%_88^7O6O:ZQ;6F@":ST75(X('6!
M+1;,K+CCD(<?+SU]C61J4+6/C*ZU'4M'NM4LI[>..U:"W\_[.1G<NSJ,GG-
M&?-KFHCX:3SR75T9I+K[-:7:J5EEB,@"R<<Y*YZ=>/6M+P[+8KKPMFN/$<-Y
MY;-';ZK.Q65>Y4$D''YBH=)BUS1M O+NPTPK')J)GBTV4?O$MCC<% .%8\D+
MR!Z9-6XGNO$7BW2[]--O+.STQ)F:2\B,32/(NW:JGG '.: ,SQ#H\EM=Z?I.
MF:WKAU&^DX9]0D98HEY=R,^G ]Z[N-5L[-5:1W2&, R2'<Q '4GN>*P-,M)Y
M_'6M:C<02K'###:VKNA 9<;G*D]1NQT]*UY[Q7U$:6UI=E9H&<W"Q_N5'3:6
M[-[8H \YAUQ=2L5U%_%<]IK,\F^" LXM(1N^6.0!2O*]<\\_GTUY]KUWQ:^D
M-?W-G:V=FDTXLY3&TDKDX&[KM %8D,-]8>"KCP@= O)KTB2".9(?]'?<Q(E,
MG08R#SSD5JFWN_"^OQWYL[N_M9]/BMIGM(S(ZRQ\ E1S@B@"@VMZK!I=SH@O
M7-^NKIIL=XX!<1O\P<_[07(S[>M:D8G\,^*+"S;4KR[L-0AFW"\E,K1R1C=N
M!ZX*YX]JS&T35)]+N-;%BZW[:NFI1V;D!S&@VA#_ +17<<>_K6G&9_$WBBPO
M&TV\M+#3X)LF\B,3222#;@ \X"YY]Z ,A/[7N_!\OBY=7O5O@KW:6RR?Z.L:
MD_(4Z'Y1UZUW]G<K>6-O=*,+-&L@&<X!&?ZUP*?VM:>#Y?"*Z1?-?%7M$N5C
M_P!':-B?G+]!\IZ=<UW]G;+9V5O:H<K#&L8.,9 &/Z4 34444 %4M9U#^R-#
MU#4O*\W[);23^7NV[]BEL9P<9QUQ5VL?Q9#+<^#M<@@B>6:33YT2-%+,S&-@
M  .I)[4UN)[,Y.W^*L,_@*Y\2G2BL\-RML+'S\EV;:1\VWNK9Z=JU%\=*WP_
MMO$XTXF:Z*I!8K-DR2-)L50VWOUZ5YO9>$-;_M?2;1K"[33);&WU"X#0-A+B
M&!D"'T8MC(//(K3TC0/$6K:5X2T2(76CC3(9+^6ZN+(LJS^8PC7:^ 6 )/L&
MS6KC$Y8SGU.YE\<PCX=-XMAL_,"1!GM3+M*ON"LA;'8YYQSCH*@C^(=J/&]M
MX;NK7R#=6R2PW!ER#(P!$97 QWYSR<#'-<=?Z'X@TKP[XO\ #<L-UJHNE2_M
MKN"S*K+(TB^8@5<@'(SM!Z G%7YO"%QKWBC5(+BVN+='T>V%M>-$P6.X3!4A
ML=01R!SC(I<L2N>>EOZW.X\/^(_[=O\ 6K;[)Y']F7C6N[S-WF8_BQ@8^G-;
MM>>_"RVUF)?$$^N64UK>7%^9&WQ%%<[>67/49[CBO0JB2LS:#;C=A1114EA1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP?PJX(&"/8D8X[<])10Y-JP*"3N%%%%26%%%% !1110 4444 %%%% !1110
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M(KIHF8C ^8>6[C'..N>#QTS<HHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "% . # 2(  A$! Q$!_\0
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M^U>+6O\ R7A/^PP?YFOI2BHWH%&*=].H4445B=(4444 %%%% !1110 4444
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M_F:^E*RQX;T1=0^WC2+(7F_S//$"[]WKNQG/O6I1*7-8*<.6X4445!H%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
E44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>ck0001859807-20250630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 09 20:42:43 UTC 2025 -->
<xs:schema xmlns:ck0001859807="http://www.profusa.com/20250630" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2025" targetNamespace="http://www.profusa.com/20250630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001859807-20250630_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001859807-20250630_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001859807-20250630_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001859807-20250630_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.profusa.com/role/ConsolidatedBalanceSheet" id="ck0001859807_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals" id="ck0001859807_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ConsolidatedIncomeStatement" id="ck0001859807_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals" id="ck0001859807_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ShareholdersEquityType2or3" id="ck0001859807_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders&#8217; Deficit (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ConsolidatedCashFlow" id="ck0001859807_r_ConsolidatedCashFlow">
        <link:definition>006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties" id="ck0001859807_r_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties">
        <link:definition>007 - Disclosure - Organization, Description of Business, Going Concern and Significant Risks and Uncertainties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/SummaryofSignificantAccountingPolicies" id="ck0001859807_r_SummaryofSignificantAccountingPolicies">
        <link:definition>008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/FairValueMeasurement" id="ck0001859807_r_FairValueMeasurement">
        <link:definition>009 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/BalanceSheetComponents" id="ck0001859807_r_BalanceSheetComponents">
        <link:definition>010 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/Debt" id="ck0001859807_r_Debt">
        <link:definition>011 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/CommitmentsandContingencies" id="ck0001859807_r_CommitmentsandContingencies">
        <link:definition>012 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ConvertiblePreferredStock" id="ck0001859807_r_ConvertiblePreferredStock">
        <link:definition>013 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/CommonStock" id="ck0001859807_r_CommonStock">
        <link:definition>014 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/StockOptionPlan" id="ck0001859807_r_StockOptionPlan">
        <link:definition>015 - Disclosure - Stock Option Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/RelatedPartyTransactions" id="ck0001859807_r_RelatedPartyTransactions">
        <link:definition>016 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders" id="ck0001859807_r_NetLossPerShareAttributabletoCommonStockholders">
        <link:definition>017 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/GovernmentGrantRevenue" id="ck0001859807_r_GovernmentGrantRevenue">
        <link:definition>018 - Disclosure - Government Grant Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/IncomeTaxes" id="ck0001859807_r_IncomeTaxes">
        <link:definition>019 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/Segments" id="ck0001859807_r_Segments">
        <link:definition>020 - Disclosure - Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/SubsequentEvents" id="ck0001859807_r_SubsequentEvents">
        <link:definition>021 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/InitialPublicOffering" id="ck0001859807_r_InitialPublicOffering">
        <link:definition>022 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/PrivatePlacement" id="ck0001859807_r_PrivatePlacement">
        <link:definition>023 - Disclosure - Private Placement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/AccountingPoliciesByPolicy" id="ck0001859807_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/SignificantAccountingPoliciesTables" id="ck0001859807_r_SignificantAccountingPoliciesTables">
        <link:definition>996001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/FairValueMeasurementTables" id="ck0001859807_r_FairValueMeasurementTables">
        <link:definition>996002 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/BalanceSheetComponentsTables" id="ck0001859807_r_BalanceSheetComponentsTables">
        <link:definition>996003 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/DebtTables" id="ck0001859807_r_DebtTables">
        <link:definition>996004 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ConvertiblePreferredStockTables" id="ck0001859807_r_ConvertiblePreferredStockTables">
        <link:definition>996005 - Disclosure - Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/CommonStockTables" id="ck0001859807_r_CommonStockTables">
        <link:definition>996006 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/StockOptionPlanTables" id="ck0001859807_r_StockOptionPlanTables">
        <link:definition>996007 - Disclosure - Stock Option Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" id="ck0001859807_r_NetLossPerShareAttributabletoCommonStockholdersTables">
        <link:definition>996008 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/IncomeTaxesTables" id="ck0001859807_r_IncomeTaxesTables">
        <link:definition>996009 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/SegmentsTables" id="ck0001859807_r_SegmentsTables">
        <link:definition>996010 - Disclosure - Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails" id="ck0001859807_r_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails">
        <link:definition>996011 - Disclosure - Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails" id="ck0001859807_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>996012 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/FairValueMeasurementDetails" id="ck0001859807_r_FairValueMeasurementDetails">
        <link:definition>996013 - Disclosure - Fair Value Measurement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable" id="ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable">
        <link:definition>996014 - Disclosure - Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable" id="ck0001859807_r_ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable">
        <link:definition>996015 - Disclosure - Fair Value Measurement - Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" id="ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable">
        <link:definition>996016 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable" id="ck0001859807_r_ScheduleofAccruedLiabilitiesTable">
        <link:definition>996017 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/DebtDetails" id="ck0001859807_r_DebtDetails">
        <link:definition>996018 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable" id="ck0001859807_r_ScheduleofChangesinDebtInstrumentsTable">
        <link:definition>996019 - Disclosure - Debt - Schedule of Changes in Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable" id="ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable">
        <link:definition>996020 - Disclosure - Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable" id="ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable">
        <link:definition>996021 - Disclosure - Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/CommitmentsandContingenciesDetails" id="ck0001859807_r_CommitmentsandContingenciesDetails">
        <link:definition>996022 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ConvertiblePreferredStockDetails" id="ck0001859807_r_ConvertiblePreferredStockDetails">
        <link:definition>996023 - Disclosure - Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable" id="ck0001859807_r_ScheduleofConvertiblePreferredStockTable">
        <link:definition>996024 - Disclosure - Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/CommonStockDetails" id="ck0001859807_r_CommonStockDetails">
        <link:definition>996025 - Disclosure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable" id="ck0001859807_r_ScheduleofReservedSharesofCommonStockTable">
        <link:definition>996026 - Disclosure - Common Stock - Schedule of Reserved Shares of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/StockOptionPlanDetails" id="ck0001859807_r_StockOptionPlanDetails">
        <link:definition>996027 - Disclosure - Stock Option Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable" id="ck0001859807_r_ScheduleofActivityUnderthePlanisSetForthTable">
        <link:definition>996028 - Disclosure - Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable" id="ck0001859807_r_ScheduleofStockCompensationExpenseTable">
        <link:definition>996029 - Disclosure - Stock Option Plan - Schedule of Stock Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/RelatedPartyTransactionsDetails" id="ck0001859807_r_RelatedPartyTransactionsDetails">
        <link:definition>996030 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" id="ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable">
        <link:definition>996031 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable" id="ck0001859807_r_ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable">
        <link:definition>996032 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/IncomeTaxesDetails" id="ck0001859807_r_IncomeTaxesDetails">
        <link:definition>996033 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable" id="ck0001859807_r_ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable">
        <link:definition>996034 - Disclosure - Income Taxes - Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable" id="ck0001859807_r_ScheduleofProvisionforIncomeTaxesTable">
        <link:definition>996035 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable" id="ck0001859807_r_ScheduleofDeferredTaxAssetsTable">
        <link:definition>996036 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/SegmentsDetails" id="ck0001859807_r_SegmentsDetails">
        <link:definition>996037 - Disclosure - Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable" id="ck0001859807_r_ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable">
        <link:definition>996038 - Disclosure - Segments - Schedule of Other Financial Information Regarding The Company&#8217;s Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals" id="ck0001859807_r_ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals">
        <link:definition>996039 - Disclosure - Segments - Schedule of Other Financial Information Regarding The Company&#8217;s Operating Segment (Parentheticals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/SubsequentEventsDetails" id="ck0001859807_r_SubsequentEventsDetails">
        <link:definition>996040 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0" id="ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0">
        <link:definition>996041 - Disclosure - Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0" id="ck0001859807_r_ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0">
        <link:definition>996042 - Disclosure - Fair Value Measurement - Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0" id="ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0">
        <link:definition>996043 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0" id="ck0001859807_r_ScheduleofAccruedLiabilitiesTable0">
        <link:definition>996044 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofDebtInstrumentsTable" id="ck0001859807_r_ScheduleofDebtInstrumentsTable">
        <link:definition>996045 - Disclosure - Debt - Schedule of Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0" id="ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0">
        <link:definition>996046 - Disclosure - Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0" id="ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0">
        <link:definition>996047 - Disclosure - Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0" id="ck0001859807_r_ScheduleofConvertiblePreferredStockTable0">
        <link:definition>996048 - Disclosure - Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0" id="ck0001859807_r_ScheduleofReservedSharesofCommonStockTable0">
        <link:definition>996049 - Disclosure - Common Stock - Schedule of Reserved Shares of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable" id="ck0001859807_r_ScheduleofActivityUnderthePlanTable">
        <link:definition>996050 - Disclosure - Stock Option Plan - Schedule of Activity Under the Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0" id="ck0001859807_r_ScheduleofStockCompensationExpenseTable0">
        <link:definition>996051 - Disclosure - Stock Option Plan - Schedule of Stock Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" id="ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0">
        <link:definition>996052 - Disclosure - Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" id="ck0001859807_r_ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0">
        <link:definition>996053 - Disclosure - Net Loss per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable" id="ck0001859807_r_ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable">
        <link:definition>996054 - Disclosure - Segments - Schedule of Consolidated Condensed Financial Statements of Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable" id="ck0001859807_r_ScheduleofFairValueofInvestmentsHeldinTrustAccountTable">
        <link:definition>996055 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV6][ucz1W0BXsCz1Bwvz+q/RO6liTkikeEbeEAn4yk7zmpSR1L1CLA7aP7zZbxFiZR5mONOVNgmmsNIJcKPJdzEwNvMsdjE1+8qQuc7klNP/GgHV4dzh+3mxPLtyjp7uYzIUgqX+VYhw982LRX3WQ0VkNqnfOfThjWFt2BFyBA4xosQA3UBQmYBPOKmjQVuZtgXmauxCwk3HPCtJk8q0Bqo4wR1W+HefHJxENSXjjGBwB8YSdOCVN4cJ33nLR1SZDG2Oq9BMRD3z/XHobTc7/UuVM1lxhZpGFiSKF/fhUGPS3fXo1ubMnS3BQhej4IEQGcwHrZrdy3usnQ==] CSR-->
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable" id="ck0001859807_r_ScheduleofBasicandDilutedNetLossIncomePerShareTable">
        <link:definition>996056 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable" id="ck0001859807_r_ScheduleofConsolidatedBalanceSheetTable">
        <link:definition>996057 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/InitialPublicOfferingDetails" id="ck0001859807_r_InitialPublicOfferingDetails">
        <link:definition>996058 - Disclosure - Initial Public Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/PrivatePlacementDetails" id="ck0001859807_r_PrivatePlacementDetails">
        <link:definition>996059 - Disclosure - Private Placement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable" id="ck0001859807_r_ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable">
        <link:definition>996060 - Disclosure - Fair Value Measurements - Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" id="ck0001859807_r_ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable">
        <link:definition>996061 - Disclosure - Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable" id="ck0001859807_r_ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable">
        <link:definition>996062 - Disclosure - Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable" id="ck0001859807_r_ScheduleofConvertiblePromissoryNoteTable">
        <link:definition>996063 - Disclosure - Fair Value Measurements - Schedule of Convertible Promissory Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable" id="ck0001859807_r_ScheduleofNetDeferredTaxAssetsTable">
        <link:definition>996064 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable" id="ck0001859807_r_ScheduleofIncomeTaxProvisionTable">
        <link:definition>996065 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable" id="ck0001859807_r_ScheduleofReconciliationoftheFederalIncomeTaxRateTable">
        <link:definition>996066 - Disclosure - Income Taxes - Schedule of Reconciliation of the Federal Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable" id="ck0001859807_r_ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable">
        <link:definition>996067 - Disclosure - Segment Information  - Schedule of Company&#8217;s Performance and Making Key Decisions Regarding Resource Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0" id="ck0001859807_r_ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0">
        <link:definition>996068 - Disclosure - Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable" id="ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareTable">
        <link:definition>996069 - Disclosure - Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable" id="ck0001859807_r_ScheduleofCondensedConsolidatedBalanceSheetTable">
        <link:definition>996070 - Disclosure - Significant Accounting Policies - Schedule of Condensed Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0" id="ck0001859807_r_ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0">
        <link:definition>996071 - Disclosure - Fair Value Measurements - Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" id="ck0001859807_r_ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable">
        <link:definition>996072 - Disclosure - Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0" id="ck0001859807_r_ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0">
        <link:definition>996073 - Disclosure - Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0" id="ck0001859807_r_ScheduleofConvertiblePromissoryNoteTable0">
        <link:definition>996074 - Disclosure - Fair Value Measurements - Schedule of Convertible Promissory Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0" id="ck0001859807_r_ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0">
        <link:definition>996075 - Disclosure - Segment Information  - Schedule of Company&#8217;s Performance and Making Key Decisions Regarding Resource Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.profusa.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd"/>
  <xs:element name="ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
  <xs:element name="ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract"/>
  <xs:element name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract"/>
  <xs:element name="ScheduleOfAccruedLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfChangesInDebtInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract"/>
  <xs:element name="ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract"/>
  <xs:element name="ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract"/>
  <xs:element name="ScheduleOfConvertiblePreferredStockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfConvertiblePreferredStockAbstract"/>
  <xs:element name="ScheduleOfReservedSharesOfCommonStockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract"/>
  <xs:element name="ScheduleOfActivityUnderThePlanIsSetForthAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract"/>
  <xs:element name="ScheduleOfStockCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfStockCompensationExpenseAbstract"/>
  <xs:element name="ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract"/>
  <xs:element name="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract"/>
  <xs:element name="ScheduleOfDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract"/>
  <xs:element name="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract"/>
  <xs:element name="ScheduleOfDebtInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfDebtInstrumentsAbstract"/>
  <xs:element name="ScheduleOfActivityUnderThePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfActivityUnderThePlanAbstract"/>
  <xs:element name="ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract"/>
  <xs:element name="ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract"/>
  <xs:element name="ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract"/>
  <xs:element name="InitialPublicOfferingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_InitialPublicOfferingAbstract"/>
  <xs:element name="ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract"/>
  <xs:element name="ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract"/>
  <xs:element name="ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract"/>
  <xs:element name="ScheduleOfConvertiblePromissoryNoteAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract"/>
  <xs:element name="ScheduleOfIncomeTaxProvisionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfIncomeTaxProvisionAbstract"/>
  <xs:element name="ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract"/>
  <xs:element name="ScheduleOfBasicAndDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract"/>
  <xs:element name="ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract"/>
  <xs:element name="AssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AssetsAbstract0"/>
  <xs:element name="AssetsAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AssetsAbstract1"/>
  <xs:element name="AssetsAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AssetsAbstract2"/>
  <xs:element name="OperatingExpensesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OperatingExpensesAbstract0"/>
  <xs:element name="LiabilitiesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LiabilitiesAbstract0"/>
  <xs:element name="DeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DeferredTaxAssetsAbstract"/>
  <xs:element name="OperatingExpensesAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OperatingExpensesAbstract1"/>
  <xs:element name="OtherIncomeExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OtherIncomeExpensesAbstract"/>
  <xs:element name="LiabilitiesAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LiabilitiesAbstract1"/>
  <xs:element name="LiabilitiesAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LiabilitiesAbstract2"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnlabeledAbstract"/>
  <xs:element name="OperatingExpensesAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OperatingExpensesAbstract2"/>
  <xs:element name="OperatingExpensesAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OperatingExpensesAbstract3"/>
  <xs:element name="BasicAndDilutedNetLossIncomePerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract"/>
  <xs:element name="LessAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LessAbstract"/>
  <xs:element name="PlusAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PlusAbstract"/>
  <xs:element name="LessAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LessAbstract0"/>
  <xs:element name="PlusAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PlusAbstract0"/>
  <xs:element name="BasicAndDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BasicAndDilutedNetLossPerShareAbstract"/>
  <xs:element name="LessAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LessAbstract1"/>
  <xs:element name="PlusAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PlusAbstract1"/>
  <xs:element name="LessAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LessAbstract2"/>
  <xs:element name="PlusAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PlusAbstract2"/>
  <xs:element name="LessAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LessAbstract3"/>
  <xs:element name="PlusAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PlusAbstract3"/>
  <xs:element name="PrepaidFranchiseTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PrepaidFranchiseTax"/>
  <xs:element name="PaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaycheckProtectionProgramLoan"/>
  <xs:element name="AdvanceFromProfusa" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AdvanceFromProfusa"/>
  <xs:element name="SecuritiesPurchaseAgreementCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SecuritiesPurchaseAgreementCurrent"/>
  <xs:element name="ChangeInFairValueOfConvertibleNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ChangeInFairValueOfConvertibleNote"/>
  <xs:element name="ChangeInFairValueOfSecuritiesPurchaseAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement"/>
  <xs:element name="AccretionOfCommonStockToRedemptionValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AccretionOfCommonStockToRedemptionValue"/>
  <xs:element name="ExciseTaxLiabilityInConnectionWithStockRedemptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions"/>
  <xs:element name="GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt"/>
  <xs:element name="IncreaseDecreaseInPrepaidFranchiseTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes"/>
  <xs:element name="PaymentOfExtensionFeeIntoTrustAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount"/>
  <xs:element name="CashWithdrawnFromTrustAccountInConnectionWithRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption"/>
  <xs:element name="PaymentOfDeferredOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaymentOfDeferredOfferingCosts"/>
  <xs:element name="IncreasedecreaseInUnpaidDeferredOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts"/>
  <xs:element name="ChangeInFairValueOfConvertiblePromissoryNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
  <xs:element name="ChangesInFairValueOfSecuritiesPurchaseAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement"/>
  <xs:element name="ExciseTaxPayableRedemptionOfCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock"/>
  <xs:element name="ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed"/>
  <xs:element name="RedemptionPaymentsDueToRedeemingStockholders" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders"/>
  <xs:element name="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable"/>
  <xs:element name="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SummaryofSignificantAccountingPoliciesTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems"/>
  <xs:element name="FairValueMeasurementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_FairValueMeasurementTable"/>
  <xs:element name="FairValueMeasurementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FairValueMeasurementLineItems"/>
  <xs:element name="CommitmentsandContingenciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_CommitmentsandContingenciesTable"/>
  <xs:element name="CommitmentsandContingenciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommitmentsandContingenciesLineItems"/>
  <xs:element name="CommonStockTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_CommonStockTable"/>
  <xs:element name="CommonStockLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommonStockLineItems"/>
  <xs:element name="RelatedPartyTransactionsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_RelatedPartyTransactionsTable"/>
  <xs:element name="RelatedPartyTransactionsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RelatedPartyTransactionsLineItems"/>
  <xs:element name="IncomeTaxesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_IncomeTaxesTable"/>
  <xs:element name="IncomeTaxesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IncomeTaxesLineItems"/>
  <xs:element name="SegmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SegmentsTable"/>
  <xs:element name="SegmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SegmentsLineItems"/>
  <xs:element name="SubsequentEventsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SubsequentEventsTable"/>
  <xs:element name="SubsequentEventsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SubsequentEventsLineItems"/>
  <xs:element name="InitialPublicOfferingTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_InitialPublicOfferingTextBlock"/>
  <xs:element name="InitialPublicOfferingTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_InitialPublicOfferingTable"/>
  <xs:element name="InitialPublicOfferingLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_InitialPublicOfferingLineItems"/>
  <xs:element name="PrivatePlacementsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PrivatePlacementsTextBlock"/>
  <xs:element name="PrivatePlacementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_PrivatePlacementTable"/>
  <xs:element name="PrivatePlacementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PrivatePlacementLineItems"/>
  <xs:element name="AccountingPoliciesbyPolicyPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable"/>
  <xs:element name="AccountingPoliciesbyPolicyPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems"/>
  <xs:element name="ConvertiblePreferredStockPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertiblePreferredStockPolicyTextBlock"/>
  <xs:element name="EmergingGrowthCompanyStatusPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock"/>
  <xs:element name="WarrantLiabilitiesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_WarrantLiabilitiesPolicyTextBlock"/>
  <xs:element name="SecuritiesPurchaseAgreementPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock"/>
  <xs:element name="SignificantAccountingPoliciesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SignificantAccountingPoliciesTablesTable"/>
  <xs:element name="FairValueMeasurementTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_FairValueMeasurementTablesTable"/>
  <xs:element name="ScheduleOfConvertiblePreferredStockTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
  <xs:element name="IncomeTaxesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_IncomeTaxesTablesTable"/>
  <xs:element name="SegmentsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SegmentsTablesTable"/>
  <xs:element name="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable"/>
  <xs:element name="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems"/>
  <xs:element name="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable"/>
  <xs:element name="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems"/>
  <xs:element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest"/>
  <xs:element name="PrepaidLegal" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PrepaidLegal"/>
  <xs:element name="StatedInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_StatedInterest"/>
  <xs:element name="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable"/>
  <xs:element name="FairValueRemeasurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FairValueRemeasurement"/>
  <xs:element name="InterestExpensesNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_InterestExpensesNotesPayable"/>
  <xs:element name="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable"/>
  <xs:element name="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems"/>
  <xs:element name="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable"/>
  <xs:element name="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled"/>
  <xs:element name="IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance"/>
  <xs:element name="DeferredTaxAssetsDepreciationAndAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization"/>
  <xs:element name="DeferredTaxAssetsConvertibleDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DeferredTaxAssetsConvertibleDebt"/>
  <xs:element name="AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
  <xs:element name="RentAndOfficeCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RentAndOfficeCosts"/>
  <xs:element name="LegalAndAccountingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LegalAndAccountingCosts"/>
  <xs:element name="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
  <xs:element name="StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems"/>
  <xs:element name="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable"/>
  <xs:element name="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable"/>
  <xs:element name="PrincipalBorrowing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PrincipalBorrowing"/>
  <xs:element name="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable"/>
  <xs:element name="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems"/>
  <xs:element name="IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable"/>
  <xs:element name="IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems"/>
  <xs:element name="EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate"/>
  <xs:element name="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems"/>
  <xs:element name="DepositDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DepositDomainDomain"/>
  <xs:element name="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable"/>
  <xs:element name="RevenueTarget" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RevenueTarget"/>
  <xs:element name="WorkingCapitalDeficit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_WorkingCapitalDeficit"/>
  <xs:element name="TransactionCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_TransactionCost"/>
  <xs:element name="UnderwritingDiscountAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnderwritingDiscountAmount"/>
  <xs:element name="RepresentativeSharesCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RepresentativeSharesCost"/>
  <xs:element name="RepresentativeWarrantCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RepresentativeWarrantCost"/>
  <xs:element name="OtherOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OtherOfferingCosts"/>
  <xs:element name="PercentageOfAggregateFairMarketValueOfAsset" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset"/>
  <xs:element name="BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum"/>
  <xs:element name="PaymentsForInvestmentOfCashInTrustAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount"/>
  <xs:element name="OperatingBankAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OperatingBankAccount"/>
  <xs:element name="MaturityDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_MaturityDays"/>
  <xs:element name="PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
  <xs:element name="PaymentofInteresttoDistributionExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaymentofInteresttoDistributionExpense"/>
  <xs:element name="WorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_WorkingCapital"/>
  <xs:element name="ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
  <xs:element name="UnsecuredPromissoryNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnsecuredPromissoryNote"/>
  <xs:element name="OutstandingPrincipalAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OutstandingPrincipalAmount"/>
  <xs:element name="SharesRedeemedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SharesRedeemedPercentage"/>
  <xs:element name="EstimatedInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_EstimatedInterestRate"/>
  <xs:element name="UnderpaymentPenaltyRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnderpaymentPenaltyRate"/>
  <xs:element name="UnpaidTotalLiabilityRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnpaidTotalLiabilityRate"/>
  <xs:element name="PurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PurchasePrice"/>
  <xs:element name="PercentageOfOriginalIssuanceDiscount" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfOriginalIssuanceDiscount"/>
  <xs:element name="PercentageOfPublicShares" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfPublicShares"/>
  <xs:element name="RedemptionPublicShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RedemptionPublicShares"/>
  <xs:element name="AmountDrawn" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AmountDrawn"/>
  <xs:element name="StockholdersAmendmentPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_StockholdersAmendmentPercentage"/>
  <xs:element name="PercentageOfRedeemingPublicShareholders" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfRedeemingPublicShareholders"/>
  <xs:element name="InterestFromTrustAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_InterestFromTrustAccount"/>
  <xs:element name="FundingOperatingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FundingOperatingExpenses"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="OperationsAndRedeemRepurchasePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OperationsAndRedeemRepurchasePercentage"/>
  <xs:element name="OfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OfferingCosts"/>
  <xs:element name="FairValueMeasurementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_FairValueMeasurementDetailsTable"/>
  <xs:element name="ConvertibleDebtOfTermFairValue" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertibleDebtOfTermFairValue"/>
  <xs:element name="ConvertibleDebtOfDiscountRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertibleDebtOfDiscountRate"/>
  <xs:element name="DebtDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_DebtDetailsTable"/>
  <xs:element name="DebtInstrumentDiscount" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DebtInstrumentDiscount"/>
  <xs:element name="DebtInstrumentsContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DebtInstrumentsContractualTerm"/>
  <xs:element name="BusinessDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BusinessDays"/>
  <xs:element name="DebtInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DebtInterestRate"/>
  <xs:element name="CommonStockConvertibleConversionPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommonStockConvertibleConversionPrice"/>
  <xs:element name="LossOnFairValueRemeasurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LossOnFairValueRemeasurement"/>
  <xs:element name="MaturityMonth" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_MaturityMonth"/>
  <xs:element name="PromissoryNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PromissoryNotes"/>
  <xs:element name="UnrelatedPartyRepayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnrelatedPartyRepayable"/>
  <xs:element name="MonthlyPayments" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_MonthlyPayments"/>
  <xs:element name="LatePenaltiesAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LatePenaltiesAmount"/>
  <xs:element name="GainOnFairValueRemeasurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_GainOnFairValueRemeasurement"/>
  <xs:element name="PercentageOfAccrueInterest" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfAccrueInterest"/>
  <xs:element name="UnpaidInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnpaidInterest"/>
  <xs:element name="CommitmentsandContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_CommitmentsandContingenciesDetailsTable"/>
  <xs:element name="NumberOfDaysForUnderwriterOptions" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NumberOfDaysForUnderwriterOptions"/>
  <xs:element name="UnitsIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues"/>
  <xs:element name="InitialPublicOfferingGrossProceedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_InitialPublicOfferingGrossProceedPercentage"/>
  <xs:element name="BusinessCombinationPercentageRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BusinessCombinationPercentageRate"/>
  <xs:element name="CashPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CashPercentage"/>
  <xs:element name="EquityPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_EquityPercentage"/>
  <xs:element name="LockupPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_LockupPeriod"/>
  <xs:element name="PercentageOfNetProceeds" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfNetProceeds"/>
  <xs:element name="WeightedAveragePricePerSharePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_WeightedAveragePricePerSharePercentage"/>
  <xs:element name="NumberOfTradingDay" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NumberOfTradingDay"/>
  <xs:element name="TradingPricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_TradingPricePerShare"/>
  <xs:element name="ConvertiblePreferredStockDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_ConvertiblePreferredStockDetailsTable"/>
  <xs:element name="CommonStockDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_CommonStockDetailsTable"/>
  <xs:element name="CommonStockDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommonStockDetailsLineItems"/>
  <xs:element name="FounderSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FounderSharesIssued"/>
  <xs:element name="VotingSharesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_VotingSharesPercentage"/>
  <xs:element name="StockOptionPlanDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_StockOptionPlanDetailsTable"/>
  <xs:element name="PercentageOfExcercisePriceOption" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfExcercisePriceOption"/>
  <xs:element name="RelatedPartyTransactionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_RelatedPartyTransactionsDetailsTable"/>
  <xs:element name="RelatedPartyTransactionsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RelatedPartyTransactionsDetailsLineItems"/>
  <xs:element name="CommonStockExceedsPerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommonStockExceedsPerShare"/>
  <xs:element name="ConvertibleWorkingCapitalPromissoryNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertibleWorkingCapitalPromissoryNote"/>
  <xs:element name="PercentageOfOriginalIssueDiscount" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfOriginalIssueDiscount"/>
  <xs:element name="PercentageOfLowestVolumeWeightedAveragePrice" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice"/>
  <xs:element name="RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth"/>
  <xs:element name="AggregateNumberOfSharesOwned" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AggregateNumberOfSharesOwned"/>
  <xs:element name="RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty"/>
  <xs:element name="IncomeTaxesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_IncomeTaxesDetailsTable"/>
  <xs:element name="ReceivedPaycheckProtectionProgramLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ReceivedPaycheckProtectionProgramLoans"/>
  <xs:element name="PaycheckProtectionProgramLoansOutstanding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaycheckProtectionProgramLoansOutstanding"/>
  <xs:element name="SegmentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SegmentsDetailsTable"/>
  <xs:element name="SegmentsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SegmentsDetailsLineItems"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_SubsequentEventsDetailsTable"/>
  <xs:element name="PercentageOfNonRedeemingPublicShareholders" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfNonRedeemingPublicShareholders"/>
  <xs:element name="PercentageOfAverageDailyTradedValueOfCommonStock" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock"/>
  <xs:element name="NumberOfTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NumberOfTradingDays"/>
  <xs:element name="PercentageOfLimitForOutstandingCommonStock" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfLimitForOutstandingCommonStock"/>
  <xs:element name="InitialPublicOfferingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_InitialPublicOfferingDetailsTable"/>
  <xs:element name="NumberOfSharesIssuedPerUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NumberOfSharesIssuedPerUnit"/>
  <xs:element name="EquityProceedOwnershipPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_EquityProceedOwnershipPercentage"/>
  <xs:element name="PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
  <xs:element name="PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance"/>
  <xs:element name="ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption"/>
  <xs:element name="RedemptionPricePerWarrant" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RedemptionPricePerWarrant"/>
  <xs:element name="NumberOfDaysForWrittenNoticeOfRedemption" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption"/>
  <xs:element name="MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders"/>
  <xs:element name="CommonStockThresholdTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommonStockThresholdTradingDays"/>
  <xs:element name="CommonStockThresholdConsecutiveTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommonStockThresholdConsecutiveTradingDays"/>
  <xs:element name="PrivatePlacementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="ck0001859807_PrivatePlacementDetailsTable"/>
  <xs:element name="DepositAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="ck0001859807_DepositAxis"/>
  <xs:element name="AdministrativeSupportAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AdministrativeSupportAgreementMember"/>
  <xs:element name="AdvisoryFeeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AdvisoryFeeMember"/>
  <xs:element name="AprilJune2025SeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AprilJune2025SeniorNotesMember"/>
  <xs:element name="AprilJuneTwoThousandTwentyFourSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember"/>
  <xs:element name="AprilTwoThousandTwentyOneConvertibleNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember"/>
  <xs:element name="AprilTwoThousandTwentyThreeSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember"/>
  <xs:element name="ArrangementFeeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ArrangementFeeMember"/>
  <xs:element name="AscentNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AscentNoteMember"/>
  <xs:element name="AugustTwoThousandTwentyConvertibleNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember"/>
  <xs:element name="AugustTwoThousandTwentyOneSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember"/>
  <xs:element name="BankersAndDawsonJamesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BankersAndDawsonJamesMember"/>
  <xs:element name="BusinessCombinationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BusinessCombinationMember"/>
  <xs:element name="BusinessCombinationProfusaMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BusinessCombinationProfusaMember"/>
  <xs:element name="CashAndMarketableSecuritiesHeldInTrustAccountMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember"/>
  <xs:element name="CashAndMarketableSecuritiesHeldInTrustMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember"/>
  <xs:element name="CashFeeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CashFeeMember"/>
  <xs:element name="ChiefOperatingOfficerDecisionMakerMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ChiefOperatingOfficerDecisionMakerMember"/>
  <xs:element name="CommonStockSubjectToPossibleRedemptionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
  <xs:element name="ConvertibleLoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertibleLoansMember"/>
  <xs:element name="ConvertibleNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertibleNotesMember"/>
  <xs:element name="ConvertibleNotesNovember2022AmendmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertibleNotesNovember2022AmendmentMember"/>
  <xs:element name="ConvertiblePromissoryNoteAscentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertiblePromissoryNoteAscentMember"/>
  <xs:element name="ConvertiblePromissoryNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertiblePromissoryNoteMember"/>
  <xs:element name="ConvertiblePromissoryNoteRelatedPartyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember"/>
  <xs:element name="ConvertibleWorkingCapitalPromissoryNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember"/>
  <xs:element name="DawsonJamesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DawsonJamesMember"/>
  <xs:element name="DecemberTwoThousandTwentyOneSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember"/>
  <xs:element name="DecemberTwoThousandTwentyTwoSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember"/>
  <xs:element name="DissolutionExpenseWaiverMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DissolutionExpenseWaiverMember"/>
  <xs:element name="EquityIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_EquityIncentivePlanMember"/>
  <xs:element name="FebruaryExtensionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FebruaryExtensionMember"/>
  <xs:element name="FounderShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FounderShareMember"/>
  <xs:element name="FounderShares1Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_FounderShares1Member"/>
  <xs:element name="IBankersAndDawsonJamesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IBankersAndDawsonJamesMember"/>
  <xs:element name="IBankersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IBankersMember"/>
  <xs:element name="InitialNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_InitialNotesMember"/>
  <xs:element name="IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember"/>
  <xs:element name="JanuaryExtensionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_JanuaryExtensionMember"/>
  <xs:element name="JanuaryMarch2024SeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_JanuaryMarch2024SeniorNotesMember"/>
  <xs:element name="JanuaryMarch2025SeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_JanuaryMarch2025SeniorNotesMember"/>
  <xs:element name="JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember"/>
  <xs:element name="JanuaryTwoThousandTwentyOneConvertibleNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember"/>
  <xs:element name="JulySeptemberTwoThousandTwentyFourSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember"/>
  <xs:element name="JuneJulyAndAugustExtensionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_JuneJulyAndAugustExtensionMember"/>
  <xs:element name="MarchTwoThousandTwentyThreeSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember"/>
  <xs:element name="MergerAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_MergerAgreementMember"/>
  <xs:element name="NewProfusaCommonStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NewProfusaCommonStockMember"/>
  <xs:element name="NewSeriesAConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NewSeriesAConvertiblePreferredStockMember"/>
  <xs:element name="NewSeriesBConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NewSeriesBConvertiblePreferredStockMember"/>
  <xs:element name="NewSeriesC1ConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember"/>
  <xs:element name="NewSeriesCConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NewSeriesCConvertiblePreferredStockMember"/>
  <xs:element name="NoRedemptionScenarioMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NoRedemptionScenarioMember"/>
  <xs:element name="NonrecoursePromissoryNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NonrecoursePromissoryNotesMember"/>
  <xs:element name="NorthViewAcquisitionCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NorthViewAcquisitionCorpMember"/>
  <xs:element name="NorthViewTrustMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NorthViewTrustMember"/>
  <xs:element name="NorthviewAcquisitionCorporationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NorthviewAcquisitionCorporationMember"/>
  <xs:element name="NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember"/>
  <xs:element name="NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember"/>
  <xs:element name="OctoberDecember2024SeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OctoberDecember2024SeniorNotesMember"/>
  <xs:element name="OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember"/>
  <xs:element name="OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember"/>
  <xs:element name="OctoberTwoThousandTwentyTwoSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember"/>
  <xs:element name="OptionsToPurchaseCommonStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OptionsToPurchaseCommonStockMember"/>
  <xs:element name="OutstandingOptionsUnderTwoThousandTenPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember"/>
  <xs:element name="PIPEConvertibleNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PIPEConvertibleNoteMember"/>
  <xs:element name="PPPLoanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PPPLoanMember"/>
  <xs:element name="PaycheckProtectionProgramLoanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaycheckProtectionProgramLoanMember"/>
  <xs:element name="PaycheckProtectionProgramMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PaycheckProtectionProgramMember"/>
  <xs:element name="Plan2018Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_Plan2018Member"/>
  <xs:element name="PrivatePlacementWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PrivatePlacementWarrantsMember"/>
  <xs:element name="ProfusaAsiaPacificPteLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ProfusaAsiaPacificPteLtdMember"/>
  <xs:element name="ProfusaIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ProfusaIncMember"/>
  <xs:element name="ProfusaMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ProfusaMember"/>
  <xs:element name="ProfusaPreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ProfusaPreferredStockMember"/>
  <xs:element name="PromissoryNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PromissoryNoteMember"/>
  <xs:element name="PromissoryNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PromissoryNotesMember"/>
  <xs:element name="PublicSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PublicSharesMember"/>
  <xs:element name="PublicWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PublicWarrantMember"/>
  <xs:element name="PublicWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_PublicWarrantsMember"/>
  <xs:element name="RedeemableSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RedeemableSharesMember"/>
  <xs:element name="RedeemableWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RedeemableWarrantMember"/>
  <xs:element name="RelatedPartyLoanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RelatedPartyLoanMember"/>
  <xs:element name="RepresentativesWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_RepresentativesWarrantsMember"/>
  <xs:element name="SecondPurchaseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SecondPurchaseMember"/>
  <xs:element name="SecuritiesPurchaseAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SecuritiesPurchaseAgreementMember"/>
  <xs:element name="SeniorConvertibleBridgeNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeniorConvertibleBridgeNotesMember"/>
  <xs:element name="SeniorConvertiblesNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeniorConvertiblesNotesMember"/>
  <xs:element name="SeniorNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeniorNoteMember"/>
  <xs:element name="SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember"/>
  <xs:element name="SeniorSecuredConvertibleNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeniorSecuredConvertibleNoteMember"/>
  <xs:element name="SeniorSecuredConvertibleNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeniorSecuredConvertibleNotesMember"/>
  <xs:element name="SeniorSecuredNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeniorSecuredNoteMember"/>
  <xs:element name="SeriesCC1PreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SeriesCC1PreferredStockMember"/>
  <xs:element name="ShortTermLeasesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ShortTermLeasesMember"/>
  <xs:element name="ShortTermLoanAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ShortTermLoanAgreementMember"/>
  <xs:element name="SpecialMeetingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SpecialMeetingMember"/>
  <xs:element name="SponsorMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SponsorMember"/>
  <xs:element name="TaslyConvertibleDebtMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_TaslyConvertibleDebtMember"/>
  <xs:element name="USFederalMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_USFederalMember"/>
  <xs:element name="UnrelatedPartiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_UnrelatedPartiesMember"/>
  <xs:element name="WarrantLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_WarrantLiabilityMember"/>
  <xs:element name="WarrantsLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_WarrantsLiabilityMember"/>
  <xs:element name="BalanceSheetComponentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_BalanceSheetComponentsAbstract"/>
  <xs:element name="ScheduleOfProvisionForIncomeTaxesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract"/>
  <xs:element name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ck0001859807_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>18
<FILENAME>ck0001859807-20250630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 09 20:42:43 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedBalanceSheet" roleURI="http://www.profusa.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedIncomeStatement" roleURI="http://www.profusa.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedCashFlow" roleURI="http://www.profusa.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable" roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofAccruedLiabilitiesTable" roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable" roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable" roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofProvisionforIncomeTaxesTable" roleURI="http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable" roleURI="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0" roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0" roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofAccruedLiabilitiesTable0" roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0" roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0" roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable" roleURI="http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofNetDeferredTaxAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofIncomeTaxProvisionTable" roleURI="http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofReconciliationoftheFederalIncomeTaxRateTable" roleURI="http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"/>
  <calculationLink xlink:role="http://www.profusa.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidTaxes" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidFranchiseTax" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidFranchiseTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="ck0001859807_PrepaidFranchiseTax" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredCosts" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramLoan" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoan"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="ck0001859807_PaycheckProtectionProgramLoan" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdvanceFromProfusa" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdvanceFromProfusa"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="ck0001859807_AdvanceFromProfusa" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="ck0001859807_SecuritiesPurchaseAgreementCurrent" order="13" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" order="14" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingCostsAndExpenses" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherIncome" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpenseNonoperating" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertibleNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertibleNote"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="ck0001859807_ChangeInFairValueOfConvertibleNote" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InvestmentIncomeInterest" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" order="18" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" order="19" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDecommissioningFund" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDecommissioningFund"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromDecommissioningFund" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfExtensionFeeIntoTrustAccount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromNotesPayable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentOfDeferredOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfDeferredOfferingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="ck0001859807_PaymentOfDeferredOfferingCosts" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<!-- [WMV6][5DX8zRlOKr9AUJIrXKJtdjEvM3tj+E24yTn+HrA8pApXFUw9DCYWtIbY55fn/on3vJRFJIMU6G2uqwktNHFEFQnAhIH0SHLR0WTxI08tepCIgr2FRZ+kInwBqWthVZCo2+DX4uoupM11av/pcyS6pv9ljV6mwr3HbqLViclKgZveXirsfRKTomi9a5Q0uSWnBh2XtUQt39iWTyNcUIc3R9DPNrYbQoYfsu4ALFVYH3mhP7Xd16TKalR17e12v4f1vMnX6Cif0eIvS3BPGvYYRQtr5PhiVCtcoWA2o6WXroVa/466qh0dtVV+s10P20DJz/d+UEO6] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_NotesPayableFairValueDisclosure" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvanceRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvanceRoyalties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_AdvanceRoyalties" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidLegal" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidLegal"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="ck0001859807_PrepaidLegal" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidInsurance" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueRemeasurement"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="ck0001859807_FairValueRemeasurement" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InterestExpensesNotesPayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestExpensesNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="ck0001859807_InterestExpensesNotesPayable" order="4" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsDepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DeferredTaxAssetsConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="ck0001859807_DeferredTaxAssetsConvertibleDebt" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsOther" order="8" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OtherCostAndExpenseOperating" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RentAndOfficeCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RentAndOfficeCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="ck0001859807_RentAndOfficeCosts" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LegalAndAccountingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LegalAndAccountingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="ck0001859807_LegalAndAccountingCosts" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OtherExpenses" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherIncome" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpenseNonoperating" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_NotesPayableFairValueDisclosure" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidLegal" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidLegal"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="ck0001859807_PrepaidLegal" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueRemeasurement"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="ck0001859807_FairValueRemeasurement" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InterestExpensesNotesPayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestExpensesNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="ck0001859807_InterestExpensesNotesPayable" order="4" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ShareBasedCompensation" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OtherCostAndExpenseOperating" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RentAndOfficeCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RentAndOfficeCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="ck0001859807_RentAndOfficeCosts" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LegalAndAccountingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LegalAndAccountingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="ck0001859807_LegalAndAccountingCosts" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OtherExpenses" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpenseNonoperating" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>19
<FILENAME>ck0001859807-20250630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 09 20:42:43 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedBalanceSheet" roleURI="http://www.profusa.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedIncomeStatement" roleURI="http://www.profusa.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ShareholdersEquityType2or3" roleURI="http://www.profusa.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedCashFlow" roleURI="http://www.profusa.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties" roleURI="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.profusa.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_FairValueMeasurement" roleURI="http://www.profusa.com/role/FairValueMeasurement"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_BalanceSheetComponents" roleURI="http://www.profusa.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_Debt" roleURI="http://www.profusa.com/role/Debt"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommitmentsandContingencies" roleURI="http://www.profusa.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConvertiblePreferredStock" roleURI="http://www.profusa.com/role/ConvertiblePreferredStock"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommonStock" roleURI="http://www.profusa.com/role/CommonStock"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_StockOptionPlan" roleURI="http://www.profusa.com/role/StockOptionPlan"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_RelatedPartyTransactions" roleURI="http://www.profusa.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_GovernmentGrantRevenue" roleURI="http://www.profusa.com/role/GovernmentGrantRevenue"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_IncomeTaxes" roleURI="http://www.profusa.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_Segments" roleURI="http://www.profusa.com/role/Segments"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SubsequentEvents" roleURI="http://www.profusa.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_InitialPublicOffering" roleURI="http://www.profusa.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_PrivatePlacement" roleURI="http://www.profusa.com/role/PrivatePlacement"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_AccountingPoliciesByPolicy" roleURI="http://www.profusa.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SignificantAccountingPoliciesTables" roleURI="http://www.profusa.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_FairValueMeasurementTables" roleURI="http://www.profusa.com/role/FairValueMeasurementTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_BalanceSheetComponentsTables" roleURI="http://www.profusa.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_DebtTables" roleURI="http://www.profusa.com/role/DebtTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConvertiblePreferredStockTables" roleURI="http://www.profusa.com/role/ConvertiblePreferredStockTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommonStockTables" roleURI="http://www.profusa.com/role/CommonStockTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_StockOptionPlanTables" roleURI="http://www.profusa.com/role/StockOptionPlanTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_IncomeTaxesTables" roleURI="http://www.profusa.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SegmentsTables" roleURI="http://www.profusa.com/role/SegmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable" roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable" roleURI="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofAccruedLiabilitiesTable" roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofChangesinDebtInstrumentsTable" roleURI="http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable" roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable" roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePreferredStockTable" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofReservedSharesofCommonStockTable" roleURI="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofActivityUnderthePlanisSetForthTable" roleURI="http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofStockCompensationExpenseTable" roleURI="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable" roleURI="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable" roleURI="http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofProvisionforIncomeTaxesTable" roleURI="http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable" roleURI="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals" roleURI="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0" roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0" roleURI="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0" roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofAccruedLiabilitiesTable0" roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDebtInstrumentsTable" roleURI="http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0" roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0" roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePreferredStockTable0" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofReservedSharesofCommonStockTable0" roleURI="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofActivityUnderthePlanTable" roleURI="http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofStockCompensationExpenseTable0" roleURI="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" roleURI="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable" roleURI="http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueofInvestmentsHeldinTrustAccountTable" roleURI="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossIncomePerShareTable" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConsolidatedBalanceSheetTable" roleURI="http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable" roleURI="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" roleURI="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable" roleURI="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePromissoryNoteTable" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofNetDeferredTaxAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofIncomeTaxProvisionTable" roleURI="http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofReconciliationoftheFederalIncomeTaxRateTable" roleURI="http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable" roleURI="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0" roleURI="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareTable" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCondensedConsolidatedBalanceSheetTable" roleURI="http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0" roleURI="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" roleURI="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0" roleURI="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePromissoryNoteTable0" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0" roleURI="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails" roleURI="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_FairValueMeasurementDetails" roleURI="http://www.profusa.com/role/FairValueMeasurementDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_DebtDetails" roleURI="http://www.profusa.com/role/DebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommitmentsandContingenciesDetails" roleURI="http://www.profusa.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConvertiblePreferredStockDetails" roleURI="http://www.profusa.com/role/ConvertiblePreferredStockDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommonStockDetails" roleURI="http://www.profusa.com/role/CommonStockDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_StockOptionPlanDetails" roleURI="http://www.profusa.com/role/StockOptionPlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_RelatedPartyTransactionsDetails" roleURI="http://www.profusa.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_IncomeTaxesDetails" roleURI="http://www.profusa.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SegmentsDetails" roleURI="http://www.profusa.com/role/SegmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SubsequentEventsDetails" roleURI="http://www.profusa.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_InitialPublicOfferingDetails" roleURI="http://www.profusa.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_PrivatePlacementDetails" roleURI="http://www.profusa.com/role/PrivatePlacementDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd#eedm" roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://www.profusa.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthviewAcquisitionCorporationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthviewAcquisitionCorporationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthviewAcquisitionCorporationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssetsNoncurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsPayableCurrent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConvertibleDebtCurrent" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayableCurrent" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramLoan" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_PaycheckProtectionProgramLoan" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrent" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Liabilities" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockValue" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdditionalPaidInCapital" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PrepaidTaxes" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdvanceFromProfusa" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdvanceFromProfusa"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_AdvanceFromProfusa" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockValue" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidFranchiseTax" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidFranchiseTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_PrepaidFranchiseTax" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_SecuritiesPurchaseAgreementCurrent" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" order="39" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthviewAcquisitionCorporationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthviewAcquisitionCorporationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthviewAcquisitionCorporationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthviewAcquisitionCorporationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthviewAcquisitionCorporationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthviewAcquisitionCorporationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpenses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpenseNonoperating" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherIncome" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertibleNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertibleNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_ChangeInFairValueOfConvertibleNote" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpenseOther" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RestatementAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AccretionOfCommonStockToRedemptionValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccretionOfCommonStockToRedemptionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_AccretionOfCommonStockToRedemptionValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNoncashExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromNotesPayable" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentOfDeferredOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfDeferredOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_PaymentOfDeferredOfferingCosts" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfExtensionFeeIntoTrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDecommissioningFund" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDecommissioningFund"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromDecommissioningFund" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxesPaid" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ExciseTaxPayableRedemptionOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AccretionOfCommonStockToRedemptionValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccretionOfCommonStockToRedemptionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_AccretionOfCommonStockToRedemptionValue" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPaymentsDueToRedeemingStockholders"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="44" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" xlink:to="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/FairValueMeasurement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="ck0001859807_FairValueMeasurementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/BalanceSheetComponents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_BalanceSheetComponentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_BalanceSheetComponentsAbstract" xlink:to="srt_CondensedFinancialStatementsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/Debt" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_CommitmentsandContingenciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommitmentsandContingenciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_CommitmentsandContingenciesLineItems" xlink:to="ck0001859807_CommitmentsandContingenciesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommitmentsandContingenciesLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ConvertiblePreferredStock" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/CommonStock" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_CommonStockLineItems" xlink:to="ck0001859807_CommonStockTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommonStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/StockOptionPlan" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/RelatedPartyTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_RelatedPartyTransactionsLineItems" xlink:to="ck0001859807_RelatedPartyTransactionsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/GovernmentGrantRevenue" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentAssistanceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentAssistanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GovernmentAssistanceAbstract" xlink:to="us-gaap_GovernmentAssistanceTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/IncomeTaxes" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_IncomeTaxesLineItems" xlink:to="ck0001859807_IncomeTaxesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_IncomeTaxesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/Segments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SegmentsLineItems" xlink:to="ck0001859807_SegmentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SegmentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SegmentsLineItems" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SubsequentEventsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SubsequentEventsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SubsequentEventsLineItems" xlink:to="ck0001859807_SubsequentEventsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SubsequentEventsLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/InitialPublicOffering" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_InitialPublicOfferingLineItems" xlink:to="ck0001859807_InitialPublicOfferingTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_InitialPublicOfferingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_InitialPublicOfferingLineItems" xlink:to="ck0001859807_InitialPublicOfferingTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/PrivatePlacement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_PrivatePlacementLineItems" xlink:to="ck0001859807_PrivatePlacementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_PrivatePlacementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementsTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_PrivatePlacementLineItems" xlink:to="ck0001859807_PrivatePlacementsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccountingPoliciesbyPolicyPoliciesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="ck0001859807_ConvertiblePreferredStockPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_DebtPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WarrantLiabilitiesPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantLiabilitiesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="ck0001859807_WarrantLiabilitiesPolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SignificantAccountingPoliciesTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001859807_SignificantAccountingPoliciesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SignificantAccountingPoliciesTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_MarketableSecuritiesTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquityTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/FairValueMeasurementTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="ck0001859807_FairValueMeasurementTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_BalanceSheetComponentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_BalanceSheetComponentsAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_BalanceSheetComponentsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/DebtTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ConvertiblePreferredStockTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/CommonStockTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/StockOptionPlanTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/IncomeTaxesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_IncomeTaxesLineItems" xlink:to="ck0001859807_IncomeTaxesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_IncomeTaxesTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesLineItems" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/SegmentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SegmentsLineItems" xlink:to="ck0001859807_SegmentsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SegmentsTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SegmentsLineItems" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SegmentsLineItems" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:to="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_ProfusaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:to="us-gaap_NotesPayableFairValueDisclosure" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvanceRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvanceRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_AdvanceRoyalties" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidLegal" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidLegal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="ck0001859807_PrepaidLegal" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidInsurance" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_ConvertibleNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TaslyConvertibleDebtMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TaslyConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_TaslyConvertibleDebtMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorNoteMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_PromissoryNotesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PPPLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PPPLoanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_PPPLoanMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StatedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_StatedInterest" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_SeniorNotesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebt" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueRemeasurement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_FairValueRemeasurement" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InterestExpensesNotesPayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestExpensesNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_InterestExpensesNotesPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:to="us-gaap_LongTermDebt" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesAConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesAConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesAConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesBConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesBConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesBConvertiblePreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesCConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesCConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesCConvertiblePreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesC1ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConversionOfStockTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" xlink:to="srt_StatementScenarioAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleLoansMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ck0001859807_ConvertibleLoansMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OptionsToPurchaseCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OptionsToPurchaseCommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ck0001859807_OptionsToPurchaseCommonStockMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsDepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DeferredTaxAssetsConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="ck0001859807_DeferredTaxAssetsConvertibleDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OtherCostAndExpenseOperating" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RentAndOfficeCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RentAndOfficeCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="ck0001859807_RentAndOfficeCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LegalAndAccountingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LegalAndAccountingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="ck0001859807_LegalAndAccountingCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OtherExpenses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OperatingExpenses" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_InterestExpenseNonoperating" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OtherIncome" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_NetIncomeLoss" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_InterestExpenseOther" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_NotesPayableFairValueDisclosure" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidLegal" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidLegal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="ck0001859807_PrepaidLegal" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidInsurance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofDebtInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_ConvertibleNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TaslyConvertibleDebtMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TaslyConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_TaslyConvertibleDebtMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorNoteMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_PromissoryNotesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PPPLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PPPLoanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_PPPLoanMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StatedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_StatedInterest" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SeniorNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueRemeasurement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_FairValueRemeasurement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InterestExpensesNotesPayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestExpensesNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_InterestExpensesNotesPayable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebt" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesAConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesAConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesAConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesBConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesBConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesBConvertiblePreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesCConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesCConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesCConvertiblePreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesC1ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConversionOfStockTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeriesCC1PreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeriesCC1PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_SeriesCC1PreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" xlink:to="srt_StatementScenarioAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleLoansMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ck0001859807_ConvertibleLoansMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OptionsToPurchaseCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OptionsToPurchaseCommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ck0001859807_OptionsToPurchaseCommonStockMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="srt_ConsolidationItemsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_OtherCostAndExpenseOperating" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RentAndOfficeCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RentAndOfficeCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="ck0001859807_RentAndOfficeCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LegalAndAccountingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LegalAndAccountingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="ck0001859807_LegalAndAccountingCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_OtherExpenses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_OperatingExpenses" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_InterestExpenseNonoperating" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_NonoperatingIncomeExpense" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_NetIncomeLoss" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CashMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetHeldInTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetHeldInTrustMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_AssetHeldInTrustMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="us-gaap_TemporaryEquityNetIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedemptionPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedemptionPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_RedemptionPremium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_ConvertiblePromissoryNoteMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PublicWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PrivatePlacementWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_RepresentativesWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExercisePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExercisePriceMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PrivatePlacementWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_RepresentativesWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WarrantLiabilityMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_WarrantLiabilityMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_DebtInstrumentAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_ConvertiblePromissoryNoteMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrincipalBorrowing" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrincipalBorrowing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="ck0001859807_PrincipalBorrowing" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<!-- [WMV6][U2piZXy3kSeCYghhRsISejB/axQS2MuSZFQNEP0KCEGLEQd4ZhS7U0O54AY/n8vgJ2PtD8LUNXjcxgiSoLhybop6HlMC5xiIQd13O2B6HzQH5OXOe2CM1A1hzCjARMSjFPGIIhWrOaM3rzj1flQJ+TpsgublCuyK/LGuz+sL27ULiUuWvXWd+0M5JT7gdr8Bl6k5IPhT8PtiEbEFpOT9JkbX7dCRmIoszBtjbaLfPljX/0vy2SJuG/wNqckUA+PDez42aLUcdS5EwtQ2RBOL4BV971xkHIMNYrPA0TU8qDtcmv3z+LnNIqxRGQrMi6YfkE8aC/7a/GU=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChiefOperatingOfficerDecisionMakerMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChiefOperatingOfficerDecisionMakerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="ck0001859807_ChiefOperatingOfficerDecisionMakerMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_Cash" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CashMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="us-gaap_TemporaryEquityNetIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedemptionPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedemptionPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_RedemptionPremium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_ConvertiblePromissoryNoteMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PublicWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PrivatePlacementWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_RepresentativesWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ck0001859807_SecuritiesPurchaseAgreementCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExercisePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExercisePriceMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteAscentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteAscentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="ck0001859807_ConvertiblePromissoryNoteAscentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PrivatePlacementWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_RepresentativesWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WarrantsLiabilityMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantsLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_WarrantsLiabilityMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_SecuritiesPurchaseAgreementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeSecuritiesOtherUSGovernment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeSecuritiesOtherUSGovernment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_InterestIncomeSecuritiesOtherUSGovernment" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_OwnershipAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DepositAxis" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DepositAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="ck0001859807_DepositAxis" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DepositDomainDomain" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DepositDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ck0001859807_DepositAxis" xlink:to="ck0001859807_DepositDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DepositDomainDomain_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DepositDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ck0001859807_DepositAxis" xlink:to="ck0001859807_DepositDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="dei_LegalEntityAxis" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedeemableWarrantMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedeemableWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_RedeemableWarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_USFederalMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_USFederalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_USFederalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DissolutionExpenseWaiverMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DissolutionExpenseWaiverMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001859807_DissolutionExpenseWaiverMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewTrustMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewTrustMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedeemableSharesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedeemableSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_RedeemableSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaAsiaPacificPteLtdMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaAsiaPacificPteLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="ck0001859807_ProfusaAsiaPacificPteLtdMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="ck0001859807_ProfusaMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JuneJulyAndAugustExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JuneJulyAndAugustExtensionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_DepositDomainDomain" xlink:to="ck0001859807_JuneJulyAndAugustExtensionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryExtensionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_DepositDomainDomain" xlink:to="ck0001859807_JanuaryExtensionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FebruaryExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FebruaryExtensionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_DepositDomainDomain" xlink:to="ck0001859807_FebruaryExtensionMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_RightsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="3" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_CommonStockMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicSharesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001859807_PublicSharesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001859807_SponsorMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SpecialMeetingMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SpecialMeetingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="ck0001859807_SpecialMeetingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RevenueTarget" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RevenueTarget"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_RevenueTarget" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WorkingCapitalDeficit" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WorkingCapitalDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_WorkingCapitalDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TransactionCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TransactionCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_TransactionCost" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnderwritingDiscountAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderwritingDiscountAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_UnderwritingDiscountAmount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativeSharesCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativeSharesCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_RepresentativeSharesCost" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativeWarrantCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativeWarrantCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_RepresentativeWarrantCost" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OtherOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OtherOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_OtherOfferingCosts" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAggregateFairMarketValueOfAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentsForInvestmentOfCashInTrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperatingBankAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingBankAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_OperatingBankAccount" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MaturityDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MaturityDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_MaturityDays" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentofInteresttoDistributionExpense" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentofInteresttoDistributionExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PaymentofInteresttoDistributionExpense" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WorkingCapital" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WorkingCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_WorkingCapital" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashContributionExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NoncashContributionExpense" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Deposits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Deposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Deposits" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_InterestIncomeOther" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PartnersCapitalAccountContributions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PartnersCapitalAccountContributions" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnsecuredPromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnsecuredPromissoryNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_UnsecuredPromissoryNote" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OutstandingPrincipalAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingPrincipalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_OutstandingPrincipalAmount" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" order="45" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="46" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" order="47" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExciseAndSalesTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ExciseAndSalesTaxes" order="48" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SharesRedeemedPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SharesRedeemedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_SharesRedeemedPercentage" order="49" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EstimatedInterestRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EstimatedInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_EstimatedInterestRate" order="50" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnderpaymentPenaltyRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderpaymentPenaltyRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_UnderpaymentPenaltyRate" order="51" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnpaidTotalLiabilityRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnpaidTotalLiabilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_UnpaidTotalLiabilityRate" order="52" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent" order="53" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PurchasePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PurchasePrice" order="54" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfOriginalIssuanceDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssuanceDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PercentageOfOriginalIssuanceDiscount" order="55" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Cash" order="56" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="57" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentForAdministrativeFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentForAdministrativeFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentForAdministrativeFees" order="58" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfPublicShares" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfPublicShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PercentageOfPublicShares" order="59" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedemptionPublicShares" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPublicShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_RedemptionPublicShares" order="60" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="61" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AmountDrawn" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AmountDrawn"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_AmountDrawn" order="62" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockholdersAmendmentPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockholdersAmendmentPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_StockholdersAmendmentPercentage" order="63" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfRedeemingPublicShareholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfRedeemingPublicShareholders"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_PercentageOfRedeemingPublicShareholders" order="64" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" order="65" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InterestFromTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestFromTrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_InterestFromTrustAccount" order="66" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="67" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RestrictedCash" order="68" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FundingOperatingExpenses" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FundingOperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ck0001859807_FundingOperatingExpenses" order="69" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="70" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_AssetsHeldInTrust" order="71" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" order="72" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicWarrantMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PublicWarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PrivatePlacementWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessCombinationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001859807_BusinessCombinationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="2" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalizedContractCostNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_CapitalizedContractCostNetCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeSecuritiesTaxable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeSecuritiesTaxable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_InterestIncomeSecuritiesTaxable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayableCommonStockRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayableCommonStockRedeemed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_PayableCommonStockRedeemed" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashContributionExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_NoncashContributionExpense" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperationsAndRedeemRepurchasePercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperationsAndRedeemRepurchasePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ck0001859807_OperationsAndRedeemRepurchasePercentage" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestCostsIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestCostsIncurred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_InterestCostsIncurred" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ck0001859807_OfferingCosts" order="17" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/FairValueMeasurementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="ck0001859807_FairValueMeasurementDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_FairValueMeasurementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PublicWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleDebtOfTermFairValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfTermFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="ck0001859807_ConvertibleDebtOfTermFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleDebtOfDiscountRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfDiscountRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="ck0001859807_ConvertibleDebtOfDiscountRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShorttermDebtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ShorttermDebtFairValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ConvertibleDebt" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/DebtDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_DebtDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_DebtDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesNovember2022AmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesNovember2022AmendmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_ConvertibleNotesNovember2022AmendmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TaslyConvertibleDebtMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TaslyConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_TaslyConvertibleDebtMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_SeniorNotesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_PromissoryNotesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_PaycheckProtectionProgramMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_ConvertibleNotesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShortTermLoanAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShortTermLoanAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="ck0001859807_ShortTermLoanAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnrelatedPartiesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnrelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_UnrelatedPartiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" order="3" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_ConvertibleNotesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorSecuredConvertibleNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorSecuredConvertibleNoteMember" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberDecember2024SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecember2024SeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_OctoberDecember2024SeniorNotesMember" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_PaycheckProtectionProgramLoanMember" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryMarch2024SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarch2024SeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_JanuaryMarch2024SeniorNotesMember" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryMarch2025SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarch2025SeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_JanuaryMarch2025SeniorNotesMember" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilJune2025SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilJune2025SeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_AprilJune2025SeniorNotesMember" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtInstrumentDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInstrumentDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_DebtInstrumentDiscount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DerivativeLiabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtInstrumentsContractualTerm" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInstrumentsContractualTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_DebtInstrumentsContractualTerm" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_BusinessDays" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermBorrowings" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtInterestRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_DebtInterestRate" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockConvertibleConversionPrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockConvertibleConversionPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_CommonStockConvertibleConversionPrice" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebt" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LossOnFairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LossOnFairValueRemeasurement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_LossOnFairValueRemeasurement" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleDebtOfDiscountRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfDiscountRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_ConvertibleDebtOfDiscountRate" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ExtinguishmentOfDebtAmount" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AdditionalPaidInCapital" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MaturityMonth" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MaturityMonth"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_MaturityMonth" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SeniorNotes" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNotes" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_PromissoryNotes" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtInterestRateIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtInterestRateIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermDebtInterestRateIncrease" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromShortTermDebt" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnrelatedPartyRepayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnrelatedPartyRepayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_UnrelatedPartyRepayable" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermDebtWeightedAverageInterestRate" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MonthlyPayments" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MonthlyPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_MonthlyPayments" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LatePenaltiesAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LatePenaltiesAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_LatePenaltiesAmount" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDefaultLongtermDebtAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_GainOnFairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_GainOnFairValueRemeasurement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_GainOnFairValueRemeasurement" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfAccrueInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAccrueInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_PercentageOfAccrueInterest" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="45" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest" order="46" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnpaidInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnpaidInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001859807_UnpaidInterest" order="47" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansHeldForSaleTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansHeldForSaleTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LoansHeldForSaleTerm" order="48" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_CommitmentsandContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_ExtinguishmentOfDebtAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseContractualTermAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseContractualTermDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseContractualTermDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashFeeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="ck0001859807_CashFeeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdvisoryFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdvisoryFeeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="ck0001859807_AdvisoryFeeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ArrangementFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ArrangementFeeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="ck0001859807_ArrangementFeeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="ck0001859807_SecuritiesPurchaseAgreementMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewProfusaCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewProfusaCommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewProfusaCommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShortTermLeasesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShortTermLeasesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="ck0001859807_ShortTermLeasesMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BankersAndDawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BankersAndDawsonJamesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_BankersAndDawsonJamesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IBankersMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IBankersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_IBankersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DawsonJamesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_DawsonJamesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_PrivatePlacementMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_InvestorMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_ConvertibleNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_InitialNotesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecondPurchaseMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecondPurchaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SecondPurchaseMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseAndRentalExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShortTermLeasePayments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsForRent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShortTermLeaseCost" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableLeasePayment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeasePayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_VariableLeasePayment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfDaysForUnderwriterOptions" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfDaysForUnderwriterOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_NumberOfDaysForUnderwriterOptions" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnderwritingExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_UnderwritingExpenseRatio" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnderwritingDiscountAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderwritingDiscountAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_UnderwritingDiscountAmount" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingGrossProceedPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingGrossProceedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_InitialPublicOfferingGrossProceedPercentage" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessCombinationPercentageRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationPercentageRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_BusinessCombinationPercentageRate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_CashPercentage" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EquityPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_EquityPercentage" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentDueInSecondAndThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentDueInSecondAndThirdYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OtherCommitmentDueInSecondAndThirdYear" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LockupPeriod" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LockupPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_LockupPeriod" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_Cash" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_AssetsHeldInTrust" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredLeasingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredLeasingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInDeferredLeasingFees" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsForFees" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OtherExpenses" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfNetProceeds" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfNetProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_PercentageOfNetProceeds" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WeightedAveragePricePerSharePercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WeightedAveragePricePerSharePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_WeightedAveragePricePerSharePercentage" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfTradingDay" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDay"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_NumberOfTradingDay" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CommonStockValue" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TradingPricePerShare" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TradingPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001859807_TradingPricePerShare" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LegalFees" order="44" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/ConvertiblePreferredStockDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_ConvertiblePreferredStockDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_ConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Dividends"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_Dividends" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/CommonStockDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="ck0001859807_CommonStockDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommonStockDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommonStockDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommonStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommonStockDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_CommonStockDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderShareMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_FounderShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderShares1Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShares1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_FounderShares1Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_SponsorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderSharesIssued" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="ck0001859807_FounderSharesIssued" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_VotingSharesPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_VotingSharesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="ck0001859807_VotingSharesPercentage" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsShares" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/StockOptionPlanDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ck0001859807_StockOptionPlanDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_StockOptionPlanDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EquityIncentivePlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001859807_EquityIncentivePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_Plan2018Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_Plan2018Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001859807_Plan2018Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfExcercisePriceOption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfExcercisePriceOption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ck0001859807_PercentageOfExcercisePriceOption" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_RelatedPartyTransactionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="srt_RangeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderShares1Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShares1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_FounderShares1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdministrativeSupportAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativeSupportAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_AdministrativeSupportAgreementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_SponsorMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderShareMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_FounderShareMember" order="3" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_SponsorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AscentNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AscentNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_AscentNoteMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PIPEConvertibleNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PIPEConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_PIPEConvertibleNoteMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyLoanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_RelatedPartyLoanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockExceedsPerShare" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockExceedsPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_CommonStockExceedsPerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfTradingDay" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDay"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_NumberOfTradingDay" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleWorkingCapitalPromissoryNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_ConvertibleWorkingCapitalPromissoryNote" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_NotesPayable" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfOriginalIssueDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssueDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_PercentageOfOriginalIssueDiscount" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ConvertibleDebtCurrent" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SponsorFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SponsorFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SponsorFees" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AggregateNumberOfSharesOwned" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AggregateNumberOfSharesOwned"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_AggregateNumberOfSharesOwned" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" order="29" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/IncomeTaxesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="ck0001859807_IncomeTaxesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_IncomeTaxesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_IncomeTaxesDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_IncomeTaxesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaIncMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ck0001859807_ProfusaIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ReceivedPaycheckProtectionProgramLoans" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ReceivedPaycheckProtectionProgramLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="ck0001859807_ReceivedPaycheckProtectionProgramLoans" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramLoansOutstanding" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoansOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="ck0001859807_PaycheckProtectionProgramLoansOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/SegmentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001859807_SegmentsDetailsLineItems" xlink:to="ck0001859807_SegmentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SegmentsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SegmentsDetailsLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SegmentsDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SegmentsDetailsLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001859807_SegmentsDetailsLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SubsequentEventsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ck0001859807_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="srt_OwnershipAxis" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="srt_StatementScenarioAxis" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_ConvertibleNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorConvertiblesNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorConvertiblesNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="ck0001859807_SeniorConvertiblesNotesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="ck0001859807_SecuritiesPurchaseAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MergerAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MergerAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="ck0001859807_MergerAgreementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaPreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001859807_ProfusaPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DissolutionExpenseWaiverMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DissolutionExpenseWaiverMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001859807_DissolutionExpenseWaiverMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NoRedemptionScenarioMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NoRedemptionScenarioMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001859807_NoRedemptionScenarioMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewProfusaCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewProfusaCommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001859807_NewProfusaCommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessCombinationProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationProfusaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="ck0001859807_BusinessCombinationProfusaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_SponsorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_ConvertibleNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_PromissoryNoteMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NonrecoursePromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NonrecoursePromissoryNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_NonrecoursePromissoryNotesMember" order="2" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorConvertiblesNotesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorConvertibleBridgeNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorConvertibleBridgeNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorConvertibleBridgeNotesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorSecuredConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorSecuredConvertibleNotesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorSecuredNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001859807_SeniorSecuredNoteMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfOriginalIssueDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssueDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ck0001859807_PercentageOfOriginalIssueDiscount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfNonRedeemingPublicShareholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfNonRedeemingPublicShareholders"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ck0001859807_PercentageOfNonRedeemingPublicShareholders" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ck0001859807_NumberOfTradingDays" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfLimitForOutstandingCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLimitForOutstandingCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ck0001859807_PercentageOfLimitForOutstandingCommonStock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashMergerRelatedCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NoncashMergerRelatedCosts" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity" order="30" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/InitialPublicOfferingDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_InitialPublicOfferingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_InitialPublicOfferingDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001859807_PublicWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PublicWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfSharesIssuedPerUnit" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfSharesIssuedPerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_NumberOfSharesIssuedPerUnit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EquityProceedOwnershipPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityProceedOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_EquityProceedOwnershipPercentage" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedemptionPricePerWarrant" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPricePerWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_RedemptionPricePerWarrant" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockThresholdTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockThresholdTradingDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_CommonStockThresholdTradingDays" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockThresholdConsecutiveTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockThresholdConsecutiveTradingDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ck0001859807_CommonStockThresholdConsecutiveTradingDays" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.profusa.com/role/PrivatePlacementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="ck0001859807_PrivatePlacementDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_PrivatePlacementDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_PrivatePlacementDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_PrivatePlacementDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001859807_PrivatePlacementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_SponsorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IBankersAndDawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IBankersAndDawsonJamesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ck0001859807_IBankersAndDawsonJamesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ck0001859807_PrivatePlacementWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="0" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>ck0001859807-20250630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 09 20:42:43 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Total segment expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Balance Beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance Ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Total stockholders&#8217; deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance Beginning (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance Ending (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Cash in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net (decrease) in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash at the beginning of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash at the end of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash &#8211; beginning of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl0" xml:lang="en-US">Restricted cash &#8211; end of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl1" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl2" xml:lang="en-US">Restricted Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash, end of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Measurement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Total liabilities measured at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Fair value as of beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0" xml:lang="en-US">Fair value as of Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BalanceSheetComponentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BalanceSheetComponentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BalanceSheetComponentsAbstract_lbl" xml:lang="en-US">Balance Sheet Components [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BalanceSheetComponentsAbstract" xlink:to="ck0001859807_BalanceSheetComponentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfAccruedLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Accrued Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract" xlink:to="ck0001859807_ScheduleOfAccruedLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xml:lang="en-US">Accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Balance of beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Balance of ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US">Aggregate principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl2" xml:lang="en-US">Senior secured convertible promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Total convertible notes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayable_lbl0" xml:lang="en-US">Convertible debt payable, loans and notes payable to a related party (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleNotesPayable_lbl1" xml:lang="en-US">Convertible note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ConvertibleNotesPayable_lbl2" xml:lang="en-US">Issuance amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl3" xml:lang="en-US">Convertible notes balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebt_lbl0" xml:lang="en-US">Long term debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl" xml:lang="en-US">Convertible Preferred Stock [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xml:lang="en-US">Common Stock [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ClassOfStockDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Stock Option Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecuritiesAbstract_lbl" xml:lang="en-US">Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_DilutiveSecuritiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" xml:lang="en-US">Shares of common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentAssistanceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GovernmentAssistanceAbstract_lbl" xml:lang="en-US">Government Grant Revenue [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentAssistanceAbstract" xlink:to="us-gaap_GovernmentAssistanceAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract_lbl" xml:lang="en-US">Schedule of Provision for Income Taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Current, total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred, total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other expense, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Total other (expense) income, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Fair value as of beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl0" xml:lang="en-US">Fair value as of Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xml:lang="en-US">Schedule of Contractual Future Minimum Payments for the PPP Loan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Balance, Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0" xml:lang="en-US">Ending balances Shares available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Balance, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Ending balances Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Balance, Weighted-Average Exercise Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Ending balances Weighted- average exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidationItemsAxis_lbl" xml:lang="en-US">Consolidation Items [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">Schedule of Consolidated Balance Sheet [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Contingently redeemable common stock at beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl0" xml:lang="en-US">Contingently redeemable common stock at ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl1" xml:lang="en-US">Convertible preferred stock, value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InitialPublicOfferingAbstract_lbl" xml:lang="en-US">Initial Public Offering [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingAbstract" xlink:to="ck0001859807_InitialPublicOfferingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US">Private Placement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Fair value, beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Fair value, ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl1" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl2" xml:lang="en-US">Aggregate value of public warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Fair value beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl0" xml:lang="en-US">Fair value Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl1" xml:lang="en-US">Convertible promissory note &#8211; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl2" xml:lang="en-US">Convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl3" xml:lang="en-US">Convertible Promissory Note &#8211; Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule of Net Deferred Tax Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax (liability), net of allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl0" xml:lang="en-US">Deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Total provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl" xml:lang="en-US">Schedule of Federal Income Tax Rate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective income tax rate, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xml:lang="en-US">Income for taxable percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract_lbl" xml:lang="en-US">Schedule of Company&#8217;s Performance and Making Key Decisions Regarding Resource Allocation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract" xlink:to="ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xml:lang="en-US">Schedule of Condensed Consolidated Balance Sheet [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Current Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities, convertible preferred stock, and stockholders&#8217; deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities, Redeemable Common Stock and Stockholders&#8217; Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Current Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible debt payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl0" xml:lang="en-US">Convertible loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Promissory notes payable to related parties (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_lbl0" xml:lang="en-US">Outstanding amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramLoan" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PaycheckProtectionProgramLoan_lbl" xml:lang="en-US">PPP loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoan" xlink:to="ck0001859807_PaycheckProtectionProgramLoan_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl" xml:lang="en-US">Convertible Preferred Stock:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Convertible preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Convertible preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Convertible preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl0" xml:lang="en-US">Common stock remaining outstanding after the redemption (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl1" xml:lang="en-US">Common stock subject to redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Convertible preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl0" xml:lang="en-US">Outstanding redemption share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US">Convertible preferred stock, liquidation preference (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">Total convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl0" xml:lang="en-US">Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; deficit:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&#8217; Deficit:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Aggregate share value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common stock per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, authorized shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Aggregate shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Common stock shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common stock remaining outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US">Common stock shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, convertible preferred stock and stockholders&#8217; deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AssetsAbstract0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AssetsAbstract0_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AssetsAbstract0" xlink:to="ck0001859807_AssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AssetsAbstract1" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AssetsAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AssetsAbstract1_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AssetsAbstract1" xlink:to="ck0001859807_AssetsAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidTaxes_lbl" xml:lang="en-US">Prepaid income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl" xml:lang="en-US">Cash and marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl0" xml:lang="en-US">Trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl1" xml:lang="en-US">Trust account current asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Cash and marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl0" xml:lang="en-US">Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl1" xml:lang="en-US">Fair values of investments held in the Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl2" xml:lang="en-US">Trust account noncurrent asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdvanceFromProfusa" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdvanceFromProfusa"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AdvanceFromProfusa_lbl" xml:lang="en-US">Advance from Profusa</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdvanceFromProfusa" xlink:to="ck0001859807_AdvanceFromProfusa_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Excise tax payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl0" xml:lang="en-US">Accrued accompanying balance sheet</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xml:lang="en-US">Common stock to be redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income tax payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Due to related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US">Common stock subject to possible redemption, shares redemption (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Convertible preferred stock at a par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US">Authorized to issue shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Share Issued and Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US">Preferred Stock, Shares Issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred stock shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AssetsAbstract2" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AssetsAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AssetsAbstract2_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AssetsAbstract2" xlink:to="ck0001859807_AssetsAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidFranchiseTax" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidFranchiseTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PrepaidFranchiseTax_lbl" xml:lang="en-US">Prepaid franchise tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrepaidFranchiseTax" xlink:to="ck0001859807_PrepaidFranchiseTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl" xml:lang="en-US">Securities purchase agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:to="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl0" xml:lang="en-US">Securities Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:to="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue_lbl" xml:lang="en-US">Due to redeeming stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Government grant revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl1" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expenses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0" xml:lang="en-US">Other income (expense):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" xml:lang="en-US">Other (expense) income:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on change in the fair value of related party Tasly convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseOther_lbl" xml:lang="en-US">Interest expense, related parties (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpenseOther_lbl0" xml:lang="en-US">Related parties amounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss (income) and comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net loss and comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net (loss) income per share, basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Net loss per share attributable to common stockholders &#8211; basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Net loss per share attributable to common stockholders &#8212; basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl2" xml:lang="en-US">Basic net (loss) income per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl3" xml:lang="en-US">Basic net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net (loss) income per share, Diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Net loss per share attributable to common stockholders &#8211; diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US">Net loss per share attributable to common stockholders &#8212; diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl2" xml:lang="en-US">Diluted net (loss) income per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl3" xml:lang="en-US">Diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average common shares outstanding, basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted average shares used to computing basic net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US">Weighted-average shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted-average common shares outstanding, Diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted average shares used to computing diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperatingExpensesAbstract0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingExpensesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OperatingExpensesAbstract0_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract0" xlink:to="ck0001859807_OperatingExpensesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Formation and operating costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income earned on cash held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl0" xml:lang="en-US">Interest income on cash held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl1" xml:lang="en-US">Interest earned on the Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">(Loss) income before provision for income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Options exercised Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Options exercised, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xml:lang="en-US">Stock option exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3" xml:lang="en-US">Exercised stock option (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net income (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions_lbl" xml:lang="en-US">Excise tax payable attributable to redemption of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions" xlink:to="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Non-cash interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Research personnel compensation costs, including stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_lbl" xml:lang="en-US">Proceeds from issuance of senior notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from issuance of convertible loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds received through convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from issuance of promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0" xml:lang="en-US">Supplemental disclosure of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts_lbl" xml:lang="en-US">Increase (decrease) in unpaid deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts" xlink:to="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Change in fair value of warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl1" xml:lang="en-US">Change in fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl" xml:lang="en-US">Changes in fair value of convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl0" xml:lang="en-US">Change in fair value of convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income tax payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Due to related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption_lbl" xml:lang="en-US">Cash withdrawn from Trust Account in connection with redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" xlink:to="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDecommissioningFund" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDecommissioningFund"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDecommissioningFund_lbl" xml:lang="en-US">Reimbursement of franchise and income taxes from Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDecommissioningFund" xlink:to="us-gaap_ProceedsFromDecommissioningFund_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Advance from Profusa</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ExciseTaxPayableRedemptionOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock_lbl" xml:lang="en-US">Excise tax payable attributable to redemption of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock" xlink:to="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AccretionOfCommonStockToRedemptionValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccretionOfCommonStockToRedemptionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl" xml:lang="en-US">Accretion of common stock to redemption value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AccretionOfCommonStockToRedemptionValue" xlink:to="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl0" xml:lang="en-US">Accretion of common stock to redemption value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AccretionOfCommonStockToRedemptionValue" xlink:to="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed_lbl" xml:lang="en-US">Reclassification of common stock subject to redemption to common stock to be redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" xlink:to="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement_lbl" xml:lang="en-US">Changes in fair value of securities purchase agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" xlink:to="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPaymentsDueToRedeemingStockholders"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders_lbl" xml:lang="en-US">Redemption payments due to redeeming stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders" xlink:to="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Reconciliation of Cash and Restricted Cash:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl0" xml:lang="en-US">Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December 31, 2024 and 2023, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl1" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfConvertibleNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertibleNote"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_ChangeInFairValueOfConvertibleNote_lbl" xml:lang="en-US">Change in fair value of convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfConvertibleNote" xlink:to="ck0001859807_ChangeInFairValueOfConvertibleNote_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl" xml:lang="en-US">Change in fair value of securities purchase agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:to="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl0" xml:lang="en-US">Change in fair value of securities purchase agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:to="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt_lbl" xml:lang="en-US">Gain on change in fair value of related party convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" xlink:to="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Loss on disposition of property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfSeniorDebt_lbl" xml:lang="en-US">Repayment of senior notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSeniorDebt" xlink:to="us-gaap_RepaymentsOfSeniorDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of related party promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentOfDeferredOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfDeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_PaymentOfDeferredOfferingCosts_lbl" xml:lang="en-US">Payment of deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentOfDeferredOfferingCosts" xlink:to="ck0001859807_PaymentOfDeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xml:lang="en-US">Prepaid income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xml:lang="en-US">Deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfExtensionFeeIntoTrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount_lbl" xml:lang="en-US">Payment of extension fee into Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" xlink:to="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Redemption of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes_lbl" xml:lang="en-US">Prepaid franchise taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" xlink:to="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyMember_lbl0" xml:lang="en-US">Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl0" xml:lang="en-US">Series A Convertible</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl1" xml:lang="en-US">Conversion of Series A preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl0" xml:lang="en-US">Series B Convertible</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl1" xml:lang="en-US">Conversion of Series B preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C/C-1 convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl0" xml:lang="en-US">Series C/C-1 Convertible</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl1" xml:lang="en-US">Conversion of Series C/C-1 preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember_lbl" xml:lang="en-US">Common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember_lbl0" xml:lang="en-US">Common stock subject to possible redemption [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthviewAcquisitionCorporationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthviewAcquisitionCorporationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NorthviewAcquisitionCorporationMember_lbl" xml:lang="en-US">Northview Acquisition Corporation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthviewAcquisitionCorporationMember" xlink:to="ck0001859807_NorthviewAcquisitionCorporationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl0" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockMember_lbl0" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember_lbl" xml:lang="en-US">NorthView Acquisition Corp</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthViewAcquisitionCorpMember" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember_lbl0" xml:lang="en-US">NorthView Acquisition Corp [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthViewAcquisitionCorpMember" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember_lbl1" xml:lang="en-US">NorthView [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthViewAcquisitionCorpMember" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayableFairValueDisclosure_lbl" xml:lang="en-US">Convertible Notes at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableFairValueDisclosure" xlink:to="us-gaap_NotesPayableFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LiabilitiesAbstract0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LiabilitiesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LiabilitiesAbstract0_lbl" xml:lang="en-US">Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LiabilitiesAbstract0" xlink:to="ck0001859807_LiabilitiesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US">Issuance of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest_lbl" xml:lang="en-US">Accrued stated interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl0" xml:lang="en-US">Change in fair value included in other income and gain loss on change in the fair value of Tasly convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_CondensedFinancialStatementsTextBlock_lbl" xml:lang="en-US">Balance Sheet Components</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialStatementsTextBlock" xlink:to="srt_CondensedFinancialStatementsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvanceRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvanceRoyalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdvanceRoyalties_lbl" xml:lang="en-US">Employee advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvanceRoyalties" xlink:to="us-gaap_AdvanceRoyalties_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrepaidLegal" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidLegal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PrepaidLegal_lbl" xml:lang="en-US">Prepaid legal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrepaidLegal" xlink:to="ck0001859807_PrepaidLegal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidInsurance_lbl" xml:lang="en-US">Prepaid insurance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Debt Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl0" xml:lang="en-US">Schedule of Debt Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Issuance of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl0" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StatedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_StatedInterest_lbl" xml:lang="en-US">Stated interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StatedInterest" xlink:to="ck0001859807_StatedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt discount and issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Less: Current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Payments for the Convertible Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Total future principal payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebt_lbl0" xml:lang="en-US">Total future payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ConvertibleDebt_lbl1" xml:lang="en-US">Convertible debt of issuance amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl2" xml:lang="en-US">Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl2"/>
    <loc xlink:type="locator" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl" xml:lang="en-US">Schedule of Contractual Future Minimum Payments for the PPP Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl0" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl" xml:lang="en-US">Schedule of Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:to="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US">Liquidation Preference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xml:lang="en-US">Original Issue Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl" xml:lang="en-US">Schedule of Reserved Shares of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Reserved shares of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock_lbl" xml:lang="en-US">Stock Option Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Activity Under the Plan is Set Forth</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Activity Under the Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Ending balances Weighted- average remaining contractual term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Balance, Weighted-Average Remaining Contractual Term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl" xml:lang="en-US">Options granted Shares available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl0" xml:lang="en-US">Options granted, Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options granted Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Options granted, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options granted Weighted- average exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options granted, Weighted-Average Exercise Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl" xml:lang="en-US">Options exercised Shares available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl0" xml:lang="en-US">Options exercised, Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options exercised Weighted- average exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options exercised, Weighted-Average Exercise Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl" xml:lang="en-US">Options expired Shares available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl0" xml:lang="en-US">Options expired, Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options expired Weighted- average exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options expired, Weighted-Average Exercise Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl" xml:lang="en-US">Options cancelled/forfeited Shares available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl0" xml:lang="en-US">Options cancelled/forfeited, Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options cancelled/forfeited Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Options cancelled/forfeited, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xml:lang="en-US">Cancellation shares of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl2" xml:lang="en-US">Cancellation shares of common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options cancelled/forfeited Weighted- average exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options cancelled/forfeited, Weighted-Average Exercise Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Exercisable, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable Weighted- average exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Exercisable, Weighted-Average Exercise Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Exercisable Weighted- average remaining contractual term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Exercisable, Weighted-Average Remaining Contractual Term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Vested and expected to vest Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl0" xml:lang="en-US">Vested and expected to vest, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Vested and expected to vest Weighted- average exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Vested and expected to vest, Weighted-Average Exercise Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Vested and expected to vest Weighted- average remaining contractual term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Vested and expected to vest, Weighted-Average Remaining Contractual Term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Stock Compensation Expense by Function Recognized for the Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0" xml:lang="en-US">Schedule of Stock Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Stock Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Loss Per Share Attributable To Common Stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Basic and Diluted Net (Loss) Income Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xml:lang="en-US">Schedule of Basic and Diluted Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentAssistanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GovernmentAssistanceTextBlock_lbl" xml:lang="en-US">Government Grant Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentAssistanceTextBlock" xlink:to="us-gaap_GovernmentAssistanceTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Reconciliation of the Federal Income Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Tax benefit at U.S. federal statutory rate, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Statutory federal income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US">Percentage of excise tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Tax benefit at U.S. federal statutory rate, amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State Tax, net of federal benefit, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State Tax, net of federal benefit, amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">State</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent difference, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Permanent difference, amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Prior-Year deferred taxes adjustment, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl0" xml:lang="en-US">Prior Year Trueup</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Prior-Year deferred taxes adjustment, amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change of valuation allowance, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change of valuation allowance, amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" xlink:to="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingenciesOther_lbl" xml:lang="en-US">Effective income tax rate, amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingenciesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Provision for Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0" xml:lang="en-US">Schedule of Income Tax Provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Current:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl0" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Deferred:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Net Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DeferredTaxAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsAbstract" xlink:to="ck0001859807_DeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses &amp; other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsDepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DeferredTaxAssetsConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DeferredTaxAssetsConvertibleDebt_lbl" xml:lang="en-US">Convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsConvertibleDebt" xlink:to="ck0001859807_DeferredTaxAssetsConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Capitalized R&amp;D</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0" xml:lang="en-US">Organizational costs/Startup expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">R&amp;D credit carryforward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl0" xml:lang="en-US">Research credit carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl" xml:lang="en-US">Schedule of Other Financial Information Regarding The Company&#8217;s Operating Segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl0" xml:lang="en-US">Schedule of Consolidated Condensed Financial Statements of Operating Segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperatingExpensesAbstract1" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingExpensesAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OperatingExpensesAbstract1_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract1" xlink:to="ck0001859807_OperatingExpensesAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research personnel compensation costs, including stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCostAndExpenseOperating_lbl" xml:lang="en-US">CRO and regulatory costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation_lbl" xml:lang="en-US">Administrative personnel compensation costs, including stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:to="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RentAndOfficeCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RentAndOfficeCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RentAndOfficeCosts_lbl" xml:lang="en-US">Rent and office costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RentAndOfficeCosts" xlink:to="ck0001859807_RentAndOfficeCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LegalAndAccountingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LegalAndAccountingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LegalAndAccountingCosts_lbl" xml:lang="en-US">Legal and accounting costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LegalAndAccountingCosts" xlink:to="ck0001859807_LegalAndAccountingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherExpenses_lbl0" xml:lang="en-US">Other exepnses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OtherIncomeExpensesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OtherIncomeExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OtherIncomeExpensesAbstract_lbl" xml:lang="en-US">Other income (expenses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OtherIncomeExpensesAbstract" xlink:to="ck0001859807_OtherIncomeExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LiabilitiesAbstract1" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LiabilitiesAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LiabilitiesAbstract1_lbl" xml:lang="en-US">Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LiabilitiesAbstract1" xlink:to="ck0001859807_LiabilitiesAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LiabilitiesAbstract2" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LiabilitiesAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LiabilitiesAbstract2_lbl" xml:lang="en-US">Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LiabilitiesAbstract2" xlink:to="ck0001859807_LiabilitiesAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnlabeledAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnlabeledAbstract" xlink:to="ck0001859807_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">As of June 30, 2025 (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xml:lang="en-US">2025 (remainder)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperatingExpensesAbstract2" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingExpensesAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OperatingExpensesAbstract2_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract2" xlink:to="ck0001859807_OperatingExpensesAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperatingExpensesAbstract3" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingExpensesAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OperatingExpensesAbstract3_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract3" xlink:to="ck0001859807_OperatingExpensesAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US">Shedule of Fair Value of Investments Held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xml:lang="en-US">Fair values of investments held in the Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl0" xml:lang="en-US">Cash and marketable securities held in trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract_lbl" xml:lang="en-US">Basic and diluted net (loss) income per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract" xlink:to="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityNetIncome_lbl" xml:lang="en-US">Allocation of net (loss) income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNetIncome" xlink:to="us-gaap_TemporaryEquityNetIncome_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityNetIncome_lbl0" xml:lang="en-US">Allocation of net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNetIncome" xlink:to="us-gaap_TemporaryEquityNetIncome_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of Consolidated Balance Sheet</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Condensed Consolidated Balance Sheet</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LessAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LessAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LessAbstract_lbl" xml:lang="en-US">Less:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract" xlink:to="ck0001859807_LessAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PlusAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PlusAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PlusAbstract_lbl" xml:lang="en-US">Plus:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract" xlink:to="ck0001859807_PlusAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xml:lang="en-US">Accretion of redeemable common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0" xml:lang="en-US">Aggregate redemption amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LessAbstract0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LessAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LessAbstract0_lbl" xml:lang="en-US">Less:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract0" xlink:to="ck0001859807_LessAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PlusAbstract0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PlusAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PlusAbstract0_lbl" xml:lang="en-US">Plus:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract0" xlink:to="ck0001859807_PlusAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_InitialPublicOfferingTextBlock_lbl" xml:lang="en-US">Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingTextBlock" xlink:to="ck0001859807_InitialPublicOfferingTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementsTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PrivatePlacementsTextBlock_lbl" xml:lang="en-US">Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementsTextBlock" xlink:to="ck0001859807_PrivatePlacementsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract_lbl" xml:lang="en-US">Input</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="us-gaap_FairValueInputsQuantitativeInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrant liabilities measurement inputs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xml:lang="en-US">Convertible promissory note measurement inputs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US">Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of Convertible Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrincipalBorrowing" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrincipalBorrowing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PrincipalBorrowing_lbl" xml:lang="en-US">Principal borrowing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrincipalBorrowing" xlink:to="ck0001859807_PrincipalBorrowing_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax asset/(liability)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_lbl" xml:lang="en-US">Business combination expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate_lbl" xml:lang="en-US">Penalties and interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" xlink:to="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of Company&#8217;s Performance and Making Key Decisions Regarding Resource Allocation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BasicAndDilutedNetLossPerShareAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BasicAndDilutedNetLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BasicAndDilutedNetLossPerShareAbstract_lbl" xml:lang="en-US">Basic and diluted net loss per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BasicAndDilutedNetLossPerShareAbstract" xlink:to="ck0001859807_BasicAndDilutedNetLossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LessAbstract1" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LessAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LessAbstract1_lbl" xml:lang="en-US">Less:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract1" xlink:to="ck0001859807_LessAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PlusAbstract1" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PlusAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PlusAbstract1_lbl" xml:lang="en-US">Plus:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract1" xlink:to="ck0001859807_PlusAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LessAbstract2" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LessAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LessAbstract2_lbl" xml:lang="en-US">Less:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract2" xlink:to="ck0001859807_LessAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PlusAbstract2" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PlusAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PlusAbstract2_lbl" xml:lang="en-US">Plus:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract2" xlink:to="ck0001859807_PlusAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LessAbstract3" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LessAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LessAbstract3_lbl" xml:lang="en-US">Less:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract3" xlink:to="ck0001859807_LessAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US">Redemption payment due to stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PlusAbstract3" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PlusAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PlusAbstract3_lbl" xml:lang="en-US">Plus:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract3" xlink:to="ck0001859807_PlusAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeSecuritiesOtherUSGovernment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeSecuritiesOtherUSGovernment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeSecuritiesOtherUSGovernment_lbl" xml:lang="en-US">Interest earned on the Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeSecuritiesOtherUSGovernment" xlink:to="us-gaap_InterestIncomeSecuritiesOtherUSGovernment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" xml:lang="en-US">Accrued compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Debt repayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl0" xml:lang="en-US">Repaid amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueRemeasurement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_FairValueRemeasurement_lbl" xml:lang="en-US">Add: fair value remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueRemeasurement" xlink:to="ck0001859807_FairValueRemeasurement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ck0001859807_FairValueRemeasurement_lbl0" xml:lang="en-US">Less: fair value remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueRemeasurement" xlink:to="ck0001859807_FairValueRemeasurement_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xml:lang="en-US">Add (less): unamortized debt (premium) discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl0" xml:lang="en-US">Less: unamortized debt discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InterestExpensesNotesPayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestExpensesNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ck0001859807_InterestExpensesNotesPayable_lbl" xml:lang="en-US">Less: interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InterestExpensesNotesPayable" xlink:to="ck0001859807_InterestExpensesNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Options expired Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl0" xml:lang="en-US">Options expired, Number of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedemptionPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedemptionPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RedemptionPremium_lbl" xml:lang="en-US">Partial redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedemptionPremium" xlink:to="us-gaap_RedemptionPremium_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl" xml:lang="en-US">Unrealized gain/loss - Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ProfusaMember_lbl" xml:lang="en-US">Profusa [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaMember" xlink:to="ck0001859807_ProfusaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Quoted Prices In Active Markets (Level 1) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl0" xml:lang="en-US">Significant Other Observable Inputs (Level 2) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl0" xml:lang="en-US">Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl1" xml:lang="en-US">Significant Other Unobservable Inputs (Level 3) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl2" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl2"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleNotesMember" xlink:to="ck0001859807_ConvertibleNotesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ConvertibleNotesMember_lbl0" xml:lang="en-US">Tasly Convertible Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleNotesMember" xlink:to="ck0001859807_ConvertibleNotesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TaslyConvertibleDebtMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TaslyConvertibleDebtMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_TaslyConvertibleDebtMember_lbl" xml:lang="en-US">Tasly Convertible Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TaslyConvertibleDebtMember" xlink:to="ck0001859807_TaslyConvertibleDebtMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeniorNoteMember_lbl" xml:lang="en-US">Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorNoteMember" xlink:to="ck0001859807_SeniorNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PromissoryNotesMember_lbl" xml:lang="en-US">Promissory Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PromissoryNotesMember" xlink:to="ck0001859807_PromissoryNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PPPLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PPPLoanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PPPLoanMember_lbl" xml:lang="en-US">PPP Loan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PPPLoanMember" xlink:to="ck0001859807_PPPLoanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl0" xml:lang="en-US">Convertible Notes Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl1" xml:lang="en-US">Convertible notes payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xml:lang="en-US">Tasly Convertible Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtMember_lbl0" xml:lang="en-US">Convertible Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeniorNotesMember_lbl" xml:lang="en-US">Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotesMember" xlink:to="us-gaap_SeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesAConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesAConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NewSeriesAConvertiblePreferredStockMember_lbl" xml:lang="en-US">New Series A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesAConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesAConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesBConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesBConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NewSeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US">New Series B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesBConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesBConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesCConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesCConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NewSeriesCConvertiblePreferredStockMember_lbl" xml:lang="en-US">New Series C [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesCConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesCConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesC1ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember_lbl" xml:lang="en-US">New Series C-1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Convertible preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember_lbl" xml:lang="en-US">Outstanding options under 2010 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember" xlink:to="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember_lbl" xml:lang="en-US">Issuance of options under the 2010 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" xlink:to="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General Administrative [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleLoansMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertibleLoansMember_lbl" xml:lang="en-US">Convertible Loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleLoansMember" xlink:to="ck0001859807_ConvertibleLoansMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ConvertibleLoansMember_lbl0" xml:lang="en-US">Convertible loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleLoansMember" xlink:to="ck0001859807_ConvertibleLoansMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OptionsToPurchaseCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OptionsToPurchaseCommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OptionsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Options to Purchase Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OptionsToPurchaseCommonStockMember" xlink:to="ck0001859807_OptionsToPurchaseCommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_OptionsToPurchaseCommonStockMember_lbl0" xml:lang="en-US">Options to purchase common stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OptionsToPurchaseCommonStockMember" xlink:to="ck0001859807_OptionsToPurchaseCommonStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeriesCC1PreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeriesCC1PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeriesCC1PreferredStockMember_lbl" xml:lang="en-US">Conversion of Series C/C-1 preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeriesCC1PreferredStockMember" xlink:to="ck0001859807_SeriesCC1PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xml:lang="en-US">Operating Segments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashMember_lbl" xml:lang="en-US">Cash [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US">U.S. Treasury Bills [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetHeldInTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetHeldInTrustMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetHeldInTrustMember_lbl" xml:lang="en-US">Trust Account [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetHeldInTrustMember" xlink:to="us-gaap_AssetHeldInTrustMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember_lbl" xml:lang="en-US">Cash and marketable securities held in trust [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember" xlink:to="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PublicWarrantsMember_lbl" xml:lang="en-US">Warrant liabilities &#8211; Public Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicWarrantsMember" xlink:to="ck0001859807_PublicWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_PublicWarrantsMember_lbl0" xml:lang="en-US">Public Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicWarrantsMember" xlink:to="ck0001859807_PublicWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US">Warrant liabilities &#8211; Private Placement Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementWarrantsMember" xlink:to="ck0001859807_PrivatePlacementWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_PrivatePlacementWarrantsMember_lbl0" xml:lang="en-US">Private Placement Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementWarrantsMember" xlink:to="ck0001859807_PrivatePlacementWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RepresentativesWarrantsMember_lbl" xml:lang="en-US">Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativesWarrantsMember" xlink:to="ck0001859807_RepresentativesWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_RepresentativesWarrantsMember_lbl0" xml:lang="en-US">Representative&#8217;s Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativesWarrantsMember" xlink:to="ck0001859807_RepresentativesWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Convertible Promissory Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember_lbl0" xml:lang="en-US">Convertible promissory note &#8211; Related party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember_lbl1" xml:lang="en-US">Convertible promissory note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Risk-free interest rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Expected term (years) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Expected volatility [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExercisePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Exercise price [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Fair value of Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WarrantLiabilityMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_WarrantLiabilityMember_lbl" xml:lang="en-US">Warrant Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WarrantLiabilityMember" xlink:to="ck0001859807_WarrantLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ChiefOperatingOfficerDecisionMakerMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChiefOperatingOfficerDecisionMakerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ChiefOperatingOfficerDecisionMakerMember_lbl" xml:lang="en-US">Chief Operating Officer Decision Maker [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChiefOperatingOfficerDecisionMakerMember" xlink:to="ck0001859807_ChiefOperatingOfficerDecisionMakerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteAscentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteAscentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertiblePromissoryNoteAscentMember_lbl" xml:lang="en-US">Convertible promissory note &#8211; Ascent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteAscentMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteAscentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WarrantsLiabilityMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantsLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_WarrantsLiabilityMember_lbl" xml:lang="en-US">Warrant Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WarrantsLiabilityMember" xlink:to="ck0001859807_WarrantsLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember_lbl" xml:lang="en-US">Convertible Promissory Note &#8211; Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementMember" xlink:to="ck0001859807_SecuritiesPurchaseAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DepositAxis" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DepositAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DepositAxis_lbl" xml:lang="en-US">Deposit [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DepositAxis" xlink:to="ck0001859807_DepositAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Combination [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAxis_lbl" xml:lang="en-US">Extinguishment of Debt [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseContractualTermAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xml:lang="en-US">Lease Contractual Term [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xml:lang="en-US">Business Combination, Contingent Consideration, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RevenueTarget" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RevenueTarget"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RevenueTarget_lbl" xml:lang="en-US">Revenue target</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RevenueTarget" xlink:to="ck0001859807_RevenueTarget_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Stockholders redeeme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Share issued amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US">Aggregate purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl2" xml:lang="en-US">Common stock aggregate value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stockholders redeemed shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Aggregate shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl2" xml:lang="en-US">Common stock shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl2"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WorkingCapitalDeficit" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WorkingCapitalDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WorkingCapitalDeficit" xlink:to="ck0001859807_WorkingCapitalDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl" xml:lang="en-US">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PurchasePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PurchasePrice_lbl" xml:lang="en-US">Purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PurchasePrice" xlink:to="ck0001859807_PurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfOriginalIssuanceDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssuanceDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfOriginalIssuanceDiscount_lbl" xml:lang="en-US">Percentage of original issuance discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfOriginalIssuanceDiscount" xlink:to="ck0001859807_PercentageOfOriginalIssuanceDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentForAdministrativeFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentForAdministrativeFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentForAdministrativeFees_lbl" xml:lang="en-US">Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForAdministrativeFees" xlink:to="us-gaap_PaymentForAdministrativeFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Units issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Issuance of warrant (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US">Warrant price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2" xml:lang="en-US">Warrant exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl3" xml:lang="en-US">Price per warrant (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sold at a price per Unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Common stock price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Cash proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Generating gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0" xml:lang="en-US">Generating proceeds of private placement (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TransactionCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TransactionCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_TransactionCost_lbl" xml:lang="en-US">Transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TransactionCost" xlink:to="ck0001859807_TransactionCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnderwritingDiscountAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderwritingDiscountAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnderwritingDiscountAmount_lbl" xml:lang="en-US">Underwriting discount amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnderwritingDiscountAmount" xlink:to="ck0001859807_UnderwritingDiscountAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativeSharesCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativeSharesCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RepresentativeSharesCost_lbl" xml:lang="en-US">Represent shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativeSharesCost" xlink:to="ck0001859807_RepresentativeSharesCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RepresentativeWarrantCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativeWarrantCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RepresentativeWarrantCost_lbl" xml:lang="en-US">Representative warrants cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativeWarrantCost" xlink:to="ck0001859807_RepresentativeWarrantCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OtherOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OtherOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OtherOfferingCosts_lbl" xml:lang="en-US">Other offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OtherOfferingCosts" xlink:to="ck0001859807_OtherOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAggregateFairMarketValueOfAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset_lbl" xml:lang="en-US">Percentage of aggregate fair market value of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset" xlink:to="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum_lbl" xml:lang="en-US">Ownership interest to be acquired on post-transaction company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" xlink:to="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentsForInvestmentOfCashInTrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount_lbl" xml:lang="en-US">Investment of cash in trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Common stock price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl1" xml:lang="en-US">Price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperatingBankAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingBankAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OperatingBankAccount_lbl" xml:lang="en-US">Operating bank account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingBankAccount" xlink:to="ck0001859807_OperatingBankAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MaturityDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MaturityDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_MaturityDays_lbl" xml:lang="en-US">Maturity days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MaturityDays" xlink:to="ck0001859807_MaturityDays_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl" xml:lang="en-US">Redeem public shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:to="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaymentofInteresttoDistributionExpense" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentofInteresttoDistributionExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PaymentofInteresttoDistributionExpense_lbl" xml:lang="en-US">Interest expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentofInteresttoDistributionExpense" xlink:to="ck0001859807_PaymentofInteresttoDistributionExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Common stock redeemed (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl0" xml:lang="en-US">Common stock shares redeemed (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl" xml:lang="en-US">Trust account to redeeming stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WorkingCapital" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WorkingCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_WorkingCapital_lbl" xml:lang="en-US">Convertible working capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WorkingCapital" xlink:to="ck0001859807_WorkingCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashContributionExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashContributionExpense_lbl" xml:lang="en-US">Contribution amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashContributionExpense" xlink:to="us-gaap_NoncashContributionExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Deposits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Deposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Deposits_lbl" xml:lang="en-US">Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeOther_lbl" xml:lang="en-US">Lost interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl" xml:lang="en-US">Net tangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:to="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PartnersCapitalAccountContributions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PartnersCapitalAccountContributions_lbl" xml:lang="en-US">Capital contribution</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountContributions" xlink:to="us-gaap_PartnersCapitalAccountContributions_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnsecuredPromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnsecuredPromissoryNote"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnsecuredPromissoryNote_lbl" xml:lang="en-US">Unsecured promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnsecuredPromissoryNote" xlink:to="ck0001859807_UnsecuredPromissoryNote_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xml:lang="en-US">Warrants price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OutstandingPrincipalAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingPrincipalAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OutstandingPrincipalAmount_lbl" xml:lang="en-US">Outstanding principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OutstandingPrincipalAmount" xlink:to="ck0001859807_OutstandingPrincipalAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_lbl" xml:lang="en-US">Percentage of fair market value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Redemption amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl0" xml:lang="en-US">Aggregate redeemed amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Stockholders&#8217; deficit of excise tax payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExciseAndSalesTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExciseAndSalesTaxes_lbl" xml:lang="en-US">Excise tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExciseAndSalesTaxes" xlink:to="us-gaap_ExciseAndSalesTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SharesRedeemedPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SharesRedeemedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SharesRedeemedPercentage_lbl" xml:lang="en-US">Shares redeemed percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SharesRedeemedPercentage" xlink:to="ck0001859807_SharesRedeemedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EstimatedInterestRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EstimatedInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_EstimatedInterestRate_lbl" xml:lang="en-US">Percentage of estimated interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EstimatedInterestRate" xlink:to="ck0001859807_EstimatedInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnderpaymentPenaltyRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderpaymentPenaltyRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnderpaymentPenaltyRate_lbl" xml:lang="en-US">Percentage of underpayment penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnderpaymentPenaltyRate" xlink:to="ck0001859807_UnderpaymentPenaltyRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnpaidTotalLiabilityRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnpaidTotalLiabilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnpaidTotalLiabilityRate_lbl" xml:lang="en-US">Percentage of unpaid total liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnpaidTotalLiabilityRate" xlink:to="ck0001859807_UnpaidTotalLiabilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfPublicShares" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfPublicShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfPublicShares_lbl" xml:lang="en-US">Percentage of public shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfPublicShares" xlink:to="ck0001859807_PercentageOfPublicShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedemptionPublicShares" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPublicShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RedemptionPublicShares_lbl" xml:lang="en-US">Redemption public shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPublicShares" xlink:to="ck0001859807_RedemptionPublicShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Percentage of owns outstanding common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl0" xml:lang="en-US">Ownership percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AmountDrawn" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AmountDrawn"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AmountDrawn_lbl" xml:lang="en-US">Amount drawn</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AmountDrawn" xlink:to="ck0001859807_AmountDrawn_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockholdersAmendmentPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockholdersAmendmentPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_StockholdersAmendmentPercentage_lbl" xml:lang="en-US">Stockholders amendment percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StockholdersAmendmentPercentage" xlink:to="ck0001859807_StockholdersAmendmentPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfRedeemingPublicShareholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfRedeemingPublicShareholders"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfRedeemingPublicShareholders_lbl" xml:lang="en-US">Percentage of redeeming public shareholders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfRedeemingPublicShareholders" xlink:to="ck0001859807_PercentageOfRedeemingPublicShareholders_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl" xml:lang="en-US">Tax expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InterestFromTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestFromTrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_InterestFromTrustAccount_lbl" xml:lang="en-US">Interest from trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InterestFromTrustAccount" xlink:to="ck0001859807_InterestFromTrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FundingOperatingExpenses" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FundingOperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_FundingOperatingExpenses_lbl" xml:lang="en-US">Funding Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FundingOperatingExpenses" xlink:to="ck0001859807_FundingOperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrust"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xml:lang="en-US">Trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrust_lbl0" xml:lang="en-US">Asset in held in trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Interest and penalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalizedContractCostNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalizedContractCostNetCurrent_lbl" xml:lang="en-US">Offering costs capitalized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNetCurrent" xlink:to="us-gaap_CapitalizedContractCostNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OfferingCosts_lbl" xml:lang="en-US">Offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OfferingCosts" xlink:to="ck0001859807_OfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Federal depository insurance coverage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeSecuritiesTaxable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeSecuritiesTaxable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeSecuritiesTaxable_lbl" xml:lang="en-US">Interest income from trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeSecuritiesTaxable" xlink:to="us-gaap_InterestIncomeSecuritiesTaxable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayableCommonStockRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayableCommonStockRedeemed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PayableCommonStockRedeemed_lbl" xml:lang="en-US">Payable common stock redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayableCommonStockRedeemed" xlink:to="us-gaap_PayableCommonStockRedeemed_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Interest and penalties expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Issued warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0" xml:lang="en-US">Warrant issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US">Warrants issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OperationsAndRedeemRepurchasePercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperationsAndRedeemRepurchasePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OperationsAndRedeemRepurchasePercentage_lbl" xml:lang="en-US">Percentage of perations and redeem repurchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperationsAndRedeemRepurchasePercentage" xlink:to="ck0001859807_OperationsAndRedeemRepurchasePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestCostsIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestCostsIncurred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestCostsIncurred_lbl" xml:lang="en-US">Interest Costs Incurred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestCostsIncurred" xlink:to="us-gaap_InterestCostsIncurred_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleDebtOfTermFairValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfTermFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertibleDebtOfTermFairValue_lbl" xml:lang="en-US">Term of time event</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleDebtOfTermFairValue" xlink:to="ck0001859807_ConvertibleDebtOfTermFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleDebtOfDiscountRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfDiscountRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertibleDebtOfDiscountRate_lbl" xml:lang="en-US">Percentage of discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleDebtOfDiscountRate" xlink:to="ck0001859807_ConvertibleDebtOfDiscountRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ConvertibleDebtOfDiscountRate_lbl0" xml:lang="en-US">Conversion price discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleDebtOfDiscountRate" xlink:to="ck0001859807_ConvertibleDebtOfDiscountRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShorttermDebtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShorttermDebtFairValue_lbl" xml:lang="en-US">Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShorttermDebtFairValue" xlink:to="us-gaap_ShorttermDebtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xml:lang="en-US">Convertible debt fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate per year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Maturity term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentTerm_lbl0" xml:lang="en-US">Maturity of convertible note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0" xml:lang="en-US">Trust account balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl1" xml:lang="en-US">Conversion price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl2" xml:lang="en-US">Converted price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl2"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtInstrumentDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInstrumentDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DebtInstrumentDiscount_lbl" xml:lang="en-US">Percentage of discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInstrumentDiscount" xlink:to="ck0001859807_DebtInstrumentDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xml:lang="en-US">Outstanding principal percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Derivative liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtInstrumentsContractualTerm" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInstrumentsContractualTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DebtInstrumentsContractualTerm_lbl" xml:lang="en-US">Contractual term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInstrumentsContractualTerm" xlink:to="ck0001859807_DebtInstrumentsContractualTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BusinessDays_lbl" xml:lang="en-US">Business days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessDays" xlink:to="ck0001859807_BusinessDays_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xml:lang="en-US">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl0" xml:lang="en-US">Purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xml:lang="en-US">Carrying value of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Effective interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of debt discount and issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable_lbl" xml:lang="en-US">Short-term loan agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Short term borrowed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtInterestRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DebtInterestRate_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInterestRate" xlink:to="ck0001859807_DebtInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockConvertibleConversionPrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockConvertibleConversionPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CommonStockConvertibleConversionPrice_lbl" xml:lang="en-US">Conversion price of common stock (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockConvertibleConversionPrice" xlink:to="ck0001859807_CommonStockConvertibleConversionPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Accrued interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LossOnFairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LossOnFairValueRemeasurement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LossOnFairValueRemeasurement_lbl" xml:lang="en-US">Loss on fair value remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LossOnFairValueRemeasurement" xlink:to="ck0001859807_LossOnFairValueRemeasurement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xml:lang="en-US">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xml:lang="en-US">Conversion price dicount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl0" xml:lang="en-US">Original issue discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl" xml:lang="en-US">Conversion price per share of common stock (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_lbl" xml:lang="en-US">Debt extinguishment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Interest terms percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_lbl" xml:lang="en-US">Convert into new per shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:to="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MaturityMonth" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MaturityMonth"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_MaturityMonth_lbl" xml:lang="en-US">Maturity month</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MaturityMonth" xlink:to="ck0001859807_MaturityMonth_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeniorNotes_lbl" xml:lang="en-US">Senior notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotes" xlink:to="us-gaap_SeniorNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl" xml:lang="en-US">Outstanding amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNotes" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PromissoryNotes_lbl" xml:lang="en-US">Promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PromissoryNotes" xlink:to="ck0001859807_PromissoryNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtInterestRateIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtInterestRateIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermDebtInterestRateIncrease_lbl" xml:lang="en-US">Simple interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtInterestRateIncrease" xlink:to="us-gaap_ShortTermDebtInterestRateIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Borrowed amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Short-term debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnrelatedPartyRepayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnrelatedPartyRepayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnrelatedPartyRepayable_lbl" xml:lang="en-US">Unrelated party repayable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnrelatedPartyRepayable" xlink:to="ck0001859807_UnrelatedPartyRepayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermDebtWeightedAverageInterestRate_lbl" xml:lang="en-US">Annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="us-gaap_ShortTermDebtWeightedAverageInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MonthlyPayments" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MonthlyPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_MonthlyPayments_lbl" xml:lang="en-US">Monthly payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MonthlyPayments" xlink:to="ck0001859807_MonthlyPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LatePenaltiesAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LatePenaltiesAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LatePenaltiesAmount_lbl" xml:lang="en-US">Late penalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LatePenaltiesAmount" xlink:to="ck0001859807_LatePenaltiesAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDefaultLongtermDebtAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount_lbl" xml:lang="en-US">PPP loan repayment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDefaultLongtermDebtAmount" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_GainOnFairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_GainOnFairValueRemeasurement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_GainOnFairValueRemeasurement_lbl" xml:lang="en-US">Gain on fair value remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_GainOnFairValueRemeasurement" xlink:to="ck0001859807_GainOnFairValueRemeasurement_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfAccrueInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAccrueInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfAccrueInterest_lbl" xml:lang="en-US">Percentage of accrue interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAccrueInterest" xlink:to="ck0001859807_PercentageOfAccrueInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xml:lang="en-US">Accrued and unpaid interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnpaidInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnpaidInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnpaidInterest_lbl" xml:lang="en-US">Unpaid interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnpaidInterest" xlink:to="ck0001859807_UnpaidInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansHeldForSaleTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansHeldForSaleTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansHeldForSaleTerm_lbl" xml:lang="en-US">PPP loan term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansHeldForSaleTerm" xlink:to="us-gaap_LoansHeldForSaleTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseAndRentalExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Rent payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermLeasePayments_lbl" xml:lang="en-US">Variable lease costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeasePayments" xlink:to="us-gaap_ShortTermLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Lease expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Rent payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short-term leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableLeasePayment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeasePayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableLeasePayment_lbl" xml:lang="en-US">Variable lease costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeasePayment" xlink:to="us-gaap_VariableLeasePayment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Lease expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfDaysForUnderwriterOptions" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfDaysForUnderwriterOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NumberOfDaysForUnderwriterOptions_lbl" xml:lang="en-US">Number of days for underwriter options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfDaysForUnderwriterOptions" xlink:to="ck0001859807_NumberOfDaysForUnderwriterOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">units issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Units issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnderwritingExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnderwritingExpenseRatio_lbl" xml:lang="en-US">Cash underwriting discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderwritingExpenseRatio" xlink:to="us-gaap_UnderwritingExpenseRatio_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingGrossProceedPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingGrossProceedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_InitialPublicOfferingGrossProceedPercentage_lbl" xml:lang="en-US">Initial public offering gross proceed percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingGrossProceedPercentage" xlink:to="ck0001859807_InitialPublicOfferingGrossProceedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessCombinationPercentageRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationPercentageRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BusinessCombinationPercentageRate_lbl" xml:lang="en-US">Business combination percentage rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessCombinationPercentageRate" xlink:to="ck0001859807_BusinessCombinationPercentageRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CashPercentage_lbl" xml:lang="en-US">Cash percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashPercentage" xlink:to="ck0001859807_CashPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EquityPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_EquityPercentage_lbl" xml:lang="en-US">Equity percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityPercentage" xlink:to="ck0001859807_EquityPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentDueInSecondAndThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentDueInSecondAndThirdYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCommitmentDueInSecondAndThirdYear_lbl" xml:lang="en-US">Payable in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondAndThirdYear" xlink:to="us-gaap_OtherCommitmentDueInSecondAndThirdYear_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Representative shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Aggregate exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0" xml:lang="en-US">Expire term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_LockupPeriod" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LockupPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_LockupPeriod_lbl" xml:lang="en-US">Lockup period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LockupPeriod" xlink:to="ck0001859807_LockupPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl" xml:lang="en-US">Convertible note offering percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US">Payment of post combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredLeasingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredLeasingFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredLeasingFees_lbl" xml:lang="en-US">Deferred fees paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredLeasingFees" xlink:to="us-gaap_IncreaseDecreaseInDeferredLeasingFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForFees_lbl" xml:lang="en-US">Payment for fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForFees" xlink:to="us-gaap_PaymentsForFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xml:lang="en-US">Closing of business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfNetProceeds" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfNetProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfNetProceeds_lbl" xml:lang="en-US">Percentage of net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfNetProceeds" xlink:to="ck0001859807_PercentageOfNetProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xml:lang="en-US">Initial closing amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WeightedAveragePricePerSharePercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WeightedAveragePricePerSharePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_WeightedAveragePricePerSharePercentage_lbl" xml:lang="en-US">Weighted average price per share percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WeightedAveragePricePerSharePercentage" xlink:to="ck0001859807_WeightedAveragePricePerSharePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfTradingDay" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDay"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NumberOfTradingDay_lbl" xml:lang="en-US">Number of trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfTradingDay" xlink:to="ck0001859807_NumberOfTradingDay_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_TradingPricePerShare" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TradingPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_TradingPricePerShare_lbl" xml:lang="en-US">Trading price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TradingPricePerShare" xlink:to="ck0001859807_TradingPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Percentage of annul rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Dividends"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Dividends_lbl" xml:lang="en-US">Dividends declared</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Dividends" xlink:to="us-gaap_Dividends_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xml:lang="en-US">Gross offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Number of votes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockDividendsShares_lbl" xml:lang="en-US">Common stock, dividend shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsShares" xlink:to="us-gaap_CommonStockDividendsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Common stock, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderSharesIssued" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_FounderSharesIssued_lbl" xml:lang="en-US">Founder shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FounderSharesIssued" xlink:to="ck0001859807_FounderSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_VotingSharesPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_VotingSharesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_VotingSharesPercentage_lbl" xml:lang="en-US">Voting shares percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_VotingSharesPercentage" xlink:to="ck0001859807_VotingSharesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_lbl" xml:lang="en-US">Common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfExcercisePriceOption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfExcercisePriceOption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfExcercisePriceOption_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfExcercisePriceOption" xlink:to="ck0001859807_PercentageOfExcercisePriceOption_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription_lbl" xml:lang="en-US">Date of grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vest over years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Fair value of options vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Excepted term recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_lbl" xml:lang="en-US">Reserved shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Date of grant expiration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_lbl" xml:lang="en-US">Stock option grants total (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AggregateNumberOfSharesOwned" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AggregateNumberOfSharesOwned"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AggregateNumberOfSharesOwned_lbl" xml:lang="en-US">Aggregate number of shares owned (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AggregateNumberOfSharesOwned" xlink:to="ck0001859807_AggregateNumberOfSharesOwned_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Forfeiture shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockExceedsPerShare" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockExceedsPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CommonStockExceedsPerShare_lbl" xml:lang="en-US">Common stock exceeds per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockExceedsPerShare" xlink:to="ck0001859807_CommonStockExceedsPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleWorkingCapitalPromissoryNote"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNote_lbl" xml:lang="en-US">Sponsor amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleWorkingCapitalPromissoryNote" xlink:to="ck0001859807_ConvertibleWorkingCapitalPromissoryNote_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth_lbl" xml:lang="en-US">Expenses per month</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Administrative service fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl" xml:lang="en-US">Expenses incurred and paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xml:lang="en-US">Business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfOriginalIssueDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssueDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfOriginalIssueDiscount_lbl" xml:lang="en-US">Percentage of original issue discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfOriginalIssueDiscount" xlink:to="ck0001859807_PercentageOfOriginalIssueDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice_lbl" xml:lang="en-US">Percentage of lowest volume-weighted average price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" xlink:to="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SponsorFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SponsorFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SponsorFees_lbl" xml:lang="en-US">Paid costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Federal net operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US">Federal and state net operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xml:lang="en-US">Federal net operating loss not expire</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ReceivedPaycheckProtectionProgramLoans" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ReceivedPaycheckProtectionProgramLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ReceivedPaycheckProtectionProgramLoans_lbl" xml:lang="en-US">Received paycheck protection program loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ReceivedPaycheckProtectionProgramLoans" xlink:to="ck0001859807_ReceivedPaycheckProtectionProgramLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramLoansOutstanding" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoansOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PaycheckProtectionProgramLoansOutstanding_lbl" xml:lang="en-US">Paycheck protection program loans outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoansOutstanding" xlink:to="ck0001859807_PaycheckProtectionProgramLoansOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Imposes nondeductible excise tax percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment_lbl" xml:lang="en-US">Income for taxable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Operating segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xml:lang="en-US">Description of CODM</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Reportable segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xml:lang="en-US">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Converted equity valuation amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xml:lang="en-US">Vested options outstanding and exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Converted shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal_lbl" xml:lang="en-US">Repaid in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRepaidPrincipal" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashMergerRelatedCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl" xml:lang="en-US">Incentive equity value of converted share amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl" xml:lang="en-US">Shares allocated to merger consideration (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Aggregate purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock_lbl" xml:lang="en-US">Percentage of average daily traded value of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock" xlink:to="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NumberOfTradingDays_lbl" xml:lang="en-US">Number of trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfTradingDays" xlink:to="ck0001859807_NumberOfTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Net proceeds from sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xml:lang="en-US">Purchase of share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xml:lang="en-US">Earnout revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xml:lang="en-US">Payable in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfNonRedeemingPublicShareholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfNonRedeemingPublicShareholders"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfNonRedeemingPublicShareholders_lbl" xml:lang="en-US">Percentage of non-redeeming public shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfNonRedeemingPublicShareholders" xlink:to="ck0001859807_PercentageOfNonRedeemingPublicShareholders_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfLimitForOutstandingCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLimitForOutstandingCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfLimitForOutstandingCommonStock_lbl" xml:lang="en-US">Percentage of limit for outstanding common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfLimitForOutstandingCommonStock" xlink:to="ck0001859807_PercentageOfLimitForOutstandingCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfSharesIssuedPerUnit" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfSharesIssuedPerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NumberOfSharesIssuedPerUnit_lbl" xml:lang="en-US">Number of shares issued per unit (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfSharesIssuedPerUnit" xlink:to="ck0001859807_NumberOfSharesIssuedPerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Number of securities called by each warrant (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EquityProceedOwnershipPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityProceedOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_EquityProceedOwnershipPercentage_lbl" xml:lang="en-US">Total equity proceeds percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityProceedOwnershipPercentage" xlink:to="ck0001859807_EquityProceedOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl" xml:lang="en-US">Market value price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:to="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance_lbl" xml:lang="en-US">Market value percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" xlink:to="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption_lbl" xml:lang="en-US">Redemption trigger price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" xlink:to="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedemptionPricePerWarrant" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPricePerWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RedemptionPricePerWarrant_lbl" xml:lang="en-US">Redemption price per warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPricePerWarrant" xlink:to="ck0001859807_RedemptionPricePerWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption_lbl" xml:lang="en-US">Redemption period days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption" xlink:to="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders_lbl" xml:lang="en-US">Redemption period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" xlink:to="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockThresholdTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockThresholdTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CommonStockThresholdTradingDays_lbl" xml:lang="en-US">Common stock threshold trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockThresholdTradingDays" xlink:to="ck0001859807_CommonStockThresholdTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockThresholdConsecutiveTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockThresholdConsecutiveTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CommonStockThresholdConsecutiveTradingDays_lbl" xml:lang="en-US">Consecutive trading day threshold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockThresholdConsecutiveTradingDays" xlink:to="ck0001859807_CommonStockThresholdConsecutiveTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-Based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertiblePreferredStockPolicyTextBlock_lbl" xml:lang="en-US">Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePreferredStockPolicyTextBlock" xlink:to="ck0001859807_ConvertiblePreferredStockPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Government Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
<!-- [WMV6][Ye15W8ZIZ2r9TGO+ZRex5AHfFfGB07t4hXxHi/ozZUyxjsT5OripU/LXCYxUlj2sExoHxlCJOUdpdJH78BNXz5RQ4HqcUSXu+6dfSGDhsAMlqEj4RuYNSosW41kZBmNP+oVt41CKxbzgYtvilzsbl02c2WVMlcUvThR5cDMB6uqcZDAmao/4L57MzLEdGbVTntfLjgFQFkCTjNcVvyARmFEsbaJ3o1cK9WaKuKHkB9psbXfuUAQxjWHhMn8+73y6U3LBDg3eg+VVGgGQzwWRKtRPIo4diMAY47DyQUVuVHLu1Mwm2DhptzWP/C8V6MpEi/1kgNrZ] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Loss Per Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Cash Held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Convertible Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_WarrantLiabilitiesPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantLiabilitiesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_WarrantLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US">Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WarrantLiabilitiesPolicyTextBlock" xlink:to="ck0001859807_WarrantLiabilitiesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xml:lang="en-US">Common Stock Subject to Possible Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock_lbl" xml:lang="en-US">Securities Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock" xlink:to="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaAsiaPacificPteLtdMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaAsiaPacificPteLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ProfusaAsiaPacificPteLtdMember_lbl" xml:lang="en-US">Profusa Asia Pacific Pte.Ltd [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaAsiaPacificPteLtdMember" xlink:to="ck0001859807_ProfusaAsiaPacificPteLtdMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_ProfusaAsiaPacificPteLtdMember_lbl0" xml:lang="en-US">Profusa Asia Pacific Pte. Ltd [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaAsiaPacificPteLtdMember" xlink:to="ck0001859807_ProfusaAsiaPacificPteLtdMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NorthViewTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewTrustMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NorthViewTrustMember_lbl" xml:lang="en-US">NorthView Trust [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthViewTrustMember" xlink:to="ck0001859807_NorthViewTrustMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">Initial Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RightsMember_lbl" xml:lang="en-US">Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightsMember" xlink:to="us-gaap_RightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedeemableWarrantMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedeemableWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RedeemableWarrantMember_lbl" xml:lang="en-US">Redeemable Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedeemableWarrantMember" xlink:to="ck0001859807_RedeemableWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicSharesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PublicSharesMember_lbl" xml:lang="en-US">Public Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicSharesMember" xlink:to="ck0001859807_PublicSharesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_PublicSharesMember_lbl0" xml:lang="en-US">Public shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicSharesMember" xlink:to="ck0001859807_PublicSharesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JuneJulyAndAugustExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JuneJulyAndAugustExtensionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_JuneJulyAndAugustExtensionMember_lbl" xml:lang="en-US">June, July and August extension [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JuneJulyAndAugustExtensionMember" xlink:to="ck0001859807_JuneJulyAndAugustExtensionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryExtensionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_JanuaryExtensionMember_lbl" xml:lang="en-US">January Extension [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryExtensionMember" xlink:to="ck0001859807_JanuaryExtensionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SponsorMember" xlink:to="ck0001859807_SponsorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember_lbl" xml:lang="en-US">Convertible Working Capital Promissory Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember" xlink:to="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_USFederalMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_USFederalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_USFederalMember_lbl" xml:lang="en-US">U.S. Federal [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_USFederalMember" xlink:to="ck0001859807_USFederalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RedeemableSharesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedeemableSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RedeemableSharesMember_lbl" xml:lang="en-US">Redeemable Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedeemableSharesMember" xlink:to="ck0001859807_RedeemableSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FebruaryExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FebruaryExtensionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_FebruaryExtensionMember_lbl" xml:lang="en-US">February Extension [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FebruaryExtensionMember" xlink:to="ck0001859807_FebruaryExtensionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SpecialMeetingMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SpecialMeetingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SpecialMeetingMember_lbl" xml:lang="en-US">Special Meeting [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SpecialMeetingMember" xlink:to="ck0001859807_SpecialMeetingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DissolutionExpenseWaiverMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DissolutionExpenseWaiverMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DissolutionExpenseWaiverMember_lbl" xml:lang="en-US">Dissolution Expense Waiver [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DissolutionExpenseWaiverMember" xlink:to="ck0001859807_DissolutionExpenseWaiverMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember_lbl" xml:lang="en-US">Cash and Marketable Securities Held in Trust Account [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember" xlink:to="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PublicWarrantMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PublicWarrantMember_lbl" xml:lang="en-US">Public Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicWarrantMember" xlink:to="ck0001859807_PublicWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessCombinationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BusinessCombinationMember_lbl" xml:lang="en-US">Business Combination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessCombinationMember" xlink:to="ck0001859807_BusinessCombinationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US">Business Combination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0" xml:lang="en-US">Business Combination, Series of Individually Immaterial Business Combinations [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember_lbl" xml:lang="en-US">August 2020 Convertible Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember" xlink:to="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember_lbl" xml:lang="en-US">January 2021 Convertible Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember" xlink:to="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember_lbl" xml:lang="en-US">April 2021 Convertible Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember" xlink:to="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember_lbl" xml:lang="en-US">November 2022 Convertible Notes Amendment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" xlink:to="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertibleNotesNovember2022AmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesNovember2022AmendmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ConvertibleNotesNovember2022AmendmentMember_lbl" xml:lang="en-US">Convertible Notes November 2022 Amendment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleNotesNovember2022AmendmentMember" xlink:to="ck0001859807_ConvertibleNotesNovember2022AmendmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember_lbl" xml:lang="en-US">August 2021 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember" xlink:to="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember_lbl" xml:lang="en-US">December 2021 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember" xlink:to="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember_lbl" xml:lang="en-US">Senior Notes September 2022 Amendment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" xlink:to="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember_lbl0" xml:lang="en-US">Senior Notes September Two Thousand Twenty Two Amendment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" xlink:to="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember_lbl" xml:lang="en-US">October 2022 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember" xlink:to="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember_lbl" xml:lang="en-US">November 2022 Senior Notes Amendment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" xlink:to="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember_lbl" xml:lang="en-US">December 2022 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember" xlink:to="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember_lbl" xml:lang="en-US">March 2023 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember" xlink:to="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember_lbl" xml:lang="en-US">April 2023 Senior Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember" xlink:to="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember_lbl" xml:lang="en-US">October-December 2023 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" xlink:to="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember_lbl" xml:lang="en-US">January-March 2024 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember_lbl" xml:lang="en-US">April-June 2024 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember_lbl" xml:lang="en-US">July-September 2024 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorSecuredConvertibleNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredConvertibleNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeniorSecuredConvertibleNoteMember_lbl" xml:lang="en-US">Senior Secured Convertible Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorSecuredConvertibleNoteMember" xlink:to="ck0001859807_SeniorSecuredConvertibleNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember_lbl" xml:lang="en-US">October-December 2024 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_UnrelatedPartiesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnrelatedPartiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_UnrelatedPartiesMember_lbl" xml:lang="en-US">Unrelated Parties [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnrelatedPartiesMember" xlink:to="ck0001859807_UnrelatedPartiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OctoberDecember2024SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecember2024SeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_OctoberDecember2024SeniorNotesMember_lbl" xml:lang="en-US">October-December 2024 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberDecember2024SeniorNotesMember" xlink:to="ck0001859807_OctoberDecember2024SeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PaycheckProtectionProgramMember_lbl" xml:lang="en-US">Paycheck Protection Program [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramMember" xlink:to="ck0001859807_PaycheckProtectionProgramMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PaycheckProtectionProgramLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PaycheckProtectionProgramLoanMember_lbl" xml:lang="en-US">Paycheck Protection Program loan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoanMember" xlink:to="ck0001859807_PaycheckProtectionProgramLoanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShortTermLoanAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShortTermLoanAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ShortTermLoanAgreementMember_lbl" xml:lang="en-US">Short-Term Loan Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShortTermLoanAgreementMember" xlink:to="ck0001859807_ShortTermLoanAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryMarch2024SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarch2024SeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_JanuaryMarch2024SeniorNotesMember_lbl" xml:lang="en-US">January-March 2024 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryMarch2024SeniorNotesMember" xlink:to="ck0001859807_JanuaryMarch2024SeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_JanuaryMarch2025SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarch2025SeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_JanuaryMarch2025SeniorNotesMember_lbl" xml:lang="en-US">January-March 2025 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryMarch2025SeniorNotesMember" xlink:to="ck0001859807_JanuaryMarch2025SeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AprilJune2025SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilJune2025SeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AprilJune2025SeniorNotesMember_lbl" xml:lang="en-US">April &#8212; June 2025 Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilJune2025SeniorNotesMember" xlink:to="ck0001859807_AprilJune2025SeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermDebtMember_lbl" xml:lang="en-US">Short-Term Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtMember" xlink:to="us-gaap_ShortTermDebtMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ShortTermLeasesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShortTermLeasesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ShortTermLeasesMember_lbl" xml:lang="en-US">Short-Term Leases [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShortTermLeasesMember" xlink:to="ck0001859807_ShortTermLeasesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BankersAndDawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BankersAndDawsonJamesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BankersAndDawsonJamesMember_lbl" xml:lang="en-US">Bankers and Dawson James [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BankersAndDawsonJamesMember" xlink:to="ck0001859807_BankersAndDawsonJamesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ck0001859807_BankersAndDawsonJamesMember_lbl0" xml:lang="en-US">I-Bankers and Dawson James [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BankersAndDawsonJamesMember" xlink:to="ck0001859807_BankersAndDawsonJamesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IBankersMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IBankersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_IBankersMember_lbl" xml:lang="en-US">I-Bankers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IBankersMember" xlink:to="ck0001859807_IBankersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DawsonJamesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_DawsonJamesMember_lbl" xml:lang="en-US">Dawson James [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DawsonJamesMember" xlink:to="ck0001859807_DawsonJamesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CashFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashFeeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_CashFeeMember_lbl" xml:lang="en-US">Cash Fee [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashFeeMember" xlink:to="ck0001859807_CashFeeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdvisoryFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdvisoryFeeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AdvisoryFeeMember_lbl" xml:lang="en-US">Advisory Fee [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdvisoryFeeMember" xlink:to="ck0001859807_AdvisoryFeeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ArrangementFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ArrangementFeeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ArrangementFeeMember_lbl" xml:lang="en-US">Arrangement Fee [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ArrangementFeeMember" xlink:to="ck0001859807_ArrangementFeeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_InitialNotesMember_lbl" xml:lang="en-US">Initial Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialNotesMember" xlink:to="ck0001859807_InitialNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NewProfusaCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewProfusaCommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NewProfusaCommonStockMember_lbl" xml:lang="en-US">New Profusa Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewProfusaCommonStockMember" xlink:to="ck0001859807_NewProfusaCommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SecondPurchaseMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecondPurchaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SecondPurchaseMember_lbl" xml:lang="en-US">Second Purchase [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecondPurchaseMember" xlink:to="ck0001859807_SecondPurchaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderShareMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_FounderShareMember_lbl" xml:lang="en-US">Founder Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FounderShareMember" xlink:to="ck0001859807_FounderShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FounderShares1Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShares1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_FounderShares1Member_lbl" xml:lang="en-US">Founder Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FounderShares1Member" xlink:to="ck0001859807_FounderShares1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_EquityIncentivePlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_EquityIncentivePlanMember_lbl" xml:lang="en-US">Equity Incentive Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityIncentivePlanMember" xlink:to="ck0001859807_EquityIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_Plan2018Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_Plan2018Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_Plan2018Member_lbl" xml:lang="en-US">2018 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_Plan2018Member" xlink:to="ck0001859807_Plan2018Member_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyLoanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_RelatedPartyLoanMember_lbl" xml:lang="en-US">Related Party Loan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyLoanMember" xlink:to="ck0001859807_RelatedPartyLoanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AdministrativeSupportAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativeSupportAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AdministrativeSupportAgreementMember_lbl" xml:lang="en-US">Administrative Support Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdministrativeSupportAgreementMember" xlink:to="ck0001859807_AdministrativeSupportAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AscentNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AscentNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_AscentNoteMember_lbl" xml:lang="en-US">Ascent Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AscentNoteMember" xlink:to="ck0001859807_AscentNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PIPEConvertibleNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PIPEConvertibleNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PIPEConvertibleNoteMember_lbl" xml:lang="en-US">PIPE Convertible Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PIPEConvertibleNoteMember" xlink:to="ck0001859807_PIPEConvertibleNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaIncMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ProfusaIncMember_lbl" xml:lang="en-US">Profusa, Inc [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaIncMember" xlink:to="ck0001859807_ProfusaIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_CA_lbl" xml:lang="en-US">California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_MergerAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MergerAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_MergerAgreementMember_lbl" xml:lang="en-US">Merger Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MergerAgreementMember" xlink:to="ck0001859807_MergerAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_PromissoryNoteMember_lbl" xml:lang="en-US">Promissory Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PromissoryNoteMember" xlink:to="ck0001859807_PromissoryNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorConvertiblesNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorConvertiblesNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeniorConvertiblesNotesMember_lbl" xml:lang="en-US">Senior Convertibles Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorConvertiblesNotesMember" xlink:to="ck0001859807_SeniorConvertiblesNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ProfusaPreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_ProfusaPreferredStockMember_lbl" xml:lang="en-US">Profusa Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaPreferredStockMember" xlink:to="ck0001859807_ProfusaPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NonrecoursePromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NonrecoursePromissoryNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NonrecoursePromissoryNotesMember_lbl" xml:lang="en-US">Nonrecourse Promissory Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NonrecoursePromissoryNotesMember" xlink:to="ck0001859807_NonrecoursePromissoryNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorConvertibleBridgeNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorConvertibleBridgeNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeniorConvertibleBridgeNotesMember_lbl" xml:lang="en-US">Senior Convertible Bridge Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorConvertibleBridgeNotesMember" xlink:to="ck0001859807_SeniorConvertibleBridgeNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorSecuredConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredConvertibleNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeniorSecuredConvertibleNotesMember_lbl" xml:lang="en-US">Senior Secured Convertible Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorSecuredConvertibleNotesMember" xlink:to="ck0001859807_SeniorSecuredConvertibleNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SeniorSecuredNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SeniorSecuredNoteMember_lbl" xml:lang="en-US">Senior Secured Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorSecuredNoteMember" xlink:to="ck0001859807_SeniorSecuredNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_NoRedemptionScenarioMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NoRedemptionScenarioMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_NoRedemptionScenarioMember_lbl" xml:lang="en-US">No Redemption Scenario [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NoRedemptionScenarioMember" xlink:to="ck0001859807_NoRedemptionScenarioMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_BusinessCombinationProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationProfusaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_BusinessCombinationProfusaMember_lbl" xml:lang="en-US">Business Combination Profusa [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessCombinationProfusaMember" xlink:to="ck0001859807_BusinessCombinationProfusaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IBankersAndDawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IBankersAndDawsonJamesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_IBankersAndDawsonJamesMember_lbl" xml:lang="en-US">I-Bankers and Dawson James [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IBankersAndDawsonJamesMember" xlink:to="ck0001859807_IBankersAndDawsonJamesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US">Consolidated Entities [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementDomain_lbl" xml:lang="en-US">Revision of Prior Period [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable_lbl" xml:lang="en-US">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" xlink:to="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems_lbl" xml:lang="en-US">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" xlink:to="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesTable" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementTable_lbl" xml:lang="en-US">Fair Value Measurement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementTable" xlink:to="ck0001859807_FairValueMeasurementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementLineItems_lbl" xml:lang="en-US">Fair Value Measurement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementLineItems" xlink:to="ck0001859807_FairValueMeasurementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommitmentsandContingenciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommitmentsandContingenciesTable_lbl" xml:lang="en-US">Commitments and Contingencies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommitmentsandContingenciesTable" xlink:to="ck0001859807_CommitmentsandContingenciesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommitmentsandContingenciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommitmentsandContingenciesLineItems_lbl" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommitmentsandContingenciesLineItems" xlink:to="ck0001859807_CommitmentsandContingenciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockTable_lbl" xml:lang="en-US">Common Stock [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockTable" xlink:to="ck0001859807_CommonStockTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockLineItems_lbl" xml:lang="en-US">Common Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockLineItems" xlink:to="ck0001859807_CommonStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RelatedPartyTransactionsTable_lbl" xml:lang="en-US">Related Party Transactions [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionsTable" xlink:to="ck0001859807_RelatedPartyTransactionsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RelatedPartyTransactionsLineItems_lbl" xml:lang="en-US">Related Party Transactions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionsLineItems" xlink:to="ck0001859807_RelatedPartyTransactionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesTable_lbl" xml:lang="en-US">Income Taxes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesTable" xlink:to="ck0001859807_IncomeTaxesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesLineItems_lbl" xml:lang="en-US">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesLineItems" xlink:to="ck0001859807_IncomeTaxesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SegmentsTable_lbl" xml:lang="en-US">Segments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SegmentsTable" xlink:to="ck0001859807_SegmentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SegmentsLineItems_lbl" xml:lang="en-US">Segments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SegmentsLineItems" xlink:to="ck0001859807_SegmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SubsequentEventsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SubsequentEventsTable_lbl" xml:lang="en-US">Subsequent Events [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SubsequentEventsTable" xlink:to="ck0001859807_SubsequentEventsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SubsequentEventsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SubsequentEventsLineItems_lbl" xml:lang="en-US">Subsequent Events [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SubsequentEventsLineItems" xlink:to="ck0001859807_SubsequentEventsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InitialPublicOfferingTable_lbl" xml:lang="en-US">Initial Public Offering [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingTable" xlink:to="ck0001859807_InitialPublicOfferingTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InitialPublicOfferingLineItems_lbl" xml:lang="en-US">Initial Public Offering [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingLineItems" xlink:to="ck0001859807_InitialPublicOfferingLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrivatePlacementTable_lbl" xml:lang="en-US">Private Placement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementTable" xlink:to="ck0001859807_PrivatePlacementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrivatePlacementLineItems_lbl" xml:lang="en-US">Private Placement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementLineItems" xlink:to="ck0001859807_PrivatePlacementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccountingPoliciesbyPolicyPoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable_lbl" xml:lang="en-US">Accounting Policies, by Policy (Policies) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable" xlink:to="ck0001859807_AccountingPoliciesbyPolicyPoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems_lbl" xml:lang="en-US">Accounting Policies, by Policy (Policies) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SignificantAccountingPoliciesTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SignificantAccountingPoliciesTablesTable_lbl" xml:lang="en-US">Significant Accounting Policies (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SignificantAccountingPoliciesTablesTable" xlink:to="ck0001859807_SignificantAccountingPoliciesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementTablesTable_lbl" xml:lang="en-US">Fair Value Measurement (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementTablesTable" xlink:to="ck0001859807_FairValueMeasurementTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesTablesTable_lbl" xml:lang="en-US">Income Taxes (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesTablesTable" xlink:to="ck0001859807_IncomeTaxesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SegmentsTablesTable_lbl" xml:lang="en-US">Segments (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SegmentsTablesTable" xlink:to="ck0001859807_SegmentsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US">Measurement Frequency [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable_lbl" xml:lang="en-US">Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems_lbl" xml:lang="en-US">Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:to="ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable_lbl" xml:lang="en-US">Fair Value Measurement - Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:to="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems_lbl" xml:lang="en-US">Fair Value Measurement - Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Schedule of Debt Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xml:lang="en-US">Short-Term Debt, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable_lbl" xml:lang="en-US">Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl0" xml:lang="en-US">Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable_lbl" xml:lang="en-US">Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:to="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems_lbl" xml:lang="en-US">Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockTable_lbl" xml:lang="en-US">Conversion of Stock [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_ConversionOfStockTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockLineItems_lbl" xml:lang="en-US">Schedule of Reserved Shares of Common Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConversionOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable_lbl" xml:lang="en-US">Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" xlink:to="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems_lbl" xml:lang="en-US">Schedule of Activity Under the Plan is Set Forth [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Statement of Income Location, Balance [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Schedule of Stock Compensation Expense [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US">Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xml:lang="en-US">Long-Term Debt, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Schedule of Convertible Preferred Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable_lbl" xml:lang="en-US">Stock Option Plan - Schedule of Activity Under the Plan (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" xlink:to="ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Schedule of Activity Under the Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidationItemsDomain_lbl" xml:lang="en-US">Consolidation Items [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_lbl" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_lbl" xml:lang="en-US">Schedule of Consolidated Condensed Financial Statements of Operating Segment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xml:lang="en-US">Marketable Securities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xml:lang="en-US">Shedule of Fair Value of Investments Held in Trust Account [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xml:lang="en-US">Temporary Equity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable_lbl" xml:lang="en-US">Fair Value Measurements - Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl0" xml:lang="en-US">Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xml:lang="en-US">Measurement Input Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable_lbl" xml:lang="en-US">Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_lbl" xml:lang="en-US">Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockLineItems_lbl0" xml:lang="en-US">Schedule of Convertible Promissory Note [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConversionOfStockLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable_lbl" xml:lang="en-US">Income Taxes - Schedule of Net Deferred Tax Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" xlink:to="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems_lbl" xml:lang="en-US">Income Taxes - Schedule of Net Deferred Tax Assets (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable_lbl" xml:lang="en-US">Income Taxes - Schedule of Income Tax Provision (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" xlink:to="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems_lbl" xml:lang="en-US">Income Taxes - Schedule of Income Tax Provision (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentDomain_lbl" xml:lang="en-US">Segments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedIncomeStatementTable_lbl" xml:lang="en-US">Condensed Income Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Income Statements, Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl0" xml:lang="en-US">Schedule of Fair Value of Investments Held in Trust Account [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:to="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl1" xml:lang="en-US">Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US">Financial Instruments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl0" xml:lang="en-US">Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl0" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipDomain_lbl" xml:lang="en-US">Ownership [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Combination [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DepositDomainDomain" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DepositDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DepositDomainDomain_lbl" xml:lang="en-US">DepositDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DepositDomainDomain" xlink:to="ck0001859807_DepositDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable_lbl" xml:lang="en-US">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related and Nonrelated Parties [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_FairValueMeasurementDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementDetailsTable_lbl" xml:lang="en-US">Fair Value Measurement (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementDetailsTable" xlink:to="ck0001859807_FairValueMeasurementDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl1" xml:lang="en-US">Fair Value Measurement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_DebtDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DebtDetailsTable_lbl" xml:lang="en-US">Debt (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtDetailsTable" xlink:to="ck0001859807_DebtDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl1" xml:lang="en-US">Debt [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xml:lang="en-US">Business Combination, Contingent Consideration, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain_lbl" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseContractualTermDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xml:lang="en-US">Lease Contractual Term [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommitmentsandContingenciesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommitmentsandContingenciesDetailsTable" xlink:to="ck0001859807_CommitmentsandContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertiblePreferredStockDetailsTable_lbl" xml:lang="en-US">Convertible Preferred Stock (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePreferredStockDetailsTable" xlink:to="ck0001859807_ConvertiblePreferredStockDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockLineItems_lbl0" xml:lang="en-US">Convertible Preferred Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockDetailsTable_lbl" xml:lang="en-US">Common Stock (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockDetailsTable" xlink:to="ck0001859807_CommonStockDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_CommonStockDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockDetailsLineItems_lbl" xml:lang="en-US">Common Stock (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockDetailsLineItems" xlink:to="ck0001859807_CommonStockDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_StockOptionPlanDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_StockOptionPlanDetailsTable_lbl" xml:lang="en-US">Stock Option Plan (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StockOptionPlanDetailsTable" xlink:to="ck0001859807_StockOptionPlanDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Stock Option Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RelatedPartyTransactionsDetailsTable_lbl" xml:lang="en-US">Related Party Transactions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsTable" xlink:to="ck0001859807_RelatedPartyTransactionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RelatedPartyTransactionsDetailsLineItems_lbl" xml:lang="en-US">Related Party Transactions (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionsDetailsLineItems" xlink:to="ck0001859807_RelatedPartyTransactionsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_IncomeTaxesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxesDetailsTable_lbl" xml:lang="en-US">Income Taxes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxesDetailsTable" xlink:to="ck0001859807_IncomeTaxesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xml:lang="en-US">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SegmentsDetailsTable_lbl" xml:lang="en-US">Segments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SegmentsDetailsTable" xlink:to="ck0001859807_SegmentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SegmentsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SegmentsDetailsLineItems_lbl" xml:lang="en-US">Segments (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SegmentsDetailsLineItems" xlink:to="ck0001859807_SegmentsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_SubsequentEventsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SubsequentEventsDetailsTable" xlink:to="ck0001859807_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Events [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_InitialPublicOfferingDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InitialPublicOfferingDetailsTable_lbl" xml:lang="en-US">Initial Public Offering (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingDetailsTable" xlink:to="ck0001859807_InitialPublicOfferingDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfStockLineItems_lbl1" xml:lang="en-US">Initial Public Offering [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_PrivatePlacementDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrivatePlacementDetailsTable_lbl" xml:lang="en-US">Private Placement (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementDetailsTable" xlink:to="ck0001859807_PrivatePlacementDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Private Placement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl1" xml:lang="en-US">Accretion of common stock to redemption value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AccretionOfCommonStockToRedemptionValue" xlink:to="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation_lbl0" xml:lang="en-US">The amount of administrative personnel compensation costs, including stock-based compensation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:to="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_AdvanceFromProfusa_lbl0" xml:lang="en-US">Advance from Profusa amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdvanceFromProfusa" xlink:to="ck0001859807_AdvanceFromProfusa_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_AggregateNumberOfSharesOwned_lbl0" xml:lang="en-US">The number of shares owned by the founders after the impact of the stock dividend.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AggregateNumberOfSharesOwned" xlink:to="ck0001859807_AggregateNumberOfSharesOwned_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_AmountDrawn_lbl0" xml:lang="en-US">Amount drawn.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AmountDrawn" xlink:to="ck0001859807_AmountDrawn_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum_lbl0" xml:lang="en-US">Percentage of voting equity interests to be acquired on post transaction in the business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" xlink:to="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_BusinessCombinationPercentageRate_lbl0" xml:lang="en-US">Business combination percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessCombinationPercentageRate" xlink:to="ck0001859807_BusinessCombinationPercentageRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_BusinessDays_lbl0" xml:lang="en-US">Business days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessDays" xlink:to="ck0001859807_BusinessDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_CashPercentage_lbl0" xml:lang="en-US">Cash percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashPercentage" xlink:to="ck0001859807_CashPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption_lbl0" xml:lang="en-US">Cash withdrawn from Trust Account in connection with redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" xlink:to="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ChangeInFairValueOfConvertibleNote_lbl0" xml:lang="en-US">Amount of change in fair value of convertible note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfConvertibleNote" xlink:to="ck0001859807_ChangeInFairValueOfConvertibleNote_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl1" xml:lang="en-US">The amount of change in fair value of convertible promissory note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl1" xml:lang="en-US">Represents the amount of change in fair value of securities purchase agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:to="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement_lbl0" xml:lang="en-US">Represents the amount of changes in fair value of securities purchase agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" xlink:to="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption_lbl0" xml:lang="en-US">Trigger share price of warrants or rights for redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" xlink:to="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_CommonStockConvertibleConversionPrice_lbl0" xml:lang="en-US">Per share conversion price of common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockConvertibleConversionPrice" xlink:to="ck0001859807_CommonStockConvertibleConversionPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_CommonStockExceedsPerShare_lbl0" xml:lang="en-US">Common stock exceeds per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockExceedsPerShare" xlink:to="ck0001859807_CommonStockExceedsPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_CommonStockThresholdConsecutiveTradingDays_lbl0" xml:lang="en-US">Common stock threshold consecutive trading days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockThresholdConsecutiveTradingDays" xlink:to="ck0001859807_CommonStockThresholdConsecutiveTradingDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_CommonStockThresholdTradingDays_lbl0" xml:lang="en-US">Common stock, threshold trading days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockThresholdTradingDays" xlink:to="ck0001859807_CommonStockThresholdTradingDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl0" xml:lang="en-US">Amount of net tangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:to="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ConvertibleDebtOfDiscountRate_lbl1" xml:lang="en-US">Percentage of convertible debt of discount rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleDebtOfDiscountRate" xlink:to="ck0001859807_ConvertibleDebtOfDiscountRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ConvertibleDebtOfTermFairValue_lbl0" xml:lang="en-US">Convertible debt of term fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleDebtOfTermFairValue" xlink:to="ck0001859807_ConvertibleDebtOfTermFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ConvertiblePreferredStockPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePreferredStockPolicyTextBlock" xlink:to="ck0001859807_ConvertiblePreferredStockPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNote_lbl0" xml:lang="en-US">Convertible working capital promissory note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleWorkingCapitalPromissoryNote" xlink:to="ck0001859807_ConvertibleWorkingCapitalPromissoryNote_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_DebtInstrumentDiscount_lbl0" xml:lang="en-US">Percentage of debt instrument discount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInstrumentDiscount" xlink:to="ck0001859807_DebtInstrumentDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_DebtInstrumentsContractualTerm_lbl0" xml:lang="en-US">Debt instruments contractual Term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInstrumentsContractualTerm" xlink:to="ck0001859807_DebtInstrumentsContractualTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_DebtInterestRate_lbl0" xml:lang="en-US">The loans bear interest at a stated rate per annum.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInterestRate" xlink:to="ck0001859807_DebtInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_DeferredTaxAssetsConvertibleDebt_lbl0" xml:lang="en-US">Amount of the difference between reported convertible debt.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsConvertibleDebt" xlink:to="ck0001859807_DeferredTaxAssetsConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization_lbl0" xml:lang="en-US">Amount of the difference between reported depreciation and amortization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate_lbl0" xml:lang="en-US">Penalties and interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" xlink:to="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for emerging growth company status.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_EquityPercentage_lbl0" xml:lang="en-US">Equity percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityPercentage" xlink:to="ck0001859807_EquityPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_EquityProceedOwnershipPercentage_lbl0" xml:lang="en-US">The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityProceedOwnershipPercentage" xlink:to="ck0001859807_EquityProceedOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_EstimatedInterestRate_lbl0" xml:lang="en-US">Percentage of estimated interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EstimatedInterestRate" xlink:to="ck0001859807_EstimatedInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions_lbl0" xml:lang="en-US">Excise tax on stock redemptions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions" xlink:to="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock_lbl0" xml:lang="en-US">Excise tax payable attributable to redemption of common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock" xlink:to="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US">Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity&apos;s own assumption about the assumptions market participants would use in pricing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest_lbl0" xml:lang="en-US">The amount of accrued stated interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_FairValueRemeasurement_lbl1" xml:lang="en-US">Amount of fair value measurement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueRemeasurement" xlink:to="ck0001859807_FairValueRemeasurement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_FounderSharesIssued_lbl0" xml:lang="en-US">Founder Shares issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FounderSharesIssued" xlink:to="ck0001859807_FounderSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_FundingOperatingExpenses_lbl0" xml:lang="en-US">Funding Operating Expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FundingOperatingExpenses" xlink:to="ck0001859807_FundingOperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt_lbl0" xml:lang="en-US">Gain (loss) on change in fair value of related party convertible debt.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" xlink:to="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_GainOnFairValueRemeasurement_lbl0" xml:lang="en-US">Amount of recognized gain from the hedging ineffectiveness of a fair value hedge.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_GainOnFairValueRemeasurement" xlink:to="ck0001859807_GainOnFairValueRemeasurement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" xlink:to="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes_lbl0" xml:lang="en-US">Represents the amount of prepaid franchise taxes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" xlink:to="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts_lbl0" xml:lang="en-US">Increase (decrease) in unpaid deferred offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts" xlink:to="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_InitialPublicOfferingGrossProceedPercentage_lbl0" xml:lang="en-US">Initial public offering gross proceed percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingGrossProceedPercentage" xlink:to="ck0001859807_InitialPublicOfferingGrossProceedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_InterestExpensesNotesPayable_lbl0" xml:lang="en-US">Represent the amount of interest expenses notes payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InterestExpensesNotesPayable" xlink:to="ck0001859807_InterestExpensesNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_InterestFromTrustAccount_lbl0" xml:lang="en-US">Interest from trust account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InterestFromTrustAccount" xlink:to="ck0001859807_InterestFromTrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_LatePenaltiesAmount_lbl0" xml:lang="en-US">Late penalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LatePenaltiesAmount" xlink:to="ck0001859807_LatePenaltiesAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_LegalAndAccountingCosts_lbl0" xml:lang="en-US">The amount of legal and accounting costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LegalAndAccountingCosts" xlink:to="ck0001859807_LegalAndAccountingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_LockupPeriod_lbl0" xml:lang="en-US">Represents the lockup period for the registration statement of IPO.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LockupPeriod" xlink:to="ck0001859807_LockupPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_LossOnFairValueRemeasurement_lbl0" xml:lang="en-US">Amount of recognized loss from the hedging ineffectiveness of a fair value hedge.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LossOnFairValueRemeasurement" xlink:to="ck0001859807_LossOnFairValueRemeasurement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_MaturityDays_lbl0" xml:lang="en-US">United States government treasury bills with a maturity days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MaturityDays" xlink:to="ck0001859807_MaturityDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_MaturityMonth_lbl0" xml:lang="en-US">Maturity month</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MaturityMonth" xlink:to="ck0001859807_MaturityMonth_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders_lbl0" xml:lang="en-US">Minimum threshold price of common stock specified to send notice of redemption to the warrant holders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" xlink:to="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_MonthlyPayments_lbl0" xml:lang="en-US">Monthly payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MonthlyPayments" xlink:to="ck0001859807_MonthlyPayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_NumberOfDaysForUnderwriterOptions_lbl0" xml:lang="en-US">Number of days for underwriter options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfDaysForUnderwriterOptions" xlink:to="ck0001859807_NumberOfDaysForUnderwriterOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption_lbl0" xml:lang="en-US">Number of days for written notice of redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption" xlink:to="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_NumberOfSharesIssuedPerUnit_lbl0" xml:lang="en-US">Number of Shares Issued Per Unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfSharesIssuedPerUnit" xlink:to="ck0001859807_NumberOfSharesIssuedPerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_NumberOfTradingDay_lbl0" xml:lang="en-US">Number of trading days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfTradingDay" xlink:to="ck0001859807_NumberOfTradingDay_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_NumberOfTradingDays_lbl0" xml:lang="en-US">Represent the number of trading days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfTradingDays" xlink:to="ck0001859807_NumberOfTradingDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_OfferingCosts_lbl0" xml:lang="en-US">Costs incurred in connection with the offering and selling of additional partner interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OfferingCosts" xlink:to="ck0001859807_OfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_OperatingBankAccount_lbl0" xml:lang="en-US">Operating bank account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingBankAccount" xlink:to="ck0001859807_OperatingBankAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_OperationsAndRedeemRepurchasePercentage_lbl0" xml:lang="en-US">Percentage of perations and redeem repurchase.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperationsAndRedeemRepurchasePercentage" xlink:to="ck0001859807_OperationsAndRedeemRepurchasePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_OtherOfferingCosts_lbl0" xml:lang="en-US">Represent the amount of other offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OtherOfferingCosts" xlink:to="ck0001859807_OtherOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_OutstandingPrincipalAmount_lbl0" xml:lang="en-US">outstanding principal amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OutstandingPrincipalAmount" xlink:to="ck0001859807_OutstandingPrincipalAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PaycheckProtectionProgramLoan_lbl0" xml:lang="en-US">The amount of PPP loan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoan" xlink:to="ck0001859807_PaycheckProtectionProgramLoan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PaycheckProtectionProgramLoansOutstanding_lbl0" xml:lang="en-US">Paycheck protection program loans outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoansOutstanding" xlink:to="ck0001859807_PaycheckProtectionProgramLoansOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PaymentOfDeferredOfferingCosts_lbl0" xml:lang="en-US">Payment of deferred offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentOfDeferredOfferingCosts" xlink:to="ck0001859807_PaymentOfDeferredOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount_lbl0" xml:lang="en-US">Payment of extension fee into trust account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" xlink:to="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PaymentofInteresttoDistributionExpense_lbl0" xml:lang="en-US">Amount of interest to distribution expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentofInteresttoDistributionExpense" xlink:to="ck0001859807_PaymentofInteresttoDistributionExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount_lbl0" xml:lang="en-US">The amount of cash outflow for investment of cash in trust account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl0" xml:lang="en-US">Public share percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:to="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfAccrueInterest_lbl0" xml:lang="en-US">Percentage of accrue interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAccrueInterest" xlink:to="ck0001859807_PercentageOfAccrueInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset_lbl0" xml:lang="en-US">Represents the minimum percentage of aggregate fair market value of assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset" xlink:to="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock_lbl0" xml:lang="en-US">Represent the percentage of average daily traded value of common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock" xlink:to="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfExcercisePriceOption_lbl0" xml:lang="en-US">Percentage of exercise price option.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfExcercisePriceOption" xlink:to="ck0001859807_PercentageOfExcercisePriceOption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfLimitForOutstandingCommonStock_lbl0" xml:lang="en-US">Represent the percentage of limit for outstanding common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfLimitForOutstandingCommonStock" xlink:to="ck0001859807_PercentageOfLimitForOutstandingCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice_lbl0" xml:lang="en-US">Represent the percentage of Lowest volume-weighted average price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" xlink:to="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfNetProceeds_lbl0" xml:lang="en-US">Percentage of net proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfNetProceeds" xlink:to="ck0001859807_PercentageOfNetProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfNonRedeemingPublicShareholders_lbl0" xml:lang="en-US">Percentage of non-redeeming public shareholders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfNonRedeemingPublicShareholders" xlink:to="ck0001859807_PercentageOfNonRedeemingPublicShareholders_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfOriginalIssuanceDiscount_lbl0" xml:lang="en-US">Percentage of original issuance discount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfOriginalIssuanceDiscount" xlink:to="ck0001859807_PercentageOfOriginalIssuanceDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfOriginalIssueDiscount_lbl0" xml:lang="en-US">The percentage of original issue discount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfOriginalIssueDiscount" xlink:to="ck0001859807_PercentageOfOriginalIssueDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfPublicShares_lbl0" xml:lang="en-US">Percentage of public shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfPublicShares" xlink:to="ck0001859807_PercentageOfPublicShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfRedeemingPublicShareholders_lbl0" xml:lang="en-US">Percentage of redeeming public shareholders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfRedeemingPublicShareholders" xlink:to="ck0001859807_PercentageOfRedeemingPublicShareholders_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance_lbl0" xml:lang="en-US">Percentage of warrant exercise price adjusted to price received in new issuance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" xlink:to="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PrepaidFranchiseTax_lbl0" xml:lang="en-US">Represents the amount of prepaid franchise tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrepaidFranchiseTax" xlink:to="ck0001859807_PrepaidFranchiseTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PrepaidLegal_lbl0" xml:lang="en-US">Prepaid legal.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrepaidLegal" xlink:to="ck0001859807_PrepaidLegal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl0" xml:lang="en-US">Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:to="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PrincipalBorrowing_lbl0" xml:lang="en-US">Principal borrowing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrincipalBorrowing" xlink:to="ck0001859807_PrincipalBorrowing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PrivatePlacementsTextBlock_lbl0" xml:lang="en-US">Private placements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementsTextBlock" xlink:to="ck0001859807_PrivatePlacementsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PromissoryNotes_lbl0" xml:lang="en-US">Promissory notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PromissoryNotes" xlink:to="ck0001859807_PromissoryNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_PurchasePrice_lbl0" xml:lang="en-US">Represent the amount of purchase price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PurchasePrice" xlink:to="ck0001859807_PurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ReceivedPaycheckProtectionProgramLoans_lbl0" xml:lang="en-US">Received paycheck protection program loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ReceivedPaycheckProtectionProgramLoans" xlink:to="ck0001859807_ReceivedPaycheckProtectionProgramLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed_lbl0" xml:lang="en-US">Reclassification of common stock subject to redemption to common stock to be redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" xlink:to="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders_lbl0" xml:lang="en-US">Redemption payments due to redeeming stockholders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders" xlink:to="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RedemptionPricePerWarrant_lbl0" xml:lang="en-US">Redemption Price Per Warrant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPricePerWarrant" xlink:to="ck0001859807_RedemptionPricePerWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RedemptionPublicShares_lbl0" xml:lang="en-US">Redemption public shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPublicShares" xlink:to="ck0001859807_RedemptionPublicShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl0" xml:lang="en-US">Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth_lbl0" xml:lang="en-US">The contractual monthly amount to be paid for support services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RentAndOfficeCosts_lbl0" xml:lang="en-US">The amount of rent and office costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RentAndOfficeCosts" xlink:to="ck0001859807_RentAndOfficeCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RepresentativeSharesCost_lbl0" xml:lang="en-US">The Represent amount of share cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativeSharesCost" xlink:to="ck0001859807_RepresentativeSharesCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RepresentativeWarrantCost_lbl0" xml:lang="en-US">The represent cost of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativeWarrantCost" xlink:to="ck0001859807_RepresentativeWarrantCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_RevenueTarget_lbl0" xml:lang="en-US">Total revenues from an insurance company&apos;s segregated group of participating or dividend-paying.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RevenueTarget" xlink:to="ck0001859807_RevenueTarget_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:to="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl1" xml:lang="en-US">Represents the amount of securities purchase agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:to="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for securities purchase agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock" xlink:to="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl1" xml:lang="en-US">he difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on Options granted, net of cancellations and forfeitures, if applicable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl1" xml:lang="en-US">The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options cancelled.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl1" xml:lang="en-US">The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options exercised.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl1" xml:lang="en-US">The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options expired.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_SharesRedeemedPercentage_lbl0" xml:lang="en-US">Percentage of shares redeemed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SharesRedeemedPercentage" xlink:to="ck0001859807_SharesRedeemedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_StatedInterest_lbl0" xml:lang="en-US">Amount of interest payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StatedInterest" xlink:to="ck0001859807_StatedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_StockholdersAmendmentPercentage_lbl0" xml:lang="en-US">Stockholders amendment percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StockholdersAmendmentPercentage" xlink:to="ck0001859807_StockholdersAmendmentPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_TradingPricePerShare_lbl0" xml:lang="en-US">Trading price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TradingPricePerShare" xlink:to="ck0001859807_TradingPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_TransactionCost_lbl0" xml:lang="en-US">Amount of transaction costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TransactionCost" xlink:to="ck0001859807_TransactionCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_UnderpaymentPenaltyRate_lbl0" xml:lang="en-US">Percentage of underpayment penalty.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnderpaymentPenaltyRate" xlink:to="ck0001859807_UnderpaymentPenaltyRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_UnderwritingDiscountAmount_lbl0" xml:lang="en-US">Amount of underwriting discount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnderwritingDiscountAmount" xlink:to="ck0001859807_UnderwritingDiscountAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Number of new units issued during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_UnpaidInterest_lbl0" xml:lang="en-US">Unpaid interest on the promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnpaidInterest" xlink:to="ck0001859807_UnpaidInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_UnpaidTotalLiabilityRate_lbl0" xml:lang="en-US">Percentage of unpaid total liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnpaidTotalLiabilityRate" xlink:to="ck0001859807_UnpaidTotalLiabilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_UnrelatedPartyRepayable_lbl0" xml:lang="en-US">Unrelated party repayable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnrelatedPartyRepayable" xlink:to="ck0001859807_UnrelatedPartyRepayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_UnsecuredPromissoryNote_lbl0" xml:lang="en-US">Unsecured promissory note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnsecuredPromissoryNote" xlink:to="ck0001859807_UnsecuredPromissoryNote_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_VotingSharesPercentage_lbl0" xml:lang="en-US">Voting shares percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_VotingSharesPercentage" xlink:to="ck0001859807_VotingSharesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_WarrantLiabilitiesPolicyTextBlock_lbl0" xml:lang="en-US">Accounting policy for warrant liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WarrantLiabilitiesPolicyTextBlock" xlink:to="ck0001859807_WarrantLiabilitiesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_WeightedAveragePricePerSharePercentage_lbl0" xml:lang="en-US">Weighted average price per share percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WeightedAveragePricePerSharePercentage" xlink:to="ck0001859807_WeightedAveragePricePerSharePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_WorkingCapital_lbl0" xml:lang="en-US">Working Capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WorkingCapital" xlink:to="ck0001859807_WorkingCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ck0001859807_WorkingCapitalDeficit_lbl0" xml:lang="en-US">Amount of working capital deficit as of balance sheet date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WorkingCapitalDeficit" xlink:to="ck0001859807_WorkingCapitalDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl0" xml:lang="en-US">Temporary Equity, Liquidation Preference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract_lbl" xml:lang="en-US">Schedule Of Future Minimum Payments For The Convertible Notes Payable Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract" xlink:to="ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl0" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl0" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AdvisoryFeeMember_lbl0" xml:lang="en-US">Advisory Fee Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdvisoryFeeMember" xlink:to="ck0001859807_AdvisoryFeeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DepositAxis_lbl0" xml:lang="en-US">Deposit Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DepositAxis" xlink:to="ck0001859807_DepositAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl0" xml:lang="en-US">Features of Convertible Preferred Stock [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AscentNoteMember_lbl0" xml:lang="en-US">Ascent Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AscentNoteMember" xlink:to="ck0001859807_AscentNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl2" xml:lang="en-US">Series B Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PublicWarrantsMember_lbl1" xml:lang="en-US">Public Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicWarrantsMember" xlink:to="ck0001859807_PublicWarrantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SecondPurchaseMember_lbl0" xml:lang="en-US">Second Purchase Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecondPurchaseMember" xlink:to="ck0001859807_SecondPurchaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl0" xml:lang="en-US">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NumberOfSharesIssuedPerUnit_lbl1" xml:lang="en-US">Number Of Shares Issued Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfSharesIssuedPerUnit" xlink:to="ck0001859807_NumberOfSharesIssuedPerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract_lbl0" xml:lang="en-US">Restricted Cash and Cash Equivalent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl0" xml:lang="en-US">Long-Term Debt, Current Maturities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl2" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_TransactionCost_lbl1" xml:lang="en-US">Transaction Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TransactionCost" xlink:to="ck0001859807_TransactionCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtMember_lbl0" xml:lang="en-US">Short-Term Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtMember" xlink:to="us-gaap_ShortTermDebtMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_lbl0" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Shares in ESOP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl0" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockThresholdConsecutiveTradingDays_lbl1" xml:lang="en-US">Common Stock Threshold Consecutive Trading Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockThresholdConsecutiveTradingDays" xlink:to="ck0001859807_CommonStockThresholdConsecutiveTradingDays_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl2" xml:lang="en-US">Investment Income, Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl0" xml:lang="en-US">Other Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl0" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeSecuritiesOtherUSGovernment_lbl0" xml:lang="en-US">Interest Income, Securities, Other US Government</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeSecuritiesOtherUSGovernment" xlink:to="us-gaap_InterestIncomeSecuritiesOtherUSGovernment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_TradingPricePerShare_lbl1" xml:lang="en-US">Trading Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TradingPricePerShare" xlink:to="ck0001859807_TradingPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl0" xml:lang="en-US">Proceeds from Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl0" xml:lang="en-US">Other Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtInterestRateIncrease_lbl0" xml:lang="en-US">Short-Term Debt, Interest Rate Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtInterestRateIncrease" xlink:to="us-gaap_ShortTermDebtInterestRateIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl3" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNote_lbl1" xml:lang="en-US">Convertible Working Capital Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleWorkingCapitalPromissoryNote" xlink:to="ck0001859807_ConvertibleWorkingCapitalPromissoryNote_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RelatedPartyLoanMember_lbl0" xml:lang="en-US">Related Party Loan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyLoanMember" xlink:to="ck0001859807_RelatedPartyLoanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockThresholdTradingDays_lbl1" xml:lang="en-US">Common Stock Threshold Trading Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockThresholdTradingDays" xlink:to="ck0001859807_CommonStockThresholdTradingDays_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ProfusaPreferredStockMember_lbl0" xml:lang="en-US">Profusa Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaPreferredStockMember" xlink:to="ck0001859807_ProfusaPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_GainOnFairValueRemeasurement_lbl1" xml:lang="en-US">Gain On Fair Value Remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_GainOnFairValueRemeasurement" xlink:to="ck0001859807_GainOnFairValueRemeasurement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl0" xml:lang="en-US">Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt_lbl1" xml:lang="en-US">Gain Loss On Change In Fair Value Of Related Party Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" xlink:to="ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfLimitForOutstandingCommonStock_lbl1" xml:lang="en-US">Percentage Of Limit For Outstanding Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfLimitForOutstandingCommonStock" xlink:to="ck0001859807_PercentageOfLimitForOutstandingCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_EquityProceedOwnershipPercentage_lbl1" xml:lang="en-US">Equity Proceed Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityProceedOwnershipPercentage" xlink:to="ck0001859807_EquityProceedOwnershipPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NorthViewAcquisitionCorpMember_lbl2" xml:lang="en-US">North View Acquisition Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthViewAcquisitionCorpMember" xlink:to="ck0001859807_NorthViewAcquisitionCorpMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl2" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xml:lang="en-US">Liabilities, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems_lbl0" xml:lang="en-US">Summary Of Significant Accounting Policies Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember_lbl0" xml:lang="en-US">November Two Thousand Twenty Two Convertible Notes Amendment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" xlink:to="ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl0" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RevenueTarget_lbl1" xml:lang="en-US">Revenue Target</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RevenueTarget" xlink:to="ck0001859807_RevenueTarget_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum_lbl1" xml:lang="en-US">Business Acquisition Percentage Of Voting Interests To Be Acquired On Post Transaction Entity Minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" xlink:to="ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl0" xml:lang="en-US">Common Stock, Convertible, Conversion Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember_lbl0" xml:lang="en-US">April Two Thousand Twenty Three Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember" xlink:to="ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes_lbl1" xml:lang="en-US">Increase Decrease In Prepaid Franchise Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes" xlink:to="ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InterestFromTrustAccount_lbl1" xml:lang="en-US">Interest From Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InterestFromTrustAccount" xlink:to="ck0001859807_InterestFromTrustAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl0" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract_lbl0" xml:lang="en-US">Basic And Diluted Net Loss Income Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract" xlink:to="ck0001859807_BasicAndDilutedNetLossIncomePerShareAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfStockCompensationExpenseAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfStockCompensationExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfStockCompensationExpenseAbstract_lbl" xml:lang="en-US">Schedule Of Stock Compensation Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfStockCompensationExpenseAbstract" xlink:to="ck0001859807_ScheduleOfStockCompensationExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnrelatedPartiesMember_lbl0" xml:lang="en-US">Unrelated Parties Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnrelatedPartiesMember" xlink:to="ck0001859807_UnrelatedPartiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl0" xml:lang="en-US">Income Tax Contingency [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SpecialMeetingMember_lbl0" xml:lang="en-US">Special Meeting Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SpecialMeetingMember" xlink:to="ck0001859807_SpecialMeetingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl2" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl0" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl1" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl0" xml:lang="en-US">Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeniorSecuredNoteMember_lbl0" xml:lang="en-US">Senior Secured Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorSecuredNoteMember" xlink:to="ck0001859807_SeniorSecuredNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl1" xml:lang="en-US">Stock Redeemed or Called During Period, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OptionsToPurchaseCommonStockMember_lbl1" xml:lang="en-US">Options To Purchase Common Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OptionsToPurchaseCommonStockMember" xlink:to="ck0001859807_OptionsToPurchaseCommonStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GovernmentAssistanceTextBlock_lbl0" xml:lang="en-US">Government Assistance [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentAssistanceTextBlock" xlink:to="us-gaap_GovernmentAssistanceTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LessAbstract_lbl0" xml:lang="en-US">Less Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract" xlink:to="ck0001859807_LessAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_JanuaryMarch2024SeniorNotesMember_lbl0" xml:lang="en-US">January March2024 Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryMarch2024SeniorNotesMember" xlink:to="ck0001859807_JanuaryMarch2024SeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl1" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember_lbl0" xml:lang="en-US">August Two Thousand Twenty Convertible Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember" xlink:to="ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl0" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl0" xml:lang="en-US">Payments for Repurchase of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayableCommonStockRedeemed_lbl0" xml:lang="en-US">Payable, Common Stock Redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayableCommonStockRedeemed" xlink:to="us-gaap_PayableCommonStockRedeemed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl0" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NumberOfTradingDay_lbl1" xml:lang="en-US">Number Of Trading Day</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfTradingDay" xlink:to="ck0001859807_NumberOfTradingDay_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl0" xml:lang="en-US">Proceeds from Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl1" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember_lbl0" xml:lang="en-US">Cash And Marketable Securities Held In Trust Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember" xlink:to="ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl1" xml:lang="en-US">Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:to="ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDecommissioningFund_lbl0" xml:lang="en-US">Proceeds from Decommissioning Trust Fund Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDecommissioningFund" xlink:to="us-gaap_ProceedsFromDecommissioningFund_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract_lbl" xml:lang="en-US">Schedule Of Diluted Net Loss Per Share Attributable To Common Stockholders Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract" xlink:to="ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeasePayments_lbl0" xml:lang="en-US">Short-Term Lease Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeasePayments" xlink:to="us-gaap_ShortTermLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Deposits_lbl0" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnsecuredPromissoryNote_lbl1" xml:lang="en-US">Unsecured Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnsecuredPromissoryNote" xlink:to="ck0001859807_UnsecuredPromissoryNote_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember_lbl0" xml:lang="en-US">October December Two Thousand Twenty Four Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtMember_lbl1" xml:lang="en-US">Convertible Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount_lbl1" xml:lang="en-US">Payments For Investment Of Cash In Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="ck0001859807_PaymentsForInvestmentOfCashInTrustAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_WorkingCapitalDeficit_lbl1" xml:lang="en-US">Working Capital Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WorkingCapitalDeficit" xlink:to="ck0001859807_WorkingCapitalDeficit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl2" xml:lang="en-US">Accretion Of Common Stock To Redemption Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AccretionOfCommonStockToRedemptionValue" xlink:to="ck0001859807_AccretionOfCommonStockToRedemptionValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PlusAbstract3_lbl0" xml:lang="en-US">Plus Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract3" xlink:to="ck0001859807_PlusAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PlusAbstract2_lbl0" xml:lang="en-US">Plus Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract2" xlink:to="ck0001859807_PlusAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfNetProceeds_lbl1" xml:lang="en-US">Percentage Of Net Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfNetProceeds" xlink:to="ck0001859807_PercentageOfNetProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeniorConvertibleBridgeNotesMember_lbl0" xml:lang="en-US">Senior Convertible Bridge Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorConvertibleBridgeNotesMember" xlink:to="ck0001859807_SeniorConvertibleBridgeNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrepaidFranchiseTax_lbl1" xml:lang="en-US">Prepaid Franchise Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrepaidFranchiseTax" xlink:to="ck0001859807_PrepaidFranchiseTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PlusAbstract1_lbl0" xml:lang="en-US">Plus Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract1" xlink:to="ck0001859807_PlusAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PlusAbstract0_lbl0" xml:lang="en-US">Plus Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract0" xlink:to="ck0001859807_PlusAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BusinessDays_lbl1" xml:lang="en-US">Business Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessDays" xlink:to="ck0001859807_BusinessDays_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract_lbl" xml:lang="en-US">Schedule Of Consolidated Condensed Financial Statements Of Operating Segment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract" xlink:to="ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InitialPublicOfferingTextBlock_lbl0" xml:lang="en-US">Initial Public Offering Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingTextBlock" xlink:to="ck0001859807_InitialPublicOfferingTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl1" xml:lang="en-US">Other Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_WarrantsLiabilityMember_lbl0" xml:lang="en-US">Warrants Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WarrantsLiabilityMember" xlink:to="ck0001859807_WarrantsLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertibleLoansMember_lbl1" xml:lang="en-US">Convertible Loans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleLoansMember" xlink:to="ck0001859807_ConvertibleLoansMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember_lbl0" xml:lang="en-US">Cash And Marketable Securities Held In Trust Account Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember" xlink:to="ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl0" xml:lang="en-US">Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Gains on Trading Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl2" xml:lang="en-US">Fair Value Measurement With Unobservable Input Reconciliations Recurring Basis Liability Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForAdministrativeFees_lbl0" xml:lang="en-US">Payment for Administrative Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForAdministrativeFees" xlink:to="us-gaap_PaymentForAdministrativeFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl1" xml:lang="en-US">Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl0" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Convertible Preferred Stock Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:to="ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityNetIncome_lbl1" xml:lang="en-US">Temporary Equity, Net Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNetIncome" xlink:to="us-gaap_TemporaryEquityNetIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnpaidInterest_lbl1" xml:lang="en-US">Unpaid Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnpaidInterest" xlink:to="ck0001859807_UnpaidInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl1" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PPPLoanMember_lbl0" xml:lang="en-US">PPPLoan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PPPLoanMember" xlink:to="ck0001859807_PPPLoanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaycheckProtectionProgramLoansOutstanding_lbl1" xml:lang="en-US">Paycheck Protection Program Loans Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoansOutstanding" xlink:to="ck0001859807_PaycheckProtectionProgramLoansOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl0" xml:lang="en-US">Sales and Excise Tax Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl1" xml:lang="en-US">Temporary Equity, Aggregate Amount of Redemption Requirement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of The Company SLevel3 Financial Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract" xlink:to="ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_lbl0" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Shares Contributed to ESOP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PromissoryNoteMember_lbl0" xml:lang="en-US">Promissory Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PromissoryNoteMember" xlink:to="ck0001859807_PromissoryNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl1" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl0" xml:lang="en-US">Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableLeasePayment_lbl0" xml:lang="en-US">Variable Lease, Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeasePayment" xlink:to="us-gaap_VariableLeasePayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SecuritiesPurchaseAgreementMember_lbl0" xml:lang="en-US">Securities Purchase Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementMember" xlink:to="ck0001859807_SecuritiesPurchaseAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PromissoryNotes_lbl1" xml:lang="en-US">Promissory Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PromissoryNotes" xlink:to="ck0001859807_PromissoryNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl0" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NewSeriesCConvertiblePreferredStockMember_lbl0" xml:lang="en-US">New Series CConvertible Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesCConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesCConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_CA_lbl0" xml:lang="en-US">CALIFORNIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl2" xml:lang="en-US">Convertible Notes Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl0" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExciseAndSalesTaxes_lbl0" xml:lang="en-US">Excise and Sales Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExciseAndSalesTaxes" xlink:to="us-gaap_ExciseAndSalesTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrust_lbl1" xml:lang="en-US">Asset, Held-in-Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of Investments Held In Trust Account Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract" xlink:to="ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DeferredTaxAssetsAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsAbstract" xlink:to="ck0001859807_DeferredTaxAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember_lbl0" xml:lang="en-US">January Two Thousand Twenty One Convertible Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember" xlink:to="ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment_lbl0" xml:lang="en-US">Income Tax Effects Allocated Directly to Equity, Prior Period Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl0" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PublicSharesMember_lbl1" xml:lang="en-US">Public Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicSharesMember" xlink:to="ck0001859807_PublicSharesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate During Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LatePenaltiesAmount_lbl1" xml:lang="en-US">Late Penalties Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LatePenaltiesAmount" xlink:to="ck0001859807_LatePenaltiesAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl0" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl2" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl0" xml:lang="en-US">Number of Operating Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl2" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl1" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl0" xml:lang="en-US">Amortization of Debt Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_lbl0" xml:lang="en-US">Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AprilJune2025SeniorNotesMember_lbl0" xml:lang="en-US">April June2025 Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilJune2025SeniorNotesMember" xlink:to="ck0001859807_AprilJune2025SeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl0" xml:lang="en-US">US Treasury Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl1" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfAccrueInterest_lbl1" xml:lang="en-US">Percentage Of Accrue Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAccrueInterest" xlink:to="ck0001859807_PercentageOfAccrueInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_lbl0" xml:lang="en-US">Payments for Repurchase of Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Dividends_lbl0" xml:lang="en-US">Dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Dividends" xlink:to="us-gaap_Dividends_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ChangeInFairValueOfConvertibleNote_lbl1" xml:lang="en-US">Change In Fair Value Of Convertible Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfConvertibleNote" xlink:to="ck0001859807_ChangeInFairValueOfConvertibleNote_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BusinessCombinationMember_lbl0" xml:lang="en-US">Business Combination Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessCombinationMember" xlink:to="ck0001859807_BusinessCombinationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InitialPublicOfferingGrossProceedPercentage_lbl1" xml:lang="en-US">Initial Public Offering Gross Proceed Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialPublicOfferingGrossProceedPercentage" xlink:to="ck0001859807_InitialPublicOfferingGrossProceedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OfferingCosts_lbl1" xml:lang="en-US">Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OfferingCosts" xlink:to="ck0001859807_OfferingCosts_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract_lbl" xml:lang="en-US">Schedule Of Contractual Future Minimum Payments For The Ppp Loan Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:to="ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US">Income Tax Reconciliations Change In Deferred Tax Assets Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" xlink:to="ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnderpaymentPenaltyRate_lbl1" xml:lang="en-US">Underpayment Penalty Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnderpaymentPenaltyRate" xlink:to="ck0001859807_UnderpaymentPenaltyRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl0" xml:lang="en-US">Temporary Equity, Redemption Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrepaidLegal_lbl1" xml:lang="en-US">Prepaid Legal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrepaidLegal" xlink:to="ck0001859807_PrepaidLegal_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInSecondAndThirdYear_lbl0" xml:lang="en-US">Other Commitment, to be Paid, Year Two and Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondAndThirdYear" xlink:to="us-gaap_OtherCommitmentDueInSecondAndThirdYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BusinessCombinationProfusaMember_lbl0" xml:lang="en-US">Business Combination Profusa Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessCombinationProfusaMember" xlink:to="ck0001859807_BusinessCombinationProfusaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AdministrativeSupportAgreementMember_lbl0" xml:lang="en-US">Administrative Support Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdministrativeSupportAgreementMember" xlink:to="ck0001859807_AdministrativeSupportAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl0" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl1" xml:lang="en-US">Convertible Debt, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Other Selling, General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ArrangementFeeMember_lbl0" xml:lang="en-US">Arrangement Fee Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ArrangementFeeMember" xlink:to="ck0001859807_ArrangementFeeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts_lbl1" xml:lang="en-US">Increasedecrease In Unpaid Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts" xlink:to="ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ShortTermLeasesMember_lbl0" xml:lang="en-US">Short Term Leases Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShortTermLeasesMember" xlink:to="ck0001859807_ShortTermLeasesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl0" xml:lang="en-US">Payments for Repurchase of Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SharesRedeemedPercentage_lbl1" xml:lang="en-US">Shares Redeemed Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SharesRedeemedPercentage" xlink:to="ck0001859807_SharesRedeemedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LossOnFairValueRemeasurement_lbl1" xml:lang="en-US">Loss On Fair Value Remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LossOnFairValueRemeasurement" xlink:to="ck0001859807_LossOnFairValueRemeasurement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl2" xml:lang="en-US">Change In Fair Value Of Securities Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:to="ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AdvanceFromProfusa_lbl1" xml:lang="en-US">Advance From Profusa</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdvanceFromProfusa" xlink:to="ck0001859807_AdvanceFromProfusa_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl0" xml:lang="en-US">Accrued Employee Benefits, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl0" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0" xml:lang="en-US">Deferred Tax Asset, In-Process Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NewProfusaCommonStockMember_lbl0" xml:lang="en-US">New Profusa Common Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewProfusaCommonStockMember" xlink:to="ck0001859807_NewProfusaCommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ProfusaMember_lbl0" xml:lang="en-US">Profusa Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaMember" xlink:to="ck0001859807_ProfusaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember_lbl0" xml:lang="en-US">Outstanding Options Under Two Thousand Ten Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember" xlink:to="ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl2" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Options Cancelled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl1" xml:lang="en-US">Debt Instrument, Issued, Principal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertibleNotesMember_lbl1" xml:lang="en-US">Convertible Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleNotesMember" xlink:to="ck0001859807_ConvertibleNotesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RedeemableWarrantMember_lbl0" xml:lang="en-US">Redeemable Warrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedeemableWarrantMember" xlink:to="ck0001859807_RedeemableWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl2" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0" xml:lang="en-US">Repayments of Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_lbl2" xml:lang="en-US">Interest Expense, Nonoperating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashMember_lbl0" xml:lang="en-US">Cash [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl0" xml:lang="en-US">Short-Term Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertibleDebtOfDiscountRate_lbl2" xml:lang="en-US">Convertible Debt Of Discount Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleDebtOfDiscountRate" xlink:to="ck0001859807_ConvertibleDebtOfDiscountRate_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SponsorFees_lbl0" xml:lang="en-US">Sponsor Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Changes In Debt Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract" xlink:to="ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl0" xml:lang="en-US">Loss Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiability_lbl0" xml:lang="en-US">Contract with Customer, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl0" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RedemptionPublicShares_lbl1" xml:lang="en-US">Redemption Public Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPublicShares" xlink:to="ck0001859807_RedemptionPublicShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl1" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LiabilitiesAbstract1_lbl0" xml:lang="en-US">Liabilities Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LiabilitiesAbstract1" xlink:to="ck0001859807_LiabilitiesAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LiabilitiesAbstract2_lbl0" xml:lang="en-US">Liabilities Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LiabilitiesAbstract2" xlink:to="ck0001859807_LiabilitiesAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription_lbl0" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Plan Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LiabilitiesAbstract0_lbl0" xml:lang="en-US">Liabilities Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LiabilitiesAbstract0" xlink:to="ck0001859807_LiabilitiesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl0" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember_lbl0" xml:lang="en-US">August Two Thousand Twenty One Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember" xlink:to="ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl1" xml:lang="en-US">Temporary Equity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PurchasePrice_lbl1" xml:lang="en-US">Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PurchasePrice" xlink:to="ck0001859807_PurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockConvertibleConversionPrice_lbl1" xml:lang="en-US">Common Stock Convertible Conversion Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockConvertibleConversionPrice" xlink:to="ck0001859807_CommonStockConvertibleConversionPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl2" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl0" xml:lang="en-US">Other Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostAndExpenseOperating_lbl0" xml:lang="en-US">Other Cost and Expense, Operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_MonthlyPayments_lbl1" xml:lang="en-US">Monthly Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MonthlyPayments" xlink:to="ck0001859807_MonthlyPayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl1" xml:lang="en-US">Proceeds from Issuance of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsShares_lbl0" xml:lang="en-US">Common Stock Dividends, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsShares" xlink:to="us-gaap_CommonStockDividendsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl0" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LockupPeriod_lbl1" xml:lang="en-US">Lockup Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LockupPeriod" xlink:to="ck0001859807_LockupPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption_lbl1" xml:lang="en-US">Class Of Warrant Or Right Trigger Share Price Of Warrants Or Rights For Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" xlink:to="ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DebtInterestRate_lbl1" xml:lang="en-US">Debt Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInterestRate" xlink:to="ck0001859807_DebtInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock_lbl1" xml:lang="en-US">Emerging Growth Company Status Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xml:lang="en-US">Long-Term Debt, Maturity, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember_lbl0" xml:lang="en-US">July September Two Thousand Twenty Four Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl1" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl0" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NorthViewTrustMember_lbl0" xml:lang="en-US">North View Trust Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthViewTrustMember" xlink:to="ck0001859807_NorthViewTrustMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtWeightedAverageInterestRate_lbl0" xml:lang="en-US">Short-Term Debt, Weighted Average Interest Rate, at Point in Time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="us-gaap_ShortTermDebtWeightedAverageInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="ck0001859807_ScheduleOfDeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_lbl0" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl0" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_StatedInterest_lbl1" xml:lang="en-US">Stated Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StatedInterest" xlink:to="ck0001859807_StatedInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl0" xml:lang="en-US">Marketable Securities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashContributionExpense_lbl0" xml:lang="en-US">Noncash Contribution Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashContributionExpense" xlink:to="us-gaap_NoncashContributionExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl2" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember_lbl0" xml:lang="en-US">October Two Thousand Twenty Two Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember" xlink:to="ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember_lbl0" xml:lang="en-US">Convertible Working Capital Promissory Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember" xlink:to="ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl0" xml:lang="en-US">Subsequent Event [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl0" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl0" xml:lang="en-US">Operating Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl0" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl1" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl2" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PublicWarrantMember_lbl0" xml:lang="en-US">Public Warrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PublicWarrantMember" xlink:to="ck0001859807_PublicWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl0" xml:lang="en-US">Other Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SponsorMember_lbl0" xml:lang="en-US">Sponsor Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SponsorMember" xlink:to="ck0001859807_SponsorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_lbl0" xml:lang="en-US">Extinguishment of Debt, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember_lbl0" xml:lang="en-US">November Two Thousand Twenty Two Senior Notes Amendment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" xlink:to="ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember_lbl0" xml:lang="en-US">Issuance Of Options Under The Two Thousand Ten Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" xlink:to="ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfActivityUnderThePlanAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfActivityUnderThePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfActivityUnderThePlanAbstract_lbl" xml:lang="en-US">Schedule Of Activity Under The Plan Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfActivityUnderThePlanAbstract" xlink:to="ck0001859807_ScheduleOfActivityUnderThePlanAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl2" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl1" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FounderShareMember_lbl0" xml:lang="en-US">Founder Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FounderShareMember" xlink:to="ck0001859807_FounderShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl1" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization_lbl1" xml:lang="en-US">Deferred Tax Assets Depreciation And Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="ck0001859807_DeferredTaxAssetsDepreciationAndAmortization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl0" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl0" xml:lang="en-US">Interest Income, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock_lbl1" xml:lang="en-US">Excise Tax Payable Redemption Of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock" xlink:to="ck0001859807_ExciseTaxPayableRedemptionOfCommonStock_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract_lbl" xml:lang="en-US">Schedule Of Activity Under The Plan Is Set Forth Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract" xlink:to="ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingenciesOther_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingenciesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal_lbl0" xml:lang="en-US">Debt Instrument, Repaid, Principal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRepaidPrincipal" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock_lbl1" xml:lang="en-US">Percentage Of Average Daily Traded Value Of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock" xlink:to="ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NonrecoursePromissoryNotesMember_lbl0" xml:lang="en-US">Nonrecourse Promissory Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NonrecoursePromissoryNotesMember" xlink:to="ck0001859807_NonrecoursePromissoryNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfRedeemingPublicShareholders_lbl1" xml:lang="en-US">Percentage Of Redeeming Public Shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfRedeemingPublicShareholders" xlink:to="ck0001859807_PercentageOfRedeemingPublicShareholders_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract_lbl" xml:lang="en-US">Schedule Of Inputs Into The Monte Carlo Simulation Model For The Warrant Liabilities And Convertible Promissory Note Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:to="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl1" xml:lang="en-US">Debt Conversion, Converted Instrument, Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">New Series C1 Convertible Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesC1ConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl2" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingSegmentsMember_lbl0" xml:lang="en-US">Operating Segments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OperatingBankAccount_lbl1" xml:lang="en-US">Operating Bank Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingBankAccount" xlink:to="ck0001859807_OperatingBankAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertiblePromissoryNoteMember_lbl2" xml:lang="en-US">Convertible Promissory Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl1" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnderwritingDiscountAmount_lbl1" xml:lang="en-US">Underwriting Discount Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnderwritingDiscountAmount" xlink:to="ck0001859807_UnderwritingDiscountAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth_lbl1" xml:lang="en-US">Related Party Transaction Expenses From Transaction With Related Party Per Month</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DawsonJamesMember_lbl0" xml:lang="en-US">Dawson James Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DawsonJamesMember" xlink:to="ck0001859807_DawsonJamesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_lbl0" xml:lang="en-US">Deposit Liabilities, Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaycheckProtectionProgramLoanMember_lbl0" xml:lang="en-US">Paycheck Protection Program Loan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoanMember" xlink:to="ck0001859807_PaycheckProtectionProgramLoanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl0" xml:lang="en-US">Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xml:lang="en-US">Current Federal Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AmountDrawn_lbl1" xml:lang="en-US">Amount Drawn</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AmountDrawn" xlink:to="ck0001859807_AmountDrawn_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract_lbl" xml:lang="en-US">Schedule Of Effective Tax Rate And The Federal Statutory Income Tax Rate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl0" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl2" xml:lang="en-US">Temporary Equity, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InterestExpensesNotesPayable_lbl1" xml:lang="en-US">Interest Expenses Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InterestExpensesNotesPayable" xlink:to="ck0001859807_InterestExpensesNotesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl0" xml:lang="en-US">Debt Instrument, Annual Principal Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvanceRoyalties_lbl0" xml:lang="en-US">Advance Royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvanceRoyalties" xlink:to="us-gaap_AdvanceRoyalties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember_lbl0" xml:lang="en-US">December Two Thousand Twenty Two Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember" xlink:to="ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl4" xml:lang="en-US">Convertible Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl1" xml:lang="en-US">Marketable Securities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl0" xml:lang="en-US">Stockholders&apos; Equity, Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl0" xml:lang="en-US">Other Payments to Acquire Businesses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidTaxes_lbl0" xml:lang="en-US">Prepaid Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeniorNotes_lbl0" xml:lang="en-US">Senior Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotes" xlink:to="us-gaap_SeniorNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember_lbl0" xml:lang="en-US">April June Two Thousand Twenty Four Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl3" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl2" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl0" xml:lang="en-US">Measurement Input, Exercise Price [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl2" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Options Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember_lbl0" xml:lang="en-US">December Two Thousand Twenty One Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember" xlink:to="ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfOriginalIssuanceDiscount_lbl1" xml:lang="en-US">Percentage Of Original Issuance Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfOriginalIssuanceDiscount" xlink:to="ck0001859807_PercentageOfOriginalIssuanceDiscount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation_lbl1" xml:lang="en-US">Administrative Personnel Compensation Costs Including Stockbased Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:to="ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl0" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ReceivedPaycheckProtectionProgramLoans_lbl1" xml:lang="en-US">Received Paycheck Protection Program Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ReceivedPaycheckProtectionProgramLoans" xlink:to="ck0001859807_ReceivedPaycheckProtectionProgramLoans_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_JanuaryExtensionMember_lbl0" xml:lang="en-US">January Extension Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryExtensionMember" xlink:to="ck0001859807_JanuaryExtensionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DeferredTaxAssetsConvertibleDebt_lbl1" xml:lang="en-US">Deferred Tax Assets Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DeferredTaxAssetsConvertibleDebt" xlink:to="ck0001859807_DeferredTaxAssetsConvertibleDebt_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract_lbl" xml:lang="en-US">Schedule Of Level3 Financial Instruments That Are Measured At Fair Value On ARecurring Basis Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrincipalBorrowing_lbl1" xml:lang="en-US">Principal Borrowing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrincipalBorrowing" xlink:to="ck0001859807_PrincipalBorrowing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OtherOfferingCosts_lbl1" xml:lang="en-US">Other Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OtherOfferingCosts" xlink:to="ck0001859807_OtherOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl1" xml:lang="en-US">Sales and Excise Tax Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl0" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeniorConvertiblesNotesMember_lbl0" xml:lang="en-US">Senior Convertibles Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorConvertiblesNotesMember" xlink:to="ck0001859807_SeniorConvertiblesNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl1" xml:lang="en-US">Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ProfusaAsiaPacificPteLtdMember_lbl1" xml:lang="en-US">Profusa Asia Pacific Pte Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaAsiaPacificPteLtdMember" xlink:to="ck0001859807_ProfusaAsiaPacificPteLtdMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount_lbl1" xml:lang="en-US">Payment Of Extension Fee Into Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount" xlink:to="ck0001859807_PaymentOfExtensionFeeIntoTrustAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetHeldInTrustMember_lbl0" xml:lang="en-US">Asset, Held-in-Trust [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetHeldInTrustMember" xlink:to="us-gaap_AssetHeldInTrustMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract_lbl" xml:lang="en-US">Schedule Of Reserved Shares Of Common Stock Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract" xlink:to="ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl0" xml:lang="en-US">Derivative Liability, Measurement Input</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_WorkingCapital_lbl1" xml:lang="en-US">Working Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WorkingCapital" xlink:to="ck0001859807_WorkingCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_MaturityMonth_lbl1" xml:lang="en-US">Maturity Month</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MaturityMonth" xlink:to="ck0001859807_MaturityMonth_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_WeightedAveragePricePerSharePercentage_lbl1" xml:lang="en-US">Weighted Average Price Per Share Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WeightedAveragePricePerSharePercentage" xlink:to="ck0001859807_WeightedAveragePricePerSharePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IBankersMember_lbl0" xml:lang="en-US">IBankers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IBankersMember" xlink:to="ck0001859807_IBankersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertiblePreferredStockPolicyTextBlock_lbl1" xml:lang="en-US">Convertible Preferred Stock Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePreferredStockPolicyTextBlock" xlink:to="ck0001859807_ConvertiblePreferredStockPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidInsurance_lbl0" xml:lang="en-US">Prepaid Insurance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl0" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl1" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl0" xml:lang="en-US">Noncash Merger Related Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertibleDebtOfTermFairValue_lbl1" xml:lang="en-US">Convertible Debt Of Term Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleDebtOfTermFairValue" xlink:to="ck0001859807_ConvertibleDebtOfTermFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl0" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaycheckProtectionProgramMember_lbl0" xml:lang="en-US">Paycheck Protection Program Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramMember" xlink:to="ck0001859807_PaycheckProtectionProgramMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForFees_lbl0" xml:lang="en-US">Payments for Other Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForFees" xlink:to="us-gaap_PaymentsForFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FebruaryExtensionMember_lbl0" xml:lang="en-US">February Extension Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FebruaryExtensionMember" xlink:to="ck0001859807_FebruaryExtensionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl1" xml:lang="en-US">Temporary Equity, Including Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement_lbl1" xml:lang="en-US">Changes In Fair Value Of Securities Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement" xlink:to="ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl1" xml:lang="en-US">Repayments of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl0" xml:lang="en-US">Accrued Income Taxes, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalAccountContributions_lbl0" xml:lang="en-US">Partners&apos; Capital Account, Contributions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountContributions" xlink:to="us-gaap_PartnersCapitalAccountContributions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl1" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl0" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeniorSecuredConvertibleNoteMember_lbl0" xml:lang="en-US">Senior Secured Convertible Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorSecuredConvertibleNoteMember" xlink:to="ck0001859807_SeniorSecuredConvertibleNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedContractCostNetCurrent_lbl0" xml:lang="en-US">Capitalized Contract Cost, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNetCurrent" xlink:to="us-gaap_CapitalizedContractCostNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl0" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl0" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestCostsIncurred_lbl0" xml:lang="en-US">Interest Costs Incurred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestCostsIncurred" xlink:to="us-gaap_InterestCostsIncurred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl0" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl2" xml:lang="en-US">Change In Fair Value Of Convertible Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote" xlink:to="ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NumberOfDaysForUnderwriterOptions_lbl1" xml:lang="en-US">Number Of Days For Underwriter Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfDaysForUnderwriterOptions" xlink:to="ck0001859807_NumberOfDaysForUnderwriterOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl2" xml:lang="en-US">Securities Purchase Agreement Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementCurrent" xlink:to="ck0001859807_SecuritiesPurchaseAgreementCurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_USFederalMember_lbl0" xml:lang="en-US">USFederal Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_USFederalMember" xlink:to="ck0001859807_USFederalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CashPercentage_lbl1" xml:lang="en-US">Cash Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashPercentage" xlink:to="ck0001859807_CashPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl2" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_StockholdersAmendmentPercentage_lbl1" xml:lang="en-US">Stockholders Amendment Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_StockholdersAmendmentPercentage" xlink:to="ck0001859807_StockholdersAmendmentPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_VotingSharesPercentage_lbl1" xml:lang="en-US">Voting Shares Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_VotingSharesPercentage" xlink:to="ck0001859807_VotingSharesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset_lbl1" xml:lang="en-US">Percentage Of Aggregate Fair Market Value Of Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset" xlink:to="ck0001859807_PercentageOfAggregateFairMarketValueOfAsset_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl0" xml:lang="en-US">Restricted Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RedeemableSharesMember_lbl0" xml:lang="en-US">Redeemable Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedeemableSharesMember" xlink:to="ck0001859807_RedeemableSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedemptionPremium_lbl0" xml:lang="en-US">Redemption Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedemptionPremium" xlink:to="us-gaap_RedemptionPremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember_lbl0" xml:lang="en-US">Convertible Promissory Note Related Party Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue_lbl0" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Redemption Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption_lbl1" xml:lang="en-US">Number Of Days For Written Notice Of Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption" xlink:to="ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl0" xml:lang="en-US">Increase (Decrease) in Due to Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaymentofInteresttoDistributionExpense_lbl1" xml:lang="en-US">Paymentof Interestto Distribution Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentofInteresttoDistributionExpense" xlink:to="ck0001859807_PaymentofInteresttoDistributionExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfOriginalIssueDiscount_lbl1" xml:lang="en-US">Percentage Of Original Issue Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfOriginalIssueDiscount" xlink:to="ck0001859807_PercentageOfOriginalIssueDiscount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl2" xml:lang="en-US">Asset, Held-in-Trust, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl2"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfConvertiblePreferredStockAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePreferredStockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfConvertiblePreferredStockAbstract_lbl" xml:lang="en-US">Schedule Of Convertible Preferred Stock Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfConvertiblePreferredStockAbstract" xlink:to="ck0001859807_ScheduleOfConvertiblePreferredStockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract_lbl" xml:lang="en-US">Schedule Of Basic And Diluted Net Loss Income Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract" xlink:to="ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable_lbl0" xml:lang="en-US">Short-Term Bank Loans and Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShorttermDebtFairValue_lbl0" xml:lang="en-US">Short-Term Debt, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShorttermDebtFairValue" xlink:to="us-gaap_ShorttermDebtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueRemeasurement_lbl2" xml:lang="en-US">Fair Value Remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueRemeasurement" xlink:to="ck0001859807_FairValueRemeasurement_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl0" xml:lang="en-US">Temporary Equity, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BasicAndDilutedNetLossPerShareAbstract_lbl0" xml:lang="en-US">Basic And Diluted Net Loss Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BasicAndDilutedNetLossPerShareAbstract" xlink:to="ck0001859807_BasicAndDilutedNetLossPerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl1" xml:lang="en-US">Deferred Income Tax Liabilities, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl0" xml:lang="en-US">Investor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl1" xml:lang="en-US">Temporary Equity, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Schedule Of Company SAssets And Liabilities That Are Measured At Fair Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract" xlink:to="ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl0" xml:lang="en-US">Preferred Stock, Convertible, Conversion Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl1" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfExcercisePriceOption_lbl1" xml:lang="en-US">Percentage Of Excercise Price Option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfExcercisePriceOption" xlink:to="ck0001859807_PercentageOfExcercisePriceOption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl0" xml:lang="en-US">Business Combination, Acquisition-Related Cost, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ShortTermLoanAgreementMember_lbl0" xml:lang="en-US">Short Term Loan Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShortTermLoanAgreementMember" xlink:to="ck0001859807_ShortTermLoanAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrivatePlacementsTextBlock_lbl1" xml:lang="en-US">Private Placements Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementsTextBlock" xlink:to="ck0001859807_PrivatePlacementsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DebtInstrumentDiscount_lbl1" xml:lang="en-US">Debt Instrument Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInstrumentDiscount" xlink:to="ck0001859807_DebtInstrumentDiscount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeniorSecuredConvertibleNotesMember_lbl0" xml:lang="en-US">Senior Secured Convertible Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorSecuredConvertibleNotesMember" xlink:to="ck0001859807_SeniorSecuredConvertibleNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OtherIncomeExpensesAbstract_lbl0" xml:lang="en-US">Other Income Expenses Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OtherIncomeExpensesAbstract" xlink:to="ck0001859807_OtherIncomeExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl0" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_InitialNotesMember_lbl0" xml:lang="en-US">Initial Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_InitialNotesMember" xlink:to="ck0001859807_InitialNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl0" xml:lang="en-US">Preferred Stock [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl2" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl2" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnlabeledAbstract" xlink:to="ck0001859807_UnlabeledAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract_lbl" xml:lang="en-US">Schedule Of Convertible Promissory Note Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract" xlink:to="ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl0" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl0" xml:lang="en-US">Schedule of Conversions of Stock [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest_lbl1" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Accrued Stated Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:to="ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl0" xml:lang="en-US">Investment Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl2" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertibleNotesNovember2022AmendmentMember_lbl0" xml:lang="en-US">Convertible Notes November2022 Amendment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertibleNotesNovember2022AmendmentMember" xlink:to="ck0001859807_ConvertibleNotesNovember2022AmendmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and Cash Equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NewSeriesAConvertiblePreferredStockMember_lbl0" xml:lang="en-US">New Series AConvertible Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesAConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesAConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract_lbl" xml:lang="en-US">Schedule Of Basic And Diluted Net Loss Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl0" xml:lang="en-US">Schedule of Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl1" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AggregateNumberOfSharesOwned_lbl1" xml:lang="en-US">Aggregate Number Of Shares Owned</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AggregateNumberOfSharesOwned" xlink:to="ck0001859807_AggregateNumberOfSharesOwned_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions_lbl1" xml:lang="en-US">Excise Tax Liability In Connection With Stock Redemptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions" xlink:to="ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember_lbl0" xml:lang="en-US">April Two Thousand Twenty One Convertible Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember" xlink:to="ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeriesCC1PreferredStockMember_lbl0" xml:lang="en-US">Series CC1 Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeriesCC1PreferredStockMember" xlink:to="ck0001859807_SeriesCC1PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OperationsAndRedeemRepurchasePercentage_lbl1" xml:lang="en-US">Operations And Redeem Repurchase Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperationsAndRedeemRepurchasePercentage" xlink:to="ck0001859807_OperationsAndRedeemRepurchasePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_JanuaryMarch2025SeniorNotesMember_lbl0" xml:lang="en-US">January March2025 Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryMarch2025SeniorNotesMember" xlink:to="ck0001859807_JanuaryMarch2025SeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSeniorDebt_lbl0" xml:lang="en-US">Repayments of Senior Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSeniorDebt" xlink:to="us-gaap_RepaymentsOfSeniorDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NumberOfTradingDays_lbl1" xml:lang="en-US">Number Of Trading Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NumberOfTradingDays" xlink:to="ck0001859807_NumberOfTradingDays_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl2" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_Plan2018Member_lbl0" xml:lang="en-US">Plan2018 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_Plan2018Member" xlink:to="ck0001859807_Plan2018Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract_lbl" xml:lang="en-US">Schedule Of Financial Liabilities Measured At Fair Value On ARecurring Basis Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock_lbl1" xml:lang="en-US">Securities Purchase Agreement Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock" xlink:to="ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl0" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfDebtInstrumentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDebtInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfDebtInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Debt Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfDebtInstrumentsAbstract" xlink:to="ck0001859807_ScheduleOfDebtInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DebtInstrumentsContractualTerm_lbl1" xml:lang="en-US">Debt Instruments Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DebtInstrumentsContractualTerm" xlink:to="ck0001859807_DebtInstrumentsContractualTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FundingOperatingExpenses_lbl1" xml:lang="en-US">Funding Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FundingOperatingExpenses" xlink:to="ck0001859807_FundingOperatingExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl0" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl0" xml:lang="en-US">Repayments of Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl1" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl1" xml:lang="en-US">Condition For Future Business Combination Threshold Net Tangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:to="ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnderwritingExpenseRatio_lbl0" xml:lang="en-US">Underwriting Expense Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderwritingExpenseRatio" xlink:to="us-gaap_UnderwritingExpenseRatio_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember_lbl0" xml:lang="en-US">Securities Sold under Agreements to Repurchase [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl3" xml:lang="en-US">Restricted Cash, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeniorNotesMember_lbl0" xml:lang="en-US">Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotesMember" xlink:to="us-gaap_SeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl2" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders_lbl1" xml:lang="en-US">Redemption Payments Due To Redeeming Stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders" xlink:to="ck0001859807_RedemptionPaymentsDueToRedeemingStockholders_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RentAndOfficeCosts_lbl1" xml:lang="en-US">Rent And Office Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RentAndOfficeCosts" xlink:to="ck0001859807_RentAndOfficeCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NewSeriesBConvertiblePreferredStockMember_lbl0" xml:lang="en-US">New Series BConvertible Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NewSeriesBConvertiblePreferredStockMember" xlink:to="ck0001859807_NewSeriesBConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl0" xml:lang="en-US">Measurement Input, Share Price [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl2" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_MergerAgreementMember_lbl0" xml:lang="en-US">Merger Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MergerAgreementMember" xlink:to="ck0001859807_MergerAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl0" xml:lang="en-US">Proceeds from Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FounderShares1Member_lbl0" xml:lang="en-US">Founder Shares1 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FounderShares1Member" xlink:to="ck0001859807_FounderShares1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CashFeeMember_lbl0" xml:lang="en-US">Cash Fee Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashFeeMember" xlink:to="ck0001859807_CashFeeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember_lbl0" xml:lang="en-US">October December Two Thousand Twenty Three Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" xlink:to="ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableFairValueDisclosure_lbl0" xml:lang="en-US">Notes Payable, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableFairValueDisclosure" xlink:to="us-gaap_NotesPayableFairValueDisclosure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_EstimatedInterestRate_lbl1" xml:lang="en-US">Estimated Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EstimatedInterestRate" xlink:to="ck0001859807_EstimatedInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl0" xml:lang="en-US">Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl2" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:to="ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl0" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl0" xml:lang="en-US">Common Stock, Voting Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedFinancialStatementsTextBlock_lbl0" xml:lang="en-US">Condensed Financial Statements [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialStatementsTextBlock" xlink:to="srt_CondensedFinancialStatementsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfPublicShares_lbl1" xml:lang="en-US">Percentage Of Public Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfPublicShares" xlink:to="ck0001859807_PercentageOfPublicShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice_lbl1" xml:lang="en-US">Percentage Of Lowest Volume Weighted Average Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice" xlink:to="ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption_lbl1" xml:lang="en-US">Cash Withdrawn From Trust Account In Connection With Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption" xlink:to="ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NorthviewAcquisitionCorporationMember_lbl0" xml:lang="en-US">Northview Acquisition Corporation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NorthviewAcquisitionCorporationMember" xlink:to="ck0001859807_NorthviewAcquisitionCorporationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl0" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance_lbl1" xml:lang="en-US">Percentage Of Warrant Exercise Price Adjusted To Price Received In New Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" xlink:to="ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_JuneJulyAndAugustExtensionMember_lbl0" xml:lang="en-US">June July And August Extension Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JuneJulyAndAugustExtensionMember" xlink:to="ck0001859807_JuneJulyAndAugustExtensionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl0" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl0" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeSecuritiesTaxable_lbl0" xml:lang="en-US">Interest Income, Securities, Operating, Taxable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeSecuritiesTaxable" xlink:to="us-gaap_InterestIncomeSecuritiesTaxable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BankersAndDawsonJamesMember_lbl1" xml:lang="en-US">Bankers And Dawson James Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BankersAndDawsonJamesMember" xlink:to="ck0001859807_BankersAndDawsonJamesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl1" xml:lang="en-US">Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PercentageOfNonRedeemingPublicShareholders_lbl1" xml:lang="en-US">Percentage Of Non Redeeming Public Shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PercentageOfNonRedeemingPublicShareholders" xlink:to="ck0001859807_PercentageOfNonRedeemingPublicShareholders_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_NoRedemptionScenarioMember_lbl0" xml:lang="en-US">No Redemption Scenario Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_NoRedemptionScenarioMember" xlink:to="ck0001859807_NoRedemptionScenarioMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl1" xml:lang="en-US">Subsidiary, Ownership Percentage, Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember_lbl1" xml:lang="en-US">Senior Notes September Two Thousand Twenty Two Amendment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" xlink:to="ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders_lbl1" xml:lang="en-US">Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" xlink:to="ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfIncomeTaxProvisionAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfIncomeTaxProvisionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfIncomeTaxProvisionAbstract_lbl" xml:lang="en-US">Schedule Of Income Tax Provision Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfIncomeTaxProvisionAbstract" xlink:to="ck0001859807_ScheduleOfIncomeTaxProvisionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount_lbl0" xml:lang="en-US">Debt Instrument, Debt Default, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDefaultLongtermDebtAmount" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_BusinessCombinationPercentageRate_lbl1" xml:lang="en-US">Business Combination Percentage Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_BusinessCombinationPercentageRate" xlink:to="ck0001859807_BusinessCombinationPercentageRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaycheckProtectionProgramLoan_lbl1" xml:lang="en-US">Paycheck Protection Program Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaycheckProtectionProgramLoan" xlink:to="ck0001859807_PaycheckProtectionProgramLoan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnrelatedPartyRepayable_lbl1" xml:lang="en-US">Unrelated Party Repayable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnrelatedPartyRepayable" xlink:to="ck0001859807_UnrelatedPartyRepayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ChiefOperatingOfficerDecisionMakerMember_lbl0" xml:lang="en-US">Chief Operating Officer Decision Maker Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ChiefOperatingOfficerDecisionMakerMember" xlink:to="ck0001859807_ChiefOperatingOfficerDecisionMakerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_WarrantLiabilityMember_lbl0" xml:lang="en-US">Warrant Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WarrantLiabilityMember" xlink:to="ck0001859807_WarrantLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl0" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PrivatePlacementWarrantsMember_lbl1" xml:lang="en-US">Private Placement Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PrivatePlacementWarrantsMember" xlink:to="ck0001859807_PrivatePlacementWarrantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansHeldForSaleTerm_lbl0" xml:lang="en-US">Loan, Held-for-Sale, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansHeldForSaleTerm" xlink:to="us-gaap_LoansHeldForSaleTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RepresentativeWarrantCost_lbl1" xml:lang="en-US">Representative Warrant Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativeWarrantCost" xlink:to="ck0001859807_RepresentativeWarrantCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract_lbl0" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="us-gaap_FairValueInputsQuantitativeInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_MaturityDays_lbl1" xml:lang="en-US">Maturity Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MaturityDays" xlink:to="ck0001859807_MaturityDays_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl0" xml:lang="en-US">Accrued Liabilities and Other Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl0" xml:lang="en-US">Investment Owned, Balance, Principal Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl0" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl1" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract_lbl" xml:lang="en-US">Schedule Of Other Financial Information Regarding The Company SOperating Segment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl0" xml:lang="en-US">Measurement Input, Price Volatility [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl0" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_IBankersAndDawsonJamesMember_lbl0" xml:lang="en-US">IBankers And Dawson James Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_IBankersAndDawsonJamesMember" xlink:to="ck0001859807_IBankersAndDawsonJamesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl1" xml:lang="en-US">Debt Instrument, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_SeniorNoteMember_lbl0" xml:lang="en-US">Senior Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_SeniorNoteMember" xlink:to="ck0001859807_SeniorNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OperatingExpensesAbstract2_lbl0" xml:lang="en-US">Operating Expenses Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract2" xlink:to="ck0001859807_OperatingExpensesAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OperatingExpensesAbstract3_lbl0" xml:lang="en-US">Operating Expenses Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract3" xlink:to="ck0001859807_OperatingExpensesAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OperatingExpensesAbstract0_lbl0" xml:lang="en-US">Operating Expenses Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract0" xlink:to="ck0001859807_OperatingExpensesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OperatingExpensesAbstract1_lbl0" xml:lang="en-US">Operating Expenses Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OperatingExpensesAbstract1" xlink:to="ck0001859807_OperatingExpensesAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate_lbl1" xml:lang="en-US">Effective Income Tax Rate Reconciliation At Penalties And Interest Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" xlink:to="ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_DissolutionExpenseWaiverMember_lbl0" xml:lang="en-US">Dissolution Expense Waiver Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_DissolutionExpenseWaiverMember" xlink:to="ck0001859807_DissolutionExpenseWaiverMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl0" xml:lang="en-US">Deferred Tax Assets, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_EquityPercentage_lbl1" xml:lang="en-US">Equity Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityPercentage" xlink:to="ck0001859807_EquityPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RedemptionPricePerWarrant_lbl1" xml:lang="en-US">Redemption Price Per Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RedemptionPricePerWarrant" xlink:to="ck0001859807_RedemptionPricePerWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_TaslyConvertibleDebtMember_lbl0" xml:lang="en-US">Tasly Convertible Debt Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_TaslyConvertibleDebtMember" xlink:to="ck0001859807_TaslyConvertibleDebtMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseOther_lbl1" xml:lang="en-US">Interest Expense, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl0" xml:lang="en-US">Long-Term Purchase Commitment, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl0" xml:lang="en-US">Legal Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember_lbl0" xml:lang="en-US">January March Two Thousand Twenty Four Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" xlink:to="ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PIPEConvertibleNoteMember_lbl0" xml:lang="en-US">PIPEConvertible Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PIPEConvertibleNoteMember" xlink:to="ck0001859807_PIPEConvertibleNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_lbl0" xml:lang="en-US">Debt Instrument, Convertible, Liquidation Preference, Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:to="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_WarrantLiabilitiesPolicyTextBlock_lbl1" xml:lang="en-US">Warrant Liabilities Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_WarrantLiabilitiesPolicyTextBlock" xlink:to="ck0001859807_WarrantLiabilitiesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RepresentativeSharesCost_lbl1" xml:lang="en-US">Representative Shares Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativeSharesCost" xlink:to="ck0001859807_RepresentativeSharesCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember_lbl0" xml:lang="en-US">March Two Thousand Twenty Three Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember" xlink:to="ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_FounderSharesIssued_lbl1" xml:lang="en-US">Founder Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_FounderSharesIssued" xlink:to="ck0001859807_FounderSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PlusAbstract_lbl0" xml:lang="en-US">Plus Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PlusAbstract" xlink:to="ck0001859807_PlusAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OutstandingPrincipalAmount_lbl1" xml:lang="en-US">Outstanding Principal Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OutstandingPrincipalAmount" xlink:to="ck0001859807_OutstandingPrincipalAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockSubjectToPossibleRedemptionMember_lbl1" xml:lang="en-US">Common Stock Subject To Possible Redemption Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockSubjectToPossibleRedemptionMember" xlink:to="ck0001859807_CommonStockSubjectToPossibleRedemptionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl2" xml:lang="en-US">Units Issued During Period Shares New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightsMember_lbl0" xml:lang="en-US">Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightsMember" xlink:to="us-gaap_RightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PromissoryNotesMember_lbl0" xml:lang="en-US">Promissory Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PromissoryNotesMember" xlink:to="ck0001859807_PromissoryNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AssetsAbstract1_lbl0" xml:lang="en-US">Assets Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AssetsAbstract1" xlink:to="ck0001859807_AssetsAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed_lbl1" xml:lang="en-US">Reclassification Of Common Stock Subject To Redemption To Common Stock To Be Redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" xlink:to="ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl0" xml:lang="en-US">Operating Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_EquityIncentivePlanMember_lbl0" xml:lang="en-US">Equity Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_EquityIncentivePlanMember" xlink:to="ck0001859807_EquityIncentivePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AssetsAbstract2_lbl0" xml:lang="en-US">Assets Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AssetsAbstract2" xlink:to="ck0001859807_AssetsAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredLeasingFees_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Leasing Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredLeasingFees" xlink:to="us-gaap_IncreaseDecreaseInDeferredLeasingFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_AssetsAbstract0_lbl0" xml:lang="en-US">Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_AssetsAbstract0" xlink:to="ck0001859807_AssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ConvertiblePromissoryNoteAscentMember_lbl0" xml:lang="en-US">Convertible Promissory Note Ascent Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ConvertiblePromissoryNoteAscentMember" xlink:to="ck0001859807_ConvertiblePromissoryNoteAscentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract_lbl" xml:lang="en-US">Schedule Of Inputs Into The Monte Carlo Simulation For The Warrant Liabilities And Convertible Promissory Note Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:to="ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl0" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl1" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl0" xml:lang="en-US">Debt, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_UnpaidTotalLiabilityRate_lbl1" xml:lang="en-US">Unpaid Total Liability Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_UnpaidTotalLiabilityRate" xlink:to="ck0001859807_UnpaidTotalLiabilityRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl1" xml:lang="en-US">Business Combination, Series of Individually Immaterial Business Combinations [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl0" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl0" xml:lang="en-US">Cash, FDIC Insured Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RepresentativesWarrantsMember_lbl1" xml:lang="en-US">Representatives Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RepresentativesWarrantsMember" xlink:to="ck0001859807_RepresentativesWarrantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl1" xml:lang="en-US">Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:to="ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl3" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl1" xml:lang="en-US">Related Party Transaction Expenses From Transaction With Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:to="ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl0" xml:lang="en-US">Condensed Income Statement [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_OctoberDecember2024SeniorNotesMember_lbl0" xml:lang="en-US">October December2024 Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_OctoberDecember2024SeniorNotesMember" xlink:to="ck0001859807_OctoberDecember2024SeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl0" xml:lang="en-US">Derivative Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl0" xml:lang="en-US">Measurement Input, Expected Term [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LessAbstract1_lbl0" xml:lang="en-US">Less Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract1" xlink:to="ck0001859807_LessAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl0" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LessAbstract2_lbl0" xml:lang="en-US">Less Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract2" xlink:to="ck0001859807_LessAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LessAbstract3_lbl0" xml:lang="en-US">Less Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract3" xlink:to="ck0001859807_LessAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LessAbstract0_lbl0" xml:lang="en-US">Less Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LessAbstract0" xlink:to="ck0001859807_LessAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl0" xml:lang="en-US">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_ProfusaIncMember_lbl0" xml:lang="en-US">Profusa Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_ProfusaIncMember" xlink:to="ck0001859807_ProfusaIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl0" xml:lang="en-US">Interest Expense, Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_LegalAndAccountingCosts_lbl1" xml:lang="en-US">Legal And Accounting Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_LegalAndAccountingCosts" xlink:to="ck0001859807_LegalAndAccountingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCosts_lbl0" xml:lang="en-US">Deferred Costs, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_PaymentOfDeferredOfferingCosts_lbl1" xml:lang="en-US">Payment Of Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_PaymentOfDeferredOfferingCosts" xlink:to="ck0001859807_PaymentOfDeferredOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock_lbl0" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Disclosures [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl0" xml:lang="en-US">Income Taxes Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl0" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ck0001859807_CommonStockExceedsPerShare_lbl1" xml:lang="en-US">Common Stock Exceeds Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001859807_CommonStockExceedsPerShare" xlink:to="ck0001859807_CommonStockExceedsPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>21
<FILENAME>ck0001859807-20250630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 09 20:42:43 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedBalanceSheet" roleURI="http://www.profusa.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedIncomeStatement" roleURI="http://www.profusa.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ShareholdersEquityType2or3" roleURI="http://www.profusa.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConsolidatedCashFlow" roleURI="http://www.profusa.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties" roleURI="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.profusa.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_FairValueMeasurement" roleURI="http://www.profusa.com/role/FairValueMeasurement"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_BalanceSheetComponents" roleURI="http://www.profusa.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_Debt" roleURI="http://www.profusa.com/role/Debt"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommitmentsandContingencies" roleURI="http://www.profusa.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConvertiblePreferredStock" roleURI="http://www.profusa.com/role/ConvertiblePreferredStock"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommonStock" roleURI="http://www.profusa.com/role/CommonStock"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_StockOptionPlan" roleURI="http://www.profusa.com/role/StockOptionPlan"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_RelatedPartyTransactions" roleURI="http://www.profusa.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_GovernmentGrantRevenue" roleURI="http://www.profusa.com/role/GovernmentGrantRevenue"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_IncomeTaxes" roleURI="http://www.profusa.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_Segments" roleURI="http://www.profusa.com/role/Segments"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SubsequentEvents" roleURI="http://www.profusa.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_InitialPublicOffering" roleURI="http://www.profusa.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_PrivatePlacement" roleURI="http://www.profusa.com/role/PrivatePlacement"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_AccountingPoliciesByPolicy" roleURI="http://www.profusa.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SignificantAccountingPoliciesTables" roleURI="http://www.profusa.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_FairValueMeasurementTables" roleURI="http://www.profusa.com/role/FairValueMeasurementTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_BalanceSheetComponentsTables" roleURI="http://www.profusa.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_DebtTables" roleURI="http://www.profusa.com/role/DebtTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConvertiblePreferredStockTables" roleURI="http://www.profusa.com/role/ConvertiblePreferredStockTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommonStockTables" roleURI="http://www.profusa.com/role/CommonStockTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_StockOptionPlanTables" roleURI="http://www.profusa.com/role/StockOptionPlanTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_IncomeTaxesTables" roleURI="http://www.profusa.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SegmentsTables" roleURI="http://www.profusa.com/role/SegmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable" roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable" roleURI="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofAccruedLiabilitiesTable" roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofChangesinDebtInstrumentsTable" roleURI="http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable" roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable" roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePreferredStockTable" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofReservedSharesofCommonStockTable" roleURI="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofActivityUnderthePlanisSetForthTable" roleURI="http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofStockCompensationExpenseTable" roleURI="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable" roleURI="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable" roleURI="http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofProvisionforIncomeTaxesTable" roleURI="http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable" roleURI="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals" roleURI="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0" roleURI="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0" roleURI="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0" roleURI="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofAccruedLiabilitiesTable0" roleURI="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDebtInstrumentsTable" roleURI="http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0" roleURI="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0" roleURI="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePreferredStockTable0" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofReservedSharesofCommonStockTable0" roleURI="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofActivityUnderthePlanTable" roleURI="http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofStockCompensationExpenseTable0" roleURI="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" roleURI="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable" roleURI="http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueofInvestmentsHeldinTrustAccountTable" roleURI="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossIncomePerShareTable" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConsolidatedBalanceSheetTable" roleURI="http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable" roleURI="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" roleURI="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable" roleURI="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePromissoryNoteTable" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofNetDeferredTaxAssetsTable" roleURI="http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofIncomeTaxProvisionTable" roleURI="http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofReconciliationoftheFederalIncomeTaxRateTable" roleURI="http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable" roleURI="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0" roleURI="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofBasicandDilutedNetLossPerShareTable" roleURI="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCondensedConsolidatedBalanceSheetTable" roleURI="http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0" roleURI="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" roleURI="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0" roleURI="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofConvertiblePromissoryNoteTable0" roleURI="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0" roleURI="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails" roleURI="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_FairValueMeasurementDetails" roleURI="http://www.profusa.com/role/FairValueMeasurementDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_DebtDetails" roleURI="http://www.profusa.com/role/DebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommitmentsandContingenciesDetails" roleURI="http://www.profusa.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_ConvertiblePreferredStockDetails" roleURI="http://www.profusa.com/role/ConvertiblePreferredStockDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_CommonStockDetails" roleURI="http://www.profusa.com/role/CommonStockDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_StockOptionPlanDetails" roleURI="http://www.profusa.com/role/StockOptionPlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_RelatedPartyTransactionsDetails" roleURI="http://www.profusa.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_IncomeTaxesDetails" roleURI="http://www.profusa.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SegmentsDetails" roleURI="http://www.profusa.com/role/SegmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_SubsequentEventsDetails" roleURI="http://www.profusa.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_InitialPublicOfferingDetails" roleURI="http://www.profusa.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#ck0001859807_r_PrivatePlacementDetails" roleURI="http://www.profusa.com/role/PrivatePlacementDetails"/>
  <roleRef xlink:type="simple" xlink:href="ck0001859807-20250630.xsd#DocumentAndEntityInformation" roleURI="http://www.profusa.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:role="http://www.profusa.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="CommonStockSubjectToPossibleRedemptionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthviewAcquisitionCorporationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthviewAcquisitionCorporationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthviewAcquisitionCorporationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidTaxes" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaidFranchiseTax" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidFranchiseTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="PrepaidFranchiseTax" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleDebtCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaycheckProtectionProgramLoan" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="PaycheckProtectionProgramLoan" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvanceFromProfusa" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdvanceFromProfusa"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="AdvanceFromProfusa" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecuritiesPurchaseAgreementCurrent" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="SecuritiesPurchaseAgreementCurrent" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="CommonStockSubjectToPossibleRedemptionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthviewAcquisitionCorporationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthviewAcquisitionCorporationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthviewAcquisitionCorporationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="CommonStockSubjectToPossibleRedemptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthviewAcquisitionCorporationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthviewAcquisitionCorporationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthviewAcquisitionCorporationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingExpensesAbstract0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingExpensesAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OperatingExpensesAbstract0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpenseNonoperating" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherIncome" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfConvertibleNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertibleNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="ChangeInFairValueOfConvertibleNote" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="ChangeInFairValueOfSecuritiesPurchaseAgreement" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpenseOther" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RestatementAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="3.0"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccretionOfCommonStockToRedemptionValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccretionOfCommonStockToRedemptionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AccretionOfCommonStockToRedemptionValue" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ExciseTaxLiabilityInConnectionWithStockRedemptions" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ExciseTaxLiabilityInConnectionWithStockRedemptions" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ChangeInFairValueOfConvertiblePromissoryNote" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ChangesInFairValueOfSecuritiesPurchaseAgreement" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xlink:to="us-gaap_OtherNoncashExpense" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xlink:to="GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt" order="1.01" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="2.01" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xlink:to="us-gaap_ShareBasedCompensation" order="3.01" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInPrepaidFranchiseTaxes" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidFranchiseTaxes" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfExtensionFeeIntoTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfExtensionFeeIntoTrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentOfExtensionFeeIntoTrustAccount" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="CashWithdrawnFromTrustAccountInConnectionWithRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="CashWithdrawnFromTrustAccountInConnectionWithRedemption" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDecommissioningFund" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDecommissioningFund"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromDecommissioningFund" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfDeferredOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentOfDeferredOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentOfDeferredOfferingCosts" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedemptionPaymentsDueToRedeemingStockholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPaymentsDueToRedeemingStockholders"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="RedemptionPaymentsDueToRedeemingStockholders" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_RestrictedCashCurrent_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExciseTaxPayableRedemptionOfCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ExciseTaxPayableRedemptionOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ExciseTaxPayableRedemptionOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccretionOfCommonStockToRedemptionValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccretionOfCommonStockToRedemptionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="AccretionOfCommonStockToRedemptionValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreasedecreaseInUnpaidDeferredOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0" xlink:to="IncreasedecreaseInUnpaidDeferredOfferingCosts" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable"/>
    <loc xlink:type="locator" xlink:label="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable" xlink:to="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesTable" xlink:to="SummaryofSignificantAccountingPoliciesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/FairValueMeasurement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="FairValueMeasurementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementTable" xlink:to="FairValueMeasurementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/BalanceSheetComponents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="srt_CondensedFinancialStatementsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/Debt" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesTable" xlink:to="CommitmentsandContingenciesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ConvertiblePreferredStock" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/CommonStock" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="CommonStockTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockTable"/>
    <loc xlink:type="locator" xlink:label="CommonStockLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="CommonStockTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockTable" xlink:to="CommonStockLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/StockOptionPlan" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/RelatedPartyTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsTable" xlink:to="RelatedPartyTransactionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/GovernmentGrantRevenue" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentAssistanceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentAssistanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GovernmentAssistanceAbstract" xlink:to="us-gaap_GovernmentAssistanceTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/IncomeTaxes" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesTable" xlink:to="IncomeTaxesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/Segments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsTable"/>
    <loc xlink:type="locator" xlink:label="SegmentsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="SegmentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsTable" xlink:to="SegmentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsLineItems" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsTable" xlink:to="SubsequentEventsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/InitialPublicOffering" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingAbstract"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingTable"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingAbstract" xlink:to="InitialPublicOfferingTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingTable" xlink:to="InitialPublicOfferingLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingLineItems" xlink:to="InitialPublicOfferingTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/PrivatePlacement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementTable"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="PrivatePlacementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementTable" xlink:to="PrivatePlacementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementsTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementLineItems" xlink:to="PrivatePlacementsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesbyPolicyPoliciesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccountingPoliciesbyPolicyPoliciesTable"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="AccountingPoliciesbyPolicyPoliciesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesTable" xlink:to="AccountingPoliciesbyPolicyPoliciesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="ConvertiblePreferredStockPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmergingGrowthCompanyStatusPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="EmergingGrowthCompanyStatusPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_DebtPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilitiesPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantLiabilitiesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="WarrantLiabilitiesPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecuritiesPurchaseAgreementPolicyTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="SecuritiesPurchaseAgreementPolicyTextBlock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesTablesTable"/>
    <loc xlink:type="locator" xlink:label="SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTablesTable" xlink:to="SummaryOfSignificantAccountingPoliciesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_MarketableSecuritiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/FairValueMeasurementTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementTablesTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="FairValueMeasurementTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementTablesTable" xlink:to="FairValueMeasurementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementLineItems" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementLineItems" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/DebtTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ConvertiblePreferredStockTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ScheduleOfConvertiblePreferredStockTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/CommonStockTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/StockOptionPlanTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/IncomeTaxesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesTablesTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesTablesTable" xlink:to="IncomeTaxesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesLineItems" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/SegmentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentsTablesTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsTablesTable"/>
    <loc xlink:type="locator" xlink:label="SegmentsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="SegmentsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsTablesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsTablesTable" xlink:to="SegmentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsLineItems" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsLineItems" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="ProfusaMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_NotesPayableFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NotesPayableFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract" xlink:to="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:to="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvanceRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvanceRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_AdvanceRoyalties" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaidLegal" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidLegal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="PrepaidLegal" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidInsurance" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfAccruedLiabilitiesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInDebtInstrumentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInDebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaslyConvertibleDebtMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TaslyConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TaslyConvertibleDebtMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorNoteMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PromissoryNotesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PPPLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PPPLoanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PPPLoanMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="StatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StatedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="StatedInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract" xlink:to="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ConvertibleDebtMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_SeniorNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueRemeasurement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleDebt" xlink:to="FairValueRemeasurement" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="InterestExpensesNotesPayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestExpensesNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleDebt" xlink:to="InterestExpensesNotesPayable" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertiblePreferredStockAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePreferredStockAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConvertiblePreferredStockAbstract" xlink:to="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NewSeriesAConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesAConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesAConvertiblePreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewSeriesBConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesBConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesBConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewSeriesCConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesCConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesCConvertiblePreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewSeriesC1ConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesC1ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesC1ConvertiblePreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:to="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfReservedSharesOfCommonStockAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReservedSharesOfCommonStockAbstract" xlink:to="us-gaap_ConversionOfStockTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingOptionsUnderTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OutstandingOptionsUnderTwoThousandTenPlanMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_ConversionOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfActivityUnderThePlanIsSetForthAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract"/>
    <loc xlink:type="locator" xlink:label="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable"/>
    <loc xlink:type="locator" xlink:label="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfActivityUnderThePlanIsSetForthAbstract" xlink:to="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable" xlink:to="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfStockCompensationExpenseAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfStockCompensationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockCompensationExpenseAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleLoansMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="ConvertibleLoansMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsToPurchaseCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OptionsToPurchaseCommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="OptionsToPurchaseCommonStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfProvisionForIncomeTaxesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsDepreciationAndAmortization" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsDepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsDepreciationAndAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsConvertibleDebt" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DeferredTaxAssetsConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsConvertibleDebt" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingExpensesAbstract1" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingExpensesAbstract1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="OperatingExpensesAbstract1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract1" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract1" xlink:to="us-gaap_OtherCostAndExpenseOperating" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract1" xlink:to="AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RentAndOfficeCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RentAndOfficeCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract1" xlink:to="RentAndOfficeCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LegalAndAccountingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LegalAndAccountingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract1" xlink:to="LegalAndAccountingCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract1" xlink:to="us-gaap_OtherExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OperatingExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_InterestExpenseNonoperating" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OtherIncome" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_NetIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract" xlink:to="us-gaap_InterestExpenseOther" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LiabilitiesAbstract1" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LiabilitiesAbstract1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesAbstract1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAbstract1" xlink:to="us-gaap_NotesPayableFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAbstract1" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract" xlink:to="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="PrepaidLegal" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrepaidLegal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="PrepaidLegal" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidInsurance" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfAccruedLiabilitiesAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofDebtInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDebtInstrumentsAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDebtInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaslyConvertibleDebtMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TaslyConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TaslyConvertibleDebtMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorNoteMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PromissoryNotesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PPPLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PPPLoanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PPPLoanMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="StatedInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StatedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="StatedInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract" xlink:to="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_SeniorNotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ConvertibleDebtMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_ConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueRemeasurement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="FairValueRemeasurement" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestExpensesNotesPayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestExpensesNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="InterestExpensesNotesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_ConvertibleNotesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertiblePreferredStockAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePreferredStockAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConvertiblePreferredStockAbstract" xlink:to="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NewSeriesAConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesAConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesAConvertiblePreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewSeriesBConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesBConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesBConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewSeriesCConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesCConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesCConvertiblePreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewSeriesC1ConvertiblePreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewSeriesC1ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewSeriesC1ConvertiblePreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfReservedSharesOfCommonStockAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReservedSharesOfCommonStockAbstract" xlink:to="us-gaap_ConversionOfStockTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesCC1PreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeriesCC1PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesCC1PreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingOptionsUnderTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OutstandingOptionsUnderTwoThousandTenPlanMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="IssuanceOfOptionsUnderTheTwoThousandTenPlanMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_ConversionOfStockLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfActivityUnderThePlanAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfActivityUnderThePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfActivityUnderThePlanAbstract" xlink:to="StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanScheduleofActivityUnderthePlanDetailsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfStockCompensationExpenseAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfStockCompensationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockCompensationExpenseAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleLoansMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="ConvertibleLoansMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsToPurchaseCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OptionsToPurchaseCommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="OptionsToPurchaseCommonStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract" xlink:to="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="srt_ConsolidationItemsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="us-gaap_OperatingSegmentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingExpensesAbstract2" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingExpensesAbstract2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="OperatingExpensesAbstract2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract2" xlink:to="us-gaap_ShareBasedCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract2" xlink:to="us-gaap_OtherCostAndExpenseOperating" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract2" xlink:to="AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RentAndOfficeCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RentAndOfficeCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract2" xlink:to="RentAndOfficeCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LegalAndAccountingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LegalAndAccountingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract2" xlink:to="LegalAndAccountingCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract2" xlink:to="us-gaap_OtherExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract2" xlink:to="us-gaap_OperatingExpenses" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpenseNonoperating" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract" xlink:to="us-gaap_MarketableSecuritiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetHeldInTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetHeldInTrustMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_AssetHeldInTrustMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract" xlink:to="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="CommonStockSubjectToPossibleRedemptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable" xlink:to="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityNetIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="LessAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LessAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="LessAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedemptionPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedemptionPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LessAbstract" xlink:to="us-gaap_RedemptionPremium" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PlusAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PlusAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="PlusAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlusAbstract" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlusAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract" xlink:to="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CashAndMarketableSecuritiesHeldInTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="CashAndMarketableSecuritiesHeldInTrustMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="ConvertiblePromissoryNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PublicWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PrivatePlacementWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="RepresentativesWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExercisePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
<!-- [WMV6][qkVCmF8G/FitgekBXCoGwvBJWQfFbbINJzhzvdXXM9TnSKjrNYX8gT06MK1YGiPaSDpVcDqPfHsGO7CXx6NuBUIS1glPto6YQEYJLllmXq21zP17eF3LfKEiEhAlGqBOTDCqj1X7/V/B0Qk9XTIL7PN0Twg5zsqYm38QDTE0yKYQxMCpUpCwDcaL3/DkK4/CKnE1B+xln9kpnJrSCwlNGB+0cKji/c2ldKXzlEwBzNOP60CZPWXWEIWneif4Mtk4K6yPZxaztBItB1inyLlG4ZMwMesxUVUMuGcVufGgPadj4GQ73cHSdrjwq2tEDYcfCHiQqpOGKw==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputExercisePriceMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueInputsQuantitativeInformationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PrivatePlacementWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="RepresentativesWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilityMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantLiabilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertiblePromissoryNoteAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConvertiblePromissoryNoteAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertiblePromissoryNoteMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_ConversionOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="PrincipalBorrowing" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrincipalBorrowing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="PrincipalBorrowing" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="ChangeInFairValueOfConvertiblePromissoryNote" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable" xlink:to="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeTaxProvisionAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfIncomeTaxProvisionAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxProvisionAbstract" xlink:to="IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable" xlink:to="IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract" xlink:to="srt_CondensedIncomeStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ChiefOperatingOfficerDecisionMakerMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChiefOperatingOfficerDecisionMakerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="ChiefOperatingOfficerDecisionMakerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_Cash" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract" xlink:to="us-gaap_MarketableSecuritiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasicAndDilutedNetLossPerShareAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CommonStockSubjectToPossibleRedemptionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockSubjectToPossibleRedemptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="CommonStockSubjectToPossibleRedemptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable" xlink:to="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityNetIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedemptionPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedemptionPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_RedemptionPremium" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract" xlink:to="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CashAndMarketableSecuritiesHeldInTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="CashAndMarketableSecuritiesHeldInTrustMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="ConvertiblePromissoryNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PublicWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PrivatePlacementWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="RepresentativesWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="SecuritiesPurchaseAgreementCurrent" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="SecuritiesPurchaseAgreementCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuritiesPurchaseAgreementCurrent" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExercisePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputExercisePriceMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteAscentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteAscentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="ConvertiblePromissoryNoteAscentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueInputsQuantitativeInformationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PrivatePlacementWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RepresentativesWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativesWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="RepresentativesWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsLiabilityMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WarrantsLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantsLiabilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable" xlink:to="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertiblePromissoryNoteAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConvertiblePromissoryNoteAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteRelatedPartyMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="ConvertiblePromissoryNoteRelatedPartyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecuritiesPurchaseAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="SecuritiesPurchaseAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfConvertiblePromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ChangeInFairValueOfConvertiblePromissoryNote" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract" xlink:to="srt_CondensedIncomeStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeSecuritiesOtherUSGovernment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeSecuritiesOtherUSGovernment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_InterestIncomeSecuritiesOtherUSGovernment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RedeemableSharesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedeemableSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="RedeemableSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="USFederalMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_USFederalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="USFederalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleWorkingCapitalPromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="ConvertibleWorkingCapitalPromissoryNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NorthViewTrustMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewTrustMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewTrustMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_OwnershipAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ProfusaAsiaPacificPteLtdMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaAsiaPacificPteLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="ProfusaAsiaPacificPteLtdMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="ProfusaMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_RightsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="PublicSharesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PublicSharesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="SponsorMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="DissolutionExpenseWaiverMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DissolutionExpenseWaiverMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="DissolutionExpenseWaiverMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="DepositAxis" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DepositAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="DepositAxis" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DepositDomainDomain" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DepositDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositAxis" xlink:to="DepositDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="JuneJulyAndAugustExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JuneJulyAndAugustExtensionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositAxis" xlink:to="JuneJulyAndAugustExtensionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JanuaryExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryExtensionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositAxis" xlink:to="JanuaryExtensionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FebruaryExtensionMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FebruaryExtensionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositAxis" xlink:to="FebruaryExtensionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RedeemableWarrantMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedeemableWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="RedeemableWarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="dei_LegalEntityAxis" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SpecialMeetingMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SpecialMeetingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="SpecialMeetingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevenueTarget" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RevenueTarget"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="RevenueTarget" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapitalDeficit" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WorkingCapitalDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="WorkingCapitalDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TransactionCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="TransactionCost" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritingDiscountAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderwritingDiscountAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="UnderwritingDiscountAmount" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RepresentativeSharesCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativeSharesCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="RepresentativeSharesCost" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RepresentativeWarrantCost" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RepresentativeWarrantCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="RepresentativeWarrantCost" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherOfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OtherOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="OtherOfferingCosts" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfAggregateFairMarketValueOfAsset" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAggregateFairMarketValueOfAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageOfAggregateFairMarketValueOfAsset" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsForInvestmentOfCashInTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentsForInvestmentOfCashInTrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PaymentsForInvestmentOfCashInTrustAccount" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingBankAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperatingBankAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="OperatingBankAccount" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaturityDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MaturityDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="MaturityDays" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentofInteresttoDistributionExpense" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaymentofInteresttoDistributionExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PaymentofInteresttoDistributionExpense" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapital" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WorkingCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="WorkingCapital" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashContributionExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_NoncashContributionExpense" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Deposits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Deposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Deposits" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_InterestIncomeOther" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PartnersCapitalAccountContributions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PartnersCapitalAccountContributions" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnsecuredPromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnsecuredPromissoryNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="UnsecuredPromissoryNote" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="41.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingPrincipalAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OutstandingPrincipalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="OutstandingPrincipalAmount" order="42.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="43.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="44.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" order="45.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="46.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" order="47.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExciseAndSalesTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ExciseAndSalesTaxes" order="48.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesRedeemedPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SharesRedeemedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="SharesRedeemedPercentage" order="49.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EstimatedInterestRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EstimatedInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="EstimatedInterestRate" order="50.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderpaymentPenaltyRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderpaymentPenaltyRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="UnderpaymentPenaltyRate" order="51.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnpaidTotalLiabilityRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnpaidTotalLiabilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="UnpaidTotalLiabilityRate" order="52.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent" order="53.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PurchasePrice" order="54.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOriginalIssuanceDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssuanceDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageOfOriginalIssuanceDiscount" order="55.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Cash" order="56.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="57.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentForAdministrativeFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentForAdministrativeFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentForAdministrativeFees" order="58.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfPublicShares" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfPublicShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageOfPublicShares" order="59.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedemptionPublicShares" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPublicShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="RedemptionPublicShares" order="60.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="61.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountDrawn" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AmountDrawn"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="AmountDrawn" order="62.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockholdersAmendmentPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockholdersAmendmentPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="StockholdersAmendmentPercentage" order="63.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfRedeemingPublicShareholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfRedeemingPublicShareholders"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageOfRedeemingPublicShareholders" order="64.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" order="65.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestFromTrustAccount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InterestFromTrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="InterestFromTrustAccount" order="66.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="67.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RestrictedCash" order="68.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FundingOperatingExpenses" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FundingOperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="FundingOperatingExpenses" order="69.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="70.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_AssetsHeldInTrust" order="71.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" order="72.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CashAndMarketableSecuritiesHeldInTrustAccountMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="CashAndMarketableSecuritiesHeldInTrustAccountMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="BusinessCombinationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="NorthViewAcquisitionCorpMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PublicWarrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PrivatePlacementWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsLineItems" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalizedContractCostNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_CapitalizedContractCostNetCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeSecuritiesTaxable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeSecuritiesTaxable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_InterestIncomeSecuritiesTaxable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayableCommonStockRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayableCommonStockRedeemed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_PayableCommonStockRedeemed" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrustCurrent" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashContributionExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_NoncashContributionExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperationsAndRedeemRepurchasePercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OperationsAndRedeemRepurchasePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="OperationsAndRedeemRepurchasePercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestCostsIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestCostsIncurred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_InterestCostsIncurred" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OfferingCosts" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="OfferingCosts" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/FairValueMeasurementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FairValueMeasurementDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="FairValueMeasurementDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ConvertibleDebtMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PublicWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementDetailsTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleDebtOfTermFairValue" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfTermFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="ConvertibleDebtOfTermFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleDebtOfDiscountRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfDiscountRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="ConvertibleDebtOfDiscountRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShorttermDebtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ShorttermDebtFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ConvertibleDebt" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/DebtDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="DebtDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="DebtDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrelatedPartiesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnrelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="UnrelatedPartiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesNovember2022AmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesNovember2022AmendmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="ConvertibleNotesNovember2022AmendmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaslyConvertibleDebtMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TaslyConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="TaslyConvertibleDebtMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_SeniorNotesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="PromissoryNotesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaycheckProtectionProgramMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="PaycheckProtectionProgramMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="ConvertibleNotesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ConvertibleDebtMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ShortTermLoanAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShortTermLoanAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="ShortTermLoanAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AugustTwoThousandTwentyConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="AugustTwoThousandTwentyConvertibleNotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JanuaryTwoThousandTwentyOneConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="JanuaryTwoThousandTwentyOneConvertibleNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AprilTwoThousandTwentyOneConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="AprilTwoThousandTwentyOneConvertibleNotesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleNotesMember_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AugustTwoThousandTwentyOneSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="AugustTwoThousandTwentyOneSeniorNotesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DecemberTwoThousandTwentyOneSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="DecemberTwoThousandTwentyOneSeniorNotesMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OctoberTwoThousandTwentyTwoSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="OctoberTwoThousandTwentyTwoSeniorNotesMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DecemberTwoThousandTwentyTwoSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="DecemberTwoThousandTwentyTwoSeniorNotesMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarchTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="MarchTwoThousandTwentyThreeSeniorNotesMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AprilTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="AprilTwoThousandTwentyThreeSeniorNotesMember" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="JanuaryMarchTwoThousandTwentyFourSeniorNotesMember" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AprilJuneTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="AprilJuneTwoThousandTwentyFourSeniorNotesMember" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JulySeptemberTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="JulySeptemberTwoThousandTwentyFourSeniorNotesMember" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorSecuredConvertibleNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorSecuredConvertibleNoteMember" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="OctoberDecemberTwoThousandTwentyFourSeniorNotesMember" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OctoberDecember2024SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_OctoberDecember2024SeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="OctoberDecember2024SeniorNotesMember" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaycheckProtectionProgramLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PaycheckProtectionProgramLoanMember" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JanuaryMarch2024SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarch2024SeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="JanuaryMarch2024SeniorNotesMember" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JanuaryMarch2025SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_JanuaryMarch2025SeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="JanuaryMarch2025SeniorNotesMember" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AprilJune2025SeniorNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AprilJune2025SeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="AprilJune2025SeniorNotesMember" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDetailsTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DebtInstrumentDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInstrumentDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="DebtInstrumentDiscount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DerivativeLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DebtInstrumentsContractualTerm" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInstrumentsContractualTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="DebtInstrumentsContractualTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="BusinessDays" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermBorrowings" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DebtInterestRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DebtInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="DebtInterestRate" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockConvertibleConversionPrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockConvertibleConversionPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="CommonStockConvertibleConversionPrice" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebt" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnFairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LossOnFairValueRemeasurement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="LossOnFairValueRemeasurement" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleDebtOfDiscountRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleDebtOfDiscountRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ConvertibleDebtOfDiscountRate" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ExtinguishmentOfDebtAmount" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AdditionalPaidInCapital" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaturityMonth" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MaturityMonth"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="MaturityMonth" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SeniorNotes" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissoryNotes" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="PromissoryNotes" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtInterestRateIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtInterestRateIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermDebtInterestRateIncrease" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromShortTermDebt" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrelatedPartyRepayable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnrelatedPartyRepayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="UnrelatedPartyRepayable" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermDebtWeightedAverageInterestRate" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MonthlyPayments" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MonthlyPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="MonthlyPayments" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LatePenaltiesAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LatePenaltiesAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="LatePenaltiesAmount" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDefaultLongtermDebtAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount" order="41.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnFairValueRemeasurement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_GainOnFairValueRemeasurement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="GainOnFairValueRemeasurement" order="42.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="43.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfAccrueInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAccrueInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="PercentageOfAccrueInterest" order="44.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="45.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest" order="46.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnpaidInterest" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnpaidInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="UnpaidInterest" order="47.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansHeldForSaleTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansHeldForSaleTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LoansHeldForSaleTerm" order="48.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommitmentsandContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="NewProfusaCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewProfusaCommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewProfusaCommonStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BankersAndDawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BankersAndDawsonJamesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="BankersAndDawsonJamesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="IBankersMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IBankersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="IBankersMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DawsonJamesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="DawsonJamesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_PrivatePlacementMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_InvestorMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_ExtinguishmentOfDebtAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ShortTermDebtMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseContractualTermAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseContractualTermDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ShortTermLeasesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ShortTermLeasesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="ShortTermLeasesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleNotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="InitialNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecondPurchaseMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecondPurchaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SecondPurchaseMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CashFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashFeeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="CashFeeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvisoryFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdvisoryFeeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="AdvisoryFeeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ArrangementFeeMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ArrangementFeeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="ArrangementFeeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecuritiesPurchaseAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="SecuritiesPurchaseAgreementMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_LossContingenciesLineItems" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseAndRentalExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShortTermLeasePayments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsForRent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShortTermLeaseCost" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableLeasePayment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeasePayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_VariableLeasePayment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfDaysForUnderwriterOptions" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfDaysForUnderwriterOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="NumberOfDaysForUnderwriterOptions" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="UnitsIssuedDuringPeriodSharesNewIssues" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnderwritingExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_UnderwritingExpenseRatio" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritingDiscountAmount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnderwritingDiscountAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="UnderwritingDiscountAmount" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingGrossProceedPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingGrossProceedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="InitialPublicOfferingGrossProceedPercentage" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationPercentageRate" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationPercentageRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="BusinessCombinationPercentageRate" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CashPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="CashPercentage" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EquityPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="EquityPercentage" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentDueInSecondAndThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentDueInSecondAndThirdYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OtherCommitmentDueInSecondAndThirdYear" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LockupPeriod" xlink:href="ck0001859807-20250630.xsd#ck0001859807_LockupPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="LockupPeriod" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_Cash" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_AssetsHeldInTrust" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredLeasingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredLeasingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInDeferredLeasingFees" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsForFees" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OtherExpenses" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfNetProceeds" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfNetProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="PercentageOfNetProceeds" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAveragePricePerSharePercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_WeightedAveragePricePerSharePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="WeightedAveragePricePerSharePercentage" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfTradingDay" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDay"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="NumberOfTradingDay" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="41.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CommonStockValue" order="42.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TradingPricePerShare" xlink:href="ck0001859807-20250630.xsd#ck0001859807_TradingPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="TradingPricePerShare" order="43.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LegalFees" order="44.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/ConvertiblePreferredStockDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertiblePreferredStockDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ConvertiblePreferredStockDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Dividends"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_Dividends" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/CommonStockDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="CommonStockDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommonStockDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="CommonStockDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FounderShareMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="FounderShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FounderShares1Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShares1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="FounderShares1Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsTable" xlink:to="CommonStockDetailsLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FounderSharesIssued" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="FounderSharesIssued" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="16.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="VotingSharesPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_VotingSharesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="VotingSharesPercentage" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsShares" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/StockOptionPlanDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="StockOptionPlanDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_StockOptionPlanDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="StockOptionPlanDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EquityIncentivePlanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="EquityIncentivePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Plan2018Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_Plan2018Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="Plan2018Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionPlanDetailsTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfExcercisePriceOption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfExcercisePriceOption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="PercentageOfExcercisePriceOption" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="srt_RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FounderShares1Member" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShares1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="FounderShares1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdministrativeSupportAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AdministrativeSupportAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="AdministrativeSupportAgreementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="SponsorMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FounderShareMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_FounderShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="FounderShareMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SponsorMember_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AscentNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AscentNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="AscentNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PIPEConvertibleNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PIPEConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PIPEConvertibleNoteMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyLoanMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyLoanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="RelatedPartyLoanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="RelatedPartyTransactionsDetailsLineItems" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockExceedsPerShare" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockExceedsPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="CommonStockExceedsPerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfTradingDay" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDay"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="NumberOfTradingDay" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleWorkingCapitalPromissoryNote" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleWorkingCapitalPromissoryNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="ConvertibleWorkingCapitalPromissoryNote" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_NotesPayable" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOriginalIssueDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssueDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="PercentageOfOriginalIssueDiscount" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfSecuritiesPurchaseAgreement" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="ChangeInFairValueOfSecuritiesPurchaseAgreement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfLowestVolumeWeightedAveragePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="PercentageOfLowestVolumeWeightedAveragePrice" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ConvertibleDebtCurrent" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SponsorFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SponsorFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SponsorFees" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateNumberOfSharesOwned" xlink:href="ck0001859807-20250630.xsd#ck0001859807_AggregateNumberOfSharesOwned"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="AggregateNumberOfSharesOwned" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/IncomeTaxesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IncomeTaxesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="stpr_CA" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ProfusaIncMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="ProfusaIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxContingencyLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ReceivedPaycheckProtectionProgramLoans" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ReceivedPaycheckProtectionProgramLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="ReceivedPaycheckProtectionProgramLoans" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaycheckProtectionProgramLoansOutstanding" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PaycheckProtectionProgramLoansOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="PaycheckProtectionProgramLoansOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/SegmentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SegmentsDetailsLineItems" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SegmentsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="SegmentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsDetailsTable" xlink:to="SegmentsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsDetailsLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsDetailsLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsDetailsLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NewProfusaCommonStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NewProfusaCommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="NewProfusaCommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="ConvertibleNotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorConvertiblesNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorConvertiblesNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="SeniorConvertiblesNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleNotesMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissoryNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="PromissoryNoteMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonrecoursePromissoryNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NonrecoursePromissoryNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="NonrecoursePromissoryNotesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorConvertiblesNotesMember_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorConvertiblesNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorConvertiblesNotesMember_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorConvertibleBridgeNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorConvertibleBridgeNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorConvertibleBridgeNotesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorSecuredConvertibleNotesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorSecuredConvertibleNotesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeniorSecuredNoteMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SeniorSecuredNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="SeniorSecuredNoteMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_OwnershipAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationProfusaMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_BusinessCombinationProfusaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="BusinessCombinationProfusaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="DissolutionExpenseWaiverMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DissolutionExpenseWaiverMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="DissolutionExpenseWaiverMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NoRedemptionScenarioMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NoRedemptionScenarioMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="NoRedemptionScenarioMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecuritiesPurchaseAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SecuritiesPurchaseAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="SecuritiesPurchaseAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MergerAgreementMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MergerAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="MergerAgreementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ProfusaPreferredStockMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ProfusaPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="ProfusaPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_StatementScenarioAxis" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventLineItems" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOriginalIssueDiscount" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfOriginalIssueDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="PercentageOfOriginalIssueDiscount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfNonRedeemingPublicShareholders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfNonRedeemingPublicShareholders"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="PercentageOfNonRedeemingPublicShareholders" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfLowestVolumeWeightedAveragePrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="PercentageOfLowestVolumeWeightedAveragePrice" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfAverageDailyTradedValueOfCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="PercentageOfAverageDailyTradedValueOfCommonStock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfTradingDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="NumberOfTradingDays" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfLimitForOutstandingCommonStock" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfLimitForOutstandingCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="PercentageOfLimitForOutstandingCommonStock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="21.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="23.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashMergerRelatedCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NoncashMergerRelatedCosts" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/InitialPublicOfferingDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingAbstract"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_InitialPublicOfferingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingAbstract" xlink:to="InitialPublicOfferingDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PublicWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember_0" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PublicWarrantsMember_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="ck0001859807-20250630.xsd#ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="UnitsIssuedDuringPeriodSharesNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesIssuedPerUnit" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfSharesIssuedPerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NumberOfSharesIssuedPerUnit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityProceedOwnershipPercentage" xlink:href="ck0001859807-20250630.xsd#ck0001859807_EquityProceedOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="EquityProceedOwnershipPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RedemptionPricePerWarrant" xlink:href="ck0001859807-20250630.xsd#ck0001859807_RedemptionPricePerWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="RedemptionPricePerWarrant" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfDaysForWrittenNoticeOfRedemption" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NumberOfDaysForWrittenNoticeOfRedemption" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" xlink:href="ck0001859807-20250630.xsd#ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockThresholdTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockThresholdTradingDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="CommonStockThresholdTradingDays" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockThresholdConsecutiveTradingDays" xlink:href="ck0001859807-20250630.xsd#ck0001859807_CommonStockThresholdConsecutiveTradingDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="CommonStockThresholdConsecutiveTradingDays" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/PrivatePlacementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementDetailsTable" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="PrivatePlacementDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NorthViewAcquisitionCorpMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_NorthViewAcquisitionCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="NorthViewAcquisitionCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SponsorMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_SponsorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SponsorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IBankersAndDawsonJamesMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_IBankersAndDawsonJamesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="IBankersAndDawsonJamesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsMember" xlink:href="ck0001859807-20250630.xsd#ck0001859807_PrivatePlacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PrivatePlacementWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.profusa.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="ck0001859807-20250630.xsd#ck0001859807_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001859807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PROFUSA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 44,000<span></span>
</td>
<td class="nump">$ 191,000<span></span>
</td>
<td class="nump">$ 142,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">209,000<span></span>
</td>
<td class="nump">69,000<span></span>
</td>
<td class="nump">146,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash and marketable securities held in Trust Account</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">253,000<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
<td class="nump">333,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and marketable securities held in Trust Account</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,274,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,136,000<span></span>
</td>
<td class="nump">2,757,000<span></span>
</td>
<td class="nump">1,527,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,444,000<span></span>
</td>
<td class="nump">3,073,000<span></span>
</td>
<td class="nump">1,893,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,884,000<span></span>
</td>
<td class="nump">4,954,000<span></span>
</td>
<td class="nump">3,993,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,299,000<span></span>
</td>
<td class="nump">3,968,000<span></span>
</td>
<td class="nump">2,351,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,971,000<span></span>
</td>
<td class="nump">45,921,000<span></span>
</td>
<td class="nump">38,185,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">940,000<span></span>
</td>
<td class="nump">910,000<span></span>
</td>
<td class="nump">849,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaycheckProtectionProgramLoan', window );">PPP loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,383,000<span></span>
</td>
<td class="nump">1,376,000<span></span>
</td>
<td class="nump">1,362,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63,477,000<span></span>
</td>
<td class="nump">57,129,000<span></span>
</td>
<td class="nump">46,740,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63,477,000<span></span>
</td>
<td class="nump">57,129,000<span></span>
</td>
<td class="nump">46,740,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Convertible Preferred Stock:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Total convertible preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,149,000<span></span>
</td>
<td class="nump">65,149,000<span></span>
</td>
<td class="nump">65,149,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,840,000<span></span>
</td>
<td class="nump">5,753,000<span></span>
</td>
<td class="nump">5,732,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(130,022,000)<span></span>
</td>
<td class="num">(124,958,000)<span></span>
</td>
<td class="num">(115,728,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(124,182,000)<span></span>
</td>
<td class="num">(119,205,000)<span></span>
</td>
<td class="num">(109,996,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock and stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,444,000<span></span>
</td>
<td class="nump">3,073,000<span></span>
</td>
<td class="nump">1,893,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember', window );">Northview Acquisition Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,204<span></span>
</td>
<td class="nump">4,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,166<span></span>
</td>
<td class="nump">6,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,504<span></span>
</td>
<td class="nump">30,492<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PrepaidFranchiseTax', window );">Prepaid franchise tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash and marketable securities held in Trust Account</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">661,012<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,565,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">687,867<span></span>
</td>
<td class="nump">60,862<span></span>
</td>
<td class="nump">1,576,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and marketable securities held in Trust Account</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,274,549<span></span>
</td>
<td class="nump">8,330,835<span></span>
</td>
<td class="nump">9,308,328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,962,416<span></span>
</td>
<td class="nump">8,391,697<span></span>
</td>
<td class="nump">10,884,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,744,538<span></span>
</td>
<td class="nump">684,483<span></span>
</td>
<td class="nump">449,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AdvanceFromProfusa', window );">Advance from Profusa</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,299,040<span></span>
</td>
<td class="nump">791,407<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Excise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,952,662<span></span>
</td>
<td class="nump">1,880,944<span></span>
</td>
<td class="nump">1,864,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Common stock to be redeemed</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,565,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">49,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note &#8211; related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,288,111<span></span>
</td>
<td class="nump">8,908,052<span></span>
</td>
<td class="nump">944,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SecuritiesPurchaseAgreementCurrent', window );">Securities purchase agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">193,878<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue', window );">Due to redeeming stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">661,012<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">41,180<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,180,421<span></span>
</td>
<td class="nump">12,314,886<span></span>
</td>
<td class="nump">4,921,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,961,700<span></span>
</td>
<td class="nump">696,170<span></span>
</td>
<td class="nump">156,639<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,142,121<span></span>
</td>
<td class="nump">13,011,056<span></span>
</td>
<td class="nump">5,091,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">519<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,510,739)<span></span>
</td>
<td class="num">(12,957,266)<span></span>
</td>
<td class="num">(3,459,829)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,510,220)<span></span>
</td>
<td class="num">(12,956,747)<span></span>
</td>
<td class="num">(3,459,310)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock and stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,962,416<span></span>
</td>
<td class="nump">8,391,697<span></span>
</td>
<td class="nump">10,884,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A convertible preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Convertible Preferred Stock:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,231,000<span></span>
</td>
<td class="nump">5,231,000<span></span>
</td>
<td class="nump">5,231,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B convertible preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Convertible Preferred Stock:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,701,000<span></span>
</td>
<td class="nump">13,701,000<span></span>
</td>
<td class="nump">13,701,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C/C-1 convertible preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Convertible Preferred Stock:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,217,000<span></span>
</td>
<td class="nump">46,217,000<span></span>
</td>
<td class="nump">46,217,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember', window );">Common stock subject to possible redemption | Northview Acquisition Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Convertible Preferred Stock:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,330,515<span></span>
</td>
<td class="nump">$ 8,337,388<span></span>
</td>
<td class="nump">$ 9,252,208<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In connection with the special meeting of stockholders to vote on extending the Combination Period, on
December 21, 2023, 140,663 shares of the Company&#8217;s common stock were redeemed at a per share price of $11.13. In January 2024, $1,565,078
was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company has recorded a liability
of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December 31, 2023 on the consolidated
balance sheet.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AdvanceFromProfusa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance from Profusa amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AdvanceFromProfusa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of PPP loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PrepaidFranchiseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of prepaid franchise tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PrepaidFranchiseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SecuritiesPurchaseAgreementCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SecuritiesPurchaseAgreementCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FeaturesOfConvertiblePreferredStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption value, as if currently redeemable, of redeemable noncontrolling interest for common shares, units or ownership interests classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt payable, loans and notes payable to a related party (in Dollars)</a></td>
<td class="nump">$ 26,670<span></span>
</td>
<td class="nump">$ 25,056<span></span>
</td>
<td class="nump">$ 21,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory notes payable to related parties (in Dollars)</a></td>
<td class="nump">$ 878<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="nump">$ 801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember', window );">Northview Acquisition Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference (in Dollars)</a></td>
<td class="nump">$ 5,307<span></span>
</td>
<td class="nump">$ 5,307<span></span>
</td>
<td class="nump">$ 5,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference (in Dollars)</a></td>
<td class="nump">$ 13,815<span></span>
</td>
<td class="nump">$ 13,815<span></span>
</td>
<td class="nump">$ 13,815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C/C-1 convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">8,907,893<span></span>
</td>
<td class="nump">8,907,893<span></span>
</td>
<td class="nump">8,907,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">8,220,445<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">8,220,445<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference (in Dollars)</a></td>
<td class="nump">$ 45,062<span></span>
</td>
<td class="nump">$ 45,062<span></span>
</td>
<td class="nump">$ 45,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember', window );">Common stock subject to possible redemption | Northview Acquisition Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">101,777<span></span>
</td>
<td class="nump">687,519<span></span>
</td>
<td class="nump">833,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Common stock subject to possible redemption, shares redemption (in Dollars per share)</a></td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="nump">$ 12.13<span></span>
</td>
<td class="nump">$ 11.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Government grant revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">393,000<span></span>
</td>
<td class="nump">432,000<span></span>
</td>
<td class="nump">827,000<span></span>
</td>
<td class="nump">938,000<span></span>
</td>
<td class="nump">1,608,000<span></span>
</td>
<td class="nump">2,036,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">610,000<span></span>
</td>
<td class="nump">569,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,402,000<span></span>
</td>
<td class="nump">2,992,000<span></span>
</td>
<td class="nump">4,079,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,003,000<span></span>
</td>
<td class="nump">1,001,000<span></span>
</td>
<td class="nump">2,427,000<span></span>
</td>
<td class="nump">2,340,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">6,115,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,003,000)<span></span>
</td>
<td class="num">(976,000)<span></span>
</td>
<td class="num">(2,427,000)<span></span>
</td>
<td class="num">(2,315,000)<span></span>
</td>
<td class="num">(4,500,000)<span></span>
</td>
<td class="num">(6,070,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on change in the fair value of related party Tasly convertible debt</a></td>
<td class="num">(57,000)<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
<td class="num">(11,000)<span></span>
</td>
<td class="num">(311,000)<span></span>
</td>
<td class="num">(22,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(1,289,000)<span></span>
</td>
<td class="num">(1,081,000)<span></span>
</td>
<td class="num">(2,519,000)<span></span>
</td>
<td class="num">(2,161,000)<span></span>
</td>
<td class="num">(4,424,000)<span></span>
</td>
<td class="num">(4,283,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">94,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income, net</a></td>
<td class="num">(1,345,000)<span></span>
</td>
<td class="num">(1,095,000)<span></span>
</td>
<td class="num">(2,637,000)<span></span>
</td>
<td class="num">(2,166,000)<span></span>
</td>
<td class="num">(4,730,000)<span></span>
</td>
<td class="num">(4,211,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss (income) and comprehensive loss</a></td>
<td class="num">$ (2,348,000)<span></span>
</td>
<td class="num">$ (2,071,000)<span></span>
</td>
<td class="num">$ (5,064,000)<span></span>
</td>
<td class="num">$ (4,481,000)<span></span>
</td>
<td class="num">$ (9,230,000)<span></span>
</td>
<td class="num">$ (10,281,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share, basic (in Dollars per share)</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (1.84)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share, Diluted (in Dollars per share)</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (1.84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in Shares)</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,600,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, Diluted (in Shares)</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,600,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember', window );">Northview Acquisition Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">$ (967,084)<span></span>
</td>
<td class="num">$ (253,130)<span></span>
</td>
<td class="num">$ (1,550,665)<span></span>
</td>
<td class="num">$ (723,971)<span></span>
</td>
<td class="num">$ (1,351,038)<span></span>
</td>
<td class="num">$ (1,508,683)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income earned on cash held in Trust Account</a></td>
<td class="nump">15,159<span></span>
</td>
<td class="nump">108,520<span></span>
</td>
<td class="nump">95,084<span></span>
</td>
<td class="nump">225,184<span></span>
</td>
<td class="nump">425,416<span></span>
</td>
<td class="nump">2,248,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfConvertibleNote', window );">Change in fair value of convertible promissory note</a></td>
<td class="num">(1,154,729)<span></span>
</td>
<td class="nump">66,021<span></span>
</td>
<td class="num">(1,380,059)<span></span>
</td>
<td class="nump">126,098<span></span>
</td>
<td class="num">(7,165,953)<span></span>
</td>
<td class="nump">177,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement', window );">Change in fair value of securities purchase agreement</a></td>
<td class="num">(170,391)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(193,878)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(5,917,445)<span></span>
</td>
<td class="num">(295,872)<span></span>
</td>
<td class="num">(6,265,530)<span></span>
</td>
<td class="num">(800,595)<span></span>
</td>
<td class="num">(539,531)<span></span>
</td>
<td class="nump">701,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income, net</a></td>
<td class="num">(7,227,406)<span></span>
</td>
<td class="num">(121,331)<span></span>
</td>
<td class="num">(7,744,383)<span></span>
</td>
<td class="num">(449,313)<span></span>
</td>
<td class="num">(7,280,068)<span></span>
</td>
<td class="nump">3,127,383<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before provision for income tax</a></td>
<td class="num">(8,194,490)<span></span>
</td>
<td class="num">(374,461)<span></span>
</td>
<td class="num">(9,295,048)<span></span>
</td>
<td class="num">(1,173,284)<span></span>
</td>
<td class="num">(8,631,106)<span></span>
</td>
<td class="nump">1,618,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="num">(2,386)<span></span>
</td>
<td class="num">(23,026)<span></span>
</td>
<td class="num">(21,738)<span></span>
</td>
<td class="num">(44,480)<span></span>
</td>
<td class="num">(80,513)<span></span>
</td>
<td class="num">(456,790)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss (income) and comprehensive loss</a></td>
<td class="num">$ (8,196,876)<span></span>
</td>
<td class="num">$ (397,487)<span></span>
</td>
<td class="num">$ (9,316,786)<span></span>
</td>
<td class="num">$ (1,217,764)<span></span>
</td>
<td class="num">$ (8,711,619)<span></span>
</td>
<td class="nump">$ 1,161,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share, basic (in Dollars per share)</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share, Diluted (in Dollars per share)</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in Shares)</a></td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, Diluted (in Shares)</a></td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Formation and operating costs</a></td>
<td class="nump">$ 967,084<span></span>
</td>
<td class="nump">$ 253,130<span></span>
</td>
<td class="nump">$ 1,550,665<span></span>
</td>
<td class="nump">$ 723,971<span></span>
</td>
<td class="nump">$ 1,351,038<span></span>
</td>
<td class="nump">$ 1,508,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember', window );">Common stock subject to possible redemption | Northview Acquisition Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share, basic (in Dollars per share)</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share, Diluted (in Dollars per share)</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in Shares)</a></td>
<td class="nump">146,440<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="nump">412,717<span></span>
</td>
<td class="nump">783,151<span></span>
</td>
<td class="nump">747,644<span></span>
</td>
<td class="nump">4,866,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, Diluted (in Shares)</a></td>
<td class="nump">146,440<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="nump">412,717<span></span>
</td>
<td class="nump">783,151<span></span>
</td>
<td class="nump">747,644<span></span>
</td>
<td class="nump">4,866,356<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ChangeInFairValueOfConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of change in fair value of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ChangeInFairValueOfConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of change in fair value of securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthviewAcquisitionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Interest expense, related parties (in Dollars)</a></td>
<td class="nump">$ 629<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 1,333<span></span>
</td>
<td class="nump">$ 1,199<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 2,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders&#8217; Deficit (Unaudited) - USD ($)<br></strong></div></th>
<th class="th">
<div>Preferred Stock </div>
<div>Previously Reported </div>
<div>Series A Convertible</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Previously Reported </div>
<div>Series B Convertible</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Previously Reported </div>
<div>Series C/C-1 Convertible</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series A Convertible</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series B Convertible</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series C/C-1 Convertible</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Previously Reported</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>NorthView Acquisition Corp</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Previously Reported</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>NorthView Acquisition Corp</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Previously Reported</div>
</th>
<th class="th">
<div>Accumulated Deficit </div>
<div>NorthView Acquisition Corp</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Previously Reported</div></th>
<th class="th"><div>NorthView Acquisition Corp</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (619,995)<span></span>
</td>
<td class="num">$ (105,447,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (619,476)<span></span>
</td>
<td class="num">$ (99,771,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Beginning (in Shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,570,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,137,638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,137,638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions', window );">Excise tax payable attributable to redemption of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,864,106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,864,106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,161,910<span></span>
</td>
<td class="num">(10,281,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,161,910<span></span>
</td>
<td class="num">(10,281,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,732,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,459,829)<span></span>
</td>
<td class="num">(115,728,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,459,310)<span></span>
</td>
<td class="num">(109,996,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205,732)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205,732)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions', window );">Excise tax payable attributable to redemption of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(820,277)<span></span>
</td>
<td class="num">(2,071,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(820,277)<span></span>
</td>
<td class="num">(2,071,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Mar. 31, 2024</a></td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,737,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (117,799,000)<span></span>
</td>
<td class="num">(4,496,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (112,062,000)<span></span>
</td>
<td class="num">(4,496,203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Mar. 31, 2024</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,732,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,459,829)<span></span>
</td>
<td class="num">(115,728,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,459,310)<span></span>
</td>
<td class="num">$ (109,996,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Beginning (in Shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(387,062)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Jun. 30, 2024</a></td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,743,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(120,209,000)<span></span>
</td>
<td class="num">(5,075,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114,466,000)<span></span>
</td>
<td class="num">(5,075,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Jun. 30, 2024</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,732,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,459,829)<span></span>
</td>
<td class="num">(115,728,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,459,310)<span></span>
</td>
<td class="num">$ (109,996,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Beginning (in Shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(768,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(768,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions', window );">Excise tax payable attributable to redemption of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,711,619)<span></span>
</td>
<td class="num">(9,230,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,711,619)<span></span>
</td>
<td class="num">(9,230,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,957,266)<span></span>
</td>
<td class="num">(124,958,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,956,747)<span></span>
</td>
<td class="num">(119,205,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Mar. 31, 2024</a></td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,737,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,799,000)<span></span>
</td>
<td class="num">(4,496,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112,062,000)<span></span>
</td>
<td class="num">(4,496,203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Beginning (in Shares) at Mar. 31, 2024</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181,330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181,330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,410,000)<span></span>
</td>
<td class="num">(397,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,410,000)<span></span>
</td>
<td class="num">(397,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Jun. 30, 2024</a></td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,743,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (120,209,000)<span></span>
</td>
<td class="num">(5,075,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (114,466,000)<span></span>
</td>
<td class="num">(5,075,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Jun. 30, 2024</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,957,266)<span></span>
</td>
<td class="num">(124,958,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,956,747)<span></span>
</td>
<td class="num">(119,205,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Beginning (in Shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions', window );">Excise tax payable attributable to redemption of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,119,910)<span></span>
</td>
<td class="num">(2,716,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,119,910)<span></span>
</td>
<td class="num">(2,716,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,298,283)<span></span>
</td>
<td class="num">(127,674,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,297,764)<span></span>
</td>
<td class="num">(121,916,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,957,266)<span></span>
</td>
<td class="num">(124,958,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,956,747)<span></span>
</td>
<td class="num">$ (119,205,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Beginning (in Shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(164,969)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,510,739)<span></span>
</td>
<td class="num">(130,022,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,510,220)<span></span>
</td>
<td class="num">$ (124,182,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,298,283)<span></span>
</td>
<td class="num">(127,674,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,297,764)<span></span>
</td>
<td class="num">(121,916,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Beginning (in Shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions', window );">Excise tax payable attributable to redemption of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,196,876)<span></span>
</td>
<td class="num">(2,348,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,196,876)<span></span>
</td>
<td class="num">(2,348,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,231,000<span></span>
</td>
<td class="nump">$ 13,701,000<span></span>
</td>
<td class="nump">$ 46,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,510,739)<span></span>
</td>
<td class="num">$ (130,022,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,510,220)<span></span>
</td>
<td class="num">$ (124,182,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance Ending (in Shares) at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AccretionOfCommonStockToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of common stock to redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AccretionOfCommonStockToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Excise tax on stock redemptions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,064,000)<span></span>
</td>
<td class="num">$ (4,481,000)<span></span>
</td>
<td class="num">$ (9,230,000)<span></span>
</td>
<td class="num">$ (10,281,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Non-cash interest expense</a></td>
<td class="nump">2,519,000<span></span>
</td>
<td class="nump">2,161,000<span></span>
</td>
<td class="nump">4,424,000<span></span>
</td>
<td class="nump">4,283,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt', window );">Gain on change in fair value of related party convertible debt</a></td>
<td class="nump">118,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">311,000<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposition of property and equipment, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expenses</a></td>
<td class="nump">82,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Non-cash interest expense</a></td>
<td class="nump">2,519,000<span></span>
</td>
<td class="nump">2,161,000<span></span>
</td>
<td class="nump">4,424,000<span></span>
</td>
<td class="nump">4,283,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt', window );">Gain on change in fair value of related party convertible debt</a></td>
<td class="nump">118,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">311,000<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposition of property and equipment, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expenses</a></td>
<td class="nump">82,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(140,000)<span></span>
</td>
<td class="num">(110,000)<span></span>
</td>
<td class="nump">77,000<span></span>
</td>
<td class="num">(64,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,027,000<span></span>
</td>
<td class="nump">513,000<span></span>
</td>
<td class="nump">645,000<span></span>
</td>
<td class="nump">533,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">331,000<span></span>
</td>
<td class="nump">842,000<span></span>
</td>
<td class="nump">1,664,000<span></span>
</td>
<td class="nump">1,118,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,126,000)<span></span>
</td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="num">(2,066,000)<span></span>
</td>
<td class="num">(4,402,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes</a></td>
<td class="nump">1,450,000<span></span>
</td>
<td class="nump">1,120,000<span></span>
</td>
<td class="nump">3,210,000<span></span>
</td>
<td class="nump">3,235,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible loan</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">375,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(115,000)<span></span>
</td>
<td class="num">(150,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(151,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaymentOfDeferredOfferingCosts', window );">Payment of deferred offering costs</a></td>
<td class="num">(476,000)<span></span>
</td>
<td class="num">(117,000)<span></span>
</td>
<td class="num">(961,000)<span></span>
</td>
<td class="num">(614,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">974,000<span></span>
</td>
<td class="nump">904,000<span></span>
</td>
<td class="nump">2,115,000<span></span>
</td>
<td class="nump">4,468,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) in cash</a></td>
<td class="num">(152,000)<span></span>
</td>
<td class="num">(104,000)<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the beginning of the period</a></td>
<td class="nump">191,000<span></span>
</td>
<td class="nump">142,000<span></span>
</td>
<td class="nump">142,000<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract', window );"><strong>Reconciliation of Cash and Restricted Cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, end of the period</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,000<span></span>
</td>
<td class="nump">142,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the end of the period</a></td>
<td class="nump">39,000<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
<td class="nump">191,000<span></span>
</td>
<td class="nump">142,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts', window );">Increase (decrease) in unpaid deferred offering costs</a></td>
<td class="nump">904,000<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts', window );">Increase (decrease) in unpaid deferred offering costs</a></td>
<td class="nump">904,000<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(9,316,786)<span></span>
</td>
<td class="num">(1,217,764)<span></span>
</td>
<td class="num">(8,711,619)<span></span>
</td>
<td class="nump">1,161,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income on cash held in Trust Account</a></td>
<td class="num">(95,084)<span></span>
</td>
<td class="num">(225,184)<span></span>
</td>
<td class="num">(425,416)<span></span>
</td>
<td class="num">(2,248,538)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">6,265,530<span></span>
</td>
<td class="nump">800,595<span></span>
</td>
<td class="nump">539,531<span></span>
</td>
<td class="num">(701,148)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote', window );">Changes in fair value of convertible promissory note</a></td>
<td class="nump">1,380,059<span></span>
</td>
<td class="num">(126,098)<span></span>
</td>
<td class="nump">7,165,953<span></span>
</td>
<td class="num">(177,697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement', window );">Changes in fair value of securities purchase agreement</a></td>
<td class="nump">193,878<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income on cash held in Trust Account</a></td>
<td class="num">(95,084)<span></span>
</td>
<td class="num">(225,184)<span></span>
</td>
<td class="num">(425,416)<span></span>
</td>
<td class="num">(2,248,538)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">6,265,530<span></span>
</td>
<td class="nump">800,595<span></span>
</td>
<td class="nump">539,531<span></span>
</td>
<td class="num">(701,148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote', window );">Changes in fair value of convertible promissory note</a></td>
<td class="nump">1,380,059<span></span>
</td>
<td class="num">(126,098)<span></span>
</td>
<td class="nump">7,165,953<span></span>
</td>
<td class="num">(177,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement', window );">Changes in fair value of securities purchase agreement</a></td>
<td class="nump">193,878<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">14,166<span></span>
</td>
<td class="num">(33,750)<span></span>
</td>
<td class="num">(7,416)<span></span>
</td>
<td class="nump">311,468<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,060,055<span></span>
</td>
<td class="nump">255,717<span></span>
</td>
<td class="nump">235,369<span></span>
</td>
<td class="nump">634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">20,988<span></span>
</td>
<td class="num">(66,525)<span></span>
</td>
<td class="num">(30,492)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes', window );">Prepaid franchise taxes</a></td>
<td class="num">(15,600)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(49,061)<span></span>
</td>
<td class="num">(49,061)<span></span>
</td>
<td class="num">(413,210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred tax liability</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(13,661)<span></span>
</td>
<td class="num">(13,661)<span></span>
</td>
<td class="num">(23,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="num">(8,820)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(501,614)<span></span>
</td>
<td class="num">(675,731)<span></span>
</td>
<td class="num">(1,296,812)<span></span>
</td>
<td class="num">(2,064,860)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaymentOfExtensionFeeIntoTrustAccount', window );">Payment of extension fee into Trust Account</a></td>
<td class="num">(99,285)<span></span>
</td>
<td class="num">(235,733)<span></span>
</td>
<td class="num">(485,350)<span></span>
</td>
<td class="num">(438,360)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption', window );">Cash withdrawn from Trust Account in connection with redemption</a></td>
<td class="nump">6,510,830<span></span>
</td>
<td class="nump">2,653,439<span></span>
</td>
<td class="nump">3,248,878<span></span>
</td>
<td class="nump">184,845,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDecommissioningFund', window );">Reimbursement of franchise and income taxes from Trust Account</a></td>
<td class="nump">78,813<span></span>
</td>
<td class="nump">204,460<span></span>
</td>
<td class="nump">204,459<span></span>
</td>
<td class="nump">1,192,438<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">6,490,358<span></span>
</td>
<td class="nump">2,622,166<span></span>
</td>
<td class="nump">2,967,987<span></span>
</td>
<td class="nump">185,599,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible loan</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">708,981<span></span>
</td>
<td class="nump">797,981<span></span>
</td>
<td class="nump">1,121,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Advance from Profusa</a></td>
<td class="nump">507,633<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">791,407<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Redemption of common stock</a></td>
<td class="num">(6,510,830)<span></span>
</td>
<td class="num">(2,653,439)<span></span>
</td>
<td class="num">(3,248,878)<span></span>
</td>
<td class="num">(184,845,836)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="num">(6,003,197)<span></span>
</td>
<td class="num">(1,944,458)<span></span>
</td>
<td class="num">(1,659,490)<span></span>
</td>
<td class="num">(183,724,021)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) in cash</a></td>
<td class="num">(14,453)<span></span>
</td>
<td class="nump">1,977<span></span>
</td>
<td class="nump">11,685<span></span>
</td>
<td class="num">(188,967)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the beginning of the period</a></td>
<td class="nump">16,204<span></span>
</td>
<td class="nump">4,519<span></span>
</td>
<td class="nump">4,519<span></span>
</td>
<td class="nump">193,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract', window );"><strong>Reconciliation of Cash and Restricted Cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, end of the period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,496<span></span>
</td>
<td class="nump">16,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash &#8211; end of the period</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at the end of the period</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">6,496<span></span>
</td>
<td class="nump">16,204<span></span>
</td>
<td class="nump">4,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RedemptionPaymentsDueToRedeemingStockholders', window );">Redemption payments due to redeeming stockholders</a></td>
<td class="nump">661,012<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash &#8211; beginning of the period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">173,727<span></span>
</td>
<td class="nump">173,727<span></span>
</td>
<td class="nump">912,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ExciseTaxPayableRedemptionOfCommonStock', window );">Excise tax payable attributable to redemption of common stock</a></td>
<td class="nump">71,718<span></span>
</td>
<td class="nump">10,884<span></span>
</td>
<td class="nump">16,838<span></span>
</td>
<td class="nump">1,864,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="nump">164,969<span></span>
</td>
<td class="nump">387,062<span></span>
</td>
<td class="nump">768,980<span></span>
</td>
<td class="nump">2,137,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed', window );">Reclassification of common stock subject to redemption to common stock to be redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,565,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">173,727<span></span>
</td>
<td class="nump">173,727<span></span>
</td>
<td class="nump">912,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ExciseTaxPayableRedemptionOfCommonStock', window );">Excise tax payable attributable to redemption of common stock</a></td>
<td class="nump">71,718<span></span>
</td>
<td class="nump">10,884<span></span>
</td>
<td class="nump">16,838<span></span>
</td>
<td class="nump">1,864,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccretionOfCommonStockToRedemptionValue', window );">Accretion of common stock to redemption value</a></td>
<td class="nump">$ 164,969<span></span>
</td>
<td class="nump">$ 387,062<span></span>
</td>
<td class="nump">768,980<span></span>
</td>
<td class="nump">2,137,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed', window );">Reclassification of common stock subject to redemption to common stock to be redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AccretionOfCommonStockToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of common stock to redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AccretionOfCommonStockToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash withdrawn from Trust Account in connection with redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in fair value of convertible promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of changes in fair value of securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ExciseTaxPayableRedemptionOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Excise tax payable attributable to redemption of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ExciseTaxPayableRedemptionOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on change in fair value of related party convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of prepaid franchise taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in unpaid deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PaymentOfDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PaymentOfDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PaymentOfExtensionFeeIntoTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of extension fee into trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PaymentOfExtensionFeeIntoTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of common stock subject to redemption to common stock to be redeemed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RedemptionPaymentsDueToRedeemingStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption payments due to redeeming stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RedemptionPaymentsDueToRedeemingStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDecommissioningFund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of assets held in a decommissioning trust fund.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDecommissioningFund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Organization, Description
of Business, Going Concern and Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa, Inc. (the &#8220;Company&#8221;)
was incorporated in the state of California on May&#160;11, 2009. The Company engaged in the development of a new generation of biointegrated
sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s technology
enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable,
clinical-grade data for personal and medical use. The Company&#8217;s first offering in the European Union, the Lumee&#8482; Oxygen Platform,
is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee&#8482; Oxygen
Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease
that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores)
that do not heal properly; and reconstructive surgery.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s research
and development efforts are primarily focused on its Lumee&#8482; Glucose Platform which is a system designed to monitor glucose levels
in interstitial fluid, continuously and long-term. A tiny, biocompatible gel injected under the skin acts as a continuous glucose monitor
(CGM) for several&#160;months. The ability of Lumee&#8482; Glucose to provide continuous glucose monitoring with only an initial single
injection, is an attractive alternative for people with diabetes to manage their disease without the need for frequent finger sticks required
by standard glucometers, or the need for weekly sensor replacement as required by current short-term needle-type CGMs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;6, 2022,
the Company&#8217;s board of directors unanimously approved the pursuit of a business combination transaction involving the Company. On
November&#160;7, 2022, the Company entered into an Agreement and Plan of Merger (&#8220;Merger&#8221;) with NorthView Acquisition Corp
(&#8220;NorthView&#8221;). The Company obtained Shareholder approval and successfully completed the merger on July&#160;11, 2025 where
a subsidiary of NorthView merged with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
the parties to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the &#8220;Amendment&#8221;) pursuant to which
the parties agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received
by Profusa prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment
(i)&#160;revised the definition of &#8220;Milestone Event&#160;III&#8221; such that the parties extended the period for Profusa to consummate
the APAC Joint Venture (as defined in the Merger Agreement) and receive the related funding from December&#160;31, 2024 until December&#160;31,
2025, and (ii)&#160;revised the definition of &#8220;Milestone Event&#160;IV&#8221; to change the earnout revenue target from $99,702,000
for the fiscal year ended December&#160;31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December&#160;31,
2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In relation to Milestone Event&#160;III:&#160;On
August&#160;8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (&#8220;APAC&#8221;), was created and incorporated by
the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $1,000 for 1,000&#160;Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (&#8220;Tasly&#8221;)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the &#8220;APAC Joint
Venture&#8221;) setting forth the relative and other terms under which the development and business activities of the entity will be conducted.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has incurred significant
net operating losses from operations. As of June&#160;30, 2025, the Company has a working capital deficit of approximately $63.2&#160;million.
For the six&#160;months-ended June&#160;30, 2025, the Company incurred a net loss of approximately $5.1&#160;million and used approximately
$1.1&#160;million of cash in operating activities. Management expects to continue to incur additional substantial losses in the foreseeable
future as a result of research and development activities. The Company has been able to finance its operations primarily with the proceeds
from the issuance of equity and debt instruments and to a lesser extent, revenues from government grants. Additional funds may be necessary
to maintain current operations and will be required for successful product commercialization efforts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s condensed
consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business. The Company has reviewed the relevant conditions and events surrounding its ability to
continue as a going concern including among others: historical losses, projected future results, increased tariffs, cash requirements
for the upcoming year, funding capacity, net working capital, and future access to capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025 Profusa,
Inc., a Delaware corporation formerly known as NorthView Acquisition Corporation, consummated its previously announced business combination
with Profusa, Inc., a California corporation, pursuant to that certain Merger Agreement and Plan of Reorganization. At the Closing and
pursuant to the PIPE Subscription Agreement, New Profusa issued a PIPE Convertible Note in the principal amount of $10,000,000 (the &#8220;Initial
Note&#8221;) for a purchase price of $9,000,000, reflecting a 10% Original Issuance Discount (&#8220;OID&#8221;). Management believes
this liquidity is not sufficient to alleviate the relevant conditions or events that raise substantial doubt about the Company&#8217;s
ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued in August&#160;2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the closing, the
Company had cash inflows of $1.3&#160;million from the NorthView trust account, net of redemptions, and the $9&#160;million net PIPE convertible
note. Cash outflows included marketing fees and vendor payments which totaled $3.4&#160;million due at closing. Subsequent to the closing
of the Merger, there continue to be factors which raise substantial doubt about the Company&#8217;s ability to continue as a going concern
within one year from the date the condensed consolidated financial statements are issued. The condensed consolidated financial statements
do not contain any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company operates in a
dynamic and highly competitive industry and believes that changes in any of the following areas could have a material adverse effect on
the Company&#8217;s future financial position, results of operations, or cash flows: ability to obtain future financing; advances and
trends in new technologies and industry standards; results of clinical trials; regulatory approval and market acceptance of the Company&#8217;s
products; development of sales channels; certain strategic relationships; litigation or claims against the Company based on intellectual
property, patent, product, regulatory, or other factors; and the Company&#8217;s ability to attract and retain employees necessary to
support its growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Products developed by the
Company require approvals from the U.S.&#160;Food and Drug Administration (&#8220;FDA&#8221;) or other international regulatory agencies
prior to commercial sales. There can be no assurance that the products will receive the necessary approvals. If the Company is denied
approval, approval is delayed or the Company is unable to maintain approval, it could have a materially adverse impact on the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has expended and will continue to
expend substantial funds to complete the research, development and clinical testing of product candidates. The Company also will be required
to expend additional funds to establish commercial-scale manufacturing arrangements and to provide for the marketing and distribution
of products that receive regulatory approval. For any periods after the twelve&#160;months subsequent to the filing of these financial
statements as of June&#160;30, 2025, the Company may be required to seek additional equity or debt financing to commercialize its products. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If adequate funds are unavailable on a timely
basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more
of its research or development programs which would materially and adversely affect its business, financial condition and results of
operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Inflation, Monetary Response, and Economic
Impacts</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The world economy is experiencing
stubbornly high inflation, a challenge not faced for decades. Following the global financial crisis, with inflationary pressures muted,
interest rates were extremely low for&#160;years and investors became accustomed to low volatility. The resulting easing of financial
conditions supported economic growth, but it also contributed to a buildup of financial vulnerabilities. With inflation at multi-decade
highs, monetary authorities in advanced economies are accelerating the pace of policy normalization. Policymakers have continued to tighten
policy against a backdrop of rising inflation and currency pressures, albeit with notable differences across regions. Global financial
conditions have tightened notably this year, leading to capital outflows. Amid heightened economic and geopolitical uncertainties, investors
have aggressively pulled back from risk-taking and adjusted their investment preferences generally. Key gauges of systemic risk, such
as higher dollar funding costs and counterparty credit spreads, have risen. There is a risk of a disorderly tightening of financial conditions
that may be amplified by vulnerabilities built over the&#160;years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our business,
growth, financial condition or results of operations could be materially adversely affected by instability or changes in a country&#8217;s
or region&#8217;s economic conditions; inflation; changes in laws or regulations or in the interpretation of existing laws or regulations,
whether caused by a change in government or otherwise; increased difficulty of conducting business in a country or region due to actual
or potential political or military conflict; or action by the U.S.&#160;or foreign governments that may restrict our ability to transact
business in a foreign country or with certain foreign individuals or entities. A possible slowdown in global trade caused by increasing
tariffs or other restrictions could decrease consumer or corporate confidence and reduce consumer, government and corporate spending
in countries inside or outside the U.S., which could adversely affect our operations. Climate-related&#160;events, including extreme
weather events and natural disasters and their effect on critical infrastructure in the U.S.&#160;or internationally, could have similar
adverse effects on our operations, users, or third-party&#160;suppliers.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;1 &#8212;&#160;Organization, Description of Business,
Going Concern and Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Profusa, Inc. (the &#8220;Company&#8221;)
was incorporated in the state of California on May&#160;11, 2009. The Company engaged in the development of a new generation of biointegrated
sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s technology
enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable,
clinical-grade data for personal and medical use. The Company&#8217;s first offering in the European Union, the Lumee&#8482; Oxygen Platform,
is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee&#8482; Oxygen
Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease
that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores)
that do not heal properly; and reconstructive surgery.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s research
and development efforts are primarily focused on its Lumee&#8482; Glucose Platform which is a system designed to monitor glucose levels
in interstitial fluid, continuously and long-term. A tiny, biocompatible gel injected under the skin acts as a continuous glucose monitor
(CGM) for several&#160;months. The&#160;ability of Lumee&#8482; Glucose to provide continuous glucose monitoring with only an initial
single injection, is an attractive alternative for people with diabetes to manage their disease without the need for frequent finger sticks
required by standard glucometers, or the need for weekly sensor replacement as required by current short-term needle-type CGMs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;6, 2022, the
Company&#8217;s board of directors unanimously approved the pursuit of a business combination transaction involving the Company. On November&#160;7,
2022, the Company entered into an Agreement and Plan of Merger (&#8220;Merger&#8221;) with NorthView Acquisition Corp (&#8220;NorthView&#8221;),
where a subsidiary of NorthView will merge with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 11, 2025, the parties
to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the &#8220;Amendment&#8221;) pursuant to which the parties
agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received by Profusa
prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment (i) revised
the definition of &#8220;Milestone Event III&#8221; such that the parties extended the period for Profusa to consummate the APAC Joint
Venture (as defined in the Merger Agreement) and receive the related funding from December 31, 2024 until December 31, 2025, and (ii)
revised the definition of &#8220;Milestone Event IV&#8221; to change the earnout revenue target from $99,702,000 for the fiscal year ended
December 31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December 31, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In relation to Milestone Event
III: On August&#160;8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (&#8220;APAC&#8221;), was created and incorporated
by the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $1,000 for 1,000&#160;Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (&#8220;Tasly&#8221;)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the &#8220;APAC Joint
Venture&#8221;) setting forth the relative and other terms under which the development and business activities of the entity will be conducted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has incurred significant
net operating losses from operations. As of December&#160;31, 2024, the Company has a working capital deficit of approximately $56.9&#160;million.
For the year ended December&#160;31, 2024, the Company incurred a net loss of approximately $9.2&#160;million and used approximately $2.1&#160;million
of cash in operating activities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has been able to
finance its operations primarily with the proceeds from the issuance of equity and debt instruments and to a lesser extent, revenues from
government grants. Additional funds may be necessary to maintain current operations and will be required for successful product commercialization
efforts. The Company&#8217;s management plans to obtain additional funds through the merger with a special purpose acquisition company
(&#8220;SPAC&#8221;), issuance of additional equity or refinancing of current debt, which is intended to mitigate the relevant conditions
or events that raise substantial doubt about the Company&#8217;s ability to continue as a going&#160;concern within one year from the
date the consolidated financial statements are issued. As the ability to refinance its current debt or raise additional equity financing
is outside of management&#8217;s control, the Company cannot conclude that management&#8217;s plans will be effectively implemented within
one year from the date the consolidated financial statements are issued. These factors raise substantial doubt about the Company&#8217;s
ability to continue as a going concern within one year from the date the consolidated financial statements are issued. The consolidated
financial statements do not contain any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Significant Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company operates in a dynamic
and highly competitive industry and believes that changes in any of the following areas could have a material adverse effect on the Company&#8217;s
future financial position, results of operations, or cash flows: ability to obtain future financing; advances and trends in new technologies
and industry standards; results of clinical trials; regulatory approval and market acceptance of the Company&#8217;s products; development
of sales channels; certain strategic relationships; litigation or claims against the Company based on intellectual property, patent, product,
regulatory, or other factors; and the Company&#8217;s ability to attract and retain employees necessary to support its growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Products developed by the Company
require approvals from the U.S.&#160;Food and Drug Administration (&#8220;FDA&#8221;) or other international regulatory agencies prior
to commercial sales. There can be no assurance that the products will receive the necessary approvals. If the Company is denied approval,
approval is delayed or the Company is unable to maintain approval, it could have a materially adverse impact on the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has expended and
will continue to expend substantial funds to complete the research, development and clinical testing of product candidates. The Company
also will be required to expend additional funds to establish commercial-scale manufacturing arrangements and to provide for the marketing
and distribution of products that receive regulatory approval. The Company will require additional funds to commercialize its products.
The Company is unable to entirely fund these efforts with its current financial resources. If adequate funds are unavailable on a timely
basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more
of its research or development programs which would materially and adversely affect its business, financial condition and results of operations.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Description of Business, Going Concern and Significant Risks and Uncertainties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;1 &#8212;&#160;Description of Organization
and Business Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NorthView Acquisition Corporation
(now known as Profusa, Inc.) (the &#8220;Company&#8221; or &#8220;Northview&#8221;) was a blank check company incorporated in Delaware
on April&#160;19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more businesses (&#8220;Business Combination&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had a wholly-owned
subsidiary, NV Profusa Merger Sub Inc. (&#8220;Merger Sub&#8221;), a Delaware corporation incorporated on October&#160;13, 2022, which
was formed solely in contemplation of the Merger with Profusa (See below). In connection with the Merger, which was consummated on July&#160;11,
2025, Merger Sub is no longer in existence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Combination</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, the
Company, Profusa, Inc., a California corporation (&#8220;Profusa&#8221;) and Merger Sub entered into a Merger Agreement and Plan of Reorganization
(as the same has been amended, supplemented or otherwise modified from time to time, the &#8220;Merger Agreement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;5, 2025 (the &#8220;Redemption
Date&#8221;), the Company received requests to redeem a total of 52,784 Public Shares (as defined below), representing 32.4% of the total
Public Shares of the Company outstanding prior to the Redemption Date. Following the redemption, 5,295,527 Public Shares were outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the special meeting of the
stockholders held on June&#160;9, 2025 (the &#8220;Special Meeting&#8221;), the Company&#8217;s stockholders voted to approve the proposals
outlined in the final prospectus and definitive proxy statement filed by the Company with the U.S.&#160;Securities and Exchange Commission
(the &#8220;SEC&#8221;) on May&#160;15, 2025 (the &#8220;Proxy Statement/Prospectus&#8221;), including, among other things, the adoption
of the Merger Agreement and approval of the transactions contemplated thereby, including the merger of Merger Sub with and into Profusa,
with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;), and the
issuance of the Company&#8217;s common stock as consideration thereunder (together with the other transactions contemplated by the Merger
Agreement, the &#8220;Business Combination&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025 (the
&#8220;Closing Date&#8221;), the Company closed the Business Combination with Profusa. As a result of the Business Combination, the Company
owns 100% of the outstanding common stock of Profusa.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the closing
of the Business Combination, the Company changed its name from &#8220;NorthView Acquisition Corporation&#8221; to &#8220;Profusa, Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Prior to the Business Combination</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company consummated its Initial Public Offering (&#8220;IPO&#8221;) of 18,975,000&#160;units (the &#8220;Units&#8221;), which included
2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists
of one share of common stock of the Company, par value $0.0001 per share, one right (the &#8220;Rights&#8221;), and one-half of one redeemable
warrant of the Company (the &#8220;Warrants&#8221;). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of
common stock. Each Warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment.
The Units&#160;were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Simultaneously with the closing
of the IPO, the Company completed the private sale of an aggregate of 7,347,500&#160;warrants (the &#8220;Private Placement Warrants&#8221;),
which included 697,500 Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters,
to NorthView Sponsor&#160;I, LLC (&#8220;the Sponsor&#8221;),&#160;I-Bankers Securities, Inc., and Dawson James Securities, Inc. at a
purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,347,500, which is discussed in Note&#160;4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Transaction costs in connection
with the IPO amounted to $7,959,726, consisting of $3,450,000 of underwriting discount, $3,570,576 of Representative&#8217;s Shares cost,
$259,527 of Representative&#8217;s Warrants cost and $679,623 of other offering costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the closing of the
IPO on December&#160;22, 2021, an amount of $191,647,500 ($10.10 per Unit), excluding $741,228 that was wired to the Company&#8217;s operating
bank account on December&#160;31, 2021 for working capital purposes, from the net proceeds of the sale of the public units in the IPO
and the sale of the Private Placement Warrants was placed in a Trust Account (&#8220;Trust Account&#8221;) and invested in United&#160;States
government treasury bills with a maturity of 185&#160;days or less or in money market funds investing solely in United&#160;States Treasuries
and meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act as determined by the Company. Except with respect
to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from
the IPO will not be released from the Trust Account until the earliest of (i)&#160;the completion of the Company&#8217;s initial Business
Combination, (ii)&#160;the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company&#8217;s
amended and restated certificate of incorporation (A)&#160;to modify the substance or timing of the Company&#8217;s obligation to redeem
100% of the public shares if the Company does not complete the initial Business Combination within the extended period (or any additional
extension from the closing of our IPO if we extend the period of time to consummate a business combination) (the &#8220;Combination Period&#8221;),
or (B)&#160;with respect to any other provision relating to stockholders&#8217; rights or pre-Business Combination activity, and (iii)&#160;the
redemption of all of the Company&#8217;s public shares if the Company is unable to complete the Business Combination within the Combination
Period, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#8217;s
creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company provided its public
stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination
in connection with a stockholder meeting called to approve the initial Business Combination. The decision as to whether the Company will
seek stockholder approval of a proposed initial Business Combination or conduct a tender offer was made by the Company, solely in its
discretion. The stockholders were entitled to redeem all or a portion of their public shares upon the completion of the initial Business
Combination at a per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two&#160;business
days prior to the consummation of the initial Business Combination, including interest (which interest shall be net of taxes payable)
divided by the number of then outstanding public shares, subject to the limitations described herein. The per share amount the Company
distributed to investors who properly redeemed their shares was not reduced by the fee payable to&#160;I-Bankers&#160;and Dawson James
pursuant to the Business Combination Marketing Agreement (see Note&#160;6).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;10, 2023, the
Company held a vote to amend its amended and restated certificate of incorporation to extend the date by which the Company must consummate
a Business Combination from March&#160;22, 2023 to December&#160;22, 2023 (the &#8220;First Extension Meeting&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024. In connection with the extension, 140,663 shares of the Company&#8217;s
common stock were redeemed, with 6,027,219 shares of Common Stock remaining outstanding after the Redemption; 833,469 shares of Common
Stock remaining outstanding after the Redemption are shares issued in connection with our IPO (the &#8220;Public Shares&#8221;). In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;2, 2024, the
Company and Continental Stock Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;) entered into Amendment No. 1 to Investment Management
Trust Agreement, dated December&#160;20, 2021, by and between the Company and CST, to allow CST, upon written instruction of the Company,
to (i)&#160;hold the funds in the Company&#8217;s trust account uninvested or (ii)&#160;hold the funds in an interest-bearing bank demand
deposit account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024, the
Company&#8217;s Board of Directors approved, and the Company amended, its Convertible Working Capital Promissory Note (the &#8220;Note&#8221;)
with the sponsor to increase the principal amount of the Note that could be drawn on to $1.5&#160;million. The amended and restated Note
also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company common stock at a price
of $2.22 per share at the election of the sponsor. On May&#160;31, 2024, the Company&#8217;s Board of Directors approved and the Company
entered into a second amendment of its Convertible Working Capital Promissory Note with the sponsor to increase the principal amount of
the Note that could be drawn on to $2.5&#160;million. The second amended and restated Note also allows for the conversion of the outstanding
principal balance of the Note to be repaid in shares of Company common stock at a price of $2.22&#160;per share at the election of the
sponsor.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;21, 2024, the
Company held its 2024 Annual Meeting of Stockholders (the &#8220;Meeting&#8221;). At the meeting, the Company&#8217;s stockholders approved
the amendment of the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company&#8217;s
common stock issued in the Company&#8217;s initial public offering, from March&#160;22, 2024, monthly for up to six additional&#160;months
at the election of the Company and only upon contribution of $0.05 per month per outstanding public share, ultimately until September&#160;22,
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the meeting,
the holders of&#160;95,394&#160;Public Shares properly exercised their right to redeem, with 5,931,825 shares of Common Stock remaining
outstanding after the Redemption; 738,075 shares of Common Stock remaining outstanding after the Redemption are Public Shares. Consequently,
the contribution was $36,904&#160;per month needed for the Company to continue to extend the Combination Period monthly. On May&#160;8,
2024 and May&#160;31, 2024, the Company made two deposits of $36,904 each for April and May extension contributions. On September&#160;10,
2024, the Company made a deposit of $112,114, of which $110,714 was for June, July and August extension contributions and $1,400 for lost
interest due to late trust payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September&#160;19, 2024,
the Company held a special meeting of stockholders (the &#8220;Meeting&#8221;). At the Meeting, the Company&#8217;s stockholders approved
an amendment to the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
its initial Business Combination to March&#160;22, 2025. In connection with the approval of the extension amendment, holders of&#160;50,556&#160;shares
of the Company&#8217;s common stock exercised their right to redeem, with 5,881,269 shares of common stock remaining outstanding after
the redemption; 687,519 shares of common stock remaining outstanding after the redemption are Public Shares. Consequently, the contribution
is $34,376&#160;per month needed for the Company to continue to extend the Combination Period monthly. On December&#160;13, 2024, the
Company made a deposit of $68,752 for the October and November extension contributions and on December&#160;23, 2024, the Company made
a deposit of 34,376 for the December extension contribution. In October&#160;2024, $595,439 was paid from the trust account to redeeming
stockholders in connection with the extension. On February&#160;27, 2025, the Company made a deposit of $49,376 for the January extension
contribution and a portion ($15,000) of the February extension contribution. On March&#160;7, 2025, the Company deposited the remainder
of the February extension contribution of $19,376, plus interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the meeting and the stockholders approved the extension of the business combination period
until June&#160;22, 2025. In connection with the approval of the extension amendment, holders of&#160;532,958&#160;shares of the Company&#8217;s
common stock exercised their right to redeem, for an aggregate redemption amount of approximately $6.5&#160;million, with 5,348,311 shares
of common stock remaining outstanding after the redemption; 154,561 shares of common stock remaining outstanding after the redemption
are Public Shares. As a condition of the extension, the Company contributed $30,000 to the Trust Account, for the entire extension period,
on March&#160;21, 2025. Additionally, the stockholders at the meeting approved the amendment of the Company&#8217;s charter to remove
the requirement that prevented the Company from redeeming public shares to the extent that it would cause the Company&#8217;s net tangible
assets to be less than $5,000,001 (the &#8220;NTA Requirement&#8221;), and our charter was amended on March&#160;21, 2025 to reflect the
extension of the business combination and the removal of the NTA Requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;2, 2025, the
parties to the Merger Agreement entered into an Amendment No. 5 to the Merger Agreement (&#8220;Amendment No. 5&#8221;) pursuant to which
Section&#160;9.01 of the Merger Agreement was amended such that the reference to &#8220;March&#160;22, 2025&#8221; shall be replaced with
&#8220;June&#160;22, 2025&#8221; by which the Company must consummate a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;8, 2025, the Company
entered into a non-redemption&#160;agreement (the &#8220;Non-Redemption&#160;Agreement&#8221;) with&#160;I-Bankers Securities, Inc. and
Dawson James Securities, Inc. (together, the &#8220;Investors&#8221;), pursuant to which such Investors agreed that to the extent that
redemptions in connection with the vote to approve the Business Combination reduces the Company&#8217;s trust account balance below $1.25&#160;million,
the Investors would offer such redeeming shareholders an opportunity to rescind the redemption of their shares and would instead purchase
such shares. Such purchases would be structured in compliance with the requirements of&#160;Rule&#160;14e-5&#160;under the&#160;Exchange&#160;Act&#160;or
would otherwise not constitute a tender offer pursuant to the&#160;Exchange&#160;Act. As of the Closing Date, the Company&#8217;s trust
account balance was not below $1.25&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;9, 2025, the Company
held a special meeting of stockholders. At the meeting, the Company&#8217;s stockholders approved the Merger Agreement and the actions
and transactions contemplated thereby, including (i)&#160;adopt an amended and restated Certificate of Incorporation, to be effective
upon closing of the Merger, (ii)&#160;approving certain advisory proposals related to the amended and restated Certificate of Incorporation,
(iii)&#160;approved the issuance of new shares of the Company&#8217;s Common Stock as merger consideration, (iv)&#160;elected new directors,
and (v)&#160;approved new employee incentive plans. In connection with the meeting, the holders of 52,784 Public Shares properly exercised
their right to redeem, with 5,295,527 shares of Common Stock remaining outstanding after such redemptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;1, 2025, the Company
filed an amendment to its Certificate of Incorporation (the &#8220;Amendment&#8221;) to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company&#8217;s
common stock issued in the Company&#8217;s initial public offering, from June&#160;22, 2025 to August&#160;22, 2025. Previously, on June&#160;27,
2025, the Company had filed a copy of the Amendment with a date that mistakenly referenced &#8220;July&#160;22, 2025&#8221; rather than
&#8220;August&#160;22, 2025,&#8221; however such filing was corrected in connection with the filing of the Amendment on July&#160;1, 2025.
The Company&#8217;s stockholders approved the Amendment by a supermajority of at least 65% via written consent on June&#160;27, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company agreed to waive
its right to withdraw up to $100,000 of interest from the Company&#8217;s trust account to pay dissolution expenses, should the Company
ultimately liquidate prior to a business combination (the &#8220;Dissolution Expense Waiver&#8221;). As a result, the Company was no longer
able to withdraw up to $100,000 of interest for such dissolution expenses upon liquidation, and such interest will be held in the trust
account and not be released until the earliest to occur of (i)&#160;the completion of the initial business combination, (ii)&#160;the
redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination within
the Extension, and (iii)&#160;the redemption of Public Shares in connection with a vote seeking to amend the provisions of our Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also agreed to
waive its right to withdraw interest from the Company&#8217;s trust account to pay the Company&#8217;s tax expenses (the &#8220;Tax Expense
Waiver&#8221;). As a result, the Company was no longer able to withdraw interest in order to pay future tax expenses, and such interest
will be held in the trust account and not be released until the earliest to occur of (i)&#160;the completion of the initial business combination,
(ii)&#160;the redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination
within the Extension, and (iii)&#160;the redemption of Public Shares in connection with a vote seeking to amend the provisions of our
Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to such announcement,
and subsequent to the record date of February&#160;21, 2025, for the Special Meeting, the Company withdrew approximately $23,200 of interest
from the trust account for tax expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Public Shares contain
a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder
vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and
restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified
in ASC&#160;480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to
be classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., public
warrants), the initial carrying value of common stock classified as temporary equity was the allocated proceeds determined in accordance
with ASC&#160;470-20. The common stock is subject to ASC&#160;480-10-S99. If it is probable that the equity instrument will become redeemable,
the Company has the option to either (i)&#160;accrete changes in the redemption value over the period from the date of issuance (or from
the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument
or (ii)&#160;recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal
the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor, officers and directors
have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with the completion
of the initial Business Combination, (ii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to
their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will
be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete
the Business Combination within such time period); and (iii)&#160;vote their Founder Shares and any public shares purchased during or
after the IPO in favor of the initial Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor
has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to
the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount
of funds in the Trust Account to below (i)&#160;$10.10 per public share or (ii)&#160;such lesser amount per public share held in the Trust
Account as of the date of the liquidation of the Trust Account due to reductions in value of the trust assets, in each case net of the
amount of interest which may be released to the Company to pay taxes, except as to any claims by a third party who executed a waiver of
any and all rights to seek access to the Trust Account and except as to any claims under indemnity of the underwriters of the IPO against
certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nasdaq Delisting Notification</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;20, 2024,
the Company received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market that the Company&#8217;s
securities would be delisted from The Nasdaq Stock Market by reason of the failure of the Company to complete its initial business combination
by December&#160;20, 2024 (36&#160;months from the effectiveness of its IPO registration statement) as required by Listing Rule IM-5101-2.
Accordingly, trading in the Company&#8217;s Common Stock, Rights and Warrants was suspended at the opening of business on December&#160;27,
2024 and a Form&#160;25-NSE was filed by Nasdaq with the Securities and Exchange Commission, which removed the Company&#8217;s securities
from on the Nasdaq Stock Market. The Company&#8217;s Common Stock, Rights and Warrants began to be quoted on the Pink Markets operated
on The OTC Market systems (&#8220;OTC Market&#8221;) under the symbols &#8220;NVAC,&#8221; &#8220;NVACR&#8221; and &#8220;NVACW.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Funds Restricted for Payment of Taxes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From inception to date, the
Company has withdrawn a total of $1,484,219 of interest from the Trust Account of which $1,453,297 was paid for franchise and income taxes.
Of the aggregate withdrawals, $30,922 was restricted for the payment of the Company&#8217;s income taxes. The Company utilized $29,171
of these withdrawals towards funding operating expenses, as well as the monthly extension deposits. As of June&#160;30, 2025, the Company
has restricted cash of $1,751. The Company intends to deposit $29,171 back into the Trust Account or use the $29,171 (or a portion thereof)
for tax obligations until a deposit is made into the trust on a future date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of&#160;June&#160;30, 2025,
the Company had $1,751 in restricted cash and a working capital deficit of $15,492,554. Prior to the completion of the Company&#8217;s
IPO, the Company&#8217;s liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000 for the founder
shares to cover certain of the offering costs and the loan under an unsecured promissory note from the Sponsor of $204,841, which was
fully paid upon the IPO.&#160;Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company&#8217;s
liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account,
and the drawdowns on the convertible promissory note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain
of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note&#160;5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024, the
Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;31, 2024, the Company&#8217;s
Board of Directors approved, and the Company second amended its Note to increase the principal amount of the Note that could be drawn
on to $2.5&#160;million. The second amended and restated Note also allows for the conversion of the outstanding principal balance of the
Note to be repaid in shares of Company common stock at a price of $2.22&#160;per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had principal outstanding
of $1,919,796 and is presenting the Note at fair value on its balance sheet at June&#160;30, 2025 in the amount of $10,288,111. As of
June&#160;30, 2025, no amounts were repaid against the loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company incurred significant
costs in pursuit of its Business Combination. As part of the closing, the Company had cash inflows of $1.3&#160;million from the Trust
Account, net of redemptions, and the $9&#160;million net PIPE convertible note. Cash outflows included marketing fees and vendor payments
which totaled $3.4&#160;million due at closing. In connection with the Company&#8217;s assessment of going concern considerations in accordance
with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;)&#160;2014-15, &#8220;Disclosures
of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management believes that subsequent to the closing
of the Merger, there continues to be factors which raise substantial doubt about the Company&#8217;s ability to continue as a going concern
within one year from the date the condensed consolidated financial statements are issued. The condensed consolidated financial statements
do not contain any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for, among other
things, a new U.S.&#160;federal 1% excise tax on certain repurchases of stock occurring on or after January&#160;1, 2023, by publicly
traded U.S.&#160;domestic corporations, by certain U.S.&#160;domestic subsidiaries of publicly traded foreign corporations, by &#8220;covered
surrogate foreign corporations&#8221; (as defined in the IR Act) and by certain affiliates of the foregoing. The excise tax is imposed
on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally
1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock
repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any redemption or other repurchase
that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the
excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension
vote or otherwise would depend on a number of factors, including (i)&#160;the fair market value of the redemptions and repurchases in
connection with the Business Combination, extension or otherwise, (ii)&#160;the structure of a Business Combination, (iii)&#160;the nature
and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination (or otherwise issued not in connection
with a Business Combination but issued within the same taxable year of a Business Combination) and (iv)&#160;the content of regulations
and other guidance from the Treasury. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination
and in the Company&#8217;s ability to complete a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;22, 2023 and
December&#160;21, 2023, the Company&#8217;s stockholders redeemed 18,000,868 and 140,663 shares, respectively, for a total of $184,845,836
and $1,565,078, respectively. On March&#160;26, 2024, the Company&#8217;s stockholders redeemed 95,394 shares for a total of $1,088,361.
On September&#160;30, 2024, the Company&#8217;s stockholders redeemed 50,556 shares for a total of $595,439. On March&#160;26, 2025, the
Company&#8217;s stockholders redeemed 532,958 shares for a total of $6,510,830. On June&#160;16, 2025, the Company&#8217;s stockholders
redeemed 52,784 shares for a total of $661,012. The Company determined that an excise tax liability should be recorded due to the redeemed
shares. As of June&#160;30, 2025 and December&#160;31, 2024, the Company has a charge to stockholders&#8217; deficit of $1,952,662 and
$1,880,944 of excise tax liability, including $71,718 and $16,838 charged during the six&#160;months ended June&#160;30, 2025 and the
year ended December&#160;31, 2024, respectively, calculated as 1% of the value of shares redeemed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;3, 2024, the Treasury
issued final regulations with respect to the procedure and administration of the Excise Tax. These regulations provided that the filing
and payment deadline for any liability incurred during the period from January&#160;1, 2023 to December&#160;31, 2023 would be October&#160;31,
2024. As of June&#160;30, 2025 and the date of this report, the excise tax was not paid and was recorded as excise tax payable. Any amount
of such Excise Tax not paid in full, could be subject to additional interest and penalties which are currently estimated at 7% or 9% interest
per annum and a 0.5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, $1,952,662 and $1,880,944 in excise tax was accrued on the accompanying condensed consolidated balance sheets,
respectively. On January&#160;29, 2025, the Company claimed disaster relief under IRC Section&#160;7508A relating to Hurricane Beryl as
announced in IRS Announcement TX-2024-08. Under the disaster relief claim, the time for filing of the September&#160;30, 2024 Quarterly
Federal Excise Tax Return and payment of the 2023 excise taxes on repurchases of corporate stock normally due on October&#160;31, 2024
should be postponed to February&#160;3, 2025. The Company was not subject to excise tax interest and penalties until February&#160;3,
2025. On January&#160;29, 2025, the Company filed their 2024 excise tax return. The Company did not repay the excise tax in full by June&#160;30,
2025. As of June&#160;30, 2025, the Company accrued approximately $105,970 interest and penalties in the accompanying condensed consolidated
statements of operations.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;1 &#8212;&#160;Description of Organization and Business
Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NorthView Acquisition Corporation
(the &#8220;Company&#8221; or &#8220;Northview&#8221;) is a blank check company incorporated in Delaware on April&#160;19, 2021. The Company
was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar
business combination with one or more businesses (&#8220;Business Combination&#8221;). The Company has identified a target company for
a business combination and is consummating the acquisition of Profusa.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a wholly-owned
subsidiary, NV Profusa Merger Sub Inc. (&#8220;Merger Sub&#8221;), a Delaware corporation incorporated on October&#160;13, 2022, formed
solely in contemplation of the Merger with Profusa (See Note&#160;6). Merger Sub has not commenced any operations and has only nominal
assets and no liabilities or contingent liabilities, nor any outstanding commitments other than in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company consummated its Initial Public Offering (&#8220;IPO&#8221;) of 18,975,000&#160;units (the &#8220;Units&#8221;), which included
2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists
of one share of common stock of the Company, par value $0.0001 per share, one right (the &#8220;Rights&#8221;), and one-half of one redeemable
warrant of the Company (the &#8220;Warrants&#8221;). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of
common stock. Each Warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment.
The Units&#160;were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Simultaneously with the closing
of the IPO, the Company completed the private sale of an aggregate of 7,347,500&#160;warrants (the &#8220;Private Placement Warrants&#8221;),
which included 697,500 Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters,
to NorthView Sponsor&#160;I, LLC (&#8220;the Sponsor&#8221;),&#160;I-Bankers Securities, Inc., and Dawson James Securities, Inc. at a
purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,347,500, which is discussed in Note&#160;4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Transaction costs amounted
to $7,959,726 consisting of $3,450,000 of underwriting discount, $3,570,576 of Representative&#8217;s Shares cost, $259,527 of Representative&#8217;s
Warrants cost and $679,623 of other offering costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Business
Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the value of the
assets held in the Trust Account (as defined below) (excluding taxes payable on the interest earned on the Trust Account) at the time
of the signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business
Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the closing of
the Public Offering on December&#160;22, 2021, an amount of $191,647,500 ($10.10 per Unit), excluding $741,228 that was wired to the
Company&#8217;s operating bank account on December&#160;31, 2021 for working capital purposes, from the net proceeds of the sale of the
public units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account (&#8220;Trust Account&#8221;) and
invested in United&#160;States government treasury bills with a maturity of 185&#160;days or less or in money market funds investing
solely in United&#160;States Treasuries and meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act as determined
by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to
pay its taxes, if any, the proceeds from the IPO will not be released from the Trust Account until the earliest of (i)&#160;the completion
of the Company&#8217;s initial Business Combination, (ii)&#160;the redemption of any public shares properly tendered in connection with
a stockholder vote to amend the Company&#8217;s amended and restated certificate of incorporation (A)&#160;to modify the substance or
timing of the Company&#8217;s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination
within the extended period (or any additional extension from the closing of our IPO if we extend the period of time to consummate a business
combination) (the &#8220;Combination Period&#8221;), or (B)&#160;with respect to any other provision relating to stockholders&#8217;
rights or pre-Business Combination activity, and (iii)&#160;the redemption of all of the Company&#8217;s public shares if the Company
is unable to complete the Business Combination within the Combination Period, subject to applicable law. The proceeds deposited in the
Trust Account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims
of the Company&#8217;s public stockholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will provide its
public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business
Combination either (i)&#160;in connection with a stockholder meeting called to approve the initial Business Combination or (ii)&#160;by
means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination
or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a
portion of their public shares upon the completion of the initial Business Combination at a per-share&#160;price, payable in cash, equal
to the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to the consummation of the initial Business
Combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares,
subject to the limitations described herein. The per share amount the Company will distribute to investors who properly redeem their shares
will not be reduced by the fee payable to&#160;I-Bankers&#160;and Dawson James pursuant to the Business Combination Marketing Agreement
(see Note&#160;6).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company is unable to
complete an initial Business Combination within the Combination Period, it will: (i)&#160;cease all operations except for the purpose
of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten&#160;business days thereafter, redeem the public shares,
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust account, including interest (which interest
shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding
public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive
further liquidation distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such
redemption, subject to the approval of the Company&#8217;s remaining stockholders and its board of directors, dissolve and liquidate,
subject in each case to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#8217;s rights and warrants,
which will expire worthless if the Company fails to complete the Business Combination within the Combination Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 10, 2023, the Company
held a vote to amend its amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business
Combination from March 22, 2023 to December 22, 2023 (the &#8220;First Extension Meeting&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024. In connection with the extension, 140,663 shares of the Company&#8217;s
common stock were redeemed, with 6,027,219 shares of Common Stock remaining outstanding after the Redemption; 833,469 shares of Common
Stock remaining outstanding after the Redemption are shares issued in connection with our initial public offering. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;2, 2024, the
Company and Continental Stock Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;) entered into Amendment No. 1 to Investment Management
Trust Agreement, dated December&#160;20, 2021, by and between the Company and CST, to allow CST, upon written instruction of the Company,
to (i)&#160;hold the funds in the Company&#8217;s trust account uninvested or (ii)&#160;hold the funds in an interest-bearing bank demand
deposit account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024,
the Company&#8217;s Board of Directors approved, and the Company amended, its Convertible Working Capital Promissory Note (the &#8220;Note&#8221;)
with the sponsor to increase the principal amount of the Note that could be drawn on to $1.5&#160;million. The amended and restated Note
also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company common stock at a price
of $2.22 per share at the election of the sponsor. On May 31, 2024, the Company&#8217;s Board of Directors approved and the Company entered
into a second amendment of its Convertible Working Capital Promissory Note with the sponsor to increase the principal amount of the Note
that could be drawn on to $2.5 million. The second amended and restated Note also allows for the conversion of the outstanding principal
balance of the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;21, 2024, the
Company held its 2024 Annual Meeting of Stockholders (the &#8220;Meeting&#8221;). At the meeting, the Company&#8217;s stockholders approved
the amendment of the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company&#8217;s
common stock issued in the Company&#8217;s initial public offering, from March&#160;22, 2024, monthly for up to six additional&#160;months
at the election of the Company and only upon contribution of $0.05 per month per outstanding public share, ultimately until September&#160;22,
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the meeting,
the holders of&#160;95,394&#160;Public Shares properly exercised their right to redeem, with 5,931,825 shares of Common Stock remaining
outstanding after the Redemption; 738,075 shares of Common Stock remaining outstanding after the Redemption are shares issued in connection
with the initial public offering. Consequently, the contribution is $36,904&#160;per month needed for the Company to continue to extend
the Combination Period monthly. On May&#160;8, 2024 and May&#160;31, 2024, the Company made two deposits of $36,904 each for April and
May extension contributions. On September&#160;10, 2024, the Company made a deposit of $112,114, of which $110,714 was for June, July
and August extension contributions and $1,400 for lost interest due to late trust payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September&#160;19, 2024,
the Company held an extraordinary general meeting of stockholders (the &#8220;Meeting&#8221;). At the Meeting, the Company&#8217;s stockholders
approved an amendment to the Company&#8217;s amended and restated certificate of incorporation to extend the date by which the Company
must consummate its initial Business Combination to March&#160;22, 2025. In connection with the approval of the extension amendment, holders
of&#160;50,556&#160;shares of the Company&#8217;s common stock exercised their right to redeem, with 5,881,269 shares of common stock
remaining outstanding after the redemption; 687,519 shares of common stock remaining outstanding after the redemption are shares issued
in connection with our initial public offering. Consequently, the contribution is $34,376&#160;per month needed for the Company to continue
to extend the Combination Period monthly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 13, 2024, the Company
made a deposit of $68,752 for the October and November extension contributions and on December 23, 2024, the company made a deposit of
34,376 for the December extension contribution. In October 2024, $595,439 was paid from the trust account to redeeming stockholders in
connection with the extension. On February 27, 2025, the Company made a deposit of $49,376 for the January extension contribution and
a portion ($15,000) of the February extension contribution. On March 7, 2025, the Company deposited the remainder of the February extension
contribution of $19,376, plus interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the meeting and the stockholders approved the extension of the business combination period until June 22, 2025.
In connection with the approval of the extension amendment, holders of 532,958 shares of the Company&#8217;s common stock exercised their
right to redeem, for an aggregate redemption amount of approximately $6.5 million, with 5,348,311 shares of common stock remaining outstanding
after the redemption; 154,561 shares of common stock remaining outstanding after the redemption are shares issued in connection with our
initial public offering. As a condition of the extension, the Company contributed $30,000 to the Trust Account, for the entire extension
period, on March 21, 2025. Additionally, the stockholders at the meeting approved the amendment of the Company&#8217;s charter to remove
the requirement that prevented the Company from redeeming public shares to the extent that it would cause the Company&#8217;s net tangible
assets to be less than $5,000,001 (the &#8220;NTA Requirement&#8221;), and our charter was amended on March 21, 2025 to reflect the extension
of the business combination and the removal of the NTA Requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Public Shares,
or shares of our common stock sold as part of the IPO, contain a redemption feature which allows for the redemption of such Public Shares
in connection with our liquidation, if there is a stockholder vote or tender offer in connection with our initial business combination
and in connection with certain amendments to our amended and restated certificate of incorporation. In accordance with SEC and its guidance
on redeemable equity instruments, which has been codified in ASC&#160;480-10-S99, redemption provisions not solely within the control
of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were
issued with other freestanding instruments (i.e., public warrants), the initial carrying value of common stock classified as temporary
equity was the allocated proceeds determined in accordance with ASC&#160;470-20. The common stock is subject to ASC&#160;480-10-S99.
If it is probable that the equity instrument will become redeemable, the Company has the option to either (i)&#160;accrete changes in
the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become
redeemable, if later) to the earliest redemption date of the instrument or (ii)&#160;recognize changes in the redemption value immediately
as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The
Company has elected to recognize the changes immediately.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor, officers and directors
have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with the completion
of the initial Business Combination, (ii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to
their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will
be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete
the Business Combination within such time period); and (iii)&#160;vote their Founder Shares and any public shares purchased during or
after the IPO in favor of the initial Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor
has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to
the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount
of funds in the Trust Account to below (i)&#160;$10.10 per public share or (ii)&#160;such lesser amount per public share held in the Trust
Account as of the date of the liquidation of the Trust Account due to reductions in value of the trust assets, in each case net of the
amount of interest which may be released to the Company to pay taxes, except as to any claims by a third party who executed a waiver of
any and all rights to seek access to the Trust Account and except as to any claims under indemnity of the underwriters of the IPO against
certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Nasdaq Delisting Notification</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 20, 2024, the Company
received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market that the Company&#8217;s securities
would be delisted from The Nasdaq Stock Market by reason of the failure of the Company to complete its initial business combination by
December 20, 2024 (36 months from the effectiveness of its IPO registration statement) as required by Listing Rule IM-5101-2. Accordingly,
trading in the Company&#8217;s Common Stock, Rights and Warrants was suspended at the opening of business on December 27, 2024 and a Form
25-NSE was filed by Nasdaq with the Securities and Exchange Commission, which removed the Company&#8217;s securities from on the Nasdaq
Stock Market. The Company&#8217;s Common Stock, Rights and Warrants began to be quoted on the Pink Markets operated on The OTC Market
systems (&#8220;OTC Market&#8221;) under the symbols &#8220;NVAC,&#8221; &#8220;NVACR&#8221; and &#8220;NVACW.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of&#160;December 31, 2024,
the Company had $16,204 in cash and a working capital deficit of $12,254,024. Prior to the completion of the Company&#8217;s IPO, the
Company&#8217;s liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000 for the founder shares to
cover certain of the offering costs and the loan under an unsecured promissory note from the Sponsor of $204,841, which was fully paid
upon the IPO. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company&#8217;s liquidity
needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account, and the drawdowns
on the convertible promissory note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain
of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note&#160;5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;10, 2024, the
Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;31, 2024, the Company&#8217;s
Board of Directors approved, and the Company second amended its Note to increase the principal amount of the Note that could be drawn
on to $2.5&#160;million. The second amended and restated Note also allows for the conversion of the outstanding principal balance of the
Note to be repaid in shares of Company common stock at a price of $2.22&#160;per share at the election of the sponsor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had principal outstanding
of $1,919,796 and is presenting the Note at fair value on its balance sheet at December 31, 2024 in the amount of $8,908,052. As of December
31, 2024, no amounts were repaid against the loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has until June&#160;22,
2025 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by June&#160;22,
2025. If a Business Combination is not consummated by the required date, there will be an option to either extend the time available for
us to consummate our initial business combination or execute a mandatory liquidation and subsequent dissolution. In connection with the
Company&#8217;s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standards
Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;)&#160;2014-15, &#8220;Disclosure of Uncertainties About an Entity&#8217;s
Ability to Continue as a Going Concern,&#8221; management has determined that mandatory liquidation, and subsequent dissolution, should
the Company be unable to complete a business combination, raises substantial doubt about the Company&#8217;s ability to continue as a
going concern for the next twelve&#160;months from the issuance of these consolidated financial statements. No adjustments have been made
to the carrying amounts of assets and liabilities should the Company be required to liquidate after June&#160;22, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for, among other
things, a new U.S.&#160;federal 1% excise tax on certain repurchases of stock occurring on or after January&#160;1, 2023, by publicly
traded U.S.&#160;domestic corporations, by certain U.S.&#160;domestic subsidiaries of publicly traded foreign corporations, by &#8220;covered
surrogate foreign corporations&#8221; (as defined in the IR Act) and by certain affiliates of the foregoing. The excise tax is imposed
on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally
1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock
repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any redemption or other repurchase
that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the
excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension
vote or otherwise would depend on a number of factors, including (i)&#160;the fair market value of the redemptions and repurchases in
connection with the Business Combination, extension or otherwise, (ii)&#160;the structure of a Business Combination, (iii)&#160;the nature
and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination (or otherwise issued not in
connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv)&#160;the content of
regulations and other guidance from the Treasury. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#8217;s ability to complete a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;22, 2023 and
December&#160;21, 2023, the Company&#8217;s stockholders redeemed 18,000,868 and 140,663 shares, respectively, for a total of $184,845,836
and $1,565,078, respectively. On March&#160;26, 2024, the Company&#8217;s stockholders redeemed 95,394 shares for a total of $1,088,361.
On September&#160;30, 2024, the Company&#8217;s stockholders redeemed 50,556 shares for a total of $595,439. The Company determined that
an excise tax liability should be recorded due to the redeemed shares. As of December 31, 2024, the Company has a charge to stockholders&#8217;
deficit of $1,880,944 of excise tax liability, including $16,838 charged during the year ended December 31, 2024, calculated as 1% of
the value of shares redeemed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;3, 2024, the Treasury
issued final regulations with respect to the procedure and administration of the Excise Tax. These regulations provided that the filing
and payment deadline for any liability incurred during the period from January&#160;1, 2023 to December&#160;31, 2023 would be October&#160;31,
2024. As of December 31, 2024 and the date of this report, the excise tax was not paid and recorded as excise tax payable. Any amount
of such Excise Tax not paid in full, could be subject to additional interest and penalties which are currently estimated at 7% interest
per annum and a 5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2024 and
2023, $1,880,944 and $1,864,106 were accrued on the accompanying consolidated balance sheets, respectively. On January 29, 2025, the Company
claimed disaster relief under IRC Section 7508A relating to Hurricane Beryl as announced in IRS Announcement TX-2024-08. Under the disaster
relief claim, the time for filing of the September 30, 2024 Quarterly Federal Excise Tax Return and payment of the 2023 excise taxes on
repurchases of corporate stock normally due on October 31, 2024 should be postponed to February 3, 2025. The Company was not subject to
excise tax interest and penalties until February 3, 2025. On January 29, 2025, the Company filed their 2024 excise tax return. No excise
tax payment had been made by the Company.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Summary of Significant
Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed
consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States
of America (&#8220;U.S.&#160;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission
(&#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unaudited Interim Financial Information</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S.&#160;(&#8220;U.S.&#160;GAAP&#8221;).
The interim unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated
financial statements and in accordance with the rules and regulations of the United&#160;States Securities and Exchange Commission (the
&#8220;SEC&#8221;). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only
normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2025,
the results of its operations and changes to stockholders&#8217; equity for the three and six&#160;months ended June&#160;30, 2025 and
2024, and its cash flows for the six&#160;months ended June&#160;30, 2025 and 2024. The results for the three and six&#160;months ended
June&#160;30, 2025, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2025, or any other
interim periods, or any future year or period. All amounts included herein have been rounded except where otherwise stated. As figures
are rounded, numbers presented throughout this document may not add up precisely to the totals we provide and percentages may not precisely
reflect the absolute figures. Certain disclosures have been consolidated or omitted from the unaudited interim condensed consolidated
financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying interim
unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and the related disclosures as of December&#160;31, 2024 and for the year then ended as found in the Form&#160;S-4/A filed by the Company
with the SEC on April&#160;3, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of condensed
consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and
expenses in the condensed consolidated financial statements and accompanying notes. The Company&#8217;s management regularly assesses
these estimates, including those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance
for deferred tax assets, and valuation of stock-based awards. Actual results could differ from these estimates, and such differences
could be material to the Company&#8217;s financial position and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accounts Receivable and Allowance for Credit
Losses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have
any accounts receivable with customers in the six&#160;months ended June&#160;30, 2025 and 2024. The Company has developed policies that
when accounts receivables are held with customers, they are recorded at the point in time in which management determines it is probable
that the Company will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services
transferred to the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of June&#160;30, 2025 and 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#8217;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash. The Company&#8217;s other receivables are represented by amounts owned by two government agencies under the government
grants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all
highly liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of June&#160;30,
2025 and 2024, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred Offering Costs</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of
securities, all of the costs are expensed. Offering costs capitalized as of June&#160;30, 2025 and December&#160;31, 2024 were $4.1&#160;million
and $2.8&#160;million, respectively. The deferred offering costs as of June&#160;30, 2025 and December&#160;31, 2024 includes $1.3&#160;million
and $0.8&#160;million respectively, of advances to NorthView to fund costs associated with the business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Government Grants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives payments
from government entities under non-refundable grants in support of product development programs. The grants received fall within two categories:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">a.</td><td style="text-align: justify">Expense Reimbursement Grants&#160;&#8212;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">b.</td><td style="text-align: justify">Fixed Fee Grants&#160;&#8212;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non- exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as the Company is a business entity, and the grants are with governmental
agencies or units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In absence of explicit U.S.&#160;GAAP
guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#8220;IAS
20&#8221;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method,
grant income is recognized using the same proportion as the costs incurred to date to the total expected cost of the project, but limiting
the income to be recognized to the amount to which the Company is entitled based on the submitted deliverables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value of Financial Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s financial
instruments consist of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company
states accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment.
The promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June&#160;2023-February&#160;2024
(Note&#160;5) is carried at fair value based on unobservable market inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Accounting Standards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the six&#160;months ended June&#160;30, 2025 and through the date of issuance
of these condensed consolidated financial statements, there have been no new, or existing, recently issued accounting pronouncements that
are of significance, or potential significance, that impact the Company&#8217;s condensed consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Recently issued accounting standards not yet
adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU&#160;2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early
adoption permitted and can be applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine
its impact on the income tax disclosures. No material financial impact will result in this expanded disclosure requirement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2024, the
FASB issued ASU No.&#160;2024-03 (&#8220;ASU&#160;2024-03&#8221;), Disaggregation of Income Statement Expenses (&#8220;DISE&#8221;). ASU&#160;2024-03
requires disaggregated disclosure of income statement expenses for public business entities. ASU&#160;2024-03 does not change the expense
captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified
categories in disclosures within the footnotes to the financial statements. As revised by ASU No.&#160;2025-01, Income Statement&#160;&#8212;&#160;Reporting
Comprehensive Income&#160;&#8212;&#160;Expense Disaggregation Disclosures, the provisions of ASU&#160;2024-03 are effective for fiscal&#160;years
beginning after December&#160;15, 2026, and interim periods within fiscal&#160;years beginning after December&#160;15, 2027, with early
adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, the Company
does not expect the adoption of ASU&#160;2024-03 to have a material effect on our consolidated financial statements taken as a whole.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;2 &#8212;&#160;Summary of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States of America
(&#8220;U.S.&#160;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;)
and include all adjustments necessary for the fair presentation of the Company&#8217;s financial position as of December&#160;31, 2024
and 2023, and the results of operations and cash flows for the&#160;years then ended. The accompanying consolidated financial statements
include the accounts of Profusa Inc. and its wholly owned subsidiary, APAC.&#160;All intercompany balances and transactions have been
eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated
financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses in
the consolidated financial statements and accompanying notes. The Company&#8217;s management regularly assesses these estimates, including
those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance for deferred tax assets,
and valuation of stock-based awards. Actual results could differ from these estimates, and such differences could be material to the Company&#8217;s
financial position and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounts Receivable and Allowance for Credit Losses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have any
accounts receivable with customers in the years ended December 31, 2024 and 2023. The Company has developed policies that when accounts
receivables are held with customers, they are recorded at the point in time in which management determines it is probable that the Company
will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services transferred to
the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of December 31, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#8217;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s other receivables
are represented by amounts owned by two government agencies under the government grants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all highly
liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of December&#160;31, 2024
and 2023, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Deferred Offering Costs</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of securities,
all of the costs are expensed. Offering costs capitalized as of December&#160;31, 2024 and December&#160;31, 2023 were $2.8&#160;million
and $1.5&#160;million, respectively. The deferred offering costs as of December 31, 2024 and 2023 includes $0.8 million and $0, respectively,
of advances to NorthView to fund costs associated with the business combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Share-Based Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for
share-based compensation arrangements with employees and non-employees using a fair value method which requires the recognition of
compensation expense for costs related to all share-based payments including stock options. The fair value method requires the
Company to estimate the fair value of share-based payment awards on the date of grant using an option pricing model. The Company
uses the Black-Scholes pricing model to estimate the fair value of options granted that are then expensed on a straight-line basis
over the vesting period. The Company accounts for forfeitures as they occur. Option valuation models, including the Black-Scholes
option-pricing model, require the input of highly subjective assumptions, and changes in the assumptions used can materially affect
the grant-date fair value of an award. These assumptions include the risk-free rate of interest, expected dividend yield, expected
volatility, and the expected life of the award.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Preferred Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company records all shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The convertible preferred
stock is recorded outside of permanent equity because while it is not mandatorily redeemable, in certain events considered not solely
within the Company&#8217;s control, such as a merger, acquisition, or sale of all or substantially all of the Company&#8217;s assets (each,
a &#8220;deemed liquidation event&#8221;), the convertible preferred stock will become redeemable at the option of the holders of at least
a majority of the then outstanding preferred shares. The Company has not adjusted the carrying values of the convertible preferred stock
to its liquidation preference because a deemed liquidation event obligating the Company to pay the liquidation preferences to holders
of shares of convertible preferred stock is not probable of occurring. Subsequent adjustments to the carrying values to the liquidation
preferences will be made only when it becomes probable that such a deemed liquidation event will occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Government Grants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives payments
from government entities under non-refundable grants in support of our product development programs. The grants received fall within two
categories:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">a.</td><td style="text-align: justify">Expense Reimbursement Grants&#160;&#8212;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">b.</td><td style="text-align: justify">Fixed Fee Grants&#160;&#8212;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non-exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as we are a business entity, and the grants are with governmental agencies
or units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In absence of explicit U.S.
GAAP guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#8220;IAS
20&#8221;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method
the Company recognizes grant income using the same proportion as the costs incurred to date to the total expected cost of the project,
but limiting the income to be recognized to the amount to which it is entitled based on the submitted deliverables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s financial instruments consist
primarily of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company states
accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. The
promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June 2023-February
2024 (Notes 3 and 5) carried at fair value based on unobservable market inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Research and Development</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses
consist of costs related to employee compensation and benefits, costs for contract manufacturing organizations (&#8220;CMOs&#8221;), costs
for contract research organizations (&#8220;CROs&#8221;), costs for sponsored research, costs for clinical trials, consultant services,
laboratory supplies, product licenses, facility-related expenses and depreciation. All research and development costs are charged to research
and development expenses within the statements of operations as incurred. Payments associated with licensing agreements to acquire exclusive
licenses to develop, use, manufacture and commercialize products that have not reached technological feasibility and do not have alternate
commercial use are also expensed as incurred. Payments made to third parties under these arrangements in advance of the performance of
the related services by the third parties are recorded as prepaid expenses until the services are rendered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes using the asset and liability method whereby deferred tax asset and liability accounts are determined based on differences between
financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are for the year
in which the differences are expected to affect taxable income. Valuation allowances are established where necessary to reduce deferred
tax assets to the amounts expected to be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain
tax positions by assessing all material positions taken in any assessment or challenge by relevant taxing authorities. Assessing an uncertain
tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit
that is greater than fifty percent likely of being realized upon ultimate settlement. The Company&#8217;s policy is to recognize interest
and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. The Company recognizes interest
and penalties related to unrecognized tax benefits within the income tax expense line. Accrued interest and penalties are included within
the Accrued liabilities in the balance sheets. To date, there have been no interest or penalties charged in relation to the unrecognized
tax benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Net Loss per Share Attributable to Common Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic net loss per common
share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock
outstanding during the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing
the net loss attributable to common stockholders by the weighted-average number of shares of common stock and potentially dilutive securities
outstanding for the period. For purposes of the diluted net loss per share calculation, the convertible preferred stock, common stock
subject to repurchase and stock options are considered to be potentially dilutive securities. Basic and diluted net loss attributable
to common stockholders per share is presented in conformity with the two-class method required for participating securities as the convertible
preferred stock is considered a participating security. The Company&#8217;s participating securities do not have a contractual obligation
to share in the Company&#8217;s losses. As such, the net loss is attributed entirely to common stockholders. Because the Company has reported
a net loss for the reporting periods presented, the diluted net loss per common share is the same as basic net loss per common share for
those periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recent Accounting Standards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the year ended December 31, 2024 and through the date of issuance of these consolidated
financial statements, there have been no new, or existing, recently issued accounting pronouncements that are of significance, or potential
significance, that impact the Company&#8217;s consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently issued accounting standards as adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued
ASU 2020-06, Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#160;&#8212;&#160;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40)&#160;&#8212;&#160;Accounting for Convertible Instruments and Contracts in an Entity&#8217;s
Own Equity (&#8220;ASU 2020-06&#8221;). ASU 2020-06 reduces the number of accounting models for convertible debt instruments and redeemable
convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives
under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded
conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered
in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging&#160;&#8212;&#160;Contracts in Entity&#8217;s
Own Equity, and clarifies the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related
to the disclosures and earnings per-share (EPS) for convertible instruments and contracts in an entity&#8217;s own equity. For private
companies, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. The Company early adopted the standard in prior years, which did not have a material impact on its consolidated financial statements
and related disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued ASU&#160;2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures, requiring public entities
to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis.
Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing
segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. The Company adopted ASU 2023-07 effective
December 31, 2024, on a retrospective basis. The adoption of 2023-07 did not change the way that the Company identifies its reportable
segment. However, it has resulted in incremental disclosures within the notes of the Company&#8217;s consolidated financial statements
(Note 14).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently issued accounting standards not yet adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU 2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early adoption permitted and can be
applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine its impact on our income
tax disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2024, the FASB
issued ASU No. 2024-03 (&#8220;ASU 2024-03&#8221;), Disaggregation of Income Statement Expenses (&#8220;DISE&#8221;). ASU 2024-03 requires
disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an
entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories
in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement&#160;&#8212;&#160;Reporting
Comprehensive Income&#160;&#8212;&#160;Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years
beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted.
With the exception of expanding disclosures to include more granular income statement expense categories, the Company does not expect
the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements taken as a whole.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;2 &#8212;&#160;Significant Accounting
Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements are presented in U.S.&#160;dollars in conformity with accounting principles generally accepted
in the United&#160;States of America (&#8220;GAAP&#8221;) for financial information and pursuant to the rules and regulations of the SEC.&#160;Accordingly,
they do not include all of the information and footnotes required by GAAP.&#160;In the opinion of management, the unaudited condensed
consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement
of the balances and results for the periods presented. The interim results for the three and six&#160;months ended June&#160;30, 2025
are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any future periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited financial statements and notes
thereto included in the Form&#160;10-K annual report filed by the Company with the SEC on March&#160;31, 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Principles of Consolidation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances
and transactions have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging Growth Company Status</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an &#8220;emerging
growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act&#160;of&#160;2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#8217;s condensed consolidated financial statements with another public company,
which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period
difficult or impossible because of the potential differences in accounting standards used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of these condensed
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates are in
connection with determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results
could differ significantly from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents and Restricted Cash</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. At June&#160;30, 2025 and December&#160;31,
2024, the Company had $1,751&#160;and <span style="-sec-ix-hidden: hidden-fact-393">$0</span>&#160;of restricted cash, respectively, related to funds withdrawn from the Trust Account reserved
for the payment of income and state franchise taxes. The Company did not have any cash equivalents as of June&#160;30, 2025 and December&#160;31,
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash Held in Trust Account</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June&#160;30, 2025 and December&#160;31,
2024, substantially all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six&#160;months
ended June&#160;30, 2025, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $78,813 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six&#160;months
ended June&#160;30, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $204,460 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,935,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December&#160;21, 2023, 140,663 shares of the Company&#8217;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the condensed consolidated balance sheets, which was paid from the Trust Account
in January&#160;2024 to redeeming stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial
business combination from March&#160;22, 2025 to June&#160;22, 2025. The meeting was adjourned until March&#160;21, 2025, at which the
stockholders approve the extension of the business combination period until June&#160;22, 2025. As a condition of the extension, the Company
contributed $30,000 to the Trust Account, for the entire extension period, on March&#160;21, 2025. On July&#160;1, 2025, the Company filed
the Amendment to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations
and redeem or repurchase 100% of the shares of the Company&#8217;s common stock issued in the Company&#8217;s initial public offering,
from June&#160;22, 2025 to August&#160;22, 2025.&#160;In connection with the special meeting of stockholders to approve the Business Combination,
stockholders of the Company redeemed 52,784 shares of common stock for an aggregate amount of $661,012.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, $1,274,549
of the Trust assets were classified as noncurrent assets and $661,012 of the Trust assets due to redeeming stockholders were classified
as current assets. As a result of the Business Combination, the $661,012 due to redeeming stockholders was paid at the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value of Financial Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
assets and liabilities approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily
due to their short-term nature, except for the warrant liabilities, convertible promissory note, and securities purchase agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes under ASC&#160;740, &#8220;Income Taxes.&#8221; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the condensed consolidated financial statements and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#8217;s deferred tax asset had a full valuation allowance
recorded against it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s condensed consolidated financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company incurred $340 and <span style="-sec-ix-hidden: hidden-fact-394"><span style="-sec-ix-hidden: hidden-fact-395">no</span></span> amount
of interest and penalty expenses during the three and six&#160;months ended June&#160;30, 2025 and 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has identified
the United&#160;States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Derivative Financial Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the condensed consolidated statements
of operations. Derivative assets and liabilities are classified in the condensed consolidated balance sheets as current or non-current&#160;based
on whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Convertible Promissory Note</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
securities purchase agreement is valued using Monte Carlo models on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. The instrument
is subject to re-measurement at each balance sheet date, with changes in fair value recognized in the condensed consolidated statements
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrant Liabilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for the&#160;17,404,250&#160;warrants
issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants, and the&#160;569,250&#160;Representative
Warrants inclusive of the underwriters&#8217; over-allotment&#160;option) in accordance with the guidance contained in ASC&#160;815-40.
Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded
as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement&#160;at
each balance sheet date. With each such re-measurement, the warrant liabilities will be adjusted to fair value, with the change in fair
value recognized in the Company&#8217;s condensed consolidated statements of operations (See Note&#160;8).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the fair value
of the Private Placement Warrants and the Representative&#8217;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Net Loss Per Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250&#160;potential shares of common stock for outstanding warrants to purchase the
Company&#8217;s shares were excluded from diluted earnings per share for the three and six&#160;months ended June&#160;30, 2025 and 2024
because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per share
of common stock is the same as basic net loss per share of common stock for the periods presented.&#160;The table below presents a reconciliation
of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below presents a
reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Allocation of net loss</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(224,777</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(7,972,099</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(49,458</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(348,029</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(685,851</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(8,630,935</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(159,563</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(1,058,201</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">146,440</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,075</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">412,717</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">783,151</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.53</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.53</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.66</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.66</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock Subject to Possible Redemption</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s common
stock sold as part of the Units&#160;in the IPO (&#8220;public common stock&#8221;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#8217;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#8217;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the
following table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">9,252,208</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,683,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">768,980</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">8,337,388</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,510,830</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155,999</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, March&#160;31, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,982,557</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Redemption payment due to stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(661,012</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,970</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,330,515</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recently Issued Accounting Standards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Standards Adopted</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued&#160;ASU&#160;2023-07,&#160;Segment Reporting&#160;(Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments
in this&#160;ASU&#160;require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided
to the chief operating officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in
the reported measure of segment profit or loss. The&#160;ASU&#160;requires that a public entity disclose the title and position of the
CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and
deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280&#160;in
interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments
in this&#160;ASU&#160;and existing segment disclosures in Topic&#160;280. This&#160;ASU&#160;is effective for fiscal&#160;years beginning
after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption
permitted. The Company adopted ASU&#160;2023-07, which was applied retrospectively to all prior periods presented. See Note&#160;9 for
further details regarding this adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Standards not yet Adopted</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#8220;ASU&#160;2023-09&#8221;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#8217;s condensed consolidated financial statements.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;2 &#8212;&#160;Summary of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements are presented in conformity with accounting principles generally accepted in the United&#160;States of America (&#8220;GAAP&#8221;)
and pursuant to the rules and regulations of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principles of Consolidation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Emerging Growth Company Status</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an &#8220;emerging
growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public company, which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of these consolidated
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Some of the more significant estimates are in connection with
determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results could differ significantly
from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company did not have any
cash equivalents as of December&#160;31, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Marketable Securities Held in Trust Account</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2024, substantially
all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank and at December&#160;31,
2023, substantially all of the assets held in the Trust Account were held in U.S.&#160;Treasury Bills. All of the Company&#8217;s investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the consolidated balance sheets at
fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust
Account are shown in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;
Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $204,459 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2023, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;
Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $1,192,438 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December
    31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,406</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">U.S.&#160;Treasury Bills</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,872,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,330,835</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10,873,406</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December 21, 2023, 140,663 shares of the Company&#8217;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the consolidated balance sheets, which was paid from the Trust Account in January&#160;2024
to redeeming stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial business combination
from March 22, 2025 to June 22, 2025. The meeting was adjourned until March 21, 2025, at which the stockholders approve the extension
of the business combination period until June 22, 2025. As a condition of the extension, the Company contributed $30,000 to the Trust
Account, for the entire extension period, on March 21, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2024, all
of the Trust assets were classified as noncurrent assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
assets and liabilities approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to
their short-term nature, except for the warrant liabilities and convertible promissory note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes under ASC&#160;740, &#8220;Income Taxes.&#8221; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the consolidated financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires
a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
As of December&#160;31, 2024 and 2023, the Company&#8217;s deferred tax asset had a full valuation allowance recorded against it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure
and transition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. Interest and penalties expense amounted
to $0 and $19,158 during the years ended December 31, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has identified
the United&#160;States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Derivative Financial Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the consolidated statements of
operations. Derivative assets and liabilities are classified in the consolidated balance sheets as current or non-current&#160;based on
whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Promissory Note</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Warrant Liabilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for the&#160;17,404,250
warrants issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants,
and the 569,250 Representative Warrants inclusive of the underwriters&#8217; over-allotment&#160;option) in accordance with the guidance
contained in ASC&#160;815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder,
each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This
liability is subject to re-measurement&#160;at each balance sheet date. With each such re-measurement, the warrant liabilities will be
adjusted to fair value, with the change in fair value recognized in the Company&#8217;s consolidated statements of operations (See Note&#160;8).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the fair value
of the Private Placement Warrants and the Representative&#8217;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Net (Loss) Income Per Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250 potential shares of common stock for outstanding warrants to purchase the Company&#8217;s
shares were excluded from diluted earnings per share for the years ended December 31, 2024 and 2023 because the warrants are contingently
exercisable, and the contingencies have not yet been met. As a result, diluted net (loss) income per share of common stock is the same
as basic net (loss) income per share of common stock for the periods presented.&#160;The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Basic and diluted net (loss) income per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net (loss) income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,096,239</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(7,615,380</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">562,049</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">599,861</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">747,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,866,356</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Basic and diluted net (loss) income per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.47</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.47</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.12</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.12</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Stock Subject to Possible Redemption</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s common
stock sold as part of the Units&#160;in the IPO (&#8220;public common stock&#8221;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#8217;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#8217;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2022</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">193,525,484</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(186,410,914</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,137,638</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">9,252,208</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,683,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">768,980</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,337,388</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recently Issued Accounting Standards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued ASU 2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments in this ASU
require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating
officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in the reported measure of
segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the
CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public
entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single
reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures
in Topic 280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years
beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU 2023-07, which was applied retrospectively
to all prior periods presented. See Note 10 for further details regarding this adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Standards not yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#8220;ASU&#160;2023-09&#8221;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#8217;s consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SummaryofSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SummaryofSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Fair Value Measurement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities recorded
at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used
to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize
the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes
a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 0.5in; padding-bottom: 2.25pt">&#160;</td>
    <td style="width: 0.65in; text-align: justify"><span style="font-size: 10pt">Level&#160;1&#160;&#8212;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Level&#160;2&#160;&#8212;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Level&#160;3&#160;&#8212;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining fair value,
the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the
extent possible as well as considers counterparty credit risk in its assessment of fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities measured
at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The
Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management
to make judgments and consider factors specific to the asset or liability. As of June&#160;30, 2025 and December&#160;31, 2024, the Company
had no financial assets measured at fair value on a recurring basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
Company&#8217;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of June&#160;30, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,543</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,543</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,234</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,234</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments for the three and six&#160;months ended
June&#160;30, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> convertible <br/> debt at fair <br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of January&#160;1, 2024</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1,714</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Issuance of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 0.125in">Change in fair value included in other income and gain on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of March&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,774</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of January&#160;1, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">61</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of March&#160;31, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">57</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to measure
its Tasly convertible debt at fair value (Note&#160;5) with changes in fair value reported in earnings as they occur. The Convertible
Debt fair values were determined using the discounted cash flow methodology based on probability weighted scenarios of the convertible
notes conversion. At issuance of the first $1&#160;million on June&#160;26, 2023 the time to event was 0.28&#160;years and the discount
rate applied was 14.54%. At issuance of the next $0.3&#160;million on July&#160;20, 2023, the time to event was 0.22&#160;years and the
discount rate applied was 13.82%. At issuance of the additional $0.3&#160;million on August&#160;15, 2023, the time to event was 0.15&#160;years
and the discount rate applied was 13.70%. The final amount which was less than $0.02&#160;million was issued on February&#160;6, 2024;
the time to event was 0.66&#160;years and the discount rate applied was 13.69%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;30, 2025, the
time event was .03&#160;years and the discount rate applied was 12.66%. Based on this method, the Fair value of the convertible debt at
the date of inception was $1.6&#160;million, the fair value at June&#160;30, 2025 was $2.1&#160;million.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;3 &#8212;&#160;Fair Value Measurement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities recorded
at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used
to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize
the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes
a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;1&#160;&#8212;&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;2&#160;&#8212;&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&#160;3&#160;&#8212;&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining fair value,
the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the
extent possible as well as considers counterparty credit risk in its assessment of fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets and liabilities measured
at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The
Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management
to make judgments and consider factors specific to the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the Company had no financial assets measured at fair value on a recurring basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the Company&#8217;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,235</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,235</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,714</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,714</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total assets measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the changes in the fair value of the Company&#8217;s Level&#160;3 financial instruments for the&#160;years ended December&#160;31,
2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> convertible <br/> debt at fair <br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value as of January&#160;1, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Issuance of Convertible Notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,600</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value as of January&#160;1, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,714</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Issuance of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">194</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to measure
its Tasly convertible debt at fair value (Note&#160;5) with changes in fair value reported in earnings as they occur. The Convertible
Debt fair values were determined using the discounted cash flow methodology based on probability weighted scenarios of the convertible
notes conversion. At issuance of the first $1&#160;million on June&#160;26, 2023 the time to event was 0.28&#160;years and the discount
rate applied was 14.54%. At issuance of the next $0.3&#160;million on July&#160;20, 2023, the time to event was 0.22&#160;years and the
discount rate applied was 13.82%. At issuance of the additional $0.3&#160;million on August&#160;15, 2023, the time to event was 0.15&#160;years
and the discount rate applied was 13.70%. The final amount which was less than $0.02 million was issued on February 6, 2024; the time
to event was 0.66 years and the discount rate applied was 13.69%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;31, 2024
the time event was 0.41&#160;years and the discount rate applied was 11.78%. The fair value of the convertible debt as of December&#160;31,
2023 was $1.71&#160;million and the fair value as of December&#160;31, 2024 was $2.2 million.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Fair value is defined as the
price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants
at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). The Company&#8217;s financial instruments are classified as either
Level 1, Level 2 or Level 3. These tiers include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Level 1, defined as observable inputs such as quoted prices
(unadjusted) for identical instruments in active markets;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Level 2, defined as inputs other than quoted prices in active
markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices
for identical or similar instruments in markets that are not active; and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Level 3, defined as unobservable inputs in which little or
no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques
in which one or more significant inputs or significant value drivers are unobservable.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables present
information about the Company&#8217;s assets and liabilities that are measured at fair value on June&#160;30, 2025 and December&#160;31,
2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Quoted<span style="text-decoration:underline"><br/> </span>Prices In<span style="text-decoration:underline"><br/> </span>Active<span style="text-decoration:underline"><br/> </span>Markets<span style="text-decoration:underline"><br/> </span>(Level 1)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Observable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 2)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Unobservable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 3)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1,935,561</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1,274,549</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,795,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,795,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,939,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,939,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">227,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">227,700</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible Promissory Note&#160;&#8211;&#160;Related Party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,288,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,288,111</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Securities Purchase Agreement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,878</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,878</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,443,689</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-413">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,795,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,648,689</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Quoted<span style="text-decoration:underline"><br/> </span>Prices In<span style="text-decoration:underline"><br/> </span>Active<span style="text-decoration:underline"><br/> </span>Markets<span style="text-decoration:underline"><br/> </span>(Level 1)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Observable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 2)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Unobservable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 3)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible Promissory Note&#160;&#8211;&#160;Related Party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,604,222</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">379,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,224,722</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Public Warrants, the Private
Placement Warrants and the Representative&#8217;s Warrants were accounted for as liabilities in accordance with ASC&#160;815-40 and are
presented within liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception
and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated
statements of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilized a Monte
Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants at June&#160;30,
2025 and December&#160;31, 2024 was classified as Level 2 due to the lack of an active market. As of June&#160;30, 2025 and December&#160;31,
2024, the aggregate value of Public Warrants was $3,795,000 and $379,500, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company uses a Monte Carlo
simulation model to value the Private Placement Warrants and the Representative&#8217;s Warrants. The Private Placement Warrants and the
Representative&#8217;s Warrants were classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent
in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates
the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free
interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining
life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, <span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, <span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.22</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.89</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, <span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, <span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.28</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt">De minimis</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the securities purchase agreement were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.83</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.59</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.84</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the three and six&#160;months ended June&#160;30, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">293,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">22,770</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">316,670</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">146,950</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,385</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">158,335</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">440,850</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">34,155</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">475,005</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,498,150</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,545</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,691,695</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,939,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">227,700</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,166,700</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">66,128</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,123</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">71,251</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">213,077</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">229,586</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">279,205</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">21,632</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">300,837</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">124,908</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,676</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">134,584</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">404,113</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">31,308</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">435,421</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Convertible<span style="text-decoration:underline"><br/> </span>Promissory<span style="text-decoration:underline"><br/> </span>Note&#160;&#8211;&#160;related<span style="text-decoration:underline"><br/> </span>party</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2024</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">8,908,052</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">225,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">9,133,382</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,154,729</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,288,111</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Convertible<span style="text-decoration:underline"><br/> </span>Promissory<span style="text-decoration:underline"><br/> </span>Note</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">944,118</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Principal proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">378,185</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(60,077</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Fair value at March&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,262,226</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds received through convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">330,796</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,527,001</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The convertible promissory
note was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent in pricing models are assumptions
related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common
stock based on historical volatility that matches the expected remaining life of the note.
The risk-free interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the
expected remaining life of the note. The expected life of the note is assumed to be equivalent to their remaining contractual term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Securities<span style="text-decoration:underline"><br/> </span>Purchase<span style="text-decoration:underline"><br/> </span>Agreement</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at February&#160;11, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">Change in fair value of securities purchase agreement</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">23,487</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">23,487</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of securities purchase agreement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">170,391</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">193,878</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilizes a Monte
Carlo model to estimate the fair value of the conversion feature within the securities purchase agreement, which is required to be recorded
at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the
conversion feature are recognized as non-cash gains or losses in the accompanying condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key assumptions in the
model relate to expected share-price volatility, risk-free interest rate, exercise price, expected term and the probability of occurrence
of the transaction. The expected volatility was based on the average volatility of special purpose acquisition companies that are searching
for an acquisition target. The risk-free interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for
a maturity similar to the expected remaining life of the note. The expected life of the note is assumed to be equivalent to their remaining
contractual term.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;8 &#8212;&#160;Fair Value Measurements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Fair value is defined as the
price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants
at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). The Company&#8217;s financial instruments are classified as either
Level 1, Level 2 or Level 3. These tiers include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in
active markets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly
observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets
that are not active; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring
an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs
or significant value drivers are unobservable.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables present
information about the Company&#8217;s assets and liabilities that are measured at fair value on December&#160;31, 2024 and 2023, and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted <br/> Prices In<br/> Active <br/> Markets <br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Observable <br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Unobservable <br/> Inputs <br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash and marketable securities held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,604,222</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">379,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,224,722</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active <br/> Markets <br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Observable <br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Unobservable <br/> Inputs <br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash and marketable securities held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">10,873,406</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">10,873,406</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">85,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">85,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,128</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,123</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">944,118</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">944,118</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,100,757</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,388</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,015,369</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Public Warrants, the Private
Placement Warrants and the Representative&#8217;s Warrants were accounted for as liabilities in accordance with ASC&#160;815-40 and are
presented within liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on
a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company utilized a Monte
Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants at December
31, 2024 was classified as Level 2 due to the lack of an active market. At December&#160;31, 2023, the Public Warrants was classified
as Level 1 due to the use of an observable market quote in an active market. As of December&#160;31, 2024 and 2023, the aggregate value
of Public Warrants was $379,500 and $85,388, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company uses a Monte Carlo
simulation model to value the Private Placement Warrants and the Representative&#8217;s Warrants. The Private Placement Warrants and the
Representative&#8217;s Warrants were classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent
in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates
the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The risk-free interest rate
is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of
the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at December&#160;31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, <br/> 2023</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.06</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.89</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.71</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">De&#160;minimis </div></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.16</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at December&#160;31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, <br/> 2023</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.48</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.19</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.16</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the years ended December 31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">66,128</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,123</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">71,251</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,772</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,647</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">245,419</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">293,900</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">22,770</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">316,670</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">377,857</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">29,274</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,131</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(311,729</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,151</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(335,880</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">66,128</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,123</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">71,251</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Promissory <br/> Note</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">944,118</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Principal borrowing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">797,981</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,165,953</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December&#160;31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,908,052</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Promissory <br/> Note</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value at December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Principal borrowing</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,121,815</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(177,697</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">944,118</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The convertible promissory
note was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent in pricing models are assumptions
related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common
stock based on historical volatility that matches the expected remaining life of the note. The risk-free interest rate is based on the
U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the note. The expected
life of the note is assumed to be equivalent to their remaining contractual term.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueMeasurementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueMeasurementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsTextBlock', window );">Balance Sheet Components</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;4 &#8212;&#160;Balance Sheet Components</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid expenses and other current assets (in
thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid legal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">130</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">69</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accrued Liabilities (in thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Accrued compensation</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(3,472</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(209</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(496</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(4,299</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,968</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;4 &#8212;&#160;Balance Sheet Components</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid expenses and other current assets (in
thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Employee advances</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">96</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid legal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">69</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">146</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accrued Liabilities (in thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Accrued compensation</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(3,472</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,960</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(496</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(391</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,968</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,351</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the debt instruments and their changes during the six&#160;months ended June&#160;31, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px">Balance at January&#160;1, 2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18,419</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,234</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25,268</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">910</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,376</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Balance at June&#160;30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">27,895</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">940</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,383</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,533</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,543</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">27,895</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">940</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,383</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 36px">Long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px">Balance at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,316</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,714</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">20,155</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">849</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,362</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(115</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">993</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">994</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Balance at June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,348</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">22,154</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">880</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,369</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Long term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All debt was classified as
current debt as of June&#160;30, 2024 and 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Debt</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Convertible Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Convertible Notes was estimated from 12.54% to 53.28% per year for the six&#160;months ended June&#160;30, 2025 and 12.66% to
53.28% per year for the six&#160;months ended June&#160;30, 2024. The interest expense for the three&#160;months ended June&#160;30, 2025
and 2024 was $0.6&#160;million and $0.5&#160;million, respectively. The interest expense for the six&#160;months ended June&#160;30, 2025,
and 2024 was $1.1&#160;million and $1.0&#160;million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 the
outstanding balance of convertible notes includes related party convertible notes of $14.1&#160;million. As of December&#160;31, 2024
the outstanding balance of convertible notes includes related party convertible notes of $13.3&#160;million. These notes were converted
into New Profusa common stock upon the successful closing of the merger on July&#160;11, 2025; see subsequent events (Note&#160;14).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tasly Convertible Debt</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June&#160;2023, the Company
entered into a short-term loan agreement with a related party under which it may borrow up to $1.6&#160;million, of which $1.0&#160;million
was borrowed on June&#160;26, 2023, $0.3&#160;million was borrowed on July&#160;20, 2023, $0.3&#160;million was borrowed on August&#160;15,
2023 and the final $0.02&#160;million was borrowed in February&#160;2024 (the &#8220;Convertible debt&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The loans bear interest at
a rate of 12% per annum, 24% per annum default interest rate, and originally matured on December&#160;31, 2023. The original maturity
date was extended to March&#160;31, 2024, subject to the parties&#8217; decision to extend thereafter. Upon occurrence of certain events
of default by the Company, including failure to repay in full the amounts owed at maturity, the lender will have an option to convert
the entire outstanding balance and accrued but unpaid interest under the Convertible debt into senior unsecured promissory notes on substantially
the same terms as the outstanding Senior Notes as of June&#160;30, 2025. In the event the Company fails to complete the formation of the
APAC Joint Venture or fail to repay the amounts under the Tasly Convertible Debt when they become due, the lender will have an option
to convert the entire outstanding balance and accrued but unpaid interest under the Convertible debt into either (i)&#160;senior unsecured
promissory notes on substantially the same terms as the outstanding Senior Notes as of June&#160;30, 2025, or (ii)&#160;the Company&#8217;s
common stock at a conversion price of $1.92 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to apply
the fair value option to account for the Tasly Convertible debt. Accordingly, no features of the Convertible debt are bifurcated and separately
accounted for. The fair value of the Convertible debt was $2.1&#160;million as of June&#160;30, 2025. Accrued stated interest on the Tasly
Convertible debt was $0.1&#160;million and $0.2&#160;million for the three and six&#160;months ended June&#160;30, 2025, respectively.
Accrued stated interest on the Tasly Convertible debt was $0.05&#160;million and $0.1&#160;million
for the three and six&#160;months ended June&#160;30, 2024, respectively. Accrued interest since note origination is $0.47&#160;million
in total. The total loss on fair value remeasurement from origination through June&#160;30, 2025 was $0.45&#160;million, and the loss
on fair value remeasurement was recognized of $0.1&#160;million through June&#160;30, 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Senior Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January &#8211; March&#160;2024
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months January through March&#160;2024, the Company issued additional Senior Notes
to investors with the principal amount of $0.7&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;&#8211;&#160;June&#160;2024
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months April through June&#160;2024, the Company issued additional Senior Notes to
investors with the principal amount of $0.4&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022). Additionally, the Company repaid $0.1&#160;million of principal on Senior Notes with investors during the respective
period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January &#8211; March&#160;2025
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months January through March&#160;2025, the Company issued additional Senior Secured
Convertible Notes to investors with the principal amount of $0.8&#160;million on substantially the same terms as the Senior Notes issued
in 2022 (as amended in November&#160;2022). These notes were issued at the same 12% interest terms as all of their other Senior Secured
Convertible Notes, and will convert into New Profusa shares at $0.50 per share. These notes have an 18-month maturity, which will be accelerated
and convert into New Profusa shares upon the successful closing of the business combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;&#8211;&#160;June&#160;2025
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months April through June&#160;2025, the Company issued additional Senior Secured Convertible
Notes to investors with the principal amount of $0.4&#160;million issued on substantially the same terms as the Senior Notes issued in
2022 (as amended in November&#160;2022). These notes were issued at the same 12% interest terms as all of their other Senior Secured Convertible
Notes, and will convert into New Profusa shares at $0.50 per share. These notes have an 18-month maturity, which will be accelerated and
convert into New Profusa shares upon the successful closing of the business combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the Company issued
$0.3&#160;million in Senior Notes repayable upon the closing of the Business Combination which accrue interest at 0%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Of the $27.9&#160;million of
Senior Notes, $10.0&#160;million is outstanding with related parties and $17.9&#160;million is outstanding with unrelated parties as of
June&#160;30, 2025. Of the $25.3&#160;million of Senior Notes outstanding on December&#160;31, 2024, $9.5&#160;million was outstanding
with related parties and $15.8&#160;million was outstanding with unrelated parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Senior Notes was estimated from 0% to 12.15% and 0% to 12.55% per year for the six&#160;months ended June&#160;30, 2025 and 2024,
respectively. The interest expense for the three&#160;months ended June&#160;30, 2025 and 2024 was $0.6&#160;million and $0.5&#160;million,
respectively. The interest expense for the six&#160;months ended June&#160;30, 2025 and 2024 was $1.2&#160;million and $1.0&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, future
minimum payments for the convertible notes payable were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; padding-bottom: 1.5pt">As of June&#160;30, 2025</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">19,603</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,287</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">26,003</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total future payments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,603</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,287</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 12px">Less: fair value remeasurement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 12px">Less: unamortized debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,967</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 12px">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(70</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(195</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">27,895</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These notes were converted
into New Profusa common stock upon the successful closing of the merger on July&#160;11, 2025; see subsequent events (Note&#160;14).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Promissory Notes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In a series of transactions
during 2010 and 2011 two of the Company&#8217;s founders provided $0.2&#160;million to the Company to fund general corporate purposes
in exchange for promissory notes. The notes accrue interest annually at a simple interest rate of 5% with no set maturity date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2022, the Company borrowed $0.3&#160;million from two of its founders at <span style="-sec-ix-hidden: hidden-fact-324">zero</span> interest rate to finance its short-term operations, from
which $0.2&#160;million was repaid in the same period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2023, the Company borrowed short-term promissory notes of $0.3&#160;million from an existing investor and additional $0.1&#160;million
from an unrelated party repayable on demand at any time after December&#160;31, 2023, with annual interest rate of 12%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the three and six&#160;months
ended June&#160;30, 2025 and 2024, the Company did not make any repayments from the outstanding balance of the promissory notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, accrued and unpaid interest on the promissory notes was $0.3&#160;million and $0.3&#160;million, respectively.
Interest expense on the promissory notes was less than $0.1&#160;million for each of the three and six&#160;months ended June&#160;30,
2025 and 2024. The carrying value of the promissory notes as of June&#160;30, 2025 and December&#160;31, 2024 was $0.9&#160;million and
$0.9&#160;million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Paycheck Protection Program</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;25, 2021, the Company
borrowed $1.3&#160;million (the &#8220;PPP Loan 2&#8221;) as a Paycheck Protection Program loan. The Paycheck Protection Program, established
as part of the Coronavirus Aid, Relief, and Economic Security (&#8220;CARES&#8221;) Act, provides for loans to qualifying businesses and
is administered by the U.S.&#160;Small Business Administration (the &#8220;SBA&#8221;). The annual interest rate of the PPP Loan 2 is
1%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of PPP Loan
2, if the Company does not submit forgiveness application within 24&#160;weeks the initial disbursement of the loan (the &#8220;Covered
Period&#8221;), the Company must begin to make equal monthly payments of principal and interest starting 10&#160;months from the end of
the Covered Period until May&#160;25, 2026. Interest on the loan continues to accumulate during any deferment period. As of June&#160;30,
2025, the Company has not applied for forgiveness under PPP Loan 2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and June&#160;30, 2025, the Company was in default on PPP Loan 2 due to non-payment of minimal repayment amounts required by the terms
of PPP Loan 2. Accordingly, the Company classified the entire amount outstanding under PPP Loan 2 as current and accrued respective late
penalties for the total amount of less than $0.1&#160;million as of June&#160;30, 2025 and December&#160;31, 2024, respectively. The total
past due amount of PPP Loan 2 repayments as of June&#160;30, 2025 and December&#160;31, 2024 was $1.0&#160;million and $0.8&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
contractual future minimum payments for the PPP Loan 2 were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year Ending December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0pt">2025 (remainder)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,245</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">145</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 12px">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the debt instruments (which are all classified as current liabilities in the accompanying consolidated balance sheets and
their changes during the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balance at January 1, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,149</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">576</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">375</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(151</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-213">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-214">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">515</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,714</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,362</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at January 1, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,714</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,362</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(150</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,057</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,053</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">18,419</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">25,268</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">910</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,419</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,234</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,268</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">910</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,376</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Debt</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>August&#160;2020 Convertible
Notes</i>&#160;&#8212;&#160;In August, September, October and December&#160;2020 the Company received $9.1&#160;million in total gross
proceeds from the issuance of convertible promissory notes (the &#8220;2020 Convertible Notes&#8221;). Interest on the unpaid principal
balance of the August&#160;2020 Convertible Notes accrues from the issuance date at a rate of 12% per year, compounded semi-annually,
and is payable at maturity. Unless converted or redeemed upon the occurrence of certain events, the August&#160;2020 Convertible Notes
were to mature within 12&#160;months of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of an equity financing with
aggregate proceeds to the Company of no less than $20.0&#160;million (the &#8220;Qualified Financing&#8221;), the notes&#8217; outstanding
principal balance and accrued but unpaid interest are to convert into the shares of convertible preferred stock issued in such a Qualified
Financing at a conversion price equal to the lesser of (i)&#160;the per share price obtained by dividing $150.0&#160;million by the Company&#8217;s
fully diluted capitalization, or (ii)&#160;the per share price paid by investors in the Qualified Financing, subject to 30%&#160;discount.
Upon the occurrence of a change of control, the August&#160;2020 Convertible Notes are required to be repaid in the amount equal to 200%
of the notes&#8217; outstanding principal balance plus accrued but unpaid interest.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The August&#160;2020 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that is required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The aggregate issuance date estimated fair values of the derivative liability
issued with the August&#160;2020 Convertible Notes was $1.8&#160;million and was recorded as a debt discount. The discount on the August&#160;2020
Convertible Notes was to be amortized over the contractual term of 12&#160;months from issuance, using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;25, 2021, the
August&#160;2020 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2021 (the &#8220;Amendment&#160;1&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the August&#160;2020 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022 (the &#8220;Amendment&#160;2&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January&#160;2021 Convertible
Notes</i>&#160;&#8212;&#160;In January&#160;2021 the Company received $1.0&#160;million in gross proceeds from the issuance of convertible
promissory notes (the &#8220;January&#160;2021 Convertible Notes&#8221;). Interest on the unpaid principal balance of the January&#160;2021
Convertible Notes accrues from the issuance date at a rate of 12% per year, compounded semi-annually, and is payable at maturity. Unless
converted or redeemed upon the occurrence of certain events, the January&#160;2021 Convertible Notes were to mature within 12&#160;months
of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of a
Qualified Financing, the notes&#8217; outstanding principal balance and accrued but unpaid interest are to convert into the shares of
convertible preferred stock issued in such a Qualified Financing at a conversion price equal to the lesser of (i)&#160;the per share price
obtained by dividing $150.0&#160;million by the Company&#8217;s fully diluted capitalization, or (ii)&#160;the per share price paid by
investors in the Qualified Financing, subject to 30% discount. Upon the occurrence of a change of control, the January&#160;2021 Convertible
Notes are required to be repaid in the amount equal to 200% of the notes&#8217; outstanding principal balance plus accrued but unpaid
interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The January&#160;2021 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that were required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The issuance date estimated fair values of the derivative liability issued
with the January&#160;2021 Convertible Notes was $0.2&#160;million and was recorded as a debt discount. The discount on the January&#160;2021
Convertible Notes was to be amortized over the contractual term of 12&#160;months from issuance, using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the January&#160;2021 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;2021 Convertible
Notes</i>&#160;&#8212;&#160;In April, May and June&#160;2021 the Company received $1.2&#160;million in total gross proceeds from the issuance
of convertible promissory notes (together with January&#160;2021 Convertible Notes, the &#8220;2021 Convertible Notes&#8221;). Interest
on the unpaid principal balance of the April&#160;2021 Convertible Notes accrues from the issuance date at a rate of 12% per year, compounded
semi-annually, and is payable at maturity. Unless converted or redeemed upon the occurrence of certain events, the April&#160;2021 Convertible
Notes were to mature within 12&#160;months of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of a Qualified Financing,
the notes&#8217; outstanding principal balance and accrued but unpaid interest are to convert into the shares of convertible preferred
stock issued in such a Qualified Financing at a conversion price equal to the lesser of (i)&#160;the per share price obtained by dividing
$150.0&#160;million by the Company&#8217;s fully diluted capitalization, or (ii)&#160;the per share price paid by investors in the Qualified
Financing, subject to 30% discount. Upon the occurrence of a change of control, the April&#160;2021 Convertible Notes are required to
be repaid in the amount equal to 200% of the notes&#8217; outstanding principal balance plus accrued but unpaid interest.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The April&#160;2021 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that were required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The issuance date estimated fair values of the derivative liabilities issued
with the April&#160;2021 Convertible Notes was $0.3&#160;million and was recorded as debt discounts. The discount on the April&#160;2021
Convertible Notes was to be amortized over the contractual term of 12&#160;months from issuance, using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the April&#160;2021 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Convertible Notes November&#160;2022 Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;3, 2022,
all of the convertible notes outstanding, referred to as the 2020 Convertible Notes and 2021 Convertible Notes based on the original board
approvals (together the &#8220;Convertible Notes&#8221;) were amended as follows: 1) all unpaid interest and principal shall be due and
payable on the date which is <span style="-sec-ix-hidden: hidden-fact-242">five</span>&#160;business days after the termination of the Merger prior to the occurrence of the Merger closing,
2)&#160;the maximum aggregate initial principal amount was increased from $11.0&#160;million to $11.3&#160;million, 3)&#160;automatic
conversion to SPAC shares of at then outstanding all notes and accrued interest upon the Merger at $7.00 per share was introduced, 4)
upon consummation of the Merger, all noteholders will have a right to receive additional shares upon achievement by the combined company
of certain share price and sales milestones (the&#160;earnout shares) (the &#8220;November&#160;2022 Convertible Notes Amendment&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The November&#160;2022 Convertible
Notes Amendment represented a troubled debt restructuring (the &#8220;TDR&#8221;). The TDR did not result in a gain recognition. As a
result, a new effective interest rate was established based on the $14.4&#160;million carrying value of the debt immediately prior to
the November&#160;2022 Convertible Notes Amendment and the future cash flows after such amendment, net of the issuance costs paid to or
received from the Convertible Notes holders, which were capitalized and amortized based on the new effective interest rate. Fees paid
to third parties in connection with the November&#160;2022 Convertible Notes Amendment were expensed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Convertible Notes was estimated from 12.54% to 53.28% and 12.95% to 53.28% per year for the&#160;years ended December&#160;31,
2024 and 2023, respectively. The interest expense for the&#160;years ended December&#160;31, 2024 and 2023 was $2.1&#160;million and $2.3&#160;million,
which includes the amortization of debt discount and issuance costs of $0.1&#160;million and $0.5&#160;million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the outstanding balance of convertible notes includes related party convertible notes of $13.3&#160;million and $11.8&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tasly Convertible Debt</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June&#160;2023, the Company
entered into a short-term loan agreement with a related party under which it may borrow up to $1.6&#160;million, of which $1.0&#160;million
was borrowed on June&#160;26, 2023, $0.3&#160;million was borrowed on July&#160;20, 2023, $0.3&#160;million was borrowed on August&#160;15,
2023 and the final $0.02 million was borrowed in February 2024 (the &#8220;Convertible debt&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The loans bear interest
at a rate of 12% per annum and originally matured on December 31, 2023. The original maturity date was extended to March&#160;31,
2024, subject to the parties&#8217; decision to extend thereafter. The Company is currently in default, as this loan will be repaid
in parallel with the closing of the SPAC transaction. Accordingly, the Company classified the entire amount outstanding under the
Tasly Convertible Debt as current on the Consolidated Balance Sheet. Upon occurrence of certain events of default by the Company,
including failure to repay in full the amounts owed at&#160;maturity, the lender will have an option to convert the entire
outstanding balance and accrued but unpaid interest under the Convertible debt into senior unsecured promissory notes on
substantially the same terms as the outstanding Senior Notes as of December&#160;31, 2024. In the event the Company fails to
complete the Merger, the lender will have an option to convert the entire outstanding balance and accrued but unpaid interest under
the Convertible debt into either (i)&#160;senior unsecured promissory notes on substantially the same terms as the outstanding
Senior Notes as of December&#160;31, 2024 or (ii)&#160;the Company&#8217;s common stock at a conversion price of $2.33 per
share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company elected to apply
the fair value option to account for the Tasly Convertible debt. Accordingly, no features of the Convertible debt are bifurcated and separately
accounted for. The fair value of the Convertible debt was $2.2 million as of December 31, 2024, compared to $1.71&#160;million as of December&#160;31,
2023. Accrued stated interest on the Convertible debt was $0.2 million for the year ended December 31, 2024 compared to less than $0.1&#160;million
for the year ended December&#160;31, 2023. The total loss on fair value remeasurement is $0.33 million, of which, $0.31 million in loss
on fair value remeasurement is from the year ended December 31, 2024, compared to less than $0.1 million in loss on fair value remeasurement
from the year ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes 2021</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>August&#160;2021 Senior
Notes</i>&#160;&#8212;&#160;In August&#160;2021 the Company received $4.0&#160;million in total gross proceeds from the issuance of senior
unsecured promissory notes (the &#8220;August&#160;2021 Senior Notes&#8221;). Simple interest on the unpaid principal balance of the August&#160;2021
Senior Notes accrued from the issuance date at a rate of 12% per year and is payable at maturity. The August&#160;2021 Senior Notes were
to mature on the earlier of (a)&#160;issuance of the next round of preferred stock of (b)&#160;August&#160;25, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;6, 2021,
the August&#160;2021 Senior Notes were amended to provide the note holders with an option to convert the notes&#8217; outstanding principal
balance and accrued but unpaid interest into (a)&#160;the shares of convertible preferred stock issued upon consummation of a Qualified
Financing at a conversion price equal to the per share price paid by investors in such Qualified Financing, subject to 20% discount, or
(b)&#160;shares of the Company&#8217;s Series&#160;C convertible preferred stock at the conversion price equal to the original issue price
prior to Qualified Financing in the event the Qualified Financing had not occurred prior to February&#160;25, 2022, or (c)&#160;shares
of the Company&#8217;s Series&#160;C convertible preferred stock at the conversion price equal to the original issue price upon change
of control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The optional conversion upon
Qualified Financing represents an embedded feature that is required to be bifurcated and accounted for separately as a derivative instrument
initially and subsequently measured at fair value with the change in the gain (loss) on change in the fair value of derivative liabilities
in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>December&#160;2021 Senior
Notes</i>&#160;&#8212;&#160;In December&#160;2021 the Company received $1.3&#160;million in total gross proceeds from the issuance of
senior unsecured promissory notes (the &#8220;December&#160;2021 Senior Notes&#8221;, together with August&#160;2021 Senior Notes, the
&#8220;2021 Senior Notes&#8221;). Simple interest on the unpaid principal balance of the December&#160;2021 Senior Notes accrued from
the issuance date at a rate of 12% per year and is payable at maturity. The December&#160;2021 Senior Notes mature on August&#160;25,
2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2022 the Company issued additional Senior Notes to the existing investors for the aggregate principal amount of $5.5&#160;million (the
&#8220;2022 Senior Notes&#8221;) on substantially the same terms as the other Senior Notes issued in 2021 (as amended in December&#160;2021).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Senior Notes September&#160;2022 Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September&#160;2022,
the 2021 Senior Notes and 2022 Senior Notes (together &#8220;Senior Notes&#8221;) were amended as follows: a) the maturity dates for
all Senior Notes were extended to December&#160;31, 2022, b) the conversion price discount in the event of a Qualified Financing was
increased to 60%, c) the February&#160;25, 2022 deadline for the occurrence of a Qualified Financing for conversion of the Senior
Notes into Series&#160;C convertible preferred stock prior to a Qualified Financing was extended to December&#160;31, 2022 and the
respective conversion price discount of 60% was introduced for conversion prior to a Qualified Financing; d) the conversion price
discount of 60% in the event of change of control was introduced; e) conversion option prior to entering into a definitive agreement
with a SPAC (the &#8220;Definitive Qualified Agreement&#8221;) was introduced. Under this option, in the event that the Company
executes a Definitive Qualified Agreement, then the Senior Note&#160;holders will have the option (but not the obligation) to
convert the entire outstanding principal balance and all accrued but unpaid interest into shares of the Company&#8217;s common stock
at a conversion price equal to 40% of the per share price of the common stock as determined pursuant to the Definitive Qualified
Agreement; provided, that, if such conversion price per share of the common stock is greater than $4.00, then such conversion price
shall be deemed to be $4.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This 2022&#160;amendment was
accounted for as debt extinguishment resulting in $8.8&#160;million debt extinguishment loss recognized in loss on debt extinguishment,
net in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The optional conversion upon
a Qualified Financing and Qualified conversion option represents embedded features that are required to be bifurcated and accounted for
separately as a combined single derivative instrument initially and subsequently measured at fair value with the change in the gain (loss)
on change in the fair value of derivative liabilities in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>October&#160;2022 Senior
Notes</i>&#160;&#8212;&#160;In September and October&#160;2022, the Company issued an additional Senior Notes to existing investors with
the principal amount of $1.3&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in September&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes November&#160;2022 Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;3, 2022,
all Senior Notes were amended as follows: 1) all unpaid interest and principal shall be due and payable on the date which is <span style="-sec-ix-hidden: hidden-fact-243">five</span>&#160;business
days after the termination of the Merger prior to the occurrence of the Merger closing, 2) automatic conversion to SPAC shares of at then
outstanding all notes and accrued interest upon the Merger at $4.00 per share was introduced, 3) upon consummation of the Merger, all
noteholders will have a right to receive additional shares upon achievement by the combined company of certain share price and sales milestones
(the earnout shares) (the &#8220;November&#160;2022 Senior Notes Amendment&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The November&#160;2022 Senior
Notes Amendment represented a TDR.&#160;Since the total future undiscounted cash flows under Senior Notes were less than their outstanding
principal amount and unpaid accrued interest plus fair value of the bifurcated derivative immediately before November&#160;2022 Senior
Notes Amendment, the Company recognized TDR gain of $3.98&#160;million for the Senior Notes issued to unrelated parties in its Statement
of Operations for the year ended December&#160;31, 2022 and it recognized $3.97&#160;million in Additional Paid-in Capital for the year
ended December&#160;31, 2022 for the Senior Notes issued to related parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>December&#160;2022 Senior
Notes</i>&#160;&#8212;&#160;In November and December&#160;2022, the Company issued additional Senior Notes to investors with the principal
amount of $1.0&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes 2023</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>March&#160;2023 Senior
Notes</i>&#160;&#8212;&#160;In January, February and March&#160;2023, the Company issued additional Senior Notes to investors with the
principal amount of $1.6&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April&#160;2023 Senior
Notes</i>&#160;&#8212;&#160;In April&#160;2023, the Company issued additional Senior Notes to investors with the principal amount of $0.6&#160;million
on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>October-December&#160;2023
Senior Notes</i>&#160;&#8212;&#160;During the&#160;months October through December&#160;2023, the Company issued additional Senior Notes
to investors with the principal amount of $1.1&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022). These notes were issued at the same 12% interest terms as all of their other Senior Convertible Notes, and will
convert into New Profusa shares at $2.22 per share upon the successful closing of the business combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Notes 2024</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>January-March 2024 Senior
Notes</i> &#8212; During the months January through March 2024, the Company issued additional Senior Notes to investors with the principal
amount of $0.7 million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>April-June 2024 Senior
Notes &#8212; </i>During the months April through June 2024, the Company issued additional Senior Notes to investors with the principal
amount of $0.4 million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022). Additionally,
the Company repaid $0.11 million of principal on Senior Notes with investors during the respective period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>July-September 2024 Senior
Notes </i>&#8212; During the months July through September 2024, the Company issued additional Senior Notes to investors with the principal
amount of $0.7 million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022). Additionally,
during the months of July through September 2024, the Company issued a Senior Secured Convertible Note with the principal amount of $0.25
million. This note was issued at the same 12% interest terms as all of their other Senior Convertible Notes, and has an 18-month maturity,
which will be accelerated and converts into New Profusa shares upon the successful closing of the business combination. The Company repaid
$0.04 million of principal on Senior Notes with investors during the respective period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>October-December 2024 Senior
Notes</i> &#8212; During the months October through December 2024, the Company issued two Senior Secured Convertible Notes with a total
principal amount of $1.1 million. These notes were issued at the same 12% interest terms as all of their other Senior Convertible Notes,
and have an 18-month maturity, which will be accelerated and converted into New Profusa shares upon the successful closing of the business
combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2024, the
outstanding balance of senior notes totaled $25.3 million, of which $9.5 million is outstanding with related parties and $15.8 million
is outstanding with unrelated parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The annual effective interest
rate of Senior Notes was estimated from 0% to 12.15% and 0% to 12.55% per year for the&#160;years ended December&#160;31, 2024 and 2023,
respectively. The interest expense was $2.1&#160;million and $1.8&#160;million for the&#160;years ended December&#160;31, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
future minimum payments for the convertible notes payable were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Total future principal payments</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">19,533</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,998</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">24,396</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Add: fair value remeasurement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Add (less): unamortized debt (premium) discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,112</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(97</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,183</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">18,419</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">25,268</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Promissory Notes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In a series of transactions
during 2010 and 2011 two of the Company&#8217;s founders provided $0.2&#160;million to the Company to fund general corporate purposes
in exchange for promissory notes. The notes accrue interest annually at a simple interest rate of 5% with no set maturity date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2022, the Company borrowed $0.3&#160;million from two of its founders at zero interest rate to finance its short-term operations, from
which $0.2&#160;million was repaid in the same period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December&#160;31,
2023, the Company borrowed short-term promissory notes of $0.3&#160;million from an existing investor and an additional $0.1&#160;million
from an unrelated party repayable on demand at any time after December&#160;31, 2024, with annual interest rate of 12%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interest expense on the promissory
notes was less than $0.1&#160;million for each of the&#160;years ended December&#160;31, 2024 and 2023. The carrying value of the promissory
notes as of December&#160;31, 2024 and 2023 was $0.9&#160;million and $0.8&#160;million, respectively. As of December&#160;31, 2024 and
2023, outstanding balance of promissory notes includes all related party promissory notes of $0.9&#160;million and $0.8&#160;million,
respectively. The Company recognized that the promissory notes from December 31, 2023 are in default as of the date of this filing. The
note holders will be repaid upon closing the business transaction, and the full balance of these notes are held in current liabilities
on the Consolidated Balance Sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Paycheck Protection Program</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;25, 2021, the
Company borrowed $1.3&#160;million (the &#8220;PPP Loan 2&#8221;) as a Paycheck Protection Program loan. The Paycheck Protection Program,
established as part of the Coronavirus Aid, Relief, and Economic Security (&#8220;CARES&#8221;) Act, provides for loans to qualifying
businesses and is administered by the U.S.&#160;Small Business Administration (the &#8220;SBA&#8221;). The annual interest rate of the
PPP Loan 2 is 1%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of PPP Loan
2, if the Company does not submit forgiveness application within 24&#160;weeks the initial disbursement of the loan (the &#8220;Covered
Period&#8221;), the Company must begin to make equal monthly payments of principal and interest starting 10&#160;months from the end of
the Covered Period until May&#160;25, 2026. Interest on the loan continues to accumulate during any deferment period. As of December&#160;31,
2024, and as of the date of this filing, the Company has not applied for forgiveness under PPP Loan 2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and December 31, 2023, the Company was in default on PPP Loan 2 due to non-payment of minimal repayment amounts required by the terms
of PPP Loan 2. Accordingly, the Company classified the entire amount outstanding under PPP Loan 2 as current and accrued respective late
penalties for the total amount of less than $0.1&#160;million as of December&#160;31, 2024 and December 31, 2023, respectively. The total
past due amount of PPP Loan 2 repayments as of December&#160;31, 2024 and December 31, 2023 was $0.8&#160;million and $0.4&#160;million,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
the contractual future minimum payments for the PPP Loan 2 were as follows (in&#160;thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Year Ending December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,231</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">145</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommitmentsandContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Operating Lease Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beginning in October&#160;2024,
the Company entered into a lease agreement whereby the Company agreed to rent its office and lab facilities under month-to-month tenancy.
The monthly rent payable under the lease is $25 thousand. This month-to-month lease automatically renews every four&#160;months, unless
written termination is provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Operating costs for short-term
leases include variable lease costs of $0.1&#160;million and less than $0.1&#160;million during the three&#160;months ended June&#160;30,
2025 and 2024, compared to $0.2&#160;million and $0.1&#160;million during the six&#160;months ended June&#160;30, 2025 and 2024. Starting
from August&#160;2022 the Company recognized lease expense in the amount of monthly rent as incurred. The Company recognized operating
lease costs for monthly rent of $75 thousand and $150 thousand for each of the three and six month periods ending June&#160;30, 2025 and
2024. Total operating lease costs with common area maintenance variable costs were $0.3&#160;million and $0.2&#160;million for the six&#160;months
ended June&#160;30, 2025 and 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Contingencies and Indemnifications</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company
may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability
for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant
judgment is required to determine both probability and the estimated amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the normal course of business,
the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications.
The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future, but that have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to
its indemnification obligations. However, the Company may record charges in the future as a result of these indemnification obligations.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Lease Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2022 the Company
entered into a new lease agreement (the &#8220;Amended Lease&#8221;) whereby the Company agreed to rent its office and lab facilities
under month-to-month tenancy. The monthly rent payable under the Amended Lease was $25 thousand. This month-to-month lease ended in July
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beginning in October 2024,
the Company entered into a new lease agreement whereby the Company agreed to rent its office and lab facilities under month-to-month tenancy.
The monthly rent payable under the new lease is also $25&#160;thousand. This month-to-month lease automatically renews every four months,
unless written termination is provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Operating costs for short-term
leases and variable lease costs were less than $0.1&#160;million during the&#160;years ended December&#160;31, 2024 and 2023. The Company
recognized a total of $0.3&#160;million and $0.3&#160;million in lease expense for the&#160;years ended December&#160;31, 2024 and 2023,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Contingencies and Indemnifications</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company
may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability
for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant
judgment is required to determine both probability and the estimated amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the normal course of business,
the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications.
The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future, but that have not yet been made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To date, the Company has not
paid any claims; however, the Company may record charges in the future as a result of these indemnification obligations. The Company is
currently defending one litigation with a vendor. Management has accrued estimated incremental legal costs which totals less than $0.1
million related to the matter.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommitmentsandContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Registration Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of the Founder
Shares, the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any underlying securities)
are entitled to registration rights pursuant to a registration rights agreement signed on the closing date of the IPO requiring the Company
to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration
rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective
until termination of the applicable Lock-up&#160;period described in Note&#160;5. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Underwriters Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters had a 30-day&#160;option
from the date of IPO to purchase up to an additional&#160;2,475,000&#160;units to cover over-allotments, if any. On December&#160;22,
2021, the over-allotment was fully exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters received a
cash underwriting discount of approximately&#160;1.82% of the gross proceeds of the IPO, or $3,450,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Business Combination Marketing Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under a Business Combination
marketing agreement, the Company engaged&#160;I-Bankers and Dawson James as advisors in connection with the Business Combination to assist
the Company in holding meetings with the stockholders to discuss the potential Business Combination and the target business&#8217;s attributes,
introduce the Company to potential investors that are interested in purchasing the Company&#8217;s securities in connection with the potential
Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company was obligated to pay&#160;I-Bankers and Dawson
James a cash fee for such marketing services upon the consummation of the initial Business Combination in an amount of&#160;3.68% of the
gross proceeds of the IPO, or $6,986,250. The agreement was amended on November&#160;7, 2022 to allow for the 3.68% business combination
fee to be paid as (a)&#160;27.5% cash and (b)&#160;72.5% to be rolled into equity at closing. Subsequently, on January&#160;19, 2025,
the agreement was modified by the parties such that the Company will be required to pay $2,000,000, payable in cash, if a business combination
is consummated. As a result of the Business Combination,&#160;I-Bankers was paid $900,000 and Dawson James was paid $600,000 under the
Business Combination marketing agreement. The payment of the remaining $500,000 has been deferred until after the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Non-Redemption Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;8, 2025, the Company
entered into a non-redemption&#160;agreement (the &#8220;Non-Redemption&#160;Agreement&#8221;) with&#160;I-Bankers Securities, Inc. and
Dawson James Securities, Inc. (together, the &#8220;Investors&#8221;), pursuant to which such Investors agreed that to the extent that
redemptions in connection with the vote to approve the Business Combination reduces the Company&#8217;s trust account balance below $1.25&#160;million,
the Investors would offer such redeeming shareholders an opportunity to rescind the redemption of their shares and would instead purchase
such shares. Such purchases would be structured in compliance with the requirements of&#160;Rule&#160;14e-5&#160;under the&#160;Exchange&#160;Act&#160;or
would otherwise not constitute a tender offer pursuant to the&#160;Exchange&#160;Act. As of the Closing Date, the Company&#8217;s trust
account balance was not below $1.25&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Representative&#8217;s Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company issued&#160;450,000&#160;shares (Representative Shares) of common stock (which included&#160;37,500&#160;Representative Shares
issued pursuant to the full exercise of the over-allotment option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James
(and/or their designees).&#160;I-Bankers&#160;and Dawson James (and/or their designees) have agreed not to transfer, assign or sell any
such shares until the completion of the initial Business Combination. In addition,&#160;I-Bankers&#160;and Dawson James (and/or their
designees) have agreed (i)&#160;to waive their redemption rights with respect to such shares in connection with the completion of the
initial Business Combination and (ii)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to such
shares if the Company fails to complete its initial Business Combination within the Combination Period. The fair value of the Representative&#8217;s
Shares issued are recognized as&#160;offering costs directly attributable to the issuance of an equity contract to be classified in equity
and are recorded as a reduction of equity (see Note&#160;1).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Representative&#8217;s Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company granted to&#160;I-Bankers&#160;and
Dawson James (and/or their designees) 569,250&#160;warrants (which included 74,250&#160;warrants issued pursuant to the full exercise
of the over-allotment option) exercisable at $11.50&#160;per share (or an aggregate exercise price of $6,546,375) at the closing of the
IPO.&#160;The Representative Warrants issued are recognized as derivative liabilities in accordance with ASC&#160;815-40 and recorded
as liabilities at fair value each reporting period (see Notes 1 and 8). The warrants may be exercised for cash or on a cashless basis,
at the holder&#8217;s option, at any time during the period commencing on the later of the first anniversary of the effective date of
the registration statement of which the IPO forms a part and the closing of the initial Business Combination and terminating on the fifth
anniversary of such effectiveness date. Notwithstanding anything to the contrary,&#160;I-Bankers&#160;and Dawson James have agreed that
neither they nor their designees will be permitted to exercise the warrants after the&#160;five year&#160;anniversary of the effective
date of the registration statement of which the IPO forms a part. The warrants and such shares purchased pursuant to the warrants have
been deemed compensation by FINRA and are therefore subject to a lock-up&#160;for a period of 180&#160;days immediately following the
date of the effectiveness of the registration statement of which the IPO forms a part pursuant to FINRA Rule&#160;5110I(1). Pursuant to
FINRA Rule&#160;5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the economic disposition of the securities by any person for a period of 180&#160;days immediately following the effective
date of the registration statement of which the IPO forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated
for a period of 180&#160;days immediately following the effective date of the registration statement of which the IPO forms a part except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The warrants grant to holders
demand and &#8220;piggy back&#8221; rights for periods of five and seven&#160;years, respectively, from the effective date of the registration
statement of which the IPO forms a part with respect to the registration under the Securities Act&#160;of&#160;the shares issuable upon
exercise of the warrants. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting
commissions, which will be paid for by the holders themselves. The exercise price and number of shares issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a share dividend, or the Company&#8217;s recapitalization, reorganization,
merger or consolidation. However, the warrants will not be adjusted for issuances of shares at a price below its exercise price. The Company
will have no obligation to net cash settle the exercise of the warrants. The holder of the warrants will not be entitled to exercise the
warrants for cash unless a registration statement covering the securities underlying the warrants is effective or an exemption from registration
is available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Merger Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, NorthView
entered into a Merger Agreement and Plan of Reorganization (the &#8220;Merger Agreement&#8221;), by and among Merger Sub., and Profusa,
Inc., a California corporation (&#8220;Profusa&#8221;). The Merger Agreement provides that, among other things, at the closing of the
transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Profusa (the &#8220;Merger&#8221;), with Profusa
surviving as a wholly-owned subsidiary of NorthView.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Special Meeting held
on June&#160;9, 2025, the Company&#8217;s stockholders voted to approve the proposals outlined in the Proxy Statement/Prospectus, including,
among other things, the adoption of the Merger Agreement and approval of the transactions contemplated by the Merger Agreement, including
the merger of Merger Sub with and into Profusa, with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary
the Company, and the issuance of the Company&#8217;s common stock as consideration thereunder. On July&#160;11, 2025, the Closing was
completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Closing,
the Company changed its name to &#8220;Profusa, Inc.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Advisory Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;19,
2024, the Company engaged A.G.P to serve as the placement agent in connection with a proposed business combination transaction. The
Company shall pay to A.G.P. a cash fee (the &#8220;Cash Fee&#8221;) equal to 9.0% in a convertible note offering, note, or other
similar equity-linked offerings, and shall be calculated from the face value of notes issued, which is payable at the close of a
Business Combination. On June&#160;17, 2025, the Company entered a settlement agreement with A.G.P. for the Cash Fee of $968,000
related to the debt private placement (the &#8220;Offering&#8221;) that was issued at the Closing. Pursuant to the settlement
agreement, as a result of the Business Combination, the Company paid A.G.P. $550,000 at the Closing and the remaining $418,000 of
the fees was deferred and due on the earlier of (i)&#160;the second tranche of the debt private placement being issued and
(ii)&#160;December&#160;31, 2025. The Company also agreed to reimburse A.G.P. $50,000 for expenses incurred in connection with the
offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;15, 2023, the
Company engaged the Benchmark Company LLC (&#8220;Benchmark&#8221;) to provide advisory services related to the Business Combination and
the Convertible Notes. The Company was to pay Benchmark at the closing of the Business Combination an advisory fee of $750,000 in two
tranches. The first tranche will be $500,000 earned upon the closing of the Business Combination in the surviving public entity&#8217;s
common stock (&#8220;Tranche 1&#8221;). The number of shares to be issued is calculated on the 30<sup>th</sup>&#160;day following the
Closing by dividing $500,000 and the trailing 5-day VWAP of the Company&#8217;s common stock as calculated by Bloomburg with a minimum
price of $2.00. The second tranche will be $250,000, at the Company&#8217;s option, in either cash or in the surviving entity&#8217;s
common shares calculated by dividing $250,000 by the lowest trailing 5-day VWAP in the prior 30&#160;days (&#8220;Tranche 2&#8221;). Upon
funding of the Convertible Notes by investors introduced by Benchmark, the Company will pay to Benchmark fees in cash equal to 5% of the
net proceeds of any Convertible Note draw at the time of funding of such draw (&#8220;Arrangement Fees&#8221;). The Tranche 2 fee shall
be reduced by the amount of any fees paid to Benchmark for other transactions during the Term other than Arrangement Fees associated with
Convertible Notes, after the Business Combination, up to $250,000. As a result of the Business Combination, Benchmark was paid in shares
of the post-combination company in the amount of $500,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
in a private transaction, the Company entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an institutional investor
(the &#8220;Investor&#8221;). Pursuant to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth
in the SPA, to purchase from the Company&#8217;s senior secured convertible promissory notes in an aggregate principal amount of up to
$22,222,222 (the &#8220;Convertible Notes&#8221;) for a purchase price of up to $20,000,000, after a 10% original issue discount (&#8220;OID&#8221;).
As a result of the Business Combination, pursuant to the SPA, the Company issued a Convertible Note in the principal amount of $10,000,000
(the &#8220;Initial Note&#8221;) for a purchase price of $9,000,000, reflecting a 10% OID.&#160;The Initial Note matures on the date that
is 18-months from the closing of the Business Combination and is convertible at any time at the Investor&#8217;s option at a conversion
price equal to the lower of $10 or 95% of the lowest daily volume-weighted average price per share of the post-combination company common
stock in the 10&#160;trading days prior to the original issue date of the Initial Note and shall be adjusted, without limitation, based
on down-round and most-favored nation (MFN) price and terms protections (the &#8220;Conversion Price&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SPA contemplates that additional
Convertible Notes will be purchased in multiple tranches:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Prior to the one-year anniversary of the Initial Closing Date,
subject to the conditions set forth in the SPA, the Company may request that the Investor purchase additional Convertible Notes having
an aggregate principal amount of up to $12,222,222 at a purchase price of $11,000,000 (reflecting a 10% OID), as follows:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">Provided a registration statement has been filed for the
shares underlying the Initial Note, shares of combined company common stock, par value $0.0001 (&#8220;New Profusa Common Stock&#8221;)
have traded a volume of at least 15,000,000 shares in the aggregate, and no default or event of default has occurred, the Company may
call and thereby require the Investor to purchase Convertible Notes in the aggregate principal amount of $2,222,222 for a purchase price
of $2,000,000 (reflecting a 10% OID) (&#8220;Second Purchase&#8221;);</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(b)</td><td style="text-align: justify">Provided a registration statement is effective for the shares
underlying the Initial Note, New Profusa Common Stock has traded a volume of at least $35,000,000 in the aggregate after the $2,000,000
Second Purchase has closed, no default or event of default has occurred and the stock has traded at a trading price of no less than $4.00
for a period of five&#160;trading days preceding such purchase, the Company may call and thereby require the Investor to purchase Convertible
Notes in the aggregate principal amount of $5,555,555 for a purchase price of $5,000,000 (reflecting a 10% OID); and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(c)</td><td style="text-align: justify">The Investor at its sole discretion may call from the Company
and thereby require the Company to sell an additional Convertible Note having an aggregate principal amount of $4,444,444 at a purchase
price of $4,000,000 (reflecting a 10% OID) to be purchased at any time within 12&#160;months of the Initial Closing.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Business
Combination, the Company paid $90,000 at the Closing to an advisor for legal services in connection with the issuance of the Convertible
Note.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;6 &#8212;&#160;Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Registration Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of the Founder
Shares, the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any underlying securities)
are entitled to registration rights pursuant to a registration rights agreement signed on the closing date of the IPO requiring the Company
to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration
rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective
until termination of the applicable Lock-up&#160;period described in Note&#160;5. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Underwriters Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters had a 30-day&#160;option
from the date of IPO to purchase up to an additional&#160;2,475,000&#160;units to cover over-allotments, if any. On December&#160;22,
2021, the over-allotment was fully exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters received a
cash underwriting discount of approximately&#160;1.82% of the gross proceeds of the IPO, or $3,450,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Business Combination Marketing Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under a Business Combination
marketing agreement, the Company engaged&#160;I-Bankers and Dawson James as advisors in connection with the Business Combination to assist
the Company in holding meetings with the stockholders to discuss the potential Business Combination and the target business&#8217;s attributes,
introduce the Company to potential investors that are interested in purchasing the Company&#8217;s securities in connection with the potential
Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company was obligated to pay&#160;I-Bankers and Dawson
James a cash fee for such marketing services upon the consummation of the initial Business Combination in an amount of&#160;3.68% of the
gross proceeds of the IPO, or $6,986,250. The agreement was amended on November&#160;7, 2022 to allow for the 3.68% business combination
fee to be paid as (a)&#160;27.5% cash and (b)&#160;72.5% to be rolled into equity at closing. Subsequently, on January 19, 2025, the agreement
was modified by the parties such that the Company will be required to pay $2,000,000, payable in cash, if a business combination is consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Representative&#8217;s Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company issued&#160;450,000&#160;shares (Representative Shares) of common stock (which included&#160;37,500&#160;Representative Shares
issued pursuant to the full exercise of the over-allotment option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James
(and/or their designees).&#160;I-Bankers&#160;and Dawson James (and/or their designees) have agreed not to transfer, assign or sell any
such shares until the completion of the initial Business Combination. In addition,&#160;I-Bankers&#160;and Dawson James (and/or their
designees) have agreed (i)&#160;to waive their redemption rights with respect to such shares in connection with the completion of the
initial Business Combination and (ii)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to
such shares if the Company fails to complete its initial Business Combination within the Combination Period. The fair value of the Representative&#8217;s
Shares issued are recognized as&#160;offering costs directly attributable to the issuance of an equity contract to be classified in equity
and are recorded as a reduction of equity (see Note&#160;1).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Representative&#8217;s Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company granted to&#160;I-Bankers&#160;and
Dawson James (and/or their designees)&#160;569,250&#160;warrants (which included&#160;74,250&#160;warrants issued pursuant to the full
exercise of the over-allotment option) exercisable at $11.50&#160;per share (or an aggregate exercise price of $6,546,375) at the closing
of the IPO.&#160;The Representative Warrants issued are recognized as derivative liabilities in accordance with ASC&#160;815-40 and recorded
as liabilities at fair value each reporting period (see Notes 1 and 8). The warrants may be exercised for cash or on a cashless basis,
at the holder&#8217;s option, at any time during the period commencing on the later of the first anniversary of the effective date of
the registration statement of which the IPO forms a part and the closing of the initial Business Combination and terminating on the fifth
anniversary of such effectiveness date. Notwithstanding anything to the contrary,&#160;I-Bankers&#160;and Dawson James have agreed that
neither they nor their designees will be permitted to exercise the warrants after the&#160;five year&#160;anniversary of the effective
date of the registration statement of which the IPO forms a part. The warrants and such shares purchased pursuant to the warrants have
been deemed compensation by FINRA and are therefore subject to a lock-up&#160;for a period of 180&#160;days immediately following the
date of the effectiveness of the registration statement of which the IPO forms a part pursuant to FINRA Rule&#160;5110I(1). Pursuant to
FINRA Rule&#160;5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the economic disposition of the securities by any person for a period of 180&#160;days immediately following the effective
date of the registration statement of which the IPO forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated
for a period of 180&#160;days immediately following the effective date of the registration statement of which the IPO forms a part except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The warrants grant to holders
demand and &#8220;piggy back&#8221; rights for periods of five and seven&#160;years, respectively, from the effective date of the registration
statement of which the IPO forms a part with respect to the registration under the Securities Act&#160;of&#160;the shares issuable upon
exercise of the warrants. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting
commissions, which will be paid for by the holders themselves. The exercise price and number of shares issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a share dividend, or the Company&#8217;s recapitalization, reorganization,
merger or consolidation. However, the warrants will not be adjusted for issuances of shares at a price below its exercise price. The Company
will have no obligation to net cash settle the exercise of the warrants. The holder of the warrants will not be entitled to exercise the
warrants for cash unless a registration statement covering the securities underlying the warrants is effective or an exemption from registration
is available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Merger Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, NorthView
entered into a Merger Agreement and Plan of Reorganization (the &#8220;Merger Agreement&#8221;), by and among Merger Sub., and Profusa,
Inc., a California corporation (&#8220;Profusa&#8221;). The Merger Agreement provides that, among other things, at the closing of the
transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Profusa (the &#8220;Merger&#8221;), with Profusa
surviving as a wholly-owned subsidiary of NorthView. In connection with the Merger, NorthView will change its name to &#8220;Profusa,
Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Business Combination is
subject to customary closing conditions, including the satisfaction of the minimum available cash condition of $15,000,000, the receipt
of certain governmental approvals and the required approval by the stockholders of NorthView and Profusa. There is no assurance that the
Business Combination will be completed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advisory Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 19, 2024, the Company
engaged A.G.P to serve as the placement agent in connection with a proposed business combination transaction. The Company shall pay to
A.G.P. a cash fee (the &#8220;Cash Fee&#8221;) equal to 9.0% in a convertible note offering, note, or other similar equity-linked offerings,
and shall be calculated from the face value of notes issued, which is payable at the close of a Business Combination. If the Business
Combination does not successfully close, A.G.P. will not be entitled to any cash fee.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CommitmentsandContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CommitmentsandContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;7 &#8212;&#160;Convertible Preferred
Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Company&#8217;s Amended
and Restated Certificate of Incorporation, as amended, the Company is authorized to issue two classes of shares: preferred and common
stock. The preferred stock is issuable in series, and the Company&#8217;s Board of Directors is authorized to determine the rights, preferences,
and terms of each series. Under the Company&#8217;s Articles of Incorporation, as amended, the Company is authorized to issue 18,551,382
shares of convertible preferred stock at a par value of $0.0001.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
as of June&#160;30, 2025 and December&#160;31, 2024 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share <br/> Issued and <br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liquidation <br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying <br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Original <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">New Series&#160;A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,231</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.22</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">New Series&#160;B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,815</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,701</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.61</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Series&#160;C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,358,151</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,670,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,476</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.64</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">New Series&#160;C-1</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">4.80</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">18,551,382</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,863,934</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">64,184</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">65,149</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of convertible
preferred stock shares are entitled to vote on all matters on which the common stockholders are entitled to vote. Each holder of convertible
preferred stock is entitled to the number of votes equal to the number of common stock shares into which the shares held by such holder
could be converted as of the Record Date. Holders of convertible preferred stock and common stock generally vote as a single class.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dividends</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of convertible preferred
stock are entitled to receive dividends, when, as and if declared by the board of directors, at the annual rate of 8% of the original
issue price, payable in preference and priority to any declaration or payment of any distribution on common stock of the Company in such
calendar year. No distributions may be made with respect to the common stock unless dividends on the convertible preferred stock have
been declared and all declared dividends on the convertible preferred stock have been paid or set aside for payment to the holders of
the convertible preferred stock. Dividends are noncumulative, and <span style="-sec-ix-hidden: hidden-fact-325"><span style="-sec-ix-hidden: hidden-fact-326">none</span></span> were declared as of December&#160;31, 2024 and June&#160;30, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidation Preference</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any liquidation,
dissolution, or winding up of the Company, the holders of Series&#160;C/C-1 convertible preferred stock shall be entitled to receive,
prior and in preference to any distribution of any of the assets of the Company to the holders of the Series&#160;B convertible preferred
stock, the Series&#160;A convertible preferred stock or common stock, an amount per share for each share of Series&#160;C/C-1 convertible
preferred stock held by them equal to the sum of the liquidation preference amount of respective original issue price per share, as adjusted
for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event
(&#8220;anti-dilution adjustments&#8221;) plus all declared but unpaid dividends on such shares. Should the Company&#8217;s legally available
assets be insufficient to satisfy the liquidation preferences, the funds will be distributed with equal priority and&#160;<i>pro rata</i>&#160;among
the holders of Series&#160;C/C-1 convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled
to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;C/C-1 convertible preferred stock, payment should be made to the holders of Series&#160;B convertible preferred stock,
in preference to the holders of the Series&#160;A convertible preferred stock or common stock, in the amount per share for each share
of Series&#160;B convertible preferred stock held by them equal to the original issue price of such share, adjusted for any anti-dilution
adjustments, plus all declared and unpaid dividends on such shares. Should the Company&#8217;s legally available assets be insufficient
to satisfy the liquidation preferences, the funds will be distributed with equal priority and&#160;<i>pro rata</i>&#160;among the holders
of Series&#160;B convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;B convertible preferred stock, payment should be made to the holders of Series&#160;A convertible preferred stock,
in preference to the holders of the common stock, in the amount per share for each share of Series&#160;A convertible preferred stock
held by them equal to the original issue price of such share, adjusted for any anti-dilution adjustments, plus all declared and unpaid
dividends on such shares. Should the Company&#8217;s legally available assets be insufficient to satisfy the liquidation preferences,
the funds will be distributed with equal priority and&#160;<i>pro rata</i>&#160;among the holders of Series&#160;A convertible preferred
stock in proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the payment to the holders
of convertible preferred stock of the full preferential amounts specified above, the entire remaining assets of the Company legally available
for distribution by the Company shall be distributed with equal priority and&#160;<i>pro rata</i>&#160;among the holders of the common
stock and holders of convertible preferred stock as-if-converted to common stock basis in proportion to the number of shares of common
stock held by them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Conversion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible preferred
stock is convertible, at the option of the holder, into the number of fully-paid and non-assessable shares of common stock that result
from dividing the applicable original issue price per share by the applicable conversion price per share at the time of conversion, as
adjusted for any anti-dilution adjustments If, after the issuance date of convertible preferred stock, the Company issues or sells, or
is deemed to have sold, additional shares of common stock at a price lower than the original issuance price, except for certain exceptions
allowed, the conversion price of convertible preferred stock
would be adjusted. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#8217;s convertible preferred stock was convertible
into the Company&#8217;s shares of common stock on a one-for-one basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible preferred
stock is convertible into common stock automatically upon the earlier of (i)&#160;immediately upon the closing of a firmly underwritten
public offering pursuant to an effective registration statement under the Securities Act&#160;of&#160;1933, as amended, covering the offer
and sale of any class or security of the Company in which (a)&#160;the gross offering price per share reflects a pre-offering valuation
of the Company of not less than $200&#160;million, calculated on a fully-diluted and as-converted basis before giving effect to the issuance
of the securities to be sold in such public offering, and (b)&#160;the cash proceeds to the Company (net of underwriting discounts and
commissions) are at least $50&#160;million (a &#8220;Qualified IPO&#8221;); or (ii)&#160;the Company&#8217;s receipt of a written request
for such conversion from at least a majority of holders of the then outstanding shares of convertible preferred stock, voting as a single
class on an as-if-converted basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Redemption and Balance Sheet Classification</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
is recorded in mezzanine equity because while it is not mandatorily redeemable, it will become redeemable at the option of the stockholders
upon the occurrence of certain deemed liquidation events that are considered not solely within the Company&#8217;s control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the closing of the merger,
all Profusa Convertible Preferred stock was converted into New Profusa common shares, as further described in the Subsequent Events disclosure
below (See Note&#160;14).</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;7 &#8212;&#160;Convertible Preferred Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Company&#8217;s
Amended and Restated Certificate of Incorporation, as amended, the Company is authorized to issue two classes of shares: preferred and
common stock. The preferred stock is issuable in series, and the Company&#8217;s Board of Directors is authorized to determine the rights,
preferences, and terms of each series. Under the Company&#8217;s Articles of Incorporation, as amended, the Company is authorized to issue
18,551,382 shares of convertible preferred stock at a par value of $0.0001.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
as of December&#160;31, 2024 and December 31, 2023 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share <br/> Issued and <br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liquidation <br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying <br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Original <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">New Series&#160;A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,231</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.22</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">New Series&#160;B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,815</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,701</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.61</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Series&#160;C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,358,151</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,670,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,476</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.64</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">New Series&#160;C-1</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">4.80</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">18,551,382</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,863,934</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">64,184</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">65,149</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of convertible
preferred stock shares are entitled to vote on all matters on which the common stockholders are entitled to vote. Each holder of convertible
preferred stock is entitled to the number of votes equal to the number of common stock shares into which the shares held by such holder
could be converted as of the Record Date. Holders of convertible preferred stock and common stock generally vote as a single class.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividends</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of convertible preferred
stock are entitled to receive dividends, when, as and if declared by the board of directors, at the annual rate of 8% of the original
issue price, payable in preference and priority to any declaration or payment of any distribution on common stock of the Company in such
calendar year. No distributions may be made with respect to the common stock unless dividends on the convertible preferred stock have
been declared and all declared dividends on the convertible preferred stock have been paid or set aside for payment to the holders of
the convertible preferred stock. Dividends are noncumulative, and <span style="-sec-ix-hidden: hidden-fact-244">none</span> were declared as of December&#160;31, 2024 and December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidation Preference</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any liquidation,
dissolution, or winding up of the Company, the holders of Series&#160;C/C-1 convertible preferred stock shall be entitled to receive,
prior and in preference to any distribution of any of the assets of the Company to the holders of the Series&#160;B convertible preferred
stock, the Series&#160;A convertible preferred stock or common stock, an amount per share for each share of Series&#160;C/C-1 convertible
preferred stock held by them equal to the sum of the liquidation preference amount of respective original issue price per share, as adjusted
for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event
(&#8220;anti-dilution adjustments&#8221;) plus all declared but unpaid dividends on such shares. Should the Company&#8217;s legally available
assets be insufficient to satisfy the liquidation preferences, the funds will be distributed with equal priority and <i>pro rata</i> among
the holders of Series&#160;C/C-1 convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled
to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;C/C-1 convertible preferred stock, payment should be made to the holders of Series&#160;B convertible preferred stock,
in preference to the holders of the Series&#160;A convertible preferred stock or common stock, in the amount per share for each share
of Series&#160;B convertible preferred stock held by them equal to the original issue price of such share, adjusted for any anti-dilution
adjustments, plus all declared and unpaid dividends on such shares. Should the Company&#8217;s legally available assets be insufficient
to satisfy the liquidation preferences, the funds will be distributed with equal priority and <i>pro rata</i> among the holders of Series&#160;B
convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After full payment to holders
of the Series&#160;B convertible preferred stock, payment should be made to the holders of Series&#160;A convertible preferred stock,
in preference to the holders of the common stock, in the amount per share for each share of Series&#160;A convertible preferred stock
held by them equal to the original issue price of such share, adjusted for any anti-dilution adjustments, plus all declared and unpaid
dividends on such shares. Should the Company&#8217;s legally available assets be insufficient to satisfy the liquidation preferences,
the funds will be distributed with equal priority and <i>pro rata</i> among the holders of Series&#160;A convertible preferred stock in
proportion to the preferential amount each holder is otherwise entitled to receive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the payment to the holders
of convertible preferred stock of the full preferential amounts specified above, the entire remaining assets of the Company legally available
for distribution by the Company shall be distributed with equal priority and <i>pro rata</i> among the holders of the common stock and
holders of convertible preferred stock as-if-converted to common stock basis in proportion to the number of shares of common stock held
by them.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conversion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible
preferred stock is convertible, at the option of the holder, into the number of fully-paid and non-assessable shares of common stock that
result from dividing the applicable original issue price per share by the applicable conversion price per share at the time of conversion,
as adjusted for any anti-dilution adjustments If, after the issuance date of convertible preferred stock, the Company issues or sells,
or is deemed to have sold, additional shares of common stock at a price lower than the original issuance price, except for certain exceptions
allowed, the conversion price of convertible preferred stock would be adjusted. As of December&#160;31, 2024 and December 31, 2023, the
Company&#8217;s convertible preferred stock was convertible into the Company&#8217;s shares of common stock on a one-for-one basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of convertible
preferred stock is convertible into common stock automatically upon the earlier of (i)&#160;immediately upon the closing of a firmly underwritten
public offering pursuant to an effective registration statement under the Securities Act&#160;of&#160;1933, as amended, covering the offer
and sale of any class or security of the Company in which (a)&#160;the gross offering price per share reflects a pre-offering valuation
of the Company of not less than $200&#160;million, calculated on a fully-diluted and as-converted basis before giving effect to the issuance
of the securities to be sold in such public offering, and (b)&#160;the cash proceeds to the Company (net of underwriting discounts and
commissions) are at least $50&#160;million (a &#8220;Qualified IPO&#8221;); or (ii)&#160;the Company&#8217;s receipt of a written request
for such conversion from at least a majority of holders of the then outstanding shares of convertible preferred stock, voting as a single
class on an as-if-converted basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Redemption and Balance Sheet Classification</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
is recorded in mezzanine equity because while it is not mandatorily redeemable, it will become redeemable at the option of the stockholders
upon the occurrence of certain deemed liquidation events that are considered not solely within the Company&#8217;s control.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockLineItems', window );"><strong>Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;8 &#8212;&#160;Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, the Company&#8217;s certificate of incorporation authorized issuance of 40,000,000 shares of common stock. Each
share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally
available and when declared by the Board of Directors, subject to prior rights of the preferred stockholders. As of June&#160;30, 2025,
<span style="-sec-ix-hidden: hidden-fact-327">no</span> dividends have been declared to date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Conversion of Series&#160;A preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Conversion of Series&#160;B preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Series&#160;C/C-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding options under 2010 Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,520,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of options under the 2010 Plan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,550,091</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;8 &#8212;&#160;Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and December 31, 2023, the Company&#8217;s certificate of incorporation authorized issuance of 40,000,000&#160;shares of common stock.
Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds
are legally available and when declared by the Board of Directors, subject to prior rights of the preferred stockholders. As of December&#160;31,
2024, no dividends have been declared to date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Conversion of Series&#160;A preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Conversion of Series&#160;B preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Series&#160;C/C-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding options under 2010 Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,982,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of options under the 2010 Plan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,560,091</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,550,091</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockLineItems', window );"><strong>Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;7 &#8212;&#160;Stockholders&#8217;
Deficit</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Preferred stock</i></b>&#160;&#8212;&#160;The
Company is authorized to issue&#160;1,000,000&#160;shares of preferred stock with a par value of $0.0001&#160;and with such designations,
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.&#160;As of June&#160;30, 2025
and December&#160;31, 2024, there was <span style="-sec-ix-hidden: hidden-fact-397"><span style="-sec-ix-hidden: hidden-fact-398"><span style="-sec-ix-hidden: hidden-fact-399"><span style="-sec-ix-hidden: hidden-fact-400">no</span></span></span></span> preferred stock issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Common Stock&#160;</i></b>&#8212;&#160;The
Company is authorized to issue a total of&#160;100,000,000&#160;shares of common stock at par value of $0.0001&#160;each. In April&#160;2021,
the Company issued&#160;5,175,000&#160;shares of common stock to its Sponsor for $25,000, or approximately $0.005&#160;per share. In October&#160;2021,
the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration&#160;862,500&#160;shares of common stock.&#160;On
December&#160;20, 2021,&#160;the Company effected a 1.1- for-1&#160;stock dividend of its common stock, resulting in an aggregate of 4,743,750
Founder Shares issued&#160;and outstanding.&#160;On December&#160;22, 2021, the Company has also issued&#160;450,000&#160;shares (Representative&#8217;s
Shares) of common stock (which included&#160;37,500&#160;Representative Shares issued pursuant to the full exercise of the over-allotment
option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James (and/or their designees).&#160;As of June&#160;30, 2025
and December&#160;31, 2024, there were&#160;5,193,750 shares of common stock issued and outstanding, excluding&#160;101,777 and 687,519
shares of common stock subject to redemption, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Common stockholders of record
are entitled to one vote for each share held on all matters to be voted on by stockholders. Unless specified in the Company&#8217;s amended
and restated certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange
rules, the affirmative vote of a majority of the Company&#8217;s common stock that are voted is required to approve any such matter voted
on by the stockholders. There is no cumulative voting with respect to the election of directors, with the result that the holders of more
than&#160;50% of the shares voted for the election of directors can elect all of the directors (prior to consummation of the initial Business
Combination). The Company&#8217;s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors
out of funds legally available therefor.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;7 &#8212;&#160;Stockholders&#8217; Deficit</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Preferred stock</i></b>&#160;&#8212;&#160;The
Company is authorized to issue&#160;1,000,000&#160;shares of preferred stock with a par value of $0.0001&#160;and with such designations,
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.&#160;As of December&#160;31,
2024 and 2023, there was <span style="-sec-ix-hidden: hidden-fact-358"><span style="-sec-ix-hidden: hidden-fact-359"><span style="-sec-ix-hidden: hidden-fact-360"><span style="-sec-ix-hidden: hidden-fact-361">no</span></span></span></span> preferred stock issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Common Stock&#160;</i></b>&#8212;&#160;The
Company is authorized to issue a total of&#160;100,000,000&#160;shares of common stock at par value of $0.0001&#160;each. In April&#160;2021,
the Company issued&#160;5,175,000&#160;shares of common stock to its Sponsor for $25,000, or approximately $0.005&#160;per share. In October&#160;2021,
the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration&#160;862,500&#160;shares of common stock.&#160;On
December&#160;20, 2021,&#160;the Company effected a 1.1-for-1&#160;stock dividend of its common stock, resulting in an aggregate of 4,743,750
Founder Shares issued&#160;and outstanding.&#160;On December&#160;22, 2021, the Company has also issued&#160;450,000&#160;shares (Representative&#8217;s
Shares) of common stock (which included&#160;37,500&#160;Representative Shares issued pursuant to the full exercise of the over-allotment
option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James (and/or their designees).&#160;As of December&#160;31,
2024 and 2023, there were&#160;5,193,750 shares of common stock issued and outstanding, excluding&#160;687,519 and 833,469 shares of common
stock subject to redemption, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Common stockholders of record
are entitled to one vote for each share held on all matters to be voted on by stockholders. Unless specified in the Company&#8217;s amended
and restated certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange
rules, the affirmative vote of a majority of the Company&#8217;s common stock that are voted is required to approve any such matter voted
on by the stockholders. There is no cumulative voting with respect to the election of directors, with the result that the holders of more
than&#160;50% of the shares voted for the election of directors can elect all of the directors (prior to consummation of the initial Business
Combination). The Company&#8217;s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors
out of funds legally available therefor.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CommonStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CommonStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock Option Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock', window );">Stock Option Plan</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Stock Option Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2010, the Company adopted
the 2010 Equity Incentive Plan (the &#8220;Plan&#8221;) under which 2,000,000 shares of the Company&#8217;s common stock have been initially
reserved for issuance to employees, directors and consultants. The number of reserved shares has been increased over the&#160;years and
currently equals 4,636,454 shares. Options granted under the Plan may be either incentive stock options (&#8220;ISO&#8221;) or nonqualified
stock options (&#8220;NSO&#8221;). ISOs may be granted only to Company employees, including officers and directors who are also employees.
NSOs may be granted to Company employees, consultants and advisors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A person who owns (or is deemed
to own) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company will not
be granted an ISO unless the exercise price of such option is at least one hundred ten percent (110%) of the Fair Market Value on the
date of grant and the option is not exercisable after the expiration of <span style="-sec-ix-hidden: hidden-fact-343">five</span>&#160;years from the date of grant. Options granted generally
vest over <span style="-sec-ix-hidden: hidden-fact-344">four</span>&#160;years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity under the Plan is
set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Stock Option Activity</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available for <br/> Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at January&#160;1, 2025</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,560,091</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,972,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.00</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(1,560,091</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,560,091</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1.26</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,896</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.63</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at June&#160;30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,896</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,520,250</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.70</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">6.48</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at June&#160;30, 2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,364,814</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5.48</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at June&#160;30, 2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4,520,250</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.70</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6.48</td><td style="text-align: left">&#160;</td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Stock Option Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available for <br/> Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at December&#160;31, 2023</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,550,091</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,982,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.70</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-335">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-337">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(10,000</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.001</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,560,091</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,972,055</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">3.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at June&#160;30, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,464,429</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.88</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at June&#160;30, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.40</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3.53</td><td style="text-align: left">&#160;</td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the three and six&#160;months
ended June&#160;30, 2025, stock option activity comprised of grants totaling 1,560,091 options, with no options exercised during the period.
Intrinsic values are calculated as the difference between the exercise price of the underlying options and the fair value of the common
stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total fair value of options
vested for the three and six&#160;months ended June&#160;30, 2025 and 2024 was less than $0.1&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
total unrecognized stock-based compensation expense for stock options was $3.0&#160;million which is expected to be recognized over a
weighted-average period of 1.3&#160;years. The Company estimates the fair value of stock options using the Black Scholes option-pricing
model. The fair value of stock options is being recognized on a straight-line basis over the requisite service period of the awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2024, the
total unrecognized stock-based compensation expense for stock options was less than $0.1&#160;million which is expected to be recognized
over a weighted-average period of 1.1&#160;years. The Company estimates the fair value of stock options using the Black Scholes option-pricing
model. The fair value of stock options is being recognized on a straight-line basis over the requisite service period of the awards.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nonrecourse Promissory Notes to Early Exercise
Stock Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2018, one of the Company&#8217;s
executives early exercised 1,380,015 of his stock options by issuing a promissory note to the Company. As the promissory note is nonrecourse
this exercise of stock options with a promissory note is not considered a substantive exercise for accounting purposes. Therefore, no
receivable for the promissory note was recorded on the Company&#8217;s balance sheet. This arrangement was accounted for as modifications
to the original stock options which were exercised by issuing a promissory note. Such modification did not result in additional stock-based
compensation expense. As of June&#160;30, 2025 these options were fully vested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stock-Based Compensation Expense by Function</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table is a summary
of stock compensation expense by function recognized for the three and six&#160;months ended June&#160;30, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">54</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">87</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">82</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Stock Option Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2010, the Company adopted
the 2010 Equity Incentive Plan (the &#8220;Plan&#8221;) under which 2,000,000 shares of the Company&#8217;s common stock have been initially
reserved for issuance to employees, directors and consultants. Options granted under the Plan may be either incentive stock options (&#8220;ISO&#8221;)
or nonqualified stock options (&#8220;NSO&#8221;). ISOs may be granted only to Company employees, including officers and directors who
are also employees. NSOs may be granted to Company employees, consultants and advisors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A person who owns (or is deemed
to own) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company will not
be granted an ISO unless the exercise price of such option is at&#160;least one hundred ten percent (110%) of the Fair Market Value on
the date of grant and the option is not exercisable after the expiration of five&#160;years from the date of grant. Options granted generally
vest over <span style="-sec-ix-hidden: hidden-fact-254">four</span>&#160;years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity under the Plan is
set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Stock Option Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available <br/> for Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price Per <br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at January&#160;1, 2024</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,550,091</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,982,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.70</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(10,000</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.001</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at December&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,560,091</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,972,055</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">3.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at December&#160;31, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,548,910</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.32</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at December 31, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.40</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">&#160;</td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were no new options
granted or exercised during the year ended December&#160;31, 2024. Intrinsic values are calculated as the difference between the exercise
price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the
fair value per share of the common stock on the date of exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total fair value of options
vested for the&#160;year-ended December&#160;31, 2024 was less than $0.1&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
the total unrecognized stock-based compensation expense for stock options was less than $0.1&#160;million which is expected to be recognized
over a weighted-average period of 0.4&#160;years. On the grant date, the Company estimates the fair value of stock options using the Black
Scholes option-pricing model. The fair value of stock options is being recognized on a straight-line basis over the requisite service
period of the awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nonrecourse Promissory Notes to Early Exercise Stock Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2018, one of the Company&#8217;s
executives early exercised 1,380,015 of his stock options by issuing a promissory note to the Company. As the promissory note is nonrecourse
this exercise of stock options with a promissory note is not considered a substantive exercise for accounting purposes. Therefore, no
receivable for the promissory note was recorded on the Company&#8217;s balance sheet. This arrangement was accounted for as modifications
to the original stock options which were exercised by issuing a promissory note. Such modification did not result in additional stock-based
compensation expense. As of December&#160;31, 2024 these options were fully vested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock-Based Compensation Expense by Function</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table is a summary
of stock compensation expense by function recognized for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">33</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the details pertaining to each employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-20<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;10 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued convertible
notes (also referred to as junior notes), Tasly convertible debt and promissory notes to certain shareholders. Refer to Note&#160;5 for
detail.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;10 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued convertible
notes (also referred to as junior notes), Tasly convertible debt, and promissory notes to certain shareholders. Refer to Note&#160;5 for
detail.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Founder Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2021, the Sponsor
paid $25,000, or approximately $0.005 per share, to cover certain of the offering costs in exchange for an aggregate of 5,175,000 shares
of common stock, par value $0.0001 per share (the &#8220;Founder Shares&#8221;). In October&#160;2021, the Sponsor irrevocably surrendered
to the Company for cancellation and for no consideration 862,500 shares of common stock. On December&#160;20, 2021, the Company effected
a 1.1- for-1 stock dividend of its common stock, resulting in the Sponsor holding
an aggregate of 4,743,750 shares of common stock. The Founder Shares include an aggregate of up to 618,750 shares subject to forfeiture
if the over-allotment option is not exercised by the underwriters in full. On December&#160;22, 2021, the over-allotment option was fully
exercised and such shares are no longer subject to forfeiture.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The Sponsor has agreed not to transfer, assign
or sell any of their Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of the initial Business Combination
or (B)&#160;the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the initial
Business Combination that results in all of the Company&#8217;s public stockholders having the right to exchange their shares of common
stock for cash, securities or other property (the &#8220;Lock-up&#8221;). Notwithstanding the foregoing, if the last sale price of the
Company&#8217;s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 150&#160;days after the initial
Business Combination, the Founder Shares will be released from the Lock-up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Convertible Promissory Note&#160;&#8212;&#160;Related
Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant. On January&#160;10, 2024,
the Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor. On May&#160;31,
2024, the Company&#8217;s Board of Directors approved and the Company entered into a second amendment of its Convertible Working Capital
Promissory Note with the sponsor to increase the principal amount of the Note that could be drawn on to $2.5&#160;million. The second
amended and restated Note also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company
common stock at a price of $2.22&#160;per share at the election of the sponsor. As of June&#160;30, 2025 and December&#160;31, 2024, the
Company had principal outstanding of $1,919,796 and is presenting the Note at fair value on its balance sheet at June&#160;30, 2025 and
December&#160;31, 2024 in the amount of $10,288,111 and $8,908,052, respectively. The Company has deferred the repayment of the Note to
six&#160;months after the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;11, 2025,
in a private transaction, the Company entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an institutional investor
(the &#8220;Investor&#8221;). Pursuant to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth
in the SPA, to purchase from the Company&#8217;s senior secured convertible promissory notes (&#8220;Ascent Note&#8221;) in an aggregate
principal amount of up to $22,222,222 for a purchase price of up to $20,000,000, after a 10% original issue discount (&#8220;OID&#8221;).
As of June&#160;30, 2025 and December&#160;31, 2024, the Company is presenting the Ascent Note at fair value on its balance sheet at June&#160;30,
2025 and December&#160;31, 2024 in the amount of $193,878 and $0, respectively (See details on Note&#160;6).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Business
Combination, pursuant to the SPA, the Company issued a PIPE Convertible Note in the principal amount of $10,000,000 (the &#8220;Initial
Note&#8221;) for a purchase price of $9,000,000, reflecting a 10% OID.&#160;The Initial Note matures on the date that is 18-months from
the Closing and is convertible at any time at the Investor&#8217;s option at a conversion price equal to the lower of $10 or 95% of the
lowest daily volume-weighted average price per share of the post-combination company common stock in the 10&#160;trading days prior to
the original issue date of the Initial Note and shall be adjusted, without limitation, based on down-round and most-favored nation (MFN)
price and terms protections (the &#8220;Conversion Price&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Related Party Loans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended initial Business Combination, the initial stockholders or an affiliate of the initial stockholders
or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the
&#8220;Working Capital Loans&#8221;). If the Company completes the initial Business Combination, the Company would repay such loaned amounts
out of the proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside
the Trust Account. Up to $1,500,000 of such loans may be convertible, at the option of the lender, into warrants at a price of $1.00 per
warrant of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants, including as to exercise
price, exercisability and exercise period. At June&#160;30, 2025 and December&#160;31, 2024, the Company had no borrowings under the Working
Capital Loans, other than the Note described in &#8220;Note&#160;5 &#8212;&#160;Related Party Transactions&#160;&#8212;&#160;Convertible
Promissory Note&#160;&#8212;&#160;Related Party&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Administrative Service Fee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing on the effective
date of the IPO, the Company began paying its Sponsor a total of $5,000&#160;per month for office space, utilities, secretarial support
and other administrative and consulting services. As of June&#160;30, 2023, the Company and the Sponsor terminated this agreement. For
the three and six&#160;months ended June&#160;30, 2025 and 2024, $0 had been incurred and billed relating to the administrative service
fee, respectively. As of June&#160;30, 2025 and December&#160;31, 2024, $50,000 relating to the administrative service fee was not paid
and recorded as due to related party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Advances from Profusa</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the three and six&#160;months
ended June&#160;30, 2025 and 2024, Profusa agreed to advance funds to the Company to pay for operating expenses. As of June&#160;30, 2025
and December&#160;31, 2024, there was $1,299,040 and $791,407, respectively owed to Profusa, which is due upon demand or at the completion
of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Due to Related Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, $50,000 relating to the administrative service fee was not paid and recorded as due to related party. On February&#160;24,
2025, the Company paid costs on behalf of its Sponsor which reduced the balance due by $8,820.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;5 &#8212;&#160;Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Founder Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2021, the Sponsor
paid $25,000, or approximately $0.005 per share, to cover certain of the offering costs in exchange for an aggregate of 5,175,000 shares
of common stock, par value $0.0001 per share (the &#8220;Founder Shares&#8221;). In October&#160;2021, the Sponsor irrevocably surrendered
to the Company for cancellation and for no consideration 862,500 shares of common stock. On December&#160;20, 2021, the Company effected
a 1.1-for-1 stock dividend of its common stock, resulting in the Sponsor holding an aggregate of 4,743,750 shares of common stock. The
Founder Shares include an aggregate of up to 618,750 shares subject to forfeiture if the over-allotment option is not exercised by the
underwriters in full. On December&#160;22, 2021, the over-allotment option was fully exercised and such shares are no longer subject to
forfeiture.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor has agreed not
to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of the initial
Business Combination or (B)&#160;the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction
after the initial Business Combination that results in all of the Company&#8217;s public stockholders having the right to exchange their
shares of common stock for cash, securities or other property (the &#8220;Lock-up&#8221;). Notwithstanding the foregoing, if the last
sale price of the Company&#8217;s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 150&#160;days after
the initial Business Combination, the Founder Shares will be released from the Lock-up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Promissory Note&#160;&#8212;&#160;Related Party</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#8220;the Note&#8221;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant. On January&#160;10, 2024,
the Company&#8217;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor. On May&#160;31,
2024, the Company&#8217;s Board of Directors approved and the Company entered into a second amendment of its Convertible Working Capital
Promissory Note with the sponsor to increase the principal amount of the Note that could be drawn on to $2.5&#160;million. The second
amended and restated Note also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company
common stock at a price of $2.22&#160;per share at the election of the sponsor. As of December 31, 2024, the Company had principal outstanding
of $1,919,796 and is presenting the Note at fair value on its balance sheet at December 31, 2024 in the amount of $8,908,052.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Related Party Loans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction
costs in connection with an intended initial Business Combination, the initial stockholders or an affiliate of the initial stockholders
or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the
&#8220;Working Capital Loans&#8221;). If the Company completes the initial Business Combination, the Company would repay such loaned amounts
out of the proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside
the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital
held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned
amounts. Up to $1,500,000 of such loans may be convertible, at the option of the lender, into warrants at a price of $1.00 per warrant
of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants, including as to exercise price,
exercisability and exercise period. At December&#160;31, 2024 and 2023, the Company had no borrowings under the Working Capital Loans,
other than the Note described in &#8220;Note&#160;5 &#8212;&#160;Related Party Transactions&#160;&#8212;&#160;Convertible Promissory Note&#160;&#8212;&#160;Related
Party&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Administrative Service Fee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing on the effective
date of the IPO, the Company began paying its Sponsor a total of $5,000&#160;per month for office space, utilities, secretarial support
and other administrative and consulting services. As of June&#160;30, 2023, the Company and the Sponsor terminated this agreement. For
the year ended December 31, 2024, $0 had been incurred and billed relating to the administrative service fee, respectively. For the year
ended December 31, 2023, $30,000 had been incurred and billed relating to the administrative service fee. As of December&#160;31, 2024
and 2023, $50,000 relating to the administrative service fee was not paid and recorded as due to related party.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advances from Profusa</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ending December
31, 2024, Profusa agreed to advance funds to the Company to pay for operating expenses. As of December 31, 2024, there was $791,407 owed
to Profusa, which is due upon demand or at the completion of the Business Combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RelatedPartyTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RelatedPartyTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Net Loss Per Share Attributable to Common Stockholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable To Common Stockholders</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;11 &#8212;&#160;Net Loss per Share
Attributable to Common Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net loss per common share is
calculated in accordance with ASC Topic&#160;260, Earnings Per Share. Basic net loss per share is computed by dividing net loss by the
weighted-average number of shares of common stock outstanding during the period. The computation of diluted net loss per share does not
include dilutive common stock equivalents in the weighted-average shares outstanding, as the inclusion of common share equivalents would
be antidilutive. The common share equivalents consist of stock options, convertible notes, convertible preferred stock and common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(2,348</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(2,071</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,604,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,601,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.42</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.37</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;months ended <br/> June&#160;30,</td><td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="vertical-align: top; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Convertible notes payable<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,430,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,721,548</td><td style="vertical-align: top; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">&#8212;</div></td><td style="text-align: left"><sup>(2)&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="vertical-align: top; text-align: left"><sup>(2)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,520,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="vertical-align: top; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">64,814,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">46,557,537</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td>(2)</td><td style="text-align: justify">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(5,064</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(4,481</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,604,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,601,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.90</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.80</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Convertible notes payable<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,430,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,721,548</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">&#8212;</div></td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left"><sup>(2)</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,520,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">64,814,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">46,557,537</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td>(2)</td><td style="text-align: justify">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</td></tr></table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;11 &#8212;&#160;Net Loss per Share Attributable to Common
Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic net loss per share is
computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Because the Company reported
a net loss for the years ended December&#160;31, 2024 and 2023, the number of shares used to calculate diluted net loss per common share
is the same as the number of shares used to calculate basic net loss per common share for those periods presented because the potentially
dilutive shares would have been antidilutive if included in the calculation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(9,230</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(10,281</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,604,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,600,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.65</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.84</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding
shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,363,624</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,251,941</span></td><td style="text-align: left"><sup>(1)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-255; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,982,055</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">24,199,613</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23,097,930</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Government Grant Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceAbstract', window );"><strong>Government Grant Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceTextBlock', window );">Government Grant Revenue</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;12 &#8212;&#160;Government Grant
Revenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Government grant revenue consists
of amounts we earn under grants from two government agencies: NIH and DARPA.&#160;These grants are provided either in the form of expense
reimbursement (expense reimbursement grants) or as on a fixed fee basis (fixed fee grants). Under the expense reimbursement grants the
government agencies reimburse us for a portion of our expenses (allowable expenses) that have been incurred in a given period on the basis
of reports that we provide to these agencies. Fixed fee grants are awarded for specific research and development programs undertaken by
us. Under these grants we receive milestone payments from the government agencies upon our submission and approval by the government of
agreed upon deliverables, consisting primarily of the documented results of the specific research and development programs.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;12 &#8212;&#160;Government Grant Revenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Government grant revenue consists
of amounts the Company earns under grants from two government agencies: NIH and DARPA.&#160;These grants are provided either in the form
of expense reimbursement (expense reimbursement grants) or on a fixed fee basis (fixed fee grants). Under the expense reimbursement grants
the government agencies reimburse us for a portion of our expenses (allowable expenses) that have been incurred in a given period on the
basis of reports that the Company provides to these agencies. Fixed fee grants are awarded for specific research and development programs
undertaken by us. Under these grants the Company receives milestone payments from the government agencies upon our submission and approval
by the government of agreed upon deliverables, consisting primarily of the documented results of the specific research and development
programs.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;13 &#8212;&#160;Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income taxes in the Company&#8217;s
combined financial statements have been calculated on a separate tax return basis. The following table presents the principal reasons
for the difference between the effective tax rate and the federal statutory income tax rate (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Tax benefit at U.S.&#160;federal statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,941</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,159</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State Tax, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.58</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,347</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.14</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Permanent difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.06</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.06</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prior-Year deferred taxes adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.32</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.57</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change of valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(35.84</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20.51</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,109</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective income tax rate</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The components of the provision for income taxes
are as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Current:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Federal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,607</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,127</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,705</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,312</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,109</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,109</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total provision for income taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant components of the Company&#8217;s deferred
tax assets as of December&#160;31, 2024 and 2023 were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Deferred tax assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Accrued expenses&#160;&amp; other</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">70</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">38</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Capitalized R&amp;D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,542</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Net operating loss carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,033</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">R&amp;D credit carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,511</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,485</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,455</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,455</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,143</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No income tax expense was recorded during the year
ended December&#160;31, 2024 and 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
Profusa, Inc. had Federal and state net operating loss carryforwards of $114.8M and $116.3M, respectively. The Federal and state net operating
loss carryforwards begin to expire in 2029. Federal net operating losses generated in tax&#160;years 2018 or thereafter have an indefinite
carryforward period. The amount of Federal net operating loss that does not expire is $91.6&#160;million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
Profusa, Inc. had Federal and California research credit carryforwards of $2.1M and $1.8M, respectively. The Federal tax credit carryforwards
begin to expire in 2032. The state tax credit carryforwards carryforward indefinitely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management believes that,
based upon a number of factors, which include the Company&#8217;s historical operating performance and accumulated deficit, it is more
likely than not that the deferred tax assets will not be utilized. Therefore, the Company has recorded a full valuation allowance against
its deferred tax assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Internal Revenue Code (IRC)
section 382 limits the use of net operating loss and tax credit carryforwards in certain situations where changes occur in stock ownership
of a company. The annual limitation may result in the expiration of the Company&#8217;s net operating loss and tax credit carryforwards
prior to utilization. The Company has not completed an IRC section 382 study as of December&#160;31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No liability related to uncertain
tax positions is recorded in the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accrues for interest
and penalties as part of income tax expense. As of December&#160;31, 2024 and 2023, the Company has not accrued interest and/or penalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company files tax returns
in the U.S.&#160;Federal, California and various other states. Due to the Company&#8217;s net operating losses, its Federal and state
income tax returns remain subject to examination since inception. As of December&#160;31, 2024, there are no ongoing tax examinations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;27, 2020, Congress
passed the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The act contains many tax incentives intended
to assist companies and individuals during the COVID-19 outbreak. The Company received Paycheck Protection Program Loans during the&#160;years
ended December&#160;31, 2021 and December&#160;31, 2020 of $1.3&#160;million and $1.2&#160;million, respectively. The Company had $1.4&#160;million
of Paycheck Protection Program loans outstanding as of December&#160;31, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (&#8220;IRA&#8221;) was signed into federal law. IRA, among other things, imposes a nondeductible
1% excise tax after December&#160;31, 2022 on the fair market value of certain stock that is &#8220;repurchased&#8221; by a publicly traded
U.S.&#160;corporation or acquired by certain of its subsidiaries. The taxable amount is reduced by the fair market value of certain issuances
of stock throughout the year. The Company does not expect this tax law change to have a material impact on its consolidated financial
position; however, it will continue to evaluate its impact as further information becomes available. If average annual adjusted financial
statement income exceeds $1&#160;billion over a 3-taxable-year period, IRA also imposes a 15% corporate alternative minimum tax on adjusted
financial statement income for taxable&#160;years beginning after December&#160;31, 2022. The Company does not expect to incur this tax
in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Tax Cuts and Jobs
Act&#160;of&#160;2017, research and development costs are no longer fully deductible and are required to be capitalized and amortized
for U.S.&#160;tax purposes effective January&#160;1, 2022. The mandatory capitalization requirement increases our deferred tax assets
and is fully offset with the valuation allowance.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;9 &#8212;&#160;Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s net deferred
tax assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Deferred tax asset/(liability)</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Organizational costs/Startup expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">694,480</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">436,196</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Unrealized gain/loss&#160;&#8211;&#160;Trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,661</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">694,480</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">422,535</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(694,480</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(436,196</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Deferred tax (liability), net of allowance</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(13,661</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The income tax provision consists
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Federal</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">94,174</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">480,069</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(271,945</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(226,991</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">258,284</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">203,712</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">80,513</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">456,790</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the Company had $0 in U.S.&#160;federal net operating loss carryovers available to offset future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In assessing the realization
of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets
will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during
the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration
of all of the information available, management believes that significant uncertainty exists with respect to future realization of the
deferred tax assets and has therefore established a full valuation allowance. For the&#160;years ended December&#160;31, 2024 and 2023,
the change in the valuation allowance was $258,284 and $203,712.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A reconciliation of the federal
income tax rate to the Company&#8217;s effective tax rate is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prior Year Trueup</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18.7</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11.4</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Business combination expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.8</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Penalties and interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.0</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12.6</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(0.90</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">28.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company files income tax
returns in the U.S.&#160;federal, New&#160;York and New&#160;York City jurisdictions and is subject to examination by the various taxing
authorities since inception.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SegmentsLineItems', window );"><strong>Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;13 &#8212;&#160;Segments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company operates as one
operating segment. The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is its <span style="-sec-ix-hidden: hidden-fact-353">Chief Executive Officer</span>, Ben Hwang,
who reviews financial information presented on a consolidated net loss basis as reported on the consolidated condensed statement of operations
and comprehensive loss in order to make decisions about allocating resources and assessing performance for the entire Company. The CODM
also utilizes the Company&#8217;s long-range plan, which includes product development roadmaps and long-range financial models, as a key
input to resource allocation. The CODM function approves of key operating and strategic decisions. The CODM function views the Company&#8217;s
operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly
provided with the following significant segment expenses. Significant expenses include research and development and general and administrative
expenses, which are each separately presented in the Company&#8217;s consolidated condensed statements of operations and comprehensive
loss. The CODM reviews significant expenses within both the research and development and the general and administrative categories. Other
segment items within net loss include interest income, interest expense and loss on change in fair value of related party loan. See the
consolidated condensed financial statements for other financial information regarding the Company&#8217;s operating segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; width: 76%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Research personnel compensation costs, including stock-based
    compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">401</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">179</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; padding-bottom: 1.5pt"><span style="font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">54</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,001</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,003</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(976</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(57</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,289</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,081</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,345</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,095</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,348</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,071</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(1)</sup></td><td style="text-align: justify">Other expenses includes small balances of research materials
and supplies along with insurance costs.</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government grant revenuet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Research personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">818</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">712</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">592</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; padding-bottom: 1.5pt"><span style="font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,427</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,340</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,315</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(118</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,519</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,161</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,637</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,166</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(5,064</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(4,481</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify">Other expenses includes small balances of research materials and supplies along with insurance costs.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;14 &#8212;&#160;Segments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company operates as one operating segment.
The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is its Chief Executive Officer, Ben Hwang, who reviews financial
information presented on a consolidated net loss basis as reported on the consolidated statement of operations in order to make decisions
about allocating resources and assessing performance for the entire Company. The CODM also utilizes the Company&#8217;s long-range plan,
which includes product development roadmaps and long-range financial models, as a key input to resource allocation. The CODM function
approves of key operating and strategic decisions. The CODM function views the Company&#8217;s operations and manages its business on
a consolidated basis and as a single reportable operating segment. The CODM function is regularly provided with the following significant
segment expenses. Significant expenses include research and development and general and administrative expenses, which are each separately
presented in the Company&#8217;s Consolidated Statements of Operations. The CODM reviews significant expenses within both the research
and development and the general and administrative categories. Other segment items within net loss include interest income, interest expense
and loss on change in fair value of related party loan. See the consolidated financial statements for other financial information regarding
the Company&#8217;s operating segment.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Research personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,641</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">186</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,592</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">279</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">365</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,223</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,287</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">120</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,600</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,115</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,070</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(311</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(22</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December&#160;31, 2024 and 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,424</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,283</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,730</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,211</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,230</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(10,281</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses includes small balances of research materials and supplies along with insurance costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SegmentsLineItems', window );"><strong>Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;9 &#8212;&#160;Segment Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC Topic&#160;280,&#160;&#8220;Segment
Reporting,&#8221; establishes standards for companies to report in their financial statement information about operating segments, products,
services, geographic areas, and major customers.&#160;Operating segments are defined as components of an enterprise that engage in business
activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is
regularly evaluated by the Company&#8217;s chief operating decision maker, or group, in deciding how to allocate resources and assess
performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s chief operating
decision maker (&#8220;CODM&#8221;) has been identified as its Chief Financial Officer, who reviews the assets, operating results, and
financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that there is only one reportable segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The CODM assesses performance
for the single segment and decides how to allocate resources based on net loss that also is reported on the statement of operations as
net loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company&#8217;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net loss and total assets, which
include the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>As of<span style="text-decoration:underline"><br/> </span>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>As of<span style="text-decoration:underline"><br/> </span>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,935,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,204</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Three&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Six&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Formation and operating costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">967,084</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">253,130</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,550,665</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">723,971</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest income earned on cash and marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108,520</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,184</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key measures of segment
profit or loss reviewed by our CODM are interest earned on the Trust Account and general and administrative expenses. The CODM reviews
interest earned on the Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment
with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and
monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the
business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;10 &#8212;&#160;Segment Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC Topic 280, &#8220;Segment
Reporting,&#8221; establishes standards for companies to report in their financial statement information about operating segments, products,
services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business
activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is
regularly evaluated by the Company&#8217;s chief operating decision maker, or group, in deciding how to allocate resources and assess
performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s chief operating
decision maker (&#8220;CODM&#8221;) has been identified as its Chief Financial Officer, who reviews the assets, operating results, and
financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that there is only one reportable segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The CODM assesses performance
for the single segment and decides how to allocate resources based on net loss that also is reported on the statement of operations as
net loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company&#8217;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net (loss) income and total assets,
which include the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,873,406</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,204</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,519</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General and administrative expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,351,038</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,508,683</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest earned on the Trust Account</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">425,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,248,538</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key measures of segment
profit or loss reviewed by our CODM are interest earned on the Trust Account and general and administrative expenses. The CODM reviews
interest earned on the Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment
with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and
monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the
business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SubsequentEventsLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;14 &#8212;&#160;Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has evaluated its
subsequent events from June&#160;30, 2025, through the date these condensed consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in&#160;these condensed consolidated financial statements other than the items
noted below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;7, 2022, the
Company entered into the Merger Agreement with NorthView, and on July&#160;11, 2025, the Business Combination closed. In accordance with
the terms and subject to the conditions of the Merger Agreement, at Closing, each share of issued and outstanding Profusa Common Stock
was converted into a number of shares of New Profusa Common Stock, based on the Exchange Ratio that reflects an equity valuation of Profusa
of $155,000,000 (as adjusted for the Incentive Equity Value, the Private Placement Value and the Aggregate Company Incentive Amount),
divided by an assumed value of New Profusa Common Stock of $10.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total consideration received
by Profusa Security Holders at the Closing of the transactions contemplated by the Merger Agreement is the newly issued shares of Common
Stock and securities convertible or exchangeable for newly issued shares of Common Stock with an aggregate value equal $255,958,617, with
each Profusa Stockholder receiving for each share of Profusa Common Stock held (after giving effect to the exchange or conversion of all
outstanding Profusa Preferred Stock for shares of Profusa Common Stock and treating all vested in-the-money Profusa Convertible Securities
(including, on a net exercise basis, all vested qualified Profusa Options) as if such securities had been exercised as of immediately
prior to the Merger, but excluding all unvested Profusa Options) a number of shares of Common Stock equal to a conversion ratio of approximately
0.34. As a result, the Profusa Security Holders received an aggregate of 25,595,862 shares of newly issued Common Stock as Merger Consideration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Business Combination was
accounted for as a reverse capitalization in accordance with GAAP.&#160;Profusa was deemed the accounting predecessor of the combined
business, and New Profusa is the successor SEC registrant, meaning that Profusa&#8217;s financial statements for previous periods will
be disclosed in the registrant&#8217;s future periodic reports filed with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
Company had outstanding Profusa Preferred Stock of 17,863,934 shares, common stock of 6,984,666 shares which are made up of 5,604,651
common shares outstanding and 1,380,015 shares of common stock from in-substance nonrecourse promissory notes, and fully vested options
outstanding and exercisable of 2,364,814 shares. These shares were fully converted at the completion of the Business Combination. Additionally,
as of June&#160;30, 2025, the Convertible Notes of $19.5&#160;million and Senior Convertibles Notes of $27.9&#160;million were converted
in full at the closing of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From June&#160;30, 2025 through
the closing of the Business Combination, options continued to vest on normal vesting schedules, and interest continued to accrue on the
notes. Upon completing the Business Combination on July&#160;11, 2025, all outstanding Profusa Preferred Stock of 17,863,934 shares, common
stock of 6,984,666 shares, were converted into New Profusa at an exchange ratio of .3459 for 6,178,315 shares from Profusa Preferred Stock,
and <span style="-sec-ix-hidden: hidden-fact-355">2,415,67</span> shares of Common Stock of which 1,938,392 were from common shares outstanding and 477,284 were from common shares issued
from the in-substance nonrecourse promissory notes. Additionally, 2.3&#160;million outstanding options which were vested or expected to
vest were rolled over from Profusa into New Profusa outstanding options at an exchange rate of .3459.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the following
convertible notes were converted into New Profusa Common Stock based on the principal and accrued interest as of July&#160;11, 2025. Convertible
Notes with an outstanding balance of $19.6&#160;million in principal and accrued interest converted into 2,801,697 shares of New Profusa
at $7.00/share, Senior Convertible Notes with an outstanding balance of $20.8&#160;million in principal and accrued interest converted
into 5,189,138 shares of New Profusa at $4.00/share, Senior Convertible Bridge Notes of $3.1&#160;million in principal and accrued interest
were repaid in cash in the amount of $0.25&#160;million with the remaining $2.85&#160;million converted into 1,277,162 shares of New Profusa
at $2.22/share, Senior Secured Convertible Notes of $2.8&#160;million in principal and accrued interest converted into 5,542,261 shares
of New Profusa at $0.50/share. Of the 5,542,261 New Profusa shares issued to Senior Secured Note holders, 710,220 shares were contributed
by the Sponsor. As part of the initial shares at closing, the Incentive Equity Value of $29,018,330 was converted to shares at $10 per
share for 2,901,833 shares allocated to the merger consideration, as defined in the Business Combination Amendment No. 4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;28, 2025, the
Company entered into the Purchase Agreement and a related registration rights agreement (the &#8220;ELOC Registration Rights Agreement&#8221;),
with Ascent (&#8220;Purchaser&#8221;). Pursuant to the terms and conditions set forth in the Purchase Agreement, the Company may issue
and sell to Ascent, shares of its common stock for an aggregate purchase price of up to $100&#160;million, subject to certain limitations
and conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Purchase Agreement,
the Company may deliver advance notices to the Purchaser to request the purchase of shares of common stock, with each closing to occur
on a&#160;trading&#160;day following the end of a 10 or fewer&#160;trading&#160;day valuation period commencing on the trading date immediately
following the delivery of the Advance Notice, or as determined by the Purchaser. The purchase price per share at each Closing will be
equal to 97% of the lowest volume-weighted average price (&#8220;VWAP&#8221;) of the Company&#8217;s common stock during the applicable
valuation period, subject to a floor price and other adjustments as set forth in the Purchase Agreement. The maximum purchase price at
any single Closing is limited to the lower of (a)&#160;$5.0&#160;million or (b)&#160;100% of the average daily traded value of the common
stock for the <span style="-sec-ix-hidden: hidden-fact-354">five</span>&#160;trading&#160;days immediately preceding such Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net proceeds from sales
that the Company makes to Ascent under the Purchase Agreement, will depend on the frequency and prices at which the Company sells shares
of Common Stock. We expect that any proceeds received from sales of Common Stock to Ascent will be used solely for the purchase of Bitcoin
(which can be used for debt repayment) provided that the Company&#8217;s cash balance on the date of the applicable sale exceeds $5.0&#160;million.
If the cash balance is less than $5.0&#160;million, proceeds to the Company shall be allocated first to bring the balance to $5.0&#160;million
and the remaining proceeds to purchase Bitcoin. As of the filing date of these June&#160;30, 2025 financial statements, the Company has
purchased $1.0&#160;million of Bitcoin as part of the Company&#8217;s ongoing treasury strategy.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;15 &#8212;&#160;Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has evaluated
its subsequent events from December&#160;31, 2024, through the date these consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in these consolidated financial statements other than the items noted below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On various dates in February
and March 2025, the Company received an aggregate amount of $0.8 million from the issuance of Senior Secured Convertible Notes which are
expected to be converted in 2025 upon the closing of the Company&#8217;s Qualified Financing transaction. These subsequent notes issued
in 2025 are on similar terms as all other Senior Secured Convertible Notes in issued in 2024.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SubsequentEventsLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;10 &#8212;&#160;Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements
were issued. Based on the Company&#8217;s review, the Company did not identify any subsequent events that would have required adjustment
or disclosure in the condensed consolidated financial statements, other than as previously disclosed, and as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Consummation of Business Combination</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;11, 2025, the
Company, consummated its previously announced Business Combination Profusa, pursuant to that certain Merger Agreement and Plan of Reorganization,
dated as of November&#160;7, 2022 (as the same has been amended, supplemented or otherwise modified from time to time, the &#8220;Merger
Agreement&#8221;), between the Company, Profusa, and NV Profusa Merger Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary
of the Company (&#8220;Merger Sub&#8221; and, collectively, the &#8220;Parties&#8221;). The consummation of the Business Combination involved
the merger (the &#8220;Merger&#8221;) of Merger Sub with and into Profusa, pursuant to which, at the closing of the transactions contemplated
by the Merger Agreement (the &#8220;Closing&#8221;), the separate corporate existence of Merger Sub ceased, with Profusa as the surviving
corporation becoming a wholly-owned subsidiary of the Company, pursuant to the terms of the Merger Agreement and in accordance with the
DGCL.&#160;As a result of the Business Combination, the Company owns 100% of the outstanding common stock of Profusa. In connection with
the closing of the Business Combination, the Company changed its name from &#8220;NorthView Acquisition Corporation&#8221; to &#8220;Profusa,
Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Securities Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;28, 2025, the
Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Ascent Partners Fund LLC (the &#8220;Purchaser&#8221;).
Pursuant to the terms and conditions set forth in the Purchase Agreement, the Company may, from time to time and at its discretion, issue
and sell to the Purchaser shares of its common stock (the &#8220;Purchased Securities&#8221;) for an aggregate purchase price of up to
$100,000,000 (the &#8220;Maximum Aggregate Purchase Price&#8221;), subject to certain limitations and conditions described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Purchase Agreement,
the Company may deliver advance notices (each, an &#8220;Advance Notice&#8221;) to the Purchaser to request the purchase of shares of
common stock, with each closing (a &#8220;Closing&#8221;) to occur on a&#160;trading day following the end of a 10 or fewer&#160;trading
day valuation period commencing on the trading date immediately following the delivery of the Advance Notice, or as determined by the
Purchaser. The purchase price per share at each Closing will be equal to 97% of the lowest volume-weighted average price (&#8220;VWAP&#8221;)
of the Company&#8217;s common stock during the applicable valuation period, subject to a floor price and other adjustments as set forth
in the Purchase Agreement. The maximum purchase price at any single Closing is limited to the lower of (a)&#160;$5,000,000 or (b)&#160;100%
of the average daily traded value of the common stock for the five&#160;trading days immediately preceding such Closing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
certain limitations, including that the aggregate number of shares issued under the Purchase Agreement may not exceed the number of shares
registered under the applicable registration statement or the exchange cap (generally 19.9% of the Company&#8217;s outstanding common
stock as of the effective date), unless stockholder approval is obtained or as otherwise permitted by the rules of the principal trading
market. In addition, the Purchaser&#8217;s beneficial ownership of the Company&#8217;s common stock is limited to 9.99% of the outstanding
shares immediately after giving effect to any issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement also
provides for the issuance of a warrant to the Purchaser for the purchase of 900,000 shares of common stock, and includes a Registration
Rights Agreement, Lock-Up Agreements from the Company&#8217;s officers and directors, and a Transfer Agent Instruction Letter. The Company
is required to reserve sufficient shares of common stock to satisfy its obligations under the Purchase Agreement and to maintain the listing
of its common stock on its principal trading market.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11 &#8212; Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued.
Based on the Company&#8217;s review, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the consolidated financial statements other than as previously disclosed, and as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 11, 2025, the Company
entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an institutional investor (the &#8220;Investor&#8221;). Pursuant
to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth in the SPA, to purchase from the Company
senior secured convertible promissory notes in an aggregate principal amount of up to $22,222,222 (the &#8220;Convertible Notes&#8221;)
for a purchase price of up to $20,000,000, after a 10% original issue discount (&#8220;OID&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 21, 2025, the Sponsor
and its designees have now agreed to contribute an amount (the &#8220;Revised Contribution Amount&#8221;) equal to $30,000 for the entire
Extension Period. All funds in the Company&#8217;s trust account, including those funds deposited in connection with the Revised Contribution
Amount, will be held in an interest-bearing demand deposit account at a bank until the earlier of the consummation of the Company&#8217;s
initial business combination or liquidation. The Revised Contribution Amount will be deposited in the Company&#8217;s trust account promptly
at the beginning of the Extension Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company announced that
is has agreed to waive its right to withdraw up to $100,000 of interest from the Company&#8217;s trust account to pay dissolution expenses,
should the Company ultimately liquidate prior to a business combination (the &#8220;Dissolution Expense Waiver&#8221;). As a result, the
Company will not be able to withdraw up to $100,000 of interest for such dissolution expenses upon liquidation, and such interest will
be held in the trust account and no be released until the earliest to occur of (i) the completion of the initial business combination,
(ii) the redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination
within the Extension, and (iii) the redemption of Public Shares in connection with a vote seeking to amend the provisions of our Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also announced
that is has agreed to waive its right to withdraw interest from the Company&#8217;s trust account to pay the Company&#8217;s tax expenses
(the &#8220;Tax Expense Waiver&#8221;). As a result, the Company will not be able to withdraw interest in order to pay future tax expenses,
and such interest will be held in the trust account and not be released until the earliest to occur of (i) the completion of the initial
business combination, (ii) the redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial
Business Combination within the Extension, and (iii) the redemption of Public Shares in connection with a vote seeking to amend the provisions
of our Charter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to such announcement,
and subsequent to the record date of February 21, 2025, for the Special Meeting, the Company withdrew approximately $23,400 of interest
from the trust account for tax expenses.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SubsequentEventsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SubsequentEventsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InitialPublicOfferingLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InitialPublicOfferingTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;3 &#8212;&#160;Initial Public Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Public Units</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company sold 18,975,000&#160;Units, (which included 2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment
option) at a purchase price of $10.00 per Unit. Each unit that the Company is offering has a price of $10.00 and consists of one share
of common stock, one right, and one-half&#160;of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth&#160;(1/10)
of one share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof
to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Public Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each whole warrant entitles
the holder to purchase one share of common stock at a price of $11.50&#160;per share, subject to adjustment as discussed herein. In addition,
if (x)&#160;the Company issues additional shares of common stock or equity-linked&#160;securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20&#160;per share of common
stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any
such issuance to the initial stockholders or their affiliates, without taking into account any founder shares held by such stockholders
or their affiliates, as applicable, prior to such issuance (the &#8220;Newly Issued Price&#8221;)), (y)&#160;the aggregate gross proceeds
from such issuances represent more than&#160;60% of the total equity proceeds, and interest thereon, available for funding the initial
Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of the common stock during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates the Business Combination (such price,
the &#8220;Market Value&#8221;) is below $9.20&#160;per share, the exercise price shall be adjusted (to the nearest cent) to be equal
to&#160;115% of the higher of the Market Value and the Newly Issued Price, and the $18.00&#160;per share redemption trigger price described
in the section &#8220;Redemption of warrants&#8221; will be adjusted (to the nearest cent) to be equal to&#160;180% of the higher of the
Market Value and the Newly Issued Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warrants will become exercisable
on the later of 12&#160;months from the closing of the IPO or 30&#160;days after the completion of its initial Business Combination and
will expire <span style="-sec-ix-hidden: hidden-fact-396">five</span>&#160;years after the completion of the Company&#8217;s initial Business Combination, at 5:00&#160;p.m., New&#160;York
City time, or earlier upon redemption or liquidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has agreed that as soon as
practicable, but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company
will use its reasonable best efforts to file, and within 60&#160;business days after the closing of the initial Business
Combination, to have declared effective, a registration statement relating to those shares of common stock, and to maintain a
current prospectus relating to such shares of common stock until the warrants expire or are redeemed. Notwithstanding the foregoing,
if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective within the
above specified period following the consummation of the initial Business Combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company shall have failed to maintain an effective
registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section&#160;3(a)(9)&#160;of the
Securities Act&#160;of&#160;1933, as amended, or the Securities Act, provided that such exemption is available. If that exemption,
or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Redemption of Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">in whole and not in part;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">at a price of $0.01 per warrant;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">upon a minimum of 30&#160;days&#8217; prior written notice
of redemption (the &#8220;30-day&#160;redemption period&#8221;);</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">if, and only if, the last sale price of the common stock equals
or exceeds $18.00 per share for any 20&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior
to the date on which the Company sends the notice of redemption to the warrant holders.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company calls the warrants
for redemption as described above, management will have the option to require all holders that wish to exercise warrants to do so on a
&#8220;cashless basis.&#8221; In determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221;
management will consider, among other factors, the Company&#8217;s cash position, the number of warrants that are outstanding and the
dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants.
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to
the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair
market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of the common stock for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;3 &#8212;&#160;Initial Public Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Public Units</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;22, 2021,
the Company sold 18,975,000&#160;Units, (which included 2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment
option) at a purchase price of $10.00 per Unit. Each unit that the Company is offering has a price of $10.00 and consists of one share
of common stock, one right, and one-half&#160;of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth&#160;(1/10)
of one share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof
to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Public Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each whole warrant entitles
the holder to purchase one share of common stock at a price of $11.50&#160;per share, subject to adjustment as discussed herein. In addition,
if (x)&#160;the Company issues additional shares of common stock or equity-linked&#160;securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20&#160;per share of common
stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any
such issuance to the initial stockholders or their affiliates, without taking into account any founder shares held by such stockholders
or their affiliates, as applicable, prior to such issuance (the &#8220;Newly Issued Price&#8221;)), (y)&#160;the aggregate gross proceeds
from such issuances represent more than&#160;60% of the total equity proceeds, and interest thereon, available for funding the initial
Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of the common stock during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates the Business Combination (such price,
the &#8220;Market Value&#8221;) is below $9.20&#160;per share, the exercise price shall be adjusted (to the nearest cent) to be equal
to&#160;115% of the higher of the Market Value and the Newly Issued Price, and the $18.00&#160;per share redemption trigger price described
in the section &#8220;Redemption of warrants&#8221; will be adjusted (to the nearest cent) to be equal to&#160;180% of the higher of the
Market Value and the Newly Issued Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warrants will become exercisable
on the later of 12&#160;months from the closing of the IPO or 30&#160;days after the completion of its initial Business Combination and
will expire <span style="-sec-ix-hidden: hidden-fact-357">five</span>&#160;years after the completion of the Company&#8217;s initial Business Combination, at 5:00&#160;p.m., New&#160;York
City time, or earlier upon redemption or liquidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has agreed that as soon as practicable,
but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company will use its reasonable
best efforts to file, and within 60&#160;business days after the closing of the initial Business Combination, to have declared effective,
a registration statement relating to those shares of common stock, and to maintain a current prospectus relating to such shares of common
stock until the warrants expire or are redeemed. Notwithstanding the foregoing, if a registration statement covering the shares of common
stock issuable upon exercise of the warrants is not effective within the above specified period following the consummation of the initial
Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when
the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption
provided by Section&#160;3(a)(9)&#160;of the Securities Act&#160;of&#160;1933, as amended, or the Securities Act, provided that such exemption
is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Redemption of Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td>in whole and not in part;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td>at a price of $0.01 per warrant;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td>upon a minimum of 30 days&#8217; prior written notice of redemption (the &#8220;30-day redemption period&#8221;);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">if, and only if, the last sale price of the common stock equals or exceeds $18.00 per share for any 20
trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of
redemption to the warrant holders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company calls the warrants
for redemption as described above, management will have the option to require all holders that wish to exercise warrants to do so on a
&#8220;cashless basis.&#8221; In determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221;
management will consider, among other factors, the Company&#8217;s cash position, the number of warrants that are outstanding and the
dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants.
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to
the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair
market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of the common stock for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_InitialPublicOfferingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_InitialPublicOfferingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PrivatePlacementLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PrivatePlacementsTextBlock', window );">Private Placement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note&#160;4 &#8212;&#160;Private Placement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor,&#160;I-Bankers
and Dawson James have purchased an aggregate of 7,347,500 Private Placement Warrants (which included 697,500 Private Placement Warrants
issued pursuant to the full exercise of the over-allotment option) at a price of $1.00 per warrant ($7,347,500 in the aggregate) in a
private placement that closed simultaneously with the closing of the IPO.&#160;Of such amount, 5,162,500 Private Placement Warrants were
purchased by the Sponsor and 2,185,000 Private Placement Warrants were purchased by&#160;I-Bankers and Dawson James.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Private Placement Warrants
are identical to the warrants included in the units sold in the IPO, except that the Private Placement Warrants: (i)&#160;will not be
redeemable by the Company and (ii)&#160;may be exercised for cash or on a cashless basis, in each case so long as they are held by the
initial purchasers or any of their permitted transferees. If the Private Placement Warrants are held by holders other than the initial
purchasers or any of their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by
the holders on the same basis as the warrants included in the Units&#160;being sold in the IPO.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note&#160;4 &#8212;&#160;Private Placement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Sponsor,&#160;I-Bankers
and Dawson James have purchased an aggregate of 7,347,500 Private Placement Warrants (which included 697,500 Private Placement Warrants
issued pursuant to the full exercise of the over-allotment option) at a price of $1.00 per warrant ($7,347,500 in the aggregate) in a
private placement that closed simultaneously with the closing of the IPO.&#160;Of such amount, 5,162,500 Private Placement Warrants were
purchased by the Sponsor and 2,185,000 Private Placement Warrants were purchased by&#160;I-Bankers and Dawson James.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Private Placement Warrants
are identical to the warrants included in the units sold in the IPO, except that the Private Placement Warrants: (i)&#160;will not be
redeemable by the Company and (ii)&#160;may be exercised for cash or on a cashless basis, in each case so long as they are held by the
initial purchasers or any of their permitted transferees. If the Private Placement Warrants are held by holders other than the initial
purchasers or any of their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by
the holders on the same basis as the warrants included in the Units&#160;being sold in the IPO.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PrivatePlacementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PrivatePlacementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PrivatePlacementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private placements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PrivatePlacementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems', window );"><strong>Accounting Policies, by Policy (Policies) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed
consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States
of America (&#8220;U.S.&#160;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission
(&#8220;SEC&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unaudited Interim Financial Information</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S.&#160;(&#8220;U.S.&#160;GAAP&#8221;).
The interim unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated
financial statements and in accordance with the rules and regulations of the United&#160;States Securities and Exchange Commission (the
&#8220;SEC&#8221;). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only
normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2025,
the results of its operations and changes to stockholders&#8217; equity for the three and six&#160;months ended June&#160;30, 2025 and
2024, and its cash flows for the six&#160;months ended June&#160;30, 2025 and 2024. The results for the three and six&#160;months ended
June&#160;30, 2025, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2025, or any other
interim periods, or any future year or period. All amounts included herein have been rounded except where otherwise stated. As figures
are rounded, numbers presented throughout this document may not add up precisely to the totals we provide and percentages may not precisely
reflect the absolute figures. Certain disclosures have been consolidated or omitted from the unaudited interim condensed consolidated
financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying interim
unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and the related disclosures as of December&#160;31, 2024 and for the year then ended as found in the Form&#160;S-4/A filed by the Company
with the SEC on April&#160;3, 2025.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States of America
(&#8220;U.S.&#160;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;)
and include all adjustments necessary for the fair presentation of the Company&#8217;s financial position as of December&#160;31, 2024
and 2023, and the results of operations and cash flows for the&#160;years then ended. The accompanying consolidated financial statements
include the accounts of Profusa Inc. and its wholly owned subsidiary, APAC.&#160;All intercompany balances and transactions have been
eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of condensed
consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and
expenses in the condensed consolidated financial statements and accompanying notes. The Company&#8217;s management regularly assesses
these estimates, including those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance
for deferred tax assets, and valuation of stock-based awards. Actual results could differ from these estimates, and such differences
could be material to the Company&#8217;s financial position and results of operations.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated
financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses in
the consolidated financial statements and accompanying notes. The Company&#8217;s management regularly assesses these estimates, including
those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance for deferred tax assets,
and valuation of stock-based awards. Actual results could differ from these estimates, and such differences could be material to the Company&#8217;s
financial position and results of operations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accounts Receivable and Allowance for Credit
Losses</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have
any accounts receivable with customers in the six&#160;months ended June&#160;30, 2025 and 2024. The Company has developed policies that
when accounts receivables are held with customers, they are recorded at the point in time in which management determines it is probable
that the Company will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services
transferred to the customer.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of June&#160;30, 2025 and 2024.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounts Receivable and Allowance for Credit Losses</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have any
accounts receivable with customers in the years ended December 31, 2024 and 2023. The Company has developed policies that when accounts
receivables are held with customers, they are recorded at the point in time in which management determines it is probable that the Company
will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services transferred to
the customer.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of December 31, 2024 and 2023.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#8217;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash. The Company&#8217;s other receivables are represented by amounts owned by two government agencies under the government
grants.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#8217;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s other receivables
are represented by amounts owned by two government agencies under the government grants.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all
highly liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of June&#160;30,
2025 and 2024, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all highly
liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of December&#160;31, 2024
and 2023, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred Offering Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of
securities, all of the costs are expensed. Offering costs capitalized as of June&#160;30, 2025 and December&#160;31, 2024 were $4.1&#160;million
and $2.8&#160;million, respectively. The deferred offering costs as of June&#160;30, 2025 and December&#160;31, 2024 includes $1.3&#160;million
and $0.8&#160;million respectively, of advances to NorthView to fund costs associated with the business combination.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Deferred Offering Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of securities,
all of the costs are expensed. Offering costs capitalized as of December&#160;31, 2024 and December&#160;31, 2023 were $2.8&#160;million
and $1.5&#160;million, respectively. The deferred offering costs as of December 31, 2024 and 2023 includes $0.8 million and $0, respectively,
of advances to NorthView to fund costs associated with the business combination.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Share-Based Compensation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for
share-based compensation arrangements with employees and non-employees using a fair value method which requires the recognition of
compensation expense for costs related to all share-based payments including stock options. The fair value method requires the
Company to estimate the fair value of share-based payment awards on the date of grant using an option pricing model. The Company
uses the Black-Scholes pricing model to estimate the fair value of options granted that are then expensed on a straight-line basis
over the vesting period. The Company accounts for forfeitures as they occur. Option valuation models, including the Black-Scholes
option-pricing model, require the input of highly subjective assumptions, and changes in the assumptions used can materially affect
the grant-date fair value of an award. These assumptions include the risk-free rate of interest, expected dividend yield, expected
volatility, and the expected life of the award.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Preferred Stock</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company records all shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The convertible preferred
stock is recorded outside of permanent equity because while it is not mandatorily redeemable, in certain events considered not solely
within the Company&#8217;s control, such as a merger, acquisition, or sale of all or substantially all of the Company&#8217;s assets (each,
a &#8220;deemed liquidation event&#8221;), the convertible preferred stock will become redeemable at the option of the holders of at least
a majority of the then outstanding preferred shares. The Company has not adjusted the carrying values of the convertible preferred stock
to its liquidation preference because a deemed liquidation event obligating the Company to pay the liquidation preferences to holders
of shares of convertible preferred stock is not probable of occurring. Subsequent adjustments to the carrying values to the liquidation
preferences will be made only when it becomes probable that such a deemed liquidation event will occur.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Government Grants</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives payments
from government entities under non-refundable grants in support of our product development programs. The grants received fall within two
categories:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">a.</td><td style="text-align: justify">Expense Reimbursement Grants&#160;&#8212;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;</td></tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">b.</td><td style="text-align: justify">Fixed Fee Grants&#160;&#8212;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non-exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as we are a business entity, and the grants are with governmental agencies
or units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In absence of explicit U.S.
GAAP guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#8220;IAS
20&#8221;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method
the Company recognizes grant income using the same proportion as the costs incurred to date to the total expected cost of the project,
but limiting the income to be recognized to the amount to which it is entitled based on the submitted deliverables.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p>The Company&#8217;s financial instruments consist
primarily of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company states
accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. The
promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertiblePreferredStockPolicyTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Preferred Stock</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company records all shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The convertible preferred
stock is recorded outside of permanent equity because while it is not mandatorily redeemable, in certain events considered not solely
within the Company&#8217;s control, such as a merger, acquisition, or sale of all or substantially all of the Company&#8217;s assets (each,
a &#8220;deemed liquidation event&#8221;), the convertible preferred stock will become redeemable at the option of the holders of at least
a majority of the then outstanding preferred shares. The Company has not adjusted the carrying values of the convertible preferred stock
to its liquidation preference because a deemed liquidation event obligating the Company to pay the liquidation preferences to holders
of shares of convertible preferred stock is not probable of occurring. Subsequent adjustments to the carrying values to the liquidation
preferences will be made only when it becomes probable that such a deemed liquidation event will occur.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Government Grants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Government Grants</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives payments
from government entities under non-refundable grants in support of product development programs. The grants received fall within two categories:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">a.</td><td style="text-align: justify">Expense Reimbursement Grants&#160;&#8212;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;</td></tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">b.</td><td style="text-align: justify">Fixed Fee Grants&#160;&#8212;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non- exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as the Company is a business entity, and the grants are with governmental
agencies or units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In absence of explicit U.S.&#160;GAAP
guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#8220;IAS
20&#8221;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method,
grant income is recognized using the same proportion as the costs incurred to date to the total expected cost of the project, but limiting
the income to be recognized to the amount to which the Company is entitled based on the submitted deliverables.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Government Grants</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company receives payments
from government entities under non-refundable grants in support of our product development programs. The grants received fall within two
categories:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">a.</td><td style="text-align: justify">Expense Reimbursement Grants&#160;&#8212;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;</td></tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">b.</td><td style="text-align: justify">Fixed Fee Grants&#160;&#8212;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non-exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as we are a business entity, and the grants are with governmental agencies
or units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In absence of explicit U.S.
GAAP guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#8220;IAS
20&#8221;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method
the Company recognizes grant income using the same proportion as the costs incurred to date to the total expected cost of the project,
but limiting the income to be recognized to the amount to which it is entitled based on the submitted deliverables.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s financial
instruments consist of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company
states accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment.
The promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June&#160;2023-February&#160;2024
(Note&#160;5) is carried at fair value based on unobservable market inputs.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s financial instruments consist
primarily of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company states
accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. The
promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June 2023-February
2024 (Notes 3 and 5) carried at fair value based on unobservable market inputs.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Research and Development</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses
consist of costs related to employee compensation and benefits, costs for contract manufacturing organizations (&#8220;CMOs&#8221;), costs
for contract research organizations (&#8220;CROs&#8221;), costs for sponsored research, costs for clinical trials, consultant services,
laboratory supplies, product licenses, facility-related expenses and depreciation. All research and development costs are charged to research
and development expenses within the statements of operations as incurred. Payments associated with licensing agreements to acquire exclusive
licenses to develop, use, manufacture and commercialize products that have not reached technological feasibility and do not have alternate
commercial use are also expensed as incurred. Payments made to third parties under these arrangements in advance of the performance of
the related services by the third parties are recorded as prepaid expenses until the services are rendered.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes using the asset and liability method whereby deferred tax asset and liability accounts are determined based on differences between
financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are for the year
in which the differences are expected to affect taxable income. Valuation allowances are established where necessary to reduce deferred
tax assets to the amounts expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain
tax positions by assessing all material positions taken in any assessment or challenge by relevant taxing authorities. Assessing an uncertain
tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit
that is greater than fifty percent likely of being realized upon ultimate settlement. The Company&#8217;s policy is to recognize interest
and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. The Company recognizes interest
and penalties related to unrecognized tax benefits within the income tax expense line. Accrued interest and penalties are included within
the Accrued liabilities in the balance sheets. To date, there have been no interest or penalties charged in relation to the unrecognized
tax benefits.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Net Loss per Share Attributable to Common Stockholders</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic net loss per common
share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock
outstanding during the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing
the net loss attributable to common stockholders by the weighted-average number of shares of common stock and potentially dilutive securities
outstanding for the period. For purposes of the diluted net loss per share calculation, the convertible preferred stock, common stock
subject to repurchase and stock options are considered to be potentially dilutive securities. Basic and diluted net loss attributable
to common stockholders per share is presented in conformity with the two-class method required for participating securities as the convertible
preferred stock is considered a participating security. The Company&#8217;s participating securities do not have a contractual obligation
to share in the Company&#8217;s losses. As such, the net loss is attributed entirely to common stockholders. Because the Company has reported
a net loss for the reporting periods presented, the diluted net loss per common share is the same as basic net loss per common share for
those periods.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Accounting Standards</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the six&#160;months ended June&#160;30, 2025 and through the date of issuance
of these condensed consolidated financial statements, there have been no new, or existing, recently issued accounting pronouncements that
are of significance, or potential significance, that impact the Company&#8217;s condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Recently issued accounting standards not yet
adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU&#160;2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early
adoption permitted and can be applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine
its impact on the income tax disclosures. No material financial impact will result in this expanded disclosure requirement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2024, the
FASB issued ASU No.&#160;2024-03 (&#8220;ASU&#160;2024-03&#8221;), Disaggregation of Income Statement Expenses (&#8220;DISE&#8221;). ASU&#160;2024-03
requires disaggregated disclosure of income statement expenses for public business entities. ASU&#160;2024-03 does not change the expense
captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified
categories in disclosures within the footnotes to the financial statements. As revised by ASU No.&#160;2025-01, Income Statement&#160;&#8212;&#160;Reporting
Comprehensive Income&#160;&#8212;&#160;Expense Disaggregation Disclosures, the provisions of ASU&#160;2024-03 are effective for fiscal&#160;years
beginning after December&#160;15, 2026, and interim periods within fiscal&#160;years beginning after December&#160;15, 2027, with early
adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, the Company
does not expect the adoption of ASU&#160;2024-03 to have a material effect on our consolidated financial statements taken as a whole.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recent Accounting Standards</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the year ended December 31, 2024 and through the date of issuance of these consolidated
financial statements, there have been no new, or existing, recently issued accounting pronouncements that are of significance, or potential
significance, that impact the Company&#8217;s consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently issued accounting standards as adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued
ASU 2020-06, Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#160;&#8212;&#160;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40)&#160;&#8212;&#160;Accounting for Convertible Instruments and Contracts in an Entity&#8217;s
Own Equity (&#8220;ASU 2020-06&#8221;). ASU 2020-06 reduces the number of accounting models for convertible debt instruments and redeemable
convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives
under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded
conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered
in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging&#160;&#8212;&#160;Contracts in Entity&#8217;s
Own Equity, and clarifies the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related
to the disclosures and earnings per-share (EPS) for convertible instruments and contracts in an entity&#8217;s own equity. For private
companies, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. The Company early adopted the standard in prior years, which did not have a material impact on its consolidated financial statements
and related disclosures.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued ASU&#160;2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures, requiring public entities
to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis.
Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing
segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. The Company adopted ASU 2023-07 effective
December 31, 2024, on a retrospective basis. The adoption of 2023-07 did not change the way that the Company identifies its reportable
segment. However, it has resulted in incremental disclosures within the notes of the Company&#8217;s consolidated financial statements
(Note 14).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently issued accounting standards not yet adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU 2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early adoption permitted and can be
applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine its impact on our income
tax disclosures.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2024, the FASB
issued ASU No. 2024-03 (&#8220;ASU 2024-03&#8221;), Disaggregation of Income Statement Expenses (&#8220;DISE&#8221;). ASU 2024-03 requires
disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an
entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories
in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement&#160;&#8212;&#160;Reporting
Comprehensive Income&#160;&#8212;&#160;Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years
beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted.
With the exception of expanding disclosures to include more granular income statement expense categories, the Company does not expect
the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements taken as a whole.</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems', window );"><strong>Accounting Policies, by Policy (Policies) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements are presented in U.S.&#160;dollars in conformity with accounting principles generally accepted
in the United&#160;States of America (&#8220;GAAP&#8221;) for financial information and pursuant to the rules and regulations of the SEC.&#160;Accordingly,
they do not include all of the information and footnotes required by GAAP.&#160;In the opinion of management, the unaudited condensed
consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement
of the balances and results for the periods presented. The interim results for the three and six&#160;months ended June&#160;30, 2025
are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any future periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited financial statements and notes
thereto included in the Form&#160;10-K annual report filed by the Company with the SEC on March&#160;31, 2025.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements are presented in conformity with accounting principles generally accepted in the United&#160;States of America (&#8220;GAAP&#8221;)
and pursuant to the rules and regulations of the SEC.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of these condensed
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial
statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates are in
connection with determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results
could differ significantly from those estimates.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of these consolidated
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Some of the more significant estimates are in connection with
determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results could differ significantly
from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents and Restricted Cash</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. At June&#160;30, 2025 and December&#160;31,
2024, the Company had $1,751&#160;and <span style="-sec-ix-hidden: hidden-fact-393">$0</span>&#160;of restricted cash, respectively, related to funds withdrawn from the Trust Account reserved
for the payment of income and state franchise taxes. The Company did not have any cash equivalents as of June&#160;30, 2025 and December&#160;31,
2024.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company did not have any
cash equivalents as of December&#160;31, 2024 and 2023.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income Taxes</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes under ASC&#160;740, &#8220;Income Taxes.&#8221; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the condensed consolidated financial statements and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#8217;s deferred tax asset had a full valuation allowance
recorded against it.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s condensed consolidated financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company incurred $340 and <span style="-sec-ix-hidden: hidden-fact-394"><span style="-sec-ix-hidden: hidden-fact-395">no</span></span> amount
of interest and penalty expenses during the three and six&#160;months ended June&#160;30, 2025 and 2024, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has identified
the United&#160;States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
taxes under ASC&#160;740, &#8220;Income Taxes.&#8221; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the consolidated financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires
a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
As of December&#160;31, 2024 and 2023, the Company&#8217;s deferred tax asset had a full valuation allowance recorded against it.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure
and transition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. Interest and penalties expense amounted
to $0 and $19,158 during the years ended December 31, 2024 and 2023, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has identified
the United&#160;States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Net Loss Per Common Stock</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250&#160;potential shares of common stock for outstanding warrants to purchase the
Company&#8217;s shares were excluded from diluted earnings per share for the three and six&#160;months ended June&#160;30, 2025 and 2024
because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per share
of common stock is the same as basic net loss per share of common stock for the periods presented.&#160;The table below presents a reconciliation
of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below presents a
reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Allocation of net loss</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(224,777</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(7,972,099</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(49,458</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(348,029</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(685,851</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(8,630,935</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(159,563</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(1,058,201</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">146,440</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,075</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">412,717</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">783,151</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.53</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.53</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.66</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.66</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Net (Loss) Income Per Common Stock</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250 potential shares of common stock for outstanding warrants to purchase the Company&#8217;s
shares were excluded from diluted earnings per share for the years ended December 31, 2024 and 2023 because the warrants are contingently
exercisable, and the contingencies have not yet been met. As a result, diluted net (loss) income per share of common stock is the same
as basic net (loss) income per share of common stock for the periods presented.&#160;The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Basic and diluted net (loss) income per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net (loss) income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,096,239</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(7,615,380</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">562,049</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">599,861</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">747,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,866,356</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Basic and diluted net (loss) income per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.47</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.47</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.12</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.12</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recently Issued Accounting Standards</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Standards Adopted</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued&#160;ASU&#160;2023-07,&#160;Segment Reporting&#160;(Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments
in this&#160;ASU&#160;require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided
to the chief operating officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in
the reported measure of segment profit or loss. The&#160;ASU&#160;requires that a public entity disclose the title and position of the
CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and
deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280&#160;in
interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments
in this&#160;ASU&#160;and existing segment disclosures in Topic&#160;280. This&#160;ASU&#160;is effective for fiscal&#160;years beginning
after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption
permitted. The Company adopted ASU&#160;2023-07, which was applied retrospectively to all prior periods presented. See Note&#160;9 for
further details regarding this adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Standards not yet Adopted</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#8220;ASU&#160;2023-09&#8221;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#8217;s condensed consolidated financial statements.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recently Issued Accounting Standards</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2023, the
FASB issued ASU 2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments in this ASU
require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating
officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in the reported measure of
segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the
CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public
entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single
reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures
in Topic 280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years
beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU 2023-07, which was applied retrospectively
to all prior periods presented. See Note 10 for further details regarding this adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Standards not yet Adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#8220;ASU&#160;2023-09&#8221;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#8217;s consolidated financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Principles of Consolidation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances
and transactions have been eliminated in consolidation.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principles of Consolidation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock', window );">Emerging Growth Company Status</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging Growth Company Status</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an &#8220;emerging
growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act&#160;of&#160;2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#8217;s condensed consolidated financial statements with another public company,
which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period
difficult or impossible because of the potential differences in accounting standards used.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Emerging Growth Company Status</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an &#8220;emerging
growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public company, which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Cash Held in Trust Account</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash Held in Trust Account</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June&#160;30, 2025 and December&#160;31,
2024, substantially all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six&#160;months
ended June&#160;30, 2025, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $78,813 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six&#160;months
ended June&#160;30, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $204,460 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,935,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December&#160;21, 2023, 140,663 shares of the Company&#8217;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the condensed consolidated balance sheets, which was paid from the Trust Account
in January&#160;2024 to redeeming stockholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial
business combination from March&#160;22, 2025 to June&#160;22, 2025. The meeting was adjourned until March&#160;21, 2025, at which the
stockholders approve the extension of the business combination period until June&#160;22, 2025. As a condition of the extension, the Company
contributed $30,000 to the Trust Account, for the entire extension period, on March&#160;21, 2025. On July&#160;1, 2025, the Company filed
the Amendment to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations
and redeem or repurchase 100% of the shares of the Company&#8217;s common stock issued in the Company&#8217;s initial public offering,
from June&#160;22, 2025 to August&#160;22, 2025.&#160;In connection with the special meeting of stockholders to approve the Business Combination,
stockholders of the Company redeemed 52,784 shares of common stock for an aggregate amount of $661,012.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, $1,274,549
of the Trust assets were classified as noncurrent assets and $661,012 of the Trust assets due to redeeming stockholders were classified
as current assets. As a result of the Business Combination, the $661,012 due to redeeming stockholders was paid at the Closing.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Marketable Securities Held in Trust Account</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2024, substantially
all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank and at December&#160;31,
2023, substantially all of the assets held in the Trust Account were held in U.S.&#160;Treasury Bills. All of the Company&#8217;s investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the consolidated balance sheets at
fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust
Account are shown in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;
Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $204,459 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2023, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;
Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $1,192,438 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December
    31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,406</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">U.S.&#160;Treasury Bills</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,872,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,330,835</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10,873,406</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December 21, 2023, 140,663 shares of the Company&#8217;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the consolidated balance sheets, which was paid from the Trust Account in January&#160;2024
to redeeming stockholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial business combination
from March 22, 2025 to June 22, 2025. The meeting was adjourned until March 21, 2025, at which the stockholders approve the extension
of the business combination period until June 22, 2025. As a condition of the extension, the Company contributed $30,000 to the Trust
Account, for the entire extension period, on March 21, 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2024, all
of the Trust assets were classified as noncurrent assets.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
assets and liabilities approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily
due to their short-term nature, except for the warrant liabilities, convertible promissory note, and securities purchase agreement.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
assets and liabilities approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to
their short-term nature, except for the warrant liabilities and convertible promissory note.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Derivative Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the condensed consolidated statements
of operations. Derivative assets and liabilities are classified in the condensed consolidated balance sheets as current or non-current&#160;based
on whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet
date.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Derivative Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the consolidated statements of
operations. Derivative assets and liabilities are classified in the consolidated balance sheets as current or non-current&#160;based on
whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet date.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Convertible Promissory Note</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Convertible Promissory Note</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Promissory Note</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#8217;s own assumption about the assumptions a market participant would use in pricing the working capital loan.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_WarrantLiabilitiesPolicyTextBlock', window );">Warrant Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrant Liabilities</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for the&#160;17,404,250&#160;warrants
issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants, and the&#160;569,250&#160;Representative
Warrants inclusive of the underwriters&#8217; over-allotment&#160;option) in accordance with the guidance contained in ASC&#160;815-40.
Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded
as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement&#160;at
each balance sheet date. With each such re-measurement, the warrant liabilities will be adjusted to fair value, with the change in fair
value recognized in the Company&#8217;s condensed consolidated statements of operations (See Note&#160;8).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the fair value
of the Private Placement Warrants and the Representative&#8217;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Warrant Liabilities</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for the&#160;17,404,250
warrants issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants,
and the 569,250 Representative Warrants inclusive of the underwriters&#8217; over-allotment&#160;option) in accordance with the guidance
contained in ASC&#160;815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder,
each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This
liability is subject to re-measurement&#160;at each balance sheet date. With each such re-measurement, the warrant liabilities will be
adjusted to fair value, with the change in fair value recognized in the Company&#8217;s consolidated statements of operations (See Note&#160;8).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the fair value
of the Private Placement Warrants and the Representative&#8217;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Common Stock Subject to Possible Redemption</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock Subject to Possible Redemption</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s common
stock sold as part of the Units&#160;in the IPO (&#8220;public common stock&#8221;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#8217;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#8217;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the
following table:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">9,252,208</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,683,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">768,980</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">8,337,388</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,510,830</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155,999</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, March&#160;31, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,982,557</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Redemption payment due to stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(661,012</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,970</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,330,515</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Stock Subject to Possible Redemption</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s common
stock sold as part of the Units&#160;in the IPO (&#8220;public common stock&#8221;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#8217;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#8217;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2022</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">193,525,484</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(186,410,914</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,137,638</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">9,252,208</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,683,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">768,980</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,337,388</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock', window );">Securities Purchase Agreement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Purchase Agreement</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
securities purchase agreement is valued using Monte Carlo models on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. The instrument
is subject to re-measurement at each balance sheet date, with changes in fair value recognized in the condensed consolidated statements
of operations.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ConvertiblePreferredStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ConvertiblePreferredStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_WarrantLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting policy for warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_WarrantLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479693/815-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4F<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/480/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables) - NorthView Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Shedule of Fair Value of Investments Held in Trust Account</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six&#160;months
ended June&#160;30, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $204,460 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fair Value<span style="text-decoration:underline"><br/> </span>as of<span style="text-decoration:underline"><br/> </span>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,935,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2023, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;
Trust Company (&#8220;CST&#8221;), the trustee of the Trust Account, $1,192,438 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value <br/> as of <br/> December
    31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,406</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">U.S.&#160;Treasury Bills</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,872,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,330,835</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10,873,406</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below presents a
reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six&#160;Months Ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Common <br/> stock<span style="text-decoration:underline"><br/> </span>subject to<span style="text-decoration:underline"><br/> </span>possible<span style="text-decoration:underline"><br/> </span>redemption</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Allocation of net loss</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(224,777</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(7,972,099</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(49,458</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(348,029</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(685,851</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(8,630,935</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(159,563</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right">(1,058,201</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">146,440</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,075</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">412,717</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">783,151</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Basic and diluted net loss per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.53</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.53</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.66</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.66</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text">The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the&#160;Year&#160;Ended&#160;<br/> December&#160;31,&#160;2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock <br/> subject&#160;to <br/> possible <br/> redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/> stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Basic and diluted net (loss) income per share:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net (loss) income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,096,239</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(7,615,380</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">562,049</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">599,861</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">747,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,866,356</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,193,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Basic and diluted net (loss) income per share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.47</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.47</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.12</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.12</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Condensed Consolidated Balance Sheet</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025 and
December&#160;31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the
following table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">9,252,208</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,683,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">768,980</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">8,337,388</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,510,830</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155,999</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, March&#160;31, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,982,557</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Redemption payment due to stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(661,012</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,970</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,330,515</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2022</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">193,525,484</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(186,410,914</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,137,638</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Contingently redeemable common stock, December&#160;31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">9,252,208</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Partial redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,683,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accretion of redeemable common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">768,980</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Contingently redeemable common stock, December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,337,388</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text">As of June&#160;30, 2025, the
Company&#8217;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands)<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of June&#160;30, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,543</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,543</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,234</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,234</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024
and 2023, the Company&#8217;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,235</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,235</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value as of December&#160;31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level&#160;3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Liabilities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Convertible Notes at fair value</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,714</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,714</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total assets measured at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments for the three and six&#160;months ended
June&#160;30, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> convertible <br/> debt at fair <br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of January&#160;1, 2024</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1,714</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Issuance of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 0.125in">Change in fair value included in other income and gain on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of March&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,774</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of January&#160;1, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">61</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of March&#160;31, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">57</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the changes in the fair value of the Company&#8217;s Level&#160;3 financial instruments for the&#160;years ended December&#160;31,
2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> convertible <br/> debt at fair <br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value as of January&#160;1, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Issuance of Convertible Notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,600</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value as of January&#160;1, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,714</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Issuance of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">194</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables present
information about the Company&#8217;s assets and liabilities that are measured at fair value on June&#160;30, 2025 and December&#160;31,
2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Quoted<span style="text-decoration:underline"><br/> </span>Prices In<span style="text-decoration:underline"><br/> </span>Active<span style="text-decoration:underline"><br/> </span>Markets<span style="text-decoration:underline"><br/> </span>(Level 1)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Observable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 2)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Unobservable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 3)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1,935,561</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1,274,549</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,795,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,795,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,939,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,939,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">227,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">227,700</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible Promissory Note&#160;&#8211;&#160;Related Party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,288,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,288,111</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Securities Purchase Agreement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,878</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,878</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,443,689</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-413">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,795,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,648,689</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Quoted<span style="text-decoration:underline"><br/> </span>Prices In<span style="text-decoration:underline"><br/> </span>Active<span style="text-decoration:underline"><br/> </span>Markets<span style="text-decoration:underline"><br/> </span>(Level 1)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Observable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 2)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Significant<span style="text-decoration:underline"><br/> </span>Other<span style="text-decoration:underline"><br/> </span>Unobservable<span style="text-decoration:underline"><br/> </span>Inputs<span style="text-decoration:underline"><br/> </span>(Level 3)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible Promissory Note&#160;&#8211;&#160;Related Party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,604,222</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">379,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,224,722</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables present
information about the Company&#8217;s assets and liabilities that are measured at fair value on December&#160;31, 2024 and 2023, and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted <br/> Prices In<br/> Active <br/> Markets <br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Observable <br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Unobservable <br/> Inputs <br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash and marketable securities held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">8,330,835</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">379,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,770</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,908,052</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,604,222</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">379,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,224,722</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active <br/> Markets <br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Observable <br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant <br/> Other <br/> Unobservable <br/> Inputs <br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt">Cash and marketable securities held in trust</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">10,873,406</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">10,873,406</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">&#8212;</div></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">85,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">85,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,128</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities&#160;&#8211;&#160;Representative&#8217;s Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,123</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">944,118</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">944,118</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,100,757</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,388</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,015,369</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, <span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, <span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.22</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.89</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, <span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, <span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.28</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt">De
minimis</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt">De minimis</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the securities purchase agreement were as follows at June&#160;30, 2025 and December&#160;31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Risk-free interest rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.83</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.59</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.84</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">Fair value of Common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at December&#160;31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, <br/> 2023</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.06</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.89</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.71</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">De&#160;minimis </div></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.16</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at December&#160;31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, <br/> 2023</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Input</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Risk-free interest rate </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.48</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (years) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.19</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">&#160;De&#160;minimis </div></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value of Common stock </td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.16</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the three and six&#160;months ended June&#160;30, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">293,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">22,770</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">316,670</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">146,950</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,385</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">158,335</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">440,850</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">34,155</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">475,005</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,498,150</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,545</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,691,695</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,939,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">227,700</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,166,700</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">66,128</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,123</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">71,251</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">213,077</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">229,586</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">279,205</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">21,632</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">300,837</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">124,908</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,676</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">134,584</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">404,113</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">31,308</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">435,421</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the years ended December 31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">66,128</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,123</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">71,251</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,772</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,647</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">245,419</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">293,900</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">22,770</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">316,670</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Private <br/> Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Representative&#8217;s <br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Fair value at December&#160;31, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">377,857</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">29,274</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,131</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(311,729</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,151</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(335,880</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">66,128</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,123</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">71,251</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Convertible Promissory Note</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Convertible<span style="text-decoration:underline"><br/> </span>Promissory<span style="text-decoration:underline"><br/> </span>Note&#160;&#8211;&#160;related<span style="text-decoration:underline"><br/> </span>party</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2024</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">8,908,052</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">225,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">9,133,382</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,154,729</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,288,111</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Convertible<span style="text-decoration:underline"><br/> </span>Promissory<span style="text-decoration:underline"><br/> </span>Note</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">944,118</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Principal proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">378,185</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(60,077</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Fair value at March&#160;31, 2024</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,262,226</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds received through convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">330,796</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,527,001</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Securities<span style="text-decoration:underline"><br/> </span>Purchase<span style="text-decoration:underline"><br/> </span>Agreement</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at February&#160;11, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">Change in fair value of securities purchase agreement</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">23,487</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Fair value at March&#160;31, 2025</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">23,487</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of securities purchase agreement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">170,391</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at June&#160;30, 2025</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">193,878</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Promissory <br/> Note</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Fair value at December&#160;31, 2023</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">944,118</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Principal borrowing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">797,981</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,165,953</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December&#160;31, 2024</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,908,052</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Promissory <br/> Note</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value at December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Principal borrowing</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,121,815</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(177,697</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Fair value at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">944,118</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueMeasurementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueMeasurementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid expenses and other current assets (in
thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid legal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">130</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">69</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid expenses and other current assets (in
thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Employee advances</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">96</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid legal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">69</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">146</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accrued Liabilities (in thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Accrued compensation</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(3,472</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(209</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(496</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(4,299</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,968</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accrued Liabilities (in thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Accrued compensation</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(3,472</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,960</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(496</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(391</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,968</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,351</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Changes in Debt Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the debt instruments and their changes during the six&#160;months ended June&#160;31, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px">Balance at January&#160;1, 2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18,419</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,234</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25,268</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">910</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,376</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">191</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Balance at June&#160;30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">27,895</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">940</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,383</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,533</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,543</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">27,895</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">940</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,383</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 36px">Long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px">Balance at December&#160;31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,316</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,714</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">20,155</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">849</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,362</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(115</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12px; padding-left: 12px">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">993</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">994</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px">Balance at June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,348</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">22,154</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">880</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,369</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px">Long term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
a summary of the debt instruments (which are all classified as current liabilities in the accompanying consolidated balance sheets and
their changes during the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Promissory <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">PPP <br/> Loan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balance at January 1, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,149</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">576</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">375</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(151</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-213">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-214">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">515</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,714</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,362</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance at January 1, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,714</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,362</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Issuance of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(150</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stated interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,057</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,053</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Amortization of debt discount and issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at December 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">18,419</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">25,268</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">910</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,419</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,234</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,268</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">910</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,376</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">&#8212;</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Future Minimum Payments for the Convertible Notes Payable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, future
minimum payments for the convertible notes payable were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; padding-bottom: 1.5pt">As of June&#160;30, 2025</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">19,603</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">2,287</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">26,003</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total future payments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,603</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,287</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 12px">Less: fair value remeasurement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 12px">Less: unamortized debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,967</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 12px">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(70</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(195</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,533</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,543</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">27,895</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
future minimum payments for the convertible notes payable were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tasly <br/> Convertible <br/> Debt</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Senior <br/> Notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Total future principal payments</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">19,533</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,998</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">24,396</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Add: fair value remeasurement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Add (less): unamortized debt (premium) discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,112</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(97</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,183</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">18,419</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,234</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">25,268</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Schedule of Contractual Future Minimum Payments for the PPP Loan</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June&#160;30, 2025, the
contractual future minimum payments for the PPP Loan 2 were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year Ending December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0pt">2025 (remainder)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,245</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">145</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 12px">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2024,
the contractual future minimum payments for the PPP Loan 2 were as follows (in&#160;thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Year Ending December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,231</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">145</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Subparagraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock', window );">Schedule of Convertible Preferred Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
as of June&#160;30, 2025 and December&#160;31, 2024 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share <br/> Issued and <br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liquidation <br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying <br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Original <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">New Series&#160;A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,231</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.22</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">New Series&#160;B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,815</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,701</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.61</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Series&#160;C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,358,151</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,670,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,476</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.64</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">New Series&#160;C-1</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">4.80</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">18,551,382</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,863,934</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">64,184</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">65,149</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Convertible preferred stock
as of December&#160;31, 2024 and December 31, 2023 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share <br/> Issued and <br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liquidation <br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying <br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Original <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">New Series&#160;A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,231</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.22</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">New Series&#160;B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,815</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,701</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.61</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Series&#160;C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,358,151</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,670,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,476</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.64</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">New Series&#160;C-1</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,549,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">4.80</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">18,551,382</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,863,934</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">64,184</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">65,149</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Common Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfConversionsOfStockTextBlock', window );">Schedule of Reserved Shares of Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Conversion of Series&#160;A preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Conversion of Series&#160;B preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Series&#160;C/C-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding options under 2010 Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,520,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of options under the 2010 Plan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,550,091</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Conversion of Series&#160;A preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,350,314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Conversion of Series&#160;B preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,293,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Series&#160;C/C-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220,445</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding options under 2010 Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,982,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of options under the 2010 Plan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,560,091</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,550,091</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,396,080</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfConversionsOfStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfConversionsOfStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock Option Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Activity Under the Plan is Set Forth</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity under the Plan is
set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Stock Option Activity</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available for <br/> Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at January&#160;1, 2025</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,560,091</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,972,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.00</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(1,560,091</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,560,091</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1.26</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,896</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.63</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at June&#160;30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,896</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,520,250</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.70</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">6.48</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at June&#160;30, 2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,364,814</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5.48</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at June&#160;30, 2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4,520,250</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.70</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6.48</td><td style="text-align: left">&#160;</td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Stock Option Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available for <br/> Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at December&#160;31, 2023</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,550,091</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,982,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.70</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-335">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-337">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(10,000</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.001</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at June&#160;30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,560,091</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,972,055</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">3.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at June&#160;30, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,464,429</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.88</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at June&#160;30, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.40</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3.53</td><td style="text-align: left">&#160;</td></tr> </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity under the Plan is
set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Stock Option Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/> Available <br/> for Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price Per <br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Remaining <br/> Contractual <br/> Term <br/> (in&#160;years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Balances at January&#160;1, 2024</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,550,091</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,982,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.70</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Options expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(10,000</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.001</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 2.5pt">Balances at December&#160;31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,560,091</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,972,055</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">3.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Exercisable at December&#160;31, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,548,910</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.32</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Vested and expected to vest at December 31, 2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,972,055</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.40</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">&#160;</td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock Compensation Expense by Function Recognized for the Years</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table is a summary
of stock compensation expense by function recognized for the three and six&#160;months ended June&#160;30, 2025 and 2024 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">54</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">87</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">51</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">82</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table is a summary
of stock compensation expense by function recognized for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General Administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">33</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Net Loss Per Share Attributable to Common Stockholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(2,348</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(2,071</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,604,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,601,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.42</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.37</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months <br/> Ended <br/> June&#160;30, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(5,064</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(4,481</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,604,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,601,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.90</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.80</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(9,230</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(10,281</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average shares used to computing basic and diluted net loss per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,604,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,600,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders&#160;&#8211;&#160;basic and diluted:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.65</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1.84</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;months ended <br/> June&#160;30,</td><td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="vertical-align: top; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Convertible notes payable<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,430,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,721,548</td><td style="vertical-align: top; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">&#8212;</div></td><td style="text-align: left"><sup>(2)&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="vertical-align: top; text-align: left"><sup>(2)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,520,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="vertical-align: top; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">64,814,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">46,557,537</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td>(2)</td><td style="text-align: justify">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;months ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Convertible notes payable<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,430,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,721,548</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">&#8212;</div></td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left"><sup>(2)</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,520,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">64,814,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">46,557,537</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td>(2)</td><td style="text-align: justify">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</td></tr></table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following outstanding
shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Convertible preferred stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,863,934</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,363,624</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,251,941</span></td><td style="text-align: left"><sup>(1)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-255; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Options to purchase common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,972,055</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,982,055</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">24,199,613</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23,097,930</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate</a></td>
<td class="text">The following table presents the principal reasons
for the difference between the effective tax rate and the federal statutory income tax rate (in thousands):<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Tax benefit at U.S.&#160;federal statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,941</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,159</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State Tax, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.58</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,347</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.14</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Permanent difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.06</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.06</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prior-Year deferred taxes adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.32</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.57</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change of valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(35.84</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20.51</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,109</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective income tax rate</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The components of the provision for income taxes
are as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Current:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Federal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,607</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,127</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,705</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,312</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,109</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Less: change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,109</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total provision for income taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant components of the Company&#8217;s deferred
tax assets as of December&#160;31, 2024 and 2023 were as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Deferred tax assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Accrued expenses&#160;&amp; other</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">70</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">38</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Capitalized R&amp;D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,542</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Net operating loss carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,033</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">R&amp;D credit carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,511</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,485</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,455</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,455</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,143</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A reconciliation of the federal
income tax rate to the Company&#8217;s effective tax rate is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prior Year Trueup</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18.7</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11.4</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Business combination expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.8</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Penalties and interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.0</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12.6</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(0.90</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">28.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The income tax provision consists
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Federal</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">94,174</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">480,069</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(271,945</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(226,991</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">258,284</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">203,712</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Income tax provision</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">80,513</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">456,790</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s net deferred
tax assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Deferred tax asset/(liability)</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Organizational costs/Startup expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">694,480</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">436,196</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Unrealized gain/loss&#160;&#8211;&#160;Trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,661</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">694,480</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">422,535</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(694,480</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(436,196</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Deferred tax (liability), net of allowance</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">&#8212;</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(13,661</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SegmentsLineItems', window );"><strong>Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of Other Financial Information Regarding The Company&#8217;s Operating Segment</a></td>
<td class="text">See the
consolidated condensed financial statements for other financial information regarding the Company&#8217;s operating segment.<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -12px; padding-left: 12px">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; width: 76%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Research personnel compensation costs, including stock-based
    compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">401</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">179</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; padding-bottom: 1.5pt"><span style="font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">54</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,001</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,003</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(976</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(57</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,289</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,081</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,345</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,095</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,348</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,071</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(1)</sup></td><td style="text-align: justify">Other expenses includes small balances of research materials
and supplies along with insurance costs.</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six&#160;Months Ended <br/> June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government grant revenuet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Research personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">818</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">712</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">592</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; padding-bottom: 1.5pt"><span style="font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,427</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,340</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,315</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(118</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12px; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,519</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,161</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 12px; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,637</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,166</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(5,064</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(4,481</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify">Other expenses includes small balances of research materials and supplies along with insurance costs.</td></tr></table><span></span>
</td>
<td class="text">Other segment items within net loss include interest income, interest expense
and loss on change in fair value of related party loan. See the consolidated financial statements for other financial information regarding
the Company&#8217;s operating segment.<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government grant revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Research personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,641</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">CRO and regulatory costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">186</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Administrative personnel compensation costs, including stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,592</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Rent and office costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">279</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">365</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Legal and accounting costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,223</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,287</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">120</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total segment expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,600</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,115</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,070</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Loss on change in the fair value of related party Tasly convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(311</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(22</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December&#160;31, 2024 and 2023, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,424</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,283</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,730</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,211</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,230</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(10,281</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses includes small balances of research materials and supplies along with insurance costs.</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SegmentsLineItems', window );"><strong>Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">Schedule of Company&#8217;s Performance and Making Key Decisions Regarding Resource Allocation</a></td>
<td class="text">When evaluating the Company&#8217;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net loss and total assets, which
include the following:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>As of<span style="text-decoration:underline"><br/> </span>June&#160;30,<span style="text-decoration:underline"><br/> </span>2025</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>As of<span style="text-decoration:underline"><br/> </span>December&#160;31,<span style="text-decoration:underline"><br/> </span>2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,935,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,204</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Three&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the Six&#160;Months Ended<span style="text-decoration:underline"><br/> </span>June&#160;30,</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Formation and operating costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">967,084</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">253,130</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,550,665</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">723,971</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest income earned on cash and marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108,520</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,184</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text">When evaluating the Company&#8217;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net (loss) income and total assets,
which include the following:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Trust Account</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,330,835</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,873,406</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,204</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,519</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the <br/> Year Ended <br/>
    December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">General and administrative expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,351,038</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,508,683</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest earned on the Trust Account</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">425,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,248,538</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 11, 2025</div></th>
<th class="th"><div>Jul. 01, 2025</div></th>
<th class="th"><div>Jun. 27, 2025</div></th>
<th class="th"><div>Jun. 05, 2025</div></th>
<th class="th"><div>Mar. 26, 2025</div></th>
<th class="th"><div>Mar. 18, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Sep. 10, 2024</div></th>
<th class="th"><div>Mar. 26, 2024</div></th>
<th class="th"><div>Mar. 22, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Jan. 10, 2024</div></th>
<th class="th"><div>Dec. 21, 2023</div></th>
<th class="th"><div>Aug. 28, 2023</div></th>
<th class="th"><div>Aug. 08, 2023</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Mar. 22, 2023</div></th>
<th class="th"><div>Aug. 16, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 08, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 07, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
<th class="th"><div>Feb. 21, 2025</div></th>
<th class="th"><div>Dec. 23, 2024</div></th>
<th class="th"><div>Dec. 13, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>May 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RevenueTarget', window );">Revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,348,000)<span></span>
</td>
<td class="num">$ (2,071,000)<span></span>
</td>
<td class="num">(5,064,000)<span></span>
</td>
<td class="num">$ (4,481,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,230,000)<span></span>
</td>
<td class="num">$ (10,281,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,126,000)<span></span>
</td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,066,000)<span></span>
</td>
<td class="num">$ (4,402,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191,000<span></span>
</td>
<td class="nump">$ 142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Percentage of excise tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForAdministrativeFees', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AmountDrawn', window );">Amount drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RevenueTarget', window );">Revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,864,000<span></span>
</td>
<td class="nump">$ 99,702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalancePrincipalAmount', window );">Principal amount</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PurchasePrice', window );">Purchase price</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfOriginalIssuanceDiscount', window );">Percentage of original issuance discount</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="nump">1,938,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=ck0001859807_ProfusaAsiaPacificPteLtdMember', window );">Profusa Asia Pacific Pte. Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stockholders redeeme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stockholders redeemed shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=ck0001859807_ProfusaMember', window );">Profusa [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of owns outstanding common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stockholders redeeme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stockholders redeemed shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,492,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,492,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,254,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,316,786)<span></span>
</td>
<td class="num">(1,217,764)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,711,619)<span></span>
</td>
<td class="nump">$ 1,161,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (501,614)<span></span>
</td>
<td class="num">(675,731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,296,812)<span></span>
</td>
<td class="num">$ (2,064,860)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sold at a price per Unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_TransactionCost', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,959,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,959,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,959,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnderwritingDiscountAmount', window );">Underwriting discount amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RepresentativeSharesCost', window );">Represent shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,570,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,570,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RepresentativeWarrantCost', window );">Representative warrants cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 679,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfAggregateFairMarketValueOfAsset', window );">Percentage of aggregate fair market value of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum', window );">Ownership interest to be acquired on post-transaction company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaymentsForInvestmentOfCashInTrustAccount', window );">Investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_MaturityDays', window );">Maturity days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">185 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination', window );">Redeem public shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52784.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaymentofInteresttoDistributionExpense', window );">Interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering', window );">Trust account to redeeming stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 595,439<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_WorkingCapital', window );">Convertible working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalancePrincipalAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Contribution amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,376<span></span>
</td>
<td class="nump">$ 68,752<span></span>
</td>
<td class="nump">$ 36,904<span></span>
</td>
<td class="nump">$ 36,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Lost interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Common stock remaining outstanding after the redemption (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687,519<span></span>
</td>
<td class="nump">833,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Aggregate redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 768,980<span></span>
</td>
<td class="nump">$ 2,137,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,496<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountContributions', window );">Capital contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnsecuredPromissoryNote', window );">Unsecured promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Warrants price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OutstandingPrincipalAmount', window );">Outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,919,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,919,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Percentage of excise tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther', window );">Percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,510,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 595,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,088,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 184,845,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 595,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Stockholders&#8217; deficit of excise tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,952,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,952,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,880,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExciseAndSalesTaxes', window );">Excise tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SharesRedeemedPercentage', window );">Shares redeemed percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_EstimatedInterestRate', window );">Percentage of estimated interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnderpaymentPenaltyRate', window );">Percentage of underpayment penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnpaidTotalLiabilityRate', window );">Percentage of unpaid total liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Accrued accompanying balance sheet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,952,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,952,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,880,944<span></span>
</td>
<td class="nump">$ 1,864,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForAdministrativeFees', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfPublicShares', window );">Percentage of public shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RedemptionPublicShares', window );">Redemption public shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,295,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StockholdersAmendmentPercentage', window );">Stockholders amendment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfRedeemingPublicShareholders', window );">Percentage of redeeming public shareholders.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InterestFromTrustAccount', window );">Interest from trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,484,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,453,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,453,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FundingOperatingExpenses', window );">Funding Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Special Meeting [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,348,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Contribution amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Common stock remaining outstanding after the redemption (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Aggregate redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Redeemable Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | June, July and August extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | January Extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | February Extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stockholders redeemed shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">5,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sold at a price per Unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Common Stock [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Dissolution Expense Waiver [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaymentofInteresttoDistributionExpense', window );">Interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,348,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Contribution amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Common stock remaining outstanding after the redemption (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Aggregate redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Subsequent Event [Member] | January Extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sold at a price per Unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaymentsForInvestmentOfCashInTrustAccount', window );">Investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191,647,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OperatingBankAccount', window );">Operating bank account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 741,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Outstanding redemption share (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | IPO [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,881,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">697,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">697,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">697,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Over-Allotment Option [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Generating gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Outstanding redemption share (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,027,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,027,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Public shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,295,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,295,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Public shares [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,931,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,931,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,931,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_WorkingCapital', window );">Convertible working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewTrustMember', window );">NorthView Trust [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember', window );">Convertible Working Capital Promissory Note [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,908,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_USFederalMember', window );">U.S. Federal [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Percentage of excise tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_EstimatedInterestRate', window );">Percentage of estimated interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock remaining outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_EstimatedInterestRate', window );">Percentage of estimated interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_RedeemableSharesMember', window );">Redeemable Shares [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AmountDrawn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount drawn.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AmountDrawn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests to be acquired on post transaction in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net tangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_EstimatedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of estimated interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_EstimatedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FundingOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Funding Operating Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FundingOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_InterestFromTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest from trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_InterestFromTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_MaturityDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>United States government treasury bills with a maturity days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_MaturityDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OperatingBankAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating bank account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OperatingBankAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OutstandingPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>outstanding principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OutstandingPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PaymentofInteresttoDistributionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest to distribution expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PaymentofInteresttoDistributionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public share percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfAggregateFairMarketValueOfAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum percentage of aggregate fair market value of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfAggregateFairMarketValueOfAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfOriginalIssuanceDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of original issuance discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfOriginalIssuanceDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfPublicShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfPublicShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfRedeemingPublicShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of redeeming public shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfRedeemingPublicShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RedemptionPublicShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption public shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RedemptionPublicShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RepresentativeSharesCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Represent amount of share cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RepresentativeSharesCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RepresentativeWarrantCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The represent cost of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RepresentativeWarrantCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RevenueTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total revenues from an insurance company's segregated group of participating or dividend-paying.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RevenueTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SharesRedeemedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SharesRedeemedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_StockholdersAmendmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders amendment percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_StockholdersAmendmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_TransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_TransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnderpaymentPenaltyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of underpayment penalty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnderpaymentPenaltyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnderwritingDiscountAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnderwritingDiscountAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnpaidTotalLiabilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of unpaid total liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnpaidTotalLiabilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnsecuredPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unsecured promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnsecuredPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working Capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital deficit as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExciseAndSalesTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExciseAndSalesTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalancePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of investment owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalancePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashContributionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash charitable contributions made by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashContributionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total contributions made by each class of partners (i.e., general, limited and preferred partners).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForAdministrativeFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount paid to managing member or general partner, affiliate of managing member or general partner, or affiliate of limited liability company (LLC) or limited partnership (LP) for administrative services provided to the LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477867/946-230-45-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForAdministrativeFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ck0001859807_ProfusaAsiaPacificPteLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ck0001859807_ProfusaAsiaPacificPteLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ck0001859807_ProfusaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ck0001859807_ProfusaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ck0001859807_SpecialMeetingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ck0001859807_SpecialMeetingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RedeemableWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RedeemableWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DepositAxis=ck0001859807_JuneJulyAndAugustExtensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DepositAxis=ck0001859807_JuneJulyAndAugustExtensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DepositAxis=ck0001859807_JanuaryExtensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DepositAxis=ck0001859807_JanuaryExtensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DepositAxis=ck0001859807_FebruaryExtensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DepositAxis=ck0001859807_FebruaryExtensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001859807_DissolutionExpenseWaiverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001859807_DissolutionExpenseWaiverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001859807_PublicSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ck0001859807_PublicSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001859807_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ck0001859807_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_USFederalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_USFederalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_RedeemableSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_RedeemableSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 26, 2025</div></th>
<th class="th"><div>Mar. 18, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Mar. 26, 2024</div></th>
<th class="th"><div>Dec. 21, 2023</div></th>
<th class="th"><div>Mar. 22, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetCurrent', window );">Offering costs capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Trust account current asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OperationsAndRedeemRepurchasePercentage', window );">Percentage of perations and redeem repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Trust account noncurrent asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,274,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,274,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsIncurred', window );">Interest Costs Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares of common stock (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,814,447<span></span>
</td>
<td class="nump">64,814,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,199,613<span></span>
</td>
<td class="nump">23,097,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OfferingCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Federal depository insurance coverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeSecuritiesTaxable', window );">Interest income from trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,813<span></span>
</td>
<td class="nump">204,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,459<span></span>
</td>
<td class="nump">1,192,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock shares redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayableCommonStockRedeemed', window );">Payable common stock redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Trust account current asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,453,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,453,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Contribution amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Aggregate redeemed amount</a></td>
<td class="nump">$ 6,510,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 595,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,088,361<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
<td class="nump">$ 184,845,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 595,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Trust account noncurrent asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,935,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,935,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,330,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Interest and penalties expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares of common stock (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issued warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,347,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock shares redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001859807_BusinessCombinationMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock shares redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Aggregate redeemed amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember', window );">Cash and Marketable Securities Held in Trust Account [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Common stock to be redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember', window );">Cash and Marketable Securities Held in Trust Account [Member] | Common Stock [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Trust account current asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,565,078<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock shares redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Contribution amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Common stock shares redeemed (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | NorthView Acquisition Corp [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issued warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | NorthView Acquisition Corp [Member] | Public Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issued warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,487,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,487,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,487,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issued warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | NorthView Acquisition Corp [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issued warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | NorthView Acquisition Corp [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issued warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">697,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">697,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">697,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred in connection with the offering and selling of additional partner interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OperationsAndRedeemRepurchasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of perations and redeem repurchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OperationsAndRedeemRepurchasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total interest costs incurred during the period and either capitalized or charged against earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeSecuritiesTaxable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including amortization and accretion of premiums and discounts, on securities subject to state, federal and other income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph b<br> -Subparagraph (1)(Instruction 4)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeSecuritiesTaxable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashContributionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash charitable contributions made by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashContributionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayableCommonStockRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable for common stock reacquired. Includes, but is not limited to, unit, membership interest, or other ownership interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(10)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478790/946-405-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayableCommonStockRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001859807_BusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001859807_BusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 06, 2024</div></th>
<th class="th"><div>Feb. 04, 2024</div></th>
<th class="th"><div>Aug. 15, 2023</div></th>
<th class="th"><div>Jul. 20, 2023</div></th>
<th class="th"><div>Jun. 26, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertibleDebtOfDiscountRate', window );">Percentage of discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.69%<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="nump">13.82%<span></span>
</td>
<td class="nump">14.54%<span></span>
</td>
<td class="nump">12.66%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt of issuance amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Aggregate value of public warrants</a></td>
<td class="nump">$ 379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Issuance amount</a></td>
<td class="nump">$ 2,234,000<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 2,543,000<span></span>
</td>
<td class="nump">1,710,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertibleDebtOfTermFairValue', window );">Term of time event</a></td>
<td class="text">4 months 28 days<span></span>
</td>
<td class="text">7 months 28 days<span></span>
</td>
<td class="text">7 months 28 days<span></span>
</td>
<td class="text">1 month 24 days<span></span>
</td>
<td class="text">2 months 19 days<span></span>
</td>
<td class="text">3 months 10 days<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertibleDebtOfDiscountRate', window );">Percentage of discount rate</a></td>
<td class="nump">11.78%<span></span>
</td>
<td class="nump">13.69%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="nump">13.82%<span></span>
</td>
<td class="nump">14.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Fair value</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt of issuance amount</a></td>
<td class="nump">1,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 2,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Aggregate value of public warrants</a></td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,795,000<span></span>
</td>
<td class="nump">85,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Fair Value, Inputs, Level 3 [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Aggregate value of public warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ConvertibleDebtOfDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of convertible debt of discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ConvertibleDebtOfDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ConvertibleDebtOfTermFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible debt of term fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ConvertibleDebtOfTermFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - Profusa [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="nump">$ 2,235<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">2,235<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="nump">2,235<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 2,235<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_ProfusaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_ProfusaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement - Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments (Details) - Level 3 [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems', window );"><strong>Fair Value Measurement - Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value as of beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest', window );">Accrued stated interest</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value as of Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,235<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accrued stated interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2G<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2G<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract', window );"><strong>Schedule of Prepaid Expenses and Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvanceRoyalties', window );">Employee advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PrepaidLegal', window );">Prepaid legal</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PrepaidLegal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid legal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PrepaidLegal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvanceRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount paid to music publishers, record producers, songwriters, or other artists in advance of their earning royalties from record or music sales. Such an amount is based on contractual terms and is generally nonrefundable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477426/928-340-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvanceRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfAccruedLiabilitiesAbstract', window );"><strong>Schedule of Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued compensation</a></td>
<td class="num">$ (4,090)<span></span>
</td>
<td class="num">$ (3,472)<span></span>
</td>
<td class="num">$ (1,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other liabilities</a></td>
<td class="num">$ (209)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
<td class="num">(391)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,968)<span></span>
</td>
<td class="num">$ (2,351)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfAccruedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfAccruedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="12">1 Months Ended</th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 06, 2024</div></th>
<th class="th"><div>Feb. 04, 2024</div></th>
<th class="th"><div>Aug. 15, 2023</div></th>
<th class="th"><div>Jul. 20, 2023</div></th>
<th class="th"><div>Jun. 26, 2023</div></th>
<th class="th"><div>Nov. 03, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Aug. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2011</div></th>
<th class="th"><div>Dec. 31, 2010</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 20, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 06, 2021</div></th>
<th class="th"><div>May 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_BusinessDays', window );">Business days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertibleDebtOfDiscountRate', window );">Conversion price discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.69%<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="nump">13.82%<span></span>
</td>
<td class="nump">14.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.66%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-in Capital</a></td>
<td class="nump">$ 5,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,732,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,753,000<span></span>
</td>
<td class="nump">$ 5,732,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_MaturityMonth', window );">Maturity month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PromissoryNotes', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repaid amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfAccrueInterest', window );">Percentage of accrue interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember', window );">August 2020 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share (in Dollars per share)</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInstrumentDiscount', window );">Percentage of discount</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Outstanding principal percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInstrumentsContractualTerm', window );">Contractual term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember', window );">January 2021 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInstrumentDiscount', window );">Percentage of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Outstanding principal percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInstrumentsContractualTerm', window );">Contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember', window );">April 2021 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInstrumentDiscount', window );">Percentage of discount</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2021.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Outstanding principal percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInstrumentsContractualTerm', window );">Contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember', window );">November 2022 Convertible Notes Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of debt</a></td>
<td class="nump">$ 14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000.00<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repaid amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember', window );">August 2021 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInstrumentDiscount', window );">Percentage of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember', window );">December 2021 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember', window );">Senior Notes September 2022 Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share (in Dollars per share)</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertibleDebtOfDiscountRate', window );">Conversion price discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockConvertibleConversionPriceIncrease', window );">Conversion price per share of common stock (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember', window );">October 2022 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember', window );">November 2022 Senior Notes Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_BusinessDays', window );">Business days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="nump">$ 3,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember', window );">December 2022 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember', window );">March 2023 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember', window );">April 2023 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember', window );">October-December 2023 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare', window );">Convert into new per shares (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember', window );">January-March 2024 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember', window );">April-June 2024 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember', window );">July-September 2024 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_MaturityMonth', window );">Maturity month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredConvertibleNoteMember', window );">Senior Secured Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember', window );">October-December 2024 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_MaturityMonth', window );">Maturity month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_PaycheckProtectionProgramLoanMember', window );">Paycheck Protection Program loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDefaultLongtermDebtAmount', window );">PPP loan repayment</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarch2024SeniorNotesMember', window );">January-March 2024 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarch2025SeniorNotesMember', window );">January-March 2025 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare', window );">Convert into new per shares (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilJune2025SeniorNotesMember', window );">April &#8212; June 2025 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare', window );">Convert into new per shares (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesNovember2022AmendmentMember', window );">Convertible Notes November 2022 Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes balance</a></td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_TaslyConvertibleDebtMember', window );">Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Short-term loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockConvertibleConversionPrice', window );">Conversion price of common stock (in Dollars per share)</a></td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 1,710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LossOnFairValueRemeasurement', window );">Loss on fair value remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_GainOnFairValueRemeasurement', window );">Gain on fair value remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_TaslyConvertibleDebtMember', window );">Tasly Convertible Debt [Member] | Short-Term Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Short-term loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes balance</a></td>
<td class="nump">25,268,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,268,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,268,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="nump">24,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000.00<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_MaturityMonth', window );">Maturity month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 25,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Conversion price dicount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_PromissoryNotesMember', window );">Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PromissoryNotes', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtInterestRateIncrease', window );">Simple interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Borrowed amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnrelatedPartyRepayable', window );">Unrelated party repayable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Annual interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnpaidInterest', window );">Unpaid interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_PaycheckProtectionProgramMember', window );">Paycheck Protection Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_MonthlyPayments', window );">Monthly payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LatePenaltiesAmount', window );">Late penalties</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansHeldForSaleTerm', window );">PPP loan term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">168 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">168 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes balance</a></td>
<td class="nump">13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes balance</a></td>
<td class="nump">2,234,000<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,543,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,234,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,543,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,234,000<span></span>
</td>
<td class="nump">1,710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="nump">$ 1,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertibleDebtOfDiscountRate', window );">Conversion price discount rate</a></td>
<td class="nump">11.78%<span></span>
</td>
<td class="nump">13.69%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="nump">13.82%<span></span>
</td>
<td class="nump">14.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Outstanding amount</a></td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PromissoryNotes', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_UnrelatedPartiesMember', window );">Unrelated Parties [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Outstanding amount</a></td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | November 2022 Convertible Notes Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.54%<span></span>
</td>
<td class="nump">12.66%<span></span>
</td>
<td class="nump">12.54%<span></span>
</td>
<td class="nump">12.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | October-December 2024 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | April &#8212; June 2025 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LossOnFairValueRemeasurement', window );">Loss on fair value remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Outstanding amount</a></td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | November 2022 Convertible Notes Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.28%<span></span>
</td>
<td class="nump">53.28%<span></span>
</td>
<td class="nump">53.28%<span></span>
</td>
<td class="nump">53.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | October-December 2024 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="nump">12.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.15%<span></span>
</td>
<td class="nump">12.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | April &#8212; June 2025 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest terms percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.55%<span></span>
</td>
<td class="nump">12.15%<span></span>
</td>
<td class="nump">12.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DebtInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LossOnFairValueRemeasurement', window );">Loss on fair value remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Outstanding amount</a></td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_BusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_BusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CommonStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CommonStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ConvertibleDebtOfDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of convertible debt of discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ConvertibleDebtOfDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DebtInstrumentDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of debt instrument discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DebtInstrumentDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DebtInstrumentsContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instruments contractual Term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DebtInstrumentsContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DebtInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The loans bear interest at a stated rate per annum.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DebtInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_GainOnFairValueRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recognized gain from the hedging ineffectiveness of a fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_GainOnFairValueRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_LatePenaltiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Late penalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_LatePenaltiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_LossOnFairValueRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recognized loss from the hedging ineffectiveness of a fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_LossOnFairValueRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_MaturityMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity month</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_MaturityMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_MonthlyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_MonthlyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfAccrueInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of accrue interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfAccrueInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnpaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unpaid interest on the promissory notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnpaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnrelatedPartyRepayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrelated party repayable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnrelatedPartyRepayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockConvertibleConversionPriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockConvertibleConversionPriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDefaultLongtermDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDefaultLongtermDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of annual principal payment for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilitiesAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued but unpaid interest on deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilitiesAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-21<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-20<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansHeldForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of loan held for sale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansHeldForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtInterestRateIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase in the stated interest rate on a short-term debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtInterestRateIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarch2024SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarch2024SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarch2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_JanuaryMarch2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_AprilJune2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_AprilJune2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesNovember2022AmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesNovember2022AmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_TaslyConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_TaslyConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ck0001859807_ShortTermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ck0001859807_ShortTermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_PaycheckProtectionProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_PaycheckProtectionProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_UnrelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_UnrelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecember2024SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_OctoberDecember2024SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Schedule of Changes in Debt Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">$ 18,419<span></span>
</td>
<td class="nump">$ 16,316<span></span>
</td>
<td class="nump">$ 16,316<span></span>
</td>
<td class="nump">$ 13,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">19,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="nump">2,057<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">19,533<span></span>
</td>
<td class="nump">17,348<span></span>
</td>
<td class="nump">18,419<span></span>
</td>
<td class="nump">16,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_TaslyConvertibleDebtMember', window );">Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="nump">1,838<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNoteMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">25,268<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
<td class="nump">15,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">27,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="nump">1,450<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
<td class="nump">3,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">27,895<span></span>
</td>
<td class="nump">22,154<span></span>
</td>
<td class="nump">25,268<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNotesMember', window );">Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">849<span></span>
</td>
<td class="nump">849<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">880<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="nump">849<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_PPPLoanMember', window );">PPP Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">1,376<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">1,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">$ 1,383<span></span>
</td>
<td class="nump">$ 1,369<span></span>
</td>
<td class="nump">$ 1,376<span></span>
</td>
<td class="nump">$ 1,362<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_StatedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_StatedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_TaslyConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_TaslyConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_PPPLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_PPPLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 06, 2024</div></th>
<th class="th"><div>Feb. 04, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 15, 2023</div></th>
<th class="th"><div>Jul. 20, 2023</div></th>
<th class="th"><div>Jun. 26, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total future principal payments</a></td>
<td class="nump">$ 19,603,000<span></span>
</td>
<td class="nump">$ 19,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueRemeasurement', window );">Add: fair value remeasurement</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Add (less): unamortized debt (premium) discount</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InterestExpensesNotesPayable', window );">Less: interest</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(1,112,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="nump">19,533,000<span></span>
</td>
<td class="nump">18,419,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total future principal payments</a></td>
<td class="nump">2,287,000<span></span>
</td>
<td class="nump">1,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueRemeasurement', window );">Add: fair value remeasurement</a></td>
<td class="nump">451,000<span></span>
</td>
<td class="nump">333,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Add (less): unamortized debt (premium) discount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InterestExpensesNotesPayable', window );">Less: interest</a></td>
<td class="num">(195,000)<span></span>
</td>
<td class="num">(97,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="nump">$ 2,543,000<span></span>
</td>
<td class="nump">2,234,000<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,710,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total future principal payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueRemeasurement', window );">Add: fair value remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Add (less): unamortized debt (premium) discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,055,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InterestExpensesNotesPayable', window );">Less: interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,183,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,268,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_InterestExpensesNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of interest expenses notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_InterestExpensesNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract', window );"><strong>Schedule Of Contractual Future Minimum Payments For The Ppp Loan Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 145,000<span></span>
</td>
<td class="nump">$ 1,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 1,390,000<span></span>
</td>
<td class="nump">$ 1,376<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 17, 2025</div></th>
<th class="th"><div>Feb. 11, 2025</div></th>
<th class="th"><div>Jan. 19, 2025</div></th>
<th class="th"><div>Dec. 19, 2024</div></th>
<th class="th"><div>Jun. 15, 2023</div></th>
<th class="th"><div>Aug. 01, 2022</div></th>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 11, 2025</div></th>
<th class="th"><div>May 08, 2025</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeasePayments', window );">Variable lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeasePayment', window );">Variable lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage', window );">Convertible note offering percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other exepnses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="nump">$ 202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Aggregate shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Aggregate share value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Aggregate shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,533,000<span></span>
</td>
<td class="nump">$ 17,348,000<span></span>
</td>
<td class="nump">19,533,000<span></span>
</td>
<td class="nump">17,348,000<span></span>
</td>
<td class="nump">18,419,000<span></span>
</td>
<td class="nump">16,316,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Trust account balance (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=ck0001859807_ShortTermLeasesMember', window );">Short-Term Leases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeasePayment', window );">Variable lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ShortTermDebtMember', window );">Short-Term Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfDaysForUnderwriterOptions', window );">Number of days for underwriter options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnderwritingDiscountAmount', window );">Underwriting discount amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InitialPublicOfferingGrossProceedPercentage', window );">Initial public offering gross proceed percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_BusinessCombinationPercentageRate', window );">Business combination percentage rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.68%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CashPercentage', window );">Cash percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_EquityPercentage', window );">Equity percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondAndThirdYear', window );">Payable in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LockupPeriod', window );">Lockup period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage', window );">Convertible note offering percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Asset in held in trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Trust account balance (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">Payment for fees</a></td>
<td class="nump">$ 418,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other exepnses</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfNetProceeds', window );">Percentage of net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Initial closing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_WeightedAveragePricePerSharePercentage', window );">Weighted average price per share percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDay', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Aggregate shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Cash Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">Payment for fees</a></td>
<td class="nump">550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Arrangement Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">Payment for fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payment of post combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Closing of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondAndThirdYear', window );">Payable in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Business Combination [Member] | Advisory Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">Payment for fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues', window );">units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnderwritingExpenseRatio', window );">Cash underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | IPO [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,404,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues', window );">units issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,546,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,546,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Over-Allotment Option [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Convertible Notes [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Initial Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Initial Notes [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Second Purchase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_BankersAndDawsonJamesMember', window );">I-Bankers and Dawson James [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,986,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,986,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Representative shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_BankersAndDawsonJamesMember', window );">I-Bankers and Dawson James [Member] | NorthView Acquisition Corp [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Representative shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_IBankersMember', window );">I-Bankers [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_DawsonJamesMember', window );">Dawson James [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredLeasingFees', window );">Deferred fees paid</a></td>
<td class="nump">$ 968,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember', window );">Investor [Member] | NorthView Acquisition Corp [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,444,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,444,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Closing of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember', window );">New Profusa Common Stock [Member] | Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Trust account balance (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember', window );">New Profusa Common Stock [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDay', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Aggregate shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Aggregate share value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_TradingPricePerShare', window );">Trading price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember', window );">New Profusa Common Stock [Member] | NorthView Acquisition Corp [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,555,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,555,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember', window );">New Profusa Common Stock [Member] | NorthView Acquisition Corp [Member] | Second Purchase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_BusinessCombinationPercentageRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_BusinessCombinationPercentageRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CashPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CashPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_EquityPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_EquityPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_InitialPublicOfferingGrossProceedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial public offering gross proceed percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_InitialPublicOfferingGrossProceedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_LockupPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the lockup period for the registration statement of IPO.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_LockupPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_NumberOfDaysForUnderwriterOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of days for underwriter options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_NumberOfDaysForUnderwriterOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_NumberOfTradingDay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_NumberOfTradingDay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of net proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_TradingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_TradingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnderwritingDiscountAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnderwritingDiscountAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_WeightedAveragePricePerSharePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_WeightedAveragePricePerSharePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-42<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment made to pay deferred cash remuneration expressed as a percentage of the individual's base salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredLeasingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the book value of deferred leasing fees. Amortization of these fees over the terms of the leases reduces deferred leasing fees. Originating new leases increases the balance of deferred leasing fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredLeasingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInSecondAndThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in second and third fiscal years following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInSecondAndThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for fees classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term lease payment excluded from lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderwritingExpenseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio of non-life acquisition expenses and certain non-life general and administrative expenses, to non-life net premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderwritingExpenseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeasePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for variable lease payment excluded from lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeasePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=ck0001859807_ShortTermLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=ck0001859807_ShortTermLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ShortTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ShortTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ck0001859807_CashFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ck0001859807_CashFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ck0001859807_ArrangementFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ck0001859807_ArrangementFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ck0001859807_AdvisoryFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ck0001859807_AdvisoryFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ck0001859807_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ck0001859807_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_InitialNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_InitialNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SecondPurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SecondPurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_BankersAndDawsonJamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_BankersAndDawsonJamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_IBankersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_IBankersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_DawsonJamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_DawsonJamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Convertible Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Percentage of annul rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Gross offering</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Cash proceeds</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Convertible Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Authorized to issue shares (in Shares)</a></td>
<td class="nump">18,551,382<span></span>
</td>
<td class="nump">18,551,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock at a par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesAConvertiblePreferredStockMember', window );">New Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems', window );"><strong>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 5,307<span></span>
</td>
<td class="nump">$ 5,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 5,231<span></span>
</td>
<td class="nump">$ 5,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesBConvertiblePreferredStockMember', window );">New Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems', window );"><strong>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 13,815<span></span>
</td>
<td class="nump">$ 13,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 13,701<span></span>
</td>
<td class="nump">$ 13,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesCConvertiblePreferredStockMember', window );">New Series C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems', window );"><strong>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">7,358,151<span></span>
</td>
<td class="nump">7,358,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">6,670,703<span></span>
</td>
<td class="nump">6,670,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 37,623<span></span>
</td>
<td class="nump">$ 37,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 37,476<span></span>
</td>
<td class="nump">$ 37,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 5.64<span></span>
</td>
<td class="nump">$ 5.64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesC1ConvertiblePreferredStockMember', window );">New Series C-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems', window );"><strong>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">1,549,742<span></span>
</td>
<td class="nump">1,549,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">1,549,742<span></span>
</td>
<td class="nump">1,549,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 7,439<span></span>
</td>
<td class="nump">$ 7,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 8,741<span></span>
</td>
<td class="nump">$ 8,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems', window );"><strong>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">18,551,382<span></span>
</td>
<td class="nump">18,551,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="nump">17,863,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 64,184<span></span>
</td>
<td class="nump">$ 64,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 65,149<span></span>
</td>
<td class="nump">$ 65,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesC1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesC1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Dec. 20, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Number of votes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancellation shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,896<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsShares', window );">Common stock, dividend shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Number of votes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issued amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancellation shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">862,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Common stock subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687,519<span></span>
</td>
<td class="nump">833,469<span></span>
</td>
<td class="nump">687,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_VotingSharesPercentage', window );">Voting shares percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issued amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_FounderShareMember', window );">Founder Shares [Member] | NorthView Acquisition Corp [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FounderSharesIssued', window );">Founder shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,743,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_FounderShares1Member', window );">Founder Shares [Member] | NorthView Acquisition Corp [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FounderSharesIssued', window );">Founder shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,743,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercised</a></td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,984,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NorthView Acquisition Corp [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockDetailsLineItems', window );"><strong>Common Stock (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancellation shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">862,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">862,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Common stock, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
December&#160;20, 2021,&#160;the Company effected a 1.1- for-1&#160;stock dividend of its common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-1&#160;stock dividend of its common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CommonStockDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CommonStockDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FounderSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Founder Shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FounderSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_VotingSharesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Voting shares percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_VotingSharesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_FounderShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_FounderShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_FounderShares1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_FounderShares1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Schedule of Reserved Shares of Common Stock (Details) - Previously Reported [Member] - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">22,396,080<span></span>
</td>
<td class="nump">22,396,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Conversion of Series A preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Conversion of Series B preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Conversion of Series C/C-1 preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">8,220,445<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Outstanding options under 2010 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">2,972,055<span></span>
</td>
<td class="nump">2,982,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Issuance of options under the 2010 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">1,560,091<span></span>
</td>
<td class="nump">1,550,091<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Stock Option Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vest over years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Excepted term recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
<td class="text">4 months 24 days<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised stock option (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP', window );">Reserved shares (in Shares)</a></td>
<td class="nump">4,636,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,636,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Stock option grants total (in Shares)</a></td>
<td class="nump">1,560,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ck0001859807_EquityIncentivePlanMember', window );">Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Stock Option Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP', window );">Common stock (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfExcercisePriceOption', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription', window );">Date of grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">five<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised stock option (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Date of grant expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ck0001859807_Plan2018Member', window );">2018 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Stock Option Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised stock option (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfExcercisePriceOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of exercise price option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfExcercisePriceOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the plan, including the basis for determining contributions, the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the description generally includes the basis for releasing shares and how dividends on allocated and unallocated shares are used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-20<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the number of shares provided to the Employee Stock Ownership Plan (ESOP) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the allocated, committed-to-be-released and suspense shares of the entity held by the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-20<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480520/718-40-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ck0001859807_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ck0001859807_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ck0001859807_Plan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ck0001859807_Plan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems', window );"><strong>Schedule of Activity Under the Plan is Set Forth [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Ending balances Shares available for grant</a></td>
<td class="nump">1,560,091<span></span>
</td>
<td class="nump">1,550,091<span></span>
</td>
<td class="nump">1,550,091<span></span>
</td>
<td class="nump">11,896<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balances Number of options</a></td>
<td class="nump">2,972,055<span></span>
</td>
<td class="nump">2,982,055<span></span>
</td>
<td class="nump">2,982,055<span></span>
</td>
<td class="nump">4,520,250<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balances Weighted- average exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Ending balances Weighted- average remaining contractual term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
<td class="text">3 years 6 months 10 days<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted', window );">Options granted Shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted Number of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted Weighted- average exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised', window );">Options exercised Shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised Number of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised Weighted- average exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired', window );">Options expired Shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options expired Number of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options expired Weighted- average exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled', window );">Options cancelled/forfeited Shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,896<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled/forfeited Number of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,896<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled/forfeited Weighted- average exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable Number of options</a></td>
<td class="nump">1,548,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,364,814<span></span>
</td>
<td class="nump">1,464,429<span></span>
</td>
<td class="nump">1,548,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable Weighted- average exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable Weighted- average remaining contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 5 months 23 days<span></span>
</td>
<td class="text">4 years 10 months 17 days<span></span>
</td>
<td class="text">4 years 3 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest Number of options</a></td>
<td class="nump">2,972,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,520,250<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest Weighted- average exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest Weighted- average remaining contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
<td class="text">3 years 6 months 10 days<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>he difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on Options granted, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options cancelled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Schedule of Stock Compensation Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Schedule of Stock Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Schedule of Stock Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Schedule of Stock Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 24, 2025</div></th>
<th class="th"><div>Feb. 11, 2025</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Dec. 20, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>May 08, 2025</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Jan. 10, 2024</div></th>
<th class="th"><div>Jun. 15, 2023</div></th>
<th class="th"><div>Dec. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancellation shares of common stock (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">862,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockExceedsPerShare', window );">Common stock exceeds per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDay', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalancePrincipalAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,919,796<span></span>
</td>
<td class="nump">$ 1,919,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,919,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,919,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfOriginalIssueDiscount', window );">Percentage of original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement', window );">Change in fair value of securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Administrative service fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SponsorFees', window );">Paid costs</a></td>
<td class="nump">$ 8,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty', window );">Expenses incurred and paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Ascent Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior secured convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfOriginalIssueDiscount', window );">Percentage of original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">PIPE Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDay', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior secured convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturity of convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice', window );">Percentage of lowest volume-weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Related Party Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,299,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 791,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ConvertibleWorkingCapitalPromissoryNote', window );">Sponsor amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember', window );">Sponsor [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,288,111<span></span>
</td>
<td class="nump">10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,908,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_FounderShares1Member', window );">Founder Shares [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_SponsorMember', window );">Sponsor [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_FounderShareMember', window );">Founder Shares [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,743,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDay', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDay', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Common stock, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On December&#160;20, 2021, the Company effected
a 1.1- for-1 stock dividend of its common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-1 stock dividend of its common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">618,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">618,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AggregateNumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders after the impact of the stock dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AggregateNumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of change in fair value of securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CommonStockExceedsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock exceeds per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CommonStockExceedsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ConvertibleWorkingCapitalPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible working capital promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ConvertibleWorkingCapitalPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_NumberOfTradingDay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_NumberOfTradingDay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of Lowest volume-weighted average price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfOriginalIssueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of original issue discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfOriginalIssueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The contractual monthly amount to be paid for support services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RelatedPartyTransactionsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RelatedPartyTransactionsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-7<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalancePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of investment owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalancePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SponsorFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SponsorFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_AscentNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_AscentNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_PIPEConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_PIPEConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_RelatedPartyLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_RelatedPartyLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_FounderShares1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_FounderShares1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_FounderShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_FounderShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,348)<span></span>
</td>
<td class="num">$ (2,071)<span></span>
</td>
<td class="num">$ (5,064)<span></span>
</td>
<td class="num">$ (4,481)<span></span>
</td>
<td class="num">$ (9,230)<span></span>
</td>
<td class="num">$ (10,281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used to computing basic net loss per share</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,600,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used to computing diluted net loss per share</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,600,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders &#8211; basic</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (1.84)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders &#8211; diluted</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (1.84)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">64,814,447<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">64,814,447<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,199,613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,097,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">42,430,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">42,430,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,363,624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,251,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_ConvertibleLoansMember', window );">Convertible Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_OptionsToPurchaseCommonStockMember', window );">Options to Purchase Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">4,520,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,520,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,972,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,982,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_ConvertibleLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_ConvertibleLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_OptionsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_OptionsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 16, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Federal net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Federal and state net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Federal net operating loss not expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,511<span></span>
</td>
<td class="nump">$ 3,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ReceivedPaycheckProtectionProgramLoans', window );">Received paycheck protection program loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PaycheckProtectionProgramLoansOutstanding', window );">Paycheck protection program loans outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Imposes nondeductible excise tax percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment', window );">Income for taxable</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income for taxable percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,312<span></span>
</td>
<td class="num">$ (2,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_ProfusaIncMember', window );">Profusa, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income for taxable percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="nump">28.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 258,284<span></span>
</td>
<td class="nump">$ 203,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PaycheckProtectionProgramLoansOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Paycheck protection program loans outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PaycheckProtectionProgramLoansOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ReceivedPaycheckProtectionProgramLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Received paycheck protection program loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ReceivedPaycheckProtectionProgramLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax effect of correction of an error charged or credited directly to the opening balance of retained earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_ProfusaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_ProfusaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 16, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract', window );"><strong>Schedule Of Effective Tax Rate And The Federal Statutory Income Tax Rate Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax benefit at U.S. federal statutory rate, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax benefit at U.S. federal statutory rate, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,941)<span></span>
</td>
<td class="num">$ (2,159)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State Tax, net of federal benefit, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.58%<span></span>
</td>
<td class="nump">0.14%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State Tax, net of federal benefit, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,347)<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Permanent difference, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.06%)<span></span>
</td>
<td class="num">(0.06%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Permanent difference, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Prior-Year deferred taxes adjustment, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.32%<span></span>
</td>
<td class="num">(0.57%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Prior-Year deferred taxes adjustment, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30)<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change of valuation allowance, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35.84%)<span></span>
</td>
<td class="num">(20.51%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance', window );">Change of valuation allowance, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,312<span></span>
</td>
<td class="nump">$ 2,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate, percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingenciesOther', window );">Effective income tax rate, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingenciesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in other income tax contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingenciesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current, total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(1,607)<span></span>
</td>
<td class="nump">2,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(1,705)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred, total</a></td>
<td class="num">(3,312)<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Less: change in valuation allowance</a></td>
<td class="nump">3,312<span></span>
</td>
<td class="num">(2,109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses &amp; other</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock based compensation</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_DeferredTaxAssetsConvertibleDebt', window );">Convertible debt</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized R&amp;D</a></td>
<td class="nump">1,549<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">32,173<span></span>
</td>
<td class="nump">29,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credit carryforward</a></td>
<td class="nump">3,511<span></span>
</td>
<td class="nump">3,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">37,455<span></span>
</td>
<td class="nump">34,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">$ (37,455)<span></span>
</td>
<td class="num">$ (34,143)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DeferredTaxAssetsConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DeferredTaxAssetsConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SegmentsDetailsLineItems', window );"><strong>Segments (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Operating segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Reportable segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Description of CODM</a></td>
<td class="text">The Company operates as one
operating segment. The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is its Chief Executive Officer, Ben Hwang,
who reviews financial information presented on a consolidated net loss basis as reported on the consolidated condensed statement of operations
and comprehensive loss in order to make decisions about allocating resources and assessing performance for the entire Company. The CODM
also utilizes the Company&#8217;s long-range plan, which includes product development roadmaps and long-range financial models, as a key
input to resource allocation. The CODM function approves of key operating and strategic decisions. The CODM function views the Company&#8217;s
operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly
provided with the following significant segment expenses. Significant expenses include research and development and general and administrative
expenses, which are each separately presented in the Company&#8217;s consolidated condensed statements of operations and comprehensive
loss. The CODM reviews significant expenses within both the research and development and the general and administrative categories. Other
segment items within net loss include interest income, interest expense and loss on change in fair value of related party loan. See the
consolidated condensed financial statements for other financial information regarding the Company&#8217;s operating segment.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">Chief Executive Officer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SegmentsDetailsLineItems', window );"><strong>Segments (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Operating segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Reportable segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SegmentsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SegmentsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Schedule of Other Financial Information Regarding The Company&#8217;s Operating Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract', window );"><strong>Schedule Of Other Financial Information Regarding The Company SOperating Segment Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Government grant revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OperatingExpensesAbstract1', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research personnel compensation costs, including stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="nump">1,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">CRO and regulatory costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation', window );">Administrative personnel compensation costs, including stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RentAndOfficeCosts', window );">Rent and office costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LegalAndAccountingCosts', window );">Legal and accounting costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
<td class="nump">2,340<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">6,115<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,003)<span></span>
</td>
<td class="num">(976)<span></span>
</td>
<td class="num">(2,427)<span></span>
</td>
<td class="num">(2,315)<span></span>
</td>
<td class="num">(4,500)<span></span>
</td>
<td class="num">(6,070)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on change in the fair value of related party Tasly convertible debt</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December 31, 2024 and 2023, respectively)</a></td>
<td class="num">(1,289)<span></span>
</td>
<td class="num">(1,081)<span></span>
</td>
<td class="num">(2,519)<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
<td class="num">(4,424)<span></span>
</td>
<td class="num">(4,283)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(1,345)<span></span>
</td>
<td class="num">(1,095)<span></span>
</td>
<td class="num">(2,637)<span></span>
</td>
<td class="num">(2,166)<span></span>
</td>
<td class="num">(4,730)<span></span>
</td>
<td class="num">(4,211)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (2,348)<span></span>
</td>
<td class="num">$ (2,071)<span></span>
</td>
<td class="num">$ (5,064)<span></span>
</td>
<td class="num">$ (4,481)<span></span>
</td>
<td class="num">$ (9,230)<span></span>
</td>
<td class="num">$ (10,281)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of administrative personnel compensation costs, including stock-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_LegalAndAccountingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of legal and accounting costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_LegalAndAccountingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OperatingExpensesAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OperatingExpensesAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RentAndOfficeCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of rent and office costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RentAndOfficeCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Schedule of Other Financial Information Regarding The Company&#8217;s Operating Segment (Parentheticals) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract', window );"><strong>Schedule Of Other Financial Information Regarding The Company SOperating Segment Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Related parties amounts</a></td>
<td class="nump">$ 629<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 1,333<span></span>
</td>
<td class="nump">$ 1,199<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 2,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 28, 2025</div></th>
<th class="th"><div>Jul. 11, 2025</div></th>
<th class="th"><div>Feb. 11, 2025</div></th>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>May 08, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 18, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 21, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Vested options outstanding and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2,364,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,984,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,863,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ck0001859807_MergerAgreementMember', window );">Merger Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock aggregate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 255,958,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,595,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate purchase price</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock', window );">Percentage of average daily traded value of common stock</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1', window );">Shares allocated to merger consideration (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,901,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from sales</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Purchase of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,984,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,938,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,863,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Profusa Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,178,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate purchase price</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice', window );">Percentage of lowest volume-weighted average price</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Merger Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Converted equity valuation amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior secured convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,533,000<span></span>
</td>
<td class="nump">$ 18,419,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,348,000<span></span>
</td>
<td class="nump">$ 16,316,000<span></span>
</td>
<td class="nump">$ 13,981,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Converted price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashMergerRelatedCosts', window );">Incentive equity value of converted share amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,018,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_NonrecoursePromissoryNotesMember', window );">Nonrecourse Promissory Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorConvertiblesNotesMember', window );">Senior Convertibles Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Converted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,189,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Converted price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorConvertibleBridgeNotesMember', window );">Senior Convertible Bridge Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Converted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,277,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Converted price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepaidPrincipal', window );">Repaid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredConvertibleNotesMember', window );">Senior Secured Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Converted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,542,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Converted price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredNoteMember', window );">Senior Secured Note [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Converted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,542,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfOriginalIssueDiscount', window );">Percentage of original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payable in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfNonRedeemingPublicShareholders', window );">Percentage of non-redeeming public shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock aggregate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Converted price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issuance of warrant (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Earnout revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issuance of warrant (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">5,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Common Stock [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issuance of warrant (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Dissolution Expense Waiver [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payable in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | No Redemption Scenario [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfNonRedeemingPublicShareholders', window );">Percentage of non-redeeming public shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Tax expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,348,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice', window );">Percentage of lowest volume-weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock', window );">Percentage of average daily traded value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfLimitForOutstandingCommonStock', window );">Percentage of limit for outstanding common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issuance of warrant (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Business Combination Profusa [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior secured convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Convertible Notes [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior secured convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,100,000<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member] | Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_SeniorConvertiblesNotesMember', window );">Senior Convertibles Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember', window );">Sponsor [Member] | Senior Secured Note [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Converted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember', window );">Sponsor [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock aggregate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember', window );">New Profusa Common Stock [Member] | Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Converted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,801,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Converted price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember', window );">New Profusa Common Stock [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember', window );">New Profusa Common Stock [Member] | NorthView Acquisition Corp [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior secured convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,555,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from sales</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | NorthView Acquisition Corp [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from sales</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_NumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_NumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of average daily traded value of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfLimitForOutstandingCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of limit for outstanding common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfLimitForOutstandingCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of Lowest volume-weighted average price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfNonRedeemingPublicShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of non-redeeming public shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfNonRedeemingPublicShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfOriginalIssueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of original issue discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfOriginalIssueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ck0001859807_MergerAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ck0001859807_MergerAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001859807_ProfusaPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001859807_ProfusaPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ck0001859807_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ck0001859807_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_NonrecoursePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_NonrecoursePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorConvertiblesNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorConvertiblesNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorConvertibleBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorConvertibleBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorSecuredNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001859807_DissolutionExpenseWaiverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001859807_DissolutionExpenseWaiverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001859807_NoRedemptionScenarioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001859807_NoRedemptionScenarioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ck0001859807_BusinessCombinationProfusaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ck0001859807_BusinessCombinationProfusaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_SeniorConvertiblesNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_SeniorConvertiblesNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewProfusaCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LiabilitiesAbstract1', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="nump">$ 2,543<span></span>
</td>
<td class="nump">$ 2,234<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LiabilitiesAbstract1', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LiabilitiesAbstract1', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LiabilitiesAbstract1', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Convertible Notes at fair value</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 2,543<span></span>
</td>
<td class="nump">$ 2,234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_LiabilitiesAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_LiabilitiesAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement - Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments (Details) - Level 3 [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Schedule of Fair Value of the Company&#8217;s Level 3 Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue', window );">Fair value as of beginning balance</a></td>
<td class="nump">$ 2,390<span></span>
</td>
<td class="nump">$ 2,234<span></span>
</td>
<td class="nump">$ 1,774<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue', window );">Fair value as of Ending balance</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="nump">2,390<span></span>
</td>
<td class="nump">1,838<span></span>
</td>
<td class="nump">1,774<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest', window );">Accrued stated interest</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value included in other income and gain loss on change in the fair value of Tasly convertible debt</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accrued stated interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2G<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2G<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract', window );"><strong>Schedule of Prepaid Expenses and Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PrepaidLegal', window );">Prepaid legal</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PrepaidLegal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid legal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PrepaidLegal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ScheduleOfAccruedLiabilitiesAbstract', window );"><strong>Schedule of Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,090)<span></span>
</td>
<td class="num">$ (3,472)<span></span>
</td>
<td class="num">$ (1,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
<td class="num">(391)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="num">$ (4,299)<span></span>
</td>
<td class="num">$ (4,299)<span></span>
</td>
<td class="num">$ (3,968)<span></span>
</td>
<td class="num">$ (2,351)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ScheduleOfAccruedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ScheduleOfAccruedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Schedule of Debt Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">$ 18,419<span></span>
</td>
<td class="nump">$ 16,316<span></span>
</td>
<td class="nump">$ 16,316<span></span>
</td>
<td class="nump">$ 13,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">19,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="nump">2,057<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">19,533<span></span>
</td>
<td class="nump">17,348<span></span>
</td>
<td class="nump">18,419<span></span>
</td>
<td class="nump">16,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_TaslyConvertibleDebtMember', window );">Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="nump">1,838<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNoteMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">25,268<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
<td class="nump">15,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">27,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="nump">1,450<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
<td class="nump">3,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">27,895<span></span>
</td>
<td class="nump">22,154<span></span>
</td>
<td class="nump">25,268<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNotesMember', window );">Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">849<span></span>
</td>
<td class="nump">849<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">880<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="nump">849<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001859807_PPPLoanMember', window );">PPP Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of beginning</a></td>
<td class="nump">1,376<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion</a></td>
<td class="nump">1,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_StatedInterest', window );">Stated interest</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Balance of ending</a></td>
<td class="nump">$ 1,383<span></span>
</td>
<td class="nump">$ 1,369<span></span>
</td>
<td class="nump">$ 1,376<span></span>
</td>
<td class="nump">$ 1,362<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_StatedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_StatedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_TaslyConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_TaslyConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_SeniorNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_PPPLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_PPPLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 06, 2024</div></th>
<th class="th"><div>Feb. 04, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 15, 2023</div></th>
<th class="th"><div>Jul. 20, 2023</div></th>
<th class="th"><div>Jun. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total future payments</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">As of June 30, 2025 (in Shares)</a></td>
<td class="nump">19,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total future payments</a></td>
<td class="nump">$ 19,603,000<span></span>
</td>
<td class="nump">$ 19,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueRemeasurement', window );">Less: fair value remeasurement</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InterestExpensesNotesPayable', window );">Less: interest</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(1,112,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="nump">$ 19,533,000<span></span>
</td>
<td class="nump">18,419,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Tasly Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">As of June 30, 2025 (in Shares)</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total future payments</a></td>
<td class="nump">$ 2,287,000<span></span>
</td>
<td class="nump">1,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueRemeasurement', window );">Less: fair value remeasurement</a></td>
<td class="nump">451,000<span></span>
</td>
<td class="nump">333,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InterestExpensesNotesPayable', window );">Less: interest</a></td>
<td class="num">(195,000)<span></span>
</td>
<td class="num">(97,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="nump">$ 2,543,000<span></span>
</td>
<td class="nump">$ 2,234,000<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,710,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">As of June 30, 2025 (in Shares)</a></td>
<td class="nump">26,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total future payments</a></td>
<td class="nump">$ 26,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_FairValueRemeasurement', window );">Less: fair value remeasurement</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount</a></td>
<td class="nump">1,967,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_InterestExpensesNotesPayable', window );">Less: interest</a></td>
<td class="num">(75,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total convertible notes payable</a></td>
<td class="nump">$ 27,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_FairValueRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_FairValueRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_InterestExpensesNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of interest expenses notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_InterestExpensesNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Schedule of Contractual Future Minimum Payments for the PPP Loan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2025 (remainder)</a></td>
<td class="nump">$ 1,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2026</a></td>
<td class="nump">145,000<span></span>
</td>
<td class="nump">$ 1,231<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 1,390,000<span></span>
</td>
<td class="nump">$ 1,376<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesAConvertiblePreferredStockMember', window );">New Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Schedule of Convertible Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 5,307<span></span>
</td>
<td class="nump">$ 5,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 5,231<span></span>
</td>
<td class="nump">$ 5,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesBConvertiblePreferredStockMember', window );">New Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Schedule of Convertible Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 13,815<span></span>
</td>
<td class="nump">$ 13,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 13,701<span></span>
</td>
<td class="nump">$ 13,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesCConvertiblePreferredStockMember', window );">New Series C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Schedule of Convertible Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">7,358,151<span></span>
</td>
<td class="nump">7,358,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">6,670,703<span></span>
</td>
<td class="nump">6,670,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 37,623<span></span>
</td>
<td class="nump">$ 37,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 37,476<span></span>
</td>
<td class="nump">$ 37,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 5.64<span></span>
</td>
<td class="nump">$ 5.64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesC1ConvertiblePreferredStockMember', window );">New Series C-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Schedule of Convertible Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">1,549,742<span></span>
</td>
<td class="nump">1,549,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">1,549,742<span></span>
</td>
<td class="nump">1,549,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 7,439<span></span>
</td>
<td class="nump">$ 7,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 8,741<span></span>
</td>
<td class="nump">$ 8,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original Issue Price</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Schedule of Convertible Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">18,551,382<span></span>
</td>
<td class="nump">18,551,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Share Issued and Outstanding</a></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="nump">17,863,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="nump">$ 64,184<span></span>
</td>
<td class="nump">$ 64,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Carrying Amount</a></td>
<td class="nump">$ 65,149<span></span>
</td>
<td class="nump">$ 65,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesC1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_NewSeriesC1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Schedule of Reserved Shares of Common Stock (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">22,396,080<span></span>
</td>
<td class="nump">22,396,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Conversion of Series A preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">4,350,314<span></span>
</td>
<td class="nump">4,350,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Conversion of Series B preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">5,293,175<span></span>
</td>
<td class="nump">5,293,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_SeriesCC1PreferredStockMember', window );">Conversion of Series C/C-1 preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">8,220,445<span></span>
</td>
<td class="nump">8,220,445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember', window );">Outstanding options under 2010 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">4,520,250<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember', window );">Issuance of options under the 2010 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Reserved Shares of Common Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved shares of common stock</a></td>
<td class="nump">11,896<span></span>
</td>
<td class="nump">1,550,091<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_SeriesCC1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_SeriesCC1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Schedule of Activity Under the Plan (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Schedule of Activity Under the Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted', window );">Options granted, Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,560,091)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted, Number of Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, Weighted-Average Exercise Price Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised', window );">Options exercised, Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised, Number of Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised, Weighted-Average Exercise Price Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired', window );">Options expired, Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options expired, Number of Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options expired, Weighted-Average Exercise Price Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled', window );">Options cancelled/forfeited, Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,896<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled/forfeited, Number of Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,896)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled/forfeited, Weighted-Average Exercise Price Per Share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance, Shares Available for Grant</a></td>
<td class="nump">1,560,091<span></span>
</td>
<td class="nump">1,550,091<span></span>
</td>
<td class="nump">1,550,091<span></span>
</td>
<td class="nump">11,896<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
<td class="nump">1,560,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance, Number of Options</a></td>
<td class="nump">2,972,055<span></span>
</td>
<td class="nump">2,982,055<span></span>
</td>
<td class="nump">2,982,055<span></span>
</td>
<td class="nump">4,520,250<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance, Weighted-Average Exercise Price Per Share (in Dollars per share)</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance, Weighted-Average Remaining Contractual Term (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
<td class="text">3 years 6 months 10 days<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, Number of Options</a></td>
<td class="nump">1,548,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,364,814<span></span>
</td>
<td class="nump">1,464,429<span></span>
</td>
<td class="nump">1,548,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted-Average Exercise Price Per Share (in Dollars per share)</a></td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted-Average Remaining Contractual Term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 5 months 23 days<span></span>
</td>
<td class="text">4 years 10 months 17 days<span></span>
</td>
<td class="text">4 years 3 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, Number of Options</a></td>
<td class="nump">2,972,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,520,250<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
<td class="nump">2,972,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest, Weighted-Average Exercise Price Per Share (in Dollars per share)</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest, Weighted-Average Remaining Contractual Term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
<td class="text">3 years 6 months 10 days<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>he difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on Options granted, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options cancelled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Schedule of Stock Compensation Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock Compensation Expense</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock Compensation Expense</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock Compensation Expense</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,348)<span></span>
</td>
<td class="num">$ (2,071)<span></span>
</td>
<td class="num">$ (5,064)<span></span>
</td>
<td class="num">$ (4,481)<span></span>
</td>
<td class="num">$ (9,230)<span></span>
</td>
<td class="num">$ (10,281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used to computing basic net loss per share</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,600,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used to computing diluted net loss per share</a></td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,601,651<span></span>
</td>
<td class="nump">5,604,651<span></span>
</td>
<td class="nump">5,600,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders &#8212; basic</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (1.84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders &#8212; diluted</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (1.84)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities</a></td>
<td class="nump">64,814,447<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">64,814,447<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,199,613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,097,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities</a></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,863,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible notes payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities</a></td>
<td class="nump">42,430,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">42,430,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,363,624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,251,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_ConvertibleLoansMember', window );">Convertible loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_OptionsToPurchaseCommonStockMember', window );">Options to purchase common stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities</a></td>
<td class="nump">4,520,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,520,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,972,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,982,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_ConvertibleLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_ConvertibleLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_OptionsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ck0001859807_OptionsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segments - Schedule of Consolidated Condensed Financial Statements of Operating Segment (Details) - Operating Segments [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Schedule of Consolidated Condensed Financial Statements of Operating Segment [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Government grant revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_OperatingExpensesAbstract2', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Research personnel compensation costs, including stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">320<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="nump">658<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">CRO and regulatory costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation', window );">Administrative personnel compensation costs, including stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">401<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">736<span></span>
</td>
<td class="nump">712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RentAndOfficeCosts', window );">Rent and office costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">118<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LegalAndAccountingCosts', window );">Legal and accounting costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">54<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total segment expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
<td class="nump">2,340<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,003)<span></span>
</td>
<td class="num">(976)<span></span>
</td>
<td class="num">(2,427)<span></span>
</td>
<td class="num">(2,315)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on change in the fair value of related party Tasly convertible debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,289)<span></span>
</td>
<td class="num">(1,081)<span></span>
</td>
<td class="num">(2,519)<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,345)<span></span>
</td>
<td class="num">(1,095)<span></span>
</td>
<td class="num">(2,637)<span></span>
</td>
<td class="num">(2,166)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2,348)<span></span>
</td>
<td class="num">$ (2,071)<span></span>
</td>
<td class="num">$ (5,064)<span></span>
</td>
<td class="num">$ (4,481)<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Other expenses includes small balances of research materials
and supplies along with insurance costs.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of administrative personnel compensation costs, including stock-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_LegalAndAccountingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of legal and accounting costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_LegalAndAccountingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_OperatingExpensesAbstract2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_OperatingExpensesAbstract2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RentAndOfficeCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of rent and office costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RentAndOfficeCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Shedule of Fair Value of Investments Held in Trust Account [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Fair values of investments held in the Trust Account</a></td>
<td class="nump">$ 8,330,835<span></span>
</td>
<td class="nump">$ 1,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Bills [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Shedule of Fair Value of Investments Held in Trust Account [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Fair values of investments held in the Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,872,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_AssetHeldInTrustMember', window );">Trust Account [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Shedule of Fair Value of Investments Held in Trust Account [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Fair values of investments held in the Trust Account</a></td>
<td class="nump">$ 8,330,835<span></span>
</td>
<td class="nump">$ 10,873,406<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_AssetHeldInTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_AssetHeldInTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember', window );">Common stock subject to possible redemption [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Allocation of net (loss) income</a></td>
<td class="num">$ (224,777)<span></span>
</td>
<td class="num">$ (49,458)<span></span>
</td>
<td class="num">$ (685,851)<span></span>
</td>
<td class="num">$ (159,563)<span></span>
</td>
<td class="num">$ (1,096,239)<span></span>
</td>
<td class="nump">$ 562,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding</a></td>
<td class="nump">146,440<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="nump">412,717<span></span>
</td>
<td class="nump">783,151<span></span>
</td>
<td class="nump">747,644<span></span>
</td>
<td class="nump">4,866,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Allocation of net (loss) income</a></td>
<td class="num">$ (7,972,099)<span></span>
</td>
<td class="num">$ (348,029)<span></span>
</td>
<td class="num">$ (8,630,935)<span></span>
</td>
<td class="num">$ (1,058,201)<span></span>
</td>
<td class="num">$ (7,615,380)<span></span>
</td>
<td class="nump">$ 599,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding</a></td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Consolidated Balance Sheet (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable common stock at beginning</a></td>
<td class="nump">$ 8,337,388<span></span>
</td>
<td class="nump">$ 9,252,208<span></span>
</td>
<td class="nump">$ 193,525,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_LessAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedemptionPremium', window );">Partial redemption</a></td>
<td class="num">(6,510,830)<span></span>
</td>
<td class="num">(1,683,800)<span></span>
</td>
<td class="num">(186,410,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PlusAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Accretion of redeemable common stock</a></td>
<td class="nump">155,999<span></span>
</td>
<td class="nump">768,980<span></span>
</td>
<td class="nump">2,137,638<span></span>
</td>
<td class="nump">$ 8,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable common stock at ending</a></td>
<td class="nump">$ 1,982,557<span></span>
</td>
<td class="nump">$ 8,337,388<span></span>
</td>
<td class="nump">$ 9,252,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_LessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_LessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PlusAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PlusAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedemptionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedemptionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details) - NorthView Acquisition Corp [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of securities called by each warrant (in Shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_EquityProceedOwnershipPercentage', window );">Total equity proceeds percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice', window );">Market value price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance', window );">Market value percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption', window );">Redemption trigger price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expire term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_RedemptionPricePerWarrant', window );">Redemption price per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption', window );">Redemption period days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders', window );">Redemption period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockThresholdTradingDays', window );">Common stock threshold trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_CommonStockThresholdConsecutiveTradingDays', window );">Consecutive trading day threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfSharesIssuedPerUnit', window );">Number of shares issued per unit (in Shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance', window );">Market value percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of securities called by each warrant (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues', window );">Units issued (in Shares)</a></td>
<td class="nump">18,975,000<span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues', window );">Units issued (in Shares)</a></td>
<td class="nump">2,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001859807_PublicWarrantsMember', window );">Public Warrants [Member] | Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_NumberOfSharesIssuedPerUnit', window );">Number of shares issued per unit (in Shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trigger share price of warrants or rights for redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CommonStockThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock threshold consecutive trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CommonStockThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_CommonStockThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock, threshold trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_CommonStockThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_EquityProceedOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_EquityProceedOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum threshold price of common stock specified to send notice of redemption to the warrant holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of days for written notice of redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_NumberOfSharesIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Shares Issued Per Unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_NumberOfSharesIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of warrant exercise price adjusted to price received in new issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_RedemptionPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption Price Per Warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_RedemptionPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001859807_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ck0001859807_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement (Details) - NorthView Acquisition Corp [Member] - Private Placement Warrants [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="nump">7,347,500<span></span>
</td>
<td class="nump">7,347,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Price per warrant (in Dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Generating proceeds of private placement (in Dollars)</a></td>
<td class="nump">$ 7,347,500<span></span>
</td>
<td class="nump">$ 7,347,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="nump">5,162,500<span></span>
</td>
<td class="nump">5,162,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">I-Bankers and Dawson James [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="nump">2,185,000<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Private Placement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="nump">697,500<span></span>
</td>
<td class="nump">697,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_IBankersAndDawsonJamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ck0001859807_IBankersAndDawsonJamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,604,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember', window );">Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember', window );">Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember', window );">Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,908,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">944,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember', window );">Cash and marketable securities held in trust [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,330,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,873,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">$ 3,795,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">2,939,000<span></span>
</td>
<td class="nump">$ 440,850<span></span>
</td>
<td class="nump">293,900<span></span>
</td>
<td class="nump">$ 404,113<span></span>
</td>
<td class="nump">$ 279,205<span></span>
</td>
<td class="nump">66,128<span></span>
</td>
<td class="nump">$ 377,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">227,700<span></span>
</td>
<td class="nump">$ 34,155<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">$ 31,308<span></span>
</td>
<td class="nump">$ 21,632<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">$ 29,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note</a></td>
<td class="nump">10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,908,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,604,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Quoted Prices In Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Quoted Prices In Active Markets (Level 1) [Member] | Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Quoted Prices In Active Markets (Level 1) [Member] | Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Quoted Prices In Active Markets (Level 1) [Member] | Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Quoted Prices In Active Markets (Level 1) [Member] | Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Observable Inputs (Level 2) [Member] | Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">3,795,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Observable Inputs (Level 2) [Member] | Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Observable Inputs (Level 2) [Member] | Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Observable Inputs (Level 2) [Member] | Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,224,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Unobservable Inputs (Level 3) [Member] | Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Unobservable Inputs (Level 3) [Member] | Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">2,939,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Unobservable Inputs (Level 3) [Member] | Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">227,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Significant Other Unobservable Inputs (Level 3) [Member] | Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note</a></td>
<td class="nump">10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,908,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">944,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,224,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Cash and marketable securities held in trust [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="nump">1,935,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,330,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Cash and marketable securities held in trust [Member] | Quoted Prices In Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="nump">1,274,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,330,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,873,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Cash and marketable securities held in trust [Member] | Significant Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">NorthView Acquisition Corp [Member] | Cash and marketable securities held in trust [Member] | Significant Other Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note (Details) - NorthView Acquisition Corp [Member]<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">4.22<span></span>
</td>
<td class="nump">4.18<span></span>
</td>
<td class="nump">5.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">4.28<span></span>
</td>
<td class="nump">4.18<span></span>
</td>
<td class="nump">5.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (years) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">0.61<span></span>
</td>
<td class="nump">0.89<span></span>
</td>
<td class="nump">0.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Exercise price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">12.52<span></span>
</td>
<td class="nump">12.12<span></span>
</td>
<td class="nump">11.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">12.52<span></span>
</td>
<td class="nump">12.12<span></span>
</td>
<td class="nump">11.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsQuantitativeInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsQuantitativeInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, beginning balance</a></td>
<td class="nump">$ 440,850<span></span>
</td>
<td class="nump">$ 293,900<span></span>
</td>
<td class="nump">$ 279,205<span></span>
</td>
<td class="nump">$ 66,128<span></span>
</td>
<td class="nump">$ 293,900<span></span>
</td>
<td class="nump">$ 66,128<span></span>
</td>
<td class="nump">$ 66,128<span></span>
</td>
<td class="nump">$ 377,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">2,498,150<span></span>
</td>
<td class="nump">146,950<span></span>
</td>
<td class="nump">124,908<span></span>
</td>
<td class="nump">213,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,772<span></span>
</td>
<td class="num">(311,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, ending balance</a></td>
<td class="nump">2,939,000<span></span>
</td>
<td class="nump">440,850<span></span>
</td>
<td class="nump">404,113<span></span>
</td>
<td class="nump">279,205<span></span>
</td>
<td class="nump">2,939,000<span></span>
</td>
<td class="nump">404,113<span></span>
</td>
<td class="nump">293,900<span></span>
</td>
<td class="nump">66,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, beginning balance</a></td>
<td class="nump">34,155<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">21,632<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">29,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">193,545<span></span>
</td>
<td class="nump">11,385<span></span>
</td>
<td class="nump">9,676<span></span>
</td>
<td class="nump">16,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,647<span></span>
</td>
<td class="num">(24,151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, ending balance</a></td>
<td class="nump">$ 227,700<span></span>
</td>
<td class="nump">34,155<span></span>
</td>
<td class="nump">$ 31,308<span></span>
</td>
<td class="nump">21,632<span></span>
</td>
<td class="nump">227,700<span></span>
</td>
<td class="nump">31,308<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,251<span></span>
</td>
<td class="nump">$ 316,670<span></span>
</td>
<td class="nump">$ 71,251<span></span>
</td>
<td class="nump">71,251<span></span>
</td>
<td class="nump">407,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,419<span></span>
</td>
<td class="num">(335,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316,670<span></span>
</td>
<td class="nump">$ 71,251<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Convertible Promissory Note (Details) - NorthView Acquisition Corp [Member] - Convertible Promissory Note [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Schedule of Convertible Promissory Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Fair value beginning balance</a></td>
<td class="nump">$ 944,118<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Fair value Ending balance</a></td>
<td class="nump">8,908,052<span></span>
</td>
<td class="nump">944,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_PrincipalBorrowing', window );">Principal borrowing</a></td>
<td class="nump">797,981<span></span>
</td>
<td class="nump">1,121,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote', window );">Change in fair value of convertible promissory note</a></td>
<td class="nump">$ 7,165,953<span></span>
</td>
<td class="num">$ (177,697)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in fair value of convertible promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_PrincipalBorrowing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal borrowing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_PrincipalBorrowing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001859807_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001859807_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Net Deferred Tax Assets (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax asset/(liability)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Organizational costs/Startup expenses</a></td>
<td class="nump">$ 694,480<span></span>
</td>
<td class="nump">$ 436,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities', window );">Unrealized gain/loss - Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(13,661)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax asset</a></td>
<td class="nump">694,480<span></span>
</td>
<td class="nump">422,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(694,480)<span></span>
</td>
<td class="num">(436,196)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax (liability), net of allowance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (13,661)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Tax Provision (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Federal</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 94,174<span></span>
</td>
<td class="nump">$ 480,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(271,945)<span></span>
</td>
<td class="num">(226,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">258,284<span></span>
</td>
<td class="nump">203,712<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">$ 80,513<span></span>
</td>
<td class="nump">$ 456,790<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of the Federal Income Tax Rate (Details) - NorthView Acquisition Corp [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Prior Year Trueup</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(18.70%)<span></span>
</td>
<td class="num">(11.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness', window );">Business combination expenses</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate', window );">Penalties and interest</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(3.00%)<span></span>
</td>
<td class="nump">12.60%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="nump">28.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Penalties and interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information  - Schedule of Company&#8217;s Performance and Making Key Decisions Regarding Resource Allocation (Details) - Chief Operating Officer Decision Maker [Member] - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Trust Account</a></td>
<td class="nump">$ 8,330,835<span></span>
</td>
<td class="nump">$ 10,873,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">16,204<span></span>
</td>
<td class="nump">4,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(1,351,038)<span></span>
</td>
<td class="num">(1,508,683)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned on the Trust Account</a></td>
<td class="nump">$ 425,416<span></span>
</td>
<td class="nump">$ 2,248,538<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedIncomeStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedIncomeStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ck0001859807_ChiefOperatingOfficerDecisionMakerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ck0001859807_ChiefOperatingOfficerDecisionMakerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash [Member] | NorthView Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Schedule of Fair Value of Investments Held in Trust Account [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Fair values of investments held in the Trust Account</a></td>
<td class="nump">$ 1,935,561<span></span>
</td>
<td class="nump">$ 8,330,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember', window );">Common stock subject to possible redemption [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Allocation of net loss</a></td>
<td class="num">$ (224,777)<span></span>
</td>
<td class="num">$ (49,458)<span></span>
</td>
<td class="num">$ (685,851)<span></span>
</td>
<td class="num">$ (159,563)<span></span>
</td>
<td class="num">$ (1,096,239)<span></span>
</td>
<td class="nump">$ 562,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding</a></td>
<td class="nump">146,440<span></span>
</td>
<td class="nump">738,075<span></span>
</td>
<td class="nump">412,717<span></span>
</td>
<td class="nump">783,151<span></span>
</td>
<td class="nump">747,644<span></span>
</td>
<td class="nump">4,866,356<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Allocation of net loss</a></td>
<td class="num">$ (7,972,099)<span></span>
</td>
<td class="num">$ (348,029)<span></span>
</td>
<td class="num">$ (8,630,935)<span></span>
</td>
<td class="num">$ (1,058,201)<span></span>
</td>
<td class="num">$ (7,615,380)<span></span>
</td>
<td class="nump">$ 599,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding</a></td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
<td class="nump">5,193,750<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share</a></td>
<td class="num">$ (1.53)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.66)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (1.47)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001859807_CommonStockSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Condensed Consolidated Balance Sheet (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable common stock at beginning</a></td>
<td class="nump">$ 1,982,557<span></span>
</td>
<td class="nump">$ 8,337,388<span></span>
</td>
<td class="nump">$ 9,252,208<span></span>
</td>
<td class="nump">$ 193,525,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable common stock at ending</a></td>
<td class="nump">1,330,515<span></span>
</td>
<td class="nump">1,982,557<span></span>
</td>
<td class="nump">8,337,388<span></span>
</td>
<td class="nump">9,252,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedemptionPremium', window );">Partial redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,510,830)<span></span>
</td>
<td class="num">(1,683,800)<span></span>
</td>
<td class="num">(186,410,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Redemption payment due to stockholders</a></td>
<td class="num">(661,012)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Accretion of redeemable common stock</a></td>
<td class="nump">$ 8,970<span></span>
</td>
<td class="nump">$ 155,999<span></span>
</td>
<td class="nump">$ 768,980<span></span>
</td>
<td class="nump">$ 2,137,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedemptionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedemptionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">$ 3,795,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">2,939,000<span></span>
</td>
<td class="nump">$ 440,850<span></span>
</td>
<td class="nump">293,900<span></span>
</td>
<td class="nump">$ 404,113<span></span>
</td>
<td class="nump">$ 279,205<span></span>
</td>
<td class="nump">66,128<span></span>
</td>
<td class="nump">$ 377,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">227,700<span></span>
</td>
<td class="nump">$ 34,155<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">$ 31,308<span></span>
</td>
<td class="nump">$ 21,632<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">$ 29,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Convertible promissory note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible Promissory Note &#8211; Related Party</a></td>
<td class="nump">10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,908,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,604,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SecuritiesPurchaseAgreementCurrent', window );">Securities Purchase Agreement</a></td>
<td class="nump">193,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">17,443,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Quoted Prices In Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Quoted Prices In Active Markets (Level 1) [Member] | Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Quoted Prices In Active Markets (Level 1) [Member] | Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Quoted Prices In Active Markets (Level 1) [Member] | Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Quoted Prices In Active Markets (Level 1) [Member] | Convertible promissory note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible Promissory Note &#8211; Related Party</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Quoted Prices In Active Markets (Level 1) [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SecuritiesPurchaseAgreementCurrent', window );">Securities Purchase Agreement</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Observable Inputs (Level 2) [Member] | Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">3,795,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Observable Inputs (Level 2) [Member] | Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Observable Inputs (Level 2) [Member] | Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Observable Inputs (Level 2) [Member] | Convertible promissory note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible Promissory Note &#8211; Related Party</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Observable Inputs (Level 2) [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SecuritiesPurchaseAgreementCurrent', window );">Securities Purchase Agreement</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">3,795,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,224,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Unobservable Inputs (Level 3) [Member] | Warrant liabilities &#8211; Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Unobservable Inputs (Level 3) [Member] | Warrant liabilities &#8211; Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">2,939,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Unobservable Inputs (Level 3) [Member] | Warrant liabilities &#8211; Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">227,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Unobservable Inputs (Level 3) [Member] | Convertible promissory note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible Promissory Note &#8211; Related Party</a></td>
<td class="nump">10,288,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,908,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">944,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,224,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Significant Other Unobservable Inputs (Level 3) [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_SecuritiesPurchaseAgreementCurrent', window );">Securities Purchase Agreement</a></td>
<td class="nump">193,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">13,648,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Cash and marketable securities held in trust [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="nump">1,935,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,330,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Cash and marketable securities held in trust [Member] | Quoted Prices In Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="nump">1,274,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,330,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,873,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Cash and marketable securities held in trust [Member] | Significant Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Cash and marketable securities held in trust [Member] | Significant Other Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Company&#8217;s Assets and Liabilities that are Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Cash and marketable securities held in trust</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_SecuritiesPurchaseAgreementCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of securities purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_SecuritiesPurchaseAgreementCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ck0001859807_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note (Details) - NorthView Acquisition Corp [Member]<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">4.22<span></span>
</td>
<td class="nump">4.18<span></span>
</td>
<td class="nump">5.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">4.28<span></span>
</td>
<td class="nump">4.18<span></span>
</td>
<td class="nump">5.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Convertible promissory note &#8211; Ascent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">3.83<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (years) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">0.61<span></span>
</td>
<td class="nump">0.89<span></span>
</td>
<td class="nump">0.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (years) [Member] | Convertible promissory note &#8211; Ascent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">1.59<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Convertible promissory note &#8211; Ascent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">4.84<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Exercise price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Exercise price [Member] | Convertible promissory note &#8211; Ascent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant liabilities measurement inputs</a></td>
<td class="nump">12.52<span></span>
</td>
<td class="nump">12.12<span></span>
</td>
<td class="nump">11.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">12.52<span></span>
</td>
<td class="nump">12.12<span></span>
</td>
<td class="nump">11.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of Common Stock [Member] | Convertible promissory note &#8211; Ascent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Input</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Convertible promissory note measurement inputs</a></td>
<td class="nump">12.52<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsQuantitativeInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsQuantitativeInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ck0001859807_ConvertiblePromissoryNoteAscentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ck0001859807_ConvertiblePromissoryNoteAscentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, beginning balance</a></td>
<td class="nump">$ 440,850<span></span>
</td>
<td class="nump">$ 293,900<span></span>
</td>
<td class="nump">$ 279,205<span></span>
</td>
<td class="nump">$ 66,128<span></span>
</td>
<td class="nump">$ 293,900<span></span>
</td>
<td class="nump">$ 66,128<span></span>
</td>
<td class="nump">$ 66,128<span></span>
</td>
<td class="nump">$ 377,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">2,498,150<span></span>
</td>
<td class="nump">146,950<span></span>
</td>
<td class="nump">124,908<span></span>
</td>
<td class="nump">213,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,772<span></span>
</td>
<td class="num">(311,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, ending balance</a></td>
<td class="nump">2,939,000<span></span>
</td>
<td class="nump">440,850<span></span>
</td>
<td class="nump">404,113<span></span>
</td>
<td class="nump">279,205<span></span>
</td>
<td class="nump">2,939,000<span></span>
</td>
<td class="nump">404,113<span></span>
</td>
<td class="nump">293,900<span></span>
</td>
<td class="nump">66,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Representative&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, beginning balance</a></td>
<td class="nump">34,155<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">21,632<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="nump">29,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">193,545<span></span>
</td>
<td class="nump">11,385<span></span>
</td>
<td class="nump">9,676<span></span>
</td>
<td class="nump">16,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,647<span></span>
</td>
<td class="num">(24,151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, ending balance</a></td>
<td class="nump">227,700<span></span>
</td>
<td class="nump">34,155<span></span>
</td>
<td class="nump">31,308<span></span>
</td>
<td class="nump">21,632<span></span>
</td>
<td class="nump">227,700<span></span>
</td>
<td class="nump">31,308<span></span>
</td>
<td class="nump">22,770<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember', window );">Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, beginning balance</a></td>
<td class="nump">475,005<span></span>
</td>
<td class="nump">316,670<span></span>
</td>
<td class="nump">300,837<span></span>
</td>
<td class="nump">71,251<span></span>
</td>
<td class="nump">316,670<span></span>
</td>
<td class="nump">71,251<span></span>
</td>
<td class="nump">71,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">2,691,695<span></span>
</td>
<td class="nump">158,335<span></span>
</td>
<td class="nump">134,584<span></span>
</td>
<td class="nump">229,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value, ending balance</a></td>
<td class="nump">$ 3,166,700<span></span>
</td>
<td class="nump">$ 475,005<span></span>
</td>
<td class="nump">$ 435,421<span></span>
</td>
<td class="nump">$ 300,837<span></span>
</td>
<td class="nump">$ 3,166,700<span></span>
</td>
<td class="nump">$ 435,421<span></span>
</td>
<td class="nump">$ 316,670<span></span>
</td>
<td class="nump">$ 71,251<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_RepresentativesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_WarrantsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ck0001859807_WarrantsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Convertible Promissory Note (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember', window );">Convertible Promissory Note &#8211; Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Fair value beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,133,382<span></span>
</td>
<td class="nump">$ 8,908,052<span></span>
</td>
<td class="nump">$ 1,262,226<span></span>
</td>
<td class="nump">$ 944,118<span></span>
</td>
<td class="nump">$ 8,908,052<span></span>
</td>
<td class="nump">$ 944,118<span></span>
</td>
<td class="nump">$ 944,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Fair value Ending balance</a></td>
<td class="nump">$ 9,133,382<span></span>
</td>
<td class="nump">10,288,111<span></span>
</td>
<td class="nump">9,133,382<span></span>
</td>
<td class="nump">1,527,001<span></span>
</td>
<td class="nump">1,262,226<span></span>
</td>
<td class="nump">10,288,111<span></span>
</td>
<td class="nump">$ 1,527,001<span></span>
</td>
<td class="nump">$ 8,908,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received through convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,796<span></span>
</td>
<td class="nump">378,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote', window );">Change in fair value of convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154,729<span></span>
</td>
<td class="nump">225,330<span></span>
</td>
<td class="num">$ (66,021)<span></span>
</td>
<td class="num">$ (60,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Fair value beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">23,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Fair value Ending balance</a></td>
<td class="nump">23,487<span></span>
</td>
<td class="nump">193,878<span></span>
</td>
<td class="nump">$ 23,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote', window );">Change in fair value of convertible promissory note</a></td>
<td class="nump">$ 23,487<span></span>
</td>
<td class="nump">$ 170,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in fair value of convertible promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001859807_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ck0001859807_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ck0001859807_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information  - Schedule of Company&#8217;s Performance and Making Key Decisions Regarding Resource Allocation (Details) - NorthView Acquisition Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Trust Account</a></td>
<td class="nump">$ 1,935,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,935,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,330,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 6,496<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 6,496<span></span>
</td>
<td class="nump">16,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted Cash</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">967,084<span></span>
</td>
<td class="nump">253,130<span></span>
</td>
<td class="nump">1,550,665<span></span>
</td>
<td class="nump">723,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeSecuritiesOtherUSGovernment', window );">Interest earned on the Trust Account</a></td>
<td class="nump">$ 15,159<span></span>
</td>
<td class="nump">$ 108,520<span></span>
</td>
<td class="nump">$ 95,084<span></span>
</td>
<td class="nump">$ 225,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedIncomeStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedIncomeStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeSecuritiesOtherUSGovernment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest income on securities issued by US government agencies not including US Treasury Securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeSecuritiesOtherUSGovernment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001859807_NorthViewAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001859807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Profusa, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Oct. 08, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">42,594,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 13,630,095.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 2,086.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act of 1933, as amended, based upon the average of the high and low prices for a share of the registrant&#8217;s common stock as reported on The NASDAQ Stock Market on October 3, 2025.<br/><br/>Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder for the selling shareholders include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 08, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 13,630,095.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">2,086.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 2,086.77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>920</ContextCount>
  <ElementCount>538</ElementCount>
  <EntityCount>2</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>167</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders??? Deficit (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders??? Deficit (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Organization, Description of Business, Going Concern and Significant Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties</Role>
      <ShortName>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConvertiblePreferredStock</Role>
      <ShortName>Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Stock Option Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/StockOptionPlan</Role>
      <ShortName>Stock Option Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Government Grant Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/GovernmentGrantRevenue</Role>
      <ShortName>Government Grant Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Private Placement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/PrivatePlacement</Role>
      <ShortName>Private Placement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.profusa.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/FairValueMeasurement</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/BalanceSheetComponents</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/Debt</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConvertiblePreferredStockTables</Role>
      <ShortName>Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/ConvertiblePreferredStock</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/CommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/CommonStock</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Stock Option Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/StockOptionPlanTables</Role>
      <ShortName>Stock Option Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/StockOptionPlan</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.profusa.com/role/Segments</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails</Role>
      <ShortName>Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Fair Value Measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/FairValueMeasurementDetails</Role>
      <ShortName>Fair Value Measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/FairValueMeasurementTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable</Role>
      <ShortName>Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Fair Value Measurement - Schedule of Fair Value of the Company???s Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable</Role>
      <ShortName>Fair Value Measurement - Schedule of Fair Value of the Company???s Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/DebtTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Debt - Schedule of Changes in Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable</Role>
      <ShortName>Debt - Schedule of Changes in Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable</Role>
      <ShortName>Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable</Role>
      <ShortName>Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/CommitmentsandContingencies</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ConvertiblePreferredStockDetails</Role>
      <ShortName>Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/ConvertiblePreferredStockTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable</Role>
      <ShortName>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/CommonStockDetails</Role>
      <ShortName>Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/CommonStockTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Common Stock - Schedule of Reserved Shares of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable</Role>
      <ShortName>Common Stock - Schedule of Reserved Shares of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Stock Option Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/StockOptionPlanDetails</Role>
      <ShortName>Stock Option Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/StockOptionPlanTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable</Role>
      <ShortName>Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Stock Option Plan - Schedule of Stock Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable</Role>
      <ShortName>Stock Option Plan - Schedule of Stock Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/RelatedPartyTransactions</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>996031 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>996032 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>996033 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/IncomeTaxesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>996034 - Disclosure - Income Taxes - Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable</Role>
      <ShortName>Income Taxes - Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable</Role>
      <ShortName>Income Taxes - Schedule of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>996036 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/SegmentsDetails</Role>
      <ShortName>Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/SegmentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996038 - Disclosure - Segments - Schedule of Other Financial Information Regarding The Company???s Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable</Role>
      <ShortName>Segments - Schedule of Other Financial Information Regarding The Company???s Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996039 - Disclosure - Segments - Schedule of Other Financial Information Regarding The Company???s Operating Segment (Parentheticals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals</Role>
      <ShortName>Segments - Schedule of Other Financial Information Regarding The Company???s Operating Segment (Parentheticals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996040 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/SubsequentEvents</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996041 - Disclosure - Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0</Role>
      <ShortName>Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996042 - Disclosure - Fair Value Measurement - Schedule of Fair Value of the Company???s Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0</Role>
      <ShortName>Fair Value Measurement - Schedule of Fair Value of the Company???s Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996043 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996044 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Debt - Schedule of Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofDebtInstrumentsTable</Role>
      <ShortName>Debt - Schedule of Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996046 - Disclosure - Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0</Role>
      <ShortName>Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996047 - Disclosure - Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0</Role>
      <ShortName>Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996048 - Disclosure - Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0</Role>
      <ShortName>Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996049 - Disclosure - Common Stock - Schedule of Reserved Shares of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0</Role>
      <ShortName>Common Stock - Schedule of Reserved Shares of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996050 - Disclosure - Stock Option Plan - Schedule of Activity Under the Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable</Role>
      <ShortName>Stock Option Plan - Schedule of Activity Under the Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996051 - Disclosure - Stock Option Plan - Schedule of Stock Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0</Role>
      <ShortName>Stock Option Plan - Schedule of Stock Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996052 - Disclosure - Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0</Role>
      <ShortName>Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996053 - Disclosure - Net Loss per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0</Role>
      <ShortName>Net Loss per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996054 - Disclosure - Segments - Schedule of Consolidated Condensed Financial Statements of Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable</Role>
      <ShortName>Segments - Schedule of Consolidated Condensed Financial Statements of Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>996056 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>996057 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>996058 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/InitialPublicOffering</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>996059 - Disclosure - Private Placement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/PrivatePlacementDetails</Role>
      <ShortName>Private Placement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.profusa.com/role/PrivatePlacement</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>996060 - Disclosure - Fair Value Measurements - Schedule of Company???s Assets and Liabilities that are Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable</Role>
      <ShortName>Fair Value Measurements - Schedule of Company???s Assets and Liabilities that are Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>996061 - Disclosure - Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable</Role>
      <ShortName>Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>996062 - Disclosure - Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable</Role>
      <ShortName>Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>996063 - Disclosure - Fair Value Measurements - Schedule of Convertible Promissory Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable</Role>
      <ShortName>Fair Value Measurements - Schedule of Convertible Promissory Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>996064 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable</Role>
      <ShortName>Income Taxes - Schedule of Net Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable</Role>
      <ShortName>Income Taxes - Schedule of Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>996066 - Disclosure - Income Taxes - Schedule of Reconciliation of the Federal Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of the Federal Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>996067 - Disclosure - Segment Information  - Schedule of Company???s Performance and Making Key Decisions Regarding Resource Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable</Role>
      <ShortName>Segment Information  - Schedule of Company???s Performance and Making Key Decisions Regarding Resource Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>996068 - Disclosure - Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0</Role>
      <ShortName>Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>996069 - Disclosure - Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable</Role>
      <ShortName>Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>996070 - Disclosure - Significant Accounting Policies - Schedule of Condensed Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable</Role>
      <ShortName>Significant Accounting Policies - Schedule of Condensed Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>996071 - Disclosure - Fair Value Measurements - Schedule of Company???s Assets and Liabilities that are Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0</Role>
      <ShortName>Fair Value Measurements - Schedule of Company???s Assets and Liabilities that are Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>996072 - Disclosure - Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable</Role>
      <ShortName>Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>996073 - Disclosure - Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0</Role>
      <ShortName>Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>996074 - Disclosure - Fair Value Measurements - Schedule of Convertible Promissory Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0</Role>
      <ShortName>Fair Value Measurements - Schedule of Convertible Promissory Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="ea0258580-s1_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Segment Information  - Schedule of Company???s Performance and Making Key Decisions Regarding Resource Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0</Role>
      <ShortName>Segment Information  - Schedule of Company???s Performance and Making Key Decisions Regarding Resource Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="ea025858001ex-fee_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="ea025858001ex-fee_profusa.htm">
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="ea025858001ex-fee_profusa.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ck0001859807-20250630.xsd</File>
    <File>ck0001859807-20250630_cal.xml</File>
    <File>ck0001859807-20250630_def.xml</File>
    <File>ck0001859807-20250630_lab.xml</File>
    <File>ck0001859807-20250630_pre.xml</File>
    <File doctype="S-1" isDefinitelyFs="true" isUsgaap="true" original="ea0258580-s1_profusa.htm">ea0258580-s1_profusa.htm</File>
    <File doctype="EX-FILING FEES" original="ea025858001ex-fee_profusa.htm">ea025858001ex-fee_profusa.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image-007.jpg</File>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_008.jpg</File>
    <File>image_009.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="6">http://fasb.org/srt/2025</BaseTaxonomy>
    <BaseTaxonomy items="2696">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>134
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0258580-s1_profusa.htm": {
   "nsprefix": "ck0001859807",
   "nsuri": "http://www.profusa.com/20250630",
   "dts": {
    "schema": {
     "local": [
      "ck0001859807-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ck0001859807-20250630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ck0001859807-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ck0001859807-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ck0001859807-20250630_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0258580-s1_profusa.htm"
     ]
    }
   },
   "keyStandard": 386,
   "keyCustom": 130,
   "axisStandard": 32,
   "axisCustom": 1,
   "memberStandard": 42,
   "memberCustom": 102,
   "hidden": {
    "total": 439,
    "http://fasb.org/us-gaap/2025": 388,
    "http://www.profusa.com/20250630": 49,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 918,
   "entityCount": 1,
   "segmentCount": 166,
   "elementCount": 913,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 2696,
    "http://xbrl.sec.gov/dei/2025": 8,
    "http://fasb.org/srt/2025": 6
   },
   "report": {
    "R1": {
     "role": "http://www.profusa.com/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.profusa.com/role/ConsolidatedBalanceSheet",
     "longName": "001 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "us-gaap:OtherReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c12",
      "name": "us-gaap:ConvertibleNotesPayable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.profusa.com/role/ConsolidatedIncomeStatement",
     "longName": "003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c25",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals",
     "longName": "004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals)",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:InterestExpenseOther",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://www.profusa.com/role/ShareholdersEquityType2or3",
     "longName": "005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders\u2019 Deficit (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders\u2019 Deficit (Unaudited)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c39",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c39",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.profusa.com/role/ConsolidatedCashFlow",
     "longName": "006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c26",
      "name": "us-gaap:IncreaseDecreaseInOtherReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties",
     "longName": "007 - Disclosure - Organization, Description of Business, Going Concern and Significant Risks and Uncertainties",
     "shortName": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.profusa.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "008 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.profusa.com/role/FairValueMeasurement",
     "longName": "009 - Disclosure - Fair Value Measurement",
     "shortName": "Fair Value Measurement",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.profusa.com/role/BalanceSheetComponents",
     "longName": "010 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "srt:CondensedFinancialStatementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "srt:CondensedFinancialStatementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.profusa.com/role/Debt",
     "longName": "011 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.profusa.com/role/CommitmentsandContingencies",
     "longName": "012 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.profusa.com/role/ConvertiblePreferredStock",
     "longName": "013 - Disclosure - Convertible Preferred Stock",
     "shortName": "Convertible Preferred Stock",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.profusa.com/role/CommonStock",
     "longName": "014 - Disclosure - Common Stock",
     "shortName": "Common Stock",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.profusa.com/role/StockOptionPlan",
     "longName": "015 - Disclosure - Stock Option Plan",
     "shortName": "Stock Option Plan",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.profusa.com/role/RelatedPartyTransactions",
     "longName": "016 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders",
     "longName": "017 - Disclosure - Net Loss Per Share Attributable to Common Stockholders",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.profusa.com/role/GovernmentGrantRevenue",
     "longName": "018 - Disclosure - Government Grant Revenue",
     "shortName": "Government Grant Revenue",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:GovernmentAssistanceTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:GovernmentAssistanceTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.profusa.com/role/IncomeTaxes",
     "longName": "019 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.profusa.com/role/Segments",
     "longName": "020 - Disclosure - Segments",
     "shortName": "Segments",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.profusa.com/role/SubsequentEvents",
     "longName": "021 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.profusa.com/role/InitialPublicOffering",
     "longName": "022 - Disclosure - Initial Public Offering",
     "shortName": "Initial Public Offering",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c173",
      "name": "ck0001859807:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c173",
      "name": "ck0001859807:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.profusa.com/role/PrivatePlacement",
     "longName": "023 - Disclosure - Private Placement",
     "shortName": "Private Placement",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c173",
      "name": "ck0001859807:PrivatePlacementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c173",
      "name": "ck0001859807:PrivatePlacementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.profusa.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.profusa.com/role/SignificantAccountingPoliciesTables",
     "longName": "996001 - Disclosure - Significant Accounting Policies (Tables)",
     "shortName": "Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c173",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c173",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.profusa.com/role/FairValueMeasurementTables",
     "longName": "996002 - Disclosure - Fair Value Measurement (Tables)",
     "shortName": "Fair Value Measurement (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.profusa.com/role/BalanceSheetComponentsTables",
     "longName": "996003 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.profusa.com/role/DebtTables",
     "longName": "996004 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.profusa.com/role/ConvertiblePreferredStockTables",
     "longName": "996005 - Disclosure - Convertible Preferred Stock (Tables)",
     "shortName": "Convertible Preferred Stock (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.profusa.com/role/CommonStockTables",
     "longName": "996006 - Disclosure - Common Stock (Tables)",
     "shortName": "Common Stock (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.profusa.com/role/StockOptionPlanTables",
     "longName": "996007 - Disclosure - Stock Option Plan (Tables)",
     "shortName": "Stock Option Plan (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables",
     "longName": "996008 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.profusa.com/role/IncomeTaxesTables",
     "longName": "996009 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.profusa.com/role/SegmentsTables",
     "longName": "996010 - Disclosure - Segments (Tables)",
     "shortName": "Segments (Tables)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
     "longName": "996011 - Disclosure - Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details)",
     "shortName": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c365",
      "name": "ck0001859807:RevenueTarget",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c365",
      "name": "ck0001859807:RevenueTarget",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "996012 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:CapitalizedContractCostNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:CapitalizedContractCostNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.profusa.com/role/FairValueMeasurementDetails",
     "longName": "996013 - Disclosure - Fair Value Measurement (Details)",
     "shortName": "Fair Value Measurement (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c378",
      "name": "ck0001859807:ConvertibleDebtOfDiscountRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:ShorttermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "1",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
     "longName": "996014 - Disclosure - Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c192",
      "name": "us-gaap:NotesPayableFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c192",
      "name": "us-gaap:NotesPayableFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable",
     "longName": "996015 - Disclosure - Fair Value Measurement - Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments (Details)",
     "shortName": "Fair Value Measurement - Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c201",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R41": {
     "role": "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable",
     "longName": "996016 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "us-gaap:AdvanceRoyalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "us-gaap:AdvanceRoyalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable",
     "longName": "996017 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c107",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.profusa.com/role/DebtDetails",
     "longName": "996018 - Disclosure - Debt (Details)",
     "shortName": "Debt (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "1",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "1",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
     "longName": "996019 - Disclosure - Debt - Schedule of Changes in Debt Instruments (Details)",
     "shortName": "Debt - Schedule of Changes in Debt Instruments (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c316",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R45": {
     "role": "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
     "longName": "996020 - Disclosure - Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)",
     "shortName": "Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c465",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c274",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable",
     "longName": "996021 - Disclosure - Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)",
     "shortName": "Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
     "longName": "996022 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c322",
      "name": "us-gaap:LeaseAndRentalExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c322",
      "name": "us-gaap:LeaseAndRentalExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.profusa.com/role/ConvertiblePreferredStockDetails",
     "longName": "996023 - Disclosure - Convertible Preferred Stock (Details)",
     "shortName": "Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PreferredStockDividendRatePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PreferredStockDividendRatePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
     "longName": "996024 - Disclosure - Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)",
     "shortName": "Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c471",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R50": {
     "role": "http://www.profusa.com/role/CommonStockDetails",
     "longName": "996025 - Disclosure - Common Stock (Details)",
     "shortName": "Common Stock (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c107",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c107",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
     "longName": "996026 - Disclosure - Common Stock - Schedule of Reserved Shares of Common Stock (Details)",
     "shortName": "Common Stock - Schedule of Reserved Shares of Common Stock (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c341",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c341",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.profusa.com/role/StockOptionPlanDetails",
     "longName": "996027 - Disclosure - Stock Option Plan (Details)",
     "shortName": "Stock Option Plan (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable",
     "longName": "996028 - Disclosure - Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details)",
     "shortName": "Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R54": {
     "role": "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
     "longName": "996029 - Disclosure - Stock Option Plan - Schedule of Stock Compensation Expense (Details)",
     "shortName": "Stock Option Plan - Schedule of Stock Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R55": {
     "role": "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
     "longName": "996030 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c173",
      "name": "ck0001859807:CommonStockExceedsPerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
     "longName": "996031 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R57": {
     "role": "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
     "longName": "996032 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://www.profusa.com/role/IncomeTaxesDetails",
     "longName": "996033 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable",
     "longName": "996034 - Disclosure - Income Taxes - Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate (Details)",
     "shortName": "Income Taxes - Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable",
     "longName": "996035 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Schedule of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable",
     "longName": "996036 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.profusa.com/role/SegmentsDetails",
     "longName": "996037 - Disclosure - Segments (Details)",
     "shortName": "Segments (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable",
     "longName": "996038 - Disclosure - Segments - Schedule of Other Financial Information Regarding The Company\u2019s Operating Segment (Details)",
     "shortName": "Segments - Schedule of Other Financial Information Regarding The Company\u2019s Operating Segment (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c25",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals",
     "longName": "996039 - Disclosure - Segments - Schedule of Other Financial Information Regarding The Company\u2019s Operating Segment (Parentheticals) (Details)",
     "shortName": "Segments - Schedule of Other Financial Information Regarding The Company\u2019s Operating Segment (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:InterestExpenseOther",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R65": {
     "role": "http://www.profusa.com/role/SubsequentEventsDetails",
     "longName": "996040 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0",
     "longName": "996041 - Disclosure - Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c384",
      "name": "us-gaap:NotesPayableFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c384",
      "name": "us-gaap:NotesPayableFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0",
     "longName": "996042 - Disclosure - Fair Value Measurement - Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments (Details)",
     "shortName": "Fair Value Measurement - Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c394",
      "name": "ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c396",
      "name": "ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0",
     "longName": "996043 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "ck0001859807:PrepaidLegal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R69": {
     "role": "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0",
     "longName": "996044 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c107",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c107",
      "name": "us-gaap:AccruedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "srt:CondensedFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable",
     "longName": "996045 - Disclosure - Debt - Schedule of Debt Instruments (Details)",
     "shortName": "Debt - Schedule of Debt Instruments (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c316",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R71": {
     "role": "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0",
     "longName": "996046 - Disclosure - Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)",
     "shortName": "Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c463",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0",
     "longName": "996047 - Disclosure - Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)",
     "shortName": "Debt - Schedule of Contractual Future Minimum Payments for the PPP Loan (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0",
     "longName": "996048 - Disclosure - Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)",
     "shortName": "Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c471",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R74": {
     "role": "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0",
     "longName": "996049 - Disclosure - Common Stock - Schedule of Reserved Shares of Common Stock (Details)",
     "shortName": "Common Stock - Schedule of Reserved Shares of Common Stock (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c11",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
     "longName": "996050 - Disclosure - Stock Option Plan - Schedule of Activity Under the Plan (Details)",
     "shortName": "Stock Option Plan - Schedule of Activity Under the Plan (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R76": {
     "role": "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0",
     "longName": "996051 - Disclosure - Stock Option Plan - Schedule of Stock Compensation Expense (Details)",
     "shortName": "Stock Option Plan - Schedule of Stock Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R77": {
     "role": "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
     "longName": "996052 - Disclosure - Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "shortName": "Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R78": {
     "role": "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
     "longName": "996053 - Disclosure - Net Loss per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "shortName": "Net Loss per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R79": {
     "role": "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
     "longName": "996054 - Disclosure - Segments - Schedule of Consolidated Condensed Financial Statements of Operating Segment (Details)",
     "shortName": "Segments - Schedule of Consolidated Condensed Financial Statements of Operating Segment (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c502",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c502",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable",
     "longName": "996055 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c595",
      "name": "us-gaap:MarketableSecuritiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c595",
      "name": "us-gaap:MarketableSecuritiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
     "longName": "996056 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c771",
      "name": "us-gaap:TemporaryEquityNetIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R82": {
     "role": "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable",
     "longName": "996057 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Balance Sheet (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Consolidated Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c139",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R83": {
     "role": "http://www.profusa.com/role/InitialPublicOfferingDetails",
     "longName": "996058 - Disclosure - Initial Public Offering (Details)",
     "shortName": "Initial Public Offering (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c605",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ck0001859807:InitialPublicOfferingTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c605",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ck0001859807:InitialPublicOfferingTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.profusa.com/role/PrivatePlacementDetails",
     "longName": "996059 - Disclosure - Private Placement (Details)",
     "shortName": "Private Placement (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c768",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c768",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ck0001859807:PrivatePlacementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
     "longName": "996060 - Disclosure - Fair Value Measurements - Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value (Details)",
     "shortName": "Fair Value Measurements - Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
     "longName": "996061 - Disclosure - Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note (Details)",
     "shortName": "Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c859",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R87": {
     "role": "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
     "longName": "996062 - Disclosure - Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c878",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c708",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
     "longName": "996063 - Disclosure - Fair Value Measurements - Schedule of Convertible Promissory Note (Details)",
     "shortName": "Fair Value Measurements - Schedule of Convertible Promissory Note (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c712",
      "name": "us-gaap:ConvertibleNotesPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c714",
      "name": "us-gaap:ConvertibleNotesPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable",
     "longName": "996064 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Assets (Details)",
     "shortName": "Income Taxes - Schedule of Net Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c139",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c139",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
     "longName": "996065 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Details)",
     "shortName": "Income Taxes - Schedule of Income Tax Provision (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable",
     "longName": "996066 - Disclosure - Income Taxes - Schedule of Reconciliation of the Federal Income Tax Rate (Details)",
     "shortName": "Income Taxes - Schedule of Reconciliation of the Federal Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable",
     "longName": "996067 - Disclosure - Segment Information  - Schedule of Company\u2019s Performance and Making Key Decisions Regarding Resource Allocation (Details)",
     "shortName": "Segment Information  - Schedule of Company\u2019s Performance and Making Key Decisions Regarding Resource Allocation (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c717",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c717",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0",
     "longName": "996068 - Disclosure - Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)",
     "shortName": "Significant Accounting Policies - Schedule of Fair Value of Investments Held in Trust Account (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c770",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c770",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable",
     "longName": "996069 - Disclosure - Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c771",
      "name": "us-gaap:TemporaryEquityNetIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R95": {
     "role": "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
     "longName": "996070 - Disclosure - Significant Accounting Policies - Schedule of Condensed Consolidated Balance Sheet (Details)",
     "shortName": "Significant Accounting Policies - Schedule of Condensed Consolidated Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c147",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c155",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
     "longName": "996071 - Disclosure - Fair Value Measurements - Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value (Details)",
     "shortName": "Fair Value Measurements - Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c777",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c853",
      "name": "ck0001859807:SecuritiesPurchaseAgreementCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
     "longName": "996072 - Disclosure - Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note (Details)",
     "shortName": "Fair Value Measurements - Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c859",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c864",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0",
     "longName": "996073 - Disclosure - Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c878",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c883",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0",
     "longName": "996074 - Disclosure - Fair Value Measurements - Schedule of Convertible Promissory Note (Details)",
     "shortName": "Fair Value Measurements - Schedule of Convertible Promissory Note (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c900",
      "name": "us-gaap:ConvertibleNotesPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c906",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0",
     "longName": "996075 - Disclosure - Segment Information  - Schedule of Company\u2019s Performance and Making Key Decisions Regarding Resource Allocation (Details)",
     "shortName": "Segment Information  - Schedule of Company\u2019s Performance and Making Key Decisions Regarding Resource Allocation (Details)",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c155",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c151",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0258580-s1_profusa.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AccountingPoliciesbyPolicyPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AccountingPoliciesbyPolicyPoliciesLineItems",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies, by Policy (Policies) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AccountingPoliciesbyPolicyPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AccountingPoliciesbyPolicyPoliciesTable",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies, by Policy (Policies) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r1097"
     ]
    },
    "ck0001859807_AccretionOfCommonStockToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AccretionOfCommonStockToRedemptionValue",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion of common stock to redemption value",
        "negatedLabel": "Accretion of common stock to redemption value",
        "documentation": "Accretion of common stock to redemption value.",
        "label": "Accretion Of Common Stock To Redemption Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable",
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accrued compensation",
        "label": "Accrued Employee Benefits, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r91"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Accrued liabilities",
        "label": "Accrued Liabilities and Other Liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Accrued liabilities",
        "terseLabel": "Accrued liabilities",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in-capital",
        "verboseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r1097",
      "r1380"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r1190",
      "r1191",
      "r1192",
      "r1195",
      "r1304",
      "r1385"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "verboseLabel": "Adjustments to reconcile net (loss) income to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administrative personnel compensation costs, including stock-based compensation",
        "documentation": "The amount of administrative personnel compensation costs, including stock-based compensation.",
        "label": "Administrative Personnel Compensation Costs Including Stockbased Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AdministrativeSupportAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AdministrativeSupportAgreementMember",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administrative Support Agreement [Member]",
        "label": "Administrative Support Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AdvanceFromProfusa": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AdvanceFromProfusa",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance from Profusa",
        "documentation": "Advance from Profusa amount.",
        "label": "Advance From Profusa"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvanceRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvanceRoyalties",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee advances",
        "label": "Advance Royalties",
        "documentation": "The amount paid to music publishers, record producers, songwriters, or other artists in advance of their earning royalties from record or music sales. Such an amount is based on contractual terms and is generally nonrefundable."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "ck0001859807_AdvisoryFeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AdvisoryFeeMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advisory Fee [Member]",
        "label": "Advisory Fee Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AggregateNumberOfSharesOwned": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AggregateNumberOfSharesOwned",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate number of shares owned (in Shares)",
        "documentation": "The number of shares owned by the founders after the impact of the stock dividend.",
        "label": "Aggregate Number Of Shares Owned"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation expense",
        "verboseLabel": "Stock Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r504",
      "r514"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt discount and issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r397",
      "r1176",
      "r1321"
     ]
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt discount and issuance costs",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r1053",
      "r1054",
      "r1176",
      "r1321"
     ]
    },
    "ck0001859807_AmountDrawn": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AmountDrawn",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount drawn",
        "documentation": "Amount drawn.",
        "label": "Amount Drawn"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Antidilutive Securities",
        "verboseLabel": "Shares of common stock (in Shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "ck0001859807_AprilJune2025SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AprilJune2025SeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April \u2014 June 2025 Senior Notes [Member]",
        "label": "April June2025 Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AprilJuneTwoThousandTwentyFourSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AprilJuneTwoThousandTwentyFourSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April-June 2024 Senior Notes [Member]",
        "label": "April June Two Thousand Twenty Four Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AprilTwoThousandTwentyOneConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AprilTwoThousandTwentyOneConvertibleNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April 2021 Convertible Notes [Member]",
        "label": "April Two Thousand Twenty One Convertible Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AprilTwoThousandTwentyThreeSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AprilTwoThousandTwentyThreeSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April 2023 Senior Notes",
        "label": "April Two Thousand Twenty Three Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ArrangementFeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ArrangementFeeMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Fee [Member]",
        "label": "Arrangement Fee Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ck0001859807_AscentNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AscentNoteMember",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ascent Note [Member]",
        "label": "Ascent Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetHeldInTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetHeldInTrustMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trust Account [Member]",
        "label": "Asset, Held-in-Trust [Member]",
        "documentation": "Asset held in trust."
       }
      }
     },
     "auth_ref": [
      "r1338"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r102",
      "r164",
      "r188",
      "r192",
      "r193",
      "r233",
      "r247",
      "r266",
      "r270",
      "r309",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r618",
      "r623",
      "r686",
      "r799",
      "r800",
      "r807",
      "r920",
      "r1037",
      "r1038",
      "r1055",
      "r1097",
      "r1110",
      "r1111",
      "r1122",
      "r1228",
      "r1229",
      "r1329"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r171",
      "r188",
      "r192",
      "r193",
      "r309",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r618",
      "r623",
      "r686",
      "r1097",
      "r1228",
      "r1229",
      "r1329"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "verboseLabel": "Current Assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsHeldInTrust": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsHeldInTrust",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trust account",
        "verboseLabel": "Asset in held in trust",
        "label": "Asset, Held-in-Trust",
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1182"
     ]
    },
    "us-gaap_AssetsHeldInTrustCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsHeldInTrustCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and marketable securities held in Trust Account",
        "verboseLabel": "Trust account",
        "netLabel": "Trust account current asset",
        "label": "Asset, Held-in-Trust, Current",
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1182"
     ]
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsHeldInTrustNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and marketable securities held in Trust Account",
        "verboseLabel": "Trust Account",
        "netLabel": "Fair values of investments held in the Trust Account",
        "label": "Trust account noncurrent asset",
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1182"
     ]
    },
    "ck0001859807_AugustTwoThousandTwentyConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AugustTwoThousandTwentyConvertibleNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "August 2020 Convertible Notes [Member]",
        "label": "August Two Thousand Twenty Convertible Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_AugustTwoThousandTwentyOneSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "AugustTwoThousandTwentyOneSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "August 2021 Senior Notes [Member]",
        "label": "August Two Thousand Twenty One Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_BalanceSheetComponentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "BalanceSheetComponentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Components [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Condensed Consolidated Balance Sheet [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_BankersAndDawsonJamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "BankersAndDawsonJamesMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bankers and Dawson James [Member]",
        "verboseLabel": "I-Bankers and Dawson James [Member]",
        "label": "Bankers And Dawson James Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1179"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Domain]",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r855",
      "r1064",
      "r1065",
      "r1290",
      "r1293",
      "r1294"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r855",
      "r1064",
      "r1065",
      "r1290",
      "r1293",
      "r1294"
     ]
    },
    "ck0001859807_BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership interest to be acquired on post-transaction company",
        "documentation": "Percentage of voting equity interests to be acquired on post transaction in the business combination.",
        "label": "Business Acquisition Percentage Of Voting Interests To Be Acquired On Post Transaction Entity Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination",
        "label": "Business Combination, Acquisition-Related Cost, Expense",
        "documentation": "Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department."
       }
      }
     },
     "auth_ref": [
      "r1288",
      "r1292"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing of business combination",
        "label": "Business Combination, Consideration Transferred, Equity Interest",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074",
      "r1077",
      "r1078"
     ]
    },
    "ck0001859807_BusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "BusinessCombinationMember",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Member]",
        "label": "Business Combination Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_BusinessCombinationPercentageRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "BusinessCombinationPercentageRate",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination percentage rate",
        "documentation": "Business combination percentage.",
        "label": "Business Combination Percentage Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_BusinessCombinationProfusaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "BusinessCombinationProfusaMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination Profusa [Member]",
        "label": "Business Combination Profusa Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_BusinessDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "BusinessDays",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business days",
        "documentation": "Business days.",
        "label": "Business Days"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "CA",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "California [Member]",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedContractCostNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalizedContractCostNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering costs capitalized",
        "label": "Capitalized Contract Cost, Net, Current",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r811",
      "r883",
      "r914",
      "r1097",
      "r1110",
      "r1111",
      "r1122",
      "r1162"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash, end of the period",
        "terseLabel": "Cash",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r162",
      "r1012"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ck0001859807_CashAndMarketableSecuritiesHeldInTrustAccountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CashAndMarketableSecuritiesHeldInTrustAccountMember",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Marketable Securities Held in Trust Account [Member]",
        "label": "Cash And Marketable Securities Held In Trust Account Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CashAndMarketableSecuritiesHeldInTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CashAndMarketableSecuritiesHeldInTrustMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and marketable securities held in trust [Member]",
        "label": "Cash And Marketable Securities Held In Trust Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash at the beginning of the period",
        "periodEndLabel": "Cash at the end of the period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r69",
      "r185"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) in cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r69"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal depository insurance coverage",
        "label": "Cash, FDIC Insured Amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CashFeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CashFeeMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Fee [Member]",
        "label": "Cash Fee Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of non-cash investing and financing information:",
        "verboseLabel": "Supplemental disclosure of cash flow information:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash [Member]",
        "label": "Cash [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ck0001859807_CashPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CashPercentage",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash percentage",
        "documentation": "Cash percentage.",
        "label": "Cash Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CashWithdrawnFromTrustAccountInConnectionWithRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CashWithdrawnFromTrustAccountInConnectionWithRedemption",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash withdrawn from Trust Account in connection with redemption",
        "documentation": "Cash withdrawn from Trust Account in connection with redemption.",
        "label": "Cash Withdrawn From Trust Account In Connection With Redemption"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ChangeInFairValueOfConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ChangeInFairValueOfConvertibleNote",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of convertible promissory note",
        "documentation": "Amount of change in fair value of convertible note.",
        "label": "Change In Fair Value Of Convertible Note"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ChangeInFairValueOfConvertiblePromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ChangeInFairValueOfConvertiblePromissoryNote",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in fair value of convertible promissory note",
        "verboseLabel": "Change in fair value of convertible promissory note",
        "documentation": "The amount of change in fair value of convertible promissory note.",
        "label": "Change In Fair Value Of Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ChangeInFairValueOfSecuritiesPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ChangeInFairValueOfSecuritiesPurchaseAgreement",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of securities purchase agreement",
        "terseLabel": "Change in fair value of securities purchase agreement",
        "documentation": "Represents the amount of change in fair value of securities purchase agreement.",
        "label": "Change In Fair Value Of Securities Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ChangesInFairValueOfSecuritiesPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ChangesInFairValueOfSecuritiesPurchaseAgreement",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in fair value of securities purchase agreement",
        "documentation": "Represents the amount of changes in fair value of securities purchase agreement.",
        "label": "Changes In Fair Value Of Securities Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ChiefOperatingOfficerDecisionMakerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ChiefOperatingOfficerDecisionMakerMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Operating Officer Decision Maker [Member]",
        "label": "Chief Operating Officer Decision Maker Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r166",
      "r167",
      "r168",
      "r188",
      "r193",
      "r222",
      "r223",
      "r225",
      "r227",
      "r235",
      "r236",
      "r309",
      "r364",
      "r367",
      "r368",
      "r369",
      "r373",
      "r374",
      "r408",
      "r409",
      "r411",
      "r412",
      "r414",
      "r418",
      "r422",
      "r423",
      "r427",
      "r430",
      "r437",
      "r686",
      "r861",
      "r862",
      "r863",
      "r864",
      "r871",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r884",
      "r906",
      "r928",
      "r949",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r1137",
      "r1183",
      "r1185",
      "r1196"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Convertible Preferred Stock [Line Items]",
        "terseLabel": "Convertible Preferred Stock [Line Items]",
        "verboseLabel": "Initial Public Offering [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r235",
      "r411",
      "r422",
      "r423",
      "r425",
      "r427",
      "r430",
      "r435",
      "r437",
      "r636",
      "r861",
      "r862",
      "r863",
      "r864",
      "r1056",
      "r1137",
      "r1180",
      "r1183"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r1244"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant exercise price (in Dollars per share)",
        "verboseLabel": "Exercise price per share (in Dollars per share)",
        "netLabel": "Warrant price per share (in Dollars per share)",
        "label": "Warrant exercise price",
        "totalLabel": "Price per warrant (in Dollars per share)",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r195",
      "r438"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.profusa.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of securities called by each warrant (in Shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued warrants (in Shares)",
        "verboseLabel": "Warrant issued (in Shares)",
        "netLabel": "Warrants issued",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued (in Shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption trigger price",
        "documentation": "Trigger share price of warrants or rights for redemption.",
        "label": "Class Of Warrant Or Right Trigger Share Price Of Warrants Or Rights For Redemption"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 6)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r94",
      "r810",
      "r905"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r353",
      "r354",
      "r995",
      "r1219",
      "r1224"
     ]
    },
    "ck0001859807_CommitmentsandContingenciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommitmentsandContingenciesDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CommitmentsandContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommitmentsandContingenciesLineItems",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CommitmentsandContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommitmentsandContingenciesTable",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reserved shares of common stock",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ck0001859807_CommonStockConvertibleConversionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockConvertibleConversionPrice",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price of common stock (in Dollars per share)",
        "documentation": "Per share conversion price of common stock.",
        "label": "Common Stock Convertible Conversion Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockConvertibleConversionPriceIncrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockConvertibleConversionPriceIncrease",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price per share of common stock (in Dollars per share)",
        "label": "Common Stock, Convertible, Conversion Price, Increase",
        "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ck0001859807_CommonStockDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CommonStockDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockDividendsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockDividendsShares",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, dividend shares",
        "label": "Common Stock Dividends, Shares",
        "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ck0001859807_CommonStockExceedsPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockExceedsPerShare",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock exceeds per share (in Dollars per share)",
        "documentation": "Common stock exceeds per share.",
        "label": "Common Stock Exceeds Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CommonStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockLineItems",
     "presentation": [
      "http://www.profusa.com/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "verboseLabel": "Common stock [Member]",
        "netLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1112",
      "r1113",
      "r1114",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1190",
      "r1191",
      "r1195",
      "r1304",
      "r1378",
      "r1385"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in Dollars per share)",
        "verboseLabel": "Common stock per share (in Dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, authorized shares",
        "verboseLabel": "Common stock, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r906"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued",
        "verboseLabel": "Aggregate shares issued (in Shares)",
        "netLabel": "Common stock shares issued (in Shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding",
        "verboseLabel": "Common stock remaining outstanding (in Shares)",
        "netLabel": "Common stock shares outstanding (in Shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r52",
      "r906",
      "r926",
      "r1385",
      "r1386"
     ]
    },
    "ck0001859807_CommonStockSubjectToPossibleRedemptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockSubjectToPossibleRedemptionMember",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock subject to possible redemption",
        "verboseLabel": "Common stock subject to possible redemption [Member]",
        "label": "Common Stock Subject To Possible Redemption Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CommonStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockTable",
     "presentation": [
      "http://www.profusa.com/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CommonStockThresholdConsecutiveTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockThresholdConsecutiveTradingDays",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consecutive trading day threshold",
        "documentation": "Common stock threshold consecutive trading days.",
        "label": "Common Stock Threshold Consecutive Trading Days"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_CommonStockThresholdTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "CommonStockThresholdTradingDays",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock threshold trading days",
        "documentation": "Common stock, threshold trading days.",
        "label": "Common Stock Threshold Trading Days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, value",
        "verboseLabel": "Aggregate share value",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r409",
      "r417",
      "r813",
      "r1097"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of votes",
        "label": "Common Stock, Voting Rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Net Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset/(liability)",
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r683",
      "r684"
     ]
    },
    "srt_CondensedFinancialStatementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedFinancialStatementsTextBlock",
     "presentation": [
      "http://www.profusa.com/role/BalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Condensed Financial Statements [Text Block]",
        "documentation": "The entire disclosure for condensed financial statements."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r189",
      "r199",
      "r803"
     ]
    },
    "srt_CondensedIncomeStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedIncomeStatementTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Income Statement [Table]",
        "documentation": "Disclosure of information about condensed income statement including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r189",
      "r199",
      "r803",
      "r1139"
     ]
    },
    "srt_CondensedIncomeStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedIncomeStatementsCaptionsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Income Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r189",
      "r199",
      "r803",
      "r1139"
     ]
    },
    "ck0001859807_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net tangible assets",
        "documentation": "Amount of net tangible assets.",
        "label": "Condition For Future Business Combination Threshold Net Tangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy",
      "http://www.profusa.com/role/CommitmentsandContingencies",
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStock",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/FairValueMeasurement",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/FairValueMeasurementTables",
      "http://www.profusa.com/role/IncomeTaxes",
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/IncomeTaxesTables",
      "http://www.profusa.com/role/InitialPublicOffering",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacement",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactions",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0",
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0",
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable",
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable",
      "http://www.profusa.com/role/Segments",
      "http://www.profusa.com/role/SegmentsDetails",
      "http://www.profusa.com/role/SegmentsTables",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SignificantAccountingPoliciesTables",
      "http://www.profusa.com/role/SubsequentEvents",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPolicies",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r126",
      "r189",
      "r199",
      "r618",
      "r619",
      "r622",
      "r623",
      "r624",
      "r725",
      "r803",
      "r1000",
      "r1157",
      "r1160",
      "r1161",
      "r1227",
      "r1230",
      "r1231"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy",
      "http://www.profusa.com/role/CommitmentsandContingencies",
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStock",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/FairValueMeasurement",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/FairValueMeasurementTables",
      "http://www.profusa.com/role/IncomeTaxes",
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/IncomeTaxesTables",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactions",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/Segments",
      "http://www.profusa.com/role/SegmentsDetails",
      "http://www.profusa.com/role/SegmentsTables",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SubsequentEvents",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPolicies",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r126",
      "r189",
      "r199",
      "r618",
      "r619",
      "r622",
      "r623",
      "r624",
      "r725",
      "r803",
      "r1000",
      "r1157",
      "r1160",
      "r1161",
      "r1227",
      "r1230",
      "r1231"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r112",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r188",
      "r189",
      "r197",
      "r199",
      "r233",
      "r249",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r803",
      "r1037",
      "r1038",
      "r1158",
      "r1159",
      "r1228",
      "r1229"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r1024"
     ]
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration, Type [Axis]",
        "documentation": "Information by type of contingent consideration arrangement in business combination."
       }
      }
     },
     "auth_ref": [
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300"
     ]
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration, Type [Domain]",
        "documentation": "Type of contingent consideration arrangement in business combination."
       }
      }
     },
     "auth_ref": [
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnout revenue",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r442",
      "r443",
      "r452"
     ]
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Contractual Future Minimum Payments for the PPP Loan",
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r1156",
      "r1181",
      "r1189",
      "r1341"
     ]
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted equity valuation amount",
        "label": "Conversion of Stock, Amount Converted",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_ConversionOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reserved Shares of Common Stock [Line Items]",
        "terseLabel": "Schedule of Convertible Promissory Note [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock [Table]",
        "documentation": "Disclosure of information about stock converted into another financial instrument in noncash or part noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total future principal payments",
        "verboseLabel": "Total future payments",
        "netLabel": "Convertible debt of issuance amount",
        "label": "Convertible Debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r1344"
     ]
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible debt payable",
        "verboseLabel": "Convertible loans",
        "label": "Convertible Debt, Current",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible debt fair value",
        "label": "Convertible Debt, Fair Value Disclosures",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1315",
      "r1316",
      "r1317",
      "r1318"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tasly Convertible Debt [Member]",
        "verboseLabel": "Convertible Debt [Member]",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r376",
      "r377",
      "r387",
      "r388",
      "r389",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054"
     ]
    },
    "ck0001859807_ConvertibleDebtOfDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertibleDebtOfDiscountRate",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of discount rate",
        "verboseLabel": "Conversion price discount rate",
        "documentation": "Percentage of convertible debt of discount rate.",
        "label": "Convertible Debt Of Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertibleDebtOfTermFairValue": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertibleDebtOfTermFairValue",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of time event",
        "documentation": "Convertible debt of term fair value.",
        "label": "Convertible Debt Of Term Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertibleLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertibleLoansMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Loans [Member]",
        "verboseLabel": "Convertible loans [Member]",
        "label": "Convertible Loans Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes [Member]",
        "verboseLabel": "Tasly Convertible Debt [Member]",
        "label": "Convertible Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertibleNotesNovember2022AmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertibleNotesNovember2022AmendmentMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes November 2022 Amendment [Member]",
        "label": "Convertible Notes November2022 Amendment Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total convertible notes payable",
        "terseLabel": "Convertible debt payable, loans and notes payable to a related party (in Dollars)",
        "verboseLabel": "Convertible note",
        "netLabel": "Issuance amount",
        "label": "Convertible notes balance",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r1344"
     ]
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value beginning balance",
        "periodEndLabel": "Fair value Ending balance",
        "terseLabel": "Convertible promissory note \u2013 related party",
        "verboseLabel": "Convertible promissory note",
        "netLabel": "Convertible Promissory Note \u2013 Related Party",
        "label": "Convertible Notes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleNotesPayableMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes [Member]",
        "verboseLabel": "Convertible Notes Payable [Member]",
        "netLabel": "Convertible notes payable [Member]",
        "label": "Convertible Notes Payable [Member]",
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r90"
     ]
    },
    "ck0001859807_ConvertiblePreferredStockDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertiblePreferredStockDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock [Member]",
        "verboseLabel": "Convertible preferred stock [Member]",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r427",
      "r1116",
      "r1117",
      "r1118",
      "r1119"
     ]
    },
    "ck0001859807_ConvertiblePreferredStockPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertiblePreferredStockPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock",
        "documentation": "Disclosure of accounting policy for convertible preferred stock.",
        "label": "Convertible Preferred Stock Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertiblePreferredStockScheduleofConvertiblePreferredStockDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertiblePromissoryNoteAscentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertiblePromissoryNoteAscentMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory note \u2013 Ascent [Member]",
        "label": "Convertible Promissory Note Ascent Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note [Member]",
        "verboseLabel": "Convertible promissory note \u2013 Related party [Member]",
        "netLabel": "Convertible promissory note [Member]",
        "label": "Convertible Promissory Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertiblePromissoryNoteRelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertiblePromissoryNoteRelatedPartyMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note \u2013 Related Party [Member]",
        "label": "Convertible Promissory Note Related Party Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertibleWorkingCapitalPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertibleWorkingCapitalPromissoryNote",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsor amount",
        "documentation": "Convertible working capital promissory note.",
        "label": "Convertible Working Capital Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ConvertibleWorkingCapitalPromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ConvertibleWorkingCapitalPromissoryNoteMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Working Capital Promissory Note [Member]",
        "label": "Convertible Working Capital Promissory Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "verboseLabel": "Federal",
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "verboseLabel": "Current",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1145",
      "r1180",
      "r1187",
      "r1286"
     ]
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1145",
      "r1180",
      "r1187"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current, total",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r1180",
      "r1187"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1145",
      "r1180",
      "r1187",
      "r1286"
     ]
    },
    "ck0001859807_DawsonJamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DawsonJamesMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dawson James [Member]",
        "label": "Dawson James Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtConversionConvertedInstrumentRate",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price dicount",
        "verboseLabel": "Original issue discount",
        "label": "Debt Conversion, Converted Instrument, Rate",
        "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r22"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted shares (in Shares)",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r22"
     ]
    },
    "us-gaap_DebtDefaultLongtermDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDefaultLongtermDebtAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PPP loan repayment",
        "label": "Debt Instrument, Debt Default, Amount",
        "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r190"
     ]
    },
    "ck0001859807_DebtDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DebtDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.profusa.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r188",
      "r190",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r361",
      "r362",
      "r375",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r391",
      "r398",
      "r399",
      "r401",
      "r636",
      "r705"
     ]
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "label": "Debt Instrument, Annual Principal Payment",
        "documentation": "Amount of annual principal payment for debt instrument."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r42",
      "r43",
      "r90",
      "r93",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1095",
      "r1180",
      "r1181",
      "r1184",
      "r1189",
      "r1220",
      "r1221",
      "r1222",
      "r1320",
      "r1322",
      "r1341"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of debt",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price per share (in Dollars per share)",
        "verboseLabel": "Trust account balance (in Dollars per share)",
        "netLabel": "Conversion price (in Dollars per share)",
        "label": "Converted price per share (in Dollars per share)",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r378"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentConvertibleLiquidationPreferencePerShare",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convert into new per shares (in Dollars per share)",
        "label": "Debt Instrument, Convertible, Liquidation Preference, Per Share",
        "documentation": "Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ck0001859807_DebtInstrumentDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DebtInstrumentDiscount",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of discount",
        "documentation": "Percentage of debt instrument discount.",
        "label": "Debt Instrument Discount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance of beginning",
        "periodEndLabel": "Balance of ending",
        "terseLabel": "Aggregate principal amount",
        "verboseLabel": "Senior secured convertible promissory notes",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r705",
      "r706",
      "r1051",
      "r1052",
      "r1095"
     ]
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1184"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r394",
      "r1320"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest terms percentage",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r404",
      "r705",
      "r706",
      "r1095"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate per year",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r377"
     ]
    },
    "us-gaap_DebtInstrumentIssuedPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentIssuedPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "verboseLabel": "Purchase price",
        "label": "Debt Instrument, Issued, Principal",
        "documentation": "Amount of principal of debt issued."
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Debt Instruments [Line Items]",
        "terseLabel": "Schedule of Future Minimum Payments for the Convertible Notes Payable [Line Items]",
        "verboseLabel": "Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r400",
      "r636",
      "r803",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1095",
      "r1180",
      "r1181",
      "r1184",
      "r1189",
      "r1320",
      "r1322"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1095",
      "r1180",
      "r1181",
      "r1184",
      "r1189",
      "r1220",
      "r1221",
      "r1222",
      "r1320",
      "r1322",
      "r1341"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding principal percentage",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "documentation": "Percentage of principal amount of debt redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRepaidPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRepaidPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repaid in cash",
        "label": "Debt Instrument, Repaid, Principal",
        "documentation": "Amount of principal of debt repaid."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r32",
      "r33",
      "r38",
      "r79",
      "r80",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r400",
      "r636",
      "r803",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1095",
      "r1180",
      "r1181",
      "r1184",
      "r1189",
      "r1320",
      "r1322"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity term",
        "verboseLabel": "Maturity of convertible note",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Add (less): unamortized debt (premium) discount",
        "negatedTerseLabel": "Less: unamortized debt discount",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r402",
      "r704",
      "r705",
      "r706",
      "r1051",
      "r1052",
      "r1095"
     ]
    },
    "ck0001859807_DebtInstrumentsContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DebtInstrumentsContractualTerm",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual term",
        "documentation": "Debt instruments contractual Term.",
        "label": "Debt Instruments Contractual Term"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_DebtInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DebtInterestRate",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "documentation": "The loans bear interest at a stated rate per annum.",
        "label": "Debt Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note",
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ck0001859807_DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DebtScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt - Schedule of Future Minimum Payments for the Convertible Notes Payable (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_DecemberTwoThousandTwentyOneSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DecemberTwoThousandTwentyOneSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "December 2021 Senior Notes [Member]",
        "label": "December Two Thousand Twenty One Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_DecemberTwoThousandTwentyTwoSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DecemberTwoThousandTwentyTwoSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "December 2022 Senior Notes [Member]",
        "label": "December Two Thousand Twenty Two Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredChargesPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Offering Costs",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible note offering percentage",
        "label": "Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage",
        "documentation": "Commitment made to pay deferred cash remuneration expressed as a percentage of the individual's base salary."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "label": "Deferred Costs, Noncurrent",
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r1163"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "verboseLabel": "Deferred",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1187",
      "r1285",
      "r1286"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred:",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred, total",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r107",
      "r1180",
      "r1187"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Deferred tax (liability), net of allowance",
        "terseLabel": "Deferred tax liability",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r525",
      "r808"
     ]
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "label": "Deferred Offering Costs",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r1218"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1187",
      "r1285",
      "r1286"
     ]
    },
    "ck0001859807_DeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_DeferredTaxAssetsConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DeferredTaxAssetsConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible debt",
        "documentation": "Amount of the difference between reported convertible debt.",
        "label": "Deferred Tax Assets Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_DeferredTaxAssetsDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "documentation": "Amount of the difference between reported depreciation and amortization.",
        "label": "Deferred Tax Assets Depreciation And Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized R&amp;D",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1280"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable",
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforward",
        "verboseLabel": "Organizational costs/Startup expenses",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal net operating loss not expire",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal and state net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D credit carryforward",
        "verboseLabel": "Research credit carryforwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses &amp; other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDeferredTaxAssetsTable",
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: valuation allowance",
        "negatedTerseLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax expenses",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized gain/loss - Trust",
        "label": "Deferred Tax Liabilities, Unrealized Gains on Trading Securities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "ck0001859807_DepositAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DepositAxis",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposit [Axis]",
        "label": "Deposit Axis"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_DepositDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DepositDomainDomain",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DepositDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositLiabilitiesAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepositLiabilitiesAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and unpaid interest",
        "label": "Deposit Liabilities, Accrued Interest",
        "documentation": "Amount of accrued but unpaid interest on deposit liabilities."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_Deposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Deposits",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposit",
        "label": "Deposits",
        "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liability",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r173",
      "r632",
      "r657",
      "r658",
      "r672",
      "r680",
      "r681",
      "r682",
      "r885",
      "r886",
      "r887",
      "r888",
      "r890",
      "r891",
      "r892",
      "r894",
      "r895",
      "r921",
      "r923",
      "r924",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1309",
      "r1310",
      "r1311",
      "r1379"
     ]
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeLiabilityMeasurementInput",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory note measurement inputs",
        "label": "Derivative Liability, Measurement Input",
        "documentation": "Value of input used to measure derivative liability."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r198",
      "r217",
      "r625",
      "r629",
      "r631",
      "r633",
      "r634",
      "r635",
      "r637",
      "r638"
     ]
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DilutiveSecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_DissolutionExpenseWaiverMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DissolutionExpenseWaiverMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dissolution Expense Waiver [Member]",
        "label": "Dissolution Expense Waiver Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Dividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Dividends",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared",
        "label": "Dividends",
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r82"
     ]
    },
    "ck0001859807_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income per share, basic (in Dollars per share)",
        "verboseLabel": "Net loss per share attributable to common stockholders \u2013 basic",
        "netLabel": "Net loss per share attributable to common stockholders \u2014 basic",
        "label": "Basic net (loss) income per share",
        "totalLabel": "Basic net loss per share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r181",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r211",
      "r212",
      "r214",
      "r220",
      "r222",
      "r225",
      "r226",
      "r227",
      "r232",
      "r407",
      "r503",
      "r559",
      "r615",
      "r654",
      "r655",
      "r798",
      "r824",
      "r1027"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income per share, Diluted (in Dollars per share)",
        "verboseLabel": "Net loss per share attributable to common stockholders \u2013 diluted",
        "netLabel": "Net loss per share attributable to common stockholders \u2014 diluted",
        "label": "Diluted net (loss) income per share",
        "totalLabel": "Diluted net loss per share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r181",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r211",
      "r212",
      "r214",
      "r222",
      "r225",
      "r226",
      "r227",
      "r232",
      "r407",
      "r503",
      "r559",
      "r615",
      "r654",
      "r655",
      "r798",
      "r824",
      "r1027"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Common Stock",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r229"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share Attributable To Common Stockholders",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r228",
      "r230",
      "r231"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable",
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income tax provision",
        "terseLabel": "Effective income tax rate, percentage",
        "verboseLabel": "Income for taxable percentage",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r1071"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Federal Income Tax Rate [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable",
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax benefit at U.S. federal statutory rate, percentage",
        "verboseLabel": "Statutory federal income tax rate",
        "netLabel": "Percentage of excise tax",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r194",
      "r527",
      "r550",
      "r1071"
     ]
    },
    "ck0001859807_EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Penalties and interest",
        "documentation": "Penalties and interest",
        "label": "Effective Income Tax Rate Reconciliation At Penalties And Interest Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable",
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change of valuation allowance, percentage",
        "verboseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r1071",
      "r1180",
      "r1188",
      "r1276"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liabilities",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1071",
      "r1180",
      "r1188",
      "r1276"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfBusiness",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination expenses",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1188",
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent difference, percentage",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r531",
      "r1071",
      "r1180",
      "r1188",
      "r1276"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r1071"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Imposes nondeductible excise tax percentage",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r535",
      "r1180",
      "r1188",
      "r1276"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable",
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior-Year deferred taxes adjustment, percentage",
        "verboseLabel": "Prior Year Trueup",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1188",
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State Tax, net of federal benefit, percentage",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r1071",
      "r1180",
      "r1188",
      "r1276"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Table]",
        "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r1071"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsOther",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of fair market value",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits."
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1180",
      "r1188",
      "r1276",
      "r1278"
     ]
    },
    "ck0001859807_EmergingGrowthCompanyStatusPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "EmergingGrowthCompanyStatusPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Growth Company Status",
        "documentation": "Disclosure of accounting policy for emerging growth company status.",
        "label": "Emerging Growth Company Status Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Compensation Expense [Line Items]",
        "terseLabel": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1272"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excepted term recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPlanDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOwnershipPlanESOPPlanDescription",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Date of grant",
        "label": "Employee Stock Ownership Plan (ESOP), Plan Description",
        "documentation": "Description of the plan, including the basis for determining contributions, the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the description generally includes the basis for releasing shares and how dividends on allocated and unallocated shares are used."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOwnershipPlanESOPSharesContributedToESOP",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock (in Shares)",
        "label": "Employee Stock Ownership Plan (ESOP), Shares Contributed to ESOP",
        "documentation": "This item represents the number of shares provided to the Employee Stock Ownership Plan (ESOP) during the period."
       }
      }
     },
     "auth_ref": [
      "r1273"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOwnershipPlanESOPSharesInESOP",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reserved shares (in Shares)",
        "label": "Employee Stock Ownership Plan (ESOP), Shares in ESOP",
        "documentation": "Sum of the allocated, committed-to-be-released and suspense shares of the entity held by the plan."
       }
      }
     },
     "auth_ref": [
      "r1069",
      "r1070",
      "r1274"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.profusa.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r148",
      "r150",
      "r151",
      "r177",
      "r178",
      "r179",
      "r200",
      "r201",
      "r202",
      "r204",
      "r212",
      "r215",
      "r217",
      "r234",
      "r310",
      "r313",
      "r341",
      "r406",
      "r440",
      "r503",
      "r548",
      "r549",
      "r556",
      "r557",
      "r558",
      "r560",
      "r614",
      "r615",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r653",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r707",
      "r709",
      "r716",
      "r822",
      "r843",
      "r844",
      "r845",
      "r871",
      "r949"
     ]
    },
    "ck0001859807_EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "EquityIncentivePlanMember",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Incentive Plan [Member]",
        "label": "Equity Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_EquityPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "EquityPercentage",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity percentage",
        "documentation": "Equity percentage.",
        "label": "Equity Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_EquityProceedOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "EquityProceedOwnershipPercentage",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total equity proceeds percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Proceed Ownership Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_EstimatedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "EstimatedInterestRate",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of estimated interest",
        "documentation": "Percentage of estimated interest.",
        "label": "Estimated Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExciseAndSalesTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExciseAndSalesTaxes",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excise tax liability",
        "label": "Excise and Sales Taxes",
        "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "ck0001859807_ExciseTaxLiabilityInConnectionWithStockRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ExciseTaxLiabilityInConnectionWithStockRedemptions",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excise tax payable attributable to redemption of common stock",
        "documentation": "Excise tax on stock redemptions.",
        "label": "Excise Tax Liability In Connection With Stock Redemptions"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ExciseTaxPayableRedemptionOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ExciseTaxPayableRedemptionOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excise tax payable attributable to redemption of common stock",
        "documentation": "Excise tax payable attributable to redemption of common stock.",
        "label": "Excise Tax Payable Redemption Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExtinguishmentOfDebtAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt extinguishment",
        "label": "Extinguishment of Debt, Amount",
        "documentation": "Gross amount of debt extinguished."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExtinguishmentOfDebtAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguishment of Debt [Axis]",
        "documentation": "Information by type of debt extinguished."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguishment of Debt, Type [Domain]",
        "documentation": "Type of debt extinguished."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liabilities",
        "negatedLabel": "Change in fair value of warrant liabilities",
        "verboseLabel": "Change in fair value",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value [Line Items]",
        "verboseLabel": "Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r658",
      "r672",
      "r1084"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note [Line Items]",
        "terseLabel": "Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note [Line Items]",
        "verboseLabel": "Fair Value Measurement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r660",
      "r661",
      "r1072",
      "r1075",
      "r1087"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r660",
      "r661",
      "r1072",
      "r1075",
      "r1087"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inputs into the Monte Carlo Simulation for the Warrant Liabilities and Convertible Promissory Note",
        "verboseLabel": "Schedule of Inputs into the Monte Carlo Simulation Model for the Warrant Liabilities and Convertible Promissory Note",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r660",
      "r1087"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r656",
      "r658",
      "r659",
      "r660",
      "r661",
      "r670",
      "r672",
      "r674",
      "r680",
      "r732",
      "r733",
      "r734",
      "r1010",
      "r1051",
      "r1052",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1084",
      "r1087",
      "r1094"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r658",
      "r659",
      "r661",
      "r1084",
      "r1310",
      "r1313"
     ]
    },
    "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r666",
      "r668",
      "r669",
      "r670",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r797",
      "r1084",
      "r1088"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1 [Member]",
        "verboseLabel": "Quoted Prices In Active Markets (Level 1) [Member]",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r454",
      "r459",
      "r461",
      "r658",
      "r672",
      "r680",
      "r732",
      "r1010",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1084",
      "r1094"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2 [Member]",
        "verboseLabel": "Significant Other Observable Inputs (Level 2) [Member]",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r454",
      "r459",
      "r461",
      "r463",
      "r658",
      "r659",
      "r672",
      "r680",
      "r733",
      "r1010",
      "r1051",
      "r1052",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1084",
      "r1094"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2 [Member]",
        "verboseLabel": "Level 3 [Member]",
        "netLabel": "Significant Other Unobservable Inputs (Level 3) [Member]",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r658",
      "r659",
      "r660",
      "r661",
      "r672",
      "r680",
      "r734",
      "r1010",
      "r1051",
      "r1052",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1084",
      "r1087",
      "r1094"
     ]
    },
    "us-gaap_FairValueInputsQuantitativeInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsQuantitativeInformationAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Input",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments",
        "label": "Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r658"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r1307",
      "r1308"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r673"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Convertible Promissory Note",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r667",
      "r673"
     ]
    },
    "ck0001859807_FairValueMeasurementDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementLineItems",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurement",
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement - Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement - Schedule of Fair Value of the Company\u2019s Level 3 Financial Instruments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement - Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementTable",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementTablesTable",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value as of beginning balance",
        "periodEndLabel": "Fair value as of Ending balance",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Measurement With Unobservable Input Reconciliations Recurring Basis Liability Value"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued stated interest",
        "documentation": "The amount of accrued stated interest.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Accrued Stated Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt",
        "verboseLabel": "Change in fair value included in other income and gain loss on change in the fair value of Tasly convertible debt",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r663",
      "r673"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of Convertible Notes",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r665",
      "r671",
      "r673"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueoftheCompanysLevel3FinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value as of beginning balance",
        "periodEndLabel": "Fair value as of Ending balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r673"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r656",
      "r658",
      "r659",
      "r660",
      "r661",
      "r670",
      "r672",
      "r674",
      "r680",
      "r732",
      "r733",
      "r734",
      "r1010",
      "r1051",
      "r1052",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1084",
      "r1087",
      "r1094"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring [Member]",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r1084",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1313"
     ]
    },
    "ck0001859807_FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementsScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements - Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueMeasurementsScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements - Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1314"
     ]
    },
    "ck0001859807_FairValueRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FairValueRemeasurement",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Add: fair value remeasurement",
        "negatedTerseLabel": "Less: fair value remeasurement",
        "documentation": "Amount of fair value measurement.",
        "label": "Fair Value Remeasurement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FeaturesOfConvertiblePreferredStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FeaturesOfConvertiblePreferredStockAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock:",
        "label": "Features of Convertible Preferred Stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FebruaryExtensionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FebruaryExtensionMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "February Extension [Member]",
        "label": "February Extension Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r400",
      "r435",
      "r636",
      "r650",
      "r679",
      "r685",
      "r688",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r806",
      "r823",
      "r1045",
      "r1084",
      "r1085",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1098",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1306",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1315",
      "r1316"
     ]
    },
    "ck0001859807_FounderShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FounderShareMember",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder Shares [Member]",
        "label": "Founder Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FounderShares1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FounderShares1Member",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder Shares [Member]",
        "label": "Founder Shares1 Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FounderSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FounderSharesIssued",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder shares issued",
        "documentation": "Founder Shares issued.",
        "label": "Founder Shares Issued"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_FundingOperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "FundingOperatingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funding Operating Expenses",
        "documentation": "Funding Operating Expenses.",
        "label": "Funding Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on change in fair value of related party convertible debt",
        "documentation": "Gain (loss) on change in fair value of related party convertible debt.",
        "label": "Gain Loss On Change In Fair Value Of Related Party Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposition of property and equipment, net",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ck0001859807_GainOnFairValueRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "GainOnFairValueRemeasurement",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on fair value remeasurement",
        "documentation": "Amount of recognized gain from the hedging ineffectiveness of a fair value hedge.",
        "label": "Gain On Fair Value Remeasurement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on change in the fair value of related party Tasly convertible debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r29",
      "r30"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "verboseLabel": "General and administrative expenses",
        "negatedLabel": "General and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r931"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General Administrative [Member]",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_GovernmentAssistanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Government Grant Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GovernmentAssistanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceTextBlock",
     "presentation": [
      "http://www.profusa.com/role/GovernmentGrantRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Grant Revenue",
        "label": "Government Assistance [Text Block]",
        "documentation": "The entire disclosure for government assistance."
       }
      }
     },
     "auth_ref": [
      "r697",
      "r698",
      "r699",
      "r700",
      "r701"
     ]
    },
    "ck0001859807_IBankersAndDawsonJamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IBankersAndDawsonJamesMember",
     "presentation": [
      "http://www.profusa.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "I-Bankers and Dawson James [Member]",
        "label": "IBankers And Dawson James Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IBankersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IBankersMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "I-Bankers [Member]",
        "label": "IBankers Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IPOMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO [Member]",
        "verboseLabel": "Initial Public Offering [Member]",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Loss) income before provision for income tax",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r96",
      "r101",
      "r799",
      "r801",
      "r819",
      "r1020",
      "r1022",
      "r1023",
      "r1031",
      "r1037",
      "r1198",
      "r1200",
      "r1201",
      "r1202",
      "r1203"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r349",
      "r350",
      "r626",
      "r627",
      "r628",
      "r630",
      "r663",
      "r667",
      "r673",
      "r687",
      "r688",
      "r689",
      "r840",
      "r842",
      "r934",
      "r1008",
      "r1010",
      "r1072",
      "r1073",
      "r1082",
      "r1083",
      "r1086",
      "r1094",
      "r1289",
      "r1291",
      "r1349"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r626",
      "r627",
      "r628",
      "r630",
      "r663",
      "r667",
      "r673",
      "r687",
      "r688",
      "r689",
      "r840",
      "r842",
      "r934",
      "r1008",
      "r1010",
      "r1072",
      "r1073",
      "r1082",
      "r1083",
      "r1086",
      "r1094",
      "r1289",
      "r1291",
      "r1349"
     ]
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Line Items]",
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r194",
      "r521",
      "r527",
      "r536",
      "r537",
      "r538",
      "r539",
      "r544",
      "r551",
      "r553",
      "r554",
      "r555",
      "r805",
      "r854",
      "r866",
      "r1071"
     ]
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income for taxable",
        "label": "Income Tax Effects Allocated Directly to Equity, Prior Period Adjustment",
        "documentation": "The tax effect of correction of an error charged or credited directly to the opening balance of retained earnings."
       }
      }
     },
     "auth_ref": [
      "r1287"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r1279"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties expense",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r1279"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      },
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income tax provision",
        "negatedLabel": "Income tax provision",
        "terseLabel": "Total provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r108",
      "r188",
      "r216",
      "r217",
      "r233",
      "r255",
      "r270",
      "r526",
      "r527",
      "r552",
      "r827",
      "r1020",
      "r1022",
      "r1023",
      "r1071"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r522",
      "r523",
      "r539",
      "r540",
      "r543",
      "r546",
      "r860"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
      "http://www.profusa.com/role/ScheduleofProvisionforIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: change in valuation allowance",
        "verboseLabel": "Change in valuation allowance",
        "netLabel": "Valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r1071",
      "r1276"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax benefit at U.S. federal statutory rate, amount",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r1071"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent difference, amount",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior-Year deferred taxes adjustment, amount",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable",
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State Tax, net of federal benefit, amount",
        "verboseLabel": "State",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r1071",
      "r1276"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxContingenciesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationTaxContingenciesOther",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate, amount",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in other income tax contingencies."
       }
      }
     },
     "auth_ref": [
      "r1276"
     ]
    },
    "ck0001859807_IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofEffectiveTaxRateandtheFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change of valuation allowance, amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Income Tax Reconciliations Change In Deferred Tax Assets Valuation Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IncomeTaxesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesLineItems",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxes",
      "http://www.profusa.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes paid",
        "label": "Income Taxes Paid",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r71",
      "r1177",
      "r1281",
      "r1282"
     ]
    },
    "ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesScheduleofIncomeTaxProvisionDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes - Schedule of Income Tax Provision (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesScheduleofIncomeTaxProvisionDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes - Schedule of Income Tax Provision (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes - Schedule of Net Deferred Tax Assets (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesScheduleofNetDeferredTaxAssetsDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes - Schedule of Net Deferred Tax Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesTable",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_IncomeTaxesTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncomeTaxesTablesTable",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax payable",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liability",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredLeasingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredLeasingFees",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred fees paid",
        "label": "Increase (Decrease) in Deferred Leasing Fees",
        "documentation": "The increase (decrease) during the reporting period in the book value of deferred leasing fees. Amortization of these fees over the terms of the leases reduces deferred leasing fees. Originating new leases increases the balance of deferred leasing fees."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to related party",
        "label": "Increase (Decrease) in Due to Related Parties, Current",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in assets and liabilities:",
        "verboseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other non-current assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other receivables",
        "label": "Increase (Decrease) in Other Receivables",
        "documentation": "Amount of increase (decrease) in receivables classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ck0001859807_IncreaseDecreaseInPrepaidFranchiseTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncreaseDecreaseInPrepaidFranchiseTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid franchise taxes",
        "documentation": "Represents the amount of prepaid franchise taxes.",
        "label": "Increase Decrease In Prepaid Franchise Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid income taxes",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ck0001859807_IncreasedecreaseInUnpaidDeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IncreasedecreaseInUnpaidDeferredOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in unpaid deferred offering costs",
        "documentation": "Increase (decrease) in unpaid deferred offering costs.",
        "label": "Increasedecrease In Unpaid Deferred Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InitialNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InitialNotesMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Notes [Member]",
        "label": "Initial Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InitialPublicOfferingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InitialPublicOfferingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InitialPublicOfferingDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InitialPublicOfferingDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InitialPublicOfferingGrossProceedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InitialPublicOfferingGrossProceedPercentage",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial public offering gross proceed percentage",
        "documentation": "Initial public offering gross proceed percentage.",
        "label": "Initial Public Offering Gross Proceed Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InitialPublicOfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InitialPublicOfferingLineItems",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InitialPublicOfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InitialPublicOfferingTable",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InitialPublicOfferingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InitialPublicOfferingTextBlock",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Public Offering",
        "label": "Initial Public Offering Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestCostsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestCostsIncurred",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Costs Incurred",
        "label": "Interest Costs Incurred",
        "documentation": "Total interest costs incurred during the period and either capitalized or charged against earnings."
       }
      }
     },
     "auth_ref": [
      "r702",
      "r703"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r395",
      "r405",
      "r1053",
      "r1054",
      "r1382"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December 31, 2024 and 2023, respectively)",
        "negatedNetLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r1020",
      "r1023",
      "r1171"
     ]
    },
    "us-gaap_InterestExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseOther",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense, related parties (in Dollars)",
        "verboseLabel": "Related parties amounts",
        "label": "Interest Expense, Other",
        "documentation": "Amount of interest expense classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InterestExpensesNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InterestExpensesNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 4.0
      },
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: interest",
        "documentation": "Represent the amount of interest expenses notes payable.",
        "label": "Interest Expenses Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_InterestFromTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "InterestFromTrustAccount",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest from trust account",
        "documentation": "Interest from trust account.",
        "label": "Interest From Trust Account"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lost interest",
        "label": "Interest Income, Other",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "us-gaap_InterestIncomeSecuritiesOtherUSGovernment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeSecuritiesOtherUSGovernment",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest earned on the Trust Account",
        "label": "Interest Income, Securities, Other US Government",
        "documentation": "Interest income on securities issued by US government agencies not including US Treasury Securities."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_InterestIncomeSecuritiesTaxable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeSecuritiesTaxable",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income from trust account",
        "label": "Interest Income, Securities, Operating, Taxable",
        "documentation": "Amount of operating interest income, including amortization and accretion of premiums and discounts, on securities subject to state, federal and other income tax."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r110",
      "r111"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income earned on cash held in Trust Account",
        "negatedLabel": "Interest income on cash held in Trust Account",
        "verboseLabel": "Interest earned on the Trust Account",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r250",
      "r270",
      "r1037",
      "r1170"
     ]
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Investment Interest Rate",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r957",
      "r958",
      "r961",
      "r962",
      "r964",
      "r965",
      "r976",
      "r977",
      "r1114",
      "r1208",
      "r1209"
     ]
    },
    "us-gaap_InvestmentOwnedBalancePrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentOwnedBalancePrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "label": "Investment Owned, Balance, Principal Amount",
        "documentation": "Amount of principal of investment owned."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r893",
      "r959",
      "r967",
      "r978",
      "r1114"
     ]
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestorMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor [Member]",
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r1326",
      "r1327"
     ]
    },
    "ck0001859807_IssuanceOfOptionsUnderTheTwoThousandTenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "IssuanceOfOptionsUnderTheTwoThousandTenPlanMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of options under the 2010 Plan [Member]",
        "label": "Issuance Of Options Under The Two Thousand Ten Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_JanuaryExtensionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "JanuaryExtensionMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Extension [Member]",
        "label": "January Extension Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_JanuaryMarch2024SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "JanuaryMarch2024SeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January-March 2024 Senior Notes [Member]",
        "label": "January March2024 Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_JanuaryMarch2025SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "JanuaryMarch2025SeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January-March 2025 Senior Notes [Member]",
        "label": "January March2025 Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_JanuaryMarchTwoThousandTwentyFourSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "JanuaryMarchTwoThousandTwentyFourSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January-March 2024 Senior Notes [Member]",
        "label": "January March Two Thousand Twenty Four Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_JanuaryTwoThousandTwentyOneConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "JanuaryTwoThousandTwentyOneConvertibleNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2021 Convertible Notes [Member]",
        "label": "January Two Thousand Twenty One Convertible Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_JulySeptemberTwoThousandTwentyFourSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "JulySeptemberTwoThousandTwentyFourSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July-September 2024 Senior Notes [Member]",
        "label": "July September Two Thousand Twenty Four Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_JuneJulyAndAugustExtensionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "JuneJulyAndAugustExtensionMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June, July and August extension [Member]",
        "label": "June July And August Extension Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_LatePenaltiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "LatePenaltiesAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Late penalties",
        "documentation": "Late penalties.",
        "label": "Late Penalties Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseAndRentalExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseAndRentalExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent payable",
        "label": "Operating Leases, Rent Expense",
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r1141"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Domain]",
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r1141"
     ]
    },
    "ck0001859807_LegalAndAccountingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "LegalAndAccountingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal and accounting costs",
        "documentation": "The amount of legal and accounting costs.",
        "label": "Legal And Accounting Costs"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal services",
        "label": "Legal Fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r1146",
      "r1383",
      "r1384"
     ]
    },
    "ck0001859807_LessAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "LessAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less:",
        "label": "Less Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r42",
      "r43",
      "r44",
      "r46",
      "r47",
      "r48",
      "r49",
      "r188",
      "r192",
      "r193",
      "r309",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r619",
      "r623",
      "r624",
      "r686",
      "r904",
      "r1030",
      "r1055",
      "r1122",
      "r1228",
      "r1329",
      "r1330"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_LiabilitiesAbstract1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "LiabilitiesAbstract1",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities Abstract1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, convertible preferred stock and stockholders\u2019 deficit",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r95",
      "r816",
      "r1097",
      "r1110",
      "r1111",
      "r1180",
      "r1186",
      "r1214",
      "r1319"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r161",
      "r188",
      "r192",
      "r193",
      "r309",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r619",
      "r623",
      "r624",
      "r686",
      "r1097",
      "r1228",
      "r1329",
      "r1330"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "verboseLabel": "Current Liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities measured at fair value",
        "terseLabel": "Total",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r1307"
     ]
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding amount",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "documentation": "Fair value of the amount outstanding under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r1315"
     ]
    },
    "us-gaap_LoansHeldForSaleTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LoansHeldForSaleTerm",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PPP loan term",
        "label": "Loan, Held-for-Sale, Term",
        "documentation": "Period between issuance and maturity of loan held for sale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "ck0001859807_LockupPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "LockupPeriod",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lockup period",
        "documentation": "Represents the lockup period for the registration statement of IPO.",
        "label": "Lockup Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable",
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Long term debt",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r189",
      "r199",
      "r388",
      "r403",
      "r803",
      "r1051",
      "r1052",
      "r1095",
      "r1344"
     ]
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtByMaturityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Contractual Future Minimum Payments for the PPP Loan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Current portion",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable",
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "verboseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r189",
      "r199",
      "r393",
      "r803"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r189",
      "r199",
      "r393",
      "r803"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofContractualFutureMinimumPaymentsforthePPPLoanTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025 (remainder)",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1189"
     ]
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermPurchaseCommitmentAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial closing amount",
        "label": "Long-Term Purchase Commitment, Amount",
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermConvertibleDebtCurrentAndNoncurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r1220",
      "r1221",
      "r1222"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r27",
      "r1220",
      "r1221",
      "r1222"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r355",
      "r356",
      "r357",
      "r360",
      "r518",
      "r1049",
      "r1225",
      "r1226"
     ]
    },
    "ck0001859807_LossOnFairValueRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "LossOnFairValueRemeasurement",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on fair value remeasurement",
        "documentation": "Amount of recognized loss from the hedging ineffectiveness of a fair value hedge.",
        "label": "Loss On Fair Value Remeasurement"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_MarchTwoThousandTwentyThreeSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "MarchTwoThousandTwentyThreeSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2023 Senior Notes [Member]",
        "label": "March Two Thousand Twenty Three Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketableSecuritiesLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shedule of Fair Value of Investments Held in Trust Account [Line Items]",
        "terseLabel": "Schedule of Fair Value of Investments Held in Trust Account [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketableSecuritiesNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair values of investments held in the Trust Account",
        "verboseLabel": "Cash and marketable securities held in trust",
        "label": "Marketable Securities, Noncurrent",
        "documentation": "Amount of investment in marketable security, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1164"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Held in Trust Account",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_MarketableSecuritiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketableSecuritiesTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Table]",
        "documentation": "Disclosure of information about investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.profusa.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shedule of Fair Value of Investments Held in Trust Account",
        "label": "Marketable Securities [Table Text Block]",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_MaturityDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "MaturityDays",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity days",
        "documentation": "United States government treasury bills with a maturity days.",
        "label": "Maturity Days"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_MaturityMonth": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "MaturityMonth",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity month",
        "documentation": "Maturity month",
        "label": "Maturity Month"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115",
      "r117",
      "r118",
      "r120",
      "r132",
      "r134",
      "r135",
      "r146",
      "r147",
      "r241",
      "r356",
      "r357",
      "r358",
      "r359",
      "r465",
      "r496",
      "r497",
      "r498",
      "r518",
      "r661",
      "r760",
      "r839",
      "r841",
      "r853",
      "r894",
      "r895",
      "r957",
      "r961",
      "r965",
      "r966",
      "r976",
      "r990",
      "r991",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1044",
      "r1056",
      "r1066",
      "r1072",
      "r1075",
      "r1076",
      "r1087",
      "r1088",
      "r1092",
      "r1093",
      "r1107",
      "r1232",
      "r1331",
      "r1332",
      "r1333",
      "r1334",
      "r1335",
      "r1336"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price [Member]",
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r1266",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years) [Member]",
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility [Member]",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1087",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate [Member]",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of Common Stock [Member]",
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r659",
      "r660",
      "r661",
      "r1072",
      "r1075",
      "r1076",
      "r1087"
     ]
    },
    "ck0001859807_MergerAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "MergerAgreementMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merger Agreement [Member]",
        "label": "Merger Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115",
      "r117",
      "r118",
      "r120",
      "r132",
      "r134",
      "r135",
      "r146",
      "r147",
      "r241",
      "r356",
      "r357",
      "r358",
      "r359",
      "r465",
      "r496",
      "r497",
      "r498",
      "r518",
      "r661",
      "r760",
      "r839",
      "r841",
      "r853",
      "r894",
      "r895",
      "r957",
      "r961",
      "r965",
      "r966",
      "r976",
      "r990",
      "r991",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1044",
      "r1056",
      "r1066",
      "r1072",
      "r1075",
      "r1076",
      "r1087",
      "r1088",
      "r1092",
      "r1107",
      "r1232",
      "r1331",
      "r1332",
      "r1333",
      "r1334",
      "r1335",
      "r1336"
     ]
    },
    "ck0001859807_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption period",
        "documentation": "Minimum threshold price of common stock specified to send notice of redemption to the warrant holders",
        "label": "Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of owns outstanding common stock",
        "verboseLabel": "Ownership percentage",
        "label": "Subsidiary, Ownership Percentage, Parent",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_MonthlyPayments": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "MonthlyPayments",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly payments",
        "documentation": "Monthly payments.",
        "label": "Monthly Payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "verboseLabel": "Cash flows from financing activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "verboseLabel": "Cash flows from investing activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "terseLabel": "Cash in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r72"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "verboseLabel": "Cash flows from operating activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss (income) and comprehensive loss",
        "verboseLabel": "Net loss",
        "totalLabel": "Net loss and comprehensive loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r72",
      "r98",
      "r151",
      "r159",
      "r174",
      "r175",
      "r179",
      "r188",
      "r192",
      "r193",
      "r197",
      "r203",
      "r207",
      "r208",
      "r210",
      "r211",
      "r212",
      "r216",
      "r217",
      "r224",
      "r309",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r407",
      "r410",
      "r413",
      "r420",
      "r503",
      "r559",
      "r615",
      "r655",
      "r686",
      "r821",
      "r927",
      "r947",
      "r948",
      "r1020",
      "r1022",
      "r1023",
      "r1120",
      "r1228"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Share Attributable to Common Stockholders [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NewProfusaCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NewProfusaCommonStockMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Profusa Common Stock [Member]",
        "label": "New Profusa Common Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NewSeriesAConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NewSeriesAConvertiblePreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Series A [Member]",
        "label": "New Series AConvertible Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NewSeriesBConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NewSeriesBConvertiblePreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Series B [Member]",
        "label": "New Series BConvertible Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NewSeriesC1ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NewSeriesC1ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Series C-1 [Member]",
        "label": "New Series C1 Convertible Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NewSeriesCConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NewSeriesCConvertiblePreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Series C [Member]",
        "label": "New Series CConvertible Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NoRedemptionScenarioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NoRedemptionScenarioMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No Redemption Scenario [Member]",
        "label": "No Redemption Scenario Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashContributionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashContributionExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution amount",
        "label": "Noncash Contribution Expense",
        "documentation": "Noncash charitable contributions made by the entity during the period."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_NoncashMergerRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashMergerRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive equity value of converted share amount",
        "label": "Noncash Merger Related Costs",
        "documentation": "Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares allocated to merger consideration (in Shares)",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued",
        "documentation": "The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expense, net",
        "terseLabel": "Total other (expense) income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expenses)",
        "verboseLabel": "Other income (expense):",
        "netLabel": "Other (expense) income:",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NonrecoursePromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NonrecoursePromissoryNotesMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrecourse Promissory Notes [Member]",
        "label": "Nonrecourse Promissory Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NorthViewAcquisitionCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NorthViewAcquisitionCorpMember",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy",
      "http://www.profusa.com/role/CommitmentsandContingencies",
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStock",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/FairValueMeasurement",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/FairValueMeasurementTables",
      "http://www.profusa.com/role/IncomeTaxes",
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/IncomeTaxesTables",
      "http://www.profusa.com/role/InitialPublicOffering",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacement",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactions",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0",
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable",
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable0",
      "http://www.profusa.com/role/ScheduleofIncomeTaxProvisionTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0",
      "http://www.profusa.com/role/ScheduleofNetDeferredTaxAssetsTable",
      "http://www.profusa.com/role/ScheduleofReconciliationoftheFederalIncomeTaxRateTable",
      "http://www.profusa.com/role/Segments",
      "http://www.profusa.com/role/SegmentsDetails",
      "http://www.profusa.com/role/SegmentsTables",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SignificantAccountingPoliciesTables",
      "http://www.profusa.com/role/SubsequentEvents",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPolicies",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NorthView Acquisition Corp",
        "verboseLabel": "NorthView Acquisition Corp [Member]",
        "netLabel": "NorthView [Member]",
        "label": "North View Acquisition Corp Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NorthViewTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NorthViewTrustMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NorthView Trust [Member]",
        "label": "North View Trust Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NorthviewAcquisitionCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NorthviewAcquisitionCorporationMember",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Northview Acquisition Corporation",
        "label": "Northview Acquisition Corporation Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory notes payable to related parties (in Dollars)",
        "verboseLabel": "Outstanding amount",
        "label": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r1344",
      "r1345"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory notes",
        "label": "Notes Payable, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43"
     ]
    },
    "us-gaap_NotesPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesPayableFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes at fair value",
        "label": "Notes Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of notes payable."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r42",
      "r43",
      "r1308",
      "r1312",
      "r1315",
      "r1316",
      "r1317",
      "r1318"
     ]
    },
    "ck0001859807_NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 2022 Convertible Notes Amendment [Member]",
        "label": "November Two Thousand Twenty Two Convertible Notes Amendment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 2022 Senior Notes Amendment [Member]",
        "label": "November Two Thousand Twenty Two Senior Notes Amendment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NumberOfDaysForUnderwriterOptions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NumberOfDaysForUnderwriterOptions",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of days for underwriter options",
        "documentation": "Number of days for underwriter options.",
        "label": "Number Of Days For Underwriter Options"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NumberOfDaysForWrittenNoticeOfRedemption": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NumberOfDaysForWrittenNoticeOfRedemption",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption period days",
        "documentation": "Number of days for written notice of redemption.",
        "label": "Number Of Days For Written Notice Of Redemption"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.profusa.com/role/SegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating segment",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1199"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.profusa.com/role/SegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable segment",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r1032",
      "r1042",
      "r1199"
     ]
    },
    "ck0001859807_NumberOfSharesIssuedPerUnit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NumberOfSharesIssuedPerUnit",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued per unit (in Shares)",
        "documentation": "Number of Shares Issued Per Unit.",
        "label": "Number Of Shares Issued Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NumberOfTradingDay": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NumberOfTradingDay",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading days",
        "documentation": "Number of trading days.",
        "label": "Number Of Trading Day"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_NumberOfTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "NumberOfTradingDays",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading days",
        "documentation": "Represent the number of trading days.",
        "label": "Number Of Trading Days"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OctoberDecember2024SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OctoberDecember2024SeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October-December 2024 Senior Notes [Member]",
        "label": "October December2024 Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OctoberDecemberTwoThousandTwentyFourSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OctoberDecemberTwoThousandTwentyFourSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October-December 2024 Senior Notes [Member]",
        "label": "October December Two Thousand Twenty Four Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October-December 2023 Senior Notes [Member]",
        "label": "October December Two Thousand Twenty Three Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OctoberTwoThousandTwentyTwoSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OctoberTwoThousandTwentyTwoSeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October 2022 Senior Notes [Member]",
        "label": "October Two Thousand Twenty Two Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering costs",
        "documentation": "Costs incurred in connection with the offering and selling of additional partner interest.",
        "label": "Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OperatingBankAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OperatingBankAccount",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating bank account",
        "documentation": "Operating bank account.",
        "label": "Operating Bank Account"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Formation and operating costs",
        "label": "Operating Costs and Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "terseLabel": "Total segment expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OperatingExpensesAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OperatingExpensesAbstract0",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OperatingExpensesAbstract1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OperatingExpensesAbstract1",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses Abstract1"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OperatingExpensesAbstract2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OperatingExpensesAbstract2",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses Abstract2"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r1020",
      "r1023",
      "r1031",
      "r1198",
      "r1200",
      "r1201",
      "r1202",
      "r1203"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r711",
      "r1096"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments [Member]",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r271",
      "r1037",
      "r1038"
     ]
    },
    "ck0001859807_OperationsAndRedeemRepurchasePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OperationsAndRedeemRepurchasePercentage",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of perations and redeem repurchase",
        "documentation": "Percentage of perations and redeem repurchase.",
        "label": "Operations And Redeem Repurchase Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OptionsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OptionsToPurchaseCommonStockMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options to Purchase Common Stock [Member]",
        "verboseLabel": "Options to purchase common stock [Member]",
        "label": "Options To Purchase Common Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r152",
      "r154",
      "r156",
      "r856",
      "r857"
     ]
    },
    "ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesLineItems",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesTable",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertainties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Description of Business, Going Concern and Significant Risks and Uncertainties [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable",
      "http://www.profusa.com/role/ScheduleofAccruedLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accrued other liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_OtherCommitmentDueInSecondAndThirdYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentDueInSecondAndThirdYear",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable in cash",
        "label": "Other Commitment, to be Paid, Year Two and Three",
        "documentation": "Amount of commitment classified as other to be paid in second and third fiscal years following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCostAndExpenseOperating",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CRO and regulatory costs",
        "label": "Other Cost and Expense, Operating",
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r826",
      "r1037"
     ]
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expenses",
        "verboseLabel": "Other exepnses",
        "label": "Other Expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r1110",
      "r1111"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r929",
      "r979",
      "r980",
      "r981",
      "r1110",
      "r1111"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to related party",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r1097"
     ]
    },
    "us-gaap_OtherNoncashExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNoncashExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Other Noncash Expense",
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r1081"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense)",
        "label": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OtherOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other offering costs",
        "documentation": "Represent the amount of other offering costs.",
        "label": "Other Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherPaymentsToAcquireBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherPaymentsToAcquireBusinesses",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable in cash",
        "label": "Other Payments to Acquire Businesses",
        "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable",
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid other",
        "label": "Other Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1167",
      "r1217"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r915",
      "r1038",
      "r1110",
      "r1111",
      "r1347"
     ]
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research personnel compensation costs, including stock-based compensation",
        "label": "Other Research and Development Expense",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r1275"
     ]
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administrative service fee",
        "label": "Other Selling, General and Administrative Expense",
        "documentation": "Amount of selling, general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ck0001859807_OutstandingOptionsUnderTwoThousandTenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OutstandingOptionsUnderTwoThousandTenPlanMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding options under 2010 Plan [Member]",
        "label": "Outstanding Options Under Two Thousand Ten Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_OutstandingPrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "OutstandingPrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding principal amount",
        "documentation": "outstanding principal amount.",
        "label": "Outstanding Principal Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option [Member]",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PIPEConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PIPEConvertibleNoteMember",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PIPE Convertible Note [Member]",
        "label": "PIPEConvertible Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PPPLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PPPLoanMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PPP Loan [Member]",
        "label": "PPPLoan Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PartnersCapitalAccountContributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PartnersCapitalAccountContributions",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital contribution",
        "label": "Partners' Capital Account, Contributions",
        "documentation": "Total contributions made by each class of partners (i.e., general, limited and preferred partners)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82"
     ]
    },
    "us-gaap_PayableCommonStockRedeemed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PayableCommonStockRedeemed",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable common stock redeemed",
        "label": "Payable, Common Stock Redeemed",
        "documentation": "Amount of payable for common stock reacquired. Includes, but is not limited to, unit, membership interest, or other ownership interest."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r983",
      "r1122"
     ]
    },
    "ck0001859807_PaycheckProtectionProgramLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaycheckProtectionProgramLoan",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PPP loan",
        "documentation": "The amount of PPP loan.",
        "label": "Paycheck Protection Program Loan"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PaycheckProtectionProgramLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaycheckProtectionProgramLoanMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paycheck Protection Program loan [Member]",
        "label": "Paycheck Protection Program Loan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PaycheckProtectionProgramLoansOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaycheckProtectionProgramLoansOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paycheck protection program loans outstanding",
        "documentation": "Paycheck protection program loans outstanding.",
        "label": "Paycheck Protection Program Loans Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PaycheckProtectionProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaycheckProtectionProgramMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paycheck Protection Program [Member]",
        "label": "Paycheck Protection Program Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForAdministrativeFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentForAdministrativeFees",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments",
        "label": "Payment for Administrative Fees",
        "documentation": "Amount paid to managing member or general partner, affiliate of managing member or general partner, or affiliate of limited liability company (LLC) or limited partnership (LP) for administrative services provided to the LLC or LP, for example, but not limited to, salaries, rent, or overhead costs."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1326",
      "r1387"
     ]
    },
    "ck0001859807_PaymentOfDeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaymentOfDeferredOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of deferred offering costs",
        "documentation": "Payment of deferred offering costs.",
        "label": "Payment Of Deferred Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PaymentOfExtensionFeeIntoTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaymentOfExtensionFeeIntoTrustAccount",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of extension fee into Trust Account",
        "documentation": "Payment of extension fee into trust account.",
        "label": "Payment Of Extension Fee Into Trust Account"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PaymentofInteresttoDistributionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaymentofInteresttoDistributionExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expenses",
        "documentation": "Amount of interest to distribution expenses.",
        "label": "Paymentof Interestto Distribution Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForFees",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for fees",
        "label": "Payments for Other Fees",
        "documentation": "Amount of cash outflow for fees classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ck0001859807_PaymentsForInvestmentOfCashInTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PaymentsForInvestmentOfCashInTrustAccount",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment of cash in trust account",
        "documentation": "The amount of cash outflow for investment of cash in trust account.",
        "label": "Payments For Investment Of Cash In Trust Account"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent payable",
        "label": "Payments for Rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Redemption of common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of share",
        "label": "Payments for Repurchase of Equity",
        "documentation": "The cash outflow to reacquire common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r864"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfInitialPublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trust account to redeeming stockholders",
        "label": "Payments for Repurchase of Initial Public Offering",
        "documentation": "The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of post combination",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property and equipment, net",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ck0001859807_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeem public shares",
        "documentation": "Public share percentage.",
        "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfAccrueInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfAccrueInterest",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of accrue interest",
        "documentation": "Percentage of accrue interest.",
        "label": "Percentage Of Accrue Interest"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfAggregateFairMarketValueOfAsset": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfAggregateFairMarketValueOfAsset",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of aggregate fair market value of assets",
        "documentation": "Represents the minimum percentage of aggregate fair market value of assets.",
        "label": "Percentage Of Aggregate Fair Market Value Of Asset"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfAverageDailyTradedValueOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfAverageDailyTradedValueOfCommonStock",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of average daily traded value of common stock",
        "documentation": "Represent the percentage of average daily traded value of common stock.",
        "label": "Percentage Of Average Daily Traded Value Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfExcercisePriceOption": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfExcercisePriceOption",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price",
        "documentation": "Percentage of exercise price option.",
        "label": "Percentage Of Excercise Price Option"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfLimitForOutstandingCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfLimitForOutstandingCommonStock",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of limit for outstanding common stock",
        "documentation": "Represent the percentage of limit for outstanding common stock.",
        "label": "Percentage Of Limit For Outstanding Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfLowestVolumeWeightedAveragePrice": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfLowestVolumeWeightedAveragePrice",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of lowest volume-weighted average price",
        "documentation": "Represent the percentage of Lowest volume-weighted average price.",
        "label": "Percentage Of Lowest Volume Weighted Average Price"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfNetProceeds": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfNetProceeds",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of net proceeds",
        "documentation": "Percentage of net proceeds.",
        "label": "Percentage Of Net Proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfNonRedeemingPublicShareholders": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfNonRedeemingPublicShareholders",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of non-redeeming public shareholders",
        "documentation": "Percentage of non-redeeming public shareholders.",
        "label": "Percentage Of Non Redeeming Public Shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfOriginalIssuanceDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfOriginalIssuanceDiscount",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of original issuance discount",
        "documentation": "Percentage of original issuance discount.",
        "label": "Percentage Of Original Issuance Discount"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfOriginalIssueDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfOriginalIssueDiscount",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of original issue discount",
        "documentation": "The percentage of original issue discount.",
        "label": "Percentage Of Original Issue Discount"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfPublicShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfPublicShares",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of public shares",
        "documentation": "Percentage of public shares.",
        "label": "Percentage Of Public Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfRedeemingPublicShareholders": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfRedeemingPublicShareholders",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of redeeming public shareholders.",
        "documentation": "Percentage of redeeming public shareholders.",
        "label": "Percentage Of Redeeming Public Shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market value percentage",
        "documentation": "Percentage of warrant exercise price adjusted to price received in new issuance.",
        "label": "Percentage Of Warrant Exercise Price Adjusted To Price Received In New Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_Plan2018Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "Plan2018Member",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 Plan [Member]",
        "label": "Plan2018 Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271"
     ]
    },
    "ck0001859807_PlusAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PlusAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plus:",
        "label": "Plus Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockConvertibleConversionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockConvertibleConversionPrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Original Issue Price",
        "label": "Preferred Stock, Convertible, Conversion Price",
        "documentation": "Per share conversion price of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockDividendRatePercentage",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of annul rate",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r958",
      "r962",
      "r964",
      "r977"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockLiquidationPreferenceValue",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidation Preference",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r191",
      "r427",
      "r439"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock",
        "verboseLabel": "Preferred Stock [Member]",
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r1112",
      "r1113",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1378",
      "r1385"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in Dollars per share)",
        "verboseLabel": "Convertible preferred stock at a par value (in Dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r422"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "verboseLabel": "Shares Authorized",
        "netLabel": "Authorized to issue shares (in Shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r906"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued",
        "verboseLabel": "Share Issued and Outstanding",
        "netLabel": "Preferred Stock, Shares Issued (in Shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r422"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred stock shares outstanding (in Shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r906",
      "r926",
      "r1385",
      "r1386"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock",
        "label": "Preferred Stock [Text Block]",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r411"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, value",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r409",
      "r416",
      "r812",
      "r1097"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Prepaid expenses and other current assets",
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1168"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Prepaid expenses current",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r322",
      "r323",
      "r1013"
     ]
    },
    "ck0001859807_PrepaidFranchiseTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrepaidFranchiseTax",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid franchise tax",
        "documentation": "Represents the amount of prepaid franchise tax.",
        "label": "Prepaid Franchise Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable",
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1046",
      "r1217"
     ]
    },
    "ck0001859807_PrepaidLegal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrepaidLegal",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable",
      "http://www.profusa.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid legal",
        "documentation": "Prepaid legal.",
        "label": "Prepaid Legal"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid income taxes",
        "label": "Prepaid Taxes",
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1047",
      "r1217"
     ]
    },
    "ck0001859807_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market value price",
        "documentation": "Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price",
        "label": "Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PrincipalBorrowing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrincipalBorrowing",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal borrowing",
        "documentation": "Principal borrowing.",
        "label": "Principal Borrowing"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PrivatePlacementDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrivatePlacementDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PrivatePlacementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrivatePlacementLineItems",
     "presentation": [
      "http://www.profusa.com/role/PrivatePlacement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement Warrants [Member]",
        "verboseLabel": "Private Placement [Member]",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PrivatePlacementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrivatePlacementTable",
     "presentation": [
      "http://www.profusa.com/role/PrivatePlacement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PrivatePlacementWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrivatePlacementWarrantsMember",
     "presentation": [
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities \u2013 Private Placement Warrants [Member]",
        "verboseLabel": "Private Placement Warrants [Member]",
        "label": "Private Placement Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PrivatePlacementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PrivatePlacementsTextBlock",
     "presentation": [
      "http://www.profusa.com/role/PrivatePlacement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "documentation": "Private placements.",
        "label": "Private Placements Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of convertible loan",
        "verboseLabel": "Proceeds received through convertible promissory note",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ProceedsFromDecommissioningFund": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromDecommissioningFund",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursement of franchise and income taxes from Trust Account",
        "label": "Proceeds from Decommissioning Trust Fund Assets",
        "documentation": "The cash inflow from the sale of assets held in a decommissioning trust fund."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "verboseLabel": "Cash proceeds",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross offering",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of debt",
        "verboseLabel": "Gross proceeds",
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Generating gross proceeds",
        "verboseLabel": "Generating proceeds of private placement (in Dollars)",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of senior notes",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate exercise price",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from sales",
        "label": "Proceeds from Issuance or Sale of Equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r861"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of promissory notes",
        "label": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance from Profusa",
        "label": "Proceeds from Related Party Debt",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromShortTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowed amount",
        "label": "Proceeds from Short-Term Debt",
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r11"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss)",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r159",
      "r174",
      "r175",
      "r183",
      "r188",
      "r192",
      "r193",
      "r197",
      "r203",
      "r212",
      "r216",
      "r217",
      "r309",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r407",
      "r503",
      "r559",
      "r615",
      "r617",
      "r620",
      "r621",
      "r655",
      "r686",
      "r799",
      "r801",
      "r820",
      "r870",
      "r927",
      "r947",
      "r948",
      "r1079",
      "r1080",
      "r1121",
      "r1169",
      "r1228"
     ]
    },
    "ck0001859807_ProfusaAsiaPacificPteLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ProfusaAsiaPacificPteLtdMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Profusa Asia Pacific Pte.Ltd [Member]",
        "verboseLabel": "Profusa Asia Pacific Pte. Ltd [Member]",
        "label": "Profusa Asia Pacific Pte Ltd Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ProfusaIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ProfusaIncMember",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Profusa, Inc [Member]",
        "label": "Profusa Inc Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ProfusaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ProfusaMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofFinancialLiabilitiesMeasuredatFairValueonaRecurringBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Profusa [Member]",
        "label": "Profusa Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ProfusaPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ProfusaPreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Profusa Preferred Stock [Member]",
        "label": "Profusa Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PromissoryNoteMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory Note [Member]",
        "label": "Promissory Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PromissoryNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PromissoryNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory notes",
        "documentation": "Promissory notes.",
        "label": "Promissory Notes"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PromissoryNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory Notes [Member]",
        "label": "Promissory Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r713",
      "r804",
      "r818",
      "r1097"
     ]
    },
    "ck0001859807_PublicSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PublicSharesMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Shares [Member]",
        "verboseLabel": "Public shares [Member]",
        "label": "Public Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PublicWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PublicWarrantMember",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Warrant [Member]",
        "label": "Public Warrant Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PublicWarrantsMember",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities \u2013 Public Warrants [Member]",
        "verboseLabel": "Public Warrants [Member]",
        "label": "Public Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_PurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "PurchasePrice",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price",
        "documentation": "Represent the amount of purchase price.",
        "label": "Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115",
      "r117",
      "r118",
      "r120",
      "r132",
      "r134",
      "r135",
      "r146",
      "r147",
      "r241",
      "r356",
      "r357",
      "r358",
      "r359",
      "r453",
      "r465",
      "r496",
      "r497",
      "r498",
      "r502",
      "r518",
      "r661",
      "r735",
      "r744",
      "r760",
      "r839",
      "r841",
      "r853",
      "r894",
      "r895",
      "r957",
      "r961",
      "r965",
      "r966",
      "r976",
      "r990",
      "r991",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1044",
      "r1056",
      "r1066",
      "r1072",
      "r1075",
      "r1076",
      "r1087",
      "r1088",
      "r1092",
      "r1093",
      "r1107",
      "r1114",
      "r1223",
      "r1232",
      "r1310",
      "r1332",
      "r1333",
      "r1334",
      "r1335",
      "r1336"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115",
      "r117",
      "r118",
      "r120",
      "r132",
      "r134",
      "r135",
      "r146",
      "r147",
      "r241",
      "r356",
      "r357",
      "r358",
      "r359",
      "r453",
      "r465",
      "r496",
      "r497",
      "r498",
      "r502",
      "r518",
      "r661",
      "r735",
      "r744",
      "r760",
      "r839",
      "r841",
      "r853",
      "r894",
      "r895",
      "r957",
      "r961",
      "r965",
      "r966",
      "r976",
      "r990",
      "r991",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1044",
      "r1056",
      "r1066",
      "r1072",
      "r1075",
      "r1076",
      "r1087",
      "r1088",
      "r1092",
      "r1093",
      "r1107",
      "r1114",
      "r1223",
      "r1232",
      "r1310",
      "r1332",
      "r1333",
      "r1334",
      "r1335",
      "r1336"
     ]
    },
    "ck0001859807_ReceivedPaycheckProtectionProgramLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ReceivedPaycheckProtectionProgramLoans",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Received paycheck protection program loans",
        "documentation": "Received paycheck protection program loans.",
        "label": "Received Paycheck Protection Program Loans"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of common stock subject to redemption to common stock to be redeemed",
        "documentation": "Reclassification of common stock subject to redemption to common stock to be redeemed",
        "label": "Reclassification Of Common Stock Subject To Redemption To Common Stock To Be Redeemed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26"
     ]
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.profusa.com/role/SegmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Financial Information Regarding The Company\u2019s Operating Segment",
        "verboseLabel": "Schedule of Consolidated Condensed Financial Statements of Operating Segment",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock to be redeemed",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form."
       }
      }
     },
     "auth_ref": [
      "r1235",
      "r1238",
      "r1241"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedeemableNoncontrollingInterestEquityCommonRedemptionValue",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to redeeming stockholders",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Redemption Value",
        "documentation": "Redemption value, as if currently redeemable, of redeemable noncontrolling interest for common shares, units or ownership interests classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date."
       }
      }
     },
     "auth_ref": [
      "r1235",
      "r1238",
      "r1241",
      "r1242"
     ]
    },
    "ck0001859807_RedeemableSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RedeemableSharesMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Shares [Member]",
        "label": "Redeemable Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RedeemableWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RedeemableWarrantMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Warrant [Member]",
        "label": "Redeemable Warrant Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RedemptionPaymentsDueToRedeemingStockholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RedemptionPaymentsDueToRedeemingStockholders",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption payments due to redeeming stockholders",
        "documentation": "Redemption payments due to redeeming stockholders.",
        "label": "Redemption Payments Due To Redeeming Stockholders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedemptionPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedemptionPremium",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Partial redemption",
        "label": "Redemption Premium",
        "documentation": "The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RedemptionPricePerWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RedemptionPricePerWarrant",
     "presentation": [
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption price per warrant",
        "documentation": "Redemption Price Per Warrant.",
        "label": "Redemption Price Per Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RedemptionPublicShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RedemptionPublicShares",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption public shares (in Shares)",
        "documentation": "Redemption public shares.",
        "label": "Redemption Public Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r196",
      "r197",
      "r278",
      "r460",
      "r464",
      "r720",
      "r721",
      "r809",
      "r817",
      "r898",
      "r899",
      "r900",
      "r902",
      "r903",
      "r925",
      "r956",
      "r1381"
     ]
    },
    "ck0001859807_RelatedPartyLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RelatedPartyLoanMember",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Loan [Member]",
        "label": "Related Party Loan Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "verboseLabel": "Related Party [Member]",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r196",
      "r197",
      "r720",
      "r721",
      "r722",
      "r723",
      "r809",
      "r817",
      "r898",
      "r899",
      "r900",
      "r902",
      "r903",
      "r925",
      "r956"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r196",
      "r197",
      "r720",
      "r721",
      "r1328"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/IncomeTaxesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r196",
      "r197",
      "r1328"
     ]
    },
    "ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RelatedPartyTransactionExpensesFromTransactionWithRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses incurred and paid",
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction Expenses From Transaction With Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses per month",
        "documentation": "The contractual monthly amount to be paid for support services.",
        "label": "Related Party Transaction Expenses From Transaction With Related Party Per Month"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r196",
      "r197",
      "r278",
      "r460",
      "r464",
      "r720",
      "r721",
      "r809",
      "r817",
      "r898",
      "r899",
      "r900",
      "r902",
      "r903",
      "r925",
      "r956",
      "r1328",
      "r1381"
     ]
    },
    "ck0001859807_RelatedPartyTransactionsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RelatedPartyTransactionsDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RelatedPartyTransactionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RelatedPartyTransactionsDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r717",
      "r718",
      "r719",
      "r721",
      "r724",
      "r867",
      "r868",
      "r869",
      "r932",
      "r933",
      "r934",
      "r953",
      "r955"
     ]
    },
    "ck0001859807_RelatedPartyTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RelatedPartyTransactionsLineItems",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RelatedPartyTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RelatedPartyTransactionsTable",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RentAndOfficeCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RentAndOfficeCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent and office costs",
        "documentation": "The amount of rent and office costs.",
        "label": "Rent And Office Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt repayments",
        "terseLabel": "Repaid amount",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of related party promissory notes",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfSeniorDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of senior notes",
        "label": "Repayments of Senior Debt",
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfShortTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term debt",
        "label": "Repayments of Short-Term Debt",
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ck0001859807_RepresentativeSharesCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RepresentativeSharesCost",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Represent shares",
        "documentation": "The Represent amount of share cost.",
        "label": "Representative Shares Cost"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RepresentativeWarrantCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RepresentativeWarrantCost",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Representative warrants cost",
        "documentation": "The represent cost of warrants.",
        "label": "Representative Warrant Cost"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_RepresentativesWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RepresentativesWarrantsMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities \u2013 Representative\u2019s Warrants [Member]",
        "verboseLabel": "Representative\u2019s Warrants [Member]",
        "label": "Representatives Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r1008",
      "r1020",
      "r1021",
      "r1037",
      "r1339"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development [Member]",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r149",
      "r150",
      "r151",
      "r153",
      "r182",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r232",
      "r311",
      "r312",
      "r406",
      "r407",
      "r503",
      "r557",
      "r558",
      "r559",
      "r560",
      "r614",
      "r615",
      "r652",
      "r653",
      "r654",
      "r655",
      "r708",
      "r715",
      "r716",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r858",
      "r1204"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r149",
      "r150",
      "r151",
      "r153",
      "r182",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r232",
      "r311",
      "r312",
      "r406",
      "r407",
      "r503",
      "r557",
      "r558",
      "r559",
      "r560",
      "r614",
      "r615",
      "r652",
      "r653",
      "r654",
      "r655",
      "r708",
      "r715",
      "r716",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r858",
      "r1204"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted payment",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1178",
      "r1340",
      "r1346"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Cash and Restricted Cash:",
        "label": "Restricted Cash and Cash Equivalent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable0",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Restricted cash \u2013 beginning of the period",
        "periodEndLabel": "Restricted cash \u2013 end of the period",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted Cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1178"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r82",
      "r815",
      "r847",
      "r852",
      "r865",
      "r907",
      "r1097"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r150",
      "r151",
      "r200",
      "r201",
      "r202",
      "r204",
      "r212",
      "r215",
      "r217",
      "r310",
      "r313",
      "r341",
      "r406",
      "r503",
      "r548",
      "r549",
      "r556",
      "r557",
      "r558",
      "r560",
      "r614",
      "r615",
      "r639",
      "r641",
      "r642",
      "r644",
      "r653",
      "r707",
      "r709",
      "r843",
      "r845",
      "r871",
      "r1385"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Grants",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r1009"
     ]
    },
    "ck0001859807_RevenueTarget": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "RevenueTarget",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue target",
        "documentation": "Total revenues from an insurance company's segregated group of participating or dividend-paying.",
        "label": "Revenue Target"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable",
      "http://www.profusa.com/role/ScheduleofOtherFinancialInformationRegardingTheCompanysOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grant revenue",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r180",
      "r188",
      "r192",
      "r193",
      "r233",
      "r248",
      "r249",
      "r264",
      "r270",
      "r273",
      "r275",
      "r277",
      "r309",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r686",
      "r799",
      "r801",
      "r1037",
      "r1081",
      "r1110",
      "r1111",
      "r1228"
     ]
    },
    "us-gaap_RightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RightsMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rights [Member]",
        "label": "Rights [Member]",
        "documentation": "A security giving shareholders entitlement to acquire new shares issued by the entity at an established price in proportion to the number of shares already owned. Generally, rights expire within in a short time after issuance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Units issued (in Shares)",
        "verboseLabel": "Issuance of warrant (in Shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sold at a price per Unit (in Dollars per share)",
        "verboseLabel": "Common stock price (in Dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excise tax payable",
        "verboseLabel": "Accrued accompanying balance sheet",
        "label": "Sales and Excise Tax Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 deficit of excise tax payable",
        "label": "Sales and Excise Tax Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast [Member]",
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r1154"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Previously Reported",
        "verboseLabel": "Previously Reported [Member]",
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r200",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r217",
      "r232",
      "r406",
      "r407",
      "r503",
      "r557",
      "r559",
      "r560",
      "r614",
      "r615",
      "r652",
      "r653",
      "r654",
      "r708",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r858",
      "r1142",
      "r1143",
      "r1144",
      "r1193",
      "r1194",
      "r1204",
      "r1215",
      "r1216",
      "r1305",
      "r1324",
      "r1325"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r155",
      "r157",
      "r218",
      "r466",
      "r1138"
     ]
    },
    "ck0001859807_ScheduleOfAccruedLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfAccruedLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfActivityUnderThePlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfActivityUnderThePlanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Activity Under The Plan Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfActivityUnderThePlanIsSetForthAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfActivityUnderThePlanIsSetForthAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Activity Under The Plan Is Set Forth Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ck0001859807_ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfBasicAndDilutedNetLossIncomePerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Basic And Diluted Net Loss Income Per Share Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfBasicAndDilutedNetLossPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfBasicAndDilutedNetLossPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Basic And Diluted Net Loss Per Share Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfChangesInDebtInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfChangesInDebtInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In Debt Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfCompanySAssetsAndLiabilitiesThatAreMeasuredAtFairValueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Company SAssets And Liabilities That Are Measured At Fair Value Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfCompanySPerformanceAndMakingKeyDecisionsRegardingResourceAllocationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Company\u2019s Performance and Making Key Decisions Regarding Resource Allocation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Provision for Income Taxes",
        "verboseLabel": "Schedule of Income Tax Provision",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1284"
     ]
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/SegmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company\u2019s Performance and Making Key Decisions Regarding Resource Allocation",
        "label": "Condensed Income Statement [Table Text Block]",
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r1155",
      "r1181",
      "r1189",
      "r1341"
     ]
    },
    "ck0001859807_ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfConsolidatedCondensedFinancialStatementsOfOperatingSegmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Consolidated Condensed Financial Statements Of Operating Segment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfContractualFutureMinimumPaymentsForThePppLoanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Contractual Future Minimum Payments For The Ppp Loan Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfConversionsOfStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfConversionsOfStockTextBlock",
     "presentation": [
      "http://www.profusa.com/role/CommonStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reserved Shares of Common Stock",
        "label": "Schedule of Conversions of Stock [Table Text Block]",
        "documentation": "Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "ck0001859807_ScheduleOfConvertiblePreferredStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfConvertiblePreferredStockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Convertible Preferred Stock Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfConvertiblePreferredStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfConvertiblePreferredStockTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/ConvertiblePreferredStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Convertible Preferred Stock",
        "documentation": "Tabular disclosure of convertible preferred stock.",
        "label": "Schedule Of Convertible Preferred Stock Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfConvertiblePromissoryNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfConvertiblePromissoryNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Convertible Promissory Note Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfDebtInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfDebtInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Debt Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.profusa.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Debt Instruments",
        "verboseLabel": "Schedule of Debt Instruments",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r32",
      "r33",
      "r38",
      "r79",
      "r80",
      "r1051",
      "r1053",
      "r1181",
      "r1189",
      "r1320",
      "r1341"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Payments for the Convertible Notes Payable",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfDeferredTaxAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Tax Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets",
        "verboseLabel": "Schedule of Net Deferred Tax Assets",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1280"
     ]
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Level 3 Financial Instruments that are Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of derivative liabilities at fair value."
       }
      }
     },
     "auth_ref": [
      "r1301",
      "r1302",
      "r1303"
     ]
    },
    "ck0001859807_ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Diluted Net Loss Per Share Attributable To Common Stockholders Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/NetLossPerShareAttributabletoCommonStockholdersTables",
      "http://www.profusa.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders",
        "verboseLabel": "Schedule of Basic and Diluted Net (Loss) Income Per Share",
        "netLabel": "Schedule of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1197"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Tax Rate and the Federal Statutory Income Tax Rate",
        "verboseLabel": "Schedule of Reconciliation of the Federal Income Tax Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r1071",
      "r1276"
     ]
    },
    "ck0001859807_ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfEffectiveTaxRateAndTheFederalStatutoryIncomeTaxRateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Effective Tax Rate And The Federal Statutory Income Tax Rate Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable",
      "http://www.profusa.com/role/ScheduleofStockCompensationExpenseTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Compensation Expense by Function Recognized for the Years",
        "verboseLabel": "Schedule of Stock Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option Plan",
        "label": "Employee Stock Ownership Plan (ESOP) Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of the details pertaining to each employee stock ownership plan."
       }
      }
     },
     "auth_ref": [
      "r1069",
      "r1070",
      "r1274"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company\u2019s Assets and Liabilities that are Measured at Fair Value",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1307",
      "r1308"
     ]
    },
    "ck0001859807_ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfFairValueOfInvestmentsHeldInTrustAccountAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of Investments Held In Trust Account Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfFairValueOfTheCompanySLevel3FinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of The Company SLevel3 Financial Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Liabilities Measured At Fair Value On ARecurring Basis Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfFutureMinimumPaymentsForTheConvertibleNotesPayableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Future Minimum Payments For The Convertible Notes Payable Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfIncomeTaxProvisionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfIncomeTaxProvisionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Income Tax Provision Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfInputsIntoTheMonteCarloSimulationForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Inputs Into The Monte Carlo Simulation For The Warrant Liabilities And Convertible Promissory Note Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfInputsIntoTheMonteCarloSimulationModelForTheWarrantLiabilitiesAndConvertiblePromissoryNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Inputs Into The Monte Carlo Simulation Model For The Warrant Liabilities And Convertible Promissory Note Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfLevel3FinancialInstrumentsThatAreMeasuredAtFairValueOnARecurringBasisAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Level3 Financial Instruments That Are Measured At Fair Value On ARecurring Basis Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfOtherFinancialInformationRegardingTheCompanySOperatingSegmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Financial Information Regarding The Company SOperating Segment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepaid Expenses and Other Current Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfProvisionForIncomeTaxesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfProvisionForIncomeTaxesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Provision for Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ScheduleOfReservedSharesOfCommonStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfReservedSharesOfCommonStockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Reserved Shares Of Common Stock Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Activity Under the Plan is Set Forth",
        "verboseLabel": "Schedule of Activity Under the Plan",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r10",
      "r84"
     ]
    },
    "ck0001859807_ScheduleOfStockCompensationExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ScheduleOfStockCompensationExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Stock Compensation Expense Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SecondPurchaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SecondPurchaseMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second Purchase [Member]",
        "label": "Second Purchase Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SecuritiesPurchaseAgreementCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SecuritiesPurchaseAgreementCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities purchase agreement",
        "verboseLabel": "Securities Purchase Agreement",
        "documentation": "Represents the amount of securities purchase agreement.",
        "label": "Securities Purchase Agreement Current"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/ScheduleofConvertiblePromissoryNoteTable0",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Purchase Agreement [Member]",
        "label": "Securities Purchase Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SecuritiesPurchaseAgreementPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SecuritiesPurchaseAgreementPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Purchase Agreement",
        "documentation": "Disclosure of accounting policy for securities purchase agreement.",
        "label": "Securities Purchase Agreement Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecuritiesSoldUnderAgreementsToRepurchaseMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Purchase Agreement [Member]",
        "label": "Securities Sold under Agreements to Repurchase [Member]",
        "documentation": "The securities that an institution sells and agrees to repurchase (the identical or substantially the same securities) as a seller-borrower at a specified date for a specified price, also known as a repurchase agreement, or repo. Most repos involve obligations of the federal government or its agencies, but other financial instruments, such as commercial paper, banker's acceptances, and negotiable certificates of deposit, are sometimes used in repos."
       }
      }
     },
     "auth_ref": [
      "r1337"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r116",
      "r119",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r135",
      "r238",
      "r275",
      "r276",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r799",
      "r800",
      "r801",
      "r802",
      "r887",
      "r889",
      "r891",
      "r960",
      "r963",
      "r968",
      "r982",
      "r990",
      "r992",
      "r993",
      "r994",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1011",
      "r1028",
      "r1057",
      "r1058",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1108",
      "r1114",
      "r1348",
      "r1350",
      "r1351",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://www.profusa.com/role/SegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r1036",
      "r1043"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://www.profusa.com/role/SegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of CODM",
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r1033",
      "r1040"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.profusa.com/role/Segments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r233",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r259",
      "r261",
      "r262",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r277",
      "r1032",
      "r1034",
      "r1035",
      "r1037",
      "r1039",
      "r1041",
      "r1042"
     ]
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Consolidated Condensed Financial Statements of Operating Segment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SegmentsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SegmentsDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/SegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SegmentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SegmentsDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/SegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SegmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SegmentsLineItems",
     "presentation": [
      "http://www.profusa.com/role/Segments",
      "http://www.profusa.com/role/SegmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SegmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SegmentsTable",
     "presentation": [
      "http://www.profusa.com/role/Segments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SegmentsTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SegmentsTablesTable",
     "presentation": [
      "http://www.profusa.com/role/SegmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SeniorConvertibleBridgeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeniorConvertibleBridgeNotesMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Bridge Notes [Member]",
        "label": "Senior Convertible Bridge Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SeniorConvertiblesNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeniorConvertiblesNotesMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertibles Notes [Member]",
        "label": "Senior Convertibles Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SeniorNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeniorNoteMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes [Member]",
        "label": "Senior Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeniorNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes",
        "label": "Senior Notes",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r1344"
     ]
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes [Member]",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes September 2022 Amendment [Member]",
        "verboseLabel": "Senior Notes September Two Thousand Twenty Two Amendment [Member]",
        "label": "Senior Notes September Two Thousand Twenty Two Amendment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SeniorSecuredConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeniorSecuredConvertibleNoteMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Convertible Note [Member]",
        "label": "Senior Secured Convertible Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SeniorSecuredConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeniorSecuredConvertibleNotesMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Convertible Notes [Member]",
        "label": "Senior Secured Convertible Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SeniorSecuredNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeniorSecuredNoteMember",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Note [Member]",
        "label": "Senior Secured Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A convertible preferred stock",
        "verboseLabel": "Series A Convertible",
        "netLabel": "Conversion of Series A preferred stock [Member]",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1165",
      "r1166",
      "r1236",
      "r1243"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B convertible preferred stock",
        "verboseLabel": "Series B Convertible",
        "netLabel": "Conversion of Series B preferred stock [Member]",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1165",
      "r1166",
      "r1236",
      "r1243"
     ]
    },
    "ck0001859807_SeriesCC1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SeriesCC1PreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Series C/C-1 preferred stock [Member]",
        "label": "Series CC1 Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C/C-1 convertible preferred stock",
        "verboseLabel": "Series C/C-1 Convertible",
        "netLabel": "Conversion of Series C/C-1 preferred stock [Member]",
        "label": "Series C Preferred Stock [Member]",
        "documentation": "Series C preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1165",
      "r1166",
      "r1236",
      "r1243"
     ]
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Member]",
        "verboseLabel": "Business Combination, Series of Individually Immaterial Business Combinations [Member]",
        "label": "Business Combination, Series of Individually Immaterial Business Combinations [Member]",
        "documentation": "Series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r1290",
      "r1293",
      "r1294"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.profusa.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ScheduleofConsolidatedCondensedFinancialStatementsofOperatingSegmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expenses",
        "verboseLabel": "Research personnel compensation costs, including stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vest over years",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Activity Under the Plan [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r502"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance, Shares Available for Grant",
        "terseLabel": "Ending balances Shares available for grant",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted Shares available for grant",
        "negatedLabel": "Options granted, Shares Available for Grant",
        "documentation": "he difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on Options granted, net of cancellations and forfeitures, if applicable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Granted"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options cancelled/forfeited Shares available for grant",
        "verboseLabel": "Options cancelled/forfeited, Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options cancelled.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Options Cancelled"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised Shares available for grant",
        "verboseLabel": "Options exercised, Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options exercised.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Options Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options expired Shares available for grant",
        "verboseLabel": "Options expired, Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), options expired.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Options Expired"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable Number of options",
        "verboseLabel": "Exercisable, Number of Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable Weighted- average exercise price per share (in Dollars per share)",
        "verboseLabel": "Exercisable, Weighted-Average Exercise Price Per Share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options expired Number of options",
        "negatedTerseLabel": "Options expired, Number of Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options cancelled/forfeited Number of options",
        "negatedLabel": "Options cancelled/forfeited, Number of Options",
        "verboseLabel": "Cancellation shares of common stock",
        "netLabel": "Cancellation shares of common stock (in Shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted Number of options",
        "verboseLabel": "Options granted, Number of Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance, Number of Options",
        "terseLabel": "Ending balances Number of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r476"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance, Weighted-Average Exercise Price Per Share (in Dollars per share)",
        "terseLabel": "Ending balances Weighted- average exercise price per share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r476"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested options outstanding and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest Number of options",
        "verboseLabel": "Vested and expected to vest, Number of Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest Weighted- average exercise price per share (in Dollars per share)",
        "verboseLabel": "Vested and expected to vest, Weighted-Average Exercise Price Per Share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised Weighted- average exercise price per share (in Dollars per share)",
        "verboseLabel": "Options exercised, Weighted-Average Exercise Price Per Share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options expired Weighted- average exercise price per share (in Dollars per share)",
        "verboseLabel": "Options expired, Weighted-Average Exercise Price Per Share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options cancelled/forfeited Weighted- average exercise price per share (in Dollars per share)",
        "verboseLabel": "Options cancelled/forfeited, Weighted-Average Exercise Price Per Share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted Weighted- average exercise price per share (in Dollars per share)",
        "verboseLabel": "Options granted, Weighted-Average Exercise Price Per Share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r467",
      "r474",
      "r493",
      "r494",
      "r495",
      "r496",
      "r499",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Date of grant expiration",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable Weighted- average remaining contractual term",
        "verboseLabel": "Exercisable, Weighted-Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ending balances Weighted- average remaining contractual term",
        "verboseLabel": "Balance, Weighted-Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest Weighted- average remaining contractual term",
        "verboseLabel": "Vested and expected to vest, Weighted-Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of options vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in Dollars per share)",
        "verboseLabel": "Common stock price (in Dollars per share)",
        "netLabel": "Price per share",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance Beginning (in Shares)",
        "periodEndLabel": "Balance Ending (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SharesRedeemedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SharesRedeemedPercentage",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares redeemed percentage",
        "documentation": "Percentage of shares redeemed.",
        "label": "Shares Redeemed Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Subject to Possible Redemption",
        "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security."
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermBankLoansAndNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term loan agreement",
        "label": "Short-Term Bank Loans and Notes Payable",
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r901",
      "r1343"
     ]
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term borrowed",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r90",
      "r1097",
      "r1343"
     ]
    },
    "us-gaap_ShortTermDebtInterestRateIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtInterestRateIncrease",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Simple interest rate",
        "label": "Short-Term Debt, Interest Rate Increase",
        "documentation": "Percentage increase in the stated interest rate on a short-term debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Debt [Member]",
        "label": "Short-Term Debt [Member]",
        "documentation": "Debt arrangement having an initial term within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r1220",
      "r1221",
      "r1222"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r1220",
      "r1221",
      "r1222"
     ]
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual interest rate",
        "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r363"
     ]
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term leases",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r712",
      "r1096"
     ]
    },
    "us-gaap_ShortTermLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease costs",
        "label": "Short-Term Lease Payments",
        "documentation": "Amount of cash outflow for short-term lease payment excluded from lease liability."
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ck0001859807_ShortTermLeasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ShortTermLeasesMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Leases [Member]",
        "label": "Short Term Leases Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_ShortTermLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "ShortTermLoanAgreementMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Loan Agreement [Member]",
        "label": "Short Term Loan Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShorttermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShorttermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value",
        "label": "Short-Term Debt, Fair Value",
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r1307",
      "r1315",
      "r1316",
      "r1317",
      "r1318"
     ]
    },
    "ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SignificantAccountingPoliciesScheduleofBasicandDilutedNetLossPerShareDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Share (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SignificantAccountingPoliciesTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SignificantAccountingPoliciesTablesTable",
     "presentation": [
      "http://www.profusa.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187"
     ]
    },
    "ck0001859807_SpecialMeetingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SpecialMeetingMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special Meeting [Member]",
        "label": "Special Meeting Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SponsorFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SponsorFees",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paid costs",
        "label": "Sponsor Fees",
        "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ck0001859807_SponsorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SponsorMember",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsor [Member]",
        "label": "Sponsor Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_StatedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "StatedInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest",
        "documentation": "Amount of interest payable.",
        "label": "Stated Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCompanysPerformanceandMakingKeyDecisionsRegardingResourceAllocationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r102",
      "r158",
      "r233",
      "r243",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r277",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r340",
      "r343",
      "r351",
      "r352",
      "r607",
      "r610",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r1033",
      "r1037",
      "r1038",
      "r1048",
      "r1109",
      "r1348",
      "r1350",
      "r1351",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ConvertiblePreferredStockDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable",
      "http://www.profusa.com/role/ScheduleofReservedSharesofCommonStockTable0",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r166",
      "r167",
      "r168",
      "r188",
      "r193",
      "r222",
      "r223",
      "r225",
      "r227",
      "r235",
      "r236",
      "r309",
      "r364",
      "r367",
      "r368",
      "r369",
      "r373",
      "r374",
      "r408",
      "r409",
      "r411",
      "r412",
      "r414",
      "r418",
      "r422",
      "r423",
      "r427",
      "r430",
      "r437",
      "r686",
      "r861",
      "r862",
      "r863",
      "r864",
      "r871",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r884",
      "r906",
      "r928",
      "r949",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r1137",
      "r1183",
      "r1185",
      "r1196"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r52",
      "r55",
      "r56",
      "r148",
      "r150",
      "r151",
      "r177",
      "r178",
      "r179",
      "r200",
      "r201",
      "r202",
      "r204",
      "r212",
      "r215",
      "r217",
      "r234",
      "r310",
      "r313",
      "r341",
      "r406",
      "r440",
      "r503",
      "r548",
      "r549",
      "r556",
      "r557",
      "r558",
      "r560",
      "r614",
      "r615",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r653",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r707",
      "r709",
      "r716",
      "r822",
      "r843",
      "r844",
      "r845",
      "r871",
      "r949"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.profusa.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r116",
      "r119",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r135",
      "r238",
      "r275",
      "r276",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r799",
      "r800",
      "r801",
      "r802",
      "r887",
      "r889",
      "r891",
      "r960",
      "r963",
      "r968",
      "r982",
      "r990",
      "r992",
      "r993",
      "r994",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1011",
      "r1028",
      "r1057",
      "r1058",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1108",
      "r1114",
      "r1348",
      "r1350",
      "r1351",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r234",
      "r408",
      "r409",
      "r411",
      "r414",
      "r709",
      "r761",
      "r859",
      "r872",
      "r884",
      "r896",
      "r898",
      "r899",
      "r900",
      "r902",
      "r903",
      "r906",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r930",
      "r931",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r949",
      "r1022",
      "r1023",
      "r1115",
      "r1381"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r155",
      "r157",
      "r218",
      "r466",
      "r1138",
      "r1140"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/ConsolidatedCashFlow",
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r234",
      "r278",
      "r408",
      "r409",
      "r411",
      "r414",
      "r709",
      "r761",
      "r859",
      "r872",
      "r884",
      "r896",
      "r898",
      "r899",
      "r900",
      "r902",
      "r903",
      "r906",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r930",
      "r931",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r949",
      "r1022",
      "r1023",
      "r1115",
      "r1381"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFutureMinimumPaymentsfortheConvertibleNotesPayableTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of June 30, 2025 (in Shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r32",
      "r52",
      "r55",
      "r82",
      "r392"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option grants total (in Shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r52",
      "r82",
      "r516"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders redeemed shares (in Shares)",
        "verboseLabel": "Shares issued",
        "netLabel": "Aggregate shares (in Shares)",
        "label": "Common stock shares issued (in Shares)",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r52",
      "r82",
      "r861",
      "r949",
      "r985"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Representative shares issued (in Shares)",
        "label": "Stock Issued During Period, Shares, Other",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeiture shares (in Shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": [
      "r1243"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable",
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable",
      "http://www.profusa.com/role/ShareholdersEquityType2or3",
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of stock options (in Shares)",
        "verboseLabel": "Options exercised Number of options",
        "netLabel": "Options exercised, Number of Options",
        "label": "Stock option exercised",
        "totalLabel": "Exercised stock option (in Shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r52",
      "r82",
      "r480"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders redeeme",
        "verboseLabel": "Share issued amount (in Dollars)",
        "netLabel": "Aggregate purchase price",
        "label": "Common stock aggregate value",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r52",
      "r82",
      "r871",
      "r949",
      "r985",
      "r1121"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r52",
      "r55",
      "r56",
      "r82"
     ]
    },
    "ck0001859807_StockOptionPlanDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "StockOptionPlanDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/StockOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "StockOptionPlanScheduleofActivityUnderthePlanDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan - Schedule of Activity Under the Plan (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Activity Under the Plan is Set Forth [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "StockOptionPlanScheduleofActivityUnderthePlanisSetForthDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofActivityUnderthePlanisSetForthTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan - Schedule of Activity Under the Plan is Set Forth (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock redeemed (in Shares)",
        "verboseLabel": "Common stock shares redeemed (in Shares)",
        "label": "Stock Redeemed or Called During Period, Shares",
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption amount",
        "verboseLabel": "Aggregate redeemed amount",
        "label": "Stock Redeemed or Called During Period, Value",
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ck0001859807_StockholdersAmendmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "StockholdersAmendmentPercentage",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders amendment percentage",
        "documentation": "Stockholders amendment percentage.",
        "label": "Stockholders Amendment Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance Beginning",
        "periodEndLabel": "Balance Ending",
        "totalLabel": "Total stockholders\u2019 deficit",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r55",
      "r56",
      "r73",
      "r908",
      "r926",
      "r950",
      "r951",
      "r1097",
      "r1122",
      "r1180",
      "r1185",
      "r1186",
      "r1214",
      "r1319",
      "r1385"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 deficit:",
        "verboseLabel": "Stockholders\u2019 Deficit:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.profusa.com/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r421",
      "r423",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r440",
      "r636",
      "r651",
      "r952",
      "r954",
      "r989"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, description",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r727"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Member]",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r727"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r727"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r727"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SubsequentEventsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SubsequentEventsDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SubsequentEventsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SubsequentEventsLineItems",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SubsequentEventsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SubsequentEventsTable",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.profusa.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r726",
      "r728"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/PrivatePlacementDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.profusa.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SummaryofSignificantAccountingPoliciesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SummaryofSignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SummaryofSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SummaryofSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetLossIncomePerShareDetailsTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net (Loss) Income Per Share (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_SummaryofSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "SummaryofSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.profusa.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flow information:",
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_TaslyConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "TaslyConvertibleDebtMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/ScheduleofChangesinDebtInstrumentsTable",
      "http://www.profusa.com/role/ScheduleofDebtInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tasly Convertible Debt [Member]",
        "label": "Tasly Convertible Debt Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Consolidated Balance Sheet [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption payment due to stockholders",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r413",
      "r420"
     ]
    },
    "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion of redeemable common stock",
        "verboseLabel": "Aggregate redemption amount",
        "label": "Temporary Equity, Aggregate Amount of Redemption Requirement",
        "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r411",
      "r413",
      "r419",
      "r649"
     ]
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, by Class of Stock [Table]",
        "documentation": "Disclosure of information about equity instrument classified as temporary equity. Includes, but not is limited to, description of share, value, share authorized, issued, and outstanding, redemption price per share, and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r409",
      "r411",
      "r412",
      "r418"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Contingently redeemable common stock at beginning",
        "periodEndLabel": "Contingently redeemable common stock at ending",
        "terseLabel": "Convertible preferred stock, value",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r367",
      "r368",
      "r369",
      "r373",
      "r374",
      "r408",
      "r409",
      "r411",
      "r415",
      "r513",
      "r515",
      "r814"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable",
      "http://www.profusa.com/role/ScheduleofConvertiblePreferredStockTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total convertible preferred stock",
        "terseLabel": "Carrying Amount",
        "label": "Temporary Equity, Including Noncontrolling Interest",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r188",
      "r193",
      "r309",
      "r408",
      "r409",
      "r411",
      "r412",
      "r414",
      "r415",
      "r1185",
      "r1240",
      "r1319"
     ]
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityDisclosureAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofCondensedConsolidatedBalanceSheetTable",
      "http://www.profusa.com/role/ScheduleofConsolidatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r411",
      "r412",
      "r414",
      "r418"
     ]
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityLiquidationPreference",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, liquidation preference (in Dollars)",
        "label": "Temporary Equity, Liquidation Preference",
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityNetIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allocation of net (loss) income",
        "verboseLabel": "Allocation of net loss",
        "label": "Temporary Equity, Net Income",
        "documentation": "The portion of net income or loss attributable to temporary equity interest."
       }
      }
     },
     "auth_ref": [
      "r1234",
      "r1237",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, par value (in Dollars per share)",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock subject to possible redemption, shares redemption (in Dollars per share)",
        "label": "Temporary Equity, Redemption Price Per Share",
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares authorized",
        "label": "Temporary Equity, Shares Authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r411"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails",
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares issued",
        "verboseLabel": "Common stock remaining outstanding after the redemption (in Shares)",
        "netLabel": "Common stock subject to redemption",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r411"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares outstanding",
        "verboseLabel": "Outstanding redemption share (in Shares)",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r411"
     ]
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityTableTextBlock",
     "presentation": [
      "http://www.profusa.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Consolidated Balance Sheet",
        "verboseLabel": "Schedule of Condensed Consolidated Balance Sheet",
        "label": "Temporary Equity [Table Text Block]",
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r1234",
      "r1236",
      "r1237",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1205",
      "r1206",
      "r1207"
     ]
    },
    "ck0001859807_TradingPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "TradingPricePerShare",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading price per share (in Dollars per share)",
        "documentation": "Trading price per share.",
        "label": "Trading Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_TransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "TransactionCost",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs",
        "documentation": "Amount of transaction costs.",
        "label": "Transaction Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r400",
      "r435",
      "r636",
      "r650",
      "r679",
      "r685",
      "r688",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r806",
      "r823",
      "r1084",
      "r1085",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1098",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1306",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1315",
      "r1316"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/DebtDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ck0001859807_USFederalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "USFederalMember",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Federal [Member]",
        "label": "USFederal Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofFairValueofInvestmentsHeldinTrustAccountTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Treasury Bills [Member]",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r1025",
      "r1026",
      "r1059",
      "r1061",
      "r1063",
      "r1084",
      "r1342"
     ]
    },
    "ck0001859807_UnderpaymentPenaltyRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnderpaymentPenaltyRate",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of underpayment penalty",
        "documentation": "Percentage of underpayment penalty.",
        "label": "Underpayment Penalty Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_UnderwritingDiscountAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnderwritingDiscountAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discount amount",
        "documentation": "Amount of underwriting discount.",
        "label": "Underwriting Discount Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnderwritingExpenseRatio": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnderwritingExpenseRatio",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash underwriting discount",
        "label": "Underwriting Expense Ratio",
        "documentation": "Ratio of non-life acquisition expenses and certain non-life general and administrative expenses, to non-life net premiums earned."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_UnitsIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnitsIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "units issued (in Shares)",
        "verboseLabel": "Units issued (in Shares)",
        "documentation": "Number of new units issued during the period.",
        "label": "Units Issued During Period Shares New Issues"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_UnpaidInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnpaidInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unpaid interest",
        "documentation": "Unpaid interest on the promissory notes",
        "label": "Unpaid Interest"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_UnpaidTotalLiabilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnpaidTotalLiabilityRate",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of unpaid total liability",
        "documentation": "Percentage of unpaid total liability.",
        "label": "Unpaid Total Liability Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_UnrelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnrelatedPartiesMember",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrelated Parties [Member]",
        "label": "Unrelated Parties Member"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_UnrelatedPartyRepayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnrelatedPartyRepayable",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrelated party repayable",
        "documentation": "Unrelated party repayable.",
        "label": "Unrelated Party Repayable"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_UnsecuredPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "UnsecuredPromissoryNote",
     "crdr": "debit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured promissory note",
        "documentation": "Unsecured promissory note.",
        "label": "Unsecured Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r237",
      "r239",
      "r240",
      "r241",
      "r799",
      "r801",
      "r1029"
     ]
    },
    "us-gaap_VariableLeasePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableLeasePayment",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease costs",
        "label": "Variable Lease, Payment",
        "documentation": "Amount of cash outflow for variable lease payment excluded from lease liability."
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ck0001859807_VotingSharesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "VotingSharesPercentage",
     "presentation": [
      "http://www.profusa.com/role/CommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voting shares percentage",
        "documentation": "Voting shares percentage.",
        "label": "Voting Shares Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantExercisePriceIncrease",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants price per share (in Dollars per share)",
        "label": "Warrant, Exercise Price, Increase",
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ck0001859807_WarrantLiabilitiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "WarrantLiabilitiesPolicyTextBlock",
     "presentation": [
      "http://www.profusa.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liabilities",
        "documentation": "Accounting policy for warrant liability.",
        "label": "Warrant Liabilities Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability [Member]",
        "label": "Warrant Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails",
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails",
      "http://www.profusa.com/role/RelatedPartyTransactionsDetails",
      "http://www.profusa.com/role/SubsequentEventsDetails",
      "http://www.profusa.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant [Member]",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r1112",
      "r1113",
      "r1116",
      "r1117",
      "r1118",
      "r1119"
     ]
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.profusa.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedBalanceSheet",
      "http://www.profusa.com/role/FairValueMeasurementDetails",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable",
      "http://www.profusa.com/role/ScheduleofCompanysAssetsandLiabilitiesthatareMeasuredatFairValueTable0",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable",
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value, beginning balance",
        "periodEndLabel": "Fair value, ending balance",
        "terseLabel": "Warrant liabilities",
        "verboseLabel": "Aggregate value of public warrants",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationModelfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable",
      "http://www.profusa.com/role/ScheduleofInputsintotheMonteCarloSimulationfortheWarrantLiabilitiesandConvertiblePromissoryNoteTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities measurement inputs",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails",
      "http://www.profusa.com/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants term",
        "verboseLabel": "Expire term",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "ck0001859807_WarrantsLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "WarrantsLiabilityMember",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofLevel3FinancialInstrumentsthatareMeasuredatFairValueonaRecurringBasisTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability [Member]",
        "label": "Warrants Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding, Diluted (in Shares)",
        "verboseLabel": "Weighted average shares used to computing diluted net loss per share",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r227"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.profusa.com/role/ConsolidatedIncomeStatement",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable0",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding, basic (in Shares)",
        "verboseLabel": "Weighted average shares used to computing basic net loss per share",
        "netLabel": "Weighted-average shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r227"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "presentation": [
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossIncomePerShareTable",
      "http://www.profusa.com/role/ScheduleofBasicandDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_WeightedAveragePricePerSharePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "WeightedAveragePricePerSharePercentage",
     "presentation": [
      "http://www.profusa.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average price per share percentage",
        "documentation": "Weighted average price per share percentage.",
        "label": "Weighted Average Price Per Share Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_WorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "WorkingCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible working capital",
        "documentation": "Working Capital.",
        "label": "Working Capital"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001859807_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.profusa.com/20250630",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.profusa.com/role/OrganizationDescriptionofBusinessGoingConcernandSignificantRisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working capital deficit",
        "documentation": "Amount of working capital deficit as of balance sheet date.",
        "label": "Working Capital Deficit"
       }
      }
     },
     "auth_ref": []
    }
   }
  },
  "ea025858001ex-fee_profusa.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea025858001ex-fee_profusa.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 20,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R101": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025858001ex-fee_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025858001ex-fee_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025858001ex-fee_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025858001ex-fee_profusa.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025858001ex-fee_profusa.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025858001ex-fee_profusa.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r1128",
      "r1131"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1127"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r1131"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r1132"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1134"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481244/470-50-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)(Instruction 4)",
   "Publisher": "SEC"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "3",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 1.B.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-23"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-7"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479772/718-30-S55-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480520/718-40-45-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2AG",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AG"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8C"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479693/815-10-S50-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2G",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2G"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-4"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-4"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-4"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-4"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477426/928-340-45-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(10)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478790/946-405-45-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-15"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-20"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480459/718-40-55-20"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480459/718-40-55-9"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-42"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-11"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "11",
   "Subsection": "03",
   "Publisher": "SEC"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Subparagraph": "(a)",
   "Publisher": "SEC"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/480/tableOfContent"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-11"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477867/946-230-45-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>135
<FILENAME>0001213900-25-097860-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-097860-xbrl.zip
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MB=R\HK)RYA#+]4F($?TC"^"?1@8"$Y@$Q#\-#L.(<?"%(H/$X%#XMSDPG78
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MRO-+.'1I0Y-5SN*A>-ND]9"M2\O>.X61*B1)[%4E2=1Y=&KA5Q.><IY G0<
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M)VB N K0@ 4Y,)?6#%GW ^P'+%3.]^BG*3;G+,1ZB]1:&-F-D OBAXS'GOW
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M6,!:/6N&:_C -+N:&W=K*D%]DNQ*[MCXY2K0DZV>PG>MTPG6ZQ%RA1>K.<^
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M-P&]N^RPN^RP!9<=JEIQ&<3J]B6*WXHH7J"\NR>QNR=10$7S[TDTLF!_=_-
M56:6<ERP?Z?@<HY1^8CEKVL.$8G]:7;-HQ*6?;ILR[:/DE%]%Z(;JB&[L3 $
M)BL%</VCH37!P,U9L4LVBMNO%F.C6=TY\XBW(,S\4$?2&P8A?M0U#^91*[]J
M*^JXG;.E=B.T389H4]5.2OMLSF'XML[4WZL9^TN9?[%F??TNE8(3W08]*5"P
M#';W^%1.&4IY=:JD+=D])5-.;@6?D)'4"V+WIL4+>-."TWM;F=F*<HRF]@QN
MKMHQL#/?D1=9L6?3*=38X7J$$BL_-2R'>LU^Q(0LV<%) <+" 74RC2C:O4"S
ML[HPAXZUBGQ<R:R+<51SUJGXB@GO4BDBD6QQ\_ TP@;"K(PU],II#6LCD8U:
M-;3ZY9 ,?6H"4\D2""S)F04TVS4D-2D(#B.U.V?JEP)/!!R[K6HEG!ID@8C!
M_CB<GCC$L*#TY+(X'R_>/G#@Y[[04:+(+Y^Y&D$+F"Q-TK/TX- N43WD+%,K
M3W4KUX!LY+E/>ZBV$-7'>;*YJS<369TA*1(5QAX6X82$[SN,)5:$S+[Y?U!+
M P04    " !LBDE;;6X6TMRP  #YEPP '0   &-K,# P,3@U.3@P-RTR,#(U
M,#8S,%]D968N>&UL[+U;<^/(L2[ZOG]%GSDOY\2*<<]T>^RQPSX[J%N/O-02
M+:EG[+UCAP,BBR2F04!3 -7-^?6G"A<2(.J&JDP42.%A+?=T2Y6)_*JRLO+Z
MM__Y=1V]>2$T#9/X[]]\_X?OOGE#XEDR#^/EW[_Y]/#MY.'\^OJ;__G_O7GS
M/_[V?WW[[9L/)"8TR,C\S=/VS7FR?GZ8A6\>:1"GBX2NW_P_V?K_??/MFU66
M/?_U[=LO7[[\8<9^)IV%E*3)ALY(RO_BS;??L@6K)<\IX0O^]<WC:O/F;I:]
M^>XO;]Y]]]<_OOOK']^_^?1XSO[CW0_%K_R/OT5A_/DI2,D;QG><_OV;&J6O
M3S3Z0T*7;]]]]]W[M]4/?E/\Y%^_\K]H_/R7]_E/?_^7O_SE;?ZONQ]-0]$/
MLF6_?_NOCS</LQ59!]^&<9H%\8P32,._IOE?WB2S(,LEJ>7KC?0G^']]6_W8
MM_ROOOW^W;?OO__#UW2^8Y']S#S;D:DO\,/;XA^_X?)Z\^9O-(G(/5F\R3_Q
MK]GVF?S]FS1</T><\_SO5I0L_O[-[/-W[ -__.$O/W[WYV^YR+_[T_OO.,W_
MN_XO_Z'_.4_B-(G".0?M+(BX#!Y6A&3?O.&D/MU?-[[^F2:+31IPV-_R?W\K
M_?6W^9[HE^?_3 -*XFQ%LG 61*GC)QRNUM<77;,3NR8/&?OSFM&W^(K#%1CG
M?7/M#H5F0:QO>E@Q.JLDFC,M>OG;)LRVCVS1=PE];_@-B@6*'80.Q7F0KJZB
MY(N%T'>_^A9+W]S191"'O^>*]8*D,QH^\S\FB[--&L8D33\D[+9B/,T(C8-X
M_A NXW#!,(^S^S#]G+*_^L3_+0O". N)Z<X")XLFH(?->AW0;;*HL3"9S9(-
MHQLOIPRIF?EG&RZ6;TR4K[D*0OIS$&W(1Q*D&]I%HPE_%4WL=<W/+:$D9N1,
MQ2SY92P==4&>3(68_RCNS;5>AQG'AI\1=H#XQF)&I_D>5:V >',Q,SD+GR(R
M9;])*"7SARR9?3;7F9+?1]N@7$Q)W(W)_6\@7CTY@;M<G4[9,3#53 >_A2:W
M>Q+QFXV9#^PFYD^;8,:)FNY.Z:]C'JI;DMTD:3HE-+<F)EE&PZ=-%K#MEB4U
M6$LSP_!3NJZ*=?@^).SLQ/S ?Z#\?B4O)-X0PX^0_#(6KX45^AA\-59G]=_
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MB4\SI'E4L'2+85IILUW@3AA&<]=BK?5]/JPZH" 0#%(5S '>N ?A:!P^+:F
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M[M+K>$K8XV_^@28I_' -> Y'LZ SIMH!8CC;+^W$ZY L6$#.O==#^=RLD#M
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MQ7!U3YML9SH.5^;*;T>[PME5Q)XCO^>I8G=5ZZQRHA(?BQBF^9 EZ,-A3'9
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M$O(.(/=DEBQCWB:]< +EDZ!;Z *=.VCNK)U.)3AW"QB.,+JFXO"(]S22-K]
MVI(-A8.#)T"##*OM>1TS-4)V1? W);,(S5Y5E-"<YL;=7E&/:7W_* 6.E! D
MH8G2.59-JX>FI8H.L@:;W0 J\QX<X%B!]Y75H^6UR2PD8&:M.BS5Z <2,^LP
M8G;D9+YF<N(SC+/PA93V%TJ+4S.:/N.11GJG#J"A&+$:.?-&<^SS5HS^!7DA
M4?+,V<;$T(2B5Q=S9PB-9(C3,J>\E,M9#*T[N^0!&$%#HG[?WCW8Q:;"-SF[
MR*]DQEPX8X_[BS#:,(9O"=O6:<H^-&>]/CXF2VH]*5=)Q%A/$:9ZY(PP-?=
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M'S&? L"C7M&?IK/!1B,=Z++NL5)H\)5"8\-J[*1D4TFC05R=<L9QKB/J[3J
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MM6DW?_VR_@R<?FJ 3"1K,NW5YO36OF<?5@Q3OCK[-N#3JR%VVJ=7)^D2845
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MB(&P)86J  S*O@,6U9?<DXA;*M. 9ML\^R>8Y2C!.^U4E-",M>Y50,"'LSF
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M:46P5^6)Q3%B*DU)K5 F=-1O43MEV^3$D\K".O<0+$4Y9GAEDJ0],8%(XLO
M3UB3&8LZ:[1/D  GE*LO5Q:X*A2RXM=6!"$&\]X[?+E T&D< ;-)V=;193R
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M\-/*D7'8IU5R%%^" 3>JA1R_C^GF>]4&2HV>\\ZNHV=6$Y)L1HYD9R^1=-B
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M>//TG2CKNGB V%*^VJ(X):JO!?F[HI]T]Z;CG+!:X4,9 J^$^P(5B7%*E!4
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M3LD^3E\?JZ])O'[>13G990F=0.&L!A7#SWQO6:.F8Y+;61A-6,Y+]*W;VRS
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MLOG3L)3G3!=#7U0%S&3Q1++&U?("QV2HM-?&"-'QEA)MY1E1_6_ YQZ'^&3
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MT?-#C=5)59<9R.*NR_/:/_]E,T'<P(74"*_AW1O,JK_NOX.^9Y7[_^4'Z&N
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MDS1APC&4D=*<%%A+I3&]&N=[-RB%+*(#,OL$C;"YP.0(CU)RH$?5GO#V"1W
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MPY81CJ7FU<0MI%B[O>6+'1)\^WTSE>>#6V/"X%YV-4TBBU9K!R'L*?,LP^G
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MV<!W*%VJJ<=PJ"0<TN#<;-'<@8!2@GFTB%2^PZ,PM0ZUN3'5[T2K] V($U^
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ME1:7^^)*O3<.\9>\P8EH7->=F0* KC<9P-$GITC43X:BC=91Q\RTDO3@]M#
MC9PP"X?<E,DJS(WV!2 ;1DT5M_9]5#ZPL)QM]SHJN_</+*/L>G%L<LTY>1>5
MR9I&?B?IOL+Q)\P27FJ%:84+9E9S,NT;30!2G-*$0H'$8$,P#,;U("C#%?J>
M5N7YH;VK$:T"E72L92A&-HR?J$K&6^=PDMWB[2XOHN+I_>_[I'HZ9,C.9$!0
MSP=A.U!2)2H7M=]2K38O?H1U"&ASL2\&]19M;1X8#4]07"-X7D =I@FNC8LH
M$7F84K9_-'2?J$,3R09M>U*Q3X*DX<IG^)XUE!X923QU9\H-R@S@]%Q?/#BR
M=<[]BI/[!W($G9(=C^XQ$7=WU -2NP6O]E59D=.9W.GK$VN>$\..!HA3Q(I2
M86'N+-\FV?AL 8&A$PKZ&+7?(%^GT*R-@^1S09]'QBV !K4-WD4I;?&$;AXP
MAKWO:7%4(AD%;7W CRCS_CV'>A,ZK%K$$>:!6\:'V2A!IW0+\1\, !-/UR=!
MUL02/IZ.M]N<G*G1<ESXNTKW;OP=# ##WSX) O[21Q; 7]YN3_@[68ZE,CJ2
M#*?W]P6^I\UZM]14?+6YQC%Y@JKPUY@\4> 9*K7;T;  DX8>I9)F1[B]&Q7D
M1;QE]F!RO]B27[)$\V5=E<S (3E_#/8-(LW/FEKN';A]F_&X?HTV!!HX8KY.
MYCIG&O8/N2-GQ>,HI-=/3(6>\K$([>-(2_TX\I#:WS_N[#@]' &*TP,J]-20
M1>@A8DY/5^3&Z<LLJ9(H7>WOTF1]M=E@&C@O,"YHLEXQ)% JEYPJ 3::EU#]
M%FI?6P!:]/@V@8_&+C@%P*V*Y)&<1:LT6M<5(]V@)!D.+ !.3)-(P-0OH.Z-
M!<!'S:>IY)&OVS[X[=#BF(;7L%@N7H/CCSBBCKWXBN@U-,RAL;&&ZJ/N@S:
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M;&9/H?HQ8%Y+-IZR6;0F^]($[_9EDN&R/%W_OD\(:)(\F^$,$,T26'$0D"&
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MW*7)/2NJ?9M?LT)B=8!0(X0V]9WC/,?EI[PB)]TNQ15N[S2]$N2NEB9?9,#
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M'<M!L6)3NSH::H6S**V>K $C&@O.#,ZE1PLS^]Z[1."PE^&=?PIN\4N)"7;
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MF>,T('-[+IDRO/$A/5W^NF<G2.F\A%? 8K'FTXJ_#-V9OM/4DU_TNF"'^Q8
M!,2=[-*\4!W>(8_H/B+71<0Z<\;CVE?6)#RGXK]72;EH((Z*;127=/#BRFYS
MAD@K=L +;9,AOB1K]@V!A+K0)GLGR38SCUW9X+DE7J;9"-IU##ULD+Y!9<K=
M"Z+E0&OFL&4=B02)TU<5H)<&:![PF*62QRL>PYDF#^P$SH7."=]^F9TJ(VK8
M18:[*89O:C\D9@$T;T#T,8MRD\(> &?NH^:A.:02CZ!5Z@(8FK=>]VVUD@@S
M"DH'7J^K-P8K5. #@H]3H9B$%F6T33Z'=VR+G(P58HYI[_VP!(6PP,]SR^3U
MS*/CRW>L4:J@6:>;WK2SH62)ZEK*3:]=33I( K^;-)O)_ [T^_2[/BKDR9OT
ME8U]/&,I'$&'VJW<T,.<_'(PB<3H5M/'&44,=A-Q:V?KP*=ADG;8>0P.[O/H
MT$OM-&!"I^74J%CS< KQ*<_'F86?&I<*FFQS1*Z?5DA@#;7KI1=:0('* NMP
M051#?MK:8"RMZ$*IBTE<+85!V="_5,U3M!G!-U'#G=S=6DV-IGNROY.<9B^,
MB8&[BK78WZP^HQ+B%?$BW5H\N.8<G@%HLKKC%8A'>JARFG+J0B,N2+D5Z4R2
M_68691:[B+89!^/("H^NP1+HT%M+#7?Z,M/EU)AOO/P[6=$E.VCH*FA-DI8$
M&D^&#5H&CZ=3WF.;NC;X1M-M]NEOY!TQQ$I.\_2J\E$[J >]G[SM47AFEO1\
M@H'[?YIP,!]32"L4<4$#:R$V2X@@=@07ZT7J)7R358NP5!4R4=G;?:@ K;9'
M$7D\GKX<3S2U482C@D;:P "2PX@3LI)C9!AZ:'O(+D%$B72T>Q1Y!)#/Z6;%
MN"^>2.[H"TB"_^%^MXD'K]?E,&.(EE!VM-S4C.;++-XU'MX"J5@'V;82&QPX
MX?58=IGR$@!"A\5C7"_7CPY.D*Q.#2*(OL@OF^DPLW (&H32<O!@]/KF>HHS
M4H#U?*5 0(6)9-8C@Y6!XQ^7&C*C!P>S=%I*8B"ZIY5\L=UMT@,5>]'B-6&\
M?XYWMXQ[%_>+6S$3,\^++'[<%W3UD,*O!S[!^N$0PL+NA:G#,1>\J-,@ZJ >
M>OTY-5R?H8LO2Y&RQKWFHHJ9=_2(%FB8+="&%I8'KT_DFT/XB$EBQC@2E/Q1
MMD7X[WEMETZZ'1[/'<"T[X0@YC"->*8&>8)$A+"^AUZR=M_K=/SH7_R9[9MO
MHQS-]WA[J#^1T:P\X8/_ST>:%U5>]?=#7T.'1&UJ5\B0R&,F*/3G2MF]CQQH
ME 6-A!Y#BYJEK0?FID_/#3;/HQV5QV-49,U30 ;Z10ELJNZ(HRR>,= ,4[E]
M'&*PZW_=BI.=)[(.+WGA0(*OLA%5K[7BQF)Y;Z=Z=2Z*B O]MG"3)D)6(C'Q
M(2VBC?IW*'-]DQ9_I\4=7:9/2?S;X$F$X^$Y^3OU:*2@+>&RZA-QE7W#=0SR
M)2IX,^G:,KHZ:FW"403A\6@_&F)R[X 6)_Q7\-W0Y^3$R(>\6TU"(>HA@+7$
M5C'OJE*O\-_K C:J[B2K&I=.WZNBBP/N*@GDS9433Q^2XXX<6H(-XD=I^>H]
MHZIKW07>U5^K,*:G6ZVWG<HK$Y55<%OU=\+=OUIX?547KF/L77QU8,S)08$[
M- ZL2H/<I[0<':=:)KYBQP@PZ8%%J*"3[JABG>7XTYSP* CESTD!I_ELGNL\
M%<2Y_*:%=5Z1*U6%R3(G2E;\9+/T"V$Q @R5WV9"REIZ,ZE"-:75D<*PX%K8
M68RM)SPK5\;9.O5V.[.^US0N!G<O>:$RMTW4@B\:HL7_OL_H_.SF(33%>2-U
M89_7;JH$ML(MGJYRKTQ0 [A@Y?YQG%PB;:@8XIX>.JU6=A1FNUN$F3G=7]*.
MH%>)&I_2[#-3[K-H%S.+Z)8A'^=YFAUNTIY=:EQAA^DQXH8<9DCNTH1]TJZM
M$4ZQ.LE1HV7N[/ -8+VCFPA*5499<>#UAZ(E[)FR21C/)%)^#04OU1%,^]^G
M2?'<2R4'FCI0YOPPV*,N8@&%[YA;^' &:CVLJK2T?D"&]F[A#'T0[NEF UW(
M*+N'19O39'6ZVL9)G!<9[PLA\1G8BNTR<[ .+F[X8?>MQK=EG0"H6QC80NTA
M]%9?EPZ<\0O ]5LD ;;I0,&[?DC;=N4X6>YYK=8H61V7:OTZ=^>1=F6?UPQ-
MM41>LSCGSW=R%GCM&SJ)M,/$TS^QN2/7H;EC4"]K=SE;:FJ:^.%3H4Z-B%]D
M\1.;;L,]$>>R(W"O[=4.=0Y5-+68.=5T2>5(D3D8O'MR/XD:LR-PW@R7;'.=
MOM*\^)AN]ENJJX/GK7K6"8(X!KI@Z*2-&PZ$O' H;UZUQ1/GX)OJ(WNCDCIQ
MSR/P33IA1BAYID*>/'.AGANMP1Y#."8[7X)&0[>YWW":'Y'A47Q*UH]YB+Z<
MYCDM\L6.%Z].GJY3=@A'6798IQF/S+I,,Z9G0S^7]T @P"-/=RRQIQT*Q<$W
MO"IU6L)@NQC8;RJ4T,4;^NN%KMU.1[;U=?=TF.Z^8'8DN]=?,X";<"K=1&/J
MW; OHA;=ADMT7O"7>%<MG[>&:Y6EIYZW&3G)YGV3%O?[QU_HLGA(ZZBK<(J/
MX#/OK5V/=/>=/DEE7" -6_9P*/7IN10,[/1ZU+^C2QJ_\$C#Y3-=?K[-TH)R
M=Q;[Z2F+MM=IE/1KC.$(.M0-WPT]-%9;#"8[.1K:9LCA\".,9_K+ ,SBKM]-
MRAH_J#.K/&_]Q@F4OJO]KOS.T(,%H#BCB'?%,JLC26L8X>MS=!5W^Y;?B5_]
MK8>+]1K O]"K9)EN*=NPH:PQ9-0DRW@3E\DY*[K:+WGLPC@OI;W1F-I:[HLH
MUDEFNTOA[2E1AT"\%=2:*:(O^GZL05)E/!6ED3CCP\3^NE[-)N;/3S?\>[HZ
M9T;8LM@<F 7":PW>9G&:B1#$T]4O^YQWQ!E8XSV1"=(&TP-AM),2 .6]#IFV
M0P^TT#Z/893DJ'&F+^-Z/K;B5O?0@2[X1%-OT#@J6$WGUM4L=.B*56J-2!4S
MO?UWRS*]H)K@GC[Q3I\#ZPX^3P _ (H,HCS5=R07'P:]RUM%IBJ.F=3>U;8$
MD#NZ2S, >I:NMLQR7<<%Z.=[&N7[C/Z4OG[(V?XW6CFXOEB$R!SIARK:;[KZ
M AY&SQ;G[T.GBO@I1./!RX-5??6Y7"5B4C!01MX&-1--?83BJ*!.H_+#]C88
M="/$I:;;"1%Z/2JI:13V*N%- /;1YB$N-O (<)N*L*9%]BY+][M%)KIP%I3>
M1%MV]2G8U8=?@I+]EH[BLA\/S\F+.8U&"I:F(N8CU80G?-,](?6DA,_*'\3*
M>0F[[_"9"<Q'?JYG),J4_PR;)SVV\MJV]N'$YA$!([)V<IATS3/$1&-<F<Q#
M!R\):I\O3)<<"U9H%J'\@%!^P^4U!T5]LZ.\KB#=3QQ%VVR"XL*)_BG8?<N
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M+-KGM,ZH7JQEU"65NNY1:W6@N<.591F& $2QWT?99UK(][?Y5&$=5F':1NV
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M*%38^09\VF#.H4>R#C&71LE%.6Y>D:&.8C0U1D8Y,H*&02P^7>XA2VT,94/
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MXZ?C.<V76<P#H])U>=Z\2^/DZ0SPS9(H62F/CG=Q_AE*T7Z OQ4,'7#+>$?
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M"_H,)B"1(OI"JI5:APKEX2^GW4G%A=F3:P%MH!+CV^@ %39JU!HY]0["W0D
M)"J*+'[<%_P?S<H#IL"@\.(W<\ N<Q<.AKKU5"\^[VD$YBH, G7\D*2/.<U>
M /&K9+<OFN9[?@>!CU"5Z&V4QWFEU<8Z%)>-J-%UG$0,8+11O;U+")Z+US';
MN2-V7R*;$C [?#E^*P)/QD_L<*[Q8P 8@A"N&A5,J]8;MJK$N<U3 _\MVJ7Y
M?_&<:7ACWTN=BQ[3O?BL_F5.ME'VF1:UG0">SM=TOX%Y>3 T1+(US_U@"CJ&
M[%!M'D]19J_Z>9.D)D50:F0/#VOJ4>U8DT,,+7VS<S)51N2-OX;UE4=(LZDB
M[HYN:_+0BCV5CBB1]LJX603PZ4FRBU?#@6!WC$M1.D/4D;ABYP!>AT-^2L2W
M).8?S\-2T5"!BP&C.-@VS/!ABW?!+O,1W*@OOD#E'(I>&^3WI!I RA$S$09"
M#RX1(P-"B>5=%"?0>GJ1:/*@U-8JCL]> (]\LV$0OX7K'I9=ELE6-3O>JF:>
M+V!]68-J@!^O0QYK@/DBP;=V\R-9QL[QIP3ZF9$G4 ^>40X6^3-=<<]XG-#R
M+8'770"C2548^&X6#E@3'XQB-S,O8+!K_7;3M.=+#6T][ $-XFEGLTE?H?*6
M_RMI+)I\@!>!BEV1?//(5&$=%]_RUS3X[=+Z);RL[ M1,"O:[38'T"T^-QN3
MLXL>6;.[><:NHOSMI8!X,04@!$WP*C^[C,*_Y9_D9L:5=LE[=^P!;BKV<;A,
M'GL\V,",0G;D-RLJ?OJV]$&_E-PC4<D^[H1>E7&),/%QA'CP?CG]=0-=%(/I
M73";\DI*^5S*^"JY90H=Q:O+C&'W+'Q"N'V#YM_N!!2F<!(,Z 2=0\* (\4F
MF;MS+)1!5"*YJI#\D ".I4*69;IY24A,N%?Z'6#/(=6+/2U+?O."G',XX#I1
M;Q5T!QZ&\X!KJ\F_R]BF+Y_,[(^4927WG:CD7HGU":! =#* T;XESZKXOIYH
M@Y0[,BZHF2,\1.6E"X*G<^FPM^[01QMT%7$I+9"<!YWGY0/(/)8Q3JY!GC8>
MS4" Q\67\"4IA20N&[Q\E7S.G\/JTQ-C%8V>^E!'Y364Z:_"N[8F<5R+@&3Y
M[1R6B 9YE/THH<$X3Y^B#8155@$J1G.D^1ZQ@<$B&+4.6)N-!8*0ALO&Q(J
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MG/&D(.;PKJ&NMGD]:NCI<)&'[D$CE"SJ'C4/3#GR:*DD8^2B.G'U:VCJIH[
M>XC*,MI*:4U&QG[#RQ'(^LT5U)Q\0[\L-WL>;M7X/>\+":'R%&*S$MEL#VI0
MY.DF7O%_IQF<SH]Q LV?J\Z45575_%M1IZ+1GF@&?@ _QAN4S%^>7ZDRL@W.
M6)(2GK:AVTO&AN^9BFQE=3IY,1-6G7"\,YW*]SMH94.@?R';/>?P(#<,>T92
MG2;W0QXN27&:0,XGDUJ'$MH9W-.A D?*1\ZG>G:;((,$];0'M;>E#R2"ZLGB
MR /,3$*I_2:U>$3&% AE'C+14V60C(D-X8QD%2MI'=JDDU72 6DH+]NS\94@
M1#D*I\6&D'O9"TW8!2O*GO"4I(>T8(=9)CZ5Q<NC!%IS[S,>> <]U**D:J:=
M4YFELX)F-OL=]TB63;.Y?0;-R^*7>$63U1MVP9U)S^P&,PRR;+$LX.YWOWRF
MJ_V&Y[Y4_1]O,UF70'A'H!>+]16%?;7?1!F/OMND4)U=^*[J)IN[$NI\LHLZ
M4X]*M2<?0^VK]]#7.H;.(J73_)2M.7X=.8-">GC[:#0F)*] UL\'40ET%L*V
MTHQ+UY%=,Q3G+;N&+@_6Y7O>6+9*CY8='R\N'(X2GJ& C[C01]!:1@:[B'(#
M[2VTNX.,<W;]$6TJP3!XXNB^/=2?2%?H*3.#5LTBN*<O4;R!?>DRS=Z!42%+
M4O.?A3-<MPGH6ZOR?./H"\\WKHNB"E\8^0:2UGCU.> .3TW\=1\7AV])M"^>
MTXQ[8'CUB3(<7[1$YQE1;'+R39Q4'ACV.]'O1'0Z8<2MA).;-QBJ(D3R;T_X
M;^#[G"&5KO]?\OVW1T5;[?AM,AJM#K(K.]GO>,D3&:4#X>>"9:0"( :^>036
MDPB8GA\1\U\<K1^^M4\.>VWV<LP:AH$4%+.0N*1.>%(1+]?!/MALE(*-;.2:
MQ@5;VOD)B=>\2VV\/.H:%VS-3J+'^'J?<!G]GO8*2=^94#9\HWCXBG:*<ATO
M2Z)F8;2,+[LI%X=>;X*93:,16$8F_JX61GGH_<X71B6[  OC2&]^CPMC%V>_
MMV7!29I%T.CH@@NR)A25"6M$Y6644-<2ZE)5RXBLV6R@&H+,$D8Y$&RK@F?T
ME:V4F::*I:9S=D!A-*C 1: A-ASCZTBJTW*?M*\+=5B]OV*5!L/)PTB<04 .
M3 D9AB^;NY3Q5GQ-HRY]V<Y&)'TR"8EM; Z;EXX,5"@XS>$>SI0X!=-S9KUO
M*5%'LVG;<$2$20!M8L/QGG?@DW&QHL/ZX8[MJVXG^5X9+)O+SR%8"Z$)%8F1
M!P'?(ZONB-"!2A:Z,/?2J)?(7AFKJP(25#9:FLSB,; AY!$"_?)D][SS/52M
M%PW6A7DH,]U%U*CNAE<WL(/* 7N 57K65QQ:60.-@9R%[%R(-<C1G5=!5QU$
M%=J,:/%5;4&GXF*^.TK9FX/05'(,PFE3'<J:%KCP2)GK.'J,-W&W0XE+IN"!
M-IMR_#RN-AAE%K%@K @GH$R));VC\OJ(KY5&.#?$I+7OF^%$HJ7%(!$#[4&W
M+1Z2P/!JY-[B,I&?'V]9\Y")EA:#3 RT!Y3)QQ1L%G' V;T!XNO2/:9S H22
MAYX.5!PFLH/Y+&6@:+F+0E2+6S30J3;^IZP/I3M@0HG)2B(J,4?F!%Q*NJJW
MI?_"OK0^:4L%UVZ<6:TV-U)Q67;@5$B!IMEG*%X=[>("+_ DOR+RLUGX0YN8
MXW+0$!C*8&OB<D[7\1+O>5\[$5XE]Y=B'+2?@X$DX@^"C]&&OR#FSY06!-+[
M9B@>2:NCE!J<:?H5TB8)[-]1D69'3,^SXE]GSS&%:DS+/>0GB.R>[#V%FW[Y
M]7-&UX+BG)',R5U'^2.GF8%@=/_PYS_239'#O][ O_[P)5_]'QOTH<_6!J?=
M* 3.:52*CR#5$"+'A-AJ'44$BN)"Z^">6QW3]_F;IRC:_>N!;G=I%F6'"_ZH
M?QVS_ZPBD3-.99P ^H!1CB5B\ E1AI-Z?! SI@N!JH2Z,Z;'HD9R&R[W$$;Z
M7O044MJG/3Q3)>V!US^Z%7?$T\><I[,VMP$5/%_KW_WEQ^_X>A]^XN'/>YVZ
M#HXWLJN4H*%4H !.)'12@B<,/H% &F4&PJ<@<@Y23A+<[AM2M0PY.9YBF'3#
MXT_(F,M8'V5S*2*\\;)"8K"L/WE"Q#_E?]]P<*7V$"5BYX14@$,HRA ,T6V<
M_@R>5!_.*:_JQTYBU]N[,N*$B#'D9_E?&$SXZ'^&E"E.E$YB-A:,\!IFW>-/
M5R\Q.-TN*:U-(^W50GY(V)=$?!K>;=+"'MU$$3JGL+L;>)S379K'Q>F7&"V7
M(#\A\,T<;F4*RBA[6V1-I,OETKJD$<\,,N2MJD>ACNTE"+@?JR9'!446//ZY
M!/3/0,+I0;-N-^K,L@ 6Z&D./B\P:"R;$_^.6X>MO2G@RCE&']^=M'1.O(;N
MV?%$\[=-%:CQ^4%GD/$AY&U[D8AQ00]G SU:>\I&_N1GA:A>)AW\>8V*+AY%
M]KLN/VZO@G U;]M$H.L IW@26_4XASI-5F7^M'G_$=^2\N/Y<%]'!'[11"F>
M]N9(G^#:=D>A+!AODKG:7B6\4,H^VCS$!;O6,C3!WH *J=D[**ZRR* 0:EP4
ME-Y$6WKQI6"7'CC1+I+]EF;&7O%R0E+->$+.%N?O3T@]*^'3\NR9<F)(E.93
M$YB0_%Q/290Y_QE&"4;GI7X''55P [_ 6#> 9D:/N&FS.S;$PEFB A=KTG!5
M\!*G,&X65HF!+G1KL/)BBL.QU+,[RLS2>%G0U5F4/S.5@O^ ^_@EVH!'S&;I
MU^,)C.2KFO]0P]!:^0'6KRNINN78C4V3;O'7:?+T0+/M.7U4*\_HA 6?OH%O
M"7S,=F;Q.7D/MQ<>[Q#X&J:A12<-E.0)MK6FB7O6P\(_F[&%KZ4'M_ -Y$]N
MX6LR2K3IQ$K2#'P7WO'FD3(SD2U?"?V9&2/EPK-8\?!IO=>T53R0#=>F0*O=
M&*$3;C 7V]TF/5#*5];B-:%9_ASO;AF7+^X7M])XX#^C!:TE!+G+5##(+4]Q
MAZ'?EB\_4*$:?A'*JNI.M4YN77DVI:5U&<79QVBSITIXX7L:07VUU2*Y@\A=
M>'EZ&^5Q_B%)'Z'($SP[7B6[/;L' ._8*&[#6Y][8"[")X/XAFHZ4LX'>1K5
MC(1/>4+420F?E32G)3_S>H7:!Z-0?ML1F*IU\(XFO*EO8FJ/D[*SWEG*(\?A
M-4TFQIY'!S1=2T H6Q96+0T5(*1,$P8PL[BGN5.-'K]=&3?EWG*5O%!1A>0J
M6:9;JB8PZ2S1^GLB!H!_1@P)>D7#Z- M23/-$Q[4"R@T<YKGM,AO&(GF*QC_
MF(BO3TC]?4C37TN CN4&2B=^7U&>V<!$J[;GNF8I^B2LOD>*:W!]6A)E?$B)
M.)"GDX\S5R:]-90+4RS3NIPJUZ8/]^]2AG.R-:R9$D"U5]4P3HA84!_N20TG
MM%'B3+!^6^O$K:G7G5CSEVE&XZ?D(?HB&VV\I0E=X['TI:-)CB-L()$CR3=R
M[+>!KX86TK3KS84;$TMHL>.._N2I;(%B\^!6 TC5 $D?EA'D:,*HT1Y/9M*G
M?_;$JLP@?BEN,M=]W/CG<PA:&J2RSL2NJM/5BK^,19M;GM"OY!_IN%]_3FY%
M08,RURKT"D (T>F_D>9I(HY*5&ZS=$GIBO=?:CC3T.(%<H!H!7+D/0PM Y0:
MG10LI$^Z"KC1 *8ZO%:)3=%\,9'?ED=!\%M)$W?T3J(C<<JW(%7,I0$']2F8
M$9?1"&?ZD9[7MW "HTDY/'#<@XTZJP<=9\FTNU(9#'6:K.X@.SA?[(N\B!(X
ML "?'S4BJJ+ X&5;C"+*L-!;DXDDG5SL+ @0FJK<6YN)J.U"%GJ'9'VC/\J4
M)C4$'M$Z@S R1V(-?L@.S)IR$U3J7(K\0]7\ULFMS, \+8HL?MP7_'&A2)D%
MEF%A(\&2C;2$:3<^"QM")*:H+2^OTR@Q/]W*KPG_G,#W\XG!U%."KA43X9,'
M*.@>$/H_M^B?6.;TOM+W447[DC+UDF&;Z7J?1UA\"W*%@2&MZ)[9+!X#3:B
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M$1@XIVQ\,W'HJG3AR:0/9,K^+:+#C]SA.A&I1UQ=.$G[)A D= RG2!O#8N7
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MD,$,@[_ '&S8$5 YY3S9W[;3L(O\0DZY&^E%FHOBK:VKWXKG4+R :LADR]D
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MNF;^/E)ZLN'*O M7R6_N/3=Q*&8=4T#7>A3OFOJU! ?"B6KH>@;.4IH[8F'
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MSI.KW[?&>DA,Z:,02E73E?]293[6.C\::O>TTF4)D%^@==&()DY_N,24.FK
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MQ'(."T7ZB)<H84F+L[WK]+!AF8KT=Y47;;97 )"#"*H]GF:96BXQ&,:[MPE
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M CD]5X<O"B(:[VU8Z_O%L*]P@BE65[C\;V-G5<JONU;#JH#'G#QK0D? _EI
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M3<%"S#HTYX'KYU@;=("&55ICX_0)UA8E3TEI8,=-P=2U$ND1/*.=([^JAC"
M\K*(^/J4D7.@P5&@P<!P&GN@ >B4N+XK(5XYH=Y1?B'9JC-;)6VGS:9M[[HV
MS+?%6@.\M]CC.,XD&B"CJ^\=!X#%YBIC4[22>\I0DEG5%YMN3+"OVS3-L3,3
M Q3'L^S:L=A7Y3/,=JJ)+D7"^OPVHBCAU,PC=XG/&&/'@!+JE)6@4PE\Z]4/
MB$2LJ.8V*CN^W49UB[=QZUH)WB/2O\#JPZ'RE<F!UT<6)P;2?]Z.1+I[K>!1
MB/$XS8A>#IL_T)=&\'4T=]PP8T?7:8(WB,RKEC IBN:">8# I6 '<"<\N$#/
M"EJ@C*_'R?R%#>-[C+<H9"]1P.>\L[R7]@I6[&L>O2ZU?+2DJG9QAY<H-,SH
M;BS@O8++E"EM,GC."*R0H:H\3YB( )^CSO+'?8ZZU )LU*3-NP+W]I:JG0!S
M40+HN/DIHZ"Y56'/V2&8.AY^JLLSYRP*V&:=?>+8$!0,! ;/+>G" 3+S) N;
MNH#5DO5\E*IA8NI&_'N >;<N^AG7,O!Z2&=P*GXL13:B9DJ&Y[9V1G&VNWMR
M>%^)@1T9;_M(9V!!PO*6LYWJ(F[\RLWQ[8'I.]7(Z!#WT=' Y&SS>S;D17>Y
M0M$2IR0Z'/;=<]T9WG<5N-M#<$"W7N_RYJ>HO2(GO='ZS/ @F-[5[;4Z<3\G
M&-]Y'^^A+V?-\\WE,$0FEST#'>3U<0#XGLHB.6)B/H$EW.EPJ3'"N<C0MVB#
M(%C*<]V!6/P8)T3;]Q&UG*$TW![,Y+9@AV0YOQ,OI0R1$<%7'L<3CDB<,/FP
M8$=GD1$SH;MAP*)CW>8L:Y*F<;*UU4[\E4;,!,'6H:*%VIR83N]B%-EPH+6"
MUS'0<L*W=VI>!,Q-5O"^745KY XT6]G><+Q! 9ZLXQP\AB,$,R*>==P>,=^:
M=()-VC6K@(VCY0PG:X:DFQ@<#\*QL(Y+'<"YIU;L<L@GSV4U$J$4<<=?)\+]
M,U0<8#PONI6SS&;V+,S&_8 S2@)H/)>V]%C)2.4WV?81;]"VB-\X85UG^2-A
M6)<L!F:N^*W!+D]T,O\U3S.&W</B%Y0DB*+I*MN3"^M8;K,>BID;TJ)1(XKN
MNWWE!*?88=0<$508_,F/TJ/F:)*1WZL!'%56;[2\C--B.AUKZ<'L5?"7.U6P
MHXI02D^8.B4KCO_@)<5>Y)& 9\E+?;?C8*F,5A43_PR1;^Z\PTV>Y0G^2"*R
MSM?3ZC9?L.E3^##(7G4!ZGV8->URP\/D)DYF0DR@^MR8 ]9TUYC0V)#>NK4-
M* +GIV'#_C+6@LX4$:PL^7IE?EI1'&MG?4:_X."AF0_#AXOEXORWQ@GSJ0G2
M#,:$NX)M..D&(X?EU1>3"GF3?SWT\MP54>&-&Y*+[8?OHV*>B]=O(^VZ>Q#F
M/L'::];.^GY=;&5><0@#%F \N5O%P0,C3&C]X,2Y545'Y)MVZ.*E<'\75GS$
MZWU!MY';(EC*,T<$XM?J.W*P=] R"P#GZU.$RM 4W@6AIA17DJ]96(I]M'J&
M*4)5]]CM([X^-KX31B4B $9P;^4;=1RZKIYLWAE&QUBZH$\;3\)&.1&L2RVL
MS#O!?3Z,8^7][)E=B%S^F1CG0[<BIWLH8D Y"B4F7I4$YRI&VX=$&<6:;C8,
M":B2&B.8 (DT'Q&%5M14-=^YIPF) K)AW6WN*4UG7W#X@C]2'%?0<2L[7/P6
MWEL)BBB9QX AOK-_M-#_-T;)[$OL4XQJ%'P71OJ1GQT#SKE\KF]OFX/A)-GO
MX#YW?YO7%LFTQO,IBX//#F]N/D"X6[IG??,*M_:""D2T?B<% Z[O=0& %CRI
M#K?W]FNKWVM$3>H/B@HM)<[;@UN10,;TYV6(4JI#R[TZ>%(5PO$4DX/6%JW'
M C%1!V?T/?[RA!/6^4&X'8M2+_75_;ZG]DDYXYX&I;R$QW?X73CE9._J1\3)
M?DJ!E1H;<?+2*2=[5S\B3O93"O@Y5I>3W[ME9>_RGI^V-+G93RVX\F?+0'D_
M,R$#YB+>CINQRF0#J[$^%9,1UGGS5,!]@/F*4C"=Y-DJ3MBS)?!AZ0%VO.Z$
M]$&JC\1PD]X,-28/P6(NSQ#\KP#YT),^&%_3U=QXY3 =@.MWY+><S NJEW_
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M?4T4F%*L29K&R=96._%7&C$3!%OW-35X.IW>Q2BRX4!K!9_UM#V$;^\4>("
M]^TJ6B-WH/FH]H;C#0KP9,UF.S@U'QM@1L2SCKLCYEN33L YG$:5C7&TG.%D
MS9!T$V?A03@6UG&IX_-=KXF00SYYSLB6"*6(.R[Z).@^S,4!QO/TAFZ%I12R
M1V G@PXD@,9S:4N/E8Q4?K(P:\P>\09MBP".$]9UEC\2AG7)8F#FBI\)++N9
MSG_-TZP<C_$+2A(4'4[5 NQ.RH-U++=9#\4@<^ZTW'?[I&5.GO&H.2)([P48
MM&7TXK:.DXS\7M!HU[NV&M#&)I62M)C9!GVHE,&.*D(I/6'JE*PX_H.7=B8B
MC^2P LNM[W8<+)71JF+BGT&JG5PW-,FS/,$?2436^7I:W>8+*JZLSK8=9*_:
M\/0D$1GV,^&A<1,G,R$:4!U-S %K^FI,8FSH;MW$!!2!\WNP8?,0:T%G6@A6
MEGQU[F:.>E8YZC/Z>0>/S%P0GFX9%PK@,.[1)>=8F.ND_[H B/\PE4BL9?P2
MM4\WH?[^*9#[^&9-^.[ZQT%S#EU\QFV?5O3 S]RJ0#X,'Q$FUPI00$V0OBP@
MW'6B T50?"=3265;RC;A' DC+@B$R8E:E,/R&A!49D</O3P/CU!(M(+D8CO[
MZJB8QTG! JI,.Z$KHR]Y8O!\G1W'LSCX7+0@F5_EK$A^6C[MKRBITG*S:1%-
M;&S\B174%YG^T%>,'3*CC[M#$=US9?;!X7>K%7W':F$.B$1W@HX<->O]\XC7
M^Y8:1C$_P5(GPSL1J:S+U6;0SRF?(E2^ N'=>\^48DOR-7L!8A^M,AZ*5Z%[
M[#9?3A\;[^X$^'FWYH]]&9UQ .%@1G+:M'F,%(5T0:^F+QC?Y32#S%P!=%.'
M<5!/\'0+Z6F1&#YPU2O=0O'RDZ-0XOE4>>^ S[*\1,J+[4>4,7)O^0^OH'FF
M'&#F5G%SX6I9*C+-U+4I%;B ;%!(C0A$*,$2EJ21!BC\-T;0P05K=+Q&D=1$
M0I2-:T9^O[.:-/"_C>[IB9M]P>$+_DC/[LK%:Z8Y+CYO<:=RPZ.[>9BRX[N=
M$_)5N&I\-IRD[K=O:O?W=&UJ3&LT"X/&2:J4$!I01E3_^N:UZNT%%2AHG?0$
M!MPB+!>BE!Z%8LE.^!'*KN?"\-MJ3UE0#RKZ+87$6\>,(GN;Z;TF,UP\Z OA
M> KK01_P=DA>2-3!&7V/OSQ1MQ2G$^%V+.JLU5?W^X[<)^6,>QJ4\C+ <X??
MA5-.]JY^1)SLIQ189H 1)R^=<K)W]2/B9#^EP(HMS3CYO5M6]B[O_75,BYO]
MU(++9; ,;/<S$S+ +>+MN!FK3#:P!B>G9C(*_"V8\7R&O;F;.RS>-"9YMHH3
M]MH(? !Z@'G6;5)?^* 9MY1F@+D94"PMGZ\&8&<%R*<JL^)C32C &"T $^_(
M;SF9%T0L_X"C ',F8@*S5 +V.,^JC(Z^^M'5F,[P>A,G*-E>4QRS[25*DBV)
MEF7I;CEPB+T]LSP02N8L2\ASGA5%K_%]' 7L/38.Z<++.I< .K;C $&_3P3*
M0N2"-6"&K[UV:5@S^W2&:4)<S,]1 WN<VD5&1V"+V.63T2-FD]%PE>#"C-WU
M.HY4'HU,>YNW(3XT(0(]'*E L*[C*;. ]H1RXCYV@%@ZOXWUG#T B0'Y?072
MD+NN^]OE]OEUQYO"EIZ_X=YL;)]@G11A<@#X3ZG4B39Q"-0IOS0K1"^>@0:(
M_,D@^;6!M3@A)9A-64-V9QG&JMZ!!F,E']+1L5) ,)OB 6-6U@] WX,]J\A7
M/ )F]9#$5QWH0YZE&8J8S_NP831+/[',V-F7>+:*<S9,>(:C:6C5V5T7QC&\
MBVG3#<YIU*K?V;6W;6&YPJ ,UH=R! ?6@'1P?32/POZ6.9T0KV!FCO#.[;M$
M&Y*AL'0(:_?P)D[*&I>:O>#^L2Y\KQD=_7&#-L.UB0M;JNYVC&U&7DBV+8XY
MJW<*JV(G28C,?)!M ]:LA 4VRE:RM*9;6W"ZU'YL&3FMK%.HS:%9^!I,?B]0
MBN=4MEFY9G7X$A0MBQOB8KO_2%4/-_F"DKFK^!H 0G[C<"JB7?:@-I:MP6-S
M:9+M;8:G $<H(;%J3(Y^N<%X^J\]T\7K>FL@:GOB&6LEY&JP3O>&+U:M%OL4
MI1L<D 7!<_4P6Q\CA&O[,59[A6Y':C%1!*&U8Q,H2&T]?'J6,=;W.7,KJ&%6
M9B6]4-HPRE KZP.;F5"Y)<7/A_E JE?N,*CY=NC!+OGBXAJ(G7!3[@<UC)K;
M2&^CLK_"AR1.1V,I23#T[7O#2JI37D(FU3FRW5.M??V"R7)%C\V$XH>6^/HK
M3@*28A>Y,T-B[CG2YD>@(3EO;C!P!-VSW5!MO][A:(R&#EZG)+6#\-'\_0@F
MQUG:6*GA!(ADSVWO4#X")V66VC#"X&V*^T;LY1:O]W&4%[D>\J<IL ,+@/DC
MG55%C\M;8$.2$=[E)58G);,#,-%\,M^A>/IP^XMM%-_9G<:1N?T\#,]NOS(O
M#68.2AL>^[,:.IL[+KM!#_U3\J?\R4 E_'\YH5# )4O3",/1F0][O$Y)= ?A
M8R6E/WH+!5C>.W13"TQ8&M%8;0@>AF<;0IF7]=/!6)^V^NX-SJ:.R7;01?^4
M%+ _&:B%?LP/9H8OUV/1SGUHGE6T'E=KD35X^N(,F/=B2S3*-,KMCD56A?CY
M'?\W*@$5\["63(/GKJYD>I;+,9D.0%B?%:T5SVOI-J@5 ]6[S_U[?=;>:SE\
M@_Z^,76&M>)_YT+6!][!2;UU>!6%^@A O-)Y>@@ICC0SJ$9I>'3Q.QL>"CRL
MY1+@><Z_8!Z1Y:&*]=GRL.)Y+=XZSWO0K\\65XUXGZ*KYON161TF.SA;'5"B
M4(L_R .?#^7^,T[91J,YFST:L-?VF/UJ[%$09;3]3C_PIYT@+P-U&8&<2S[6
M\W!$-I#E9KS;]Z_AZ*B95YZ:R=MR07O[QV)U 6YL% [(2$[:.#@"7L#EL@E-
MU7MZ3[)JB'QOLV;33C0B@$#=:'J7MPB$[(!<KS=AO,7X"2<O5,\*M'Q8+$=8
MIZ-'',3+B WX*%_N+^,TXS6NL5=,3G TIQD,%AW'#8A:T-AY\1;TCU9+;[H1
M:F_=K&\CJN3PKHW)786M@W[6,DB>,YA<*JJF\$B)[:DCM@ G)\VQY;"\Q@X4
MSH$")P5M?4SX\@%'U&X*J84UF:^IX<144D9><*6CG+1;5H/I][!J,DJ1C& C
M2XUXS=HS4@JL*)97^ 6'\89MS26G52!Z#EMK,EJ)AE!CIT[_J@(W1.$F?IF<
ML K3:OI(9R.5F  ?,D6@OB,2CGR.IC2IDA\RH.TX$$ W00)$E0T)<[JQ>TPU
M5)I2@A1;;,XER^)&6]Y5'-(MIJ"SG6HJ%ZC0N^T)!WE",C8]@ALDL!9L"2!#
M*Y22K]3W=_!]R-IK^SYM_4QJ'IP#NOA_\#F(ZK53U!O1O^)X #-2#[9G\T6/
MSYID]?Q.(<"V4H4=I(<1 R%TO_X*B!R(*>NM^=G.>D )B^KO;CX7!Y\/PZ<=
MKL=5 8T,6H+!#7$ZQ*D2,<><JZ$<URTLI!5,7R['EJHC"]7T0:L?G1D'':#G
M+DO@$(]ADR@C\X[X77]E@XWQ_(:**7.-\JQRM@YES^TK& AR%N:E)7Q7#U]@
M:/FQ1: /'_]!#$:P/3V#6")_L>4OX. =S26FXPAM0FK(5A3*)8^]O>#RD;I'
M:^SD#:\7G%]W:X!SW"]23>*##,]M#+L?8.IJ'S2?6F)@_O82'K++OJ5DW,<9
M3J=HR]2?:[G@P/+Z?.]/+'A4!QKIJR,/#8SN8A2E%L-"!4MYCJ<.Q&$1'>':
MMVL-_RV3;6?Q-$^"%4IQPS:WF??;O^RKN,55R&L^%EBDX,^VM=1Q'W[^%] >
M)NLX!^^U!8/3,=_-\L0"&)8!#L%U'<VE%U0:AV3.LBGHSW.6.#&_(1&* H+"
M7;I4&B\>-ICEND7+)[QDO^J;E6L6SE7%YZ&##U!(%P !TW=0E@A#H82D$J\=
M@"GE'RE";$P$*W I"ZWM<741R 5 R+0S0+GD(][$"0.XPR1:LL-;],&5X=)&
MQ54<UQ66OL.Z<(>PG5)I+]Y>1@'O\:!X%QP"F@4L6-CK]0JGA.IYM2+R>0MQ
M'@HMU[NU5@XB*+[>JOLEN7E8A30"MFU.0<B=7UH0/HR90?*"HQQ#7YN[97V+
M@6,KHWWYU:0$/$!ZL9]J)U5V].X5]IV1P2Q9SF_3%O<LE5$2KO 'L'\*M-7+
M!^+':.T7Z_Z&()")T$;V2+;"":MZJ/H?T&WLM@5ME,A ^5+'>CR44POP &KQ
MLET..*5KQ5&$PZ:8%74MMQ&+)3&[BD6%.QTSC'0Q%&POBEN-^6#DA:L;TY./
M1^8<1_.'Q8($N$#5B-6<97P\GZLQC;=G\X>O _KK$/\.+\N:W2!@ =JB:XPI
M!T1KC9<-PMV;OT59\**EQFN\7=QRN[6/Z%K;T\-\:JV=GNKX_ZY8U%G_&.Q'
M#E7,Y[>"6/P[C)S5._(@G+J+)Z6NA0D19RBT/YI,4]S'4=Q&3MK("T:E]@-]
M11$=53: 63R&C5\0B5*V2YP^1-=?&:(Y25=LLP^+*_P,+2C]\'S+B-[Y:75_
MZ:<E?'A<M_\270>G=:>2YC:!&2V#Y#<]R9S!4NH9A!;:4RSO[<LLY5L;5.?[
MSN TYW(?$<%B!$:M*P9B[@GRM9^E)I=PVV8[=R,9B?G%;V5B$LLX-,H=9]S=
M()+\C,*<_G@;O=#+IGAB_CL.YR2:)7F:57&:OOPZTPR['?R'0_BW+?A ^73:
MX P?43ZBY#,N2D[WB9LN<N+$<,QO==Z:'>%WB/_=6%KHFLIF4S%(! $DX\BL
MK@JEK)4@^\_U;SEY02';F(-R7@D@GW5VO:>S50XE(18,"XUYZ*80;K^P9]NK
M7TP/^>0N+4R/.9^>9@E&:9YL]P+FA%D20#X/F![G9-2">D$W*IE)4YPUU+T3
M#@J ^(U9Z/%/1"<OGFL[L13/KZ-,JUF%<I+TP=*CO\_DA!F^,.V>.F6KGPG^
M,@FHB*6DS)I(-A:EGSU+CB/7F2^2C$-]% %N(#MB655T1<SC*)8Y^SR\[N.(
M_LBV/X"/U #FV4A3\A;[>-JD'9SMYJ5)<AD&XI<4'X9-S$(F!=R)'"Y0N$0+
ME/9I>LK7:Y1LX\43649DP8B9[=."IE1=!E0V] A^146+A+Q8B^KF72.E:] X
M1$@0U?%/J78(R(=ZLSMN3-^YEVYO)6N[FDOF'&1;EM,:1XY"2')8?B*$ ^FM
M5JV G.0#-Q9LM!)YRI]_Q4$VBZ=T3ZRSS".>XW71>\2J38\& ,_M1U0.0]E]
M1X=H?HM >EKQ '3;&E=/'F4F2@CDJ6_]:PIX#*EYW<=+SM&2<[1D!((^C(,!
M$JLQNLMF]&:-$[K#4K=?D30(XS07.<G6=UL_/&].S8"N9/.R5." ISIT 8:[
M=!ZWHK$'X[6$0?F 2'C:H!@4*YU/<')T_LUP>&TZP9!3GEL:G">$*>H4JX-H
M/SQ,1_GPQPZ=YT4-SVOY**GAXYRO>XR4,[8>3IBR3#H8LBGI!0I1Q,;(8MR?
M$@U@B [CHO"-$"O$+[:7(4I3*BXL1.8B]5D!H&F)Q,'2@F<RZ!W<^<U[5I1
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M*V!9Z %VZK+01VLH4\UQ$409^2=1%F<K_#&.,GR)DC!^(NL\+-9=L/P[7*G
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M%H8X=/!#">:Q,EN1HIX'S%"K)TL(ZXO*$'43_N3#&)O]H,95 ;T PQ*&C/R
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MPS2+KTB:)>2YV071QL3K6_H470%5JM9LMX[V&1<%E&)+79#D$H4A+T7=156
M M23-/NU25\+"$1RH)&0S/!Z0S>:;,NV?R5>[M[E>\&=YGN .K5K@3"(2D)E
MHS=\UT>\R9-@A5+\L!@DJ4<']$EK$#TFU%(#D/EG4UYD9$8<+'&:"N"03C7#
M[+/VC$8([D-27R(\OT ARP&94ED*R :%O(=[ZZ.M!O,TN:])][K.#" B:%DP
MX-H<D((ZU4B2&IUK(0"8N&Q4DD8WB-+591S)?47[$C0QH%/T'%7H6[-^V(Y
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MB_PIVB RG\49"N\(>J9.@Q4;!8N=IE85TZYFI9\$PA[+;5B+^23/L#*E:T$
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M29X#A66+6DHAA#ZD KJ1G9AZP[%]7WRU<!_! N:\TBNZ2'*L!00IEUZ<CA/
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M0=MVY.9%D;]C9>&L,4I/0BBG(A,=/Y'8[:R/EI6%XZ8WR-R)F'ZUERCI7J%
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M.+6,T(0LF-)/K<Q)<IF;=C4<*?XBITT)'(($JW;.X=)N:50,E@:(?S^'2\^
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M:ZJQ*9)L'N4R:B?L8<J;CWK!$P."/)>E5"VI)L/&IM+)N8"=80$[@[UA%Z=
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MTT^O_O?PX,P_.T;F@X_O#K'^.O!?[R-?0N.'=&=##_3<K^=SC+V4ZL'+G)E
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M$' #BBK#:7P#C_3?O3L(P&: ^;_ ]1!KHV=:PU*_!M_'S)P;F0EEIM@6PZ_
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MBU6E^<4C_RH3*4H-9C/&CV(!*H=&ZY->O0"'"7-S].X4P2/E 6^OP@S/!">
MMX51Y<W-2X)X >H:@G*IF+ M/>'GGWW/_J$(.JYE&^?9^J4H"23E\(_'E!#0
M,M]V<SV4/]*Y"Z..&WH@'\%@0H8,@41/PW,.%O1>3)4N]KH)9CAT)*'/0J!0
M @W9PS QC!2/ BT<)SSJTR;66=ZENTFJ:9'7DZG4-]#-BN0<9=\Y1&#B86NJ
MA)@C4".%"8T*LS,*U$N!U>L$IZKTSU/,JTSR*J'#E:_@5^H.$)>$\/X-%9=+
M9,"UNIKSH+4 W]%S7[EKOF%D8H;I''X9&3,N"E86P)-PO^)_:;^'_%C6(V,'
M4+AT47 T7O\BZ'G.BYCC+Z,B_ZP*C+0U)QK&:11$I2Q$';Z*DP(T LPLO!1/
M/?SG,SX<AXC:TDHH[7]^)!58T-*A;L'7!'6:C+2M2H)-@D@8#CRUM'68O/R8
M4LC'?XWBFHQJO.[7QXFV_BA'D63K_E'7K(#'>C@+-+KNA.C"#;P#O7 PN- !
MO8*C-O$3K*^%__(TDO#%"AX!_R3#""D6*'.7@)%<@YW&0Y%H74,S=]6R/I/\
M?KW<AX 5?=L V_E==3,@'<X6;;H9K7G@IR08E<L4ZD,PSN()_8LC03"9BB1%
MEDOQON3EAWD F2_SH@1_; U=L20##8G[K:P\';1$06J<W2!T"DY$]YC4I5-M
M:Y?WW= 6P?/)GR3C2H^;'!<R_:?)W X:(Y]FT/J]?OJS:YGF\714V;&_<!T;
MOH_><21A?>O6,)ZT4N0],JP:N4B.58UWB7;SKZZ5+O.@?Q4=!.9DCXI:EPV,
MJLH[:TQ+8TI$'8"52>\U3KZ8PXI."=&R<E@X)U_/)+C'"D<5^! S/_+<N\EI
MV3TC?W8Q!YUYD8 PS\.%X#GF*BN5=6$]8S^Q 3=8P]=CV>DZPWXG!1U\\NG;
MXJ>#1$M"0"X31*HFX!218V$1)&.%!A!BRI>++B\!T05MO> _CLU+G!B3U!VX
MM^3,<#8"2#JL"!]B&245^?:;.RMG_KBM+$$ L' %Q"WG\_]#6,;AG_[;-!_!
MXK[GK6QEKUS,1GFJ;8F/;T[WM0[RCRTU^U/MV>-/TA"<?5I/U@AH!'24=EA*
M9< E([F "W_96-_>YLDTX;^??F7%!@LOK;<PY1:EK[U^N[QC!?]JEI"FX07Y
M#^1WHXD9L/^F<6D8JB.P&9O#UO6+ZXC@8^1PR<.=X138?J&@8$(I94VMD*)D
MG4TH) 8_B(*/X[JJX5W'=-S\X*/D]H3\821'V3F8N.P.M#VE)#O/TW/T!?TI
M>.*P^!C+(?:VI/QLRX Z7A*]F-'E\)2K1M-/X+[^&[")T!+76<?12U=5P]W"
M^5R%14=;[_)_\K'7,>+0I*!@62T](<8-< /%U\II7J<Q(1; ($MB-1 4#A$,
M@9-&Z(/.K*T08XV1?)#82!>:X?5!,S*J/-/V+Q@S-=@7.9K->;P@<&N(/!7G
M3&4 *VK_[ :C. !4(G2UGLL1 79'7831@JS,&!0*_-OK^FOK_CZK'K"&X(U$
M3#BTB<C4 DUYJL8#TQQQ(RD95&".W6@*]693Y6=+_-ND_'_F__@H_V%S< 4X
MW=8*3K>"TWW_3/[9_JMWA]CEX>#XP]GAA[/3VZ +;D4-Z;?QAC?.E+6-]<TM
M.%9L#0]S8YF/981["#1>PCF\M-YR^4^OS(B]]ZV$V+@COH$*FT<$DP\#FA3@
M6,=K@NXJ)J.'6QL[P=;VLV!K=_?17YOD2]\ +,4"*S;^*T0$U8.7^Z^./YWY
M9[\=G38P9>'74IE_9Q;I)/G&";[)Z=MZ\-+.F7_ZZ?W[_9-__?BYV[P7LKD-
MYLQOJ*O?')X<?7C[XZ=UYPY(Y YX:$>G__#?[!^<'9_<@GV\>R]D<??!RX/]
M3PAG1NSMA^.S0__D\.W^R6L03/_-\<D?\,^U=\?'_\"_3<.I6S#]3_;N@- ^
MX9U.W?+.$"M^^'\_'9W]"X7XZ!W\X\=/X].->R'&3Q^\_'1*YB\<6P>'AZ]O
M@80^_58-<9,3]PPF[L/^I]?4^1'F#O?\^WUT(EX??CB%ST!V7QU]@'^\.?JP
M_^'@:/^=?_2!+D*E<0MF^<F]$."]!R]?'_U^!),.RW#\[NC@%NB&O6_5#3<X
M<9O@<H-M^H_#L]LEEM\\=[=*+#<W<78_[+^E4U^ZI9SZKX].#SY1]U?J"@L7
MO/O7*;A9H'ZMED 5<G2FKSDY//WT[NQ44J=O_../A]S%\A8HZKUO=2MN<B7
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MZ.Q 4(6-\3*9)6E8:+;54H=VK1V_Q+C-AM 10B@[55[SY0YTQV S4/@P:,T
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M@Y.="2RO[/9.L/=L*]C;VFK8:'3?J4I)^L#M7[.I+I.\DB=@O'K=.VI@PI;
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MBLO1_JN(T;V3_6-'FY)4,?1-]VQ-1G5%\B4:T9\AU!1I@$W89=0(:HHNIF_
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MF6F]5#8E%(KM0IID4VY^)6[/H"&W$I,[+";'?1)!QA6F%-,$M!J:3F'6[-5
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MZ8)'M/4L\+<VMG9Q%3R*")-^%<GN60)2TWH1YG6!$39:&#[\^1M0+>QS\K9
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M=,?,\GH5KV-09T2\X 90=K:"K<W-8'?G64=V4-!&BGN,(YB#[$:[F*<VI8#
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M/HV!E*(0ZV&LV'Y/4[K*F3]X^?'2I :XXQ+YIGC@@+Z0PX%Y[@/AP%PXZ<7
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M9P3:M5BH$(Q>9"?V7X-)2)&+[4T"O^VPV0!O-3<9BJ1L-*IH90=:$R3S0D5
MGID5>FR=A76<-!L6]XRNFA9*T#[)%U]L5Q[M_]:9\K<%IL>F,QM\>CUU 8(N
M1V#>B>\G&BB)^B5HM@97VKZL'K1'@R:#.9DM[1$A:RZ *MP:#K:,VT>0AV@0
MY<*01E&34J<C8<<@M%._&I4Y-6BOT3D5PF"=F"%_J^RYEIG7^5Z)3HLY-JSQ
M>B6*:#R+AN0<]T^UUYUJC0$G6T)"4:(GG8#&N*:D*OFDG7;<O.I1.*=V+A33
MSL#,Q7QMX7-#0C5G'@[*P%$ WI3 @C1&?#C&<$X2+RTUF$-W$:O'L#S*E)-)
MH,UJHZ#9?5LGVYR:=(IJ4]F6VSR&VMN!L^7UU+WB1J]O+!+VHT_AKX(N;:^@
M2T/0I;T5=.G;9>Z^FEEM*S?D@EA4C:S"0!%S/Z,%!U?P%!4R>7'\+&L GMLN
M_P 'D.7.<)0AR4&LK3:XA&A>!/B$A8$6#M#B*'8#SW0?5U5ZV@Q$'8I)L+"4
M0BIT1TN%)U_*DXKF#G8'),H%YYZV15?R']7$>$D_<8EBJ>*<8C;\AQ*>6:)D
M\+AZV+U1!NO2^_M;:L__@#&<-J4@,.("LYJC&#;#55*<@BOD]H+EGC"ELQHF
MDN=.O^Z28);!UV+/-U-QZ_#&$!V\64)=X0M3/N5"""4AALERC $[#&CV[D;T
M&]WA2&HY2&TQZ?1F;,1A0$Y$VPEQ$@H?"3&H3M'I!V$HUCQ7"$.3WLVS-;:K
MG,81^HE+9XF31(4$B9T!4G]RL,#(\]%6CC7J/./-9A)J[I]!LHW,K 6^-(8"
M#RC*TQ0L<X>AA+B >69U>C2_NG;X1EWPKIZ!&W+\93%1/)5OTSI"R^TC3!1R
MRO2I [^C#KQA=="G^U@+40=X$0!X-VR>U0[A$GX^YC=YOJ+HOTM<=XV$:IVD
MXB@P_HT!/IHGP,U (951 :=<@?F%8D!J74GSM*2]6#$CW@]IT5JFH[U7*WT/
M5KKO5,IPC7W$55%GT;*JXV2US'=ZF;7)@*S/^$D@;E6@49$!>&,16@"XM1^#
M!6.V/>4'EO@F%I0N>7:*C)NV2T)!O5(<]U2B$!N#QC?!;BJTDW&)P9RTJ8<*
M)DTQAA"N 9<'C'8,.H[S-,E70G /A""LP).2I2\4^6+E9W D,,6DBC+/,I52
M$GVUV'=XL>LY9_N:@0O*HT@B47J7WB;JZEN22NZ#HPD=L; 9<SI+#DKWG!3@
M-0=E2F2;/L<PD9"1E'6$[!P^-4W$W!TZ[DYI7P#N7D49/AUNK?*5[WZG-EX:
MUEDTU>ZYZW]3\E),+*=MU<K:NF\BP %.+0+:YK*5N_1-74WS0@=BVY *HE/I
M"\(Z-_.<("]U:$RDB2.%4Q&W4*A484<#&%F1E$@DAV? 2K3NL&BYPF1\?K+A
MHSS+9_0GXWD)MI[%:W5)G1!0%V%7W9DT5*3FZ'@7E9TG19X1?F0E&G=8-*39
M!:L=5@FL:L#/FV9YFD^,L)@:4=LJ?+7T=WCI,S7)JX2S\N/P/"\L9DD3JS9R
M9CI^1-E079;A% &67"1@^ >ID)-@*"LIN;M2@BW7P?$KI_V6258C)I*Y<,?<
M7F 52+['*][('#(3)EB'TV1>ZFJZI(C7$%)@X)S8-%S*!?TP1A9%<(P?(C$>
M Q7P$4BM"+[SHYYDI(Y)-"@*##I(V[FKT-,=ESI'R$R<60L@AYH-"D?'E;E8
MLB_TS+V;7?8CA$)@7QNNAT2(2*'$.\(N.FO3_.+'A+1^-""V =A;@BW2-?AS
M!,2U:[D9*-.X4 (5MQ2<]D,:.@Q.L6?AD<TYQ,G^OK@R'W%E]I8]P+@& FX5
M1KQ32A2I;<("B7YII2TTS^6LOA(*;67!W6$Q:.,ZC+6T6O;[O.R6M-Y8[2IS
M@;&K//U]7GQ!]X9EF2-!A8HMOTD7Q"T2T5 (1@FL?*D[+PMA5CK+?)$7GZGR
M<)6V;QOE@OS/J1:<K2>O;3V9O<4U 8R;IP;)62:T$]P?F>E6"&<9VTQ+A3U/
MW:YF[KU#I);GXM?","=X;FB# ?UIF3=(W/ *Z1#'B/UX!H_C-@#GJ@7V;Q4U
M\ O$V%XYG.7H5@O)#0@QM;ZE6N^&%'4UB*ZKOEI! Y4!VPI;X[W(Z)VLY*B&
M/965GM,QB_B8"'TR56%:3;&#+Y]QV.@*ZZX5H2@8FY*TN19-Y5</\QA[K@/^
MEQ#.45D-O!!_US]G1,- -6]93\_K=L6N,&6)7W;;:F^7E<3NK$IBATIB-S=6
M-;%W*^9%O:H4E^-S67^7! #K4P7JNM22&H9/VQNXATS'10=M 88XU? ASY@S
M$$W<XNG>6HUNE'V4 SY7KR(ON_\&+I10NM30$8&"[?C41V4PX]9\D>9($+("
MPI=YN=/*U7WWOLDI^M[1I@]M%&L5*'2@A$YPCPX5[!H&QVSL=7L/$:L<$;/U
MU4#;ND:NKVPV+[(RIN]U:?&7$6U/1%L7$2RO1[3CT+RCN+U*W70K[K.F\"K#
M'G60ST8H<$+Q549$' ]6BDN.<>E8 KT3B2XE"RW=C,XIH:5,,!G9%/BY-K.B
MO)CG!.N<U_"O4MZ-.:694<294GV'OGH;M@B#*RF6=O%XKX+19>-+5J%!NI@W
MC!ZD_Y'.#PCP46V29$*=FE:\FJ)%4(DIDX9FF$;)>(4#3VKU705+0/*6?D7R
M[#S3I,HXC$S%/Q$YX##OJRWBUA7//)T>36>+I=)='R?IM0K>WRFOG<F5&"BN
M >34WZ>1YU[%9>[V"H-KC)GIRC9M+X@V$7GVT<C"?_00,:P6_JXOO(W(2!)8
MZCDL@"IP^$8"8LBW"!R- %_I@GLB$BUZ0&/0MC!UCB> E9BJBX!RBT/(#F@6
MB*R$Y X+B3DP* 1**ZK<*',.WOE$PJVS/$O@R*!6@HNR4K/5TM^/I4<?($DU
M+JZD'"\?%F-I_D<8N0SC-1K'SW W)-M,9F[FH3<#[#%<;B4N=UQ<-*L6K.ND
MT(QY*$,ZE/"U&:F51-QQB="5P[+^E\6>5^M]Q]=;S50QT3VZ;"U77G"M)Y7I
M4%\_4]RUVN1W?M&Y8HL"P1Q40/[M9O'6N7*+MZS:;U1ON;V+30W(2CKNN'28
M\S_31.BFZ)NR+*F:=#$8DLX@N="]R'5=#S68S"V&89Z#9*WTR#V2E$$B D="
MX$@A,0";$DP*!ID6)EK9"4[DFN?5,]DI6YO#?4G1-9D4%K?(&LI >HRXK0J^
M[H_($3-=F>ATIZ;Z#IHY3-=: 6V4@KQ@D0N2&IH4)*7),\Y>)]+7 @52=T0M
M/;<$ H]';H6 V>C%7'&?=)#C,HPT'&$%E+1#P [.NG23$[<(P4,LB@&B4)\+
M%Z$BR+UE>(+*LD%?*.Z=;M@)Y6ZTL!J!PAT&7<KIHILX]]J('+A(,Q]RXYDB
M]FV%JI)JP>Y8W1NX,FCIY*GOANTSJ[G2&K=9]S1\TWT=:?O19N<-#-^&J7MU
M.B#JNBQ=M27%/!8HNN_*M4[8<W>0:5C,O Z?OFT7@Q@%VHBW#8UXK0_'5'LS
M*L)M"Y%M"WN/9I-JRGSLG+Y!:"V=3J;_C.EOO>Z?<#-K*K@+BS3!190"'&=?
MS M%I#KGRND_W1J#M,4.= .=,APK:I3L*6RE'$8+'.88VWT2%3DV-#92L )2
M&7"WGG;NK$V;HP&MUCP7+M61CVVR4M,Z@*TAY>;@FBQ,2(2(\^_>8]W_( WE
MF_H.[!\VD:3#KE44I ETV>>G+#%=L$^QC1/#=^@<=W!\SHC:=I?[@@AD[MY1
M-W-GW=+@>K* Z9'2KD#LXIA<E%,SI+CN'Y@/%,.6DM*S#<!)D6/E*S]>QR0"
M(@FHL&GXC)HN&DY]_F:DTZ?).0._(_!<<5_U;4/<TRFX.VOH&.ON57@H<(O>
MSOK[*0@8'&:FU?H<%I8,"#$J*NI@+7LY-G#VPF[W$N2AXN>9":FYQS+*AC5Z
MI1.7!E]BS:[H V?(YA8CE:EQP@<0(D/@(WM5$V7^,[4R'V@@^E4X]MT5CGT0
MQ[ZYPK'?\;UPUE1/V+):=(JG+1+NQ=?,![7/*]'WTJ^.VFL3X) C2<:G]]U[
M-F\E#EJ@L9U]@8!!VZBE9+$XJI/#"GP#YTUF[M5AVZ8:5KW4U=(876C'6?@5
M'_65MN'BI"27TM9[T:/GR(BLO5B8J% ":CP:;BG:S;\)ZEA3;WGZ>ADI''>$
MVW=[5X71-%'8/S:9@==5F$=09YP>2Q+>YJ-=_.:B\S@+G.H*C[>Z).0XC@26
M^QRF".$%S?<K!682I@LNA:((D1#'49Q&=YZ'08Y4BH.-I>6@6?"Y*K N#&DG
MX*8E^RD)T8@,BJHVJ-LB*T=TAFW:J7OT&-Q1J>A05$!6*7>6>H7(%DF@L9%'
M",["\@EXK[("=8+&0]2R:[CK9*?2'H5$ S4R->%BO!S%!#M0IC59,,:\=V#2
ML8J26 5\U(O\Z7;NNEMEX%UBA.'],GQ.VP:SV&]V@3'@IBU<#;MN(L23"CT@
MTPN45O7-ZWT20P\,-[A#P#AQXSDR5+S?2AY;;:'E(&B$F8V<Z_>#)U1K0OH$
M&^%<P8,ISJBG&KRASO1W!]0;GW2;)]L&G(*_[.VB3.Y6I3^GW=_VNGYN\PN/
M'%@,(A04!@+..9J6L*@E^K8+Z_US-&OB@!>!#XIIF%;B*(%QK@I41UBZBN$Y
M*;P@MP \ 5Q?^B5M<JINT/F.YE;WJ+&?8^S+#;5$<+!$;&OL$<<UG%WD;FYX
MN<=UZKSJ -;"Y:*2.E^/=B)Z\&F:7ZSP^G<M@"V*N^4CE_5HEN#9(2UVDXFN
M<Y8B9?5%S>:\1[C"62IR"O_H]6'@BU" JA61]&;P0'@*M3]F9P_/D#D<SX4)
M-E)]H.D;/*UAWONLNV:]M$GMT>-$&?Y;5\/#:.0\P=?UZF:"F VV2=)YS"H-
M>(=%NF5Y&&LW++5<2O0&+1H#*%FB]EZXQHP$]I,,GE;5O"NP-4("\SK*PR+F
M@.?1R2O^APY[XP4HWJ.\$4O5!@;5J$K<R^XY*E4SNT-U_ &.K1ISRLLM=4/7
M=T!CT+2F%8L._XW\;7))F51J)?MW6/8=Q580D[[)'?:56+,)Z(H$2@]UR#$H
MN[R8@$OT'UV="C)S<'(LQ9$M 4/I*;DW*M\>MI,8)!S^A&/EWZ:2MY)(J&%P
M-I1/"_3;%BZW(-HPQ%>!05A%R7@<!>4TG&>O1/<.BV[[I+\^)Q3,@.!JF0!R
MMT9P[SPSE<MNYI9 RN&J2.%."QXU1C>NE.BHTMK#E./J$4Y0:)1TD<+O"[=A
M<>"KK "7B*2$TU>E\@;N K9$C;FE1,  )7A2 W?5IJX=;_N>(\4 .1WTE!#0
M!'9+AFZ?\N2ITV0R=2)\%'U3^%S+RF'F@OQ-<Y<>&\1<21NPH#:LE<WB=S#[
ME1?2 - TDO[.K7==;:D[O*70BG7!EMJL:);V2PBO62OHXE5$BGLB( 3=ZXFR
M"DW52$W#=,R$5AA+%2-ZGBYTOZ%>E"C>E:H3.=:K1XUE1ODH%2>X9'H(SKKB
MAH*;SC#X6 2>8:Q92>\=EEZT(Q!-97!.95TR2X7+&=262-21.M]@XG%6UD.$
M*8G4,V3,,TH3\Q>LM]47C$E3#*;.''.=*>.XRGXE6W=<MAP$73A373\*&P?D
M49ZZ.M U4K6RH_30& LAA?*&E)+5;5Y;MTWJ),8L0M#L;],?_".$*<8Q=,BC
MZ,\HCNFK-?4EG FWT4I [[" 6I<IH""6C6%IM*F;SJ.UY_!4;$*KO6&L/AUJ
M#6(3;KA$BPJ&$$,#8@5@IK!5#3)PN@^*Y4HJ;[U4NJ4= U[4!,2EZG6;5OKH
M#J^\S;9BA,_&S6-024H'],U%^N@D2[[EBK8#XE<7B\9D=J?R"JGK2^_@_/8J
MR+\G*^3?(/)O:X7\ZVBHE;[Y^H0X.&!2_0,F3E%C/MQW G5#(3A15#G732S8
M;,*#:-5J]&Y+QK!EW)O=17??'X<86C4XRTZH"Z$W+"RV[Z1'85,;/+,_P@;&
M="_COI$RY9:E-M/7"%@W6[%305::Z#0=_;5@VCZF8C7O-$-CBL!&EF1YF 6V
M+Y2-=KNIMR-+W2FTX[BTFY%$\XYBR1<=4!3!-XN: ">E1[4J..[5;KK#N\E4
M^^C2>R=?1U%6$$H$]##@43=1P#,9H1MN+ *Y0O2F$^I?BLUR4-8KP.M4A2Z:
M:0*'&YF7L8.M7(G6'1:MWII]OP'5I_A;G5&Q+J>ZL+&K5"%9)5AGS/F-C5"F
M(>8"8*K@*5'YPEM5[M]I(4EF,""NL@!E(@U="G^2YB-42FZG%C^"15=-L@=%
MK.^(0SG^_>CUVN:>CR3H:@8_:J%O/4'?-J##<FIBF*)0;IX+\UIIF#E'K1O^
M&F&C ZX %* P(KYU86+" 6#./,O-\HQ :=AX05<$!@;B[.;5!+R#/S'4&?R:
MS&Z@>@E]@\;9C)/Y6;5?T^%BP_M[8G3 AH+!QDFI#W:.'PI^'0V0SPH!_#-0
M^?8=.21>(B+([06AC&$C&"(Q7G"&B6R\)XF_8D=H#*%1=D_E(P4:7Z0OO286
M"\OP?;<,/^BKP:>5T."R-G?_S+)7-$GY4;X9O).J$/,1 1SE+!1)YIDF S R
MASO!@:WW&:9$7( ;!.4"QB]W%BQHAJ/N)ZQN%9,ACBU.8JIE_ME+)3ZR-FGA
M7$Q"WB%G;*Z/:"$I&/#K^>4M 'A_$_'&6#H*\SWF^5S,179GLI!.>KF*AN#I
MB"!? 7]]P?8OBT:)-"K;EAXD(CJ8AD2*9> (()5B.H:U03!Z3#89$5CRN@[R
MQZ(GX5)#"T0;1@9EJ(+ <5.B("V">9XC-2KW/SF'31E.A/UE:@P=R2CK@N_$
M=KK'F@VA3C/N&/X9SDE%.SGK;$%M2"H,K3L%3N+L-5@ J%MS%DLI@#G:G/H!
M+#=[DV,OD! %(C 'DKX?G 5P=A;P+C&7&]J33.IAVM.8."MM8[^2]"%>E!FG
MTL$"F;B@4ZS+LJ_ED2<>UX6XXD8TT:U&![UT"2RHDD\S6%!<N:,>-.?%PM0&
M@2U0AS$G6$U$J-(-^"HUPZ8LF<KKLB,K'+IF48*=(8)1=I_:4K%F>NWSEDQE
M(UK.P4^ON7/M3-,B&N]<U_#KN@RJ@D)6 ]L*L,7P\MH4.<V[6H1B(5S(Z.Q1
M*1HT+>]:<]@!NS,0%$^-Y<=%WU:F(XB+7VR;1%,\Y?7^2MA(\;T$>:I!=7S"
MF1?J_O2G/TH.VJ+(M4(6Q(@AGS"*P)&P25Z<QS2\*%W6/QTWT,5 #D>D#2'T
MPQBTNF4FP29UH'-W3U 4<#1DNO0(U9R#;,]Q-Q!\:+00:VJ"GV549I+:> 7^
MEN*(PB"E]X]36E)B/[-"]0A-Z3F.0Z?NM;.YVS.JBS_%9A8S1P<!!78=L^)T
M)T^[U9,\CYO13-"A:.='K/NBM^\_MDIC[6(X\PDG0EW@AVCE$V5+@08:[$VJ
M,FAA"(9J#JB@@ K-/3D YSAL)A.59IFD*I=02%],D8A(EQ-;RC59/#%#DD+(
MV0A:Z_@U^H?47(XD=IQRW@E_+C\5+*&4CJ,L4PFH-8"8%5\SGNI71LNH3S;P
M.RJ#<.*R/:_GT1G3A$C0^CE94V?IWAZT5F[=/V.C@X[/JF>0<OS36#3<DC5Z
M(_OA&4+%=EFIQ6CR6]!I2]D3^! &A!7L68S%510/+)2IL.5*6,<]H277>M<V
M$R=F/'J8Y]@W1$2 _QK7,%9[" 4.-(K==VYBI ^$6-?12@& XXV/0,9Q-[IR
M:WP06P.#YQG8.W^"/-# >=_:@FX.3VBYL97<;=NA58M\B1X@ZZVA.%@XZJPB
M)B(X^RD0UL_?1 /3FHY;*HYY]^KW)]/(]O!N]%^S<U=.$RZ?D$FTT#9O")BK
M<>\JFX03.<K'B/U9^[1^NLZ#9(T1HNF))!.E@"EEI-R@J-U7W$Q00]%X%].<
MILEI"&?J6>F@-V5(CF".X>-PDN5E L,HX665Y1^5[8L]?W_ZX_X0:P@2UL2M
MV"P?:DAVP,7SQL,8Y!0+KM#,-,E,WL"*.M,>:AQ;+\&"-UH,@1YI/"A<YH9(
M&M9'(NNX%E35QG5L#:HR(0.C8NL\/5<=T?=:?;&EW!0M\!PDSTHC>DTLH2X:
M*C#DM(.3Z.A$BS-U /9:OW@]831_,'*D21N7=92^/(3D\.$T.JW>IEUT%<S.
MTQ5F9Q"SL[W"['P%9N>OW_F&&4J/775L('Q" T6Q?N;G]H0J1V !:""OB$ -
M$2@I4BD_1989J7E%0DZVB\PYV6 7'@>7=-IZ>/#V_2/=;\N]K3&CPR(5%JE2
MFG*8(U?'9]_5,Z6\XR\+<&_]CW!DHHNC;W#XR7_8HF_J4-LTQVSOZ;?N^6@9
MP2@*FC#:>*W^LDS5K>5J><=S_02P+0,T5;0=XA"UZ;[+DB-$R\YGZ65>'_P;
MG&.PL$VX DU04_TC%\]!:0LMFM#'85YQ3L=\*V[6'"*YE;8[2I-KW&5;,T@V
M3XK@5.50L*0+Y US\R^<O90SNM7?SW %I8L>2FP='%C:1;[Q,X_:?)E8=CM3
MWUH3-%'4BE_H3J79HVF8(@.UDN:PNC6H_Q"-9&3.+[CNC;84R-6:47"/+%_Y
M @V:VLD2A]2F7+!E:"'K^#CN&V055KPM3 ;;5$&!UXCCE-[$J(R$#<:.= 7^
MN<,"9\H^'/=AGE/6APCC1:G:?(H)_;8.H,$N],PZ8JCT.7J0@;-'\KEJZ7''
M!8@M!G(_ZCGR?DP793=-RY%LY^SG&"J*@+(B-6QOK, G;>LV"C/R"DHBC.5X
M',;B2-]?;EX(0\52$X+LH0DBAD9%'FHV_,8J%6*@Z=2PD^UA@Q+N/,LKY9AP
MRU;9/QJ[5[8["GWSJW@8,2^9B9ZT%E-_TC]+ADPABPBBI+ <3J,8*<"?C)W6
M,4W[S$8SI7$'A[UK0^?K^&PEK&>ORQ8TXCJ\6SAN0[21',SA\-M(&:A6RHGU
M-FFEBG^J5AZP#WBN)*N-'"EL:QOKAN?;8];E2-GOD* 641-$2A-0%'S-M,!3
ML<-NS,D_)V=BNK*0@Q.XH?N@29;H=L1!3\)S/8F5K^[2R,9P24%\T*9<0]86
MDRYL@*:6TL=1$6;+I\EGU?6$\1=OQ8TWGC8%?;N^O4[I$M8"C],:Q",0YQ[1
M,(A0=<0K<%/9B B*-::>]$.3DLW)C#G6$MZ8_V6"V[JD1#2%3IMR6DCFR<T4
MNDDZE4U1J\##\W%U00F"<,Y.::)3\!II8EC+C\X01DLS(U&!@[?O&SU,_!'E
MHB0*C2GC(E'-OJ*+P!O558-HU^XA-ZVCJ]>Q/H=L@;HH:QP[@:?<IDL:*>6L
M$-Q5KUN*"AQSXESWT,B6(Y^#"TL,'4\:UN(\D2*:H4 /J6Q8;R->O&Y.AQ?'
M))8H0'.YA6-:ZY_.H2<!I'8*4NA<>SKUPDP4V 0-$4<4M8)W4!4)*\M$$P,8
MFKC0!QU[.9)T.!=-_<9H;2MP^A K=':.;V\["!=FQF@2L?45/NL"<YG4K)ZP
M3-C/BKD.DAG%@1SSP+DO-6TI* 0=-!OT&)(-A%.@T(W G<4PS,CM8DO-4C".
M+=-"F]8,VDI,8!\?Z"%2VHOLBE5^\8C%$3>\B"2'"R2&Y_7T+/K_V7O7)C>.
M[%KT>_X*Q#WG.L2(:IJD-&/ISHT;P2'%,>VA.28U5MR/!2#1*+. :M>C6YA?
M?_8[=U85FI3LD0AV?9D1&T ]\K%S/]9>*XD%:8)L6[5@VY0O"A?=2YV)%X0_
M !/6<;&QD)H>K3EX_.=KC'E6?U9\!,J*KM[$+1C%8[4!N[11"%^P:_X)9OSF
M#S .F_&="/Z<;I:^@I5FZD1!%N5; C9?[2/LVC]7N_A^@^/Y^KAYS.'*\XYT
M<\OQM9$C-!A-I^LT5!P])3332E;[A2T(=;RZ:2JL.L(_2":LVGQ0@FC^Y>/5
MBZ:NU3\HE W.C&B2/D1XUW#LPQ3/ 8,[I)3P7=/6VSO$*)#J'#'VQ7IW)=LC
MID-090/4+#WT;?$>#$5;UOX(:Z/+R 6A^1DG][.Y=^<+'B14@(8U?=]QILET
MRIJCN:9,;PUAE<#+:#U]H&^5?9C?@".%0-YA^[(3@,R?JS6EVP\5=[/FASTL
MY+3]=$ES-%4C^DO"GAK/0GGVX-XHX6QK%.7XTX#]-!!4O6B.1W24$/&3UP0D
MECE?IWCH:S%-1SJL,TG+D->Z$NK+\L?8NEFC5SL<;KJ)[JXW_N0YH.TG5EAG
MJ_&6QVL!^V=E#J8JDEMDZ(OF*$A!_,T P;/!L4>K'A\74>12]BB'OL%0%]U.
M00NOFYIH!/D]M@W:U >_,E1F5+1WK@<J%K)P0"CO6.G'V3"/6(,),NQ*+A(
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M9&XT<AI+TA2,KXN$KM-ROB*KXT]5ES7$*4 06TQ7&=#Q#NF$-XAD&-J/+M?
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MW3L\3%XT2H6G<W>61XCCAGUV'P*IU'5SES/CIE\5FF_L_-S:.O!/"=<GR8>
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M=X[2(7CL2@VQ=S$:D-)&.322(:Y[ CH3S]^=%P!@1\LAI^8N+[2DKI!<IJI
MCO:<<0&= 4?V40\"*>AV5XKGF3/HUA#2DA4[-IS<*IGA7))0HZ[^&;U;>K<T
M\@&MKD0<<AA;ERXG/ I\(YEX/:GX6O@OGOXK.INM5S ]OG:/P"BAG<<:0IK_
M-83<<.OAN*4*B%MG\">X1&_YPCE5&C*2[FIU%&RIWS*6%DJ-1HW+BZ'L4%:%
M5W@O?9*ZC%5>1FHSZ:;'DD'%,\V11+QP.I:,&Z!N)V]!Q'APT1W]_H$;B=7O
M"3_3[YGS!OC4UII6?;HG0#%3 O.E<G[PXN_X(=!O"9FF*3P-9PWS,QZ%2BD
MG>@OB!+%?9Z2P)K&S9 J$O20(I>I(HW4:AU)I80;P5B^'*F75Z+!:F753COX
M:/U-%5+TN",\"M^>$\"U'1;LY]U6#7%&D$7!APBCAU@"GURNQF/UG$Q:.#NU
M0@[GJI#)[?:B7DDPJVE3!<-C[]D0:XW>X6S-!]*6Q<+!^-F2</+"?ENUF^&
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M3^U=<,S2OOT*ORY[#K^D>ZZ@.+.]D79X#@;IIM<-^=OZH^8.X^Q]=2/P9+D
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M[.[BR-#PX X&.J+DX\: AP7_'A9'PT!$"M+3A>CK0E=E.2I:-&*%FLX_) V
MO@5'1O"3C;PO+-T GL0LH"%KZ! <5<1\WX0I&0SA+1$9L;BYTUA>_3&G0*(B
MN%1R*8O&U.SDHX2:EG0YVA7R*D1W,9V&DVW"C"[U$W6B"5;! ,[49A!4C%LC
M&)[?PZQ@-]9\8>KZ!Y]Z@N,<@0*X%F#&#;Z'S;+70]EN0[X=]'SFN"&.1M>X
M# LB7"0B_T(YD9ASB'IPW?>84VIWA<QK\-9-6W)S$P*3$T-L*)E^BW'&<-.K
M0[FE7&_9]01Q%!# KD(DQ*YNFFVQBK"F]O\UP.LA#)S1'-1C7'6'8K4YK6-[
M5?8]5CXMLM0#X5;63[HT?!QF4;[E42 )LS2!)\W.\8;R()/4<3S.V+&10=8Y
MV/7-B3G'P19,3Y]@=(:4NX/_;]I3P19CT[1;3]!EC@OFOQW\3@^BU?<V8,KG
MW8HE0ODY(U-SR4'L?H4+QC ]%ITMRRPT6[9DN]$2VWVO;A"9CE\I,81V^YB/
M3#"<,^R;=B?T^Q*_(V6K71K$U@U\2Y>3+J'NX[8TZ\/K2.&UY7X/H]60@D>0
M+W0*4S'>O'N]A[O(E;(>+!];_0WY<062M]P)9)6HYTBB8,S83<+TMN_@:D%9
M6JV:0A,J^Z/S&\2+!DZ&)BNXTFQTF:56PB(JYV)?(#X6XHIHZ@,+5]KB01K7
MQZO$X&@/3+_%[3]_"K0J>[<;T.&E^I:0'A*&"89Z)V2F%I%[!J9,LF$>LJ],
M<!Q)?VZLP9^"$_EVP8F<Q8E\L^!$?D6UI'N#LQ?&0]1F_A^A022?UUK;3T _
M-7)7 A^RY$"NFZ&7 )UK_>.,Y2A/EQH$N.FCY9!X";Y&:9W$R&XITW"WQ_[N
MD> *RUAC2\GJ&@Z4E4X3Y4'!;EPUNZL#3-*>?)$#G,G;TCQ,2L)A#&0-'#D*
M</7"\K5X<SS+X4#JX (=HK*#-H14K<OX=8G7W!.\&'X13Y8;%*:RCC)Y9D/O
M4J9Y2J6]KAL$MC?M<$B^(A4# UX/3A6)%-4QKHXE!I;$XP>+SG7"80J@C^D)
M;$5SMGG\9-FB1_<[2BF2?6'L!8SP]6V!+*5==-S\V104^!>JZT@MB!Z>_AI1
M.!K<+O9FNV;#+7<]\L23LQ5+IJ98G^S%(5S=.G[3R0X+ML-<39@+LM1H"(^)
M++[4ZW'@3/X.UI$@0GX+ZO[/(FF%'ER'\%LMMGL\M>0FP'/'!"8Z14&* LB2
MSPY3/":.9)4^P]".$$Z)>1+14 <$%;2,6 ;7%WY&98?%(KITE Z* =-F!G\L
M3I<5S,2F96FM->5F*:MQ' YK9N,3Z%0]4>5,CR!,Y</AQG =J06>LSD0<XA*
M,&SN=:1?;=J&/.$-:BA(IH?['@[-=5O>[%F$8%?5U,1 \@ZP'M:QKN*M@*72
M7:VU#@-T1BC5)\%N!?>LA"-32M)"945&UTG?=RX_ KQ@W5/XIU&JZ$<D0THI
MGJHSQ,@@I-$T&$TAK0K2 (VL/MRP.-E3"MC*IU*GJ_COS%<8S9=M/LZ<B6"%
M'1,C11JO2S>JMYR;:2K"6(I9R_AL[N&4NA&UB"*;^1[6[-8:(HDE7V?XS&U4
MLH#O8Y$<ICT+B@XQRWG^]R%5W,LNO5V1DY=R:,TH.D(K;NS.ZG*XZDDGF$[<
MFF[E6Q^+KVF7 W@5\*M-4!T>Z:B&10(G<.KLEEZ/>RS >-E,Y"G3OI_.NR[S
MAVYFGTOV[$,D3\1UTH5)8PMUZO157?V-DT T^C ;L6PWG& LP1MI-NBJM@A)
MVZXQ7-5.L!6!"W!)=3W835XV9,*(E(##_P-/4^:"A!^HV5Z?@JT>_IY6R+'W
M]&!,#N;Z(=D!&NOP40*]E*>NN'N)D]N^\BS]3)%*J&'VA$$+=3.TW2"HT'$/
M%-*-)3R#26YQ(BH?0,/:)NHSK)72A8Y8 6.G(9#/2?AAW12*[^$KCK81UR (
M41L[KJ>3R^J-?AMW-7<&Z277,#P(?Y6'])S98@$"<O>KDXVD(-?[G@NK/ P=
M92^MU5[))"RH&9TP:2'H2*+CJQ.8I3R3R!D^6[ !3&^IG:)5;5P8RGP$A\8)
MYYF.NB/.2U0G&<]SQL$C9+DM[X[GN@JEEXMJ*W+!0)<_,;!8'GTWU%J[*H0K
M(+O-'=]&2U Q/9T!H@]5I[5EHC2WX_D-&/R&UI(:_;2FTI"@:TJ@Y;B5_/.:
M%'_\OB-T32Q3&Z"J\C!=B@8)[%5@T[[H"^5'M? 1L$K9L:&CEQ*+04A#]2IT
M3F+^E0KGLP@K'JLRI1>P@[C1W^)<*'>V_8*QU)(DU;=Y\-;]M1R:--K.?;+9
MH,S"G2RV8]Q5?3+7V=P*7@^E4M4ZXEQ3$\+XM)65?L]1G5H6.HV$PC@2HK3[
M_0H>YX#,9Q0\SN);'TZ$^V/4V<EQ-Z0="&OAP,<>]IP$B53G,:VN<*,0(P<
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M$A^^4G!^!Z<"*)KZ:9VZK-*%98)W+0D_T?9G Z50 *$J1$]+QYAP W6S7Y8
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M(-YICWFG#6U;*V\\WET7TZX$K[<0%6ZW &<[*(;Z,8&7;=RIW:Y0K!*9TN+
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M[^&T4K)8+_60\N#F'1PY/"(0/,+?V"=I>%!W>$1G$?LX?65:T'?I:IQ8.G,
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MG*MX!M"6A9(S]R!-)WR"5@8,%BO:Z*!Y(<I#?#AT]#\T]N_PVO@UGF7^%'=
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M.SE-FZ(@,U]LI%#1"K='(E]?7-GR?'Z0<"HK.4!X^>4+P7KGQ#:E0-0&HPJ
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M18ULG$%F?YU/J?A^O/:VI2@X&O5GVJ*I'Y%)ANMCL*28UYE;"Q]6? X*T%$
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M\7%>Z7QSHL(Y&':8,N>_Z$%+*./*#=SG1BZ@PX],[@P-HZH7.ML'?\2QGR:
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MS ;/G]I H1FE(&KU*\16AYY2AHJ WU\2VS75OD+#-:_FT*-!N_>GH M/1X0
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M!0[49(/_M:268<?$!07IJ:2F+.T6@N_ @_HIAX*?BPB"#&%BQ-\;UP2$GN?
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M2Q*&.):B0^)7AM"Y4T5/$=68D!O Z^@'B&YU2PGI./#E:A@6!X&: VO/0./
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M:G8J-8W'H 0<,+Q?_\@,RZ]D+S96;U7RHPI :-BD'"[;&AF1EC=MBUL6'']
M?"RD@ '+KFB73;F86OI<,\>G$Q>,TF]1+2M4H2(M,XS06LF('J:\/.KJ-W@
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M4B!H@[*?X+"X(:7$#H U%"7]"92W6KS43P\$8H?7 Q9<T-MJL8L8L<-211D
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MLD!L U"F*X)HRT8W.!?P:=DV_N77G[6C6/W[$ZM'*C^P)@/Q&S8D/_>UZ*+
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M]VXIC/JY+_-,MJKL,>\= MD#?QH>.M) '+;\&>^5 A^9XF/&\N/>1 D3>2!
MF.AW!IN*[&]T-!W?^4?\SL?O5ET/40 $(^K710,!82!39J_5STU%@6*7&&)R
MZNP3+YG\6:B=[(0"0I#:S'O7R,K#ML0,J9!G@*6BN'-<=G^,9:<O=G]N$U,
M(H]05+!<X8.J@P POI5PH_Z@YQG)D@EY"ZRI1_>R^_>>/)AD+TJ/2O(?_[H*
MY#.S7(+=)2I>X_M_5J"G5#>0V(7>)C&'KW=M5VSBB"-TEDIO B])O@H:OI_*
M[C)OLFO(KOG+09^M=XXJ6:KW '!]/^255W88.H:@JXHQDFZ'2*:3+&I!@N3L
MTP4\/PI1M)3*INSUHO#76=U\2TYT2R1((PU1(&.Q];8NOBT#\D33!0![<@66
M5=?JQ/P0[CU[\]0?"N5Z??_T?>_(WQ=>]E8XI,^..*19'-+#(P[I=[[4%U^]
M,<J0LTP31R3X;#L7M"*ZK <FAXY)#K056@PQ]4BWG6G=7"$&F^CO/T?>[2_2
M@*^.*C)QOP-Z8UMMA<$&5<&4SR!/YPYA3AZ&XM1%4X.09MR%" P^40\&(\'M
M4)F1#H@G=@%GLMXY[52JHE[9VGP<G 3(81BJU#O0D>$MY.O+NNE.7GO7$1MN
MF^0?17Z!L!WA!CUN.VG \,N^#8ALJM[TK:-."^! &( IPB::)2"$*PH-N_&U
MZM7*+U1($[*S!7T#'<;9_CQ@Q"!F9M:6QC5U176!'RC1":1-4)!PN(G3K_V(
MV[I SEJB0)""LOPKG6 J@VY/6S)>+HF#N=$.7?VETU\:U8,#GX')<OVR1-).
MY*'5O0E5.1OA <7L0Z(R"M%>\OH?KZ2QU,9U]R<;6'B&+WG=8]P@325D^@*,
M!-2;@$&5AJ>Y5<2&,704S>O@'K1$*'B@@7,/:Z8ID/WKY#0Q*Y#XG[@D>;"H
M!9!45-@#]^NM-VJ!IS47+;GY944W==3 XBU^/9CS5LSX?[3^DH/6GYMZICM@
M]@FU!7.C.B>C7:$(QPGVMX3Y ?&3E_7:?[(]GA+:@3W-A.>$6YG0M:$O>$R2
M8C"X=:,07%"S.Y L7'O_"#,K,B1%;CRT >AVA8W2 R$2@:+6H/R'Z-LFQBXL
MD-FY8!8'B,FI?7J/5,EP2,[<>72_>4"R%>*99QJR*O)SDB;,,N3NO0/+T/TT
MN8%FB.9C2N(ELX*'0=# #2?,O+U]4\5PS@M_XXI5!<0J%@UTB&*[*#=$0TLG
M;GV88 P&!*=""I"P[UET8%Y< /B3BB4(54J_J']5E^7%I5\.5S4<Q; <9DW,
ME,3&/D!Y1"N.'*4C680I4=5)#08D$8=G[]<=ZLAB@^P2&C+'*E<^X$E=RW@V
M6V+>IR)AX/2:+<3W1PMW< M+KC_C =QQ79R7*^I]A-9[8D,5CGIGJ./W*WH<
M,,TI=P5;=VO)O3U4Y&:*"D-X3MA^!\LD&2X3\YW$ J[K*58GOZ?!&3-&"PMH
M71!E9K SN(.J(YH:/=7K2\/SQ;?%^\P:='OQ#E\=;K-U^1;V!'!D#&_.WE;=
M!KX.,LPX&7 Z-"5DV%SXXAKD3/'EY*5 'JBE@29LB<R#@!\ O63HPXH_%ZY4
M]QV4@%BD'#!(]/!H(%BL%K2]9$+\D%P8DI\SL5B,G8U8AX3]Y++8A?S#_NF+
MY5Q9O55,:UZ,).,RG47B2T(@%+NNB&(G0*T,?YN5N7BWI<I[#(<Q$#,K5RJH
MD$63JL1L[J#=LK^9'_SZE1FJE60094&_2]N:.@6R204>QT?4ID#' LZY*IPV
M!NUB)11QG:$P1=D1G S61[F$ES"PL-"6UV$,0G\[00P+[.7@_7"O-+\[V*3"
ML9;3O^@$5(DUJ%P;6++_SR5R_Y%3'<0F[CP5R]>%.A.!14TWEC/3:J/)+5+(
M-1/]43'!M9&\"W(E_!)NMO-"WN9BST"5H.6;2. V3<[V/\KT\SW[E$,&BJB1
M)IT,]F.U:B#^\]X@%/AT7';WS%'3C6<1Z;25 $HG=8HB?#214T*?^Z*-@0S@
MD,XE)<H,B/:1PYH?<%$H^])E?0U1^6AHJ1MV.*C$$D8$=.[\.B/%(]6_DE?>
M;00CJ6JP.'C_8OPL/WZ0?O[DR_31V>>TN_984<-GAG0BE$AZ]#C]\HN'Z9</
M'T87P(M?%A38>,_A)*@PT>?"': D?>I>1D1&>X(M/"'BP"'$(#)5 PU+(KG7
M@,LRL\4KV,',U*LT<G)$W(F3I"0O]HOXV$_.3A\I#6!7=_902B8XX$;J!_#N
MXBL^/OW\3^[=KWCXM&,2E=@QD3UF:KG<=2_]=E7KSX]5Z]FJ]:-CU?HCWPOG
M:Q\D";QHXC!B$$Q\ .-I-I;5WB^)!N17B+8\4"UX/C,XU8X?S@XW/CMFR0WH
MP)MC-X"L6"EL>)!:*\/8Q?4:Z3L;B>G9G!A,$M7?YM2G67$.D8('Z5 'UJVQ
M,(T;J)W<0R4YT;3#*CGX.IBY*!FZQ1)UZ(NA[$RD$'1?]%[P'/93,?!T^-S'
M(S>\XE'2T&2O.EP8_BH;4G&<]B!)(L<[*.'L%I]7)$!PCN?3@77EN+W<_TC.
MQ<]E%N&)J*$3EJK.0726?_K@\>EC5ICVLX78M0ED@&C]40+EDN)MG11-'(YF
M8K\H^C-,+)H\KLU_SCAY ^*W9ZB;J8@)T5%4?SH:W_A-[8^WQ?%E/46*5JM"
M>@AI/\SOXF 9]@7_DWXB2X]V]46!J55EPMAC8O:P69 ^I"LJ#)$H6)]UYXGD
M0E? 34S\-[ :!JVAJH ^LJS9.2Q;YEQPI-'HZM3[ZII3KN]!:=(::VVO-M^7
MP9CNZI 6[FIW R'C7?<KH88R*RO@3!)_;\ 3\+YQR(.8 B29@%TH>FHWJSZH
MWJG9Z+J2_RS:O^\6F\Y5DH3N>G_NSAV: <'3B?FT+U69DUCEK\IU<1$,!:;G
M\!PP9=\4*7*WAFJW\,=9O2F7*$9T57?$!@)G=4L-'QA"[;NF;E), A>Y#\VM
M*S7U7J;K+_8.+KH#( GT^;T? -W93&FR+Z@7T>0;AFZBWZ3UX<4:8&90A*LZ
M[Q>++T?!ZG2(.A;RQD41*!>.I.?!,!@5"#2GTI/<76)B-TC%#_P'=4G$WMM4
M/_X=Q6K8N1B></<"J>O(EYZR/NY&EWDO']A]Z]*UH]'L/_<Z4*='#;XX^]J^
M!^K87V'][&UGX1A_Z5]ZMFU];"M_&_2O'#[\Z286']KNZ6.AD/D3#H"GVU'6
MQ:JC<9Q<%V!8X6OK_) TQ3F[Z^>LE#$@?/_>OVM\\<-NF(F;\12&(!_N$^;>
M?U^?P<^DGX3JOSYY^,F>"T[E00Y(O,"5HZNN,N_D[_YRT]O!S[;EOPMZF81;
ME2/@;XOFSU\Q_1KL//JW4H?CORRLAG[RDK*;)7_]1;]>TW3H%T$9\]Z#^R21
M2= F&/]7P_F>G-R)=Q[-]]U[7]_KX0>6E&;]E3GXZ!71S\_QI/L[27TP4HU^
MPZ[,2_& _+_Y*X13QI?V\"Z_M+_C ?>]'' T.Q(F\V[@XRS>*=$;" <-J53Q
M3\W9PM,>&C-^C0F&QJY#C*Z?"/_@_BSW9QX< W7SEZ2Y6-Q[>/8X??CHB_3A
MDR?WQX:9SX;/'O\IGEPPTI]\]>G9Z8/'P\>0X^1/TR]R^*FIZTXO(/[*EX.O
MH//]R5<AJIX=T*UO]:&? >H\MQK]G][#P#^]Y9C3+\^^3#][\/D[3_OA*_AF
MQP'79/+H,5FU1VK5:&C[YN30-WBKI7?31=_3@*;6T9[%<[M1C-;'Q  >/$X?
M/7F0?OGPL]O-R/LU9I.+Y<G9<75\X-7Q\$'ZX.Q)^OGGH[/C QN*SY\<W_T'
M?O>/'J2?/?DB_>RS![]SR_#@].QH&3[TZGC7&9'5$1,<_&:YF;D,C:GU0PO>
MB:WW#]RFAT^\"Q<A$RB,013"*(:)XT<;0^%]QTB#T>U_9886(%[YC^1C?B5N
MEG>G8Z&TV']] FFQ=^-FF>1EH>?%),D!C"SGU%<SGZI-#DK5NG=*U1Z4G[5P
MN#GL0(F*@)B?=7[B:=!C5,"@\TO0=%A9*GXIFF796EZKP;<"((2_9PI(6^Z\
M\U=9]L2YL@J]G^UE470CFK[I_CUJ^C^3\GS6QC $G"*D_ KCFQ:$HS*%"_@\
MPFZ<S6$WIC$G6:B#Z;L9U'T.@-"X/1":_04S+.(A#J(R0T3,(W*83<%JVF'J
M?5J28W]>/TT$DH*M6*0W"E4IDB0U,,^9BK<?MZE_3E4<9P@93J,3Y_?X?],T
M/W]P@_KP,(,*A2]_\M38B A[U9LYY.+P"R/@E.<6C:DZNDD@J]"8DOD1[9AN
M4(#N]I7EQPJ)_I(9+DOOSO:;*O2*H&E'M!2V=YI=B;@E!=]S-60 8A)(3-FT
M<FFJE?NA@3D;S,[>03M\/ 2F[*NHF>+?'J3+?1&Q7-8-L /4@J*FXL[,X_AI
M<]&T10_VN]VT=W*S/CILLTY":L$=/W0&:+\?#,1+IH!X+@#4WS.1VI0;_.N&
M+E02^< 4"GK36X'<OSB"W&=![H^/(/=?9Z'C?[*DS/_KD^S_G9U]#HLT^^I]
MC^C'U\^35R^2[W]X]?3Y\V>OCQ0@GWSU4S$-])9(UHU RY'I7NR,P$(BK%R6
M9^7.([ZB5F<&1?-,NXFH;Q8]?@@8<\?]RGB;M\7M"!L<NJ"((+> =;QBP([>
M /HVE!?LNJX:,I/$KLWH]*P+F',, 8-3X(9MW0%?.M.&>NI?$?GZ+4D*)%W9
M 4<2D]P&FAL(#YY3B_4+[W2M_5^$WG;L#;N5:"Z6%6B@?E"2O=_M<OZIT,[Y
M&KER(VLA$9*8DOV+5OA>Y%?^U7Y==LO:OPL.6)89L/_"?2@)!HH0 %?-=B39
MJ<2\"N<=T',[[%A99&L* :O!.HJZG]'" 3P8UOZG3V1+8H,+1D7V4GZI,/L.
M*,,\"42/NGL&JA,J:N/_J%'^A0,E 'IIO[9<'LS"DV 4.$U%C&R(BS1WT?GC
MR9/6X ,[M^%'_G53FP2W./L-8C(Y0#D)= 49-!P(?P:-!Z^'AP:F0ENQ</*0
M- O O4'?E*9N:V=<6#!^Z$L??$+@M2:@.@.4L>]ZT=19/N)(@H$$TN8V-#^\
MA[TZA3.SV#'9H(SC>@^WOY4O_^71EY_UY9\<??E?>WD/O/HO/I!7_]WYC\]>
MOGG^#!S[Y,6K'[X]3YZ^^N[9\^]>^Y\]??7MUR^_\W]Y\?*[\^^>OCS_QKW\
M#C_TYN6K[SXTD^'?2IW#\JO?X.8O@3\R[]%+^L!#^-UZ-'%+1E]E?0Z:O7",
M./3[D+"MJ, '6=:;!7*O@+Q;M022(N,<)MQ&P^+#^%GE")_^AO_%=Y [O2K]
M8YT#<U?+H8)1%7#WV)/%C_Z/_RA[K??Q)/Z^J5=]FZ7)RVIYFLAG^:?RR3A!
M#JQ[0C[#?LK7+% ##HN.&RXO%$26])2"A9E92VXY:T!:AO+'6_#L&E8,1S\
M?2&B4@(79%W0>GGP(";0I9^^/OG?.^^>_Q@X(8$LUG\B4#\Y9MA!-TSKVI>!
M]N>>D:-9%/X#]]/ ,(2N)J^MZR*5N(E_XEW*P4]\1#?\$3RM+%;^E1-7DC]B
MW'?X(MX=;ARM<;^6DV=^55Y#/6-IU#=@317->I>\K:!CSC^.[AB[N>S>0F?6
M4>6X0A^&^+:,_-Z=7U3O9"$EDJ$B/Q7M_ME71?+(%/&AL-2&X&W2!JF6**(
MS 6H:*;#<7M-CY:WJ5]QR[B!5J/0MOR%6_F17C4A%;'AB"NEMTMVA8^'Z%//
M?/0"!3JZP*,'6+MXG,IY8(SB(3:W1:(Z('/,R2Z"+.*ZZ'@*LJK/FAT;0AS8
MX^,*G9O,LA5J=Q%6)09$U'B#J#/;EIV_ PE6<K[BQ]/7I_10?S\__Y[_^F.
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M%=OQ (<)X,ETLDJ:)UL0<*J9WU+!@:8OO"_$W^'L1;R@$9HNLC?_U[-#@N
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M;*D&E&A[G+V^X]XA_)$@L;_88]AL%%Y VVJWZ;\I>N-EGW0#[86PV5CX!F;
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M_#<B.P^Q%<.=A**[\%),:7)$-J>,!IQ-IE-BSJE[-9!X+#0E2FL26U6:A&A
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M7)3H[?RDS3]?M&1R)4)A*LP6,W,O)N.M-![_?5I?GDJ;D3.V17>$B7MS\S!
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M+N5@:WOIU'MB5L,=SQ.&P3_>U=\]_=V"^8$5XMF3"(A>_NW E+/QZO5?U.]
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M?FGP=*,IY_7I8A&QAH2!*TKB>%,ZW\:^Z2TK%,VR5BV_(5$WBZ(9K2BCIG'
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M2;I[$Q#=M[JMTD03WP)$FU:WOO0<B[<*K)U&!Y3DLOJE7TFY/P^#.S?"3D?
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M;]%(MZ/(B2/<BJ(5B\Z,>._"NH,'PKDL^2*ZZ\^;^O.*Q.@XL+/8!-J( 97
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M;87DN9MK6?M['0OD9;%@4DJV[@AFVT+(U&^N!]@*E&@>PUN!^LU+6DC9-"/
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M#=V?#'@@DO@6=:T1/)8[B3]2OW\ [4;\Z A49E39^?E6PS+@UVWIGHJTC2W
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M,QHRSP+<!%AM7_NQE0)E#$P#*#Z$/^76$0 JWRRS')$.7#>S9"NERM 9VWC
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M0]%W\3H8)J(KDH@S(%L9N("\/FF(H*6)'I= ",#*PN .76:T-C!I[,O.I>-
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M51&*,O/P&+'OQX%Y&]QC%,U*1W%@;,@)T4B5FQ+0_5Z[!',ELZLQ>IV# 5W
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MRL^$Z",D1N1X'BNAQ$X,016(#IBN8(> HJ3_^AZ)$D].Y[$H*(8?^B[&<,;
M"SP9@C/!' KA2KGU<<W\EMX6]A$F?)']F5@F ::CV'%BM'(! 8R_03Y&(Q'$
MYWM'7(&3"@GU0;0Y#F$/G@VD3584"]<,A\0M94@B*T"5XU<LDHI)V:T)9\@T
MZ\W6]$KJF4C8S<S8Z$&3G^I8NNU;()=3@SVEA1\.L#'0NI!2/6(JD;GSS[.O
MT0?<"QU1[%&ZB+_[:&4P;I%S*$(&$P"%8Q\N5$FP^]($# WX-S 2,G2E\F7N
MG/>//M!:\Q07VBGE=B#6&)SS =!'ULJ#@=%XR7341*4FC/CF68S V_ @.$?,
M_)W8--C-_003-M@3^(74!(MM7ORI (Y 6-),]?LSB#L2^Z..5U$*4*Q#2$=>
MP8$2N1<*R7NQE R"#P*303415SH$$-X$LAO7B7EX?@4/"9]2%K]@1UO/45)/
M94[XN-<TF^$>6X??.T(CA#MA8B=%(@&"EVJNA3]"B4U\>SS T2-TOZ.$0B,X
MA?F&1#PKT82"-'(MB#@Y"%,3(IZL@FP-:.R:K7N0.'!3M!L@A4A^8((\DQ:&
M)8J-Y:*36QL0=/C BZ9KBL=-'E3'Q@DR2)%=,7B X_T$NY^TAVL/Y(]0360N
M&&>$.&'-^ R,P!V+9FGPN:B&Y@P/&]\0*@:EMC-P?.?:C0E8PEN"?T45 BX>
M%<GK!]HI/DX$2=J&Y^@Q )KZ M8>.M_TN86)[[D_D+$#/[<)U*F)0/^"]Q33
M!BTIU3_0U4)6MH :KQW'(V?)M0@@JADQ[/O@7TO!+70VZL4%MQ--\UV+V]&+
MO#38.AI0>/P!3H>%QQ_$DI+Z"[15OFNIDXJ<,M2S$B !X("&W ;CI707$:[=
MR[MPL;$YH@%S-EZ9M9T1W"K-'0<,2#!.&.MY(W=P$ZA4ULR^:+N'81I4B2S=
MD(4S&4!VP'+1W4BHH;29E"5IMT>]MB>82BBSC1"_49N268W(&87%&J)AX>$_
M@'6+,0#.A!%]:G4#!5LRXX))*K!<9\J<<#,Y5@3=.YPT@=,!1$LYB>=;SS>G
M7SXO8Z=39>S,S-AI5!D[&TX+E]20%5D,:]66Y%9D$--<4,K(!&4MH,XAGB>3
M^\!4@?\3>2G*;B$&GR9*4RSM'NT=FX>3*-LYBA,:N$9A'%=CJ.C(SSKQLQY(
M(VL-B'!9',2 JY$F#CE,%*,NCZ-1R7' <H"2*F)'4UK!B@_$&$N,)4K;'S@U
MK :[9>8]MCG6@XJ)(7U&4B/5K;?=U'R#\[(_2'H>*%Q!W5GIU+)LER6F;M;5
MS"])B/L= W70O= N1;B+_(W\-B,'<Z'(W""_9PWBAGKY;SWC9V3'/R9*[Z7K
MEU-2,+<5_L(^8C^A*FH:GDL!R33-HH:Y >RMNPT=$0^>ZM*:=H]4K5JYO?"]
M-K]9ZTL%&/6^66N)U4"XX]QD? H^K6<^S<U74[N9W3'V.7OIU!H%>VG7.G/W
M<I0.8WS>=NA&R.)\W\CM@#SW\.D\:%BX=RH1D9$^OC:\4\5L4LKG-"_< !;,
M1Z@PD0[,/A4Q0V7$8PC>=Z:N1V8T (N[R^*!F.R8/>G6DZ#*DT [A "-C@S*
MPP,S)+TM]#^!#@NO<8&)JO[*<G 1$V2^@[F8(<?L<("I;V"\)EI:'_J+T9N/
MD1\*3EER1I=8,>69AN"9\V@+<6KZCJV,S8T41=A(ZXN,PPPN$F;E<5JX5=D"
M>%^O];+?2IN6#!AN\2U<7VU&;4REI]?"XA2_H$1^6"A/4#,0E:UR^'TSQP+H
M]PM.?=QN5->FZND#CU6/\<<245,Z47W&22^Y";!N&)X? JJR]TUJ%QA%<-""
M%JFKY/.7<4/4A@#UM137"+Z(KKF5/NHSGLOA'#>=PR),CV& 7CQR :DR-WUJ
M($;!@))<YYZSGU"9<^YL=OJ)Z#*]EO.7T-ZG'@X\CBY28:0X,&1J"2F,?%A3
M'C8=>:_5MD6_ZN,/6&!;,H,*@9O+(4H7(6?I]36-3D.C_>RODZ/=1L\BRC$R
M%6^2X)+),"#/$39;MZ@V4#1=L8>4C83TGFO%@E6$Y"73ZFX$1@"? A7;Y7I"
ML='4(RV'5&X[)9UQ JS(T!-9L"HIW>#$71NXDF??TXB,()P$8A 5Z<H8KA 9
M<)'6?+\_A!N..-O\,'W&2HO''$Z2G2!N!TE$D1<_P)RYD:($<YCFZI(^8.92
MBFU3RR$>ZN^9 %4E2"44B@-;1:9/?'/"&Q!2:J(13P)%%RW@Z85#N1""KI4S
MZU"D$J..E%U83';3&]/HD[GPOF1:L&B:9D_-@J,,6<D50#+[F$?F(1TF[*)\
MWZ V6C0]3$^:/"$_EV=PAJU,H$(_*!Z?)S>IJK;W/;F&)0=Z<-P;1]B=A2Z@
M#[ST1,K\(S'5,DW'/CE*<S*U )APV$8&Y>=[+MS[B,;-VI&8_PWLRI5C3PNY
M%\:][M*T^M!V(\JPQ,Z9%+W /A"QR)@LJG%8D,<)C1+3!VB@@])T:'*L<&0O
M7LV@)H1O/1?IHW(?RI"8S+RG\(&1RK&1M!VNO>!>ZF:MG/8EKR1E):!G1K'T
M]+,4H.I.-0<DG;GS/J?+X6^)VK3.=P::)37@&Q$E=_%>A.] C^-<.\)XN:.@
M'UHO(M.:] &2.VA(M6KM[$O1HD%^PT"H$6\@]YUB&;F1\<R19"FK0F#.*!'5
MY>*M+R$-<PYI&"LC#=)EGO"L(;L4<!X+A73L$6*?5GC#F:RL=J1;%:EZC(7
MB]+\ZTIC/J%,!;0"M81X'2G0&!K;/[+(Q6Z[L4QY'"2NI_1*E>> -#(=KM>R
MZY#B0QOMQ2%K8:BL^K?"6E/Q'Q%YC'2?&W[N RP""BU-.>W<<0:OTP(OD;:8
MQK^1/?D.#6\U^Y%K;SU"9%IUD)M*FU)FB"FF$3$S#)2ECIZ(M N*AHD$6UWO
M5P]J,3S\&=@_J%4H;T.8>(X<*7\CQC"H$D;,OQ2XE%:7S$@BMV1^_.7QH10$
MHB:+Q @W.>!*^&^<D?/UZZ'2:D[[ET?]_U7*D_X[2Q_;YH+62HD<"C26H [R
M3<L#:*Z'-#8J0Z<AY>];F1B^3!-&3D8.<$P 'U(<-:(,/&)Q*M5$+6JHKB/W
MZ44B:[P7P4L5 $[/D'I(9.N5G%>(_/V@":-SA3NPD,<#:U,BQ_E!P0@20,R4
M%;;(1B8R#U<XBP*,CF,R/UX1>8W4#J(,<(<@S#%=,B1'H9Y\0[KL4"_8N^;L
MS]!$+I "1EB+AHB;4#H.V>%#Q[=#-U# 0=&4^-(]9@\92E%RC<8B%<@H*&'>
M6/H/7Q1<*,L>DYY$#%G+WH.'/F,7&13N1[*+#"<M%HEBS,I @\+)-+HQ \JP
M FQ1WC5.&.4\4_6K"5;!)C[!RL(YKZ!KTZA7S'[T18<>WZ#$[S%R]2$Q9E'A
MFPE#R9@0TY"^F<+N-7-*B-7Z:?T17#:F<3C>@V&34P 5 ^G]DY5:PM>FQJY-
M^WW3&NB\>U(@08$^(=KRN-$/_%U6Z5'3YN#D[DTF0G:=T+93VP5+C^"E5V*L
M=V.6%<=&'AMA0$-P2V"]Y3R0)1,^BX3JNU6H?F:HOEF%ZHN;:Y2FKDHK^:Y*
MJY3C[S2XTT(->^3[:V:-=J(=64)A^S.\9L*E)G6JO(=-:5>D_<WV$:9*F?R)
MJOLWN"U$ID^ '%Y.:Y'.,\87ISJF;-<Q]0GZR.] 3Q."1.R7-%N]/\&LE]6,
M\YP/,']B*ZWV91_;M7T74"*_B;D>F=64I:[[L"VYY&4RL"AX?.\]F"(Y(=V6
MH2]DJ?YV! >9*>B+VQ-NR)KY?<+-,1;LX45:% 9)T!$@7:PB;<]A\6NDF\4F
M5)B*@FG8!\KUR4G6!'3680<.6>J+P5N&8.3Q0%NP$0Z:<Y7]P0;UY+J!6[CA
MS?JPG-!+5(&.J"@3\ER-%M$;=[E:UK=-A1_:8&2IW=ZA.&0G5J<C7:O<J\61
M9@J]6NT;'N0RF!W[ ].<_J@E^B[2UM"LID'&H_0]4_-KV%AA_W"M7M>:DU7,
MS?SB#$)M_+2(;%@&5WZ%9%W,H-XLU^MCMP+Z^#2HF>V9#^F.>?6,8GUZU("P
M.;,1&U<1:OZ=R^FWBEFI+D6L@0'V1!3;TCK;Y#?S@3-V$4:DBJ9FC(KR2T(P
M -LD$4ST+G\S1I%[@<RH(HN.':N1,A\Q \BG,G71C8[)3CH#^\KH$]GE*7B-
M'5=0!<- -@:]IFQ>YE)2P+@>&MY@!Q[?$9 I;_OD1%;,<WF\3*>60*:TA)%8
M5Q@;"!QY>C;+1'"*KJ=_WC\T_Z1"K;_@/>B[6@CX;!L1?&7,@_V=(J1)'LOB
M0+^)V>S>])=&FCFPX[X04'])..&)F5%1N-8.??0BB[0-F?Y,FWW?ZUE[]2;R
M*4,U@'4Q?>_1T=@=4?@W8WEB7PUKO]NF\-83%D>0="M6!TH9T*TG&K-H;3&-
M)[$Y5.XRG*XSF]/EN1S_?@ZORS2/Z=7J#3,3^M#6!M$K2DYDEY@L,8>*&:8=
MV[YAIJ8XOP" X@2DC9#<Y^I5CB*+!]/<G-QS(FHAHKX4 L$>H#%6_5RS$UKM
M#_8Q'4'?>K2<"GKI[IG(R/AGBE(0K-D]N_ F "DPDX.]-.1?=BB%&DM"4(_G
M8*%TQ+ GE3Q0,O%#1/BQ_!!_'(Y2]_3O_?ZY<#\K_96X/HV!ILKLXLYC,OI)
M>]6R&)AM3VFKJ;GCW!NY1F<F8QO*+B[O8U5@]AM<_KV "VSF\O@07>OD=D:#
M1#:%4A7'A<$W:G(A,C*$C(R4_HKA%2")5/*EZZ?=!CG1AA]UATAWH+9B%T)/
M6B3"62] ?#7CF@UZ*V>0ZYY*K*:RJ3Z-3\'ODQ[H;) IC5JH#*61LXN^0/+H
M<CD=5;METNJ!#!)T\%*VK<$.^ERG"&80XR"*,WMC:4I!)NVZ\\!AF&3BGY,@
MDIE<H9.IO<5VY2 \1;,@K-T=AE3C2B.LHUO22&1&H_1'#VR/\#FZ=2@I+9Z5
M&0S?%.LA'RBG#4MZ?]*+@<S>]W)N3"2>Z:Q1\HN>J,"A**V?>IC"D=?7V'MQ
M\$"M5!#E1LC>*1U/Q [@:)%(JYM*U59Q= K5:P$GRB;3!A-FH_I*QT@-JI/S
M,VEDB@:#,E>9N@G:&K^9:SD;&@+7@(4J@^"[ZI>)0Y._T-#D0Q44/Y3T_$4A
MQ$G:R+(FF,*VBY037\-BK%^W=#/)R&HS6* 8QKL8LN&@DJU4#%% *?$%M:0'
M4=<A"DFX'=L@",/@'C  4>I]H];-9<:K#B13&<8&R@M^G)T(VKZ[1%^P]_?U
M?.[+]%-2*C;KBS_%'=*%-.V0EMS*&*=7-B;;Z9$+M.32W*Z^K\?FTBRT3*YS
MO3F]BU%HWU-+S:SMS2=NLW>&*P$&J-:K$@#JBD%.)7A+H_D+.3*P2&3,7%SD
MIGE8AAPG(EFWD&VUF"_+)_CWZ*Q1*IPT C'=0=,;TSQKK;F!9CRF.:6BY0FU
MX>#I&:BO4LNC;-ZNWG4?F36P-AMDD,6B'5/E !1&ZM/"B1[D <OF"EVB#:JY
MG^:^1%78R+>E0);P;;8U^+)F<FM'QM"SHPC$F-!PT(9'(2HN/QUBK?7JG\:C
M(_0(V&I+VF^'.6Q3_-4#O@<$YXQ%AP5#YXI:JM!G(=$N4:)MO78]G1L@D\@,
MW7/$\4WRM&:50[;W0 G;916.&"<IJ90.L2MF-*0)'IH#5B86)&18WN9R#+B7
M@.]XI#=AR3DSW;3=EZPJQ*W(TO(1=BS,997HO46F)J0, 3H 4/AJ@D-2.&-B
M?DJ+J#I3"2H%B2RH&61GNV!2'"8KJ'DPDA$08\*< 2WA7.;X/Z39(NF3E$]H
M$50R:24 >YD&@@R%_Z'L"VS+>2.^SJ:1I#6B):.&1:+)>U4T>68TN55%D\L9
M37[5EU\X-#[U*+53HRJ2K82AD($CH>/D1@=,"T59'4%UL'53*K'PZ&<W'@8N
M%;/H&>WYK&J0$)1)%*,MGF _3='*!VLKL/^NP^ZA_5JG)==<!:.F/YM3 RY3
MY,FB[4I>7W?]V6\'.]83H:-O@>_$*+(O1.]#TCZ-8] - VQC<T*.G6@U.]TL
ME$85_SX(/= )"#H/LB-;Z#H4QS.B.!F T,,V"+?N#1=5R!!=F@C(J6S4M?&:
M<C"']H@2J3.)=#=>,$C30RD?T^7*1[24U<JL;8&B1EK<.,%D02-C7T0\APL.
MA+H:YA2"_0PO9HAB+$<&"3EQ-I+>%E!X2*%C]PT^=1?@2U&9TD<R4(:Q+:<Z
MJ T;6BU1E$R$=\V1B,6IK-S&&NL!L=5#VOQ:U"Y3;CO8^OJZYEWB^4ZH*C=!
MQ<Q !"U7:E"ZRY U\"H ;F.)Z:(7F*SZM$=W-M6WB:TY[.[#JD1/>BK9Z.2L
MQ@FH+L,'H:HHS^,Y?8JY^J&H9)79I.S\PMH(QS?$P_8-=@-%"QO'>X_"@(Z(
M%XQY_.E)2*E&LVVHW3+&>P>.*WPF@$QDLZ5MK]#33CF.:$90\X;?<[BD7PWM
M56P/R[=IN0?FUESSB;T!17ZR].C*$IV:V1^#@7SKJ.?5_=+ 2"?  W.OOTSC
M_31/.S+8G8P)(F#L8B4U2 +J18NP81<F>H=W8^Y&PEHW4BJ;Q6ZH540@E!08
M;AS$$P^;-/S3>3!O[.2&J\^Y12<ZPF%=BX)96.B-B((3/8$.L=A&EKHJ7R>'
M+T+V38GTZ&B"'0/A/'0*6,]A9P#5VJ ]*')<J8D[Z<,(7 97GF*TZCM#S1]
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MDA$"</6876 ]RVHHTU4!&-N:0&C=03X-#3IV7*^\('>J!/1=N!I!@Q$R[>5
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M1_UNK.+NHTO-M<TJ7K:*CRY-M_RWK.$G2.9/7\B]2V7UIRQC1WS_R,5P74:
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MQO#:;+DLS]5<QC_' #_!4I,H)\T$%L[F]'1.CY<@B89\619&)^;!#RPEH]0
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MX,(1Z4#E.DN$B;.VT1MQ3"2#0:/$I5Z5T[28(U7)"3ED#6#!PFFMBXE(&IR
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MJ9%>16HDMUU67 D%^6"#@ER/@MS;H" '4) W9L)[IVYCPO=4=*BG?!HV)$,
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MXK*73;B%VKC V%:B[93&,LH*)YN].)?29_L"O3+1LFPK?;WSV>L_A%H21<H
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M=)3,UP#@1BC;*RCO=5#<"Y)Y]+CO_I7TX6"B/7X< (KM[NRK$?7DX:,G%V(
MW&;^X0(UTHZ"-U:4Q"38V)@ DN]N/E^6U7FN(@5UFOXWH@JRX 8G\YS,U*G>
M01=T$C$UJ8X7A;GUT6NMV'/&04/4,82ED&49#=@U#?):1CM'+3U7;Q)(%1U3
M)P06A)^ZU:(#;TNS,T@M:P!MC4^/:R@%70?7N@YZ#+]A=;63_"'*BPG386)N
M'TU.JE**8?WG+AF33D[>R'$3#9JU:*ZG"SA5!Z"M,Z3$MDO2V!I3!@4W2TWC
M;)%0%ZN"\&C0/[-<*+:UZ]>YA.!VTC<R.Z\81!UWU7T\1QGW=C35D5.M7" %
M<X2)IR76V*S&?R+\<QJI0.6CCT.(H=[G@ GIZ#5:DM=MF_<M.*[<^4/V5D+4
M_@L!E^O04=7C_)?VQ8SUM>OKQP>?;)#M69WG;'Y(UV.Q1T;.Y4Q(:A53,-&>
MPR+V?P@,%,^*X/Y8HD&N4ACP)(;'(J3H0V:,3-K2(6@6%*1":+$R(> 4%MV@
M@W+#YT:.D'9P1Y"UX:9:<:ZED^7QQD2JR(-.Q@5>?[#-0^_V*=JODY_=:**O
MIXG(K'AAQQ==.V!+:/-NUS$.3-GLVI2PKUOG=$AE'JD?L:Q%KKONMXUW&)(S
M]C XJBM->(,F!;T3S@Y#_A$TU V87Y$#48MV2<IHVR2F*#[AOV9O2"3".#_)
M3HNJEEGTQI>$R=V^ /94)P$8AU< TC@G?TE$%^<ZW*_T&=NN_0/X@D5#L=:F
MKZ!@43\F&G%>3+>7W-4U;&%MHV'):&.99Q^+^6H>C8FVI]"T,'^V4)&KK2'C
MW;/T)WU(5D$)H'F("0]QOBK;8EGFW;EXINM<:R95R;KNXVXBC5\0%8+V#&-[
MSNB09\?:UTT[(T!/X]=EF42#WHB5_Q*Q\A^G,@>$BYB*TB74Z]9 1;'G&,0[
MQNCLD-'/*"#&&0ODAWN T<#0[M&(:M"<,\D[/>HLYTZ%OLOAXAS'E,TE>=2Y
MH[:/^VW\D0M'O>^F70G.Y*^\.Y!ULUI,.Q<SBI0T/5DX-!!MVAR(U\U-^;9O
MRCM8I"]AD;ZRR-@[$NG^MGB3-0J=I5U5QKHN5Z,U:(7B%;%^T*.-WL-.7-&9
M_RNOJVWR.Y:@7T<@5%47.A2":X<5/HZL;T[52]3PW[F7DC8#9AMX<SJ_Z=/Y
MW%RA_XM3)8>21"$+3TA1)BAB9OV*EH0#Q:Z[$]QU\<4!7)+G.&]QP6TCV9_8
M20[#AJMG^OB@;0J<_,@GTQY:.+9?_83=-H#H.^F1$\!#W];5H@(J2!/J&XSH
M42[N?J/0E;9H2SI(2*[O[SZ5%4S6KB!_;.\ICBIR/)KS,;-6NQY7GP\.M8@$
ML@$)V^7O.&T@6,,*;M("*$0V\+_%Y/"C37)X?7+X_B8Y/,3C=;$XY?_+TF+Z
MS^^R_[>[MT]?^#'[UU>Y#T9[0"/Z^?>C5[^].#JZ;A%_,XKE'V"0B R"*3D;
M$F;XB8,("&%_]Z\W9(T@2?F/'_&%36^7!5?ASE9-QG$O,E6.N?W329Z5[4GB
M6F^=<_":X469 @I_SNL/>9F3U?/L<"1I!" RI0,23/M3!:Z7&1J6!LVYA**'
ME84099*YV:'/0KBFJ99P*\EV1& ;';-6K%[P?"#GV2<N2PL<S=&_,/J.[Y^$
ME'K1KBR.W7$EMGS>H=/<[O[ N)+G^8PC]X?34RZ#>&=OH97\D[LI'1XC9\V1
MMN>'[]X>^HC[;YGVV7JE(Q*6K'_S<H.B*_WMU;_O04,KEI7V9,5HB'1<5 V]
M%VTWR2^'CDT$O]"DY D!D5\L_M38Q&H\6;79(J]6C8"?-68U<L41VD:63A#J
M'\@ZEQ_I;,!819R.WC<YR><%PA"ZOXBE8I5SSFX@L7)V4I1H\[=@6\6ZZ_FM
M;8J/&H%#1UH^$/3;#XOJ#/%.;0D&C -TX<HUS0S0'FTUS<YW4CVE#F+(O?KH
MOPX>[S]-_3%-G"T?H V!9"/[/+<&7(*KI<F0?  .,7,KJKTR:8C+"EWQ)/M3
M9C2_$]>53J9H44<Z,26.VP:=[66)VR6-CW(BL<UI>R AN*0(Z9MJ3,_B<\O=
MX?2.U&P=^///K5QI-R:T9<!*>Y&406*AS2LWJ1/Y--*33>?JQ:JNECBB&L(G
MT06(4]TDG#OJ-964:)K<3\0>##V$7&F>M2Z+F=5Y7X9$;J")5,R6'JSF='?T
MBVERG E^VT: G!X.&$_!G=:P4>5(@AO/7O@OZ5A>_&Z\O:V@32>Y$,'/BV,E
M#T;!1DYW:D'[_OKYNZB-9>)6C"'M^[O[#]T\I#4=?5MO MO];GC%3,<B0<Z7
MSP]%S,2R^ PL $"9X68[#+^V+,4^9G6[R&N)Z4\A=8KQ2E#POJ$EF87 >DD*
MV.?[)-B4<9? PN/ Y*9VSV2X!;K%W'%/@OM^1[$_+W[7_SB*YN)U$"NJPZ;(
M1E*11!M^_T7Z<U&INJ(K)>BBMVA5F(DB^,_KH_29]%E$T@G(!!15H1VS9>SK
M[1KI"$QSG"_R6=$BQ=R=BA-;+J91+<ISN6 6<%,V[R;GJQ@H8)&"_$VGL]%V
MO/..N%MKPBD;WWM=(LK21U8#?#3.<<YY*=G1P;!)^K[B[,](,6I^17E X*<3
M#>/$@UD4WS^(=7(B;-/*8JGA.VYGW&'+2OT".G4B.;UP&KX<4\.(?F2"J\C&
M98&6]^F?G +3?4Z"O) ]VR!K3 A>\2DA9VJ"U+D=T)T4WKZZ]FA J,51[X!:
MP1A.BJ6<_'>*8WG++8'3]S7=R$RZ3,MR:-&R_(?;Q-Y?#M\>/DO^AX?^'[6H
MD#U-CTY(,"!&I@&$.Z_*7CJ62I7@BC?JW(\DENBA.9">TH9'38:=I![UKMF"
MAD"3RY?VH?#>F3 O&M]M-E 9Y"F?)'$W8V\:QTV-'9NPEW,O*TT>/Z]7QV34
M(D/%^IH9Z^TP!U4%6KFG[6%U67P+V61"KI;+!+FL>NNUB-YNO7D+C7/Q=9'^
MSUCU 07-79['K#'YP]TUC!T&A'%E[5IYPTBR8-QQ=>JD$]TP+[ND.E"[HL*^
MG><,2^G)LDA-D&ZKRREZ3??LU 23UGT[YK+'8-^&SL;O1Z1#MW/&T[(.%K94
M4:W]+]N^TK<A'^0KG,O6!SP"2AHV>OPR$BJK]J2JN>!$T'+=_MG>K+"VT&I(
MR(:'%@A-SIL4O&V"M.J,D0WSY!P0[G4O9UW/9>;D:OZYJHN&UM\5O=MA=$8^
MGL4*8\B<<QS,F71'P2/5P#)3/NEMYX"*U9+R_@IU'B;,LMP'' >/$U(7GN>4
MN\:7.;F1;1).MA'X'1RG\EQP=XX@.EM8E^0&(.EI5X5$TOX7J,P%RY!W;F,&
MM +9;+2XN<+GGY5T?#+#41W::-\%UB)G4U15W'5-T1-#'2_]1 ,4SJ5D86#-
MM;E!ASG=?"/@CDL]6>B"2UZ=?LJS^<@RG.AOWF;FIXYS((Z IJFW9[",IU)1
M,%>R@5%B)K)D]1GLDX[K*IORESBV,THA;M DNJ99,IR2@Q-LN3.F5HS8  7(
M-IKT_H -W7+CZ6F-1N%,86"/%A^-SBRLI4X%@'/_+U(Y(OY#2HE@43.$8]I,
M.]6(BV+VL0A^850HVG#]$RA/J>';YBRPDD&8^ .6=%O LTZOA2X_<R]XUX;3
MB45&.\'8(>?G9"ROK%173&^&)#?D5.4"+DHF'#:)[8G0#:9%Q9=Z(DKD3XHT
M#&F+HN* 3Q"_:+/)AS+7H(H;DBO#G) /1A,+BC"8 :3T+7 $.HD=;@T^-\.<
M92=,S@8CEZ6>ZM&1I?%^>(D6/H"7K.8LF.F8\RFH%4>'.Z<Z/EDMM]MJF[ZU
M37;)"O=EXNM$)B<5%_KH6?#WB!U""23T3:W@(FG]LP!3Z"Y\R&WL@I'CW3^N
MJS,:27 -&JG]=BY?2T*<+07 I#$PG3?;!F2'<;/U224.G5Z?R*',/18Z7 ]1
M/'Q"YQ693*BS2>AX'2\J?-6@A<%.TZRS94XW:9(N5_62U.XF*/5JCILA<HJC
MB>Y()+&(L9BB'!,?;Q5L<PMI)R5MM-_T7DY].1&CLJTACQ JOF6\HSBP+*R;
M:NX@UGP!?(1'S1!@'%48\OD:D(0P-WQ J2LO$+?44/"X+J;'<MN.LZ5,+_]8
M-*VS8$W^!K'3$DSX$SH_&L1=%,!TL>TRI)$DZN+:.6E5'HTR+UBNL&%&YD]9
MP3,?DIXH-L05TUH-K+.H'2Q6PGK#!WD:'V)Y]LOK1K;R*8Q=T6!>$WB%(QY&
M0_L::$3_LLX;1"Q;,,@&G*P,-F^O'[K=9S"94,F^D[[AV4=6(:)9$YR_IIJU
M9Z8H&(.'>[RM7=I\#'Q(LB02UM"P$"UCDP9$3=UAISKLL%2=4\_<ML/V$[*P
M'UP/SA2O<MHS8<)X!]O8.G(67S@S7$T3RK@@S<":S^W:4LU2Z7.23]&>I"T8
M:W!<5F.)Q;:@IZAB:B3LXRT3;E="&#S>( S6(PP.-@B#VUE^WI41K'Q\)M)+
MC*(9,A"AN<20<LD@%QH21%'S%5JP;!"67P]A^1O"^>PRF0,2N$Z:>W/A1A<M
M(@T51:+D",P9RYLSGU.#(C-R=!C+FU3R,1RAU9*CGYV.6KZ;D%IKD@7GX.4K
ME(DB>J<#7#6Y+ZD+[1!S86+WR/MUW##9,2^1JAW3,6=#*//:BJ9-DS@6'#VY
MXC2F9A3%[U;:A',^ME"0_YQ6*V**ZF\-1(QV$C,).^1DD477\\#-K"S^TM+8
MX9EDD[IJY/;^OH QH;FOUA7@R;9FBX3^7DD8,0),S#AF:@U?=6&\'>OQM<@"
MTT%?2,.Q@<!:-S:J!PK45BXVJ@:13T'1)OA(7M.NIA+CH*4%\XYM=!#Z?GZH
M:\,6E08E90PNG+H3CP4%01J!"P>>3_NQ1*DTNN@E+ATN<<)\@SG_EB7B2[FW
M'7&H2>)^E!#QEFZ27V/E(S)W]6"#'.58(^C>)4M,\RHRAP-<9I![\]Z^B!!3
M*=$$)ZY0R2@=_WA\%K6*)-&0" K1#8F%T7@BU6R;_D?CGN2TZU$:2-[QX, '
MQ_0M@A&!M5#[;S0%/K'5GE7!U6=XB/P&J=1[^.%D1><I;5&EW>PDOS>*AXX-
M%16+6H6L+E>:E<>TDNW)7,H$;:6"E#IRW[3B8JZ$_B5[QSGJO<?L]^3",@#9
MYQE)DZW7A^^>W^/$0R0C]_9^D(B Z#,2@7FDT$"?HWBJC!TXU(Z&6BU,G==Y
M0-.+D@*H-Q0;:%ALFI\6DWS;^C0R"B!'J#2O05%SRB=AZ^CPQ;UA*<V^79O5
MK24[.$\99$1%REJ@D'$K)UDYP\<Y%R7\,>X4>5&<1*)\7=0WPLQ8^(#C#"R(
M.229AZ'?(++<OS7K0&;P9N-0NNN9S<"%%4A>,"4$#!J&;"#6HL@,LW**.+3H
M^WB;7B;71W9ZSU^#P/]M*Z[&F\/UYPA1S5])]Q4#E6\/?,MJ R79BQ27CX*B
MA+X% ZRGO\S@%\&^H:_FH??=!( 1; U*D:&N''P!^+UM0#E%9?=DDT02#L6$
M .;+O9/O=I,+_?!H\)AE:XT6P%X@8$5,/.@"19TTN[KMDHKM@G+,Q53/Z8.-
MWOV&]>Y;+YDOTL"2[1 -D/L06YF!#X+$Z;,W^Z,T!T"U*D?I\M\A6:J%D,%+
M4T-]%(L!AV%M/L7<'"DF;W&Y6W$)NMK*09:#Y ]S2&X.Z'_1 8T/IA(!F>9P
M^2S.%4;91M\F>EW:"JH,$6)0R<=)N6U+RND8.+_E<UJ"V1LS'+.5&D7R[^F$
M+K*&B_:"SUH@YX(T6')9&LQ96DH@* K T12Q.L4^,F[$%^K")H7VSTK&^W]_
M8!IAK!HADNN/=Q)&OZ@F<J\4JAKG@1HX1]2[,- =V[WV1J!8$(B:Y\>UD$)W
MH^VC83LF$>8@7C6G%_UHQ!3WAZ$?IX^,:0;HBKV%>E(\,%AY$ETGYPU250*:
M414I^EVSIPD=S+)TE-.G1<.&%@"^8TTZEH"%M<A2@1&6:_J"!VL2LI#5FN7Y
M%*V^W, F,)V8\:B[V:-P@F1H" U2<9IWDA(,C#EV-N@8Q"TX/H[BJH8M[7B4
M\ !O)QK)V(J,W.;'B::E.BD+MZ0V>EP=/@%KC-$1TA -?4-,;QGF6DBN>49Z
MQPL.$$7AJ$:\MG'W!ELP2C^&1O/GFAL+%R%(#KLC93<24%6!N8G]S?8R K;R
M2; (K^ PFESJIX" >TH$MZ;8-T/B\P)*^X509C$8?[:J607J4>>T5AVBL.]<
MQ?-5"].ZZW\86,*OV1+>E*R%5+B1XSN'WP.ZI?FRY>H.0\U$(H$=RGZ,) )9
M\36+X2A*QV(^E6@K5C[,YT9:A^0;(KLL]"RBEVB0 &%M,P^//5BS;SN:;Z=T
MNE*>Y0M2O-\+966>;?!\N:LM^G$$OVX2FC,P[74.4@,A.\+[,7/@DS,T29AM
M!SXR,K@L_.TM6T>O?_[E7H<E*Z)D-+B^0H'IWM/:N^?0:Y*,1/YBDK<.(WTN
M0"*,+OIPP<!'J!WDS)>>DZL%/2'*)!@(RS_E-3F<%DASZR,+H2T-3/GI_!(1
M?IVP&$?FA8'RPJ!;NO7LE]?W-*:B(]/SU,3?U1  =_'HQN*"W=E)L-?T4#]Z
MR[1;;,%54Q@YNV.?BH(-,IB<7L'8$(Y0L]L<QK9XNIQ+I^MRS(@#KOI+QMH0
MB)XE2%\U0#OKI,4ZVCY(Y  7Y[V'L98IJI#&2/:$@!FC)[K=<$+NN#R?T,V;
MZ N@;YRG)7.%3=-&C(/YQPFI=8/>1>A)#]WAH]2LCD%>+V/7$ H"7G1BA'.Z
M$P9C*GT<K^3D?%FYL<%,/E_FM?N%@BGL:(FY*-L3_)JMIC\%YMZL2K3_J.UZ
M3BWOQ!UT( 64)Z1!S$DE@.6UDN,Z6]+VIF0LK"08:;=N+@VV3H,(&$.SZ4!Q
MN(0N[K-O$2'Q9(.06(^0>+!!2%P'0N*22,,0ZX*.H9B3M"[;?W[W7=K4DW]^
M5\QISO]O=W=_Y\_E,6(*M^I"7O\0N%%)731B+<P*U(4SKR\:U257,D>>W4N#
MW.]%VOJ6B;\;Z -G\8_(8@Z-9=BN<%:/S].S[%0<9?!S%XO3K!$$J]HLH07;
MU^;C:LI$ ?A /B/QTFHU)^,^%LI[M2)MR$D%\D #;&)1)Q;U" P)<G/9@\Q
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M[G_Y$,'GQS$^+6BWM[L)VJT/VCW<!.VNL:SIZTN3"VV@F^BSMW8DAZ4BL(L
M;42O6($3@F1_G9SE8P"N79=BP2:HUZ*$<F!^/('C0^;'3YNV?=\:  UL^/E'
M\M+27Q[*[FW A-_P7AZ.,= 4G3?XD^FO!2F(='^SM=_\UK[.IZW AW]99?44
M6+MGPI&VV=QO?G./X.!C<YOT!4,/X)N_N'\=._NMFB]=7!SB2F_%1DFVHIJY
M>QKX](7&5I#9JP<14^?_'--AV7^TZV,%*;WI6%K&]5H42?G8A-UW'X3JTOVY
M,K*Z.J[!+^1*VE GM7.]C9>_-<SC>Q<5WF =/7L11YN[2\5!]=DH<4>4%IQ7
MEONB!Q"N<>$JYUPT,*B1\U$K#=YI/6D&U![_VJ)D$GKGN@-+:%@N(^GE)QCQ
M3Q_99KATFDTK:[Z+.*,'Z+4AT F7BJXSH-#P-<@]H95CGJN?!N+S;H)A+-5'
MC3G4&64K1VFNJ/0@!&8L<I:$P,"YTDTZ9T9UF!(]K5;@:G-3$C2B9%I\-=TH
MD0>="5\^YPK)@9^"]A[O V2Q I9,*<DE+1(\4C)25RHTO/,IA\_B7S1D@4AW
M[L/LV2U=-V,DH"N^8;/.6>6_+/#A#6W)MV:&_?M\2NHY+],C/BG7;WY]$['H
M XU%?ZT;?O$A_WJ29?E1_KWSB,[.FG?WJF&RAI,G+D7D) -W?M<6)NBUH#WC
MN>DT,V#J67.E>TP'5\P+8) 426Q?$OFNI:(571Z!GI B3$NX"E*V-L^F&JOS
MHYGF#7-F(F,$Y"_7!;*BD3[T3GP-)0>E[\:J\:B"B/= 8%L&/S?N;JN:B#J^
M"J/!0TFP.7)E*P:+VU@P_QY__HE^_C/L[?02>YN39(GM 9*9,Q+A;!^AO+":
M"7Q[J=E*)N;,:X 5+%.+L;O]J8ROR"$B9N6*UE0*)!5;IMLTMBP=E\#[CR7^
M8^,"[]-'"7]GM19RH-U14+H5O+-C**72\%Y9J!5Z=7:2,V8F?#*M"@\0^(W5
MPH\U]6NER5PAM3ZMBJEQ:.<E(^?8C86>9;K@ANRBB4)B](@OR_.> AW:BL2:
M(_F)3?(^$& G?1[.*DBJ@B7!%UZBR)J10L5\C 1YRLTA^)G>/)QQ+M9^;U2I
MR53P/WSVE'3?VIYW5\9S5L7T'@>[NRE=BUH[34T+ =+ J+LOU$@*K %E>[XX
MUOI8;D0A[9N23OLF*=-!3<(4O:0GAG1PE"!"CTA[+J6 ^XQ.V-M3;N^'T5M=
M"H#&/LO0.N5W;IQKSQH%"YL$DD7% ([CL<@%Z;ZCU"!</>)1 NJ)TS_%).=.
MS^FAPA2]T#*A2@LAP,21M)-2OT5V&EU8Z( 6D5.S!I(#JD_E>:U@]->,%XQ0
M"L'K.51@%*U,1DF"BMN,1*09(BR9RBFQLJ-TBY9E4A<X7^2)56?W GR*G4U
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MU=N<$&J%*;*QSV"(\XJ]47?H1X+\L;/IR<F2J$]Q5.0,5]C=!F205HT-S/.
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M[ITVI7?TTY8BZ&0)A]OVCM3;X7Q-R#*31 R1C&UN:1\K!UR.ZHV"GB,6RQO
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MK$7BN\(_1I32%&CMA6A1^A5@.\IB7K21BK>4-WF>Y*87'#6SHI'L/$=CP8A
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MXR)<77?T25$:_NM,7P,BP%T2+\B?TH/*,&''?"GII/+DGR\=),O!K$2_!Z'
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MEC&(<":.10[RA&-;%8A<]'08KW9@'*,BLI](\^'(\ZW$63K3M%/6KK:SK.Z
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M-LXIO#P6?HABC:-?G ",@")8(1CS-?+O-"?XAK5C0)>%321\EI-:*%T8VXA
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MXP4N4)D!(^=ONO*%\=JCN3-9.S !JF,^JJ)"Q0,,^9Q^1(_IA!02.AXZ&@*
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MB<CJ&&IU[Z@"P@;XT313Z=**RB4+ZO[%MW&3$2L4?9!W/@-G#9.XQCLL#-:
M^KJ,UJ2>P^$*$'#CM;3V:604[9'O.4>T**@'Z56MZ78OX]!T#NSJRSH61DKR
M=44.HAS%S'6/ PMK0(*0;-RFPJ 6?2$Q1=U5?!5CJ] _0N=UKL12(J=ZT'1
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M0-8[@Y-FD!#54WK+F^#CXD'R="I<N[KQ(*3,A"LA85C5O%1+9#BNQFQ0'UL
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M8:B<=OT,/:T(OG]:+">JQWCL3N(C%)YHH_WH@0=GQ;2II"?6-N@>GP;9NS]
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MOWEY_/+D>?SJY_CMK\_CDU<O7A^__-_OH^;,28:596?B[64H3[M(R8V[0+9
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M7$&*;BK_<WF&]JV?HFY9&[ZJ=W[J^^9(&,GC!P\?2\F5#V1"4Q%8/$3>L--
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M)H+MIT/@<U7=F;O]3=K3XBK3YBU?G<5:][K 6WWH-HS[<A;8(J:6"UPN<+G
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M'5 %=N\&Q 70J+B,L!JZY,2'?)J6.?8]#&IQ$#JNO[;GB"[W2.]1=[$].F"
M ,KX6$T$2Z.[NQMN;>QX^X4F\^9.N+>[Z?Y:84X?T;R6869RLVBGV?8>W>"6
M_Z&KPW4\@@9?3?3GG2_*C_._HC0_S51"0WJ%LM?JDTC0^N>&H=EZP]^I I0
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MJ4GU!:((42I=[4*K.5H577$S*!;\GEYCHD\H]')ZQMZO!:=FZO4OQH*[U0E
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MI]KO@4X*;%0G6N0-89 P KO.Y02V$/91S#XH#%,/84+L=":>_(QX8)2FH)5
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MN9VV@:N<(B(]XG>;@GJ:]XQ4CWKYOCM)^T%LDD(!=VRV)D7CME,8]?O2]&R
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M+'G.CP;)\R1$205JT$GJ4+5F'%DLKBS]$%I6MGY4H[.>V_O< ^7(K"J)[]:
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M_8K-44[_O(+!D;:RSS3W/A4=1 /\&V86.1!@\BYQBTUE\)FDQ;+C;),9LZ.
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M3(O9.ZVY16)>FJ<0=@19&N-09-=?E!$V^Z'6*GP3(\O5D)I,Z$QWQR)3#4U
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M '\[O#5EB/@'\/L%[8]Y%<] SG!I%ZA_<=9B'IN67@8RIXWFC.W<*)P%1EW
MV10U+Q@@;_&?N8<A]6!B.2K]7+#7:UD @\4L*1-$7I>6X<7-*Q!-[Z,\X>M"
M5,&EV-$-ZIKXC/I[R6T\A1.4R''PKW;#\F-S"KC]5N6MA(YQ_'5*H.1@Q:6^
M.EX=KE'Z]2)T:$GK$5)0X:0+$%S4 LKHPC8:\#4Q_K1(<XS SZ 2YG1XV'):
MK5_H;]2J:%N4FF456(0PS&*O:V(O]B DN343*T_5%B6"AY@-2*$V4_US_4R
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M_)MQPM$&J)T3ST0E^[F20<8_N0D@G^YX/Q+<+WSUJ9X>\I>"-9T**2_8 R1
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M_@']><@F[>;G<W[=TU^MSQ^U%P-AH\>..W=<NM/!.,''Z4)' I[#>"#C;=/
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M-EP3U@@//F)R%])2=FQJH!OA"9:\\)G%,4$L!RP3^';&UY(P(TW.2'^"T_K
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MG+0!53'Y"1;J82X#$#ADB&"YPL$1U>]!.&).#B[36DP8)V7"CSE72>YE!-<
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MVM_5Q/LP\=BTHQO7T*BP5!0#@9P*P6+A#\J$EGOH.6#GR6+$*"R7@J5;:2V
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M=RI4*%XD@L5I6*-\;(&(U:E61$//";U6MCGE*,-1AYG*-_B_*3-]ZI3* >]
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M Z.^L[M&5"MN%YF<<MP\:;5[V(!HJ2>1_#A[3OO,@1G\S0O6A.,V!&+%/)P
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MR.9V<$"E7RDX%4$L1; 4O"*%=.W2TNBR.(Z;61S'+3AT@Y,$_YOBY.6\#D;
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MG7<1W]EWX*SKZ3D(8M/_9HRQ8/0U:-QR/>45U-<AD;,M#DSG40(:9-B^Q8L
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M1OWW]@+'05YDL,THK,S';S:2D$%$\V+$CC?:$AUF=8$\L@>69Q&T:*.TCH;
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M@T:9FOR!JK!@[JA]EN^THU6N;29-)1%:4^N*'@JN*Q.+T=!!'!LYTUU$WQ/
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MZ#")#VP>'%LS</(!(( :+HO\O],O\>GX/+*70-;Q"3A^2]>RHOML:?:$2K;
MQ!G3.O.5\_E&#ZTXQRPJJ'+^8DP5R<?+HG]JC^4O/E/6@E098NK:X+?-!+I:
MC-/6W3ZG&V;0!\+)T#M!9):7(RXL#7LTC[/3:=9;_=6^=KFQ&> 0G)&ZC%D:
MH3/7;+]G.,Y;#5T\W?;(\,7O-/O6?B"BIT3J';,)%NO2W/#W*#!0/RU6%*^
M8-]FS1;)J5!MM+\G,"!+EZ3[VB+-0;>P>6#15[]83V6U+2J@ 5P.=HI-9.L&
MK]'$HL2J(O/=[POD0E&LB/-EXQ'MR$, B/OCH@9A)?!?!/9\'P]$ONK_66#+
M-ZHD#H8[SU@X'BA<R!D?@C5R+"H^A.O?@J&HX["F &< '>AYD<!."JO;C<AB
M7M04#V3@BD*=0ZBR;JFAZ1_7-U_V80H/3L[;]5:G46\UXV>>;P^@]PYYKFB2
M0KW5*#_45VI[\P-XR@Q_&-X!9>9K,?*"$B7]6\V3\TZ]U8C?R7+L8']D,XP
MV&]7 '#W3:I/KC>O:0X2_'B'B[(L<^BZMCY:D('_:-U8)F40P"R'C\A^=2<9
M@E1$4*[]'8>"H'1#,\)L$? A^3\=8A!0[^F" BV<77"FQJ^9VDMWS:JJ_[S/
MI7,MM;]_%=YJ$\,,6O5F+^M*N7<#QI3ZN+,_$*[(DXS0VZMRQ47AK7J_>61
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MZ;,^@2_]IO#_GDZ!*$[5=NQRJ]:&#O^I_I--3O]FMK6RD4@>,=&T]@Z< D[
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MV4>G<W*N-E9[T#C$Q,8/0(AFC!=\ZP<Q,-=))+ME(8,3\#:Y=\G-<^4)- ^
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MQGQ8E=<H65ZC:DPK=3;DN'(_[Z,Q[2)0V33W2J%(IA;0++6Q"VNKCJE.(\L
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M0/V'Z_N+CS6'<>G3ZJN*H<\06 CLA4/+[B+4.B)_+6L"&X^9[0+@%4=W.4H
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MT+$:$:=JH*3Z<AH$@P3 )^7Q;0Y7']K V^-/R@UP/ ?2C870:#6"W_I5?HT
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M+PT"90A>>$*F/6J>,QZ<QH=)9K%FCY(:.I5_\*6\%&:PX. &5J;8/(O@UF6
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MCP=4U-J$80P3Q5Z/*\N>K!:1Y^K/*QO1QV3)SI7^/Q&*X%W ')=UR2FK(2N
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MFWM!O$M9^Q&6/KRX;E\-MB^=\ &Q)(RZ4[G+&>2OW2B+=V&K*/GRTY!J^T7
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MM#'7U^9B(31%B$FB*#<X!=03*5.I\?.(4G^EC^!S'HJE#3K3<?4I(ZOBR]1
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M#==[&UF8>T#3E?X@ZB5X,\9H]01G/C!2[8C!\=C8?7((*Y*?8ED&+)J9P@O
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M3^+Z(KM9J$:SXJ"9ULM2QJ(+]2H.$""J;J#=4P-MH7O3LF1R<(Q5%Q3*8=U
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MVAO8^,I>^O(WV0ERQ:UC(JC*Z<"0LR?<U'<2*2#5)\L?VZZ_V@57//U1$3.
M<UL.8P8Z43,@%NJ?E]I/$8OMO+QQ)_-[SYU:2^RX^YV9R-9_N"]_^&SR"83"
ML^C*2.5O!S'9?E#L/5^8#AR]!?8!8^CMZ]D+HYN1?#!>_&%.^ 6<?Y\YL;Y
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M])Z>9\*U_\#&K,'&[,>PO.BB=_,Y]+:PR,G7U#R&QK'DDC-+ZE(43D(\PIZ
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M% 2F.I[P]4YX7$HC!_V>)50_[P]>1!%\)K,#A3*?#L#N'JO9:EJ5-<H$"^F
MX[SHGWU>=.LX+WK%O.C.<5YTZ7G1[;V:%WU]\W!Y;S[<F)'!T5^OKGO7%U>]
M/[01TML9&IU)/5;GU_,Q?+F?X$K@;]S)W!GTX(+ZYXW_9$_<_]"M<Z&T$OS0
MFPQN?2? X#_?2%^EFKI76NJ+R@D\P#L^C^ R.L67_!/?\<_JB>G ;31%L\Y'
M\S0:<-OTF\,KKEZI8=9F,Z3&H3A,[JHI;"'^\0MLSG=5L$O?#@7$/\\#=^($
M@2&PXV"+DF' J\V*,8[1<H<+\4MI/U?.FNY$/_*[?>^UY\^>_^'"8WO]?\_=
MP"727'C^U&-Z&!_P+D2BUBJ?+OC^I)^JGTS/EW^@Q_R QX@_?31=N%S-QY$]
M^<OL/SMP.XB[E^! ^.E<./[%&=DO> _#>WM3WQT)1G8MLU:I5<],O+K%BXT7
M.R"[#6]D,=![.H>G!93K<*@@BVK033A93XYOF2#;[HRN;701'%&^9?%,&3 )
MU*8M\1'9'F"!J^'I\@+O"]RQ.[)]XU&(#6[J$00_A!KR)@Y^< Q7@2D_!7S[
M(.@DY0TW)+\H21;9J0E+@+,"K )[$W9KFS/@,)9QBK_#]@W;3%P(@:X$9+_,
MQV,&]YR1_1-R&*@EVM/.WH^PQ^EKFR_/WFBT./5>)L[  "\S< >N[2\L\_H?
MDC[FGR1))ECXYM6D?Z9X&?Y><A"D*A3G?GB&HC(//]_T9]ZCXPM)KY.DURPA
MV09H66>T$$!6H$NG(^45(QO%>TG<Y!H_W#N.&6K!%@B3MFS<*]B[Y"VC:0/B
M!!3PE,HCB<$/>9,1=OB.09)&AC9G:^+IH[90P/F">G*BTR(M-//XX?,9&,H3
M=$KHM:Z8VLN#G6;/9'0O 76%VWM'4GF#.K#OC)5 H"B@ZK.,F2:PZCBCV@1*
M7H'GB/[(+?C#8$/<@.[SD=I2/*]N;Y0R!LE9Z1PWZZWUDW+WX,O>#,G+!8,&
M=@$_/,,)"*Z"@ 80//CV).#7)KJ^ 7TZXOUB4*/:L;KM9-1FIA,^ %2K=C]]
MP]^$I_'EV>T_<SI\ .<J@P0E\I);(0&!T3964D#L%__ITIOP]@KF.,-UYM%I
M&LY'([CU')_2@D*#>#_ =[-'(V_&B%UL'SWA:$^<A<#?G(.4^B^^"Z9W<&9>
MVD!)?!W)H1O, B-;J#KI%,60%E+U!1Q)L")W0E P-^%Z7B*E29]=BCD*6HGC
M9V%H0 SW_*^,;4?*Z!K%2J7"B-&M[=_X9$P/R'>_=7PB05KT"/Z>M.GZR7GE
M#*-8R_L&_<][MS(8V:CL%R,;*8RD.&!$(=SA;S2-0+,%)\[ILST:9FO%QHJB
MM[?8=S-MWQ18Q"">(4<X1Z4W0A,YQ#>T.^EP$ZE,-#AG([CF\ M@' WHMG;
M%!YR]+WO4&$1T' &GWTV/U1_K59RW#"-VG[1LI6A# Q=&0@2"<IE$4EZ$%D4
M65%5_A84:1=2C^A^92C"1D/?8*V8(L10NQHX?>.3=%Z*>^S6=_M..(U:_#6H
M%E2-V(I3/4M &]8UHY9ZLM4D[#,#70GM]GT!YF/D$RQK<"K-*2X025;HJBA&
M(4T&B!YKW@^89L +(ID(N$7+!#-?#HEX\CWP-J<2*4C8"E+-Y-AQ"4-3QR-!
M04>D%6$%LQ$L;>!<"98NF9A=J]VL)%I8[\@#N7?'\Q%X:XXW#\ !5*X81N^
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MX7 3J*S'K;;8Z\R[A$W1MA\0Q"C?IEK4'-^I)U@JS,6!'B6FT Z7 28(@HR
M,V)UD<WF2R-$:K%8*\BS!:<)'2]P(',F#%KMM(0!Y?/#H+E,$/![WE%P&\ON
MYR-9?JL?=AE[DXCH6"0P,O7(70(V)+=,#S! RIC4H*%"N!D1LV4Q-A\P2OU
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M+&G /!#-]815(A#TI@SBH5>]"_2\CPK!S]:[="34E&CYP3DA"A+&T#[G"91
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M4<FD:7=-W]Y=T;2]CJ8K,Z\6,ZD,"D-*(I-DN6$)X;THQQS)Y9A$U!<@832
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M&B&Q9K!I,D'8 -$0CYWCCEK2Y/GNJ)@F3YQP_$^\7'@/:+"2,"<"1S/OW66
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MS V5'%"-HDC>)%UWO/VT;5[K<M#*L"Z;BM["Q-^!N@BCZ))]#$9B/E5AYC:
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M=4!75J\B12#KPK4PCIND&5=1@JM2T#T:ZOV3[,ZR-0=<UI:^!M!7/\G&]E2
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M9,]!X[.C*A?G6#@,"I[*ZD!PM:& !/Q8<AG@#U^1 OQY]!Y9)-33T0AL/OC
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M% V[<)U%%%6B0%ZD_)D0 *D3:<TV+1:6<!E;ZC/&A0+;_LZ=,Z"HR\Y_V-F
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MN!R+U&E%@TJ,]U,"\0L^.;;,P/G;9I)%$BH*(&@U.,U%_@(]<8S6 EEW/R_
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M/_B@3[&:6O4F"HY/7XA9JB@A8VRA1W^C>Y+<R8GC6B[-F@\PO$W(U)/J-Y1
MJEQ3U/O-%/7T*>K]5C-%??,IZH-:35'_X^KTC_/+.S9%/6F>^NT=_/'UXNKN
M5KW^HE[?7+!O-Y/5:SQ9O;>'P>)?/%]%S7_WZ-L\:OX5/O88J!=P 8PWFC,>
M'^=>]<#Q-T7V6^?'01"]])3WBGG6KIYGF"BJJ81N9[?==[7;AK=;//:;!:KY
M]6RT$P:9IQ+S"SFGE.K%A//,1KT(SLW("U9'J$B3TK<1E2PVHC[W\S898M\I
M4;1Q+8AXAC2DIJBL?7HN[WT -O2@9VJM?J')]24;(KPCSK;WQED==(G1T?1.
M=E*AX>P&G.WLC;,T!LTP6EJOEUU0U?!V ]YV]\;;SM'0;'>T@9G==:(L9[?0
M%#+?\!TO"-C< FX >&[=V\&M3Q]6<GU?TNAVI$VQ_.&@F_\&KRA+7&M>5''A
M;LP+(_^=^QYX4<45N3$O>D5NR?? C2HNM8VY8>:_U[:#96@ZZ#2+.9S*X=B3
MJ<<P(NS)D/RH.G0(F_+M9C&U[$M0MD)1M/_G<J[:EN_:8Q7OL\RAZ_NH9BAC
M_E^ZS[!31&*PFU7L/9^SB,@K0].-PZP"*6.JEZ,;]G!N]34C!]ZVEH0K85>7
M(9S1PFBQD<O5K"7=2EC Y>B&L=@VG-32A-M!2Y+4PO%'RWVP4?-.+,>/^IF-
MTJ>.;9G9U4=E8K.4V(8OW2^P70*F74^6AF7E8SZ%:W6CJYGM313U7LL:-]'1
M)8B8Z4@:K0[.]-%:.;KR[DD%51\3V8I4=JDK6[^EM38R'_8KE1LH\NU*)96<
M@5@.=M>-;8NF>=$K(-CC/+W=7P)K9NSE.WH8F31;B)FOX\'+V22GVZMGDY_=
MJ]_2\F"6&;98&WDHU_1IGQ/JTM3:RQL<R;*]3&9X(D['_UTP5^EZ(@9^Y#L(
M?>QT,M!-K=O-3MDTM?<5Q%$J8-H ?-N! =HK>\AFP[(*(CCE6:;3\*-VS]",
M'(GJAFD5A(\J8)I^-.RW6IHQJ%XUUGLR&JL<]R@)QG-@FNK:;[TM3IF[^,IS
MO7C*GJ/0BKFU>OMH:&KM-ES(K>H;J;Q=SI6XD*OB'+;1;6/;_>+3J]XOWTK<
MRE7QK8LGSNQVM4Y_=2Y%P[DM7,U5<<XX&G:[ ZV3,$]D=_=S@V%J%G,X()%5
M6#CK3X!YQ&<GP&,._Q0XD+GUX^!BR5'Z6. FO_C>$YL$MP 5<!TBX'^EG;//
MW5D_[.#BQ]RW0%4ZKN6_7L[MIP T%2[(]Z93TE6K&>@<:JJ'[5KT05?K#C9!
M/VP[W+@]RZH^+#"/AAT3&-"K8_Q_>R92?1C0/QH.- Q:M;IU#+EOS]:I#PL&
M!(HP.UI[(TQ,!:WL<L<?+L/K)[J7WKH]7?JJ ]GA9O2OMFM/G'RIL';K:-@&
MUZ<)-NSP2MR053J-R&ZU&U[M\/;<D%<XSES7S$[V;=?PJK)K=D->=3".H'7[
MU6=F:MBYFCIS7MES=0HVR?+^WGQGSRTF .SYAJ5Z1KO+/,2>UC>WV\]UDW[4
M;YKA9?(&)1AN@#\Z,$'E;+=_:\/N"M,-)=C=0^^WH_<T<P,[NV'X?BJPRS <
M\85:6S<ULY?M:U? \"9=T2SF+:8K-JYI35%SOUJ!,Z).>&-GNL .W>R X3PV
M6#RV3.9STZ31;!KHE&B"9\9$M:S#75K;EG+0TAZ4JP3$*#.7[T].YU-&YJL%
MSI:[GIPS-FPZJL]H9XUCW,JJ5Y9+<I5[S1B)[?:T;C?7<,%<ET5>J7A#XEAJ
M3.26Q+&3-=QR*ZLN)X[@] Y-4,,M,PGFV(AC3G$TZRB.6?/GM[+JDN*(T3B]
MK9EZDF_<B&-.<>S741R[^UAU27$T0#OV.YINY!@K7HDX[J#A0/[>D;GM:)='
ME-69[3,;NI39_-[C%C&KM5WH&(BAGC>V3Z+/3VUF! ,^GR3_65/GJUSJRLDL
MLE",N9P825#0)N"V.\'MU49P,SW#"I=:2G#!'6R=M*JS=AK!W41PS;H(;C?3
MAZQPJ64$MZNCQDV<]]P([NX$MU\;P<WT-BM<:BG![:#&36Q%5Z=4S5N*FK]A
M3UNOH:?=S?2TM['J<IYVU\!>%-B6Q32:P'@)@6S742 SW<AMK+JD0)J-0%8B
MD)TZ"F2F>[B-59<4R$$CD)4(9+>& FEDNGW;6'4Y@33TW0ODVPR/-T[M&O-T
MGTZMD>G45KC4,DZMT6GBWS40W'9M!#?3!:QPJ:4$UVCBWS40W$YM!#?35:QP
MJ:4$UVSBWS40W&YM!#?3I:QPJ:4$=U"#^/>GN04R0,V.AXK"&QC/9*'^6=5;
M("QWSI,=J%?VB_K->[)<C?U 4V]MWYE\5I\L_\&!E^!'6_'WB@'O0O)G.WG;
MW:.M6B,P[F>6^PK$HKD<@0I< (] =>!##[XUA3/JSU5OHLSAXPO76HP=]!-
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M51*(/BU*U0+.51XJ6#_>7>8F\@]A:_"IR%F"WPVG'GT%4>SF&%CV43)/Z=S
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MM[<%@&]+^[J)3$2=H%U"0[1K^]K%)\F&@H5HZOHFVA88O;5LGF8;Q2SH=TO
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M65OB,;^/);@''T!_1FB,1+TJO1C>AN@_>RI$-S718AOV;/W9UZ4&5@6*3U4
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ME\P^U(>9]1YA1G$4[^@N6J9*O2KCY,>Y"+7,MT%SE5>PTNC<G5=0;P:MI8Y
M%!<O,FR4.3=\XPC )^=/8KS+T-=. 5:&X+)"B-FYM%O#DL@%=W_ :S_*PBPG
MR-(T$A-)^W;^]0RYVW',_)!^MS$XQ>](>%OB_P.1GZ,0C(I?1?J$++2>ZC)-
MM^CYURNX<TW;:?_Z_SM"&3QJ#([]/S05>O']-*[  /"(%YDL&J4/*H*KV)@
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M*P'[6[@3G>T]DO8K<S"Q&.9)Y._:T>QNOZT[JU2L=#1=&ZW4T43C"PRE8]L
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MP'U56JM?3Y202!9I"H:X(R"R*7$BQEU>*L/1WRW.Z3[\)F2E"+L\;&EFU,)
MYF.RNR2E.IY[3W^J.QNH.TB-+BL.CQATL26J28-:3%5")W]EIF06W=X^'=V$
MHV^J%5K)HGJ4J)9&],+64!$TZY-)A//,YC<9(8FLZJ5U^,*._7^ C?Z 64"N
M!C0O\Q9V&4OEH['(%I=(]W?@G@6^6;;BP.6X3?K)JKP[Y1FKIO ZTB_9TV2
MV)I9.)M-HQ$U,=!L73+<C:Q&3KK*RE.Y)9&2GBCDX2CGU,3.'!R!IXOX$0#
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M1GKPLEF$9RD-IG&>AL(V\MIY,@3 Q9LJ6H;B!N^RC*=U<.$;![X\]1GJ2U0
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M1DT'6G3I4Q;U<FL ;NB5-)WYW@WO0FJ,ZU*?RVK9VD;K[*ITB;:HX?ZKC1'
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M?E/+$C1YL[T"<_?PK%/>M GJED_4W4TG2'E13>L)N6L@=U%MYJG-YL";24[
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M#IA>LP_W*##=:NW38&Y6SZZ:91 ?B]>7G&H/#C0$M-<<=K,&'E>YZI2:BV<
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MZ"Z/IG5!(+*HHAVKSE7'A0 C8LR6!#;]^80:X?, <SF7,]UO$3#0@!O;C9M
M\&>/GL^N;M*B:AE_#UZP%W0U$E+ILJI]G4-]\IJ3,S@Q*KDO%;,77%F;FH@5
M8S*RDB/RHVA,&K*_G,]&WTT^3X]]G'2QW^_5-+E-'B-*:8X_/N,95VEMF_4(
MO:&M5BOMJ*&M7,IDLV+P;(;O;?6SI6;RQ:U048P42SS'O*WUV,HN MF'"U</
M&[D-I?[4DCH9J?93V?G-[2JS.J\-'6^1]<+=+1$PYJ7]7N^6S9;8LV1P4ETZ
M7:^+S:NJ4VAJXP^30]KRD 09#R#NN\\B:85WNXA$$MD@_[MQ[E UE"]Q$L<.
MT$C!=^&(9)SW_.P%DV@P5<\574>V!X%.B3JA]XAB60R"ERU/ZON;%[.AM]4K
M0*^Z 4Q-AC+>"6KQO1+^-XGPWS8@AW47[WS['Y-!9I(;,;(E&=DA_B*L86O'
M.,4^K@^*&*Y>UXA*^QX,KTGD.MC6C@,:9+<V<'Q'A*06?Q7A$W!F/"J/N/ >
MKC.2YZL(PB?7]_[#72@6<[A+MMT7L+>3*NTF 5ZQSUWNL8M '23->O /3/@Y
M</U&8!?@>_ NAWPM7K!U=!ATN9N/&D3'@%L"%?[D6RV; 1E<*P97-08Z\*+Q
M"[Y+$P%.<GX\U9=_JG^K4X,>L,&=N(3?VQ_$P'UQ2>^'(YF%E./9NR /.C0N
M(Q@,IA?!BR_%I=?UW'!JI8?'QXV+R4M4.S \SJ&\/5N(@VGJ;/<X$5U$ZDAL
M_70R-P8_;R0U6)C!X%ET+;)$^=7G.<S%C93P* T);-E0URU@W<@UU#7DV$J,
M@\Q"ZS0_B2%B^P+L/V062YJ6.3;30;OAAR6TY-$ELL-7T0--63#TJ-(J#7U'
MN"1 Z12*Q(H1)^&S]\Q#"1*Z/@JP-GEH_PRB9C8"9&^0H+D&D?J4\1:AT4G-
MG"GCW?KPR\UGV6U]C8VDW'PZC[9IO0:01O-[/=OE5,"BLI2;_:OG!SA%0KG;
M=X"8,.I[HWL18N8-K.KW4V!5W=&^J,QK_RQC86\I'_OY09TYF(RI.5ZZ.^"7
ML+N%OY?DQ%'&>$A?=&('PC(PXF+T=6CN# M2/#D+',F)7X)PW/\GF!+@EB7S
M/&X2SE$W&9A W5IY62P4)/+7KTEE)X$66PUCM;7!JF]65U=:!EW-PQ"$E*.N
M/1=Y*1F8_W4LJDER7$=X^6S4$7@?[4^X9^3SYQOC0V(Q?VG=&\46BB>T7SV6
MV!%8[3UD?67;YJ%)7Z*A"Q(QIZE97?+(*+1K0\'7CTQX:GV-Q&"@((F!Y?E!
M47H*N)0 IM-U-;3&2%)C>)Z>L),6E$4\[XKG$N&$='1)K+\N$)UK1"@?7"P2
M?$# T= %QX.%QE>Y]^W._Y;HR6)1RB:)3J?$_\]WT*<TO/O=&TZ&0#.%@YB,
M]XB#1+^"FOLW+G'!2(VT P?>T!NKON\T=^S2(3FL"_\;%J'-NA!6YD( G@9
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MW^FS"4I9CY_L<P]=53@VLXO<OTDQ[2^%$RZSPN6 JT]>"#C_QB_6<:4B&^X
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M<LI #Y04-O[&*7A.(*D5LW,4!<,](-W0#3H3&?H,A2S)Q9Z:,4;2L47"[73
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M))+<1S'8#*IVR''W7S\>(C+O0X$6#5_>0V*_?8<1;W#K(Q6UV31 R>551Q_
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M88XMYL;)4 K<<+JSYX71V)J@)<<AGEAXX*:Q2^S)>@:=TW7L?O BGI%DI+3
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MA>!OW>!<)7\%[;T8(!-.8KG<^:,$'->JMUNEYD_7W6><4?DI#(:RD6@5>%;
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M(QY;AWL-C3@UJXN#@->$W_Q(@*W>61/*\KW^VP2A;K*\9G3P[]YMF]&@OU5
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M8Q7K77M)L-RS@:3.6-CM+VY'<<SBBU?6_)?QLAV_1W<QR;]8*?9H&E".2'<
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M)63.3O=X^FJ5DC 38 B.%(<&P^>O(.ZV< >2T=<<=YBT2 (_2.5!<_"#REO
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M G1H 8_<5\*D5JR42.CYB@K7#C@&A6B'HAI&L1AY3#4'1'_[Q2CINU""L?E
M>J:X!I2Q#M"[HRJM!;4>KO*;8:J\G:K6@'G#C7E7V=Z7[YG=A1_^(G<LO[D[
MCN-#',<.+&H^$(RITK4$0)] <4!:BML$FR!SA(CC9W)H8"1<*/(J<N.P.'IG
M:@V+2@F14UG;)]IV%0;]+5/!%E>#6F9@A7VYO8Z?K9&+X!WDJ]MNX*BITV\*
MQQRL<![! 0>U:DY;EP+D"IXKX5@]I4-A!S:)2]Q(RG-(&3@YA\+KV@D;?&]+
M/29:[_5\WL-;C9A\1/E=MO8"Z+ZY9..=<[LD3N#0=#"A7QF8YN8)D"T]C4H6
M[RIM(<O_'WG_D6=[NM$>3AG9Q,J>)-2A741V@K-5(A3@,><?5K-NDD,W>99+
M3V?.KY<@/HK[0O$T9MH<6^\#GWI+JK9SGS]*:W3.FE9OMKJ9ZAJ2Z%ID7Q-#
M5>VXKL6ITZ66?-(?KH0.+8%-TH&H105[7OTL\_,7"1!'K$M3C9Z7G],B)(P:
M.A3Y?P5P6F[$WYH\P,F['A<&%/FN;4-8NE2N^9 BO^H9[)^!\?CD$>\;B8<M
M-VROO$B1\\K=+\;7%Z]==G4BSU3?QT-Y<SN:N68P<EH-D''_U3*/^SECMIL^
M-<-#8,)WW5:P9>!^X)-,(]BA"ED>][T(XZ:PP<K#>G6:<R>PF:O&T^OM=EZK
M%7*I8J60T@OE6+28IQ6&]^MK!86#/K91/-@AH4!3G9(8>Y93XK;:S5<+7-!J
M>B:?^P!1(9U1T^)N5\ZB5C/RJ5)>3^F58B9?VDS@-?QMCI#@<)@V30D6]H/?
M6+(2[B!&I'S9>.]M! G!.[>[<SM:+9?2RZ7,SLY\\9:EB86-T\39>GJ=@GHM
MF+>JWM\,T9;:"1^.YUUD7U[:3'J=;X#CK?3R7RSS6U4-<-PMB7-7+M0*D^(Z
MJDYE=<LQ]$I9R8TYQM+Y=Q?KQ]2GL7@21\NO.@%?-O)2A<3GRK9T4=GX3-FB
MP875&%9XP@V@R M+LA5&]XXC2]C_( ?%=E3T8FF5;VY=*:L:7"\.@R^((*"/
M;?I,3H_RS(_TES97X>X?!OP_<N<GU[S:W'-AQ:(-MQVTL>4XF3/6C)/9\#)Y
MT95Y>;.7 :7Y#QVTVH^U_X1]^4_)28XW(%_DU^U>?*_U5F/A%?A*?_E7()7H
MCA:5*<4%SV3B3M*<=!!4FET2Y!."*QMJJ%Z-<&E2?!1IK%76Y?!I+A  B^0,
MHQZ'DP\LE*@^)U FXWT+7@R8\942;"-.^=,7!8")"(=0TP3'PJ?QH%_5#V^=
M2*&X@__Y U#@LDD/E]3-\,;!J.3S*4(E 7$<QEF*X*-P1@(/$.,2"EM">SS&
MT =]AL\J+'= /+QWD2&_-&K]Q6!^\A+EMU_*.6-G5X(VPO:AQ/8A$HS<$TC!
MX!4L:=<O#^O?H_8B.:7^ T0YF#HSE8NO*X'+\/5I:-/AC_/ EP%0P!9N)*M1
M A>&T#)'UE0X)B=C'8ZZ]"?][3[\C%;'^I?@"P@42M8'%^:^!$6;5L!@,C#[
M\,$XK+:%@_=1$$V04U !.A1N#1S347LNW,,9!=ATA*UG(66 3U6Z:LPX0US(
M#2*"C0$F96"%NQ6ME9XE%'A<],7$(SY;9$ #W$C8PJ* !_]W0!2AY)QG/4G(
M K-/@A;$+WQ)CW$,']G7_@U02P,$%     @ ;(I)6RMC!Q_2 0  L04  !T
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M)F@O=3,>;:3M)M9]#6;IX-IHAQ"2/=(WS<>98_\2G)?UCX1^%L"'$, ;\*V
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MKLQXZ$M3F),GE69 (^=<(]B:AJ1O:,2$M#E8C_ $XF/)%2.FZA:1H4T:]S:
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M;*_ !@TG^-(.%X.42%(CPH8,A:^3K8,;[+NQ)6D0%>ZH4Q\V]TC0S'X_ET?
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M3B'^A2K9=(&-L9'UM'R)@RBT 3GD&2Z).2F2:UOM%NXOVCYE:0A\,KCV .>
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M?QJ'Z==L%^ZCPC+9)CXN!';YF; 3%=FSF3&TE[CE=CUJ?VEQ.6*VKWL]W#O
MZGNR)T$!]P1IS%TL-YW8'5E9I5Y(_ FLO+ US*QPUT"KO:^C$?+RD"05U7\6
MXA+B[S^U/UQ8V,(YC-W5]XM"J,'1-/'RE597'Q]^R J"P8_BS;NC:#)6=@ER
M\[#F_<J4-PI%H&?S#_* I#GD X,@I]_%:+<!XE+6G0DT\.Q@=H5[<YKEY X*
M5\VB(:3MW!7,E*Q7R2CZM#*IROG57-EEITI'1<;$2?=4?\@'W0^=/XLH>>6\
M_']\S$:\FM?67@R<WZOREM_^9N[Q5MUF2Z!I:Y;C9>"??OFK<C4N2""V<G1Z
MT7H41@EDW* *& *1]#_PM%/!>MTX?;P_1*INC3-\D$L 0]FMF5=9GP;Q=IJM
MA3Q;PC-+VU0;^'E?A(VPZVU)_/KRR/"C?*B XG(F-75 ,9@ .7E7*-RX;W)@
M0\T!I?V-+X_Y$8BO.7E=)EV3B5YP>AS/SFB^^PO_L"(US=WP]S=)EEK2\-$X
M"'!3HL:QB;9\5=]BKM!#\?L@W\F_7%LMN:$(_3X;#19A'%!+GLT$;5Q"E@I'
M[5C.5UCZ=\^Y=Y5_6K+2>WT- $$][>.A;:YC/C$7 M&]JIC+C3U<,1R-2.@-
M$/N^/NQY(*+7CB$;.DKLYD[II4L)"OJHYZ>0"'2OW/$B2ZQUI%UR8YZD&./#
M._BE73XAC*U)XCK0!R$HV)M>T,9T D&YZ6>O%$I// )D*[5;K(HK7\K-"$*Y
MMZTZ6GNFT- L@CTU?XH%'MW=_318/H\WILY"]=DQ<;']_!&9QKK\DE+F+3'I
MUP?I?KMW%#E27Z87SEM?Z8]I-_;-M^FV-3?.BKGTP/H*O\136#]+S7JV45+@
MQD$T*76W*_AN9(PX&H(0L0R4KE6SC0GU06SIR#;B*O5[ SQP;+AO:L)I-D-U
M;#@PL#_52<?DZI?9B+9::'5K[^L0\LWWBT[5Z#VTB*B-9'5MC7D%L[ISJY\L
MYE>RW(.X2N$@H^&%[,IIAE4V">2?F&/87="(!!5>"N>\(7'/(Y@@A_N'LI4P
MP-3L&N9T=?1C'Z0_J<'EG[\@[2@IQX6-I/VI^9("ICO7?3DD^=>C\O0)LN&-
M;$8<X>Y,+VNY#L+ D:]S(<@RT7/]GB<BE7\^J$_S,;%NP)?5//\Q%1[:ISU&
M<E88G\6R@8Z+J#[<)NI2I4;59V1!P !S.RFRW 9LC-PIF6YWH@=X!?DP?JVI
M]BCSF&:L:FE\>Q"7V]^V5/H^G<B;P;<L!)-)[4_S2)K,)I"1H'XE!?&^!MB!
MZSN(7[%T0FLX)-ZCI%BS&SFR,:$=C%-U]O4ZF? VS=#@9[NFD\V[?EL5;-A1
ML\_K8DJP;^ $!<OTAPQ?YJJ MVWU7C92UVX9U;D9Q[J;C"QD'^X:T.YGI5G:
M>8@UM"Z*BA0VL4P[97V=TNH0*$SW0W"89@S0.+P0>4VBP,/KVJ\ILZT*N ;L
MS?S[ !3"@Z] X[_#$%B&N<]'0<W-!\ZN%V&[?[T)IG>S_SF1' C,+"RL'OAT
M$2J'81A#4!24'>INL'AXLH$85)F.RS>K1$DP@[EM$&<9R6$E*:*BHH'KM\"P
M)]BVBOXLFMA650_4Q9')7*"@[')G0UQ%7UO1Y-K3DVFZQ^L@_$U51$/P=KB.
M2PV\P-7GT^DE+@,27(D>;AQC@ H9/@*,(&$TX)*A)<T\3!F<;325P(HS1T4X
MP3U1@PX!$?4>?X.[@_L7E)]V*!\VU:U:CM2T4I;4K&_-&6K?U6=Y0[[Q*ET%
M"@P\:U@&"^R0HI@3_O%;PE>$S!..][FL<$/4?=[,$R? 8.<$="T7#=&P(G"9
M-G]N[ EC;)V6^.0:4Q&EN+4QA3%I0K8?2Z)PJQ0'R[<,HO0ZLWYAQ>2LJC.?
M8,7D[#*RV.Q*3<,T;E=&Q0GC/WE]WSX3R,6=CMG/6V[ 14;^@+6UYY2#U\VN
M2F6YXV"LM:^!$DCM7B6D!)45.&OC-Q<#9GUTDCO)L\HMCTOJ9Q#WC0F6F#N-
M8(?_W#/:^4Z57E.['6RFD,8?SZ?E>L!S28;KL<(JI!$4('+8AAO)%M6OT()E
M^@"*#X)1VWJ6T/#/MRX7D5EGC('NX5U1&;<MH*^YDR-%L2YMU&4^U&E>XB6>
MR"OQ2SA624UT_NL5):X4V_,$%^S5&F[M6<( WC.ENDK:J+LW)E[I2X:'[<XT
MR5\PQ9&M=<ZUT=\+8A<S"DT>LU=.R6#%51^#:/'/YNO.Q)S\(D#P?!<<1  9
M*^ _^'FID\RP[Z[.BJ?RF_ D"VA91>\C(<)'3$J:VEN6_9;XEKN+#32^)428
M*XY98OB'5S@9H7:G=ZX6W\1%Y+[Z]Z;[IP''XG<G21KGL+VZE).D495)HZ*W
M%1B3A\WJ(X-&+,>HG"U2[=@8//^PMC^8S8&ZIE5Y,'X9J0["!B&4RRQU(!-Q
MK)IUIHS45H$(X9[P&TF1R*7\X_1&+'GF(>3MZ&=;(]AUYN4ZN?141KCIY2CT
MQ.\$%;D:1@,2X,I,36'-!EP?*-*,4*SD76 >!WK=SSOG5AIQ_7D5O]0KW1>^
M/FQO;G_:T1[%$,TD^$.X@4=TI4?*Q=&R^M=D[NNB[]$O3/Z]<:V.FYY$''$$
MJN4\M.[1WFS[WO=)K+>#7_?3;OV[C5J_.#*ZK]1S9H/3<A>WB24FCH%DY]XO
M\EXV0[H6:E+J8@=_!NZ@_'(\](.:P(D_DW,E&(WJW/E 82QAXKG<Y E#+S&G
M#@;'O7#IT2V6RM11E+"CR,1IE8# _O9C(:L<1B$^?8XFG6L QY)W^2;_$=M&
MT^K IM^4+@:LBD!\V7@;9IZ)*T.M92%]$M68<!$!99[F'03A-Y,^4->[?3EE
MH1D<GB),=/*K/5N"Y9IQVM_]VF%T>(T*O L6E "T_>)V 8K:#PSJGZGW.:RK
MLWBZ9JF5;WE+^)GZ6[4="LFE :*!LR-&O2^Z&T4AP_VWFF:!Y@W\22$!2).X
M@WJZBYV/01W6U@,LB5MB6;^_EA8*"M1!'VO!E7 1PS8"3X8ITS/NO;)[X)MK
MG(+\AB N<FJVXQKX8^.7-Z1T6T42I;0Y37;0Z4J;E.Y4[.P[/)?1-&1:9E>A
MK&]JE,O$PG;JE%&FWRL%9@.GRGYQXM//M-BE0HKH=Y?M_\.TV6)9/(]T EWE
M:O,,J.;[!H/:.]O?#PVZTNIQC/!.!7>E+7M>E+UL4")F5%1B00,VMDC"SJ8Y
M$Q7W,NH@19=\;F&C[Y"<+B>C>>NNN+@ZCQ"%-1Y,]D51V^IZ0IGEIK59_I!2
M<?@+/W96"D56TMMA,6<V(4S'K4D,C>.\'L^K.!*/N'F2>,S$$YI_W](7^8VW
MV+C+Q8Z]!C!@S&P+3%$0;LIY^(N2>T:34HK/Q57-!U]6SXTZT,<BC85S)>BM
MXJWSC:LQH6EW3; 6'F>F;L.%DU1/R-)&''QQ#?4_R@1'%;_.%-U!I%89>]<I
M>QOY?=H2?EMFJCC:ZWYIH7!@"@-"O6@6:] 9HP;DGDLA;X#&E> LK7F(Y4:$
MXR5RJJQ:"RGFYA;)@>5Z5VNOAUD>RX]5,..FZ>=UWZN<#$#:LZCVI,F?AW):
ML2XI92$Y70GD?I>Z'C# ON@IE 6B\ ,84>$1^3#C"2X(=<!L@/V^69R#LD]G
M$QC6PH8D1DKN+%T#XO?EIE.ID'UBLC 6\) /S6XSN'CIJWLP(GAV5T&A\@(
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ML/0.<MZCR; L:L@XYZ[/XE .VXM8%_2_Y+A-MTKEK)PSH\)JL\+ZP@H^(9V
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M\_A"T8SX!T*BO7> R,YAU7)FW^!<^V<7\+&'?5?W4E)]?>8JT&DX?_C".D[
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MW.YX(%<P+F<:*^76->^7SU4"-BRN-$BO0/0Y\!CTOYKRKOFL26_-+?>26V$
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MF1 W@=58R&3R$FDR)_:C1*X"W&>J#K"@>S8)E4[4.X[S.!'X4P?37*B ?/:
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M$UO#/A_9NAR\$DMPV2MTH\(K?I9%<V#;KEU#EIG#FKKP)K';+"R"89CJD,2
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M%.+HK;]&T]Z6S:OILI"O&?_%MB5<SZ]].1BFUI] ,1(X)O.)T'VX2_5:$<*
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M-KVMJ;K!\MHCDPFGYWZ)(\X$;*?& IP1:BV2YGDW+6G.3]59C@V[8#HM_UD
M1OV"^-Y4YH<UGGQPZIG6FAO$DWN@:ED3?;I$;[]O"'^^:JM&1(F^>^]G\[C
MSKUKRM"9I U:;7^R*LYG+ B,'7#T9W*=C6;Y'TOG&=7$\[[]* HJ)4KO^2I-
MNO060$6Z@(#T$A0!J:%*A !*ERI=*4&D29=>#24!! 2D=T(2 6F24 .$\.?W
MG.?%[IN=F=V9,_=U?Z[9.;N9#/Z%NKI#%2 ]RTVY;+21>(UYSI]>K?(JDRB]
M1.6]"/1>?V8Q1LPZN^C/-MZ],YK"!O<E:G>KQ[."KH2]AO*XA:J28HCNS\+N
MP%@.=J3U$T51\V(7@-<W2]P4]C2]')TS^=C#KR%H-5B=/HG%N>]4N3^-L'71
M3@UV]L^D)XC4[A5U>\B(7OO(<OU5W_-U:F08,7^'XTS^-4+B^_XACPP.A!85
M=7TY[J'&2_*"QJH)-;W_5/7+7+DZWCW \65_Y='>9N9XU.+35Z]X94/'U#GA
MF@'\:E=)0%"4_TP*6ODR X&8;#8DB/^HN6([A+"-4W*Z#ME@RC_<40^.XX;5
M2Z6?YU2Q+2IH=18ILFH?6 :;Y(B==@=GI^(\9I0K,KS[:9VM]LJ4P^;!<IF.
MWJTA'C7B5F9T+*#MT[?V:M5\=V+0+]6^E^/X-WV<K+0$M)DB2@\3=NDYCU'!
M(G*;%J5:T,^F:%RQ@);?4;7?N*N6N*:$9>%6//WMN8=-3:&>_9D*.A,Z$X9[
MCJZI5NPR.C8 7JENP*V?1)H/':(K9U;0#B=</CW)9/Y^0B]9HW)V0\R!AM<-
M%2QKP=C'1=O&GNL23DT/KZ]R[63K\'-S).;WTUN@CE)OFGO28'D_.*[$=K0^
MZ%&"ZWH'A#$V?'\@<NE0Y]V&.-1><8 =_N9?#V5^'9CB%M,SO<Q/O*:92XKH
MFU% /)C^5165^?S'3 E2:L"'4A<F[)B(\7L;@#0[\/7+>.K"0SP4(7TVP$FQ
MJ[$,5N!KS4(.1]ERG>N[G @!;QLRN:[$IK_@]<_O00X!>TY^X6^<<<O;Z6K)
M![@%!Z4D[YW1J:3ZNA=MS84TU3AM6)?N6!%PSUN;27Z%L"T<I>HV@KF)P!95
MDY0Z8QS1*$@T;VLSBMXI"%DH:,MYQKI7GL95BVO=JHF%@ XK; ((U5%84/3O
M36OXR[W=ON8]TBBZS8X4*"Y>G5*L_)<QPX3Q4J\Y5GS5WZ E\%,A!8S,X<RW
M'W%^U::[];&;L5J^Z!F:4593(TKS8;GBU0+WW.3/SQ',W!^7_/9=5#[P?=E:
M_+-_FJF!#8P&JSXN1WG[UP^FEHV"75C76/:G8H]5<YWW%E7%ZL5*#=.,J_1X
M1YH[R6;&((T(+!V2D/DB$?W2Z4:[%NUF>EI[L$E:V:\%+\K$9\V]5EV^(<E+
M_D_NC=E19T)*P;6)Z; %]9@#3UL8;0]3Y;N;545C<#%Q%\3P:64@VZX(XEJ'
M^7IT*#=<E6 .Z4'>)!PE^J\^S2)8]JI5J&@/ZJI5P20"A-<T?S(.^(^GZBZ[
MURZU6GWX+_HGX/LUWEQN)LR,$$*X>^K= " B:EZ9CAN1A_QG]/1LK5.KYV6M
MHL>][I5B;?&N/HG<!U:"7/1I#H4&@JFGU7817?SI'D450\RK@[E%"QY'WT_L
M+=YG(VBO1!7*MH:4%QH&%!U[F97W56D+M;GVC19/#0BT9GMP6-4W,-P<>M E
MD*R2;%N++SN5LXU=5/$4>-#"S7WUX;RT-K]?RJR/<1.-(M5'ZBM+H_9!;_[L
M)U!D=PKPJH"[,4/'2<Q)BC]-WTDA0A[XPC8%M@M,)+-]35>_E0J(I/KDK2KY
M67N=:L[-';9N!.NE)J2]25L-3 ]L**P1J0O=3 _E8?KQ+S0(_O3\ZZ4&U3!1
M)M7$S[/"G'9IR?<HDR1-0DT/B$5-#+: MYN)-_RX0V3<-X[I5KM!:/J\<O+B
M!UMV1DG*-[O-^?/]46C)?9V"B7_\H(ZSLZ?*D=GFB-/+5'A:/SO75'$]<MS6
MTF8ST976[8&5[=.44;ET"X3_F[11;E-]CQ1],5>^.LD^#.L%P%&0B.F;4W]M
M% WB0HJ&CD*8&SNONF+HX"$5<,7XGJ"\F&0R2R'$(*3@494KK_3OPR$N3S_4
ML%\ 0P1.] 86.;&"T+SZ>*ZF_J!*&J\_=G"N;#.TI&6G;E17&Z)M')!E,KD\
M.,UE,=EXLS!.-ON4U.=5\TH'G_C/*6/LCI5Q:']<[:(PN#3"@NX"X/*L2ENP
MQWB4@)GCR!,[<:D 6B-\/@S+)!B*-%EE.]1^*C.M2)OH^ETHQL";FFB)6DXT
M HH7?NYGRM&7.OU5(.;DNN(6XAQE2]6M5TQH^#[KYH^'T%I'L9:]7+[G=S3A
MX[\J  K,)L6/HJ"Q[UPD5]0Y#Q05+P"1%F8<.TDJ^?"7G>Z=SI@3!<B[L"--
M)&O8)GV!!:X4K3A+5B!%/U887I'D\I4YUHYJ=/ -8E 24CP>#IT*'>ZU.'I#
MNM':APG'T%IP$Y.I7C_N1%YVYCR3"AT54.S%;J Z13@IPN5M_\/>UPTT,2HC
M <>O_FNF\P\=DC%OFWN.LIH_GK';#@T,ZS;4[I9DAFN3^&K@FJWG6>"P KC2
M_[97854=L1> '2#QTDZI7]OQEV0EQ>@2,DNAE23S792\\H<IN#YO_.V&:3$Y
M&#C'#FC2T%Z7RA7C*+0)VIZ$RX=>)0NKW9Z @PI)MB0%/0IJ0@U$*MGMH]RJ
MG>AHVA,GR^ 6_G[I(%*G1J@[3?Z[&V<3-?"*G>7D?\L]-Z!Q:E=(]<6P]9[.
M1B!Z]\;?MGS4P)<Q-2JRZGF6&BW9B;,YH09NAY6D@@6])FL30:;C)IC>3B:X
MXR7@TI,D>UBS4[)!.U<40Q[W/XW#IAUH'&DC)^2 <^U8N>4,G!$GJ8D/6Q)^
M ; C);H4;RPKMQ"O(\J^6<%*1GN5G2,+-<8/0T#HIM.F1+_BO]&>( /*J V/
M"&ZM9WD9!SD 4WS5D@K)%P!$!E$=#5R@WL*NQU+D22[F)-TJM0+"$(5YJ3.<
M59WYK^@%@-;&F+2$6[+I6F9L:N#B@ L R?S93[_;&E3I@DMZD?/BD^^]EJV*
M+@#=&CG/IL@OBA?)[),[]TA2_^L)3/(HLA/"\7<?M<*CW8MA[; A1#SI(/2V
MU-K4\%CJ5I#4CNTZ]NZ-2XC[JYS+/?&S'Y)]D#\S6HJC^=-)9I[ @E"0#R""
M,9!Y4TV-\"8/5Y$'//(E:; F"WZ=@=*GVI'J<7R+I7/8ECAA\'J<O. 3?@]V
MU4<$+F!$Y_4&M*XL)B*?7KSZGJT "@;1S]84D:ZD[=F327A57ZM:\5=RX1@/
M[-'YWR9*=>;*-=+G%44O_^3WF!L']"8<8*.BDS;SUE)8#D[4C5.K@'&)M7'2
MD_$UY]J(=WU/O>8/-N^:;"A2 <XW\27S#UF;$'#:URE0G5*QL'F:MX#_T_1]
M_."HM;.S/26NGXZU:6^ /_*^:>X,GOO9MWYP_XC9@\ERK>=.0N8EG$QU1=EI
MIF6L5>R=B4*#:?:;K91T$E<L*@PMB!61D_+'#QA)A_;!RJHMQ";8E(HUIY_O
MB@X:2K!""ST6)CT\Q+V*ZB=DAQ7TXZZ_'^>1&%PP:/9U_)4@ON,8+01W\'(2
M>PY09!F&\Q)VR4(7 (Z.1_B<OU0P4RQ+ P5$R!Y\D%V:U+@E22H#:[ZV?.LW
M_Y=3_]'7A<4G]O=WU]M%-/[4EL#!I/?$/IRJ8^].!?DN2>?= %MTJOE$J!!L
MNO?YB2DLPOC=+D$BZDWD@PEQ6O=F\]W54;EW;Q+.5;_VKF"H_RJ;12$J"F&!
MW:&@]DO=L.X;[U,L_3$^3GX[&/'TH=<A2'G]E:^=7;UAGWFVP9Z7(WD E_Q!
M"2Z][660^G+344IN4TS"-:'G<96]K:Q(3P,!QO&B;/)T^E['MW*SJALFQ8_E
M1$12_Y1!6W#5_#T.>V26^\%@>;N;E_&E=,:9T<I]GHUZ,5GXSQ2M.%.AG#MB
M*#76HZM^KY'(,I, %\4KB758.14NNK+JEEB]GK<K>A.T7%:N7:;7)-_T C/R
M8Q__[-BT9U"/3<3L43F2@[#^_K#]-9SJ[3>W97FB>0%V6,-JHK+&Z B>#4+[
MOTG]9_-Y77Q=T]WCWHUA_A04M\-=E4\WJL@"*[:P=G1_EYI8)['Z79T!S9QS
MTO(0*LB._%4E,=3R[J=X2.-_NG3::TDWLQ?O+JX$);5CDWF0%=A=$,Q&ES"=
MB*,WN0%6JG1[$\0\ 3-%/1LN2J\?/]3MR PDLE:P9=PS8KTU2"P4[9_9 Z\G
M"&O(COC:T_82&73#+1/LPWI(FS4B YM_./X9]9#5<T0^;6L9:"B.2MGRQ9:9
M2O5:_"K'^V[61TN4,.:!-<5LRU GIO*X*1N.N$PNV;Y*)$)EP4'4(M5^Q-,X
MRMZ\BL4\H.QYE,BSM 1QSNH'Y>DS_6IL)*&PP&\0A;@OQ)?PAQ-PC0)8#I82
M4U2(^7N:MG&:'AK\RY.J[^B835=9_]H8RT?/DU GMS->'H45B_C=T/]@I?B:
M<+"1 EH4RKA12S+9?=J74;1H_WIZ"UKVVF0V7U"S)?FXC*>A5@KQ3$_'TN%4
M,MI?,D:-<<)#[:ZK&A^I^"OI M!# ?T.H)6;VI&4:/@4T,YC;ERFVI>_2MU,
M:$@9 $_77V.-?/?S;"RU990;KD\(2%COHZ@0J=_CAN\-]0=N86>F_!?RZ _=
M:Q@UN-N28[=I^TI-.,47=+F!G#K\<4H"&EQ7\F=(A;T01E&7.<,76<ZUN'^2
M./:7OMSM][&W O89>%%_YF* S\H^8TF^D:)CO::]+VM/WH"8N.4E8*W8=5-I
MM-]@H@BCFE[GG9>P3OD*.@$P"JA<'LUU)[80<B?REY1$IL  =G6[^);HM3+-
MR;(;?5F-/HGI);F(3K+8#T[)F[,2$81I?+<]3^=$5I=U&)EOW%8^C:C=)UZF
M+1[5'/]?YHVJ5ZP,9EZ:0SK)"CE0OECOC*JW7W2QK;+ *W 68DTL7(B(6#"/
MW5*G!]NH)B:8<QXUEXX$0&[#G$_&7XN3)3V=P.,"'=0&BH\M;329-^GAW5A,
M(A\.$X=9\8,E 6^3Q0G4.3@0"^FEI"K\P03L\VIJL/MLH^P+'_\C_O+N6W7;
M6><"J)6XHYHX-7I2=R&<FQ2"'V;K+B,6XC(K?+YNG-:/NJZZ(3D)2]N^^O[]
MQLTMR<;(-F]QSU>3>,3U<(&WK"SFGAB9OD^+A3WDA?"]2[_M<[L,C132E^QV
MXI9"SV[7B_2L%"9V6XQ*DT.%F! XQ_>#KU\09CT\Q?;8U\-KN,V"%'5>KG^H
M4:9-4\1NVQN+:=J:\S99F-*+M/S2_+H?-/MIYOEZ#%HO0W@ EZ>CEZ?Y5N_Y
M>L!@=BTQ:V>A#';<@P"3H 00A97ZDQ=EB)TH?HD1<K2PE],!55JOSBDUW[J>
MFBX8A(AWMZ67?K[JM8BF@KA0NC$W0^^ZAM&I\<$"<4[]$8?#;)93<@:@I^,[
MC9:-+2_JVQ/.RP^+HZSXXQRZYFVX1<MO=@/V<4%LVSEG.G"[\Z^R]%!\%@IX
M!1:V\B^FV,;Z]4PH=\<$?LI_"#;N<B9EF:V?]_CUO Z\HOU/JLNGI8[A5-'#
M8&QG3S(-6>)WT>\.KNM3C:G2>3,6)AB[Q0ZI$^$U<.YUG6Z=<0$SX]\!-3W(
M;)!>&!W)XN]ZCQHUS""7L*R0L']_U=8)+1KIZ@0V^_CJ!(6K7(A=3T(1JQF;
M:)G>X8*88&+RZK1T:O(U K<L+5\6QJ!*;:8&MASJ/4KR]"9E-)-*N=5H&?>?
MEB<QI#O%H"UZQ0PM2X7-"S@'.^[/5!9P?HK22BV3=-'5W+>_3C+#JL>$@G)Z
MVK027SA]E<]C29QJ2J7O""I*\;H ?$C<OL4H\,-)I$9,OU-T*)?*3B)B913X
METVY>"W>@<ED>OEF@'ZS"V+O>'O09%[XU<?4>\TFYJ(!:#?=N[Y3ZQ< 1@J8
M+$^">,O^"+;+L2':H9VVX50K6PI$H<3=8J4]7/*3VN6C#WS>$H=*'CO/8L3O
M/P]!@K[!AH[>D4I2!!JF,?7'X:^6QVU<UX;0^:P![KI^9Q55CYI)P=TS#,4:
MYQ_=9CXR+O#K,BJHKV9:]%#42(VQ(_L=Z[%^N<WW\6![6CE<[G&L'W>H3:8/
M#YR>4R1:I-JPF+O_0^WS%UJ\(S />FOX[P*VQ/A2H[F0:$ADQ2<_;9K')?(U
M':LF?EZYMO.>HW?,U08&&9/BCW.STA+$0N[B1^/"Z$*9YN>UB51]G$+10C_>
M>*H_21_RJ5C6>?C2XT!50C1/#R\V6'7/FOU845J9*@4O']887553&-932V(C
M\J%_5X"?;?$J)O5CDR+:9"($ TZ<ITJ;YLTM7\6A7FT:3IO_9Z&$A40C;Q$R
MSI?K2UP]@W%Y!O<,;/KL[W;DH^T?3-]ZI14@'O9<!J//[9 1-T\3/;[(>+<Y
M$58]XNKDNN G!:9KLGRG.**[XI"&>*#(QUXS[1MV%2S]$QM%62C()4Z[6)<V
MY<$70#;\@ZIMD=SK&L)#K;53PF4"U\\+LML.)P5$?I<J)V%>A*^<&#+6?'9\
M_@HC@G)@$VIG[OP05\&9FINWM*3\')?7:B&<^ T6<_21F, 0$!;+2T>R<Y$P
M/K@ 1"_S9J';#C1M?)6(V@EO9GOYA/Y5WVTF;!/_7=^I]HG;'Z!0D8!6'<DF
MQ'-,?*C(YN\8K392(B[/R+X^X TCLP'5KR8"V9S8NG2-MJ2N"_7'H= S:&3]
M6L+IX6D@Z,-N@L]X]B.^,GP9+XI*$4]&Y'6:#7G#P*FYW[Q'3%.\?\@-7=L#
M%]X,1^M=/JF'QU_<OO*$:V=0B5/%E*;M$8&LGO)B2;A?LM3Z!]>@8L)SA$A%
M"&2W]5O?P(:;L(I;C;OY^$&BT*,F W6-<?\EQI&[475CV^*R6V: Z\]>-B3Q
M2["QN] +2NUS7Y5L?R?-O Y2815*Q>>^2D0G=SSB7\^]]4)IX*]?@L]'GTG$
MEZ#U#03LL4SF'^)&JLK.$:CD0?#T%*]@)5:$%)=1+B2XB1,PJ3*TM[?2-:LP
M]TTHGS^TFT_5%6+.5@T08%=\?.NFU>,'>K*X*G+*:GCJ]'1XW1O]+V-W;3_J
MX&F2O&&["PD@VQ#I]V=D=+)C"D))E?(97RWLF%#;0T:)^"0DI^?R2DU0"2TL
M5_(S*JD\UU+($!O*Q=/P\6C;KI=Z!%1N3J'&#1F]TY>R(P/2="&?JU^?E0F>
MY+::-'L;5\B>O%QUASR9RL&89XS_72X"I,V4*G+[!OET7\/G.JH&_PXZV-W)
M)2)RO8-\>FURQ=/57W=D<MEXX\_O;?HWO7/PXLA\HQ.C-6()_^("N$5(9@H=
MQUSI$/<13QQ%YP%MIG#.\6=LW15^> .K:D</U<\-A%_*'_6'9Y\WMZ12_^0#
MT%F49:V^K?:Q,AZ0SAV215M/%(=WOZR]E:_<P)1WBT58XE5U3OG,<91%:E[Z
M.O."Z_TM(:<Z/>EV.Y/.C%'7.[4;F7^.A;[O;+S#Y%]C0O^,N7*4VMHE5 9^
MWP]88<B7"?RS#I):")W@Y2?>&F)#)<\=XQAJ[_ OD-+ZF]L@J#"@X>=N*)]Q
M\'!(G,(OSQR#YI2N$QM^)B/3J4[7?-8;F6'<E]*F6<(JN#;:A>!H)5:WM]8]
M3=E"B+J'J FW*X>],KHCVGKCBLXYER0!B@:[&7%EK-3=DAB>'O&[Q5S*">_D
M_O[)+*%/MQ5J8!J)&!E>W$0YD;:?A!1S\[S5.%EG><Q9-&'8S+\:7+1C]!DZ
M.%INZZG]EL/APZ- A/,=#<X:@7FM\_E[WX94;@.NI3X0'>[0)C:O-$?PIV+0
MG<Q@D&,@N\GI*\Y/4X?.P PNV>$[ ;33BZB7M>\$K1XYZ-;D[*I1;U@OZ%#4
MB+N]P ]JP=1M3410PB&7^%5G]2U3RIUD8%-&455E_U5]8;[69@>=^X]ZWX0R
MD8)70%>[66HBX!Q8".W<$RMR%4B[MEY0>R#E,_Z=WJNT0B8A(1IG;_==Z1J
M;Z?331>R*83%)EO$$AXCFL2;+BPT+!)F^VM335.P,YZ.+\NRNYUOHOBC8_G]
MMHSOL^88A;;5^&Q=V;*6O?&(W.)7J>M3.Z\\PU#/K#:[T[#KW9@XI-2--<5&
M<1?]1@)K^#^UUVMGT-A2_8%MP6><*BUB?Y;95]EH%(\1"N?%<(T?QA0.N-A$
ML?,KR_\F*7=)J8K$S&B7;$_0H[AG#$0_K^/726QP.NG&_9H^]87\E9KNL ^<
MG3TU;*X7 );&9&:88S>G!3J,973%*'I^/;%!G88$LFIM::@C@F+_'5ADXE &
M<3;Z,>VI*EP1[M<,9.,;[D#T8*:]2![B>A1<'0^A<3=7XR>4QC?$ V_#H&C.
M5UL^I9NG6F6W;&<Q\WI7_X7CJ&VIK^K,RIIHI6H-JC]'D:2ZW_)R74_*OVF&
M-NV]'P+A0$SUX@OMQ;6*A4U*.4D>;+L.>9J&EC"E\?4R [U;ZX9VF7_D-G$$
MH/S;3 4J)3$O1H3$'01GL5(/4SQJK)36M-C<?J2X?,JX?$JX9;(!^!\IA8 Q
MG^F@Q^MCN.'FI R\0GRWO5B+<O#6,Y([RI.?DZ% 3%CP/;8]1&W>/^[AC7W^
MM*!W]3+A<Y1\=>?O0V=*Y"NW#,<(IEA+VQ)#FO?^MZ7U&6'_=(?#E"&W1]1
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M[WY(Z^V\XT];I6$QT?"<L(.H/D)P$J,32U#EJ()[&Z!Y\^EG&-7WP:Y"L*(
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M<781JU3T$*U(W9%T%5B]WC1 V"3T-#*[+EB5#>+S-4[TF.^D0905PO"7<9,
MB[-CTTU#R[\QV9C.)F<'Y&R9M\%'QH=?0"O @A1:X5?.;ST=6RQY/DA$IN65
MWZ?:%]4]+Z (+5)FFG@9>24)A_U1 <E)EY$0>@U#YDI^.&8!^=TAM:(>GJV
MKA+"^6>3)2_]JH:;-:+^6TY.QB1_5L\NEMY=J_[[A*=<1HYI^[E<M3WH&DP>
MTVMAKQS1@^2)Z&MN@UL;[,:_'&OX2]8-+.YZ%&/4.IVYZ"8SK_4X,EP_.M'L
MSL/Y6!KCA]>9+X]08\HXJ"$_$<E--CDO)H.*R(&$D'1.H>[.=\A[OP^$/<!
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M7>5Z<CYV7/L-\[R$K+568+TOGU'-AD1'7@(J+5HZZ%:K?0[M;V2^+ YEGAX
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MKX9U?<*K&\)-_ DTA,O:_H?-)D#(@1^II6]X"I]?T%RY -VH4LIXI[?(>7V
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M3/=&=$RS*B-5FIJ,W;U5C>,%BX=:'2 ;(HRI6:):B:NV\FAK"!QQ*2+(VM6
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M%Z!N" ,RC #OD@3C)3%A%R!G*"/*GW@MMQ2'I";PIWPV+MMB?^3:&L#D*AY
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MV'W(^XV3::IU(BIA+V4"67[T!;'YC9I<$5(?^^[9HJUNX6]%&4M+H07RCG>
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M%YVBZ8P-[[=62'RD<>BC(%YN.,%6.D-+,A\"1MC/37"3"/L[R9"=!F4%%I>
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MOHZVA(H>QJ(W%BW0%A?604&^E;VG1ETB?()R_7A+>Y+4HM#Y=?8>[M-E<Z-
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M@LHT)0V5"2Q0[J) U4PRKFHI["H2[TO3R+/CA>^G@VN?B#)$LQ;^\\$KL)-
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MOS'>#_308R8J)&J?;QQ=S=IYNMKARH-7_QSY_BWCK5_WK@(EGFB)*%:N(I*
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M\A\>245TWD G^4'VXY;*\.=G<@($QBI_O3$Q@5K$TZ-,;<=^#LV4D-O%W#J
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M;/EGSD;)8_?OEEX*$M;E5KC !.]WTQ863F=T+D^W7*"(KW-A 3IH+TM4'/A
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M]U ?%"/@(QY3WN2DF!+L4]KJG^>>3/"I6.-:GBR,DF=3D \6ZE#MB[PR,*0
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MF29_+ I*L7X)A4Y[0"'I_!6RZIKD2(<Q>4G@S_D$$FNON'5UQC?\EU05D,V
M]9*>UL=B;!T8X7/$3$L!_ ]=Z:#N5F09'32L1,C='ARB,@3/1J*NA<T+TP*,
MU;ABVGY&.,1T!MD+?EQ3^9DM*A=Y>,?9Y&W)%^^AC#O)(Y@T9&U70&1DIIRV
M>L_S!U(A%VO@KWNRSJ(JKW\J)EU[7&+@1G1AR:3X7DR9BL^L;DX_2*.)AI.Y
M:-%+&]?HH BE]EGJBT0@D.^KR8$XIKJ0QC_+A:9,4K&?\%YT4!03 ;VCUH\F
M.UK30=_[%S>!]&?2=- GEP@\^84/'=3+M!I)U6"=$S_BZI\TIX/.(J+QP :$
MO"/[$K-CHNEF0I5K.;;0\[B_,!T(!00@:)$!FS368S#^^P!/<JMKI$5G"])!
MK1/]=) \I.3?&U:C"3];3J('U(_R-<F=0 8=E#"V$,R-;C]%Q!^(+.$!64DZ
M:.$1'<1EU#&[<X\\1F/O0__]N&\RB:>Q\)#5",?UC_7P 8#X.EO-F%R&8J3$
M90L!F( B*C>%)[X"=ZB(>I!$(."YY=<.4^L2%*%L(Q_)B1U&YZ<_H!H3&595
M_>*\ICVVOH7\HH,B/U)/\W<19B?O)5RWGO./OGL)% K.^!EZ1N/Z[66=$#V@
MMJT!G= D3DH\[3Z@ _TP#P%[0/E;$AZ>?3IK]QEC_/2A]LE+2B?O<5!!.UC(
M46J393!I]B4&+#[Z[$H=!1(A?S@;*2J9-!>&G!$#W(I_ >+FV?O"P:6F@M(M
ME==6ETS90W:]>KZVB"2H\MNXV R&>TH;[#S)2?,Q0 8.1%QDWPF "RJX61FH
M4N&.UT1C#HR\[GTI>0\\7V)OJ$.U)?!QZ _W:62Z/OY<51I1+B#QQ_A9"X1+
M]U-C*$[^G;.?[#0=]&]AH$E<AIW07,X.&<0 3B@C.JC+8ZLE9OW? D.-)I81
MBU_^0,1213+IH.W;!SG'EEL+8*:#[FSOO:.#"$(D!$U-[]]C)<1Z0(]Z"RI$
M!^7,!!W;[BT\S0I"D9]V.&[9SX:>6U^B@]+!(^#_S:YIDDZ09X_8MV>I?"ET
MT-:Q5XPN(&T>B"$]Z" F%TWJSY"B?X^H@?^NK["4'5,ZZ!PX@@Y:]L^F@^::
MCFM=2N0QMO&A!VX28(":"AVT&+:K_;\IIT3@)4J)#M)NVJ>#&!;0U#+-_X/Q
M?W3_.%QS4*>/I1IP:( FQE..-RV2^^]=Q4LNY]+.0]CHH)^;&L<="8#109+@
M8Y7+_+^J_#B7AGZD,FA 1?]K%TR_HH,T@HU"K"U\' B%K5Y%]F>G5O;&!,._
M?H,L[UUO'OXK7O XO/.Y5V;VB3SJ:6)>9G9 =C[WU+-LNR=)\)I<@SU]I8(*
M LS 6#8YSHF@KKAP35?.H,)[ZEU>+C=^4@E>5!'=K>1;=G0XET;EUIO#1FEZ
M(";GYRN*Y_"38/,AN!X!/-%#7*D&;I*$,N+!VH#S)T=D(XDQ)5C8Y\N$@SW5
M@+)7JM;Z]M*D[;B]4?)%'<1>[?\8UWWT+[;_F"5L:^+$R=&GP FB)K=CQ\(J
MA@N'$4+9CD!."T6'7  :K<=\2R-/)SDTR8I'DK95[U5*E8;[F>ZTZ*_ZV(]#
M3M8%<8412!(N*K_%'=]Y>'=FV\[S#WNGR&<6.^"?K*AHU&>6YR>L]Z^H="A+
M$81"<PF9*E;\]XSN*>%2/.?3?3[.&Y25"^M))-8F7+Q>A;]\H7?3Y[\+#!S%
MI!T-7"UL13#3IF!5^YUV8$;:@-4DN!T1@>?$N\@*/?B%XA];3UHS,^P5(B42
M)-<,7]1SN3=\=P\$1^\(/?@4A\.EU@9?NGO![212^@G5Y)]+IYF2]8XI+"8P
M,K9C%;E_!P@CS]\A<T\Z1S0T1!(VC._.M@MFUY9J^\#SE\<XIV>7-9^$]I'V
M+6(\=N-:A47A*$2T.@\1':Y^Z;U7H:!7MG/2DP"_>PH2[YN<U;E3['4EJMWN
MMSU:?O1\I%(YSNK"H:5NBJ!YRDJ]OH2[=^(DTH$T%@N5\4IU:!46^&HCYI/U
M5)[BEQO91KHI\2P"PAI1;E5QD\.:*S9?*Y4WW*3DZ+&?A.YP2:_6KC#'0>^_
M:1@VMO_?J6>Q>;<VP@_#9H/<_IK64$83:1[)_ZD A]C'3&KXMV5?L$/4$@IA
M^H_[7="%JXI7*GS+C<&2?>>F;ZN?Z^$52L.:AZDKDH?:9?B_*W>%U74I]@$^
MZ@1U*YL/CXH7OO.L2"3GF]THM(I7'?8P+3?.%QR6-"^T2C'PCINK]MY2GN_<
MY&E2)L5-A2D/O?PB%1M]0W4-_,&Y+N9O]8*!3Z'@<*%QN;K%\EB.8QS1,3Q0
M0<*LU"!/7,!]\/^+H+%%_Y:?D___//A_+ _^S\YJTT&^_^NU_2L[;3C4;C23
MT]&O]V#\LVVS@G/D9CHH3IQ\1]4>S83R* 'Z-!QG!H/&&NO)J:\*5P^::R)^
M3M4EVJ9S5[K%/1<X776GG&"/;M5'NZP]$*NO)]=N",'A".[D:7O[D%Z(X/G:
MVE!NMZ?9 8ODUU[:9^4D]:6^J.:YEOW1*E88H+7:H[CK!.B@#ST.1PSXE:Z0
MX"-H'I!&= !W:;)3_>?P7'8F <1^7J1V>XC(6%FY'YNV0?:^WJA\;*.(0:^"
MM,1BO]F70\O,[5M#$PYVTQ?OSMB7&'O\;8SV_JXB>\Y%15<TWW;XQG071UBN
MU9?0<K,L@=NZEI::7D;;T&<F+]:T#_;#;O[0XR07W,:0B@8(I)LH+%M"N3;[
MJBIWB96E2H[^Z+N2!K=6[T-]%?<_$UO8-BQP5>DK)%YP-G0'%GF [H2;R49Q
M3A:&4_7\R$JDD ]S/<NR\-\-U<-YE/#]R ODHYID=8ZT6(OT(T][^2 QA)Q2
M, $F%M*&.8OB(OOL:1UA0H10RH.%/U$<1$3$I$A:9+4^+M[%0=#AW;?]@CXV
M;4?\\*X2+B+H@]7@C$?WQ:K:K0VXF:1K;G1(%?;<P<-/,5=/+6%C0V0'J1Q8
MUW1<X2O4"1*:8\9M3'&S",CM"F$CRU05KO!N2^99^4/%:NH:6RI3%W[?N)+1
MQ<UU*>"#?\<3*F\=GH*/;4+,;W( Z*^CC#/!8 /R/5%1BNSK)C\T<4UGP 9U
M-PD924@]IQ&ZIM0OW/M(HQU[V4OJ_1WG."?:X&B+X)C\[\$FH[G8\?#<9<&^
M>,J-36('OAU]9F4L$(KW*,.P(PM-!FVW.U(#&:@US.PUW863*V8/?NE?<G>[
M*&]4>JBX'.A0CH^CVCB1$L-MIVE*(_*E4^6R<S/OTS5#=YX.5.<-OOWT)8E&
M!]U/MAKFO:E8[(<:_3-8]KR,Y<+IEI?!&CK<9B? E@?'DH9%HFL2J9G@&#IH
M780X>Z20'T(2+=VE1>#9Z2 XY*\RA(<.&E<CX \\#(XRON+_2JT=OX^5HX.&
MWM_\.[9RK$VQPU-TD#/4A@XJFHC>RN<VA8TA_%?I($7TZ?#_.E7YE/(*+20[
M91O2ZIS<AA? NT,B!JN])HSF$]E0[N2.AL]F\OA84>%:T2OO;G'SYR1VSHB.
M2B<+Q,^HB%['WQ@;2MGFB[GCR'=4T<*Y-G7V.=4*T*&P$K-S)))XC6!$&K8
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M8UT=VY:4%S,R2?G;P;.6D*/2:M993EHO3'"G5SH_T2KR:V!%?5[OB7:R>XB
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M]U**IM/JZH86!^=JAA&^"Q\^?LY6%N?HW+^L> TKN[Q"ZA/JW&3Y N-P??*
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M<??PQ,>W;1ATQ":,T8JU\H?W*D=.*)%KN_3>1'9D]'QX_O#W[S7=;30[G#-
M68N<$TPH@'E1GC);)ER-0W_>.@*K0]R)1E?PA*P<,Q*K ECALX=H>S1*MX?;
MJ9?B+&_KI<U-SOI^;:QF[8[0OBY",:AN3#O3PL_'1B!S3\O\,QA\PT"A5\B?
M%QX?8V!+0[K/*"6>^G.X='_YZ:@Y9W,DO$VRY;-8KOTI0DW0H!IYRX/X^4ER
M>I?Y#GWS#<XT=>6%RO.9ISYHF,8>NA@>55;J3$;4D;8-/'HN!1D7#QGCCG$7
M$8RIG?A-^#Z.3GY*,)F@C);H <>$-[V$)@WH0%..D07!BMWJF:=U-7WS/[X5
M&(S>[8BJG$/A988JD>7F1"5"_V%@20I*^G>=HV5! .&O-<0OX=VEWT1A:=5.
M.3X'JGW]N_)]0#OA3Y>DQKC--L/71Z_Z)G8.%FM]2ET[O?SZ#)9#J6176CP[
M/?RZI^3WY;^)AVW__,G8'F 0J6^:WKB2U3B6"B1K;[= SWAG&1Y^[.0(EMNN
M$6LQ&SSTZNR+TR9^CT('RC=].61YR/6?_\G>\B6I[IT1XB-2D+H4]#OM7Y]=
M P/9?AY2D ,U60K:'$3__0I8 AY+Y&1"T*E,F!;+:/U)]O_C+O^W2[_ZW\LY
M0?:B)DG1JV*)'EM%"NJKWBNK4:\E29@4E##S/T#BQ^,$Y4U78-MIM@N1E#ZQ
M'$ [QVYJ(F[!1 <^^#!=L2GCIK=[L5_=4]_I"%:Q?LQMTIHUS@UEO=-Q";K!
MM%D/%I?+UJ>_^G 8F24^L_+AAAQ[LC@SKV6YO06W%!?J!\W J9^9*[K-LAB<
M<%2_>R]VZN(.(VL,K:E^!4.77>4E\UCZ1AW3*%-E;&1NA\\/9AFVFM&TDA"M
MDFXUU9)]4JA66!JV#648'AJNUHV986KXB]Y"KGO<R@+OS[J?XS[G9D/?V_W3
M9K0'_>3JI[2H"L3'R.C(:-39\Q=0/75GSI65?3FP^<.;P@A$Q5HG^'-C^.[W
M9M1T.<\6G(E'0O%=YG![(USQ_&-52\V1*/[V\.*ON)Y=&?YY^8WGG%2_ZK:>
M<U+9\+.A$Z8(%$U@Q(>*432=QIKA*!U?)'W(1&(T1]@A=@E"<5-)$99PDAG&
MO$URX.FO+D,4IG0HHIOURNEO'[*285V6N^C\L/@H3\>T8W7F?A2:Y+SD/QC(
MIOB:IJZNL'1\)*<LL%D%31VE/(@"-F#^=!;G_;!%EWS<-N,0RLU;N>H/6;%R
M+&)RD8EP"ZD$J&[-!3SCKW:=8%/UJK#HSEUAIMQL5:QON_,(O/)0]:][G*+,
M5][CG/TC[#S1RH-Q1_MNTD1EPJ::,<!UVE0->WF%)3DL_/=.[^]V"+YOY@X_
M5)%B?4L"4U>G'W>T)%//L?_7*,49XW'^V5[S\3FM9]\:K)4_OAWS'O-EI"#=
M"S9R7KU,._YOI/[O!QZ/9^>?$^\#)M;T\$.U&HLX>RY,9YY0U\LBG4JZ^!8(
M6CM5EOGR&^?Q0GMZG+^A S#,C4C4*JL@1)V\9>,UM!^LU;4WHF_/#3-G\#'=
MZ>E5Q-_B   QO90YM0,7(\CG;2E:+4^@[06"+@JJZ"CE-PC#X->^U'TK9QH/
MSO1Z#IKLL,E[^,JY# /S()-;$I2/)]&.K#^3@E!\ >,4/9@XIMUA8W 7#\59
MU]C$)%/C^/8.;"9TUWH9?C?*R8AJ+8QI#=@[8G)I((+J=+LLW38B=7*;UOVB
M?8+RC,M#)7D]_MO73@^%'X>. \^$V@SZ5KP.EL\C9D4?)&=O$=L)BNA\F/+<
M3;/7H]]HNP=-HGU7CK??;@!OKG-"AS_-F_G":T@,\%8$=Q-KDIE3*@!LVD[7
M$L@.@A8*(T2)PN0T6&AO6A-FO-)R))%'2&LX,A<+2PA^>/$L,3D 5"\(83[W
M./H/[N!@Q;IP8YLXAF]O*)*"  I79JPP>5.N,&*A5'"S(]8Z"X8BI*YZI/?^
M(?80-B0L;[6LEO597?8]2B-NPKPC[U; (?*@7:0P_>S E99^"Q+,H0^W%_J2
MDT<G!(+G]FPX?A%T$/3OXPAHXQW0](96%1!9-KFJ/XP@9%C*U_6F9=CH7T"<
MDZ[R("'8WY8OQA]2ERF8X"&<I[V4QD:"QXZC97@\FN#L9C.VR(N$C+G-WS?]
M;#*X/(Q'X\* #6O>LU)0?6GR(G+-:@+?V]225+IF-2H&"1'W)99SR%V_T%T>
M@4('/F]3P)X^4YSBR_E=X]N>OXN'PC''CP<56#Z.T=L-BHWO%:L8B"Z3@1*H
M:C<O0BU5"N*&&;0F UE$!6J<0=M6VK%__C!H>X^W,$@>X_)PCFB&!6$!LC@P
MS_O#[MC^]U4/RSVGDO]K[]L8EE;GPB)WT9#WEV/ ^FM*=GJ #K"W&/DM8.^@
MI:D*6@K:N*46>CBT821_U4\)0'L('DWJL#'A"^*335<:K&/=%BDI[PK43@-G
MF))M_#5GIU)??#<;:@?8RA3Z(7A15H(*:9,'?2%JO<+U ?<L]S4WZ[8O@V4-
M[G(L442&V7J.:9I;U?N*WFGYZ,$0P9,1$_TA]2ZH,:%-3_(G>M)DO0*Z#W<
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M1E0-)[O?[YNGZ0Z*+W(/TO9\TSTX3/4N+ZM\X8O"'Q[X+CZGDU5M7SGF!R+
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MNO>H_;A?<_G*GK+/75LE\ECV62!=4-RJ:SU,>D$>QKER,ZW/#>^M1\!/5%A
M+XKK(__Q.;7PW>1E'J_'.@2[6)JJ.?'H[:^YX[?QN?Q>U3";E11R(3T1;]2_
M8('V=^"?82]%4.WUG_&.7?M\H8$\N(\R--.2%._D]?X:6R3JWU?Q<]+\[H6H
M[!3)D2&<.4_GQL_IKYE1& ]GM<XS HKH!1=E&:&D^7.F*M^^K Y:J$CI7');
M_E)S+=NH'MV'\R!U<HD[@/3V7 >V(I;@,$QYC^F[\Y-5\LD/^?X/I:V>CXT_
MAIWZTVCGSJ/(0S@UH)\/5AS=AG/!\";B.E97$NVL^2VFK?EXM3X[S<N3JFP*
M7-N6%-*V6ABVDODZ=%+7S6=$Y^1\@U4LJS-7A_%I?W[?2?<^<-@[()NO8;<W
MD/<G30$8F?=J'M*O:Q1<\Y$UK=_@8K'9[=C'W>U-#)0;YHC3IP=(5YO?:;I'
MD\:L&H1@%L<'"'R#WP5T(6T6[UO'OD2Q)S43J8<B]1QJ49S.,4I<I/W'/UQN
M0]RLKYLQ#?+UE'6EH&SQQ;63XHL"8N("U%@!Z3Q,AFB@"1JX8Z6 &A+<N9F>
M#&&H0_<,BG5>$S!M-G,Q'TTL#C0+3\:<>CCN1+"S0H<:<1]*<H"+/'==1Z%<
MIXR],#PX4E,!PI!L$=[*K6:^\/FF?C9;*3-@[.) M?&U SDC7GM;!C=/YA_<
M9G>K06GLS-4?2E<QEO1E3.LO^6HM( ^\VQ?K"4DJ.MC<5[Y+$W=;=>8>39?R
M$_/Y:?M([9PKZ6A#E.]M.Y(]$[[OD='=IY?Z[:)YSQ !;'+Z4F*14=\;BW1_
M!QZS72MQ*?GJ(.[$@6?MU\<XJ+?>8753+*M2;0JK#NDSYK0[LJ8QE+@]'IIV
M'"MY+-3KL$E.$CN2)L1:PJJ'%:&+819+.R;#H&JYGD*MWFQ+\GM,="H9H+V7
M@HSS5N<^%=F1ONZY'=*!W(ZUY5<SNO4'^:8+95*0FE%^^\.I$X(NEDAW&]L2
M#)ZSB>'D=+)NU<UI%:+JK=':=K?8L0'%NN4J"(PF)_MPECO_:P<LE;Z3ZL%#
MCQU:-M9FTC0&Q-LJL![NR=SO)!YF(\^BH#,%5D<-0E4!C(Z1.3;# Q7I'A(8
MI-H]\G??>SN?7,KXS?V'ODELA WMQD@>[#Y4#1ONC=>&MAAD40[AO&^7S^H>
M:!JV@&V=;3KZEN@X^*41#3\5;8_PSUYT]+A SQJ#-R8:\WU??5<=6Q9;RR]]
MMF7<LH&U9LL!\JV$+5+0U>9J!> P>INI+X, )N'4N=WJK>RFQ^.(V,SZBDL%
MB??5M?Y>0>1;%V1^+S(M^,'3?EKZKLA;M>17\Y06-@NFY8MUQ6MBBU:.-Y_R
M).QFQ3PG,(Y=:U"KA9N-^W15Z-?RY,ZA31^7_Z/K>N%%Z,H1()U))X>P>M6P
M<NU(E>(1"XPNFWN%OB.*L OK#-G9%HWFM\!]93CCKAE&X*B;K]-=ZH>,HP].
M,40B6]:COIG9)4_/"^OZF0G[CFS:XG0)O.F/#:#LLV +B\$Z"=G]1RA8#D"*
MD!M]Q\5'!"&M&!=N_K\[V8VA71CO2\L3HZ2@;0$A%XI^+^)@I2BM]-[+JQ.+
MZS,E23,?1O2,?KZ_,6MT7Z<%PH-E6)KN!)*]J< QOK_Z^?Z\+8-42\(KK/^R
MN])3YRMN)FBWR_%0_08I*"]),O=)-[5@>57@K@E4=MI .DT3BG3)PU$IXFW\
M4.K-D-??^*=0T>GI4A 8\.'[4EHP8?!G]36.D2I'2Y]1RI?Z2]&I0*;#QO"O
M/)>,2X*D9[P_)0I8SKQ7R[!!S3O!-9OLQ*2&,DZ[R8Y8TG![ 0/E'G(],,,Y
M;V5@O)IS>6K[8G[P,S0/G&[12#4\D,^ :<QG\N1/A5MZD=>DH!T=$J4"EWIO
M(TINW!O?-S^/ZS^<^,6,4_1%.=@>S8#]'5IT",@O$U\2)B>QVU%"%^:J*7,=
MT1Y+RP_F=ILR!P!DAWE8GA+6H,U3:PB!P=R,YQEOFAN8\ W[D?KF?)?;<%5I
M0\/P>?.925.@5VCMEMN)W$6*P/PBRN,L@$+!3ZZD5-##=ZBE#T6GX%Q*L?M^
MMK/5)_>D<;_O&3$VM;NYP\==Y//^LK(C.+UQV1E;@)!0%^0&?*92*7%2D(KK
MM/;2_=7O[[@Z8</D=00K7PD(GV<H>879X!BK@QX#2Y:01=MFY_,<S.+;0?TL
M?L\ARO35,('['?I&_#;<+F%#YA59C-D-W)Q^_''5?X8(R[(SY?9N#*W@M9C#
M::A?ZUL8&-W99;3;X1_<L;,U Z5)O7\UY*_4CC&M%+R <T)K7L +7F_"5Q9'
M4EC];6HW?C>0W7D$I>:CHG4>NV\-KF52$5@^NWK?W/7FZT\Z$#]_LUF*Y=K)
M?!&<H-TI>FH\N)"&3-%U+!&["&5QL'<7&D&4PZ&+YWQ@#]>)W,(Q*4C^_6L@
MNWN/ZWJ^<=E;*%%]],=?Q(@FRHX-H\U[!MR%D(ZC6)NN]K=B;2&IHR[ZM5N@
M];WB(3N3IL7,$@+JQS(Z/=7RT8!/#T'?_B$S_L"']9?VPAW0<2+'I7WRF #1
M-J4)=+9J53TLG@]0&S"A_#:AQ!^@/,KK=<L8AP>C0\,QE^#IO,IKX=^UG"A)
MKOI9V_2]A%^E(&7H'F"M#:9J'$$]\1J;P*!OG.X7*Y6W^[@G_'+?%5K-<PL*
MD$W(U4%6$W7U ?N7O$(VM\O7MTM!=V9$C5X0E_YJTVTY_I<AL!^;MA=+/Y7
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MTA:65V=V8[E%% !1110!_]E02P,$%     @ ;(I)6^K=*$(_Z@  J^\   T
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M4[@.'N!73GMJ?% I3FEQ[+_,EI"2N ):\^?R+^^ITS,YE30B=SU3.E97UG-
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MQT?^N5E&6^_TTIX,8NFH%='FR".,DY@4COYCM^0!(_H-H&[?&!POO]6-X5]
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M26XH,4\*"X,$?-6"U'MNA%P=Y#33$;V?[U7_U&[:Z]T99+[S_M'V:OQ?"8L
M2:2P?*=#^(]?4#T@8BQ-!C?:S[_NX,XX\6O3RPUWFRR3K?\QN3C9U27NS$OI
M72O>2&V0(E#-P\R-YE9++$4$1,L!2']WPP9(DGZ[O@(;U# +,SH]YS%2;I$_
M3XF\W="4WFRJ]M657\1F6S2#Q-\AO^(NTT 9UNF6]T0GX3PI*"$W1+YKXB8T
M</I4S8Z_Y3!V83T!/50@"TMZE[9D:COS?<$,-9A'T\'OE;SR0.WQ#[9%\XU2
M,8P7LV!FFC]S840V=-T-JPCQ^2 [???;,>9K3OI@^&[_#F&#V@E/RWRW7@6M
M]][OT*#VQYJYPO7SXHA(9P%EW367K*^6#QOF*E,AAKM*#]KKM.F+#E))G1OA
MH-@O'D@08,2-.(G <;VU-B)\34%HS6SF4M?LRLWKCGWU75DT+#N5D_AEV^'U
MQH6YWU/JS#P63\?+VI4@ZASAIPW-J@Q6!:.K;_8).SO7/\[5@FM;SUE$CK;_
MF-#)'FC)3=58 E=PI#'&FH4;W6*#S$_LFD?]8D*7/TUC!(.,;EX(7_)[_OB#
MW^]-ROA2;]-<?(9J@^FB?T*!?J8-\L/Q']W##^R[;S +%\".HU5(+?*0>JQ-
M_F5L<VM+0+":1V703//G%+6\2-QGNU#E0U\JL:YG,\Z.QM=<A'"FQMLS&SA'
M<$SC71HOADP"_MG 7I>]LTPB8&9U5Z"S9Y:_]].A&\D_/OS-+/[M6:>,/+U<
M@_)#S=()A#UH@G:'$B*81" &-Q@EZ5=K6T1K56,KCC4G!%T$_R&H$^458&&F
MKRO<)@^N%SSO2/:D7[+^6'"Q4[\<7D7H+"FS".7WOR8F:-NV+?_T_/%.T#.]
MK$L&BL9IRM ;DO<S@WDF#XYL!QT#8W;QIXD7@_\FB!HLZ3$4 ?&H<D3;-4P7
M2_'C)/+Q;;5<RGZI4;4V_K8^?=?)?6&SA3B&HS?]SCS4U_7VIIBN,!]@MV_B
M'[2XG\LP7IQ799@'H&-]<7C8<>KVS36=RL^GY-=8!L)J):=R[JEQ OA=2$/P
MG_;>85/+B"Q'*/*U*^7:;6-3*XFLS<.V#AUC::V/E%;"S^FK9H0+BA^YHO)R
M>/[CI8(&+*?$ XW_4[_O.[!&/RS41;6.#/OW5(*)MQ?&I+55KY$^]EV5%>%R
M>O/A[')'1#Y99Z,C#"/FO[T"%4U 4S:=2#=IPJ_S)FW@58%-Z% M+',PZ*JD
MOD[D@X$[85=]42_2O&L: 16J^Y;+./*VSV*MZ+>U)B6E1(*[>4O0\<]].B+6
MQ=_\KP9,9_4^G/[MKIT9?O].%7?=4Q<F^9:<CZT$X". 2G#,\8C*M:NE2,0M
MT2[>GU[XHZX8]%C;W^H7<=;SZPZ*TPQN_8=$^IVI^G=4'A>2/(S2"PCA_Q3;
MEME_['6XHIG^ "=X<Q4!D_/GY7D.#UTNV99/'WI./O_-^+MK&GCVW>*%T48V
M2 B34 @V$<FILJ,(0RX?V]^@YWT>ZY)JC8.N%M[ZB-A\XW+JQZ7TZ)O?"V"U
M3TA\6^$0V74CKP-COE-F465#)8CN'=;L3]@>\K?[D%;)JL>;4@W5>NS#WRYJ
MGP420&+^66-;!HIFLY]XF)E&,C,'2,R3HJ1,A9ICS)];ISLK9ML.BD^Z9O]/
M_XY<'=P_AY1I:*)^SR:)ZI_([\ST&B++0)M^7GB<6H&UR>LW\N.UOVC= C?Z
MS%PZ<CODX+_-2YTL&Y^LFG6?$ILU^;-/_N](( -MP 9EK7?BZ8$XAWTV:+I6
MR.$MX3CKO9_('AL$IS)S'B_J[?]=]=E]C4?CO]^;PF\2V"#[IO#^&:W]?Q@1
MP#EJ:/\">*SC!/+"*%*V$FD]786$+ :97C<:]P2R7#PA=NF+#;$.]>W/!1&^
M;8U/EYPZ9%H]<3,/1T<>'VFP2I\23P@[;F%US>37U8&;/D9/'^3W:^"TR0/#
MT9\K)J^6&5T)-#CV0^"L[80CLOY^H/:JG=6,IVAV]N_?J,)*JD0*E_.'Q(NJ
M(]D611*+$LAW;1*W#GCX;KZ1".$J/G[-5*^O4D%W8/@83_KH@<&CIPZ8)#@-
M])P^* %2'AO2'BGY50W;C [V5)HA[GFM)KEK=N&B]AU97S"'.HX!H61P3VU:
M!S_5J*=6=I4N7YN .THQ7:\49'I<F0KW2!>TPV70JN:L&Q,=IZN#PRIE)K&:
M*N%1@EV'VC:%M_ZYG2MP=46J-=ASI;J@:KU@H!K;U "J;EQ\+5\Q7GE%_X?3
MRTM659&K+1.OKU\R=;\:+/,"JMM@7Q:ET" *P->W)%+LAY*^ #2-'O7/ER\_
MS.E1?WC<E MI_7&#IV/+8 C5#2<[ %?X"/#-5P[I(_&8OG<7979+V"#R8;0S
MVCK*L;:W;GS*ZIW^0])=V(\.TYZW7PG[GUX*#&(/7[FBT?*@^\HG+0TC_Z:J
M[UD3=IOO1-?+_A9<E_[180+,4BO)!<RFETL8^=4\WHK((IWD3?W!VY,Z6,%:
M4:.D/QA^-NB>!S$@.Z+!_E:'ZDQ8P?'E=(^[NW67UK2R ][NG#;V^11\L?+8
MUD5O/_N5>M"#M-5MY9"2G&6Y(Q,O33)37E=,IJGFIY5<"=2UF?VDD^5&LBOQ
M)=J%['?LL.ZX3D2+L4&9<$L.9(=!]@V0 _P^0L6Z'X2JBG7K"].JBA.<UT3T
M>J.,R*)_9?Y ]_DL_K!T?D/D^TJ'!K'O8=>_CZ,>64[,[T67V5E*N5@561Y<
MFF1J+NFD8IJA7:*Q)IN_8BAHP$XGN/%O<5-;SH51J--3S5<IR47JFV(#R/I/
M9KUI/9O/,KX:8(^<0_[S^H13A7M Z-F)U"S;5:^AX6)%I[7YY[_VP;YCT-</
M4=1KI%E;BNG_Q<A;1K7UA5^#J5+<BEN+%I?BEI;^\ +%M5#<&IP2"B0MQ=UI
ML11W4MRA>'&WH,&U)&BPY*4SLV;-^Y\/,U_O/>>N^YSS[/WL?>ZYI['"VX+>
M<6R>6T+D/5C^,HI#@5K5JB[!5[OO^Q>V%U9&'\@\+5QNQ#&I2);(+,+Q%NBJ
MAF*M*^'^6&MO^N?S280ZJ^)SU8=U]=R,8TU-<=I3S%DYF?X"7$2'8=D&D8<Z
M%-]F0;/?#Q @?DIMUQR70TZ$@<O(L@5;JQV!A 3 0_79!X J>V(,X S.CX[M
M=0U=?AP[-.N] /XUQ&1I^?+YZQ0\2ZEG4(*_7,]\X$EM;-@QGR9L>1G8YVT[
M/4ETP>+B@OG0:]-&R.!+A9N_AG:?HL."J!3?4EMGR7NUHE="RP_%R@,.#K;&
M10E]-]K1U,6,-+,7E#W,EQ]^Q6QRU=<+Q68I&]G8RI#=WX[]WK,=]RU):(0R
MP2,R4Y%727MKZX+-?I#9V%RGRL#O[)JQ.IAG)HK7.ED?O_-E-#T)CX96?(=:
M65(N#0?'(&VQ.$*S;^<][/ U2N>.+>O1F6D#0A03NYQ5C<ES]TLI%O.<D$UX
M!KQ9!0VMT//L\75'UK%#9-QSMM$4VW0NEL[G_'1[PB="&S9N[IAO@H?VJ,+N
MIN'M<VBWJ6DD U1Z2X:%;*=..B5M^ D(1;@@%+(L0! JE-,+0=USD[K3*CA
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M>UEJ6+I<(TR 7<#[X%#MVM!W+2AHR%W6$D.6\9D)33U+G2>,C!&*!4\7='
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MG@E-TZUAIT6^)S[),\JKM?G+0Y^I[9TZ]\.@WVQL6:&/VQ5EN5?3(]6-9@=
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MNU23IO[*+8$(F1#BS1[9> L^U9>L=5/Q05$EW0]BY*^[(+0]* E*Y,E!G\#
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M'C@EH9D6-L[@E;4E]8TDC]OOB!/7_]<FX+?_'YN IX@P>V<PI@6'J_RM[XB
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M?4S]V1Q$^H5"0C-*CDMJ(Q%I;'<O5.;"_BGZ!)LPY>48$I]SP*91;2F/SKM
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M%G&]Q/?,L9M9C@[2X4<PUV5<,>CG\4]\8V\%_[>[YKAN@+K.(>:'-D!"?><
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MUM!63CHYQMA>>B3N_DR1)QD#>4)\DX'2LHNF$#>:KE0$24]Y*C8 *IF5K'^
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M3,PX-VJ*S1O&"-/R]?SAG][!>H^YWY$Y353EO[85[S$$J_NM/>]QK<>K6&R
MI-/.1XKW1*4N8U_F/.I#N7)=Y5[W3(;/F'%?Y!@6;REU5464C\HW(63VJMK-
MJA]CGWDM#R"71#LSJM366+G?'*8,U,'Q?;8#N2RZ-NY45MV@QGM:W_=^GYM2
M"J,F<=$:Z477QDX]9D/#SVZGCU/*NT2)8.D-$(N\9P,TA::ROK^J%%%<MFZ
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M]3P-Y(LK-W^\?I.>G40^,3-<G>.7D8&EOJD)\@JQ$@0OZZPGB-7U'C7($C=
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MHM"_1/*MP]ECT?"#GLJA.H+9E*9 "0KNAVL1>0NM&3*"GX_ABOF/1 X"I!F
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M GJ.2=B=^IJJ5^\4AW+:B&*K/4/;,,2.SS<JJ+UO9>L^KIZ+.M!01IBD?[,
M)2&A G?R(?PE(2^FBOMDRPJI<[4Z4*%OQ2=C5>Y<]3UK0^I_5[T<%44MC-$7
MH$">)7>*_7(U!O[1XQ+[%Q9MQG@HP(D9(*9#-_;X*!(M[CUK:,OJ#  ;1C#E
M=),7B1#AB@JA/'NBYL3<YM#$C4TVZX 2M$S]5[\XOX^TGZ/;C*EP9\7JU V'
M08_/DZZ.@A4+N<7;MNSXHEG#"ZXP1(M91*%I[Y2=2DXE+:[\*SXP/P)Q8*<S
M>[HC\_B>GQ@Q(R/>479U@FB<P/ZUQ1H/JXQY#8'M&,:'!9LGSQ3B^'9@H2>Z
M*]QH*-SUA'NY"+N[#:LMAE5VY= %F?"EPGG\[>9FW2WD-_GM',6-=/8B'P!5
M@,>>XMS-D=H%="YYS?#C&!50,9:3QX5FC@CAQ;J8T+ST9M.IORE!19-3D_,K
M0:4QA57%KXY%?F^"/Y24[X-OA'!C*B",5I-IJ*1?[!FV;US+50;H$"K/9&PY
M((PN.D^2X8_B;%^V?Z^LZ0D*@E6Q\(&$C7$-Q'J,QD:TW+A*(L<U2J8-=&#.
MZ-0@3T>8^_1VPR#I=#_'1'T'Z=XZJH.EGYR"-TZ?_3"R;FC-P$=WY#F.:!3#
M[RI-*?DM,6\\.3=X#?R:3\L[("T?OK)DI(JGF!-S5]LWNBF9>#RJ0=T]Q(X]
M-1DK_M0N.KO/A2GOY5C[Y(HLC>:Z %/@MP4&S,+B2>G;SCQ=<O,((@RHUCU]
M''<#>KR- .42VJ*JTTK\:/2GH:5A2Q$4F8B;M95X7M2!ONI&+[B?QOV1Q>HJ
M:A<3_@H<U^B]?8$'K.6/-"2B37<2T0.[ %]4J#\3*$<)HC"3M3JGS1/D6^OU
M@MK#DE6_W&@<<RKNO^FL72&)]%1OCT8@9Y"4_F/%==+OBMVG)Q9HF\]Y%N43
M1@6AJ6XLC_/L3O(SG6 2I%M9W.HMC2)?:S*WD7E.8VE*;<\C(<W"6$$^BA&J
MR77K%6(G4#*.H@L:V;-D83HW^*=P^, Z5 (V5M?Z=3NT;G0M1M(ETR[MJ[('
M3&\+,31!IVR$_R(B:<,?[^K:8;S?H+:V;7T'0[-XI@+&]:B3B;\(]F3"(7(Y
M0NVR&\4/?FLG.V8[#C%&:7 '^%LWCT[?4C=3%#II&O,M@9%1Q:!+<)'=^SK(
M$L 6UR!&HD[%BCPJ:?ONJ&HMVYNGCXNOQT9_4NBK7&L6?NY<C5BZJTH5H;ZA
M?<G\R?_> THR]B'O0=6YC!#5E^RZ&EQLZY@VH"Y\_]-ZW'$ZC"0^"O8LM'JX
MD7NF>>C^]IB]O%$?84DB=#A,&.L:/=%\'N29PGQDZ/LQ]RSF!$JQC:21,1CZ
M+]B!82?*38'LS_SJJD9=PQK:+$D_*/5V]6FZ5%DD^>60HO^O?1652-$Y%TP<
MSS@?Y6N98EE/$)VC^<05FVE7@=_-;YG](QOS3_"7[RU#*L06Z]4/P+-[%ZU4
M&_P ?SZD)/!<MY%0[LT611Q/SBSO-[5UJT5X(YD6J_C1SHR#>W;8Z)$_^XG5
MXL%(0T,4H:<%5<N&=Q1ON*EE006.YS+R-\\NGV'\GQ4W@SP8<XAG%_6?YRFL
M'M]*43H:-+N-Y?+*0[:27I(=*+N O;B=R/Q=0/$Y12/^^2AR7]Y1?XRXD0$J
MHH-\3'5@@I)[9A 9JS7-%6O7/T@L7*ACL5_Q#H9E7W5P?'JGKJ9AR E:"SE1
M2>V9?2G74QQCKAY_;_9[_DXEVIFYX]7FX"=+H!C'\0]P$QF[ *R',KNZE6-P
MDW,PO\R-AKZ8]E'VU  $X5TYIZM)W 4D$E>.?U)^R=+-OCZX9)YW?&Q3L65'
MJ'EX"73_?>/[Y]I.FC;'VZR2D_KES,Y6IBZ^O-K2<*&N:_[R7XYM@+%'O&MY
M#%Q[<UY<AC";MMVQQ2_6P<5C1+051?T::(4#'[539Y,=[-+7U;-"IT"VT9@]
MKOXR^EU%%RKU\&$5/7_56G^9./3OMO5.&5_-_QUL:V1:EMT0%XXDG83]S9,A
M#_%,Z)+H"+&44'<U^U&TZ<R.-5- 675UPP&%H]6SP\S6@96JI;=L4GW3<I%O
M4 A2OO%D)7^8+K7D:L7Q>%6!DNP<TT+K4-$6H$=@4 GJJ1U4B-5(NLPNB7]K
MI]A3 1<6^6XD63>*# RT^3)]?$2Y>1BDN$B-\NYIJ=O,%J-MS\0W,H&2GQI'
MBE)G!T(G5B2FYZ7_FD09V'-RDHLKBE&8NXVY&*XEXLN&3(8#W,G%NXB:6B3<
M?+;,W6SCT5W@OHT&KE9E=8%&^AMX\8(;1'A%]-NW.=DP:A%'A=AG#1*=?W?/
MU"OD8F(E2^^EOFX:TW=X77E(*?ONA\303VJI '"9,0R'<]+UT$VS'2"=G"YY
MC-['4>LL<'@BO&,_W-F4&?]S<+%%LVBB,1[M4 W#6\%W[!V8YZJ(,5&PI<K9
M-!O=(3<[J7I%29(^&LTN?LPY..%1Q_:I*/$C@49C90U_/:W'R**0+B.Q$^QL
M5\YZ7E+]E(GQ,?\(67585'$&7I@2 !(9<@.ND_*](R5<>@<G^.-XQ7B> X$;
MTDD7\V:K)8 U0RJYL?(76)^%D>)651-V,\(Q9TWKAI<FYX)=%F03DG/-1H $
MXW=QR?FCLBP#U'(A;@$41Q='@S@AE,;8,P.+OQX'Z+2:4K:^YI2YNKQ:6\+<
M3-E3ZK)33(54Z=U)/MOT;()%0XS^B/LNB2F8?"]QX5%D!,48:W2&$_$"4Q=F
M)XDV'GIKI,0A).#:Y[5;8;$J\YHHQY*&NN:1]:MA94"5I@_Q(_Z;+XT>PXO=
MYO'IY; Q0L@^G;&1,&M#/;ND#82U@?J-D< SD,CU PV/D;Z-SY>3IN'$%VZ0
M_8@O0> 7SZ_1WE8/'(#3N;\%"HL VP6L.8SA^/W&JY9H]5V .\]N%U 62_8@
M1UVK;]IL>+^C% S_9.R;EO=,0<IXC=ZIN)6YL OX9;B5HKX*_I]3L*_SR%3"
M42G^CJ%=/D6-7^XK^K77^)-DC-0JCT^/R6G^MJ&?@_PHC9\N"ROK+76[MFED
M.U<0KWIC%<%L/.%SWY9QS"NU35GT@#>FO>+=+N -D<[?)P"63J?R06CU;TBS
M47AO[3;NPBX@SLEK%W =3N8))?PI6.)+N>-V#E3O M@*BOP+K7>3T$/+[8);
M4W] V>6+F#E@Q"[@D4"5<.[\OR^&X-W'G<.AP>"*__T6'-<QW'A-6K \'U$8
M;OFZRWG! /BDZ][?8CZM$O[W16.&X_@N8,!E91>PA_&G3&74KP#O3E]?%=;H
M7;9(%W1:\Q^=[G#_#)=@-E2_-E2_8&AT5?9._>/3SJ<.^!Y^K7G+4BCMHYI4
MOIGJQ-2DA-64>BAXN-N%T&EC8,_^#A5#GV% )>:=(LS #I%,1:DI;OB">9V,
MM)_:T!*PWMU1!V930;_IF1%]3/7)H99V-5]L9G:'8OU>Q5/"F 0%0'KHMV-H
M8YC1:99XGF17&.C\1,=IE/<N@''*>^AQBW!@&&+,:_&5>,;KZ)SC\:@B$IDS
MM0X]9!K"WOR8ZK=)\X?,NLZU1,< ?SXN3PM5KA^\B$L0U^G5OE.G'F;8]?I'
M258DP*3XIC+'>.DR6BL2)>"/6%D0]NP8$+@8ZLDQ<$ HS5+Z?=6G6"$L.OOY
MOP/^QZ8K[W)@O9X7'4Q6#-PKU#+H-VY?4P!IM'*^P&DY]5 QWE&^/)9BOF U
M,M$=T5/F@:J$O;/6AK=>0:&Z884YCD5U^O41$9([+[6;=14>YEH_Q+1;;5O(
M:[4/Y<4KBII719;3KS.W%;G.LIG?M&V4#)J5APEKV#;&;=6ZR#!?%=ZFM$-;
M25$+M8&MO%I%L9(A#SZ*2@*PFW''^ -6H&3J!*.1\N^#X4DQ )A\C'@HKZ,T
M;/_S!A*6D:"@X%F<V20<0"-LV5?5&,A]E0Y87TGIKT3IRZTDD XV#JP+'RKB
M?,T7PB&K02T&I1G-SE6A<@?9WX,6-CZ]^Z;O-NDV_V(I2#_+Z1-4CS;W<>WX
MGM_MW+R-#".Y$8ULAA/E-C-K?0*.,+!4E"1J%4VAPI9^PEMM?SGN IY9VB!*
MVX)K+*1?-SB87;2W.M/\XHT3+0W*93<MYR-D*/2]5HSQ%OW-J,!2OA'9QF2A
M<Y]U"FHM.D>/+]Z50H?$W.]]$&;6G.%89]:Z+6GY\\#&I)@=DC+T0LP:P%;A
MJ"V=",4=M8V5X>G+3OU\AQ'"!@AU)-\8G\.?<I*N*/:7-=OD*3U>SUYH]FW)
M8+7#8XP,8*>?Z#1EV?;+5Q".\3 I&#F5$@INCYOK_'+!1XE>SA'^2;!E'M(R
MI\7T!'OD*:4#5NQ: \QV//A#>ISAVJ?PRPR BLE[;F1D5#7S"<F71QVAFY/?
M/;&3ATYP^?SH?E%Z_5B%8</3!].R*8:QT^<DVBV7-32TNS(@KV8UE2;RT[3X
M$E":'5]\RG:%+Q5!\62BP@1KIVYN++&N533-C9S-J28:M+KRQ4&Z_?;Q=QHM
M0[_7YIY_"7.N'OZ\A_3TX]K;1V 7]XC9\H7-C1J>,5N+&P@2L8DH\:]%K>[H
M&.1)5:?+=\@"O^+!^IR)^<L+YNZ&ZV'-&:C%VT@SK"7=YP2'F[F1JF\1_RN3
M@:0\HRZO9\^!;]\G2Q!5WPVNG?M.E(TM*)H66"#56O^Q,4V=V4G8ZH2S1>"
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M"RGS5SCM;K(+L&X9 3N5<N-7+/"_*:0SPSYL0KR&-A:A+XR%>R)5TELRJ*2
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M&'D2;RMM@"P29 T*/B35,U)ZF_@HY2;EDKUVE([K3L<>(J]USELW/H?R4(;
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M+(B%@G:^&F(EAA1NU.G$I25,?$'KNI,XC.6A,*(6JDNPHM '.PW[VI@([RG
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MBS\P4*VDMI$FQ@]M=BY_5UGK_3W?&+\:D;X[V#L?'Z%$M"DD7V@>4OPEM4A
M],Q'0UGW?;_H/TTE<7>G./5^J8.FX</SCZPF;G@_ISST#>LN",.V9[720F<$
M/<;(4UZ.$P*W,FY\I/Q<8 -CRK7.N#<8)3XX%[@Q"OK1=JXB3ZTIFBWOOFZ1
MU'BN.Y-TCX<S0<%@O3[-5>)1G?Y2]X 9$I4FE( [6R=1:%UB\'A_8B1ENN1
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MN\[BY+1?UHNH<WN</9&BV&^_SILU?1D2TK0<'+*GV:9N=J9Q](.[6O2G%U3
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MA$K&TUK=&C.2]V84@L;A5Z4"2U;2S2M6_9+?K]UB//><#QS8%I[C#_>X/+$
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M)_)=C0*(KYC ,#]&]+;C7\X4^M,^)A<0,\A"$@1:Q.0*$;!-K@3'C9,?1GH
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M8,*]<RM,F*[7J)$0]MJ,LM^_]?V=$KD[<J^R2=1NI'+J91OF:$F]FF11%/S
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M\O%5?5-5D^F-OX-8Y<A(W'6H*E]>P VUAZ5)U<(T3GX$_.K"$;(12$PRV*0
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MP*P)+B?)3.:U$K,6V;!R="2-RE$O)6\!IVO#<K4II1N<5K($*'R0QY-UQ"9
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M'#P67?50JMCY"51"4!2#X1%*@&-^9V#QX.F5KT%EX!/"9B4D>,S+,:\H#8]
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M*RGLJDSSI4C=PJW9UD/X2_JH>CEA^[1=!M723$:JW16!'LEIR8["S[T*:GU
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M/O\@UCC6]$3R*"2RDK9]L3)['T'WG=J7YE:IVFJ04S[161R93-+0RQ&/1'N
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M@'#V^XWP:U\O3ZA(,\1]+B&4_N2FJ>BG5TP^M%B8UY 8'^MBM3OSR3JN;E<
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M1'2@$L(8K:8D#H.VYWXV@9//QCB,W8T#!6$?=VA%A<J3%.QO[;1&F,YT;;[
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M_;SS?D\7>/"'AM^_.(-8W_R3%<4"0KY ?+K$ =O%%LA+,BXOH=<*OEEBJX3
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M?"B*QZC.*(WGJ -9/3?79GW96=K/!7\+I<R'N,V9M36%&Y?9R>NF@2W$ G6
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M>MP@8XU.'7Q*!N>?T44%AMW;PVS<X]$<CX).1)T]D=0"AU><YWYO=%?,SW4
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M<O?.#_5(M,%STZ3,AN>[MF6<*/UDUW#62O(7!"D)_,SF%LD]NEB.6RNN\S7
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M^!@^Z/J,)GQR6?57;PBJH]<D?*(JKE>K7=N3MY]H77PW#RWZ'0#M[5T(2C>
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MCCK^55;IO^/^?J'ZZ+S\BA-:6213R-96C(56:9&MX0D[VW,4LV4(>2/:-DC
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MM;AH-CO(Q3='=-$Y5@"&,+D-D-@^RZ<MK-96D\-ND,<L/G)&$5?+%R/,D7
M W%OFP/F/)ZU\%V?B.22?4(W>*<)>"(QQVS0-!^ZC8Q23''VN7:1)YX&TJPC
MR2AS]V^'W,FAZ3(1MWV%JV.> 8EP.>>F*^ERJEGM&I7AG#I2@X0="5-P?O\
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M,Z,5.FZLW33E95(22IO9:+236BU29\IV>EZM?SB&SLI)RV%4!'. 1C+L 5!
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M-Y*OO10P4CY\,%_#<S>;=YB^U(T5J+2%$BMXH1#-9B0G?(DLRM<-.P$J,WE
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M099 #M>&[[0;:[U&#Q'>:K'IK7@7P_?ZE>W<,4MHB -':N753$LF0B-\Q09
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M&<)14HRBU=-2335F?G6+5L5B=&OW]71Z/XWNNC[F;XKXL8C_ -/$8'U&3_\
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MV]6Y*[7567J>GGQ)IIQY?VJ</D@Q6TQ&#P"I?;P<#L..1[.C\2:4QV2R30D
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M-+EUDDO<FU>2DTXIIIZ=4N]CE]&TEH;>1)8'M;B+4[FXB:'4C--:6TBH8XD
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MZVMR,.+FU)D@C$K ,OD2I&^2?NI@FLOS2!C((##Y5SCV^F#T]3G.0 *Z_P
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M[6)7,!U%X;CR,KN<>5:W5Q+L\JUM9[AXHG^W3T.>G>OS[_X*$^.F^&7PBO\
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MCI)<MXN-US;VTLM"Q@\523SBWU[28/*G,<WF>%WB6YF"J3<(_P#:@,P;@"8
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MY8$<E5P .1CD7/\ A9%],RM+,JD* (Y&WE%R,&0@@+)P R=O3/%?VKEWTV_
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M21+!KD,3JBB633YUB)#$[DVJ7!; W':&.%]ZF7QKHLC@#5K9(XR-Z3NUK(N
M>"EP(CZX)X;/<U])F;XWP.&J8K$<(Y[["C""J5<+1CC88:;?ORQE/!XG$U*5
M&A"TZM25.+5OX:DN4YZ<\)5J1I4<13G.5N6/O7E=Z<MZ>KDWTT^6IZ9'>PR
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M)2TITM_>2<DY65VO).\/6=AX9T@6[.JW_ER2.TY%U>R. Q57A0L[Q*<[+:+
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M-N&7!_!1V.W=^#G]B11->N_ Q&[^,YYXV@!_;M7TEM/3VQ<WC"@+!II@7U)
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M\]45>03%%B5:\V?ZH;&2;UE<LL(T2I5]S_C49.\\?GF*__&C#_T*Y )F"D9
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MUK@'X4Y2F[ _EPTX@U<8?*L?^CB+1_F;L">L3=AS]/WD8O12L]A*\J,U(#2
M\KHX_"J)A?JG_-R>UN"WY_"G.-ZPX5NIS:D?E1<D7@CB]"C#^^_=;BY2$@*0
M^+J-J(NA(%(@#9+EW$GR5L% $:^F'1-%WB$\4'*8%36G5T6.="VEY;86"AW
MSHGZ(Z^>^M6E#^;4Q0RPSI5WZ\W],%/*FP\YW$^;Y+10H:.T%*%)WM8.-_KG
M$<QX9BWDO4+5C>*YAKM$:VZG S.-) ,E GP>[1-9;&8@+0,3)?3G47;/C!T
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M]=Y,#Q@2\"W9>G1 V9U0X?:^!_GGT[2T87TG&Y"6M!5>+\F ,TMVABIMO*@
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MH:#,>]IC[(=5H[W^"R/5;/_AM7KW1M9]P[;0-Z^2U,2M4E"OQ"@>H3W15Q[
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MK]!G6(T!8JZSD9;%N061O,S.TY<8?:\Q/:QL='##-I##C6V=926%*L8&VX"
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M<T:@!-:5*O-SK?\X32RX<%-..Q^N3IE*9!OMGS\<<^#*=^L317\^T&S;77+
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M/N(?6,!)<+4J*PQSI'QI.Y/UT;V9,]?1LOCK]XW;I::5C%^#D0:GESP0,L"
M=>MO-4_F*^OTFTLW,DU> ]#<WB-&0>^8&;)1N4<ORFL[YMIGF?<9RGE?;MS3
MQ[5/O? 9=>\KXWB;E_-7U,UTGL[-@!>^"?E*R\/V425'&Y4"7AT^<%&69G+T
MLE' /ZXCXP2R%T*EBC?R'4K\DW+9:6)::N[#[]M_>YPVBY=#'3]369@?(\%_
M+K#^#\NTF-0M+/,9NYT_,J\4+>22>@O=/SQ>^N(4?67GO[<...=N.W^9%]:5
ML'/LPK+6K,CX<TOSV$V_GQ)/)".^?]W?K#5(S#U^1J5]PM_H[J&$2=PWW24#
M*1%E3!&Z_I*W5"K];Y%]9WG03)>H^^N2RF6_Q.:;?AT9U8IBR&NWWO_C6W2^
M^&T3N\A.Y[JA3'XH?HH0F7(R/?[]\ON7U>:RS3W/"M\/WK4XIJ>4JEZB5,6W
M8?B?'*U=<I7&9QRWKTQ_"F4LCI=0DXTQ,=DZU8 E2&L+*(;2+P'THC?.-V80
M^UC-ZUCXYZ)9,\/&I/>^O9 1ZPK0<7C@S;Q%$J:@)'/;'\="13J0'Q#;\K?'
M-,ELBPDZ0SFM:Z,IN87.!!J3I-+' \WBC4=/SX7ZKW16%WD9S0S_C'F*$[CI
MIKDLE@2-X-7%;9T?EBWUD61(W^NJJ\;A:H3 IDU8)5QHLO@$M8LT6B?>@E 3
MVH [:>%  CI!9-&/5.)(<+C'7-/C#!H,:8,S(J5N_7FALE;D<I:L7=7[ZFY_
M$XK!=1</@PO/Q]&M#-G935@%IA4A=V[]$M3+G612A^L_N8K> C,3;/[>2/YB
MC*$[415D1!!M>1WQ0CM0V1[42D3JAO/UG)J<//02>GZ%:S!_N4*Y5WO'&WJK
M;"$WP?,?E._NGEP&$R/[?5J$ +4>BU2@R M :_730@+^P@#1)->WG5EC:G_#
MBG9CVM5=E&5*S;/R5JIT]6K+>-\A+7LF1^.</.HMP.%NL5"20TL&*P*EZD$\
MTV^<V*EC0;8'6#'>8$S^ZW;?:K.U4%\G4[MB#]S5Z=4_VA9&[SP;UM7NK,RY
M^4\N2<:'+K$%4\DLKD&2:RLM"74,1ZZ\_'+< /'?_[&("L9HA2RQ]E^^9-DY
M_8/](G'BGUO/MB!2GLK6[!'NP!>U J\)5F>ZFO-[G&?V3==LOV$]:[X):Z)(
M^U(K:^820=8XXS$:%Z:JRR3O1OL:Q-3IOP5C6ZAR*Z=9VX5_@1[17"D,=Z((
M]#L+FB55V6["H#^K+!PN#!S#5TG4KN@I^=^4JA_99E+5!-N(&Z#O$VJ#AQ-P
MV>J0W[AJV"7*N?= G_G#JO%-&-PWS9 08E.KF.'Q1#Y?0$5*3PW[#TO42QF=
M'.CYQCT[T'WNX#'_,>%QR/_MC(?"0!4B5K2KSX0J9BV)VM-?UJ#U>M37 Q[S
M_6 $0H*#H55]>R*G=LWCFNNEM'CI!*.$X@2GWQN-@/=\:Q'Q. 4#!8O/IW(-
M%+X+#T#77XMZUB@4HE>QNY]Y^_RV8'"6:PABXT1B-[!0K&-EK^PEX&\H_RTA
MT@EPIZ>.Q]-5W7T<34,#/C[1T]N$G1'M(SCPTIEE(V&M)$0O%^H'%<>K2\:U
MYSU!?$M6&$_.%=[TDFB0"QEU,.GR0.?81]X6P3$4Y^B';JCZ.::W*BJ9U+0@
MX+.NI,J,B;(B9T[K4=CZ\^;[PF,@)19IA^-:H)M#VZ-6T-)0V27P'M7SC7.6
MK MXM._>,:+?SD::[:VTNM*<X,+\%J4?[/LWPNL"-.R._=:[49- VD\TZA5:
MY$ &9WN$>L#,F*C##4!$>P.,**$6+B37&<KNL4WV.P^4-&ZUY/2"]B+EHV7!
MI]%SLQVJUX;49]+,GFJ/0$M>@*>@%HKD9[E9@F.YZY<(Y$\V? 2D0ZKWTXI&
MJ4-EGV[]+-UJXC&3@LOP=Y##C5Z34\:LN18P>I%I<?)&25S,B'W"S&C)[8P!
M/END)32"/H/*6S,7RJ3SM%H9XD)/$-$"CR++T>6A3/Y\>L2*>X@MF!U?.(O8
MC;3DVF%;LO6[A2:E.(-WKM/TDXU=-##HR:)==-)P27=UVC>W02_8&D> A.37
M#0EN31Z'0;.F44\;Z /2&C07S+:BI0V6\7L^]1)M(;3%:C,[TK9+:,(E2Q"L
MFT-(VSYVK6#W6OIS,5)3@)NOF'/]^8Q9^_J/U.E1J_'59@O[A8%-F"/D"2PZ
MT#_4#QC,;>'0#L(]@>#;>HL9VA_<,9_5/Y"IUUHU5D_8,58>()=HFA^THW6D
MTU2%C,I6VLC>A-U#1"&D*L.Q@K!>NC$AA%?6 D_" O:%0G]NLG>;:P,#OD6*
M>PA%K53YAIN 4XLI7:HO.%ZHRM7S=.J[V66"C25I]@1UZ)U9]&"_5NK\GN::
MVM.^2I[;X%(HC@@8V;?32B1#25H-K8DCR77Z S7<U12A!;\1T4;:!>7D;Z6W
M7EI5,)<L+;0$O>,;K(IGU'1 S;KMORR]R3N?Y!$B;=<OQU/GW6I>PWMK (.(
M']W!!E(=6X)\YG;>F9E9=P+6IT(]I^KRYU?8(XME)GJ&)7:I*YTKP+K_]]7C
MG_5:!Q5E*CJ7^M34 /ACX:&PTIEL.8 <C=0K)+Q977=HJ8N-)5KD^81DJ_?%
M"&?,1\<RO?U116'I3^G=89H]"VG6WUW/>T(ZC-UH_V3]D7%:M D"0>H6J?2:
M<(;"QN<%\>"A>W1-XG40$;'5]TONS*CZ\8_0P-.V/43O/#<[LE]A]4O\&RBP
M]?T,6HH+C)96O!YTF?Z[\;N3PDK^EC?&SS+VB9!^5 GD(9#,;:O@E0TM"AJZ
M9)LS?JXF!F/%I\F*#5I\_!^NPC] 1"32FX]7\QO;G[[5^/<U' C@8V0@#_A.
M KJ9I )\#TW.CBWT55S,>S/RF%3K0? 3>(&8!+H14;=;N!O(;4'(^ <Q) B]
M/$;DW:T).@LMP[7B-F%5"T1Q'ES.+CQ70GEVX_SBA7[]( N'JQDS?K;UMHEO
M@-IC?4'XP<7Q<S6M',C#B?1'USWB)8XD"D$T[D4:%FTEXEIL-%(1MU4"6^C'
MP9CG19#3)259*7BK70EATE$II:3 0U,VOS%QQ(UY#(/<A,5F4)L-AJTN;P&X
M$T^KJ2R&474G<=T<^D4>>LCDN4#E[XAG!^@&A**F,0GH$<C L(-F9?%\'$K;
M)F>**FN"V#9*6+7M(MKBC@W?'DX>R/(+R\$$X@)7\$VG#9+1VTDFD'([ B'T
M7S]/M(9"\H@[("F S;5KB.>52?J@M*!.T)/OW8:&'WG)(\>F>VC4/<>"E B1
MVDSVWO<#P2RE[[XR33DNTV/JC=CY%WJ:E; -%^AI@1 &3,2#I]O(<I78F"LX
M+:XHEX=.K*N)%Z*YZ],F6Y2RH[*VKZP*H61ED=PIJ.=2)-W<6/=SK\:L];2T
MV0\I.)ZUT(IH. R\QY$40?3C!NWQ3"E3=^5UJV8E1DS#J3S<U=;74,%PL\@E
MR+NBO/K9EXX;U;&7:^M2=CS!*T@XUB4/RTG\/K#^4,1"68!F\WI@!0\>+4(0
M'4!_1@L#.FP];P)H-&50HJK<0Y>:K?A2+35U*4^VO&S?U)79AVN'4Q<3@L(F
M*$Q6X?0)9]_AJGH-C$*N_]WV-J0U$"OH@\Z,J0%.S7C(1\]A_/;8'QM)1!LP
M@>4(EE&0?KQ:K9[*1=4I](%E@YAT;5X]1G'::/<\776,^"> ?UQ5LN=$WK"M
M?N3=OS\7#KK#2%/#1%G(Q)-&R+4NAS#  ,L&K$\'2]-QXQB))AJAL8&#I,H.
M,O,/5]>V/;B'YGG)M]T[4 I;<F[$#Q$M +5,[OHF;/<T71(HH'(M'%BB7J"1
M$AL4AMX[HSYS]'6=V[S"V#<]T^E[KR/VWSL[L*"5HFD3\B8:$:VT^(DUS&DI
MAPH.D#1)_>:":"YYT(Q'32#!?<<0H$$+(MJ,)HBC\JF)*YNP:)'20-  >$UT
M"$0G"37&H4I5"6M*N^+P*X^#P),JM4/5=6;Z1>L5P-ILB]D8##BWF/CZ&;LU
M/1L.]+/CYPOB]7[6@%)MB5[Z5=O?'_(9?Z9GL^!)^/N?^'_>/'MW5&R2<4#T
M!2M!TH0";T#^A81;&#&A8;](<XI^&J1%-L#%HX5FW,4D[7PWRT<;T?S3_HH7
M;7\+M0O]'(>#5^."!K+;KX+;,RX]5&3W^J0[/31#N^A$77D-D_L+!H.%PH[#
M5&%BL/LGB_U-ORF[;=SQF3]8_4P@T(V?B,]_9'##[=R>SON:S=8ZZL=TWJ?9
MQ14_TG,+@ET])P>SOQU*^7K=K'<^#^?^M,;.I'(Q7A/6X3,#H,S&M]^V__>U
MYHN6A$]/711$<MW^MRN?[=(Z7]YO(N7+#A;E'*1<[5?/5AYZ>;O.*^.4S,1?
M:17%:>\5=H[M?ZFALXVA_=4>UJ)*^7+S%9&V8]MX[4F=70>KQ8ELJM &RAU'
M1W#@1$L0S8N-/PC0GC0<OHDG\PRD9P+<[>23S!0?UGF]:2REXD/"@L/""\=<
MI@4/3172S4+JHD<;\XME.HU]0@N73TOHRE=4V>1&*+ME^OP]=B/=N?3VH\D_
M>"[95^8U9"HJD$_W[HN&P0VA=B#2#FH$ZMNQ<+SBV32$"A3:855?":;$99L!
M__SM@I'Z;KI6$UU66N)O<MHFXV!ZF+Y>J>9A?9G@[%W.L( ,]GS\N@7A#LNC
M <2DZ MUB'J @^/&&Z+U31YY)S3YYT E)C)4K7A-H8AO@3G33S3S*QJVPKT[
M+RC)L[M=M_SZ&##]S.W_U?#M\4SV__\K127)64XKQ^X<UL&AF.TNE;0D'<@<
M=I?D,"PY#;,5,8<0[BANEH3DL)S/6\PA27(N8C9)3KFN8JYLYKL^C]_OC]<?
M>SRN7=?[_;Y>K^=A>[_>C>?9IL)!-G %'HV60,$%+DV01U@@:,TM:NM3$RA!
MKF5$A[Y6BAR=9,&AJ G"0 1K0[KU,-2# Y8?F.S0BI*"<TVITZJ]2J?K6T!U
M8;)[U6!I<EZ$?WXWTGL3MNW9$,EZZC20G,2WA_@V0\U6?#/!U8TG*"TH!0=T
MYDPWM41P^MHI:G:@Q(4:X"VH6V'"CJ&R-L[CH#,"! &55[X?L,XL=+,QV7AA
M'AVA*^*D;3/ 2)X(S+GL>];M;+F3!/ *KQ(ZP[^*>:GSW'C]S":LK8*// 0=
M+AJ_ZI,5\IH)\W,PO SV_D@45:S)Y\%4<BOA&RQBJ6@I%' ^.:P#H-O[-#X1
MCW&5J$(U'[8,R0D>A]29WH1M)5Z>M@+\4_-]T'MK-F$[%L@6 "_5H_P[2E$X
M]KI^2*MR*%CJ"J:24:7RWU\!LX<\W<A?V%6W<_+F<O</DYRY+;HLI]<C)B62
MD8X<O8X)"^?T-B&\=K!\M4^EE]/$%+/BJJ*W>CNL,[)&)TV:!_<#O<V9WF+S
M-SFWXE&&X!^))R<R<XKD_<2Z3K@LPP3J:7\-19_>*" =<Z<8)=TD:XYYP:O=
MB7=_&.I?ANY'4"(#B^=H.PE(1,&8P*+_YH"OL5<U/JAJV-=_-J(DFW8!HHI6
M[S?HV,%4(=IQF2*2?I@ED234\Z)(!Q.BR0?JAX0JMC?^'&&#&%K%N'IAY]WV
M]).\B\JSN==7*4M^IZ8O50PY8X;VCWCV$X*>!BTXVQT46Z##A0/L;0P9[UR-
M$9+W=+Q#3Y=Y2!F7OHMR8T[C #CSK89CJ76^<F25IN@=3H@*HNV=MVHU-WT<
M>2/B)3'9^?J*\[8A ]F(F6S[J@32DTV8+^WS<]S>,>@R.E%%DA@K7&8!G^9H
MGL/M=5FA"<B=@:"9->A1G50D&4;:CKA?:F(8OL;=>H&D].),P7QM>&V31[%W
MYL@=8DJ7W2?]-K@2"0/8=4ZJC%13=A"CIQSOD3R!Q-,?RZM5>_&<;V7 0B=/
MN#OEVD<$4K^0F,(:]+X\%ZHA_E'G8U)&(:\V8^\7K\P,LQ!'']YD&!<'Z72Q
MV'("*VK73VC\4K_L^%1A'E]WC&C%PBID/.8D2G]6:A=*#",MIPG18[ZV@<$O
M/\\WCCXTZ;7B:F1.=S#2G8#5#48Z9_RXQT?#\BDF;)7R9PLD6?)SQQ]U(AJE
M40US*[&1Q4TNWKXT&X4ZY,70 A^GL)BQX;3V"K/6#;@]8%)3UVX1T0NW:6RB
M7:EJ3CRGXODXN CGUHL\;%/'04,']19'N7 J91?YP'RN#J@4O40V(*& V?9Q
M*:7VW*W@%Y6N!Z0#7'R3[5&6*Q2MSHPMHKX1POW<EH(@I!TW/H@FS8XK&C(P
MT<\QVDEW_Z6W<:^F3[&#;^E$PD'3D=,]B,\]%T7I&2,X9IHYU8)NS:+%D[1$
M,Q;)IAW/0+5&AQ*3_U1XF>X4\=?KA8F>-_PHH3<S?ETW+&NOH&?/X8#S&[(#
ME*UL8C17,0G<M7 1.@+PIY3:%Z15B7OFEUEH6>1.X-6T?0U@^CQ78Q#I4>1$
MC,#5 1_R43%<U<.-]-AF&^WE8M>Y2[W;CCR2_OAG8P9Z)T.;WKZO>3M=I,\K
M(0\*7:3&AE>8NZ"*9M1Z5\P/$TF$S'>A"JC>&2\>+<)#JZ&@D@W$U4H@([^T
MUZ/8N>5Q6U= 7-^L  =<P\5@6>0NM(PQ?1=QT!:RX=MZ,ZMO9=46T8EBW =L
MF68]D>7 6 ^:X(,&4&K$P+;&VCHNWN^FT[+G4 U>RHAO-U!=8MJ8S#^",\#9
M">0W4MTA#)@]#>\H JL#/Y&NU2FR@3*!%N>E0&;*PM"*[^DR5 1%%WLY9-7F
M%?G Y6M<CSFGM*VO)0;Q+947L&>3BK[X.(1B_TUW0?PK,-RXY\M0PY'?*S;2
M.O I\EARSQAAZ0AG$R8^9LM)0MLP0(G[0I0S]M.8M_EB;5UE,0.PK326*OUL
M+;;0D9\Q/SEF_>BP1,L9OC^Y)]3,;6]4#W<RI1@+35\$]I3D+30Z9'(MK[0]
M<A)<23M'5J/)BM+Q;#TP&NU/\C#VVT-UYRXYGFYI>)SO4)?RX4'W.#&3]QA"
M<.!Q8REM291.S<'.=:4H+I3(+=D1A)#%S;GM BS?$:.<T7+00H<Y.2680]CN
M;09"5]I3;@1P(SW/*Y4\QV4'[(]3%/R$3H@ ZB$4"?C\8AW!$NNL16E&I522
MY3^3_O[(T(345U_6+.&FYFT\.6@9HI^OP*YH3JC1(.RIZS<L'*173X1TCMKW
MI[M6_*33C11;9GFTC7ND8WQ[P:G7H%D<R5TO"HDB(<J)[AUPX)Z7S'>X+,G[
MQ0)#)+NHRT@]+B%N9"S+KHR$(D V<)?$-FQG4C'V$SXKR,S<)4-W$W;)^V]+
MQ6G>[XU_?9O-0KEEUES2F-MC3RX<!KGF#9.D0+D+HT8U*0DEQ?!8^[E<Y1;@
M/PWMX5(!>1U5Y,=1M[LP4+ZR=)?W#B^I6DSX^]X"T9TWOI%%\@Z=DD*TY:);
M1D4L$Q].3Z@F2$%8UAOF7EK'2*9P^Z@AR6SZ*I@2HPV4D@] 802.Y=UU40EN
M7TLQ9N]Q\KX[,=X=?.?1^31:IC$"TC6+]1583EE:.("A5.EXP1;0<\JN?0<R
MC$.CLC^1M4!/JG"[S^AZ9RH'K6BY%K_Z:28%VS*DUYCK>F2Q="6BH?R'<=,V
M?,/6,5!)(&=M,T*R*O49@<OK?)2.8WHS%<G]CI.Z \TZ!$\0PQH1&HXBMY<L
M4*0$4N">'J?JH2#T+F*^'7 $H"65(0R#,7!9B.+&-,O"XYR=[)0E&O'HNM%%
MJN>-:<R2X[148?9SHB2+; &*G"6^3**ST3&F!K%+L)^9/,KU;YBB*[D00Z2E
M!:=? ^H<1>%?N*WS9$T\\ES::9"J-<>F_OF5SA"T:!4)Y^5H! (A,.1FHY?4
MQ46OJC^8OL<%]\FX2MLLWQK4I17@'49&O64:*S*6[>X3?+7KA@Q)XZI/]-)_
MEG2*($D*T4&1@$\AXE!(GY\"'9%E()\@64)RS^NB5O3],!P(6D..K(5WQ0>W
M-QXC+EP"SJ927A(CVDQ_MN:/NXU/JK+W%A84:SO*"'.A*V_"RY-*B&G+KJ A
M,VX%G[+7V4>XM?\**R-<']K33O0?/#U4/3*T^*. UCXP[UA2[.-Y>>AY%.9<
M#6+Q[7Z^Y0O9O=*V7\R__O,P.K5O$^8\^3#%_O?((6($YB'VE95FV>.RF<>O
ME1R)R>.7]D_D:9"UO4W+NW5^:4?#&X*ZWYWD+!T=.28O<R'.K]1OAUGH7;/4
MHF.6SY?3.+2[%D?"S,*J/'V7-1]>$O_V]WS !9*"K]R:\X]_:@-:[3<X M3J
M/89B?]KIQ__\APR?Z8I[E+W $Q,Y.T[6W;(@^SROB:A/E=D[NJ74*RM+)/=^
MSS -6=A>V:,64##?R<0WZ)#9!G5*IS$& ZC9+,=;MV_NWZ:-PAXJ@WD[_W=2
M VMM(?_CWRW'2 DVJ5=AVGHZ_^Y1-?E'[>'ZJ F":H!8\G=_NKK#81-F6S/H
MB?%S^'E,H:46:UJ;M2_U68-.RM.P+<EA0X@G7[<DLC_5-AAXM!@$*Z]:)?;<
M*_RFO:/XM4TUUL^^\3TEO\DCZVA[%FST X4VBTNBU2 $\E9<D2;L2Z&I,10$
M)Z! %6(@+P1P7.RB$VGMDX>!PJK YQ#;>:. <71N$R;MZUM-D/N$SQC!:M X
M.5M,+$JN!!=.3$ I[?@P]WV5-?VZ:;]6NX0R2>C@IK"Q1Z9UV,=?B$-TF'>P
ML_>2?X;][$VORQ;Q*@/[Q*P]#B;C/9+/]5-%4FL?^A^T.,E]1(A:,,]LARM_
M+P-_M6W"*MDQP7C\CE(C)=8(KI+=WN+,=;L?6-@;VHCO65; S0]X9PWW_D)F
MA#QZL1ZAT_.V7:PYFO=M(V=F2'"DT(Z;O6$AE&7&LZO-VES1]L-!\2M+FH,=
ME,HI4$MP,]UQR-]U_Z"QK3A\YT*H8F-'M^+80\7GUT-*XVDGLH6[,'Q#+X8Z
MB$@,[B5P4=$>1=8 W_7U@, :&.W$4N)(KE/L!(;1@& +P.]B[A&8!!24UW#I
MXL3\CO"<Y'1/5+JW:<GVKV !+Q6O,_S<[ILY4R!;PNE*0!W J]0E"O^"V.UH
M"3HIF']><') *-Y=^#W$_&QF*7E40V&DV01\-T!1<>K,U1^N+O/'R2R,]5&7
MC/PU*5)N/G5'G/N"MX['X0)$?- ]0'*E<&PCN+2E+=/T>/)1R$VDS8T1,<*#
M#<!HC+$J70*2G++N8$H*;@PV(UY>_QZOGAEOTJ>\X*8X4"T2T!#S:K)%]\KW
MYWYFMH/?'EK<BQ0!1%W7XJ WUT9@4@K5.0#33IA7<^:%#5SIW7@L(;::IOI=
M8W<3%,-%QV*37_/ZY'$R)(NI<2DK[ C23.4\KZUS^0+F:? 3^$7%*SP.A B8
M@L>B+"H&A;H^:0)O\^H_FYDE"D@6H\'2\?"]QJZR ^PK0Z1KSZ"+P]KU&K+1
M5BVO1^'MV,>=M$+K&R_G/O8BL06KY3F(A.\TP!81FRL'<4")::788-S.?\&U
MAX)0\,0*;1])!5!*%MAQ:*)[KIPP[HUP Y;;RP+0'+W: >SO#R*.62AH3![;
MN2HER[Y$M1[2K576^/,'AX>3X)B=!#&;P^Q*D840W-'H8'H"HHA89 .8Q0QR
M)HKN,0ZC8V?!E#::-$F>?XJ(:17N\+-KS54 Q5.].8F]Y@L84#'3-$_^Y\F7
MD]?K)1KP%.!2RF<JJS$S,6@#US'6\A]JSR!9\\OD@BSDZ9!R:MB$^8"\;TB
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MH43[9&=+R4L>YFX5R&,Z,3.ML;8T!1)<5(LDTCDH]*50).S'*+("29VBQ<$
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MUOFJ:FAC38%PU=$=+VGNEM-34A>R)X4GGCA2B'D"1880;RA40'NE8"Z%'ZX
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MN9+588OK -?1,X3/P>CO5T+.5EFM!NZ:\CZ.[Q&VEVT:%5/$'0Z!MFJYB*M
MZOM-J>Y_+D!M[($",C4H*2U= 88P>D]#M[_D\]VBH4:(TC1;&//>"Y^QO18S
M'B;#^04@^2QM 2'8^\3-7J##F3@[=WP49T$5]O.[6O:6YZ=FWP2>L\D;\"YU
MP*1W73-(K>]%,=J)ZW[-1KN(;F\+XO&9B_KVMGFGY1H=J^ZEML"D[+U-$:W
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MKR,6_TLFL CA^*9&#;1QA7@%M[MI]<+8I-Q["+NCFYLC/0ZU*+7*3YYXD2L
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MM:RH>BZ4OE_Y,O1F^4A<,;Y@M.#50,KDNE<Q$[O AOM^ZFHK:UF;2#A1.N\
MF6$^8VMC %DY='*,5ABE=^(PKM3R-_4NNBX8LK>586/48H#(+@L5N"P&NX#?
M!T?G'_=#$\-5I@5^.(A7=]KS_V(#N9BEG S*#:2.<J607Y-/W2\ ^\"<)/%*
MY+AYO*1XUF=LC $WVBC:7?VG)*SIFZW!*_W'+UB^#9LE?.._T>OEJ"W8GL=
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MCY%BSY ;'DBJK"[26D ([EB'9_/AG*%@K%C=KH'<7,FOK!:9@T3*G45NAPI
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M-AS)[,65$Y UE?U^VK9P4;?^4YH9*QBIV+HS0<-S8CZD).M2T;9<=BU@Y="
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M&/.(?WY4_Y>WP5ZN:AC!LD(O<%_<.FDNY78JC*HPLXS4UP05O2M1TYGFQ/Y
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M[KM]>/,-9,U,\2YP8:D;?:2:L\OUKOQ+,X44/Y$^]TY2L!<1T^2 :ZE#+E_
M9'UIB?VD:2/XHD'?8WJC1/O&EJ,@R<4C4>VR3+5,OF%V[\]5DQ/1'VTU\A<*
M>6(&)"772[>S::FIRPT6?5>MJ(2(Z=/B3V%O(%&/;;$]RC'?(8/V,7_A!2XM
M'G7Y&E:>7 N?7WRTTA-.-+!+D1X<8M@ 2#./T]PPV74^O":I^*M:O'O["+V5
M!Y4@0\ R!'-=786U0T4UY*CD0E\ Z"P#9:?95SU[XUN5@ZYY0@*A:Z\+W<Q[
M;QAC7X#>\6':E,/^P9"/&996&:L\Y0,5=EG5/>H9"A,PVZ&1OW\1^AX@Z-"U
M7:^5MY)>Z@A[OT&.67#O*K/>]U?4J#.O><WG6,DH#\V%95O6D>7 !OJ56?%F
M?2.Y\.8,E51#I* J2/+WUQ3@J4(3/6&K)X8,?B!JO'B4\";S:80I7PH9@+=L
M$$BE_$$XEAR47X\S0J^)#(#P<=H,'1@SHK>FM_I+5['7E],AJ^&]#9M^CU;U
M0'__?2?P#19HDD:)GUA@\(7Y*&2TU^A[\DN'\\'*Q-,K11Z3=@:VLAR>M2?R
M+?]@C0Q-$8-ZN+#(9K1^<RA'J=T=X!A5JGQ"@C[JG]0JM_MCYV+*L9QQF)"<
M\([?7HM!.][IA=P9S2%IY4O^/VTL8 UVL@'M\%0*)LH?69; 6!3P@^O-/:&>
MN+ AKJP.0G1Q4O:8&#._K/5,:#'72=GKU:I :@JA[@[ZF.0-F6T?C]4A^8#Q
M0^5C./V92R<1AL&?6ZG2]RQ]P/PDE44]W=7\X&0Y\\0\7) +[D?CD;%:_H8J
MKJ?NB6\9TN)C(6H3T>48!OLKT!1EA%C)>?B,-J;+,K3)BJV$L?I!0KQ/HNII
MU>1#<<CIG@K_?M)08Q"MU!H]$2F,(+ )&)3C@\)4O6GX(Q9%3[LPI577&/J"
ME)KV3_^3H+EGSRJ)'*3*?@W\<<9Z>0T(/PGI@K\3#4$P5"%<WN8^3%RU5(JV
MXHT=:WBSSFK+F90F8J>I.F0^AA1$@!C7!'G[K'%#:URJVOF[KE._ME!#C,TN
MC<F?-CT=W"H/*L.)F$^LF2 <WV,6XP'X/U;N*6M^/]MXFZ98TUY+!)+H'J]F
M#]G)\?%%./$?A+.\,=P)><(B2W8P1D2/JB[R3UV^]5*\ _@)X0Q:#_0J1DXF
M[P"(BUP)#/G!0):E+\QC:>-RY_(&SN30Q.":1252$>@\]B#6NVMG<"L+YN><
MNOZ3P+*JJNJ5[P>#ST^_04>D[@!'7]=W0O./GQY06R(>%8$L4M/J=QR'-ZZ\
M;2YXFKE\ZQ<Z\Z84&S.SOE(E_E: 9N*3AL0&? W:0U27R0X1).)TBH3HX0P
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M27GO0-.,?"6K<?)W *16L0L0G?M]G?[HOW. +?!_]2;,-QV05P.=]="^+8)
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M7L#4+7T[NFI *]R'*(J_<B41S]/3RO&FP![(Z(G\>Z'DM:3\X#7&0F7B!>L
MZT'"'8"PV,O3+%,?H[6?B6'"^1S;6K5&==\"[Y?/ST>1^H+C'X2.47L7O# ]
MF>W,U%I@O25&_,/+@)ML<=*Y:RLT45\'[R1_5.[!.+$QL]VPS;N4DP1[?0\]
MYS%B(BDIFMOJ,^H_+YT9%>6$-1B#GTCG&;%_4'K^7TVB<S#?K]1G[T^=HY/F
MQ>O^W@'"G<46:B$*>V[0J,I6-+RO@Z8I<:K_'^GP##M<'<Q8UO\CSJ<<D29E
M]&:V%(]K<^72;=15>_M_!70#B_S6TTC!K*XBR-RAX9 I &2&79D;@<J"1D_I
M_LH>+OV>/@3X]25?&7P@^''B,S#$LNJ>#]"N9W'^U/)9&9OQ<^O7FO(+G_@G
M]^Q=<DM-^S7\)">IV^#])3<1C&=EN/3\#6L\5&<7&5/1[I<J^5WT_$2YU]JZ
MZZN[7Z/\#_(8CT'3L\P2$=<>1( /;&TX!_ X%3-X?MM^5M'VG&0(Y"%Y]=HZ
M].?7M7^NF?\ @G=^Q(^"?V:?A0.!P/"FF@ =?^>/O49_X)T?L1-U_9K^%AXQ
M_P BS8]/^_>*R4L.KVA-7_P2_%O3Y%W?=V]6?Y&[:-:AL1V[*!]X-;R$9P.K
M*N-IZGZG!XQ4IL+>)?\ 4' QPD$^#ZY(3:">Q) [DFO];UO^"<'[#KYW?LT?
M"LYX/_%,V0XQC'"#CV_*EA_X)P_L.VY)B_9G^%0+ AL^&+%@0>H(9",>G'%/
MGPME>@W+2\I*DU=7Z6;Z]RE5J1:LU:UM?\MG;6S?<_R0H+:&1U_T27"MG"V\
MCL>"",!.G/H3Q]3716<-Q,/+TC1M3OKM-RK#::9=3RD\< 10L>Y^A[8K_6IB
M_P"">7[$T&/+_9I^$X(((/\ PB>FDY]<^3GGOS7>>'/V/?V6/"3B3P[^SY\(
MM-E!!$L?@3P_++D8P?,GLI&R,=<YS2]M&"M3@HZ^27GHE_2%*I.3?-9K?HOR
M2_,_RJOA5^R%^V%\=[^PTCX5? 'XDZW-J(5;>\'A?5;33&0GY9&U.ZMX;.)<
M$#>\@7YAD\C/[9_LL_\ !KU^V-\4;W3M?_:'\4^'?@UX:GFCDU#1WNSJGBF6
MT?9(R116)EMH25W*!+(I1B<@<&O]!W2-"T3P_:1V&A:/I>C642A([32K"UTZ
MVC0=%2"TBBC4  8 7'%:FU>>!SC/KQTYJHXRK#F<8PYI*UWK;WE+2ZWNMWY@
MI-;:75NNSW5FVM>NA^0G[%7_  16_8N_8R@TO5=!\&6_C_QW8%)1XQ\80P7\
MZ7 109+:RD1[>(JRAHVQO4A1QR:_6AX8X8XXX$2&! (UCC58T"1C"HJ*  BG
M@   #@#'72V)_=7\A5<1JTC*1\JDL![DCOZ<]/:N.K.I43]I)ZRZ/36[O:R2
M?R)MK?J]?Z\B:)BR*2 #@<#IC Q_GMTJ2D  & , 4M-:)>GZ+8 HHHI@%%%%
M '__V5!+ P04    " !LBDE;1NKD@M"L   $MP  #0   &EM86=E7S P."YJ
M<&>LNWD\5/_?-SZB5$)V$5-1*J%""IDV)#'1(NM4$F,PE6UBS)1]GZ+X1(PE
MA)AD*\8,QE))LF\Q9I1LPSG%.#%F[NE[W8_KOJ[KON['XW[\[M]XO/]XSWE[
MG_=K>3Z?K]<Y"(8$$[#M%RRL+& B(B*P&\(?F& 4=O;O[/_I\W>3_]<]1 2-
M,)G-L(D-2J(B>V ;9$1$940$+3 X#":R\=\6P/[G1V2#J-C&3>*;MVR5$"ZH
MW@[;("(JND%,=.-&,3'AU3#A=9B8S$;9W4=.;Y*SNRF^YY[\T4=/<C=KG*EH
M4K#O!C3U;]T/W[)544EYA\K>?5K[#QPT,#QF=/R$\=ESYA:6YZTN7+YR]9K#
M=4<G]]L>=SR]T-[^ 8%!P;@'(1&14=$QL7'Q*:E/GZ6E__,\(R__94%AT:OB
MDK>55=4UM>_>US4S6EK;VC]\_-33V]<_,#@T/,)B3W[_,?5S>F86_/5[:9F[
M OU9_6N7"$STWTW_;^V2$=JU04Q,5$S\KUTB&X+_+I 1V[C[R";9TW;B-^_)
M[3GZ:+/\F2>Y%4U;-/3M 85;][NW*FH:L/:"?TW[EV7_=X:%_W^R[-\-^U]V
MC<"VB8H(@R<J T/ ^/S]>?&P?Q_EHFSQ5E0T<ZL.5>\!J->NK@SH%"7AT3EX
M8R!K,#XPX:0*L\7,!+3^9LGJVC)SV:U#/CADH8I;JX%\$Y<X"/?\)^^)ZO8W
MO,O0O7O@OM\3\^I&0!]3(6!Q\RB.*X"QYIVJ7V;KO 5<%UZMZA3%+2R9/V8Z
M3P\:O\;>W#A?H7GTVX%S[DV[U)85/N+FV@GR$)IU$M-N9C2PZZNI-FMZ]_L!
MPX1_%C1K*\+9"^-M!VY;>Q5F/2LOSTDXT@(=W>2S_Y!A55*HU6 >C7R>:CU4
M->9P^>MB]O$I9.7LB.&W-)6LU#CWI,2T]'M6VQ+CNX_8=W^8/KM=,F22MGLV
M.$/OH:G_:_0*PIW>@X>S?6W;Y@^>J*:^Z<;Z<?R"SK\F?4=NM:[N?U)S\VGQ
MKN4??>XG_B2+?QK6ZE6>/%E)<GLV$0RO&IP?#0;H;'AK CV1O*T(,@>$SMH/
MP%L6=[I F9:I3309$!$5^!2@). /L!MLT9W1Y)(9%4Z+DU1I >IPQLDS;),M
MN]%WS@^)_A)ET(%+ MB(?].X_/H_>!2HP;I6M!U*6-O#.S# *2.W$B1!'5(+
M)4X 4S#% AJ-=<26=3_FJ>IN/U.]EUZI?]W=8CS^M"X[2XQK_#3MTLFLEB-(
M>-X<JA;9GB3.+F(XDV0A$QO K S4:"2H06'N$W E**.)H(PFZ(.6G'U,*0-*
M4ATM-]<-HQ)%CPF4ELQW'?+2<G+U2)L:/-N0T7O)W1]5&%)#6=.;5=?H)HAC
MR$"1'L^Z#+^S;YDCSO(K+82N_?I]"9(H=)M>/5866(1S6NBYFLI*REK*4(L:
MJ[I&!DCM1V< *OQ]U.7FU[0C EC3,4-BE-GNE/86^-LON0"FN8:F DC'&@P%
M(#8@)Y+T+X+DN(*(9C.Y]%,JUNBN/"B_33%=]%0/9^E/0(-SR[5::7?YU439
M9[ _OUE%G,%)K CA(T$+*@-5F]7W05ELCGXK7+7<N=5-R2L0&Q'BU4TSFT-(
M\@Q9<_2X_3H9O18]-][U3(6C#1XLQ$0;K&4^7U#':3Y?O4Z<R#->C [L1#4)
M8-MY)L G&\MFX;Z_6:[^[<*@/OL*H<O'>'O7LZAR:Z=F]"'4I0$-?4O= M])
M<R"-7H!R^S8V8YP61WP@5MEZ=-0Y;!&HOPPI@'!6/#Q2B]4>;R8SIUWF]1,)
M^"9'(<++&5WWW-DZ*K_-W]2X'G%=4)D==>JA^*18I%CETVKW64B27^,5UC.K
MI&/2:$J#!!F\0@]!'B<52E(<@CSMH=")4&0,?WM]I7-F!UGVNE>PBC$N]"RU
M5M;U6T?)B-.H2[ZU:9+9S_NGS!S6240T.1%1I1;3UB4+)6,C:XP)F;D\$U"/
M(;UE6M0ULV4<7@TN-G5MY9VN$@;+)L2B-/]C"2:5X5DR4W/M*&JSWLV';VIC
M];X0-@A@X=&$K^DJEO-_6,4$99S2I%(+:B=/'1AL0\0ZD1A)%W1$&;6KMG10
M$1LSJ*X(Y./(+=R[:#,C .BMML&TW)O5GPW:_E&AYHDB&6W8_-ELJA::6]N.
M-ZD!D*W.\)V\34  0L7T9/XT82O(?0Z/6D+S@B>8VUPL"[VN*?)W]<Y/U-4#
MQ&B_:N6E=4-L^>537PL;G#%!5>CF(^ M^!!F(I#^R,_L,.3/O0\]\%6*KUZ4
MPQL3Y2'MQHP0-$V/5E?=3[W*7I1X7:>M!K^6S0W50;;0#KYUMC2Z/#(^NYJ>
MI6E_6/RSDQ;G&=C>9F8".;.4V9".$.3Z_#ZS Y Y2&PD'!; (M,$,+NOU)WD
MS7P-WFE + 29>,@0"9D'<D);N=DR;\%-6:]QW@N_+SX==\3=7VAKOQ+C6$FB
MK[\B^H6AN+>A*'8#O,5M:^\B7JL0OV?0U'="V;>@@0XB6KM4O%1LB\LQ-.EN
MW8#AJ1ZJJE%45:B)+^8*J2THB#BJ(H'RSE;OT_U"#O84KX0(BUS- 3SZ%5X<
M&'B^9HK"];2WUJ*V4_BJ:#=%P.0+>3O^>(W3LY5$J51L05@T4=UK2\F0MU)&
MRQF4[,R!L(W??CN_;K98H-HAYOL+>&B &,.[B0'B!R<%L%;25ER[#6!3T_ 2
MY\)#@HOAIKO=,4;)!F4J"[\Z>6?+<9YG>Y<S+0:K/I3OZRWC!&X>F&5^>E$*
MP_L"]=S7ZR]INX0BL9$E9"\<DH5EH#9#S!;AI$IZN^2U7YAU%-N6S"+&C"N
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MPD,#TI[\SU D8LH/Z.++.%"S?Y*4'WW\60##UZ[=)WQ.1U5[1A)D>68IVON
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M84CLQD/+PN,%C4LSO2,/$;#EQ2$E;FD_;W<)7C/B2C<5P4)&$R7I&(0(WG"
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MC'-H&D#?9*&DIL?AU2ZR&5>C&DH_0$TI#[HWMGXN2W'#Q-W.L-C[,NB63=C
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M99&%,^-;:)"S$0>;QQ^I0R0LF#H$>[!#F=LA9Y9ZYL28WL3ZS^CDJ/MI9^U
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MP][#*.5T=NJ5R4Z_"TL.,(P0&&D]EK:ZU%9K=AU#YD38O91W"NVY&;LI$ .
MW5O%E(+B(K!PZ\'XG]3M.!^/8W#7_@@5+Y*G#,H6XMZMOYX2EUG#GE0$WF5%
M_MU' 8/'SWL86Y=,M$,1O4/5N-^G)?(EF(%U,F%WMAU._SP> _V]5$@ME:Y<
MTKEOB$L4+*I^\&GQ,,IC[:2"$!.(\7^>X>R_\#QMQY5^!8P22H%X#:^MG')>
MR!)?80(/L.OCY<'Y 4Q ?!R^N>+-XBQ](;?I9F \:>TICHMN3Y7HE%48;#I;
M8%ADZ'F/C^B>4G:])37'K5)!/*2X?-%T8B$-S9Z<^//G^9(IZ064_QX#F&FY
MD&-N=+GZNT#S$U+KJNH5WB8))=^&:B;?ZJE,F-S;R3K5C9 OU">,W0G//6P5
M4[-X]F'GE1?F/\ZZKF;OE_106<WE^R'5N:L AE$Y-JD%N:&7/@S['(DD].11
MW]/$/0:T>6#'P%(3:OY6%;G_V%51,]<'5E-G,F<:[2^L6'S^42'0A5(JC==?
MM1)[+G\@?_];VZJVY /.;JF8LP22&S1$./1[\1"SDR#/+,DE83-84I?:_10M
M^]K>:@E7]3U+[ET"[."BX+1$\I87>-,G77JR5%:P:YSWJQ5+8TQ/B5T9OI/'
M(QM2"'VNM#I#H.JM?$X<'[)#P5=^#AN-OA[Y))=2%!RW&%@^K!)?>FFP.KZ
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MM[#1FWTGQV:74P(3L-E3]M>+%I/]4O9^;,CJFB9K!!PNZPU/T2H/N0!-$5S
M86H,,@QY%&)#H\%8BE<KAK,:?^S+5[1F$P/7)#]#B";R>-&OEG\EA-=@HR M
M:DLL=6_[F UG?L1+1B$LS(72U5Q@1ZPM2N$4M8@/H/E2>$E;+RG=)'B8IF2N
M&VTUWN4 UJ5(-;+I\BP3X*8;-U+ZIDL].3>W(U8TO<G-9C;CRE.25YO2/.'Z
M#0TCJX-E,U&3ZI.OGE_2"HW9^36WE0^*N%!C8(^WQ945Z+HXL]CVI;MH#7($
M90+U=K:]A[R$W-<_VSF(?5).]_4EN9VD[J\+DZ3RA9RJ'_H9^E-,.1EU=6.!
MVDWZS@3X*K0YOR"7TKH3JG<]/.+]Q+A:I^7'T!=)=ULJ@Q%&PW3[64_%JPT4
MK_":> ,C1)W;A%QSQ0*M9B4C>?NHM::E1?_Y X)_+P-"J?[E&AN><573T&']
M'^^;>+?P>U:ABO[DF3X_$G$(8 +=6>G#<..0EU^2GN *U_$]A,F>K<=4KS9$
M1"YIK9W3U)Z7C.O&Q:1UAU;#N&T[$K^AX&W)PF=P1>!VET"HCK1 ?H%KC(R/
MM7."U>QHC;0;*G$_7E?J$_7BM$OHIP?H4N[X<F&3C+7E^;:A8EON6YTJ1:1Y
MLW*'7+V:PXB7%]4*?\Q9UPJ>_%3YM58^=:#5Q-=>W<_78^1%MGZ$>&*2WFB'
M9:G.4UZWL^8_0Y9/C7]$UGEU?V$"KFNQ>A3)-L'0]9G"]T3N27<,[Z:MGO\"
M\6B(_,)31"YX<OI&?TIP-EKS144Q^:2P00!=?\R/A\U3Q5B3[=0O(\2CQ6!,
MUQM->5(FK'7B"([4=X MTG X]XY.FD[6ZBK96MRC3]>X =T34.RN:FK@CPDX
M>^';MT^_;G0\CV?M$R@$-U>#,;F3ZL=UIN=-JL5^Y8C6-KW/;CH5DKPJ^=%=
ME@8(CZB2=).FYOAC@[E"RH;U&+F[Q^AW/5^1U^VZ3%"]]U[,'7RD;F6C-'Y&
M<&^DI_U@VR Z8PM;6[8TGF&^Y&HN"%]$+N)H"NZ!H3-W!<076&I#H+:C9C.0
MN+F*H>D=8[G'5>1.T!$&\;D6GXGME#\RD!7IQ#0@S'<^D^N"]N/3A%YM#Y9$
M/_G/M!]FP[E&^<KK'59$M!O>#+C!N,A2+[(V%:4,<AUR[=I\AY<NU%JT#5D'
ML-S$UOX?'?YF/[@=MO^IS-C@O8EEV&%6Y:'0LW.KE1LZ\&R^OR0(*SV#;ZLS
M@9Y4)K#0<2]E5PF'*#.SQ\SU>4E#>W^G!)<:=L=W7BT0UYG \:([DFA-EY^/
MP!51\U&.R+G'F.JY M0$O']G]O#*0UG<FJLO$RC<:!0A^9;5(-LZ_%D1-A"Z
M-F)RW<MW*GB)WJNTML,*>_\_2YCVV[PI^(>!&C^+W0$;FKPVHVD(G@W[V@_=
M<&E;V^53(C#V%.7^G==K*+'0+NL.$W#B\(<*;F.71$NAZP%>C%@*G!89 1>"
M>Q&>C@5BL'>HL ZWZIXIKF[,44VCK'T#34XSL"]"9;)>:]5$SLM:<Y'*\(1X
MMFCE:$V][^V>C[36#8H[?%Q3K%&>$6FVV_*DB P:O-TKDG8M.;3-4+I5FW_8
MN5* QO_Z;1#G@;;1\OWX\*]TA7NR<3K<;!%3U0=##V[X>5[TC*9?8P*A\3:H
MPO<P85BG()PW1 8UMMO%!([48/9_!35:X57$Y5QRIB#)I1TN[%&:;U603^Y/
MH!$BR6XU6('+_BX>&/[-OA^]:YQ9]7NJ/!4QR[K+HUR1L@07^&,+Z$C]B!=:
M@JT5$?X M%BW8A$F>_"^_!^N"O/^ZKE6"-_;$W&TVQ,]Z'L5%9Z<PSU;'M'9
M7R4>B,W5FB"?F4'#2($<1G[YJIRVE(T5&,@UB>R 5PE44LZ0N]LH"[5PM@W$
MDP8L5H1\YT=?Q]E9=BUGXH0D-I\J4_<Q1S+BR? UY%<YX68G<F$701S4W?K$
MR% B<('K%K@9?"?LZ#=0OF.)A5!M3( 7)3QG.:8M[)%UG&+Y=,-^[^7Z!K"^
M$,3=&EEF+>"QOMEFHVEBJQ\DVF3KIGQV>4UFQ77O/'["EN&_S-H!+JJ4'B9P
M VV&-!QO)]1$=O3!KU+[E[_.I-(EJ=(FC<V,[!"A)>XEFF [D=?#@:,NR@;U
M2=$%0UYB%_(Q$#,6,25^K1,T0)D&65I9WS\Z/M)-WO]*C879+MV$R- :,AS^
MUIC-Y3>%K],B#-Z';UCC.^3C3'"QR&JV-JXG5"YX6\L^]MTK=#.=$^45PU<(
M.'W0DI3^JNWM!V68X&EB5(5GP<%$:]!/B#O]"?*-O[A6=>*AYVCEV??]')45
M:'Z\K\]Q3$_1K%: 6& ,W861H7G9BTP0#QEB L(P/>K^7FUE\,TT0"G_IB[&
M:(>'0EQNE:#IA.!9[AL'J2)+VP?V:9CJB;U*9;<D4C23A;/\4[4D0]L&"B-3
M[CDXFA8<?I$2,)BOZ7 RS<+=V]10JA$*Z/9&I:4>L4I\T#TKC1#(:OK"T9"I
M&8SJ*2DT;3IO7J*5X3PS_%-W%%*B)(11V=H<)"FZ,<MF9I2Y."5#@TOC]W[L
MB=L2SF^<_/RA[UG*^13;6.NH,R*OLE\\#.,CS*1KRU(U7)F 8 LG^FK]R/V6
MD^C]XTT*,_9FYBWCB30N0=0MG_2/]/VSY:J7SNNJQ&A>)H6_Q5HU!MSGM1Z7
M\;)&)[]%?8ZDGWK@/Z1IQ,:(;6#Q/B'\'U2OJ!KY)TB^:JY)$:-AM',+^\#<
M4 @O'3,\2SF3?:>0T$KDUA?N[^;UX 9\FPU(=7$N;T:^&<6J9)(8NA8U3S^*
M[EJ.EHUI2'5_K] ;Z>SGBNI)\O-0S+[XSC@VT/9"MO KU9*''=W[@SX9NSQW
MN_.UQ1ZG<V$+I6S)F:Z6-_(VD!HRU#2&AW@J+^2^.I/DW<[ N'NGP>VTQ7O'
MQ05K7F:1>I >?Z;CC]J".5Y)=B.Y[1Y^Q:*"AU7(&L[&$_<N*RT<2A[]VNA.
M1>X%)\;ZV_U,5)[,&F2?HL6/6%H@.97%>#[_G-XV;6RLS2(:#:]\K[[QLR[K
MXO[>>S;T^I9T7KL/;+9,@/V/'B@<)\YBY/QXS*_3(5;#A@5EPVX5?2HX,LY+
M*7.(<4?Y5%Z:NYZ><@GKCQ*M("\MV Q1HC'QGV]Y7/Y;9RQI>E33W\U[AL#=
MUB)*[;AKJ'*+2S6LYMUMNR9T$]:=F\]7I@-@.Y-BU=(';YC52AN'M,J9P-)3
M.$W6/7!]$@/[6G94GB[AH*7A&/]0DQ__)XG/^?9('*S<X&]C ?[5EOO_=A5&
M>2-#F+>FKD'<-K^+3HSWL]B;Q"+F2QX3H*%LEI:ZN!*668U5] @D4>IG.$D
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M3\>&.O_A39UK/37C KAEG1&=)6+Q_&M*@.6L()U?L9-G"7F4<(<8-MB@C1/
MSR+CM24>ZT^R5%BFRG@[Q",H\(6[Q]V7R//-_L0K?MM,]3/Q!B>D=S60GP57
M9&?56LZ%3,!%T89>"HV#VGP+(?P@)^GC#=\;7M56SE0$]II^A_1SLN%]::$S
MQE=K,RJ3GAYC<+6+LG=X:WHGJ!:^F/%&?=4KE[ IT\Y^R@3J&"TJ#\.;EX;O
MJ^>N>_%12[G:C=]W0NMJO6^LE)+7N"*+&;EQ?C:_=D7YI?07.G>O"RW(HJ[V
M*_/9WV$"%>7TY/RBVYJ?-';*'LV?/Z\(!5JN;L+6WBPA=X*90,'L#BS2#-F
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M4\_1HW)VH.5X:3YSA.?.F?H:W7:Z[LVP6B.S1#?GCFSPH=",NR/+^)L#RK>
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M1P]+9B!JCNI&3/A9T(GA1)\;KRL?YY/O]"_10:_^!5#"OHSB7W\MBB(5RBJ
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M0)=S^'3AOC]?BO[2^AK#^QG/IM%:),N-,Q'.F<2+P'US9X*&J#G-3-/![7N
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MCB82+;5?7I?I9B'NE&+72A)96QC59M_U%AC_F1W7B$IR F9?=JR5R1-;^1O
M=18"VZW+T< ,P5_%=,.^0FG6<^T,THP"O8@MID!77N=A&:*O@;Q M1M (".F
M-LA=ILR$$@9?&CJZYJIAPW.V+L"7T@5%GV4&X$X-WQP_+;W^;5>BY/GT'/;F
MMRM3G >8B7G !GN<?1N(62L $-2P# P/^CCHQ])$:=.@R6A>9@<<)V]2M-T+
M7L"<"&YU[WBWV U-[Y)F;N VY4P'*=,218'EP=+0S)9L/UMBQ]L)@YBV<442
M2PT2SX7L[\TI\.U^S!W:>\C18M_<*V## 9PW<S^UM'E1)/IA8C2SC-5[!]SG
MLX!$<^4&L-QG3']=H0?8)QZDZ,5B%T-3>9SE\_+EYJM7XZNX$*>+(=GO*(O0
M]:3]J8W!&2!W^Z_]VG ;?0N8S.@209]B4M:?8B21Z,M@,U.;5I3+.8U6 JUH
MLV%4UYT^Y E4XFKWW(%WN-ZP$*UFH1+:K)AE_3&)D: ' ]%1OJF!?&N(=1,@
MV UDLK30,2!/!9@HJ. )M@,V=.6>3*C8ZMV-N,.EM:C)[N+JE ;BNMO$AYF!
M:/'.W0125^+HP+W$#P_N^1?!5.%K3%8X6G&O .Y/2,"^)O5K3[6=8RIW$Q*[
MA$ +IK8G. M4]\^9 ).9-BELWN<HRYG>,M'7P%"VN5Y-8(3'W');<=U2Q]28
M1G1:Z+57[XJ'%0H]_[:\LU=!"MX_?5H ^W@B8D: JMP+_3J_70RFTZ"I\GK@
M6T9N]K1!6^8F\G[Q1H*Y02!A]6$05L!<M&+51W$\.E?XZK3G<ID49V""[>?O
M[U='J5N1W+D(:#W NEH*HIU:F:3NW$0?(V9J/6U=N9<DBA%'FS%+%TJW9ZY:
MJFXAQ4%GFPEMVHC&SY_H':+WWKF+(7YN3\;1;P;?_L*:H@WV4Y> 3.5" %MX
M!AZP1QQ 7\YTW">;C13X";1.'=J;J8P;=1@^#>*8S9<GB1NB8,Y\MY<@)9_&
MA?!/!W>=ZK@JV3-M3=8J+9_Q]A8HR228TI&U#:1KR*FVOJX3>T_PC+8>;1Q>
M$J/,^1<OA(&A]-Z3A*-GC]MN; I:=9NZI0L$8:3O58L&#E\)CM6/?=<2\40Q
M Z$=)^'V@:\7)KW/']"9C6V?/0(7<F._7+,],K>=F8O=\!FS[?Q)> #R$%L;
M]*Y@6S>#B\#\>7E))CQ#7SMK%Y^&/EL_&VAI.-RI4[TD$8&^\JH%6,BN0L5'
M#Q[9_'0)2>Q3N\?&RL&IM7/[(9^8S1G<]P19'#W,![@4VXSI0Z';]&.S.F#D
MW 22,%J.3DC&-]O<5[JJ[< T;*+'(^G(M):E+8(L2'890?/1E*3_WN=-K^:)
MG]\SYD;^/3P!^K,.8;MMHN"@"CZ-"PDA96)E]_5VEH3T1!?G*!""2\/(LMVY
MD&3*=OS>8RT# MP-] >$CK =88EL309<(M#1&\$@P)#+1;NDS.B*7]$RSY\I
MQCKMD5CJF'Z.&FC-LL%\Y4*(N'Z$]"WD<4M=S"C'#. 4T()GH;8=HU$;R5Q(
M,Y)LH1B(Y>\2"M2L^63Q;YO$3EOL3J9Y8)V7@!E2&"SR\&YM54:T/4C 1'/Z
M88 C/@=+Y%N?9WK3M)I9]IP!S%' * ECCHX#PI+A_H(!-%AO+I0S6F8,V@-D
MK[$HJ!!J\6_P/AUZ?!D#G6PT< XJ.SUV#9C'11<U?VG]%-%:KU.LO11$DBW:
MYM]KX!AS)N#-,93Y&2/&XGNL&$IYVX!)R<$HL/F!HO?P)/F3@&06VI6A+8'"
MN@)WG]3LLS$^DQU(;]?8A$-!=V]2(J-'7B!QT(ZI]+K0M+4^HMXO[":^B53Y
M_UZEG8Y#!JC\88_Q<V*07=7GPVD\]Y6KX*;1^ST!JW]@0.6S QFF3@>@ER!>
MZG0N9$9[NX@)72-5HF68;@6T=4DD,)3..;-L*0W66A+"L6'P%(RH%6WH."J7
M4F8T;)_1\:D.968S?)HI,SUG<YHX5U =Y/;^=&_K+PK3/0-.K>;HO!K>=P_Q
MSF>!&++44")'!ZT+&*V-S*DR+U17!<Y+L$7H"%S,O*BYY_[R(CXS%?BI&.4>
M#C]8@*4.AE@J!-1I%B5/!./D3[8]3( 'WB)0/@5S^.'T94LUL-H!@"='V6-I
M5TGD8((L"N$XKA\F'%@D68@'/DCBB4+X6A]P*MJ6;7*O8;!&JX2F3DIU*_Y'
M_F0FN2VV*/O:A'+;%\)+]>7Y*>_M+#"=J><RUBG']/X'R 2+AZC:[W.GCP_U
MRD/:QEMF#R^2\;(OT?X_4.Y.PP8-5AX=H^;6M!#W]QV=-Z,G""'1[R18MN/'
MY4QI/U\^@["*2X@7(??OC\XL+X-8KS]&U*'U>.I0=IEA%V"81"7)+YFFI*26
MU]C5H/+FR3J!>7U5LYHOF][OVJ1'Q_47NE\#TC7H5C!=\Y!?;O-IEEJH^8M[
MM5UR[!/QHCT;P X%SL^.81A'CY'&9_K/H/+WZ1W7</IU\8?IOG+OI4C/U8<M
MD928>_$6GS=TS2[2$2V0>#UK]#T P<CMA4EPOL#D, +HLZ/Z5TTP\E]!OS[+
MHV\SR7,G@;O-C2"RMVAZ^XGY]K3/VYH5)D@B%[O^S!5_A!71O[=9"G><4.H:
MP=+D7\7Q6 RY^S-C*/8L)]1O:N4BKM- .6D3D5 F#!)I5YWMQPQ4T:[UP:;S
MV9W^-(M])G[1V=8ZHK]Z?C_O0S^U$%X-QBD0^WHGB\[<E^M(B->Q1LNQ5#"C
MI..6VNP+8!$P1,<EW6;KT.%'0/7W6)&^AB(<&D&K[50/80R)HJV!(;8Z5IA,
MOQ<0$M.+.8'%5;N6],7J>2Y-_RRERQS5V'QKG6P;.829VJ<)2B]T:I3.US-_
M#-3KV=5.N]WI2LN.Z]T=69EV:XN47;0'RP$_VJ>R_'OT;#VGEM$NZ4!)$;;+
MN[&?Z'MT0;.K(PW1<@J71I1':5=="=<@>\=?=,)H&SEH/Z-4C!*JFK(KU%0U
M@_+NZS+()1>Z<V21QU:]BA+91O['MMOH'T,"G)K?2C>,23^=UJIHVVZ:6]8-
MK+[<UD2R&\M-!4^SKH)&C*H&NAR,/"?(G,?]-#?9=T=R_\ZIM '?#2?O#AH]
MW Y6> 'F>I?^;&/WW4P\TMGEYA8AG!#O]Y\M4^6,XH4M]5&IDW;,+AS-[JH9
MA<3#D<6,D* !0(L7<?]@T.),;<?QE[<[>1DU!L$S\T20;)6)(+:_F;CM;M<\
MYD7_);49#'_ULDW./<=2 ^T%3*X;4?&IL5K5P) 'B&T H13X<7._"I^ECNU2
M!O00RJA'VN:K_GJ,$S,/S(L_K,]$]LJLZ]F.A(1VJH=FOU@N.]-A-Q6J;]'(
MLVTA#B#V_:83.+G]B @^FC,;UL<*!?F(=P'O%AY663U;G1,=7]RWGYDM]Z+M
M+"YI*B#'HMV9VHG597,+L$-HEY'&EYO8M.G;HD$3L1)IIPP;=HC__YV*^R=+
ML[TZ2QFT(;A%G4_ Z$I79=:#\[3<;(Y*8)E.9\Z(-J]78!<D3Y6XKN Z-K<<
MJF'@6Z[UO''Z3V'J9V]!-5"FH/2X$C,WE00XPI-(H@H@CV$)#9]FJ@]O4<[$
M*(-&Y^+CK(G-87PK6,'.$#H)]]".\3B/$Q@5AY0!23W2A=DTOG2MLI45;WV2
MG>B=%PF6>R](9IL(4*6-S(6(SH"I<$&T!?/N.T(@Q@1H2]@,@?XSV<F+,BCU
M[H>);&VD[%IT53=XHXI#1+NEWS"AN&B!P7D!\...#5.S*F$[=C0P-R JBV2/
M@FVG M"L?>6+%R-4D "W;.JL=R]'%L15HUJ_>:YP#C"-$HFV+;EBMSHV)1#Q
M K;5L[UY,[-?[6,":I8G[YIF5Q#"8DY Y%=<9+]'O[>D!D!V&4H)$ A/@C'$
MO8!ML"\$VQABI@U#9*CT+8Y>VY>%UK;QJA&OC9#DG?#.B>7P[1+OB&--Y;JW
MY]\K/O11CV?Y@:;=&/WI3U0LS(H.W=?!DFP!P'2>;#1AZE9:CS[/W.@=@H+:
M2," E-0U6K?W(#"6[6,R<JUMC/BV5//4F?DKWRCB+>J*"3#DL(\OD$M/Q3/#
MNC/I@YHRKL#Z>!6)3CJ"PI%CAYOS78"-3+8 W=ZYQU+C2VBH_DS)K.Y>"TGX
MUN3VPR!3_]D)?(V5;,S=2-M#-90%& 0S-\<#/@3P#$0?20 4H!1WY0/.-JV3
M!@V2YRVE)Z/?G9-I,',>^_&EV,+(IW"(7&8&S#86F+'_!J 9H2U8,1""\.-"
MCFKA;TU.#)[DFVUQ<TBJGP&3S@\39USRU$/"+HUN!=^JFE;*$;PP(O/!Z7+6
MP$)%I$J^G^Y/OF!=*OY^"Q<"JK@GHIWV"]_F!A_H8QL]CYM^>C<P@  6G4\<
MZI4"\02V<LC)63 ">=Q^W^&?"/)1 M;7.J"IYF$!SZ_,W\KW"MX1]5S6M8L\
MPK<4+_YC/Y@P^FAMT"BDTH?MP"S,IZ[:1]#IH[9X-Y;/X&K)14;A@A1F,#@B
MQDJVZ>W&D0-ONLT9RGUP>4MY5#"UJYJY('<9Q-'V"M.*9PLXR:F!!C6-8=='
M-F="#+3Z'NNMF#;T$9,UHT*>YW@F#2F&*QA#MH/4*9ACZ&O-8'<%Z@45#+@"
MN*>CCS+L V@[.>9R=-6HP08[\IS*\+-78]+?@DQ/_RPO#YJ03LVN7]K]_*1V
MN:AYYLI4T)D\)]<\@S\QKOMZ-!VM-,J1"9J7"-E<(G1"H=E1"+Y;7J/HLV"
M;V"\4&>78CR\ST>SO8OI8CC/C]:++9/JY R\ PN,<$KC"UW#ZQKKT[^=$K\E
M8!(=KQ#NHSV#&?.\*#N*A.G=IO(I%)GL!4M?V\0+?[6M#-X-:7Q;-1-4N&TZ
M\40U4'_/;4*](I4S,%4\_>-T<K/8P$H-Y$6&RO^E52BJ*#Z%Z/W!1+6D6!TX
M\N%DTJ;%K8,+I&GG[=>@).LT*O@L$TO!2U<G=L+I\5&H@'-O.1_&B3C21!?9
M\L5$?4B%U]5O6H-V]V[JZJ8E5AE)F 4SPO<M8N4^_.BV6?#GGRWY \SV$R>H
MV-Z2MII-PB,XE5K@#JJS3!1.WH#+;3C[*NZGDIC2Z_K)K$*3$\:+A%B.C:48
MVVJ\Z^358*=9>ZK'6LO@^MT^_1"13BOM]"A&9?!DA\;QU;R@(QU6 A6O]5Z]
MTG"LRI;\X13\Z[,6X^DD[K>Y@^C1^]WN/;ZO'GMMJ4W6NHF[,!U>^LE[7+!M
M#(JU?:/EMM6%V[$9'ETB=)?IWKGIB5_\ANP]H13RE"F/S:/JL@E:W==?C9"_
MZ^NN;#%=@^G!3@4FUG[T:ND[O?;5]G7F&=&G]@:UV1*9G*,S;V"@3Y[L#>R'
M),;##Y R;!/"X0ULI*TE#-2 KIV@JX1JZ4,SO5J;>"NXD)OMA60:);=1(3$^
M\U2JS56!6P\4Z@L^GWME3)UDNLI<=#0Z=;J$[^0Q*L.8FF C)?=F/7];>:U(
M8H@'K/H1(8]-DU[R>U/XUR'B_<BOR?_4[9Q05H"X#_V05[W9GA+8TXI,^%&-
M*.T0KX.WE,O4VEK,("ZTL+@0/P;AF>1AH(R/-[V'N2%,KV/HA G53G;[MU9+
M.178?O3I,XK3/)X75_46ZYK$X7_'$I?%]I&96D)WL#0/D!V9Q85\$?B&B9H'
MX_C6G"+;Z)+IGX6.PHZA,3:<QZE\[83%!:7\SSS^^8.>GB86MK2+ \MO#S;&
M[KI_* Y;%V *36PX,+4SV*I47Z"D%R:WA;@O430G-VY^ 1U-V[N":MSIGI.9
M1)_UK^V-TD1<FC#(/"7_7"A3T=WK=HSC/R]0C(<VX[[@S(DT5]D[8K#F'Z^C
MJ_F43QL-BOW8L*VQ[5,WN^ >P&@O&D8DZS[Q+<]DR/[>JW,5\[=3>^XD]OR2
MAX=+?=JC(&V_2Z+]M&L+#.>Y>IESWT9RMQ*QU)>P)@==S"G4TX,/N1#%0<I>
MTY=L:-9B8J#^/I^IS:\AZV;G/);QPN;N\?>J3W>V;4]P(0*6)P<-GKIGK-\:
MK?D2D7Y'X>$+139-BID%6US+57TB_N_M1M<$C;^O4!?SWRLH7LN)Y5\G!:C'
M/+%41%7'/6P )^REE0>TMV''//NJCV3>^)FT7K5P*T%1Y1$UDM+/K,XR;I0<
MJ'X\,JAR7:W36M9"S57-)2O *:(S_Y%WL6,&^O.0^XRS[.+2\P?^47=^X\07
MH@-\ZJNE.B7DO4[_.TL?L;U%Q-;#0]'.^SEX>"\9'2Y8VI:M--'I&%8]4#/H
M?[@=\*9X9;][6=R:78.*<;EUO1WXWE0?)"W14!<H^5CJS2A1X*VME95YVK<
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M@;V&O_LQV\Z:DO2/W2LL'4S-XY3_M.==/Y&!#7#I:Z4$O)PD*Y:@]T-66+V
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M20Q8!/T5K)@GR;QR(K//R%[X:[:]5'EW+E]4;&EE-FSSOO![LHSF:F'PJSL
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M]WUH:!E[[G,#(7&OQ5BWJ@?9O-%)38(-6A2 -;J\2,"%.^3M+?8QGO:\C4O
M],]BTT/:]QHZ@SGRF]WAU&X%D3V_PAY@I*9@6FFI7!(\<6\TX^^Z6_X(5Q1@
MF=$;-"15&CL:>Y2:>%[)SA_E5!%]PQRPCK[>4,:)J\;7.?Y:YFM^U+?X*I1>
M27CFNE_ V-<.@J=N?Y)IR/4\VC@U@?DWM 2!=SORTI-D#$\J:O81FV0;#X7K
MBT7#SE*Q?J<1S,[Q4DB5X0<;-H-L;ZOF7TGW!K@2:HXU7!.LA8D%6"!SP',"
M*L*& .VN &)\/AZNW' ,U6S CZ0F%%SIP@@4_</JU19PX80M%Q3:O<Q?&S&H
MQ[^@A2ESN+YWD,&TAF1P\J$\_HLTM)ANK*Z[*"+SP-_#:,NVCU>X*BHO 1B3
M^3F0&B?^7PT1^N(BS57(*1#:J^?)Z#BYE;3MEV*JJ;C[5FWWR@<^(^IBU*,N
M ?4)>93HGY*MDE]('GB7?!9R!W8)BHZG146#*/#GSYI:(TY>)NT9V)8&/)JR
M'^_^'57..V.?-'TO/'$:X570%0#I_"R 7E3(?NMHEZH(X1VUE"(I$^J$GRIB
MN;)H+/Z#,!EMUSKHL*1=TRG_X6V/["G7O"O'JUEDJDL/TR]SRS:5K,VVV-#Y
M%Y)I^'?>;S.0&S5Q"8 3718LZGYY<:NC?6;,4='EA]P\M$'G>N&[%9)'K][G
MUT_)B:IP%&5NS?>=G0FOUUM$\[]&_<DH]/(T7\!U*V2PSFDS*&3QS$6;O/Y1
MOZ/3:_!;S#9AZD,?0Q0)EOX,B16*K5VYM<DC0]"*4(<A68+&\VK'PH(DG.0S
MD5%L4#RJBR;O-G%?_Y>WGJF>?TN@Q&QGLWS,E8GVEJ2$,)IW>RNY"$[LS9SY
MGU+ZX&/[_#:"V_D#5";K+J2(95W-N57?4%V_#[=W77O,+3^TJQ(Z\28MN"MH
M43?C$9CVOE!XGC1C42&J.]NJ:^N.<8W(FP\2#W&JPM[Z\OZ _I802%X%^#1*
MV'B$+ZS7[F# -KFUNE@P3R#@^?8?HXJ$5R(9+B*U92:#CO[FU@M"73CI[W'"
M&/S@ERHJQ=Z^P7'3];9Z$\>!E?98TPW/DY-CUDM \K?VS4N X#G.]=LE(!:)
MKP$&;_S[FG[,VG7Q73+!$SEWTO?ECB;UE5'L(YH_[ERS![WS^MHQK9Y/L@Q"
M+C*Q.7UO^O<!ACKEQEIO5S:3LR35F4BP36?3->33BPYUURSDG&2?-<,OL78%
M<C^4ZG!7JVN6+#R+NRB)[!=UUAI$OI2OSVQ'?B-)XV=0F&VK_]Y$;$H6S4I6
MN#+NVDC?:W@[O0;\(=DOC'"B7Y#!0OJ6GAZ'7Z2I"6[ST%QDMLKA,S<Z@36!
M'7UU68^KILC\6T&*M01H;!ZV(]+K@7-$Z7J\.CBDJSAWG9V_>>$X0/&<[?A@
MRKZ#:.N)7S[H7F&JS:,G9A,]T6EY7"1*_/HLCCZ"S ;OP70D@)0(%#WV6)\>
M<36R.IL3^5K[%$C&%AB]4]LF09Z$_A*<(BF(U2>M1"='7437[K,&Z!!C<:[S
M3OV7@%I()RIV66"&#(1;8.3S5B\!<T./9DC"5PTJ..+1C#>"J;(4=P'L;>>;
M(<$N 31\1E-ROKNC65A1>OH\*H=CG%9]55,N]OC8=;. XK ^L1F83S8>W5:3
MPJ,BY>CI8<J7@&A9;GICPH=2P4B,N(SIC.RNP@N"?@UM_&BI?#)F6V7HLXM<
MC@ZW_.C^B[1^2 )V7873;&]9+H2#'ZJ*F.=;%?FKL"R$B+L*VMF>3-<H=0S3
ME/<D;I_F$O#.#/ZY?P/QVG(+.(^PC361GVMAA=S[/">ZO'LN4MM)0; @TU'S
M!]!=Y+C/DMG:,*16FHJ-0]2ZP$W3];5_ZG32D]P?-Z&3Z22N&[(^ZM<0]L*K
M7IE4[4I+X-OCS6#F*MU5;F=LFC"?)%>B=AR/$D.&U2TO 6TY4F]9. YEU.]"
M";1V.DWOS7A ,#EVE>Q6-S[O/;'>GKH$N%\A30V"(%F7XHW8WF!4\?6P53C/
M,-PUYFT*_.*< .-*:#%AY8M;S2Y5*V#GXC+]*]FI8M) E,&?J;6[1$CV^2DL
MH(0:^;F\.8FX!%]%EM/=[SI5OZT'%V^$>&AYL-[<)#)JCU$D0PL[*)VM)S&0
MGBC^OC5\1'(JI8KNDPF_V[05"^U.&T23$5Q."DH_1F_KM*ER(L@4LC?K>7P)
MN"L"F7=;4K)(;?6:WRILNI<Y77AJN7>.$E5_[-KJ_\_OC(YR4__)?TH<JV<7
M_@R;>BXE6X@<8<.;_D (POR<4SYI:Z=#]&)<CX1$"^"'VG+:_ )03J=0X^;A
MB&%B*%:K&T6[^_#I50!QS\;(W;KYE!-(^TIUV%/TXA=O1V.=F$P:;9S;C<!N
M"\_D.*:AVS:T_=P7_=</49_(C&:7 $>2S>P1717Q::=R8,J]Q+ .@G6!N[1#
MDX#ZKT.83;:]1S0OO\UK=:NXY$:\-@</D0.WG=NC-()X .^*/QMCT0^S;))B
M-X=;F^PUK:7"Y.9U#/^95#<8_5O<JD9EV9RL%1@JPL%SQ7^[-"U15@+""D7U
ML%A-;4J.4>60_\X\Z"D[(,]7,Q^@!B8=9\XS]=1?'MJGGOC)9B($,]G9*-UN
M@*_?*?G(N4_7M#'E\= ])C[SP9"K2&S(GM7QU^_"8L-@ZB_W!#[_^.^1>'SK
M<WWE4*0+ D6D]]O(>]I!3,5F <//5(:XB]#@,M+CZ3<"%L_P20/!)5T/#WC*
ML# ^)YIW1NL:=BXN;M__<U57&O58#'TP(K.SSP*YD?*.*'(:H<YDJ'.G2(N>
M2N&N@4><O77MJ<-$$>=@D?F/."-GF;$1F;L<^M3M,@RB#Y[HIS#%I#J6F7N]
M+<_2MQ!O:7'T$^I4IP)R$3^1S*?S/3%M=W7;%#"]Y:LIK2EV"\8$-Q-.G\7=
M0'6M3_'C<Z>3I<-=R+DHL,$4Q2^/6P8GC\>$*&9/C<5E]'Z,[XAYY8A,<-+*
M/*]I^/&CIB%.@[:MHA;,Q<!O\Y%1BDU5_Z$O__39)8 AX!U!Y2'!-/Y G[]/
MN1;/M4_Y:57(T##"*OE%J5QH/ON@H4&9(2LJ.LERLLRX=% GVYFH*<EA 8RN
MB$.K.39&GVM5?M)KTF30&101L:P4-E.L1_DW4#%0#ON./9[]LG9,,<EO7\?[
M^O>;\;,@[L>'?,"U66FLJLF)CJZOV*I9P+I7XI*=]Z/85JVHU)])+C;Q/U@@
M_!LL;8[[XK5TJP7,9AS*+/:/AN,[_^C>@7.%0O-,!MW9 QHH,HV]@BH^OT3I
M1PKX>5:,1";%0V!/Q*>*.#N\1R1<<NC,W6.R2P+-G;R=G8O2VJBJ0OK91Y7.
MZ)\?J3\!]VI6=G+]F/>XZ?80[<'B>7 ;62R3;*APC]34*>;V'TWHU!D \<AI
MPY6'Y.!:;PV'8M F?NMM+KNP[_"(1\EP^^[]CURRI<%ECNX4B3:.9GPIN\V)
MVJ)0O<YE($$2:(>8.V7];S1'B I7 X+(W4:)?]EU).XXQ99HBBO^,XK-\:MV
ME'70-S0Y\!P^D!QP\T#;N(NDF+<I2[F5FM=F?8A7UCNH/X*UOU*QR%@\A ))
MS_&S/2T6WE.W3^:7"U$\2,R2(M51C@GN.O+^HO0=\VL(A+_;^,(3"NY3O9(_
M@8YZ3OUG1<4UN*S4M(E?XLNIJRTFG_XJW^BN8J@OZ7B[;=Z<Q.U29";^5?$<
M] CP)],N]EAT:,3>J*UU-N#I-\P1\(ZCZP9T\83UUZ?K)A]>X,5W*DQ$X3;4
M7V1LRP)UJI85&,&G%NO<047Z#Z5D/LD$]R)\W-@B2 J82KJ<YY7J\]FZABF;
MZR"#J((;#P8-W$NU^'N,C1UM?]MEE8@<&?9BW[ (ZX?9E7;T-(;&$IK6RL9?
MP)^WZR<5/<G>57KP6$#L^==)?7<=PQ(.,T^SDF\[0B,-B+&X_3Z__T)#NP#_
M];-SN6L ;((U E]^U_%(R6K)<M%;JE_YL(! +@?$^9V7.CO!BIH=NV.4#N]]
M4$6>KL<$%^>.O?X:0\E/;ZY>D4SB0:ZK;S_&-':M^7GUJ=.7_ &WY ( ^,>
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M#3."AP<H?:WLD$__$Z6?H59;KULZ4!(%"'LUX#73_N)5:T[PH[^+(=>2@MP
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MW8DZ;AW-9[HT-$/5$_B.O[_ ]\:@*=6 18;04=&M(@$>4R%;H)_K>97>T"5
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M,?GN^%KMM->V4V/XFG+28)XJHDMWEX]0T@\-!](?0JE)W'ADO#.9]0KSZQ'
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M"I,2_QG7C?])'NH@J&AV^OK,'Z!-)A[1]!;=!VC-LP-1+$\JIW]R#' _#+Q
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M_K2EET]]NH<KD.2Z+YZS*]5RKJPYU_"%NH%E!_&V41=<@.V+2HE0_Y?$S3M
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M.8@C41TS@O!,S=1X:]KQT6?5[:N9G#UA,GTRV6LZ#B_S<DF^',/3<8O, Y%
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M.ES.?0<X+GRZUC+X[>V/VT*SRT^Z^K?Z<NI4UY4'3;7&4SFWJ!;ND-__1IK
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M('9_)+.9AL2RYB>'!5(?J[#D8C]AFF_+P9D:PVM;5IY[[@#KR;VKRI$UH3M
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M$(YK-V!]Q,[]Z7<@0"$C5&&STB&#!\E*)C59'41W6ZA/]WS63U@ .F'@Q&
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MM!F/[[DN.O__7OFZ^N;I\Z>L7X%P,=V7P 18BW62^,DG8!-^'XP!2MV&U:^
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ML] A.*$+);ANGQ(K.W@/H"I&7^2T _N#K3:UK,G!5E08H[HRD]WVB)+ D\5
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M>GBV*C&?-F.DV53<=L2[2BM]?9\2B3;F(C\!^Q"_D'E@$W>RG .*168=Z92
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M=Q-6QTJ,M(!G_(T+*5!=;$,%9%(50_Y@6LN8VB8FS55V7>SG2G/-7YP9;T2
M9!F]\^+.YI[J;![?^[=$1W\6ZO1-0?XI8PTW@'$BN^U=ZPE0GPU+@E#W??FG
MK9G[%]?Z1K2ND*6,R6S0TO(D[X_WFVP<*1K%P0>7H%[8MQ!_1 H<<>,6.S1
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M0^_JL9RSUDZ/(K5V\>;D@$I7L](ZW!':9+?WL;X>19UV8+O2Y1U11CF'3+
MD4H1WZW4#?Y39!X=HUU#DN XQ)]ET$)9)4^(P8D265KA8/'LXX#1W<S/[Y?:
MC)TN^OW]IEI$&5X,!?RJP+@:.D.#_K4,1NN13L5!AC\QU&5F$:[(Y2K>WWG\
M4H:)%HZT9WX\W-*O@(=8Y]&B,GP%;W"'CO+,_IU !YHL7J(&I1.U5!8GSF*N
MGD,*ZKMJ+O =@R@T;=,N:=>4:NRRI\[1N6H$MNHW)N!8\^_*/\;VP,L&01VN
M<^C2W$*P,9U934W.3SV3DK"@6-_L#ULC'+I/T !R=D^_EZZ[H8SW@/Y@U#V
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MU8=^N3XY=:B;NGYFYP"WO,DE5*VG%I@7.F1Y#GC_U*S%0X4MO:$F[;"Y2N+
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M+TE>DEGY%2E2:,8]/:T\X??6R:R*O OL:I?OE&1I7H]<X*,,2K_>,WZ &[\
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MQF58<DQ$#2E^UF+(5CV0W>WYS[;O)W1&$*O9R!"."=E1JN>#Y<_,.0>W!:)
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MY,R [8NYRF78MA#IU\5YC\ZLF['$;"J,&H)X(*KS260;XJ'4CM<DT4G52[N
MJSU=$817$^K=KZ#;8JJ%TFV O0&:PC?WSC"9@O./K^APXWV\7FG,Q+U?-A*,
M#C,7>G^##^06&8ZR+PO"9L,_%H?]4BC/.5JVPK% MVT\Z1RA^](3Z_ROJ]\\
MM#@C__N%9<XQM?)AN]_?#PV@T<V/XQ[B[\?26A$C7M*42M"J8^P@=&?1/H-#
MH*5R=)4(,+B]D=&1.:+1U5T /9FR#2J2\5"K^5$]&VP8MU?EYW'E%HY'JB'B
MJ3S/(LVR\[IO1UDJC.G$NA+U1Q'K8Y.L)P&]24F5C'R+PB:-&4-6P%1G??YI
MCMYL6K-/G)AA07;[[X*3+*>=,M_Y@(,=S_PA@B?@DZW>B1.%7!PEC7/OD%*Y
MH! W>4JXIA5]>WMC_=OU0PL;_]G_%]!T<L?9],/Q4&'Q@<H=UV]EI47]]9?)
M9F>*%Z4=K8W:JT2#;LEVX7ZM%M:0[_-0](H9I\W@C9$.A[^].D",#*ZT+/?J
M;;Y8^JUV*K8Y66DI^=1\4F\AL[R![\<["'5AZY+G#?O<7R],45>KA1A0-3]%
M2U\\HER-LGO3C%VCY]*F#9$.%=\FEA5$0;J(-.7<G0=7-7F=0SR-"H^]]/Z5
MSHC>@9##,R\/:U\6!V4/^O^Y\F_2I:VUXI5A>QG6MRQ"GKY-#+7^?+EF9\K/
M#^5?KOMZ.R:?^K JRZPJ(^?^U0=;5I:80EQ%)_#Q+>,?RM^+&M76D^%-)XM6
MJ,HIIB2I2FE*U VQV-S764F4?O#Q:6@8C!SQ6](J$\7_,2'H$V66_V[74N!_
MXG57E](,4%<^4T:KRMA(1ALQ+7#5R>))4T2*TN1:N*E0&>B@DV;70ODN-10^
M7H:EF7'SR[.;(RH#[.B)T\WR0TZ.$FU6PQ!KRXV!&[5],/0)T\E!&_V^F6U^
M%3MB9/6'G[[)63/LZ9ZC-T9P-7,XD+/_]]-!ZUL?YG+C@B-V]8Z,CF"MFVZ^
MR3"1YIY!+#W:<<06VS/ZFU7<KP0Q/IL.;PZ5]@AIBE] 02+9@'$,<'M@S:)O
MG?*\C O-MV7#.0 ^.])JMH&T* HTO8\&LOP)N9^5]@$6L^=!2FU\V63>IK]M
M]T99VS^"]L&S_GLTR29RS !#N5G&V$2V*%HZ.TBVJB!8Z (S!6 F3[29' .B
M.]PK20@W#]T+>.B\DUGY2084AMU XO)2AF9LV6_YV<5'Z65?8?!^[JZP4WD7
M>/J&#]\DG-BUH63EZ3-;3$Q:=SS>Y39:.ZBH/2ULJV\$_OID2=@GKFC3><'X
M&SU"D-#E9O'@@H*B>KH,"Q9M"%,C!SG!C&2ZA9TC7F<$>FFNRU6C06P6V0NP
M_XD%&#5=B7DQ/"'@3Q6M;("RHI]/YC\@ZJ0R(LN:$R>%BWX7[=,A,S%17@LD
M?F\O6@WD/9A7F;4O4 W8NTCC'47VZ@]-$$W#C3%2O+'RV!!EF/'I@S3<81&Q
M@H [L PSF%,='?N1DE5ZUG9J])10=\G9QBP!+GSYH'N+(^;%30/FPS?)VP[I
M+J2M2CBSZGHV :2=>K4,2\R$1KS ZNSR99@N4H*_;^?.$AF&W-:+:'?HRIB#
M;\0 #=+(6FC'2(=Q960^/>4 VW*"JG>5SZB*++3$MC1PFC,Z#?L8-C/7I]B.
M9"<5HQ2J!1P5#Z';$C^1 =D=NK1T")D:A5[#2;O)I*V#FJ1P'M*4A,9"]R19
M6$P\3N#6\.;5JRQRL!%[2*#CP7>RJIC(=^*$#EYK^$-KOJ$GB3;6]?UX%B7J
M1\F%CN*MW[>M^?ST1ZO;L?;Z[0[):7ZI]O7/K \IZNTWK6:]GT6$[@9OG26W
MGKT@'R^EP"<1KT7R5(DULM7"'#!.F4>8="S9*T^!@JX6'5[1(>AM!:0I8VD7
MKZ#'!+KS=>BCN3VV3E ]_Z3YHD13YMZO)]C;FWJ5Q\L^@'O^744ZM]&9?J2*
M\@[-'$Q>Z$(:30;J@FYI<YR,L4-#44WP=5"$3T:/=STPE+=T";*2ZHT5RN).
M2O<9=_J@=D$W!"!DX>@2;'/O2@DIC^OS&Q-7F']NA4J[R]9KOY/GKHI=H0>(
M9CKN.W[3=M\9M3O _,S^R;.OCJ\:> R@6Q$I5)/FG4"2(I'?;!=<04:^!?-X
M6 M2IB(:",Z(&M$[OPR3T%/F ] >26<R_HWK1EI,Q*XNJY">L:,:#D.X<'N>
M-\64-7B-7]K?E2N,M"A=.DJZIB@"I*162I_:J5]Y4^#QG+[6O3R0A)M:<M[N
M\1/AU'6@IQV=G+[E;:BM EMOP^SY8I\SM.*Z\3;$Q?1K5T_\ZGMF_=,OO[]:
M_^SW.R655K!6_9*#XJ_Y=:>^[7*_*+N6'/G+MZY=Y*J2I+]V)L:LBM+F'&'"
M5R@)]04*92]E(V3O#^QI C'2H60I.F5L-Y3%("PB4EA9R(L0$1"TB3:R1+JD
MG$^DKDL:!+-3I\K,Z'IV96GU^;?*]SRN.5FJRKI_)Q8Y;2DA9B*TEV$WJ(GT
M-6HK\K$!)5J:=9B8CO-^:CMK:LG30[?G6^=E.KE50MY$?8CA&V#F.V#3?+)D
M;!CWR3VT;-*F0?M(S.Z2<^T;X6^682S;]CQ]O=.\KI 1F\_&OQJR*$TV^+]'
MM*AU^T[%[Q_P<G4B'-#OLCW_+.=,X?6LP91+#P<>!_URIZHD\?@J@>QKP1(:
MFIF2T.1K@3J?/LJ^4-&Z>;B)TA%D)#H%A +CK0RPSA?,?B*K4$9(S0U\@#]]
M[GSC;&K6*@D,%=JD"7O2Q$D7!9%9/IYUWZ,\4"-+9^%]HN%!U/8. "OAH3<W
MVS\GN4@-+<Q823RV&3 YTE$2ZG,08WOT5Y?PX*CXH"L1-KFY]KBB)^4BS09O
M5-R.N5(^B@T.7U^S0O[S_W14\?^.P%"0WI6'UD7!E=X0/;C,K7J4; ^%RQ@6
M(R$YHP5K6$^4VR7Q7KR#$YYC:>5';T_JAW:'+%PU\7C]]XU-9[RNP.8:K?[-
M14/[QNX%&;=E+L/TH>V1 <;> )7F='(),]DW*8C]$[W2;A;VS0+9P@&RLJK+
M<H2T#):?W*\UT++ HR&_YTSC@).YQ6-IIBXA+>K,=G-TUC),7,(VP*[Z9Q*O
MJ]Y*6N!1CO+G9W4GQG;WVLEAET/9J_J:74"W$U"X3GKSQ9=^8:+@ICY6W ?/
M>2?G&(E?=?R>9CYCP]/ZNXNWBK_ *$_Z\!M(T8JO4+#UPKTYK/Z><HL*V0>T
ME*7.>A$RM/%#R3MD^Q^4;5.-;-J>O*.5]NG3\[YD!"#CX3J8 AQNPN?[IX(X
MS)=<Q?NQ<PQ#]3_"@*[I<7!<9L^%IX[M'&P.!;Q'N/4R"96W"9%(C"J,Z"HR
M ["9:@N_T;#Z#XR391.4?8" A]"=?#YMW?'U]X8Z7%A^/$M5V/$<%@^Z4H+\
MJ6UNS?\9?O.'KX"<?\C.?'0PQU#I!RX\($:Q^G<! IK2N?A##?S^1N&D]UT%
M@]$6>J-WJKIB=&(!Y]&51MY&"]XQM:WC<[Y(N1D1V*^$ [K^#5"H6.[6B3 @
M:NB,9DIR<0<_S*;=M*6F(>!.T1+:RE'2SG;U 4"13BW#H--+0+O<!HEH(U3D
M;.GJ<706X\"LMZ)\]TN@_'413T?H+<-N$DTANC0UA8R4<E(=+&AB6AK5A'*,
MK _<:'H.Y<XLPWB+P1EL7??*<WP2XU1COZ0VSQT\G?=TZHA;14ACP3+L:IB1
M(C?:6W!1U!5C_)K$5;1 [F)JQD7RMB$QV$VJ#W=QY7L'.+;EUS][FEE(;C^
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M["J9-0D]NCB3OH'UE+ ,&\[+VE=7X 5\K VN^=8?T+8U+2]7(:RA!]]1^.S
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M<_8!&TX1L/5[.:$CQ-3?2'Q?L*>#D87#9LX1C3Z1+PW.J0RXC:OH.J;](UZ
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M,QYXA'Z9M/DRA!IB_=Q%.+ZV/TEUQU)JSX::031P^A)10#X[OAB7MN8/5ZN
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M1V* 'U<0.R)9;+^\CJ%^,.S^=WO/?0\Z!]MH$%8?O0#TT7C_W=.3A"#QSK
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M2^=@%B"NFGBO+RB6-.DFL=OO'F4:,-&N0>CO1B9C1, 0U#28H%7;J288=G\
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MT\4:'W/P-$T-C$R[,@+3V%K-3D\E"E7O\W.!JJ,?-'E,7HM.]7?4]]B2;)=
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M OWO]MF\X+W.^^, J\3KP\%_9?T_E'^;O3& >H :YH)J/'LA^UHI7>>,YT?
MNIHQ4>UR<%)U"A[:LX^+)XF.*^AC9]FYJ#, MH=S;L0W2*)V9\OB'B)APJ$.
MTUGQ<78ZE=8&<Y/\GIGYYH8Z%X3=O,N[@$UN567@*7TTD3T#GUD--N9IK?]K
MTHG"$<XY-SC1L]OJF(_N5FJO<17C4KP'.$YP*;.Y;?LU1W9QF^!ZO^N#94&/
MY';<A[1Y.4*M1,6Z'A?$7* 'I2.#V2E(MUEE1I!U'T.N5_(\/4FW4'EN.\P
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MFFOG)1'AG)'"97,Q,V'XBGJ5I-G?V N7KEH;]WCL7/+/H'YN7"W0ZONMO>N
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M87 8^"R$'>5)>6YT-2\2^$E7I?G.K<?B!5M5BH$R,I2F7+3L=M4UT(*>F1-
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M]]/;G+L$]XG:_LC;2UD#![QD-RS30JN;$1)S87-O\D/C"B W*YV_< 1^&,@
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M2P$"% ,4    " !LBDE;?._)1QP7   M30$ '0              @ $<*
M8VLP,# Q.#4Y.# W+3(P,C4P-C,P7V-A;"YX;6Q02P$"% ,4    " !LBDE;
M;6X6TMRP  #YEPP '0              @ %S/P  8VLP,# Q.#4Y.# W+3(P
M,C4P-C,P7V1E9BYX;6Q02P$"% ,4    " !LBDE;N<M0HEE% 0"7O!  '0
M            @ &*\   8VLP,# Q.#4Y.# W+3(P,C4P-C,P7VQA8BYX;6Q0
M2P$"% ,4    " !LBDE;3)]_ /ZT  !MO P '0              @ $>-@(
M8VLP,# Q.#4Y.# W+3(P,C4P-C,P7W!R92YX;6Q02P$"% ,4    " !LBDE;
M>J$_KH(<!P"S&D  &               @ %7ZP( 96$P,C4X-3@P+7,Q7W!R
M;V9U<V$N:'1M4$L! A0#%     @ ;(I)6YVN[YVJ"@  :C0  !T
M     ( !#P@* &5A,#(U.#4X,# Q97@M9F5E7W!R;V9U<V$N:'1M4$L! A0#
M%     @ ;(I)6RMC!Q_2 0  L04  !T              ( !]!(* &5A,#(U
M.#4X,# Q97@R,RTQ7W!R;V9U<V$N:'1M4$L! A0#%     @ ;(I)6S5KOSK/
M 0  O@4  !T              ( ! 14* &5A,#(U.#4X,# Q97@R,RTR7W!R
M;V9U<V$N:'1M4$L! A0#%     @ ;(I)6] $P+,@"P  OBX  !P
M     ( !"Q<* &5A,#(U.#4X,# Q97@U+3%?<')O9G5S82YH=&U02P$"% ,4
M    " !LBDE;]>SW_-S&  !'R   #0              @ %E(@H :6UA9V4M
M,# W+FIP9U!+ 0(4 Q0    ( &R*25N9F#.?S#T  %P_   -
M  "  6SI"@!I;6%G95\P,#$N:G!G4$L! A0#%     @ ;(I)6U_OJ:D3Q
M_LT   T              ( !8R<+ &EM86=E7S P,BYJ<&=02P$"% ,4
M" !LBDE;ZMTH0C_J  "K[P  #0              @ &AZPL :6UA9V5?,# S
M+FIP9U!+ 0(4 Q0    ( &R*25MM!&7(5?   .KU   -              "
M 0O6# !I;6%G95\P,#0N:G!G4$L! A0#%     @ ;(I)6\#9)BLW=P$ X'D!
M  T              ( !B\8- &EM86=E7S P-2YJ<&=02P$"% ,4    " !L
MBDE;Q28J?/N$  !?AP  #0              @ 'M/0\ :6UA9V5?,# V+FIP
M9U!+ 0(4 Q0    ( &R*25M&ZN2"T*P   2W   -              "  1/#
M#P!I;6%G95\P,#@N:G!G4$L! A0#%     @ ;(I)6W!?0KCG!0( &PX"  T
M             ( !#G 0 &EM86=E7S P.2YJ<&=02P4&     !, $P#W!
&('82

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>ea0258580-s1_profusa_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ck0001859807="http://www.profusa.com/20250630"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ck0001859807-20250630.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthviewAcquisitionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-12-31</endDate>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:ProfusaAsiaPacificPteLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-28</startDate>
            <endDate>2023-08-28</endDate>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-26</instant>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-26</startDate>
            <endDate>2023-06-26</endDate>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-20</instant>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-20</startDate>
            <endDate>2023-07-20</endDate>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-15</instant>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-15</startDate>
            <endDate>2023-08-15</endDate>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-06</instant>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-06</startDate>
            <endDate>2024-02-06</endDate>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-30</instant>
        </period>
    </context>
    <context id="c207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-30</startDate>
            <endDate>2020-08-30</endDate>
        </period>
    </context>
    <context id="c208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="c211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="c212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <context id="c218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <context id="c219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <context id="c220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-03</instant>
        </period>
    </context>
    <context id="c221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoConvertibleNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesNovember2022AmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-26</instant>
        </period>
    </context>
    <context id="c232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-20</instant>
        </period>
    </context>
    <context id="c233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="c234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AugustTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-06</instant>
        </period>
    </context>
    <context id="c243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyOneSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNotesSeptemberTwoThousandTwentyTwoAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <context id="c255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-03</instant>
        </period>
    </context>
    <context id="c256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NovemberTwoThousandTwentyTwoSeniorNotesAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:DecemberTwoThousandTwentyTwoSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="c260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:MarchTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:MarchTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:MarchTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecemberTwoThousandTwentyThreeSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarchTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJuneTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JulySeptemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JulySeptemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecemberTwoThousandTwentyFourSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:UnrelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:OctoberDecember2024SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-25</instant>
        </period>
    </context>
    <context id="c290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-25</instant>
        </period>
    </context>
    <context id="c291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-01</endDate>
        </period>
    </context>
    <context id="c323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ShortTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ShortTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesC1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001859807:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="c345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="c346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ProfusaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2022-08-16</startDate>
            <endDate>2022-08-16</endDate>
        </period>
    </context>
    <context id="c363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="c364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:ProfusaAsiaPacificPteLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-08</startDate>
            <endDate>2023-08-08</endDate>
        </period>
    </context>
    <context id="c367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2023-06-26</startDate>
            <endDate>2023-06-26</endDate>
        </period>
    </context>
    <context id="c373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2023-07-20</startDate>
            <endDate>2023-07-20</endDate>
        </period>
    </context>
    <context id="c374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2023-08-15</instant>
        </period>
    </context>
    <context id="c375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2023-08-15</startDate>
            <endDate>2023-08-15</endDate>
        </period>
    </context>
    <context id="c376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-04</instant>
        </period>
    </context>
    <context id="c377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-04</startDate>
            <endDate>2024-02-04</endDate>
        </period>
    </context>
    <context id="c378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-02-04</startDate>
            <endDate>2024-02-04</endDate>
        </period>
    </context>
    <context id="c379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-26</instant>
        </period>
    </context>
    <context id="c406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-20</instant>
        </period>
    </context>
    <context id="c407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-15</instant>
        </period>
    </context>
    <context id="c408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ShortTermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="c409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2024SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2024SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:JanuaryMarch2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AprilJune2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-12-31</endDate>
        </period>
    </context>
    <context id="c437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-01-01</startDate>
            <endDate>2011-12-31</endDate>
        </period>
    </context>
    <context id="c438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:TaslyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ck0001859807:ShortTermLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ck0001859807:ShortTermLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewSeriesC1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:SeriesCC1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:SeriesCC1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001859807:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001859807:Plan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:ConvertibleLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ck0001859807:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:SeniorConvertiblesNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:ProfusaPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:NonrecoursePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertiblesNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertiblesNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertibleBridgeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorConvertibleBridgeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SeniorSecuredNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-28</startDate>
            <endDate>2025-07-28</endDate>
        </period>
    </context>
    <context id="c530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-28</instant>
        </period>
    </context>
    <context id="c531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-28</startDate>
            <endDate>2025-07-28</endDate>
        </period>
    </context>
    <context id="c532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-28</instant>
        </period>
    </context>
    <context id="c533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-28</startDate>
            <endDate>2025-07-28</endDate>
        </period>
    </context>
    <context id="c534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-28</startDate>
            <endDate>2025-07-28</endDate>
        </period>
    </context>
    <context id="c535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="c540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:RightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="c545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="c554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-10</instant>
        </period>
    </context>
    <context id="c555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="c556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="c557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="c558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:JuneJulyAndAugustExtensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-10</instant>
        </period>
    </context>
    <context id="c561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-10</instant>
        </period>
    </context>
    <context id="c562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-10</startDate>
            <endDate>2024-09-10</endDate>
        </period>
    </context>
    <context id="c563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="c564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="c565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="c566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="c567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-13</instant>
        </period>
    </context>
    <context id="c568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-23</instant>
        </period>
    </context>
    <context id="c569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:JanuaryExtensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-27</instant>
        </period>
    </context>
    <context id="c571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-27</instant>
        </period>
    </context>
    <context id="c572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-07</instant>
        </period>
    </context>
    <context id="c573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-18</startDate>
            <endDate>2025-03-18</endDate>
        </period>
    </context>
    <context id="c574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-18</instant>
        </period>
    </context>
    <context id="c575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-27</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="c578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleWorkingCapitalPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:USFederalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-16</startDate>
            <endDate>2022-08-16</endDate>
        </period>
    </context>
    <context id="c580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-16</startDate>
            <endDate>2022-08-16</endDate>
        </period>
    </context>
    <context id="c581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-22</startDate>
            <endDate>2023-03-22</endDate>
        </period>
    </context>
    <context id="c582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-21</startDate>
            <endDate>2023-12-21</endDate>
        </period>
    </context>
    <context id="c583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-22</startDate>
            <endDate>2023-03-22</endDate>
        </period>
    </context>
    <context id="c584">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-21</startDate>
            <endDate>2023-12-21</endDate>
        </period>
    </context>
    <context id="c585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-26</startDate>
            <endDate>2024-03-26</endDate>
        </period>
    </context>
    <context id="c586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-26</startDate>
            <endDate>2024-03-26</endDate>
        </period>
    </context>
    <context id="c587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="c589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustAccountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:AssetHeldInTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:AssetHeldInTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="c604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="c605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="c606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="c607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:IBankersAndDawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-20</startDate>
            <endDate>2021-12-20</endDate>
        </period>
    </context>
    <context id="c619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-27</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="c623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:RelatedPartyLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="c630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-19</instant>
        </period>
    </context>
    <context id="c631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-12-19</startDate>
            <endDate>2024-12-19</endDate>
        </period>
    </context>
    <context id="c636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-20</instant>
        </period>
    </context>
    <context id="c642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c664">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ck0001859807:ChiefOperatingOfficerDecisionMakerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-11</instant>
        </period>
    </context>
    <context id="c722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-11</startDate>
            <endDate>2025-02-11</endDate>
        </period>
    </context>
    <context id="c723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-11</startDate>
            <endDate>2025-02-11</endDate>
        </period>
    </context>
    <context id="c724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:DissolutionExpenseWaiverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:NoRedemptionScenarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-21</instant>
        </period>
    </context>
    <context id="c728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-05</startDate>
            <endDate>2025-06-05</endDate>
        </period>
    </context>
    <context id="c729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:ProfusaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-05</instant>
        </period>
    </context>
    <context id="c730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="c731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c732">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-21</startDate>
            <endDate>2023-12-21</endDate>
        </period>
    </context>
    <context id="c735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-21</instant>
        </period>
    </context>
    <context id="c736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-21</instant>
        </period>
    </context>
    <context id="c737">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-31</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="c738">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2024-01-10</startDate>
            <endDate>2024-01-10</endDate>
        </period>
    </context>
    <context id="c739">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c740">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <context id="c742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:JanuaryExtensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-27</instant>
        </period>
    </context>
    <context id="c743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ck0001859807:DepositAxis">ck0001859807:FebruaryExtensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-27</instant>
        </period>
    </context>
    <context id="c744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-07</instant>
        </period>
    </context>
    <context id="c745">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ck0001859807:SpecialMeetingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-18</startDate>
            <endDate>2025-03-18</endDate>
        </period>
    </context>
    <context id="c746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ck0001859807:SpecialMeetingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-18</instant>
        </period>
    </context>
    <context id="c747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c748">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-01</endDate>
        </period>
    </context>
    <context id="c750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-27</startDate>
            <endDate>2025-06-27</endDate>
        </period>
    </context>
    <context id="c751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:DissolutionExpenseWaiverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c752">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-21</instant>
        </period>
    </context>
    <context id="c753">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c754">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertibleWorkingCapitalPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c755">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-26</startDate>
            <endDate>2025-03-26</endDate>
        </period>
    </context>
    <context id="c758">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-26</startDate>
            <endDate>2025-03-26</endDate>
        </period>
    </context>
    <context id="c759">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c760">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c761">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-21</startDate>
            <endDate>2023-12-21</endDate>
        </period>
    </context>
    <context id="c762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="c763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-18</startDate>
            <endDate>2025-03-18</endDate>
        </period>
    </context>
    <context id="c764">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001859807:BusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c766">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c768">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c769">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c771">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c772">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c775">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001859807:CommonStockSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c777">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c778">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c779">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c780">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:IBankersAndDawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c784">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShares1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:FounderShares1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c788">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AscentNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-11</instant>
        </period>
    </context>
    <context id="c790">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:AscentNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-11</startDate>
            <endDate>2025-02-11</endDate>
        </period>
    </context>
    <context id="c791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PIPEConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c792">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:PIPEConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c793">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:RelatedPartyLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c798">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="c800">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-19</instant>
        </period>
    </context>
    <context id="c804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:IBankersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-19</startDate>
            <endDate>2025-01-19</endDate>
        </period>
    </context>
    <context id="c805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:DawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-19</startDate>
            <endDate>2025-01-19</endDate>
        </period>
    </context>
    <context id="c806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="c807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:BankersAndDawsonJamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-19</startDate>
            <endDate>2024-12-19</endDate>
        </period>
    </context>
    <context id="c809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <context id="c810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:CashFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <context id="c811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <context id="c812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:AdvisoryFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <context id="c813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <context id="c814">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <context id="c815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-15</instant>
        </period>
    </context>
    <context id="c816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:ArrangementFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <context id="c817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <context id="c818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:InitialNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-11</instant>
        </period>
    </context>
    <context id="c819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:InitialNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-11</startDate>
            <endDate>2025-02-11</endDate>
        </period>
    </context>
    <context id="c820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-11</instant>
        </period>
    </context>
    <context id="c821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SecondPurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SecondPurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:SecondPurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:NewProfusaCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001859807:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c832">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ck0001859807:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001859807:FounderShares1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-20</instant>
        </period>
    </context>
    <context id="c835">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c838">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c841">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c845">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c846">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c853">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c854">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c855">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ck0001859807:CashAndMarketableSecuritiesHeldInTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ck0001859807:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c861">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c863">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c865">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c867">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c873">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ck0001859807:ConvertiblePromissoryNoteAscentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c878">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c879">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c880">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c884">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c886">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c887">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c888">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c890">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c891">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c892">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c893">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c895">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c897">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ck0001859807:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c898">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c899">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c900">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c907">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-10</instant>
        </period>
    </context>
    <context id="c909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-11</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ck0001859807:BusinessCombinationProfusaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-11</instant>
        </period>
    </context>
    <context id="c916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <context id="c917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001859807:NorthViewAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ck0001859807:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-38565">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-61">PROFUSA, INC.</dei:EntityRegistrantName>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-232">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-240">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-250">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-256">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c1" decimals="-3" id="ixv-38566" unitRef="usd">191000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="-3" id="ixv-38567" unitRef="usd">142000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherReceivables contextRef="c2" decimals="-3" id="ixv-38568" unitRef="usd">45000</us-gaap:OtherReceivables>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c1" decimals="-3" id="ixv-38569" unitRef="usd">69000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c2" decimals="-3" id="ixv-38570" unitRef="usd">146000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c1" decimals="-3" id="ixv-38571" unitRef="usd">260000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="-3" id="ixv-38572" unitRef="usd">333000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" id="ixv-38573" unitRef="usd">2000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DeferredCosts contextRef="c1" decimals="-3" id="ixv-38574" unitRef="usd">2757000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts contextRef="c2" decimals="-3" id="ixv-38575" unitRef="usd">1527000</us-gaap:DeferredCosts>
    <us-gaap:OtherAssetsNoncurrent contextRef="c1" decimals="-3" id="ixv-38576" unitRef="usd">56000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c2" decimals="-3" id="ixv-38577" unitRef="usd">31000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c1" decimals="-3" id="ixv-38578" unitRef="usd">3073000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c2" decimals="-3" id="ixv-38579" unitRef="usd">1893000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c1" decimals="-3" id="ixv-38580" unitRef="usd">4954000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c2" decimals="-3" id="ixv-38581" unitRef="usd">3993000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c1" decimals="-3" id="ixv-38582" unitRef="usd">3968000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-38583" unitRef="usd">2351000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayable contextRef="c3" decimals="-3" id="ixv-38584" unitRef="usd">25056000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="c4" decimals="-3" id="ixv-38585" unitRef="usd">21755000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtCurrent contextRef="c1" decimals="-3" id="ixv-38586" unitRef="usd">45921000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="c2" decimals="-3" id="ixv-38587" unitRef="usd">38185000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:NotesPayable contextRef="c3" decimals="-3" id="ixv-38588" unitRef="usd">850000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c4" decimals="-3" id="ixv-38589" unitRef="usd">801000</us-gaap:NotesPayable>
    <us-gaap:NotesPayableCurrent contextRef="c1" decimals="-3" id="ixv-38590" unitRef="usd">910000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c2" decimals="-3" id="ixv-38591" unitRef="usd">849000</us-gaap:NotesPayableCurrent>
    <ck0001859807:PaycheckProtectionProgramLoan contextRef="c1" decimals="-3" id="ixv-38592" unitRef="usd">1376000</ck0001859807:PaycheckProtectionProgramLoan>
    <ck0001859807:PaycheckProtectionProgramLoan contextRef="c2" decimals="-3" id="ixv-38593" unitRef="usd">1362000</ck0001859807:PaycheckProtectionProgramLoan>
    <us-gaap:LiabilitiesCurrent contextRef="c1" decimals="-3" id="ixv-38594" unitRef="usd">57129000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-38595" unitRef="usd">46740000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="c1" decimals="-3" id="ixv-38596" unitRef="usd">57129000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c2" decimals="-3" id="ixv-38597" unitRef="usd">46740000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c5"
      decimals="4"
      id="ixv-38598"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c6"
      decimals="4"
      id="ixv-38599"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-38600"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c5"
      decimals="INF"
      id="ixv-38601"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-38602"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c6"
      decimals="INF"
      id="ixv-38603"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c6"
      decimals="INF"
      id="ixv-38604"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ixv-38605"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c5" decimals="-3" id="ixv-38606" unitRef="usd">5307000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c6" decimals="-3" id="ixv-38607" unitRef="usd">5307000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c5" decimals="-3" id="ixv-38608" unitRef="usd">5231000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c6" decimals="-3" id="ixv-38609" unitRef="usd">5231000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c7"
      decimals="4"
      id="ixv-38610"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c8"
      decimals="4"
      id="ixv-38611"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c7"
      decimals="INF"
      id="ixv-38612"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c7"
      decimals="INF"
      id="ixv-38613"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ixv-38614"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c8"
      decimals="INF"
      id="ixv-38615"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c8"
      decimals="INF"
      id="ixv-38616"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="ixv-38617"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c7" decimals="-3" id="ixv-38618" unitRef="usd">13815000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c8" decimals="-3" id="ixv-38619" unitRef="usd">13815000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c7" decimals="-3" id="ixv-38620" unitRef="usd">13701000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c8" decimals="-3" id="ixv-38621" unitRef="usd">13701000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c9"
      decimals="3"
      id="ixv-38622"
      unitRef="usdPershares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c10"
      decimals="3"
      id="ixv-38623"
      unitRef="usdPershares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c9"
      decimals="INF"
      id="ixv-38624"
      unitRef="shares">8907893</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c10"
      decimals="INF"
      id="ixv-38625"
      unitRef="shares">8907893</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c9"
      decimals="INF"
      id="ixv-38626"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c10"
      decimals="INF"
      id="ixv-38627"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="ixv-38628"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c10"
      decimals="INF"
      id="ixv-38629"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c9" decimals="-3" id="ixv-38630" unitRef="usd">45062000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c10" decimals="-3" id="ixv-38631" unitRef="usd">45062000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c9" decimals="-3" id="ixv-38632" unitRef="usd">46217000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c10" decimals="-3" id="ixv-38633" unitRef="usd">46217000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c1" decimals="-3" id="ixv-38634" unitRef="usd">65149000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c2" decimals="-3" id="ixv-38635" unitRef="usd">65149000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c1"
      decimals="4"
      id="ixv-38636"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c2"
      decimals="4"
      id="ixv-38637"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c1"
      decimals="INF"
      id="ixv-38638"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c2"
      decimals="INF"
      id="ixv-38639"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c1"
      decimals="INF"
      id="ixv-38640"
      unitRef="shares">5604651</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c2"
      decimals="INF"
      id="ixv-38641"
      unitRef="shares">5604651</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c1"
      decimals="INF"
      id="ixv-38642"
      unitRef="shares">5604651</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-38643"
      unitRef="shares">5604651</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="c1" decimals="-3" id="ixv-38644" unitRef="usd">5753000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="-3" id="ixv-38645" unitRef="usd">5732000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c1" decimals="-3" id="ixv-38646" unitRef="usd">-124958000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" id="ixv-38647" unitRef="usd">-115728000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c1" decimals="-3" id="ixv-38648" unitRef="usd">-119205000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-38649" unitRef="usd">-109996000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c1" decimals="-3" id="ixv-38650" unitRef="usd">3073000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="-3" id="ixv-38651" unitRef="usd">1893000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c22" decimals="-3" id="ixv-38652" unitRef="usd">100000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c23" decimals="-3" id="ixv-38653" unitRef="usd">45000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c22" decimals="-3" id="ixv-38654" unitRef="usd">1608000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c23" decimals="-3" id="ixv-38655" unitRef="usd">2036000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c22" decimals="-3" id="ixv-38656" unitRef="usd">2992000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c23" decimals="-3" id="ixv-38657" unitRef="usd">4079000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c22" decimals="-3" id="ixv-38658" unitRef="usd">4600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c23" decimals="-3" id="ixv-38659" unitRef="usd">6115000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c22" decimals="-3" id="ixv-38660" unitRef="usd">-4500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c23" decimals="-3" id="ixv-38661" unitRef="usd">-6070000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c22" decimals="-3" id="ixv-38662" unitRef="usd">-311000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c23" decimals="-3" id="ixv-38663" unitRef="usd">-22000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseOther contextRef="c22" decimals="-3" id="ixv-38664" unitRef="usd">2400000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="c23" decimals="-3" id="ixv-38665" unitRef="usd">2530000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseNonoperating contextRef="c22" decimals="-3" id="ixv-38666" unitRef="usd">4424000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c23" decimals="-3" id="ixv-38667" unitRef="usd">4283000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherIncome contextRef="c22" decimals="-3" id="ixv-38668" unitRef="usd">5000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c23" decimals="-3" id="ixv-38669" unitRef="usd">94000</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense contextRef="c22" decimals="-3" id="ixv-38670" unitRef="usd">-4730000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c23" decimals="-3" id="ixv-38671" unitRef="usd">-4211000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="-3" id="ixv-38672" unitRef="usd">-9230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c23" decimals="-3" id="ixv-38673" unitRef="usd">-10281000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c22"
      decimals="2"
      id="ixv-38674"
      unitRef="usdPershares">-1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c22"
      decimals="2"
      id="ixv-38675"
      unitRef="usdPershares">-1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c23"
      decimals="2"
      id="ixv-38676"
      unitRef="usdPershares">-1.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c23"
      decimals="2"
      id="ixv-38677"
      unitRef="usdPershares">-1.84</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c22"
      decimals="INF"
      id="ixv-38678"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c22"
      decimals="INF"
      id="ixv-38679"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c23"
      decimals="INF"
      id="ixv-38680"
      unitRef="shares">5600741</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c23"
      decimals="INF"
      id="ixv-38681"
      unitRef="shares">5600741</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="c39"
      decimals="INF"
      id="ixv-38682"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c39" decimals="-3" id="ixv-38683" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c40"
      decimals="INF"
      id="ixv-38684"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c40" decimals="-3" id="ixv-38685" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c41"
      decimals="INF"
      id="ixv-38686"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c41" decimals="-3" id="ixv-38687" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c42"
      decimals="INF"
      id="ixv-38688"
      unitRef="shares">5570901</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c43" decimals="-3" id="ixv-38689" unitRef="usd">5676000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c44" decimals="-3" id="ixv-38690" unitRef="usd">-105447000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c45" decimals="-3" id="ixv-38691" unitRef="usd">-99771000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c49"
      decimals="INF"
      id="ixv-38692"
      unitRef="shares">33750</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c50" decimals="-3" id="ixv-38693" unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c23" decimals="-3" id="ixv-38694" unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c50" decimals="-3" id="ixv-38695" unitRef="usd">33000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c23" decimals="-3" id="ixv-38696" unitRef="usd">33000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c51" decimals="-3" id="ixv-38697" unitRef="usd">-10281000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c23" decimals="-3" id="ixv-38698" unitRef="usd">-10281000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c52"
      decimals="INF"
      id="ixv-38699"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c52" decimals="-3" id="ixv-38700" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c53"
      decimals="INF"
      id="ixv-38701"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c53" decimals="-3" id="ixv-38702" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c54"
      decimals="INF"
      id="ixv-38703"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c54" decimals="-3" id="ixv-38704" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c55"
      decimals="INF"
      id="ixv-38705"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c56" decimals="-3" id="ixv-38706" unitRef="usd">5732000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c57" decimals="-3" id="ixv-38707" unitRef="usd">-115728000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-38708" unitRef="usd">-109996000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c52"
      decimals="INF"
      id="ixv-38709"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c52" decimals="-3" id="ixv-38710" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c53"
      decimals="INF"
      id="ixv-38711"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c53" decimals="-3" id="ixv-38712" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c54"
      decimals="INF"
      id="ixv-38713"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c54" decimals="-3" id="ixv-38714" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c55"
      decimals="INF"
      id="ixv-38715"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c56" decimals="-3" id="ixv-38716" unitRef="usd">5732000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c57" decimals="-3" id="ixv-38717" unitRef="usd">-115728000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-38718" unitRef="usd">-109996000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c62" decimals="-3" id="ixv-38719" unitRef="usd">21000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c22" decimals="-3" id="ixv-38720" unitRef="usd">21000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c63" decimals="-3" id="ixv-38721" unitRef="usd">-9230000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c22" decimals="-3" id="ixv-38722" unitRef="usd">-9230000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c64"
      decimals="INF"
      id="ixv-38723"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c64" decimals="-3" id="ixv-38724" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c65"
      decimals="INF"
      id="ixv-38725"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c65" decimals="-3" id="ixv-38726" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c66"
      decimals="INF"
      id="ixv-38727"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c66" decimals="-3" id="ixv-38728" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c67"
      decimals="INF"
      id="ixv-38729"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c68" decimals="-3" id="ixv-38730" unitRef="usd">5753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c69" decimals="-3" id="ixv-38731" unitRef="usd">-124958000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c1" decimals="-3" id="ixv-38732" unitRef="usd">-119205000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="-3" id="ixv-38733" unitRef="usd">-9230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c23" decimals="-3" id="ixv-38734" unitRef="usd">-10281000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherNoncashExpense contextRef="c22" decimals="-3" id="ixv-38735" unitRef="usd">4424000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense contextRef="c23" decimals="-3" id="ixv-38736" unitRef="usd">4283000</us-gaap:OtherNoncashExpense>
    <ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt contextRef="c22" decimals="-3" id="ixv-38737" unitRef="usd">-311000</ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt>
    <ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt contextRef="c23" decimals="-3" id="ixv-38738" unitRef="usd">-22000</ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c22" decimals="-3" id="ixv-38739" unitRef="usd">-2000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ShareBasedCompensation contextRef="c22" decimals="-3" id="ixv-38740" unitRef="usd">21000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c23" decimals="-3" id="ixv-38741" unitRef="usd">33000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c22" decimals="-3" id="ixv-38742" unitRef="usd">-45000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c23" decimals="-3" id="ixv-38743" unitRef="usd">45000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c22" decimals="-3" id="ixv-38744" unitRef="usd">-77000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c23" decimals="-3" id="ixv-38745" unitRef="usd">64000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c22" decimals="-3" id="ixv-38746" unitRef="usd">25000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c23" decimals="-3" id="ixv-38747" unitRef="usd">1000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c22" decimals="-3" id="ixv-38748" unitRef="usd">645000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c23" decimals="-3" id="ixv-38749" unitRef="usd">533000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c22" decimals="-3" id="ixv-38750" unitRef="usd">1664000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c23" decimals="-3" id="ixv-38751" unitRef="usd">1118000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c22" decimals="-3" id="ixv-38752" unitRef="usd">-2066000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c23" decimals="-3" id="ixv-38753" unitRef="usd">-4402000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c23" decimals="-3" id="ixv-38754" unitRef="usd">2000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c23" decimals="-3" id="ixv-38755" unitRef="usd">-2000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c22" decimals="-3" id="ixv-38756" unitRef="usd">3210000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c23" decimals="-3" id="ixv-38757" unitRef="usd">3235000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c22" decimals="-3" id="ixv-38758" unitRef="usd">16000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c23" decimals="-3" id="ixv-38759" unitRef="usd">1600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromNotesPayable contextRef="c23" decimals="-3" id="ixv-38760" unitRef="usd">375000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfSeniorDebt contextRef="c22" decimals="-3" id="ixv-38761" unitRef="usd">150000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c23" decimals="-3" id="ixv-38762" unitRef="usd">151000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <ck0001859807:PaymentOfDeferredOfferingCosts contextRef="c22" decimals="-3" id="ixv-38763" unitRef="usd">961000</ck0001859807:PaymentOfDeferredOfferingCosts>
    <ck0001859807:PaymentOfDeferredOfferingCosts contextRef="c23" decimals="-3" id="ixv-38764" unitRef="usd">614000</ck0001859807:PaymentOfDeferredOfferingCosts>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c23" decimals="-3" id="ixv-38765" unitRef="usd">23000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c22" decimals="-3" id="ixv-38766" unitRef="usd">2115000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c23" decimals="-3" id="ixv-38767" unitRef="usd">4468000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c22" decimals="-3" id="ixv-38768" unitRef="usd">49000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c23" decimals="-3" id="ixv-38769" unitRef="usd">64000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="-3" id="ixv-38770" unitRef="usd">142000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c45" decimals="-3" id="ixv-38771" unitRef="usd">78000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c1" decimals="-3" id="ixv-38772" unitRef="usd">191000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="-3" id="ixv-38773" unitRef="usd">142000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts contextRef="c22" decimals="-3" id="ixv-38774" unitRef="usd">269000</ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts>
    <ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts contextRef="c23" decimals="-3" id="ixv-38775" unitRef="usd">72000</ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c22" id="ixv-20148">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;1 &#x2014;&#160;Organization, Description of Business,
Going Concern and Significant Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Description of Business&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Profusa, Inc. (the &#x201c;Company&#x201d;)
was incorporated in the state of California on May&#160;11, 2009. The Company engaged in the development of a new generation of biointegrated
sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s technology
enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable,
clinical-grade data for personal and medical use. The Company&#x2019;s first offering in the European Union, the Lumee&#x2122; Oxygen Platform,
is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee&#x2122; Oxygen
Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease
that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores)
that do not heal properly; and reconstructive surgery.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s research
and development efforts are primarily focused on its Lumee&#x2122; Glucose Platform which is a system designed to monitor glucose levels
in interstitial fluid, continuously and long-term. A tiny, biocompatible gel injected under the skin acts as a continuous glucose monitor
(CGM) for several&#160;months. The&#160;ability of Lumee&#x2122; Glucose to provide continuous glucose monitoring with only an initial
single injection, is an attractive alternative for people with diabetes to manage their disease without the need for frequent finger sticks
required by standard glucometers, or the need for weekly sensor replacement as required by current short-term needle-type CGMs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;6, 2022, the
Company&#x2019;s board of directors unanimously approved the pursuit of a business combination transaction involving the Company. On November&#160;7,
2022, the Company entered into an Agreement and Plan of Merger (&#x201c;Merger&#x201d;) with NorthView Acquisition Corp (&#x201c;NorthView&#x201d;),
where a subsidiary of NorthView will merge with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On February 11, 2025, the parties
to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the &#x201c;Amendment&#x201d;) pursuant to which the parties
agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received by Profusa
prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment (i) revised
the definition of &#x201c;Milestone Event III&#x201d; such that the parties extended the period for Profusa to consummate the APAC Joint
Venture (as defined in the Merger Agreement) and receive the related funding from December 31, 2024 until December 31, 2025, and (ii)
revised the definition of &#x201c;Milestone Event IV&#x201d; to change the earnout revenue target from $99,702,000 for the fiscal year ended
December 31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December 31, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In relation to Milestone Event
III: On August&#160;8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (&#x201c;APAC&#x201d;), was created and incorporated
by the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $1,000 for 1,000&#160;Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (&#x201c;Tasly&#x201d;)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the &#x201c;APAC Joint
Venture&#x201d;) setting forth the relative and other terms under which the development and business activities of the entity will be conducted.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Going Concern&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has incurred significant
net operating losses from operations. As of December&#160;31, 2024, the Company has a working capital deficit of approximately $56.9&#160;million.
For the year ended December&#160;31, 2024, the Company incurred a net loss of approximately $9.2&#160;million and used approximately $2.1&#160;million
of cash in operating activities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has been able to
finance its operations primarily with the proceeds from the issuance of equity and debt instruments and to a lesser extent, revenues from
government grants. Additional funds may be necessary to maintain current operations and will be required for successful product commercialization
efforts. The Company&#x2019;s management plans to obtain additional funds through the merger with a special purpose acquisition company
(&#x201c;SPAC&#x201d;), issuance of additional equity or refinancing of current debt, which is intended to mitigate the relevant conditions
or events that raise substantial doubt about the Company&#x2019;s ability to continue as a going&#160;concern within one year from the
date the consolidated financial statements are issued. As the ability to refinance its current debt or raise additional equity financing
is outside of management&#x2019;s control, the Company cannot conclude that management&#x2019;s plans will be effectively implemented within
one year from the date the consolidated financial statements are issued. These factors raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern within one year from the date the consolidated financial statements are issued. The consolidated
financial statements do not contain any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Significant Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company operates in a dynamic
and highly competitive industry and believes that changes in any of the following areas could have a material adverse effect on the Company&#x2019;s
future financial position, results of operations, or cash flows: ability to obtain future financing; advances and trends in new technologies
and industry standards; results of clinical trials; regulatory approval and market acceptance of the Company&#x2019;s products; development
of sales channels; certain strategic relationships; litigation or claims against the Company based on intellectual property, patent, product,
regulatory, or other factors; and the Company&#x2019;s ability to attract and retain employees necessary to support its growth.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Products developed by the Company
require approvals from the U.S.&#160;Food and Drug Administration (&#x201c;FDA&#x201d;) or other international regulatory agencies prior
to commercial sales. There can be no assurance that the products will receive the necessary approvals. If the Company is denied approval,
approval is delayed or the Company is unable to maintain approval, it could have a materially adverse impact on the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has expended and
will continue to expend substantial funds to complete the research, development and clinical testing of product candidates. The Company
also will be required to expend additional funds to establish commercial-scale manufacturing arrangements and to provide for the marketing
and distribution of products that receive regulatory approval. The Company will require additional funds to commercialize its products.
The Company is unable to entirely fund these efforts with its current financial resources. If adequate funds are unavailable on a timely
basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more
of its research or development programs which would materially and adversely affect its business, financial condition and results of operations.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <ck0001859807:RevenueTarget contextRef="c175" decimals="0" id="ixv-38776" unitRef="usd">99702000</ck0001859807:RevenueTarget>
    <ck0001859807:RevenueTarget contextRef="c176" decimals="0" id="ixv-38777" unitRef="usd">11864000</ck0001859807:RevenueTarget>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c177" decimals="0" id="ixv-38778" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c177"
      decimals="0"
      id="ixv-38779"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ck0001859807:WorkingCapitalDeficit contextRef="c1" decimals="-5" id="ixv-38780" unitRef="usd">56900000</ck0001859807:WorkingCapitalDeficit>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="-5" id="ixv-38781" unitRef="usd">-9200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c22" decimals="-5" id="ixv-38782" unitRef="usd">-2100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c22" id="ixv-20215">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;2 &#x2014;&#160;Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying consolidated
financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States of America
(&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;)
and include all adjustments necessary for the fair presentation of the Company&#x2019;s financial position as of December&#160;31, 2024
and 2023, and the results of operations and cash flows for the&#160;years then ended. The accompanying consolidated financial statements
include the accounts of Profusa Inc. and its wholly owned subsidiary, APAC.&#160;All intercompany balances and transactions have been
eliminated in consolidation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of consolidated
financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses in
the consolidated financial statements and accompanying notes. The Company&#x2019;s management regularly assesses these estimates, including
those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance for deferred tax assets,
and valuation of stock-based awards. Actual results could differ from these estimates, and such differences could be material to the Company&#x2019;s
financial position and results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Accounts Receivable and Allowance for Credit Losses&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company does not have any
accounts receivable with customers in the years ended December 31, 2024 and 2023. The Company has developed policies that when accounts
receivables are held with customers, they are recorded at the point in time in which management determines it is probable that the Company
will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services transferred to
the customer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of December 31, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#x2019;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s other receivables
are represented by amounts owned by two government agencies under the government grants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all highly
liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of December&#160;31, 2024
and 2023, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Deferred Offering Costs&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of securities,
all of the costs are expensed. Offering costs capitalized as of December&#160;31, 2024 and December&#160;31, 2023 were $2.8&#160;million
and $1.5&#160;million, respectively. The deferred offering costs as of December 31, 2024 and 2023 includes $0.8 million and $0, respectively,
of advances to NorthView to fund costs associated with the business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Share-Based Compensation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for
share-based compensation arrangements with employees and non-employees using a fair value method which requires the recognition of
compensation expense for costs related to all share-based payments including stock options. The fair value method requires the
Company to estimate the fair value of share-based payment awards on the date of grant using an option pricing model. The Company
uses the Black-Scholes pricing model to estimate the fair value of options granted that are then expensed on a straight-line basis
over the vesting period. The Company accounts for forfeitures as they occur. Option valuation models, including the Black-Scholes
option-pricing model, require the input of highly subjective assumptions, and changes in the assumptions used can materially affect
the grant-date fair value of an award. These assumptions include the risk-free rate of interest, expected dividend yield, expected
volatility, and the expected life of the award.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Convertible Preferred Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company records all shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The convertible preferred
stock is recorded outside of permanent equity because while it is not mandatorily redeemable, in certain events considered not solely
within the Company&#x2019;s control, such as a merger, acquisition, or sale of all or substantially all of the Company&#x2019;s assets (each,
a &#x201c;deemed liquidation event&#x201d;), the convertible preferred stock will become redeemable at the option of the holders of at least
a majority of the then outstanding preferred shares. The Company has not adjusted the carrying values of the convertible preferred stock
to its liquidation preference because a deemed liquidation event obligating the Company to pay the liquidation preferences to holders
of shares of convertible preferred stock is not probable of occurring. Subsequent adjustments to the carrying values to the liquidation
preferences will be made only when it becomes probable that such a deemed liquidation event will occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Government Grants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company receives payments
from government entities under non-refundable grants in support of our product development programs. The grants received fall within two
categories:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expense Reimbursement Grants&#160;&#x2014;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fixed Fee Grants&#160;&#x2014;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non-exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as we are a business entity, and the grants are with governmental agencies
or units.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In absence of explicit U.S.
GAAP guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#x201c;IAS
20&#x201d;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method
the Company recognizes grant income using the same proportion as the costs incurred to date to the total expected cost of the project,
but limiting the income to be recognized to the amount to which it is entitled based on the submitted deliverables.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s financial instruments consist
primarily of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company states
accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. The
promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June 2023-February
2024 (Notes 3 and 5) carried at fair value based on unobservable market inputs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Research and Development&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Research and development expenses
consist of costs related to employee compensation and benefits, costs for contract manufacturing organizations (&#x201c;CMOs&#x201d;), costs
for contract research organizations (&#x201c;CROs&#x201d;), costs for sponsored research, costs for clinical trials, consultant services,
laboratory supplies, product licenses, facility-related expenses and depreciation. All research and development costs are charged to research
and development expenses within the statements of operations as incurred. Payments associated with licensing agreements to acquire exclusive
licenses to develop, use, manufacture and commercialize products that have not reached technological feasibility and do not have alternate
commercial use are also expensed as incurred. Payments made to third parties under these arrangements in advance of the performance of
the related services by the third parties are recorded as prepaid expenses until the services are rendered.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income
taxes using the asset and liability method whereby deferred tax asset and liability accounts are determined based on differences between
financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are for the year
in which the differences are expected to affect taxable income. Valuation allowances are established where necessary to reduce deferred
tax assets to the amounts expected to be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for uncertain
tax positions by assessing all material positions taken in any assessment or challenge by relevant taxing authorities. Assessing an uncertain
tax position begins with the initial determination of the position&#x2019;s sustainability and is measured at the largest amount of benefit
that is greater than fifty percent likely of being realized upon ultimate settlement. The Company&#x2019;s policy is to recognize interest
and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. The Company recognizes interest
and penalties related to unrecognized tax benefits within the income tax expense line. Accrued interest and penalties are included within
the Accrued liabilities in the balance sheets. To date, there have been no interest or penalties charged in relation to the unrecognized
tax benefits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Net Loss per Share Attributable to Common Stockholders&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Basic net loss per common
share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock
outstanding during the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing
the net loss attributable to common stockholders by the weighted-average number of shares of common stock and potentially dilutive securities
outstanding for the period. For purposes of the diluted net loss per share calculation, the convertible preferred stock, common stock
subject to repurchase and stock options are considered to be potentially dilutive securities. Basic and diluted net loss attributable
to common stockholders per share is presented in conformity with the two-class method required for participating securities as the convertible
preferred stock is considered a participating security. The Company&#x2019;s participating securities do not have a contractual obligation
to share in the Company&#x2019;s losses. As such, the net loss is attributed entirely to common stockholders. Because the Company has reported
a net loss for the reporting periods presented, the diluted net loss per common share is the same as basic net loss per common share for
those periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the year ended December 31, 2024 and through the date of issuance of these consolidated
financial statements, there have been no new, or existing, recently issued accounting pronouncements that are of significance, or potential
significance, that impact the Company&#x2019;s consolidated financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recently issued accounting standards as adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB issued
ASU 2020-06, Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#160;&#x2014;&#160;Contracts
in Entity&#x2019;s Own Equity (Subtopic 815-40)&#160;&#x2014;&#160;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s
Own Equity (&#x201c;ASU 2020-06&#x201d;). ASU 2020-06 reduces the number of accounting models for convertible debt instruments and redeemable
convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives
under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded
conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered
in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging&#160;&#x2014;&#160;Contracts in Entity&#x2019;s
Own Equity, and clarifies the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related
to the disclosures and earnings per-share (EPS) for convertible instruments and contracts in an entity&#x2019;s own equity. For private
companies, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. The Company early adopted the standard in prior years, which did not have a material impact on its consolidated financial statements
and related disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2023, the
FASB issued ASU&#160;2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures, requiring public entities
to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis.
Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing
segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. The Company adopted ASU 2023-07 effective
December 31, 2024, on a retrospective basis. The adoption of 2023-07 did not change the way that the Company identifies its reportable
segment. However, it has resulted in incremental disclosures within the notes of the Company&#x2019;s consolidated financial statements
(Note 14).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recently issued accounting standards not yet adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#x201c;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#x201d;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU 2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early adoption permitted and can be
applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine its impact on our income
tax disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November 2024, the FASB
issued ASU No. 2024-03 (&#x201c;ASU 2024-03&#x201d;), Disaggregation of Income Statement Expenses (&#x201c;DISE&#x201d;). ASU 2024-03 requires
disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an
entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories
in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement&#160;&#x2014;&#160;Reporting
Comprehensive Income&#160;&#x2014;&#160;Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years
beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted.
With the exception of expanding disclosures to include more granular income statement expense categories, the Company does not expect
the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements taken as a whole.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c22" id="ixv-20220">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying consolidated
financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States of America
(&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;)
and include all adjustments necessary for the fair presentation of the Company&#x2019;s financial position as of December&#160;31, 2024
and 2023, and the results of operations and cash flows for the&#160;years then ended. The accompanying consolidated financial statements
include the accounts of Profusa Inc. and its wholly owned subsidiary, APAC.&#160;All intercompany balances and transactions have been
eliminated in consolidation.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c22" id="ixv-20255">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of consolidated
financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses in
the consolidated financial statements and accompanying notes. The Company&#x2019;s management regularly assesses these estimates, including
those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance for deferred tax assets,
and valuation of stock-based awards. Actual results could differ from these estimates, and such differences could be material to the Company&#x2019;s
financial position and results of operations.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c22" id="ixv-20263">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Accounts Receivable and Allowance for Credit Losses&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company does not have any
accounts receivable with customers in the years ended December 31, 2024 and 2023. The Company has developed policies that when accounts
receivables are held with customers, they are recorded at the point in time in which management determines it is probable that the Company
will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services transferred to
the customer.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of December 31, 2024 and 2023.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c22" id="ixv-20274">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#x2019;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s other receivables
are represented by amounts owned by two government agencies under the government grants.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c22" id="ixv-20285">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all highly
liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of December&#160;31, 2024
and 2023, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c22" id="ixv-20293">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Deferred Offering Costs&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of securities,
all of the costs are expensed. Offering costs capitalized as of December&#160;31, 2024 and December&#160;31, 2023 were $2.8&#160;million
and $1.5&#160;million, respectively. The deferred offering costs as of December 31, 2024 and 2023 includes $0.8 million and $0, respectively,
of advances to NorthView to fund costs associated with the business combination.&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:CapitalizedContractCostNetCurrent contextRef="c1" decimals="-5" id="ixv-38783" unitRef="usd">2800000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent contextRef="c2" decimals="-5" id="ixv-38784" unitRef="usd">1500000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:DeferredOfferingCosts contextRef="c1" decimals="-5" id="ixv-38785" unitRef="usd">800000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts contextRef="c2" decimals="-6" id="ixv-38786" unitRef="usd">0</us-gaap:DeferredOfferingCosts>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c22" id="ixv-20301">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Share-Based Compensation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for
share-based compensation arrangements with employees and non-employees using a fair value method which requires the recognition of
compensation expense for costs related to all share-based payments including stock options. The fair value method requires the
Company to estimate the fair value of share-based payment awards on the date of grant using an option pricing model. The Company
uses the Black-Scholes pricing model to estimate the fair value of options granted that are then expensed on a straight-line basis
over the vesting period. The Company accounts for forfeitures as they occur. Option valuation models, including the Black-Scholes
option-pricing model, require the input of highly subjective assumptions, and changes in the assumptions used can materially affect
the grant-date fair value of an award. These assumptions include the risk-free rate of interest, expected dividend yield, expected
volatility, and the expected life of the award.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Convertible Preferred Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company records all shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The convertible preferred
stock is recorded outside of permanent equity because while it is not mandatorily redeemable, in certain events considered not solely
within the Company&#x2019;s control, such as a merger, acquisition, or sale of all or substantially all of the Company&#x2019;s assets (each,
a &#x201c;deemed liquidation event&#x201d;), the convertible preferred stock will become redeemable at the option of the holders of at least
a majority of the then outstanding preferred shares. The Company has not adjusted the carrying values of the convertible preferred stock
to its liquidation preference because a deemed liquidation event obligating the Company to pay the liquidation preferences to holders
of shares of convertible preferred stock is not probable of occurring. Subsequent adjustments to the carrying values to the liquidation
preferences will be made only when it becomes probable that such a deemed liquidation event will occur.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Government Grants&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company receives payments
from government entities under non-refundable grants in support of our product development programs. The grants received fall within two
categories:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expense Reimbursement Grants&#160;&#x2014;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fixed Fee Grants&#160;&#x2014;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non-exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as we are a business entity, and the grants are with governmental agencies
or units.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In absence of explicit U.S.
GAAP guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#x201c;IAS
20&#x201d;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method
the Company recognizes grant income using the same proportion as the costs incurred to date to the total expected cost of the project,
but limiting the income to be recognized to the amount to which it is entitled based on the submitted deliverables.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;The Company&#x2019;s financial instruments consist
primarily of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company states
accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. The
promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <ck0001859807:ConvertiblePreferredStockPolicyTextBlock contextRef="c22" id="ixv-20335">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Convertible Preferred Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company records all shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The convertible preferred
stock is recorded outside of permanent equity because while it is not mandatorily redeemable, in certain events considered not solely
within the Company&#x2019;s control, such as a merger, acquisition, or sale of all or substantially all of the Company&#x2019;s assets (each,
a &#x201c;deemed liquidation event&#x201d;), the convertible preferred stock will become redeemable at the option of the holders of at least
a majority of the then outstanding preferred shares. The Company has not adjusted the carrying values of the convertible preferred stock
to its liquidation preference because a deemed liquidation event obligating the Company to pay the liquidation preferences to holders
of shares of convertible preferred stock is not probable of occurring. Subsequent adjustments to the carrying values to the liquidation
preferences will be made only when it becomes probable that such a deemed liquidation event will occur.&lt;/p&gt;</ck0001859807:ConvertiblePreferredStockPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c22" id="ixv-20345">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Government Grants&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company receives payments
from government entities under non-refundable grants in support of our product development programs. The grants received fall within two
categories:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expense Reimbursement Grants&#160;&#x2014;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fixed Fee Grants&#160;&#x2014;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non-exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as we are a business entity, and the grants are with governmental agencies
or units.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In absence of explicit U.S.
GAAP guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#x201c;IAS
20&#x201d;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method
the Company recognizes grant income using the same proportion as the costs incurred to date to the total expected cost of the project,
but limiting the income to be recognized to the amount to which it is entitled based on the submitted deliverables.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c22" id="ixv-20379">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s financial instruments consist
primarily of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company states
accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. The
promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June 2023-February
2024 (Notes 3 and 5) carried at fair value based on unobservable market inputs.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c22" id="ixv-20413">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Research and Development&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Research and development expenses
consist of costs related to employee compensation and benefits, costs for contract manufacturing organizations (&#x201c;CMOs&#x201d;), costs
for contract research organizations (&#x201c;CROs&#x201d;), costs for sponsored research, costs for clinical trials, consultant services,
laboratory supplies, product licenses, facility-related expenses and depreciation. All research and development costs are charged to research
and development expenses within the statements of operations as incurred. Payments associated with licensing agreements to acquire exclusive
licenses to develop, use, manufacture and commercialize products that have not reached technological feasibility and do not have alternate
commercial use are also expensed as incurred. Payments made to third parties under these arrangements in advance of the performance of
the related services by the third parties are recorded as prepaid expenses until the services are rendered.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c22" id="ixv-20421">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income
taxes using the asset and liability method whereby deferred tax asset and liability accounts are determined based on differences between
financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are for the year
in which the differences are expected to affect taxable income. Valuation allowances are established where necessary to reduce deferred
tax assets to the amounts expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for uncertain
tax positions by assessing all material positions taken in any assessment or challenge by relevant taxing authorities. Assessing an uncertain
tax position begins with the initial determination of the position&#x2019;s sustainability and is measured at the largest amount of benefit
that is greater than fifty percent likely of being realized upon ultimate settlement. The Company&#x2019;s policy is to recognize interest
and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. The Company recognizes interest
and penalties related to unrecognized tax benefits within the income tax expense line. Accrued interest and penalties are included within
the Accrued liabilities in the balance sheets. To date, there have been no interest or penalties charged in relation to the unrecognized
tax benefits.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c22" id="ixv-20432">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Net Loss per Share Attributable to Common Stockholders&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Basic net loss per common
share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock
outstanding during the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing
the net loss attributable to common stockholders by the weighted-average number of shares of common stock and potentially dilutive securities
outstanding for the period. For purposes of the diluted net loss per share calculation, the convertible preferred stock, common stock
subject to repurchase and stock options are considered to be potentially dilutive securities. Basic and diluted net loss attributable
to common stockholders per share is presented in conformity with the two-class method required for participating securities as the convertible
preferred stock is considered a participating security. The Company&#x2019;s participating securities do not have a contractual obligation
to share in the Company&#x2019;s losses. As such, the net loss is attributed entirely to common stockholders. Because the Company has reported
a net loss for the reporting periods presented, the diluted net loss per common share is the same as basic net loss per common share for
those periods.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c22" id="ixv-20440">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the year ended December 31, 2024 and through the date of issuance of these consolidated
financial statements, there have been no new, or existing, recently issued accounting pronouncements that are of significance, or potential
significance, that impact the Company&#x2019;s consolidated financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recently issued accounting standards as adopted&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB issued
ASU 2020-06, Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#160;&#x2014;&#160;Contracts
in Entity&#x2019;s Own Equity (Subtopic 815-40)&#160;&#x2014;&#160;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s
Own Equity (&#x201c;ASU 2020-06&#x201d;). ASU 2020-06 reduces the number of accounting models for convertible debt instruments and redeemable
convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives
under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded
conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered
in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging&#160;&#x2014;&#160;Contracts in Entity&#x2019;s
Own Equity, and clarifies the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related
to the disclosures and earnings per-share (EPS) for convertible instruments and contracts in an entity&#x2019;s own equity. For private
companies, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. The Company early adopted the standard in prior years, which did not have a material impact on its consolidated financial statements
and related disclosures.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2023, the
FASB issued ASU&#160;2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures, requiring public entities
to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis.
Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing
segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. The Company adopted ASU 2023-07 effective
December 31, 2024, on a retrospective basis. The adoption of 2023-07 did not change the way that the Company identifies its reportable
segment. However, it has resulted in incremental disclosures within the notes of the Company&#x2019;s consolidated financial statements
(Note 14).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recently issued accounting standards not yet adopted&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#x201c;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#x201d;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU 2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early adoption permitted and can be
applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine its impact on our income
tax disclosures.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November 2024, the FASB
issued ASU No. 2024-03 (&#x201c;ASU 2024-03&#x201d;), Disaggregation of Income Statement Expenses (&#x201c;DISE&#x201d;). ASU 2024-03 requires
disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an
entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories
in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement&#160;&#x2014;&#160;Reporting
Comprehensive Income&#160;&#x2014;&#160;Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years
beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted.
With the exception of expanding disclosures to include more granular income statement expense categories, the Company does not expect
the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements taken as a whole.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c22" id="ixv-20518">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;3 &#x2014;&#160;Fair Value Measurement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Assets and liabilities recorded
at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used
to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize
the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes
a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;1&#160;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;2&#160;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;3&#160;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In determining fair value,
the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the
extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Assets and liabilities measured
at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The
Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management
to make judgments and consider factors specific to the asset or liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the Company had no financial assets measured at fair value on a recurring basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the Company&#x2019;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-193"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-194"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-195"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-196"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of December&#160;31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-197"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-198"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Total assets measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-199"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-200"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the changes in the fair value of the Company&#x2019;s Level&#160;3 financial instruments for the&#160;years ended December&#160;31,
2024 and 2023 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; convertible &lt;br/&gt; debt at fair &lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value as of January&#160;1, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-201"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Issuance of Convertible Notes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Fair value as of December&#160;31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value as of January&#160;1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Issuance of Convertible Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;194&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Fair value as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company elected to measure
its Tasly convertible debt at fair value (Note&#160;5) with changes in fair value reported in earnings as they occur. The Convertible
Debt fair values were determined using the discounted cash flow methodology based on probability weighted scenarios of the convertible
notes conversion. At issuance of the first $1&#160;million on June&#160;26, 2023 the time to event was 0.28&#160;years and the discount
rate applied was 14.54%. At issuance of the next $0.3&#160;million on July&#160;20, 2023, the time to event was 0.22&#160;years and the
discount rate applied was 13.82%. At issuance of the additional $0.3&#160;million on August&#160;15, 2023, the time to event was 0.15&#160;years
and the discount rate applied was 13.70%. The final amount which was less than $0.02 million was issued on February 6, 2024; the time
to event was 0.66 years and the discount rate applied was 13.69%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;31, 2024
the time event was 0.41&#160;years and the discount rate applied was 11.78%. The fair value of the convertible debt as of December&#160;31,
2023 was $1.71&#160;million and the fair value as of December&#160;31, 2024 was $2.2 million.&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="c22" id="ixv-20558">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the Company&#x2019;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-193"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-194"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-195"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-196"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of December&#160;31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level&#160;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-197"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-198"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Total assets measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-199"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-200"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c191"
      decimals="-3"
      id="ixv-38788"
      unitRef="usd">2235000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c192"
      decimals="-3"
      id="ixv-38789"
      unitRef="usd">2235000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c191"
      decimals="-3"
      id="ixv-38790"
      unitRef="usd">2235000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c192"
      decimals="-3"
      id="ixv-38791"
      unitRef="usd">2235000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c195"
      decimals="-3"
      id="ixv-38792"
      unitRef="usd">1714000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c196"
      decimals="-3"
      id="ixv-38793"
      unitRef="usd">1714000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c195"
      decimals="-3"
      id="ixv-38794"
      unitRef="usd">1714000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c196"
      decimals="-3"
      id="ixv-38795"
      unitRef="usd">1714000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c22" id="ixv-20741">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the changes in the fair value of the Company&#x2019;s Level&#160;3 financial instruments for the&#160;years ended December&#160;31,
2024 and 2023 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; convertible &lt;br/&gt; debt at fair &lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value as of January&#160;1, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-201"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Issuance of Convertible Notes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Fair value as of December&#160;31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value as of January&#160;1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Issuance of Convertible Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;194&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Fair value as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c198"
      decimals="-3"
      id="ixv-38796"
      unitRef="usd">1600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest
      contextRef="c198"
      decimals="-3"
      id="ixv-38797"
      unitRef="usd">92000</ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="c198"
      decimals="-3"
      id="ixv-38798"
      unitRef="usd">22000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c199"
      decimals="-3"
      id="ixv-38799"
      unitRef="usd">1714000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c199"
      decimals="-3"
      id="ixv-38800"
      unitRef="usd">1714000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c200"
      decimals="-3"
      id="ixv-38801"
      unitRef="usd">16000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest
      contextRef="c200"
      decimals="-3"
      id="ixv-38802"
      unitRef="usd">194000</ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="c200"
      decimals="-3"
      id="ixv-38803"
      unitRef="usd">311000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c201"
      decimals="-3"
      id="ixv-38804"
      unitRef="usd">2235000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c178"
      decimals="-6"
      id="ixv-38805"
      unitRef="usd">1000000</us-gaap:ConvertibleNotesPayable>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c179" id="ixv-38806">P0Y3M10D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c179"
      decimals="4"
      id="ixv-38807"
      unitRef="pure">0.1454</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c180"
      decimals="-5"
      id="ixv-38808"
      unitRef="usd">300000</us-gaap:ConvertibleNotesPayable>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c181" id="ixv-38809">P0Y2M19D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c181"
      decimals="4"
      id="ixv-38810"
      unitRef="pure">0.1382</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c182"
      decimals="-5"
      id="ixv-38811"
      unitRef="usd">300000</us-gaap:ConvertibleNotesPayable>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c183" id="ixv-38812">P0Y1M24D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c183"
      decimals="4"
      id="ixv-38813"
      unitRef="pure">0.137</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c184"
      decimals="-4"
      id="ixv-38814"
      unitRef="usd">20000.00</us-gaap:ConvertibleNotesPayable>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c185" id="ixv-38815">P0Y7M28D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c185"
      decimals="4"
      id="ixv-38816"
      unitRef="pure">0.1369</ck0001859807:ConvertibleDebtOfDiscountRate>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c186" id="ixv-38817">P0Y4M28D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c186"
      decimals="4"
      id="ixv-38818"
      unitRef="pure">0.1178</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c187"
      decimals="-4"
      id="ixv-38819"
      unitRef="usd">1710000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ShorttermDebtFairValue
      contextRef="c188"
      decimals="-5"
      id="ixv-38820"
      unitRef="usd">2200000</us-gaap:ShorttermDebtFairValue>
    <srt:CondensedFinancialStatementsTextBlock contextRef="c22" id="ixv-20828">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;4 &#x2014;&#160;Balance Sheet Components&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Prepaid expenses and other current assets (in
thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Employee advances&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-202"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;96&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prepaid legal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-203"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Prepaid insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-204"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Accrued Liabilities (in thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Accrued compensation&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(3,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,960&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued other liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(496&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(391&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(3,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,351&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:CondensedFinancialStatementsTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c22" id="ixv-20833">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Prepaid expenses and other current assets (in
thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Employee advances&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-202"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;96&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prepaid legal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-203"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Prepaid insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-204"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:AdvanceRoyalties contextRef="c2" decimals="-3" id="ixv-38821" unitRef="usd">96000</us-gaap:AdvanceRoyalties>
    <ck0001859807:PrepaidLegal contextRef="c1" decimals="-3" id="ixv-38822" unitRef="usd">25000</ck0001859807:PrepaidLegal>
    <us-gaap:PrepaidInsurance contextRef="c1" decimals="-3" id="ixv-38823" unitRef="usd">37000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c1" decimals="-3" id="ixv-38824" unitRef="usd">7000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c2" decimals="-3" id="ixv-38825" unitRef="usd">50000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c1" decimals="-3" id="ixv-38826" unitRef="usd">69000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c2" decimals="-3" id="ixv-38827" unitRef="usd">146000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c22" id="ixv-20933">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Accrued Liabilities (in thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Accrued compensation&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(3,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,960&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued other liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(496&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(391&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(3,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,351&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c1" decimals="-3" id="ixv-38828" unitRef="usd">3472000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c2" decimals="-3" id="ixv-38829" unitRef="usd">1960000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c1" decimals="-3" id="ixv-38830" unitRef="usd">496000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-38831" unitRef="usd">391000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c1" decimals="-3" id="ixv-38832" unitRef="usd">3968000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c2" decimals="-3" id="ixv-38833" unitRef="usd">2351000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:DebtDisclosureTextBlock contextRef="c22" id="ixv-20985">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;5 &#x2014;&#160;Debt&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the debt instruments (which are all classified as current liabilities in the accompanying consolidated balance sheets and
their changes during the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Promissory &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;PPP &lt;br/&gt; Loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;Balance at January 1, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-205"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15,149&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;576&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-206"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;375&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-207"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-208"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-209"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-210"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(151&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-211"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-212"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-213"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-214"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-215"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;515&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-216"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-217"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-218"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;849&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance at January 1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;16,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;849&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-219"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-220"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-221"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-222"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-223"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(150&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-224"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-225"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-226"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;311&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-227"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-228"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-229"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,053&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-230"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-231"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-233"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balance at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;910&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;910&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Long term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-234"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-235"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-236"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-238"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Convertible Debt&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Convertible Notes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;August&#160;2020 Convertible
Notes&lt;/i&gt;&#160;&#x2014;&#160;In August, September, October and December&#160;2020 the Company received $9.1&#160;million in total gross
proceeds from the issuance of convertible promissory notes (the &#x201c;2020 Convertible Notes&#x201d;). Interest on the unpaid principal
balance of the August&#160;2020 Convertible Notes accrues from the issuance date at a rate of 12% per year, compounded semi-annually,
and is payable at maturity. Unless converted or redeemed upon the occurrence of certain events, the August&#160;2020 Convertible Notes
were to mature within 12&#160;months of issuance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Upon the consummation of an equity financing with
aggregate proceeds to the Company of no less than $20.0&#160;million (the &#x201c;Qualified Financing&#x201d;), the notes&#x2019; outstanding
principal balance and accrued but unpaid interest are to convert into the shares of convertible preferred stock issued in such a Qualified
Financing at a conversion price equal to the lesser of (i)&#160;the per share price obtained by dividing $150.0&#160;million by the Company&#x2019;s
fully diluted capitalization, or (ii)&#160;the per share price paid by investors in the Qualified Financing, subject to 30%&#160;discount.
Upon the occurrence of a change of control, the August&#160;2020 Convertible Notes are required to be repaid in the amount equal to 200%
of the notes&#x2019; outstanding principal balance plus accrued but unpaid interest.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The August&#160;2020 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that is required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The aggregate issuance date estimated fair values of the derivative liability
issued with the August&#160;2020 Convertible Notes was $1.8&#160;million and was recorded as a debt discount. The discount on the August&#160;2020
Convertible Notes was to be amortized over the contractual term of 12&#160;months from issuance, using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On August&#160;25, 2021, the
August&#160;2020 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2021 (the &#x201c;Amendment&#160;1&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;6, 2021,
the August&#160;2020 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022 (the &#x201c;Amendment&#160;2&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;January&#160;2021 Convertible
Notes&lt;/i&gt;&#160;&#x2014;&#160;In January&#160;2021 the Company received $1.0&#160;million in gross proceeds from the issuance of convertible
promissory notes (the &#x201c;January&#160;2021 Convertible Notes&#x201d;). Interest on the unpaid principal balance of the January&#160;2021
Convertible Notes accrues from the issuance date at a rate of 12% per year, compounded semi-annually, and is payable at maturity. Unless
converted or redeemed upon the occurrence of certain events, the January&#160;2021 Convertible Notes were to mature within 12&#160;months
of issuance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Upon the consummation of a
Qualified Financing, the notes&#x2019; outstanding principal balance and accrued but unpaid interest are to convert into the shares of
convertible preferred stock issued in such a Qualified Financing at a conversion price equal to the lesser of (i)&#160;the per share price
obtained by dividing $150.0&#160;million by the Company&#x2019;s fully diluted capitalization, or (ii)&#160;the per share price paid by
investors in the Qualified Financing, subject to 30% discount. Upon the occurrence of a change of control, the January&#160;2021 Convertible
Notes are required to be repaid in the amount equal to 200% of the notes&#x2019; outstanding principal balance plus accrued but unpaid
interest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The January&#160;2021 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that were required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The issuance date estimated fair values of the derivative liability issued
with the January&#160;2021 Convertible Notes was $0.2&#160;million and was recorded as a debt discount. The discount on the January&#160;2021
Convertible Notes was to be amortized over the contractual term of 12&#160;months from issuance, using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;6, 2021,
the January&#160;2021 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;April&#160;2021 Convertible
Notes&lt;/i&gt;&#160;&#x2014;&#160;In April, May and June&#160;2021 the Company received $1.2&#160;million in total gross proceeds from the issuance
of convertible promissory notes (together with January&#160;2021 Convertible Notes, the &#x201c;2021 Convertible Notes&#x201d;). Interest
on the unpaid principal balance of the April&#160;2021 Convertible Notes accrues from the issuance date at a rate of 12% per year, compounded
semi-annually, and is payable at maturity. Unless converted or redeemed upon the occurrence of certain events, the April&#160;2021 Convertible
Notes were to mature within 12&#160;months of issuance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Upon the consummation of a Qualified Financing,
the notes&#x2019; outstanding principal balance and accrued but unpaid interest are to convert into the shares of convertible preferred
stock issued in such a Qualified Financing at a conversion price equal to the lesser of (i)&#160;the per share price obtained by dividing
$150.0&#160;million by the Company&#x2019;s fully diluted capitalization, or (ii)&#160;the per share price paid by investors in the Qualified
Financing, subject to 30% discount. Upon the occurrence of a change of control, the April&#160;2021 Convertible Notes are required to
be repaid in the amount equal to 200% of the notes&#x2019; outstanding principal balance plus accrued but unpaid interest.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The April&#160;2021 Convertible
Notes contain embedded features, including automatic conversion into equity securities upon completion of a Qualified Financing and mandatory
redemption upon change of control that were required to be bifurcated and accounted for separately as a combined single derivative instrument
initially and subsequently measured at fair value with the change in fair value recorded in the gain (loss) on change in the fair value
of derivative liabilities in the statements of operations. The issuance date estimated fair values of the derivative liabilities issued
with the April&#160;2021 Convertible Notes was $0.3&#160;million and was recorded as debt discounts. The discount on the April&#160;2021
Convertible Notes was to be amortized over the contractual term of 12&#160;months from issuance, using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;6, 2021,
the April&#160;2021 Convertible Notes were amended to extend the maturity dates to December&#160;31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Convertible Notes November&#160;2022 Amendment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;3, 2022,
all of the convertible notes outstanding, referred to as the 2020 Convertible Notes and 2021 Convertible Notes based on the original board
approvals (together the &#x201c;Convertible Notes&#x201d;) were amended as follows: 1) all unpaid interest and principal shall be due and
payable on the date which is &lt;span style="-sec-ix-hidden: hidden-fact-242"&gt;five&lt;/span&gt;&#160;business days after the termination of the Merger prior to the occurrence of the Merger closing,
2)&#160;the maximum aggregate initial principal amount was increased from $11.0&#160;million to $11.3&#160;million, 3)&#160;automatic
conversion to SPAC shares of at then outstanding all notes and accrued interest upon the Merger at $7.00 per share was introduced, 4)
upon consummation of the Merger, all noteholders will have a right to receive additional shares upon achievement by the combined company
of certain share price and sales milestones (the&#160;earnout shares) (the &#x201c;November&#160;2022 Convertible Notes Amendment&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The November&#160;2022 Convertible
Notes Amendment represented a troubled debt restructuring (the &#x201c;TDR&#x201d;). The TDR did not result in a gain recognition. As a
result, a new effective interest rate was established based on the $14.4&#160;million carrying value of the debt immediately prior to
the November&#160;2022 Convertible Notes Amendment and the future cash flows after such amendment, net of the issuance costs paid to or
received from the Convertible Notes holders, which were capitalized and amortized based on the new effective interest rate. Fees paid
to third parties in connection with the November&#160;2022 Convertible Notes Amendment were expensed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The annual effective interest
rate of Convertible Notes was estimated from 12.54% to 53.28% and 12.95% to 53.28% per year for the&#160;years ended December&#160;31,
2024 and 2023, respectively. The interest expense for the&#160;years ended December&#160;31, 2024 and 2023 was $2.1&#160;million and $2.3&#160;million,
which includes the amortization of debt discount and issuance costs of $0.1&#160;million and $0.5&#160;million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the outstanding balance of convertible notes includes related party convertible notes of $13.3&#160;million and $11.8&#160;million,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Tasly Convertible Debt&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In June&#160;2023, the Company
entered into a short-term loan agreement with a related party under which it may borrow up to $1.6&#160;million, of which $1.0&#160;million
was borrowed on June&#160;26, 2023, $0.3&#160;million was borrowed on July&#160;20, 2023, $0.3&#160;million was borrowed on August&#160;15,
2023 and the final $0.02 million was borrowed in February 2024 (the &#x201c;Convertible debt&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The loans bear interest
at a rate of 12% per annum and originally matured on December 31, 2023. The original maturity date was extended to March&#160;31,
2024, subject to the parties&#x2019; decision to extend thereafter. The Company is currently in default, as this loan will be repaid
in parallel with the closing of the SPAC transaction. Accordingly, the Company classified the entire amount outstanding under the
Tasly Convertible Debt as current on the Consolidated Balance Sheet. Upon occurrence of certain events of default by the Company,
including failure to repay in full the amounts owed at&#160;maturity, the lender will have an option to convert the entire
outstanding balance and accrued but unpaid interest under the Convertible debt into senior unsecured promissory notes on
substantially the same terms as the outstanding Senior Notes as of December&#160;31, 2024. In the event the Company fails to
complete the Merger, the lender will have an option to convert the entire outstanding balance and accrued but unpaid interest under
the Convertible debt into either (i)&#160;senior unsecured promissory notes on substantially the same terms as the outstanding
Senior Notes as of December&#160;31, 2024 or (ii)&#160;the Company&#x2019;s common stock at a conversion price of $2.33 per
share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company elected to apply
the fair value option to account for the Tasly Convertible debt. Accordingly, no features of the Convertible debt are bifurcated and separately
accounted for. The fair value of the Convertible debt was $2.2 million as of December 31, 2024, compared to $1.71&#160;million as of December&#160;31,
2023. Accrued stated interest on the Convertible debt was $0.2 million for the year ended December 31, 2024 compared to less than $0.1&#160;million
for the year ended December&#160;31, 2023. The total loss on fair value remeasurement is $0.33 million, of which, $0.31 million in loss
on fair value remeasurement is from the year ended December 31, 2024, compared to less than $0.1 million in loss on fair value remeasurement
from the year ended December 31, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Senior Notes 2021&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;August&#160;2021 Senior
Notes&lt;/i&gt;&#160;&#x2014;&#160;In August&#160;2021 the Company received $4.0&#160;million in total gross proceeds from the issuance of senior
unsecured promissory notes (the &#x201c;August&#160;2021 Senior Notes&#x201d;). Simple interest on the unpaid principal balance of the August&#160;2021
Senior Notes accrued from the issuance date at a rate of 12% per year and is payable at maturity. The August&#160;2021 Senior Notes were
to mature on the earlier of (a)&#160;issuance of the next round of preferred stock of (b)&#160;August&#160;25, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;6, 2021,
the August&#160;2021 Senior Notes were amended to provide the note holders with an option to convert the notes&#x2019; outstanding principal
balance and accrued but unpaid interest into (a)&#160;the shares of convertible preferred stock issued upon consummation of a Qualified
Financing at a conversion price equal to the per share price paid by investors in such Qualified Financing, subject to 20% discount, or
(b)&#160;shares of the Company&#x2019;s Series&#160;C convertible preferred stock at the conversion price equal to the original issue price
prior to Qualified Financing in the event the Qualified Financing had not occurred prior to February&#160;25, 2022, or (c)&#160;shares
of the Company&#x2019;s Series&#160;C convertible preferred stock at the conversion price equal to the original issue price upon change
of control.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The optional conversion upon
Qualified Financing represents an embedded feature that is required to be bifurcated and accounted for separately as a derivative instrument
initially and subsequently measured at fair value with the change in the gain (loss) on change in the fair value of derivative liabilities
in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;December&#160;2021 Senior
Notes&lt;/i&gt;&#160;&#x2014;&#160;In December&#160;2021 the Company received $1.3&#160;million in total gross proceeds from the issuance of
senior unsecured promissory notes (the &#x201c;December&#160;2021 Senior Notes&#x201d;, together with August&#160;2021 Senior Notes, the
&#x201c;2021 Senior Notes&#x201d;). Simple interest on the unpaid principal balance of the December&#160;2021 Senior Notes accrued from
the issuance date at a rate of 12% per year and is payable at maturity. The December&#160;2021 Senior Notes mature on August&#160;25,
2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#160;31,
2022 the Company issued additional Senior Notes to the existing investors for the aggregate principal amount of $5.5&#160;million (the
&#x201c;2022 Senior Notes&#x201d;) on substantially the same terms as the other Senior Notes issued in 2021 (as amended in December&#160;2021).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Senior Notes September&#160;2022 Amendment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In September&#160;2022,
the 2021 Senior Notes and 2022 Senior Notes (together &#x201c;Senior Notes&#x201d;) were amended as follows: a) the maturity dates for
all Senior Notes were extended to December&#160;31, 2022, b) the conversion price discount in the event of a Qualified Financing was
increased to 60%, c) the February&#160;25, 2022 deadline for the occurrence of a Qualified Financing for conversion of the Senior
Notes into Series&#160;C convertible preferred stock prior to a Qualified Financing was extended to December&#160;31, 2022 and the
respective conversion price discount of 60% was introduced for conversion prior to a Qualified Financing; d) the conversion price
discount of 60% in the event of change of control was introduced; e) conversion option prior to entering into a definitive agreement
with a SPAC (the &#x201c;Definitive Qualified Agreement&#x201d;) was introduced. Under this option, in the event that the Company
executes a Definitive Qualified Agreement, then the Senior Note&#160;holders will have the option (but not the obligation) to
convert the entire outstanding principal balance and all accrued but unpaid interest into shares of the Company&#x2019;s common stock
at a conversion price equal to 40% of the per share price of the common stock as determined pursuant to the Definitive Qualified
Agreement; provided, that, if such conversion price per share of the common stock is greater than $4.00, then such conversion price
shall be deemed to be $4.00 per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;This 2022&#160;amendment was
accounted for as debt extinguishment resulting in $8.8&#160;million debt extinguishment loss recognized in loss on debt extinguishment,
net in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The optional conversion upon
a Qualified Financing and Qualified conversion option represents embedded features that are required to be bifurcated and accounted for
separately as a combined single derivative instrument initially and subsequently measured at fair value with the change in the gain (loss)
on change in the fair value of derivative liabilities in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;October&#160;2022 Senior
Notes&lt;/i&gt;&#160;&#x2014;&#160;In September and October&#160;2022, the Company issued an additional Senior Notes to existing investors with
the principal amount of $1.3&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in September&#160;2022).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Senior Notes November&#160;2022 Amendment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;3, 2022,
all Senior Notes were amended as follows: 1) all unpaid interest and principal shall be due and payable on the date which is &lt;span style="-sec-ix-hidden: hidden-fact-243"&gt;five&lt;/span&gt;&#160;business
days after the termination of the Merger prior to the occurrence of the Merger closing, 2) automatic conversion to SPAC shares of at then
outstanding all notes and accrued interest upon the Merger at $4.00 per share was introduced, 3) upon consummation of the Merger, all
noteholders will have a right to receive additional shares upon achievement by the combined company of certain share price and sales milestones
(the earnout shares) (the &#x201c;November&#160;2022 Senior Notes Amendment&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The November&#160;2022 Senior
Notes Amendment represented a TDR.&#160;Since the total future undiscounted cash flows under Senior Notes were less than their outstanding
principal amount and unpaid accrued interest plus fair value of the bifurcated derivative immediately before November&#160;2022 Senior
Notes Amendment, the Company recognized TDR gain of $3.98&#160;million for the Senior Notes issued to unrelated parties in its Statement
of Operations for the year ended December&#160;31, 2022 and it recognized $3.97&#160;million in Additional Paid-in Capital for the year
ended December&#160;31, 2022 for the Senior Notes issued to related parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;December&#160;2022 Senior
Notes&lt;/i&gt;&#160;&#x2014;&#160;In November and December&#160;2022, the Company issued additional Senior Notes to investors with the principal
amount of $1.0&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Senior Notes 2023&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;March&#160;2023 Senior
Notes&lt;/i&gt;&#160;&#x2014;&#160;In January, February and March&#160;2023, the Company issued additional Senior Notes to investors with the
principal amount of $1.6&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;April&#160;2023 Senior
Notes&lt;/i&gt;&#160;&#x2014;&#160;In April&#160;2023, the Company issued additional Senior Notes to investors with the principal amount of $0.6&#160;million
on substantially the same terms as the Senior Notes issued in 2022 (as amended in November&#160;2022).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;October-December&#160;2023
Senior Notes&lt;/i&gt;&#160;&#x2014;&#160;During the&#160;months October through December&#160;2023, the Company issued additional Senior Notes
to investors with the principal amount of $1.1&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022). These notes were issued at the same 12% interest terms as all of their other Senior Convertible Notes, and will
convert into New Profusa shares at $2.22 per share upon the successful closing of the business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Senior Notes 2024&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;January-March 2024 Senior
Notes&lt;/i&gt; &#x2014; During the months January through March 2024, the Company issued additional Senior Notes to investors with the principal
amount of $0.7 million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;April-June 2024 Senior
Notes &#x2014; &lt;/i&gt;During the months April through June 2024, the Company issued additional Senior Notes to investors with the principal
amount of $0.4 million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022). Additionally,
the Company repaid $0.11 million of principal on Senior Notes with investors during the respective period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;July-September 2024 Senior
Notes &lt;/i&gt;&#x2014; During the months July through September 2024, the Company issued additional Senior Notes to investors with the principal
amount of $0.7 million on substantially the same terms as the Senior Notes issued in 2022 (as amended in November 2022). Additionally,
during the months of July through September 2024, the Company issued a Senior Secured Convertible Note with the principal amount of $0.25
million. This note was issued at the same 12% interest terms as all of their other Senior Convertible Notes, and has an 18-month maturity,
which will be accelerated and converts into New Profusa shares upon the successful closing of the business combination. The Company repaid
$0.04 million of principal on Senior Notes with investors during the respective period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;October-December 2024 Senior
Notes&lt;/i&gt; &#x2014; During the months October through December 2024, the Company issued two Senior Secured Convertible Notes with a total
principal amount of $1.1 million. These notes were issued at the same 12% interest terms as all of their other Senior Convertible Notes,
and have an 18-month maturity, which will be accelerated and converted into New Profusa shares upon the successful closing of the business
combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2024, the
outstanding balance of senior notes totaled $25.3 million, of which $9.5 million is outstanding with related parties and $15.8 million
is outstanding with unrelated parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The annual effective interest
rate of Senior Notes was estimated from 0% to 12.15% and 0% to 12.55% per year for the&#160;years ended December&#160;31, 2024 and 2023,
respectively. The interest expense was $2.1&#160;million and $1.8&#160;million for the&#160;years ended December&#160;31, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024,
future minimum payments for the convertible notes payable were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Total future principal payments&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,998&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;24,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Add: fair value remeasurement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-239"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-240"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Add (less): unamortized debt (premium) discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-241"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Less: interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,112&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,183&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total convertible notes payable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In a series of transactions
during 2010 and 2011 two of the Company&#x2019;s founders provided $0.2&#160;million to the Company to fund general corporate purposes
in exchange for promissory notes. The notes accrue interest annually at a simple interest rate of 5% with no set maturity date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#160;31,
2022, the Company borrowed $0.3&#160;million from two of its founders at zero interest rate to finance its short-term operations, from
which $0.2&#160;million was repaid in the same period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#160;31,
2023, the Company borrowed short-term promissory notes of $0.3&#160;million from an existing investor and an additional $0.1&#160;million
from an unrelated party repayable on demand at any time after December&#160;31, 2024, with annual interest rate of 12%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Interest expense on the promissory
notes was less than $0.1&#160;million for each of the&#160;years ended December&#160;31, 2024 and 2023. The carrying value of the promissory
notes as of December&#160;31, 2024 and 2023 was $0.9&#160;million and $0.8&#160;million, respectively. As of December&#160;31, 2024 and
2023, outstanding balance of promissory notes includes all related party promissory notes of $0.9&#160;million and $0.8&#160;million,
respectively. The Company recognized that the promissory notes from December 31, 2023 are in default as of the date of this filing. The
note holders will be repaid upon closing the business transaction, and the full balance of these notes are held in current liabilities
on the Consolidated Balance Sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Paycheck Protection Program&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On May&#160;25, 2021, the
Company borrowed $1.3&#160;million (the &#x201c;PPP Loan 2&#x201d;) as a Paycheck Protection Program loan. The Paycheck Protection Program,
established as part of the Coronavirus Aid, Relief, and Economic Security (&#x201c;CARES&#x201d;) Act, provides for loans to qualifying
businesses and is administered by the U.S.&#160;Small Business Administration (the &#x201c;SBA&#x201d;). The annual interest rate of the
PPP Loan 2 is 1%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under the terms of PPP Loan
2, if the Company does not submit forgiveness application within 24&#160;weeks the initial disbursement of the loan (the &#x201c;Covered
Period&#x201d;), the Company must begin to make equal monthly payments of principal and interest starting 10&#160;months from the end of
the Covered Period until May&#160;25, 2026. Interest on the loan continues to accumulate during any deferment period. As of December&#160;31,
2024, and as of the date of this filing, the Company has not applied for forgiveness under PPP Loan 2.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and December 31, 2023, the Company was in default on PPP Loan 2 due to non-payment of minimal repayment amounts required by the terms
of PPP Loan 2. Accordingly, the Company classified the entire amount outstanding under PPP Loan 2 as current and accrued respective late
penalties for the total amount of less than $0.1&#160;million as of December&#160;31, 2024 and December 31, 2023, respectively. The total
past due amount of PPP Loan 2 repayments as of December&#160;31, 2024 and December 31, 2023 was $0.8&#160;million and $0.4&#160;million,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024,
the contractual future minimum payments for the PPP Loan 2 were as follows (in&#160;thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;Year Ending December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;145&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c22" id="ixv-20989">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the debt instruments (which are all classified as current liabilities in the accompanying consolidated balance sheets and
their changes during the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Promissory &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;PPP &lt;br/&gt; Loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;Balance at January 1, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-205"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15,149&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;576&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-206"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;375&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-207"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-208"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-209"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-210"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(151&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-211"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-212"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-213"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-214"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-215"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;515&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-216"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-217"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-218"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;849&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance at January 1, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;16,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;849&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-219"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-220"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-221"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-222"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-223"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(150&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-224"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-225"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-226"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;311&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-227"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-228"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-229"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,053&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-230"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-231"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-233"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balance at December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;910&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;910&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Long term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-234"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-235"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-236"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-238"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c296"
      decimals="-3"
      id="ixv-38834"
      unitRef="usd">13981000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c298"
      decimals="-3"
      id="ixv-38835"
      unitRef="usd">15149000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c299"
      decimals="-3"
      id="ixv-38836"
      unitRef="usd">576000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c300"
      decimals="-3"
      id="ixv-38837"
      unitRef="usd">1326000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c302"
      decimals="-3"
      id="ixv-38838"
      unitRef="usd">1600000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c303"
      decimals="-3"
      id="ixv-38839"
      unitRef="usd">3235000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c304"
      decimals="-3"
      id="ixv-38840"
      unitRef="usd">375000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="c304"
      decimals="-3"
      id="ixv-38841"
      unitRef="usd">151000</us-gaap:RepaymentsOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c302"
      decimals="-3"
      id="ixv-38842"
      unitRef="usd">22000</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001859807:StatedInterest
      contextRef="c301"
      decimals="-3"
      id="ixv-38843"
      unitRef="usd">1820000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c302"
      decimals="-3"
      id="ixv-38844"
      unitRef="usd">92000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c303"
      decimals="-3"
      id="ixv-38845"
      unitRef="usd">1771000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c304"
      decimals="-3"
      id="ixv-38846"
      unitRef="usd">49000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c305"
      decimals="-3"
      id="ixv-38847"
      unitRef="usd">36000</ck0001859807:StatedInterest>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c301"
      decimals="-3"
      id="ixv-38848"
      unitRef="usd">515000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c303"
      decimals="-3"
      id="ixv-38849"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c306"
      decimals="-3"
      id="ixv-38850"
      unitRef="usd">16316000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c307"
      decimals="-3"
      id="ixv-38851"
      unitRef="usd">1714000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c308"
      decimals="-3"
      id="ixv-38852"
      unitRef="usd">20155000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c309"
      decimals="-3"
      id="ixv-38853"
      unitRef="usd">849000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c310"
      decimals="-3"
      id="ixv-38854"
      unitRef="usd">1362000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c306"
      decimals="-3"
      id="ixv-38855"
      unitRef="usd">16316000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c307"
      decimals="-3"
      id="ixv-38856"
      unitRef="usd">1714000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c308"
      decimals="-3"
      id="ixv-38857"
      unitRef="usd">20155000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c309"
      decimals="-3"
      id="ixv-38858"
      unitRef="usd">849000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c310"
      decimals="-3"
      id="ixv-38859"
      unitRef="usd">1362000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c312"
      decimals="-3"
      id="ixv-38860"
      unitRef="usd">16000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c313"
      decimals="-3"
      id="ixv-38861"
      unitRef="usd">3210000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="c313"
      decimals="-3"
      id="ixv-38862"
      unitRef="usd">150000</us-gaap:RepaymentsOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c312"
      decimals="-3"
      id="ixv-38863"
      unitRef="usd">311000</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001859807:StatedInterest
      contextRef="c311"
      decimals="-3"
      id="ixv-38864"
      unitRef="usd">2057000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c312"
      decimals="-3"
      id="ixv-38865"
      unitRef="usd">193000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c313"
      decimals="-3"
      id="ixv-38866"
      unitRef="usd">2053000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c314"
      decimals="-3"
      id="ixv-38867"
      unitRef="usd">61000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c315"
      decimals="-3"
      id="ixv-38868"
      unitRef="usd">14000</ck0001859807:StatedInterest>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c311"
      decimals="-3"
      id="ixv-38869"
      unitRef="usd">46000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c316"
      decimals="-3"
      id="ixv-38870"
      unitRef="usd">18419000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c317"
      decimals="-3"
      id="ixv-38871"
      unitRef="usd">2234000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c318"
      decimals="-3"
      id="ixv-38872"
      unitRef="usd">25268000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c319"
      decimals="-3"
      id="ixv-38873"
      unitRef="usd">910000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c320"
      decimals="-3"
      id="ixv-38874"
      unitRef="usd">1376000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="c316"
      decimals="-3"
      id="ixv-38875"
      unitRef="usd">18419000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c317"
      decimals="-3"
      id="ixv-38876"
      unitRef="usd">2234000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c318"
      decimals="-3"
      id="ixv-38877"
      unitRef="usd">25268000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c319"
      decimals="-3"
      id="ixv-38878"
      unitRef="usd">910000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c320"
      decimals="-3"
      id="ixv-38879"
      unitRef="usd">1376000</us-gaap:LongTermDebtCurrent>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c202"
      decimals="-5"
      id="ixv-38880"
      unitRef="usd">9100000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c203"
      decimals="-5"
      id="ixv-38881"
      unitRef="usd">9100000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c204"
      decimals="-5"
      id="ixv-38882"
      unitRef="usd">9100000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c205"
      decimals="-5"
      id="ixv-38883"
      unitRef="usd">9100000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c206"
      decimals="2"
      id="ixv-38884"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="c207" id="ixv-38885">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c208"
      decimals="-5"
      id="ixv-38886"
      unitRef="usd">20000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c209"
      decimals="-5"
      id="ixv-38887"
      unitRef="usdPershares">150000000</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ck0001859807:DebtInstrumentDiscount
      contextRef="c209"
      decimals="2"
      id="ixv-38888"
      unitRef="pure">0.30</ck0001859807:DebtInstrumentDiscount>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="c208"
      decimals="2"
      id="ixv-38889"
      unitRef="pure">2</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DerivativeLiabilities
      contextRef="c209"
      decimals="-5"
      id="ixv-38890"
      unitRef="usd">1800000</us-gaap:DerivativeLiabilities>
    <ck0001859807:DebtInstrumentsContractualTerm contextRef="c209" id="ixv-38891">P12M</ck0001859807:DebtInstrumentsContractualTerm>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c210"
      decimals="-5"
      id="ixv-38892"
      unitRef="usd">1000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c211"
      decimals="2"
      id="ixv-38893"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="c210" id="ixv-38894">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c211"
      decimals="-5"
      id="ixv-38895"
      unitRef="usdPershares">150000000</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ck0001859807:DebtInstrumentDiscount
      contextRef="c211"
      decimals="2"
      id="ixv-38896"
      unitRef="pure">0.30</ck0001859807:DebtInstrumentDiscount>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="c210"
      decimals="2"
      id="ixv-38897"
      unitRef="pure">2</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DerivativeLiabilities
      contextRef="c211"
      decimals="-5"
      id="ixv-38898"
      unitRef="usd">200000</us-gaap:DerivativeLiabilities>
    <ck0001859807:DebtInstrumentsContractualTerm contextRef="c211" id="ixv-38899">P12M</ck0001859807:DebtInstrumentsContractualTerm>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c212"
      decimals="-5"
      id="ixv-38900"
      unitRef="usd">1200000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c213"
      decimals="-5"
      id="ixv-38901"
      unitRef="usd">1200000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c214"
      decimals="-5"
      id="ixv-38902"
      unitRef="usd">1200000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c215"
      decimals="2"
      id="ixv-38903"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="c213" id="ixv-38904">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c215"
      decimals="-5"
      id="ixv-38905"
      unitRef="usdPershares">150000000</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ck0001859807:DebtInstrumentDiscount
      contextRef="c216"
      decimals="2"
      id="ixv-38906"
      unitRef="pure">0.30</ck0001859807:DebtInstrumentDiscount>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="c213"
      decimals="2"
      id="ixv-38907"
      unitRef="pure">2</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DerivativeLiabilities
      contextRef="c215"
      decimals="-5"
      id="ixv-38908"
      unitRef="usd">300000</us-gaap:DerivativeLiabilities>
    <ck0001859807:DebtInstrumentsContractualTerm contextRef="c215" id="ixv-38909">P12M</ck0001859807:DebtInstrumentsContractualTerm>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="c218"
      decimals="-5"
      id="ixv-38910"
      unitRef="usd">11000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="c219"
      decimals="-5"
      id="ixv-38911"
      unitRef="usd">11300000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c220"
      decimals="2"
      id="ixv-38912"
      unitRef="usdPershares">7</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="c221"
      decimals="-5"
      id="ixv-38913"
      unitRef="usd">14400000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c222"
      decimals="4"
      id="ixv-38914"
      unitRef="pure">0.1254</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c223"
      decimals="4"
      id="ixv-38915"
      unitRef="pure">0.5328</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c224"
      decimals="4"
      id="ixv-38916"
      unitRef="pure">0.1295</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c225"
      decimals="4"
      id="ixv-38917"
      unitRef="pure">0.5328</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpenseDebt
      contextRef="c226"
      decimals="-5"
      id="ixv-38918"
      unitRef="usd">2100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c227"
      decimals="-5"
      id="ixv-38919"
      unitRef="usd">2300000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="c226"
      decimals="-5"
      id="ixv-38920"
      unitRef="usd">100000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="c227"
      decimals="-5"
      id="ixv-38921"
      unitRef="usd">500000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c228"
      decimals="-5"
      id="ixv-38922"
      unitRef="usd">13300000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c229"
      decimals="-5"
      id="ixv-38923"
      unitRef="usd">11800000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="c230"
      decimals="-5"
      id="ixv-38924"
      unitRef="usd">1600000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBorrowings
      contextRef="c230"
      decimals="-5"
      id="ixv-38925"
      unitRef="usd">1000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="c231"
      decimals="-5"
      id="ixv-38926"
      unitRef="usd">300000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="c232"
      decimals="-5"
      id="ixv-38927"
      unitRef="usd">300000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="c233"
      decimals="-4"
      id="ixv-38928"
      unitRef="usd">20000.00</us-gaap:ShortTermBorrowings>
    <ck0001859807:DebtInterestRate
      contextRef="c234"
      decimals="2"
      id="ixv-38929"
      unitRef="pure">0.12</ck0001859807:DebtInterestRate>
    <ck0001859807:CommonStockConvertibleConversionPrice
      contextRef="c235"
      decimals="2"
      id="ixv-38930"
      unitRef="usdPershares">2.33</ck0001859807:CommonStockConvertibleConversionPrice>
    <us-gaap:ConvertibleDebt
      contextRef="c235"
      decimals="-5"
      id="ixv-38931"
      unitRef="usd">2200000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="c236"
      decimals="-4"
      id="ixv-38932"
      unitRef="usd">1710000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="c237"
      decimals="-5"
      id="ixv-38933"
      unitRef="usd">200000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="c234"
      decimals="-5"
      id="ixv-38934"
      unitRef="usd">100000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <ck0001859807:LossOnFairValueRemeasurement
      contextRef="c238"
      decimals="-4"
      id="ixv-38935"
      unitRef="usd">330000</ck0001859807:LossOnFairValueRemeasurement>
    <ck0001859807:LossOnFairValueRemeasurement
      contextRef="c239"
      decimals="-4"
      id="ixv-38936"
      unitRef="usd">310000</ck0001859807:LossOnFairValueRemeasurement>
    <ck0001859807:LossOnFairValueRemeasurement
      contextRef="c234"
      decimals="-5"
      id="ixv-38937"
      unitRef="usd">100000</ck0001859807:LossOnFairValueRemeasurement>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c240"
      decimals="-5"
      id="ixv-38938"
      unitRef="usd">4000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c241"
      decimals="2"
      id="ixv-38939"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ck0001859807:DebtInstrumentDiscount
      contextRef="c242"
      decimals="2"
      id="ixv-38940"
      unitRef="pure">0.20</ck0001859807:DebtInstrumentDiscount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c243"
      decimals="-5"
      id="ixv-38941"
      unitRef="usd">1300000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c244"
      decimals="2"
      id="ixv-38942"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c245"
      decimals="-5"
      id="ixv-38943"
      unitRef="usd">5500000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <ck0001859807:DebtInstrumentDiscount
      contextRef="c215"
      decimals="2"
      id="ixv-38944"
      unitRef="pure">20.21</ck0001859807:DebtInstrumentDiscount>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c246"
      decimals="2"
      id="ixv-38945"
      unitRef="pure">0.60</ck0001859807:ConvertibleDebtOfDiscountRate>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c247"
      decimals="2"
      id="ixv-38946"
      unitRef="pure">0.60</ck0001859807:ConvertibleDebtOfDiscountRate>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c248"
      decimals="2"
      id="ixv-38947"
      unitRef="pure">0.60</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c249"
      decimals="2"
      id="ixv-38948"
      unitRef="pure">0.40</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="c248"
      decimals="2"
      id="ixv-38949"
      unitRef="usdPershares">4</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c250"
      decimals="2"
      id="ixv-38950"
      unitRef="usdPershares">4</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="c251"
      decimals="-5"
      id="ixv-38951"
      unitRef="usd">8800000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c252"
      decimals="-5"
      id="ixv-38952"
      unitRef="usd">1300000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c253"
      decimals="-5"
      id="ixv-38953"
      unitRef="usd">1300000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c255"
      decimals="2"
      id="ixv-38954"
      unitRef="usdPershares">4</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c256"
      decimals="-4"
      id="ixv-38955"
      unitRef="usd">3980000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c257"
      decimals="-4"
      id="ixv-38956"
      unitRef="usd">3970000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c258"
      decimals="-5"
      id="ixv-38957"
      unitRef="usd">1000000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c259"
      decimals="-5"
      id="ixv-38958"
      unitRef="usd">1000000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c260"
      decimals="-5"
      id="ixv-38959"
      unitRef="usd">1600000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c261"
      decimals="-5"
      id="ixv-38960"
      unitRef="usd">1600000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c262"
      decimals="-5"
      id="ixv-38961"
      unitRef="usd">1600000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c263"
      decimals="-5"
      id="ixv-38962"
      unitRef="usd">600000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c264"
      decimals="-5"
      id="ixv-38963"
      unitRef="usd">1100000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c264"
      decimals="2"
      id="ixv-38964"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare
      contextRef="c264"
      decimals="2"
      id="ixv-38965"
      unitRef="usdPershares">2.22</us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c265"
      decimals="-5"
      id="ixv-38966"
      unitRef="usd">700000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c266"
      decimals="-5"
      id="ixv-38967"
      unitRef="usd">400000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c267"
      decimals="-4"
      id="ixv-38968"
      unitRef="usd">110000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c268"
      decimals="-5"
      id="ixv-38969"
      unitRef="usd">700000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c269"
      decimals="-4"
      id="ixv-38970"
      unitRef="usd">250000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c268"
      decimals="2"
      id="ixv-38971"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <ck0001859807:MaturityMonth contextRef="c270" id="ixv-38972">P18M</ck0001859807:MaturityMonth>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c271"
      decimals="-4"
      id="ixv-38973"
      unitRef="usd">40000.00</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c272"
      decimals="-5"
      id="ixv-38974"
      unitRef="usd">1100000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c272"
      decimals="2"
      id="ixv-38975"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <ck0001859807:MaturityMonth contextRef="c273" id="ixv-38976">P18M</ck0001859807:MaturityMonth>
    <us-gaap:SeniorNotes
      contextRef="c274"
      decimals="-5"
      id="ixv-38977"
      unitRef="usd">25300000</us-gaap:SeniorNotes>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="c275"
      decimals="-5"
      id="ixv-38978"
      unitRef="usd">9500000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="c276"
      decimals="-5"
      id="ixv-38979"
      unitRef="usd">15800000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c277"
      decimals="2"
      id="ixv-38980"
      unitRef="pure">0</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c278"
      decimals="4"
      id="ixv-38981"
      unitRef="pure">0.1215</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c279"
      decimals="2"
      id="ixv-38982"
      unitRef="pure">0</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c280"
      decimals="4"
      id="ixv-38983"
      unitRef="pure">0.1255</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="c251"
      decimals="-5"
      id="ixv-38984"
      unitRef="usd">2100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c281"
      decimals="-5"
      id="ixv-38985"
      unitRef="usd">1800000</us-gaap:InterestExpenseDebt>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c22" id="ixv-21734">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024,
future minimum payments for the convertible notes payable were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Total future principal payments&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,998&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;24,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Add: fair value remeasurement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-239"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-240"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Add (less): unamortized debt (premium) discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-241"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Less: interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,112&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,183&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total convertible notes payable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="c321"
      decimals="-3"
      id="ixv-38986"
      unitRef="usd">19533000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="c188"
      decimals="-3"
      id="ixv-38987"
      unitRef="usd">1998000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="c274"
      decimals="-3"
      id="ixv-38988"
      unitRef="usd">24396000</us-gaap:ConvertibleDebt>
    <ck0001859807:FairValueRemeasurement
      contextRef="c188"
      decimals="-3"
      id="ixv-38989"
      unitRef="usd">-333000</ck0001859807:FairValueRemeasurement>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="c321"
      decimals="-3"
      id="ixv-38990"
      unitRef="usd">2000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="c274"
      decimals="-3"
      id="ixv-38991"
      unitRef="usd">-2055000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <ck0001859807:InterestExpensesNotesPayable
      contextRef="c321"
      decimals="-3"
      id="ixv-38992"
      unitRef="usd">1112000</ck0001859807:InterestExpensesNotesPayable>
    <ck0001859807:InterestExpensesNotesPayable
      contextRef="c188"
      decimals="-3"
      id="ixv-38993"
      unitRef="usd">97000</ck0001859807:InterestExpensesNotesPayable>
    <ck0001859807:InterestExpensesNotesPayable
      contextRef="c274"
      decimals="-3"
      id="ixv-38994"
      unitRef="usd">1183000</ck0001859807:InterestExpensesNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c321"
      decimals="-3"
      id="ixv-38995"
      unitRef="usd">18419000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c188"
      decimals="-3"
      id="ixv-38996"
      unitRef="usd">2234000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c274"
      decimals="-3"
      id="ixv-38997"
      unitRef="usd">25268000</us-gaap:ConvertibleNotesPayable>
    <ck0001859807:PromissoryNotes contextRef="c22" decimals="-5" id="ixv-38998" unitRef="usd">200000</ck0001859807:PromissoryNotes>
    <us-gaap:ShortTermDebtInterestRateIncrease
      contextRef="c282"
      decimals="2"
      id="ixv-38999"
      unitRef="pure">0.05</us-gaap:ShortTermDebtInterestRateIncrease>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="c283"
      decimals="-5"
      id="ixv-39000"
      unitRef="usd">300000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="c283"
      decimals="-5"
      id="ixv-39001"
      unitRef="usd">200000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="c284"
      decimals="-5"
      id="ixv-39002"
      unitRef="usd">300000</us-gaap:ShortTermBorrowings>
    <ck0001859807:UnrelatedPartyRepayable
      contextRef="c285"
      decimals="-5"
      id="ixv-39003"
      unitRef="usd">100000</ck0001859807:UnrelatedPartyRepayable>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="c286"
      decimals="2"
      id="ixv-39004"
      unitRef="pure">0.12</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:InterestExpenseDebt
      contextRef="c285"
      decimals="-5"
      id="ixv-39005"
      unitRef="usd">100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c282"
      decimals="-5"
      id="ixv-39006"
      unitRef="usd">100000</us-gaap:InterestExpenseDebt>
    <ck0001859807:PromissoryNotes
      contextRef="c282"
      decimals="-5"
      id="ixv-39007"
      unitRef="usd">900000</ck0001859807:PromissoryNotes>
    <ck0001859807:PromissoryNotes
      contextRef="c285"
      decimals="-5"
      id="ixv-39008"
      unitRef="usd">800000</ck0001859807:PromissoryNotes>
    <ck0001859807:PromissoryNotes
      contextRef="c287"
      decimals="-5"
      id="ixv-39009"
      unitRef="usd">900000</ck0001859807:PromissoryNotes>
    <ck0001859807:PromissoryNotes
      contextRef="c288"
      decimals="-5"
      id="ixv-39010"
      unitRef="usd">800000</ck0001859807:PromissoryNotes>
    <us-gaap:ShortTermBorrowings
      contextRef="c289"
      decimals="-5"
      id="ixv-39011"
      unitRef="usd">1300000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c290"
      decimals="2"
      id="ixv-39012"
      unitRef="pure">0.01</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <ck0001859807:MonthlyPayments contextRef="c291" id="ixv-39013">P10M</ck0001859807:MonthlyPayments>
    <ck0001859807:LatePenaltiesAmount
      contextRef="c292"
      decimals="-5"
      id="ixv-39014"
      unitRef="usd">100000</ck0001859807:LatePenaltiesAmount>
    <ck0001859807:LatePenaltiesAmount
      contextRef="c293"
      decimals="-5"
      id="ixv-39015"
      unitRef="usd">100000</ck0001859807:LatePenaltiesAmount>
    <us-gaap:DebtDefaultLongtermDebtAmount
      contextRef="c294"
      decimals="-5"
      id="ixv-39016"
      unitRef="usd">800000</us-gaap:DebtDefaultLongtermDebtAmount>
    <us-gaap:DebtDefaultLongtermDebtAmount
      contextRef="c295"
      decimals="-5"
      id="ixv-39017"
      unitRef="usd">400000</us-gaap:DebtDefaultLongtermDebtAmount>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="c22" id="ixv-21880">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024,
the contractual future minimum payments for the PPP Loan 2 were as follows (in&#160;thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;Year Ending December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;145&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c1" decimals="0" id="ixv-39018" unitRef="usd">1231</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c1" decimals="0" id="ixv-39019" unitRef="usd">145</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebt contextRef="c1" decimals="0" id="ixv-39020" unitRef="usd">1376</us-gaap:LongTermDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c22" id="ixv-21929">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;6 &#x2014;&#160;Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Operating Lease Obligations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On August 1, 2022 the Company
entered into a new lease agreement (the &#x201c;Amended Lease&#x201d;) whereby the Company agreed to rent its office and lab facilities
under month-to-month tenancy. The monthly rent payable under the Amended Lease was $25 thousand. This month-to-month lease ended in July
2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Beginning in October 2024,
the Company entered into a new lease agreement whereby the Company agreed to rent its office and lab facilities under month-to-month tenancy.
The monthly rent payable under the new lease is also $25&#160;thousand. This month-to-month lease automatically renews every four months,
unless written termination is provided.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Operating costs for short-term
leases and variable lease costs were less than $0.1&#160;million during the&#160;years ended December&#160;31, 2024 and 2023. The Company
recognized a total of $0.3&#160;million and $0.3&#160;million in lease expense for the&#160;years ended December&#160;31, 2024 and 2023,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Contingencies and Indemnifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, the Company
may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability
for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant
judgment is required to determine both probability and the estimated amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In the normal course of business,
the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications.
The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future, but that have not yet been made.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;To date, the Company has not
paid any claims; however, the Company may record charges in the future as a result of these indemnification obligations. The Company is
currently defending one litigation with a vendor. Management has accrued estimated incremental legal costs which totals less than $0.1
million related to the matter.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseAndRentalExpense
      contextRef="c322"
      decimals="-3"
      id="ixv-39021"
      unitRef="usd">25000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="c323"
      decimals="-3"
      id="ixv-39022"
      unitRef="usd">25000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:ShortTermLeasePayments contextRef="c22" decimals="-5" id="ixv-39023" unitRef="usd">100000</us-gaap:ShortTermLeasePayments>
    <us-gaap:OperatingLeaseExpense
      contextRef="c324"
      decimals="-5"
      id="ixv-39024"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="c325"
      decimals="-5"
      id="ixv-39025"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c22" decimals="-5" id="ixv-39026" unitRef="usd">100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:PreferredStockTextBlock contextRef="c22" id="ixv-21960">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;7 &#x2014;&#160;Convertible Preferred Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under the Company&#x2019;s
Amended and Restated Certificate of Incorporation, as amended, the Company is authorized to issue two classes of shares: preferred and
common stock. The preferred stock is issuable in series, and the Company&#x2019;s Board of Directors is authorized to determine the rights,
preferences, and terms of each series. Under the Company&#x2019;s Articles of Incorporation, as amended, the Company is authorized to issue
18,551,382 shares of convertible preferred stock at a par value of $0.0001.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Convertible preferred stock
as of December&#160;31, 2024 and December 31, 2023 consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Share &lt;br/&gt; Issued and &lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liquidation &lt;br/&gt; Preference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt; Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Original &lt;br/&gt; Issue Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;New Series&#160;A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,701&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,358,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,670,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,476&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;New Series&#160;C-1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;4.80&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,551,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,184&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;65,149&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Voting Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The holders of convertible
preferred stock shares are entitled to vote on all matters on which the common stockholders are entitled to vote. Each holder of convertible
preferred stock is entitled to the number of votes equal to the number of common stock shares into which the shares held by such holder
could be converted as of the Record Date. Holders of convertible preferred stock and common stock generally vote as a single class.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Dividends&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Holders of convertible preferred
stock are entitled to receive dividends, when, as and if declared by the board of directors, at the annual rate of 8% of the original
issue price, payable in preference and priority to any declaration or payment of any distribution on common stock of the Company in such
calendar year. No distributions may be made with respect to the common stock unless dividends on the convertible preferred stock have
been declared and all declared dividends on the convertible preferred stock have been paid or set aside for payment to the holders of
the convertible preferred stock. Dividends are noncumulative, and &lt;span style="-sec-ix-hidden: hidden-fact-244"&gt;none&lt;/span&gt; were declared as of December&#160;31, 2024 and December 31, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Liquidation Preference&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In the event of any liquidation,
dissolution, or winding up of the Company, the holders of Series&#160;C/C-1 convertible preferred stock shall be entitled to receive,
prior and in preference to any distribution of any of the assets of the Company to the holders of the Series&#160;B convertible preferred
stock, the Series&#160;A convertible preferred stock or common stock, an amount per share for each share of Series&#160;C/C-1 convertible
preferred stock held by them equal to the sum of the liquidation preference amount of respective original issue price per share, as adjusted
for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event
(&#x201c;anti-dilution adjustments&#x201d;) plus all declared but unpaid dividends on such shares. Should the Company&#x2019;s legally available
assets be insufficient to satisfy the liquidation preferences, the funds will be distributed with equal priority and &lt;i&gt;pro rata&lt;/i&gt; among
the holders of Series&#160;C/C-1 convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled
to receive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;After full payment to holders
of the Series&#160;C/C-1 convertible preferred stock, payment should be made to the holders of Series&#160;B convertible preferred stock,
in preference to the holders of the Series&#160;A convertible preferred stock or common stock, in the amount per share for each share
of Series&#160;B convertible preferred stock held by them equal to the original issue price of such share, adjusted for any anti-dilution
adjustments, plus all declared and unpaid dividends on such shares. Should the Company&#x2019;s legally available assets be insufficient
to satisfy the liquidation preferences, the funds will be distributed with equal priority and &lt;i&gt;pro rata&lt;/i&gt; among the holders of Series&#160;B
convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled to receive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;After full payment to holders
of the Series&#160;B convertible preferred stock, payment should be made to the holders of Series&#160;A convertible preferred stock,
in preference to the holders of the common stock, in the amount per share for each share of Series&#160;A convertible preferred stock
held by them equal to the original issue price of such share, adjusted for any anti-dilution adjustments, plus all declared and unpaid
dividends on such shares. Should the Company&#x2019;s legally available assets be insufficient to satisfy the liquidation preferences,
the funds will be distributed with equal priority and &lt;i&gt;pro rata&lt;/i&gt; among the holders of Series&#160;A convertible preferred stock in
proportion to the preferential amount each holder is otherwise entitled to receive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;After the payment to the holders
of convertible preferred stock of the full preferential amounts specified above, the entire remaining assets of the Company legally available
for distribution by the Company shall be distributed with equal priority and &lt;i&gt;pro rata&lt;/i&gt; among the holders of the common stock and
holders of convertible preferred stock as-if-converted to common stock basis in proportion to the number of shares of common stock held
by them.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Conversion&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Each share of convertible
preferred stock is convertible, at the option of the holder, into the number of fully-paid and non-assessable shares of common stock that
result from dividing the applicable original issue price per share by the applicable conversion price per share at the time of conversion,
as adjusted for any anti-dilution adjustments If, after the issuance date of convertible preferred stock, the Company issues or sells,
or is deemed to have sold, additional shares of common stock at a price lower than the original issuance price, except for certain exceptions
allowed, the conversion price of convertible preferred stock would be adjusted. As of December&#160;31, 2024 and December 31, 2023, the
Company&#x2019;s convertible preferred stock was convertible into the Company&#x2019;s shares of common stock on a one-for-one basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Each share of convertible
preferred stock is convertible into common stock automatically upon the earlier of (i)&#160;immediately upon the closing of a firmly underwritten
public offering pursuant to an effective registration statement under the Securities Act&#160;of&#160;1933, as amended, covering the offer
and sale of any class or security of the Company in which (a)&#160;the gross offering price per share reflects a pre-offering valuation
of the Company of not less than $200&#160;million, calculated on a fully-diluted and as-converted basis before giving effect to the issuance
of the securities to be sold in such public offering, and (b)&#160;the cash proceeds to the Company (net of underwriting discounts and
commissions) are at least $50&#160;million (a &#x201c;Qualified IPO&#x201d;); or (ii)&#160;the Company&#x2019;s receipt of a written request
for such conversion from at least a majority of holders of the then outstanding shares of convertible preferred stock, voting as a single
class on an as-if-converted basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Redemption and Balance Sheet Classification&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Convertible preferred stock
is recorded in mezzanine equity because while it is not mandatorily redeemable, it will become redeemable at the option of the stockholders
upon the occurrence of certain deemed liquidation events that are considered not solely within the Company&#x2019;s control.&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c326"
      decimals="0"
      id="ixv-39027"
      unitRef="shares">18551382</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c326"
      decimals="4"
      id="ixv-39028"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock contextRef="c22" id="ixv-21966">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Convertible preferred stock
as of December&#160;31, 2024 and December 31, 2023 consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Share &lt;br/&gt; Issued and &lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liquidation &lt;br/&gt; Preference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt; Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Original &lt;br/&gt; Issue Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;New Series&#160;A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,701&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,358,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,670,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,476&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;New Series&#160;C-1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;4.80&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,551,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,184&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;65,149&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c327"
      decimals="INF"
      id="ixv-39029"
      unitRef="shares">4350314</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c327"
      decimals="INF"
      id="ixv-39030"
      unitRef="shares">4350314</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c327"
      decimals="-3"
      id="ixv-39031"
      unitRef="usd">5307000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c327"
      decimals="-3"
      id="ixv-39032"
      unitRef="usd">5231000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c327"
      decimals="2"
      id="ixv-39033"
      unitRef="usdPershares">1.22</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c328"
      decimals="INF"
      id="ixv-39034"
      unitRef="shares">5293175</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c328"
      decimals="INF"
      id="ixv-39035"
      unitRef="shares">5293175</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c328"
      decimals="-3"
      id="ixv-39036"
      unitRef="usd">13815000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c328"
      decimals="-3"
      id="ixv-39037"
      unitRef="usd">13701000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c328"
      decimals="2"
      id="ixv-39038"
      unitRef="usdPershares">2.61</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c329"
      decimals="INF"
      id="ixv-39039"
      unitRef="shares">7358151</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c329"
      decimals="INF"
      id="ixv-39040"
      unitRef="shares">6670703</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c329"
      decimals="-3"
      id="ixv-39041"
      unitRef="usd">37623000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c329"
      decimals="-3"
      id="ixv-39042"
      unitRef="usd">37476000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c329"
      decimals="2"
      id="ixv-39043"
      unitRef="usdPershares">5.64</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c330"
      decimals="INF"
      id="ixv-39044"
      unitRef="shares">1549742</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c330"
      decimals="INF"
      id="ixv-39045"
      unitRef="shares">1549742</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c330"
      decimals="-3"
      id="ixv-39046"
      unitRef="usd">7439000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c330"
      decimals="-3"
      id="ixv-39047"
      unitRef="usd">8741000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c330"
      decimals="2"
      id="ixv-39048"
      unitRef="usdPershares">4.8</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c326"
      decimals="INF"
      id="ixv-39049"
      unitRef="shares">18551382</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c326"
      decimals="INF"
      id="ixv-39050"
      unitRef="shares">17863934</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c326"
      decimals="-3"
      id="ixv-39051"
      unitRef="usd">64184000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c326"
      decimals="-3"
      id="ixv-39052"
      unitRef="usd">65149000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="c22" decimals="2" id="ixv-39053" unitRef="pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:Dividends contextRef="c23" decimals="0" id="ixv-39054" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c22" decimals="-6" id="ixv-39055" unitRef="usd">200000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c22" decimals="-6" id="ixv-39056" unitRef="usd">50000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c22" id="ixv-22205">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;8 &#x2014;&#160;Common Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and December 31, 2023, the Company&#x2019;s certificate of incorporation authorized issuance of 40,000,000&#160;shares of common stock.
Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds
are legally available and when declared by the Board of Directors, subject to prior rights of the preferred stockholders. As of December&#160;31,
2024, no dividends have been declared to date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Conversion of Series&#160;A preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;B preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;C/C-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Outstanding options under 2010 Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Issuance of options under the 2010 Plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c1"
      decimals="0"
      id="ixv-39057"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockVotingRights contextRef="c23" id="ixv-39058">one</us-gaap:CommonStockVotingRights>
    <us-gaap:ScheduleOfConversionsOfStockTextBlock contextRef="c22" id="ixv-22211">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Conversion of Series&#160;A preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;B preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;C/C-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Outstanding options under 2010 Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Issuance of options under the 2010 Plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfConversionsOfStockTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c331"
      decimals="INF"
      id="ixv-39059"
      unitRef="shares">4350314</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c332"
      decimals="INF"
      id="ixv-39060"
      unitRef="shares">4350314</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c333"
      decimals="INF"
      id="ixv-39061"
      unitRef="shares">5293175</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c334"
      decimals="INF"
      id="ixv-39062"
      unitRef="shares">5293175</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c335"
      decimals="INF"
      id="ixv-39063"
      unitRef="shares">8220445</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c336"
      decimals="INF"
      id="ixv-39064"
      unitRef="shares">8220445</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c337"
      decimals="INF"
      id="ixv-39065"
      unitRef="shares">2972055</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c338"
      decimals="INF"
      id="ixv-39066"
      unitRef="shares">2982055</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c339"
      decimals="INF"
      id="ixv-39067"
      unitRef="shares">1560091</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c340"
      decimals="INF"
      id="ixv-39068"
      unitRef="shares">1550091</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c341"
      decimals="INF"
      id="ixv-39069"
      unitRef="shares">22396080</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c342"
      decimals="INF"
      id="ixv-39070"
      unitRef="shares">22396080</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock contextRef="c22" id="ixv-22289">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;9 &#x2014;&#160;Stock Option Plan&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In 2010, the Company adopted
the 2010 Equity Incentive Plan (the &#x201c;Plan&#x201d;) under which 2,000,000 shares of the Company&#x2019;s common stock have been initially
reserved for issuance to employees, directors and consultants. Options granted under the Plan may be either incentive stock options (&#x201c;ISO&#x201d;)
or nonqualified stock options (&#x201c;NSO&#x201d;). ISOs may be granted only to Company employees, including officers and directors who
are also employees. NSOs may be granted to Company employees, consultants and advisors.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;A person who owns (or is deemed
to own) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company will not
be granted an ISO unless the exercise price of such option is at&#160;least one hundred ten percent (110%) of the Fair Market Value on
the date of grant and the option is not exercisable after the expiration of five&#160;years from the date of grant. Options granted generally
vest over &lt;span style="-sec-ix-hidden: hidden-fact-254"&gt;four&lt;/span&gt;&#160;years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Activity under the Plan is
set forth below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Stock Option Activity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Available &lt;br/&gt; for Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Exercise &lt;br/&gt; Price Per &lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Remaining &lt;br/&gt; Contractual &lt;br/&gt; Term &lt;br/&gt; (in&#160;years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Balances at January&#160;1, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balances at December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Exercisable at December&#160;31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,548,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.32&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;Vested and expected to vest at December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;There were no new options
granted or exercised during the year ended December&#160;31, 2024. Intrinsic values are calculated as the difference between the exercise
price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the
fair value per share of the common stock on the date of exercise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The total fair value of options
vested for the&#160;year-ended December&#160;31, 2024 was less than $0.1&#160;million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024,
the total unrecognized stock-based compensation expense for stock options was less than $0.1&#160;million which is expected to be recognized
over a weighted-average period of 0.4&#160;years. On the grant date, the Company estimates the fair value of stock options using the Black
Scholes option-pricing model. The fair value of stock options is being recognized on a straight-line basis over the requisite service
period of the awards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Nonrecourse Promissory Notes to Early Exercise Stock Options&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In 2018, one of the Company&#x2019;s
executives early exercised 1,380,015 of his stock options by issuing a promissory note to the Company. As the promissory note is nonrecourse
this exercise of stock options with a promissory note is not considered a substantive exercise for accounting purposes. Therefore, no
receivable for the promissory note was recorded on the Company&#x2019;s balance sheet. This arrangement was accounted for as modifications
to the original stock options which were exercised by issuing a promissory note. Such modification did not result in additional stock-based
compensation expense. As of December&#160;31, 2024 these options were fully vested.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Stock-Based Compensation Expense by Function&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table is a summary
of stock compensation expense by function recognized for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General Administrative&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;33&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP
      contextRef="c343"
      decimals="0"
      id="ixv-39071"
      unitRef="shares">2000000</us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP>
    <ck0001859807:PercentageOfExcercisePriceOption
      contextRef="c343"
      decimals="2"
      id="ixv-39072"
      unitRef="pure">1.10</ck0001859807:PercentageOfExcercisePriceOption>
    <us-gaap:EmployeeStockOwnershipPlanESOPPlanDescription contextRef="c343" id="ixv-39073">five</us-gaap:EmployeeStockOwnershipPlanESOPPlanDescription>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c22" id="ixv-22327">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Activity under the Plan is
set forth below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Stock Option Activity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Available &lt;br/&gt; for Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Exercise &lt;br/&gt; Price Per &lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Remaining &lt;br/&gt; Contractual &lt;br/&gt; Term &lt;br/&gt; (in&#160;years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Balances at January&#160;1, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balances at December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Exercisable at December&#160;31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,548,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.32&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;Vested and expected to vest at December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c344"
      decimals="0"
      id="ixv-39074"
      unitRef="shares">1550091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c344"
      decimals="INF"
      id="ixv-39075"
      unitRef="shares">2982055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c344"
      decimals="2"
      id="ixv-39076"
      unitRef="usdPershares">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c345" id="ixv-39077">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired
      contextRef="c22"
      decimals="0"
      id="ixv-39078"
      unitRef="shares">10000</ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c22"
      decimals="INF"
      id="ixv-39079"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c22"
      decimals="3"
      id="ixv-39080"
      unitRef="usdPershares">0.001</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c1"
      decimals="0"
      id="ixv-39081"
      unitRef="shares">1560091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c1"
      decimals="INF"
      id="ixv-39082"
      unitRef="shares">2972055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c1"
      decimals="2"
      id="ixv-39083"
      unitRef="usdPershares">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c22" id="ixv-39084">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c1"
      decimals="INF"
      id="ixv-39085"
      unitRef="shares">1548910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c1"
      decimals="2"
      id="ixv-39086"
      unitRef="usdPershares">0.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c22" id="ixv-39087">P4Y3M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c1"
      decimals="INF"
      id="ixv-39088"
      unitRef="shares">2972055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c1"
      decimals="2"
      id="ixv-39089"
      unitRef="usdPershares">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c22" id="ixv-39090">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c22" decimals="-5" id="ixv-39091" unitRef="usd">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c1" decimals="-5" id="ixv-39092" unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c22" id="ixv-39093">P0Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c343"
      decimals="0"
      id="ixv-39094"
      unitRef="shares">1380015</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c22" id="ixv-22531">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table is a summary
of stock compensation expense by function recognized for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General Administrative&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;33&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c346"
      decimals="-3"
      id="ixv-39095"
      unitRef="usd">7000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c347"
      decimals="-3"
      id="ixv-39096"
      unitRef="usd">10000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c348"
      decimals="-3"
      id="ixv-39097"
      unitRef="usd">14000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c349"
      decimals="-3"
      id="ixv-39098"
      unitRef="usd">23000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c22" decimals="-3" id="ixv-39099" unitRef="usd">21000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c23" decimals="-3" id="ixv-39100" unitRef="usd">33000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c22" id="ixv-22602">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;10 &#x2014;&#160;Related Party Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company issued convertible
notes (also referred to as junior notes), Tasly convertible debt, and promissory notes to certain shareholders. Refer to Note&#160;5 for
detail.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="c22" id="ixv-22611">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;11 &#x2014;&#160;Net Loss per Share Attributable to Common
Stockholders&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Basic net loss per share is
computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Because the Company reported
a net loss for the years ended December&#160;31, 2024 and 2023, the number of shares used to calculate diluted net loss per common share
is the same as the number of shares used to calculate basic net loss per common share for those periods presented because the potentially
dilutive shares would have been antidilutive if included in the calculation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(9,230&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(10,281&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Weighted average shares used to computing basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,604,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,600,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss per share attributable to common stockholders&#160;&#x2013;&#160;basic and diluted:&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.65&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.84&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following outstanding
shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,363,624&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,251,941&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-255; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options to purchase common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;24,199,613&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23,097,930&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c22" id="ixv-22617">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(9,230&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(10,281&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Weighted average shares used to computing basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,604,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,600,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss per share attributable to common stockholders&#160;&#x2013;&#160;basic and diluted:&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.65&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.84&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="-3" id="ixv-39101" unitRef="usd">-9230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c23" decimals="-3" id="ixv-39102" unitRef="usd">-10281000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c22"
      decimals="0"
      id="ixv-39103"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c22"
      decimals="0"
      id="ixv-39104"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c23"
      decimals="0"
      id="ixv-39105"
      unitRef="shares">5600741</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c23"
      decimals="0"
      id="ixv-39106"
      unitRef="shares">5600741</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c22"
      decimals="2"
      id="ixv-39107"
      unitRef="usdPershares">-1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c22"
      decimals="2"
      id="ixv-39108"
      unitRef="usdPershares">-1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c23"
      decimals="2"
      id="ixv-39109"
      unitRef="usdPershares">-1.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c23"
      decimals="2"
      id="ixv-39110"
      unitRef="usdPershares">-1.84</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c22" id="ixv-22682">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following outstanding
shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,363,624&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,251,941&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-255; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options to purchase common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;24,199,613&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23,097,930&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c350"
      decimals="INF"
      id="ixv-39111"
      unitRef="shares">17863934</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c351"
      decimals="INF"
      id="ixv-39112"
      unitRef="shares">17863934</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c352"
      decimals="INF"
      id="ixv-39113"
      unitRef="shares">3363624</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c353"
      decimals="INF"
      id="ix_1_fact"
      unitRef="shares">2251941</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c356"
      decimals="INF"
      id="ixv-39115"
      unitRef="shares">2972055</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c357"
      decimals="INF"
      id="ixv-39116"
      unitRef="shares">2982055</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c22"
      decimals="INF"
      id="ixv-39117"
      unitRef="shares">24199613</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c23"
      decimals="INF"
      id="ixv-39118"
      unitRef="shares">23097930</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GovernmentAssistanceTextBlock contextRef="c22" id="ixv-22786">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;12 &#x2014;&#160;Government Grant Revenue&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Government grant revenue consists
of amounts the Company earns under grants from two government agencies: NIH and DARPA.&#160;These grants are provided either in the form
of expense reimbursement (expense reimbursement grants) or on a fixed fee basis (fixed fee grants). Under the expense reimbursement grants
the government agencies reimburse us for a portion of our expenses (allowable expenses) that have been incurred in a given period on the
basis of reports that the Company provides to these agencies. Fixed fee grants are awarded for specific research and development programs
undertaken by us. Under these grants the Company receives milestone payments from the government agencies upon our submission and approval
by the government of agreed upon deliverables, consisting primarily of the documented results of the specific research and development
programs.&lt;/p&gt;</us-gaap:GovernmentAssistanceTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c22" id="ixv-22813">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;13 &#x2014;&#160;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Income taxes in the Company&#x2019;s
combined financial statements have been calculated on a separate tax return basis. The following table presents the principal reasons
for the difference between the effective tax rate and the federal statutory income tax rate (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Tax benefit at U.S.&#160;federal statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,941&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,159&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State Tax, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14.58&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,347&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Permanent difference&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prior-Year deferred taxes adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.32&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(30&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.57&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change of valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(35.84&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(20.51&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,109&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective income tax rate&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The components of the provision for income taxes
are as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;State&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%"&gt;Federal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,607&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,127&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;State and local&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,705&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,312&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,109&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Less: change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,109&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Total provision for income taxes&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Significant components of the Company&#x2019;s deferred
tax assets as of December&#160;31, 2024 and 2023 were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;Accrued expenses&#160;&amp;amp; other&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;38&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Capitalized R&amp;amp;D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Net operating loss carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;R&amp;amp;D credit carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(37,455&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,143&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;No income tax expense was recorded during the year
ended December&#160;31, 2024 and 2023.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024,
Profusa, Inc. had Federal and state net operating loss carryforwards of $114.8M and $116.3M, respectively. The Federal and state net operating
loss carryforwards begin to expire in 2029. Federal net operating losses generated in tax&#160;years 2018 or thereafter have an indefinite
carryforward period. The amount of Federal net operating loss that does not expire is $91.6&#160;million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024,
Profusa, Inc. had Federal and California research credit carryforwards of $2.1M and $1.8M, respectively. The Federal tax credit carryforwards
begin to expire in 2032. The state tax credit carryforwards carryforward indefinitely.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Management believes that,
based upon a number of factors, which include the Company&#x2019;s historical operating performance and accumulated deficit, it is more
likely than not that the deferred tax assets will not be utilized. Therefore, the Company has recorded a full valuation allowance against
its deferred tax assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Internal Revenue Code (IRC)
section 382 limits the use of net operating loss and tax credit carryforwards in certain situations where changes occur in stock ownership
of a company. The annual limitation may result in the expiration of the Company&#x2019;s net operating loss and tax credit carryforwards
prior to utilization. The Company has not completed an IRC section 382 study as of December&#160;31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;No liability related to uncertain
tax positions is recorded in the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accrues for interest
and penalties as part of income tax expense. As of December&#160;31, 2024 and 2023, the Company has not accrued interest and/or penalties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company files tax returns
in the U.S.&#160;Federal, California and various other states. Due to the Company&#x2019;s net operating losses, its Federal and state
income tax returns remain subject to examination since inception. As of December&#160;31, 2024, there are no ongoing tax examinations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;27, 2020, Congress
passed the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The act contains many tax incentives intended
to assist companies and individuals during the COVID-19 outbreak. The Company received Paycheck Protection Program Loans during the&#160;years
ended December&#160;31, 2021 and December&#160;31, 2020 of $1.3&#160;million and $1.2&#160;million, respectively. The Company had $1.4&#160;million
of Paycheck Protection Program loans outstanding as of December&#160;31, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (&#x201c;IRA&#x201d;) was signed into federal law. IRA, among other things, imposes a nondeductible
1% excise tax after December&#160;31, 2022 on the fair market value of certain stock that is &#x201c;repurchased&#x201d; by a publicly traded
U.S.&#160;corporation or acquired by certain of its subsidiaries. The taxable amount is reduced by the fair market value of certain issuances
of stock throughout the year. The Company does not expect this tax law change to have a material impact on its consolidated financial
position; however, it will continue to evaluate its impact as further information becomes available. If average annual adjusted financial
statement income exceeds $1&#160;billion over a 3-taxable-year period, IRA also imposes a 15% corporate alternative minimum tax on adjusted
financial statement income for taxable&#160;years beginning after December&#160;31, 2022. The Company does not expect to incur this tax
in the foreseeable future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under the Tax Cuts and Jobs
Act&#160;of&#160;2017, research and development costs are no longer fully deductible and are required to be capitalized and amortized
for U.S.&#160;tax purposes effective January&#160;1, 2022. The mandatory capitalization requirement increases our deferred tax assets
and is fully offset with the valuation allowance.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c22" id="ixv-39119">The following table presents the principal reasons
for the difference between the effective tax rate and the federal statutory income tax rate (in thousands):&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Tax benefit at U.S.&#160;federal statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,941&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,159&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State Tax, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14.58&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,347&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Permanent difference&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prior-Year deferred taxes adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.32&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(30&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.57&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change of valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(35.84&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(20.51&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,109&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective income tax rate&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c22" decimals="4" id="ixv-39120" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c22" decimals="0" id="ixv-39121" unitRef="usd">-1941</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c23" decimals="4" id="ixv-39122" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c23" decimals="0" id="ixv-39123" unitRef="usd">-2159</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c22" decimals="4" id="ixv-39124" unitRef="pure">0.1458</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c22" decimals="0" id="ixv-39125" unitRef="usd">-1347</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c23" decimals="4" id="ixv-39126" unitRef="pure">0.0014</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c23" decimals="0" id="ixv-39127" unitRef="usd">-14</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c22" decimals="4" id="ixv-39128" unitRef="pure">-0.0006</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c22" decimals="0" id="ixv-39129" unitRef="usd">6</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c23" decimals="4" id="ixv-39130" unitRef="pure">-0.0006</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c23" decimals="0" id="ixv-39131" unitRef="usd">6</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="c22" decimals="4" id="ixv-39132" unitRef="pure">0.0032</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c22" decimals="0" id="ixv-39133" unitRef="usd">-30</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="c23" decimals="4" id="ixv-39134" unitRef="pure">-0.0057</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c23" decimals="0" id="ixv-39135" unitRef="usd">58</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c22" decimals="4" id="ixv-39136" unitRef="pure">-0.3584</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <ck0001859807:IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance contextRef="c22" decimals="0" id="ixv-39137" unitRef="usd">3312</ck0001859807:IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c23" decimals="4" id="ixv-39138" unitRef="pure">-0.2051</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <ck0001859807:IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance contextRef="c23" decimals="0" id="ixv-39139" unitRef="usd">2109</ck0001859807:IncomeTaxReconciliationsChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c22" decimals="4" id="ixv-39140" unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c23" decimals="4" id="ixv-39141" unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c22" id="ixv-22945">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The components of the provision for income taxes
are as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;State&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%"&gt;Federal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,607&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,127&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;State and local&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,705&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,312&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,109&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Less: change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,109&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Total provision for income taxes&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c22" decimals="0" id="ixv-39142" unitRef="usd">-1607</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c23" decimals="0" id="ixv-39143" unitRef="usd">2127</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c22" decimals="0" id="ixv-39144" unitRef="usd">-1705</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c23" decimals="0" id="ixv-39145" unitRef="usd">-18</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c22" decimals="0" id="ixv-39146" unitRef="usd">-3312</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c23" decimals="0" id="ixv-39147" unitRef="usd">2109</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c22" decimals="0" id="ixv-39148" unitRef="usd">3312</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c23" decimals="0" id="ixv-39149" unitRef="usd">-2109</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c22" id="ixv-23092">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Significant components of the Company&#x2019;s deferred
tax assets as of December&#160;31, 2024 and 2023 were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;Accrued expenses&#160;&amp;amp; other&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;38&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Capitalized R&amp;amp;D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Net operating loss carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;R&amp;amp;D credit carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(37,455&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,143&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c1" decimals="0" id="ixv-39150" unitRef="usd">70</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c2" decimals="0" id="ixv-39151" unitRef="usd">38</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <ck0001859807:DeferredTaxAssetsDepreciationAndAmortization contextRef="c1" decimals="0" id="ixv-39152" unitRef="usd">7</ck0001859807:DeferredTaxAssetsDepreciationAndAmortization>
    <ck0001859807:DeferredTaxAssetsDepreciationAndAmortization contextRef="c2" decimals="0" id="ixv-39153" unitRef="usd">2</ck0001859807:DeferredTaxAssetsDepreciationAndAmortization>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c1" decimals="0" id="ixv-39154" unitRef="usd">52</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c2" decimals="0" id="ixv-39155" unitRef="usd">38</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <ck0001859807:DeferredTaxAssetsConvertibleDebt contextRef="c1" decimals="0" id="ixv-39156" unitRef="usd">93</ck0001859807:DeferredTaxAssetsConvertibleDebt>
    <ck0001859807:DeferredTaxAssetsConvertibleDebt contextRef="c2" decimals="0" id="ixv-39157" unitRef="usd">5</ck0001859807:DeferredTaxAssetsConvertibleDebt>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c1" decimals="0" id="ixv-39158" unitRef="usd">1549</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c2" decimals="0" id="ixv-39159" unitRef="usd">1542</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c1" decimals="0" id="ixv-39160" unitRef="usd">32173</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c2" decimals="0" id="ixv-39161" unitRef="usd">29033</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c1" decimals="0" id="ixv-39162" unitRef="usd">3511</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c2" decimals="0" id="ixv-39163" unitRef="usd">3485</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsNet contextRef="c1" decimals="0" id="ixv-39164" unitRef="usd">37455</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c2" decimals="0" id="ixv-39165" unitRef="usd">34143</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c1" decimals="0" id="ixv-39166" unitRef="usd">37455</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c2" decimals="0" id="ixv-39167" unitRef="usd">34143</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="c1" decimals="-5" id="ixv-39168" unitRef="usd">114800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c1" decimals="-5" id="ixv-39169" unitRef="usd">116300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c1" decimals="-5" id="ixv-39170" unitRef="usd">91600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="c358"
      decimals="-5"
      id="ixv-39171"
      unitRef="usd">2100000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="c359"
      decimals="-5"
      id="ixv-39172"
      unitRef="usd">1800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <ck0001859807:ReceivedPaycheckProtectionProgramLoans
      contextRef="c360"
      decimals="-5"
      id="ixv-39173"
      unitRef="usd">1300000</ck0001859807:ReceivedPaycheckProtectionProgramLoans>
    <ck0001859807:ReceivedPaycheckProtectionProgramLoans
      contextRef="c361"
      decimals="-5"
      id="ixv-39174"
      unitRef="usd">1200000</ck0001859807:ReceivedPaycheckProtectionProgramLoans>
    <ck0001859807:PaycheckProtectionProgramLoansOutstanding contextRef="c1" decimals="-5" id="ixv-39175" unitRef="usd">1400000</ck0001859807:PaycheckProtectionProgramLoansOutstanding>
    <ck0001859807:PaycheckProtectionProgramLoansOutstanding contextRef="c2" decimals="-5" id="ixv-39176" unitRef="usd">1400000</ck0001859807:PaycheckProtectionProgramLoansOutstanding>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c362"
      decimals="2"
      id="ixv-39177"
      unitRef="pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment
      contextRef="c362"
      decimals="-9"
      id="ixv-39178"
      unitRef="usd">1000000000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c362"
      decimals="2"
      id="ixv-39179"
      unitRef="pure">0.15</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c22" id="ixv-23274">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;14 &#x2014;&#160;Segments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company operates as one operating segment.
The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) is its Chief Executive Officer, Ben Hwang, who reviews financial
information presented on a consolidated net loss basis as reported on the consolidated statement of operations in order to make decisions
about allocating resources and assessing performance for the entire Company. The CODM also utilizes the Company&#x2019;s long-range plan,
which includes product development roadmaps and long-range financial models, as a key input to resource allocation. The CODM function
approves of key operating and strategic decisions. The CODM function views the Company&#x2019;s operations and manages its business on
a consolidated basis and as a single reportable operating segment. The CODM function is regularly provided with the following significant
segment expenses. Significant expenses include research and development and general and administrative expenses, which are each separately
presented in the Company&#x2019;s Consolidated Statements of Operations. The CODM reviews significant expenses within both the research
and development and the general and administrative categories. Other segment items within net loss include interest income, interest expense
and loss on change in fair value of related party loan. See the consolidated financial statements for other financial information regarding
the Company&#x2019;s operating segment.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Government grant revenue&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;45&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Operating expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Research personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,641&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;CRO and regulatory costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;186&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Administrative personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Rent and office costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Legal and accounting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other expenses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;120&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total segment expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,115&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,070&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Loss on change in the fair value of related party Tasly convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(311&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(22&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December&#160;31, 2024 and 2023, respectively)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,424&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,283&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;94&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,211&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss and comprehensive loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(9,230&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(10,281&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other expenses includes small balances of research materials and supplies along with insurance costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments contextRef="c22" decimals="0" id="ixv-39180" unitRef="pure">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="c22" id="ixv-39181">Other segment items within net loss include interest income, interest expense
and loss on change in fair value of related party loan. See the consolidated financial statements for other financial information regarding
the Company&#x2019;s operating segment.&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Government grant revenue&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;45&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Operating expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Research personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,641&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;CRO and regulatory costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;186&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Administrative personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Rent and office costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Legal and accounting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other expenses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;120&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;202&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total segment expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,115&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,070&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Loss on change in the fair value of related party Tasly convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(311&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(22&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December&#160;31, 2024 and 2023, respectively)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,424&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,283&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;94&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,211&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss and comprehensive loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(9,230&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(10,281&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other expenses includes small balances of research materials and supplies along with insurance costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Revenues contextRef="c22" decimals="-3" id="ixv-39182" unitRef="usd">100000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c23" decimals="-3" id="ixv-39183" unitRef="usd">45000</us-gaap:Revenues>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c22" decimals="-3" id="ixv-39184" unitRef="usd">1350000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c23" decimals="-3" id="ixv-39185" unitRef="usd">1641000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherCostAndExpenseOperating contextRef="c22" decimals="-3" id="ixv-39186" unitRef="usd">36000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="c23" decimals="-3" id="ixv-39187" unitRef="usd">186000</us-gaap:OtherCostAndExpenseOperating>
    <ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation contextRef="c22" decimals="-3" id="ixv-39188" unitRef="usd">1592000</ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation contextRef="c23" decimals="-3" id="ixv-39189" unitRef="usd">1434000</ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <ck0001859807:RentAndOfficeCosts contextRef="c22" decimals="-3" id="ixv-39190" unitRef="usd">279000</ck0001859807:RentAndOfficeCosts>
    <ck0001859807:RentAndOfficeCosts contextRef="c23" decimals="-3" id="ixv-39191" unitRef="usd">365000</ck0001859807:RentAndOfficeCosts>
    <ck0001859807:LegalAndAccountingCosts contextRef="c22" decimals="-3" id="ixv-39192" unitRef="usd">1223000</ck0001859807:LegalAndAccountingCosts>
    <ck0001859807:LegalAndAccountingCosts contextRef="c23" decimals="-3" id="ixv-39193" unitRef="usd">2287000</ck0001859807:LegalAndAccountingCosts>
    <us-gaap:OtherExpenses contextRef="c22" decimals="-3" id="ixv-39194" unitRef="usd">120000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="c23" decimals="-3" id="ixv-39195" unitRef="usd">202000</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses contextRef="c22" decimals="-3" id="ixv-39196" unitRef="usd">4600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c23" decimals="-3" id="ixv-39197" unitRef="usd">6115000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c22" decimals="-3" id="ixv-39198" unitRef="usd">-4500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c23" decimals="-3" id="ixv-39199" unitRef="usd">-6070000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c22" decimals="-3" id="ixv-39200" unitRef="usd">-311000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c23" decimals="-3" id="ixv-39201" unitRef="usd">-22000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseOther contextRef="c22" decimals="-3" id="ixv-39202" unitRef="usd">2400000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="c23" decimals="-3" id="ixv-39203" unitRef="usd">2530000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseNonoperating contextRef="c22" decimals="-3" id="ixv-39204" unitRef="usd">4424000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c23" decimals="-3" id="ixv-39205" unitRef="usd">4283000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherIncome contextRef="c22" decimals="-3" id="ixv-39206" unitRef="usd">5000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c23" decimals="-3" id="ixv-39207" unitRef="usd">94000</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense contextRef="c22" decimals="-3" id="ixv-39208" unitRef="usd">-4730000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c23" decimals="-3" id="ixv-39209" unitRef="usd">-4211000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="-3" id="ixv-39210" unitRef="usd">-9230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c23" decimals="-3" id="ixv-39211" unitRef="usd">-10281000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="c22" id="ixv-23509">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;15 &#x2014;&#160;Subsequent Events&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has evaluated
its subsequent events from December&#160;31, 2024, through the date these consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in these consolidated financial statements other than the items noted below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On various dates in February
and March 2025, the Company received an aggregate amount of $0.8 million from the issuance of Senior Secured Convertible Notes which are
expected to be converted in 2025 upon the closing of the Company&#x2019;s Qualified Financing transaction. These subsequent notes issued
in 2025 are on similar terms as all other Senior Secured Convertible Notes in issued in 2024.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c363"
      decimals="-5"
      id="ixv-39212"
      unitRef="usd">800000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c364"
      decimals="-5"
      id="ixv-39213"
      unitRef="usd">800000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c11" decimals="-3" id="ixv-39214" unitRef="usd">44000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c1" decimals="-3" id="ixv-39215" unitRef="usd">191000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c11" decimals="-3" id="ixv-39216" unitRef="usd">209000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c1" decimals="-3" id="ixv-39217" unitRef="usd">69000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c11" decimals="-3" id="ixv-39218" unitRef="usd">253000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c1" decimals="-3" id="ixv-39219" unitRef="usd">260000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts contextRef="c11" decimals="-3" id="ixv-39220" unitRef="usd">4136000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts contextRef="c1" decimals="-3" id="ixv-39221" unitRef="usd">2757000</us-gaap:DeferredCosts>
    <us-gaap:OtherAssetsNoncurrent contextRef="c11" decimals="-3" id="ixv-39222" unitRef="usd">55000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c1" decimals="-3" id="ixv-39223" unitRef="usd">56000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c11" decimals="-3" id="ixv-39224" unitRef="usd">4444000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c1" decimals="-3" id="ixv-39225" unitRef="usd">3073000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c11" decimals="-3" id="ixv-39226" unitRef="usd">6884000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c1" decimals="-3" id="ixv-39227" unitRef="usd">4954000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c11" decimals="-3" id="ixv-39228" unitRef="usd">4299000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c1" decimals="-3" id="ixv-39229" unitRef="usd">3968000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayable contextRef="c12" decimals="-3" id="ixv-39230" unitRef="usd">26670000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="c3" decimals="-3" id="ixv-39231" unitRef="usd">25056000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtCurrent contextRef="c11" decimals="-3" id="ixv-39232" unitRef="usd">49971000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="c1" decimals="-3" id="ixv-39233" unitRef="usd">45921000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:NotesPayable contextRef="c12" decimals="-3" id="ixv-39234" unitRef="usd">878000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c3" decimals="-3" id="ixv-39235" unitRef="usd">850000</us-gaap:NotesPayable>
    <us-gaap:NotesPayableCurrent contextRef="c11" decimals="-3" id="ixv-39236" unitRef="usd">940000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c1" decimals="-3" id="ixv-39237" unitRef="usd">910000</us-gaap:NotesPayableCurrent>
    <ck0001859807:PaycheckProtectionProgramLoan contextRef="c11" decimals="-3" id="ixv-39238" unitRef="usd">1383000</ck0001859807:PaycheckProtectionProgramLoan>
    <ck0001859807:PaycheckProtectionProgramLoan contextRef="c1" decimals="-3" id="ixv-39239" unitRef="usd">1376000</ck0001859807:PaycheckProtectionProgramLoan>
    <us-gaap:LiabilitiesCurrent contextRef="c11" decimals="-3" id="ixv-39240" unitRef="usd">63477000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c1" decimals="-3" id="ixv-39241" unitRef="usd">57129000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="c11" decimals="-3" id="ixv-39242" unitRef="usd">63477000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c1" decimals="-3" id="ixv-39243" unitRef="usd">57129000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c13"
      decimals="4"
      id="ixv-39244"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c5"
      decimals="4"
      id="ixv-39245"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c13"
      decimals="INF"
      id="ixv-39246"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c13"
      decimals="INF"
      id="ixv-39247"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c13"
      decimals="INF"
      id="ixv-39248"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-39249"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c5"
      decimals="INF"
      id="ixv-39250"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-39251"
      unitRef="shares">4350314</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c13" decimals="-3" id="ixv-39252" unitRef="usd">5307000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c5" decimals="-3" id="ixv-39253" unitRef="usd">5307000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c13" decimals="-3" id="ixv-39254" unitRef="usd">5231000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c5" decimals="-3" id="ixv-39255" unitRef="usd">5231000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c14"
      decimals="4"
      id="ixv-39256"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c7"
      decimals="4"
      id="ixv-39257"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c14"
      decimals="INF"
      id="ixv-39258"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c14"
      decimals="INF"
      id="ixv-39259"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c14"
      decimals="INF"
      id="ixv-39260"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c7"
      decimals="INF"
      id="ixv-39261"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c7"
      decimals="INF"
      id="ixv-39262"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ixv-39263"
      unitRef="shares">5293175</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c14" decimals="-3" id="ixv-39264" unitRef="usd">13815000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c7" decimals="-3" id="ixv-39265" unitRef="usd">13815000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c14" decimals="-3" id="ixv-39266" unitRef="usd">13701000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c7" decimals="-3" id="ixv-39267" unitRef="usd">13701000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c15"
      decimals="INF"
      id="ixv-39268"
      unitRef="shares">8907893</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c9"
      decimals="INF"
      id="ixv-39269"
      unitRef="shares">8907893</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c15"
      decimals="INF"
      id="ixv-39270"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c9"
      decimals="INF"
      id="ixv-39271"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c15"
      decimals="INF"
      id="ixv-39272"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="ixv-39273"
      unitRef="shares">8220445</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c15" decimals="-3" id="ixv-39274" unitRef="usd">45062000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c9" decimals="-3" id="ixv-39275" unitRef="usd">45062000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c15" decimals="-3" id="ixv-39276" unitRef="usd">46217000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c9" decimals="-3" id="ixv-39277" unitRef="usd">46217000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c11" decimals="-3" id="ixv-39278" unitRef="usd">65149000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c1" decimals="-3" id="ixv-39279" unitRef="usd">65149000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c11"
      decimals="4"
      id="ixv-39280"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c1"
      decimals="4"
      id="ixv-39281"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c11"
      decimals="INF"
      id="ixv-39282"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c1"
      decimals="INF"
      id="ixv-39283"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c11"
      decimals="INF"
      id="ixv-39284"
      unitRef="shares">5604651</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c1"
      decimals="INF"
      id="ixv-39285"
      unitRef="shares">5604651</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c11"
      decimals="INF"
      id="ixv-39286"
      unitRef="shares">5604651</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c1"
      decimals="INF"
      id="ixv-39287"
      unitRef="shares">5604651</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="c11" decimals="-3" id="ixv-39288" unitRef="usd">5840000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c1" decimals="-3" id="ixv-39289" unitRef="usd">5753000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c11" decimals="-3" id="ixv-39290" unitRef="usd">-130022000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c1" decimals="-3" id="ixv-39291" unitRef="usd">-124958000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="-3" id="ixv-39292" unitRef="usd">-124182000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c1" decimals="-3" id="ixv-39293" unitRef="usd">-119205000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c11" decimals="-3" id="ixv-39294" unitRef="usd">4444000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c1" decimals="-3" id="ixv-39295" unitRef="usd">3073000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c25" decimals="-3" id="ixv-39296" unitRef="usd">25000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c26" decimals="-3" id="ixv-39297" unitRef="usd">25000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c24" decimals="-3" id="ixv-39298" unitRef="usd">393000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c25" decimals="-3" id="ixv-39299" unitRef="usd">432000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-39300" unitRef="usd">827000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c26" decimals="-3" id="ixv-39301" unitRef="usd">938000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c24" decimals="-3" id="ixv-39302" unitRef="usd">610000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c25" decimals="-3" id="ixv-39303" unitRef="usd">569000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ixv-39304" unitRef="usd">1600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c26" decimals="-3" id="ixv-39305" unitRef="usd">1402000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c24" decimals="-3" id="ixv-39306" unitRef="usd">1003000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c25" decimals="-3" id="ixv-39307" unitRef="usd">1001000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="-3" id="ixv-39308" unitRef="usd">2427000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c26" decimals="-3" id="ixv-39309" unitRef="usd">2340000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c24" decimals="-3" id="ixv-39310" unitRef="usd">-1003000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c25" decimals="-3" id="ixv-39311" unitRef="usd">-976000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-39312" unitRef="usd">-2427000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c26" decimals="-3" id="ixv-39313" unitRef="usd">-2315000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c24" decimals="-3" id="ixv-39314" unitRef="usd">-57000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c25" decimals="-3" id="ixv-39315" unitRef="usd">-15000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c0" decimals="-3" id="ixv-39316" unitRef="usd">-118000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c26" decimals="-3" id="ixv-39317" unitRef="usd">-11000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseOther contextRef="c24" decimals="-3" id="ixv-39318" unitRef="usd">629000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="c25" decimals="-3" id="ixv-39319" unitRef="usd">575000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="c0" decimals="-3" id="ixv-39320" unitRef="usd">1333000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="c26" decimals="-3" id="ixv-39321" unitRef="usd">1199000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseNonoperating contextRef="c24" decimals="-3" id="ixv-39322" unitRef="usd">1289000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c25" decimals="-3" id="ixv-39323" unitRef="usd">1081000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c0" decimals="-3" id="ixv-39324" unitRef="usd">2519000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c26" decimals="-3" id="ixv-39325" unitRef="usd">2161000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherIncome contextRef="c24" decimals="-3" id="ixv-39326" unitRef="usd">1000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c25" decimals="-3" id="ixv-39327" unitRef="usd">1000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c26" decimals="-3" id="ixv-39328" unitRef="usd">6000</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense contextRef="c24" decimals="-3" id="ixv-39329" unitRef="usd">-1345000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c25" decimals="-3" id="ixv-39330" unitRef="usd">-1095000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="-3" id="ixv-39331" unitRef="usd">-2637000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c26" decimals="-3" id="ixv-39332" unitRef="usd">-2166000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c24" decimals="-3" id="ixv-39333" unitRef="usd">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c25" decimals="-3" id="ixv-39334" unitRef="usd">-2071000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-39335" unitRef="usd">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c26" decimals="-3" id="ixv-39336" unitRef="usd">-4481000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c24"
      decimals="2"
      id="ixv-39337"
      unitRef="usdPershares">-0.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c24"
      decimals="2"
      id="ixv-39338"
      unitRef="usdPershares">-0.42</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c25"
      decimals="2"
      id="ixv-39339"
      unitRef="usdPershares">-0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c25"
      decimals="2"
      id="ixv-39340"
      unitRef="usdPershares">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-39341"
      unitRef="usdPershares">-0.9</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-39342"
      unitRef="usdPershares">-0.9</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c26"
      decimals="2"
      id="ixv-39343"
      unitRef="usdPershares">-0.8</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c26"
      decimals="2"
      id="ixv-39344"
      unitRef="usdPershares">-0.8</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c24"
      decimals="INF"
      id="ixv-39345"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c24"
      decimals="INF"
      id="ixv-39346"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c25"
      decimals="INF"
      id="ixv-39347"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c25"
      decimals="INF"
      id="ixv-39348"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="ixv-39349"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="INF"
      id="ixv-39350"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c26"
      decimals="INF"
      id="ixv-39351"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c26"
      decimals="INF"
      id="ixv-39352"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="c52"
      decimals="INF"
      id="ixv-39353"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c52" decimals="-3" id="ixv-39354" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c53"
      decimals="INF"
      id="ixv-39355"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c53" decimals="-3" id="ixv-39356" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c54"
      decimals="INF"
      id="ixv-39357"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c54" decimals="-3" id="ixv-39358" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c55"
      decimals="INF"
      id="ixv-39359"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c56" decimals="-3" id="ixv-39360" unitRef="usd">5732000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c57" decimals="-3" id="ixv-39361" unitRef="usd">-115728000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-39362" unitRef="usd">-109996000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c74" decimals="-3" id="ixv-39363" unitRef="usd">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c76" decimals="-3" id="ixv-39364" unitRef="usd">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c75" decimals="-3" id="ixv-39365" unitRef="usd">-2071000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c76" decimals="-3" id="ixv-39366" unitRef="usd">-2071000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c77"
      decimals="INF"
      id="ixv-39367"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c77" decimals="-3" id="ixv-39368" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c78"
      decimals="INF"
      id="ixv-39369"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c78" decimals="-3" id="ixv-39370" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c79"
      decimals="INF"
      id="ixv-39371"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c79" decimals="-3" id="ixv-39372" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c80"
      decimals="INF"
      id="ixv-39373"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c81" decimals="-3" id="ixv-39374" unitRef="usd">5737000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c82" decimals="-3" id="ixv-39375" unitRef="usd">-117799000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c83" decimals="-3" id="ixv-39376" unitRef="usd">-112062000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c84" decimals="-3" id="ixv-39377" unitRef="usd">6000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c85" decimals="-3" id="ixv-39378" unitRef="usd">6000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c86" decimals="-3" id="ixv-39379" unitRef="usd">-2410000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c85" decimals="-3" id="ixv-39380" unitRef="usd">-2410000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c87"
      decimals="INF"
      id="ixv-39381"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c87" decimals="-3" id="ixv-39382" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c88"
      decimals="INF"
      id="ixv-39383"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c88" decimals="-3" id="ixv-39384" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c89"
      decimals="INF"
      id="ixv-39385"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c89" decimals="-3" id="ixv-39386" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c90"
      decimals="INF"
      id="ixv-39387"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c91" decimals="-3" id="ixv-39388" unitRef="usd">5743000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c92" decimals="-3" id="ixv-39389" unitRef="usd">-120209000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c93" decimals="-3" id="ixv-39390" unitRef="usd">-114466000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c64"
      decimals="INF"
      id="ixv-39391"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c64" decimals="-3" id="ixv-39392" unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c65"
      decimals="INF"
      id="ixv-39393"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c65" decimals="-3" id="ixv-39394" unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c66"
      decimals="INF"
      id="ixv-39395"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c66" decimals="-3" id="ixv-39396" unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c67"
      decimals="INF"
      id="ixv-39397"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c68" decimals="-3" id="ixv-39398" unitRef="usd">5753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c69" decimals="-3" id="ixv-39399" unitRef="usd">-124958000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c1" decimals="-3" id="ixv-39400" unitRef="usd">-119205000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c98" decimals="-3" id="ixv-39401" unitRef="usd">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c100"
      decimals="-3"
      id="ixv-39402"
      unitRef="usd">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c99" decimals="-3" id="ixv-39403" unitRef="usd">-2716000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c100"
      decimals="-3"
      id="ixv-39404"
      unitRef="usd">-2716000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c101"
      decimals="INF"
      id="ixv-39405"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c101"
      decimals="-3"
      id="ixv-39406"
      unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c102"
      decimals="INF"
      id="ixv-39407"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c102"
      decimals="-3"
      id="ixv-39408"
      unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c103"
      decimals="INF"
      id="ixv-39409"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c103"
      decimals="-3"
      id="ixv-39410"
      unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c104"
      decimals="INF"
      id="ixv-39411"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c105"
      decimals="-3"
      id="ixv-39412"
      unitRef="usd">5758000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c106"
      decimals="-3"
      id="ixv-39413"
      unitRef="usd">-127674000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c107"
      decimals="-3"
      id="ixv-39414"
      unitRef="usd">-121916000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c112"
      decimals="-3"
      id="ixv-39415"
      unitRef="usd">82000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c24" decimals="-3" id="ixv-39416" unitRef="usd">82000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="c113"
      decimals="-3"
      id="ixv-39417"
      unitRef="usd">-2348000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c24" decimals="-3" id="ixv-39418" unitRef="usd">-2348000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c114"
      decimals="INF"
      id="ixv-39419"
      unitRef="shares">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c114"
      decimals="-3"
      id="ixv-39420"
      unitRef="usd">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c115"
      decimals="INF"
      id="ixv-39421"
      unitRef="shares">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c115"
      decimals="-3"
      id="ixv-39422"
      unitRef="usd">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c116"
      decimals="INF"
      id="ixv-39423"
      unitRef="shares">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c116"
      decimals="-3"
      id="ixv-39424"
      unitRef="usd">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c117"
      decimals="INF"
      id="ixv-39425"
      unitRef="shares">5604651</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c118"
      decimals="-3"
      id="ixv-39426"
      unitRef="usd">5840000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c119"
      decimals="-3"
      id="ixv-39427"
      unitRef="usd">-130022000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="-3" id="ixv-39428" unitRef="usd">-124182000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-39429" unitRef="usd">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c26" decimals="-3" id="ixv-39430" unitRef="usd">-4481000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherNoncashExpense contextRef="c0" decimals="-3" id="ixv-39431" unitRef="usd">2519000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense contextRef="c26" decimals="-3" id="ixv-39432" unitRef="usd">2161000</us-gaap:OtherNoncashExpense>
    <ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt contextRef="c0" decimals="-3" id="ixv-39433" unitRef="usd">-118000</ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt>
    <ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt contextRef="c26" decimals="-3" id="ixv-39434" unitRef="usd">-11000</ck0001859807:GainLossOnChangeInFairValueOfRelatedPartyConvertibleDebt>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c26" decimals="-3" id="ixv-39435" unitRef="usd">-2000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-39436" unitRef="usd">82000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c26" decimals="-3" id="ixv-39437" unitRef="usd">11000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c26" decimals="-3" id="ixv-39438" unitRef="usd">-44000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="-3" id="ixv-39439" unitRef="usd">140000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c26" decimals="-3" id="ixv-39440" unitRef="usd">110000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c0" decimals="-3" id="ixv-39441" unitRef="usd">-1000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c26" decimals="-3" id="ixv-39442" unitRef="usd">1000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="-3" id="ixv-39443" unitRef="usd">1027000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c26" decimals="-3" id="ixv-39444" unitRef="usd">513000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c0" decimals="-3" id="ixv-39445" unitRef="usd">331000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c26" decimals="-3" id="ixv-39446" unitRef="usd">842000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-39447" unitRef="usd">-1126000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c26" decimals="-3" id="ixv-39448" unitRef="usd">-1008000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c0" decimals="-3" id="ixv-39449" unitRef="usd">1450000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c26" decimals="-3" id="ixv-39450" unitRef="usd">1120000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c26" decimals="-3" id="ixv-39451" unitRef="usd">16000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfSeniorDebt contextRef="c26" decimals="-3" id="ixv-39452" unitRef="usd">115000</us-gaap:RepaymentsOfSeniorDebt>
    <ck0001859807:PaymentOfDeferredOfferingCosts contextRef="c0" decimals="-3" id="ixv-39453" unitRef="usd">476000</ck0001859807:PaymentOfDeferredOfferingCosts>
    <ck0001859807:PaymentOfDeferredOfferingCosts contextRef="c26" decimals="-3" id="ixv-39454" unitRef="usd">117000</ck0001859807:PaymentOfDeferredOfferingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-39455" unitRef="usd">974000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c26" decimals="-3" id="ixv-39456" unitRef="usd">904000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-39457" unitRef="usd">-152000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c26" decimals="-3" id="ixv-39458" unitRef="usd">-104000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c1" decimals="-3" id="ixv-39459" unitRef="usd">191000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="-3" id="ixv-39460" unitRef="usd">142000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c11" decimals="-3" id="ixv-39461" unitRef="usd">39000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c172"
      decimals="-3"
      id="ixv-39462"
      unitRef="usd">38000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts contextRef="c0" decimals="-3" id="ixv-39463" unitRef="usd">904000</ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts>
    <ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts contextRef="c26" decimals="-3" id="ixv-39464" unitRef="usd">102000</ck0001859807:IncreasedecreaseInUnpaidDeferredOfferingCosts>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0" id="ixv-25339">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;1 &#x2014;&#160;Organization, Description
of Business, Going Concern and Significant Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Description of Business&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Profusa, Inc. (the &#x201c;Company&#x201d;)
was incorporated in the state of California on May&#160;11, 2009. The Company engaged in the development of a new generation of biointegrated
sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s technology
enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable,
clinical-grade data for personal and medical use. The Company&#x2019;s first offering in the European Union, the Lumee&#x2122; Oxygen Platform,
is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee&#x2122; Oxygen
Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease
that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores)
that do not heal properly; and reconstructive surgery.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s research
and development efforts are primarily focused on its Lumee&#x2122; Glucose Platform which is a system designed to monitor glucose levels
in interstitial fluid, continuously and long-term. A tiny, biocompatible gel injected under the skin acts as a continuous glucose monitor
(CGM) for several&#160;months. The ability of Lumee&#x2122; Glucose to provide continuous glucose monitoring with only an initial single
injection, is an attractive alternative for people with diabetes to manage their disease without the need for frequent finger sticks required
by standard glucometers, or the need for weekly sensor replacement as required by current short-term needle-type CGMs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;6, 2022,
the Company&#x2019;s board of directors unanimously approved the pursuit of a business combination transaction involving the Company. On
November&#160;7, 2022, the Company entered into an Agreement and Plan of Merger (&#x201c;Merger&#x201d;) with NorthView Acquisition Corp
(&#x201c;NorthView&#x201d;). The Company obtained Shareholder approval and successfully completed the merger on July&#160;11, 2025 where
a subsidiary of NorthView merged with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On February&#160;11, 2025,
the parties to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the &#x201c;Amendment&#x201d;) pursuant to which
the parties agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received
by Profusa prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment
(i)&#160;revised the definition of &#x201c;Milestone Event&#160;III&#x201d; such that the parties extended the period for Profusa to consummate
the APAC Joint Venture (as defined in the Merger Agreement) and receive the related funding from December&#160;31, 2024 until December&#160;31,
2025, and (ii)&#160;revised the definition of &#x201c;Milestone Event&#160;IV&#x201d; to change the earnout revenue target from $99,702,000
for the fiscal year ended December&#160;31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December&#160;31,
2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In relation to Milestone Event&#160;III:&#160;On
August&#160;8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (&#x201c;APAC&#x201d;), was created and incorporated by
the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $1,000 for 1,000&#160;Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (&#x201c;Tasly&#x201d;)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the &#x201c;APAC Joint
Venture&#x201d;) setting forth the relative and other terms under which the development and business activities of the entity will be conducted.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Going Concern&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has incurred significant
net operating losses from operations. As of June&#160;30, 2025, the Company has a working capital deficit of approximately $63.2&#160;million.
For the six&#160;months-ended June&#160;30, 2025, the Company incurred a net loss of approximately $5.1&#160;million and used approximately
$1.1&#160;million of cash in operating activities. Management expects to continue to incur additional substantial losses in the foreseeable
future as a result of research and development activities. The Company has been able to finance its operations primarily with the proceeds
from the issuance of equity and debt instruments and to a lesser extent, revenues from government grants. Additional funds may be necessary
to maintain current operations and will be required for successful product commercialization efforts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s condensed
consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business. The Company has reviewed the relevant conditions and events surrounding its ability to
continue as a going concern including among others: historical losses, projected future results, increased tariffs, cash requirements
for the upcoming year, funding capacity, net working capital, and future access to capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;11, 2025 Profusa,
Inc., a Delaware corporation formerly known as NorthView Acquisition Corporation, consummated its previously announced business combination
with Profusa, Inc., a California corporation, pursuant to that certain Merger Agreement and Plan of Reorganization. At the Closing and
pursuant to the PIPE Subscription Agreement, New Profusa issued a PIPE Convertible Note in the principal amount of $10,000,000 (the &#x201c;Initial
Note&#x201d;) for a purchase price of $9,000,000, reflecting a 10% Original Issuance Discount (&#x201c;OID&#x201d;). Management believes
this liquidity is not sufficient to alleviate the relevant conditions or events that raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued in August&#160;2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As part of the closing, the
Company had cash inflows of $1.3&#160;million from the NorthView trust account, net of redemptions, and the $9&#160;million net PIPE convertible
note. Cash outflows included marketing fees and vendor payments which totaled $3.4&#160;million due at closing. Subsequent to the closing
of the Merger, there continue to be factors which raise substantial doubt about the Company&#x2019;s ability to continue as a going concern
within one year from the date the condensed consolidated financial statements are issued. The condensed consolidated financial statements
do not contain any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Significant Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company operates in a
dynamic and highly competitive industry and believes that changes in any of the following areas could have a material adverse effect on
the Company&#x2019;s future financial position, results of operations, or cash flows: ability to obtain future financing; advances and
trends in new technologies and industry standards; results of clinical trials; regulatory approval and market acceptance of the Company&#x2019;s
products; development of sales channels; certain strategic relationships; litigation or claims against the Company based on intellectual
property, patent, product, regulatory, or other factors; and the Company&#x2019;s ability to attract and retain employees necessary to
support its growth.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Products developed by the
Company require approvals from the U.S.&#160;Food and Drug Administration (&#x201c;FDA&#x201d;) or other international regulatory agencies
prior to commercial sales. There can be no assurance that the products will receive the necessary approvals. If the Company is denied
approval, approval is delayed or the Company is unable to maintain approval, it could have a materially adverse impact on the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has expended and will continue to
expend substantial funds to complete the research, development and clinical testing of product candidates. The Company also will be required
to expend additional funds to establish commercial-scale manufacturing arrangements and to provide for the marketing and distribution
of products that receive regulatory approval. For any periods after the twelve&#160;months subsequent to the filing of these financial
statements as of June&#160;30, 2025, the Company may be required to seek additional equity or debt financing to commercialize its products. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;If adequate funds are unavailable on a timely
basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more
of its research or development programs which would materially and adversely affect its business, financial condition and results of
operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Inflation, Monetary Response, and Economic
Impacts&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The world economy is experiencing
stubbornly high inflation, a challenge not faced for decades. Following the global financial crisis, with inflationary pressures muted,
interest rates were extremely low for&#160;years and investors became accustomed to low volatility. The resulting easing of financial
conditions supported economic growth, but it also contributed to a buildup of financial vulnerabilities. With inflation at multi-decade
highs, monetary authorities in advanced economies are accelerating the pace of policy normalization. Policymakers have continued to tighten
policy against a backdrop of rising inflation and currency pressures, albeit with notable differences across regions. Global financial
conditions have tightened notably this year, leading to capital outflows. Amid heightened economic and geopolitical uncertainties, investors
have aggressively pulled back from risk-taking and adjusted their investment preferences generally. Key gauges of systemic risk, such
as higher dollar funding costs and counterparty credit spreads, have risen. There is a risk of a disorderly tightening of financial conditions
that may be amplified by vulnerabilities built over the&#160;years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In addition, our business,
growth, financial condition or results of operations could be materially adversely affected by instability or changes in a country&#x2019;s
or region&#x2019;s economic conditions; inflation; changes in laws or regulations or in the interpretation of existing laws or regulations,
whether caused by a change in government or otherwise; increased difficulty of conducting business in a country or region due to actual
or potential political or military conflict; or action by the U.S.&#160;or foreign governments that may restrict our ability to transact
business in a foreign country or with certain foreign individuals or entities. A possible slowdown in global trade caused by increasing
tariffs or other restrictions could decrease consumer or corporate confidence and reduce consumer, government and corporate spending
in countries inside or outside the U.S., which could adversely affect our operations. Climate-related&#160;events, including extreme
weather events and natural disasters and their effect on critical infrastructure in the U.S.&#160;or internationally, could have similar
adverse effects on our operations, users, or third-party&#160;suppliers.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <ck0001859807:RevenueTarget contextRef="c365" decimals="0" id="ixv-39465" unitRef="usd">99702000</ck0001859807:RevenueTarget>
    <ck0001859807:RevenueTarget contextRef="c176" decimals="0" id="ixv-39466" unitRef="usd">11864000</ck0001859807:RevenueTarget>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c366" decimals="0" id="ixv-39467" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c366"
      decimals="0"
      id="ixv-39468"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ck0001859807:WorkingCapitalDeficit contextRef="c11" decimals="-5" id="ixv-39469" unitRef="usd">63200000</ck0001859807:WorkingCapitalDeficit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-5" id="ixv-39470" unitRef="usd">-5100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-5" id="ixv-39471" unitRef="usd">-1100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c367" decimals="0" id="ixv-39472" unitRef="usd">10000000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <ck0001859807:PurchasePrice contextRef="c368" decimals="0" id="ixv-39473" unitRef="usd">9000000</ck0001859807:PurchasePrice>
    <ck0001859807:PercentageOfOriginalIssuanceDiscount
      contextRef="c368"
      decimals="2"
      id="ixv-39474"
      unitRef="pure">0.10</ck0001859807:PercentageOfOriginalIssuanceDiscount>
    <us-gaap:Cash
      contextRef="c369"
      decimals="-5"
      id="ixv-39475"
      unitRef="usd">1300000</us-gaap:Cash>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c369"
      decimals="-6"
      id="ixv-39476"
      unitRef="usd">9000000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:PaymentForAdministrativeFees contextRef="c0" decimals="-5" id="ixv-39477" unitRef="usd">3400000</us-gaap:PaymentForAdministrativeFees>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-25451">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;2 &#x2014;&#160;Summary of Significant
Accounting Policies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying condensed
consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States
of America (&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission
(&#x201c;SEC&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Unaudited Interim Financial Information&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited
condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S.&#160;(&#x201c;U.S.&#160;GAAP&#x201d;).
The interim unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated
financial statements and in accordance with the rules and regulations of the United&#160;States Securities and Exchange Commission (the
&#x201c;SEC&#x201d;). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only
normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial position as of June&#160;30, 2025,
the results of its operations and changes to stockholders&#x2019; equity for the three and six&#160;months ended June&#160;30, 2025 and
2024, and its cash flows for the six&#160;months ended June&#160;30, 2025 and 2024. The results for the three and six&#160;months ended
June&#160;30, 2025, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2025, or any other
interim periods, or any future year or period. All amounts included herein have been rounded except where otherwise stated. As figures
are rounded, numbers presented throughout this document may not add up precisely to the totals we provide and percentages may not precisely
reflect the absolute figures. Certain disclosures have been consolidated or omitted from the unaudited interim condensed consolidated
financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying interim
unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and the related disclosures as of December&#160;31, 2024 and for the year then ended as found in the Form&#160;S-4/A filed by the Company
with the SEC on April&#160;3, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of condensed
consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and
expenses in the condensed consolidated financial statements and accompanying notes. The Company&#x2019;s management regularly assesses
these estimates, including those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance
for deferred tax assets, and valuation of stock-based awards. Actual results could differ from these estimates, and such differences
could be material to the Company&#x2019;s financial position and results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Accounts Receivable and Allowance for Credit
Losses&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company does not have
any accounts receivable with customers in the six&#160;months ended June&#160;30, 2025 and 2024. The Company has developed policies that
when accounts receivables are held with customers, they are recorded at the point in time in which management determines it is probable
that the Company will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services
transferred to the customer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of June&#160;30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#x2019;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash. The Company&#x2019;s other receivables are represented by amounts owned by two government agencies under the government
grants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all
highly liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of June&#160;30,
2025 and 2024, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Deferred Offering Costs&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of
securities, all of the costs are expensed. Offering costs capitalized as of June&#160;30, 2025 and December&#160;31, 2024 were $4.1&#160;million
and $2.8&#160;million, respectively. The deferred offering costs as of June&#160;30, 2025 and December&#160;31, 2024 includes $1.3&#160;million
and $0.8&#160;million respectively, of advances to NorthView to fund costs associated with the business combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Government Grants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company receives payments
from government entities under non-refundable grants in support of product development programs. The grants received fall within two categories:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expense Reimbursement Grants&#160;&#x2014;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fixed Fee Grants&#160;&#x2014;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non- exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as the Company is a business entity, and the grants are with governmental
agencies or units.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In absence of explicit U.S.&#160;GAAP
guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#x201c;IAS
20&#x201d;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method,
grant income is recognized using the same proportion as the costs incurred to date to the total expected cost of the project, but limiting
the income to be recognized to the amount to which the Company is entitled based on the submitted deliverables.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s financial
instruments consist of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company
states accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment.
The promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June&#160;2023-February&#160;2024
(Note&#160;5) is carried at fair value based on unobservable market inputs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the six&#160;months ended June&#160;30, 2025 and through the date of issuance
of these condensed consolidated financial statements, there have been no new, or existing, recently issued accounting pronouncements that
are of significance, or potential significance, that impact the Company&#x2019;s condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Recently issued accounting standards not yet
adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#x201c;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#x201d;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU&#160;2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early
adoption permitted and can be applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine
its impact on the income tax disclosures. No material financial impact will result in this expanded disclosure requirement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2024, the
FASB issued ASU No.&#160;2024-03 (&#x201c;ASU&#160;2024-03&#x201d;), Disaggregation of Income Statement Expenses (&#x201c;DISE&#x201d;). ASU&#160;2024-03
requires disaggregated disclosure of income statement expenses for public business entities. ASU&#160;2024-03 does not change the expense
captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified
categories in disclosures within the footnotes to the financial statements. As revised by ASU No.&#160;2025-01, Income Statement&#160;&#x2014;&#160;Reporting
Comprehensive Income&#160;&#x2014;&#160;Expense Disaggregation Disclosures, the provisions of ASU&#160;2024-03 are effective for fiscal&#160;years
beginning after December&#160;15, 2026, and interim periods within fiscal&#160;years beginning after December&#160;15, 2027, with early
adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, the Company
does not expect the adoption of ASU&#160;2024-03 to have a material effect on our consolidated financial statements taken as a whole.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-25456">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying condensed
consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United&#160;States
of America (&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission
(&#x201c;SEC&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Unaudited Interim Financial Information&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited
condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S.&#160;(&#x201c;U.S.&#160;GAAP&#x201d;).
The interim unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated
financial statements and in accordance with the rules and regulations of the United&#160;States Securities and Exchange Commission (the
&#x201c;SEC&#x201d;). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only
normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial position as of June&#160;30, 2025,
the results of its operations and changes to stockholders&#x2019; equity for the three and six&#160;months ended June&#160;30, 2025 and
2024, and its cash flows for the six&#160;months ended June&#160;30, 2025 and 2024. The results for the three and six&#160;months ended
June&#160;30, 2025, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2025, or any other
interim periods, or any future year or period. All amounts included herein have been rounded except where otherwise stated. As figures
are rounded, numbers presented throughout this document may not add up precisely to the totals we provide and percentages may not precisely
reflect the absolute figures. Certain disclosures have been consolidated or omitted from the unaudited interim condensed consolidated
financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying interim
unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and the related disclosures as of December&#160;31, 2024 and for the year then ended as found in the Form&#160;S-4/A filed by the Company
with the SEC on April&#160;3, 2025.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-25509">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of condensed
consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and
expenses in the condensed consolidated financial statements and accompanying notes. The Company&#x2019;s management regularly assesses
these estimates, including those related to accrued liabilities, valuation of the convertible debt, and senior notes, valuation allowance
for deferred tax assets, and valuation of stock-based awards. Actual results could differ from these estimates, and such differences
could be material to the Company&#x2019;s financial position and results of operations.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c0" id="ixv-25518">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Accounts Receivable and Allowance for Credit
Losses&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company does not have
any accounts receivable with customers in the six&#160;months ended June&#160;30, 2025 and 2024. The Company has developed policies that
when accounts receivables are held with customers, they are recorded at the point in time in which management determines it is probable
that the Company will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services
transferred to the customer.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company will then perform
ongoing credit evaluations of its customers and, if necessary, recognize allowances for potential credit losses. The Company does not
require any allowance for credit losses as of June&#160;30, 2025 and 2024.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0" id="ixv-25530">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to a concentration of credit risk consist of cash and other receivables. Substantially all of the Company&#x2019;s
cash is held by one financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced
any losses on its cash. The Company&#x2019;s other receivables are represented by amounts owned by two government agencies under the government
grants.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0" id="ixv-25538">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all
highly liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. As of June&#160;30,
2025 and 2024, cash consisted of cash on deposit with a bank denominated in U.S.&#160;dollars.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c0" id="ixv-25547">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Deferred Offering Costs&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Specific incremental costs,
consisting of legal, accounting and other fees and costs, directly attributable to a proposed or actual offering of securities are deferred
and charged against the gross proceeds of the offering. In the event of a significant delay or cancellation of a planned offering of
securities, all of the costs are expensed. Offering costs capitalized as of June&#160;30, 2025 and December&#160;31, 2024 were $4.1&#160;million
and $2.8&#160;million, respectively. The deferred offering costs as of June&#160;30, 2025 and December&#160;31, 2024 includes $1.3&#160;million
and $0.8&#160;million respectively, of advances to NorthView to fund costs associated with the business combination.&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <ck0001859807:OfferingCosts contextRef="c11" decimals="-5" id="ixv-39478" unitRef="usd">4100000</ck0001859807:OfferingCosts>
    <ck0001859807:OfferingCosts contextRef="c1" decimals="-5" id="ixv-39479" unitRef="usd">2800000</ck0001859807:OfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="c370"
      decimals="-5"
      id="ixv-39480"
      unitRef="usd">1300000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="c371"
      decimals="-5"
      id="ixv-39481"
      unitRef="usd">800000</us-gaap:DeferredOfferingCosts>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c0" id="ixv-25585">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Government Grants&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company receives payments
from government entities under non-refundable grants in support of product development programs. The grants received fall within two categories:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expense Reimbursement Grants&#160;&#x2014;&#160;grants in which the Company is entitled to claim from a
government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined
by each respective grant;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fixed Fee Grants&#160;&#x2014;&#160;grants in which the total amount of the grant is fixed and the disbursements
are made based on submission to the grantor of specified deliverables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has concluded that
all government grants received are outside the scope of ASC&#160;606 Revenue from Contracts with Customers, because such grants do not
involve a reciprocal transfer in which each party receives and sacrifices approximately commensurate value. Therefore, the grants meet
the definition of a contribution and are non- exchange transactions. The Company has further concluded that Subtopic&#160;958-605, Not-for-Profit-Entities-Revenue
Recognition does not apply to the government grants received, as the Company is a business entity, and the grants are with governmental
agencies or units.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In absence of explicit U.S.&#160;GAAP
guidance on contributions received by business entities, the Company made a policy decision to apply by analogy recognition and measurement
guidance in International Accounting Standard 20 Accounting for Government Grants and Disclosure of Government Assistance (&#x201c;IAS
20&#x201d;). Under this approach recognize grants at fair value only when there is reasonable assurance that the Company will comply with
the conditions attaching to them, and that the grants will be received. The Company recognizes as income the amounts received or receivable
from expense reimbursement grants to the extent, and in the period in which, the qualifying costs have been incurred. The Company recognizes
as income the amounts received or receivable from fixed fee grants by applying the proportional performance method. Under this method,
grant income is recognized using the same proportion as the costs incurred to date to the total expected cost of the project, but limiting
the income to be recognized to the amount to which the Company is entitled based on the submitted deliverables.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0" id="ixv-25613">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s financial
instruments consist of other receivables, accounts payable, promissory notes, convertible promissory notes and senior notes. The Company
states accounts payable at their carrying value, which approximates fair value due to the short time to the expected receipt or payment.
The promissory notes are stated at amortized cost, which approximates their fair value, because the Company believes their terms approximate
those that would be available to it on a similar loan from an unrelated party. The Tasly convertible debt issued between June&#160;2023-February&#160;2024
(Note&#160;5) is carried at fair value based on unobservable market inputs.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-25621">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, new accounting
standards are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) or other standard setting bodies that are adopted
by the Company as of the specified effective date. During the six&#160;months ended June&#160;30, 2025 and through the date of issuance
of these condensed consolidated financial statements, there have been no new, or existing, recently issued accounting pronouncements that
are of significance, or potential significance, that impact the Company&#x2019;s condensed consolidated financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Recently issued accounting standards not yet
adopted&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU&#160;2023-09 &#x201c;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#x201d;, to expand the disclosure
requirements for income taxes, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation.
ASU&#160;2023-09 is effective for annual reporting periods beginning after December&#160;15, 2024, with early
adoption permitted and can be applied on either a prospective or retroactive basis. The Company is currently evaluating the ASU to determine
its impact on the income tax disclosures. No material financial impact will result in this expanded disclosure requirement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2024, the
FASB issued ASU No.&#160;2024-03 (&#x201c;ASU&#160;2024-03&#x201d;), Disaggregation of Income Statement Expenses (&#x201c;DISE&#x201d;). ASU&#160;2024-03
requires disaggregated disclosure of income statement expenses for public business entities. ASU&#160;2024-03 does not change the expense
captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified
categories in disclosures within the footnotes to the financial statements. As revised by ASU No.&#160;2025-01, Income Statement&#160;&#x2014;&#160;Reporting
Comprehensive Income&#160;&#x2014;&#160;Expense Disaggregation Disclosures, the provisions of ASU&#160;2024-03 are effective for fiscal&#160;years
beginning after December&#160;15, 2026, and interim periods within fiscal&#160;years beginning after December&#160;15, 2027, with early
adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, the Company
does not expect the adoption of ASU&#160;2024-03 to have a material effect on our consolidated financial statements taken as a whole.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c0" id="ixv-25668">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;3 &#x2014;&#160;Fair Value Measurement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Assets and liabilities recorded
at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used
to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize
the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes
a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap; width: 0.5in; padding-bottom: 2.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.65in; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;1&#160;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 2.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 2.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;2&#160;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 2.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 2.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;3&#160;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In determining fair value,
the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the
extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Assets and liabilities measured
at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The
Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management
to make judgments and consider factors specific to the asset or liability. As of June&#160;30, 2025 and December&#160;31, 2024, the Company
had no financial assets measured at fair value on a recurring basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, the
Company&#x2019;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of June&#160;30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments for the three and six&#160;months ended
June&#160;30, 2025 and 2024 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; convertible &lt;br/&gt; debt at fair &lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of January&#160;1, 2024&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Issuance of Convertible Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 0.125in"&gt;Change in fair value included in other income and gain on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of March&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,774&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of June&#160;30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of January&#160;1, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;61&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of March&#160;31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;57&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company elected to measure
its Tasly convertible debt at fair value (Note&#160;5) with changes in fair value reported in earnings as they occur. The Convertible
Debt fair values were determined using the discounted cash flow methodology based on probability weighted scenarios of the convertible
notes conversion. At issuance of the first $1&#160;million on June&#160;26, 2023 the time to event was 0.28&#160;years and the discount
rate applied was 14.54%. At issuance of the next $0.3&#160;million on July&#160;20, 2023, the time to event was 0.22&#160;years and the
discount rate applied was 13.82%. At issuance of the additional $0.3&#160;million on August&#160;15, 2023, the time to event was 0.15&#160;years
and the discount rate applied was 13.70%. The final amount which was less than $0.02&#160;million was issued on February&#160;6, 2024;
the time to event was 0.66&#160;years and the discount rate applied was 13.69%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On June&#160;30, 2025, the
time event was .03&#160;years and the discount rate applied was 12.66%. Based on this method, the Fair value of the convertible debt at
the date of inception was $1.6&#160;million, the fair value at June&#160;30, 2025 was $2.1&#160;million.&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="c0" id="ixv-39482">As of June&#160;30, 2025, the
Company&#x2019;s financial liabilities measured at fair value on a recurring basis, were as follows (in thousands)&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of June&#160;30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Convertible Notes at fair value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c383"
      decimals="-3"
      id="ixv-39483"
      unitRef="usd">2543000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c384"
      decimals="-3"
      id="ixv-39484"
      unitRef="usd">2543000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c383"
      decimals="-3"
      id="ixv-39485"
      unitRef="usd">2543000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c384"
      decimals="-3"
      id="ixv-39486"
      unitRef="usd">2543000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c387"
      decimals="-3"
      id="ixv-39487"
      unitRef="usd">2234000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c388"
      decimals="-3"
      id="ixv-39488"
      unitRef="usd">2234000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c387"
      decimals="-3"
      id="ixv-39489"
      unitRef="usd">2234000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c388"
      decimals="-3"
      id="ixv-39490"
      unitRef="usd">2234000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c0" id="ixv-25887">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments for the three and six&#160;months ended
June&#160;30, 2025 and 2024 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; convertible &lt;br/&gt; debt at fair &lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of January&#160;1, 2024&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Issuance of Convertible Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 0.125in"&gt;Change in fair value included in other income and gain on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of March&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,774&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of June&#160;30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of January&#160;1, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;61&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of March&#160;31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Accrued stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Change in fair value included in other income and loss on change in the fair value of Tasly convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;57&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue
      contextRef="c199"
      decimals="-3"
      id="ixv-39491"
      unitRef="usd">1714000</ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c389"
      decimals="-3"
      id="ixv-39492"
      unitRef="usd">16000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest
      contextRef="c389"
      decimals="-3"
      id="ixv-39493"
      unitRef="usd">48000</ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="c389"
      decimals="-3"
      id="ixv-39494"
      unitRef="usd">-4000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue
      contextRef="c390"
      decimals="-3"
      id="ixv-39495"
      unitRef="usd">1774000</ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest
      contextRef="c391"
      decimals="-3"
      id="ixv-39496"
      unitRef="usd">49000</ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="c391"
      decimals="-3"
      id="ixv-39497"
      unitRef="usd">15000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue
      contextRef="c392"
      decimals="-3"
      id="ixv-39498"
      unitRef="usd">1838000</ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue
      contextRef="c201"
      decimals="-3"
      id="ixv-39499"
      unitRef="usd">2234000</ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest
      contextRef="c393"
      decimals="-3"
      id="ixv-39500"
      unitRef="usd">95000</ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="c393"
      decimals="-3"
      id="ixv-39501"
      unitRef="usd">61000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue
      contextRef="c394"
      decimals="-3"
      id="ixv-39502"
      unitRef="usd">2390000</ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest
      contextRef="c395"
      decimals="-3"
      id="ixv-39503"
      unitRef="usd">96000</ck0001859807:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAccruedStatedInterest>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="c395"
      decimals="-3"
      id="ixv-39504"
      unitRef="usd">57000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue
      contextRef="c396"
      decimals="-3"
      id="ixv-39505"
      unitRef="usd">2543000</ck0001859807:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ConvertibleDebt
      contextRef="c178"
      decimals="-6"
      id="ixv-39506"
      unitRef="usd">1000000</us-gaap:ConvertibleDebt>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c179" id="ixv-39507">P0Y3M10D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c372"
      decimals="4"
      id="ixv-39508"
      unitRef="pure">0.1454</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleDebt
      contextRef="c180"
      decimals="-5"
      id="ixv-39509"
      unitRef="usd">300000</us-gaap:ConvertibleDebt>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c181" id="ixv-39510">P0Y2M19D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c373"
      decimals="4"
      id="ixv-39511"
      unitRef="pure">0.1382</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleDebt
      contextRef="c182"
      decimals="-5"
      id="ixv-39512"
      unitRef="usd">300000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c374" decimals="2" id="ixv-39513" unitRef="usd">0.15</us-gaap:ConvertibleDebtFairValueDisclosures>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c375"
      decimals="4"
      id="ixv-39514"
      unitRef="pure">0.137</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleDebt contextRef="c376" decimals="2" id="ixv-39515" unitRef="usd">0.02</us-gaap:ConvertibleDebt>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c377" id="ixv-39516">P0Y7M28D</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate
      contextRef="c378"
      decimals="4"
      id="ixv-39517"
      unitRef="pure">0.1369</ck0001859807:ConvertibleDebtOfDiscountRate>
    <ck0001859807:ConvertibleDebtOfTermFairValue contextRef="c379" id="ixv-39518">P3Y</ck0001859807:ConvertibleDebtOfTermFairValue>
    <ck0001859807:ConvertibleDebtOfDiscountRate contextRef="c0" decimals="4" id="ixv-39519" unitRef="pure">0.1266</ck0001859807:ConvertibleDebtOfDiscountRate>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c380" decimals="1" id="ixv-39520" unitRef="usd">1.6</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ShorttermDebtFairValue contextRef="c11" decimals="1" id="ixv-39521" unitRef="usd">2.1</us-gaap:ShorttermDebtFairValue>
    <srt:CondensedFinancialStatementsTextBlock contextRef="c0" id="ixv-26020">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;4 &#x2014;&#160;Balance Sheet Components&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Prepaid expenses and other current assets (in
thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Prepaid legal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prepaid insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Accrued Liabilities (in thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Accrued compensation&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(3,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued other liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(496&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(4,299&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(3,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:CondensedFinancialStatementsTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c0" id="ixv-26025">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Prepaid expenses and other current assets (in
thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Prepaid legal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prepaid insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <ck0001859807:PrepaidLegal contextRef="c11" decimals="-3" id="ixv-39522" unitRef="usd">48000</ck0001859807:PrepaidLegal>
    <ck0001859807:PrepaidLegal contextRef="c1" decimals="-3" id="ixv-39523" unitRef="usd">25000</ck0001859807:PrepaidLegal>
    <us-gaap:PrepaidInsurance contextRef="c11" decimals="-3" id="ixv-39524" unitRef="usd">31000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c1" decimals="-3" id="ixv-39525" unitRef="usd">37000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c11" decimals="-3" id="ixv-39526" unitRef="usd">130000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c1" decimals="-3" id="ixv-39527" unitRef="usd">7000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c11" decimals="-3" id="ixv-39528" unitRef="usd">209000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c1" decimals="-3" id="ixv-39529" unitRef="usd">69000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c0" id="ixv-26085">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Accrued Liabilities (in thousands)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Accrued compensation&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(3,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued other liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(496&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(4,299&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(3,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="c107"
      decimals="-3"
      id="ixv-39530"
      unitRef="usd">4090000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c1" decimals="-3" id="ixv-39531" unitRef="usd">3472000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c107"
      decimals="-3"
      id="ixv-39532"
      unitRef="usd">209000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c1" decimals="-3" id="ixv-39533" unitRef="usd">496000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c107"
      decimals="-3"
      id="ixv-39534"
      unitRef="usd">4299000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c1" decimals="-3" id="ixv-39535" unitRef="usd">3968000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0" id="ixv-26137">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;5 &#x2014;&#160;Debt&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the debt instruments and their changes during the six&#160;months ended June&#160;31, 2025 and 2024 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Promissory &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;PPP &lt;br/&gt; Loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px"&gt;Balance at January&#160;1, 2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-279"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-280"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-281"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-282"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-283"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-284"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-285"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-289"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-290"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-291"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;191&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-292"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-293"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-294"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Balance at June&#160;30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,895&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;940&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;27,895&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;940&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,383&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 36px"&gt;Long term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-295"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-296"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-297"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-298"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-299"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Promissory &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;PPP &lt;br/&gt; Loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px"&gt;Balance at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16,316&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,155&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;849&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-300"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-301"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-302"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-303"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(115&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-305"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-310"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;994&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-311"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-312"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-313"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-314"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Balance at June&#160;30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,348&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,154&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;880&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,369&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px"&gt;Long term debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-315"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-316"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-317"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-318"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-319"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;All debt was classified as
current debt as of June&#160;30, 2024 and 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Convertible Debt&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Convertible Notes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The annual effective interest
rate of Convertible Notes was estimated from 12.54% to 53.28% per year for the six&#160;months ended June&#160;30, 2025 and 12.66% to
53.28% per year for the six&#160;months ended June&#160;30, 2024. The interest expense for the three&#160;months ended June&#160;30, 2025
and 2024 was $0.6&#160;million and $0.5&#160;million, respectively. The interest expense for the six&#160;months ended June&#160;30, 2025,
and 2024 was $1.1&#160;million and $1.0&#160;million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 the
outstanding balance of convertible notes includes related party convertible notes of $14.1&#160;million. As of December&#160;31, 2024
the outstanding balance of convertible notes includes related party convertible notes of $13.3&#160;million. These notes were converted
into New Profusa common stock upon the successful closing of the merger on July&#160;11, 2025; see subsequent events (Note&#160;14).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Tasly Convertible Debt&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In June&#160;2023, the Company
entered into a short-term loan agreement with a related party under which it may borrow up to $1.6&#160;million, of which $1.0&#160;million
was borrowed on June&#160;26, 2023, $0.3&#160;million was borrowed on July&#160;20, 2023, $0.3&#160;million was borrowed on August&#160;15,
2023 and the final $0.02&#160;million was borrowed in February&#160;2024 (the &#x201c;Convertible debt&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The loans bear interest at
a rate of 12% per annum, 24% per annum default interest rate, and originally matured on December&#160;31, 2023. The original maturity
date was extended to March&#160;31, 2024, subject to the parties&#x2019; decision to extend thereafter. Upon occurrence of certain events
of default by the Company, including failure to repay in full the amounts owed at maturity, the lender will have an option to convert
the entire outstanding balance and accrued but unpaid interest under the Convertible debt into senior unsecured promissory notes on substantially
the same terms as the outstanding Senior Notes as of June&#160;30, 2025. In the event the Company fails to complete the formation of the
APAC Joint Venture or fail to repay the amounts under the Tasly Convertible Debt when they become due, the lender will have an option
to convert the entire outstanding balance and accrued but unpaid interest under the Convertible debt into either (i)&#160;senior unsecured
promissory notes on substantially the same terms as the outstanding Senior Notes as of June&#160;30, 2025, or (ii)&#160;the Company&#x2019;s
common stock at a conversion price of $1.92 per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company elected to apply
the fair value option to account for the Tasly Convertible debt. Accordingly, no features of the Convertible debt are bifurcated and separately
accounted for. The fair value of the Convertible debt was $2.1&#160;million as of June&#160;30, 2025. Accrued stated interest on the Tasly
Convertible debt was $0.1&#160;million and $0.2&#160;million for the three and six&#160;months ended June&#160;30, 2025, respectively.
Accrued stated interest on the Tasly Convertible debt was $0.05&#160;million and $0.1&#160;million
for the three and six&#160;months ended June&#160;30, 2024, respectively. Accrued interest since note origination is $0.47&#160;million
in total. The total loss on fair value remeasurement from origination through June&#160;30, 2025 was $0.45&#160;million, and the loss
on fair value remeasurement was recognized of $0.1&#160;million through June&#160;30, 2025.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Senior Notes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;January &#x2013; March&#160;2024
Senior Notes&lt;/i&gt;&#160;&#x2014;&#160;During the&#160;months January through March&#160;2024, the Company issued additional Senior Notes
to investors with the principal amount of $0.7&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;April&#160;&#x2013;&#160;June&#160;2024
Senior Notes&lt;/i&gt;&#160;&#x2014;&#160;During the&#160;months April through June&#160;2024, the Company issued additional Senior Notes to
investors with the principal amount of $0.4&#160;million on substantially the same terms as the Senior Notes issued in 2022 (as amended
in November&#160;2022). Additionally, the Company repaid $0.1&#160;million of principal on Senior Notes with investors during the respective
period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;January &#x2013; March&#160;2025
Senior Notes&lt;/i&gt;&#160;&#x2014;&#160;During the&#160;months January through March&#160;2025, the Company issued additional Senior Secured
Convertible Notes to investors with the principal amount of $0.8&#160;million on substantially the same terms as the Senior Notes issued
in 2022 (as amended in November&#160;2022). These notes were issued at the same 12% interest terms as all of their other Senior Secured
Convertible Notes, and will convert into New Profusa shares at $0.50 per share. These notes have an 18-month maturity, which will be accelerated
and convert into New Profusa shares upon the successful closing of the business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;April&#160;&#x2013;&#160;June&#160;2025
Senior Notes&lt;/i&gt;&#160;&#x2014;&#160;During the&#160;months April through June&#160;2025, the Company issued additional Senior Secured Convertible
Notes to investors with the principal amount of $0.4&#160;million issued on substantially the same terms as the Senior Notes issued in
2022 (as amended in November&#160;2022). These notes were issued at the same 12% interest terms as all of their other Senior Secured Convertible
Notes, and will convert into New Profusa shares at $0.50 per share. These notes have an 18-month maturity, which will be accelerated and
convert into New Profusa shares upon the successful closing of the business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Additionally, the Company issued
$0.3&#160;million in Senior Notes repayable upon the closing of the Business Combination which accrue interest at 0%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Of the $27.9&#160;million of
Senior Notes, $10.0&#160;million is outstanding with related parties and $17.9&#160;million is outstanding with unrelated parties as of
June&#160;30, 2025. Of the $25.3&#160;million of Senior Notes outstanding on December&#160;31, 2024, $9.5&#160;million was outstanding
with related parties and $15.8&#160;million was outstanding with unrelated parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The annual effective interest
rate of Senior Notes was estimated from 0% to 12.15% and 0% to 12.55% per year for the six&#160;months ended June&#160;30, 2025 and 2024,
respectively. The interest expense for the three&#160;months ended June&#160;30, 2025 and 2024 was $0.6&#160;million and $0.5&#160;million,
respectively. The interest expense for the six&#160;months ended June&#160;30, 2025 and 2024 was $1.2&#160;million and $1.0&#160;million,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, future
minimum payments for the convertible notes payable were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; padding-bottom: 1.5pt"&gt;As of June&#160;30, 2025&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;19,603&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;26,003&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total future payments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 12px"&gt;Less: fair value remeasurement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-320"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-321"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 12px"&gt;Less: unamortized debt discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-322"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-323"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 12px"&gt;Less: interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(70&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(195&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total convertible notes payable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,895&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;These notes were converted
into New Profusa common stock upon the successful closing of the merger on July&#160;11, 2025; see subsequent events (Note&#160;14).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In a series of transactions
during 2010 and 2011 two of the Company&#x2019;s founders provided $0.2&#160;million to the Company to fund general corporate purposes
in exchange for promissory notes. The notes accrue interest annually at a simple interest rate of 5% with no set maturity date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#160;31,
2022, the Company borrowed $0.3&#160;million from two of its founders at &lt;span style="-sec-ix-hidden: hidden-fact-324"&gt;zero&lt;/span&gt; interest rate to finance its short-term operations, from
which $0.2&#160;million was repaid in the same period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#160;31,
2023, the Company borrowed short-term promissory notes of $0.3&#160;million from an existing investor and additional $0.1&#160;million
from an unrelated party repayable on demand at any time after December&#160;31, 2023, with annual interest rate of 12%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the three and six&#160;months
ended June&#160;30, 2025 and 2024, the Company did not make any repayments from the outstanding balance of the promissory notes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 and
December&#160;31, 2024, accrued and unpaid interest on the promissory notes was $0.3&#160;million and $0.3&#160;million, respectively.
Interest expense on the promissory notes was less than $0.1&#160;million for each of the three and six&#160;months ended June&#160;30,
2025 and 2024. The carrying value of the promissory notes as of June&#160;30, 2025 and December&#160;31, 2024 was $0.9&#160;million and
$0.9&#160;million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Paycheck Protection Program&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On May&#160;25, 2021, the Company
borrowed $1.3&#160;million (the &#x201c;PPP Loan 2&#x201d;) as a Paycheck Protection Program loan. The Paycheck Protection Program, established
as part of the Coronavirus Aid, Relief, and Economic Security (&#x201c;CARES&#x201d;) Act, provides for loans to qualifying businesses and
is administered by the U.S.&#160;Small Business Administration (the &#x201c;SBA&#x201d;). The annual interest rate of the PPP Loan 2 is
1%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under the terms of PPP Loan
2, if the Company does not submit forgiveness application within 24&#160;weeks the initial disbursement of the loan (the &#x201c;Covered
Period&#x201d;), the Company must begin to make equal monthly payments of principal and interest starting 10&#160;months from the end of
the Covered Period until May&#160;25, 2026. Interest on the loan continues to accumulate during any deferment period. As of June&#160;30,
2025, the Company has not applied for forgiveness under PPP Loan 2.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and June&#160;30, 2025, the Company was in default on PPP Loan 2 due to non-payment of minimal repayment amounts required by the terms
of PPP Loan 2. Accordingly, the Company classified the entire amount outstanding under PPP Loan 2 as current and accrued respective late
penalties for the total amount of less than $0.1&#160;million as of June&#160;30, 2025 and December&#160;31, 2024, respectively. The total
past due amount of PPP Loan 2 repayments as of June&#160;30, 2025 and December&#160;31, 2024 was $1.0&#160;million and $0.8&#160;million,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, the
contractual future minimum payments for the PPP Loan 2 were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Year Ending December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-left: 0pt"&gt;2025 (remainder)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;145&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 12px"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c0" id="ixv-26141">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
a summary of the debt instruments and their changes during the six&#160;months ended June&#160;31, 2025 and 2024 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Promissory &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;PPP &lt;br/&gt; Loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px"&gt;Balance at January&#160;1, 2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;18,419&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,234&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25,268&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,376&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-279"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-280"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-281"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-282"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-283"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-284"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-285"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-289"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-290"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-291"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;191&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-292"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-293"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-294"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Balance at June&#160;30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,895&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;940&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;27,895&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;940&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,383&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 36px"&gt;Long term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-295"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-296"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-297"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-298"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-299"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Promissory &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;PPP &lt;br/&gt; Loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-weight: bold; text-indent: -12px; padding-left: 12px"&gt;Balance at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16,316&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,714&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,155&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;849&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Issuance of debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-300"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-301"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-302"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Debt repayments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-303"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(115&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-305"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-310"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -12px; padding-left: 12px"&gt;Stated interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;994&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 12px"&gt;Amortization of debt discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-311"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-312"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-313"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-314"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -12px; padding-left: 12px"&gt;Balance at June&#160;30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,348&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,154&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;880&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,369&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -12px; padding-left: 24px"&gt;Long term debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-315"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-316"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-317"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-318"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-319"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c316"
      decimals="-3"
      id="ixv-39536"
      unitRef="usd">18419000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c317"
      decimals="-3"
      id="ixv-39537"
      unitRef="usd">2234000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c318"
      decimals="-3"
      id="ixv-39538"
      unitRef="usd">25268000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c319"
      decimals="-3"
      id="ixv-39539"
      unitRef="usd">910000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c320"
      decimals="-3"
      id="ixv-39540"
      unitRef="usd">1376000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c446"
      decimals="-3"
      id="ixv-39541"
      unitRef="usd">1450000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c445"
      decimals="-3"
      id="ixv-39542"
      unitRef="usd">118000</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001859807:StatedInterest
      contextRef="c413"
      decimals="-3"
      id="ixv-39543"
      unitRef="usd">1098000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c445"
      decimals="-3"
      id="ixv-39544"
      unitRef="usd">191000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c446"
      decimals="-3"
      id="ixv-39545"
      unitRef="usd">1176000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c447"
      decimals="-3"
      id="ixv-39546"
      unitRef="usd">30000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c448"
      decimals="-3"
      id="ixv-39547"
      unitRef="usd">7000</ck0001859807:StatedInterest>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c413"
      decimals="-3"
      id="ixv-39548"
      unitRef="usd">16000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c446"
      decimals="-3"
      id="ixv-39549"
      unitRef="usd">1000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c449"
      decimals="-3"
      id="ixv-39550"
      unitRef="usd">19533000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c450"
      decimals="-3"
      id="ixv-39551"
      unitRef="usd">2543000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c451"
      decimals="-3"
      id="ixv-39552"
      unitRef="usd">27895000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c452"
      decimals="-3"
      id="ixv-39553"
      unitRef="usd">940000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c453"
      decimals="-3"
      id="ixv-39554"
      unitRef="usd">1383000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="c449"
      decimals="-3"
      id="ixv-39555"
      unitRef="usd">19533000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c450"
      decimals="-3"
      id="ixv-39556"
      unitRef="usd">2543000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c451"
      decimals="-3"
      id="ixv-39557"
      unitRef="usd">27895000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c452"
      decimals="-3"
      id="ixv-39558"
      unitRef="usd">940000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c453"
      decimals="-3"
      id="ixv-39559"
      unitRef="usd">1383000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c306"
      decimals="-3"
      id="ixv-39560"
      unitRef="usd">16316000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c307"
      decimals="-3"
      id="ixv-39561"
      unitRef="usd">1714000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c308"
      decimals="-3"
      id="ixv-39562"
      unitRef="usd">20155000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c309"
      decimals="-3"
      id="ixv-39563"
      unitRef="usd">849000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c310"
      decimals="-3"
      id="ixv-39564"
      unitRef="usd">1362000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c454"
      decimals="-3"
      id="ixv-39565"
      unitRef="usd">16000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c455"
      decimals="-3"
      id="ixv-39566"
      unitRef="usd">1120000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="c455"
      decimals="-3"
      id="ixv-39567"
      unitRef="usd">115000</us-gaap:RepaymentsOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c454"
      decimals="-3"
      id="ixv-39568"
      unitRef="usd">11000</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001859807:StatedInterest
      contextRef="c415"
      decimals="-3"
      id="ixv-39569"
      unitRef="usd">993000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c454"
      decimals="-3"
      id="ixv-39570"
      unitRef="usd">97000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c455"
      decimals="-3"
      id="ixv-39571"
      unitRef="usd">994000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c456"
      decimals="-3"
      id="ixv-39572"
      unitRef="usd">31000</ck0001859807:StatedInterest>
    <ck0001859807:StatedInterest
      contextRef="c457"
      decimals="-3"
      id="ixv-39573"
      unitRef="usd">7000</ck0001859807:StatedInterest>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c415"
      decimals="-3"
      id="ixv-39574"
      unitRef="usd">39000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c458"
      decimals="-3"
      id="ixv-39575"
      unitRef="usd">17348000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c459"
      decimals="-3"
      id="ixv-39576"
      unitRef="usd">1838000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c460"
      decimals="-3"
      id="ixv-39577"
      unitRef="usd">22154000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c461"
      decimals="-3"
      id="ixv-39578"
      unitRef="usd">880000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c462"
      decimals="-3"
      id="ixv-39579"
      unitRef="usd">1369000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c397"
      decimals="4"
      id="ixv-39580"
      unitRef="pure">0.1254</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c398"
      decimals="4"
      id="ixv-39581"
      unitRef="pure">0.5328</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c399"
      decimals="4"
      id="ixv-39582"
      unitRef="pure">0.1266</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c400"
      decimals="4"
      id="ixv-39583"
      unitRef="pure">0.5328</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpenseDebt contextRef="c24" decimals="1" id="ixv-39584" unitRef="usd">0.6</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c401"
      decimals="-5"
      id="ixv-39585"
      unitRef="usd">500000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c0" decimals="-5" id="ixv-39586" unitRef="usd">1100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c26" decimals="-5" id="ixv-39587" unitRef="usd">1000000</us-gaap:InterestExpenseDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c402"
      decimals="-5"
      id="ixv-39588"
      unitRef="usd">14100000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c403"
      decimals="-5"
      id="ixv-39589"
      unitRef="usd">13300000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="c404"
      decimals="-5"
      id="ixv-39590"
      unitRef="usd">1600000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBorrowings
      contextRef="c405"
      decimals="-5"
      id="ixv-39591"
      unitRef="usd">1000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="c406"
      decimals="-5"
      id="ixv-39592"
      unitRef="usd">300000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="c407"
      decimals="-5"
      id="ixv-39593"
      unitRef="usd">300000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="c408"
      decimals="-4"
      id="ixv-39594"
      unitRef="usd">20000.00</us-gaap:ShortTermBorrowings>
    <ck0001859807:DebtInterestRate
      contextRef="c409"
      decimals="2"
      id="ixv-39595"
      unitRef="pure">0.12</ck0001859807:DebtInterestRate>
    <ck0001859807:DebtInterestRate
      contextRef="c410"
      decimals="2"
      id="ixv-39596"
      unitRef="pure">0.24</ck0001859807:DebtInterestRate>
    <ck0001859807:CommonStockConvertibleConversionPrice
      contextRef="c411"
      decimals="2"
      id="ixv-39597"
      unitRef="usdPershares">1.92</ck0001859807:CommonStockConvertibleConversionPrice>
    <us-gaap:ConvertibleDebt contextRef="c11" decimals="-5" id="ixv-39598" unitRef="usd">2100000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="c412"
      decimals="-5"
      id="ixv-39599"
      unitRef="usd">100000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="c413"
      decimals="-5"
      id="ixv-39600"
      unitRef="usd">200000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="c414"
      decimals="-4"
      id="ixv-39601"
      unitRef="usd">50000.00</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="c415"
      decimals="-5"
      id="ixv-39602"
      unitRef="usd">100000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest contextRef="c379" decimals="2" id="ixv-39603" unitRef="usd">0.47</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <ck0001859807:LossOnFairValueRemeasurement
      contextRef="c416"
      decimals="-4"
      id="ixv-39604"
      unitRef="usd">450000</ck0001859807:LossOnFairValueRemeasurement>
    <ck0001859807:GainOnFairValueRemeasurement
      contextRef="c416"
      decimals="-5"
      id="ixv-39605"
      unitRef="usd">100000</ck0001859807:GainOnFairValueRemeasurement>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c417"
      decimals="-5"
      id="ixv-39606"
      unitRef="usd">700000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c418"
      decimals="-5"
      id="ixv-39607"
      unitRef="usd">400000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:RepaymentsOfDebt contextRef="c25" decimals="-5" id="ixv-39608" unitRef="usd">100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c419"
      decimals="-5"
      id="ixv-39609"
      unitRef="usd">800000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c419"
      decimals="2"
      id="ixv-39610"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare
      contextRef="c419"
      decimals="2"
      id="ixv-39611"
      unitRef="usdPershares">0.5</us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare>
    <ck0001859807:MaturityMonth contextRef="c420" id="ixv-39612">P18M</ck0001859807:MaturityMonth>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c421"
      decimals="-5"
      id="ixv-39613"
      unitRef="usd">400000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c422"
      decimals="2"
      id="ixv-39614"
      unitRef="pure">0.12</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare
      contextRef="c422"
      decimals="2"
      id="ixv-39615"
      unitRef="usdPershares">0.5</us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare>
    <ck0001859807:MaturityMonth contextRef="c24" id="ixv-39616">P18Y</ck0001859807:MaturityMonth>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c422"
      decimals="-5"
      id="ixv-39617"
      unitRef="usd">300000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <ck0001859807:PercentageOfAccrueInterest contextRef="c0" decimals="2" id="ixv-39618" unitRef="pure">0</ck0001859807:PercentageOfAccrueInterest>
    <us-gaap:SeniorNotes
      contextRef="c423"
      decimals="-5"
      id="ixv-39619"
      unitRef="usd">27900000</us-gaap:SeniorNotes>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="c424"
      decimals="-5"
      id="ixv-39620"
      unitRef="usd">10000000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="c425"
      decimals="-5"
      id="ixv-39621"
      unitRef="usd">17900000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:SeniorNotes
      contextRef="c274"
      decimals="-5"
      id="ixv-39622"
      unitRef="usd">25300000</us-gaap:SeniorNotes>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="c426"
      decimals="-5"
      id="ixv-39623"
      unitRef="usd">9500000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="c427"
      decimals="-5"
      id="ixv-39624"
      unitRef="usd">15800000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c428"
      decimals="2"
      id="ixv-39625"
      unitRef="pure">0</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c429"
      decimals="4"
      id="ixv-39626"
      unitRef="pure">0.1215</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c430"
      decimals="2"
      id="ixv-39627"
      unitRef="pure">0</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c431"
      decimals="4"
      id="ixv-39628"
      unitRef="pure">0.1255</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="c432"
      decimals="-5"
      id="ixv-39629"
      unitRef="usd">600000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c433"
      decimals="-5"
      id="ixv-39630"
      unitRef="usd">500000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c434"
      decimals="-5"
      id="ixv-39631"
      unitRef="usd">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c435"
      decimals="-5"
      id="ixv-39632"
      unitRef="usd">1000000</us-gaap:InterestExpenseDebt>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c0" id="ixv-26761">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, future
minimum payments for the convertible notes payable were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tasly &lt;br/&gt; Convertible &lt;br/&gt; Debt&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Senior &lt;br/&gt; Notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; padding-bottom: 1.5pt"&gt;As of June&#160;30, 2025&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;19,603&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;26,003&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total future payments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 12px"&gt;Less: fair value remeasurement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-320"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-321"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 12px"&gt;Less: unamortized debt discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-322"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-323"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 12px"&gt;Less: interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(70&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(195&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total convertible notes payable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;19,533&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,895&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c463"
      decimals="0"
      id="ixv-39633"
      unitRef="shares">19603</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c379"
      decimals="0"
      id="ixv-39634"
      unitRef="shares">2287</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c464"
      decimals="0"
      id="ixv-39635"
      unitRef="shares">26003</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ConvertibleDebt
      contextRef="c465"
      decimals="-3"
      id="ixv-39636"
      unitRef="usd">19603000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="c466"
      decimals="-3"
      id="ixv-39637"
      unitRef="usd">2287000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="c467"
      decimals="-3"
      id="ixv-39638"
      unitRef="usd">26003000</us-gaap:ConvertibleDebt>
    <ck0001859807:FairValueRemeasurement
      contextRef="c466"
      decimals="-3"
      id="ixv-39639"
      unitRef="usd">-451000</ck0001859807:FairValueRemeasurement>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="c467"
      decimals="-3"
      id="ixv-39640"
      unitRef="usd">-1967000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <ck0001859807:InterestExpensesNotesPayable
      contextRef="c465"
      decimals="-3"
      id="ixv-39641"
      unitRef="usd">70000</ck0001859807:InterestExpensesNotesPayable>
    <ck0001859807:InterestExpensesNotesPayable
      contextRef="c466"
      decimals="-3"
      id="ixv-39642"
      unitRef="usd">195000</ck0001859807:InterestExpensesNotesPayable>
    <ck0001859807:InterestExpensesNotesPayable
      contextRef="c467"
      decimals="-3"
      id="ixv-39643"
      unitRef="usd">75000</ck0001859807:InterestExpensesNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c465"
      decimals="-3"
      id="ixv-39644"
      unitRef="usd">19533000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c466"
      decimals="-3"
      id="ixv-39645"
      unitRef="usd">2543000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c467"
      decimals="-3"
      id="ixv-39646"
      unitRef="usd">27895000</us-gaap:ConvertibleNotesPayable>
    <ck0001859807:PromissoryNotes
      contextRef="c436"
      decimals="-5"
      id="ixv-39647"
      unitRef="usd">200000</ck0001859807:PromissoryNotes>
    <ck0001859807:PromissoryNotes
      contextRef="c437"
      decimals="-5"
      id="ixv-39648"
      unitRef="usd">200000</ck0001859807:PromissoryNotes>
    <us-gaap:ShortTermDebtInterestRateIncrease
      contextRef="c438"
      decimals="2"
      id="ixv-39649"
      unitRef="pure">0.05</us-gaap:ShortTermDebtInterestRateIncrease>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="c439"
      decimals="-5"
      id="ixv-39650"
      unitRef="usd">300000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="c439"
      decimals="-5"
      id="ixv-39651"
      unitRef="usd">200000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="c284"
      decimals="-5"
      id="ixv-39652"
      unitRef="usd">300000</us-gaap:ShortTermBorrowings>
    <ck0001859807:UnrelatedPartyRepayable
      contextRef="c440"
      decimals="-5"
      id="ixv-39653"
      unitRef="usd">100000</ck0001859807:UnrelatedPartyRepayable>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="c284"
      decimals="2"
      id="ixv-39654"
      unitRef="pure">0.12</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:DepositLiabilitiesAccruedInterest
      contextRef="c441"
      decimals="-5"
      id="ixv-39655"
      unitRef="usd">300000</us-gaap:DepositLiabilitiesAccruedInterest>
    <ck0001859807:UnpaidInterest
      contextRef="c286"
      decimals="-5"
      id="ixv-39656"
      unitRef="usd">300000</ck0001859807:UnpaidInterest>
    <us-gaap:InterestExpenseDebt
      contextRef="c438"
      decimals="-5"
      id="ixv-39657"
      unitRef="usd">100000</us-gaap:InterestExpenseDebt>
    <ck0001859807:PromissoryNotes
      contextRef="c438"
      decimals="-5"
      id="ixv-39658"
      unitRef="usd">900000</ck0001859807:PromissoryNotes>
    <ck0001859807:PromissoryNotes
      contextRef="c282"
      decimals="-5"
      id="ixv-39659"
      unitRef="usd">900000</ck0001859807:PromissoryNotes>
    <us-gaap:ShortTermBorrowings
      contextRef="c289"
      decimals="-5"
      id="ixv-39660"
      unitRef="usd">1300000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c290"
      decimals="2"
      id="ixv-39661"
      unitRef="pure">0.01</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LoansHeldForSaleTerm contextRef="c442" id="ixv-39662">P168D</us-gaap:LoansHeldForSaleTerm>
    <ck0001859807:MonthlyPayments contextRef="c443" id="ixv-39663">P10M</ck0001859807:MonthlyPayments>
    <ck0001859807:LatePenaltiesAmount
      contextRef="c442"
      decimals="-5"
      id="ixv-39664"
      unitRef="usd">100000</ck0001859807:LatePenaltiesAmount>
    <ck0001859807:LatePenaltiesAmount
      contextRef="c292"
      decimals="-5"
      id="ixv-39665"
      unitRef="usd">100000</ck0001859807:LatePenaltiesAmount>
    <us-gaap:DebtDefaultLongtermDebtAmount
      contextRef="c444"
      decimals="-5"
      id="ixv-39666"
      unitRef="usd">1000000</us-gaap:DebtDefaultLongtermDebtAmount>
    <us-gaap:DebtDefaultLongtermDebtAmount
      contextRef="c294"
      decimals="-5"
      id="ixv-39667"
      unitRef="usd">800000</us-gaap:DebtDefaultLongtermDebtAmount>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="c0" id="ixv-26929">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, the
contractual future minimum payments for the PPP Loan 2 were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Year Ending December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-left: 0pt"&gt;2025 (remainder)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;145&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 12px"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="c11" decimals="-3" id="ixv-39668" unitRef="usd">1245000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c11" decimals="-3" id="ixv-39669" unitRef="usd">145000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebt contextRef="c11" decimals="-3" id="ixv-39670" unitRef="usd">1390000</us-gaap:LongTermDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-26981">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;6 &#x2014;&#160;Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Operating Lease Obligations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Beginning in October&#160;2024,
the Company entered into a lease agreement whereby the Company agreed to rent its office and lab facilities under month-to-month tenancy.
The monthly rent payable under the lease is $25 thousand. This month-to-month lease automatically renews every four&#160;months, unless
written termination is provided.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Operating costs for short-term
leases include variable lease costs of $0.1&#160;million and less than $0.1&#160;million during the three&#160;months ended June&#160;30,
2025 and 2024, compared to $0.2&#160;million and $0.1&#160;million during the six&#160;months ended June&#160;30, 2025 and 2024. Starting
from August&#160;2022 the Company recognized lease expense in the amount of monthly rent as incurred. The Company recognized operating
lease costs for monthly rent of $75 thousand and $150 thousand for each of the three and six month periods ending June&#160;30, 2025 and
2024. Total operating lease costs with common area maintenance variable costs were $0.3&#160;million and $0.2&#160;million for the six&#160;months
ended June&#160;30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Contingencies and Indemnifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, the Company
may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability
for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant
judgment is required to determine both probability and the estimated amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In the normal course of business,
the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications.
The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future, but that have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to
its indemnification obligations. However, the Company may record charges in the future as a result of these indemnification obligations.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PaymentsForRent contextRef="c0" decimals="-3" id="ixv-39671" unitRef="usd">25000</us-gaap:PaymentsForRent>
    <us-gaap:ShortTermLeaseCost contextRef="c24" decimals="-5" id="ixv-39672" unitRef="usd">100000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeasePayment contextRef="c25" decimals="-5" id="ixv-39673" unitRef="usd">100000</us-gaap:VariableLeasePayment>
    <us-gaap:VariableLeasePayment contextRef="c0" decimals="-5" id="ixv-39674" unitRef="usd">200000</us-gaap:VariableLeasePayment>
    <us-gaap:VariableLeasePayment contextRef="c26" decimals="-5" id="ixv-39675" unitRef="usd">100000</us-gaap:VariableLeasePayment>
    <us-gaap:OperatingLeaseCost contextRef="c24" decimals="-3" id="ixv-39676" unitRef="usd">75000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c0" decimals="-3" id="ixv-39677" unitRef="usd">150000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeasePayment
      contextRef="c468"
      decimals="-5"
      id="ixv-39678"
      unitRef="usd">300000</us-gaap:VariableLeasePayment>
    <us-gaap:VariableLeasePayment
      contextRef="c469"
      decimals="-5"
      id="ixv-39679"
      unitRef="usd">200000</us-gaap:VariableLeasePayment>
    <us-gaap:PreferredStockTextBlock contextRef="c0" id="ixv-27008">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;7 &#x2014;&#160;Convertible Preferred
Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under the Company&#x2019;s Amended
and Restated Certificate of Incorporation, as amended, the Company is authorized to issue two classes of shares: preferred and common
stock. The preferred stock is issuable in series, and the Company&#x2019;s Board of Directors is authorized to determine the rights, preferences,
and terms of each series. Under the Company&#x2019;s Articles of Incorporation, as amended, the Company is authorized to issue 18,551,382
shares of convertible preferred stock at a par value of $0.0001.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Convertible preferred stock
as of June&#160;30, 2025 and December&#160;31, 2024 consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Share &lt;br/&gt; Issued and &lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liquidation &lt;br/&gt; Preference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt; Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Original &lt;br/&gt; Issue Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;New Series&#160;A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,701&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,358,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,670,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,476&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;New Series&#160;C-1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;4.80&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,551,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,184&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;65,149&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Voting Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The holders of convertible
preferred stock shares are entitled to vote on all matters on which the common stockholders are entitled to vote. Each holder of convertible
preferred stock is entitled to the number of votes equal to the number of common stock shares into which the shares held by such holder
could be converted as of the Record Date. Holders of convertible preferred stock and common stock generally vote as a single class.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Dividends&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Holders of convertible preferred
stock are entitled to receive dividends, when, as and if declared by the board of directors, at the annual rate of 8% of the original
issue price, payable in preference and priority to any declaration or payment of any distribution on common stock of the Company in such
calendar year. No distributions may be made with respect to the common stock unless dividends on the convertible preferred stock have
been declared and all declared dividends on the convertible preferred stock have been paid or set aside for payment to the holders of
the convertible preferred stock. Dividends are noncumulative, and &lt;span style="-sec-ix-hidden: hidden-fact-325"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-326"&gt;none&lt;/span&gt;&lt;/span&gt; were declared as of December&#160;31, 2024 and June&#160;30, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Liquidation Preference&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In the event of any liquidation,
dissolution, or winding up of the Company, the holders of Series&#160;C/C-1 convertible preferred stock shall be entitled to receive,
prior and in preference to any distribution of any of the assets of the Company to the holders of the Series&#160;B convertible preferred
stock, the Series&#160;A convertible preferred stock or common stock, an amount per share for each share of Series&#160;C/C-1 convertible
preferred stock held by them equal to the sum of the liquidation preference amount of respective original issue price per share, as adjusted
for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event
(&#x201c;anti-dilution adjustments&#x201d;) plus all declared but unpaid dividends on such shares. Should the Company&#x2019;s legally available
assets be insufficient to satisfy the liquidation preferences, the funds will be distributed with equal priority and&#160;&lt;i&gt;pro rata&lt;/i&gt;&#160;among
the holders of Series&#160;C/C-1 convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled
to receive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;After full payment to holders
of the Series&#160;C/C-1 convertible preferred stock, payment should be made to the holders of Series&#160;B convertible preferred stock,
in preference to the holders of the Series&#160;A convertible preferred stock or common stock, in the amount per share for each share
of Series&#160;B convertible preferred stock held by them equal to the original issue price of such share, adjusted for any anti-dilution
adjustments, plus all declared and unpaid dividends on such shares. Should the Company&#x2019;s legally available assets be insufficient
to satisfy the liquidation preferences, the funds will be distributed with equal priority and&#160;&lt;i&gt;pro rata&lt;/i&gt;&#160;among the holders
of Series&#160;B convertible preferred stock in proportion to the preferential amount each holder is otherwise entitled to receive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;After full payment to holders
of the Series&#160;B convertible preferred stock, payment should be made to the holders of Series&#160;A convertible preferred stock,
in preference to the holders of the common stock, in the amount per share for each share of Series&#160;A convertible preferred stock
held by them equal to the original issue price of such share, adjusted for any anti-dilution adjustments, plus all declared and unpaid
dividends on such shares. Should the Company&#x2019;s legally available assets be insufficient to satisfy the liquidation preferences,
the funds will be distributed with equal priority and&#160;&lt;i&gt;pro rata&lt;/i&gt;&#160;among the holders of Series&#160;A convertible preferred
stock in proportion to the preferential amount each holder is otherwise entitled to receive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;After the payment to the holders
of convertible preferred stock of the full preferential amounts specified above, the entire remaining assets of the Company legally available
for distribution by the Company shall be distributed with equal priority and&#160;&lt;i&gt;pro rata&lt;/i&gt;&#160;among the holders of the common
stock and holders of convertible preferred stock as-if-converted to common stock basis in proportion to the number of shares of common
stock held by them.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Conversion&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Each share of convertible preferred
stock is convertible, at the option of the holder, into the number of fully-paid and non-assessable shares of common stock that result
from dividing the applicable original issue price per share by the applicable conversion price per share at the time of conversion, as
adjusted for any anti-dilution adjustments If, after the issuance date of convertible preferred stock, the Company issues or sells, or
is deemed to have sold, additional shares of common stock at a price lower than the original issuance price, except for certain exceptions
allowed, the conversion price of convertible preferred stock
would be adjusted. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#x2019;s convertible preferred stock was convertible
into the Company&#x2019;s shares of common stock on a one-for-one basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Each share of convertible preferred
stock is convertible into common stock automatically upon the earlier of (i)&#160;immediately upon the closing of a firmly underwritten
public offering pursuant to an effective registration statement under the Securities Act&#160;of&#160;1933, as amended, covering the offer
and sale of any class or security of the Company in which (a)&#160;the gross offering price per share reflects a pre-offering valuation
of the Company of not less than $200&#160;million, calculated on a fully-diluted and as-converted basis before giving effect to the issuance
of the securities to be sold in such public offering, and (b)&#160;the cash proceeds to the Company (net of underwriting discounts and
commissions) are at least $50&#160;million (a &#x201c;Qualified IPO&#x201d;); or (ii)&#160;the Company&#x2019;s receipt of a written request
for such conversion from at least a majority of holders of the then outstanding shares of convertible preferred stock, voting as a single
class on an as-if-converted basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Redemption and Balance Sheet Classification&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Convertible preferred stock
is recorded in mezzanine equity because while it is not mandatorily redeemable, it will become redeemable at the option of the stockholders
upon the occurrence of certain deemed liquidation events that are considered not solely within the Company&#x2019;s control.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Upon the closing of the merger,
all Profusa Convertible Preferred stock was converted into New Profusa common shares, as further described in the Subsequent Events disclosure
below (See Note&#160;14).&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c470"
      decimals="0"
      id="ixv-39680"
      unitRef="shares">18551382</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c470"
      decimals="4"
      id="ixv-39681"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock contextRef="c0" id="ixv-27014">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Convertible preferred stock
as of June&#160;30, 2025 and December&#160;31, 2024 consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Share &lt;br/&gt; Issued and &lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liquidation &lt;br/&gt; Preference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt; Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Original &lt;br/&gt; Issue Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;New Series&#160;A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13,701&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;New Series&#160;C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,358,151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,670,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,476&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;New Series&#160;C-1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,549,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;4.80&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,551,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,184&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;65,149&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ck0001859807:ScheduleOfConvertiblePreferredStockTableTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c471"
      decimals="INF"
      id="ixv-39682"
      unitRef="shares">4350314</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c471"
      decimals="0"
      id="ixv-39683"
      unitRef="shares">4350314</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c471"
      decimals="-3"
      id="ixv-39684"
      unitRef="usd">5307000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c471"
      decimals="-3"
      id="ixv-39685"
      unitRef="usd">5231000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c471"
      decimals="2"
      id="ixv-39686"
      unitRef="usdPershares">1.22</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c472"
      decimals="INF"
      id="ixv-39687"
      unitRef="shares">5293175</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c472"
      decimals="0"
      id="ixv-39688"
      unitRef="shares">5293175</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c472"
      decimals="-3"
      id="ixv-39689"
      unitRef="usd">13815000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c472"
      decimals="-3"
      id="ixv-39690"
      unitRef="usd">13701000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c472"
      decimals="2"
      id="ixv-39691"
      unitRef="usdPershares">2.61</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c473"
      decimals="INF"
      id="ixv-39692"
      unitRef="shares">7358151</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c473"
      decimals="0"
      id="ixv-39693"
      unitRef="shares">6670703</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c473"
      decimals="-3"
      id="ixv-39694"
      unitRef="usd">37623000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c473"
      decimals="-3"
      id="ixv-39695"
      unitRef="usd">37476000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c473"
      decimals="2"
      id="ixv-39696"
      unitRef="usdPershares">5.64</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c474"
      decimals="INF"
      id="ixv-39697"
      unitRef="shares">1549742</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c474"
      decimals="0"
      id="ixv-39698"
      unitRef="shares">1549742</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c474"
      decimals="-3"
      id="ixv-39699"
      unitRef="usd">7439000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c474"
      decimals="-3"
      id="ixv-39700"
      unitRef="usd">8741000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c474"
      decimals="2"
      id="ixv-39701"
      unitRef="usdPershares">4.8</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c470"
      decimals="INF"
      id="ixv-39702"
      unitRef="shares">18551382</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c470"
      decimals="0"
      id="ixv-39703"
      unitRef="shares">17863934</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c470"
      decimals="-3"
      id="ixv-39704"
      unitRef="usd">64184000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="c470"
      decimals="-3"
      id="ixv-39705"
      unitRef="usd">65149000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="c0" decimals="2" id="ixv-39706" unitRef="pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c0" decimals="-6" id="ixv-39707" unitRef="usd">200000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c0" decimals="-6" id="ixv-39708" unitRef="usd">50000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-27254">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;8 &#x2014;&#160;Common Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 and
December&#160;31, 2024, the Company&#x2019;s certificate of incorporation authorized issuance of 40,000,000 shares of common stock. Each
share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally
available and when declared by the Board of Directors, subject to prior rights of the preferred stockholders. As of June&#160;30, 2025,
&lt;span style="-sec-ix-hidden: hidden-fact-327"&gt;no&lt;/span&gt; dividends have been declared to date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Conversion of Series&#160;A preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;B preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;C/C-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Outstanding options under 2010 Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Issuance of options under the 2010 Plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c107"
      decimals="0"
      id="ixv-39709"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c1"
      decimals="0"
      id="ixv-39710"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockVotingRights contextRef="c100" id="ixv-39711">one</us-gaap:CommonStockVotingRights>
    <us-gaap:ScheduleOfConversionsOfStockTextBlock contextRef="c0" id="ixv-27261">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company had reserved shares
of common stock, on an as-converted basis, for future issuance as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Conversion of Series&#160;A preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,350,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;B preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,293,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of Series&#160;C/C-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Outstanding options under 2010 Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Issuance of options under the 2010 Plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,396,080&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfConversionsOfStockTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c13"
      decimals="INF"
      id="ixv-39712"
      unitRef="shares">4350314</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c5"
      decimals="INF"
      id="ixv-39713"
      unitRef="shares">4350314</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c14"
      decimals="INF"
      id="ixv-39714"
      unitRef="shares">5293175</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c7"
      decimals="INF"
      id="ixv-39715"
      unitRef="shares">5293175</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c475"
      decimals="INF"
      id="ixv-39716"
      unitRef="shares">8220445</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c476"
      decimals="INF"
      id="ixv-39717"
      unitRef="shares">8220445</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c477"
      decimals="INF"
      id="ixv-39718"
      unitRef="shares">4520250</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c478"
      decimals="INF"
      id="ixv-39719"
      unitRef="shares">2972055</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c479"
      decimals="INF"
      id="ixv-39720"
      unitRef="shares">11896</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c480"
      decimals="INF"
      id="ixv-39721"
      unitRef="shares">1550091</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c11"
      decimals="INF"
      id="ixv-39722"
      unitRef="shares">22396080</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c1"
      decimals="INF"
      id="ixv-39723"
      unitRef="shares">22396080</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock contextRef="c0" id="ixv-27339">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;9 &#x2014;&#160;Stock Option Plan&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In 2010, the Company adopted
the 2010 Equity Incentive Plan (the &#x201c;Plan&#x201d;) under which 2,000,000 shares of the Company&#x2019;s common stock have been initially
reserved for issuance to employees, directors and consultants. The number of reserved shares has been increased over the&#160;years and
currently equals 4,636,454 shares. Options granted under the Plan may be either incentive stock options (&#x201c;ISO&#x201d;) or nonqualified
stock options (&#x201c;NSO&#x201d;). ISOs may be granted only to Company employees, including officers and directors who are also employees.
NSOs may be granted to Company employees, consultants and advisors.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;A person who owns (or is deemed
to own) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company will not
be granted an ISO unless the exercise price of such option is at least one hundred ten percent (110%) of the Fair Market Value on the
date of grant and the option is not exercisable after the expiration of &lt;span style="-sec-ix-hidden: hidden-fact-343"&gt;five&lt;/span&gt;&#160;years from the date of grant. Options granted generally
vest over &lt;span style="-sec-ix-hidden: hidden-fact-344"&gt;four&lt;/span&gt;&#160;years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Activity under the Plan is
set forth below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Stock Option Activity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Available for &lt;br/&gt; Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted-&lt;br/&gt; Average &lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted-&lt;br/&gt; Average &lt;br/&gt; Remaining &lt;br/&gt; Contractual &lt;br/&gt; Term &lt;br/&gt; (in&#160;years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Balances at January&#160;1, 2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,560,091&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-328"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-329"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-330"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-331"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-332"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-333"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balances at June&#160;30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,896&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;0.70&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;6.48&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Exercisable at June&#160;30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,364,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;Vested and expected to vest at June&#160;30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Stock Option Activity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Available for &lt;br/&gt; Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Remaining &lt;br/&gt; Contractual &lt;br/&gt; Term &lt;br/&gt; (in&#160;years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Balances at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-334"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-335"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-336"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-337"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-338"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-339"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-340"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-341"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-342"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balances at June&#160;30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;3.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Exercisable at June&#160;30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,464,429&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;Vested and expected to vest at June&#160;30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.53&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the three and six&#160;months
ended June&#160;30, 2025, stock option activity comprised of grants totaling 1,560,091 options, with no options exercised during the period.
Intrinsic values are calculated as the difference between the exercise price of the underlying options and the fair value of the common
stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The total fair value of options
vested for the three and six&#160;months ended June&#160;30, 2025 and 2024 was less than $0.1&#160;million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, the
total unrecognized stock-based compensation expense for stock options was $3.0&#160;million which is expected to be recognized over a
weighted-average period of 1.3&#160;years. The Company estimates the fair value of stock options using the Black Scholes option-pricing
model. The fair value of stock options is being recognized on a straight-line basis over the requisite service period of the awards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2024, the
total unrecognized stock-based compensation expense for stock options was less than $0.1&#160;million which is expected to be recognized
over a weighted-average period of 1.1&#160;years. The Company estimates the fair value of stock options using the Black Scholes option-pricing
model. The fair value of stock options is being recognized on a straight-line basis over the requisite service period of the awards.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Nonrecourse Promissory Notes to Early Exercise
Stock Options&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In 2018, one of the Company&#x2019;s
executives early exercised 1,380,015 of his stock options by issuing a promissory note to the Company. As the promissory note is nonrecourse
this exercise of stock options with a promissory note is not considered a substantive exercise for accounting purposes. Therefore, no
receivable for the promissory note was recorded on the Company&#x2019;s balance sheet. This arrangement was accounted for as modifications
to the original stock options which were exercised by issuing a promissory note. Such modification did not result in additional stock-based
compensation expense. As of June&#160;30, 2025 these options were fully vested.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Stock-Based Compensation Expense by Function&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table is a summary
of stock compensation expense by function recognized for the three and six&#160;months ended June&#160;30, 2025 and 2024 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General Administrative&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;87&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General Administrative&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;31&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;51&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;82&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP
      contextRef="c481"
      decimals="0"
      id="ixv-39724"
      unitRef="shares">2000000</us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP
      contextRef="c11"
      decimals="0"
      id="ixv-39725"
      unitRef="shares">4636454</us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP>
    <ck0001859807:PercentageOfExcercisePriceOption
      contextRef="c481"
      decimals="2"
      id="ixv-39726"
      unitRef="pure">1.10</ck0001859807:PercentageOfExcercisePriceOption>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0" id="ixv-27377">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Activity under the Plan is
set forth below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Stock Option Activity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Available for &lt;br/&gt; Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted-&lt;br/&gt; Average &lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted-&lt;br/&gt; Average &lt;br/&gt; Remaining &lt;br/&gt; Contractual &lt;br/&gt; Term &lt;br/&gt; (in&#160;years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Balances at January&#160;1, 2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,560,091&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-328"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-329"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-330"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-331"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-332"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-333"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balances at June&#160;30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,896&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;0.70&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;6.48&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Exercisable at June&#160;30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,364,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;Vested and expected to vest at June&#160;30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Options Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Stock Option Activity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares &lt;br/&gt; Available for &lt;br/&gt; Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted- &lt;br/&gt; Average &lt;br/&gt; Remaining &lt;br/&gt; Contractual &lt;br/&gt; Term &lt;br/&gt; (in&#160;years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Balances at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,550,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,982,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-334"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-335"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-336"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-337"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-338"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-339"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-340"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-341"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-342"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balances at June&#160;30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,560,091&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;3.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Exercisable at June&#160;30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,464,429&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;Vested and expected to vest at June&#160;30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.53&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c1"
      decimals="INF"
      id="ixv-39727"
      unitRef="shares">1560091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c1"
      decimals="INF"
      id="ixv-39728"
      unitRef="shares">2972055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c1"
      decimals="2"
      id="ixv-39729"
      unitRef="usdPershares">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c483" id="ixv-39730">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted
      contextRef="c0"
      decimals="INF"
      id="ixv-39731"
      unitRef="shares">1560091</ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c0"
      decimals="INF"
      id="ixv-39732"
      unitRef="shares">1560091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="2"
      id="ixv-39733"
      unitRef="usdPershares">1.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled
      contextRef="c0"
      decimals="INF"
      id="ixv-39734"
      unitRef="shares">11896</ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c0"
      decimals="INF"
      id="ixv-39735"
      unitRef="shares">11896</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="2"
      id="ixv-39736"
      unitRef="usdPershares">0.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c11"
      decimals="INF"
      id="ixv-39737"
      unitRef="shares">11896</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c11"
      decimals="INF"
      id="ixv-39738"
      unitRef="shares">4520250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c11"
      decimals="2"
      id="ixv-39739"
      unitRef="usdPershares">0.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c0" id="ixv-39740">P6Y5M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c11"
      decimals="INF"
      id="ixv-39741"
      unitRef="shares">2364814</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c11"
      decimals="2"
      id="ixv-39742"
      unitRef="usdPershares">1.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c0" id="ixv-39743">P5Y5M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c11"
      decimals="INF"
      id="ixv-39744"
      unitRef="shares">4520250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c11"
      decimals="2"
      id="ixv-39745"
      unitRef="usdPershares">0.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c0" id="ixv-39746">P6Y5M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c2"
      decimals="INF"
      id="ixv-39747"
      unitRef="shares">1550091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c2"
      decimals="INF"
      id="ixv-39748"
      unitRef="shares">2982055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c2"
      decimals="2"
      id="ixv-39749"
      unitRef="usdPershares">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c484" id="ixv-39750">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired
      contextRef="c26"
      decimals="INF"
      id="ixv-39751"
      unitRef="shares">10000</ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c26"
      decimals="INF"
      id="ixv-39752"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c26"
      decimals="3"
      id="ixv-39753"
      unitRef="usdPershares">0.001</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c172"
      decimals="INF"
      id="ixv-39754"
      unitRef="shares">1560091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c172"
      decimals="INF"
      id="ixv-39755"
      unitRef="shares">2972055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c172"
      decimals="2"
      id="ixv-39756"
      unitRef="usdPershares">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c26" id="ixv-39757">P3Y6M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c172"
      decimals="INF"
      id="ixv-39758"
      unitRef="shares">1464429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c172"
      decimals="2"
      id="ixv-39759"
      unitRef="usdPershares">0.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c26" id="ixv-39760">P4Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c172"
      decimals="INF"
      id="ixv-39761"
      unitRef="shares">2972055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c172"
      decimals="2"
      id="ixv-39762"
      unitRef="usdPershares">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c26" id="ixv-39763">P3Y6M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="c24"
      decimals="0"
      id="ixv-39764"
      unitRef="shares">1560091</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="c0"
      decimals="0"
      id="ixv-39765"
      unitRef="shares">1560091</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c26" decimals="-5" id="ixv-39766" unitRef="usd">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c24" decimals="-5" id="ixv-39767" unitRef="usd">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c0" decimals="-5" id="ixv-39768" unitRef="usd">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c25" decimals="-5" id="ixv-39769" unitRef="usd">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c11" decimals="-5" id="ixv-39770" unitRef="usd">3000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c0" id="ixv-39771">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c172"
      decimals="-5"
      id="ixv-39772"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c172"
      decimals="-5"
      id="ixv-39773"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c26" id="ixv-39774">P1Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c482"
      decimals="0"
      id="ixv-39775"
      unitRef="shares">1380015</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c0" id="ixv-27794">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table is a summary
of stock compensation expense by function recognized for the three and six&#160;months ended June&#160;30, 2025 and 2024 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General Administrative&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;87&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General Administrative&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;31&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;51&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;82&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c485" decimals="0" id="ixv-39776" unitRef="usd">33</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c486" decimals="0" id="ixv-39777" unitRef="usd">4</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c487" decimals="0" id="ixv-39778" unitRef="usd">54</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c488" decimals="0" id="ixv-39779" unitRef="usd">7</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c0" decimals="0" id="ixv-39780" unitRef="usd">87</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c26" decimals="0" id="ixv-39781" unitRef="usd">11</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c489" decimals="0" id="ixv-39782" unitRef="usd">31</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c490" decimals="0" id="ixv-39783" unitRef="usd">2</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c491" decimals="0" id="ixv-39784" unitRef="usd">51</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c492" decimals="0" id="ixv-39785" unitRef="usd">4</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c24" decimals="0" id="ixv-39786" unitRef="usd">82</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c25" decimals="0" id="ixv-39787" unitRef="usd">6</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-27892">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;10 &#x2014;&#160;Related Party Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company issued convertible
notes (also referred to as junior notes), Tasly convertible debt and promissory notes to certain shareholders. Refer to Note&#160;5 for
detail.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0" id="ixv-27901">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;11 &#x2014;&#160;Net Loss per Share
Attributable to Common Stockholders&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Net loss per common share is
calculated in accordance with ASC Topic&#160;260, Earnings Per Share. Basic net loss per share is computed by dividing net loss by the
weighted-average number of shares of common stock outstanding during the period. The computation of diluted net loss per share does not
include dilutive common stock equivalents in the weighted-average shares outstanding, as the inclusion of common share equivalents would
be antidilutive. The common share equivalents consist of stock options, convertible notes, convertible preferred stock and common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(2,348&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(2,071&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt"&gt;Weighted average shares used to computing basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,604,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,601,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt"&gt;Net loss per share attributable to common stockholders&#160;&#x2013;&#160;basic and diluted:&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.37&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="vertical-align: top; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Convertible notes payable&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,430,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,721,548&lt;/td&gt;&lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&#160;&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: left"&gt;&lt;sup&gt;(2)&#160;&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options to purchase common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="vertical-align: top; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,814,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;46,557,537&lt;/td&gt;&lt;td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(5,064&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(4,481&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt"&gt;Weighted average shares used to computing basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,604,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,601,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt"&gt;Net loss per share attributable to common stockholders&#160;&#x2013;&#160;basic and diluted:&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.80&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Convertible notes payable&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,430,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,721,548&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options to purchase common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,814,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;46,557,537&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-27907">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth
the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share
data):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(2,348&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(2,071&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt"&gt;Weighted average shares used to computing basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,604,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,601,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt"&gt;Net loss per share attributable to common stockholders&#160;&#x2013;&#160;basic and diluted:&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.37&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;Months &lt;br/&gt; Ended &lt;br/&gt; June&#160;30, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; width: 76%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(5,064&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(4,481&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt"&gt;Weighted average shares used to computing basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,604,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,601,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt"&gt;Net loss per share attributable to common stockholders&#160;&#x2013;&#160;basic and diluted:&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.80&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c24" decimals="-3" id="ixv-39788" unitRef="usd">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c25" decimals="-3" id="ixv-39789" unitRef="usd">-2071000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c24"
      decimals="INF"
      id="ixv-39790"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c24"
      decimals="INF"
      id="ixv-39791"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c25"
      decimals="INF"
      id="ixv-39792"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c25"
      decimals="INF"
      id="ixv-39793"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c24"
      decimals="2"
      id="ixv-39794"
      unitRef="usdPershares">-0.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c24"
      decimals="2"
      id="ixv-39795"
      unitRef="usdPershares">-0.42</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c25"
      decimals="2"
      id="ixv-39796"
      unitRef="usdPershares">-0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c25"
      decimals="2"
      id="ixv-39797"
      unitRef="usdPershares">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c0" id="ixv-28001">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="vertical-align: top; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Convertible notes payable&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,430,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,721,548&lt;/td&gt;&lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&#160;&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: left"&gt;&lt;sup&gt;(2)&#160;&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options to purchase common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="vertical-align: top; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,814,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;46,557,537&lt;/td&gt;&lt;td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;months ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Convertible preferred stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,863,934&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Convertible notes payable&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,430,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,721,548&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Options to purchase common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,520,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,972,055&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64,814,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;46,557,537&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c493"
      decimals="INF"
      id="ixv-39798"
      unitRef="shares">17863934</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c494"
      decimals="INF"
      id="ix_2_fact"
      unitRef="shares">42430263</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c496"
      decimals="INF"
      id="ixv-39800"
      unitRef="shares">4520250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c24"
      decimals="INF"
      id="ixv-39801"
      unitRef="shares">64814447</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-39804" unitRef="usd">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c26" decimals="-3" id="ixv-39805" unitRef="usd">-4481000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="ixv-39806"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="INF"
      id="ixv-39807"
      unitRef="shares">5604651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c26"
      decimals="INF"
      id="ixv-39808"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c26"
      decimals="INF"
      id="ixv-39809"
      unitRef="shares">5601651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-39810"
      unitRef="usdPershares">-0.9</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-39811"
      unitRef="usdPershares">-0.9</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c26"
      decimals="2"
      id="ixv-39812"
      unitRef="usdPershares">-0.8</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c26"
      decimals="2"
      id="ixv-39813"
      unitRef="usdPershares">-0.8</us-gaap:EarningsPerShareBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c497"
      decimals="INF"
      id="ixv-39814"
      unitRef="shares">17863934</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c498"
      decimals="INF"
      id="ix_3_fact"
      unitRef="shares">42430263</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c500"
      decimals="INF"
      id="ixv-39816"
      unitRef="shares">4520250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c25"
      decimals="INF"
      id="ixv-39817"
      unitRef="shares">64814447</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GovernmentAssistanceTextBlock contextRef="c0" id="ixv-28286">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;12 &#x2014;&#160;Government Grant
Revenue&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Government grant revenue consists
of amounts we earn under grants from two government agencies: NIH and DARPA.&#160;These grants are provided either in the form of expense
reimbursement (expense reimbursement grants) or as on a fixed fee basis (fixed fee grants). Under the expense reimbursement grants the
government agencies reimburse us for a portion of our expenses (allowable expenses) that have been incurred in a given period on the basis
of reports that we provide to these agencies. Fixed fee grants are awarded for specific research and development programs undertaken by
us. Under these grants we receive milestone payments from the government agencies upon our submission and approval by the government of
agreed upon deliverables, consisting primarily of the documented results of the specific research and development programs.&lt;/p&gt;</us-gaap:GovernmentAssistanceTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0" id="ixv-28295">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;13 &#x2014;&#160;Segments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company operates as one
operating segment. The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) is its &lt;span style="-sec-ix-hidden: hidden-fact-353"&gt;Chief Executive Officer&lt;/span&gt;, Ben Hwang,
who reviews financial information presented on a consolidated net loss basis as reported on the consolidated condensed statement of operations
and comprehensive loss in order to make decisions about allocating resources and assessing performance for the entire Company. The CODM
also utilizes the Company&#x2019;s long-range plan, which includes product development roadmaps and long-range financial models, as a key
input to resource allocation. The CODM function approves of key operating and strategic decisions. The CODM function views the Company&#x2019;s
operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly
provided with the following significant segment expenses. Significant expenses include research and development and general and administrative
expenses, which are each separately presented in the Company&#x2019;s consolidated condensed statements of operations and comprehensive
loss. The CODM reviews significant expenses within both the research and development and the general and administrative categories. Other
segment items within net loss include interest income, interest expense and loss on change in fair value of related party loan. See the
consolidated condensed financial statements for other financial information regarding the Company&#x2019;s operating segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;Months Ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; width: 76%; text-align: left"&gt;Government grant revenue&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-347"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left"&gt;Operating expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Research personnel compensation costs, including stock-based
    compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;CRO and regulatory costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-348"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Administrative personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;401&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Rent and office costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Legal and accounting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expenses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Total segment expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,001&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(976&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Other income (expense)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Loss on change in the fair value of related party Tasly convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(57&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,289&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,081&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,345&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,095&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt"&gt;Net loss and comprehensive loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,348&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Other expenses includes small balances of research materials
and supplies along with insurance costs.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;Months Ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Government grant revenuet&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-350"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Operating expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Research personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;818&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;CRO and regulatory costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-351"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Administrative personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;712&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Rent and office costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Legal and accounting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;649&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expenses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;66&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total segment expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,427&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,340&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,427&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,315&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Other income (expense)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Loss on change in the fair value of related party Tasly convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(118&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,519&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,161&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-352"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,637&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss and comprehensive loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(5,064&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(4,481&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Other expenses includes small balances of research materials and supplies along with insurance costs.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="c0" id="ixv-28300">The Company operates as one
operating segment. The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) is its Chief Executive Officer, Ben Hwang,
who reviews financial information presented on a consolidated net loss basis as reported on the consolidated condensed statement of operations
and comprehensive loss in order to make decisions about allocating resources and assessing performance for the entire Company. The CODM
also utilizes the Company&#x2019;s long-range plan, which includes product development roadmaps and long-range financial models, as a key
input to resource allocation. The CODM function approves of key operating and strategic decisions. The CODM function views the Company&#x2019;s
operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly
provided with the following significant segment expenses. Significant expenses include research and development and general and administrative
expenses, which are each separately presented in the Company&#x2019;s consolidated condensed statements of operations and comprehensive
loss. The CODM reviews significant expenses within both the research and development and the general and administrative categories. Other
segment items within net loss include interest income, interest expense and loss on change in fair value of related party loan. See the
consolidated condensed financial statements for other financial information regarding the Company&#x2019;s operating segment.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:NumberOfReportableSegments contextRef="c0" decimals="0" id="ixv-39818" unitRef="pure">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="c0" id="ixv-39819">See the
consolidated condensed financial statements for other financial information regarding the Company&#x2019;s operating segment.&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three&#160;Months Ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; width: 76%; text-align: left"&gt;Government grant revenue&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-347"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left"&gt;Operating expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Research personnel compensation costs, including stock-based
    compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;CRO and regulatory costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-348"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Administrative personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;401&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Rent and office costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Legal and accounting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expenses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Total segment expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,001&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(976&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Other income (expense)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Loss on change in the fair value of related party Tasly convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(57&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,289&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,081&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 24px; text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,345&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,095&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -12px; padding-left: 12px; text-align: left; padding-bottom: 2.5pt"&gt;Net loss and comprehensive loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,348&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Other expenses includes small balances of research materials
and supplies along with insurance costs.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six&#160;Months Ended &lt;br/&gt; June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Government grant revenuet&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-350"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Operating expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Research personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;818&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;CRO and regulatory costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-351"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Administrative personnel compensation costs, including stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;712&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Rent and office costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Legal and accounting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;649&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expenses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;66&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total segment expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,427&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,340&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,427&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,315&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Other income (expense)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Loss on change in the fair value of related party Tasly convertible debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(118&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12px; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,519&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,161&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 12px; text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-352"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,637&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss and comprehensive loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(5,064&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(4,481&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Other expenses includes small balances of research materials and supplies along with insurance costs.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Revenues
      contextRef="c502"
      decimals="-3"
      id="ixv-39820"
      unitRef="usd">25000</us-gaap:Revenues>
    <us-gaap:ShareBasedCompensation
      contextRef="c501"
      decimals="-3"
      id="ixv-39821"
      unitRef="usd">320000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c502"
      decimals="-3"
      id="ixv-39822"
      unitRef="usd">385000</us-gaap:ShareBasedCompensation>
    <ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="c501"
      decimals="-3"
      id="ixv-39823"
      unitRef="usd">401000</ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="c502"
      decimals="-3"
      id="ixv-39824"
      unitRef="usd">350000</ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <ck0001859807:RentAndOfficeCosts
      contextRef="c501"
      decimals="-3"
      id="ixv-39825"
      unitRef="usd">118000</ck0001859807:RentAndOfficeCosts>
    <ck0001859807:RentAndOfficeCosts
      contextRef="c502"
      decimals="-3"
      id="ixv-39826"
      unitRef="usd">80000</ck0001859807:RentAndOfficeCosts>
    <ck0001859807:LegalAndAccountingCosts
      contextRef="c501"
      decimals="-3"
      id="ixv-39827"
      unitRef="usd">110000</ck0001859807:LegalAndAccountingCosts>
    <ck0001859807:LegalAndAccountingCosts
      contextRef="c502"
      decimals="-3"
      id="ixv-39828"
      unitRef="usd">179000</ck0001859807:LegalAndAccountingCosts>
    <us-gaap:OtherExpenses
      contextRef="c501"
      decimals="-3"
      id="ix_4_fact"
      unitRef="usd">54000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="c502"
      decimals="-3"
      id="ix_5_fact"
      unitRef="usd">7000</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c501"
      decimals="-3"
      id="ixv-39831"
      unitRef="usd">1003000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c502"
      decimals="-3"
      id="ixv-39832"
      unitRef="usd">1001000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c501"
      decimals="-3"
      id="ixv-39833"
      unitRef="usd">-1003000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c502"
      decimals="-3"
      id="ixv-39834"
      unitRef="usd">-976000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c501"
      decimals="-3"
      id="ixv-39835"
      unitRef="usd">-57000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c502"
      decimals="-3"
      id="ixv-39836"
      unitRef="usd">-15000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseNonoperating
      contextRef="c501"
      decimals="-3"
      id="ixv-39837"
      unitRef="usd">1289000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="c502"
      decimals="-3"
      id="ixv-39838"
      unitRef="usd">1081000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c501"
      decimals="-3"
      id="ixv-39839"
      unitRef="usd">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c502"
      decimals="-3"
      id="ixv-39840"
      unitRef="usd">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c501"
      decimals="-3"
      id="ixv-39841"
      unitRef="usd">-1345000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c502"
      decimals="-3"
      id="ixv-39842"
      unitRef="usd">-1095000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="c501"
      decimals="-3"
      id="ixv-39843"
      unitRef="usd">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c502"
      decimals="-3"
      id="ixv-39844"
      unitRef="usd">-2071000</us-gaap:NetIncomeLoss>
    <us-gaap:Revenues
      contextRef="c504"
      decimals="-3"
      id="ixv-39846"
      unitRef="usd">25000</us-gaap:Revenues>
    <us-gaap:ShareBasedCompensation
      contextRef="c503"
      decimals="-3"
      id="ixv-39847"
      unitRef="usd">658000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c504"
      decimals="-3"
      id="ixv-39848"
      unitRef="usd">818000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="c504"
      decimals="-3"
      id="ixv-39849"
      unitRef="usd">15000</us-gaap:OtherCostAndExpenseOperating>
    <ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="c503"
      decimals="-3"
      id="ixv-39850"
      unitRef="usd">736000</ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="c504"
      decimals="-3"
      id="ixv-39851"
      unitRef="usd">712000</ck0001859807:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <ck0001859807:RentAndOfficeCosts
      contextRef="c503"
      decimals="-3"
      id="ixv-39852"
      unitRef="usd">318000</ck0001859807:RentAndOfficeCosts>
    <ck0001859807:RentAndOfficeCosts
      contextRef="c504"
      decimals="-3"
      id="ixv-39853"
      unitRef="usd">162000</ck0001859807:RentAndOfficeCosts>
    <ck0001859807:LegalAndAccountingCosts
      contextRef="c503"
      decimals="-3"
      id="ixv-39854"
      unitRef="usd">649000</ck0001859807:LegalAndAccountingCosts>
    <ck0001859807:LegalAndAccountingCosts
      contextRef="c504"
      decimals="-3"
      id="ixv-39855"
      unitRef="usd">592000</ck0001859807:LegalAndAccountingCosts>
    <us-gaap:OtherExpenses
      contextRef="c503"
      decimals="-3"
      id="ix_6_fact"
      unitRef="usd">66000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="c504"
      decimals="-3"
      id="ix_7_fact"
      unitRef="usd">41000</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c503"
      decimals="-3"
      id="ixv-39858"
      unitRef="usd">2427000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c504"
      decimals="-3"
      id="ixv-39859"
      unitRef="usd">2340000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c503"
      decimals="-3"
      id="ixv-39860"
      unitRef="usd">-2427000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c504"
      decimals="-3"
      id="ixv-39861"
      unitRef="usd">-2315000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c503"
      decimals="-3"
      id="ixv-39862"
      unitRef="usd">-118000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c504"
      decimals="-3"
      id="ixv-39863"
      unitRef="usd">-11000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseNonoperating
      contextRef="c503"
      decimals="-3"
      id="ixv-39864"
      unitRef="usd">2519000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="c504"
      decimals="-3"
      id="ixv-39865"
      unitRef="usd">2161000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c504"
      decimals="-3"
      id="ixv-39866"
      unitRef="usd">6000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c503"
      decimals="-3"
      id="ixv-39867"
      unitRef="usd">-2637000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c504"
      decimals="-3"
      id="ixv-39868"
      unitRef="usd">-2166000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="c503"
      decimals="-3"
      id="ixv-39869"
      unitRef="usd">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c504"
      decimals="-3"
      id="ixv-39870"
      unitRef="usd">-4481000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-28734">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;14 &#x2014;&#160;Subsequent Events&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has evaluated its
subsequent events from June&#160;30, 2025, through the date these condensed consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in&#160;these condensed consolidated financial statements other than the items
noted below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;7, 2022, the
Company entered into the Merger Agreement with NorthView, and on July&#160;11, 2025, the Business Combination closed. In accordance with
the terms and subject to the conditions of the Merger Agreement, at Closing, each share of issued and outstanding Profusa Common Stock
was converted into a number of shares of New Profusa Common Stock, based on the Exchange Ratio that reflects an equity valuation of Profusa
of $155,000,000 (as adjusted for the Incentive Equity Value, the Private Placement Value and the Aggregate Company Incentive Amount),
divided by an assumed value of New Profusa Common Stock of $10.00 per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The total consideration received
by Profusa Security Holders at the Closing of the transactions contemplated by the Merger Agreement is the newly issued shares of Common
Stock and securities convertible or exchangeable for newly issued shares of Common Stock with an aggregate value equal $255,958,617, with
each Profusa Stockholder receiving for each share of Profusa Common Stock held (after giving effect to the exchange or conversion of all
outstanding Profusa Preferred Stock for shares of Profusa Common Stock and treating all vested in-the-money Profusa Convertible Securities
(including, on a net exercise basis, all vested qualified Profusa Options) as if such securities had been exercised as of immediately
prior to the Merger, but excluding all unvested Profusa Options) a number of shares of Common Stock equal to a conversion ratio of approximately
0.34. As a result, the Profusa Security Holders received an aggregate of 25,595,862 shares of newly issued Common Stock as Merger Consideration.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Business Combination was
accounted for as a reverse capitalization in accordance with GAAP.&#160;Profusa was deemed the accounting predecessor of the combined
business, and New Profusa is the successor SEC registrant, meaning that Profusa&#x2019;s financial statements for previous periods will
be disclosed in the registrant&#x2019;s future periodic reports filed with the SEC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, the
Company had outstanding Profusa Preferred Stock of 17,863,934 shares, common stock of 6,984,666 shares which are made up of 5,604,651
common shares outstanding and 1,380,015 shares of common stock from in-substance nonrecourse promissory notes, and fully vested options
outstanding and exercisable of 2,364,814 shares. These shares were fully converted at the completion of the Business Combination. Additionally,
as of June&#160;30, 2025, the Convertible Notes of $19.5&#160;million and Senior Convertibles Notes of $27.9&#160;million were converted
in full at the closing of the Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From June&#160;30, 2025 through
the closing of the Business Combination, options continued to vest on normal vesting schedules, and interest continued to accrue on the
notes. Upon completing the Business Combination on July&#160;11, 2025, all outstanding Profusa Preferred Stock of 17,863,934 shares, common
stock of 6,984,666 shares, were converted into New Profusa at an exchange ratio of .3459 for 6,178,315 shares from Profusa Preferred Stock,
and &lt;span style="-sec-ix-hidden: hidden-fact-355"&gt;2,415,67&lt;/span&gt; shares of Common Stock of which 1,938,392 were from common shares outstanding and 477,284 were from common shares issued
from the in-substance nonrecourse promissory notes. Additionally, 2.3&#160;million outstanding options which were vested or expected to
vest were rolled over from Profusa into New Profusa outstanding options at an exchange rate of .3459.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In addition, the following
convertible notes were converted into New Profusa Common Stock based on the principal and accrued interest as of July&#160;11, 2025. Convertible
Notes with an outstanding balance of $19.6&#160;million in principal and accrued interest converted into 2,801,697 shares of New Profusa
at $7.00/share, Senior Convertible Notes with an outstanding balance of $20.8&#160;million in principal and accrued interest converted
into 5,189,138 shares of New Profusa at $4.00/share, Senior Convertible Bridge Notes of $3.1&#160;million in principal and accrued interest
were repaid in cash in the amount of $0.25&#160;million with the remaining $2.85&#160;million converted into 1,277,162 shares of New Profusa
at $2.22/share, Senior Secured Convertible Notes of $2.8&#160;million in principal and accrued interest converted into 5,542,261 shares
of New Profusa at $0.50/share. Of the 5,542,261 New Profusa shares issued to Senior Secured Note holders, 710,220 shares were contributed
by the Sponsor. As part of the initial shares at closing, the Incentive Equity Value of $29,018,330 was converted to shares at $10 per
share for 2,901,833 shares allocated to the merger consideration, as defined in the Business Combination Amendment No. 4.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;28, 2025, the
Company entered into the Purchase Agreement and a related registration rights agreement (the &#x201c;ELOC Registration Rights Agreement&#x201d;),
with Ascent (&#x201c;Purchaser&#x201d;). Pursuant to the terms and conditions set forth in the Purchase Agreement, the Company may issue
and sell to Ascent, shares of its common stock for an aggregate purchase price of up to $100&#160;million, subject to certain limitations
and conditions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under the Purchase Agreement,
the Company may deliver advance notices to the Purchaser to request the purchase of shares of common stock, with each closing to occur
on a&#160;trading&#160;day following the end of a 10 or fewer&#160;trading&#160;day valuation period commencing on the trading date immediately
following the delivery of the Advance Notice, or as determined by the Purchaser. The purchase price per share at each Closing will be
equal to 97% of the lowest volume-weighted average price (&#x201c;VWAP&#x201d;) of the Company&#x2019;s common stock during the applicable
valuation period, subject to a floor price and other adjustments as set forth in the Purchase Agreement. The maximum purchase price at
any single Closing is limited to the lower of (a)&#160;$5.0&#160;million or (b)&#160;100% of the average daily traded value of the common
stock for the &lt;span style="-sec-ix-hidden: hidden-fact-354"&gt;five&lt;/span&gt;&#160;trading&#160;days immediately preceding such Closing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The net proceeds from sales
that the Company makes to Ascent under the Purchase Agreement, will depend on the frequency and prices at which the Company sells shares
of Common Stock. We expect that any proceeds received from sales of Common Stock to Ascent will be used solely for the purchase of Bitcoin
(which can be used for debt repayment) provided that the Company&#x2019;s cash balance on the date of the applicable sale exceeds $5.0&#160;million.
If the cash balance is less than $5.0&#160;million, proceeds to the Company shall be allocated first to bring the balance to $5.0&#160;million
and the remaining proceeds to purchase Bitcoin. As of the filing date of these June&#160;30, 2025 financial statements, the Company has
purchased $1.0&#160;million of Bitcoin as part of the Company&#x2019;s ongoing treasury strategy.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c505" decimals="0" id="ixv-39871" unitRef="usd">155000000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c506"
      decimals="2"
      id="ixv-39872"
      unitRef="usdPershares">10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c507" decimals="0" id="ixv-39873" unitRef="usd">255958617</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c507"
      decimals="0"
      id="ixv-39874"
      unitRef="shares">25595862</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c508"
      decimals="0"
      id="ixv-39875"
      unitRef="shares">17863934</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c117"
      decimals="0"
      id="ixv-39876"
      unitRef="shares">6984666</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c509"
      decimals="0"
      id="ixv-39877"
      unitRef="shares">5604651</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c510"
      decimals="0"
      id="ixv-39878"
      unitRef="shares">1380015</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock contextRef="c0" id="ixv-39879">2,364,814</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c511"
      decimals="-5"
      id="ixv-39880"
      unitRef="usd">19500000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c512"
      decimals="-5"
      id="ixv-39881"
      unitRef="usd">27900000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c513"
      decimals="0"
      id="ixv-39882"
      unitRef="shares">17863934</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c514"
      decimals="0"
      id="ixv-39883"
      unitRef="shares">6984666</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c515"
      decimals="0"
      id="ixv-39884"
      unitRef="shares">6178315</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c514"
      decimals="0"
      id="ixv-39885"
      unitRef="shares">1938392</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c367"
      decimals="0"
      id="ixv-39886"
      unitRef="shares">477284</us-gaap:CommonStockSharesIssued>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c516"
      decimals="-5"
      id="ixv-39887"
      unitRef="usd">2300000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c517"
      decimals="-5"
      id="ixv-39888"
      unitRef="usd">19600000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c518"
      decimals="0"
      id="ixv-39889"
      unitRef="shares">2801697</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c519"
      decimals="2"
      id="ixv-39890"
      unitRef="usdPershares">7</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c520"
      decimals="-5"
      id="ixv-39891"
      unitRef="usd">20800000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c521"
      decimals="0"
      id="ixv-39892"
      unitRef="shares">5189138</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c520"
      decimals="2"
      id="ixv-39893"
      unitRef="usdPershares">4</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="c522"
      decimals="-5"
      id="ixv-39894"
      unitRef="usd">3100000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="c522"
      decimals="-4"
      id="ixv-39895"
      unitRef="usd">250000</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:ConvertibleNotesPayable
      contextRef="c523"
      decimals="-4"
      id="ixv-39896"
      unitRef="usd">2850000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c522"
      decimals="0"
      id="ixv-39897"
      unitRef="shares">1277162</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c523"
      decimals="2"
      id="ixv-39898"
      unitRef="usdPershares">2.22</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="c524"
      decimals="-5"
      id="ixv-39899"
      unitRef="usd">2800000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c524"
      decimals="0"
      id="ixv-39900"
      unitRef="shares">5542261</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c525"
      decimals="2"
      id="ixv-39901"
      unitRef="usdPershares">0.5</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c526"
      decimals="0"
      id="ixv-39902"
      unitRef="shares">5542261</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c527"
      decimals="0"
      id="ixv-39903"
      unitRef="shares">710220</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:NoncashMergerRelatedCosts contextRef="c528" decimals="0" id="ixv-39904" unitRef="usd">29018330</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c517"
      decimals="0"
      id="ixv-39905"
      unitRef="usdPershares">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
      contextRef="c368"
      decimals="0"
      id="ixv-39906"
      unitRef="shares">2901833</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="c529"
      decimals="-6"
      id="ixv-39907"
      unitRef="usd">100000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice
      contextRef="c530"
      decimals="2"
      id="ixv-39908"
      unitRef="pure">0.97</ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="c531"
      decimals="-5"
      id="ixv-39909"
      unitRef="usd">5000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ck0001859807:PercentageOfAverageDailyTradedValueOfCommonStock
      contextRef="c532"
      decimals="2"
      id="ixv-39910"
      unitRef="pure">1</ck0001859807:PercentageOfAverageDailyTradedValueOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="c533"
      decimals="-5"
      id="ixv-39911"
      unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="c534"
      decimals="-5"
      id="ixv-39912"
      unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="c531"
      decimals="-5"
      id="ixv-39913"
      unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="c535"
      decimals="-5"
      id="ixv-39914"
      unitRef="usd">1000000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c16" decimals="0" id="ixv-39915" unitRef="usd">16204</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c17" decimals="0" id="ixv-39916" unitRef="usd">4519</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c16" decimals="0" id="ixv-39917" unitRef="usd">14166</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c17" decimals="0" id="ixv-39918" unitRef="usd">6750</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidTaxes contextRef="c16" decimals="0" id="ixv-39919" unitRef="usd">30492</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsHeldInTrustCurrent contextRef="c17" decimals="0" id="ixv-39920" unitRef="usd">1565078</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:AssetsCurrent contextRef="c16" decimals="0" id="ixv-39921" unitRef="usd">60862</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c17" decimals="0" id="ixv-39922" unitRef="usd">1576347</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c16" decimals="0" id="ixv-39923" unitRef="usd">8330835</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c17" decimals="0" id="ixv-39924" unitRef="usd">9308328</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets contextRef="c16" decimals="0" id="ixv-39925" unitRef="usd">8391697</us-gaap:Assets>
    <us-gaap:Assets contextRef="c17" decimals="0" id="ixv-39926" unitRef="usd">10884675</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c16" decimals="0" id="ixv-39927" unitRef="usd">684483</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c17" decimals="0" id="ixv-39928" unitRef="usd">449114</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ck0001859807:AdvanceFromProfusa contextRef="c16" decimals="0" id="ixv-39929" unitRef="usd">791407</ck0001859807:AdvanceFromProfusa>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c16" decimals="0" id="ixv-39930" unitRef="usd">1880944</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c17" decimals="0" id="ixv-39931" unitRef="usd">1864106</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount contextRef="c17" decimals="0" id="ix_0_fact" unitRef="usd">1565078</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c17" decimals="0" id="ixv-39933" unitRef="usd">49061</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c16" decimals="0" id="ixv-39934" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c17" decimals="0" id="ixv-39935" unitRef="usd">944118</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c16" decimals="0" id="ixv-39936" unitRef="usd">50000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c17" decimals="0" id="ixv-39937" unitRef="usd">50000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c16" decimals="0" id="ixv-39938" unitRef="usd">12314886</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c17" decimals="0" id="ixv-39939" unitRef="usd">4921477</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c17" decimals="0" id="ixv-39940" unitRef="usd">13661</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c16" decimals="0" id="ixv-39941" unitRef="usd">696170</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c17" decimals="0" id="ixv-39942" unitRef="usd">156639</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:Liabilities contextRef="c16" decimals="0" id="ixv-39943" unitRef="usd">13011056</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c17" decimals="0" id="ixv-39944" unitRef="usd">5091777</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c18"
      decimals="INF"
      id="ixv-39945"
      unitRef="shares">687519</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c19"
      decimals="INF"
      id="ixv-39946"
      unitRef="shares">833469</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="c18"
      decimals="2"
      id="ixv-39947"
      unitRef="usdPershares">12.13</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="c19"
      decimals="2"
      id="ixv-39948"
      unitRef="usdPershares">11.1</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c18" decimals="0" id="ixv-39949" unitRef="usd">8337388</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c19" decimals="0" id="ixv-39950" unitRef="usd">9252208</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c16"
      decimals="4"
      id="ixv-39951"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c17"
      decimals="4"
      id="ixv-39952"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c16"
      decimals="INF"
      id="ixv-39953"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c17"
      decimals="INF"
      id="ixv-39954"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c16"
      decimals="4"
      id="ixv-39955"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c17"
      decimals="4"
      id="ixv-39956"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c16"
      decimals="INF"
      id="ixv-39957"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c17"
      decimals="INF"
      id="ixv-39958"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c16"
      decimals="INF"
      id="ixv-39959"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c17"
      decimals="INF"
      id="ixv-39960"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c16"
      decimals="INF"
      id="ixv-39961"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c17"
      decimals="INF"
      id="ixv-39962"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c16" decimals="0" id="ixv-39963" unitRef="usd">519</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c17" decimals="0" id="ixv-39964" unitRef="usd">519</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c16" decimals="0" id="ixv-39965" unitRef="usd">-12957266</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c17" decimals="0" id="ixv-39966" unitRef="usd">-3459829</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="0" id="ixv-39967" unitRef="usd">-12956747</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="0" id="ixv-39968" unitRef="usd">-3459310</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c16" decimals="0" id="ixv-39969" unitRef="usd">8391697</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c17" decimals="0" id="ixv-39970" unitRef="usd">10884675</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses contextRef="c27" decimals="0" id="ixv-39972" unitRef="usd">1351038</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c28" decimals="0" id="ixv-39973" unitRef="usd">1508683</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c27" decimals="0" id="ixv-39974" unitRef="usd">-1351038</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c28" decimals="0" id="ixv-39975" unitRef="usd">-1508683</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c27" decimals="0" id="ixv-39976" unitRef="usd">425416</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c28" decimals="0" id="ixv-39977" unitRef="usd">2248538</us-gaap:InvestmentIncomeInterest>
    <ck0001859807:ChangeInFairValueOfConvertibleNote contextRef="c27" decimals="0" id="ixv-39978" unitRef="usd">7165953</ck0001859807:ChangeInFairValueOfConvertibleNote>
    <ck0001859807:ChangeInFairValueOfConvertibleNote contextRef="c28" decimals="0" id="ixv-39979" unitRef="usd">-177697</ck0001859807:ChangeInFairValueOfConvertibleNote>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c27" decimals="0" id="ixv-39980" unitRef="usd">539531</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c28" decimals="0" id="ixv-39981" unitRef="usd">-701148</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:NonoperatingIncomeExpense contextRef="c27" decimals="0" id="ixv-39982" unitRef="usd">-7280068</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c28" decimals="0" id="ixv-39983" unitRef="usd">3127383</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c27" decimals="0" id="ixv-39984" unitRef="usd">-8631106</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c28" decimals="0" id="ixv-39985" unitRef="usd">1618700</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c27" decimals="0" id="ixv-39986" unitRef="usd">80513</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c28" decimals="0" id="ixv-39987" unitRef="usd">456790</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c27" decimals="0" id="ixv-39988" unitRef="usd">-8711619</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c28" decimals="0" id="ixv-39989" unitRef="usd">1161910</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c29"
      decimals="INF"
      id="ixv-39990"
      unitRef="shares">747644</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c29"
      decimals="INF"
      id="ixv-39991"
      unitRef="shares">747644</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c30"
      decimals="INF"
      id="ixv-39992"
      unitRef="shares">4866356</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c30"
      decimals="INF"
      id="ixv-39993"
      unitRef="shares">4866356</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c29"
      decimals="2"
      id="ixv-39994"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c29"
      decimals="2"
      id="ixv-39995"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c30"
      decimals="2"
      id="ixv-39996"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c30"
      decimals="2"
      id="ixv-39997"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c27"
      decimals="INF"
      id="ixv-39998"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c28"
      decimals="INF"
      id="ixv-39999"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c27"
      decimals="2"
      id="ixv-40000"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c27"
      decimals="2"
      id="ixv-40001"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c28"
      decimals="2"
      id="ixv-40002"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c28"
      decimals="2"
      id="ixv-40003"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:SharesOutstanding
      contextRef="c120"
      decimals="INF"
      id="ixv-40004"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c120" decimals="0" id="ixv-40005" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c122" decimals="0" id="ixv-40006" unitRef="usd">-619995</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c123" decimals="0" id="ixv-40007" unitRef="usd">-619476</us-gaap:StockholdersEquity>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c126" decimals="0" id="ixv-40008" unitRef="usd">2137638</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c127" decimals="0" id="ixv-40009" unitRef="usd">2137638</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c126" decimals="0" id="ixv-40010" unitRef="usd">-1864106</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c127" decimals="0" id="ixv-40011" unitRef="usd">-1864106</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <us-gaap:ProfitLoss contextRef="c126" decimals="0" id="ixv-40012" unitRef="usd">1161910</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c127" decimals="0" id="ixv-40013" unitRef="usd">1161910</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c128"
      decimals="INF"
      id="ixv-40014"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c128" decimals="0" id="ixv-40015" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c130" decimals="0" id="ixv-40016" unitRef="usd">-3459829</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c131" decimals="0" id="ixv-40017" unitRef="usd">-3459310</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c128"
      decimals="INF"
      id="ixv-40018"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c128" decimals="0" id="ixv-40019" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c130" decimals="0" id="ixv-40020" unitRef="usd">-3459829</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c131" decimals="0" id="ixv-40021" unitRef="usd">-3459310</us-gaap:StockholdersEquity>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c134" decimals="0" id="ixv-40022" unitRef="usd">768980</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c135" decimals="0" id="ixv-40023" unitRef="usd">768980</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c134" decimals="0" id="ixv-40024" unitRef="usd">-16838</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c135" decimals="0" id="ixv-40025" unitRef="usd">-16838</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <us-gaap:ProfitLoss contextRef="c134" decimals="0" id="ixv-40026" unitRef="usd">-8711619</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c135" decimals="0" id="ixv-40027" unitRef="usd">-8711619</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c136"
      decimals="INF"
      id="ixv-40028"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c136" decimals="0" id="ixv-40029" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c138" decimals="0" id="ixv-40030" unitRef="usd">-12957266</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c139" decimals="0" id="ixv-40031" unitRef="usd">-12956747</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c135" decimals="0" id="ixv-40032" unitRef="usd">-8711619</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c127" decimals="0" id="ixv-40033" unitRef="usd">1161910</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c135" decimals="0" id="ixv-40034" unitRef="usd">425416</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c127" decimals="0" id="ixv-40035" unitRef="usd">2248538</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c135" decimals="0" id="ixv-40036" unitRef="usd">539531</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c127" decimals="0" id="ixv-40037" unitRef="usd">-701148</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c135" decimals="0" id="ixv-40038" unitRef="usd">7165953</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c127" decimals="0" id="ixv-40039" unitRef="usd">-177697</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c135" decimals="0" id="ixv-40040" unitRef="usd">7416</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c127" decimals="0" id="ixv-40041" unitRef="usd">-311468</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c135" decimals="0" id="ixv-40042" unitRef="usd">235369</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c127" decimals="0" id="ixv-40043" unitRef="usd">634</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c135" decimals="0" id="ixv-40044" unitRef="usd">30492</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c135" decimals="0" id="ixv-40045" unitRef="usd">-49061</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c127" decimals="0" id="ixv-40046" unitRef="usd">-413210</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c135" decimals="0" id="ixv-40047" unitRef="usd">13661</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c127" decimals="0" id="ixv-40048" unitRef="usd">23279</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="c127" decimals="0" id="ixv-40049" unitRef="usd">25000</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c135" decimals="0" id="ixv-40050" unitRef="usd">-1296812</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c127" decimals="0" id="ixv-40051" unitRef="usd">-2064860</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <ck0001859807:PaymentOfExtensionFeeIntoTrustAccount contextRef="c135" decimals="0" id="ixv-40052" unitRef="usd">485350</ck0001859807:PaymentOfExtensionFeeIntoTrustAccount>
    <ck0001859807:PaymentOfExtensionFeeIntoTrustAccount contextRef="c127" decimals="0" id="ixv-40053" unitRef="usd">438360</ck0001859807:PaymentOfExtensionFeeIntoTrustAccount>
    <ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption contextRef="c135" decimals="0" id="ixv-40054" unitRef="usd">3248878</ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption>
    <ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption contextRef="c127" decimals="0" id="ixv-40055" unitRef="usd">184845836</ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption>
    <us-gaap:ProceedsFromDecommissioningFund contextRef="c135" decimals="0" id="ixv-40056" unitRef="usd">204459</us-gaap:ProceedsFromDecommissioningFund>
    <us-gaap:ProceedsFromDecommissioningFund contextRef="c127" decimals="0" id="ixv-40057" unitRef="usd">1192438</us-gaap:ProceedsFromDecommissioningFund>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c135" decimals="0" id="ixv-40058" unitRef="usd">2967987</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c127" decimals="0" id="ixv-40059" unitRef="usd">185599914</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c135" decimals="0" id="ixv-40060" unitRef="usd">797981</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c127" decimals="0" id="ixv-40061" unitRef="usd">1121815</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c135" decimals="0" id="ixv-40062" unitRef="usd">791407</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c135" decimals="0" id="ixv-40063" unitRef="usd">3248878</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c127" decimals="0" id="ixv-40064" unitRef="usd">184845836</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c135" decimals="0" id="ixv-40065" unitRef="usd">-1659490</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c127" decimals="0" id="ixv-40066" unitRef="usd">-183724021</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c135" decimals="0" id="ixv-40067" unitRef="usd">11685</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c127" decimals="0" id="ixv-40068" unitRef="usd">-188967</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c131" decimals="0" id="ixv-40069" unitRef="usd">4519</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c123" decimals="0" id="ixv-40070" unitRef="usd">193486</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c139" decimals="0" id="ixv-40071" unitRef="usd">16204</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c131" decimals="0" id="ixv-40072" unitRef="usd">4519</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid contextRef="c135" decimals="0" id="ixv-40073" unitRef="usd">173727</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c127" decimals="0" id="ixv-40074" unitRef="usd">912437</us-gaap:IncomeTaxesPaid>
    <ck0001859807:ExciseTaxPayableRedemptionOfCommonStock contextRef="c135" decimals="0" id="ixv-40075" unitRef="usd">16838</ck0001859807:ExciseTaxPayableRedemptionOfCommonStock>
    <ck0001859807:ExciseTaxPayableRedemptionOfCommonStock contextRef="c127" decimals="0" id="ixv-40076" unitRef="usd">1864106</ck0001859807:ExciseTaxPayableRedemptionOfCommonStock>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c135" decimals="0" id="ixv-40077" unitRef="usd">768980</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c127" decimals="0" id="ixv-40078" unitRef="usd">2137638</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed contextRef="c127" decimals="0" id="ixv-40079" unitRef="usd">1565078</ck0001859807:ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c135" id="ixv-30272">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;1 &#x2014;&#160;Description of Organization and Business
Operations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;NorthView Acquisition Corporation
(the &#x201c;Company&#x201d; or &#x201c;Northview&#x201d;) is a blank check company incorporated in Delaware on April&#160;19, 2021. The Company
was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar
business combination with one or more businesses (&#x201c;Business Combination&#x201d;). The Company has identified a target company for
a business combination and is consummating the acquisition of Profusa.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has a wholly-owned
subsidiary, NV Profusa Merger Sub Inc. (&#x201c;Merger Sub&#x201d;), a Delaware corporation incorporated on October&#160;13, 2022, formed
solely in contemplation of the Merger with Profusa (See Note&#160;6). Merger Sub has not commenced any operations and has only nominal
assets and no liabilities or contingent liabilities, nor any outstanding commitments other than in connection with the Merger.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;22, 2021,
the Company consummated its Initial Public Offering (&#x201c;IPO&#x201d;) of 18,975,000&#160;units (the &#x201c;Units&#x201d;), which included
2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists
of one share of common stock of the Company, par value $0.0001 per share, one right (the &#x201c;Rights&#x201d;), and one-half of one redeemable
warrant of the Company (the &#x201c;Warrants&#x201d;). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of
common stock. Each Warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment.
The Units&#160;were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Simultaneously with the closing
of the IPO, the Company completed the private sale of an aggregate of 7,347,500&#160;warrants (the &#x201c;Private Placement Warrants&#x201d;),
which included 697,500 Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters,
to NorthView Sponsor&#160;I, LLC (&#x201c;the Sponsor&#x201d;),&#160;I-Bankers Securities, Inc., and Dawson James Securities, Inc. at a
purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,347,500, which is discussed in Note&#160;4.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Transaction costs amounted
to $7,959,726 consisting of $3,450,000 of underwriting discount, $3,570,576 of Representative&#x2019;s Shares cost, $259,527 of Representative&#x2019;s
Warrants cost and $679,623 of other offering costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s Business
Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the value of the
assets held in the Trust Account (as defined below) (excluding taxes payable on the interest earned on the Trust Account) at the time
of the signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business
Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Following the closing of
the Public Offering on December&#160;22, 2021, an amount of $191,647,500 ($10.10 per Unit), excluding $741,228 that was wired to the
Company&#x2019;s operating bank account on December&#160;31, 2021 for working capital purposes, from the net proceeds of the sale of the
public units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account (&#x201c;Trust Account&#x201d;) and
invested in United&#160;States government treasury bills with a maturity of 185&#160;days or less or in money market funds investing
solely in United&#160;States Treasuries and meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act as determined
by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to
pay its taxes, if any, the proceeds from the IPO will not be released from the Trust Account until the earliest of (i)&#160;the completion
of the Company&#x2019;s initial Business Combination, (ii)&#160;the redemption of any public shares properly tendered in connection with
a stockholder vote to amend the Company&#x2019;s amended and restated certificate of incorporation (A)&#160;to modify the substance or
timing of the Company&#x2019;s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination
within the extended period (or any additional extension from the closing of our IPO if we extend the period of time to consummate a business
combination) (the &#x201c;Combination Period&#x201d;), or (B)&#160;with respect to any other provision relating to stockholders&#x2019;
rights or pre-Business Combination activity, and (iii)&#160;the redemption of all of the Company&#x2019;s public shares if the Company
is unable to complete the Business Combination within the Combination Period, subject to applicable law. The proceeds deposited in the
Trust Account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims
of the Company&#x2019;s public stockholders.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company will provide its
public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business
Combination either (i)&#160;in connection with a stockholder meeting called to approve the initial Business Combination or (ii)&#160;by
means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination
or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a
portion of their public shares upon the completion of the initial Business Combination at a per-share&#160;price, payable in cash, equal
to the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to the consummation of the initial Business
Combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares,
subject to the limitations described herein. The per share amount the Company will distribute to investors who properly redeem their shares
will not be reduced by the fee payable to&#160;I-Bankers&#160;and Dawson James pursuant to the Business Combination Marketing Agreement
(see Note&#160;6).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;If the Company is unable to
complete an initial Business Combination within the Combination Period, it will: (i)&#160;cease all operations except for the purpose
of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten&#160;business days thereafter, redeem the public shares,
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust account, including interest (which interest
shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding
public shares, which redemption will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive
further liquidation distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such
redemption, subject to the approval of the Company&#x2019;s remaining stockholders and its board of directors, dissolve and liquidate,
subject in each case to the Company&#x2019;s obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#x2019;s rights and warrants,
which will expire worthless if the Company fails to complete the Business Combination within the Combination Period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March 10, 2023, the Company
held a vote to amend its amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business
Combination from March 22, 2023 to December 22, 2023 (the &#x201c;First Extension Meeting&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024. In connection with the extension, 140,663 shares of the Company&#x2019;s
common stock were redeemed, with 6,027,219 shares of Common Stock remaining outstanding after the Redemption; 833,469 shares of Common
Stock remaining outstanding after the Redemption are shares issued in connection with our initial public offering. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January&#160;2, 2024, the
Company and Continental Stock Transfer&#160;&amp;amp; Trust Company (&#x201c;CST&#x201d;) entered into Amendment No. 1 to Investment Management
Trust Agreement, dated December&#160;20, 2021, by and between the Company and CST, to allow CST, upon written instruction of the Company,
to (i)&#160;hold the funds in the Company&#x2019;s trust account uninvested or (ii)&#160;hold the funds in an interest-bearing bank demand
deposit account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January&#160;10, 2024,
the Company&#x2019;s Board of Directors approved, and the Company amended, its Convertible Working Capital Promissory Note (the &#x201c;Note&#x201d;)
with the sponsor to increase the principal amount of the Note that could be drawn on to $1.5&#160;million. The amended and restated Note
also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company common stock at a price
of $2.22 per share at the election of the sponsor. On May 31, 2024, the Company&#x2019;s Board of Directors approved and the Company entered
into a second amendment of its Convertible Working Capital Promissory Note with the sponsor to increase the principal amount of the Note
that could be drawn on to $2.5 million. The second amended and restated Note also allows for the conversion of the outstanding principal
balance of the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;21, 2024, the
Company held its 2024 Annual Meeting of Stockholders (the &#x201c;Meeting&#x201d;). At the meeting, the Company&#x2019;s stockholders approved
the amendment of the Company&#x2019;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company&#x2019;s
common stock issued in the Company&#x2019;s initial public offering, from March&#160;22, 2024, monthly for up to six additional&#160;months
at the election of the Company and only upon contribution of $0.05 per month per outstanding public share, ultimately until September&#160;22,
2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In connection with the meeting,
the holders of&#160;95,394&#160;Public Shares properly exercised their right to redeem, with 5,931,825 shares of Common Stock remaining
outstanding after the Redemption; 738,075 shares of Common Stock remaining outstanding after the Redemption are shares issued in connection
with the initial public offering. Consequently, the contribution is $36,904&#160;per month needed for the Company to continue to extend
the Combination Period monthly. On May&#160;8, 2024 and May&#160;31, 2024, the Company made two deposits of $36,904 each for April and
May extension contributions. On September&#160;10, 2024, the Company made a deposit of $112,114, of which $110,714 was for June, July
and August extension contributions and $1,400 for lost interest due to late trust payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On September&#160;19, 2024,
the Company held an extraordinary general meeting of stockholders (the &#x201c;Meeting&#x201d;). At the Meeting, the Company&#x2019;s stockholders
approved an amendment to the Company&#x2019;s amended and restated certificate of incorporation to extend the date by which the Company
must consummate its initial Business Combination to March&#160;22, 2025. In connection with the approval of the extension amendment, holders
of&#160;50,556&#160;shares of the Company&#x2019;s common stock exercised their right to redeem, with 5,881,269 shares of common stock
remaining outstanding after the redemption; 687,519 shares of common stock remaining outstanding after the redemption are shares issued
in connection with our initial public offering. Consequently, the contribution is $34,376&#160;per month needed for the Company to continue
to extend the Combination Period monthly.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December 13, 2024, the Company
made a deposit of $68,752 for the October and November extension contributions and on December 23, 2024, the company made a deposit of
34,376 for the December extension contribution. In October 2024, $595,439 was paid from the trust account to redeeming stockholders in
connection with the extension. On February 27, 2025, the Company made a deposit of $49,376 for the January extension contribution and
a portion ($15,000) of the February extension contribution. On March 7, 2025, the Company deposited the remainder of the February extension
contribution of $19,376, plus interest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the meeting and the stockholders approved the extension of the business combination period until June 22, 2025.
In connection with the approval of the extension amendment, holders of 532,958 shares of the Company&#x2019;s common stock exercised their
right to redeem, for an aggregate redemption amount of approximately $6.5 million, with 5,348,311 shares of common stock remaining outstanding
after the redemption; 154,561 shares of common stock remaining outstanding after the redemption are shares issued in connection with our
initial public offering. As a condition of the extension, the Company contributed $30,000 to the Trust Account, for the entire extension
period, on March 21, 2025. Additionally, the stockholders at the meeting approved the amendment of the Company&#x2019;s charter to remove
the requirement that prevented the Company from redeeming public shares to the extent that it would cause the Company&#x2019;s net tangible
assets to be less than $5,000,001 (the &#x201c;NTA Requirement&#x201d;), and our charter was amended on March 21, 2025 to reflect the extension
of the business combination and the removal of the NTA Requirement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;All of the Public Shares,
or shares of our common stock sold as part of the IPO, contain a redemption feature which allows for the redemption of such Public Shares
in connection with our liquidation, if there is a stockholder vote or tender offer in connection with our initial business combination
and in connection with certain amendments to our amended and restated certificate of incorporation. In accordance with SEC and its guidance
on redeemable equity instruments, which has been codified in ASC&#160;480-10-S99, redemption provisions not solely within the control
of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were
issued with other freestanding instruments (i.e., public warrants), the initial carrying value of common stock classified as temporary
equity was the allocated proceeds determined in accordance with ASC&#160;470-20. The common stock is subject to ASC&#160;480-10-S99.
If it is probable that the equity instrument will become redeemable, the Company has the option to either (i)&#160;accrete changes in
the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become
redeemable, if later) to the earliest redemption date of the instrument or (ii)&#160;recognize changes in the redemption value immediately
as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The
Company has elected to recognize the changes immediately.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Sponsor, officers and directors
have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with the completion
of the initial Business Combination, (ii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to
their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will
be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete
the Business Combination within such time period); and (iii)&#160;vote their Founder Shares and any public shares purchased during or
after the IPO in favor of the initial Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s Sponsor
has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to
the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount
of funds in the Trust Account to below (i)&#160;$10.10 per public share or (ii)&#160;such lesser amount per public share held in the Trust
Account as of the date of the liquidation of the Trust Account due to reductions in value of the trust assets, in each case net of the
amount of interest which may be released to the Company to pay taxes, except as to any claims by a third party who executed a waiver of
any and all rights to seek access to the Trust Account and except as to any claims under indemnity of the underwriters of the IPO against
certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Nasdaq Delisting Notification&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December 20, 2024, the Company
received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market that the Company&#x2019;s securities
would be delisted from The Nasdaq Stock Market by reason of the failure of the Company to complete its initial business combination by
December 20, 2024 (36 months from the effectiveness of its IPO registration statement) as required by Listing Rule IM-5101-2. Accordingly,
trading in the Company&#x2019;s Common Stock, Rights and Warrants was suspended at the opening of business on December 27, 2024 and a Form
25-NSE was filed by Nasdaq with the Securities and Exchange Commission, which removed the Company&#x2019;s securities from on the Nasdaq
Stock Market. The Company&#x2019;s Common Stock, Rights and Warrants began to be quoted on the Pink Markets operated on The OTC Market
systems (&#x201c;OTC Market&#x201d;) under the symbols &#x201c;NVAC,&#x201d; &#x201c;NVACR&#x201d; and &#x201c;NVACW.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Liquidity and Going Concern&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of&#160;December 31, 2024,
the Company had $16,204 in cash and a working capital deficit of $12,254,024. Prior to the completion of the Company&#x2019;s IPO, the
Company&#x2019;s liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000 for the founder shares to
cover certain of the offering costs and the loan under an unsecured promissory note from the Sponsor of $204,841, which was fully paid
upon the IPO. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company&#x2019;s liquidity
needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account, and the drawdowns
on the convertible promissory note.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In order to finance transaction
costs in connection with an intended Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain
of the Company&#x2019;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note&#160;5).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#x201c;the Note&#x201d;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January&#160;10, 2024, the
Company&#x2019;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On May&#160;31, 2024, the Company&#x2019;s
Board of Directors approved, and the Company second amended its Note to increase the principal amount of the Note that could be drawn
on to $2.5&#160;million. The second amended and restated Note also allows for the conversion of the outstanding principal balance of the
Note to be repaid in shares of Company common stock at a price of $2.22&#160;per share at the election of the sponsor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company had principal outstanding
of $1,919,796 and is presenting the Note at fair value on its balance sheet at December 31, 2024 in the amount of $8,908,052. As of December
31, 2024, no amounts were repaid against the loan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has until June&#160;22,
2025 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by June&#160;22,
2025. If a Business Combination is not consummated by the required date, there will be an option to either extend the time available for
us to consummate our initial business combination or execute a mandatory liquidation and subsequent dissolution. In connection with the
Company&#x2019;s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standards
Board (&#x201c;FASB&#x201d;) Accounting Standards Update (&#x201c;ASU&#x201d;)&#160;2014-15, &#x201c;Disclosure of Uncertainties About an Entity&#x2019;s
Ability to Continue as a Going Concern,&#x201d; management has determined that mandatory liquidation, and subsequent dissolution, should
the Company be unable to complete a business combination, raises substantial doubt about the Company&#x2019;s ability to continue as a
going concern for the next twelve&#160;months from the issuance of these consolidated financial statements. No adjustments have been made
to the carrying amounts of assets and liabilities should the Company be required to liquidate after June&#160;22, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (the &#x201c;IR Act&#x201d;) was signed into federal law. The IR Act provides for, among other
things, a new U.S.&#160;federal 1% excise tax on certain repurchases of stock occurring on or after January&#160;1, 2023, by publicly
traded U.S.&#160;domestic corporations, by certain U.S.&#160;domestic subsidiaries of publicly traded foreign corporations, by &#x201c;covered
surrogate foreign corporations&#x201d; (as defined in the IR Act) and by certain affiliates of the foregoing. The excise tax is imposed
on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally
1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock
repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Any redemption or other repurchase
that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the
excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension
vote or otherwise would depend on a number of factors, including (i)&#160;the fair market value of the redemptions and repurchases in
connection with the Business Combination, extension or otherwise, (ii)&#160;the structure of a Business Combination, (iii)&#160;the nature
and amount of any &#x201c;PIPE&#x201d; or other equity issuances in connection with a Business Combination (or otherwise issued not in
connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv)&#160;the content of
regulations and other guidance from the Treasury. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#x2019;s ability to complete a Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;22, 2023 and
December&#160;21, 2023, the Company&#x2019;s stockholders redeemed 18,000,868 and 140,663 shares, respectively, for a total of $184,845,836
and $1,565,078, respectively. On March&#160;26, 2024, the Company&#x2019;s stockholders redeemed 95,394 shares for a total of $1,088,361.
On September&#160;30, 2024, the Company&#x2019;s stockholders redeemed 50,556 shares for a total of $595,439. The Company determined that
an excise tax liability should be recorded due to the redeemed shares. As of December 31, 2024, the Company has a charge to stockholders&#x2019;
deficit of $1,880,944 of excise tax liability, including $16,838 charged during the year ended December 31, 2024, calculated as 1% of
the value of shares redeemed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;3, 2024, the Treasury
issued final regulations with respect to the procedure and administration of the Excise Tax. These regulations provided that the filing
and payment deadline for any liability incurred during the period from January&#160;1, 2023 to December&#160;31, 2023 would be October&#160;31,
2024. As of December 31, 2024 and the date of this report, the excise tax was not paid and recorded as excise tax payable. Any amount
of such Excise Tax not paid in full, could be subject to additional interest and penalties which are currently estimated at 7% interest
per annum and a 5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2024 and
2023, $1,880,944 and $1,864,106 were accrued on the accompanying consolidated balance sheets, respectively. On January 29, 2025, the Company
claimed disaster relief under IRC Section 7508A relating to Hurricane Beryl as announced in IRS Announcement TX-2024-08. Under the disaster
relief claim, the time for filing of the September 30, 2024 Quarterly Federal Excise Tax Return and payment of the 2023 excise taxes on
repurchases of corporate stock normally due on October 31, 2024 should be postponed to February 3, 2025. The Company was not subject to
excise tax interest and penalties until February 3, 2025. On January 29, 2025, the Company filed their 2024 excise tax return. No excise
tax payment had been made by the Company.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c536"
      decimals="0"
      id="ixv-40080"
      unitRef="shares">18975000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c537"
      decimals="0"
      id="ixv-40081"
      unitRef="shares">2475000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c538"
      decimals="0"
      id="ixv-40082"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c539"
      decimals="4"
      id="ixv-40083"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c540"
      decimals="0"
      id="ixv-40084"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c541"
      decimals="0"
      id="ixv-40085"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c542"
      decimals="0"
      id="ixv-40086"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c543"
      decimals="0"
      id="ixv-40087"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c544"
      decimals="2"
      id="ixv-40088"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c539"
      decimals="2"
      id="ixv-40089"
      unitRef="usdPershares">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c536" decimals="0" id="ixv-40090" unitRef="usd">189750000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c545"
      decimals="0"
      id="ixv-40091"
      unitRef="shares">7347500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c546"
      decimals="0"
      id="ixv-40092"
      unitRef="shares">697500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c545"
      decimals="2"
      id="ixv-40093"
      unitRef="usdPershares">1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c547" decimals="0" id="ixv-40094" unitRef="usd">7347500</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <ck0001859807:TransactionCost contextRef="c139" decimals="0" id="ixv-40095" unitRef="usd">7959726</ck0001859807:TransactionCost>
    <ck0001859807:UnderwritingDiscountAmount contextRef="c139" decimals="0" id="ixv-40096" unitRef="usd">3450000</ck0001859807:UnderwritingDiscountAmount>
    <ck0001859807:RepresentativeSharesCost contextRef="c135" decimals="0" id="ixv-40097" unitRef="usd">3570576</ck0001859807:RepresentativeSharesCost>
    <ck0001859807:RepresentativeWarrantCost contextRef="c135" decimals="0" id="ixv-40098" unitRef="usd">259527</ck0001859807:RepresentativeWarrantCost>
    <ck0001859807:OtherOfferingCosts contextRef="c135" decimals="0" id="ixv-40099" unitRef="usd">679623</ck0001859807:OtherOfferingCosts>
    <ck0001859807:PercentageOfAggregateFairMarketValueOfAsset
      contextRef="c135"
      decimals="2"
      id="ixv-40100"
      unitRef="pure">0.80</ck0001859807:PercentageOfAggregateFairMarketValueOfAsset>
    <ck0001859807:BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum
      contextRef="c135"
      decimals="2"
      id="ixv-40101"
      unitRef="pure">0.50</ck0001859807:BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum>
    <ck0001859807:PaymentsForInvestmentOfCashInTrustAccount contextRef="c539" decimals="0" id="ixv-40102" unitRef="usd">191647500</ck0001859807:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c539"
      decimals="2"
      id="ixv-40103"
      unitRef="usdPershares">10.1</us-gaap:SharesIssuedPricePerShare>
    <ck0001859807:OperatingBankAccount contextRef="c548" decimals="0" id="ixv-40104" unitRef="usd">741228</ck0001859807:OperatingBankAccount>
    <ck0001859807:MaturityDays contextRef="c549" id="ixv-40105">P185D</ck0001859807:MaturityDays>
    <ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="c549"
      decimals="2"
      id="ixv-40106"
      unitRef="pure">1</ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <ck0001859807:PaymentofInteresttoDistributionExpense contextRef="c135" decimals="0" id="ixv-40107" unitRef="usd">100000</ck0001859807:PaymentofInteresttoDistributionExpense>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c550"
      decimals="0"
      id="ixv-40108"
      unitRef="shares">140663</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c551"
      decimals="0"
      id="ixv-40109"
      unitRef="shares">6027219</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c552"
      decimals="0"
      id="ixv-40110"
      unitRef="shares">833469</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering contextRef="c553" decimals="0" id="ixv-40111" unitRef="usd">1565078</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <ck0001859807:WorkingCapital
      contextRef="c554"
      decimals="-5"
      id="ixv-40112"
      unitRef="usd">1500000</ck0001859807:WorkingCapital>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c554"
      decimals="2"
      id="ixv-40113"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c555"
      decimals="-5"
      id="ixv-40114"
      unitRef="usd">2500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c555"
      decimals="2"
      id="ixv-40115"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="c556"
      decimals="2"
      id="ixv-40116"
      unitRef="pure">1</ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c557"
      decimals="2"
      id="ixv-40117"
      unitRef="usdPershares">0.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c558"
      decimals="0"
      id="ixv-40118"
      unitRef="shares">95394</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c559"
      decimals="0"
      id="ixv-40119"
      unitRef="shares">5931825</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c136"
      decimals="0"
      id="ixv-40120"
      unitRef="shares">738075</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:NoncashContributionExpense contextRef="c135" decimals="0" id="ixv-40121" unitRef="usd">36904</us-gaap:NoncashContributionExpense>
    <us-gaap:Deposits contextRef="c555" decimals="0" id="ixv-40122" unitRef="usd">36904</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c560" decimals="0" id="ixv-40123" unitRef="usd">112114</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c561" decimals="0" id="ixv-40124" unitRef="usd">110714</us-gaap:Deposits>
    <us-gaap:InterestIncomeOther contextRef="c562" decimals="0" id="ixv-40125" unitRef="usd">1400</us-gaap:InterestIncomeOther>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c563"
      decimals="0"
      id="ixv-40126"
      unitRef="shares">50556</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c564"
      decimals="0"
      id="ixv-40127"
      unitRef="shares">5881269</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c565"
      decimals="0"
      id="ixv-40128"
      unitRef="shares">687519</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:NoncashContributionExpense contextRef="c566" decimals="0" id="ixv-40129" unitRef="usd">34376</us-gaap:NoncashContributionExpense>
    <us-gaap:Deposits contextRef="c567" decimals="0" id="ixv-40130" unitRef="usd">68752</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c568" decimals="0" id="ixv-40131" unitRef="usd">34376</us-gaap:Deposits>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering contextRef="c569" decimals="0" id="ixv-40132" unitRef="usd">595439</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <us-gaap:Deposits contextRef="c570" decimals="0" id="ixv-40133" unitRef="usd">49376</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c571" decimals="0" id="ixv-40134" unitRef="usd">15000</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c572" decimals="0" id="ixv-40135" unitRef="usd">19376</us-gaap:Deposits>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c573"
      decimals="0"
      id="ixv-40136"
      unitRef="shares">532958</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="c574"
      decimals="-5"
      id="ixv-40137"
      unitRef="usd">6500000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c574"
      decimals="0"
      id="ixv-40138"
      unitRef="shares">5348311</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c574"
      decimals="0"
      id="ixv-40139"
      unitRef="shares">154561</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:NoncashContributionExpense contextRef="c573" decimals="0" id="ixv-40140" unitRef="usd">30000</us-gaap:NoncashContributionExpense>
    <ck0001859807:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets contextRef="c135" decimals="0" id="ixv-40141" unitRef="usd">5000001</ck0001859807:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c575"
      decimals="2"
      id="ixv-40142"
      unitRef="usdPershares">10.1</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c139" decimals="0" id="ixv-40143" unitRef="usd">16204</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <ck0001859807:WorkingCapitalDeficit contextRef="c139" decimals="0" id="ixv-40144" unitRef="usd">12254024</ck0001859807:WorkingCapitalDeficit>
    <us-gaap:PartnersCapitalAccountContributions contextRef="c135" decimals="0" id="ixv-40145" unitRef="usd">25000</us-gaap:PartnersCapitalAccountContributions>
    <ck0001859807:UnsecuredPromissoryNote contextRef="c135" decimals="0" id="ixv-40146" unitRef="usd">204841</ck0001859807:UnsecuredPromissoryNote>
    <ck0001859807:WorkingCapital contextRef="c576" decimals="0" id="ixv-40147" unitRef="usd">1200000</ck0001859807:WorkingCapital>
    <us-gaap:WarrantExercisePriceIncrease
      contextRef="c577"
      decimals="2"
      id="ixv-40148"
      unitRef="usdPershares">1</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c554"
      decimals="-5"
      id="ixv-40149"
      unitRef="usd">1500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c554"
      decimals="2"
      id="ixv-40150"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c555"
      decimals="-5"
      id="ixv-40151"
      unitRef="usd">2500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c555"
      decimals="2"
      id="ixv-40152"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <ck0001859807:OutstandingPrincipalAmount contextRef="c135" decimals="0" id="ixv-40153" unitRef="usd">1919796</ck0001859807:OutstandingPrincipalAmount>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c578" decimals="0" id="ixv-40154" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c579"
      decimals="2"
      id="ixv-40155"
      unitRef="pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther
      contextRef="c580"
      decimals="2"
      id="ixv-40156"
      unitRef="pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c581"
      decimals="0"
      id="ixv-40157"
      unitRef="shares">18000868</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c582"
      decimals="0"
      id="ixv-40158"
      unitRef="shares">140663</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c583" decimals="0" id="ixv-40159" unitRef="usd">184845836</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c584" decimals="0" id="ixv-40160" unitRef="usd">1565078</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c585"
      decimals="0"
      id="ixv-40161"
      unitRef="shares">95394</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c586" decimals="0" id="ixv-40162" unitRef="usd">1088361</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c587"
      decimals="0"
      id="ixv-40163"
      unitRef="shares">50556</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c587" decimals="0" id="ixv-40164" unitRef="usd">595439</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent contextRef="c139" decimals="0" id="ixv-40165" unitRef="usd">1880944</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:ExciseAndSalesTaxes contextRef="c135" decimals="0" id="ixv-40166" unitRef="usd">16838</us-gaap:ExciseAndSalesTaxes>
    <ck0001859807:SharesRedeemedPercentage
      contextRef="c135"
      decimals="2"
      id="ixv-40167"
      unitRef="pure">0.01</ck0001859807:SharesRedeemedPercentage>
    <ck0001859807:EstimatedInterestRate
      contextRef="c135"
      decimals="2"
      id="ixv-40168"
      unitRef="pure">0.07</ck0001859807:EstimatedInterestRate>
    <ck0001859807:UnderpaymentPenaltyRate
      contextRef="c135"
      decimals="2"
      id="ixv-40169"
      unitRef="pure">0.05</ck0001859807:UnderpaymentPenaltyRate>
    <ck0001859807:UnpaidTotalLiabilityRate
      contextRef="c135"
      decimals="2"
      id="ixv-40170"
      unitRef="pure">0.25</ck0001859807:UnpaidTotalLiabilityRate>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c139" decimals="0" id="ixv-40171" unitRef="usd">1880944</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c131" decimals="0" id="ixv-40172" unitRef="usd">1864106</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c135" id="ixv-30499">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;2 &#x2014;&#160;Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying consolidated
financial statements are presented in conformity with accounting principles generally accepted in the United&#160;States of America (&#x201c;GAAP&#x201d;)
and pursuant to the rules and regulations of the SEC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company is an &#x201c;emerging
growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#x2019;s consolidated financial statements with another public company, which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of these consolidated
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Some of the more significant estimates are in connection with
determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results could differ significantly
from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company did not have any
cash equivalents as of December&#160;31, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Cash and Marketable Securities Held in Trust Account&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;At December 31, 2024, substantially
all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank and at December&#160;31,
2023, substantially all of the assets held in the Trust Account were held in U.S.&#160;Treasury Bills. All of the Company&#x2019;s investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the consolidated balance sheets at
fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust
Account are shown in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December
31, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;amp;
Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $204,459 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December
31, 2023, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;amp;
Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $1,192,438 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value &lt;br/&gt; as of &lt;br/&gt; December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value &lt;br/&gt; as of &lt;br/&gt; December
    31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;U.S.&#160;Treasury Bills&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-356"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,872,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December 21, 2023, 140,663 shares of the Company&#x2019;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the consolidated balance sheets, which was paid from the Trust Account in January&#160;2024
to redeeming stockholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial business combination
from March 22, 2025 to June 22, 2025. The meeting was adjourned until March 21, 2025, at which the stockholders approve the extension
of the business combination period until June 22, 2025. As a condition of the extension, the Company contributed $30,000 to the Trust
Account, for the entire extension period, on March 21, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2024, all
of the Trust assets were classified as noncurrent assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
assets and liabilities approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to
their short-term nature, except for the warrant liabilities and convertible promissory note.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income
taxes under ASC&#160;740, &#x201c;Income Taxes.&#x201d; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the consolidated financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires
a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
As of December&#160;31, 2024 and 2023, the Company&#x2019;s deferred tax asset had a full valuation allowance recorded against it.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure
and transition.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. Interest and penalties expense amounted
to $0 and $19,158 during the years ended December 31, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has identified
the United&#160;States as its only &#x201c;major&#x201d; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#x2019;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the consolidated statements of
operations. Derivative assets and liabilities are classified in the consolidated balance sheets as current or non-current&#160;based on
whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Convertible Promissory Note&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#x2019;s own assumption about the assumptions a market participant would use in pricing the working capital loan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Warrant Liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for the&#160;17,404,250
warrants issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants,
and the 569,250 Representative Warrants inclusive of the underwriters&#x2019; over-allotment&#160;option) in accordance with the guidance
contained in ASC&#160;815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder,
each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This
liability is subject to re-measurement&#160;at each balance sheet date. With each such re-measurement, the warrant liabilities will be
adjusted to fair value, with the change in fair value recognized in the Company&#x2019;s consolidated statements of operations (See Note&#160;8).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In determining the fair value
of the Private Placement Warrants and the Representative&#x2019;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Net (Loss) Income Per Common Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250 potential shares of common stock for outstanding warrants to purchase the Company&#x2019;s
shares were excluded from diluted earnings per share for the years ended December 31, 2024 and 2023 because the warrants are contingently
exercisable, and the contingencies have not yet been met. As a result, diluted net (loss) income per share of common stock is the same
as basic net (loss) income per share of common stock for the periods presented.&#160;The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Year&#160;Ended&#160;&lt;br/&gt; December&#160;31,&#160;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Year&#160;Ended&#160;&lt;br/&gt; December&#160;31,&#160;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common stock &lt;br/&gt; subject&#160;to &lt;br/&gt; possible &lt;br/&gt; redemption&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common stock &lt;br/&gt; subject&#160;to &lt;br/&gt; possible &lt;br/&gt; redemption&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Basic and diluted net (loss) income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Allocation of net (loss) income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(1,096,239&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(7,615,380&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;562,049&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;599,861&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;747,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,866,356&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Basic and diluted net (loss) income per share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s common
stock sold as part of the Units&#160;in the IPO (&#x201c;public common stock&#x201d;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#x2019;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2022&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;193,525,484&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(186,410,914&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,137,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;9,252,208&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,683,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;768,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Contingently redeemable common stock, December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,337,388&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2023, the
FASB issued ASU 2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments in this ASU
require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating
officer decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in the reported measure of
segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the
CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public
entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single
reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures
in Topic 280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years
beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU 2023-07, which was applied retrospectively
to all prior periods presented. See Note 10 for further details regarding this adoption.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Standards not yet Adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#x201c;ASU&#160;2023-09&#x201d;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#x2019;s consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c135" id="ixv-30504">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying consolidated
financial statements are presented in conformity with accounting principles generally accepted in the United&#160;States of America (&#x201c;GAAP&#x201d;)
and pursuant to the rules and regulations of the SEC.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c135" id="ixv-30512">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <ck0001859807:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="c135" id="ixv-30520">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company is an &#x201c;emerging
growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#x2019;s consolidated financial statements with another public company, which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</ck0001859807:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c135" id="ixv-30557">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of these consolidated
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Some of the more significant estimates are in connection with
determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results could differ significantly
from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c135" id="ixv-30568">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount contextRef="c139" decimals="0" id="ixv-40173" unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c135" id="ixv-30576">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company did not have any
cash equivalents as of December&#160;31, 2024 and 2023.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c135" id="ixv-30584">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Cash and Marketable Securities Held in Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;At December 31, 2024, substantially
all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank and at December&#160;31,
2023, substantially all of the assets held in the Trust Account were held in U.S.&#160;Treasury Bills. All of the Company&#x2019;s investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the consolidated balance sheets at
fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust
Account are shown in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December
31, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;amp;
Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $204,459 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December
31, 2023, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;amp;
Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $1,192,438 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value &lt;br/&gt; as of &lt;br/&gt; December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value &lt;br/&gt; as of &lt;br/&gt; December
    31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;U.S.&#160;Treasury Bills&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-356"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,872,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December 21, 2023, 140,663 shares of the Company&#x2019;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the consolidated balance sheets, which was paid from the Trust Account in January&#160;2024
to redeeming stockholders.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March 18, 2025, the company
commenced a special meeting of stockholders, which was adjourned until March 21, 2025 without conducting any business. On March 21, 2025,
the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial business combination
from March 22, 2025 to June 22, 2025. The meeting was adjourned until March 21, 2025, at which the stockholders approve the extension
of the business combination period until June 22, 2025. As a condition of the extension, the Company contributed $30,000 to the Trust
Account, for the entire extension period, on March 21, 2025.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2024, all
of the Trust assets were classified as noncurrent assets.&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:InterestIncomeSecuritiesTaxable contextRef="c135" decimals="0" id="ixv-40174" unitRef="usd">204459</us-gaap:InterestIncomeSecuritiesTaxable>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c135" id="ixv-30620">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December
31, 2023, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock Transfer&#160;&amp;amp;
Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $1,192,438 of interest income from the Trust Account was withdrawn
by the Company for the payment of franchise and income taxes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value &lt;br/&gt; as of &lt;br/&gt; December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value &lt;br/&gt; as of &lt;br/&gt; December
    31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;U.S.&#160;Treasury Bills&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-356"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,872,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:InterestIncomeSecuritiesTaxable contextRef="c127" decimals="0" id="ixv-40175" unitRef="usd">1192438</us-gaap:InterestIncomeSecuritiesTaxable>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c595" decimals="0" id="ixv-40176" unitRef="usd">8330835</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c596" decimals="0" id="ixv-40177" unitRef="usd">1406</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c598" decimals="0" id="ixv-40178" unitRef="usd">10872000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c599" decimals="0" id="ixv-40179" unitRef="usd">8330835</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c600" decimals="0" id="ixv-40180" unitRef="usd">10873406</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c132"
      decimals="0"
      id="ixv-40181"
      unitRef="shares">140663</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:PayableCommonStockRedeemed contextRef="c588" decimals="0" id="ixv-40182" unitRef="usd">1565078</us-gaap:PayableCommonStockRedeemed>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount contextRef="c589" decimals="0" id="ixv-40183" unitRef="usd">1565078</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:AssetsHeldInTrustCurrent contextRef="c590" decimals="0" id="ixv-40184" unitRef="usd">1565078</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:NoncashContributionExpense contextRef="c573" decimals="0" id="ixv-40185" unitRef="usd">30000</us-gaap:NoncashContributionExpense>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c135" id="ixv-30682">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
assets and liabilities approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to
their short-term nature, except for the warrant liabilities and convertible promissory note.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c135" id="ixv-30690">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income
taxes under ASC&#160;740, &#x201c;Income Taxes.&#x201d; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the consolidated financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally requires
a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
As of December&#160;31, 2024 and 2023, the Company&#x2019;s deferred tax asset had a full valuation allowance recorded against it.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure
and transition.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. Interest and penalties expense amounted
to $0 and $19,158 during the years ended December 31, 2024 and 2023, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has identified
the United&#160;States as its only &#x201c;major&#x201d; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#x2019;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="c127" decimals="0" id="ixv-40186" unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="c135" decimals="0" id="ixv-40187" unitRef="usd">19158</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c135" id="ixv-30733">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the consolidated statements of
operations. Derivative assets and liabilities are classified in the consolidated balance sheets as current or non-current&#160;based on
whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet date.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="c135" id="ixv-30741">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Convertible Promissory Note&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#x2019;s own assumption about the assumptions a market participant would use in pricing the working capital loan.&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <ck0001859807:WarrantLiabilitiesPolicyTextBlock contextRef="c135" id="ixv-30749">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Warrant Liabilities&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for the&#160;17,404,250
warrants issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants,
and the 569,250 Representative Warrants inclusive of the underwriters&#x2019; over-allotment&#160;option) in accordance with the guidance
contained in ASC&#160;815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder,
each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This
liability is subject to re-measurement&#160;at each balance sheet date. With each such re-measurement, the warrant liabilities will be
adjusted to fair value, with the change in fair value recognized in the Company&#x2019;s consolidated statements of operations (See Note&#160;8).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In determining the fair value
of the Private Placement Warrants and the Representative&#x2019;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.&lt;/p&gt;</ck0001859807:WarrantLiabilitiesPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c591"
      decimals="0"
      id="ixv-40188"
      unitRef="shares">17404250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c592"
      decimals="0"
      id="ixv-40189"
      unitRef="shares">9487500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c593"
      decimals="0"
      id="ixv-40190"
      unitRef="shares">7347500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c594"
      decimals="0"
      id="ixv-40191"
      unitRef="shares">569250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c135" id="ixv-30787">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Net (Loss) Income Per Common Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250 potential shares of common stock for outstanding warrants to purchase the Company&#x2019;s
shares were excluded from diluted earnings per share for the years ended December 31, 2024 and 2023 because the warrants are contingently
exercisable, and the contingencies have not yet been met. As a result, diluted net (loss) income per share of common stock is the same
as basic net (loss) income per share of common stock for the periods presented.&#160;The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Year&#160;Ended&#160;&lt;br/&gt; December&#160;31,&#160;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Year&#160;Ended&#160;&lt;br/&gt; December&#160;31,&#160;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common stock &lt;br/&gt; subject&#160;to &lt;br/&gt; possible &lt;br/&gt; redemption&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common stock &lt;br/&gt; subject&#160;to &lt;br/&gt; possible &lt;br/&gt; redemption&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Basic and diluted net (loss) income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Allocation of net (loss) income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(1,096,239&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(7,615,380&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;562,049&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;599,861&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;747,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,866,356&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Basic and diluted net (loss) income per share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c135"
      decimals="0"
      id="ixv-40192"
      unitRef="shares">17404250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c135" id="ixv-40193">The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Year&#160;Ended&#160;&lt;br/&gt; December&#160;31,&#160;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Year&#160;Ended&#160;&lt;br/&gt; December&#160;31,&#160;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common stock &lt;br/&gt; subject&#160;to &lt;br/&gt; possible &lt;br/&gt; redemption&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common stock &lt;br/&gt; subject&#160;to &lt;br/&gt; possible &lt;br/&gt; redemption&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Basic and diluted net (loss) income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Allocation of net (loss) income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(1,096,239&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(7,615,380&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;562,049&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;599,861&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;747,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,866,356&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Basic and diluted net (loss) income per share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:TemporaryEquityNetIncome contextRef="c601" decimals="0" id="ixv-40194" unitRef="usd">-1096239</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c132" decimals="0" id="ixv-40195" unitRef="usd">-7615380</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c602" decimals="0" id="ixv-40196" unitRef="usd">562049</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c124" decimals="0" id="ixv-40197" unitRef="usd">599861</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c601"
      decimals="INF"
      id="ixv-40198"
      unitRef="shares">747644</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c132"
      decimals="INF"
      id="ixv-40199"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c602"
      decimals="INF"
      id="ixv-40200"
      unitRef="shares">4866356</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c124"
      decimals="INF"
      id="ixv-40201"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c601"
      decimals="2"
      id="ixv-40202"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c601"
      decimals="2"
      id="ixv-40203"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c132"
      decimals="2"
      id="ixv-40204"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c132"
      decimals="2"
      id="ixv-40205"
      unitRef="usdPershares">-1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c602"
      decimals="2"
      id="ixv-40206"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c602"
      decimals="2"
      id="ixv-40207"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c124"
      decimals="2"
      id="ixv-40208"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c124"
      decimals="2"
      id="ixv-40209"
      unitRef="usdPershares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="c135" id="ixv-30949">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s common
stock sold as part of the Units&#160;in the IPO (&#x201c;public common stock&#x201d;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#x2019;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2022&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;193,525,484&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(186,410,914&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,137,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;9,252,208&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,683,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;768,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Contingently redeemable common stock, December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,337,388&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="c135" id="ixv-30956">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2022&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;193,525,484&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(186,410,914&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,137,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;9,252,208&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,683,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;768,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Contingently redeemable common stock, December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,337,388&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c123" decimals="0" id="ixv-40210" unitRef="usd">193525484</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:RedemptionPremium contextRef="c127" decimals="0" id="ixv-40211" unitRef="usd">186410914</us-gaap:RedemptionPremium>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c131" decimals="0" id="ixv-40212" unitRef="usd">2137638</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c131" decimals="0" id="ixv-40213" unitRef="usd">9252208</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:RedemptionPremium contextRef="c135" decimals="0" id="ixv-40214" unitRef="usd">1683800</us-gaap:RedemptionPremium>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c139" decimals="0" id="ixv-40215" unitRef="usd">768980</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c139" decimals="0" id="ixv-40216" unitRef="usd">8337388</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c135" id="ixv-31030">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2023, the
FASB issued ASU 2023-07, Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments in this ASU
require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating
officer decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in the reported measure of
segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the
CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public
entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single
reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures
in Topic 280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years
beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU 2023-07, which was applied retrospectively
to all prior periods presented. See Note 10 for further details regarding this adoption.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Standards not yet Adopted&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#x201c;ASU&#160;2023-09&#x201d;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#x2019;s consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <ck0001859807:InitialPublicOfferingTextBlock contextRef="c135" id="ixv-31077">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;3 &#x2014;&#160;Initial Public Offering&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Public Units&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;22, 2021,
the Company sold 18,975,000&#160;Units, (which included 2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment
option) at a purchase price of $10.00 per Unit. Each unit that the Company is offering has a price of $10.00 and consists of one share
of common stock, one right, and one-half&#160;of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth&#160;(1/10)
of one share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof
to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as described herein.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Public Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Each whole warrant entitles
the holder to purchase one share of common stock at a price of $11.50&#160;per share, subject to adjustment as discussed herein. In addition,
if (x)&#160;the Company issues additional shares of common stock or equity-linked&#160;securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20&#160;per share of common
stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any
such issuance to the initial stockholders or their affiliates, without taking into account any founder shares held by such stockholders
or their affiliates, as applicable, prior to such issuance (the &#x201c;Newly Issued Price&#x201d;)), (y)&#160;the aggregate gross proceeds
from such issuances represent more than&#160;60% of the total equity proceeds, and interest thereon, available for funding the initial
Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of the common stock during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates the Business Combination (such price,
the &#x201c;Market Value&#x201d;) is below $9.20&#160;per share, the exercise price shall be adjusted (to the nearest cent) to be equal
to&#160;115% of the higher of the Market Value and the Newly Issued Price, and the $18.00&#160;per share redemption trigger price described
in the section &#x201c;Redemption of warrants&#x201d; will be adjusted (to the nearest cent) to be equal to&#160;180% of the higher of the
Market Value and the Newly Issued Price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The warrants will become exercisable
on the later of 12&#160;months from the closing of the IPO or 30&#160;days after the completion of its initial Business Combination and
will expire &lt;span style="-sec-ix-hidden: hidden-fact-357"&gt;five&lt;/span&gt;&#160;years after the completion of the Company&#x2019;s initial Business Combination, at 5:00&#160;p.m., New&#160;York
City time, or earlier upon redemption or liquidation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has agreed that as soon as practicable,
but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company will use its reasonable
best efforts to file, and within 60&#160;business days after the closing of the initial Business Combination, to have declared effective,
a registration statement relating to those shares of common stock, and to maintain a current prospectus relating to such shares of common
stock until the warrants expire or are redeemed. Notwithstanding the foregoing, if a registration statement covering the shares of common
stock issuable upon exercise of the warrants is not effective within the above specified period following the consummation of the initial
Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when
the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption
provided by Section&#160;3(a)(9)&#160;of the Securities Act&#160;of&#160;1933, as amended, or the Securities Act, provided that such exemption
is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless
basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Redemption of Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Once the warrants become exercisable,
the Company may redeem the outstanding warrants:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;in whole and not in part;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;at a price of $0.01 per warrant;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;upon a minimum of 30 days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;if, and only if, the last sale price of the common stock equals or exceeds $18.00 per share for any 20
trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of
redemption to the warrant holders.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;If the Company calls the warrants
for redemption as described above, management will have the option to require all holders that wish to exercise warrants to do so on a
&#x201c;cashless basis.&#x201d; In determining whether to require all holders to exercise their warrants on a &#x201c;cashless basis,&#x201d;
management will consider, among other factors, the Company&#x2019;s cash position, the number of warrants that are outstanding and the
dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants.
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to
the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#x201c;fair market value&#x201d; (defined below) by (y)&#160;the fair
market value. The &#x201c;fair market value&#x201d; shall mean the average reported last sale price of the common stock for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants.&lt;/p&gt;</ck0001859807:InitialPublicOfferingTextBlock>
    <ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c539"
      decimals="0"
      id="ixv-40217"
      unitRef="shares">18975000</ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues>
    <ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c603"
      decimals="0"
      id="ixv-40218"
      unitRef="shares">2475000</ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c603"
      decimals="2"
      id="ixv-40219"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c604"
      decimals="2"
      id="ixv-40220"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <ck0001859807:NumberOfSharesIssuedPerUnit
      contextRef="c538"
      decimals="0"
      id="ixv-40221"
      unitRef="shares">1</ck0001859807:NumberOfSharesIssuedPerUnit>
    <ck0001859807:NumberOfSharesIssuedPerUnit
      contextRef="c542"
      decimals="0"
      id="ixv-40222"
      unitRef="shares">1</ck0001859807:NumberOfSharesIssuedPerUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c605"
      decimals="0"
      id="ixv-40223"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c606"
      decimals="2"
      id="ixv-40224"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c607"
      decimals="0"
      id="ixv-40225"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c607"
      decimals="2"
      id="ixv-40226"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c608"
      decimals="2"
      id="ixv-40227"
      unitRef="usdPershares">9.2</us-gaap:SharesIssuedPricePerShare>
    <ck0001859807:EquityProceedOwnershipPercentage
      contextRef="c135"
      decimals="2"
      id="ixv-40228"
      unitRef="pure">0.60</ck0001859807:EquityProceedOwnershipPercentage>
    <ck0001859807:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
      contextRef="c135"
      decimals="2"
      id="ixv-40229"
      unitRef="usdPershares">9.2</ck0001859807:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice>
    <ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance
      contextRef="c139"
      decimals="2"
      id="ixv-40230"
      unitRef="pure">1.15</ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance>
    <ck0001859807:ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption
      contextRef="c135"
      decimals="2"
      id="ixv-40231"
      unitRef="usdPershares">18</ck0001859807:ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption>
    <ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance
      contextRef="c609"
      decimals="2"
      id="ixv-40232"
      unitRef="pure">1.80</ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance>
    <ck0001859807:RedemptionPricePerWarrant
      contextRef="c135"
      decimals="2"
      id="ixv-40233"
      unitRef="usdPershares">0.01</ck0001859807:RedemptionPricePerWarrant>
    <ck0001859807:NumberOfDaysForWrittenNoticeOfRedemption contextRef="c135" id="ixv-40234">P30D</ck0001859807:NumberOfDaysForWrittenNoticeOfRedemption>
    <ck0001859807:MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders
      contextRef="c135"
      decimals="2"
      id="ixv-40235"
      unitRef="usdPershares">18</ck0001859807:MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders>
    <ck0001859807:CommonStockThresholdTradingDays contextRef="c135" id="ixv-40236">P20D</ck0001859807:CommonStockThresholdTradingDays>
    <ck0001859807:CommonStockThresholdConsecutiveTradingDays contextRef="c135" id="ixv-40237">P30D</ck0001859807:CommonStockThresholdConsecutiveTradingDays>
    <ck0001859807:PrivatePlacementsTextBlock contextRef="c135" id="ixv-31165">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;4 &#x2014;&#160;Private Placement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s Sponsor,&#160;I-Bankers
and Dawson James have purchased an aggregate of 7,347,500 Private Placement Warrants (which included 697,500 Private Placement Warrants
issued pursuant to the full exercise of the over-allotment option) at a price of $1.00 per warrant ($7,347,500 in the aggregate) in a
private placement that closed simultaneously with the closing of the IPO.&#160;Of such amount, 5,162,500 Private Placement Warrants were
purchased by the Sponsor and 2,185,000 Private Placement Warrants were purchased by&#160;I-Bankers and Dawson James.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Private Placement Warrants
are identical to the warrants included in the units sold in the IPO, except that the Private Placement Warrants: (i)&#160;will not be
redeemable by the Company and (ii)&#160;may be exercised for cash or on a cashless basis, in each case so long as they are held by the
initial purchasers or any of their permitted transferees. If the Private Placement Warrants are held by holders other than the initial
purchasers or any of their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by
the holders on the same basis as the warrants included in the Units&#160;being sold in the IPO.&lt;/p&gt;</ck0001859807:PrivatePlacementsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c593"
      decimals="0"
      id="ixv-40238"
      unitRef="shares">7347500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c610"
      decimals="0"
      id="ixv-40239"
      unitRef="shares">697500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c593"
      decimals="2"
      id="ixv-40240"
      unitRef="usdPershares">1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c611" decimals="0" id="ixv-40241" unitRef="usd">7347500</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c612"
      decimals="0"
      id="ixv-40242"
      unitRef="shares">5162500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c613"
      decimals="0"
      id="ixv-40243"
      unitRef="shares">2185000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c135" id="ixv-31176">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;5 &#x2014;&#160;Related Party Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In April&#160;2021, the Sponsor
paid $25,000, or approximately $0.005 per share, to cover certain of the offering costs in exchange for an aggregate of 5,175,000 shares
of common stock, par value $0.0001 per share (the &#x201c;Founder Shares&#x201d;). In October&#160;2021, the Sponsor irrevocably surrendered
to the Company for cancellation and for no consideration 862,500 shares of common stock. On December&#160;20, 2021, the Company effected
a 1.1-for-1 stock dividend of its common stock, resulting in the Sponsor holding an aggregate of 4,743,750 shares of common stock. The
Founder Shares include an aggregate of up to 618,750 shares subject to forfeiture if the over-allotment option is not exercised by the
underwriters in full. On December&#160;22, 2021, the over-allotment option was fully exercised and such shares are no longer subject to
forfeiture.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Sponsor has agreed not
to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of the initial
Business Combination or (B)&#160;the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction
after the initial Business Combination that results in all of the Company&#x2019;s public stockholders having the right to exchange their
shares of common stock for cash, securities or other property (the &#x201c;Lock-up&#x201d;). Notwithstanding the foregoing, if the last
sale price of the Company&#x2019;s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 150&#160;days after
the initial Business Combination, the Founder Shares will be released from the Lock-up.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Convertible Promissory Note&#160;&#x2014;&#160;Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#x201c;the Note&#x201d;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant. On January&#160;10, 2024,
the Company&#x2019;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor. On May&#160;31,
2024, the Company&#x2019;s Board of Directors approved and the Company entered into a second amendment of its Convertible Working Capital
Promissory Note with the sponsor to increase the principal amount of the Note that could be drawn on to $2.5&#160;million. The second
amended and restated Note also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company
common stock at a price of $2.22&#160;per share at the election of the sponsor. As of December 31, 2024, the Company had principal outstanding
of $1,919,796 and is presenting the Note at fair value on its balance sheet at December 31, 2024 in the amount of $8,908,052.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In order to finance transaction
costs in connection with an intended initial Business Combination, the initial stockholders or an affiliate of the initial stockholders
or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the
&#x201c;Working Capital Loans&#x201d;). If the Company completes the initial Business Combination, the Company would repay such loaned amounts
out of the proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside
the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital
held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned
amounts. Up to $1,500,000 of such loans may be convertible, at the option of the lender, into warrants at a price of $1.00 per warrant
of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants, including as to exercise price,
exercisability and exercise period. At December&#160;31, 2024 and 2023, the Company had no borrowings under the Working Capital Loans,
other than the Note described in &#x201c;Note&#160;5 &#x2014;&#160;Related Party Transactions&#160;&#x2014;&#160;Convertible Promissory Note&#160;&#x2014;&#160;Related
Party&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Administrative Service Fee&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Commencing on the effective
date of the IPO, the Company began paying its Sponsor a total of $5,000&#160;per month for office space, utilities, secretarial support
and other administrative and consulting services. As of June&#160;30, 2023, the Company and the Sponsor terminated this agreement. For
the year ended December 31, 2024, $0 had been incurred and billed relating to the administrative service fee, respectively. For the year
ended December 31, 2023, $30,000 had been incurred and billed relating to the administrative service fee. As of December&#160;31, 2024
and 2023, $50,000 relating to the administrative service fee was not paid and recorded as due to related party.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Advances from Profusa&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the year ending December
31, 2024, Profusa agreed to advance funds to the Company to pay for operating expenses. As of December 31, 2024, there was $791,407 owed
to Profusa, which is due upon demand or at the completion of the Business Combination.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c614" decimals="0" id="ixv-40244" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c615"
      decimals="3"
      id="ixv-40245"
      unitRef="usdPershares">0.005</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c614"
      decimals="0"
      id="ixv-40246"
      unitRef="shares">5175000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c615"
      decimals="4"
      id="ixv-40247"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c616"
      decimals="0"
      id="ixv-40248"
      unitRef="shares">862500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c617" id="ixv-40249">1-for-1 stock dividend of its common stock</us-gaap:StockholdersEquityReverseStockSplit>
    <ck0001859807:AggregateNumberOfSharesOwned
      contextRef="c618"
      decimals="0"
      id="ixv-40250"
      unitRef="shares">4743750</ck0001859807:AggregateNumberOfSharesOwned>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="c619"
      decimals="0"
      id="ixv-40251"
      unitRef="shares">618750</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <ck0001859807:CommonStockExceedsPerShare
      contextRef="c135"
      decimals="2"
      id="ixv-40252"
      unitRef="usdPershares">12</ck0001859807:CommonStockExceedsPerShare>
    <ck0001859807:NumberOfTradingDay contextRef="c620" id="ixv-40253">P20D</ck0001859807:NumberOfTradingDay>
    <ck0001859807:NumberOfTradingDay contextRef="c621" id="ixv-40254">P30D</ck0001859807:NumberOfTradingDay>
    <ck0001859807:ConvertibleWorkingCapitalPromissoryNote contextRef="c622" decimals="0" id="ixv-40255" unitRef="usd">1200000</ck0001859807:ConvertibleWorkingCapitalPromissoryNote>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c623"
      decimals="2"
      id="ixv-40256"
      unitRef="usdPershares">1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c554"
      decimals="-5"
      id="ixv-40257"
      unitRef="usd">1500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c554"
      decimals="2"
      id="ixv-40258"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c555"
      decimals="-5"
      id="ixv-40259"
      unitRef="usd">2500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c555"
      decimals="2"
      id="ixv-40260"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:NotesPayable contextRef="c139" decimals="0" id="ixv-40261" unitRef="usd">1919796</us-gaap:NotesPayable>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c624" decimals="0" id="ixv-40262" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="c139" decimals="0" id="ixv-40263" unitRef="usd">1500000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c625"
      decimals="2"
      id="ixv-40264"
      unitRef="usdPershares">1</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth contextRef="c626" decimals="0" id="ixv-40265" unitRef="usd">5000</ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c135" decimals="0" id="ixv-40266" unitRef="usd">0</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c127" decimals="0" id="ixv-40267" unitRef="usd">30000</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty contextRef="c135" decimals="0" id="ixv-40268" unitRef="usd">50000</ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty>
    <ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty contextRef="c127" decimals="0" id="ixv-40269" unitRef="usd">50000</ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="c627" decimals="0" id="ixv-40270" unitRef="usd">791407</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c135" id="ixv-31266">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;6 &#x2014;&#160;Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The holders of the Founder
Shares, the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any underlying securities)
are entitled to registration rights pursuant to a registration rights agreement signed on the closing date of the IPO requiring the Company
to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company registers such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights
with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration
rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective
until termination of the applicable Lock-up&#160;period described in Note&#160;5. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Underwriters Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The underwriters had a 30-day&#160;option
from the date of IPO to purchase up to an additional&#160;2,475,000&#160;units to cover over-allotments, if any. On December&#160;22,
2021, the over-allotment was fully exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The underwriters received a
cash underwriting discount of approximately&#160;1.82% of the gross proceeds of the IPO, or $3,450,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Business Combination Marketing Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under a Business Combination
marketing agreement, the Company engaged&#160;I-Bankers and Dawson James as advisors in connection with the Business Combination to assist
the Company in holding meetings with the stockholders to discuss the potential Business Combination and the target business&#x2019;s attributes,
introduce the Company to potential investors that are interested in purchasing the Company&#x2019;s securities in connection with the potential
Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company was obligated to pay&#160;I-Bankers and Dawson
James a cash fee for such marketing services upon the consummation of the initial Business Combination in an amount of&#160;3.68% of the
gross proceeds of the IPO, or $6,986,250. The agreement was amended on November&#160;7, 2022 to allow for the 3.68% business combination
fee to be paid as (a)&#160;27.5% cash and (b)&#160;72.5% to be rolled into equity at closing. Subsequently, on January 19, 2025, the agreement
was modified by the parties such that the Company will be required to pay $2,000,000, payable in cash, if a business combination is consummated.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Representative&#x2019;s Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;22, 2021,
the Company issued&#160;450,000&#160;shares (Representative Shares) of common stock (which included&#160;37,500&#160;Representative Shares
issued pursuant to the full exercise of the over-allotment option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James
(and/or their designees).&#160;I-Bankers&#160;and Dawson James (and/or their designees) have agreed not to transfer, assign or sell any
such shares until the completion of the initial Business Combination. In addition,&#160;I-Bankers&#160;and Dawson James (and/or their
designees) have agreed (i)&#160;to waive their redemption rights with respect to such shares in connection with the completion of the
initial Business Combination and (ii)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to
such shares if the Company fails to complete its initial Business Combination within the Combination Period. The fair value of the Representative&#x2019;s
Shares issued are recognized as&#160;offering costs directly attributable to the issuance of an equity contract to be classified in equity
and are recorded as a reduction of equity (see Note&#160;1).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Representative&#x2019;s Warrants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company granted to&#160;I-Bankers&#160;and
Dawson James (and/or their designees)&#160;569,250&#160;warrants (which included&#160;74,250&#160;warrants issued pursuant to the full
exercise of the over-allotment option) exercisable at $11.50&#160;per share (or an aggregate exercise price of $6,546,375) at the closing
of the IPO.&#160;The Representative Warrants issued are recognized as derivative liabilities in accordance with ASC&#160;815-40 and recorded
as liabilities at fair value each reporting period (see Notes 1 and 8). The warrants may be exercised for cash or on a cashless basis,
at the holder&#x2019;s option, at any time during the period commencing on the later of the first anniversary of the effective date of
the registration statement of which the IPO forms a part and the closing of the initial Business Combination and terminating on the fifth
anniversary of such effectiveness date. Notwithstanding anything to the contrary,&#160;I-Bankers&#160;and Dawson James have agreed that
neither they nor their designees will be permitted to exercise the warrants after the&#160;five year&#160;anniversary of the effective
date of the registration statement of which the IPO forms a part. The warrants and such shares purchased pursuant to the warrants have
been deemed compensation by FINRA and are therefore subject to a lock-up&#160;for a period of 180&#160;days immediately following the
date of the effectiveness of the registration statement of which the IPO forms a part pursuant to FINRA Rule&#160;5110I(1). Pursuant to
FINRA Rule&#160;5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the economic disposition of the securities by any person for a period of 180&#160;days immediately following the effective
date of the registration statement of which the IPO forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated
for a period of 180&#160;days immediately following the effective date of the registration statement of which the IPO forms a part except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The warrants grant to holders
demand and &#x201c;piggy back&#x201d; rights for periods of five and seven&#160;years, respectively, from the effective date of the registration
statement of which the IPO forms a part with respect to the registration under the Securities Act&#160;of&#160;the shares issuable upon
exercise of the warrants. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting
commissions, which will be paid for by the holders themselves. The exercise price and number of shares issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a share dividend, or the Company&#x2019;s recapitalization, reorganization,
merger or consolidation. However, the warrants will not be adjusted for issuances of shares at a price below its exercise price. The Company
will have no obligation to net cash settle the exercise of the warrants. The holder of the warrants will not be entitled to exercise the
warrants for cash unless a registration statement covering the securities underlying the warrants is effective or an exemption from registration
is available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Merger Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;7, 2022, NorthView
entered into a Merger Agreement and Plan of Reorganization (the &#x201c;Merger Agreement&#x201d;), by and among Merger Sub., and Profusa,
Inc., a California corporation (&#x201c;Profusa&#x201d;). The Merger Agreement provides that, among other things, at the closing of the
transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Profusa (the &#x201c;Merger&#x201d;), with Profusa
surviving as a wholly-owned subsidiary of NorthView. In connection with the Merger, NorthView will change its name to &#x201c;Profusa,
Inc.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Business Combination is
subject to customary closing conditions, including the satisfaction of the minimum available cash condition of $15,000,000, the receipt
of certain governmental approvals and the required approval by the stockholders of NorthView and Profusa. There is no assurance that the
Business Combination will be completed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Advisory Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December 19, 2024, the Company
engaged A.G.P to serve as the placement agent in connection with a proposed business combination transaction. The Company shall pay to
A.G.P. a cash fee (the &#x201c;Cash Fee&#x201d;) equal to 9.0% in a convertible note offering, note, or other similar equity-linked offerings,
and shall be calculated from the face value of notes issued, which is payable at the close of a Business Combination. If the Business
Combination does not successfully close, A.G.P. will not be entitled to any cash fee.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ck0001859807:NumberOfDaysForUnderwriterOptions contextRef="c135" id="ixv-40271">P30D</ck0001859807:NumberOfDaysForUnderwriterOptions>
    <ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c552"
      decimals="0"
      id="ixv-40272"
      unitRef="shares">2475000</ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:UnderwritingExpenseRatio
      contextRef="c550"
      decimals="4"
      id="ixv-40273"
      unitRef="pure">0.0182</us-gaap:UnderwritingExpenseRatio>
    <ck0001859807:UnderwritingDiscountAmount contextRef="c139" decimals="0" id="ixv-40274" unitRef="usd">3450000</ck0001859807:UnderwritingDiscountAmount>
    <ck0001859807:InitialPublicOfferingGrossProceedPercentage
      contextRef="c139"
      decimals="4"
      id="ixv-40275"
      unitRef="pure">0.0368</ck0001859807:InitialPublicOfferingGrossProceedPercentage>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c628" decimals="0" id="ixv-40276" unitRef="usd">6986250</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <ck0001859807:BusinessCombinationPercentageRate
      contextRef="c629"
      decimals="4"
      id="ixv-40277"
      unitRef="pure">0.0368</ck0001859807:BusinessCombinationPercentageRate>
    <ck0001859807:CashPercentage
      contextRef="c629"
      decimals="3"
      id="ixv-40278"
      unitRef="pure">0.275</ck0001859807:CashPercentage>
    <ck0001859807:EquityPercentage
      contextRef="c629"
      decimals="3"
      id="ixv-40279"
      unitRef="pure">0.725</ck0001859807:EquityPercentage>
    <us-gaap:OtherCommitmentDueInSecondAndThirdYear contextRef="c630" decimals="0" id="ixv-40280" unitRef="usd">2000000</us-gaap:OtherCommitmentDueInSecondAndThirdYear>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c631"
      decimals="0"
      id="ixv-40281"
      unitRef="shares">450000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c632"
      decimals="0"
      id="ixv-40282"
      unitRef="shares">37500</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c633"
      decimals="0"
      id="ixv-40283"
      unitRef="shares">569250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c546"
      decimals="0"
      id="ixv-40284"
      unitRef="shares">74250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c594"
      decimals="2"
      id="ixv-40285"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c619" decimals="0" id="ixv-40286" unitRef="usd">6546375</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c139" id="ixv-40287">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <ck0001859807:LockupPeriod contextRef="c135" id="ixv-40288">P180D</ck0001859807:LockupPeriod>
    <us-gaap:Cash contextRef="c634" decimals="0" id="ixv-40289" unitRef="usd">15000000</us-gaap:Cash>
    <us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
      contextRef="c635"
      decimals="3"
      id="ixv-40290"
      unitRef="pure">0.09</us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c135" id="ixv-31372">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;7 &#x2014;&#160;Stockholders&#x2019; Deficit&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Preferred stock&lt;/i&gt;&lt;/b&gt;&#160;&#x2014;&#160;The
Company is authorized to issue&#160;1,000,000&#160;shares of preferred stock with a par value of $0.0001&#160;and with such designations,
rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.&#160;As of December&#160;31,
2024 and 2023, there was &lt;span style="-sec-ix-hidden: hidden-fact-358"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-359"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-360"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-361"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preferred stock issued or outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Common Stock&#160;&lt;/i&gt;&lt;/b&gt;&#x2014;&#160;The
Company is authorized to issue a total of&#160;100,000,000&#160;shares of common stock at par value of $0.0001&#160;each. In April&#160;2021,
the Company issued&#160;5,175,000&#160;shares of common stock to its Sponsor for $25,000, or approximately $0.005&#160;per share. In October&#160;2021,
the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration&#160;862,500&#160;shares of common stock.&#160;On
December&#160;20, 2021,&#160;the Company effected a 1.1-for-1&#160;stock dividend of its common stock, resulting in an aggregate of 4,743,750
Founder Shares issued&#160;and outstanding.&#160;On December&#160;22, 2021, the Company has also issued&#160;450,000&#160;shares (Representative&#x2019;s
Shares) of common stock (which included&#160;37,500&#160;Representative Shares issued pursuant to the full exercise of the over-allotment
option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James (and/or their designees).&#160;As of December&#160;31,
2024 and 2023, there were&#160;5,193,750 shares of common stock issued and outstanding, excluding&#160;687,519 and 833,469 shares of common
stock subject to redemption, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Common stockholders of record
are entitled to one vote for each share held on all matters to be voted on by stockholders. Unless specified in the Company&#x2019;s amended
and restated certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange
rules, the affirmative vote of a majority of the Company&#x2019;s common stock that are voted is required to approve any such matter voted
on by the stockholders. There is no cumulative voting with respect to the election of directors, with the result that the holders of more
than&#160;50% of the shares voted for the election of directors can elect all of the directors (prior to consummation of the initial Business
Combination). The Company&#x2019;s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors
out of funds legally available therefor.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c139"
      decimals="0"
      id="ixv-40291"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c139"
      decimals="4"
      id="ixv-40292"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c139"
      decimals="0"
      id="ixv-40293"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c139"
      decimals="4"
      id="ixv-40294"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c636"
      decimals="0"
      id="ixv-40295"
      unitRef="shares">5175000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c637" decimals="0" id="ixv-40296" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c638"
      decimals="3"
      id="ixv-40297"
      unitRef="usdPershares">0.005</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c639"
      decimals="0"
      id="ixv-40298"
      unitRef="shares">862500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c640" id="ixv-40299">1-for-1&#160;stock dividend of its common stock</us-gaap:StockholdersEquityReverseStockSplit>
    <ck0001859807:FounderSharesIssued
      contextRef="c641"
      decimals="0"
      id="ixv-40300"
      unitRef="shares">4743750</ck0001859807:FounderSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c538"
      decimals="0"
      id="ixv-40301"
      unitRef="shares">450000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c537"
      decimals="0"
      id="ixv-40302"
      unitRef="shares">37500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:CommonStockSharesIssued
      contextRef="c139"
      decimals="0"
      id="ixv-40303"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c131"
      decimals="0"
      id="ixv-40304"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c131"
      decimals="0"
      id="ixv-40305"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c139"
      decimals="0"
      id="ixv-40306"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c139"
      decimals="0"
      id="ixv-40307"
      unitRef="shares">687519</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c131"
      decimals="0"
      id="ixv-40308"
      unitRef="shares">833469</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockVotingRights contextRef="c135" id="ixv-40309">one</us-gaap:CommonStockVotingRights>
    <ck0001859807:VotingSharesPercentage
      contextRef="c139"
      decimals="2"
      id="ixv-40310"
      unitRef="pure">0.50</ck0001859807:VotingSharesPercentage>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c135" id="ixv-31397">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;8 &#x2014;&#160;Fair Value Measurements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Fair value is defined as the
price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants
at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). The Company&#x2019;s financial instruments are classified as either
Level 1, Level 2 or Level 3. These tiers include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in
active markets;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly
observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets
that are not active; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring
an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs
or significant value drivers are unobservable.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following tables present
information about the Company&#x2019;s assets and liabilities that are measured at fair value on December&#160;31, 2024 and 2023, and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Quoted &lt;br/&gt; Prices In&lt;br/&gt; Active &lt;br/&gt; Markets &lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Observable &lt;br/&gt; Inputs &lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Unobservable &lt;br/&gt; Inputs &lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash and marketable securities held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-362"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-363"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-364"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-365"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-366"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-367"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-368"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-369"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-370"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-371"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,604,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-372"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,224,722&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Quoted&lt;br/&gt; Prices In&lt;br/&gt; Active &lt;br/&gt; Markets &lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Observable &lt;br/&gt; Inputs &lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Unobservable &lt;br/&gt; Inputs &lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash and marketable securities held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-373"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-374"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;85,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;85,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-375"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-376"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-377"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-378"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-379"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-380"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-381"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-382"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,100,757&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85,388&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-383"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,015,369&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Public Warrants, the Private
Placement Warrants and the Representative&#x2019;s Warrants were accounted for as liabilities in accordance with ASC&#160;815-40 and are
presented within liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on
a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements
of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company utilized a Monte
Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants at December
31, 2024 was classified as Level 2 due to the lack of an active market. At December&#160;31, 2023, the Public Warrants was classified
as Level 1 due to the use of an observable market quote in an active market. As of December&#160;31, 2024 and 2023, the aggregate value
of Public Warrants was $379,500 and $85,388, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company uses a Monte Carlo
simulation model to value the Private Placement Warrants and the Representative&#x2019;s Warrants. The Private Placement Warrants and the
Representative&#x2019;s Warrants were classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent
in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates
the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The risk-free interest rate
is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of
the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at December&#160;31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years) &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.71&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-384"&gt;&#160;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at December&#160;31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years) &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;&#160;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;&#160;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides
a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the years ended December 31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;71,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;227,772&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,647&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;245,419&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;316,670&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;377,857&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,274&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;407,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(311,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24,151&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(335,880&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;71,251&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Promissory &lt;br/&gt; Note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Principal borrowing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;797,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,165,953&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Promissory &lt;br/&gt; Note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value at December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Principal borrowing&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,121,815&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(177,697&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#x2019;s own assumption about the assumptions a market participant would use in pricing the working capital loan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The convertible promissory
note was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent in pricing models are assumptions
related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common
stock based on historical volatility that matches the expected remaining life of the note. The risk-free interest rate is based on the
U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the note. The expected
life of the note is assumed to be equivalent to their remaining contractual term.&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c135" id="ixv-31448">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following tables present
information about the Company&#x2019;s assets and liabilities that are measured at fair value on December&#160;31, 2024 and 2023, and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Quoted &lt;br/&gt; Prices In&lt;br/&gt; Active &lt;br/&gt; Markets &lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Observable &lt;br/&gt; Inputs &lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Unobservable &lt;br/&gt; Inputs &lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash and marketable securities held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-362"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-363"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-364"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-365"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-366"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-367"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-368"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-369"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-370"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-371"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,604,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-372"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,224,722&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Quoted&lt;br/&gt; Prices In&lt;br/&gt; Active &lt;br/&gt; Markets &lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Observable &lt;br/&gt; Inputs &lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Significant &lt;br/&gt; Other &lt;br/&gt; Unobservable &lt;br/&gt; Inputs &lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash and marketable securities held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-373"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-374"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;85,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;85,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-375"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-376"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-377"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-378"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-379"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-380"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-381"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-382"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,100,757&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85,388&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-383"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,015,369&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c643" decimals="0" id="ixv-40311" unitRef="usd">8330835</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c644" decimals="0" id="ixv-40312" unitRef="usd">8330835</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c647" decimals="0" id="ixv-40313" unitRef="usd">379500</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c649" decimals="0" id="ixv-40314" unitRef="usd">379500</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c651" decimals="0" id="ixv-40315" unitRef="usd">293900</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c654" decimals="0" id="ixv-40316" unitRef="usd">293900</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c655" decimals="0" id="ixv-40317" unitRef="usd">22770</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c658" decimals="0" id="ixv-40318" unitRef="usd">22770</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c659" decimals="0" id="ixv-40319" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c662" decimals="0" id="ixv-40320" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c1" decimals="0" id="ixv-40321" unitRef="usd">9604222</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c664" decimals="0" id="ixv-40322" unitRef="usd">379500</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c665" decimals="0" id="ixv-40323" unitRef="usd">9224722</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c666" decimals="0" id="ixv-40324" unitRef="usd">10873406</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c667" decimals="0" id="ixv-40325" unitRef="usd">10873406</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c670" decimals="0" id="ixv-40326" unitRef="usd">85388</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c671" decimals="0" id="ixv-40327" unitRef="usd">85388</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c674" decimals="0" id="ixv-40328" unitRef="usd">66128</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c677" decimals="0" id="ixv-40329" unitRef="usd">66128</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c678" decimals="0" id="ixv-40330" unitRef="usd">5123</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c681" decimals="0" id="ixv-40331" unitRef="usd">5123</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c682" decimals="0" id="ixv-40332" unitRef="usd">944118</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c685" decimals="0" id="ixv-40333" unitRef="usd">944118</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c2" decimals="0" id="ixv-40334" unitRef="usd">1100757</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c686" decimals="0" id="ixv-40335" unitRef="usd">85388</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c688" decimals="0" id="ixv-40336" unitRef="usd">1015369</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c607" decimals="0" id="ixv-40337" unitRef="usd">379500</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c642" decimals="0" id="ixv-40338" unitRef="usd">85388</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c135" id="ixv-31845">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at December&#160;31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years) &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.71&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-384"&gt;&#160;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at December&#160;31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years) &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;&#160;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;&#160;De&#160;minimis &lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c689"
      decimals="2"
      id="ixv-40339"
      unitRef="pure">4.18</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c690"
      decimals="2"
      id="ixv-40340"
      unitRef="pure">5.06</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c691"
      decimals="2"
      id="ixv-40341"
      unitRef="pure">0.89</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c692"
      decimals="2"
      id="ixv-40342"
      unitRef="pure">0.71</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c695"
      decimals="2"
      id="ixv-40343"
      unitRef="pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c696"
      decimals="2"
      id="ixv-40344"
      unitRef="pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c697"
      decimals="2"
      id="ixv-40345"
      unitRef="pure">12.12</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c698"
      decimals="2"
      id="ixv-40346"
      unitRef="pure">11.16</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c689"
      decimals="2"
      id="ixv-40347"
      unitRef="pure">4.18</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c690"
      decimals="2"
      id="ixv-40348"
      unitRef="pure">5.48</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c691"
      decimals="2"
      id="ixv-40349"
      unitRef="pure">0.27</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c692"
      decimals="2"
      id="ixv-40350"
      unitRef="pure">0.19</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c695"
      decimals="2"
      id="ixv-40351"
      unitRef="pure">11.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c696"
      decimals="2"
      id="ixv-40352"
      unitRef="pure">11.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c697"
      decimals="2"
      id="ixv-40353"
      unitRef="pure">12.12</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c698"
      decimals="2"
      id="ixv-40354"
      unitRef="pure">11.16</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="c135" id="ixv-31996">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides
a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the years ended December 31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;71,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;227,772&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,647&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;245,419&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December 31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;316,670&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;377,857&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,274&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;407,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(311,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24,151&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(335,880&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;71,251&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c699" decimals="0" id="ixv-40355" unitRef="usd">66128</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c700" decimals="0" id="ixv-40356" unitRef="usd">5123</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c701" decimals="0" id="ixv-40357" unitRef="usd">71251</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c611" decimals="0" id="ixv-40358" unitRef="usd">227772</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c702" decimals="0" id="ixv-40359" unitRef="usd">17647</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c703" decimals="0" id="ixv-40360" unitRef="usd">245419</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c593" decimals="0" id="ixv-40361" unitRef="usd">293900</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c704" decimals="0" id="ixv-40362" unitRef="usd">22770</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c705" decimals="0" id="ixv-40363" unitRef="usd">316670</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c706" decimals="0" id="ixv-40364" unitRef="usd">377857</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c707" decimals="0" id="ixv-40365" unitRef="usd">29274</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c708" decimals="0" id="ixv-40366" unitRef="usd">407131</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c709" decimals="0" id="ixv-40367" unitRef="usd">-311729</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c710" decimals="0" id="ixv-40368" unitRef="usd">-24151</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c711" decimals="0" id="ixv-40369" unitRef="usd">-335880</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c699" decimals="0" id="ixv-40370" unitRef="usd">66128</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c700" decimals="0" id="ixv-40371" unitRef="usd">5123</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c701" decimals="0" id="ixv-40372" unitRef="usd">71251</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c135" id="ixv-32117">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Promissory &lt;br/&gt; Note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Principal borrowing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;797,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,165,953&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Convertible &lt;br/&gt; Promissory &lt;br/&gt; Note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value at December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Principal borrowing&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,121,815&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(177,697&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c712" decimals="0" id="ixv-40373" unitRef="usd">944118</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:PrincipalBorrowing contextRef="c713" decimals="0" id="ixv-40374" unitRef="usd">797981</ck0001859807:PrincipalBorrowing>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c713" decimals="0" id="ixv-40375" unitRef="usd">7165953</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c714" decimals="0" id="ixv-40376" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:PrincipalBorrowing contextRef="c716" decimals="0" id="ixv-40377" unitRef="usd">1121815</ck0001859807:PrincipalBorrowing>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c716" decimals="0" id="ixv-40378" unitRef="usd">-177697</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c712" decimals="0" id="ixv-40379" unitRef="usd">944118</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c135" id="ixv-32221">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;9 &#x2014;&#160;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s net deferred
tax assets are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Deferred tax asset/(liability)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;Organizational costs/Startup expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;694,480&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;436,196&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Unrealized gain/loss&#160;&#x2013;&#160;Trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,661&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;694,480&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;422,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(694,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(436,196&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Deferred tax (liability), net of allowance&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(13,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The income tax provision consists
of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,174&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;480,069&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(271,945&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(226,991&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;State&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;258,284&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;203,712&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;80,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;456,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of December&#160;31, 2024
and 2023, the Company had $0 in U.S.&#160;federal net operating loss carryovers available to offset future taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In assessing the realization
of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets
will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during
the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration
of all of the information available, management believes that significant uncertainty exists with respect to future realization of the
deferred tax assets and has therefore established a full valuation allowance. For the&#160;years ended December&#160;31, 2024 and 2023,
the change in the valuation allowance was $258,284 and $203,712.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;A reconciliation of the federal
income tax rate to the Company&#x2019;s effective tax rate is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prior Year Trueup&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Business combination expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Penalties and interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12.6&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.2&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company files income tax
returns in the U.S.&#160;federal, New&#160;York and New&#160;York City jurisdictions and is subject to examination by the various taxing
authorities since inception.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c135" id="ixv-32225">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s net deferred
tax assets are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Deferred tax asset/(liability)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;Organizational costs/Startup expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;694,480&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;436,196&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Unrealized gain/loss&#160;&#x2013;&#160;Trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,661&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;694,480&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;422,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(694,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(436,196&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Deferred tax (liability), net of allowance&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(13,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c139" decimals="0" id="ixv-40380" unitRef="usd">694480</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c131" decimals="0" id="ixv-40381" unitRef="usd">436196</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities contextRef="c131" decimals="0" id="ixv-40382" unitRef="usd">13661</us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities>
    <us-gaap:DeferredTaxAssetsGross contextRef="c139" decimals="0" id="ixv-40383" unitRef="usd">694480</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c131" decimals="0" id="ixv-40384" unitRef="usd">422535</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c139" decimals="0" id="ixv-40385" unitRef="usd">694480</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c131" decimals="0" id="ixv-40386" unitRef="usd">436196</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c131" decimals="0" id="ixv-40387" unitRef="usd">13661</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c135" id="ixv-32300">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The income tax provision consists
of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,174&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;480,069&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(271,945&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(226,991&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;State&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;258,284&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;203,712&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;80,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;456,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c135" decimals="0" id="ixv-40388" unitRef="usd">94174</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c127" decimals="0" id="ixv-40389" unitRef="usd">480069</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c135" decimals="0" id="ixv-40390" unitRef="usd">-271945</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c127" decimals="0" id="ixv-40391" unitRef="usd">-226991</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c135" decimals="0" id="ixv-40392" unitRef="usd">258284</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c127" decimals="0" id="ixv-40393" unitRef="usd">203712</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c135" decimals="0" id="ixv-40394" unitRef="usd">80513</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c127" decimals="0" id="ixv-40395" unitRef="usd">456790</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards contextRef="c139" decimals="0" id="ixv-40396" unitRef="usd">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c131" decimals="0" id="ixv-40397" unitRef="usd">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c135" decimals="0" id="ixv-40398" unitRef="usd">258284</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c127" decimals="0" id="ixv-40399" unitRef="usd">203712</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c135" id="ixv-32418">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;A reconciliation of the federal
income tax rate to the Company&#x2019;s effective tax rate is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Prior Year Trueup&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Business combination expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Penalties and interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12.6&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.2&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c135"
      decimals="3"
      id="ixv-40400"
      unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c127"
      decimals="3"
      id="ixv-40401"
      unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="c135"
      decimals="4"
      id="ixv-40402"
      unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="c127"
      decimals="4"
      id="ixv-40403"
      unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="c135"
      decimals="3"
      id="ixv-40404"
      unitRef="pure">-0.187</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="c127"
      decimals="3"
      id="ixv-40405"
      unitRef="pure">-0.114</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="c135"
      decimals="4"
      id="ixv-40406"
      unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="c127"
      decimals="3"
      id="ixv-40407"
      unitRef="pure">0.058</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <ck0001859807:EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate
      contextRef="c135"
      decimals="4"
      id="ixv-40408"
      unitRef="pure">0</ck0001859807:EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate>
    <ck0001859807:EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate
      contextRef="c127"
      decimals="3"
      id="ixv-40409"
      unitRef="pure">0.002</ck0001859807:EffectiveIncomeTaxRateReconciliationAtPenaltiesAndInterestTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c135"
      decimals="3"
      id="ixv-40410"
      unitRef="pure">-0.03</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c127"
      decimals="3"
      id="ixv-40411"
      unitRef="pure">0.126</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c135"
      decimals="4"
      id="ixv-40412"
      unitRef="pure">-0.009</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c127"
      decimals="3"
      id="ixv-40413"
      unitRef="pure">0.282</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c135" id="ixv-32508">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note&#160;10 &#x2014;&#160;Segment Information&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;ASC Topic 280, &#x201c;Segment
Reporting,&#x201d; establishes standards for companies to report in their financial statement information about operating segments, products,
services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business
activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is
regularly evaluated by the Company&#x2019;s chief operating decision maker, or group, in deciding how to allocate resources and assess
performance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s chief operating
decision maker (&#x201c;CODM&#x201d;) has been identified as its Chief Financial Officer, who reviews the assets, operating results, and
financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that there is only one reportable segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The CODM assesses performance
for the single segment and decides how to allocate resources based on net loss that also is reported on the statement of operations as
net loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company&#x2019;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net (loss) income and total assets,
which include the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Trust Account&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;16,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,351,038&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,508,683&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest earned on the Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;425,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,248,538&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key measures of segment
profit or loss reviewed by our CODM are interest earned on the Trust Account and general and administrative expenses. The CODM reviews
interest earned on the Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment
with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and
monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the
business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c135"
      decimals="0"
      id="ixv-40414"
      unitRef="pure">1</us-gaap:NumberOfOperatingSegments>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="c135" id="ixv-40415">When evaluating the Company&#x2019;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net (loss) income and total assets,
which include the following:&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Trust Account&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,873,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;16,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the &lt;br/&gt; Year Ended &lt;br/&gt;
    December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,351,038&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,508,683&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest earned on the Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;425,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,248,538&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c717" decimals="0" id="ixv-40416" unitRef="usd">8330835</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c718" decimals="0" id="ixv-40417" unitRef="usd">10873406</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Cash contextRef="c717" decimals="0" id="ixv-40418" unitRef="usd">16204</us-gaap:Cash>
    <us-gaap:Cash contextRef="c718" decimals="0" id="ixv-40419" unitRef="usd">4519</us-gaap:Cash>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c719" decimals="0" id="ixv-40420" unitRef="usd">1351038</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c720" decimals="0" id="ixv-40421" unitRef="usd">1508683</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInterest contextRef="c719" decimals="0" id="ixv-40422" unitRef="usd">425416</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c720" decimals="0" id="ixv-40423" unitRef="usd">2248538</us-gaap:InvestmentIncomeInterest>
    <us-gaap:SubsequentEventsTextBlock contextRef="c135" id="ixv-32622">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 11 &#x2014; Subsequent Events&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued.
Based on the Company&#x2019;s review, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the consolidated financial statements other than as previously disclosed, and as described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On February 11, 2025, the Company
entered into a securities purchase agreement (the &#x201c;SPA&#x201d;) with an institutional investor (the &#x201c;Investor&#x201d;). Pursuant
to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth in the SPA, to purchase from the Company
senior secured convertible promissory notes in an aggregate principal amount of up to $22,222,222 (the &#x201c;Convertible Notes&#x201d;)
for a purchase price of up to $20,000,000, after a 10% original issue discount (&#x201c;OID&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March 21, 2025, the Sponsor
and its designees have now agreed to contribute an amount (the &#x201c;Revised Contribution Amount&#x201d;) equal to $30,000 for the entire
Extension Period. All funds in the Company&#x2019;s trust account, including those funds deposited in connection with the Revised Contribution
Amount, will be held in an interest-bearing demand deposit account at a bank until the earlier of the consummation of the Company&#x2019;s
initial business combination or liquidation. The Revised Contribution Amount will be deposited in the Company&#x2019;s trust account promptly
at the beginning of the Extension Period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company announced that
is has agreed to waive its right to withdraw up to $100,000 of interest from the Company&#x2019;s trust account to pay dissolution expenses,
should the Company ultimately liquidate prior to a business combination (the &#x201c;Dissolution Expense Waiver&#x201d;). As a result, the
Company will not be able to withdraw up to $100,000 of interest for such dissolution expenses upon liquidation, and such interest will
be held in the trust account and no be released until the earliest to occur of (i) the completion of the initial business combination,
(ii) the redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination
within the Extension, and (iii) the redemption of Public Shares in connection with a vote seeking to amend the provisions of our Charter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company also announced
that is has agreed to waive its right to withdraw interest from the Company&#x2019;s trust account to pay the Company&#x2019;s tax expenses
(the &#x201c;Tax Expense Waiver&#x201d;). As a result, the Company will not be able to withdraw interest in order to pay future tax expenses,
and such interest will be held in the trust account and not be released until the earliest to occur of (i) the completion of the initial
business combination, (ii) the redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial
Business Combination within the Extension, and (iii) the redemption of Public Shares in connection with a vote seeking to amend the provisions
of our Charter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Prior to such announcement,
and subsequent to the record date of February 21, 2025, for the Special Meeting, the Company withdrew approximately $23,400 of interest
from the trust account for tax expenses.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c721" decimals="0" id="ixv-40424" unitRef="usd">22222222</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c722" decimals="0" id="ixv-40425" unitRef="usd">20000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <ck0001859807:PercentageOfOriginalIssueDiscount
      contextRef="c723"
      decimals="2"
      id="ixv-40426"
      unitRef="pure">0.10</ck0001859807:PercentageOfOriginalIssueDiscount>
    <us-gaap:ContractWithCustomerLiability contextRef="c724" decimals="0" id="ixv-40427" unitRef="usd">30000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c725" decimals="0" id="ixv-40428" unitRef="usd">100000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c135" decimals="0" id="ixv-40429" unitRef="usd">100000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <ck0001859807:PercentageOfNonRedeemingPublicShareholders
      contextRef="c135"
      decimals="2"
      id="ixv-40430"
      unitRef="pure">1</ck0001859807:PercentageOfNonRedeemingPublicShareholders>
    <ck0001859807:PercentageOfNonRedeemingPublicShareholders
      contextRef="c726"
      decimals="2"
      id="ixv-40431"
      unitRef="pure">1</ck0001859807:PercentageOfNonRedeemingPublicShareholders>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses contextRef="c727" decimals="0" id="ixv-40432" unitRef="usd">23400</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c16" decimals="0" id="ixv-40433" unitRef="usd">16204</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c20" decimals="0" id="ixv-40434" unitRef="usd">1751</us-gaap:RestrictedCashCurrent>
    <us-gaap:AssetsHeldInTrustCurrent contextRef="c20" decimals="0" id="ixv-40435" unitRef="usd">661012</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c16" decimals="0" id="ixv-40436" unitRef="usd">14166</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidTaxes contextRef="c20" decimals="0" id="ixv-40437" unitRef="usd">9504</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes contextRef="c16" decimals="0" id="ixv-40438" unitRef="usd">30492</us-gaap:PrepaidTaxes>
    <ck0001859807:PrepaidFranchiseTax contextRef="c20" decimals="0" id="ixv-40439" unitRef="usd">15600</ck0001859807:PrepaidFranchiseTax>
    <us-gaap:AssetsCurrent contextRef="c20" decimals="0" id="ixv-40440" unitRef="usd">687867</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c16" decimals="0" id="ixv-40441" unitRef="usd">60862</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c20" decimals="0" id="ixv-40442" unitRef="usd">1274549</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c16" decimals="0" id="ixv-40443" unitRef="usd">8330835</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets contextRef="c20" decimals="0" id="ixv-40444" unitRef="usd">1962416</us-gaap:Assets>
    <us-gaap:Assets contextRef="c16" decimals="0" id="ixv-40445" unitRef="usd">8391697</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c20" decimals="0" id="ixv-40446" unitRef="usd">1744538</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c16" decimals="0" id="ixv-40447" unitRef="usd">684483</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ck0001859807:AdvanceFromProfusa contextRef="c20" decimals="0" id="ixv-40448" unitRef="usd">1299040</ck0001859807:AdvanceFromProfusa>
    <ck0001859807:AdvanceFromProfusa contextRef="c16" decimals="0" id="ixv-40449" unitRef="usd">791407</ck0001859807:AdvanceFromProfusa>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c20" decimals="0" id="ixv-40450" unitRef="usd">1952662</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c16" decimals="0" id="ixv-40451" unitRef="usd">1880944</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c20" decimals="0" id="ixv-40452" unitRef="usd">10288111</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c16" decimals="0" id="ixv-40453" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:SecuritiesPurchaseAgreementCurrent contextRef="c20" decimals="0" id="ixv-40454" unitRef="usd">193878</ck0001859807:SecuritiesPurchaseAgreementCurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonRedemptionValue contextRef="c20" decimals="0" id="ixv-40455" unitRef="usd">661012</us-gaap:RedeemableNoncontrollingInterestEquityCommonRedemptionValue>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c20" decimals="0" id="ixv-40456" unitRef="usd">41180</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c16" decimals="0" id="ixv-40457" unitRef="usd">50000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c20" decimals="0" id="ixv-40458" unitRef="usd">16180421</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c16" decimals="0" id="ixv-40459" unitRef="usd">12314886</us-gaap:LiabilitiesCurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c20" decimals="0" id="ixv-40460" unitRef="usd">6961700</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c16" decimals="0" id="ixv-40461" unitRef="usd">696170</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:Liabilities contextRef="c20" decimals="0" id="ixv-40462" unitRef="usd">23142121</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c16" decimals="0" id="ixv-40463" unitRef="usd">13011056</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c21"
      decimals="INF"
      id="ixv-40464"
      unitRef="shares">101777</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c18"
      decimals="INF"
      id="ixv-40465"
      unitRef="shares">687519</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="c21"
      decimals="2"
      id="ixv-40466"
      unitRef="usdPershares">13.07</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="c18"
      decimals="2"
      id="ixv-40467"
      unitRef="usdPershares">12.13</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c21" decimals="0" id="ixv-40468" unitRef="usd">1330515</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c18" decimals="0" id="ixv-40469" unitRef="usd">8337388</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20"
      decimals="4"
      id="ixv-40470"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c16"
      decimals="4"
      id="ixv-40471"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20"
      decimals="INF"
      id="ixv-40472"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c16"
      decimals="INF"
      id="ixv-40473"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20"
      decimals="4"
      id="ixv-40474"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c16"
      decimals="4"
      id="ixv-40475"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20"
      decimals="INF"
      id="ixv-40476"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c16"
      decimals="INF"
      id="ixv-40477"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20"
      decimals="INF"
      id="ixv-40478"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c16"
      decimals="INF"
      id="ixv-40479"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20"
      decimals="INF"
      id="ixv-40480"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c16"
      decimals="INF"
      id="ixv-40481"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c20" decimals="0" id="ixv-40482" unitRef="usd">519</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c16" decimals="0" id="ixv-40483" unitRef="usd">519</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c20" decimals="0" id="ixv-40484" unitRef="usd">-22510739</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c16" decimals="0" id="ixv-40485" unitRef="usd">-12957266</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c20" decimals="0" id="ixv-40486" unitRef="usd">-22510220</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="0" id="ixv-40487" unitRef="usd">-12956747</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c20" decimals="0" id="ixv-40488" unitRef="usd">1962416</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c16" decimals="0" id="ixv-40489" unitRef="usd">8391697</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses contextRef="c31" decimals="0" id="ixv-40490" unitRef="usd">967084</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c32" decimals="0" id="ixv-40491" unitRef="usd">253130</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c33" decimals="0" id="ixv-40492" unitRef="usd">1550665</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c34" decimals="0" id="ixv-40493" unitRef="usd">723971</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c31" decimals="0" id="ixv-40494" unitRef="usd">-967084</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c32" decimals="0" id="ixv-40495" unitRef="usd">-253130</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c33" decimals="0" id="ixv-40496" unitRef="usd">-1550665</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c34" decimals="0" id="ixv-40497" unitRef="usd">-723971</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c31" decimals="0" id="ixv-40498" unitRef="usd">15159</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c32" decimals="0" id="ixv-40499" unitRef="usd">108520</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c33" decimals="0" id="ixv-40500" unitRef="usd">95084</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c34" decimals="0" id="ixv-40501" unitRef="usd">225184</us-gaap:InvestmentIncomeInterest>
    <ck0001859807:ChangeInFairValueOfConvertibleNote contextRef="c31" decimals="0" id="ixv-40502" unitRef="usd">1154729</ck0001859807:ChangeInFairValueOfConvertibleNote>
    <ck0001859807:ChangeInFairValueOfConvertibleNote contextRef="c32" decimals="0" id="ixv-40503" unitRef="usd">-66021</ck0001859807:ChangeInFairValueOfConvertibleNote>
    <ck0001859807:ChangeInFairValueOfConvertibleNote contextRef="c33" decimals="0" id="ixv-40504" unitRef="usd">1380059</ck0001859807:ChangeInFairValueOfConvertibleNote>
    <ck0001859807:ChangeInFairValueOfConvertibleNote contextRef="c34" decimals="0" id="ixv-40505" unitRef="usd">-126098</ck0001859807:ChangeInFairValueOfConvertibleNote>
    <ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement contextRef="c31" decimals="0" id="ixv-40506" unitRef="usd">170391</ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement>
    <ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement contextRef="c33" decimals="0" id="ixv-40507" unitRef="usd">193878</ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c31" decimals="0" id="ixv-40508" unitRef="usd">5917445</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c32" decimals="0" id="ixv-40509" unitRef="usd">295872</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c33" decimals="0" id="ixv-40510" unitRef="usd">6265530</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c34" decimals="0" id="ixv-40511" unitRef="usd">800595</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:NonoperatingIncomeExpense contextRef="c31" decimals="0" id="ixv-40512" unitRef="usd">-7227406</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c32" decimals="0" id="ixv-40513" unitRef="usd">-121331</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c33" decimals="0" id="ixv-40514" unitRef="usd">-7744383</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c34" decimals="0" id="ixv-40515" unitRef="usd">-449313</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c31" decimals="0" id="ixv-40516" unitRef="usd">-8194490</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c32" decimals="0" id="ixv-40517" unitRef="usd">-374461</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c33" decimals="0" id="ixv-40518" unitRef="usd">-9295048</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c34" decimals="0" id="ixv-40519" unitRef="usd">-1173284</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c31" decimals="0" id="ixv-40520" unitRef="usd">2386</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c32" decimals="0" id="ixv-40521" unitRef="usd">23026</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c33" decimals="0" id="ixv-40522" unitRef="usd">21738</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c34" decimals="0" id="ixv-40523" unitRef="usd">44480</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c31" decimals="0" id="ixv-40524" unitRef="usd">-8196876</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c32" decimals="0" id="ixv-40525" unitRef="usd">-397487</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c33" decimals="0" id="ixv-40526" unitRef="usd">-9316786</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c34" decimals="0" id="ixv-40527" unitRef="usd">-1217764</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c35"
      decimals="INF"
      id="ixv-40528"
      unitRef="shares">146440</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c35"
      decimals="INF"
      id="ixv-40529"
      unitRef="shares">146440</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c36"
      decimals="INF"
      id="ixv-40530"
      unitRef="shares">738075</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c36"
      decimals="INF"
      id="ixv-40531"
      unitRef="shares">738075</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c37"
      decimals="INF"
      id="ixv-40532"
      unitRef="shares">412717</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c37"
      decimals="INF"
      id="ixv-40533"
      unitRef="shares">412717</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c38"
      decimals="INF"
      id="ixv-40534"
      unitRef="shares">783151</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c38"
      decimals="INF"
      id="ixv-40535"
      unitRef="shares">783151</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c35"
      decimals="2"
      id="ixv-40536"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c35"
      decimals="2"
      id="ixv-40537"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c36"
      decimals="2"
      id="ixv-40538"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c36"
      decimals="2"
      id="ixv-40539"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c37"
      decimals="2"
      id="ixv-40540"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c37"
      decimals="2"
      id="ixv-40541"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c38"
      decimals="2"
      id="ixv-40542"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c38"
      decimals="2"
      id="ixv-40543"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c31"
      decimals="INF"
      id="ixv-40544"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c31"
      decimals="INF"
      id="ixv-40545"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c32"
      decimals="INF"
      id="ixv-40546"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c32"
      decimals="INF"
      id="ixv-40547"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c33"
      decimals="INF"
      id="ixv-40548"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c33"
      decimals="INF"
      id="ixv-40549"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c34"
      decimals="INF"
      id="ixv-40550"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c34"
      decimals="INF"
      id="ixv-40551"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c31"
      decimals="2"
      id="ixv-40552"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c31"
      decimals="2"
      id="ixv-40553"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c32"
      decimals="2"
      id="ixv-40554"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c32"
      decimals="2"
      id="ixv-40555"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c33"
      decimals="2"
      id="ixv-40556"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c33"
      decimals="2"
      id="ixv-40557"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c34"
      decimals="2"
      id="ixv-40558"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c34"
      decimals="2"
      id="ixv-40559"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareBasic>
    <us-gaap:SharesOutstanding
      contextRef="c136"
      decimals="INF"
      id="ixv-40560"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c136" decimals="0" id="ixv-40561" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c138" decimals="0" id="ixv-40562" unitRef="usd">-12957266</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c139" decimals="0" id="ixv-40563" unitRef="usd">-12956747</us-gaap:StockholdersEquity>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c142" decimals="0" id="ixv-40564" unitRef="usd">155999</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c143" decimals="0" id="ixv-40565" unitRef="usd">155999</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c142" decimals="0" id="ixv-40566" unitRef="usd">-65108</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c143" decimals="0" id="ixv-40567" unitRef="usd">-65108</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <us-gaap:ProfitLoss contextRef="c142" decimals="0" id="ixv-40568" unitRef="usd">-1119910</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c143" decimals="0" id="ixv-40569" unitRef="usd">-1119910</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c144"
      decimals="INF"
      id="ixv-40570"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c144" decimals="0" id="ixv-40571" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c146" decimals="0" id="ixv-40572" unitRef="usd">-14298283</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c147" decimals="0" id="ixv-40573" unitRef="usd">-14297764</us-gaap:StockholdersEquity>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c150" decimals="0" id="ixv-40574" unitRef="usd">8970</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c151" decimals="0" id="ixv-40575" unitRef="usd">8970</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c150" decimals="0" id="ixv-40576" unitRef="usd">-6610</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c151" decimals="0" id="ixv-40577" unitRef="usd">-6610</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <us-gaap:ProfitLoss contextRef="c150" decimals="0" id="ixv-40578" unitRef="usd">-8196876</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c151" decimals="0" id="ixv-40579" unitRef="usd">-8196876</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c152"
      decimals="INF"
      id="ixv-40580"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c152" decimals="0" id="ixv-40581" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c154" decimals="0" id="ixv-40582" unitRef="usd">-22510739</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c155" decimals="0" id="ixv-40583" unitRef="usd">-22510220</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c128"
      decimals="INF"
      id="ixv-40584"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c128" decimals="0" id="ixv-40585" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c130" decimals="0" id="ixv-40586" unitRef="usd">-3459829</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c131" decimals="0" id="ixv-40587" unitRef="usd">-3459310</us-gaap:StockholdersEquity>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c158" decimals="0" id="ixv-40588" unitRef="usd">205732</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c159" decimals="0" id="ixv-40589" unitRef="usd">205732</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c158" decimals="0" id="ixv-40590" unitRef="usd">-10884</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions contextRef="c159" decimals="0" id="ixv-40591" unitRef="usd">-10884</ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions>
    <us-gaap:ProfitLoss contextRef="c158" decimals="0" id="ixv-40592" unitRef="usd">-820277</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c159" decimals="0" id="ixv-40593" unitRef="usd">-820277</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c160"
      decimals="INF"
      id="ixv-40594"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c160" decimals="0" id="ixv-40595" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c162" decimals="0" id="ixv-40596" unitRef="usd">-4496722</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c163" decimals="0" id="ixv-40597" unitRef="usd">-4496203</us-gaap:StockholdersEquity>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c166" decimals="0" id="ixv-40598" unitRef="usd">181330</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c167" decimals="0" id="ixv-40599" unitRef="usd">181330</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <us-gaap:ProfitLoss contextRef="c166" decimals="0" id="ixv-40600" unitRef="usd">-397487</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c167" decimals="0" id="ixv-40601" unitRef="usd">-397487</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="c168"
      decimals="INF"
      id="ixv-40602"
      unitRef="shares">5193750</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c168" decimals="0" id="ixv-40603" unitRef="usd">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c170" decimals="0" id="ixv-40604" unitRef="usd">-5075539</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c171" decimals="0" id="ixv-40605" unitRef="usd">-5075020</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c173" decimals="0" id="ixv-40606" unitRef="usd">-9316786</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c174" decimals="0" id="ixv-40607" unitRef="usd">-1217764</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c173" decimals="0" id="ixv-40608" unitRef="usd">95084</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c174" decimals="0" id="ixv-40609" unitRef="usd">225184</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c173" decimals="0" id="ixv-40610" unitRef="usd">6265530</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c174" decimals="0" id="ixv-40611" unitRef="usd">800595</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c173" decimals="0" id="ixv-40612" unitRef="usd">1380059</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c174" decimals="0" id="ixv-40613" unitRef="usd">-126098</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <ck0001859807:ChangesInFairValueOfSecuritiesPurchaseAgreement contextRef="c173" decimals="0" id="ixv-40614" unitRef="usd">193878</ck0001859807:ChangesInFairValueOfSecuritiesPurchaseAgreement>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c173" decimals="0" id="ixv-40615" unitRef="usd">-14166</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c174" decimals="0" id="ixv-40616" unitRef="usd">33750</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c173" decimals="0" id="ixv-40617" unitRef="usd">1060055</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c174" decimals="0" id="ixv-40618" unitRef="usd">255717</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c174" decimals="0" id="ixv-40619" unitRef="usd">-49061</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c173" decimals="0" id="ixv-40620" unitRef="usd">-20988</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c174" decimals="0" id="ixv-40621" unitRef="usd">66525</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <ck0001859807:IncreaseDecreaseInPrepaidFranchiseTaxes contextRef="c173" decimals="0" id="ixv-40622" unitRef="usd">15600</ck0001859807:IncreaseDecreaseInPrepaidFranchiseTaxes>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="c173" decimals="0" id="ixv-40623" unitRef="usd">-8820</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c174" decimals="0" id="ixv-40624" unitRef="usd">13661</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c173" decimals="0" id="ixv-40625" unitRef="usd">-501614</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c174" decimals="0" id="ixv-40626" unitRef="usd">-675731</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <ck0001859807:PaymentOfExtensionFeeIntoTrustAccount contextRef="c173" decimals="0" id="ixv-40627" unitRef="usd">99285</ck0001859807:PaymentOfExtensionFeeIntoTrustAccount>
    <ck0001859807:PaymentOfExtensionFeeIntoTrustAccount contextRef="c174" decimals="0" id="ixv-40628" unitRef="usd">235733</ck0001859807:PaymentOfExtensionFeeIntoTrustAccount>
    <ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption contextRef="c173" decimals="0" id="ixv-40629" unitRef="usd">6510830</ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption>
    <ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption contextRef="c174" decimals="0" id="ixv-40630" unitRef="usd">2653439</ck0001859807:CashWithdrawnFromTrustAccountInConnectionWithRedemption>
    <us-gaap:ProceedsFromDecommissioningFund contextRef="c173" decimals="0" id="ixv-40631" unitRef="usd">78813</us-gaap:ProceedsFromDecommissioningFund>
    <us-gaap:ProceedsFromDecommissioningFund contextRef="c174" decimals="0" id="ixv-40632" unitRef="usd">204460</us-gaap:ProceedsFromDecommissioningFund>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c173" decimals="0" id="ixv-40633" unitRef="usd">6490358</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c174" decimals="0" id="ixv-40634" unitRef="usd">2622166</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c174" decimals="0" id="ixv-40635" unitRef="usd">708981</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c173" decimals="0" id="ixv-40636" unitRef="usd">507633</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c173" decimals="0" id="ixv-40637" unitRef="usd">6510830</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c174" decimals="0" id="ixv-40638" unitRef="usd">2653439</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c173" decimals="0" id="ixv-40639" unitRef="usd">-6003197</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c174" decimals="0" id="ixv-40640" unitRef="usd">-1944458</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c173" decimals="0" id="ixv-40641" unitRef="usd">-14453</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c174" decimals="0" id="ixv-40642" unitRef="usd">1977</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c139" decimals="0" id="ixv-40643" unitRef="usd">16204</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c131" decimals="0" id="ixv-40644" unitRef="usd">4519</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c155" decimals="0" id="ixv-40645" unitRef="usd">1751</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c171" decimals="0" id="ixv-40646" unitRef="usd">6496</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid contextRef="c173" decimals="0" id="ixv-40647" unitRef="usd">750</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c174" decimals="0" id="ixv-40648" unitRef="usd">173727</us-gaap:IncomeTaxesPaid>
    <ck0001859807:ExciseTaxPayableRedemptionOfCommonStock contextRef="c173" decimals="0" id="ixv-40649" unitRef="usd">71718</ck0001859807:ExciseTaxPayableRedemptionOfCommonStock>
    <ck0001859807:ExciseTaxPayableRedemptionOfCommonStock contextRef="c174" decimals="0" id="ixv-40650" unitRef="usd">10884</ck0001859807:ExciseTaxPayableRedemptionOfCommonStock>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c173" decimals="0" id="ixv-40651" unitRef="usd">164969</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue contextRef="c174" decimals="0" id="ixv-40652" unitRef="usd">387062</ck0001859807:AccretionOfCommonStockToRedemptionValue>
    <ck0001859807:RedemptionPaymentsDueToRedeemingStockholders contextRef="c173" decimals="0" id="ixv-40653" unitRef="usd">661012</ck0001859807:RedemptionPaymentsDueToRedeemingStockholders>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c139" decimals="0" id="ixv-40654" unitRef="usd">16204</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c131" decimals="0" id="ixv-40655" unitRef="usd">4519</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c139" decimals="0" id="ixv-40656" unitRef="usd">16204</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c131" decimals="0" id="ixv-40657" unitRef="usd">4519</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c171" decimals="0" id="ixv-40658" unitRef="usd">6496</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c155" decimals="0" id="ixv-40659" unitRef="usd">1751</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c155" decimals="0" id="ixv-40660" unitRef="usd">1751</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c171" decimals="0" id="ixv-40661" unitRef="usd">6496</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c173" id="ixv-34590">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;1 &#x2014;&#160;Description of Organization
and Business Operations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;NorthView Acquisition Corporation
(now known as Profusa, Inc.) (the &#x201c;Company&#x201d; or &#x201c;Northview&#x201d;) was a blank check company incorporated in Delaware
on April&#160;19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more businesses (&#x201c;Business Combination&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company had a wholly-owned
subsidiary, NV Profusa Merger Sub Inc. (&#x201c;Merger Sub&#x201d;), a Delaware corporation incorporated on October&#160;13, 2022, which
was formed solely in contemplation of the Merger with Profusa (See below). In connection with the Merger, which was consummated on July&#160;11,
2025, Merger Sub is no longer in existence.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Business Combination&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;7, 2022, the
Company, Profusa, Inc., a California corporation (&#x201c;Profusa&#x201d;) and Merger Sub entered into a Merger Agreement and Plan of Reorganization
(as the same has been amended, supplemented or otherwise modified from time to time, the &#x201c;Merger Agreement&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On June&#160;5, 2025 (the &#x201c;Redemption
Date&#x201d;), the Company received requests to redeem a total of 52,784 Public Shares (as defined below), representing 32.4% of the total
Public Shares of the Company outstanding prior to the Redemption Date. Following the redemption, 5,295,527 Public Shares were outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;At the special meeting of the
stockholders held on June&#160;9, 2025 (the &#x201c;Special Meeting&#x201d;), the Company&#x2019;s stockholders voted to approve the proposals
outlined in the final prospectus and definitive proxy statement filed by the Company with the U.S.&#160;Securities and Exchange Commission
(the &#x201c;SEC&#x201d;) on May&#160;15, 2025 (the &#x201c;Proxy Statement/Prospectus&#x201d;), including, among other things, the adoption
of the Merger Agreement and approval of the transactions contemplated thereby, including the merger of Merger Sub with and into Profusa,
with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary of the Company (the &#x201c;Merger&#x201d;), and the
issuance of the Company&#x2019;s common stock as consideration thereunder (together with the other transactions contemplated by the Merger
Agreement, the &#x201c;Business Combination&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;11, 2025 (the
&#x201c;Closing Date&#x201d;), the Company closed the Business Combination with Profusa. As a result of the Business Combination, the Company
owns 100% of the outstanding common stock of Profusa.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In connection with the closing
of the Business Combination, the Company changed its name from &#x201c;NorthView Acquisition Corporation&#x201d; to &#x201c;Profusa, Inc.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Business Prior to the Business Combination&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;22, 2021,
the Company consummated its Initial Public Offering (&#x201c;IPO&#x201d;) of 18,975,000&#160;units (the &#x201c;Units&#x201d;), which included
2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists
of one share of common stock of the Company, par value $0.0001 per share, one right (the &#x201c;Rights&#x201d;), and one-half of one redeemable
warrant of the Company (the &#x201c;Warrants&#x201d;). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of
common stock. Each Warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment.
The Units&#160;were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Simultaneously with the closing
of the IPO, the Company completed the private sale of an aggregate of 7,347,500&#160;warrants (the &#x201c;Private Placement Warrants&#x201d;),
which included 697,500 Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters,
to NorthView Sponsor&#160;I, LLC (&#x201c;the Sponsor&#x201d;),&#160;I-Bankers Securities, Inc., and Dawson James Securities, Inc. at a
purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,347,500, which is discussed in Note&#160;4.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Transaction costs in connection
with the IPO amounted to $7,959,726, consisting of $3,450,000 of underwriting discount, $3,570,576 of Representative&#x2019;s Shares cost,
$259,527 of Representative&#x2019;s Warrants cost and $679,623 of other offering costs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Following the closing of the
IPO on December&#160;22, 2021, an amount of $191,647,500 ($10.10 per Unit), excluding $741,228 that was wired to the Company&#x2019;s operating
bank account on December&#160;31, 2021 for working capital purposes, from the net proceeds of the sale of the public units in the IPO
and the sale of the Private Placement Warrants was placed in a Trust Account (&#x201c;Trust Account&#x201d;) and invested in United&#160;States
government treasury bills with a maturity of 185&#160;days or less or in money market funds investing solely in United&#160;States Treasuries
and meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act as determined by the Company. Except with respect
to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from
the IPO will not be released from the Trust Account until the earliest of (i)&#160;the completion of the Company&#x2019;s initial Business
Combination, (ii)&#160;the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company&#x2019;s
amended and restated certificate of incorporation (A)&#160;to modify the substance or timing of the Company&#x2019;s obligation to redeem
100% of the public shares if the Company does not complete the initial Business Combination within the extended period (or any additional
extension from the closing of our IPO if we extend the period of time to consummate a business combination) (the &#x201c;Combination Period&#x201d;),
or (B)&#160;with respect to any other provision relating to stockholders&#x2019; rights or pre-Business Combination activity, and (iii)&#160;the
redemption of all of the Company&#x2019;s public shares if the Company is unable to complete the Business Combination within the Combination
Period, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#x2019;s
creditors, if any, which could have priority over the claims of the Company&#x2019;s public stockholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company provided its public
stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination
in connection with a stockholder meeting called to approve the initial Business Combination. The decision as to whether the Company will
seek stockholder approval of a proposed initial Business Combination or conduct a tender offer was made by the Company, solely in its
discretion. The stockholders were entitled to redeem all or a portion of their public shares upon the completion of the initial Business
Combination at a per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two&#160;business
days prior to the consummation of the initial Business Combination, including interest (which interest shall be net of taxes payable)
divided by the number of then outstanding public shares, subject to the limitations described herein. The per share amount the Company
distributed to investors who properly redeemed their shares was not reduced by the fee payable to&#160;I-Bankers&#160;and Dawson James
pursuant to the Business Combination Marketing Agreement (see Note&#160;6).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;10, 2023, the
Company held a vote to amend its amended and restated certificate of incorporation to extend the date by which the Company must consummate
a Business Combination from March&#160;22, 2023 to December&#160;22, 2023 (the &#x201c;First Extension Meeting&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024. In connection with the extension, 140,663 shares of the Company&#x2019;s
common stock were redeemed, with 6,027,219 shares of Common Stock remaining outstanding after the Redemption; 833,469 shares of Common
Stock remaining outstanding after the Redemption are shares issued in connection with our IPO (the &#x201c;Public Shares&#x201d;). In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January&#160;2, 2024, the
Company and Continental Stock Transfer&#160;&amp;amp; Trust Company (&#x201c;CST&#x201d;) entered into Amendment No. 1 to Investment Management
Trust Agreement, dated December&#160;20, 2021, by and between the Company and CST, to allow CST, upon written instruction of the Company,
to (i)&#160;hold the funds in the Company&#x2019;s trust account uninvested or (ii)&#160;hold the funds in an interest-bearing bank demand
deposit account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January&#160;10, 2024, the
Company&#x2019;s Board of Directors approved, and the Company amended, its Convertible Working Capital Promissory Note (the &#x201c;Note&#x201d;)
with the sponsor to increase the principal amount of the Note that could be drawn on to $1.5&#160;million. The amended and restated Note
also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company common stock at a price
of $2.22 per share at the election of the sponsor. On May&#160;31, 2024, the Company&#x2019;s Board of Directors approved and the Company
entered into a second amendment of its Convertible Working Capital Promissory Note with the sponsor to increase the principal amount of
the Note that could be drawn on to $2.5&#160;million. The second amended and restated Note also allows for the conversion of the outstanding
principal balance of the Note to be repaid in shares of Company common stock at a price of $2.22&#160;per share at the election of the
sponsor.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;21, 2024, the
Company held its 2024 Annual Meeting of Stockholders (the &#x201c;Meeting&#x201d;). At the meeting, the Company&#x2019;s stockholders approved
the amendment of the Company&#x2019;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company&#x2019;s
common stock issued in the Company&#x2019;s initial public offering, from March&#160;22, 2024, monthly for up to six additional&#160;months
at the election of the Company and only upon contribution of $0.05 per month per outstanding public share, ultimately until September&#160;22,
2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In connection with the meeting,
the holders of&#160;95,394&#160;Public Shares properly exercised their right to redeem, with 5,931,825 shares of Common Stock remaining
outstanding after the Redemption; 738,075 shares of Common Stock remaining outstanding after the Redemption are Public Shares. Consequently,
the contribution was $36,904&#160;per month needed for the Company to continue to extend the Combination Period monthly. On May&#160;8,
2024 and May&#160;31, 2024, the Company made two deposits of $36,904 each for April and May extension contributions. On September&#160;10,
2024, the Company made a deposit of $112,114, of which $110,714 was for June, July and August extension contributions and $1,400 for lost
interest due to late trust payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On September&#160;19, 2024,
the Company held a special meeting of stockholders (the &#x201c;Meeting&#x201d;). At the Meeting, the Company&#x2019;s stockholders approved
an amendment to the Company&#x2019;s amended and restated certificate of incorporation to extend the date by which the Company must consummate
its initial Business Combination to March&#160;22, 2025. In connection with the approval of the extension amendment, holders of&#160;50,556&#160;shares
of the Company&#x2019;s common stock exercised their right to redeem, with 5,881,269 shares of common stock remaining outstanding after
the redemption; 687,519 shares of common stock remaining outstanding after the redemption are Public Shares. Consequently, the contribution
is $34,376&#160;per month needed for the Company to continue to extend the Combination Period monthly. On December&#160;13, 2024, the
Company made a deposit of $68,752 for the October and November extension contributions and on December&#160;23, 2024, the Company made
a deposit of 34,376 for the December extension contribution. In October&#160;2024, $595,439 was paid from the trust account to redeeming
stockholders in connection with the extension. On February&#160;27, 2025, the Company made a deposit of $49,376 for the January extension
contribution and a portion ($15,000) of the February extension contribution. On March&#160;7, 2025, the Company deposited the remainder
of the February extension contribution of $19,376, plus interest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the meeting and the stockholders approved the extension of the business combination period
until June&#160;22, 2025. In connection with the approval of the extension amendment, holders of&#160;532,958&#160;shares of the Company&#x2019;s
common stock exercised their right to redeem, for an aggregate redemption amount of approximately $6.5&#160;million, with 5,348,311 shares
of common stock remaining outstanding after the redemption; 154,561 shares of common stock remaining outstanding after the redemption
are Public Shares. As a condition of the extension, the Company contributed $30,000 to the Trust Account, for the entire extension period,
on March&#160;21, 2025. Additionally, the stockholders at the meeting approved the amendment of the Company&#x2019;s charter to remove
the requirement that prevented the Company from redeeming public shares to the extent that it would cause the Company&#x2019;s net tangible
assets to be less than $5,000,001 (the &#x201c;NTA Requirement&#x201d;), and our charter was amended on March&#160;21, 2025 to reflect the
extension of the business combination and the removal of the NTA Requirement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On April&#160;2, 2025, the
parties to the Merger Agreement entered into an Amendment No. 5 to the Merger Agreement (&#x201c;Amendment No. 5&#x201d;) pursuant to which
Section&#160;9.01 of the Merger Agreement was amended such that the reference to &#x201c;March&#160;22, 2025&#x201d; shall be replaced with
&#x201c;June&#160;22, 2025&#x201d; by which the Company must consummate a Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On May&#160;8, 2025, the Company
entered into a non-redemption&#160;agreement (the &#x201c;Non-Redemption&#160;Agreement&#x201d;) with&#160;I-Bankers Securities, Inc. and
Dawson James Securities, Inc. (together, the &#x201c;Investors&#x201d;), pursuant to which such Investors agreed that to the extent that
redemptions in connection with the vote to approve the Business Combination reduces the Company&#x2019;s trust account balance below $1.25&#160;million,
the Investors would offer such redeeming shareholders an opportunity to rescind the redemption of their shares and would instead purchase
such shares. Such purchases would be structured in compliance with the requirements of&#160;Rule&#160;14e-5&#160;under the&#160;Exchange&#160;Act&#160;or
would otherwise not constitute a tender offer pursuant to the&#160;Exchange&#160;Act. As of the Closing Date, the Company&#x2019;s trust
account balance was not below $1.25&#160;million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On June&#160;9, 2025, the Company
held a special meeting of stockholders. At the meeting, the Company&#x2019;s stockholders approved the Merger Agreement and the actions
and transactions contemplated thereby, including (i)&#160;adopt an amended and restated Certificate of Incorporation, to be effective
upon closing of the Merger, (ii)&#160;approving certain advisory proposals related to the amended and restated Certificate of Incorporation,
(iii)&#160;approved the issuance of new shares of the Company&#x2019;s Common Stock as merger consideration, (iv)&#160;elected new directors,
and (v)&#160;approved new employee incentive plans. In connection with the meeting, the holders of 52,784 Public Shares properly exercised
their right to redeem, with 5,295,527 shares of Common Stock remaining outstanding after such redemptions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;1, 2025, the Company
filed an amendment to its Certificate of Incorporation (the &#x201c;Amendment&#x201d;) to extend the date by which the Company must consummate
a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company&#x2019;s
common stock issued in the Company&#x2019;s initial public offering, from June&#160;22, 2025 to August&#160;22, 2025. Previously, on June&#160;27,
2025, the Company had filed a copy of the Amendment with a date that mistakenly referenced &#x201c;July&#160;22, 2025&#x201d; rather than
&#x201c;August&#160;22, 2025,&#x201d; however such filing was corrected in connection with the filing of the Amendment on July&#160;1, 2025.
The Company&#x2019;s stockholders approved the Amendment by a supermajority of at least 65% via written consent on June&#160;27, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company agreed to waive
its right to withdraw up to $100,000 of interest from the Company&#x2019;s trust account to pay dissolution expenses, should the Company
ultimately liquidate prior to a business combination (the &#x201c;Dissolution Expense Waiver&#x201d;). As a result, the Company was no longer
able to withdraw up to $100,000 of interest for such dissolution expenses upon liquidation, and such interest will be held in the trust
account and not be released until the earliest to occur of (i)&#160;the completion of the initial business combination, (ii)&#160;the
redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination within
the Extension, and (iii)&#160;the redemption of Public Shares in connection with a vote seeking to amend the provisions of our Charter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company also agreed to
waive its right to withdraw interest from the Company&#x2019;s trust account to pay the Company&#x2019;s tax expenses (the &#x201c;Tax Expense
Waiver&#x201d;). As a result, the Company was no longer able to withdraw interest in order to pay future tax expenses, and such interest
will be held in the trust account and not be released until the earliest to occur of (i)&#160;the completion of the initial business combination,
(ii)&#160;the redemption of 100% of the Offering Shares (as defined below) if the Company is unable to complete its initial Business Combination
within the Extension, and (iii)&#160;the redemption of Public Shares in connection with a vote seeking to amend the provisions of our
Charter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Prior to such announcement,
and subsequent to the record date of February&#160;21, 2025, for the Special Meeting, the Company withdrew approximately $23,200 of interest
from the trust account for tax expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;All of the Public Shares contain
a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder
vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and
restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified
in ASC&#160;480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to
be classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., public
warrants), the initial carrying value of common stock classified as temporary equity was the allocated proceeds determined in accordance
with ASC&#160;470-20. The common stock is subject to ASC&#160;480-10-S99. If it is probable that the equity instrument will become redeemable,
the Company has the option to either (i)&#160;accrete changes in the redemption value over the period from the date of issuance (or from
the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument
or (ii)&#160;recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal
the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Sponsor, officers and directors
have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with the completion
of the initial Business Combination, (ii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to
their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will
be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete
the Business Combination within such time period); and (iii)&#160;vote their Founder Shares and any public shares purchased during or
after the IPO in favor of the initial Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s Sponsor
has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to
the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount
of funds in the Trust Account to below (i)&#160;$10.10 per public share or (ii)&#160;such lesser amount per public share held in the Trust
Account as of the date of the liquidation of the Trust Account due to reductions in value of the trust assets, in each case net of the
amount of interest which may be released to the Company to pay taxes, except as to any claims by a third party who executed a waiver of
any and all rights to seek access to the Trust Account and except as to any claims under indemnity of the underwriters of the IPO against
certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Nasdaq Delisting Notification&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;20, 2024,
the Company received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market that the Company&#x2019;s
securities would be delisted from The Nasdaq Stock Market by reason of the failure of the Company to complete its initial business combination
by December&#160;20, 2024 (36&#160;months from the effectiveness of its IPO registration statement) as required by Listing Rule IM-5101-2.
Accordingly, trading in the Company&#x2019;s Common Stock, Rights and Warrants was suspended at the opening of business on December&#160;27,
2024 and a Form&#160;25-NSE was filed by Nasdaq with the Securities and Exchange Commission, which removed the Company&#x2019;s securities
from on the Nasdaq Stock Market. The Company&#x2019;s Common Stock, Rights and Warrants began to be quoted on the Pink Markets operated
on The OTC Market systems (&#x201c;OTC Market&#x201d;) under the symbols &#x201c;NVAC,&#x201d; &#x201c;NVACR&#x201d; and &#x201c;NVACW.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Use of Funds Restricted for Payment of Taxes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From inception to date, the
Company has withdrawn a total of $1,484,219 of interest from the Trust Account of which $1,453,297 was paid for franchise and income taxes.
Of the aggregate withdrawals, $30,922 was restricted for the payment of the Company&#x2019;s income taxes. The Company utilized $29,171
of these withdrawals towards funding operating expenses, as well as the monthly extension deposits. As of June&#160;30, 2025, the Company
has restricted cash of $1,751. The Company intends to deposit $29,171 back into the Trust Account or use the $29,171 (or a portion thereof)
for tax obligations until a deposit is made into the trust on a future date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Liquidity and Going Concern&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of&#160;June&#160;30, 2025,
the Company had $1,751 in restricted cash and a working capital deficit of $15,492,554. Prior to the completion of the Company&#x2019;s
IPO, the Company&#x2019;s liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000 for the founder
shares to cover certain of the offering costs and the loan under an unsecured promissory note from the Sponsor of $204,841, which was
fully paid upon the IPO.&#160;Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company&#x2019;s
liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account,
and the drawdowns on the convertible promissory note.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In order to finance transaction
costs in connection with an intended Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain
of the Company&#x2019;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note&#160;5).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#x201c;the Note&#x201d;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January&#160;10, 2024, the
Company&#x2019;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On May&#160;31, 2024, the Company&#x2019;s
Board of Directors approved, and the Company second amended its Note to increase the principal amount of the Note that could be drawn
on to $2.5&#160;million. The second amended and restated Note also allows for the conversion of the outstanding principal balance of the
Note to be repaid in shares of Company common stock at a price of $2.22&#160;per share at the election of the sponsor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company had principal outstanding
of $1,919,796 and is presenting the Note at fair value on its balance sheet at June&#160;30, 2025 in the amount of $10,288,111. As of
June&#160;30, 2025, no amounts were repaid against the loan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company incurred significant
costs in pursuit of its Business Combination. As part of the closing, the Company had cash inflows of $1.3&#160;million from the Trust
Account, net of redemptions, and the $9&#160;million net PIPE convertible note. Cash outflows included marketing fees and vendor payments
which totaled $3.4&#160;million due at closing. In connection with the Company&#x2019;s assessment of going concern considerations in accordance
with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Update (&#x201c;ASU&#x201d;)&#160;2014-15, &#x201c;Disclosures
of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern,&#x201d; management believes that subsequent to the closing
of the Merger, there continues to be factors which raise substantial doubt about the Company&#x2019;s ability to continue as a going concern
within one year from the date the condensed consolidated financial statements are issued. The condensed consolidated financial statements
do not contain any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On August&#160;16, 2022, the
Inflation Reduction Act&#160;of&#160;2022 (the &#x201c;IR Act&#x201d;) was signed into federal law. The IR Act provides for, among other
things, a new U.S.&#160;federal 1% excise tax on certain repurchases of stock occurring on or after January&#160;1, 2023, by publicly
traded U.S.&#160;domestic corporations, by certain U.S.&#160;domestic subsidiaries of publicly traded foreign corporations, by &#x201c;covered
surrogate foreign corporations&#x201d; (as defined in the IR Act) and by certain affiliates of the foregoing. The excise tax is imposed
on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally
1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock
repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Any redemption or other repurchase
that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the
excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension
vote or otherwise would depend on a number of factors, including (i)&#160;the fair market value of the redemptions and repurchases in
connection with the Business Combination, extension or otherwise, (ii)&#160;the structure of a Business Combination, (iii)&#160;the nature
and amount of any &#x201c;PIPE&#x201d; or other equity issuances in connection with a Business Combination (or otherwise issued not in connection
with a Business Combination but issued within the same taxable year of a Business Combination) and (iv)&#160;the content of regulations
and other guidance from the Treasury. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination
and in the Company&#x2019;s ability to complete a Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;22, 2023 and
December&#160;21, 2023, the Company&#x2019;s stockholders redeemed 18,000,868 and 140,663 shares, respectively, for a total of $184,845,836
and $1,565,078, respectively. On March&#160;26, 2024, the Company&#x2019;s stockholders redeemed 95,394 shares for a total of $1,088,361.
On September&#160;30, 2024, the Company&#x2019;s stockholders redeemed 50,556 shares for a total of $595,439. On March&#160;26, 2025, the
Company&#x2019;s stockholders redeemed 532,958 shares for a total of $6,510,830. On June&#160;16, 2025, the Company&#x2019;s stockholders
redeemed 52,784 shares for a total of $661,012. The Company determined that an excise tax liability should be recorded due to the redeemed
shares. As of June&#160;30, 2025 and December&#160;31, 2024, the Company has a charge to stockholders&#x2019; deficit of $1,952,662 and
$1,880,944 of excise tax liability, including $71,718 and $16,838 charged during the six&#160;months ended June&#160;30, 2025 and the
year ended December&#160;31, 2024, respectively, calculated as 1% of the value of shares redeemed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;3, 2024, the Treasury
issued final regulations with respect to the procedure and administration of the Excise Tax. These regulations provided that the filing
and payment deadline for any liability incurred during the period from January&#160;1, 2023 to December&#160;31, 2023 would be October&#160;31,
2024. As of June&#160;30, 2025 and the date of this report, the excise tax was not paid and was recorded as excise tax payable. Any amount
of such Excise Tax not paid in full, could be subject to additional interest and penalties which are currently estimated at 7% or 9% interest
per annum and a 0.5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 and
December&#160;31, 2024, $1,952,662 and $1,880,944 in excise tax was accrued on the accompanying condensed consolidated balance sheets,
respectively. On January&#160;29, 2025, the Company claimed disaster relief under IRC Section&#160;7508A relating to Hurricane Beryl as
announced in IRS Announcement TX-2024-08. Under the disaster relief claim, the time for filing of the September&#160;30, 2024 Quarterly
Federal Excise Tax Return and payment of the 2023 excise taxes on repurchases of corporate stock normally due on October&#160;31, 2024
should be postponed to February&#160;3, 2025. The Company was not subject to excise tax interest and penalties until February&#160;3,
2025. On January&#160;29, 2025, the Company filed their 2024 excise tax return. The Company did not repay the excise tax in full by June&#160;30,
2025. As of June&#160;30, 2025, the Company accrued approximately $105,970 interest and penalties in the accompanying condensed consolidated
statements of operations.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="c728"
      decimals="2"
      id="ixv-40662"
      unitRef="pure">527.84</ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <ck0001859807:PercentageOfPublicShares
      contextRef="c728"
      decimals="3"
      id="ixv-40663"
      unitRef="pure">0.324</ck0001859807:PercentageOfPublicShares>
    <ck0001859807:RedemptionPublicShares
      contextRef="c728"
      decimals="0"
      id="ixv-40664"
      unitRef="shares">5295527</ck0001859807:RedemptionPublicShares>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c729"
      decimals="2"
      id="ixv-40665"
      unitRef="pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c536"
      decimals="0"
      id="ixv-40666"
      unitRef="shares">18975000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c537"
      decimals="0"
      id="ixv-40667"
      unitRef="shares">2475000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c538"
      decimals="0"
      id="ixv-40668"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c539"
      decimals="4"
      id="ixv-40669"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c540"
      decimals="0"
      id="ixv-40670"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c541"
      decimals="0"
      id="ixv-40671"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c543"
      decimals="0"
      id="ixv-40672"
      unitRef="shares">1</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c730"
      decimals="2"
      id="ixv-40673"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c539"
      decimals="2"
      id="ixv-40674"
      unitRef="usdPershares">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c536" decimals="0" id="ixv-40675" unitRef="usd">189750000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c731"
      decimals="0"
      id="ixv-40676"
      unitRef="shares">7347500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c732"
      decimals="0"
      id="ixv-40677"
      unitRef="shares">697500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c731"
      decimals="2"
      id="ixv-40678"
      unitRef="usdPershares">1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c733" decimals="0" id="ixv-40679" unitRef="usd">7347500</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <ck0001859807:TransactionCost contextRef="c155" decimals="0" id="ixv-40680" unitRef="usd">7959726</ck0001859807:TransactionCost>
    <ck0001859807:UnderwritingDiscountAmount contextRef="c155" decimals="0" id="ixv-40681" unitRef="usd">3450000</ck0001859807:UnderwritingDiscountAmount>
    <ck0001859807:RepresentativeSharesCost contextRef="c173" decimals="0" id="ixv-40682" unitRef="usd">3570576</ck0001859807:RepresentativeSharesCost>
    <ck0001859807:RepresentativeWarrantCost contextRef="c173" decimals="0" id="ixv-40683" unitRef="usd">259527</ck0001859807:RepresentativeWarrantCost>
    <ck0001859807:OtherOfferingCosts contextRef="c173" decimals="0" id="ixv-40684" unitRef="usd">679623</ck0001859807:OtherOfferingCosts>
    <ck0001859807:PaymentsForInvestmentOfCashInTrustAccount contextRef="c539" decimals="0" id="ixv-40685" unitRef="usd">191647500</ck0001859807:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c539"
      decimals="2"
      id="ixv-40686"
      unitRef="usdPershares">10.1</us-gaap:SharesIssuedPricePerShare>
    <ck0001859807:OperatingBankAccount contextRef="c548" decimals="0" id="ixv-40687" unitRef="usd">741228</ck0001859807:OperatingBankAccount>
    <ck0001859807:MaturityDays contextRef="c549" id="ixv-40688">P185D</ck0001859807:MaturityDays>
    <ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="c549"
      decimals="2"
      id="ixv-40689"
      unitRef="pure">1</ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c734"
      decimals="0"
      id="ixv-40690"
      unitRef="shares">140663</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c735"
      decimals="0"
      id="ixv-40691"
      unitRef="shares">6027219</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c736"
      decimals="0"
      id="ixv-40692"
      unitRef="shares">833469</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering contextRef="c737" decimals="0" id="ixv-40693" unitRef="usd">1565078</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <ck0001859807:WorkingCapital
      contextRef="c554"
      decimals="-5"
      id="ixv-40694"
      unitRef="usd">1500000</ck0001859807:WorkingCapital>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c554"
      decimals="2"
      id="ixv-40695"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <ck0001859807:AmountDrawn
      contextRef="c738"
      decimals="-5"
      id="ixv-40696"
      unitRef="usd">2500000</ck0001859807:AmountDrawn>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c155"
      decimals="2"
      id="ixv-40697"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="c556"
      decimals="2"
      id="ixv-40698"
      unitRef="pure">1</ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c557"
      decimals="2"
      id="ixv-40699"
      unitRef="usdPershares">0.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c739"
      decimals="0"
      id="ixv-40700"
      unitRef="shares">95394</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c740"
      decimals="0"
      id="ixv-40701"
      unitRef="shares">5931825</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c152"
      decimals="0"
      id="ixv-40702"
      unitRef="shares">738075</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:NoncashContributionExpense contextRef="c173" decimals="0" id="ixv-40703" unitRef="usd">36904</us-gaap:NoncashContributionExpense>
    <us-gaap:Deposits contextRef="c741" decimals="0" id="ixv-40704" unitRef="usd">36904</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c555" decimals="0" id="ixv-40705" unitRef="usd">36904</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c560" decimals="0" id="ixv-40706" unitRef="usd">112114</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c561" decimals="0" id="ixv-40707" unitRef="usd">110714</us-gaap:Deposits>
    <us-gaap:InterestIncomeOther contextRef="c562" decimals="0" id="ixv-40708" unitRef="usd">1400</us-gaap:InterestIncomeOther>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c563"
      decimals="0"
      id="ixv-40709"
      unitRef="shares">50556</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c564"
      decimals="0"
      id="ixv-40710"
      unitRef="shares">5881269</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c565"
      decimals="0"
      id="ixv-40711"
      unitRef="shares">687519</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:NoncashContributionExpense contextRef="c566" decimals="0" id="ixv-40712" unitRef="usd">34376</us-gaap:NoncashContributionExpense>
    <us-gaap:Deposits contextRef="c567" decimals="0" id="ixv-40713" unitRef="usd">68752</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c568" decimals="0" id="ixv-40714" unitRef="usd">34376</us-gaap:Deposits>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering contextRef="c569" decimals="0" id="ixv-40715" unitRef="usd">595439</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <us-gaap:Deposits contextRef="c742" decimals="0" id="ixv-40716" unitRef="usd">49376</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c743" decimals="0" id="ixv-40717" unitRef="usd">15000</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c744" decimals="0" id="ixv-40718" unitRef="usd">19376</us-gaap:Deposits>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c745"
      decimals="0"
      id="ixv-40719"
      unitRef="shares">532958</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="c746"
      decimals="-5"
      id="ixv-40720"
      unitRef="usd">6500000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c746"
      decimals="0"
      id="ixv-40721"
      unitRef="shares">5348311</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c746"
      decimals="0"
      id="ixv-40722"
      unitRef="shares">154561</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:NoncashContributionExpense contextRef="c745" decimals="0" id="ixv-40723" unitRef="usd">30000</us-gaap:NoncashContributionExpense>
    <ck0001859807:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets contextRef="c173" decimals="0" id="ixv-40724" unitRef="usd">5000001</ck0001859807:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets>
    <ck0001859807:PaymentsForInvestmentOfCashInTrustAccount contextRef="c155" decimals="2" id="ixv-40725" unitRef="usd">1.25</ck0001859807:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c747"
      decimals="0"
      id="ixv-40726"
      unitRef="shares">52784</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c748"
      decimals="0"
      id="ixv-40727"
      unitRef="shares">5295527</us-gaap:CommonStockSharesOutstanding>
    <ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="c749"
      decimals="2"
      id="ixv-40728"
      unitRef="pure">1</ck0001859807:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <ck0001859807:StockholdersAmendmentPercentage
      contextRef="c750"
      decimals="2"
      id="ixv-40729"
      unitRef="pure">0.65</ck0001859807:StockholdersAmendmentPercentage>
    <ck0001859807:PaymentofInteresttoDistributionExpense contextRef="c751" decimals="0" id="ixv-40730" unitRef="usd">100000</ck0001859807:PaymentofInteresttoDistributionExpense>
    <ck0001859807:PaymentofInteresttoDistributionExpense contextRef="c173" decimals="0" id="ixv-40731" unitRef="usd">100000</ck0001859807:PaymentofInteresttoDistributionExpense>
    <ck0001859807:PercentageOfRedeemingPublicShareholders
      contextRef="c173"
      decimals="2"
      id="ixv-40732"
      unitRef="pure">1</ck0001859807:PercentageOfRedeemingPublicShareholders>
    <ck0001859807:PercentageOfRedeemingPublicShareholders
      contextRef="c173"
      decimals="2"
      id="ixv-40733"
      unitRef="pure">1</ck0001859807:PercentageOfRedeemingPublicShareholders>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses contextRef="c752" decimals="0" id="ixv-40734" unitRef="usd">23200</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c753"
      decimals="2"
      id="ixv-40735"
      unitRef="usdPershares">10.1</us-gaap:SharesIssuedPricePerShare>
    <ck0001859807:InterestFromTrustAccount contextRef="c173" decimals="0" id="ixv-40736" unitRef="usd">1484219</ck0001859807:InterestFromTrustAccount>
    <us-gaap:AssetsHeldInTrustCurrent contextRef="c155" decimals="0" id="ixv-40737" unitRef="usd">1453297</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:RestrictedCash contextRef="c155" decimals="0" id="ixv-40738" unitRef="usd">30922</us-gaap:RestrictedCash>
    <ck0001859807:FundingOperatingExpenses contextRef="c173" decimals="0" id="ixv-40739" unitRef="usd">29171</ck0001859807:FundingOperatingExpenses>
    <us-gaap:RestrictedCashCurrent contextRef="c155" decimals="0" id="ixv-40740" unitRef="usd">1751</us-gaap:RestrictedCashCurrent>
    <us-gaap:Deposits contextRef="c155" decimals="0" id="ixv-40741" unitRef="usd">29171</us-gaap:Deposits>
    <us-gaap:AssetsHeldInTrust contextRef="c155" decimals="0" id="ixv-40742" unitRef="usd">29171</us-gaap:AssetsHeldInTrust>
    <us-gaap:RestrictedCashCurrent contextRef="c155" decimals="0" id="ixv-40743" unitRef="usd">1751</us-gaap:RestrictedCashCurrent>
    <ck0001859807:WorkingCapitalDeficit contextRef="c155" decimals="0" id="ixv-40744" unitRef="usd">15492554</ck0001859807:WorkingCapitalDeficit>
    <us-gaap:PartnersCapitalAccountContributions contextRef="c173" decimals="0" id="ixv-40745" unitRef="usd">25000</us-gaap:PartnersCapitalAccountContributions>
    <ck0001859807:UnsecuredPromissoryNote contextRef="c173" decimals="0" id="ixv-40746" unitRef="usd">204841</ck0001859807:UnsecuredPromissoryNote>
    <ck0001859807:WorkingCapital contextRef="c576" decimals="0" id="ixv-40747" unitRef="usd">1200000</ck0001859807:WorkingCapital>
    <us-gaap:WarrantExercisePriceIncrease
      contextRef="c577"
      decimals="2"
      id="ixv-40748"
      unitRef="usdPershares">1</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c554"
      decimals="-5"
      id="ixv-40749"
      unitRef="usd">1500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c554"
      decimals="2"
      id="ixv-40750"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c555"
      decimals="-5"
      id="ixv-40751"
      unitRef="usd">2500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c555"
      decimals="2"
      id="ixv-40752"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <ck0001859807:OutstandingPrincipalAmount contextRef="c173" decimals="0" id="ixv-40753" unitRef="usd">1919796</ck0001859807:OutstandingPrincipalAmount>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c754" decimals="0" id="ixv-40754" unitRef="usd">10288111</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:Cash
      contextRef="c155"
      decimals="-5"
      id="ixv-40755"
      unitRef="usd">1300000</us-gaap:Cash>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="c173"
      decimals="-6"
      id="ixv-40756"
      unitRef="usd">9000000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:PaymentForAdministrativeFees
      contextRef="c173"
      decimals="-5"
      id="ixv-40757"
      unitRef="usd">3400000</us-gaap:PaymentForAdministrativeFees>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c579"
      decimals="2"
      id="ixv-40758"
      unitRef="pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther
      contextRef="c580"
      decimals="2"
      id="ixv-40759"
      unitRef="pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c581"
      decimals="0"
      id="ixv-40760"
      unitRef="shares">18000868</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c582"
      decimals="0"
      id="ixv-40761"
      unitRef="shares">140663</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c583" decimals="0" id="ixv-40762" unitRef="usd">184845836</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c584" decimals="0" id="ixv-40763" unitRef="usd">1565078</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c585"
      decimals="0"
      id="ixv-40764"
      unitRef="shares">95394</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c586" decimals="0" id="ixv-40765" unitRef="usd">1088361</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c755"
      decimals="0"
      id="ixv-40766"
      unitRef="shares">50556</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c756" decimals="0" id="ixv-40767" unitRef="usd">595439</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c757"
      decimals="0"
      id="ixv-40768"
      unitRef="shares">532958</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c758" decimals="0" id="ixv-40769" unitRef="usd">6510830</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c173"
      decimals="0"
      id="ixv-40770"
      unitRef="shares">52784</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c135" decimals="0" id="ixv-40771" unitRef="usd">661012</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent contextRef="c155" decimals="0" id="ixv-40772" unitRef="usd">1952662</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent contextRef="c139" decimals="0" id="ixv-40773" unitRef="usd">1880944</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:ExciseAndSalesTaxes contextRef="c173" decimals="0" id="ixv-40774" unitRef="usd">71718</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes contextRef="c135" decimals="0" id="ixv-40775" unitRef="usd">16838</us-gaap:ExciseAndSalesTaxes>
    <ck0001859807:SharesRedeemedPercentage
      contextRef="c173"
      decimals="2"
      id="ixv-40776"
      unitRef="pure">0.01</ck0001859807:SharesRedeemedPercentage>
    <ck0001859807:EstimatedInterestRate
      contextRef="c759"
      decimals="2"
      id="ixv-40777"
      unitRef="pure">0.07</ck0001859807:EstimatedInterestRate>
    <ck0001859807:EstimatedInterestRate
      contextRef="c760"
      decimals="2"
      id="ixv-40778"
      unitRef="pure">0.09</ck0001859807:EstimatedInterestRate>
    <ck0001859807:UnderpaymentPenaltyRate
      contextRef="c173"
      decimals="3"
      id="ixv-40779"
      unitRef="pure">0.005</ck0001859807:UnderpaymentPenaltyRate>
    <ck0001859807:UnpaidTotalLiabilityRate
      contextRef="c173"
      decimals="2"
      id="ixv-40780"
      unitRef="pure">0.25</ck0001859807:UnpaidTotalLiabilityRate>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c155" decimals="0" id="ixv-40781" unitRef="usd">1952662</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="c139" decimals="0" id="ixv-40782" unitRef="usd">1880944</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="c155" decimals="0" id="ixv-40783" unitRef="usd">105970</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c173" id="ixv-34871">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;2 &#x2014;&#160;Significant Accounting
Policies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited
condensed consolidated financial statements are presented in U.S.&#160;dollars in conformity with accounting principles generally accepted
in the United&#160;States of America (&#x201c;GAAP&#x201d;) for financial information and pursuant to the rules and regulations of the SEC.&#160;Accordingly,
they do not include all of the information and footnotes required by GAAP.&#160;In the opinion of management, the unaudited condensed
consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement
of the balances and results for the periods presented. The interim results for the three and six&#160;months ended June&#160;30, 2025
are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any future periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited
condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited financial statements and notes
thereto included in the Form&#160;10-K annual report filed by the Company with the SEC on March&#160;31, 2025.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying condensed
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances
and transactions have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company is an &#x201c;emerging
growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#x2019;s condensed consolidated financial statements with another public company,
which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period
difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of these condensed
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates are in
connection with determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results
could differ significantly from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents and Restricted Cash&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. At June&#160;30, 2025 and December&#160;31,
2024, the Company had $1,751&#160;and &lt;span style="-sec-ix-hidden: hidden-fact-393"&gt;$0&lt;/span&gt;&#160;of restricted cash, respectively, related to funds withdrawn from the Trust Account reserved
for the payment of income and state franchise taxes. The Company did not have any cash equivalents as of June&#160;30, 2025 and December&#160;31,
2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash Held in Trust Account&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;At June&#160;30, 2025 and December&#160;31,
2024, substantially all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the six&#160;months
ended June&#160;30, 2025, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp;amp; Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $78,813 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the six&#160;months
ended June&#160;30, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp;amp; Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $204,460 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;as of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;as of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,935,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December&#160;21, 2023, 140,663 shares of the Company&#x2019;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the condensed consolidated balance sheets, which was paid from the Trust Account
in January&#160;2024 to redeeming stockholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial
business combination from March&#160;22, 2025 to June&#160;22, 2025. The meeting was adjourned until March&#160;21, 2025, at which the
stockholders approve the extension of the business combination period until June&#160;22, 2025. As a condition of the extension, the Company
contributed $30,000 to the Trust Account, for the entire extension period, on March&#160;21, 2025. On July&#160;1, 2025, the Company filed
the Amendment to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations
and redeem or repurchase 100% of the shares of the Company&#x2019;s common stock issued in the Company&#x2019;s initial public offering,
from June&#160;22, 2025 to August&#160;22, 2025.&#160;In connection with the special meeting of stockholders to approve the Business Combination,
stockholders of the Company redeemed 52,784 shares of common stock for an aggregate amount of $661,012.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, $1,274,549
of the Trust assets were classified as noncurrent assets and $661,012 of the Trust assets due to redeeming stockholders were classified
as current assets. As a result of the Business Combination, the $661,012 due to redeeming stockholders was paid at the Closing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
assets and liabilities approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily
due to their short-term nature, except for the warrant liabilities, convertible promissory note, and securities purchase agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income
taxes under ASC&#160;740, &#x201c;Income Taxes.&#x201d; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the condensed consolidated financial statements and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#x2019;s deferred tax asset had a full valuation allowance
recorded against it.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s condensed consolidated financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company incurred $340 and &lt;span style="-sec-ix-hidden: hidden-fact-394"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-395"&gt;no&lt;/span&gt;&lt;/span&gt; amount
of interest and penalty expenses during the three and six&#160;months ended June&#160;30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has identified
the United&#160;States as its only &#x201c;major&#x201d; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#x2019;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the condensed consolidated statements
of operations. Derivative assets and liabilities are classified in the condensed consolidated balance sheets as current or non-current&#160;based
on whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet
date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Convertible Promissory Note&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#x2019;s own assumption about the assumptions a market participant would use in pricing the working capital loan.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Securities Purchase Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
securities purchase agreement is valued using Monte Carlo models on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. The instrument
is subject to re-measurement at each balance sheet date, with changes in fair value recognized in the condensed consolidated statements
of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Warrant Liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for the&#160;17,404,250&#160;warrants
issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants, and the&#160;569,250&#160;Representative
Warrants inclusive of the underwriters&#x2019; over-allotment&#160;option) in accordance with the guidance contained in ASC&#160;815-40.
Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded
as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement&#160;at
each balance sheet date. With each such re-measurement, the warrant liabilities will be adjusted to fair value, with the change in fair
value recognized in the Company&#x2019;s condensed consolidated statements of operations (See Note&#160;8).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In determining the fair value
of the Private Placement Warrants and the Representative&#x2019;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Net Loss Per Common Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250&#160;potential shares of common stock for outstanding warrants to purchase the
Company&#x2019;s shares were excluded from diluted earnings per share for the three and six&#160;months ended June&#160;30, 2025 and 2024
because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per share
of common stock is the same as basic net loss per share of common stock for the periods presented.&#160;The table below presents a reconciliation
of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The table below presents a
reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three&#160;Months Ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Six&#160;Months Ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Basic and diluted net loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Allocation of net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(224,777&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(7,972,099&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(49,458&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(348,029&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(685,851&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(8,630,935&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(159,563&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(1,058,201&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;146,440&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;738,075&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;412,717&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;783,151&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s common
stock sold as part of the Units&#160;in the IPO (&#x201c;public common stock&#x201d;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#x2019;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 and
December&#160;31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the
following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;9,252,208&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,683,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;768,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;8,337,388&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,510,830&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;155,999&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, March&#160;31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,982,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Redemption payment due to stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(661,012&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,970&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Contingently redeemable common stock, June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,330,515&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Standards Adopted&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2023, the
FASB issued&#160;ASU&#160;2023-07,&#160;Segment Reporting&#160;(Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments
in this&#160;ASU&#160;require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided
to the chief operating officer decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in
the reported measure of segment profit or loss. The&#160;ASU&#160;requires that a public entity disclose the title and position of the
CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and
deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280&#160;in
interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments
in this&#160;ASU&#160;and existing segment disclosures in Topic&#160;280. This&#160;ASU&#160;is effective for fiscal&#160;years beginning
after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption
permitted. The Company adopted ASU&#160;2023-07, which was applied retrospectively to all prior periods presented. See Note&#160;9 for
further details regarding this adoption.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Standards not yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#x201c;ASU&#160;2023-09&#x201d;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#x2019;s condensed consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c173" id="ixv-34876">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited
condensed consolidated financial statements are presented in U.S.&#160;dollars in conformity with accounting principles generally accepted
in the United&#160;States of America (&#x201c;GAAP&#x201d;) for financial information and pursuant to the rules and regulations of the SEC.&#160;Accordingly,
they do not include all of the information and footnotes required by GAAP.&#160;In the opinion of management, the unaudited condensed
consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement
of the balances and results for the periods presented. The interim results for the three and six&#160;months ended June&#160;30, 2025
are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025 or for any future periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited
condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited financial statements and notes
thereto included in the Form&#160;10-K annual report filed by the Company with the SEC on March&#160;31, 2025.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c173" id="ixv-34912">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying condensed
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances
and transactions have been eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <ck0001859807:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="c173" id="ixv-34920">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company is an &#x201c;emerging
growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups
Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Further, Section&#160;102(b)(1)&#160;of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of the Company&#x2019;s condensed consolidated financial statements with another public company,
which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period
difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</ck0001859807:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c173" id="ixv-34931">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of these condensed
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial
statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates are in
connection with determining the fair value of the warrant liabilities and convertible promissory note. Accordingly, the actual results
could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c173" id="ixv-34942">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount contextRef="c155" decimals="0" id="ixv-40784" unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c173" id="ixv-34977">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents and Restricted Cash&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all short-term
investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. At June&#160;30, 2025 and December&#160;31,
2024, the Company had $1,751&#160;and &lt;span style="-sec-ix-hidden: hidden-fact-393"&gt;$0&lt;/span&gt;&#160;of restricted cash, respectively, related to funds withdrawn from the Trust Account reserved
for the payment of income and state franchise taxes. The Company did not have any cash equivalents as of June&#160;30, 2025 and December&#160;31,
2024.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:RestrictedCashCurrent contextRef="c155" decimals="0" id="ixv-40785" unitRef="usd">1751</us-gaap:RestrictedCashCurrent>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c173" id="ixv-34986">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash Held in Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;At June&#160;30, 2025 and December&#160;31,
2024, substantially all of the assets held in the Trust Account were held in an interest-bearing demand deposit account at a bank.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the six&#160;months
ended June&#160;30, 2025, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp;amp; Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $78,813 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the six&#160;months
ended June&#160;30, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp;amp; Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $204,460 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;as of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;as of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,935,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December&#160;22, 2023 to March&#160;22, 2024, which was later extended to March&#160;22, 2025. In connection
with the extension voted on December&#160;21, 2023, 140,663 shares of the Company&#x2019;s common stock were redeemed. In January&#160;2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company recorded
a liability of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December&#160;31,
2023 on the balance sheet. Additionally, as part of the adjustment of common stock subject to possible redemption, the Company classified
$1,565,078 of the trust account as a current asset on the condensed consolidated balance sheets, which was paid from the Trust Account
in January&#160;2024 to redeeming stockholders.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&#160;18, 2025, the
Company commenced a special meeting of stockholders, which was adjourned until March&#160;21, 2025 without conducting any business. On
March&#160;21, 2025, the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial
business combination from March&#160;22, 2025 to June&#160;22, 2025. The meeting was adjourned until March&#160;21, 2025, at which the
stockholders approve the extension of the business combination period until June&#160;22, 2025. As a condition of the extension, the Company
contributed $30,000 to the Trust Account, for the entire extension period, on March&#160;21, 2025. On July&#160;1, 2025, the Company filed
the Amendment to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations
and redeem or repurchase 100% of the shares of the Company&#x2019;s common stock issued in the Company&#x2019;s initial public offering,
from June&#160;22, 2025 to August&#160;22, 2025.&#160;In connection with the special meeting of stockholders to approve the Business Combination,
stockholders of the Company redeemed 52,784 shares of common stock for an aggregate amount of $661,012.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025, $1,274,549
of the Trust assets were classified as noncurrent assets and $661,012 of the Trust assets due to redeeming stockholders were classified
as current assets. As a result of the Business Combination, the $661,012 due to redeeming stockholders was paid at the Closing.&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:InterestIncomeSecuritiesTaxable contextRef="c173" decimals="0" id="ixv-40786" unitRef="usd">78813</us-gaap:InterestIncomeSecuritiesTaxable>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c173" id="ixv-34996">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the six&#160;months
ended June&#160;30, 2024, pursuant to the trust agreement dated as of December&#160;20, 2021 between the Company and Continental Stock
Transfer&#160;&amp;amp; Trust Company (&#x201c;CST&#x201d;), the trustee of the Trust Account, $204,460 of interest income from the Trust Account
was withdrawn by the Company for the payment of franchise and income taxes.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;as of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair Value&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;as of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,935,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:InterestIncomeSecuritiesTaxable contextRef="c174" decimals="0" id="ixv-40787" unitRef="usd">204460</us-gaap:InterestIncomeSecuritiesTaxable>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c770" decimals="0" id="ixv-40788" unitRef="usd">1935561</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c595" decimals="0" id="ixv-40789" unitRef="usd">8330835</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c761"
      decimals="0"
      id="ixv-40790"
      unitRef="shares">140663</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:PayableCommonStockRedeemed contextRef="c588" decimals="0" id="ixv-40791" unitRef="usd">1565078</us-gaap:PayableCommonStockRedeemed>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount contextRef="c589" decimals="0" id="ixv-40792" unitRef="usd">1565078</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:AssetsHeldInTrustCurrent contextRef="c762" decimals="0" id="ixv-40793" unitRef="usd">1565078</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:NoncashContributionExpense contextRef="c763" decimals="0" id="ixv-40794" unitRef="usd">30000</us-gaap:NoncashContributionExpense>
    <ck0001859807:OperationsAndRedeemRepurchasePercentage contextRef="c0" decimals="2" id="ixv-40795" unitRef="pure">1</ck0001859807:OperationsAndRedeemRepurchasePercentage>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c764"
      decimals="0"
      id="ixv-40796"
      unitRef="shares">52784</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c765" decimals="0" id="ixv-40797" unitRef="usd">661012</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c11" decimals="0" id="ixv-40798" unitRef="usd">1274549</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustCurrent contextRef="c11" decimals="0" id="ixv-40799" unitRef="usd">661012</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c765" decimals="0" id="ixv-40800" unitRef="usd">661012</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c173" id="ixv-35085">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
assets and liabilities approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily
due to their short-term nature, except for the warrant liabilities, convertible promissory note, and securities purchase agreement.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c173" id="ixv-35093">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income
taxes under ASC&#160;740, &#x201c;Income Taxes.&#x201d; ASC&#160;740, Income Taxes, requires the recognition of deferred tax assets and
liabilities for both the expected impact of differences between the condensed consolidated financial statements and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC&#160;740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized. As of June&#160;30, 2025 and December&#160;31, 2024, the Company&#x2019;s deferred tax asset had a full valuation allowance
recorded against it.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;ASC&#160;740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s condensed consolidated financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC&#160;740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes interest
and penalties related to unrecognized tax benefits as a formation cost expense. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company incurred $340 and &lt;span style="-sec-ix-hidden: hidden-fact-394"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-395"&gt;no&lt;/span&gt;&lt;/span&gt; amount
of interest and penalty expenses during the three and six&#160;months ended June&#160;30, 2025 and 2024, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has identified
the United&#160;States as its only &#x201c;major&#x201d; tax jurisdiction. The Company is subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company&#x2019;s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve&#160;months.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InterestCostsIncurred contextRef="c24" decimals="0" id="ixv-40801" unitRef="usd">340</us-gaap:InterestCostsIncurred>
    <us-gaap:InterestCostsIncurred contextRef="c0" decimals="0" id="ixv-40802" unitRef="usd">340</us-gaap:InterestCostsIncurred>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c173" id="ixv-35112">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Derivative Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates its financial
instruments, such as warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
in accordance with ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Derivative instruments are initially recorded at fair value
on the grant date and re-valued&#160;at each reporting date, with changes in the fair value reported in the condensed consolidated statements
of operations. Derivative assets and liabilities are classified in the condensed consolidated balance sheets as current or non-current&#160;based
on whether or not net-cash&#160;settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet
date.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="c173" id="ixv-35120">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Convertible Promissory Note&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#x2019;s own assumption about the assumptions a market participant would use in pricing the working capital loan.&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <ck0001859807:SecuritiesPurchaseAgreementPolicyTextBlock contextRef="c173" id="ixv-35154">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Securities Purchase Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
securities purchase agreement is valued using Monte Carlo models on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. The instrument
is subject to re-measurement at each balance sheet date, with changes in fair value recognized in the condensed consolidated statements
of operations.&lt;/p&gt;</ck0001859807:SecuritiesPurchaseAgreementPolicyTextBlock>
    <ck0001859807:WarrantLiabilitiesPolicyTextBlock contextRef="c173" id="ixv-35162">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Warrant Liabilities&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for the&#160;17,404,250&#160;warrants
issued in connection with the IPO (the&#160;9,487,500&#160;Public Warrants, the&#160;7,347,500&#160;Private Placement Warrants, and the&#160;569,250&#160;Representative
Warrants inclusive of the underwriters&#x2019; over-allotment&#160;option) in accordance with the guidance contained in ASC&#160;815-40.
Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded
as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement&#160;at
each balance sheet date. With each such re-measurement, the warrant liabilities will be adjusted to fair value, with the change in fair
value recognized in the Company&#x2019;s condensed consolidated statements of operations (See Note&#160;8).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In determining the fair value
of the Private Placement Warrants and the Representative&#x2019;s Warrants, assumptions related to expected share-price volatility, expected
life and risk-free interest rate are utilized. The Company estimates the volatility of its common stock based on historical volatility
that matches the expected remaining life of the warrants.&lt;/p&gt;</ck0001859807:WarrantLiabilitiesPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c766"
      decimals="0"
      id="ixv-40803"
      unitRef="shares">17404250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c767"
      decimals="0"
      id="ixv-40804"
      unitRef="shares">9487500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c768"
      decimals="0"
      id="ixv-40805"
      unitRef="shares">7347500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c769"
      decimals="0"
      id="ixv-40806"
      unitRef="shares">569250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c173" id="ixv-35173">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Net Loss Per Common Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has two categories
of shares, which are referred to as common stock subject to possible redemption and common stock. Earnings and losses are shared pro rata
between the two categories of shares. The&#160;17,404,250&#160;potential shares of common stock for outstanding warrants to purchase the
Company&#x2019;s shares were excluded from diluted earnings per share for the three and six&#160;months ended June&#160;30, 2025 and 2024
because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per share
of common stock is the same as basic net loss per share of common stock for the periods presented.&#160;The table below presents a reconciliation
of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The table below presents a
reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three&#160;Months Ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Six&#160;Months Ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Basic and diluted net loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Allocation of net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(224,777&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(7,972,099&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(49,458&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(348,029&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(685,851&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(8,630,935&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(159,563&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(1,058,201&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;146,440&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;738,075&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;412,717&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;783,151&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c173"
      decimals="0"
      id="ixv-40807"
      unitRef="shares">17404250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c173" id="ixv-35180">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The table below presents a
reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three&#160;Months Ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Six&#160;Months Ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common &lt;br/&gt; stock&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;subject to&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;possible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;redemption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt; stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Basic and diluted net loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Allocation of net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(224,777&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(7,972,099&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(49,458&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(348,029&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(685,851&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(8,630,935&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(159,563&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: right"&gt;(1,058,201&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted-average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;146,440&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;738,075&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;412,717&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;783,151&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,193,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:TemporaryEquityNetIncome contextRef="c771" decimals="0" id="ixv-40808" unitRef="usd">-224777</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c148" decimals="0" id="ixv-40809" unitRef="usd">-7972099</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c772" decimals="0" id="ixv-40810" unitRef="usd">-49458</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c164" decimals="0" id="ixv-40811" unitRef="usd">-348029</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c773" decimals="0" id="ixv-40812" unitRef="usd">-685851</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c774" decimals="0" id="ixv-40813" unitRef="usd">-8630935</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c775" decimals="0" id="ixv-40814" unitRef="usd">-159563</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c776" decimals="0" id="ixv-40815" unitRef="usd">-1058201</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c771"
      decimals="INF"
      id="ixv-40816"
      unitRef="shares">146440</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c148"
      decimals="INF"
      id="ixv-40817"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c772"
      decimals="INF"
      id="ixv-40818"
      unitRef="shares">738075</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c164"
      decimals="INF"
      id="ixv-40819"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c773"
      decimals="INF"
      id="ixv-40820"
      unitRef="shares">412717</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c774"
      decimals="INF"
      id="ixv-40821"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c775"
      decimals="INF"
      id="ixv-40822"
      unitRef="shares">783151</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c776"
      decimals="INF"
      id="ixv-40823"
      unitRef="shares">5193750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c771"
      decimals="2"
      id="ixv-40824"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c771"
      decimals="2"
      id="ixv-40825"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c148"
      decimals="2"
      id="ixv-40826"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c148"
      decimals="2"
      id="ixv-40827"
      unitRef="usdPershares">-1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c772"
      decimals="2"
      id="ixv-40828"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c772"
      decimals="2"
      id="ixv-40829"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c164"
      decimals="2"
      id="ixv-40830"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c164"
      decimals="2"
      id="ixv-40831"
      unitRef="usdPershares">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c773"
      decimals="2"
      id="ixv-40832"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c773"
      decimals="2"
      id="ixv-40833"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c774"
      decimals="2"
      id="ixv-40834"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c774"
      decimals="2"
      id="ixv-40835"
      unitRef="usdPershares">-1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c775"
      decimals="2"
      id="ixv-40836"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c775"
      decimals="2"
      id="ixv-40837"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c776"
      decimals="2"
      id="ixv-40838"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c776"
      decimals="2"
      id="ixv-40839"
      unitRef="usdPershares">-0.2</us-gaap:EarningsPerShareBasic>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="c173" id="ixv-35524">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Common Stock Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s common
stock sold as part of the Units&#160;in the IPO (&#x201c;public common stock&#x201d;) contain a redemption feature which allows for the
redemption of such public shares in connection with the Company&#x2019;s liquidation, or if there is a stockholder vote or tender offer
in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC&#160;480-10-S99, the Company classifies public
common stock outside of permanent equity as the redemption provisions are not solely within the control of the Company. The public common
stock was issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of public common
stock classified as temporary equity was the allocated proceeds determined in accordance with ASC&#160;470-20.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 and
December&#160;31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the
following table:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;9,252,208&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,683,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;768,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;8,337,388&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,510,830&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;155,999&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, March&#160;31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,982,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Redemption payment due to stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(661,012&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,970&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Contingently redeemable common stock, June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,330,515&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="c173" id="ixv-35531">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 and
December&#160;31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the
following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;9,252,208&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,683,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;768,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, December&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;8,337,388&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Partial redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,510,830&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;155,999&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Contingently redeemable common stock, March&#160;31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,982,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Redemption payment due to stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(661,012&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of redeemable common stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,970&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Contingently redeemable common stock, June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,330,515&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c131" decimals="0" id="ixv-40840" unitRef="usd">9252208</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:RedemptionPremium contextRef="c135" decimals="0" id="ixv-40841" unitRef="usd">1683800</us-gaap:RedemptionPremium>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c139" decimals="0" id="ixv-40842" unitRef="usd">768980</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c139" decimals="0" id="ixv-40843" unitRef="usd">8337388</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:RedemptionPremium contextRef="c143" decimals="0" id="ixv-40844" unitRef="usd">6510830</us-gaap:RedemptionPremium>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c147" decimals="0" id="ixv-40845" unitRef="usd">155999</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c147" decimals="0" id="ixv-40846" unitRef="usd">1982557</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c151" decimals="0" id="ixv-40847" unitRef="usd">-661012</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c155" decimals="0" id="ixv-40848" unitRef="usd">8970</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c155" decimals="0" id="ixv-40849" unitRef="usd">1330515</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c173" id="ixv-35635">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Standards Adopted&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In November&#160;2023, the
FASB issued&#160;ASU&#160;2023-07,&#160;Segment Reporting&#160;(Topic&#160;280): Improvements to Reportable Segment Disclosures. The amendments
in this&#160;ASU&#160;require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided
to the chief operating officer decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in
the reported measure of segment profit or loss. The&#160;ASU&#160;requires that a public entity disclose the title and position of the
CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and
deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280&#160;in
interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments
in this&#160;ASU&#160;and existing segment disclosures in Topic&#160;280. This&#160;ASU&#160;is effective for fiscal&#160;years beginning
after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption
permitted. The Company adopted ASU&#160;2023-07, which was applied retrospectively to all prior periods presented. See Note&#160;9 for
further details regarding this adoption.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Standards not yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In December&#160;2023, the
FASB issued ASU No.&#160;2023-09, Income Taxes (Topic&#160;740): Improvements to Income Tax Disclosures (&#x201c;ASU&#160;2023-09&#x201d;),
which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional
information for reconciling items that meet a quantitative threshold. ASU&#160;2023-09 will also require the Company to disaggregate its
income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions.
ASU&#160;2023-09 will become effective for annual periods beginning after December&#160;15, 2024. The Company is still reviewing the impact
of ASU&#160;2023-09.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company&#x2019;s condensed consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <ck0001859807:InitialPublicOfferingTextBlock contextRef="c173" id="ixv-35689">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;3 &#x2014;&#160;Initial Public Offering&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Public Units&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;22, 2021,
the Company sold 18,975,000&#160;Units, (which included 2,475,000&#160;Units&#160;issued pursuant to the full exercise of the over-allotment
option) at a purchase price of $10.00 per Unit. Each unit that the Company is offering has a price of $10.00 and consists of one share
of common stock, one right, and one-half&#160;of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth&#160;(1/10)
of one share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof
to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as described herein.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Public Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Each whole warrant entitles
the holder to purchase one share of common stock at a price of $11.50&#160;per share, subject to adjustment as discussed herein. In addition,
if (x)&#160;the Company issues additional shares of common stock or equity-linked&#160;securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20&#160;per share of common
stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any
such issuance to the initial stockholders or their affiliates, without taking into account any founder shares held by such stockholders
or their affiliates, as applicable, prior to such issuance (the &#x201c;Newly Issued Price&#x201d;)), (y)&#160;the aggregate gross proceeds
from such issuances represent more than&#160;60% of the total equity proceeds, and interest thereon, available for funding the initial
Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of the common stock during the 20&#160;trading
day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates the Business Combination (such price,
the &#x201c;Market Value&#x201d;) is below $9.20&#160;per share, the exercise price shall be adjusted (to the nearest cent) to be equal
to&#160;115% of the higher of the Market Value and the Newly Issued Price, and the $18.00&#160;per share redemption trigger price described
in the section &#x201c;Redemption of warrants&#x201d; will be adjusted (to the nearest cent) to be equal to&#160;180% of the higher of the
Market Value and the Newly Issued Price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The warrants will become exercisable
on the later of 12&#160;months from the closing of the IPO or 30&#160;days after the completion of its initial Business Combination and
will expire &lt;span style="-sec-ix-hidden: hidden-fact-396"&gt;five&lt;/span&gt;&#160;years after the completion of the Company&#x2019;s initial Business Combination, at 5:00&#160;p.m., New&#160;York
City time, or earlier upon redemption or liquidation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company has agreed that as soon as
practicable, but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company
will use its reasonable best efforts to file, and within 60&#160;business days after the closing of the initial Business
Combination, to have declared effective, a registration statement relating to those shares of common stock, and to maintain a
current prospectus relating to such shares of common stock until the warrants expire or are redeemed. Notwithstanding the foregoing,
if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective within the
above specified period following the consummation of the initial Business Combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company shall have failed to maintain an effective
registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section&#160;3(a)(9)&#160;of the
Securities Act&#160;of&#160;1933, as amended, or the Securities Act, provided that such exemption is available. If that exemption,
or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Redemption of Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Once the warrants become exercisable,
the Company may redeem the outstanding warrants:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;in whole and not in part;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;at a price of $0.01 per warrant;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;upon a minimum of 30&#160;days&#x2019; prior written notice
of redemption (the &#x201c;30-day&#160;redemption period&#x201d;);&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;if, and only if, the last sale price of the common stock equals
or exceeds $18.00 per share for any 20&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior
to the date on which the Company sends the notice of redemption to the warrant holders.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;If the Company calls the warrants
for redemption as described above, management will have the option to require all holders that wish to exercise warrants to do so on a
&#x201c;cashless basis.&#x201d; In determining whether to require all holders to exercise their warrants on a &#x201c;cashless basis,&#x201d;
management will consider, among other factors, the Company&#x2019;s cash position, the number of warrants that are outstanding and the
dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants.
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to
the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#x201c;fair market value&#x201d; (defined below) by (y)&#160;the fair
market value. The &#x201c;fair market value&#x201d; shall mean the average reported last sale price of the common stock for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants.&lt;/p&gt;</ck0001859807:InitialPublicOfferingTextBlock>
    <ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c539"
      decimals="0"
      id="ixv-40850"
      unitRef="shares">18975000</ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues>
    <ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c603"
      decimals="0"
      id="ixv-40851"
      unitRef="shares">2475000</ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c603"
      decimals="2"
      id="ixv-40852"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c604"
      decimals="2"
      id="ixv-40853"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <ck0001859807:NumberOfSharesIssuedPerUnit
      contextRef="c538"
      decimals="0"
      id="ixv-40854"
      unitRef="shares">1</ck0001859807:NumberOfSharesIssuedPerUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c605"
      decimals="0"
      id="ixv-40855"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c606"
      decimals="2"
      id="ixv-40856"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c777"
      decimals="0"
      id="ixv-40857"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c777"
      decimals="2"
      id="ixv-40858"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c778"
      decimals="2"
      id="ixv-40859"
      unitRef="usdPershares">9.2</us-gaap:SharesIssuedPricePerShare>
    <ck0001859807:EquityProceedOwnershipPercentage
      contextRef="c173"
      decimals="2"
      id="ixv-40860"
      unitRef="pure">0.60</ck0001859807:EquityProceedOwnershipPercentage>
    <ck0001859807:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
      contextRef="c173"
      decimals="2"
      id="ixv-40861"
      unitRef="usdPershares">9.2</ck0001859807:PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice>
    <ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance
      contextRef="c155"
      decimals="2"
      id="ixv-40862"
      unitRef="pure">1.15</ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance>
    <ck0001859807:ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption
      contextRef="c173"
      decimals="2"
      id="ixv-40863"
      unitRef="usdPershares">18</ck0001859807:ClassOfWarrantOrRightTriggerSharePriceOfWarrantsOrRightsForRedemption>
    <ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance
      contextRef="c779"
      decimals="2"
      id="ixv-40864"
      unitRef="pure">1.80</ck0001859807:PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance>
    <ck0001859807:RedemptionPricePerWarrant
      contextRef="c173"
      decimals="2"
      id="ixv-40865"
      unitRef="usdPershares">0.01</ck0001859807:RedemptionPricePerWarrant>
    <ck0001859807:MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders
      contextRef="c173"
      decimals="2"
      id="ixv-40866"
      unitRef="usdPershares">18</ck0001859807:MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders>
    <ck0001859807:PrivatePlacementsTextBlock contextRef="c173" id="ixv-35780">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;4 &#x2014;&#160;Private Placement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s Sponsor,&#160;I-Bankers
and Dawson James have purchased an aggregate of 7,347,500 Private Placement Warrants (which included 697,500 Private Placement Warrants
issued pursuant to the full exercise of the over-allotment option) at a price of $1.00 per warrant ($7,347,500 in the aggregate) in a
private placement that closed simultaneously with the closing of the IPO.&#160;Of such amount, 5,162,500 Private Placement Warrants were
purchased by the Sponsor and 2,185,000 Private Placement Warrants were purchased by&#160;I-Bankers and Dawson James.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Private Placement Warrants
are identical to the warrants included in the units sold in the IPO, except that the Private Placement Warrants: (i)&#160;will not be
redeemable by the Company and (ii)&#160;may be exercised for cash or on a cashless basis, in each case so long as they are held by the
initial purchasers or any of their permitted transferees. If the Private Placement Warrants are held by holders other than the initial
purchasers or any of their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by
the holders on the same basis as the warrants included in the Units&#160;being sold in the IPO.&lt;/p&gt;</ck0001859807:PrivatePlacementsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c768"
      decimals="0"
      id="ixv-40867"
      unitRef="shares">7347500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c780"
      decimals="0"
      id="ixv-40868"
      unitRef="shares">697500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c768"
      decimals="2"
      id="ixv-40869"
      unitRef="usdPershares">1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c781" decimals="0" id="ixv-40870" unitRef="usd">7347500</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c782"
      decimals="0"
      id="ixv-40871"
      unitRef="shares">5162500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c783"
      decimals="0"
      id="ixv-40872"
      unitRef="shares">2185000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c173" id="ixv-35791">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;5 &#x2014;&#160;Related Party Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In April&#160;2021, the Sponsor
paid $25,000, or approximately $0.005 per share, to cover certain of the offering costs in exchange for an aggregate of 5,175,000 shares
of common stock, par value $0.0001 per share (the &#x201c;Founder Shares&#x201d;). In October&#160;2021, the Sponsor irrevocably surrendered
to the Company for cancellation and for no consideration 862,500 shares of common stock. On December&#160;20, 2021, the Company effected
a 1.1- for-1 stock dividend of its common stock, resulting in the Sponsor holding
an aggregate of 4,743,750 shares of common stock. The Founder Shares include an aggregate of up to 618,750 shares subject to forfeiture
if the over-allotment option is not exercised by the underwriters in full. On December&#160;22, 2021, the over-allotment option was fully
exercised and such shares are no longer subject to forfeiture.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"&gt;The Sponsor has agreed not to transfer, assign
or sell any of their Founder Shares until the earlier to occur of: (A)&#160;one year after the completion of the initial Business Combination
or (B)&#160;the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the initial
Business Combination that results in all of the Company&#x2019;s public stockholders having the right to exchange their shares of common
stock for cash, securities or other property (the &#x201c;Lock-up&#x201d;). Notwithstanding the foregoing, if the last sale price of the
Company&#x2019;s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 150&#160;days after the initial
Business Combination, the Founder Shares will be released from the Lock-up.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Convertible Promissory Note&#160;&#x2014;&#160;Related
Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On April&#160;27, 2023, the
Company signed a Convertible Working Capital Promissory Note (&#x201c;the Note&#x201d;) with the Sponsor for $1,200,000. The Note is non-interest
bearing and is due the earlier of the consummation of a business combination or the date of liquidation. The Sponsor may elect to convert
all or any portion of the unpaid principal balance of this Note into warrants, at a price of $1.00 per warrant. On January&#160;10, 2024,
the Company&#x2019;s Board of Directors approved, and the Company amended the Note to increase the principal amount of the Note that could
be drawn on to $1.5&#160;million. The amended and restated Note also allows for the conversion of the outstanding principal balance of
the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor. On May&#160;31,
2024, the Company&#x2019;s Board of Directors approved and the Company entered into a second amendment of its Convertible Working Capital
Promissory Note with the sponsor to increase the principal amount of the Note that could be drawn on to $2.5&#160;million. The second
amended and restated Note also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company
common stock at a price of $2.22&#160;per share at the election of the sponsor. As of June&#160;30, 2025 and December&#160;31, 2024, the
Company had principal outstanding of $1,919,796 and is presenting the Note at fair value on its balance sheet at June&#160;30, 2025 and
December&#160;31, 2024 in the amount of $10,288,111 and $8,908,052, respectively. The Company has deferred the repayment of the Note to
six&#160;months after the Closing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Securities Purchase Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On February&#160;11, 2025,
in a private transaction, the Company entered into a securities purchase agreement (the &#x201c;SPA&#x201d;) with an institutional investor
(the &#x201c;Investor&#x201d;). Pursuant to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth
in the SPA, to purchase from the Company&#x2019;s senior secured convertible promissory notes (&#x201c;Ascent Note&#x201d;) in an aggregate
principal amount of up to $22,222,222 for a purchase price of up to $20,000,000, after a 10% original issue discount (&#x201c;OID&#x201d;).
As of June&#160;30, 2025 and December&#160;31, 2024, the Company is presenting the Ascent Note at fair value on its balance sheet at June&#160;30,
2025 and December&#160;31, 2024 in the amount of $193,878 and $0, respectively (See details on Note&#160;6).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As a result of the Business
Combination, pursuant to the SPA, the Company issued a PIPE Convertible Note in the principal amount of $10,000,000 (the &#x201c;Initial
Note&#x201d;) for a purchase price of $9,000,000, reflecting a 10% OID.&#160;The Initial Note matures on the date that is 18-months from
the Closing and is convertible at any time at the Investor&#x2019;s option at a conversion price equal to the lower of $10 or 95% of the
lowest daily volume-weighted average price per share of the post-combination company common stock in the 10&#160;trading days prior to
the original issue date of the Initial Note and shall be adjusted, without limitation, based on down-round and most-favored nation (MFN)
price and terms protections (the &#x201c;Conversion Price&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In order to finance transaction
costs in connection with an intended initial Business Combination, the initial stockholders or an affiliate of the initial stockholders
or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the
&#x201c;Working Capital Loans&#x201d;). If the Company completes the initial Business Combination, the Company would repay such loaned amounts
out of the proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside
the Trust Account. Up to $1,500,000 of such loans may be convertible, at the option of the lender, into warrants at a price of $1.00 per
warrant of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants, including as to exercise
price, exercisability and exercise period. At June&#160;30, 2025 and December&#160;31, 2024, the Company had no borrowings under the Working
Capital Loans, other than the Note described in &#x201c;Note&#160;5 &#x2014;&#160;Related Party Transactions&#160;&#x2014;&#160;Convertible
Promissory Note&#160;&#x2014;&#160;Related Party&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Administrative Service Fee&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Commencing on the effective
date of the IPO, the Company began paying its Sponsor a total of $5,000&#160;per month for office space, utilities, secretarial support
and other administrative and consulting services. As of June&#160;30, 2023, the Company and the Sponsor terminated this agreement. For
the three and six&#160;months ended June&#160;30, 2025 and 2024, $0 had been incurred and billed relating to the administrative service
fee, respectively. As of June&#160;30, 2025 and December&#160;31, 2024, $50,000 relating to the administrative service fee was not paid
and recorded as due to related party.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Advances from Profusa&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;For the three and six&#160;months
ended June&#160;30, 2025 and 2024, Profusa agreed to advance funds to the Company to pay for operating expenses. As of June&#160;30, 2025
and December&#160;31, 2024, there was $1,299,040 and $791,407, respectively owed to Profusa, which is due upon demand or at the completion
of the Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Due to Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of June&#160;30, 2025 and
December&#160;31, 2024, $50,000 relating to the administrative service fee was not paid and recorded as due to related party. On February&#160;24,
2025, the Company paid costs on behalf of its Sponsor which reduced the balance due by $8,820.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c784" decimals="0" id="ixv-40873" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c785"
      decimals="3"
      id="ixv-40874"
      unitRef="usdPershares">0.005</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c784"
      decimals="0"
      id="ixv-40875"
      unitRef="shares">5175000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c785"
      decimals="4"
      id="ixv-40876"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c616"
      decimals="0"
      id="ixv-40877"
      unitRef="shares">862500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c786" id="ixv-40878">On December&#160;20, 2021, the Company effected
a 1.1- for-1 stock dividend of its common stock</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="c787"
      decimals="0"
      id="ixv-40879"
      unitRef="shares">618750</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <ck0001859807:CommonStockExceedsPerShare
      contextRef="c173"
      decimals="2"
      id="ixv-40880"
      unitRef="usdPershares">12</ck0001859807:CommonStockExceedsPerShare>
    <ck0001859807:NumberOfTradingDay contextRef="c759" id="ixv-40881">P20D</ck0001859807:NumberOfTradingDay>
    <ck0001859807:NumberOfTradingDay contextRef="c760" id="ixv-40882">P30D</ck0001859807:NumberOfTradingDay>
    <ck0001859807:ConvertibleWorkingCapitalPromissoryNote contextRef="c622" decimals="0" id="ixv-40883" unitRef="usd">1200000</ck0001859807:ConvertibleWorkingCapitalPromissoryNote>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c623"
      decimals="2"
      id="ixv-40884"
      unitRef="usdPershares">1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c554"
      decimals="-5"
      id="ixv-40885"
      unitRef="usd">1500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c554"
      decimals="2"
      id="ixv-40886"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="c555"
      decimals="-5"
      id="ixv-40887"
      unitRef="usd">2500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c555"
      decimals="2"
      id="ixv-40888"
      unitRef="usdPershares">2.22</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:NotesPayable contextRef="c155" decimals="0" id="ixv-40889" unitRef="usd">1919796</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c139" decimals="0" id="ixv-40890" unitRef="usd">1919796</us-gaap:NotesPayable>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c788" decimals="0" id="ixv-40891" unitRef="usd">10288111</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c624" decimals="0" id="ixv-40892" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c789" decimals="0" id="ixv-40893" unitRef="usd">22222222</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c790" decimals="0" id="ixv-40894" unitRef="usd">20000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <ck0001859807:PercentageOfOriginalIssueDiscount
      contextRef="c790"
      decimals="2"
      id="ixv-40895"
      unitRef="pure">0.10</ck0001859807:PercentageOfOriginalIssueDiscount>
    <ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement contextRef="c173" decimals="0" id="ixv-40896" unitRef="usd">193878</ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement>
    <ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement contextRef="c135" decimals="0" id="ixv-40897" unitRef="usd">0</ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c791" decimals="0" id="ixv-40898" unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c792" decimals="0" id="ixv-40899" unitRef="usd">9000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <ck0001859807:PercentageOfOriginalIssueDiscount
      contextRef="c173"
      decimals="2"
      id="ixv-40900"
      unitRef="pure">0.10</ck0001859807:PercentageOfOriginalIssueDiscount>
    <us-gaap:DebtInstrumentTerm contextRef="c792" id="ixv-40901">P18M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c791"
      decimals="0"
      id="ixv-40902"
      unitRef="usdPershares">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice
      contextRef="c791"
      decimals="2"
      id="ixv-40903"
      unitRef="pure">0.95</ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice>
    <ck0001859807:NumberOfTradingDay contextRef="c792" id="ixv-40904">P10Y</ck0001859807:NumberOfTradingDay>
    <us-gaap:ConvertibleDebtCurrent contextRef="c155" decimals="0" id="ixv-40905" unitRef="usd">1500000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c793"
      decimals="2"
      id="ixv-40906"
      unitRef="usdPershares">1</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth contextRef="c794" decimals="0" id="ixv-40907" unitRef="usd">5000</ck0001859807:RelatedPartyTransactionExpensesFromTransactionWithRelatedPartyPerMonth>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c151" decimals="0" id="ixv-40908" unitRef="usd">0</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c795" decimals="0" id="ixv-40909" unitRef="usd">0</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c174" decimals="0" id="ixv-40910" unitRef="usd">0</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c173" decimals="0" id="ixv-40911" unitRef="usd">0</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c796" decimals="0" id="ixv-40912" unitRef="usd">50000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c797" decimals="0" id="ixv-40913" unitRef="usd">50000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="c798" decimals="0" id="ixv-40914" unitRef="usd">1299040</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="c627" decimals="0" id="ixv-40915" unitRef="usd">791407</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c796" decimals="0" id="ixv-40916" unitRef="usd">50000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c797" decimals="0" id="ixv-40917" unitRef="usd">50000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:SponsorFees contextRef="c799" decimals="0" id="ixv-40918" unitRef="usd">8820</us-gaap:SponsorFees>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c173" id="ixv-35897">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;6 &#x2014;&#160;Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The holders of the Founder
Shares, the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any underlying securities)
are entitled to registration rights pursuant to a registration rights agreement signed on the closing date of the IPO requiring the Company
to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company registers such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights
with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration
rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective
until termination of the applicable Lock-up&#160;period described in Note&#160;5. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Underwriters Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The underwriters had a 30-day&#160;option
from the date of IPO to purchase up to an additional&#160;2,475,000&#160;units to cover over-allotments, if any. On December&#160;22,
2021, the over-allotment was fully exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The underwriters received a
cash underwriting discount of approximately&#160;1.82% of the gross proceeds of the IPO, or $3,450,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Business Combination Marketing Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under a Business Combination
marketing agreement, the Company engaged&#160;I-Bankers and Dawson James as advisors in connection with the Business Combination to assist
the Company in holding meetings with the stockholders to discuss the potential Business Combination and the target business&#x2019;s attributes,
introduce the Company to potential investors that are interested in purchasing the Company&#x2019;s securities in connection with the potential
Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company was obligated to pay&#160;I-Bankers and Dawson
James a cash fee for such marketing services upon the consummation of the initial Business Combination in an amount of&#160;3.68% of the
gross proceeds of the IPO, or $6,986,250. The agreement was amended on November&#160;7, 2022 to allow for the 3.68% business combination
fee to be paid as (a)&#160;27.5% cash and (b)&#160;72.5% to be rolled into equity at closing. Subsequently, on January&#160;19, 2025,
the agreement was modified by the parties such that the Company will be required to pay $2,000,000, payable in cash, if a business combination
is consummated. As a result of the Business Combination,&#160;I-Bankers was paid $900,000 and Dawson James was paid $600,000 under the
Business Combination marketing agreement. The payment of the remaining $500,000 has been deferred until after the Closing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Non-Redemption Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On May&#160;8, 2025, the Company
entered into a non-redemption&#160;agreement (the &#x201c;Non-Redemption&#160;Agreement&#x201d;) with&#160;I-Bankers Securities, Inc. and
Dawson James Securities, Inc. (together, the &#x201c;Investors&#x201d;), pursuant to which such Investors agreed that to the extent that
redemptions in connection with the vote to approve the Business Combination reduces the Company&#x2019;s trust account balance below $1.25&#160;million,
the Investors would offer such redeeming shareholders an opportunity to rescind the redemption of their shares and would instead purchase
such shares. Such purchases would be structured in compliance with the requirements of&#160;Rule&#160;14e-5&#160;under the&#160;Exchange&#160;Act&#160;or
would otherwise not constitute a tender offer pursuant to the&#160;Exchange&#160;Act. As of the Closing Date, the Company&#x2019;s trust
account balance was not below $1.25&#160;million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Representative&#x2019;s Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;22, 2021,
the Company issued&#160;450,000&#160;shares (Representative Shares) of common stock (which included&#160;37,500&#160;Representative Shares
issued pursuant to the full exercise of the over-allotment option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James
(and/or their designees).&#160;I-Bankers&#160;and Dawson James (and/or their designees) have agreed not to transfer, assign or sell any
such shares until the completion of the initial Business Combination. In addition,&#160;I-Bankers&#160;and Dawson James (and/or their
designees) have agreed (i)&#160;to waive their redemption rights with respect to such shares in connection with the completion of the
initial Business Combination and (ii)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to such
shares if the Company fails to complete its initial Business Combination within the Combination Period. The fair value of the Representative&#x2019;s
Shares issued are recognized as&#160;offering costs directly attributable to the issuance of an equity contract to be classified in equity
and are recorded as a reduction of equity (see Note&#160;1).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Representative&#x2019;s Warrants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company granted to&#160;I-Bankers&#160;and
Dawson James (and/or their designees) 569,250&#160;warrants (which included 74,250&#160;warrants issued pursuant to the full exercise
of the over-allotment option) exercisable at $11.50&#160;per share (or an aggregate exercise price of $6,546,375) at the closing of the
IPO.&#160;The Representative Warrants issued are recognized as derivative liabilities in accordance with ASC&#160;815-40 and recorded
as liabilities at fair value each reporting period (see Notes 1 and 8). The warrants may be exercised for cash or on a cashless basis,
at the holder&#x2019;s option, at any time during the period commencing on the later of the first anniversary of the effective date of
the registration statement of which the IPO forms a part and the closing of the initial Business Combination and terminating on the fifth
anniversary of such effectiveness date. Notwithstanding anything to the contrary,&#160;I-Bankers&#160;and Dawson James have agreed that
neither they nor their designees will be permitted to exercise the warrants after the&#160;five year&#160;anniversary of the effective
date of the registration statement of which the IPO forms a part. The warrants and such shares purchased pursuant to the warrants have
been deemed compensation by FINRA and are therefore subject to a lock-up&#160;for a period of 180&#160;days immediately following the
date of the effectiveness of the registration statement of which the IPO forms a part pursuant to FINRA Rule&#160;5110I(1). Pursuant to
FINRA Rule&#160;5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the economic disposition of the securities by any person for a period of 180&#160;days immediately following the effective
date of the registration statement of which the IPO forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated
for a period of 180&#160;days immediately following the effective date of the registration statement of which the IPO forms a part except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The warrants grant to holders
demand and &#x201c;piggy back&#x201d; rights for periods of five and seven&#160;years, respectively, from the effective date of the registration
statement of which the IPO forms a part with respect to the registration under the Securities Act&#160;of&#160;the shares issuable upon
exercise of the warrants. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting
commissions, which will be paid for by the holders themselves. The exercise price and number of shares issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a share dividend, or the Company&#x2019;s recapitalization, reorganization,
merger or consolidation. However, the warrants will not be adjusted for issuances of shares at a price below its exercise price. The Company
will have no obligation to net cash settle the exercise of the warrants. The holder of the warrants will not be entitled to exercise the
warrants for cash unless a registration statement covering the securities underlying the warrants is effective or an exemption from registration
is available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Merger Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November&#160;7, 2022, NorthView
entered into a Merger Agreement and Plan of Reorganization (the &#x201c;Merger Agreement&#x201d;), by and among Merger Sub., and Profusa,
Inc., a California corporation (&#x201c;Profusa&#x201d;). The Merger Agreement provides that, among other things, at the closing of the
transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Profusa (the &#x201c;Merger&#x201d;), with Profusa
surviving as a wholly-owned subsidiary of NorthView.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;At the Special Meeting held
on June&#160;9, 2025, the Company&#x2019;s stockholders voted to approve the proposals outlined in the Proxy Statement/Prospectus, including,
among other things, the adoption of the Merger Agreement and approval of the transactions contemplated by the Merger Agreement, including
the merger of Merger Sub with and into Profusa, with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary
the Company, and the issuance of the Company&#x2019;s common stock as consideration thereunder. On July&#160;11, 2025, the Closing was
completed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In connection with the Closing,
the Company changed its name to &#x201c;Profusa, Inc.&#x201d;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Advisory Agreements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On December&#160;19,
2024, the Company engaged A.G.P to serve as the placement agent in connection with a proposed business combination transaction. The
Company shall pay to A.G.P. a cash fee (the &#x201c;Cash Fee&#x201d;) equal to 9.0% in a convertible note offering, note, or other
similar equity-linked offerings, and shall be calculated from the face value of notes issued, which is payable at the close of a
Business Combination. On June&#160;17, 2025, the Company entered a settlement agreement with A.G.P. for the Cash Fee of $968,000
related to the debt private placement (the &#x201c;Offering&#x201d;) that was issued at the Closing. Pursuant to the settlement
agreement, as a result of the Business Combination, the Company paid A.G.P. $550,000 at the Closing and the remaining $418,000 of
the fees was deferred and due on the earlier of (i)&#160;the second tranche of the debt private placement being issued and
(ii)&#160;December&#160;31, 2025. The Company also agreed to reimburse A.G.P. $50,000 for expenses incurred in connection with the
offering.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On June&#160;15, 2023, the
Company engaged the Benchmark Company LLC (&#x201c;Benchmark&#x201d;) to provide advisory services related to the Business Combination and
the Convertible Notes. The Company was to pay Benchmark at the closing of the Business Combination an advisory fee of $750,000 in two
tranches. The first tranche will be $500,000 earned upon the closing of the Business Combination in the surviving public entity&#x2019;s
common stock (&#x201c;Tranche 1&#x201d;). The number of shares to be issued is calculated on the 30&lt;sup&gt;th&lt;/sup&gt;&#160;day following the
Closing by dividing $500,000 and the trailing 5-day VWAP of the Company&#x2019;s common stock as calculated by Bloomburg with a minimum
price of $2.00. The second tranche will be $250,000, at the Company&#x2019;s option, in either cash or in the surviving entity&#x2019;s
common shares calculated by dividing $250,000 by the lowest trailing 5-day VWAP in the prior 30&#160;days (&#x201c;Tranche 2&#x201d;). Upon
funding of the Convertible Notes by investors introduced by Benchmark, the Company will pay to Benchmark fees in cash equal to 5% of the
net proceeds of any Convertible Note draw at the time of funding of such draw (&#x201c;Arrangement Fees&#x201d;). The Tranche 2 fee shall
be reduced by the amount of any fees paid to Benchmark for other transactions during the Term other than Arrangement Fees associated with
Convertible Notes, after the Business Combination, up to $250,000. As a result of the Business Combination, Benchmark was paid in shares
of the post-combination company in the amount of $500,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Securities Purchase Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On February&#160;11, 2025,
in a private transaction, the Company entered into a securities purchase agreement (the &#x201c;SPA&#x201d;) with an institutional investor
(the &#x201c;Investor&#x201d;). Pursuant to the SPA, the Investor is expected, subject to the conditions relating to such purchase set forth
in the SPA, to purchase from the Company&#x2019;s senior secured convertible promissory notes in an aggregate principal amount of up to
$22,222,222 (the &#x201c;Convertible Notes&#x201d;) for a purchase price of up to $20,000,000, after a 10% original issue discount (&#x201c;OID&#x201d;).
As a result of the Business Combination, pursuant to the SPA, the Company issued a Convertible Note in the principal amount of $10,000,000
(the &#x201c;Initial Note&#x201d;) for a purchase price of $9,000,000, reflecting a 10% OID.&#160;The Initial Note matures on the date that
is 18-months from the closing of the Business Combination and is convertible at any time at the Investor&#x2019;s option at a conversion
price equal to the lower of $10 or 95% of the lowest daily volume-weighted average price per share of the post-combination company common
stock in the 10&#160;trading days prior to the original issue date of the Initial Note and shall be adjusted, without limitation, based
on down-round and most-favored nation (MFN) price and terms protections (the &#x201c;Conversion Price&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The SPA contemplates that additional
Convertible Notes will be purchased in multiple tranches:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Prior to the one-year anniversary of the Initial Closing Date,
subject to the conditions set forth in the SPA, the Company may request that the Investor purchase additional Convertible Notes having
an aggregate principal amount of up to $12,222,222 at a purchase price of $11,000,000 (reflecting a 10% OID), as follows:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(a)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Provided a registration statement has been filed for the
shares underlying the Initial Note, shares of combined company common stock, par value $0.0001 (&#x201c;New Profusa Common Stock&#x201d;)
have traded a volume of at least 15,000,000 shares in the aggregate, and no default or event of default has occurred, the Company may
call and thereby require the Investor to purchase Convertible Notes in the aggregate principal amount of $2,222,222 for a purchase price
of $2,000,000 (reflecting a 10% OID) (&#x201c;Second Purchase&#x201d;);&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(b)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Provided a registration statement is effective for the shares
underlying the Initial Note, New Profusa Common Stock has traded a volume of at least $35,000,000 in the aggregate after the $2,000,000
Second Purchase has closed, no default or event of default has occurred and the stock has traded at a trading price of no less than $4.00
for a period of five&#160;trading days preceding such purchase, the Company may call and thereby require the Investor to purchase Convertible
Notes in the aggregate principal amount of $5,555,555 for a purchase price of $5,000,000 (reflecting a 10% OID); and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(c)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Investor at its sole discretion may call from the Company
and thereby require the Company to sell an additional Convertible Note having an aggregate principal amount of $4,444,444 at a purchase
price of $4,000,000 (reflecting a 10% OID) to be purchased at any time within 12&#160;months of the Initial Closing.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As a result of the Business
Combination, the Company paid $90,000 at the Closing to an advisor for legal services in connection with the issuance of the Convertible
Note.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ck0001859807:NumberOfDaysForUnderwriterOptions contextRef="c173" id="ixv-40919">P30D</ck0001859807:NumberOfDaysForUnderwriterOptions>
    <ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="c800"
      decimals="0"
      id="ixv-40920"
      unitRef="shares">2475000</ck0001859807:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:UnderwritingExpenseRatio
      contextRef="c801"
      decimals="4"
      id="ixv-40921"
      unitRef="pure">0.0182</us-gaap:UnderwritingExpenseRatio>
    <ck0001859807:UnderwritingDiscountAmount contextRef="c155" decimals="0" id="ixv-40922" unitRef="usd">3450000</ck0001859807:UnderwritingDiscountAmount>
    <ck0001859807:InitialPublicOfferingGrossProceedPercentage
      contextRef="c155"
      decimals="4"
      id="ixv-40923"
      unitRef="pure">0.0368</ck0001859807:InitialPublicOfferingGrossProceedPercentage>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c802" decimals="0" id="ixv-40924" unitRef="usd">6986250</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <ck0001859807:BusinessCombinationPercentageRate
      contextRef="c629"
      decimals="4"
      id="ixv-40925"
      unitRef="pure">0.0368</ck0001859807:BusinessCombinationPercentageRate>
    <ck0001859807:CashPercentage
      contextRef="c629"
      decimals="3"
      id="ixv-40926"
      unitRef="pure">0.275</ck0001859807:CashPercentage>
    <ck0001859807:EquityPercentage
      contextRef="c629"
      decimals="3"
      id="ixv-40927"
      unitRef="pure">0.725</ck0001859807:EquityPercentage>
    <us-gaap:OtherCommitmentDueInSecondAndThirdYear contextRef="c803" decimals="0" id="ixv-40928" unitRef="usd">2000000</us-gaap:OtherCommitmentDueInSecondAndThirdYear>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c804" decimals="0" id="ixv-40929" unitRef="usd">900000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c805" decimals="0" id="ixv-40930" unitRef="usd">600000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c798" decimals="0" id="ixv-40931" unitRef="usd">500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:AssetsHeldInTrust
      contextRef="c806"
      decimals="-4"
      id="ixv-40932"
      unitRef="usd">1250000</us-gaap:AssetsHeldInTrust>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c806"
      decimals="2"
      id="ixv-40933"
      unitRef="usdPershares">1.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c631"
      decimals="0"
      id="ixv-40934"
      unitRef="shares">450000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c632"
      decimals="0"
      id="ixv-40935"
      unitRef="shares">37500</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c807"
      decimals="0"
      id="ixv-40936"
      unitRef="shares">569250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c732"
      decimals="0"
      id="ixv-40937"
      unitRef="shares">74250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c769"
      decimals="2"
      id="ixv-40938"
      unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c787" decimals="0" id="ixv-40939" unitRef="usd">6546375</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c155" id="ixv-40940">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <ck0001859807:LockupPeriod contextRef="c173" id="ixv-40941">P180D</ck0001859807:LockupPeriod>
    <us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
      contextRef="c808"
      decimals="3"
      id="ixv-40942"
      unitRef="pure">0.09</us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage>
    <us-gaap:IncreaseDecreaseInDeferredLeasingFees contextRef="c809" decimals="0" id="ixv-40943" unitRef="usd">968000</us-gaap:IncreaseDecreaseInDeferredLeasingFees>
    <us-gaap:PaymentsForFees contextRef="c810" decimals="0" id="ixv-40944" unitRef="usd">550000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c811" decimals="0" id="ixv-40945" unitRef="usd">418000</us-gaap:PaymentsForFees>
    <us-gaap:OtherExpenses contextRef="c811" decimals="0" id="ixv-40946" unitRef="usd">50000</us-gaap:OtherExpenses>
    <us-gaap:PaymentsForFees contextRef="c812" decimals="0" id="ixv-40947" unitRef="usd">750000</us-gaap:PaymentsForFees>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c813" decimals="0" id="ixv-40948" unitRef="usd">500000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c814" decimals="0" id="ixv-40949" unitRef="usd">500000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c815"
      decimals="2"
      id="ixv-40950"
      unitRef="usdPershares">2</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:PaymentsForFees contextRef="c816" decimals="0" id="ixv-40951" unitRef="usd">250000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c816" decimals="0" id="ixv-40952" unitRef="usd">250000</us-gaap:PaymentsForFees>
    <ck0001859807:PercentageOfNetProceeds
      contextRef="c817"
      decimals="2"
      id="ixv-40953"
      unitRef="pure">0.05</ck0001859807:PercentageOfNetProceeds>
    <us-gaap:PaymentsForFees contextRef="c817" decimals="0" id="ixv-40954" unitRef="usd">250000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c813" decimals="0" id="ixv-40955" unitRef="usd">500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c721" decimals="0" id="ixv-40956" unitRef="usd">22222222</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c722" decimals="0" id="ixv-40957" unitRef="usd">20000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c722"
      decimals="2"
      id="ixv-40958"
      unitRef="pure">0.10</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c818" decimals="0" id="ixv-40959" unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermPurchaseCommitmentAmount contextRef="c723" decimals="0" id="ixv-40960" unitRef="usd">9000000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c819"
      decimals="2"
      id="ixv-40961"
      unitRef="pure">0.10</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c820"
      decimals="0"
      id="ixv-40962"
      unitRef="usdPershares">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ck0001859807:WeightedAveragePricePerSharePercentage
      contextRef="c723"
      decimals="2"
      id="ixv-40963"
      unitRef="pure">0.95</ck0001859807:WeightedAveragePricePerSharePercentage>
    <ck0001859807:NumberOfTradingDay contextRef="c723" id="ixv-40964">P10Y</ck0001859807:NumberOfTradingDay>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c821" decimals="0" id="ixv-40965" unitRef="usd">12222222</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c822" decimals="0" id="ixv-40966" unitRef="usd">11000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c822"
      decimals="2"
      id="ixv-40967"
      unitRef="pure">0.10</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c823"
      decimals="4"
      id="ixv-40968"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="c823"
      decimals="0"
      id="ixv-40969"
      unitRef="shares">15000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c824" decimals="0" id="ixv-40970" unitRef="usd">2222222</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c825" decimals="0" id="ixv-40971" unitRef="usd">2000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c825"
      decimals="2"
      id="ixv-40972"
      unitRef="pure">0.10</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:CommonStockValue contextRef="c823" decimals="0" id="ixv-40973" unitRef="usd">35000000</us-gaap:CommonStockValue>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c826" decimals="0" id="ixv-40974" unitRef="usd">2000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <ck0001859807:TradingPricePerShare
      contextRef="c827"
      decimals="2"
      id="ixv-40975"
      unitRef="usdPershares">4</ck0001859807:TradingPricePerShare>
    <ck0001859807:NumberOfTradingDay contextRef="c827" id="ixv-40976">P5D</ck0001859807:NumberOfTradingDay>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c828" decimals="0" id="ixv-40978" unitRef="usd">5555555</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c829" decimals="0" id="ixv-40979" unitRef="usd">5000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c829"
      decimals="2"
      id="ixv-40980"
      unitRef="pure">0.10</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c830" decimals="0" id="ixv-40981" unitRef="usd">4444444</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c831" decimals="0" id="ixv-40982" unitRef="usd">4000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c831"
      decimals="2"
      id="ixv-40983"
      unitRef="pure">0.10</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:LegalFees contextRef="c173" decimals="0" id="ixv-40984" unitRef="usd">90000</us-gaap:LegalFees>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c173" id="ixv-36105">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;7 &#x2014;&#160;Stockholders&#x2019;
Deficit&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Preferred stock&lt;/i&gt;&lt;/b&gt;&#160;&#x2014;&#160;The
Company is authorized to issue&#160;1,000,000&#160;shares of preferred stock with a par value of $0.0001&#160;and with such designations,
rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.&#160;As of June&#160;30, 2025
and December&#160;31, 2024, there was &lt;span style="-sec-ix-hidden: hidden-fact-397"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-398"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-399"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-400"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preferred stock issued or outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Common Stock&#160;&lt;/i&gt;&lt;/b&gt;&#x2014;&#160;The
Company is authorized to issue a total of&#160;100,000,000&#160;shares of common stock at par value of $0.0001&#160;each. In April&#160;2021,
the Company issued&#160;5,175,000&#160;shares of common stock to its Sponsor for $25,000, or approximately $0.005&#160;per share. In October&#160;2021,
the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration&#160;862,500&#160;shares of common stock.&#160;On
December&#160;20, 2021,&#160;the Company effected a 1.1- for-1&#160;stock dividend of its common stock, resulting in an aggregate of 4,743,750
Founder Shares issued&#160;and outstanding.&#160;On December&#160;22, 2021, the Company has also issued&#160;450,000&#160;shares (Representative&#x2019;s
Shares) of common stock (which included&#160;37,500&#160;Representative Shares issued pursuant to the full exercise of the over-allotment
option) at the consummation of the IPO to&#160;I-Bankers&#160;and Dawson James (and/or their designees).&#160;As of June&#160;30, 2025
and December&#160;31, 2024, there were&#160;5,193,750 shares of common stock issued and outstanding, excluding&#160;101,777 and 687,519
shares of common stock subject to redemption, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Common stockholders of record
are entitled to one vote for each share held on all matters to be voted on by stockholders. Unless specified in the Company&#x2019;s amended
and restated certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange
rules, the affirmative vote of a majority of the Company&#x2019;s common stock that are voted is required to approve any such matter voted
on by the stockholders. There is no cumulative voting with respect to the election of directors, with the result that the holders of more
than&#160;50% of the shares voted for the election of directors can elect all of the directors (prior to consummation of the initial Business
Combination). The Company&#x2019;s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors
out of funds legally available therefor.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c155"
      decimals="0"
      id="ixv-40985"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c155"
      decimals="4"
      id="ixv-40986"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c155"
      decimals="0"
      id="ixv-40987"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c155"
      decimals="4"
      id="ixv-40988"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c636"
      decimals="0"
      id="ixv-40989"
      unitRef="shares">5175000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c637" decimals="0" id="ixv-40990" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c638"
      decimals="3"
      id="ixv-40991"
      unitRef="usdPershares">0.005</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c832"
      decimals="0"
      id="ixv-40992"
      unitRef="shares">862500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c833" id="ixv-40993">On
December&#160;20, 2021,&#160;the Company effected a 1.1- for-1&#160;stock dividend of its common stock</us-gaap:StockholdersEquityReverseStockSplit>
    <ck0001859807:FounderSharesIssued
      contextRef="c834"
      decimals="0"
      id="ixv-40994"
      unitRef="shares">4743750</ck0001859807:FounderSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c538"
      decimals="0"
      id="ixv-40995"
      unitRef="shares">450000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c537"
      decimals="0"
      id="ixv-40996"
      unitRef="shares">37500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:CommonStockSharesIssued
      contextRef="c155"
      decimals="0"
      id="ixv-40997"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c139"
      decimals="0"
      id="ixv-40998"
      unitRef="shares">5193750</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c155"
      decimals="0"
      id="ixv-40999"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c139"
      decimals="0"
      id="ixv-41000"
      unitRef="shares">5193750</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c155"
      decimals="0"
      id="ixv-41001"
      unitRef="shares">101777</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c139"
      decimals="0"
      id="ixv-41002"
      unitRef="shares">687519</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockVotingRights contextRef="c173" id="ixv-41003">one</us-gaap:CommonStockVotingRights>
    <ck0001859807:VotingSharesPercentage
      contextRef="c155"
      decimals="2"
      id="ixv-41004"
      unitRef="pure">0.50</ck0001859807:VotingSharesPercentage>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c173" id="ixv-36130">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;8 &#x2014;&#160;Fair Value Measurements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Fair value is defined as the
price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants
at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). The Company&#x2019;s financial instruments are classified as either
Level 1, Level 2 or Level 3. These tiers include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1, defined as observable inputs such as quoted prices
(unadjusted) for identical instruments in active markets;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2, defined as inputs other than quoted prices in active
markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices
for identical or similar instruments in markets that are not active; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3, defined as unobservable inputs in which little or
no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques
in which one or more significant inputs or significant value drivers are unobservable.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following tables present
information about the Company&#x2019;s assets and liabilities that are measured at fair value on June&#160;30, 2025 and December&#160;31,
2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Prices In&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Active&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Markets&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Observable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Unobservable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;1,935,561&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;1,274,549&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,795,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,795,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,939,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,939,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;227,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-407"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-408"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;227,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible Promissory Note&#160;&#x2013;&#160;Related Party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,288,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-409"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-410"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,288,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Securities Purchase Agreement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,878&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-411"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-412"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,878&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,443,689&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-413"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,795,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13,648,689&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Prices In&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Active&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Markets&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Observable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Unobservable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-414"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-415"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-416"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-417"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-418"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-419"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-420"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-421"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Convertible Promissory Note&#160;&#x2013;&#160;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-422"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-423"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,604,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-424"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,224,722&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Public Warrants, the Private
Placement Warrants and the Representative&#x2019;s Warrants were accounted for as liabilities in accordance with ASC&#160;815-40 and are
presented within liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception
and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated
statements of operations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company utilized a Monte
Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants at June&#160;30,
2025 and December&#160;31, 2024 was classified as Level 2 due to the lack of an active market. As of June&#160;30, 2025 and December&#160;31,
2024, the aggregate value of Public Warrants was $3,795,000 and $379,500, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company uses a Monte Carlo
simulation model to value the Private Placement Warrants and the Representative&#x2019;s Warrants. The Private Placement Warrants and the
Representative&#x2019;s Warrants were classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent
in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates
the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free
interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining
life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at June&#160;30, 2025 and December&#160;31, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De
minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De
minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at June&#160;30, 2025 and December&#160;31, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.28&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De
minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the securities purchase agreement were as follows at June&#160;30, 2025 and December&#160;31, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-429"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.59&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-430"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.84&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-431"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-432"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Fair value of Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-433"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides
a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the three and six&#160;months ended June&#160;30, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;316,670&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;146,950&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,385&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;158,335&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;440,850&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;34,155&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;475,005&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,498,150&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,545&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,691,695&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,939,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;227,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;3,166,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;71,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;213,077&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;229,586&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;279,205&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;21,632&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;300,837&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;124,908&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,676&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;134,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;404,113&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;31,308&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;435,421&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Convertible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Promissory&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Note&#160;&#x2013;&#160;related&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Fair value at December&#160;31, 2024&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;225,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;9,133,382&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,154,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;10,288,111&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Convertible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Promissory&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Note&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Principal proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;378,185&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(60,077&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,262,226&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds received through convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;330,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(66,021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,527,001&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s
convertible promissory note is valued using a compound option formula on the convertible feature and a present value of the host contract.
The valuation technique requires inputs that are both unobservable and significant to the overall fair value measurement. These inputs
reflect management&#x2019;s own assumption about the assumptions a market participant would use in pricing the working capital loan.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The convertible promissory
note was classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent in pricing models are assumptions
related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common
stock based on historical volatility that matches the expected remaining life of the note.
The risk-free interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for a maturity similar to the
expected remaining life of the note. The expected life of the note is assumed to be equivalent to their remaining contractual term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Securities&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Purchase&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Agreement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at February&#160;11, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-434"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of securities purchase agreement&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;23,487&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;23,487&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of securities purchase agreement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;170,391&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;193,878&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company utilizes a Monte
Carlo model to estimate the fair value of the conversion feature within the securities purchase agreement, which is required to be recorded
at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the
conversion feature are recognized as non-cash gains or losses in the accompanying condensed consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key assumptions in the
model relate to expected share-price volatility, risk-free interest rate, exercise price, expected term and the probability of occurrence
of the transaction. The expected volatility was based on the average volatility of special purpose acquisition companies that are searching
for an acquisition target. The risk-free interest rate is based on the U.S.&#160;Treasury zero-coupon yield curve on the grant date for
a maturity similar to the expected remaining life of the note. The expected life of the note is assumed to be equivalent to their remaining
contractual term.&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c173" id="ixv-36181">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following tables present
information about the Company&#x2019;s assets and liabilities that are measured at fair value on June&#160;30, 2025 and December&#160;31,
2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Prices In&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Active&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Markets&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Observable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Unobservable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;1,935,561&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;1,274,549&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,795,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,795,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,939,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,939,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;227,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-407"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-408"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;227,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible Promissory Note&#160;&#x2013;&#160;Related Party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,288,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-409"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-410"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,288,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Securities Purchase Agreement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,878&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-411"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-412"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,878&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,443,689&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-413"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,795,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13,648,689&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Prices In&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Active&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Markets&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Observable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Other&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Unobservable&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Inputs&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;(Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt"&gt;Cash held in trust&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-414"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-415"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-416"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-417"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-418"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-419"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&#160;&#x2013;&#160;Representative&#x2019;s Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-420"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-421"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Convertible Promissory Note&#160;&#x2013;&#160;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-422"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-423"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,604,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-424"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;379,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,224,722&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c835" decimals="0" id="ixv-41005" unitRef="usd">1935561</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c836" decimals="0" id="ixv-41006" unitRef="usd">1274549</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c777" decimals="0" id="ixv-41007" unitRef="usd">3795000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c840" decimals="0" id="ixv-41008" unitRef="usd">3795000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c768" decimals="0" id="ixv-41009" unitRef="usd">2939000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c844" decimals="0" id="ixv-41010" unitRef="usd">2939000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c845" decimals="0" id="ixv-41011" unitRef="usd">227700</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c848" decimals="0" id="ixv-41012" unitRef="usd">227700</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c849" decimals="0" id="ixv-41013" unitRef="usd">10288111</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c852" decimals="0" id="ixv-41014" unitRef="usd">10288111</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:SecuritiesPurchaseAgreementCurrent contextRef="c853" decimals="0" id="ixv-41015" unitRef="usd">193878</ck0001859807:SecuritiesPurchaseAgreementCurrent>
    <ck0001859807:SecuritiesPurchaseAgreementCurrent contextRef="c856" decimals="0" id="ixv-41016" unitRef="usd">193878</ck0001859807:SecuritiesPurchaseAgreementCurrent>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c853" decimals="0" id="ixv-41017" unitRef="usd">17443689</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c855" decimals="0" id="ixv-41018" unitRef="usd">3795000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c856" decimals="0" id="ixv-41019" unitRef="usd">13648689</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c857" decimals="0" id="ixv-41020" unitRef="usd">8330835</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c644" decimals="0" id="ixv-41021" unitRef="usd">8330835</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c607" decimals="0" id="ixv-41022" unitRef="usd">379500</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c649" decimals="0" id="ixv-41023" unitRef="usd">379500</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c593" decimals="0" id="ixv-41024" unitRef="usd">293900</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c654" decimals="0" id="ixv-41025" unitRef="usd">293900</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c704" decimals="0" id="ixv-41026" unitRef="usd">22770</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c658" decimals="0" id="ixv-41027" unitRef="usd">22770</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c858" decimals="0" id="ixv-41028" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c662" decimals="0" id="ixv-41029" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c858" decimals="0" id="ixv-41030" unitRef="usd">9604222</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c661" decimals="0" id="ixv-41031" unitRef="usd">379500</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c662" decimals="0" id="ixv-41032" unitRef="usd">9224722</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c777" decimals="0" id="ixv-41033" unitRef="usd">3795000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c607" decimals="0" id="ixv-41034" unitRef="usd">379500</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c173" id="ixv-36639">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the warrant liabilities were as follows at June&#160;30, 2025 and December&#160;31, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De
minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De
minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the convertible promissory note were as follows at June&#160;30, 2025 and December&#160;31, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31, &lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.28&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De
minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;De minimis&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key inputs into the Monte
Carlo simulation model for the securities purchase agreement were as follows at June&#160;30, 2025 and December&#160;31, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-429"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.59&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-430"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.84&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-431"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-432"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Fair value of Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-433"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c859"
      decimals="2"
      id="ixv-41035"
      unitRef="pure">4.22</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c689"
      decimals="2"
      id="ixv-41036"
      unitRef="pure">4.18</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c860"
      decimals="2"
      id="ixv-41037"
      unitRef="pure">0.61</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c691"
      decimals="2"
      id="ixv-41038"
      unitRef="pure">0.89</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c862"
      decimals="2"
      id="ixv-41039"
      unitRef="pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c695"
      decimals="2"
      id="ixv-41040"
      unitRef="pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c863"
      decimals="2"
      id="ixv-41041"
      unitRef="pure">12.52</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c697"
      decimals="2"
      id="ixv-41042"
      unitRef="pure">12.12</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c859"
      decimals="2"
      id="ixv-41043"
      unitRef="pure">4.28</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c689"
      decimals="2"
      id="ixv-41044"
      unitRef="pure">4.18</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c860"
      decimals="2"
      id="ixv-41045"
      unitRef="pure">0.05</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c691"
      decimals="2"
      id="ixv-41046"
      unitRef="pure">0.27</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c862"
      decimals="2"
      id="ixv-41047"
      unitRef="pure">11.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c695"
      decimals="2"
      id="ixv-41048"
      unitRef="pure">11.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c863"
      decimals="2"
      id="ixv-41049"
      unitRef="pure">12.52</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c697"
      decimals="2"
      id="ixv-41050"
      unitRef="pure">12.12</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c864"
      decimals="2"
      id="ixv-41051"
      unitRef="pure">3.83</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c866"
      decimals="2"
      id="ixv-41052"
      unitRef="pure">1.59</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c868"
      decimals="2"
      id="ixv-41053"
      unitRef="pure">4.84</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c870"
      decimals="2"
      id="ixv-41054"
      unitRef="pure">11.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c872"
      decimals="2"
      id="ixv-41055"
      unitRef="pure">12.52</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="c173" id="ixv-36911">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides
a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments that are measured at fair value on a recurring
basis for the three and six&#160;months ended June&#160;30, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;293,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;22,770&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;316,670&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;146,950&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,385&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;158,335&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;440,850&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;34,155&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;475,005&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,498,150&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,545&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,691,695&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,939,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;227,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;3,166,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Private &lt;br/&gt; Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Representative&#x2019;s &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;66,128&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,123&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;71,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;213,077&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;229,586&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;279,205&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;21,632&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;300,837&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;124,908&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,676&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;134,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;404,113&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;31,308&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;435,421&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c593" decimals="0" id="ixv-41056" unitRef="usd">293900</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c704" decimals="0" id="ixv-41057" unitRef="usd">22770</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c874" decimals="0" id="ixv-41058" unitRef="usd">316670</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c875" decimals="0" id="ixv-41059" unitRef="usd">146950</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c876" decimals="0" id="ixv-41060" unitRef="usd">11385</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c877" decimals="0" id="ixv-41061" unitRef="usd">158335</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c878" decimals="0" id="ixv-41062" unitRef="usd">440850</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c879" decimals="0" id="ixv-41063" unitRef="usd">34155</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c880" decimals="0" id="ixv-41064" unitRef="usd">475005</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c881" decimals="0" id="ixv-41065" unitRef="usd">2498150</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c882" decimals="0" id="ixv-41066" unitRef="usd">193545</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c883" decimals="0" id="ixv-41067" unitRef="usd">2691695</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c768" decimals="0" id="ixv-41068" unitRef="usd">2939000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c845" decimals="0" id="ixv-41069" unitRef="usd">227700</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c884" decimals="0" id="ixv-41070" unitRef="usd">3166700</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c699" decimals="0" id="ixv-41071" unitRef="usd">66128</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c700" decimals="0" id="ixv-41072" unitRef="usd">5123</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c885" decimals="0" id="ixv-41073" unitRef="usd">71251</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c886" decimals="0" id="ixv-41074" unitRef="usd">213077</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c887" decimals="0" id="ixv-41075" unitRef="usd">16509</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c888" decimals="0" id="ixv-41076" unitRef="usd">229586</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c889" decimals="0" id="ixv-41077" unitRef="usd">279205</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c890" decimals="0" id="ixv-41078" unitRef="usd">21632</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c891" decimals="0" id="ixv-41079" unitRef="usd">300837</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c892" decimals="0" id="ixv-41080" unitRef="usd">124908</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c893" decimals="0" id="ixv-41081" unitRef="usd">9676</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c894" decimals="0" id="ixv-41082" unitRef="usd">134584</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c895" decimals="0" id="ixv-41083" unitRef="usd">404113</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c896" decimals="0" id="ixv-41084" unitRef="usd">31308</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c897" decimals="0" id="ixv-41085" unitRef="usd">435421</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c173" id="ixv-37088">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Convertible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Promissory&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Note&#160;&#x2013;&#160;related&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;party&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Fair value at December&#160;31, 2024&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;8,908,052&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;225,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;9,133,382&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,154,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;10,288,111&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Convertible&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Promissory&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Note&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Fair value at December&#160;31, 2023&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;944,118&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Principal proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;378,185&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(60,077&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,262,226&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds received through convertible promissory note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;330,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of convertible promissory note&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(66,021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,527,001&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Securities&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Purchase&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;Agreement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at February&#160;11, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-434"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of securities purchase agreement&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;23,487&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Fair value at March&#160;31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;23,487&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of securities purchase agreement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;170,391&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Fair value at June&#160;30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;193,878&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c898" decimals="0" id="ixv-41086" unitRef="usd">8908052</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c899" decimals="0" id="ixv-41087" unitRef="usd">225330</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c900" decimals="0" id="ixv-41088" unitRef="usd">9133382</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c901" decimals="0" id="ixv-41089" unitRef="usd">1154729</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c902" decimals="0" id="ixv-41090" unitRef="usd">10288111</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c903" decimals="0" id="ixv-41091" unitRef="usd">944118</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c904" decimals="0" id="ixv-41092" unitRef="usd">378185</us-gaap:ProceedsFromConvertibleDebt>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c904" decimals="0" id="ixv-41093" unitRef="usd">-60077</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c905" decimals="0" id="ixv-41094" unitRef="usd">1262226</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c906" decimals="0" id="ixv-41095" unitRef="usd">330796</us-gaap:ProceedsFromConvertibleDebt>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c906" decimals="0" id="ixv-41096" unitRef="usd">-66021</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c907" decimals="0" id="ixv-41097" unitRef="usd">1527001</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c909" decimals="0" id="ixv-41098" unitRef="usd">23487</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c910" decimals="0" id="ixv-41099" unitRef="usd">23487</us-gaap:ConvertibleNotesPayableCurrent>
    <ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote contextRef="c911" decimals="0" id="ixv-41100" unitRef="usd">170391</ck0001859807:ChangeInFairValueOfConvertiblePromissoryNote>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c912" decimals="0" id="ixv-41101" unitRef="usd">193878</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c173" id="ixv-37274">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;9 &#x2014;&#160;Segment Information&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;ASC Topic&#160;280,&#160;&#x201c;Segment
Reporting,&#x201d; establishes standards for companies to report in their financial statement information about operating segments, products,
services, geographic areas, and major customers.&#160;Operating segments are defined as components of an enterprise that engage in business
activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is
regularly evaluated by the Company&#x2019;s chief operating decision maker, or group, in deciding how to allocate resources and assess
performance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s chief operating
decision maker (&#x201c;CODM&#x201d;) has been identified as its Chief Financial Officer, who reviews the assets, operating results, and
financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that there is only one reportable segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The CODM assesses performance
for the single segment and decides how to allocate resources based on net loss that also is reported on the statement of operations as
net loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company&#x2019;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net loss and total assets, which
include the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;As of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;As of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Trust Account&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,935,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-435"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;16,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Restricted Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-436"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;For the Three&#160;Months Ended&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;For the Six&#160;Months Ended&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Formation and operating costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;967,084&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;253,130&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,550,665&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;723,971&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest income earned on cash and marketable securities held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;108,520&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;225,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The key measures of segment
profit or loss reviewed by our CODM are interest earned on the Trust Account and general and administrative expenses. The CODM reviews
interest earned on the Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment
with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and
monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the
business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c173"
      decimals="0"
      id="ixv-41102"
      unitRef="pure">1</us-gaap:NumberOfReportableSegments>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="c173" id="ixv-41103">When evaluating the Company&#x2019;s performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net loss and total assets, which
include the following:&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;As of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;As of&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;December&#160;31,&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Trust Account&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,935,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,330,835&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-435"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;16,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Restricted Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-436"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;For the Three&#160;Months Ended&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;For the Six&#160;Months Ended&lt;span style="text-decoration:underline"&gt;&lt;br/&gt; &lt;/span&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Formation and operating costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;967,084&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;253,130&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,550,665&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;723,971&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest income earned on cash and marketable securities held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;108,520&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;225,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c155" decimals="0" id="ixv-41104" unitRef="usd">1935561</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c139" decimals="0" id="ixv-41105" unitRef="usd">8330835</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c139" decimals="0" id="ixv-41106" unitRef="usd">16204</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c155" decimals="0" id="ixv-41107" unitRef="usd">1751</us-gaap:RestrictedCashCurrent>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c151" decimals="0" id="ixv-41108" unitRef="usd">967084</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c167" decimals="0" id="ixv-41109" unitRef="usd">253130</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c173" decimals="0" id="ixv-41110" unitRef="usd">1550665</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c174" decimals="0" id="ixv-41111" unitRef="usd">723971</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InterestIncomeSecuritiesOtherUSGovernment contextRef="c151" decimals="0" id="ixv-41112" unitRef="usd">15159</us-gaap:InterestIncomeSecuritiesOtherUSGovernment>
    <us-gaap:InterestIncomeSecuritiesOtherUSGovernment contextRef="c167" decimals="0" id="ixv-41113" unitRef="usd">108520</us-gaap:InterestIncomeSecuritiesOtherUSGovernment>
    <us-gaap:InterestIncomeSecuritiesOtherUSGovernment contextRef="c173" decimals="0" id="ixv-41114" unitRef="usd">95084</us-gaap:InterestIncomeSecuritiesOtherUSGovernment>
    <us-gaap:InterestIncomeSecuritiesOtherUSGovernment contextRef="c174" decimals="0" id="ixv-41115" unitRef="usd">225184</us-gaap:InterestIncomeSecuritiesOtherUSGovernment>
    <us-gaap:SubsequentEventsTextBlock contextRef="c173" id="ixv-37440">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note&#160;10 &#x2014;&#160;Subsequent Events&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements
were issued. Based on the Company&#x2019;s review, the Company did not identify any subsequent events that would have required adjustment
or disclosure in the condensed consolidated financial statements, other than as previously disclosed, and as described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Consummation of Business Combination&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;11, 2025, the
Company, consummated its previously announced Business Combination Profusa, pursuant to that certain Merger Agreement and Plan of Reorganization,
dated as of November&#160;7, 2022 (as the same has been amended, supplemented or otherwise modified from time to time, the &#x201c;Merger
Agreement&#x201d;), between the Company, Profusa, and NV Profusa Merger Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary
of the Company (&#x201c;Merger Sub&#x201d; and, collectively, the &#x201c;Parties&#x201d;). The consummation of the Business Combination involved
the merger (the &#x201c;Merger&#x201d;) of Merger Sub with and into Profusa, pursuant to which, at the closing of the transactions contemplated
by the Merger Agreement (the &#x201c;Closing&#x201d;), the separate corporate existence of Merger Sub ceased, with Profusa as the surviving
corporation becoming a wholly-owned subsidiary of the Company, pursuant to the terms of the Merger Agreement and in accordance with the
DGCL.&#160;As a result of the Business Combination, the Company owns 100% of the outstanding common stock of Profusa. In connection with
the closing of the Business Combination, the Company changed its name from &#x201c;NorthView Acquisition Corporation&#x201d; to &#x201c;Profusa,
Inc.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Securities Purchase Agreement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On July&#160;28, 2025, the
Company entered into a Securities Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;) with Ascent Partners Fund LLC (the &#x201c;Purchaser&#x201d;).
Pursuant to the terms and conditions set forth in the Purchase Agreement, the Company may, from time to time and at its discretion, issue
and sell to the Purchaser shares of its common stock (the &#x201c;Purchased Securities&#x201d;) for an aggregate purchase price of up to
$100,000,000 (the &#x201c;Maximum Aggregate Purchase Price&#x201d;), subject to certain limitations and conditions described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Under the Purchase Agreement,
the Company may deliver advance notices (each, an &#x201c;Advance Notice&#x201d;) to the Purchaser to request the purchase of shares of
common stock, with each closing (a &#x201c;Closing&#x201d;) to occur on a&#160;trading day following the end of a 10 or fewer&#160;trading
day valuation period commencing on the trading date immediately following the delivery of the Advance Notice, or as determined by the
Purchaser. The purchase price per share at each Closing will be equal to 97% of the lowest volume-weighted average price (&#x201c;VWAP&#x201d;)
of the Company&#x2019;s common stock during the applicable valuation period, subject to a floor price and other adjustments as set forth
in the Purchase Agreement. The maximum purchase price at any single Closing is limited to the lower of (a)&#160;$5,000,000 or (b)&#160;100%
of the average daily traded value of the common stock for the five&#160;trading days immediately preceding such Closing.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Purchase Agreement contains
certain limitations, including that the aggregate number of shares issued under the Purchase Agreement may not exceed the number of shares
registered under the applicable registration statement or the exchange cap (generally 19.9% of the Company&#x2019;s outstanding common
stock as of the effective date), unless stockholder approval is obtained or as otherwise permitted by the rules of the principal trading
market. In addition, the Purchaser&#x2019;s beneficial ownership of the Company&#x2019;s common stock is limited to 9.99% of the outstanding
shares immediately after giving effect to any issuance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Purchase Agreement also
provides for the issuance of a warrant to the Purchaser for the purchase of 900,000 shares of common stock, and includes a Registration
Rights Agreement, Lock-Up Agreements from the Company&#x2019;s officers and directors, and a Transfer Agent Instruction Letter. The Company
is required to reserve sufficient shares of common stock to satisfy its obligations under the Purchase Agreement and to maintain the listing
of its common stock on its principal trading market.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c913"
      decimals="2"
      id="ixv-41116"
      unitRef="pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c914" decimals="0" id="ixv-41117" unitRef="usd">100000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice
      contextRef="c915"
      decimals="2"
      id="ixv-41118"
      unitRef="pure">0.97</ck0001859807:PercentageOfLowestVolumeWeightedAveragePrice>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c916" decimals="0" id="ixv-41119" unitRef="usd">5000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ck0001859807:PercentageOfAverageDailyTradedValueOfCommonStock
      contextRef="c915"
      decimals="2"
      id="ixv-41120"
      unitRef="pure">1</ck0001859807:PercentageOfAverageDailyTradedValueOfCommonStock>
    <ck0001859807:NumberOfTradingDays contextRef="c915" id="ixv-41121">P5D</ck0001859807:NumberOfTradingDays>
    <ck0001859807:PercentageOfLimitForOutstandingCommonStock
      contextRef="c915"
      decimals="4"
      id="ixv-41123"
      unitRef="pure">0.0999</ck0001859807:PercentageOfLimitForOutstandingCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c917"
      decimals="0"
      id="ixv-41124"
      unitRef="shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:OtherReceivables
      contextRef="c1"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c1"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c1"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c2"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c1"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c2"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherReceivables
      contextRef="c11"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherReceivables
      contextRef="c1"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c11"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c1"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c15"
      decimals="3"
      id="hidden-fact-10"
      unitRef="usdPershares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c9"
      decimals="3"
      id="hidden-fact-11"
      unitRef="usdPershares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:CommonStockValue
      contextRef="c11"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c1"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PrepaidTaxes
      contextRef="c17"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="c16"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AdvanceFromProfusa
      contextRef="c17"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="c16"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="c16"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c16"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c16"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c17"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c16"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c17"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c16"
      id="hidden-fact-24"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c17"
      id="hidden-fact-25"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c16"
      id="hidden-fact-26"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c17"
      id="hidden-fact-27"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="c16"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="c16"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:PrepaidFranchiseTax
      contextRef="c16"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:SecuritiesPurchaseAgreementCurrent
      contextRef="c16"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonRedemptionValue
      contextRef="c16"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c16"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c20"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c16"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20"
      id="hidden-fact-39"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c16"
      id="hidden-fact-40"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20"
      id="hidden-fact-41"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c16"
      id="hidden-fact-42"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="c24"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="c0"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="c0"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement
      contextRef="c32"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ChangeInFairValueOfSecuritiesPurchaseAgreement
      contextRef="c34"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c42"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c46"
      id="hidden-fact-49"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c46"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c47"
      id="hidden-fact-51"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c47"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c48"
      id="hidden-fact-53"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c48"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c49"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c51"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c46"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c47"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c48"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c49"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c51"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c46"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c47"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c48"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c49"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c50"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c55"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c55"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c58"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c59"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c60"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c61"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c62"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c63"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c22"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c58"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c59"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c60"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c61"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c63"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c58"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c59"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c60"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c61"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c62"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c67"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c55"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c70"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c71"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c72"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c73"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c75"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c70"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c71"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c72"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c73"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c74"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c80"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c67"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c94"
      id="hidden-fact-100"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c95"
      id="hidden-fact-101"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c96"
      id="hidden-fact-102"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c97"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c99"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c94"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c95"
      id="hidden-fact-106"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c96"
      id="hidden-fact-107"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c97"
      id="hidden-fact-108"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c98"
      id="hidden-fact-109"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c104"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c108"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c109"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c110"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c111"
      id="hidden-fact-114"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c113"
      id="hidden-fact-115"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c108"
      id="hidden-fact-116"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c109"
      id="hidden-fact-117"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c110"
      id="hidden-fact-118"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c111"
      id="hidden-fact-119"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c112"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c117"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c121"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c124"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c125"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c124"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c125"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c124"
      id="hidden-fact-127"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c125"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c129"
      id="hidden-fact-129"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c129"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c132"
      id="hidden-fact-131"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c133"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c132"
      id="hidden-fact-133"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c133"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c132"
      id="hidden-fact-135"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c133"
      id="hidden-fact-136"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c137"
      id="hidden-fact-137"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c137"
      id="hidden-fact-138"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c140"
      id="hidden-fact-139"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c141"
      id="hidden-fact-140"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c140"
      id="hidden-fact-141"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c141"
      id="hidden-fact-142"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c140"
      id="hidden-fact-143"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c141"
      id="hidden-fact-144"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c145"
      id="hidden-fact-145"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c148"
      id="hidden-fact-146"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c149"
      id="hidden-fact-147"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c148"
      id="hidden-fact-148"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c149"
      id="hidden-fact-149"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c148"
      id="hidden-fact-150"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c149"
      id="hidden-fact-151"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c153"
      id="hidden-fact-152"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c129"
      id="hidden-fact-153"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c156"
      id="hidden-fact-154"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c157"
      id="hidden-fact-155"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c156"
      id="hidden-fact-156"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ExciseTaxLiabilityInConnectionWithStockRedemptions
      contextRef="c157"
      id="hidden-fact-157"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c156"
      id="hidden-fact-158"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c157"
      id="hidden-fact-159"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c161"
      id="hidden-fact-160"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c164"
      id="hidden-fact-161"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:AccretionOfCommonStockToRedemptionValue
      contextRef="c165"
      id="hidden-fact-162"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c164"
      id="hidden-fact-163"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c165"
      id="hidden-fact-164"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c169"
      id="hidden-fact-165"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="c23"
      id="hidden-fact-166"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c22"
      id="hidden-fact-167"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c22"
      id="hidden-fact-168"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="c22"
      id="hidden-fact-169"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="c23"
      id="hidden-fact-170"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="c22"
      id="hidden-fact-171"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c22"
      id="hidden-fact-172"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="c0"
      id="hidden-fact-173"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c0"
      id="hidden-fact-174"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c0"
      id="hidden-fact-175"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="c0"
      id="hidden-fact-176"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="c127"
      id="hidden-fact-177"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="c135"
      id="hidden-fact-178"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="c127"
      id="hidden-fact-179"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ReclassificationOfCommonStockSubjectToRedemptionToCommonStockToBeRedeemed
      contextRef="c135"
      id="hidden-fact-180"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ChangesInFairValueOfSecuritiesPurchaseAgreement
      contextRef="c174"
      id="hidden-fact-181"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="c173"
      id="hidden-fact-182"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:IncreaseDecreaseInPrepaidFranchiseTaxes
      contextRef="c174"
      id="hidden-fact-183"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="c174"
      id="hidden-fact-184"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="c173"
      id="hidden-fact-185"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c173"
      id="hidden-fact-186"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="c174"
      id="hidden-fact-187"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:RedemptionPaymentsDueToRedeemingStockholders
      contextRef="c174"
      id="hidden-fact-188"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="c139"
      id="hidden-fact-189"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="c131"
      id="hidden-fact-190"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c155"
      id="hidden-fact-191"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="c171"
      id="hidden-fact-192"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c189"
      id="hidden-fact-193"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c190"
      id="hidden-fact-194"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c189"
      id="hidden-fact-195"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c190"
      id="hidden-fact-196"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c193"
      id="hidden-fact-197"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c194"
      id="hidden-fact-198"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c193"
      id="hidden-fact-199"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c194"
      id="hidden-fact-200"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c197"
      id="hidden-fact-201"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdvanceRoyalties
      contextRef="c1"
      id="hidden-fact-202"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:PrepaidLegal
      contextRef="c2"
      id="hidden-fact-203"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PrepaidInsurance
      contextRef="c2"
      id="hidden-fact-204"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c297"
      id="hidden-fact-205"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c301"
      id="hidden-fact-206"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c305"
      id="hidden-fact-207"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c301"
      id="hidden-fact-208"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c302"
      id="hidden-fact-209"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c303"
      id="hidden-fact-210"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c305"
      id="hidden-fact-211"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c301"
      id="hidden-fact-212"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c303"
      id="hidden-fact-213"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c304"
      id="hidden-fact-214"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c305"
      id="hidden-fact-215"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c302"
      id="hidden-fact-216"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c304"
      id="hidden-fact-217"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c305"
      id="hidden-fact-218"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c311"
      id="hidden-fact-219"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c314"
      id="hidden-fact-220"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c315"
      id="hidden-fact-221"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c311"
      id="hidden-fact-222"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c312"
      id="hidden-fact-223"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c314"
      id="hidden-fact-224"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c315"
      id="hidden-fact-225"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c311"
      id="hidden-fact-226"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c313"
      id="hidden-fact-227"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c314"
      id="hidden-fact-228"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c315"
      id="hidden-fact-229"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c312"
      id="hidden-fact-230"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c313"
      id="hidden-fact-231"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c314"
      id="hidden-fact-232"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c315"
      id="hidden-fact-233"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c316"
      id="hidden-fact-234"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c317"
      id="hidden-fact-235"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c318"
      id="hidden-fact-236"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c319"
      id="hidden-fact-237"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c320"
      id="hidden-fact-238"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:FairValueRemeasurement
      contextRef="c321"
      id="hidden-fact-239"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:FairValueRemeasurement
      contextRef="c274"
      id="hidden-fact-240"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="c188"
      id="hidden-fact-241"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:BusinessDays contextRef="c217" id="hidden-fact-242">P5Y</ck0001859807:BusinessDays>
    <ck0001859807:BusinessDays contextRef="c254" id="hidden-fact-243">P5Y</ck0001859807:BusinessDays>
    <us-gaap:Dividends
      contextRef="c22"
      id="hidden-fact-244"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted
      contextRef="c22"
      id="hidden-fact-245"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c22"
      id="hidden-fact-246"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c22"
      id="hidden-fact-247"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised
      contextRef="c22"
      id="hidden-fact-248"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c22"
      id="hidden-fact-249"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c22"
      id="hidden-fact-250"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled
      contextRef="c22"
      id="hidden-fact-251"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c22"
      id="hidden-fact-252"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c22"
      id="hidden-fact-253"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c22" id="hidden-fact-254">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c354"
      id="hidden-fact-255"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c355"
      id="hidden-fact-256"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationTaxContingenciesOther
      contextRef="c22"
      id="hidden-fact-257"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationTaxContingenciesOther
      contextRef="c23"
      id="hidden-fact-258"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c22"
      id="hidden-fact-259"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c23"
      id="hidden-fact-260"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c22"
      id="hidden-fact-261"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c23"
      id="hidden-fact-262"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c22"
      id="hidden-fact-263"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c23"
      id="hidden-fact-264"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c22"
      id="hidden-fact-265"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c23"
      id="hidden-fact-266"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c22"
      id="hidden-fact-267"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c23"
      id="hidden-fact-268"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="c1"
      id="hidden-fact-269"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="c2"
      id="hidden-fact-270"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c381"
      id="hidden-fact-271"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c382"
      id="hidden-fact-272"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c381"
      id="hidden-fact-273"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c382"
      id="hidden-fact-274"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c385"
      id="hidden-fact-275"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="c386"
      id="hidden-fact-276"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c385"
      id="hidden-fact-277"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c386"
      id="hidden-fact-278"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c413"
      id="hidden-fact-279"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c445"
      id="hidden-fact-280"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c447"
      id="hidden-fact-281"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c448"
      id="hidden-fact-282"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c413"
      id="hidden-fact-283"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c445"
      id="hidden-fact-284"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c446"
      id="hidden-fact-285"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c447"
      id="hidden-fact-286"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c448"
      id="hidden-fact-287"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c413"
      id="hidden-fact-288"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c446"
      id="hidden-fact-289"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c447"
      id="hidden-fact-290"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c448"
      id="hidden-fact-291"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c445"
      id="hidden-fact-292"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c447"
      id="hidden-fact-293"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c448"
      id="hidden-fact-294"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c449"
      id="hidden-fact-295"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c450"
      id="hidden-fact-296"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c451"
      id="hidden-fact-297"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c452"
      id="hidden-fact-298"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c453"
      id="hidden-fact-299"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c415"
      id="hidden-fact-300"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c456"
      id="hidden-fact-301"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="c457"
      id="hidden-fact-302"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c415"
      id="hidden-fact-303"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c454"
      id="hidden-fact-304"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c456"
      id="hidden-fact-305"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="c457"
      id="hidden-fact-306"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c415"
      id="hidden-fact-307"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c455"
      id="hidden-fact-308"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c456"
      id="hidden-fact-309"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c457"
      id="hidden-fact-310"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c454"
      id="hidden-fact-311"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c455"
      id="hidden-fact-312"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c456"
      id="hidden-fact-313"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c457"
      id="hidden-fact-314"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c458"
      id="hidden-fact-315"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c459"
      id="hidden-fact-316"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c460"
      id="hidden-fact-317"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c461"
      id="hidden-fact-318"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="c462"
      id="hidden-fact-319"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:FairValueRemeasurement
      contextRef="c465"
      id="hidden-fact-320"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:FairValueRemeasurement
      contextRef="c467"
      id="hidden-fact-321"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="c465"
      id="hidden-fact-322"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="c466"
      id="hidden-fact-323"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentInterestRate
      contextRef="c45"
      id="hidden-fact-324"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c22"
      id="hidden-fact-325"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c0"
      id="hidden-fact-326"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockDividendsShares
      contextRef="c100"
      id="hidden-fact-327"
      unitRef="shares"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised
      contextRef="c0"
      id="hidden-fact-328"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c0"
      id="hidden-fact-329"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      id="hidden-fact-330"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExpired
      contextRef="c0"
      id="hidden-fact-331"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c0"
      id="hidden-fact-332"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      id="hidden-fact-333"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsGranted
      contextRef="c26"
      id="hidden-fact-334"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c26"
      id="hidden-fact-335"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c26"
      id="hidden-fact-336"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsExercised
      contextRef="c26"
      id="hidden-fact-337"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c26"
      id="hidden-fact-338"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c26"
      id="hidden-fact-339"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ck0001859807:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForOptionsCancelled
      contextRef="c26"
      id="hidden-fact-340"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c26"
      id="hidden-fact-341"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c26"
      id="hidden-fact-342"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c481" id="hidden-fact-343">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c0" id="hidden-fact-344">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c495"
      id="hidden-fact-345"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c499"
      id="hidden-fact-346"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="c501"
      id="hidden-fact-347"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="c501"
      id="hidden-fact-348"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="c502"
      id="hidden-fact-349"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="c503"
      id="hidden-fact-350"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="c503"
      id="hidden-fact-351"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c503"
      id="hidden-fact-352"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="c0" id="hidden-fact-353">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <ck0001859807:NumberOfTradingDays contextRef="c532" id="hidden-fact-354">P5Y</ck0001859807:NumberOfTradingDays>
    <us-gaap:CommonStockSharesIssued
      contextRef="c515"
      decimals="0"
      id="hidden-fact-355"
      unitRef="shares">241567</us-gaap:CommonStockSharesIssued>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c597"
      id="hidden-fact-356"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c139" id="hidden-fact-357">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c139"
      id="hidden-fact-358"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c139"
      id="hidden-fact-359"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c131"
      id="hidden-fact-360"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c131"
      id="hidden-fact-361"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c645"
      id="hidden-fact-362"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c646"
      id="hidden-fact-363"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c648"
      id="hidden-fact-364"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c650"
      id="hidden-fact-365"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c652"
      id="hidden-fact-366"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c653"
      id="hidden-fact-367"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c656"
      id="hidden-fact-368"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c657"
      id="hidden-fact-369"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c660"
      id="hidden-fact-370"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c661"
      id="hidden-fact-371"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c663"
      id="hidden-fact-372"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c668"
      id="hidden-fact-373"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c669"
      id="hidden-fact-374"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c672"
      id="hidden-fact-375"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c673"
      id="hidden-fact-376"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c675"
      id="hidden-fact-377"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c676"
      id="hidden-fact-378"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c679"
      id="hidden-fact-379"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c680"
      id="hidden-fact-380"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c683"
      id="hidden-fact-381"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c684"
      id="hidden-fact-382"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c687"
      id="hidden-fact-383"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c693"
      id="hidden-fact-384"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c694"
      id="hidden-fact-385"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c693"
      id="hidden-fact-386"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c694"
      id="hidden-fact-387"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c715"
      id="hidden-fact-388"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
      contextRef="c139"
      id="hidden-fact-389"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c139"
      id="hidden-fact-390"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c135"
      id="hidden-fact-391"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c127"
      id="hidden-fact-392"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="c139"
      id="hidden-fact-393"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="c167"
      id="hidden-fact-394"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="c174"
      id="hidden-fact-395"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c155" id="hidden-fact-396">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c155"
      id="hidden-fact-397"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c139"
      id="hidden-fact-398"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c155"
      id="hidden-fact-399"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c139"
      id="hidden-fact-400"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c837"
      id="hidden-fact-401"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c838"
      id="hidden-fact-402"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c839"
      id="hidden-fact-403"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c841"
      id="hidden-fact-404"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c842"
      id="hidden-fact-405"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c843"
      id="hidden-fact-406"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c846"
      id="hidden-fact-407"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c847"
      id="hidden-fact-408"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c850"
      id="hidden-fact-409"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c851"
      id="hidden-fact-410"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:SecuritiesPurchaseAgreementCurrent
      contextRef="c854"
      id="hidden-fact-411"
      unitRef="usd"
      xsi:nil="true"/>
    <ck0001859807:SecuritiesPurchaseAgreementCurrent
      contextRef="c855"
      id="hidden-fact-412"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c854"
      id="hidden-fact-413"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c645"
      id="hidden-fact-414"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="c646"
      id="hidden-fact-415"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c648"
      id="hidden-fact-416"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c650"
      id="hidden-fact-417"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c652"
      id="hidden-fact-418"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c653"
      id="hidden-fact-419"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c656"
      id="hidden-fact-420"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c657"
      id="hidden-fact-421"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c660"
      id="hidden-fact-422"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c661"
      id="hidden-fact-423"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c660"
      id="hidden-fact-424"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c861"
      id="hidden-fact-425"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c693"
      id="hidden-fact-426"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c861"
      id="hidden-fact-427"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c693"
      id="hidden-fact-428"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c865"
      id="hidden-fact-429"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c867"
      id="hidden-fact-430"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c869"
      id="hidden-fact-431"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c871"
      id="hidden-fact-432"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="c873"
      id="hidden-fact-433"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c908"
      id="hidden-fact-434"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c155"
      id="hidden-fact-435"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="c139"
      id="hidden-fact-436"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-41564">0001859807</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-41565">false</dei:AmendmentFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-17"
          xlink:label="hidden-fact-17"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In connection with the special meeting of stockholders to vote on extending the Combination Period, on
December 21, 2023, 140,663 shares of the Company&#x2019;s common stock were redeemed at a per share price of $11.13. In January 2024, $1,565,078
was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company has recorded a liability
of $1,565,078 as common stock to be redeemed and reduced common stock subject to possible redemption as of December 31, 2023 on the consolidated
balance sheet.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-17"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-255"
          xlink:label="hidden-fact-255"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-255"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of
SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number
of common stock is not determinable.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-345"
          xlink:label="hidden-fact-345"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-346"
          xlink:label="hidden-fact-346"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Tasly Convertible Notes issued between June and August&#160;2023 and completed in February&#160;2024
are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion
is not currently estimable.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-345"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-346"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other expenses includes small balances of research materials
and supplies along with insurance costs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>ea025858001ex-fee_profusa_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-08</startDate>
            <endDate>2025-10-08</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-10-08</startDate>
            <endDate>2025-10-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-1</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001859807</dei:EntityCentralIndexKey>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_004" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_005">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_006">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">S-1</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">Profusa, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_009">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_010">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_011">Common Stock, $0.0001 par value per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_012">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_013"
      unitRef="shares">42594048</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">0.32</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">13630095.36</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="USD">2086.77</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_018"
      unitRef="USD">13630095.36</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_019"
      unitRef="USD">2086.77</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_020"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_021"
      unitRef="USD">2086.77</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_022">Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act of 1933, as amended, based upon the average of the high and low prices for a share of the registrant&#x2019;s common stock as reported on The NASDAQ Stock Market on October 3, 2025.&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder for the selling shareholders include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
